Page 1
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date: Sep. 2024 

# **Drug Master File of** **Finerenone**

#### **DMF-001**



Signature/Stamp: 



Date: 



Place: Changsha City, China 

### **Hinye Pharmaceutical Co., Ltd.**



Finerenone 

Confidential Hinye Pharmaceutical Co., Ltd. 



Page 1 of 542 





Page 2
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date: Sep. 2024 

## **Table of Contents**



**Table of Contents.............................................................................................................................. 2** 



**3.2.S.1 General Information.........................................................................................................4** 



3.2.S.1.1 Nomenclature.......................................................................................................... 4 



3.2.S.1.2 Structure...................................................................................................................5 



**3.2.S.2 Manufacture.........................................................................................................................7** 



3.2.S.2.1 Manufacturer............................................................................................................. 7 



3.2.S.2.2 Description of Manufacturing Process and Process Controls................ 8 



3.2.S.2.3 Control of Materials............................................................................................ 10 



3.2.S.2.6 Manufacturing Process Development...........................................................11 



**3.2.S.3 Characterization............................................................................................................. 13** 



3.2.S.3.1 Elucidation of Structure and other Characteristics................................13 



3.2.S.3.2 Impurities...............................................................................................................86 



**3.2.S.4** **Control of Drug Substance....................................................................................143** 



3.2.S.4.1 Specification.......................................................................................................... 143 



3.2.S.4.2 Analytical Procedures......................................................................................145 



3.2.S.4.3 Validation of Analytical Procedure................................................................ 153 



3.2.S.4.4 Batch Analyses.................................................................................................. 424 



3.2.S.4.5 Justification of Specification.........................................................................430 



**3.2.S.5** **Reference Standards or Materials..................................................................... 433** 



**3.2.S.6** **Container Closure System.................................................................................... 501** 



I. Description of Container Closure System.................................................................. 501 



II. Specification of Packaging Materials.......................................................................... 501 



Finerenone 

Confidential Hinye Pharmaceutical Co., Ltd. 



Page 2 of 542 





Page 3
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date: Sep. 2024 



III. Annexes: COAs..................................................................................................................509 



**3.2.S.7 Stability............................................................................................................................** **510** 



3.2.S.7.1 Stability Summary and Conclusions......................................................... 510 



3.2.S.7.2 Post-approval Stability Protocol and Stability Commitment............. 514 



3.2.S.7.3 Stability Data......................................................................................................518 



Finerenone 

Confidential Hinye Pharmaceutical Co., Ltd. 



Page 3 of 542 





Page 4
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date: Sep. 2024 



**3.2.S.1 General Information** 



**3.2.S.1.1** **Nomenclature** 



**Recommended International Nonproprietary Name (INN)** 



Finerenone 



**European Pharmacopoeia monograph name** 



N/A 



**United States Adopted Name (USAN)** 



Finerenone 



**Chemical name** 



(4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6- 



naphthyridine-3-carboxamide 



**Company code** 



YA2304 



**Chemical Abstracts Service (CAS) registry number** 



1050477-31-0 



Finerenone 

Confidential Hinye Pharmaceutical Co., Ltd. 



Page 4 of 542 





Page 5
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date: Sep. 2024 



**3.2.S.1.2** **Structure** 



**Structure formula** 



**Molecular formula** 



C21H22N4O3 



**Relative molecular mass (Mr)** 



378.43 



**Stereochemistry** 



The molecule of Finerenone contains one chiral centers at C-9. The active 



substance has absolute configuration (S) for the C-9 positions. 



Finerenone 

Confidential Hinye Pharmaceutical Co., Ltd. 



Page 5 of 542 





Page 6
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date: Sep. 2024 



**3.2.S.1.3** **General Properties** 



















------------------------------------------------------------------------------------------------------------------------
|Appearance                   |White to yellow powder                                                                  |
|-----------------------------|----------------------------------------------------------------------------------------|
|Melting point                |Approximately 252 ℃                                                                     |
|-----------------------------|----------------------------------------------------------------------------------------|
|Solubility                   |Dissolved in methanol, slightly soluble inethanol, acetonitrile, andacetone, slightly   |
|                             |soluble inisopropanol, almostinsoluble in water                                         |
|-----------------------------|----------------------------------------------------------------------------------------|
|Hygroscopicity               |Itis non-hygroscopic.                                                                   |
|-----------------------------|----------------------------------------------------------------------------------------|
|hydrate                      |This product does not contain crystal water.                                            |
|-----------------------------|----------------------------------------------------------------------------------------|
|Dissociation constant [(pKa)]|4.39                                                                                    |
|-----------------------------|----------------------------------------------------------------------------------------|
|partition coefficient        |LogD（1-Octanol/buffer solution pH 2.4）=0.4 LogD（1-Octanol/buffer solution pH         |
|                             |7.4）=2.8                                                                               |
|-----------------------------|----------------------------------------------------------------------------------------|
|BCS classification           |ClassⅡ                                                                                  |
------------------------------------------------------------------------------------------------------------------------

Finerenone 

Confidential Hinye Pharmaceutical Co., Ltd. 



Page 6 of 542 





Page 7
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date: Sep. 2024 



**3.2.S.2 Manufacture** 



**3.2.S.2.1 Manufacturer** 



**Manufacturer** 



Name: Hinye Pharmaceutical Co., Ltd. 



DUNS Number: 526215965 



Address: No.109, Kangtian Road, Changsha National Biological Industrial Base, 



Hunan Province, China 



Telephone Number: +86-731-82728186 



Fax Number: +86-731-82728064 



Post Code: 410331 



**Manufacturing Site** 



Name: Hinye Pharmaceutical Co., Ltd. 



DUNS Number: 526215965 



Address: No.109, Kangtian Road, Changsha National Biological Industrial Base, 



Hunan Province, China 



Telephone Number: +86-731-82728186 



Fax Number: +86-731-82728064 



Post Code: 410331 



**Responsibility of manufacturer** 



Hinye Pharmaceutical Co., Ltd. has the full responsibility of the manufacture, 



packaging and testing of Finerenone. 



Finerenone 

Confidential Hinye Pharmaceutical Co., Ltd. 



Page 7 of 542 





Page 8
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date: Sep. 2024 



**3.2.S.2.2** **Description of Manufacturing Process and Process Controls** 



**3.2.S.2.2.1** **Synthetic Process of the Manufacturing Process** 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 8 of 542 





Page 9
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date: Sep. 2024 






















































--------------------------------------------------------------------------------------------------------------------------
|CDI       |N. N-carbonyldiimidazole                                                                           |530-62-1 |
|----------|---------------------------------------------------------------------------------------------------|---------|
|DMAP      |4-Dimethylaminopyridine                                                                            |1122-58-3|
|----------|---------------------------------------------------------------------------------------------------|---------|
|HMDS      |Hexamethyldisilazane                                                                               |999-97-3 |
|----------|---------------------------------------------------------------------------------------------------|---------|
|YA2304- 1 |4-cyano-2-methoxybenzaldehyde                                                                      |21962-45-|
|          |                                                                                                   |8        |
|----------|---------------------------------------------------------------------------------------------------|---------|
|YA2304- 2 |Ethyl 2-cyanoacetoacetate                                                                          |65193-87-|
|          |                                                                                                   |5        |
|----------|---------------------------------------------------------------------------------------------------|---------|
|YA2304- 4 |4-amino-5-methyl-2-hydroxypyridine                                                                 |95306-64-|
|          |                                                                                                   |2        |
|----------|---------------------------------------------------------------------------------------------------|---------|
|YA2304- 10|D - (+) - Dibenzoyl TartaricAcid                                                                   |17026-42-|
|          |                                                                                                   |5        |
|----------|---------------------------------------------------------------------------------------------------|---------|
|YA2304- 3 |2-cyanoethyl 2- (4-cyano-2-methoxybenzylidene) -3-oxobutyricacidester                              |1050477-3|
|          |                                                                                                   |9-8      |
|----------|---------------------------------------------------------------------------------------------------|---------|
|YA2304- 5 |4- (4-cyano-2-methoxyphenyl)                                                                       |1050477-4|
|          |-2,8-dimethyl-5-oxo-1,4,5,6-tetrahydro-1,6-naphthalene-3-carboxylicacid 2-cyanoethylester          |3-4      |
|----------|---------------------------------------------------------------------------------------------------|---------|
|YA2304- 6 |4- (4-cyano-2-methoxyphenyl) -5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthalene-3-                 |1050477-4|
|          |carboxylicacid2-cyanoethylester                                                                    |4-5      |
|----------|---------------------------------------------------------------------------------------------------|---------|
|YA2304- 7 |4- (4-cyano-2-methoxyphenyl) -5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthalene-3- carboxylicacid  |1050477-4|
|          |                                                                                                   |5-6      |
|----------|---------------------------------------------------------------------------------------------------|---------|
|YA2304- 8 |4- (4-cyano-2-methoxyphenyl) -5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthalene-3- carboxamide     |1050477-2|
|          |                                                                                                   |7-4      |
|----------|---------------------------------------------------------------------------------------------------|---------|
|YA2304- 9 |Non maleketoneD - (+) - dibenzoyl tartrate                                                         |N/A      |
|----------|---------------------------------------------------------------------------------------------------|---------|
|YA2304- CP|(4S) -4- (4-cyano-2-methoxyphenyl) -5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthalene-3-           |1050477-3|
|          |carboxamide                                                                                        |1-0      |
|----------|---------------------------------------------------------------------------------------------------|---------|
|YA2304    |(4S) -4- (4-cyano-2-methoxyphenyl) -5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthalene-3-           |1050477-3|
|          |carboxamide                                                                                        |1-0      |
--------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 9 of 542 





Page 10
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.2.3** **Control of Materials** 



**3.2.S.2.3.1** **Materiased in the Manufacturing of the Drug Substance** 



Table 3.2.S.2.3-1 Materials Used in the Manufacturing of the Drug Substance 









---------------------------------------------------------------------------------------
|Starting materials|4-cyano-2-methoxybenzaldehyde (YA2304-1)     |Industrial chemicals|
|------------------|---------------------------------------------|--------------------|
|Starting materials|Ethyl 2-cyanoacetoacetate (YA2304-2)         |Industrial chemicals|
|------------------|---------------------------------------------|--------------------|
|Starting materials|4-amino-5-methyl-2-hydroxypyridine (YA2304-4)|Industrial chemicals|
|------------------|---------------------------------------------|--------------------|
|Reagents          |piperidine                                   |Industrial chemicals|
|------------------|---------------------------------------------|--------------------|
|Reagents          |GlacialaceticAcid                            |Industrial chemicals|
|------------------|---------------------------------------------|--------------------|
|Reagents          |Concentrated sulfuricacid                    |Industrial chemicals|
|------------------|---------------------------------------------|--------------------|
|Reagents          |Triethylorthoacetate                         |Industrial chemicals|
|------------------|---------------------------------------------|--------------------|
|Reagents          |Sodium Hydroxide                             |Industrial chemicals|
|------------------|---------------------------------------------|--------------------|
|Reagents          |Anhydrous sodiumacetate                      |Industrial chemicals|
|------------------|---------------------------------------------|--------------------|
|Reagents          |Concentrated hydrochloricAcid                |Industrial chemicals|
|------------------|---------------------------------------------|--------------------|
|Reagents          |N, N-carbonyl diimidazole                    |Industrial chemicals|
|------------------|---------------------------------------------|--------------------|
|Reagents          |4-dimethylaminopyridine                      |Industrial chemicals|
|------------------|---------------------------------------------|--------------------|
|Reagents          |Hexamethyldisilazane                         |Industrial chemicals|
|------------------|---------------------------------------------|--------------------|
|Reagents          |D-(+) -dibenzoyltartaricacid                 |Industrial chemicals|
|------------------|---------------------------------------------|--------------------|
|Reagents          |Sodium phosphate                             |Industrial chemicals|
|------------------|---------------------------------------------|--------------------|
|Solvents          |Isopropylalcohol                             |Industrial chemicals|
|------------------|---------------------------------------------|--------------------|
|Solvents          |2-butanol                                    |Industrial chemicals|
|------------------|---------------------------------------------|--------------------|
|Solvents          |N-methylpyrrolidone                          |Industrial chemicals|
|------------------|---------------------------------------------|--------------------|
|Solvents          |tetrahydrofuran                              |Industrial chemicals|
|------------------|---------------------------------------------|--------------------|
|Solvents          |Toluene                                      |Industrial chemicals|
|------------------|---------------------------------------------|--------------------|
|Solvents          |Anhydrousethanol                             |Industrial chemicals|
---------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 10 of 542 





Page 11
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.2.6** **Manufacturing Process Development** 



Hinye Pharmaceutical Co., Ltd. began to develop Finerenone on the basis of 



publicly available patent. Three consecutive commercial-scale validation 



batches were manufactured in Dec. 2023 to Feb. 2024. 



Based on the literature (Authorization Notice No. CN101641352A), The patent 



describes that Starting from 4-cyano-2-methoxybenzaldehyde, it undergoes a 



Krebs condensation reaction with ethyl 2-cyanoacetoacetate, followed by a 



cyclization reaction with 4-amino-5-methyl-2-hydroxypyridine. The racemate 



is then obtained through ethylation, hydrolysis, and amidation reactions, and 



finally separated and transformed into the product. 



This route involves 5 chemical reaction steps, 1 splitting step, and 1 



crystallization step, with moderate reaction steps and easy availability of raw 



materials. Compared with other synthetic routes, it avoids the use of 



expensive catalysts, has relatively high yields, is easy to operate, and is 



suitable for commercial production. Therefore, the applicant develops and 



improves the process based on this route, and proposes this route as the 



declared process route. 



The preparation of this product is divided into 7 steps: in the first step, 



YA2304-1 and YA2304-2 are used as raw materials, and pyridine and acetic 



acid are used as catalysts to prepare YA2304-3 through condensation 



reaction; The second step is to prepare intermediate YA2304-5 by cyclization 



reaction between YA2304-3 and raw material YA2304-4. In the third step, 



intermediate YA2304-5 is catalyzed by concentrated sulfuric acid to undergo 



ethylation reaction with triethyl acetate to obtain YA2304-6; Step four, 



YA2304-6 is hydrolyzed under the action of sodium hydroxide to obtain 



YA2304-7; The fifth step is to activate YA2304-7 with CDI and prepare 



intermediate YA2304-8 by ammonification reaction with 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 11 of 542 





Page 12
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



hexamethyldisilazane. Step 6: Intermediate YA2304-8 and YA2304-10 are 



chiral separated to obtain YA2304-9; Step seven, YA2304-9 was prepared 



using sodium phosphate to obtain intermediate YA2304-CP. YA2304 was 



prepared by recrystallization of YA2304-CP with anhydrous ethanol. 



In Apr. Dec. 2023 to Feb. 2024, the manufacturing process of Finerenone had 



been successfully validated by running three consecutive commercial-scale 



batches (Batch No.: 231201, 240101, 240102). The batch size of Commercial 



scale batches and the validation batches were 10 kg/batch. The 



manufacturing site and process of Commercial scale batches and the 



validation batches were same. Refers to 3.2.S.4.4, the analyses resultes show 



that the Commercial scale batches and the validation batches Finerenone 



have the same quality. 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 12 of 542 





Page 13
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.3 Characterization** 



**3.2.S.3.1** **Elucidation of Structure and other Characteristics** 



**I. Evidences of Chemical Structure** 



The drug substance described in the present dossier is Finerenone which has 



the following structure formula: 



Molecular formula: C21H22N4O3 



Molecular weight: 378.43 g/mol 



Chemical name: (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1, 



4-dihydro-1,6-naphthyridine-3-carboxamide 



The applicant conducted Elemental analysis, 1H nuclear magnetic resonance 



spectroscopy, 13C nuclear magnetic resonance spectroscopy, 2D nuclear 



magnetic resonance, infrared spectroscopy, mass spectrometry, single crystal 



X-ray powder diffraction, thermogravimetric analysis, differential scanning 



calorimetry, and X-ray powder diffraction on the sample of Finerenone (batch 



No. 231101) prepared in commercial batches according to the registration 



process described in 3.2.S.2.2, and confirmed the chemical structure of the 



product as shown in Table 3.2.S.3.1-1. 



The applicant conducted physical and chemical property analysis such as 



Raman spectroscopy, differential thermal analysis, and thermogravimetric 



analysis on commercially produced samples with batch No. 231101, 



confirming that there is no crystallization water or crystallization solvent in 



the homemade Finerenone, and that the crystal form of this product is 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 13 of 542 





Page 14
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



consistent with the crystal form of the active pharmaceutical ingredient used 



in the original manufacturer's formulation. 



Table 3.2.S.3.1-1 Sample Information for Structure Elucidation 









------------------------------------------------------------------------------------------------------------------------
|Molecular formula: C21H22N4O3 Molecular weight: 378.43 g/mol|BatchNo.: 231101 Assay: 100.1% Source of sample: Hinye   |
|                                                            |Pharmaceutical Co., Ltd. Testitems: LC-MS/MS, IR, NMR,   |
|                                                            |XRD, TGA and DSC.                                        |
------------------------------------------------------------------------------------------------------------------------

The following investigations were carried out to confirm the chemical 



structure: 



a. liquid chromatography tandem mass spectrometry (LC-MS/MS) 



b. Infrared Absorption Spectroscopy (IR) 



c. Nuclear Magnetic Resonance Spectroscopy (NMR) 



d. Thermogravimetric Analysis (TGA) 



e. Differential Scanning Calorimetry (DSC) 



f. X-ray Powder Diffraction (XRD) 



g. Elemental Analysis 



h. single crystal x-ray diffraction (single crystal XRD) 



Details and data concerning these analyses or tests are presented as follows. 



**Ia. liquid chromatography tandem mass spectrometry (LC-MS/MS)** 



Sample Batch No.: 231101 



Instrument: Vanquish-TSQ QUANTIS liquid chromatography-mass 



spectrometry 



Test method: China Pharmacopoeia 2020 Edition four General Rules 0512 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 14 of 542 





Page 15
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



and 0431. 



Test result: 



Table 3.2.S.3.1-2 Mass Spectrum Data of the Substance to be Examined 













-----------------------------------------
|231101 |379.18 |378.43 |[C21H22N4O3+H]+|
-----------------------------------------

Interpretation: 



The molecular weight of Finerenone is 378.43. In the positive ion mode, the 



mass-charge ratio of 379.18 peak is detected, which is attributed to the 



molecular ion peak in the positive ion mode, which is consistent with the 



molecular weight of Finerenone. 



The spectrum is provided in: 3.2.S.3.1 _Annex 1_ _Mass spectrum of_ Finerenone 



_(batch No.:_ 231101 _)_ 



**Ib. Infrared Absorption Spectroscopy (IR)** 



Sample Batch No.: 231101 



Instrument: Shimadzu IR Affinity-1s Fourier Transform Infrared Spectrometer 



Sample preparation: KBr pellet pressing method 



Table 3.2.S.3.1-3 Infrared Spectrum Data of the Substance to be Examined 






























---------------------------------------------------------------------------------------------------------------
|3475.73         |υNH2   |-CONH2                     |Asymmetric stretching vibration of nitrogen and hydrogen|
|----------------|-------|---------------------------|--------------------------------------------------------|
|3415.93         |υNH    |-CONH2                     |Nitrogen hydrogen symmetric stretching vibration        |
|----------------|-------|---------------------------|--------------------------------------------------------|
|3365.78         |υNH    |-NH                        |Nitrogen hydrogen stretchi ng vibration                 |
|----------------|-------|---------------------------|--------------------------------------------------------|
|3115.04, 3079.53|υCH    |Pyridine ring, benzene ring|Carbon hydrogen stretching vibration                    |
---------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 15 of 542 





Page 16
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 





































------------------------------------------------------------------------------------------------------------------------
|2229.71                            |υC≡N      |-CN                        |Carbon nitrogen triple bond stretching     |
|                                   |          |                           |vibration                                  |
|-----------------------------------|----------|---------------------------|-------------------------------------------|
|1683.86                            |υC=O      |-CONH2                     |Carbonoxygen double bond stretching        |
|                                   |          |                           |vibration                                  |
|-----------------------------------|----------|---------------------------|-------------------------------------------|
|1660.71                            |υC=C      |-C=C                       |Carbon carbon double bond stretching       |
|                                   |          |                           |vibration                                  |
|-----------------------------------|----------|---------------------------|-------------------------------------------|
|1606.70, 1573.91, 14 89.05         |υC=N，υC=C|Pyridine ring, benzene ring|Expansion and contraction vibrations of    |
|                                   |          |                           |carbon nitro gen and carbon carbon do uble |
|                                   |          |                           |bonds                                      |
|-----------------------------------|----------|---------------------------|-------------------------------------------|
|1463.97                            |δCH       |-CH2                       |In-plane shear vibration                   |
|-----------------------------------|----------|---------------------------|-------------------------------------------|
|1454.33, 1431.18, 14 08.04, 1381.03|δCH       |-CH3                       |Out of plane deformation vibration         |
|-----------------------------------|----------|---------------------------|-------------------------------------------|
|1267.23, 1257.59                   |υ=C-O-C   |-OCH3,-OCH2                |Asymmetric stretching vibration ofether    |
|                                   |          |                           |bond                                       |
|-----------------------------------|----------|---------------------------|-------------------------------------------|
|1138.00, 1031.92                   |υ=C-O-C   |-OCH3,-OCH2                |Symmetric stretching vibration ofether bond|
------------------------------------------------------------------------------------------------------------------------

**Analysis and results:** 







IR υ cm [-1] (KBr) : 3475.73cm [-1] , 3415.93cm [-1] are the stretching vibration peaks 



of the primary amide group, 1683.86cm [-1] are the stretching vibration peaks of 



the carbonyl group in the amide, indicating that the compound contains an 



amide structure. 3365.78cm [-1] is the nitrogen and hydrogen expansion 



vibration of secondary amine, indicating that the compound contains a 



secondary amine structure. 3115.04cm [-1] and 3079.53cm [-1] are the 



hydrocarbon stretching vibration of pyridine ring and benzene ring, and 



1606.70cm [-1] , 1573.91cm [-1] and 1489.05cm [-1] are the skeleton vibration of 



pyridine ring and benzene ring, indicating that the compound contains 



pyridine ring and benzene ring. 2229.71cm [-1] is cyanogroup stretching 



vibration, indicating that the compound contains a cyanogroup. 2974.23cm [-1] , 



2953.02cm [-1] , 2835.36cm [-1] and 2964.59cm [-1] are the hydrocarbon stretching 



vibrations of multiple methyl and methylene groups, and 1463.97cm [-1] , 



1454.33cm [-1] , 1431.18, 1408.04 and 1381.03 are bending vibrations. 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 16 of 542 




Table Markdown (Page 16)
Table 1 (Markdown)
|2974 23 2953 02 28 . , . , 35 36 .|υCH|CH CH C - 3 ,- 2 ,- H|Carbon hydrogen stretching vibration|
|---|---|---|---|
|2229.71|υC≡N|-CN|Carbon nitrogen triple bond stretching vibration|
|1683.86|υC=O|-CONH2|Carbon oxygen double bond stretching vibration|
|1660.71|υC=C|-C=C|Carbon carbon double bond stretching vibration|
|1606.70, 1573.91, 14 89.05|υC=N，υC=C|Pyridine ring, benzene ring|Expansion and contraction vibrations of carbon nitro gen and carbon carbon do uble bonds|
|1463.97|δCH|-CH2|In-plane shear vibration|
|1454.33, 1431.18, 14 08.04, 1381.03|δCH|-CH3|Out of plane deformation vibration|
|1267.23, 1257.59|υ=C-O-C|-OCH3,-OCH2|Asymmetric stretching vibr ation of ether bond|
|1138.00, 1031.92|υ=C-O-C|-OCH3,-OCH2|Symmetric stretching vibrat ion of ether bond|



Page 17
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Indicating that the compound contains methylene and multiple methyl groups. 



1267.23cm [-1] and 1257.59cm [-1] are asymmetric stretching vibrations of alkyl 



aromatic ether bonds, and 1138.00cm [-1] and 1031.92cm [-1] are symmetric 



stretching vibrations of ether bonds, indicating that the compound contains 



two alkyl aromatic ether bonds. According to the above IR data, the compound 



contains amide bond, secondary amine, pyridine ring, phenyl ring, 



carbon-carbon double bond, alkyl aromatic ether bond, methylene and several 



methyl groups, which is consistent with the structure of Finerenone. 



The spectrum is provided in: 



_3.2.S.3.1 Annex 2 Infrared (IR) spectrum of_ Finerenone. _(batch No.:_ 231101 _)._ 



**Ic. Nuclear Magnetic Resonance Spectroscopy (NMR)** 



Sample Batch No.: 231101 



Instrument: Bruker Avance AV 400 Superconducting Fourier-Transform NMR 



Spectrometer 



Test conditions: 



 - solvent: DMSO- _d6_ 



 - inner standard: TMS ( [1] H NMR) 



 - resonant frequency for the [1] H NMR: 400MHz 



 - resonant frequency for the [13] C NMR: 100MHz 



The serial number of carbon atoms and hydrogen atoms in the structure (not 



IUPAC nomenclature, only for NMR spectrometry): 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 17 of 542 





Page 18
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Table 3.2.S.3.1-4 1H NMR Spectrum Data of the Substance to be Examined 













---------------------------------------------
|1      |1.029-1.064|t      |3H     |27-CH3 |
|-------|-----------|-------|-------|-------|
|2      |2.118      |s      |3H     |28-CH3 |
|-------|-----------|-------|-------|-------|
|3      |2.190      |s      |3H     |22-CH3 |
|-------|-----------|-------|-------|-------|
|4      |3.824      |s      |3H     |24-CH3 |
|-------|-----------|-------|-------|-------|
|5      |3.986-4.030|m      |2H     |26-CH2 |
|-------|-----------|-------|-------|-------|
|6      |5.384      |s      |1H     |9-CH   |
|-------|-----------|-------|-------|-------|
|7      |6.714-6.804|bs     |2H     |20-NH2 |
|-------|-----------|-------|-------|-------|
|8      |7.144-7.163|d      |1H     |4-CH   |
|-------|-----------|-------|-------|-------|
|9      |7.274-7.293|d      |1H     |5-CH   |
|-------|-----------|-------|-------|-------|
|10     |7.376      |s      |1H     |1-CH   |
|-------|-----------|-------|-------|-------|
|11     |7.551      |s      |1H     |16-CH  |
|-------|-----------|-------|-------|-------|
|12     |7.711      |s      |1H     |12-NH  |
---------------------------------------------

According to H-H COSY, DEPT135, DEPT90, [13] C- [1] H HSQC [13] , C- [1] H HMBC 



spectrum, the hydrogen spectrum of the tested sample is assigned as follows: 



On [1] H NMR spectra, δ2.500 is the DMSO- _d6_ solvent peak, δ3.383 ppm is the 



water peak, both of which are the solvent peaks in deuterium reagents. 



Peak 1: δ 1.029-1.064, 3H, t, 6.8Hz, CH3, should be coupled with methylene. 



COSY shows correlation with δH3.986 (26-CH2), HSQC shows correlation with 



δC14.353 (27-C). It can be determined as 27-CH3. 



Peak 2: δ2.118, 3H, t, is CH3. COSY shows a weak correlation with 



δH7.551(16-CH), HSQC shows a strong correlation with δC13.846, HMBC 



shows a strong correlation with δC111.538, δC144.271 (16-CH) and a weak 



correlation with δC103.245, δC159.464. It can be determined as 28-CH3. 



Peak 3: δ2.190, 3H, t, is CH3. COSY shows a weak correlation with δH5.384 



(9-CH), HSQC shows a weak correlation with δC18.146, HMBC shows a strong 



correlation with δC105.399, δC138.229 and a weak correlation with δC169.843, 



and a very weak correlation with δC32.442 (9-CH). It can be determined as 



22-CH3. 



Peak 4: δ3.824, 3H, s, is CH3, HSQC shows a correlation with δC56.098, 



HMBC shows a correlation with δC155.720 (3-C) and a weak correlation with 



δC114.63, can be determined as 24-CH3. 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 18 of 542 





Page 19
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Peak 5: δ3.986-4.030, 2H, m, 6.8Hz, CH, coincidences with2 δH1.029 (27-CH3). 



COSY shows a correlation with δH1.029 (27-CH3), HSQC shows a correlation 



with δC60.624, and HMBC shows a strong correlation with δC14.353 and 



δC159.464(18-C), which can be determined as 26-CH2. 



Peak 6: δ5.384, 1H, s, COSY shows a weak correlationH with δ2.190, HSQC 



shows a correlation with δC32.442, HMBC shows a correlation with δC103.245, 



δC105.399, δC130.989, δC138.229, δC141.761, δC144.271, δC155.720, 



δC159.464, δC169.843, which can be identified as 9-CH. 



Peak 7: δ6.714-6.804, 2H, bs, HSQC shows no correlation peak and can be 



determined as 20-NH2. 



Peak 8: δ7.144-7.163, 1H, d, 7.6Hz, COSY showed correlation with δH7.274, 



HSQC showed correlation with δC130.989, HMBC showed correlation with 



δC32.442, δC109.596, δC119.057, δC155.720 (3-C). So it can be determined as 



4-CH. 



Peak 9: δ7.274-7.293, 1H, d, 7.6Hz, COSY display is associated with δH7.144, 



HSQC display is associated with δC124.852, HMBC display is associated with 



δC114.182, δC119.057, δC141.761. Can be identified as 5-CH. 



Peak 10: δ7.376, 1H, s, HSQC shows correlation with δC114.182, HMBC 



shows correlation with δC109.596, δC119.057, δC124.852, δC141.761, 



δC155.720. It can be determined as 1-CH. 



Peak 11: δ 7.551, 1H, s, HSQC shows correlation with δC144.271, HMBC 



shows correlation with δC159.464 (18-C) and can be determined as 16-CH. 



Peak 12: δ 7.711, s, 1H, HSQC shows no correlation peak and can be 



determined as 12-NH. 



Based on the above analysis, all the 22 H signals in the structure of the tested 



sample are clearly attributed, which is consistent with its structure. 



Table 3.2.S.3.1-5 13C NMR Spectrum Data of the Substance to be Examined 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 19 of 542 





Page 20
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 

---------------------------------
|1      |13.846 |1      |28-C   |
|-------|-------|-------|-------|
|2      |14.353 |1      |27-C   |
|-------|-------|-------|-------|
|3      |18.146 |1      |22-C   |
|-------|-------|-------|-------|
|4      |32.442 |1      |9-C    |
|-------|-------|-------|-------|
|5      |56.098 |1      |24-C   |
|-------|-------|-------|-------|
|6      |60.624 |1      |26-C   |
|-------|-------|-------|-------|
|7      |103.245|1      |14-C   |
|-------|-------|-------|-------|
|8      |105.399|1      |10-C   |
|-------|-------|-------|-------|
|9      |109.596|1      |2-C    |
|-------|-------|-------|-------|
|10     |111.538|1      |15-C   |
|-------|-------|-------|-------|
|11     |114.182|1      |1-C    |
|-------|-------|-------|-------|
|12     |119.057|1      |6-C    |
|-------|-------|-------|-------|
|13     |124.852|1      |5-C    |
|-------|-------|-------|-------|
|14     |130.989|1      |4-C    |
|-------|-------|-------|-------|
|15     |138.229|1      |11-C   |
|-------|-------|-------|-------|
|16     |141.761|1      |7-C    |
|-------|-------|-------|-------|
|17     |144.271|1      |13-C   |
|-------|-------|-------|-------|
|18     |144.271|1      |16-C   |
|-------|-------|-------|-------|
|19     |155.720|1      |3-C    |
|-------|-------|-------|-------|
|20     |159.464|1      |18-C   |
|-------|-------|-------|-------|
|21     |169.843|1      |19-C   |
---------------------------------



According to DEPT135, DEPT90, [13] C- [1] H HSQC, [13] C- [1] H HMBC spectrum, the 



carbon spectrum of the tested sample is classified as follows: 



δ38.905 ~ 40.121ppm on the [13] C NMR spectra are the multiple peaks of the 



solvent DMSO- _d6_ . 



Peak 1: δ13.846, DEPT135, DEPT90 spectrum shows first order carbon, 



HSQC shows direct correlation with δH2.118 (28-CH3), HMBC shows remote 



correlation with δH7.551 (16-CH). It can be determined as 28-C. 



Peak 2: δ14.353, DEPT135, DEPT90 spectrum shows first order carbon, 



HSQC shows direct correlation with δH1.029 (27-CH3), HMBC shows remote 



correlation with δH3.986 (26-CH2). It can be determined as 27-C. 



Peak 3: δ18.146, DEPT135, DEPT90 spectrum shows first order carbon, 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 20 of 542 





Page 21
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



HSQC shows direct correlation with δH2.190 (22-CH3), HMBC shows remote 



correlation with δH7.711 (12-NH). It can be determined as 22-C. 



Peak 4: δ32.442, DEPT135, DEPT90 spectrum shows tertiary carbon, HSQC 



shows direct correlation with δH5.384 (9-CH), HMBC shows remote correlation 



with δH7.144 (4-CH), δH7.376 (1-CH), δH2.190 (22-CH3). It can be determined 



as 9-C. 



Peak 5: δ56.098, DEPT135, DEPT90 spectrum shows first order carbon, 



HSQC shows direct correlation with δH3.824 (24-CH3), HMBC shows no 



remote correlation. It can be determined as 24-C. 



Peak 6: δ60.624, DEPT135, DEPT90 spectrum shows secondary carbon, 



HSQC shows direct correlation with δH3.986 (26-CH2), HMBC shows remote 



correlation with δH1.029 (27-CH3). It can be determined as 26-C. 



Peak 7: δ103.245, DEPT135, DEPT90 spectrum shows quaternary carbon, 



HSQC shows no direct correlation, HMBC shows remote correlation with 



δH5.384 (9-CH),H δ7.711 (12-NH),H δ7.551(16-CH),H δ2.118 (28-CH3). It can be 



determined to be 14-C. 



Peak 8: δ105.399, DEPT135, DEPT90 spectrum shows quaternary carbon, 



HSQC shows no direct correlation, HMBC shows remote correlation with 



δH5.384 (9-CH), δH7.711 (12-NH), δH2.190 (22-CH3). It can be determined as 



10-C. 



Peak 9: δ109.596, DEPT135, DEPT90 spectrum shows quaternary carbon, 



HSQC shows no direct correlation, HMBC shows remote correlation with 



δH7.144 (4-CH), δH7.376 (1-CH). It can be determined as 2-C. 



Peak 10: δ111.538, DEPT135, DEPT90 spectrum shows quaternary carbon, 



HSQC shows no direct correlation, HMBC shows remote correlation with 



δH2.118 (28-CH3), δH7.551 (16-CH), δH7.711 (12-NH). It can be determined as 



15-C. 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 21 of 542 





Page 22
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Peak 11: δ114.182, DEPT135, DEPT90 spectrum shows quaternary carbon, 



HSQC shows direct correlation with δH7.376 (1-CH), HMBC shows remote 



correlation with δH7.274 (5-CH), δH3.824 (24-CH3). It can be determined as 



1-C. 



Peak 12: δ119.057, DEPT135, DEPT90 spectrum shows quaternary carbon, 



HSQC shows no direct correlation, HMBC shows remote correlation with 



δH7.376 (1-CH), δH7.274 (5-CH), δH7.144 (4-CH). It can be determined as 6-C. 



Peak 13: δ124.852, DEPT135, DEPT90 spectrum shows tertiary carbon, 



HSQC shows direct correlation with δH7.274 (5-CH), HMBC shows remote 



correlation with δH7.376 (1-CH), δH7.144 (4-CH). It can be determined as 5-C. 



Peak 14: δ130.989, DEPT135, DEPT90 spectrum shows tertiary carbon, 



HSQC shows direct correlation with δH7.144 (4-CH), HMBC shows remote 



correlation with δH5.384 (9-CH). Can be determined as 4-C. 



Peak 15: δ138.229, DEPT135, DEPT90 spectrum shows quaternary carbon, 



HSQC shows no direct correlation, HMBC shows remote correlation with 



δH2.190 (22-CH3),H δ5.384 (9-CH),H δ7.711 (12-NH). It can be determined as 



11-C. 



Peak 16: δ141.761, DEPT135, DEPT90 spectrum shows quaternary carbon, 



HSQC shows no direct correlation, HMBC shows remote correlation with 



δH5.384 (9-CH), δH7.274 (5-CH), δH7.376 (1-CH). It can be determined as 7-C. 



Peak 17: δ144.271, DEPT135, DEPT90 spectrum shows quaternary carbon, 



HSQC shows direct correlation with δH7.551 (16-CH), And HMBC also shows a 



remote correlation with δH2.118 (28-CH3), δH5.384 (9-CH), δH7.551 (16-CH), 



δH7.711 (12-NH). They can be identified as 13-C and 16-C carbons. 



Peak 18: δ155.720, DEPT135, DEPT90 spectrum shows quaternary carbon, 



HSQC shows no direct correlation, HMBC showed a remote correlation withH 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 22 of 542 





Page 23
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



δ3.824 (24-CH3), δH7.144 (4-CH), δH5.384 (9-CH), δH7.376 (1-CH), δH7.274 



(5-CH). Can be determined as 3-C. 



Peak 19: δ159.464, HSQC shows no direct correlation, HMBC shows 



correlation with δH2.118 (28-CH3), δH3.986-4.030 (26-CH2), δH7.551 (16-CH), 



δH7.711 (12-NH), so it can be determined that the peak is 18-C. 



Peak 20: δ169.843, DEPT135, DEPT90 spectrum shows quaternary carbon, 



HMBC shows a remote correlation with δH5.384 (27-CH3), δH2.118 (28-CH3), 



δH7.711 (12-NH), we can determine that the peak is 19-C. 



According to the above analysis, the carbon spectrum of the tested sample 



shows 20 groups of carbon peaks, a total of 21 carbon atoms, and all of them 



are clearly attributed. 



The NMR data were consistent with the target compounds. 



The spectra are provided in: 



_3.2.S.3.1 Annex 3_ _NMR spectrum of_ Finerenone _(batch No.: 231101)_ 



**Id. Thermogravimetric Analysis (TGA)** 



_Sample Batch No.:_ 231101. 



_Instrument: : TG 209 F1 Thermogravimetric Analyze_ r 



Test conditions: 



- 35-500 ℃, heating rate of 10 ℃/min; 



- nitrogen, flow rate 20ml/min 



Test result: 



Table 3.2.S.3.1-6 TGA Result of the Substance to be Examined 










-----------------------------------
|Lot No.|Temperature    |Mass loss|
|-------|---------------|---------|
|231101 |35.0 ℃⁓ 184.2 ℃|0.60%    |
-----------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 23 of 542 





Page 24
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



242.7 ℃ ⁓ 438.8 ℃ 97.30% 



Interpretation: 



TGA shows that the weight loss of the self-made sample is 0.60% at 



35℃⁓ 184.2℃. Combined with DSC detection spectrum, the sample does not 



absorb heat before melting (about 254℃), indicating that the sample does not 



contain crystal water or crystalline solvent. 



The TGA thermogram is provided in: 



_3.2.S.3.1 Annex 4 TGA thermogram report of Finerenone_ (batch No.: 231101 ). 



_3.2.S.3.1 Annex 5 TGA thermogram report of Finerenone_ (batch No.: 231201, 



240101, 240102) 



**Ie. Differential Scanning Calorimetry (DSC)** 



Sample Batch No.: _231101_ . 



Instrument: DSC 25 Differential Scanning Calorimeter 



Test conditions: 



- experimental atmosphere: N2, 50 mL/min. 



- scanning procedure: Heat up from 30 ℃ to 350 ℃ at 20 ℃/min rate. 



Test result: 



The samples submitted for inspection were detected by differential scanning 



calorimetry, and there was a multiple endothermic process within the 



detection temperature range (30-400℃). The peak temperature is shown in 



Table 3.2.S.3.1- _7_ : 



Table 3.2.S.3.1-7 DSC Result of the Substance to be Examined 









-----------------------------------------------------------------------
|Batch No|The initial temperature ofextrapolation/℃|Peak temperature/℃|
-----------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 24 of 542 





Page 25
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



231101 254.38 257.04 



Interpretation: 



DSC showed that the self-made sample had an endothermic peak at 254℃, 



without other endothermic peaks, indicating that the endothermic peak was 



the melting point, consistent with the melting point reported in the original 



research patent (about 252℃). 



The DSC pattern is provided in: 



_3.2.S.3.1 Annex 6_ _DSC pattern on Finerenone (batch No.: 231101, 231201,_ 



_240101, 240102)_ 



**If. X-ray Diffraction Pattern (XRD)** 



Sample Batch No.: _231101._ 



Instrument: Japanese Institute of Technology (Smartlab 3kW) X-ray 



diffractometer 



Test method: Light tube voltage 40kW, filament current 15mA, Cu radiation, 



Ni filtering, Hypix 3000 two-dimensional detector. 



Detection and analysis: The sample has the maximum peak value (error range 



is ±0.2°) at 2θ angles of 8.5, 14.1, 17.2, 19.0, 20.5, 25.6 and 26.5, which is 



consistent with the characteristic peak of polycrystalline substance I reported 



in the original research patent. 



The XRD pattern is provided in: 



3.2.S.3.1 Annex 7 XRD pattern on Finerenone (batch No.: 231101) 



3.2.S.3.1 Annex 8 XRD pattern on Finerenone (batch No.: 231201) 



3.2.S.3.1 Annex 9 XRD pattern on Finerenone (batch No.: 240101) 



3.2.S.3.1 Annex 10 XRD pattern on Finerenone (batch No.: 240102) 



**Ig. Elemental Analysis** 



Instrument model: Elementar Vario EL cube element analyzer 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 25 of 542 





Page 26
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Test method: JY/T 0580-2020 element analyzer analysis method general rules 



Table 3.2.S.3.1-8 Elemental analysis data of the tested sample 










---------------------------------------------------------------------------------------------------------------
|Test results      |66.57% |5.95%  |14.96% |12.52% (This value is calculated from the first three test values)|
|------------------|-------|-------|-------|------------------------------------------------------------------|
|Theoretical result|66.65% |5.86%  |14.81% |12.68%                                                            |
---------------------------------------------------------------------------------------------------------------

Analytical results: According to the test results of C, H and N, the mass 



fraction of oxygen element can be calculated as 12.52%. The error between the 



test results of C, H, O and N and the theoretical results is less than 0.3%, 



which can be determined to be consistent with the molecular composition 



C21H22N4O3 of Finerenone. 



The Elemental Analysis report is provided in: 



3.2.S.3.1 Annex 11 Elemental Analysis report on Finerenone (batch No.: 



231101) 



**Ih. Single crystal X-ray diffraction** 



Finerenone contains a chiral center, and the stereoscopic configuration can be 



confirmed by single crystal X-ray diffraction. See the attached single crystal 



test report for details. 



Monocrystalline culture: 160mg of Finerenone and 6ml of anhydrous ethanol 



were heated and dissolved, then filtered with precision. The filtrate was placed 



in a vial and incubated at 25℃ for 3⁓ 4 days to obtain monocrystalline. 



Instrument: D8 Venture 



Testing parameters: 



- Light source: Cu target 



- X-ray: CU-k (= 1.54178 A) 



- Detector: CMOS surface detector 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 26 of 542 





Page 27
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



-Resolution: 0.80Å 



- Current voltage: 50 kV, 1.2mA 



- exposure time: 2 s 



- Face detector to sample distance: 40 mm 



- Test temperature: 150(2)K. 



Structure analysis and finishing process: 



After integral reduction of diffraction data by SAINT program, empirical 



absorption correction of data by SADABS program; SHELXT2014 was used to 



analyze the single crystal structure by direct method, and the structure was 



refined by least square method. The hydrogen atom refining process was 



obtained by isotropic calculation, the hydrogen atom on N was obtained by 



residual electron density, and the hydrogen atom on C-H was obtained by 



calculation and hydrogenation, and it was refined by riding model. The Flack 



constant is -0.01(11), and the chirality of C9 is S configuration. See Figure 



3.2.S.3.1-1 for an ellipsoid diagram of the molecular stereostructure of 



Finerenone. 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 27 of 542 





Page 28
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Fig. 3.2.S.3.1-1 Ellipsoid of the three-dimensional structure of Finerenone 



**Comprehensive analysis and conclusion** 



The molecular formula of Finerenone is C21H22N4O3, there is a chiral center, 



and the chiral configuration of C9 is S configuration (the atomic number here 



is the nuclear magnetic structure analysis number). The applicant confirmed 



the chemical plane structure of the product by elemental analysis, mass 



spectrometry, infrared spectroscopy, nuclear magnetic resonance 1H 



spectrum, nuclear magnetic resonance 13C spectrum and two-dimensional 



nuclear magnetism; In order to confirm the three-dimensional configuration of 



Finerenone, the applicant cultured single crystals with 231101 batches of 



samples, commissioned the Research Center for Drug Quality Control and 



Solid State Chemistry, Shanghai Institute of Pharmaceutical Sciences, 



Chinese Academy of Sciences to test them, and confirmed that C9 in the 



molecular structure of the product is the S configuration. TGA proved that 



this product does not contain crystal water and crystalline solvent, and the 



structural formula is as follows: 



The applicant used DSC and XRD methods to identify the crystal shape of the 



self-made Finerenone, and confirmed that the crystal shape of the product is 



consistent with that reported in the original patent. 



**II. Physicochemical Characteristics** 



**IIa. Appearance** 



According to the evaluation report of the original research formulation 



launched by the original manufacturer in the European Union, the 



appearance of the original product is White to yellow crystalline 



non-hygroscopic powder. The applicant conducted a visual inspection on the 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 28 of 542 





Page 29
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



self-made commercial batch of Finerenone, and the test results are shown in 



the table below. 

--------------------------------------------------------------------------
|Batch No.            |Appearance                                        |
|---------------------|--------------------------------------------------|
|EMA Assessment report|White to yellow crystalline non-hygroscopic powder|
|---------------------|--------------------------------------------------|
|231201               |White powder                                      |
|---------------------|--------------------------------------------------|
|240101               |White powder                                      |
|---------------------|--------------------------------------------------|
|240102               |White powder                                      |
--------------------------------------------------------------------------



**IIb. Solubility** 



Referring to the IF document of the original preparation agent listed in Japan, 



it can be seen that the solubility of the original preparation API is "dissolved in 



methanol, slightly soluble in ethanol, acetonitrile and acetone, slightly soluble 



in isopropyl alcohol, and almost insoluble in water". The applicant has studied 



the solubility of three batches of commercially produced finelidone in 



methanol, ethanol, acetonitrile, acetone, isopropyl alcohol and water in 



accordance with the General rules of the Chinese Pharmacopoeia 2020 



Edition. The test results are basically consistent with the description of 



solubility of the original research API. 



Table 3.2.S.3.1-9 Results of Solubility Studies of Finerenone 









------------------------------------------------------------------------------------------------------------------------
|231201 |This productis dissolved in methanol, slightly soluble inethanol, acetonitrile andacetone, slightly soluble   |
|       |inisopropylalcohol, andalmostinsoluble in water                                                               |
|-------|--------------------------------------------------------------------------------------------------------------|
|240101 |This productis dissolved in methanol, slightly soluble inethanol, acetonitrile, andacetone, slightly soluble  |
|       |inisopropylalcohol, andalmostinsoluble in water                                                               |
|-------|--------------------------------------------------------------------------------------------------------------|
|240102 |This productis dissolved in methanol, slightly soluble inethanol, acetonitrile, andacetone, slightly soluble  |
|       |inisopropylalcohol, andalmostinsoluble in water                                                               |
------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 29 of 542 





Page 30
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**IIc. Hygroscopicity** 



Refer to the IF file of the original development agent listed in Japan, it can be 



seen that the original research product has no moisture induction. According 



to the General Rule 9103 of the Fourth Part of the 2020 edition of Chinese 



Pharmacopoeia, the applicant conducted a humidification test on three 



batches of commercial-scale mass-produced Finerenone. The experimental 



conditions were 25±1℃ and the relative humidity was 80%±2%. The test 



results showed that the product had non-hygroscopic, which was consistent 



with that of the original product. 



Table 3.2.S.3.1-10 Results of Hygroscopicity Determination of Finerenone 






















-------------------------------------------------------------------------------------------------------------------------------------
|231201                     |20.63545                   |1.01424                    |21.64979       |0.01%          |non-hygroscopic|
|---------------------------|---------------------------|---------------------------|---------------|---------------|---------------|
|240101                     |22.77341                   |1.02158                    |23.79492       |-0.01%         |non-hygroscopic|
|---------------------------|---------------------------|---------------------------|---------------|---------------|---------------|
|240102                     |20.08668                   |1.19142                    |21.27804       |-0.01%         |non-hygroscopic|
|---------------------------|---------------------------|---------------------------|---------------|---------------|---------------|
|Original formulationIF file|Original formulationIF file|Original formulationIF file|non-hygroscopic|non-hygroscopic|non-hygroscopic|
-------------------------------------------------------------------------------------------------------------------------------------

**IId. Melting Point** 



The crystal form of Finerenone was reported in the patent CN106795155 



A applied by the original research manufacturer in China. The crystal for 



m was measured by DSC and melted at about 252℃. The curve diagram 



is as follows: 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 30 of 542 





Page 31
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Fig. 3.2.S.3.1-2 patent CN106795155A reported the DSC map of Fine 



renone crystal type 



The applicant's evaluation of a pilot lot (Batch No.: 231101) and three 



commercial-scale batch production batches of Finerenone (Batch No.: 



Differential scanning calorimetry (DSC) was performed on 231201, 240101 



and 240102. The results showed melting at about 252 ° C, and no other 



absorption and exothermic peaks were observed, indicating that no phase 



changes occurred other than melting. The DSC maps of the four batches of 



samples are consistent with those of the crystal type reported in patent 



CN106795155A. The specific data are shown in below Table. 










-------------------------------------------------------------------
|Batch No.|Endothermicprocess                  |Endothermicprocess|
|---------|------------------------------------|------------------|
|Batch No.|Extrapolation starting temperature/℃|Peak temperature/℃|
|---------|------------------------------------|------------------|
|231101   |254.38                              |257.04            |
|---------|------------------------------------|------------------|
|231201   |253.88                              |256.33            |
|---------|------------------------------------|------------------|
|240101   |254.02                              |256.74            |
|---------|------------------------------------|------------------|
|240102   |255.16                              |256.93            |
-------------------------------------------------------------------

The DSC thermogram on Finerenone is provided in: 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 31 of 542 





Page 32
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



_3.2.S.3.1 Annex 6 DSC pattern of_ Finerenone (batch No.: 231101, 231201, 



240101, 240102) 



**IIe. Thermogravimetric Analysis (TGA)** 



Combined with the chemical structure formula and molecular formula of 



Finerenone published in the evaluation report of the original preparation 



agent listed in the EU (see 3.2.S.1.2 for details), it can be seen that the 



Finerenone used in the original research does not contain crystal water or 



crystallization solvent. The applicant conducted thermogravimetric analysis of 



a pilot batch (Batch No.: 231101) and three commercial-scale batches of 



Finerenone (lBatch No.: 231201, 240101 and 240102). The specific data are 



shown in below Table. 



Table 3.2.S.3.1-12 TGA Result of the Substance to be Examined 










-------------------------------------
|Batch No.|Temperature/C|Mass loss %|
|---------|-------------|-----------|
|231101   |184 ℃        |0.60%      |
|---------|-------------|-----------|
|231201   |175 ℃        |0.16%      |
|---------|-------------|-----------|
|240101   |175 ℃        |0.24%      |
|---------|-------------|-----------|
|240102   |175 ℃        |0.16%      |
-------------------------------------

See 3.2.S.2.2.3 for the crystalline solvent of this product, it can be seen that 



the crystalline solvent of this product is anhydrous ethanol, which may bring 



a small amount of water, so the crystalline solvent most likely to be contained 



in this product is ethanol and water. From the analysis of the test results, it 



can be seen that there is basically no weight loss when the sample is heated to 



175℃, indicating that the sample does not contain crystal water or crystalline 



solvent. 



The TGA thermogram is provided in: 



_3.2.S.3.1 Annex 4_ _TGA thermogram report of Finerenone_ (batch No.: 231101 _)._ 



_3.2.S.3.1 Annex 5_ _TGA thermogram report of Finerenone_ (batch No.: 231201, 



240101, 240102 _)._ 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 32 of 542 





Page 33
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**IIf. Polymorphism** 



In the patent CN106795155A applied by the original research manufactu 



rer in China, the polycrystalline form I of Finerenone was reported. The 



crystal form by powder X-ray diffraction pattern (that is, XRD pattern) h 



as a peak maximum at the 2θ Angle of 8.5, 14.1, 17.2, 19.0, 20.5, 25.6, 



26.5. The relevant XRD pattern is shown in below Fig. 3.2.S.3.1-3. 



Figure 3.2.S.3.1-3 patent CN106795155A reported the XRD pattern of Fi 



nerenone polycrystalline form I 



Applicant for a pilot lot (Batch No.: 231101) and three commercial-scale 



batches of Finerenone (Batch No.: 231201, 240101 and 240102) were tested 



by XRD. The XRD patterns of the four batches of samples were consistent with 



those of polycrystalline Ⅰ crystal as reported in patent CN106795155A. At the 



same time, combined with the DSC and XRD test results, it can be seen that 



the applicant's self-made Finerenone crystal pattern is consistent with the 



Finerenone polycrystalline pattern I reported in patent CN106795155A, and 



the registration process can ensure that the same crystal pattern of the 



product is consistently produced. 



The XRD pattern is provided in: 



_3.2.S.3.1 Annex 7 XRD pattern of Finerenone (batch No.: 231101)_ 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 33 of 542 





Page 34
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



_3.2.S.3.1 Annex 8 XRD pattern of Finerenone (batch No.: 231201)_ 



_3.2.S.3.1 Annex 9 XRD pattern of Finerenone (batch No.: 240101)_ 



_3.2.S.3.1 Annex 10 XRD pattern of Finerenone (batch No.: 240102)_ 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 34 of 542 





Page 35
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**III. Material Safety Data Sheet** 



**SECTION 1: Identification** 



1.1 Product identifier 



Product name: Finerenone 



1.2 Recommended use of the chemical and restrictions on use 



Identified uses: Industrial and scientific research use. 



1.3 Supplier's details 



Company: Hinye Pharmaceutical Co., Ltd. 



Address: No.109, Kangtian Road, Changsha National Biological Industrial 



Base, Hunan Province 



Telephone: 86-10-69703845 



**SECTION 2: Hazard identification** 



2.1 GHS Classification 



Not a hazardous substance or mixture. 



2.2 GHS Label elements, including precautionary statements 



Not a hazardous substance or mixture. 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 35 of 542 





Page 36
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



2.3 Physical and chemical hazards 



Referring to current information, no physical or chemical hazard. 



2.4 Health hazards 



Referring to current information, no health hazard. 



2.5 Environmental hazards 



Referring to current information, no environmental hazard. 



2.6 Other hazards 



Caution: Physiologically highly active, therapeutically usable substance. The 



substance must be handled with the care required for hazardous materials. 



**SECTION 3: Composition/information on ingredients** 

-------------------------------------------------------
|Product name|CAS No.     |Formula   |Molecular weight|
|------------|------------|----------|----------------|
|Finerenone  |1050477-31-0|C21H22N4O3|378.43 g/mol    |
-------------------------------------------------------



**SECTION 4: First-aid measures** 



If inhaled 



After inhalation: fresh air. Consult doctor if feeling unwell. 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 36 of 542 





Page 37
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



In case of skin contact 



In case of skin contact: Take off immediately all contaminated clothing. Rinse 



skin with water/ shower. Consult a physician. 



In case of eye contact 



After eye contact: rinse out with plenty of water. Remove contact lenses. 



If swallowed 



After swallowing: immediately make victim drink water (two glasses at most). 



Consult a physician. 



4.2 Most important symptoms/effects, acute and delayed 



The most important known symptoms and effects are described in the 



labelling (refers to section 2.2) and/or in section 11 



4.3 Indication of any immediate medical attention and special treatment 



needed 



no data available 



4.4 Notes to physician 



No data available 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 37 of 542 





Page 38
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**SECTION 5: Firefighting measures** 



5.1 Extinguishing media 



Suitable extinguishing media 



Water Foam Carbon dioxide (CO2) Dry powder 



Unsuitable extinguishing media 



For this substance/mixture no limitations of extinguishing agents are given. 



5.2 Special hazards arising from the substance or mixture 



Carbon oxides 



Nitrogen oxides (NOx) 



Combustible. 



Development of hazardous combustion gases or vapours possible in the event 



of fire. 



5.3 Advice for firefighters 



Stay in danger area only with self-contained breathing apparatus. Prevent 



skin contact by keeping a safe distance or by wearing suitable protective 



clothing. 



Suppress (knock down) gases/vapors/mists with a water spray jet. Prevent 



fire extinguishing water from contaminating surface water or the ground 



water system. 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 38 of 542 





Page 39
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**SECTION 6: Accidental release measures** 



6.1 Personal precautions, protective equipment and emergency procedures 



Advice for non-emergency personnel: Avoid inhalation of dusts. Avoid 



substance contact. 



Ensure adequate ventilation. Evacuate the danger area, observe emergency 



procedures,consult an expert. 



For personal protection refers to section 8. 



6.2 Environmental precautions 



Do not let product enter drains. 



6.3 Methods and materials for containment and cleaning up 



Cover drains. Collect, bind, and pump off spills. Observe possible material 



restrictions (refers to sections 7 and 10). Take up dry. Dispose of properly. 



Clean up affected area. Avoid generation of dusts. 



6.4 Reference to other sections 



For disposal refers to section 13. 



**SECTION 7: Handling and storage** 



7.1 Precautions for safe handling 



For precautions refers to section 2.2. 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 39 of 542 





Page 40
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



7.2 Conditions for safe storage, including any incompatibilities 



Storage conditions 



Tightly closed. Dry. 



Storage stability 



Recommended storage temperature 



2 - 8 ℃ 



Storage class 



Storage class (TRGS 510): 11: Combustible Solids. 



**SECTION 8: Exposure controls/personal protection** 



8.1Control parameters 



Ingredients with workplace control parameters 



Contains no substances with occupational exposure limit values. 



8.2 Exposure controls 



Appropriate engineering controls 



Change contaminated clothing. Preventive skin protection recommended. 



Wash hands after working with substance. 



Personal protective equipment 



Eye/face protection 



Use equipment for eye protection tested and approved under appropriate 



government standards such as NIOSH (US) or EN 166(EU). Safety glasses 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 40 of 542 





Page 41
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Skin protection 



This recommendation applies only to the product stated in the safety data 



sheet,supplied by us and for the designated use. When dissolving in or mixing 



with other substances and under conditions deviating from those stated in 



EN374 please contact the supplier of CE-approved gloves (e.g. KCL GmbH, 



D-36124 Eichenzell, Internet: www.kcl.de). 



Full contact 



Material: Nitrile rubber 



Minimum layer thickness: 0.11 mm 



Break through time: 480 min 



Material tested:KCL 741 Dermatril® L 



Splash contact 



Material: Nitrile rubber 



Minimum layer thickness: 0.11 mm 



Break through time: 480 min 



Material tested:KCL 741 Dermatril® L 



Body Protection 



protective clothing 



Respiratory protection 



required when dusts are generated. 



Our recommendations on filtering respiratory protection are based on the 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 41 of 542 





Page 42
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



following standards: DIN EN 143, DIN 14387 and other accompanying 



standards relating to the used respiratory protection system. 



Control of environmental exposure 



Do not let product enter drains. 



**SECTION 9: Physical and chemical properties** 



9.1 Information on basic physical and chemical properties 



Appearance 



Form:solid 



Odor 



no data available 



Odor Threshold 



no data available 



pH 



no data available 



Melting point/freezing point 



no data available 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 42 of 542 





Page 43
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Initial boiling point and boiling range 



no data available 



Flash point 



No data available 



Evaporation rate 



No data available 



Flammability (solid,gas) 



no data available 



Upper/lower flammability or explosive limits 



no data available 



Vapor pressure 



no data available 



Vapor density 



no data available 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 43 of 542 





Page 44
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Density 



no data available 



Relative density 



no data available 



Water solubility 



no data available 



Partition coefficient n-octanol/water 



no data available 



Autoignition temperature 



no data available 



Decomposition temperature 



no data available 



Viscosity 



no data available 



Explosive properties 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 44 of 542 





Page 45
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



no data available 



Oxidizing properties 



none 



9.2 Other safety information 



no data available 



**SECTION 10: Stability and reactivity** 



10.1 Chemical stability 



The product is chemically stable under standard ambient conditions (room 



temperature) . 



10.2 Possibility of hazardous reactions 



no data available 



10.3Conditions to avoid 



no information available 



10.4Incompatible materials 



Strong oxidizing agents 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 45 of 542 





Page 46
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



10.5Hazardous decomposition products 



In the event of fire: refers to section 5 



**SECTION 11: Toxicological information** 



11.1 Information on toxicological effects 



Acute toxicity 



Oral: no data available 



Inhalation: no data available 



Dermal: no data available 



Skin corrosion/irritation 



no data available 



Serious eye damage/eye irritation 



No data available 



Respiratory or skin sensitization 



No data available 



Germ cell mutagenicity 



No data available 



Carcinogenicity 



No data available 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 46 of 542 





Page 47
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Reproductive toxicity 



No data available 



Specific target organ toxicity - single exposure 



No data available 



Specific target organ toxicity - repeated exposure 



No data available 



Aspiration hazard 



No data available 



11.2 Additional Information 



To the best of our knowledge, the chemical, physical, and toxicological 



properties have not been thoroughly investigated. 



**SECTION 12: Ecological information** 



12.1Toxicity 



no data available 



12.2 Persistence and degradability 



no data available 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 47 of 542 





Page 48
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



12.3 Bioaccumulative potential 



no data available 



12.4 Mobility in soil 



no data available 



12.5 Results of PBT and vPvB assessment 



no data available 



12.6 Endocrine disrupting properties 



No data available 



12.7 Other adverse effects 



no data available 



**SECTION 13: Disposal considerations** 



13.1 Waste treatment methods 



Product 



Offer surplus and non-recyclable solutions to a licensed disposal company. 



**SECTION 14: Transport information** 



14.1 UN No. 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 48 of 542 





Page 49
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



ADR/RID: - IMDG: - IATA-DGR: - 



14.2 UN Proper Shipping Name 



ADR/RID: Not dangerous goods 



IMDG: Not dangerous goods 



IATA: Not dangerous goods 



14.3 Transport hazard class(es) 



ADR/RID: -IMDG:- IATA-DGR: - 



14.4 Packing group 



ADR/RID: -IMDG:- IATA-DGR: - 



14.5 Environmental hazards 



ADR/RID: no IMDG: no IATA: no 



14.6 Special precautions for user 



no data available 



14.7 Incompatible materials 



Strong oxidizing agents 



Further information 



Not classified as dangerous in the meaning of transport regulations. 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 49 of 542 





Page 50
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**SECTION 15: Regulatory information** 



15.1 Safety, health and environmental regulations/legislation specific for the 



substance or mixture 



National regulatory information 



Other regulations 



Please pay attention on the waste treatment should also comply with local 



regulations requirement. 



**SECTION 16: Other information** 



Further information 



The above information is believed to be correct but does not purport to be all 



inclusive and shall be used only as a guide. The information in this document 



is based on the present state of our knowledge and is applicable to the product 



with regard to appropriate safety precautions. It does not represent any 



guarantee of the properties of the product. 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 50 of 542 





Page 51
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**Annexes to 3.2.S.3.1** 



3.2.S.3.1 Annex 1 Mass spectrum of Finerenone (batch No.: 231101) 



3.2.S.3.1 Annex 2 Infrared (IR) spectrum of Finerenone (batch No.: 231101) 



180301) 



3.2.S.3.1 Annex 3 NMR spectrum of Finerenone (batch No.: 231101) 



3.2.S.3.1 Annex 4 Elemental analysis report of Finerenone (batch No.: 



231101) 



3.2.S.3.1 Annex 5 TGA thermogram report of Finerenone (batch No.: 231101) 



3.2.S.3.1 Annex 6 XRD pattern on Finerenone (batch No.: 231101) 



3.2.S.3.1 Annex 7 DSC pattern of Finerenone (batch No.: 210601) 



3.2.S.3.1 Annex 8 DSC pattern of Finerenone (batch No.: 210602) 



3.2.S.3.1 Annex 9 DSC pattern of Finerenone (batch No.: 210603) 



3.2.S.3.1 Annex 10 XRD pattern of Finerenone (batch No.: 210601) 



3.2.S.3.1 Annex 11 XRD pattern of Finerenone (batch No.: 210602) 



3.2.S.3.1 Annex 12 XRD pattern of Finerenone (batch No.: 210603) 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 51 of 542 





Page 52
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.3.1 Annex 1 Mass spectrum of Finerenone (batch No.: 231101)** 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 52 of 542 





Page 53
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.3.1 Annex 2 Infrared (IR) spectrum of Finerenone (batch No.:** 



**231101)** 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 53 of 542 





Page 54
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 54 of 542 





Page 55
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 55 of 542 





Page 56
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.3.1 Annex 3 NMR spectrum of Finerenone (batch No.: 231101)** 



1H-NMR 谱 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 56 of 542 





Page 57
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



13C-NMR 谱 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 57 of 542 





Page 58
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



COSY 谱 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 58 of 542 





Page 59
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



DEPT135 谱 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 59 of 542 





Page 60
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



DEPT90 谱 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 60 of 542 





Page 61
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



HSQC 谱 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 61 of 542 





Page 62
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



HMBC 谱 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 62 of 542 





Page 63
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.3.1 Annex 4 TGA thermogram report of Finerenone (batch No.:** 



**231101)** 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 63 of 542 





Page 64
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 64 of 542 





Page 65
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 65 of 542 





Page 66
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 66 of 542 





Page 67
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.3.1 Annex 5 TGA thermogram report of Finerenone (batch No.:** 



**231201, 240101 and 240102)** 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 67 of 542 





Page 68
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 68 of 542 





Page 69
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 69 of 542 





Page 70
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 70 of 542 





Page 71
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 71 of 542 





Page 72
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.3.1 Annex 6 DSC pattern of Finerenone (batch No.: 231101, 231201, 240101, 240102)** 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 72 of 542 





Page 73
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 73 of 542 





Page 74
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 74 of 542 





Page 75
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 75 of 542 





Page 76
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.3.1 Annex 7 XRD pattern on Finerenone (batch No.: 231101)** 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 76 of 542 





Page 77
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 77 of 542 





Page 78
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.3.1 Annex 8 XRD pattern on Finerenone (batch No.: 231201)** 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 78 of 542 





Page 79
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 79 of 542 





Page 80
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.3.1 Annex 9 XRD pattern on Finerenone (batch No.: 240101)** 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 80 of 542 





Page 81
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 81 of 542 





Page 82
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.3.1 Annex 10 XRD pattern on Finerenone (batch No.: 240102)** 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 82 of 542 





Page 83
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 83 of 542 





Page 84
**Drug Master File of Finerenone** 
Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.3.1 Annex** **11 Elemental analysis** **on Finerenone (batch No.:** 



**231101)** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 84 of 542 





Page 85
**Drug Master File of Finerenone** 
Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 85 of 542 





Page 86
**Drug Master File of Finerenone** 
Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.3.2** **Impurities** 



The applicant combined the registration process to analyze the impurity 



spectrum of Finerenone, in which there may be organic impurities, inorganic 



impurities, residual solvents, metal impurities and potential genotoxic 



impurities, five categories of impurities, and the source, destination and 



related control strategies of the above five categories of impurities have been 



analyzed and studied as follows: 



**3.2.S.3.2.1 Organic Impurities** 



The organic impurities in Finerenone mainly come from the starting materials 



and intermediates, side reaction products and degradation products that are 



not completely reacted into the starting materials during the reaction process. 



For the information of the impurities, see Table 3.2.S.3.2.1-1 Organic 



impurities spectrum of Finerenone. Of the impurities, YA2304-23, 



YA2304-24, YA2304-33, YA2304-43, YA2304-38, YA2304-40, YA2304-41, 



YA2304-1, YA2304-4, 4-dimethylamino pyridine, YA2304-47, sulfate 



impurities and nitrosamines impurities With a cautionary structure, the 



applicant does not make a specific analysis in this section, but a separate 



description and analysis in section 3.2.S.3.2.5 of Genotoxic Impurities. 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 86 of 542 





Page 87
**Drug Master File of Finerenone** 
Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Table 3.2.S.3.2-1 Potential Organic Impurities in Drug Substance Finerenone 






























-------------------------------------------------------------------------------------------------------------------------------------
|YA2304-23|4-bromo-2-hydrox ybenzaldehyde       |       |Impurityintroduced by starting material       |N/A    |no                  |
|         |                                     |       |YA2304-1                                      |       |(Including          |
|         |                                     |       |                                              |       |warning             |
|         |                                     |       |                                              |       |structure,          |
|         |                                     |       |                                              |       |see                 |
|         |                                     |       |                                              |       |"3.2.S.3.2.5        |
|         |                                     |       |                                              |       |GenotoxicImpurities"|
|         |                                     |       |                                              |       |section             |
|         |                                     |       |                                              |       |for                 |
|         |                                     |       |                                              |       |relevant            |
|         |                                     |       |                                              |       |control             |
|         |                                     |       |                                              |       |strategies)         |
|---------|-------------------------------------|-------|----------------------------------------------|-------|--------------------|
|YA2304-24|4-bromo-2-metho xybenzaldehyde       |       |Impurityintroduced by starting material       |N/A    |no (Including       |
|         |                                     |       |YA2304-1                                      |       |warning structure,  |
|         |                                     |       |                                              |       |see "3.2.S.3.2.5    |
|         |                                     |       |                                              |       |GenotoxicImpurities"|
|         |                                     |       |                                              |       |section for relevant|
|         |                                     |       |                                              |       |control strategies) |
|---------|-------------------------------------|-------|----------------------------------------------|-------|--------------------|
|YA2304-33|4-cyano-2-hydrox ybenzaldehyde       |       |Impurityintroduced by starting material       |N/A    |no (Including       |
|         |                                     |       |YA2304-1                                      |       |warning structure,  |
|         |                                     |       |                                              |       |see "3.2.S.3.2.5    |
|         |                                     |       |                                              |       |GenotoxicImpurities"|
|         |                                     |       |                                              |       |section for relevant|
|         |                                     |       |                                              |       |control strategies) |
|---------|-------------------------------------|-------|----------------------------------------------|-------|--------------------|
|YA2304-43|4-aminoformyl-2- methoxybenzalde hyde|       |Impurityintroduced by starting material       |N/A    |no (Including       |
|         |                                     |       |YA2304-1                                      |       |warning structure,  |
|         |                                     |       |                                              |       |the relevant control|
|         |                                     |       |                                              |       |strategiesare       |
|         |                                     |       |                                              |       |detailed in section |
-------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 87 of 542 





Page 88
**Drug Master File of Finerenone** 
Document: YA2304-Quality Version: 001 Date:Sep. 2024 















--------------------------------------------------------------------------------------------------------------------------------
|YA2304-38|4-methylene-2-oxacyclobutanone|       |Impurityintroduced by starting material YA2304-2|N/A    |no                  |
|         |                              |       |                                                |       |(Including          |
|         |                              |       |                                                |       |warning             |
|         |                              |       |                                                |       |structure,          |
|         |                              |       |                                                |       |see                 |
|         |                              |       |                                                |       |"3.2.S.3.2.5        |
|         |                              |       |                                                |       |GenotoxicImpurities"|
|         |                              |       |                                                |       |section for         |
|         |                              |       |                                                |       |relevant            |
|         |                              |       |                                                |       |control             |
|         |                              |       |                                                |       |strategies)         |
|---------|------------------------------|-------|------------------------------------------------|-------|--------------------|
|YA2304-39|3-hydroxypropioni trile       |       |Impurityintroduced by starting material YA2304-2|N/A    |no (The impurity has|
|         |                              |       |                                                |       |been controlled by  |
|         |                              |       |                                                |       |no more than 5.0% in|
|         |                              |       |                                                |       |the starting        |
|         |                              |       |                                                |       |material YA2304-2   |
|         |                              |       |                                                |       |andis no longer     |
|         |                              |       |                                                |       |controlled in the   |
|         |                              |       |                                                |       |finished product)   |
|---------|------------------------------|-------|------------------------------------------------|-------|--------------------|
|YA2304-57|2-cyanoethylacetate           |       |Impurityintroduced by starting material YA2304-2|N/A    |no (The impurity has|
|         |                              |       |                                                |       |been controlled by  |
|         |                              |       |                                                |       |no more than 2.0% in|
|         |                              |       |                                                |       |the starting        |
|         |                              |       |                                                |       |material YA2304-2   |
|         |                              |       |                                                |       |andis no longer     |
|         |                              |       |                                                |       |controlled in the   |
|         |                              |       |                                                |       |finished product)   |
--------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 88 of 542 





Page 89
**Drug Master File of Finerenone** 
Document: YA2304-Quality Version: 001 Date:Sep. 2024 





















-------------------------------------------------------------------------------------------------------------------------------------
|YA2304-41|2-chloro-4-amino- 5-methylpyridine|       |Impurityintroduced by starting material YA2304-4 |N/A    |no                  |
|         |                                  |       |                                                 |       |(Including          |
|         |                                  |       |                                                 |       |warning             |
|         |                                  |       |                                                 |       |structure,          |
|         |                                  |       |                                                 |       |see                 |
|         |                                  |       |                                                 |       |"3.2.S.3.2.5        |
|         |                                  |       |                                                 |       |GenotoxicImpurities"|
|         |                                  |       |                                                 |       |section             |
|         |                                  |       |                                                 |       |for                 |
|         |                                  |       |                                                 |       |relevant            |
|         |                                  |       |                                                 |       |control             |
|         |                                  |       |                                                 |       |strategies)         |
|---------|----------------------------------|-------|-------------------------------------------------|-------|--------------------|
|YA2304-1 |4-cyano-2-methox ybenzaldehyde    |       |Incompletely reacted star ting material in the   |N/A    |no (Including       |
|         |                                  |       |preparation of in termediate YA2304-5            |       |warning structure,  |
|         |                                  |       |                                                 |       |see "3.2.S.3.2.5    |
|         |                                  |       |                                                 |       |GenotoxicImpurities"|
|         |                                  |       |                                                 |       |section for relevant|
|         |                                  |       |                                                 |       |control strategies) |
|---------|----------------------------------|-------|-------------------------------------------------|-------|--------------------|
|YA2304-2 |2-cyanoacetoaceta te ethylester   |       |Incompletely reacted star ting material in the   |N/A    |no (The impurity has|
|         |                                  |       |preparation of in termediate YA2304-5            |       |been controlled not |
|         |                                  |       |                                                 |       |more than 0.5% in   |
|         |                                  |       |                                                 |       |the intermediate    |
|         |                                  |       |                                                 |       |YA2304-5 andis no   |
|         |                                  |       |                                                 |       |longer controlled in|
|         |                                  |       |                                                 |       |the finished        |
|         |                                  |       |                                                 |       |product)            |
-------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 89 of 542 





Page 90
**Drug Master File of Finerenone** 
Document: YA2304-Quality Version: 001 Date:Sep. 2024 


















---------------------------------------------------------------------------------------------------------------------------------------------
|YA2304-4 |4-amino-5-methyl -2-hydroxypyridine                                         |       |Incomplete     |N/A    |no                  |
|         |                                                                            |       |starting       |       |(Including          |
|         |                                                                            |       |mate           |       |warning             |
|         |                                                                            |       |rial           |       |structure,          |
|         |                                                                            |       |for            |       |see                 |
|         |                                                                            |       |preparation    |       |"3.2.S.3.2.5        |
|         |                                                                            |       |of in          |       |GenotoxicImpurities"|
|         |                                                                            |       |termediate     |       |section             |
|         |                                                                            |       |YA2304-5       |       |for                 |
|         |                                                                            |       |               |       |relevant            |
|         |                                                                            |       |               |       |control             |
|         |                                                                            |       |               |       |strategies)         |
|---------|----------------------------------------------------------------------------|-------|---------------|-------|--------------------|
|YA2304-47|4-amino-5-methyl -2-methoxypyridi ne                                        |       |Derivedimpurity|N/A    |no (Including       |
|         |                                                                            |       |of starting    |       |warning structure,  |
|         |                                                                            |       |material       |       |see "3.2.S.3.2.5    |
|         |                                                                            |       |YA2304-4       |       |GenotoxicImpurities"|
|         |                                                                            |       |               |       |section for relevant|
|         |                                                                            |       |               |       |control strategies) |
|---------|----------------------------------------------------------------------------|-------|---------------|-------|--------------------|
|YA2304-5 |4 - (4 - cyano - 2 - methoxy phenyl) - 2, 8 - dimethyl - 5 -,4,5,6 oxygen   |       |During the     |N/A    |no (The impurity has|
|         |generation - 1-4 h - 1, 6 - nalidixic - 3-2 - ethyl cyano formate           |       |preparation    |       |been controlled not |
|         |                                                                            |       |ofintermediate |       |more than 0.3% in   |
|         |                                                                            |       |YA2304-8, the  |       |the intermediate    |
|         |                                                                            |       |interme diate  |       |YA2304-8, andis no  |
|         |                                                                            |       |was not        |       |longer controlled in|
|         |                                                                            |       |completely     |       |the finished        |
|         |                                                                            |       |reacted        |       |product)            |
---------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 90 of 542 





Page 91
**Drug Master File of Finerenone** 
Document: YA2304-Quality Version: 001 Date:Sep. 2024 


















----------------------------------------------------------------------------------------------------------------------------------------
|YA2304-7                       |4-(4-cyano-2-met hoxyphenyl) -5-ethoxy-2,             |       |Incomplete    |N/A    |no (The         |
|                               |8-dimethyl-1, 4-dihydro-1, 6-nalididine-3-car         |       |intermediate  |       |impurity        |
|                               |boxylicacid                                           |       |product       |       |has             |
|                               |                                                      |       |in the        |       |been            |
|                               |                                                      |       |preparati     |       |controlled      |
|                               |                                                      |       |on            |       |not             |
|                               |                                                      |       |ofintermediate|       |more            |
|                               |                                                      |       |YA230         |       |than            |
|                               |                                                      |       |4-8           |       |0.15%           |
|                               |                                                      |       |              |       |in the          |
|                               |                                                      |       |              |       |intermediate    |
|                               |                                                      |       |              |       |YA2304-8,       |
|                               |                                                      |       |              |       |andis           |
|                               |                                                      |       |              |       |no              |
|                               |                                                      |       |              |       |longer          |
|                               |                                                      |       |              |       |controlled      |
|                               |                                                      |       |              |       |in the          |
|                               |                                                      |       |              |       |finished        |
|                               |                                                      |       |              |       |product)        |
|-------------------------------|------------------------------------------------------|-------|--------------|-------|----------------|
|YA2304-55                      |4 - (4 - cyano - 2 - methoxy phenyl) - 2, 8 - dimethyl|       |Incomplete    |N/A    |no (The         |
|                               |- 5 -,4,5,6 oxygen generation - 1-4 h - 1, 6 -        |       |intermediate  |       |impurity has    |
|                               |nalidixic - 3 - carbonylimidazole                     |       |product in the|       |been            |
|                               |                                                      |       |preparati on  |       |controlled      |
|                               |                                                      |       |ofintermediate|       |not more        |
|                               |                                                      |       |YA230 4-8     |       |than 0.20%      |
|                               |                                                      |       |              |       |in the          |
|                               |                                                      |       |              |       |intermediate    |
|                               |                                                      |       |              |       |YA2304-8,       |
|                               |                                                      |       |              |       |andis no        |
|                               |                                                      |       |              |       |longer          |
|                               |                                                      |       |              |       |controlled      |
|                               |                                                      |       |              |       |in the          |
|                               |                                                      |       |              |       |finished        |
|                               |                                                      |       |              |       |product)        |
|-------------------------------|------------------------------------------------------|-------|--------------|-------|----------------|
|4-dimethylami nopyridine (DMAP)|4-dimethylaminop yridine (DMAP)                       |       |Reaction rea  |N/A    |no              |
|                               |                                                      |       |gent in the   |       |(Including      |
|                               |                                                      |       |synthesis     |       |warning         |
|                               |                                                      |       |ofintermediate|       |structu re,     |
|                               |                                                      |       |YA2304-8      |       |see             |
|                               |                                                      |       |              |       |"3.2.S.3.4.2.5  |
|                               |                                                      |       |              |       |Geno            |
|                               |                                                      |       |              |       |toxicImpurities"|
|                               |                                                      |       |              |       |section for     |
|                               |                                                      |       |              |       |relevant        |
|                               |                                                      |       |              |       |control         |
|                               |                                                      |       |              |       |strategie       |
----------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 91 of 542 





Page 92
**Drug Master File of Finerenone** 
Document: YA2304-Quality Version: 001 Date:Sep. 2024 





















----------------------------------------------------------------------------------------------------------------------------------------------
|YA2304-10|D- (+) -dibenzoyltartaricacid                                               |       |Resolution    |≤0.10% |is                    |
|         |                                                                            |       |reagent       |       |(Finished             |
|         |                                                                            |       |in the        |       |productsare           |
|         |                                                                            |       |synthesis     |       |controlledaccording   |
|         |                                                                            |       |ofintermediate|       |to                    |
|         |                                                                            |       |YA2304-CP     |       |specificimpurities)   |
|---------|----------------------------------------------------------------------------|-------|--------------|-------|----------------------|
|YA2304-12|4 - (4 - amino formyl - 2 - methoxy phenyl) - 5 - ethoxy - 2, 8 - dimethyl -|       |Side reaction |≤0.10% |is (Controlled by     |
|         |1, 4-2 h - 1, 6 - nalidixic - 3 - formamide                                 |       |product in the|       |non-specificimpurities|
|         |                                                                            |       |synthesis of  |       |in finished           |
|         |                                                                            |       |the           |       |product)              |
|         |                                                                            |       |intermediate  |       |                      |
|         |                                                                            |       |YA2304-CP     |       |                      |
|---------|----------------------------------------------------------------------------|-------|--------------|-------|----------------------|
|YA2304-14|4 - (4 - cyano - 2 - methoxy phenyl) - 5 - methoxy - 2, 8 - dimethyl - 1,   |       |Side reaction |≤0.15% |is (Finished          |
|         |4-2 h - 1, 6 - nalidixic - 3 - formamide                                    |       |products      |       |productsare controlled|
|         |                                                                            |       |              |       |by specificimpurities)|
|---------|----------------------------------------------------------------------------|-------|--------------|-------|----------------------|
|YA2304-15|4 - (4 - cyano - 2 - methoxy phenyl) - 5-2 - isopropyloxygen radicals, 8 -  |       |Side reaction |≤0.15% |is (Finished          |
|         |dimethyl - 1, 4-2                                                           |       |products      |       |productsare controlled|
|         |                                                                            |       |              |       |by specificimpurities)|
----------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 92 of 542 





Page 93
**Drug Master File of Finerenone** 
Document: YA2304-Quality Version: 001 Date:Sep. 2024 






























--------------------------------------------------------------------------------------------------------------------------------------------
|YA2304-16|4-(4-cyano-2-met hoxyphenyl) -5-methoxy-2, 8-dimethyl-1, 4-dihydro-1,       |       |Side        |≤0.10% |is                    |
|         |6-nalididine-3-car boxylicacid                                              |       |reaction    |       |(Controlled           |
|         |                                                                            |       |products    |       |by                    |
|         |                                                                            |       |            |       |non-specificimpurities|
|         |                                                                            |       |            |       |in                    |
|         |                                                                            |       |            |       |finished              |
|         |                                                                            |       |            |       |product)              |
|---------|----------------------------------------------------------------------------|-------|------------|-------|----------------------|
|YA2304-17|Benzoicacid                                                                 |       |Aby-product |N/A    |no (The impurityis    |
|         |                                                                            |       |in the      |       |controlledasa         |
|         |                                                                            |       |synthesis   |       |specificimpurity in   |
|         |                                                                            |       |of the      |       |the crude product, the|
|         |                                                                            |       |intermediate|       |limitis not more than |
|         |                                                                            |       |YA2304-CP   |       |0.15%, and the        |
|         |                                                                            |       |            |       |finished productis no |
|         |                                                                            |       |            |       |longer controlled)    |
|---------|----------------------------------------------------------------------------|-------|------------|-------|----------------------|
|YA2304-52|D-(+)- monobenzoyl tartaricacid                                             |       |Aby-product |N/A    |no (Has been in the   |
|         |                                                                            |       |in the      |       |finished Finerenone   |
|         |                                                                            |       |synthesis of|       |through multiple      |
|         |                                                                            |       |the         |       |batches of statistical|
|         |                                                                            |       |intermediate|       |proof can be          |
|         |                                                                            |       |YA2304-CP   |       |completely removed,   |
|         |                                                                            |       |            |       |the finished productis|
|         |                                                                            |       |            |       |no longer controlled) |
--------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 93 of 542 





Page 94
**Drug Master File of Finerenone** 
Document: YA2304-Quality Version: 001 Date:Sep. 2024 
























-----------------------------------------------------------------------------------------------------------------------------------------
|YA2304-19|4-(4-cyano-2-met hoxyphenyl) -5-ethoxy-2, 8-dimethyl-1, 6-nalididine-3-for  |       |Side        |≤0.15% |is                 |
|         |mamide                                                                      |       |reaction    |       |(Finished          |
|         |                                                                            |       |products    |       |productsare        |
|         |                                                                            |       |            |       |controlled         |
|         |                                                                            |       |            |       |by                 |
|         |                                                                            |       |            |       |specificimpurities)|
|---------|----------------------------------------------------------------------------|-------|------------|-------|-------------------|
|YA2304-20|4 - (4 - (4 r) - cyano - 2 - methoxy phenyl) - 5 - ethoxy - 2, 8 - dimethyl |       |enantiomers |≤0.15% |is (Finished       |
|         |- 1, 4-2 h - 1, 6 - nalidixic - 3 - formamide                               |       |            |       |productsare        |
|         |                                                                            |       |            |       |controlled by      |
|         |                                                                            |       |            |       |specificimpurities)|
|---------|----------------------------------------------------------------------------|-------|------------|-------|-------------------|
|imidazole|Imidazole                                                                   |       |Reaction    |N/A    |no (has been       |
|         |                                                                            |       |byproducts  |       |completely removed |
|         |                                                                            |       |and         |       |in the finished    |
|         |                                                                            |       |hydrolysates|       |fineridone through |
|         |                                                                            |       |of CDI      |       |multiple batches of|
|         |                                                                            |       |            |       |statistical proof, |
|         |                                                                            |       |            |       |no longer          |
|         |                                                                            |       |            |       |controlled in the  |
|         |                                                                            |       |            |       |finishedproduct)   |
-----------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 94 of 542 





Page 95
**Drug Master File of Finerenone** 
Document: YA2304-Quality Version: 001 Date:Sep. 2024 










































------------------------------------------------------------------------------------------------------------------------
|Diethyl sulfate     |Diethyl sulfate       |       |Side reaction products|≤75ppm |is (Including the warning          |
|                    |                      |       |                      |       |structure, the relevant control    |
|                    |                      |       |                      |       |strategyis detailed in the section |
|                    |                      |       |                      |       |"3.2.S.3.4.2.5                     |
|                    |                      |       |                      |       |GenotoxicImpurities")              |
|--------------------|----------------------|-------|----------------------|-------|-----------------------------------|
|Diisopropyl sulfate |Diisopropyl sulfate   |       |Side reaction products|≤75ppm |is (Including the warning          |
|                    |                      |       |                      |       |structure, the relevant control    |
|                    |                      |       |                      |       |strategyis detailed in the section |
|                    |                      |       |                      |       |"3.2.S.3.4.2.5                     |
|                    |                      |       |                      |       |GenotoxicImpurities")              |
|--------------------|----------------------|-------|----------------------|-------|-----------------------------------|
|Di-sec-butyl sulfate|Di-sec-butyl sulfate  |       |Side reaction products|≤75ppm |is (Including the warning          |
|                    |                      |       |                      |       |structure, the relevant control    |
|                    |                      |       |                      |       |strategyis detailed in the section |
|                    |                      |       |                      |       |"3.2.S.3.4.2.5                     |
|                    |                      |       |                      |       |GenotoxicImpurities")              |
|--------------------|----------------------|-------|----------------------|-------|-----------------------------------|
|NDMA                |N-nitrosodimethylamine|N NO   |Side reaction product |N/A    |no (No longer controlled in        |
|                    |                      |       |                      |       |finished fineridone after          |
------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 95 of 542 





Page 96
**Drug Master File of Finerenone** 
Document: YA2304-Quality Version: 001 Date:Sep. 2024 

































------------------------------------------------------------------------------------------------------------------------
|NDEA   |N-nitrosodiethyla mine              |N NO     |Side reaction products|N/A    |no (No longer controlled in     |
|       |                                    |         |                      |       |finished fineridone after       |
|       |                                    |         |                      |       |multiple batch statistics prove |
|       |                                    |         |                      |       |non-existence)                  |
|-------|------------------------------------|---------|----------------------|-------|--------------------------------|
|NDIPA  |N-nitrosodiisopro pylamine          |N NO     |Side reaction products|N/A    |no (No longer controlled in     |
|       |                                    |         |                      |       |finished fineridone after       |
|       |                                    |         |                      |       |multiple batch statistics prove |
|       |                                    |         |                      |       |non-existence)                  |
|-------|------------------------------------|---------|----------------------|-------|--------------------------------|
|NDBA   |N-nitrosodibutyla mine              |N NO     |Side reaction products|N/A    |no (No longer controlled in     |
|       |                                    |         |                      |       |finished fineridone after       |
|       |                                    |         |                      |       |multiple batch statistics prove |
|       |                                    |         |                      |       |non-existence)                  |
|-------|------------------------------------|---------|----------------------|-------|--------------------------------|
|NIEPA  |N-nitrosoethylisop ropylamine       |N NO     |Side reaction products|N/A    |no (No longer controlled in     |
|       |                                    |         |                      |       |finished fineridone after       |
|       |                                    |         |                      |       |multiple batch statistics prove |
|       |                                    |         |                      |       |non-existence)                  |
|-------|------------------------------------|---------|----------------------|-------|--------------------------------|
|NMBA   |N-nitroso-methyl- 4-aminobutyricacid|OH N NO O|Side reaction products|N/A    |no (No longer controlled in     |
|       |                                    |         |                      |       |finished fineridone after       |
|       |                                    |         |                      |       |multiple batch statistics prove |
|       |                                    |         |                      |       |non-existence)                  |
------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 96 of 542 





Page 97
**Drug Master File of Finerenone** 
Document: YA2304-Quality Version: 001 Date:Sep. 2024 



























------------------------------------------------------------------------------------------------------------------------
|NDPA   |N-nitrosodipropylamine|H3C N H3C NO|Side reaction products|N/A    |no (No longer controlled in finished       |
|       |                      |            |                      |       |fineridone after multiple batch statistics |
|       |                      |            |                      |       |prove non-existence)                       |
------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 97 of 542 





Page 98
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



（ **1** ） **YA2304-39** 



YA2304-39 is the incomplete raw material in the synthesis of the starting 



material YA2304-2. Its molecular structure formula is as follows: 



The Applicant intends to control YA2304-39 as a specific impurity by no 



more than 5.0% in the starting material YA2304-2 and calculate the impurity 



content by self-comparison method with correction factor. Refer to the 



validation report of YA2304-2 Related Substance Methodology under item 



3.2.2.3.6.1 that YA2304-39 has a correction factor of 0.9 relative to 



YA2304-2. At the same time, the reasonability of the impurity limit in the 



standard of the applicant's design of the impurity experiment is investigated. 



The investigation results show that the removal capacity of the registered 



process for impurity YA2304-39 is NLT 5.0%. The experimental process is 



detailed in section 3.2.S.2.3.5.2. Therefore, impurity YA2304-39 is no longer 



controlled in the finished Finerenone. 



（ **2** ） **YA2304-57** 



YA2304-57 is a by-product in the synthesis of the starting material YA2304-2. 



Its molecular structure formula is as follows: 



The applicant intends to control YA2304-57 as a specific impurity in the 



starting material YA2304-2 by no more than 2.0% and calculate the impurity 



content by self-comparison method with correction factor. Refer to the 



validation report of YA2304-2 Related Substance Methodology under item 



3.2.2.3.6.1 that YA2304-57 has a correction factor of 0.9 relative to 



YA2304-2. At the same time, the applicant designed an experiment to 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 98 of 542 





Page 99
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



investigate the reasonability of the impurity limit in the standard for adding 



impurities, and the investigation results show that the removal capacity of 



the registered process for impurity YA2304-57 is NLT 2.0%. The experimental 



process is detailed in section 3.2.S.2.3.5.2. Therefore, the impurity 



YA2304-57 is no longer controlled in the finished Finerenone. 



**(3) YA2304-2** 



YA2304-2 is the incomplete starting material in Finerenone synthesis. Its 



molecular structure formula is as follows: 



The applicant intends to use YA2304-2 as a specific impurity in the 



intermediate YA2304-5 to control no more than 0.5%, and calculate the 



impurity content by external standard method. At the same time, the 



applicant designed an experiment to investigate the rationality of the 



impurity limit in the standard for adding impurities, and the investigation 



results show that the removal capacity of the registration process for 



impurity YA2304-2 is NLT 0.5%. The experimental process is detailed in 



section 3.2.S.2.4.3.1.1. Therefore, impurity YA2304-2 is no longer controlled 



in the finished Finerenone. 



**(4) YA2304-3** 



YA2304-3 is an intermediate product in the synthesis of the intermediate 



YA2304-5. Its molecular structure formula is as follows: 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 99 of 542 





Page 100
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



The applicant intends to control YA2304-3 as a specific impurity not 



exceeding 1.0% in the intermediate YA2304-5, and calculate the impurity 



content by self-comparison method with correction factor. Refer to the 



validation report of YA2304-5 on Substance Methodology under item 



3.2.S.2.4.3.1.3.1 that YA2304-3 has a correction factor of 2.4 relative to 



YA2304-5. At the same time, the reasonableness of the impurity limit in the 



test standard for impurity addition designed by the applicant shows that the 



removal ability of the registration process for impurity YA2304-3 is NLT 1.0%. 



The experimental process is detailed in section 3.2.S.2.4.3.1.1. Therefore, 



impurity YA2304-3 is no longer controlled in the finished finalizone. 



**(5) YA2304-5** 



YA2304-5 is an intermediate in Finerenone synthesis. Its molecular 



structure formula is as follows: 



The applicant intends to control YA2304-5 as a specific impurity not 



exceeding 0.3% in the intermediate YA2304-8, and calculate the impurity 



content by self-comparison method with correction factor. Refer to the 



validation report of YA2304-8 on Substance Methodology under item 



3.2.S.2.4.3.2.3. The correction factor of YA2304-5 relative to YA2304-8 is 1.2. 



At the same time, the reasonability of the impurity limit in the test standard 



for impurity addition designed by the applicant shows that the removal 



capacity of the registration process for impurity YA2304-5 is NLT 0.3%, and 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 100 of 542 





Page 101
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



the experimental process is detailed in section 3.2.S.2.4.3.2.1. Therefore, 



impurity YA2304-5 is no longer controlled in the finished Finerenone. 



**(6) YA2304-6** 



YA2304-6 is an intermediate product in the synthesis of the intermediate 



YA2304-8. Its molecular structure formula is as follows: 



The applicant intends to control YA2304-6 as a specific impurity not 



exceeding 0.3% in the intermediate YA2304-8, and calculate the impurity 



content by self-comparison method with correction factor. Refer to the 



validation report of YA2304-8 Related Substance Methodology under item 



3.2.S.2.4.3.2.3, YA2304-6 has a correction factor of 1.1 relative to YA2304-8. 



At the same time, the reasonability of the impurity limit in the test standard 



for impurity addition designed by the applicant shows that the removal 



capacity of the registration process for impurity YA2304-6 is NLT 0.3%, and 



the experimental process is detailed in section 3.2.S.2.4.3.2.1. Therefore, 



impurity YA2304-6 is no longer controlled in the finished Finerenone. 



**(7) YA2304-7** 



YA2304-7 is an intermediate product in the synthesis of the intermediate 



YA2304-8. Its molecular structure formula is as follows: 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 101 of 542 





Page 102
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



The applicant intends to control YA2304-7 as a specific impurity not 



exceeding 0.15% in the intermediate YA2304-8, and calculate the impurity 



content by self-comparison method with correction factor. Refer to the 



validation report of YA2304-8 Related Substance Methodology under item 



3.2.S.2.4.3.2.3. It can be seen that YA2304-7 has a correction factor of 1.0 



relative to YA2304-8. At the same time, the applicant designed an impurity 



addition experiment to investigate the reasonability of the impurity limit in 



the standard. The experimental process is detailed in section 3.2.S.2.4.3.2.1. 



Therefore, impurity YA2304-7 is no longer controlled in the finished 



Finerenone. 



**(8) YA2304-55** 



YA2304-55 is an intermediate product in the synthesis of the intermediate 



YA2304-8. Its molecular structure formula is as follows: 



The applicant intends to control YA2304-55 as a specific impurity not 



exceeding 0.20% in the intermediate YA2304-8, and calculate the impurity 



content by self-comparison method with correction factor. Refer to the 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 102 of 542 





Page 103
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



validation report of YA2304-8 on Substance Methodology under item 



3.2.S.2.4.3.2.3 that YA2304-55 has a correction factor of 1.2 relative to 



YA2304-8. At the same time, the reasonability of the impurity limit in the test 



standard designed by the applicant for adding impurities shows that the 



removal capacity of the registered process for impurity YA2304-55 is NLT 



0.20%, and the impurity limit meets the process requirements. The 



experimental process is detailed in section 3.2.S.2.4.3.2.1. Therefore, 



impurity YA2304-55 is no longer controlled in the finished Finerenone. 



**(9) YA2304-10** 



YA2304-10 is the resolution reagent in the synthesis of intermediate 



YA2304-CP. Its molecular structure formula is as follows: 



The applicant intends to control the impurity YA2304-10 as a specific 



impurity in the finished Finerenonee, with the limit of not exceeding the 



identification threshold of 0.10%, and calculate the peak area according to 



the external standard method. 



**(10) YA2304-12** 



YA2304-12 is a possible by-product in the synthesis of intermediate 



YA2304-CP, and the impurity may be produced by hydrolysis of Finerenone 



under acidic or alkaline conditions. According to the degradation 



experimental data in 3.2.S.4.3.1 Methodology-verification of related 



substances of the finished product, Finerenone did not degrade impurity 



YA2304-12 under weak acid (destruction by 2mL of 0.1mol/l hydrochloric 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 103 of 542 





Page 104
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



acid for 24h). The known impurity YA2304-12 (content 0.07%) was mainly 



produced by the degradation of Finerenone under the condition of weak base 



(destruction of 2mL of 0.1mol/l sodium hydroxide for 24h). Its molecular 



structure formula and chemical reaction process are as follows: 



The Applicant initially controlled impurity YA2304-12 as a specific impurity 



in the finished Finerenonee to a limit of 0.15% above the defined threshold. 



Refer to the Validation report of the Methodology for the Analysis of 



Substances in 3.2.S.4.3.1 that YA2304-12 has a correction factor of 1.2 



relative to Finerenone. The applicant tested three commercial-scale batches 



of Finerenone (batch No. 231201, 240101 and 240102) by the method of 



substance related, and no impurity YA2304-12 was detected in each sample. 



For specific test data, please refer to Table 3.2.S.3.3.2.1 -2. In addition, the 



impurity was also investigated by the applicant in the stability study. See 



3.2.S.7.3 stability data for the above three commercial-scale batch 



Finerenone apis under accelerated stability test conditions (temperature 40 ° 



C ±2 ° C; Humidity 75%±5%) and long-term stability test conditions 



(temperature 30℃±2℃, relative humidity RH65%±5%) for 6 months, the 



impurity YA2304-12 was not detected, indicating that the Finerenone raw 



material will not produce impurity YA2304-12 during stable placement. 



Therefore, the applicant finally controlled the impurity YA2304-12 in the 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 104 of 542 





Page 105
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



finished product as a non-specific impurity to not exceed the identification 



threshold of 0.10%. 



**(11) YA2304-14, YA2304-15 and YA2304-16, YA2304-18** 



Impurity formation path and mutual conversion relationship of YA2304-14, 



YA2304-15 and YA2304-16 and YA2304-18 are as follows: 



① Triethyl orthoacetate may contain a small amount of methyl and isopropyl 



substituted impurities, and YA2304-50 and YA2304-51 can be formed by 



alkylation reaction with YA2304-5, and YA2304-16 and YA2304-18 can be 



formed by hydrolysis reaction in the following steps. And then the 



corresponding derivatives YA2304-14 and YA2304-15 are generated by 



ammonolysis. 



② In the presence of methanol and isopropyl alcohol, Finerenone may also 



generate impurities YA2304-14 and YA2304-15 by ether exchange, 



respectively. 



③YA2304-14 and YA2304-15 may be hydrolyzed under acidic conditions to 



produce impurities YA2304-16 and YA2304-18, respectively. 



The molecular structure formula and chemical reaction process of each 



impurity are as follows: 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 105 of 542 





Page 106
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Impurities YA2304-14 and YA2304-15 are process impurities that are finally 



converted in the finished product. The original research import registration 



preparation standard JX20220072 controls these two impurities (the code of 



the impurity in the import registration standard is BAY1814286 and 



BAY1814288, respectively) as non-specific impurities shall not exceed 0.2%. 



The applicant intends to more strictly control the impurities YA2304-14 and 



YA2304-15 as specific impurities in the finished Finerenone, which shall not 



exceed the defined threshold of 0.15%. 



The Applicant originally controlled the impurities YA2304-16 and YA2304-18 



as specific impurities in the finished finnalidone to the extent that they both 



did not exceed the defined threshold of 0.15%. Refer to the 3.2.S.4.3.1 



Validation Report on the Methodology of Substance Analysis that YA2304-16 



has a correction factor of 1.0 with respect to Finerenone and YA2304-18 has 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 106 of 542 





Page 107
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



a correction factor of 1.1 with respect to Finerenone. The applicant tested 



three commercial-scale batches of Finerenone (batch No. 231201, 240101 



and 240102) by using the substance related method. Impurities YA2304-16 



and YA2304-18 in each sample were not detected. For specific test data, 



please refer to Table 3.2.S. In addition, the impurity was also investigated by 



the applicant in the stability study. See 3.2.S.7.3 stability data for the above 



three commercial-scale batch Finerenone apis under accelerated stability 



test conditions (temperature 40 ° C ±2 ° C; Humidity 75%±5%) and long-term 



stability test conditions (temperature 30℃±2℃, relative humidity 



RH65%±5%) for 6 months, impurities YA2304-16 and YA2304-18 were not 



detected. It indicated that the impurities YA2304-16 and YA2304-18 would 



not be produced during the stable placement of Finerenone. As a result, the 



applicant ultimately controls the impurities YA2304-16 and YA2304-18 as 



non-specific impurities in the finished product without exceeding the 



identification threshold of 0.10%. 



**(12) YA2304-17 and YA2304-52** 



Impurities YA2304-17 and YA2304-52 are hydrolyzed products of the 



resolution reagent YA2304-10 (D-(+) -dibenzoyltartaric acid), and their 



molecular structure formula and chemical reaction process are as follows: 



The applicant initially controlled the impurity YA2304-17 as a specific 



impurity in the finished Finerenone, with the limit not exceeding the defined 



threshold of 0.15%, and calculated according to the external standard 



method. The Applicant tested three commercial-scale batches of Finerenone 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 107 of 542 





Page 108
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



No. 231201, 240101 and 240102 by the method of substance related, and no 



impurity YA2304-17 was detected in each sample. For specific test data, 



please refer to Table 3.2.S. In addition, the impurity was also investigated by 



the applicant in the stability study. Refer to the stability data of 3.2.S.7.3, it 



can be seen that the above three batches of commercial-scale mass produced 



Finerenone apis were placed under accelerated stability test conditions 



(temperature 40℃±2℃, humidity 75%±5%) and long-term stability test 



conditions (temperature 30℃±2℃, relative humidity RH65%±5%) for 6 



months. Impurity YA2304-17 was also not detected, indicating that the 



impurity YA2304-17 would not be produced during the stable placement of 



the Finerenone bulk drug. In summary, the registered process has a good 



ability to remove impurity YA2304-17 and does not degrade during the 



stability period to produce impurity YA2304-17. The applicant intends to 



eventually use impurity YA2304-17 as a specific impurity in the crude 



product, which shall not exceed the defined threshold of 0.15% and shall not 



control impurity YA2304-17 in the finished product. 



The applicant tested three commercial-scale batches of Finerenone No. 



231201, 240101 and 240102 by using the Substance II method. No impurity 



YA2304-52 was detected in each sample. For specific test data, please refer to 



Table 3.2.S. The test results showed that the registered process had a good 



ability to remove impurity YA2304-52. Therefore, the applicant does not 



control the impurity YA2304-52 in the finished product. 



**(13) YA2304-19** 



YA2304-19 is the oxidative degradation product in the process of preparing 



YA2304-CP. Its molecular structure formula and chemical reaction process 



are as follows: 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 108 of 542 





Page 109
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



The impurity (the code of the impurity in the import registration standard is 



BAY1040818) shall not be controlled more than 0.5% as a specific impurity 



in the original research import registration preparation standard 



JX20220072, and the applicant intends to use the impurity as a specific 



impurity in the finished Finerenonee to more strictly control that the 



impurity shall not exceed the defined threshold of 0.15%. Refer to the 



validation report of 3.2.S.4.3.1 Related Substance analysis Methodology, 



YA2304-19 has a correction factor of 0.7 relative to Finerenone. 



（ **14** ） **YA2304-20** 



YA2304-20 is the enantiomer impurity of the finished product. The chemical 



structure formula is as follows: 



The impurity was not controlled in JX20220072, the standard for imported 



registered preparations of the original research. The applicant intends to 



control the impurity as a specific impurity not exceeding the defined 



threshold value of 0.15% in the quality standard of Finerenone, and calculate 



the content of the impurity according to the external standard method. 



**(15) Imidazole** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 109 of 542 





Page 110
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Imidazole is the by-product of the reaction and the hydrolyzed product of 



reagent CDI. The applicant tested three commercially-produced batches of 



Finerenone No. 231201, 240101 and 240102 by the method of Substance II. 



No imidazole was detected in each sample. For specific test data, please refer 



to Table 3.2.S. The test results showed that the registered process had a good 



scavenging ability for imidazole. Therefore, the applicant does not control the 



imidazole in the finished product. 



**(16) Unknown degradation impurities** 



Refer to the degradation experimental data in 3.2.S.4.3.1 Methodological 



verification of finished product related substances. Under the condition of 



destruction by weak acid (destruction by 2mL of 0.1mol/l hydrochloric acid 



for 24h), the raw material of Finerenone mainly degraded to produce known 



impurities YA2304-16 (content < 0.05%) and unknown impurities of 



RRT≈0.59 (content 2.02%). The known impurity YA2304-12 (content 0.07%) 



was mainly degraded under the condition of weak base (destruction of 2mL of 



0.1mol/l sodium hydroxide for 24h). The degradation of Finerenone under 



oxidation destruction (2mL destruction of 3% hydrogen peroxide for 24h) 



mainly produced unknown impurities YA2304-19 (content 0.12%) and 



RRT≈0.64 (content 0.43%). The solid samples of Finerenone were destroyed 



by light (4500±500Lux, 90±5μWcm [2] for 30d) degradation mainly produced 5 



known impurities YA2304-14, YA2304-15, YA2304-16, YA2304-17, 



YA2304-19, and unknown impurities with RRT≈1.53 (content of 0.05%). The 



5 known impurities produced by degradation except the impurity YA2304-19 



content of 0.17%, the other known impurities produced by degradation 



content of < 0.05%; Two known impurities, YA2144-16 and YA2144-19, and 



three unknown impurities, RRT≈0.64, RRT≈0.87 and RRT≈0.96, were mainly 



produced by the degradation of fenelidone bulk drug solution by light 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 110 of 542 





Page 111
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



(4500±500Lux, 90±5μWcm [2] destroying the test product solution for 24h). 



The contents of YA2304-16 and YA2304-19 produced by degradation were < 



0.05% and 0.54%, and the contents of RRT≈0.64, RRT≈0.87 and RRT≈0.96 



produced by degradation were 0.06%, 0.06% and 0.08%, respectively. These 



unknown impurities can be effectively separated by the method of related 



substances. Under other conditions, the unknown impurities were not 



degraded in the samples. 



3.S.7.3 Accelerated Stability Test and long-term stability test data showed 



that three commercial-scale batches of Finerenone 231201, 240101 and 



240102 were subjected to accelerated stability test at 6 months (temperature 



40℃±2℃, All impurities during the relative humidity RH75%±5% and the 



6-month long-term stability test (temperature 30℃±2℃, relative humidity 



RH65%±5%) were in line with the internal control standards, and no new 



unknown degradation impurities were produced. 



In accordance with the provisions of ICHQ1A(R2) section 2.1.2: If some 



degradation products of the degradation test have been confirmed to be not 



generated under accelerated or long-term stability test conditions, it is not 



necessary to control the impurity. Therefore, the Applicant shall not control 



the said unknown degradation impurity as a specific impurity in the finished 



product and shall not exceed the identification threshold of 0.10% as a 



non-specific impurity. 



**Detection of potential organic impurities in commercial-scale mass** 



**production of Finerenone** 



The detection of potential organic impurities in three commercial-scale b 



atches of Finerenone with batch NO.s 231201, 240101 and 240102 are 



shown in Table 3.2.S. 4.1-2. 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 111 of 542 





Page 112
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Table 3.2.S.3.2.1-2 Detection of each potential organic impurity in Finer 



















----------------------------------------------------------------------------------------
|Batch No. Impurity name|Batch No. Impurity name|231201      |240101      |240102      |
|-----------------------|-----------------------|------------|------------|------------|
|Related subs tance     |YA2304-10              |Not detected|Not detected|Not detected|
|-----------------------|-----------------------|------------|------------|------------|
|Related subs tance     |YA2304-12              |Not detected|Not detected|Not detected|
|-----------------------|-----------------------|------------|------------|------------|
|Related subs tance     |YA2304-14              |Not detected|Not detected|Not detected|
|-----------------------|-----------------------|------------|------------|------------|
|Related subs tance     |YA2304-15              |Not detected|Not detected|< 0.05%     |
|-----------------------|-----------------------|------------|------------|------------|
|Related subs tance     |YA2304-16              |Not detected|Not detected|Not detected|
|-----------------------|-----------------------|------------|------------|------------|
|Related subs tance     |YA2304-17              |Not detected|Not detected|Not detected|
|-----------------------|-----------------------|------------|------------|------------|
|Related subs tance     |YA2304-18              |Not detected|Not detected|Not detected|
|-----------------------|-----------------------|------------|------------|------------|
|Related subs tance     |YA2304-19              |< 0.05%     |< 0.05%     |< 0.05%     |
|-----------------------|-----------------------|------------|------------|------------|
|Related subs tance     |Other single impurities|< 0.05%     |< 0.05%     |< 0.05%     |
|-----------------------|-----------------------|------------|------------|------------|
|Related subs tance     |Total Miscella neous   |< 0.05%     |< 0.05%     |< 0.05%     |
|-----------------------|-----------------------|------------|------------|------------|
|Related Sub stance II  |YA2304-52              |Not detected|Not detected|Not detected|
|-----------------------|-----------------------|------------|------------|------------|
|Related Sub stance II  |Imidazole              |Not detected|Not detected|Not detected|
|-----------------------|-----------------------|------------|------------|------------|
|Enantiomer             |YA2304-20              |0.03%       |0.03%       |0.02%       |
----------------------------------------------------------------------------------------

**3.2.S.3.2.2 Inorganic Impurities** 



Inorganic impurities in Finerenone may originate from reaction reagents, 



catalysts used in the production process, and inorganic salts used in the 



post-treatment process. For inorganic impurities that may be introduced into 



the starting material, the applicant intends to set up a incandescent residue 



item in each starting material quality standard to control inorganic 



impurities. Therefore, the applicant combined with 3.2.S.2.2.3 process 



description to analyze and study the inorganic impurities in the process of 



Finerenone preparation, and formulated the corresponding control strategy, 



as detailed in Table 3.2.S.3.2.2-1. 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 112 of 542 





Page 113
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Table 3.2.S.3.2.2-1 Analysis and Control Strategies of Inorganic Impurities in 


















------------------------------------------------------------------------------------------------------------------------------
|Names ofImpurities|Impurity source and removalanalysis                                                |Control     |Is the  |
|                  |                                                                                   |Limits      |negation|
|                  |                                                                                   |            |ofentry |
|                  |                                                                                   |            |criteria|
|------------------|-----------------------------------------------------------------------------------|------------|--------|
|Sodiumacetate     |Sodiumacetate is the reagentused in step 2. Thisimpurityis soluble in water and can|Incandescent|is      |
|                  |be removed by subsequent washing and crystallization processes. The                |residue     |        |
|                  |applicantintends to control sodiumacetate by burning residue.                      |≤0.1%       |        |
|------------------|-----------------------------------------------------------------------------------|------------|--------|
|Sulfuricacid      |Sulfuricacidis the reagentused in step 2 andis converted to sodium sulfate. Sodium |Incandescent|is      |
|                  |sulfate dissolveseasily in water and can be removed by subsequent washing and      |residue     |        |
|                  |crystallization processes. The applicantintends to control sodium sulfate by       |≤0.1%       |        |
|                  |burning residue.                                                                   |            |        |
|------------------|-----------------------------------------------------------------------------------|------------|--------|
|Sodium hydroxide  |Sodium hydroxide is the reagentused in step 2, which can be convertedinto sodium   |Incandescent|is      |
|                  |chloride. Sodium chloride is soluble in water and can be removed by subsequent     |residue     |        |
|                  |washing and crystallization processes. The applicantintends to control sodium      |≤0.1%       |        |
|                  |chloride by burning residue.                                                       |            |        |
|------------------|-----------------------------------------------------------------------------------|------------|--------|
|Hydrochlo ricacid |Hydrochloricacidis the reagentused in step 2 andis converted to sodium chloride.   |Incandescent|is      |
|                  |Sodium chloride is soluble in water and can be removed by subsequent washing and   |residue     |        |
|                  |crystallization processes. The applicantintends to control sodium chloride by      |≤0.1%       |        |
|                  |burning residue.                                                                   |            |        |
|------------------|-----------------------------------------------------------------------------------|------------|--------|
|Sodium phosphate  |Sodium phosphate is the reagentused in Step 3 thatis partially converted to convert|Burning     |is      |
|                  |disodium hydrogen phosphate after the base is modulated in step 3. The impurities  |residue     |        |
|                  |of                                                                                 |≤0.1%       |        |
------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 113 of 542 





Page 114
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



disodium hydrogen phosphate and sodium 



phosphate are soluble in water and can be 



removed by subsequent washing and 



crystallization processes. The applicant 



intends to control disodium hydrogen 



phosphate and sodium phosphate through 



incandescent residue. 



**Chlorides and sulfates** 



Finerenone can remove trace amounts of chloride and sulfate that may 



remain after multiple washing, filtration, and recrystallization processes. The 



applicant has tested the chlorides and sulfates of multiple batches of 



commercial-scale mass-produced Finerenone in accordance with General 



Rules 0801 and 0802 of Part 4 of the 2020 Edition of the Chinese 



Pharmacopoeia. The test results of chloride and sulfate are not more than 



0.02%, and the test results of sulfate are not more than 0.1%, as detailed in 



Table 3.2.S.3.2.2-2. Since the incandescent residue can also control chloride 



and sulfate, the applicant intends not to set up a test item for chloride and 



sulfate in the finished product standard. 



**The detection of various inorganic impurities in commercial-scale batch** 



**production of Finerenone** 



The applicant has tested the burning residue, chloride and sulfate of three 



batches of commercial-scale mass produced Finerenone (batch No. 231201, 



240101 and 240102 respectively), and the test results all meet the 



requirements of the standard. The test results are shown in Table 



3.2.S.3.2.2-2. 



Table 3.2.S.3.2.2-2 Statistics of detection data of inorganic impurities in 



Finerenone 













Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 114 of 542 





Page 115
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 

--------------------------------------------
|Chloride ≤0.02%|conforms|conforms|conforms|
|---------------|--------|--------|--------|
|Sulfate ≤0.1%  |conforms|conforms|conforms|
--------------------------------------------



**3.2.S.3.2.3 Residual solvents** 



Solvent Control Strategies". It intends to control triethylamine in starting 



material YA2304-2 with reference to ICHQ3C(R9) and the four General Rules 



The residual solvents that may be introduced into starting material 



YA2304-1 are acetone, N, N-dimethylformamide, dichloromethane, ethanol, 



methanol and methyl tert-butyl ether, the residual solvents that may be 



introduced into starting material YA2304-2 are ethyl acetate and 



triethylamine, and the residual solvents that may be introduced into starting 



material YA2304-2 are methanol and ethanol. In the preparation of 



Finerenonee, the applicant used eight dissolution reagents, including 



piperidine, acetic acid, isopropyl alcohol, secondary butanol, 



n-methylpyrrolidone, toluene, tetrahydrofuran and ethanol. The reagent was 



triethyl acetate reaction and hydrolysis to produce ethanol and ethyl acetate, 



and a trace amount of benzene may be introduced into the solvent acetone, 



toluene and ethanol. 



In summary, 16 residual solvents such as acetone, N, N-dimethylformamide, 



dichloromethane, ethanol, methyl tert-butyl ether, ethyl acetate, 



triethylamine, methanol, acetic acid, piperidine, isopropyl alcohol, secondary 



butanol, n-methylpyrrolidone, toluene, tetrahydrofuran and benzene may be 



present in the finished finnalidone. The applicant intends to control 



acetone,N, N-dimethylformamide, dichloromethane, methanol and methyl 



tert-butyl ether in starting material YA2304-1 with reference to ICHQ3C(R9) 



and the Four General Rules 0861 of the 2020 edition of the Chinese 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 115 of 542 





Page 116
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Pharmacopoeia. The relevant control strategies are detailed in section 



3.2.S.2.3.3.2 "Residual0861 of the 2020 edition of the Chinese 



Pharmacopoeia. The relevant control strategies are detailed in section 



3.2.S.2.3.5.2 "Residual Solvent Control Strategy"; It is proposed to control 



methanol in starting material YA2304-4 with reference to ICHQ3C(R9) and 



General Rules 0861 of the fourth part of the 2020 edition of Chinese 



Pharmacopoeia. The relevant control strategies are detailed in section 



3.2.S.2.3.7.2 "Residual Solvent Control Strategy"; Acetic acid is the reagent 



used in step 1, which can be easily removed by dissolving in aqueous 



solution with alkali-forming inorganic salts in subsequent steps, and the 



applicant intends not to conduct research control on it; For the remaining 



residual solvents, the applicant classifies them with reference to ICHQ3C(R9) 



and the fourth General Rule 0861 of the 2020 edition of the Chinese 



Pharmacopoeia, and formulates the corresponding control limits, as detailed 



in Table 3.2.S.3.2.3-1. 



Table 3.2.S.3.2.3-1 Classification and control limits of residual solvents 

























------------------------------------------------------------------------------------------------------------------------
|Ethylacetate       |Starting material YA2304-2 isintroduced, reagent triethylorthoacetate reaction and|Class 3|≤0.5%  |
|                   |hydrolysis                                                                        |       |       |
|-------------------|----------------------------------------------------------------------------------|-------|-------|
|Isopropylalcohol   |Steps 1                                                                           |Class 3|≤0.5%  |
|-------------------|----------------------------------------------------------------------------------|-------|-------|
|sec-butanol        |Step 1                                                                            |Class 3|≤0.5%  |
|-------------------|----------------------------------------------------------------------------------|-------|-------|
|N-methylpyrrolidone|Step 2                                                                            |Class 2|≤0.053%|
|-------------------|----------------------------------------------------------------------------------|-------|-------|
|Toluene            |Step 2                                                                            |Class 2|≤0.089%|
|-------------------|----------------------------------------------------------------------------------|-------|-------|
|tetrahydrofuran    |Step 2                                                                            |Class 2|≤0.072%|
|-------------------|----------------------------------------------------------------------------------|-------|-------|
|Ethanol            |Steps 1,3,4                                                                       |Class 3|≤0.5%  |
|-------------------|----------------------------------------------------------------------------------|-------|-------|
|Piperidine         |Steps 1                                                                           |Class 4|≤0.1%  |
------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 116 of 542 





Page 117
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 




benzene Toluene and ethanol introdu 



ced 




≤0.0002% 




Class 1 




The applicant has developed two sets of GC methods and one set of HP 



LC methods to detect the residual solvent of the finished product, one s 



et of GC methods to detect ethyl acetate, ethanol, isopropyl alcohol, sec 



ondary butanol, tetrahydrofuran, toluene, n-methylpyrrolidone, the other 



set of GC methods to detect benzene, and one set of HPLC methods to 



detect piperidine. At the same time, the applicant has carried out syste 



matic methodological verification on the above three sets of residual sol 



vent methods, and the verification results show that the method is spec 



ific, linear and has a good recovery rate. The quantification limit of etha 



nol is 0.01%, the quantification limit of isopropanol is 0.01%, the quant 



ification limit of ethyl acetate is 0.01% and the quantification limit of se 



condary butanol is 0.008%. The limit of quantification of tetrahydrofura 



n is 0.007%, the limit of quantification of toluene is 0.004%, the limit o 



f quantification of N-methylpyrrolidone is 0.006%, the limit of quantifica 



tion of benzene is 0.000053% and the limit of quantification of piperidin 



e is 0.01%, all of which are far below the standard control limit. See 3. 



2.S.4.3.4, 3.2.S.4.3.5 and 3.2.S.4.3.6 for the relevant methodological vali 



dation. 



**Detection of residual solvents in commercial-scale batch production** 



**of Finerenone** 



The applicant has tested the residual solvent of three batches of comme 



rcial-scale mass produced Finerenone (batch No. 231201, 240101 and 2 



40102 respectively), and the test results all meet the standard requirem 



ents. The detection information is shown in Table 3.2.S.3.2.3-2. 



Table 3.2.S.3.2.3-2 Test data of residual solvent in Finerenone 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 117 of 542 





Page 118
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 







































--------------------------------------------------------------------------------------------------------
|Ethanol             |≤0. 5%   |≤0.05%    |0.1%        |0.2%        |0.1%        |0.003%    |0.01%     |
|--------------------|---------|----------|------------|------------|------------|----------|----------|
|Isoprop ylalco hol  |≤0. 5%   |≤0.05%    |Not detected|Not detected|Not detected|0.003%    |0.01%     |
|--------------------|---------|----------|------------|------------|------------|----------|----------|
|Ethylacetate        |≤0. 5%   |≤0.05%    |Not detected|Not detected|Not detected|0.003%    |0.01%     |
|--------------------|---------|----------|------------|------------|------------|----------|----------|
|sec-butanol         |≤0. 5%   |≤0.05%    |Not detected|Not detected|Not detected|0.002%    |0.008%    |
|--------------------|---------|----------|------------|------------|------------|----------|----------|
|tetrahy drofuran    |≤0.07 2% |≤0.0072%  |Not detected|Not detected|Not detected|0.002%    |0.007%    |
|--------------------|---------|----------|------------|------------|------------|----------|----------|
|Toluene             |≤0.08 9% |≤0.0089%  |Not detected|Not detected|Not detected|0.001%    |0.004%    |
|--------------------|---------|----------|------------|------------|------------|----------|----------|
|N-meth ylpyrrolidone|≤0.05 3% |≤0.0053%  |Not detected|Not detected|Not detected|0.002%    |0.006%    |
|--------------------|---------|----------|------------|------------|------------|----------|----------|
|piperidi ne         |≤0. 1%   |≤0.01%    |Not detected|Not detected|Not detected|0.003%    |0.01%     |
|--------------------|---------|----------|------------|------------|------------|----------|----------|
|benzene             |≤0.00 02%|≤0.00002 %|Not detected|Not detected|Not detected|0.000016 %|0.000053 %|
--------------------------------------------------------------------------------------------------------

According to the test results of three commercial-scale batches of self-made 



samples for residual solvents, except for ethanol used in the last step of the 



process, the remaining eight residual solvents were not detected (LOD is 



detailed in Table 3.2.S.3.2.3-2), all below 10% of their acceptable limits. 



Therefore, the applicant in the final draft quality standards, the solvent used 



in the last step of the process of ethanol and the second class of solvents 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 118 of 542 





Page 119
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



N-methylpyrrolidone, toluene and tetrahydrofuran set into the quality 



standards for control, the limit of ethanol shall not be 0.5%; 



N-methylpyrrolidone shall not exceed 0.053%; Toluene must not exceed 



0.089%; Tetrahydrofuran shall not exceed 0.072%, and the remaining 



solvents shall not be controlled. 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 119 of 542 





Page 120
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.3.2.4 Impurities of Metal Elements** 



With reference to ICH-Q3D (R2), the applicant conducts risk assessment 



of potential metal element impurities in the preparation of finalizone from 



three aspects, including process introduction, material introduction and 



equipment introduction, and includes palladium and highly toxic Class 1 



and 2A metal element impurities as follows: 



**palladium** 



The catalyst palladium acetate was used in the preparation of Finer 



enone starting material YA2304-1, and trace amounts of palladium may 



remain in the finished product. The oral acceptable limit of palladium 



referenced to ICHQ3D(R2) is 10μg/g (i.e. 10 PPM). The Applicant tested 



three commercial-scale batches of Finerenone (lots 231201, 240101 and 



240102), each containing significantly less than 1ppm of palladium (1 



0% of the acceptable limit), as detailed in Table 3.2.S.3.2.4-1. 



Table.2.S.3.2.4-1 Statistics of palladium content in Finerenone 













---------------------------------------------------------
|Palladium content|0.053 ppm|0.084 ppm|0.009 ppm|1ppm   |
---------------------------------------------------------

In summary, the palladium content of Finerenone produced by regis 



tered process was less than 10% (i.e. 1ppm) of the oral acceptable limit 



of palladium in ICH-Q3D (R2). With reference to the "Implementation o 



f policy on elemental impurities in the Certification Procedure" publishe 



d by EDQM, the applicant can see that if the metal element is introduc 



ed before the final synthetic reaction, And if the corresponding metal el 



ement test results in 3 batches of commercial-scale finished products ar 



e all lower than 30% of the acceptable limit, the finished product stand 



ard may not include the impurity in the routine test project, as detailed 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 120 of 542 





Page 121
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



in 3.2.S.4.5. Based on this analysis, the risk of Finerenone introducing 



palladium element is low, and the registered process can control the i 



mpurity below 10% of the acceptable limit. Therefore, the applicant does 



not control it. 



**lead** 



See ICH-Q3D (R2) for an oral PDE of 5μg/ day for lead. The maximum 



daily dose (MDD) of Finerenone is 20mg (much less than 1g), and the 



applicant calculated an oral acceptable limit of 5μg/g (i.e. 5 PPM) for lead 



based on a daily intake of 1g. In order to exclude the possibility of the 



introduction of more toxic Group 1 (lead) metal elements into various 



manufacturing materials and equipment, the Applicant tested three 



commercial-scale batches of Finerenone (Batch No. 231201, 240101 and 



240102). The levels of lead detected in these three batches were all below 



30% of the acceptable oral limits (see Table 3.2.S.3.2.4-2 for details). 



Therefore, the Applicant intends not to control the elemental impurity lead in 



the finished product. 



Table 3.2.S.3.2.4-2 Statistics of lead detection data in Finerenone 













----------------------------------------------------
|Lead content|0.380 ppm|0.386 ppm|0.093 ppm|1.5 ppm|
----------------------------------------------------

**Other Class 1 and Class 2A elemental impurities** 



See ICH-Q3D (R2) for oral Pdes of 15μg/ day, 5μg/ day, 30μg/ day, 



50μg/ day, 200μg/ day, and 100μg/ day for arsenic, cadmium, mercury, 



cobalt, nickel, and vanadium, respectively. The maximum daily dose (MDD) 



of Finerenone is 20mg (much less than 10g), The applicant calculated the 



oral acceptable limits of arsenic, cadmium, mercury, lead, cobalt, nickel and 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 121 of 542 





Page 122
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



vanadium with a daily intake of 10g as 1.5μg/g (i.e. 1.5ppm), 0.5μg/g (i.e. 



0.5ppm), 3μg/g (i.e. 3 PPM), 5μg/g (i.e.5 PPM), 20μg/g (i.e. 20 PPM), 10μg/g 



(i.e. 20 PPM), respectively. I.e. 10ppm). In order to exclude the possibility of 



the introduction of highly toxic Class 1 (arsenic, cadmium and mercury) and 



Class 2A (cobalt, nickel and vanadium) metal elements into each production 



material and production equipment, the applicant tested three 



commercial-scale batch produced batches of Finerenone (Batch No. 231201, 



240101 and 240102), The levels of lead detected in these three batches were 



all below 30% of the acceptable oral limits (see Table 3.2.4-3 for details). 



Therefore, the Applicant intends not to control the element impurities of 



Class 1 (arsenic, cadmium and mercury) and Class 2A (cobalt, nickel and 



vanadium) in the finished product. 



Table 3.2.S.3.2.4-3 Finerenone Category 1 and 2A element impurity 



inspection status 




--------------------------------------------------------------------------
|Arsenic levels  |Undetected|Not detected|Not detected|0.004 ppm|0.45 ppm|
|----------------|----------|------------|------------|---------|--------|
|Cadmium content |Undetected|Not detected|Not detected|0.001 ppm|0.15 ppm|
|----------------|----------|------------|------------|---------|--------|
|Mercury content |Undetected|Not detected|Not detected|0.020 ppm|0.9 ppm |
|----------------|----------|------------|------------|---------|--------|
|Cobalt content  |0.005 ppm |0.028 ppm   |Undetected  |0.001 ppm|1.5 ppm |
|----------------|----------|------------|------------|---------|--------|
|Nickel content  |0.174 ppm |0.351 ppm   |0.088 ppm   |0.011 ppm|6ppm    |
|----------------|----------|------------|------------|---------|--------|
|Vanadium content|Undetected|0.004 ppm   |Undetected  |0.002 ppm|3ppm    |
--------------------------------------------------------------------------

**Heavy metal** 






















Metal reaction reagents are not used in the preparation process of Finer 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 122 of 542 





Page 123
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



enone, considering that the materials used and the equipment may intr 



oduce trace heavy metals. Therefore, the applicant proposed a heavy me 



tal test item in Finerenone, and controlled its limit to not exceed 10 pp 



m. At the same time, the applicant tested three commercial-scale batche 



s of Finerenone No. 231201, 240101 and 240102 for heavy metals, and 



the test results did not exceed 10ppm, as detailed in 3.2.S.3.2.4-4. 



Table 3.2.S.3.2.4-4 Statistics of heavy metal detection data in Finere 



none 

------------------------------------
|≤10ppm |conforms|conforms|conforms|
------------------------------------



**3.2.S.3.2.5 Potential genotoxic impurities** 



The applicant combined the preparation process of the starting material and 



the preparation process of Finerenonee to conduct genotoxic impurity 



analysis. Among them, the starting material YA2304-1 may introduce 



YA2304-23, YA2304-24, YA2304-33, YA2304-43, dimethyl sulfate and other 



five potential genotoxic impurities. The starting material YA2304-2 may 



introduce one potential genotoxic impurity such as YA2304-38; Two 



potential genotoxic impurities (YA2304-40, YA2304-41) may be introduced 



into starting material YA2304-4. Potential genotoxic impurities such as 



YA2304-1, YA2304-4, YA2304-47, diethyl sulfate, diisopropyl sulfate, 



di-sec-butylsulfate, 4-dimethylaminopyridine and nitrosamines may be 



introduced in the preparation of Finerenone. Specific studies are as follows: 



**(1) YA2304-23** 



YA2304-23 is an incomplete raw material in the synthesis of starting 



material YA2304-1. This impurity has a potential genotoxic warning 



structure and is a potential genotoxic impurity. Its molecular structure 



formula is as follows: 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 123 of 542 





Page 124
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



The applicant intends to control the impurity YA2304-23 under the relevant 



substances in the starting material YA2304-1, and design the impurity 



removal experiment to investigate the rationality of the impurity limit. The 



results show that when the impurity YA2304-23 content in the starting 



material YA2304-1 is 0.5%, The registration process can effectively ensure 



that the impurity YA2304-23 content in the subsequent production of 



intermediate YA2304-8 is far less than 30% of the maximum acceptable limit 



of genotoxic impurities in the finished product (i.e. 22.5ppm). The 



experimental process is detailed in section 3.2.S.2.3.3.2. At the same time, 



the applicant tested three commercial-scale batches of Finerenone (Batch 



No. 231201, 240101 and 240102), and no impurity YA2304-23 was detected 



in any of the batches (LOD: 6.02ppm), i.e., well below 30% of the acceptable 



limit (i.e. 22.5ppm), as detailed in Table 3.2.S.3.2.5-5. 



According to Method 3 under item 8.1 of ICH-M7, when an impurity standard 



higher than the acceptable limit of the API is proposed in the starting 



material, the appropriate analytical method combined with the knowledge of 



the impurity destination and removal as well as relevant process control is 



adopted to ensure that the impurity level in the API is less than 30% of the 



acceptable limit, and the data of the commercial scale of multiple batches are 



collected. If it is proved that the impurity level is below 30% of the acceptable 



limit, the impurity can no longer be controlled in the subsequent process. 



Therefore, the Applicant intends to control YA2304-23 as a specific impurity 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 124 of 542 





Page 125
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



by no more than 0.5% in the starting material YA2304-1, and this impurity 



will no longer be controlled in the finished product. 



**(2) YA2304-24** 



YA2304-24 is an intermediate in the synthesis of the starting material 



YA2304-1. This impurity has a potential genotoxic warning structure and is a 



potential genotoxic impurity. Its molecular structure formula is as follows: 



The applicant intends to control the impurity YA2304-24 under the relevant 



substances in the starting material YA2304-1, and design the impurity 



removal experiment to investigate the rationality of the impurity limit. The 



results show that when the impurity YA2304-24 content in the starting 



material YA2304-1 is 0.5%, The registration process can effectively ensure 



that the impurity YA2304-24 content in the subsequent production of 



intermediate YA2304-8 is far less than 30% of the maximum acceptable limit 



of genotoxic impurity in the finished product (i.e. 22.5ppm). The 



experimental process is detailed in section 3.2.S.2.3.3.2. At the same time, 



the applicant tested three commercial-scale batches of Finerenone (Batch 



No. 231201, 240101 and 240102), and no impurity YA2304-24 was detected 



in any of the batches (LOD: 6.09ppm), i.e., well below 30% of the acceptable 



limit (i.e. 22.5ppm), as detailed in Table 3.2.S.3.2.5-5. 



Referring to Method 3 under item 8.1 of ICH-M7, the Applicant intends to 



control YA2304-24 as a specific impurity by no more than 0.5% in the 



starting material YA2304-1, which will no longer be controlled in the finished 



product. 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 125 of 542 





Page 126
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**(3) YA2304-33** 



YA2304-33 is a by-product in the synthesis of the starting material YA2304-1. 



This impurity has a potential genotoxic warning structure and is a potential 



genotoxic impurity. Its molecular structure formula is as follows: 



The applicant intends to control the impurity YA2304-33 under the relevant 



substances in the starting material YA2304-1, and design the impurity 



removal experiment to investigate the rationality of the impurity limit. The 



results show that when the impurity YA2304-33 content in the starting 



material YA2304-1 is 0.5%, The registration process can effectively ensure 



that the impurity YA2304-33 content in the subsequent production of 



intermediate YA2304-8 is far less than 30% of the maximum acceptable limit 



of genotoxic impurities in the finished product (i.e. 22.5ppm). The 



experimental process is detailed in section 3.2.S.2.3.3.2. At the same time, 



the applicant tested three commercial-scale batches of Finerenone (Batch 



No. 231201, 240101 and 240102), and no impurity YA2304-33 was detected 



in any of the batches (LOD: 5.91ppm), i.e., well below 30% of the acceptable 



limit (i.e. 22.5ppm), as detailed in Table 3.2.S.3.2.5-5. 



Referring to Method 3 under item 8.1 of ICH-M7, the Applicant intends to 



control YA2304-33 as a specific impurity by no more than 0.5% in the 



starting material YA2304-1, which will no longer be controlled in the finished 



product. 



**(4) YA2304-43** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 126 of 542 





Page 127
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



YA2304-43 is the degradation product of starting material YA2304-1. This 



impurity has a potential genotoxic warning structure and is a potential 



genotoxic impurity. Its molecular structure formula is as follows: 



The applicant intends to control the impurity YA2304-43 under the relevant 



substances in the starting material YA2304-1, and design the impurity 



removal experiment to investigate the rationality of the impurity limit. The 



results show that when the impurity YA2304-43 content in the starting 



material YA2304-1 is 0.5%, The registration process can effectively ensure 



that the impurity YA2304-43 content in the subsequent production of 



intermediate YA2304-8 is far less than 30% of the maximum acceptable limit 



of genotoxic impurity in the finished product (i.e. 22.5ppm). The 



experimental process is detailed in section 3.2.S.2.3.3.2. At the same time, 



the applicant tested three commercial-scale batches of Finerenone (Batch 



No. 231201, 240101 and 240102), and no impurity YA2304-43 was detected 



in any of the batches (LOD: 7.33ppm), i.e., well below 30% of the acceptable 



limit (i.e. 22.5ppm), as detailed in Table 3.2.S.3.2.5-5. 



Referring to Method 3 under item 8.1 of ICH-M7, the Applicant intends to 



control YA2304-43 as a specific impurity by no more than 0.5% in the 



starting material YA2304-1, and this impurity will no longer be controlled in 



the finished product. 



**(5) YA2304-38** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 127 of 542 





Page 128
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



YA2304-38 is an incomplete raw material in the synthesis of starting 



material YA2304-2. This impurity has a potential genotoxic warning 



structure and is a potential genotoxic impurity. Its molecular structure 



formula is as follows: 



[The applicant queried the microbial mutation test (Ames test) data of the](https://echa.europa.eu/home）可知，2-氯丙烷显示无遗传毒性，结果详见下图) 



compound from the Ministry of Health, Labor and Welfare of Japan 



(Occupational safety website), and it can be seen that the Ames test result of 



4-methylene-2-oxacyclobutanone (YA2304-38) was Negative. The screenshot 



of the query result is as follows: 



According to the requirements of ICH-M7, the impurity can be classified into 



5 categories of potential genotoxic impurities and can be controlled as 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 128 of 542 





Page 129
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



non-mutagenic impurities. The applicant intends to limit impurity 



YA2304-38 to 1.0% under residual solvent in starting material YA2304-2, 



and to design an impurity removal experiment to investigate the rationality of 



the impurity limit. The results show that when the impurity YA2304-38 



content in starting material YA2304-2 is 1.0%, The registration process can 



effectively ensure the removal of impurity YA2304-38 in the subsequent 



production of Finerenonee. The experimental process is detailed in section 



3.2.S.2.3.5.2. At the same time, the applicant tested three commercial-scale 



batches of Finerenone No. 231201, 240101 and 240102, and no impurity 



YA2304-38 (LOD: 0.027%) was detected in each batch of samples. For details, 



see Table 3.2.5-1. Therefore, the applicant intends to control YA2304-38 as a 



specific impurity by no more than 1.0% in the starting material YA2304-2, 



and this impurity will no longer be controlled in the finished product. 



Table 3.2.5-1 Test data for YA2304-38 in Finerenone 

--------------------------------------------------------
|YA2304-38|Undetected|Not detected|Not detected|0.027% |
--------------------------------------------------------



**(6) YA2304-40** 



YA2304-40 is an incomplete raw material in the synthesis of starting 



material YA2304-4. This impurity has a potential genotoxic warning 



structure and is a potential genotoxic impurity. Its molecular structure 



formula is as follows: 



The applicant intends to control the impurity YA2304-40 under the relevant 



substances in the starting material YA2304-4, and design the impurity 



removal experiment to investigate the rationality of the impurity limit. The 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 129 of 542 





Page 130
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



results show that when the impurity YA2304-4 content is 0.5%, the impurity 



YA2304-40 should not exceed 0.5%. The registration process can effectively 



ensure that the impurity YA2304-40 content in the subsequent production of 



Finerenonee is far less than 30% of the maximum acceptable limit of 



genotoxic impurity in the finished product (i.e. 22.5ppm). The experimental 



process is detailed in section 3.2.S.2.3.7.2. At the same time, the applicant 



tested three commercial-scale batches of Finerenone (Batch No. 231201, 



240101 and 240102), and no impurity YA2304-40 was detected in any of the 



batches (LOD: 12.59ppm), i.e., well below 30% of the acceptable limit (i.e. 



22.5ppm), as detailed in Table 3.2.S.3.2.5-5. 



Referring to Method 3 under item 8.1 of ICH-M7, the Applicant intends 



to control YA2304-40 as a specific impurity by no more than 0.5% in t 



he starting material YA2304-4, which will no longer be controlled in the 



finished product. 



**(7) YA2304-41** 



YA2304-41 is an intermediate in the synthesis of the starting material 



YA2304-4. This impurity has a potential genotoxic warning structure and is a 



potential genotoxic impurity. Its molecular structure formula is as follows: 



The applicant intends to control the impurity YA2304-41 under the relevant 



substances in the starting material YA2304-4, and design the impurity 



removal experiment to investigate the reasonableness of the impurity limit. 



The results show that when the impurity YA2304-41 content in the starting 



material YA2304-4 is 0.5%, The registration process can effectively ensure 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 130 of 542 





Page 131
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



that the impurity YA2304-41 content in the subsequent production of 



Finerenonee is far less than 30% of the maximum acceptable limit of 



genotoxic impurity in the finished product (i.e. 22.5ppm). The experimental 



process is detailed in section 3.2.S.2.3.7.2. At the same time, the applicant 



tested three commercial-scale batches of Finerenone (Batch No. 231201, 



240101 and 240102), and no impurity YA2304-41 was detected in any of the 



batches (LOD: 7.51ppm), i.e., well below 30% of the acceptable limit (i.e. 



22.5ppm), as detailed in Table 3.2.S.3.2.5-5. 



Referring to Method 3 under Item 8.1 of ICH-M7, the Applicant intends 



to control YA2304-41 as a specific impurity by no more than 0.5% in t 



he starting material YA2304-4, which will no longer be controlled in the 



finished product. 



**(8) YA2304-1** 



YA2304-1 is an incomplete starting material in the synthesis of Finerenonee. 



This impurity has a potential genotoxic warning structure and is a potential 



genotoxic impurity. Its molecular structure formula is as follows: 



The applicant intends to control the impurity YA2304-1 in the intermediate 



YA2304-5 under the relevant substances by 0.5%, and design the impurity 



removal experiment to investigate the rationality of the impurity limit. The 



results show that when the impurity YA2304-1 content in the intermediate 



YA2304-5 is 0.5%, The registration process can effectively ensure that the 



impurity YA2304-1 content in the subsequent production of Finerenonee is 



far less than 30% of the maximum acceptable limit of genotoxic impurity in 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 131 of 542 





Page 132
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



the finished product (i.e. 22.5ppm). The experimental process is detailed in 



section 3.2.S.2.4.3.1.1. At the same time, the applicant tested three 



commercial-scale batches of Finerenone (Batch No. 231201, 240101 and 



240102), and no impurity YA2304-1 was detected in any of the batches (LOD: 



12.86ppm), i.e., well below 30% of the acceptable limit (i.e. 22.5ppm), as 



detailed in Table 3.2.S.3.2.5-5. 



Referring to Method 3 under item 8.1 of ICH-M7, the Applicant intends to 



control YA2304-1 as a specific impurity by no more than 0.5% in the 



intermediate YA2304-5, which will no longer be controlled in the finished 



product. 



**(9) YA2304-4** 



YA2304-4 is an incomplete starting material in Finerenone synthesis. This 



impurity has a potential genotoxic warning structure and is a potential 



genotoxic impurity. Its molecular structure formula is as follows: 



The applicant intends to control the impurity YA2304-5 in the intermediate 



YA2304-5 under the relevant substances under 1.5%, and design the 



impurity removal experiment to investigate the rationality of the impurity 



limit. The results show that when the impurity YA2304-5 content in the 



intermediate YA2304-5 is 1.5%, The registration process can effectively 



ensure that the content of impurity YA2304-4 in the subsequent production 



of Finerenonee is far less than 30% of the maximum acceptable limit of 



genotoxic impurity in the finished product (i.e. 22.5ppm). The experimental 



process is detailed in section 3.2.S.2.4.3.1.1. At the same time, the applicant 



tested three commercial-scale batches of Finerenone (Batch No. 231201, 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 132 of 542 





Page 133
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



240101 and 240102), and no impurity YA2304-4 was detected in any of the 



batches (LOD: 12.41ppm), i.e., well below 30% of the acceptable limit (i.e. 



22.5ppm), as detailed in Table 3.2.S.3.2.5-5. 



Referring to Method 3 under item 8.1 of ICH-M7, the Applicant intends to 



control YA2304-4 as a specific impurity by no more than 1.5% in the 



intermediate YA2304-5, which will no longer be controlled in the finished 



product. 



**(10) YA2304-47** 



YA2304-47 is a derivative impurity of the starting material YA2304-4 



involved in the subsequent reaction. This impurity has a potential genotoxic 



warning structure and is a potential genotoxic impurity. Its molecular 



structure formula is as follows: 



The applicant intends to limit impurity YA2304-4 to 1.5% under related 



substances in the intermediate YA2304-5, and design an impurity removal 



experiment to investigate the reasonableness of the impurity limit. The 



results show that when the impurity YA2304-4 content in the intermediate 



YA2304-5 is 1.5%, The registration process can effectively ensure that the 



impurity YA2304-47 content in the subsequent production of Finerenonee is 



far less than 30% of the maximum acceptable limit of genotoxic impurity in 



the finished product (i.e. 22.5ppm). The experimental process is detailed in 



section 3.2.S.2.4.3.1.1. At the same time, the applicant tested three 



commercial-scale batches of Finerenone (Batch No. 231201, 240101 and 



240102), and no impurity YA2304-47 was detected in any of the batches 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 133 of 542 





Page 134
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



(LOD: 6.37ppm), i.e., well below 30% of the acceptable limit (i.e. 22.5ppm), as 



detailed in Table 3.2.S.3.2.5-5. 



Referring to Method 3 under Item 8.1 of ICH-M7, the Applicant intends to 



control YA2304-4 as a specific impurity by no more than 1.5% in the 



intermediate YA2304-5, and its derived impurity YA2304-47 will no longer be 



controlled in the finished product. 



**(11) Sulfate impurities** 



Dimethyl sulfate is an incomplete reaction reagent in the synthesis of 



starting material YA2304-1. Diethyl sulfate, diisopropyl sulfate and 



disec-butyl sulfate are the by-products that may be formed by the reaction of 



concentrated sulfuric acid with ethanol, isopropyl alcohol and 2-butanol in 



the synthesis of finalizone. Four potential genotoxic impurities are dimethyl 



sulfate, diethyl sulfate, diisopropyl sulfate, and disec-butyl sulfate. Their 



molecular structure formula is as follows: 



With reference to ICH-M7, the acceptable limit of a single genotoxic impurity 



in Finerenone was calculated based on TTC as 75ppm, that is, the maximum 



acceptable limit of dimethyl sulfate, diethyl sulfate, diisopropyl sulfate and 



di-sec-butylsulfate in Finerenone was 75ppm. 



Since NLT 3 impurities containing genotoxic warning structures are 



controlled in the finished fineridone, the applicant calculated the control 



limits of multiple genotoxic impurities in the finished fineridone with 



reference to ICH-M7 (R1) : The maximum daily dose (MDD) of Finerenone is 



20mg, and the maximum daily tolerable dose (TTC) of the sum of the 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 134 of 542 





Page 135
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



impurities containing the genotoxic warning structure is 5μg according to 



the following formula: 



Genotoxic impurity limit (ppm) = TTC/MDD 



TTC: Maximum tolerable daily dose, μg/ day, 



MDD: maximum daily dose, g/ day; 



The calculated acceptable limit of the sum of impurities containing genotoxic 



warning structure in finalizone was 250ppm, that is, the maximum 



acceptable limit of the sum of dimethyl sulfate, diethyl sulfate, diisopropyl 



sulfate and di-sec-butyl sulfate in finalizone was 250ppm. 



The applicant tested the contents of the above four sulfate genotoxic 



impurities in three commercial-scale batches of Finerenone No. 231201, 



240101 and 240101. Dimethyl sulfate, diethyl sulfate, diisopropyl sulfate 



and di-sec-butylsulfate were not detected. The specific test results are shown 



in Table 3.2.S.3.2.5-4, and the relevant methodology verification report is 



shown in 3.2.S.4.3.6. 



Referring to Method 1 under ICH-M7 8.1, periodic confirmatory testing may 



be performed if the level of mutagenic impurities in the API is below 30% of 



the acceptable limit in at least 6 consecutive pilot batches or 3 consecutive 



production batches. Therefore, the applicant intends to schedule the 



genotoxic impurities of sulfate as part of the release criteria for finished 



Finerenone with a testing cycle of one batch for every 10 batches. 



**(12) 4-dimethylaminopyridine (abbreviated: DMAP)** 



4-dimethylaminopyridine contains a genotoxicity warning structure, CAS 



number 1122-58-3, the molecular structure formula is as follows: 



CH3 



CH3 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 135 of 542 





Page 136
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



The applicant queried Ames test data of the compound through the 



European Chemicals Agency (ECHA) database and found that 



4-dimethylaminopyridine has been detected in Salmonella typhimurium TA 



[1535, TA 1537, TA 98 and TA 100 and Escherichia coli WP2 uvr A reverse](https://echa.europa.eu/home）可知，2-氯丙烷显示无遗传毒性，结果详见下图) 



mutation test (Ames test) did not show mutagenic activity, as shown in the 



screenshot below: 



According to the requirements of ICH-M7, the impurity can be classified 



into 5 potentially genotoxic impurities and can be controlled as non-m 



utagenic impurities, i.e. the acceptable limit of the impurity is 0.10%. 4 



-dimethylaminopyridine is a catalyst added in the ammoniation reaction 



of step 3 of the preparation process of non-nellidone, and the amount 



of feed is very small; The compound is soluble in water and ethanol, an 



d is an organic base, after the subsequent two alcohol water system be 



ating, filtration and a recrystallization of ethanol is easy to be removed, 



and D- (+) -dibenzoyl tartar conversion into water-soluble organic salt i 



s also easy to be removed. The applicant tested three commercial-scale 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 136 of 542 





Page 137
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



batches of Finerenone (batch No. 231201, 240101, 240102), and found 



that 4-dimethylaminopyridine was not detected in each batch of sample 



s, as detailed in Table 3.2.S.3.2.5-2. 



Table 3.2.S.3.2.5-2 Detection data of 4-dimethylaminopyridine in Fineren 



one 









-------------------------------------------------------------------------
|4-dimethylaminopyridi ne|Not detected|Not detected|Not detected|0.0005%|
-------------------------------------------------------------------------

See 3.2.S.4.3.2 for the LOD of 4-dimethylaminopyridine (DMAP) in the 



finished product related Substance II analysis method is 0.0005%, which is 



far below the acceptable limit for this impurity. According to this analysis, 



although 4-dimethylaminopyridine (DMAP) was added in the preparation 



process of Finerenonee, the impurity can be effectively removed by the 



registration process. Therefore, the applicant intends not to control 



4-dimethylaminopyridine (DMAP) in the finished product. 



**(13) nitrosamine impurities** 



The applicant intends to conduct the following evaluation and research on 8 



possible nitrosamine impurities such as NDMA, NDEA, NDIPA, NDBA, NIEPA, 



NMBA, NMPA, NDPA: 



The AI values of NDMA, NDEA, NDIPA, NIEPA, NMBA and NMPA are 



announced in the "Control of Nitrosamine Impurities in Human Drugs" 



issued by FDA as follows: 



The AI values of the NDBA published in the Control of Nitrosamine Impurities 



in Human Drugs by the CHMP are as follows: 



The TD50 value of the oral pathway of NDPA (CAS: 621-64-7) rats was 



0.186mg/kg/day published in the CPDB, and the query screenshot is as 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 137 of 542 





Page 138
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



follows: 



Based on the above query results, the applicant calculated the AI of NDPA 



with reference to ICH-M7 (R2) according to the following formula, in which 



the AI of NDPA under oral route is 186ng/ day, the calculation formula is as 



follows: 



Maximum daily intake AI (ng/ day) =TD50×50kg/50000 



The applicant intends to refer to the "Control of Nitrosamine Impurities in 



Human Drugs" issued by CHMP to calculate the impurity limit according to 



TTC method, in which the AI of impurity NDPA is calculated according to 



18ng/ day. The relevant references are described as follows: 



The maximum daily dose (MDD) of Finerenone is 20mg, and the applicant 



calculates the above impurity limit with reference to ICH-M7 (R2) according 



to the following formula, the calculation results are detailed in Table 3.2.5-3. 



Impurity limit (ppm) = AI/MDD 



AI: Maximum daily intake, ng/ day; MDD: maximum daily dose, mg/ day; 



The maximum acceptable limits of NDMA, NDEA, NDIPA, NEIPA, NMBA, 



NMPA, NDBA and NDPA in finalizone were calculated to be 4.8ppm, 1.32ppm, 



1.32ppm, 1.32ppm, 1.32ppm, 4.8ppm, 1.32ppm, 1.32ppm and 0.9ppm, 



respectively . The applicant intends to strictly control the above eight 



nitrosamine impurities in the finished product to not exceed 0.3ppm during 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 138 of 542 





Page 139
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



the research process. 



The applicant intends to develop LC-MS method to detect the above eight 



nitrosamine impurities in combination with the above impurity limits, and 



conducts corresponding methodological research with reference to the 



General Rule 9101 of the 2020 edition of Chinese Pharmacopoeia. The 



verification results show that the method is specific, linear and has a good 



recovery rate, and the LOD of each impurity is about 10% of the impurity 



control limit. For details, see Table 3.2.5-3. At the same time, NDMA, NDEA, 



NDIPA, NDBA, NEIPA, NMBA, NMPA and NDPA were not detected in the 



three commercial-scale batches of Finerenone No. 231201, 240101 and 



240102. In other words, the detected amounts were all less than 10% of the 



impurity control limit, as detailed in Table 3.2.S.3.2.5-4. 



Table 3.2.5-3 Acceptable limits of nitrosamine impurities in finalizone 



















-----------------------------------------
|NDMA   |96     |4.8    |0.3    |0.0310 |
|-------|-------|-------|-------|-------|
|NDEA   |26.5   |1.32   |0.3    |0.0336 |
|-------|-------|-------|-------|-------|
|NDIPA  |26.5   |1.32   |0.3    |0.0319 |
|-------|-------|-------|-------|-------|
|NEIPA  |26.5   |1.32   |0.3    |0.0303 |
|-------|-------|-------|-------|-------|
|NMBA   |96     |4.8    |0.3    |0.0298 |
|-------|-------|-------|-------|-------|
|NMPA   |26.5   |1.32   |0.3    |0.0327 |
|-------|-------|-------|-------|-------|
|NDBA   |26.5   |1.32   |0.3    |0.0341 |
|-------|-------|-------|-------|-------|
|NDPA   |18     |0.9    |0.3    |0.0354 |
-----------------------------------------

February 26, 2021, Questions and answers for marketing authorisation 



holders/applicants on the CHMP Opinion for the Article 5(3) of the EMA As 



described in Q&A No. 15 of Regulation (EC) No 726/2004 referral on 



nitrosamine impurities in human medicinal products, When the amount of 



nitrosamine impurities detected is less than 10% of the acceptable limit in 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 139 of 542 





Page 140
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



the finished product calculated by AI, the test may not be carried out, as 



follows: 



The translation of the underlined part in red is as follows: 



Routine testing can only be avoided if the level of nitrosamine is consistently 



below 10% of the acceptable limit for AI-based calculations in the finished 



product. 



In summary, in the three batches of commercial-scale mass production of 



finnalidone, the quality inspection quantity of eight nitrosamine impurities, 



such as NDMA, NDEA, NDIPA, NDBA, NEIPA, NMBA, NMPA and NDPA, is far 



less than 10% of the acceptable limit. The applicant intends not to control the 



above eight nitrosamine impurities in the finished product. 



**The** **detection** **situation** **of** **potential** **genotoxic** **impurities** **in** 



**commercial-scale mass production of Finerenone** 



Table 3.2.S.3.2.5-4 Detection results of nitrosamine impurities in Finerenone 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 140 of 542 





Page 141
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 






























----------------------------------------------------------------------------
|NDMA   |Not detected|Not detected|Not detected|0.0310 ppm|4.8 ppm |0.3 ppm|
|-------|------------|------------|------------|----------|--------|-------|
|NDEA   |Not detected|Not detected|Not detected|0.0336 ppm|1.32 ppm|0.3 ppm|
|-------|------------|------------|------------|----------|--------|-------|
|NDIPA  |Not detected|Not detected|Not detected|0.0319 ppm|1.32 ppm|0.3 ppm|
|-------|------------|------------|------------|----------|--------|-------|
|NEIPA  |Not detected|Not detected|Not detected|0.0303 ppm|1.32 ppm|0.3 ppm|
|-------|------------|------------|------------|----------|--------|-------|
|NMBA   |Not detected|Not detected|Not detected|0.0298 ppm|4.8 ppm |0.3 ppm|
|-------|------------|------------|------------|----------|--------|-------|
|NMPA   |Not detected|Not detected|Not detected|0.0327 ppm|1.32 ppm|0.3 ppm|
|-------|------------|------------|------------|----------|--------|-------|
|NDBA   |Not detected|Not detected|Not detected|0.0341 ppm|1.32 ppm|0.3 ppm|
|-------|------------|------------|------------|----------|--------|-------|
|NDPA   |Not detected|Not detected|Not detected|0.0354 ppm|0.9 ppm |0.3 ppm|
----------------------------------------------------------------------------

Table 3.2.S.3.2.5-5 Summary of genotoxic impurity detection results in 



commercial-scale batch production of Finerenone 

























---------------------------------------------------------------------
|YA2304-23|Not detected|Not detected|Not detected|6.02 ppm |22.5 ppm|
|---------|------------|------------|------------|---------|--------|
|YA2304-24|Not detected|Not detected|Not detected|6.09 ppm |22.5 ppm|
|---------|------------|------------|------------|---------|--------|
|YA2304-33|Not detected|Not detected|Not detected|5.91 ppm |22.5 ppm|
|---------|------------|------------|------------|---------|--------|
|YA2304-43|Not detected|Not detected|Not detected|12.22 ppm|22.5 ppm|
|---------|------------|------------|------------|---------|--------|
|YA2304-40|Not         |Not         |Not         |12.59 ppm|22.5 ppm|
---------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 141 of 542 





Page 142
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 


















--------------------------------------------------------------------------------
|YA2304-41           |Not detected|Not detected|Not detected|7.51 ppm |22.5 ppm|
|--------------------|------------|------------|------------|---------|--------|
|YA2304-1            |Not detected|Not detected|Not detected|12.86 ppm|22.5 ppm|
|--------------------|------------|------------|------------|---------|--------|
|YA2304-4            |Not detected|Not detected|Not detected|12.41 ppm|22.5 ppm|
|--------------------|------------|------------|------------|---------|--------|
|YA2304-47           |Not detected|Not detected|Not detected|6.37 ppm |22.5 ppm|
|--------------------|------------|------------|------------|---------|--------|
|Dimethyl sulfate    |Not detected|Not detected|Not detected|2.2 ppm  |22.5 ppm|
|--------------------|------------|------------|------------|---------|--------|
|Diethyl sulfate     |Not detected|Not detected|Not detected|2.3 ppm  |22.5 ppm|
|--------------------|------------|------------|------------|---------|--------|
|Diisopropyl sulfate |Not detected|Not detected|Not detected|2.3 ppm  |22.5 ppm|
|--------------------|------------|------------|------------|---------|--------|
|Di-sec-butyl sulfate|Not detected|Not detected|Not detected|2.3 ppm  |22.5 ppm|
--------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 142 of 542 





Page 143
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.4** **Control of Drug Substance** 



**3.2.S.4.1 Specification** 



Specifications of Finerenone are summarized in the following table. 



Table 3.2.S.4.1-1 Specifications of Finerenone 
















-------------------------------------------------------------------------------------------------------------------------------------
|Characters     |Appearance        |white to yellow powder                                                     |Visualinspection    |
|---------------|------------------|---------------------------------------------------------------------------|--------------------|
|Characters     |Solubility        |This product should be dissolved in methanol, slightly soluble inethanol,  |In-house method     |
|               |                  |acetonitrile andacetone, slightly soluble inisopropylalcohol,              |                    |
|               |                  |andalmostinsoluble in water                                                |                    |
|---------------|------------------|---------------------------------------------------------------------------|--------------------|
|Identificati on|IR                |The infrared lightabsorption pattern of this product should be consistent  |Operating           |
|               |                  |with that of the control product                                           |procedures          |
|               |                  |                                                                           |ofinfraredabsorption|
|               |                  |                                                                           |spectrophotometry   |
|               |                  |                                                                           |(in-house           |
|               |                  |                                                                           |method)             |
|---------------|------------------|---------------------------------------------------------------------------|--------------------|
|Identificati on|HPLC              |In the chromatogram recordedunder the enantiomer determinationitem, the    |Operating procedures|
|               |                  |retention time of the main peak of the test solution should be consistent  |of HPLC (in-house   |
|               |                  |with the retention time of the main peak of the system suitability solution|method)             |
|---------------|------------------|---------------------------------------------------------------------------|--------------------|
|Tests          |Related substances|YA2304-10 NMT 0.10%; YA2304-14 NMT 0.15%; YA2304-15 NMT 0.15%; YA2304-19   |Operating procedures|
|               |                  |NMT 0.15%; Other single impurities NMT 0.10%; Totalimpurities NMT 1.0%     |of HPLC (in-house   |
|               |                  |                                                                           |method)             |
|---------------|------------------|---------------------------------------------------------------------------|--------------------|
|Tests          |Enantiomers       |YA2304-20 NMT 0.15%                                                        |Operating procedures|
|               |                  |                                                                           |of HPLC             |
-------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 143 of 542 





Page 144
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 
























---------------------------------------------------------------------------------------------------------------------------------
|(in-house method)  |                                                                                  |             |          |
|-------------------|----------------------------------------------------------------------------------|-------------|----------|
|Genotoxicimpurities|Dimethyl sulfate NMT 75ppm; Diethyl sulfate NMT 75ppm; Diisopropyl sulfate NMT    |Operating    |          |
|                   |75ppm; Disec-butyl sulfate NMT 75ppm; The sum of genotoxicimpurities NMT 250ppm   |procedures   |          |
|                   |                                                                                  |of           |          |
|                   |                                                                                  |GC-MS        |          |
|                   |                                                                                  |(in-house    |          |
|                   |                                                                                  |method)      |          |
|-------------------|----------------------------------------------------------------------------------|-------------|----------|
|Residual solvents  |Ethanol NMT 0.5 % Tetrahydrofuran NMT 0.072% Toluene NMT 0.089%                   |Operating    |          |
|                   |N-methylpyrrolidone NMT 0.053%                                                    |procedures   |          |
|                   |                                                                                  |of GC        |          |
|                   |                                                                                  |(in-house    |          |
|                   |                                                                                  |method)      |          |
|-------------------|----------------------------------------------------------------------------------|-------------|----------|
|Water              |NMT 0.5%                                                                          |Operating    |          |
|                   |                                                                                  |procedures   |          |
|                   |                                                                                  |of Loss on   |          |
|                   |                                                                                  |drying       |          |
|                   |                                                                                  |determination|          |
|                   |                                                                                  |(in-house    |          |
|                   |                                                                                  |method)      |          |
|-------------------|----------------------------------------------------------------------------------|-------------|----------|
|Residue onignition |NMT 0.1%                                                                          |Operating    |          |
|                   |                                                                                  |procedures of|          |
|                   |                                                                                  |residue      |          |
|                   |                                                                                  |onignition   |          |
|                   |                                                                                  |determination|          |
|                   |                                                                                  |(in-house    |          |
|                   |                                                                                  |method)      |          |
|-------------------|----------------------------------------------------------------------------------|-------------|----------|
|Heavy metals       |NMT 10 ppm                                                                        |Operating    |          |
|                   |                                                                                  |procedures of|          |
|                   |                                                                                  |heavy metals |          |
|                   |                                                                                  |determination|          |
|                   |                                                                                  |(in-house    |          |
|                   |                                                                                  |method)      |          |
|-------------------|----------------------------------------------------------------------------------|-------------|----------|
|Microbial limits   |TAMC: NMT 103CFU/gTYMC: NMT 102CFU/gAbsence ofEscherichia coli (1g)               |Operating    |          |
|                   |                                                                                  |procedures of|          |
|                   |                                                                                  |microbial    |          |
|                   |                                                                                  |limits       |          |
|                   |                                                                                  |determination|          |
|                   |                                                                                  |(in-house    |          |
|                   |                                                                                  |method)      |          |
|-------------------|----------------------------------------------------------------------------------|-------------|----------|
|Assay              |Assay                                                                             |98.0% to     |Operating |
|                   |                                                                                  |102.0%       |procedures|
|                   |                                                                                  |(anhydrous   |of HPLC   |
|                   |                                                                                  |substance)   |(in-house |
|                   |                                                                                  |             |method)   |
---------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 144 of 542 





Page 145
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.4.2** **Analytical Procedures** 



**CHARACTERS** 



**Appearance** 



white to yellow powder by visual inspection. 



**Solubility** 



It is dissolved in methanol, slightly soluble in ethanol, acetonitrile and 



acetone, slightly soluble in isopropyl alcohol and almost insoluble in water. 



**IDENTIFICATION** 



**Infrared Absorption Spectrophotometry** 



Examine by _Operating procedures of infrared absorption spectrophotometry_ 



(in-house method) _._ 



Comparison: Finerenone reference standard. 



The IR spectra of the substance to be examined should comply with that of 



the Finerenone reference standard. 



**High Performance Liquid Chromatography** 



In the chromatogram recorded under the enantiomer determination, the 



retention time of the main peak of the test solution should be consistent with 



the retention time of the main peak of the system suitability solution. _(refers_ 



_to enantiomer)._ 



**TESTS** 



**Related Substances** 



Examine by _Operating procedures of high performance liquid chromatography_ 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 145 of 542 





Page 146
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



(in-house method) _._ 



Solvent acetonitrile-water (30:70, v/v) 



_Test solution:_ Take an appropriate amount of this product, weigh it 



accurately, dissolve it in a brown volumetric flask with a suitable amount of 



solvent and sonicate it, and dilute it quantitatively to make a solution 



containing about 0.4mg per 1ml. Shake well to obtain the solution. 



_Reference solution:_ Accurately measure an appropriate amount of the test 



sample solution, dilute it quantitatively with solvent to prepare a solution 



containing approximately 0.4 μ g per 1ml, shake well, and obtain. 



_Reference stock solution_ ① _:_ Take appropriate amounts of YA2304-10 and 



YA2304-17 reference standards, weigh them accurately, dissolve them in a 



solvent, and dilute them quantitatively to prepare a mixed solution 



containing approximately 200 μ g of YA2304-10 and YA2304-17 per 1ml. 



_Reference solution:_ Precisely measure an appropriate amount of reference 



stock solution ①, dissolve it in a solvent and dilute it quantitatively to 



prepare a mixed solution containing approximately 0.4 μ g of YA2304-10 and 



0.4 μ g of YA2304-17 per 1ml. 



_Reference stock solution_ ② _:_ Take appropriate amounts of YA2304-14, 



YA2304-15, YA2304-16, and YA2304-19 reference samples, weigh them 



accurately, dissolve and dilute them in acetonitrile to prepare a mixed 



solution containing approximately 200 μ g of YA2304-14, YA2304-15, 



YA2304-16, and YA2304-19 per 1ml. 



_System_ _suitability_ _solution:_ Accurately weigh about 10mg of YA2304 



reference substance and place it in a 25ml volumetric flask. Add an 



appropriate amount of solvent and sonicate to dissolve it. Accurately add 100 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 146 of 542 





Page 147
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



μ l each of reference stock solution ① and reference stock solution ②, dilute 



to the mark with solvent, shake well, and obtain the solution. 



_Chromatographic system_ 



_—stationary phase:_ Octadecylsilane bonded silica gel (YMC Trairt C18 ， 



4.6mm×150mm，3μm, or other similar column). 



_—temperature:_ 20℃. 



_Mobile phase:_ see the gradient table blow. 



_- mobile phase A:_ phosphoric acid solution (take 300μl phosphoric acid, add 



1000ml water, mix well); 



_- mobile phase B:_ acetonitrile; 



Time(min) Mobile phase A(%) Mobile phase B(%) 



0 85 15 


2 80 20 



5 80 20 


8 69 31 


13 55 45 



14 55 45 


18 50 50 


22 20 80 



_Flow rate:_ 1.0 mL/min. 



_Detection:_ at 251nm or 230 nm . 



_Injection volume:_ 5 μL. 



_System suitability_ : System suitability solution: 



- Reference solution (230nm): The peak order is YA2304-17, YA2304-10; 



- System suitability solution (251nm): The peak order is YA2304-14 YA2304 、 



YA2304-15、YA2304-17、YA2304-16、YA2304-10、YA2304-19; The separation 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 147 of 542 





Page 148
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



degree between YA2304, YA2304-14, and YA2304-15 NLT 1.5; The separation 



degree between YA2304-17 and YA2304-16 and adjacent peaks NLT 1.0; 



- Reference solution (251nm): The signal-to-noise ratio (S/N) of the main peak 



NLT 20. 



**Impurity Table 1** 










------------------------------------------------
|YA2304-14              |1.0    |0.10(at 230nm)|
|-----------------------|-------|--------------|
|YA2304                 |1.0    |0.15(at 251m) |
|-----------------------|-------|--------------|
|YA2304-15              |1.2    |0.15(at 251m) |
|-----------------------|-------|--------------|
|YA2304-19              |0.7    |0.15(at 251m) |
|-----------------------|-------|--------------|
|Otherindividualimpurity|1.0    |0.10          |
|-----------------------|-------|--------------|
|Totalimpurities        |-      |1.0           |
------------------------------------------------

Typical chromatogram of system suitability solution 



**Enantiomers** 



Examine by _Operating procedures of high performance liquid chromatography_ 



(in-house method) _._ 



Solvent acetonitrile-water (30:70, v/v) 



_Test solution:_ Take an appropriate amount of this product, weigh it 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 148 of 542 





Page 149
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



accurately, dissolve it in a solvent and dilute it to make a solution containing 



approximately 1mg per 1ml. 



_Reference solution:_ Take an appropriate amount of YA2304-20 reference 



substance, weigh it accurately, dissolve it in a solvent and dilute it to prepare 



a solution containing approximately 1.5 μ g per 1ml. 



_System_ _suitability_ _solution:_ Accurately weigh about 20mg of YA2304 



reference substance, place it in a 20ml volumetric flask, dissolve and dilute 



to the mark with the reference substance solution, shake well, and obtain. 



_Chromatographic system_ 



_—stationary_ _phase:_ Covalent bonding of cellulose tri - (3,5- 



dichlorophenylcarbamate) on the surface of silicone gell (Da Sai Lu 



CHIRALPAK IC, 250 × 4.6mm, 5 μ m, or other similar column). 



_—temperature:_ 40℃. 



_Mobile phase:_ see the gradient table blow. 



_-_ 
20mmol/L ammonium acetate buffer (pH adjusted to 3.1±0.05 with 



phosphoric acid) -acetonitrile (70:30, v/v); 



_Flow rate:_ 1.0 mL/min. 



_Detection:_ at 251nm. 



_Injection volume:_ 5 μL. 



_Run time:_ 40 min 



_System suitability_ : System suitability solution: 



- System suitability solution: The peak order is YA230420, YA2304; The 



separation degree between YA2304, YA2304-14 NLT 1.5; 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 149 of 542 





Page 150
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



- Reference solution : The signal-to-noise ratio (S/N) of the main peak NLT 30. 



_Limits_ (calculate by external standard method): 



– YA2304-20 NMT 0.15% 



**Residual solvents** 



**Acetonitrile , Tetrahydrofuran , and n-butanol** 



Examine by _Operating procedures of gas chromatography_ (in-house method). 



_Solvent:_ N, N-dimethylformamide (DMF) 



_Test solution:_ Take an appropriate amount of this product, weigh it 



accurately, dissolve it in a solvent and dilute it to prepare a solution 



containing approximately 50mg of non nalide per 1ml _._ 



_Reference solution:_ Take appropriate amounts of ethanol, tetrahydrofuran, 



toluene, and N-methylpyrrolidone, accurately weigh them, and dilute with 



solvent to prepare a mixed solution containing approximately 250 μ g of 



ethanol, 36 μ g of tetrahydrofuran, 44.5 μ g of toluene, and 26.5 μ g of 



N-methylpyrrolidone per 1ml. 



Operating conditions: 










----------------------------------------------------------------------------------------------------------------------------------
|Column temperature        |Initial keep at 40 ℃for 5min, raise to 60 ℃at rate of 10 ℃/min, keep at 60 |Initial    |Initial      |
|                          |℃for 5min. raise to 120 ℃at rate of 10 ℃/min, keep at 120 ℃for 5min. raise |keep at    |keep at      |
|                          |to 240 ℃at rate of 10 ℃/min, keep at 240 ℃for 5min.                        |40 ℃for    |40 ℃for      |
|                          |                                                                           |5min,      |5min,        |
|                          |                                                                           |raise      |raise        |
|                          |                                                                           |to 60      |to 60        |
|                          |                                                                           |℃at        |℃at          |
|                          |                                                                           |rate of    |rate of      |
|                          |                                                                           |10         |10           |
|                          |                                                                           |℃/min,     |℃/min,       |
|                          |                                                                           |keep at    |keep at      |
|                          |                                                                           |60 ℃for    |60 ℃for      |
|                          |                                                                           |5min.      |5min.        |
|                          |                                                                           |raise      |raise        |
|                          |                                                                           |to 120     |to 120       |
|                          |                                                                           |℃at        |℃at          |
|                          |                                                                           |rate of    |rate of      |
|                          |                                                                           |10         |10           |
|                          |                                                                           |℃/min,     |℃/min,       |
|                          |                                                                           |keep at    |keep at      |
|                          |                                                                           |120        |120          |
|                          |                                                                           |℃for       |℃for         |
|                          |                                                                           |5min.      |5min.        |
|                          |                                                                           |raise      |raise        |
|                          |                                                                           |to 240     |to 240       |
|                          |                                                                           |℃at        |℃at          |
|                          |                                                                           |rate of    |rate of      |
|                          |                                                                           |10         |10           |
|                          |                                                                           |℃/min,     |℃/min,       |
|                          |                                                                           |keep at    |keep at      |
|                          |                                                                           |240        |240          |
|                          |                                                                           |℃for       |℃for         |
|                          |                                                                           |5min.      |5min.        |
|--------------------------|---------------------------------------------------------------------------|-----------|-------------|
|Injection port temperature|240 ℃                                                                      |Split      |10:1         |
|                          |                                                                           |ratio      |(recommended)|
|--------------------------|---------------------------------------------------------------------------|-----------|-------------|
|Detector                  |FID                                                                        |Detector   |240 ℃        |
|                          |                                                                           |temperature|             |
|--------------------------|---------------------------------------------------------------------------|-----------|-------------|
|Carriergas                |N2                                                                         |Flow rate  |1.5 mL/min   |
|--------------------------|---------------------------------------------------------------------------|-----------|-------------|
|Injection volume          |Injection volume                                                           |1.0 uL     |1.0 uL       |
----------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 150 of 542 





Page 151
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



_System suitability_ : reference solution 



– elution order: ethanol, tetrahydrofuran, toluene, N-methylpyrrolidone. 



– _resolution_ : minimum 1.5 between the adjacent peaks. 



_Limits_ (calculate by external standard method): 



– ethanol NMT 0.5%; 



- tetrahydrofuran NMT 0.072%; 



- toluene NMT 0.089%; 



- N-methylpyrrolidone NMT 0.053% 



**Water** 



Examine in accordance with Standard operating procedure of Water 



determination (in-house method) 



NMT 0.5%, determined on 0.2 g. 



**Residue on ignition** 



Examine by _Operating procedures of residue on ignition determination_ 



(in-house method). 



NMT 0.1%, determined on 1.0 g. 



**Heavy metals** 



Examine by _Operating procedures of heavy metals determination_ (in-house 



method). 



NMT 10 ppm, determined on the residue obtained in the test for _Residue on_ 



_ignition_ . 



**Microbial limits** 



Examine by _Operating procedures of microbial limits determination_ (in-house 



method) 



Limits: 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 151 of 542 





Page 152
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Total aerobic microbial counts (TAMC) is NMT 10 [3] CFU/g; 



mould and yeast count (TYMC) is NMT 10 [2] CFU/g; and 



_E.coli_ is absent in each 1 g of the substance to be examined. 



**Assay** 



Examine by Operating procedures of high performance liquid 



chromatography (in-house method). 



Solvent mixture: acetonitrile, water (30:70 V/V); 



Test solution: Take an appropriate amount of this product, weigh it 



accurately, dissolve it in a solvent with ultrasound, and dilute it to make a 



solution containing approximately 0.02mg per 1ml. 



Reference solution: Take an appropriate amount of non maleketone reference 



substance, accurately weigh it, dissolve it in solvent ultrasound and dilute it 



to prepare a solution containing approximately 0.02mg of non maleketone 



per 1ml. 



_Chromatographic system_ 



Except for the detection wavelength of 251nm, all others are Refer to the 



relevant material items. 



_System suitability_ 



-Reference solution: The theoretical number of trays NLT 3000 calculated 



based on the Finerenone peak, and the tailing factor NMT 1.5; 



-The reference solution should be injected 6 times, and the relative standard 



deviation of the main peak area NMT 2%. 



Calculate the percentage content of Finerenone (C21H22N4O3) by external 



standard method. 



It contains 98.0% to 102.0% of C21H22N4O3, calculated on the anhydrous 



basis. 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 152 of 542 





Page 153
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.4.3 Validation of Analytical Procedure** 



**3.2.S.4.3.1 Method Validation of Related Substances in Finerenone** 



**I. Analytical Procedures** 



Please refer to the analytical procedures of related substances in Finerenone 



in _section 3.2.S.4.2_ . 



**II. Validation Results and Discussion** 



**a. Selection of Detection Wavelength** 



 **Acceptance Criteria** 



The selection of the detection wavelength is carried out by measuring 



Finerenone (YA2304), YA2304-10, YA2304-12, YA2304-14, YA2304-15, 



YA2304-16, YA2304-17, YA2304-18 and YA2304-19 at 200nm ~ 400nm 



wavelengths Uv scanning, YA2304-10 and YA2304-17 should have large 



absorption at 230nm; Finerenone (YA2304), YA2304-12, YA2304-14, 



YA2304-15, YA2304-16, YA2304-18 and ya2304-19 should have greater 



absorption at 251nm. 



 **Solution Preparation** 



Blank solution: solvent. 



YA2304-12 Reference product reserve liquid: Take YA2304-12 reference 



product about 5mg, accurately weigh, put into 25ml measuring bottle, 



dissolve with solvent and dilute to scale, shake well, and then get. (About 



200μg/ml) 



YA2304-14 reference product reserve liquid: Take YA2304-14 reference 



product about 5mg, accurately weigh, put into 25ml measuring bottle, 



dissolve with acetonitrile and dilute to scale, shake well, ready. (Approx. 



200μg/ml) 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 153 of 542 





Page 154
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



YA2304 reference product reserve liquid: Take YA2304 reference product 



about 5mg, accurately weigh, put into 25ml measuring bottle, dissolve with 



acetonitrile and dilute to scale, shake well, ready. (Approx. 200μg/ml) 



YA2304-15 reference product reserve liquid: Take YA2304-15 reference 



product about 5mg, accurately weigh, put into 25ml measuring bottle, 



dissolve with acetonitrile and dilute to scale, shake well, ready. (Approx. 



200μg/ml) 



YA2304-16 reference product reserve liquid: Take YA2304-16 reference 



product about 5mg, accurately weigh, put into 25ml measuring bottle, 



dissolve with acetonitrile and dilute to scale, shake well, ready. (Approx. 



200μg/ml) 



YA2304-18 reference product reserve liquid: Take YA2304-18 reference 



product about 5mg, accurately weigh, put into 25ml measuring bottle, 



dissolve with acetonitrile and dilute to scale, shake well, ready. (Approx. 



200μg/ml) 



YA2304-19 reference product reserve liquid: Take YA2304-19 reference 



product about 5mg, accurately weigh, put into 25ml measuring bottle, 



dissolve with acetonitrile and dilute to scale, shake well, ready. (Approx. 



200μg/ml) 



YA2304-10 reference product reserve liquid: Take YA2304-10 reference 



product about 5mg, accurately weigh, put into 25ml measuring bottle, 



dissolve with solvent and dilute to scale, shake well, and then obtain. (About 



200μg/ml) 



YA2304-17 reference product reserve liquid: Take YA2304-17 reference 



product about 5mg, accurately weigh, put into 25ml measuring bottle, 



dissolve with solvent and dilute to scale, shake well, and then obtain. (About 



200μg/ml) 



Mixed control solution ① : Take 0.6ml of each control product reserve 



solution of YA2304-12, YA2304-14, YA2304, YA2304-15, YA2304-16, 



YA2304-18, YA2304-19, YA2304-10 and YA2304-17 and put them into a 



20ml measuring bottle. Dilute it with solvent to scale and shake well; Then 



accurately measure 1ml of the above solution, place it in a 10ml measuring 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 154 of 542 





Page 155
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



bottle, dilute it with solvent to the scale, shake well, and then get. (Both 



about 0.6μg/ml) 



 **Injection Sequence** 



After the blank solution, inject 1 needle mixed with reference solution ① and 



record the chromatogram. 



 **Results and Discussion** 



Wavelength Scanning Spectrum of Reference solution: 



Results of Detection Wavelength Selection: 













------------------------------------------------------------------------------------------------------------------------------------
|YA2304-10                                                                                             |15.278       |Yes, at      |
|                                                                                                      |             |230nm        |
|------------------------------------------------------------------------------------------------------|-------------|-------------|
|YA2304-17                                                                                             |11.524       |Yes, at      |
|                                                                                                      |             |230nm        |
|------------------------------------------------------------------------------------------------------|-------------|-------------|
|YA2304-12                                                                                             |3.791        |Yes, at      |
|                                                                                                      |             |251nm        |
|------------------------------------------------------------------------------------------------------|-------------|-------------|
|YA2304-14                                                                                             |8.175        |Yes, at      |
|                                                                                                      |             |251nm        |
|------------------------------------------------------------------------------------------------------|-------------|-------------|
|YA2304                                                                                                |9.329        |Yes, at      |
|                                                                                                      |             |251nm        |
|------------------------------------------------------------------------------------------------------|-------------|-------------|
|YA2304-15                                                                                             |10.295       |Yes, at      |
|                                                                                                      |             |251nm        |
|------------------------------------------------------------------------------------------------------|-------------|-------------|
|YA2304-16                                                                                             |11.942       |Yes, at      |
|                                                                                                      |             |251nm        |
|------------------------------------------------------------------------------------------------------|-------------|-------------|
|YA2304-18                                                                                             |13.183       |Yes, at      |
|                                                                                                      |             |251nm        |
|------------------------------------------------------------------------------------------------------|-------------|-------------|
|YA2304-19                                                                                             |16.435       |Yes, at      |
|                                                                                                      |             |251nm        |
|------------------------------------------------------------------------------------------------------|-------------|-------------|
|Conclusion: Impurities YA2304-10 and YA2304-17 have large absorption at 230nm wavelength; The         |Conclusion:  |Conclusion:  |
|principal component andimpurities YA2304-12, YA2304-14, YA2304-15, YA2304-16, YA2304-18 and YA2304-19 |Impurities   |Impurities   |
|all have large absorption at 251nm.                                                                   |YA2304-10    |YA2304-10    |
|                                                                                                      |and          |and          |
|                                                                                                      |YA2304-17    |YA2304-17    |
|                                                                                                      |have         |have         |
|                                                                                                      |large        |large        |
|                                                                                                      |absorption   |absorption   |
|                                                                                                      |at           |at           |
|                                                                                                      |230nm        |230nm        |
|                                                                                                      |wavelength;  |wavelength;  |
|                                                                                                      |The          |The          |
|                                                                                                      |principal    |principal    |
|                                                                                                      |component    |component    |
|                                                                                                      |andimpurities|andimpurities|
|                                                                                                      |YA2304-12,   |YA2304-12,   |
|                                                                                                      |YA2304-14,   |YA2304-14,   |
|                                                                                                      |YA2304-15,   |YA2304-15,   |
|                                                                                                      |YA2304-16,   |YA2304-16,   |
|                                                                                                      |YA2304-18    |YA2304-18    |
|                                                                                                      |and          |and          |
|                                                                                                      |YA2304-19    |YA2304-19    |
|                                                                                                      |all          |all          |
|                                                                                                      |have         |have         |
|                                                                                                      |large        |large        |
|                                                                                                      |absorption   |absorption   |
|                                                                                                      |at           |at           |
|                                                                                                      |251nm.       |251nm.       |
------------------------------------------------------------------------------------------------------------------------------------

**b. System Suitability Determination** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 155 of 542 





Page 156
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



 **Acceptance Criteria** 



The blank solution should be free of interference; Reference solution 



chromatogram (230nm), the peak order is YA2304-17, YA2304-10; In the 



chromatogram of system suitability solution (251nm), the peak order is 



YA2304-14, YA2304, YA2304-15, YA2304-17, YA2304-16, YA2304-10, 



YA2304-19. The separation degree between YA2304 and YA2304-14 and 



YA2304-15 should be NLT 1.5, and the separation degree between 



YA2304-17 and YA2304-16 and adjacent peaks should be NLT 1.0; In the 



chromatogram obtained by contrast solution (251nm) for 6 consecutive days, 



the RSD of the main peak NMT 1.0%, the RSD of the peak area NMT 5%, and 



the signal-to-noise ratio (S/N) should NLT 20. 



 **Solution preparation** 



Blank solution: solvent. 



YA2304-12 Reference storage solution: Share "YA2304-12 Reference Storage 



solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-14 Reference storage solution: Share "YA2304-14 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304 Reference stock: Share "YA2304 Reference Stock" under "4.1 



Wavelength Selection". (Approx. 200μg/ml) 



YA2304-15 Reference storage solution: Share "YA2304-15 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-16 Reference storage solution: Share "YA2304-16 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 156 of 542 





Page 157
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



YA2304-18 Reference storage solution: Share "YA2304-18 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-19 Reference storage solution: Share "YA2304-19 Reference storage 



solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-10 Reference storage Solution: Share "YA2304-10 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-17 Reference storage solution: Share "YA2304-17 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



Test product solution: Take about 10mg of this product, weigh it accurately, 



put it in a 25ml measuring bottle, dissolve it with solvent and dilute it to the 



scale, shake well, then get. (About 0.4mg/ml) 



Control solution: accurately measure 1ml of the test product solution, place 



it in a 20ml measuring bottle, dilute it with solvent to the scale, and shake 



well; Precision measure 1ml of the above solution, place it in a 50ml 



measuring bottle, dilute it with solvent to the scale, shake well, and then get. 



(About 0.4μg/ml) 



Reference solution: accurately measure 1ml each of YA2304-10 and 



YA2304-17 reference solution, place them in a 50ml measuring bottle, dilute 



them with solvent to scale, and shake well; Accurately measure 1ml of the 



above solution, place it in a 10ml measuring bottle, dilute it with solvent to 



the scale, shake well, and then obtain. (YA2304-10 and YA2304-17 contain 



about 0.4μg/ml) 



System suitability solution: Accurately weigh YA2304 reference product 



about 10mg, place it in 25ml bottle, add appropriate amount of solvent to 



dissolve by ultrasound, then accurately add 100μl each of YA2304-14, 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 157 of 542 





Page 158
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



YA2304-15, YA2304-16, YA2304-19, YA2304-10 and YA2304-17 reference 



product reserve solution. Dilute with solvent to scale, shake well, ready. 



(YA2304-14, YA2304-15, YA2304-16, YA2304-19, YA2304-10 and 



YA2304-17 all about 0.8μg/ml) 



 **Injection Sequence** 



After the blank solution, inject 1 needle of system suitability solution, 1 



needle of reference solution, 6 needles of reference solution, and record the 



chromatogram. 



 **Results and Discussion** 



Results of System Suitability: 






















































-----------------------------------------------------------------------------------------------------------------------------------------------------
|System suitabilit ysolution (251nm)|RT (min)                          |8.255     |9.307    |10.306     |11.563     |11.563         |11.979         |
|-----------------------------------|----------------------------------|----------|---------|-----------|-----------|---------------|---------------|
|System suitabilit ysolution (251nm)|Minimum separation between YA2304 |Minimum   |4.9      |Minimum    |Minimum    |Minimum        |1.2            |
|                                   |and YA2304-14 and YA2304-15       |separation|         |separation |separation |separation     |               |
|                                   |                                  |between   |         |between    |between    |between        |               |
|                                   |                                  |YA2304    |         |YA2304-17  |YA2304-17  |YA2304-17      |               |
|                                   |                                  |and       |         |and        |and        |and            |               |
|                                   |                                  |YA2304-14 |         |YA2304-16  |YA2304-16  |YA2304-16      |               |
|                                   |                                  |and       |         |andadjacent|andadjacent|andadjacent    |               |
|                                   |                                  |YA2304-15 |         |peaks      |peaks      |peaks          |               |
|-----------------------------------|----------------------------------|----------|---------|-----------|-----------|---------------|---------------|
|Map name                           |Number of samplesinjected         |Main peak |Main     |Main       |Main       |Principal      |Principal      |
|                                   |                                  |retention |peak     |peakarea   |peakarea   |peak           |peak           |
|                                   |                                  |time (min)|retention|           |           |signal-to-noise|signal-to-noise|
|                                   |                                  |          |time     |           |           |ratio (S/N)    |ratio          |
|                                   |                                  |          |(min)    |           |           |               |(S/N)          |
|-----------------------------------|----------------------------------|----------|---------|-----------|-----------|---------------|---------------|
|Control solution (251nm)           |1                                 |9.378     |9.378    |6845       |6845       |54.4           |54.4           |
|-----------------------------------|----------------------------------|----------|---------|-----------|-----------|---------------|---------------|
|Control solution (251nm)           |2                                 |9.381     |9.381    |6900       |6900       |44.5           |44.5           |
|-----------------------------------|----------------------------------|----------|---------|-----------|-----------|---------------|---------------|
|Control solution (251nm)           |3                                 |9.381     |9.381    |6907       |6907       |71.7           |71.7           |
|-----------------------------------|----------------------------------|----------|---------|-----------|-----------|---------------|---------------|
|Control solution (251nm)           |4                                 |9.389     |9.389    |6991       |6991       |73.6           |73.6           |
|-----------------------------------|----------------------------------|----------|---------|-----------|-----------|---------------|---------------|
|Control solution (251nm)           |5                                 |9.387     |9.387    |6976       |6976       |97.1           |97.1           |
|-----------------------------------|----------------------------------|----------|---------|-----------|-----------|---------------|---------------|
|Control solution (251nm)           |6                                 |9.382     |9.382    |6726       |6726       |78.4           |78.4           |
-----------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 158 of 542 





Page 159
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 

----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Conclusion: There was no interference in the blank solution, the chromatogram of the  |Conclusion:         |Conclusion:         |Conclusion:         |Conclusion:         |
|control solution (230nm), the peak sequence was YA2304-17, YA2304-10; In the          |There               |There               |There               |There               |
|chromatogram of system suitable solution (251nm), the peakorder was YA2304-14, YA2304,|was no              |was no              |was no              |was no              |
|YA2304-15, YA2304-17, YA2304-16, YA2304-10, YA2304-19. The minimum separation degree  |interference        |interference        |interference        |interference        |
|between YA2304 and YA2304-14 and YA2304-15 is 4.9 (NLT 1.5), and the minimum          |in the              |in the              |in the              |in the              |
|separation degree between YA2304-17 and YA2304-16 andadjacent peaksis 1.2 (NLT 1.0);  |blank               |blank               |blank               |blank               |
|In the chromatogramobtained by contrast solution (251nm) for 6 consecutive days, the  |solution,           |solution,           |solution,           |solution,           |
|RSD of main peak retention time was 0.05% (not more than 1.0%), the RSD of main       |the                 |the                 |the                 |the                 |
|peakarea was 1.5% (not more than 5%), and the signal-to-noise ratio (S/N) was NLT 20. |chromatogram        |chromatogram        |chromatogram        |chromatogram        |
|All the above meet the verification requirements, indicating that the method has      |of the              |of the              |of the              |of the              |
|goodapplicability in system.                                                          |control             |control             |control             |control             |
|                                                                                      |solution            |solution            |solution            |solution            |
|                                                                                      |(230nm),            |(230nm),            |(230nm),            |(230nm),            |
|                                                                                      |the                 |the                 |the                 |the                 |
|                                                                                      |peak                |peak                |peak                |peak                |
|                                                                                      |sequence            |sequence            |sequence            |sequence            |
|                                                                                      |was                 |was                 |was                 |was                 |
|                                                                                      |YA2304-17,          |YA2304-17,          |YA2304-17,          |YA2304-17,          |
|                                                                                      |YA2304-10;          |YA2304-10;          |YA2304-10;          |YA2304-10;          |
|                                                                                      |In the              |In the              |In the              |In the              |
|                                                                                      |chromatogram        |chromatogram        |chromatogram        |chromatogram        |
|                                                                                      |of                  |of                  |of                  |of                  |
|                                                                                      |system              |system              |system              |system              |
|                                                                                      |suitable            |suitable            |suitable            |suitable            |
|                                                                                      |solution            |solution            |solution            |solution            |
|                                                                                      |(251nm),            |(251nm),            |(251nm),            |(251nm),            |
|                                                                                      |the                 |the                 |the                 |the                 |
|                                                                                      |peakorder           |peakorder           |peakorder           |peakorder           |
|                                                                                      |was                 |was                 |was                 |was                 |
|                                                                                      |YA2304-14,          |YA2304-14,          |YA2304-14,          |YA2304-14,          |
|                                                                                      |YA2304,             |YA2304,             |YA2304,             |YA2304,             |
|                                                                                      |YA2304-15,          |YA2304-15,          |YA2304-15,          |YA2304-15,          |
|                                                                                      |YA2304-17,          |YA2304-17,          |YA2304-17,          |YA2304-17,          |
|                                                                                      |YA2304-16,          |YA2304-16,          |YA2304-16,          |YA2304-16,          |
|                                                                                      |YA2304-10,          |YA2304-10,          |YA2304-10,          |YA2304-10,          |
|                                                                                      |YA2304-19.          |YA2304-19.          |YA2304-19.          |YA2304-19.          |
|                                                                                      |The                 |The                 |The                 |The                 |
|                                                                                      |minimum             |minimum             |minimum             |minimum             |
|                                                                                      |separation          |separation          |separation          |separation          |
|                                                                                      |degree              |degree              |degree              |degree              |
|                                                                                      |between             |between             |between             |between             |
|                                                                                      |YA2304              |YA2304              |YA2304              |YA2304              |
|                                                                                      |and                 |and                 |and                 |and                 |
|                                                                                      |YA2304-14           |YA2304-14           |YA2304-14           |YA2304-14           |
|                                                                                      |and                 |and                 |and                 |and                 |
|                                                                                      |YA2304-15           |YA2304-15           |YA2304-15           |YA2304-15           |
|                                                                                      |is 4.9              |is 4.9              |is 4.9              |is 4.9              |
|                                                                                      |(NLT                |(NLT                |(NLT                |(NLT                |
|                                                                                      |1.5),               |1.5),               |1.5),               |1.5),               |
|                                                                                      |and the             |and the             |and the             |and the             |
|                                                                                      |minimum             |minimum             |minimum             |minimum             |
|                                                                                      |separation          |separation          |separation          |separation          |
|                                                                                      |degree              |degree              |degree              |degree              |
|                                                                                      |between             |between             |between             |between             |
|                                                                                      |YA2304-17           |YA2304-17           |YA2304-17           |YA2304-17           |
|                                                                                      |and                 |and                 |and                 |and                 |
|                                                                                      |YA2304-16           |YA2304-16           |YA2304-16           |YA2304-16           |
|                                                                                      |andadjacent         |andadjacent         |andadjacent         |andadjacent         |
|                                                                                      |peaksis             |peaksis             |peaksis             |peaksis             |
|                                                                                      |1.2                 |1.2                 |1.2                 |1.2                 |
|                                                                                      |(NLT                |(NLT                |(NLT                |(NLT                |
|                                                                                      |1.0);               |1.0);               |1.0);               |1.0);               |
|                                                                                      |In the              |In the              |In the              |In the              |
|                                                                                      |chromatogramobtained|chromatogramobtained|chromatogramobtained|chromatogramobtained|
|                                                                                      |by                  |by                  |by                  |by                  |
|                                                                                      |contrast            |contrast            |contrast            |contrast            |
|                                                                                      |solution            |solution            |solution            |solution            |
|                                                                                      |(251nm)             |(251nm)             |(251nm)             |(251nm)             |
|                                                                                      |for 6               |for 6               |for 6               |for 6               |
|                                                                                      |consecutive         |consecutive         |consecutive         |consecutive         |
|                                                                                      |days,               |days,               |days,               |days,               |
|                                                                                      |the RSD             |the RSD             |the RSD             |the RSD             |
|                                                                                      |of main             |of main             |of main             |of main             |
|                                                                                      |peak                |peak                |peak                |peak                |
|                                                                                      |retention           |retention           |retention           |retention           |
|                                                                                      |time                |time                |time                |time                |
|                                                                                      |was                 |was                 |was                 |was                 |
|                                                                                      |0.05%               |0.05%               |0.05%               |0.05%               |
|                                                                                      |(not                |(not                |(not                |(not                |
|                                                                                      |more                |more                |more                |more                |
|                                                                                      |than                |than                |than                |than                |
|                                                                                      |1.0%),              |1.0%),              |1.0%),              |1.0%),              |
|                                                                                      |the RSD             |the RSD             |the RSD             |the RSD             |
|                                                                                      |of main             |of main             |of main             |of main             |
|                                                                                      |peakarea            |peakarea            |peakarea            |peakarea            |
|                                                                                      |was                 |was                 |was                 |was                 |
|                                                                                      |1.5%                |1.5%                |1.5%                |1.5%                |
|                                                                                      |(not                |(not                |(not                |(not                |
|                                                                                      |more                |more                |more                |more                |
|                                                                                      |than                |than                |than                |than                |
|                                                                                      |5%),                |5%),                |5%),                |5%),                |
|                                                                                      |and the             |and the             |and the             |and the             |
|                                                                                      |signal-to-noise     |signal-to-noise     |signal-to-noise     |signal-to-noise     |
|                                                                                      |ratio               |ratio               |ratio               |ratio               |
|                                                                                      |(S/N)               |(S/N)               |(S/N)               |(S/N)               |
|                                                                                      |was NLT             |was NLT             |was NLT             |was NLT             |
|                                                                                      |20. All             |20. All             |20. All             |20. All             |
|                                                                                      |the                 |the                 |the                 |the                 |
|                                                                                      |above               |above               |above               |above               |
|                                                                                      |meet                |meet                |meet                |meet                |
|                                                                                      |the                 |the                 |the                 |the                 |
|                                                                                      |verification        |verification        |verification        |verification        |
|                                                                                      |requirements,       |requirements,       |requirements,       |requirements,       |
|                                                                                      |indicating          |indicating          |indicating          |indicating          |
|                                                                                      |that                |that                |that                |that                |
|                                                                                      |the                 |the                 |the                 |the                 |
|                                                                                      |method              |method              |method              |method              |
|                                                                                      |has                 |has                 |has                 |has                 |
|                                                                                      |goodapplicability   |goodapplicability   |goodapplicability   |goodapplicability   |
|                                                                                      |in                  |in                  |in                  |in                  |
|                                                                                      |system.             |system.             |system.             |system.             |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------



**c. Specificity** 



**i. Peak Specificity** 



 **Acceptance Criteria** 



The blank solution should be free from interference; In the 



chromatogram of system suitability solution (251nm), the peak order is 



YA2304-14, YA2304, YA2304-15, YA2304-17, YA2304-16, YA2304-10, 



YA2304-19, The separation degree between YA2304 and YA2304-14 and 



YA2304-15 should be NLT 1.5, and the separation degree between 



YA2304-17 and YA2304-16 and adjacent peaks should be NLT 1.0; In the 



chromatogram of test product solution (251nm) and specific mixed solution 



(251nm), the separation degree between YA2304-17 and YA2304-16 and 



adjacent peaks should NLT 1.0, and the separation degree between other 



adjacent peaks should NLT 1.5; The retention time of each known impurity 



peak in the reference solution, system suitability solution, test product 



solution and specific mixed solution should be consistent with the 



corresponding main peak in the impurity positioning solution, and the 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 159 of 542 





Page 160
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



relative retention time of each known impurity peak in the specific mixed 



solution should be basically consistent with the quality standard. 



 **Solution preparation** 



Blank solution: solvent 



YA2304-12 Reference storage solution: Share "YA2304-12 Reference Storage 



solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-14 Reference storage solution: Share "YA2304-14 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304 Reference stock: Share "YA2304 Reference Stock" under "4.1 



Wavelength Selection". (Approx. 200μg/ml) 



YA2304-15 Reference storage solution: Share "YA2304-15 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-16 Reference storage solution: Share "YA2304-16 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-18 Reference storage solution: Share "YA2304-18 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-19 Reference storage solution: Share "YA2304-19 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-10 Reference storage Solution: Share "YA2304-10 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-17 Reference storage solution: Share "YA2304-17 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 160 of 542 





Page 161
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



YA2304-12 Impurity location solution: accurately measure 0.6ml of 



YA2304-12 reference product reserve, place it in a 20ml measuring bottle, 



dilute it with solvent to the scale, and shake well; Then precisely measure 



1ml, place it in a 10ml measuring bottle, dilute it with solvent to the scale, 



and shake well, then it is ready. (About 0.6μg/ml) 



YA2304-14 Impurity location solution: accurately measure 0.6ml of 



YA2304-14 reference product reserve, place it in a 20ml measuring bottle, 



dilute it with solvent to the scale, and shake well; Then precisely measure 



1ml, place it in a 10ml measuring bottle, dilute it with solvent to the scale, 



and shake well, then it is ready. (About 0.6μg/ml) 



YA2304-15 Impurity location solution: accurately measure 0.6ml of 



YA2304-15 reference product reserve, place it in a 20ml measuring bottle, 



dilute it with solvent to the scale, and shake well; Then precisely measure 



1ml, place it in a 10ml measuring bottle, dilute it with solvent to the scale, 



shake well, and then obtain. (About 0.6μg/ml) 



YA2304-16 Impurity location solution: accurately measure 0.6ml of 



YA2304-16 reference product reserve, place it in a 20ml measuring bottle, 



dilute it with solvent to the scale, and shake well; Then precisely measure 



1ml, place it in a 10ml measuring bottle, dilute it with solvent to the scale, 



and shake well, then it is ready. (About 0.6μg/ml) 



YA2304-18 Impurity location solution: Accurately measure 0.6ml of 



YA2304-18 reference product reserve, place it in a 20ml measuring bottle, 



dilute it with solvent to the scale, and shake well; Then precisely measure 



1ml, place it in a 10ml measuring bottle, dilute it with solvent to the scale, 



and shake well, then it is ready. (About 0.6μg/ml) 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 161 of 542 





Page 162
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



YA2304-19 Impurity location solution: accurately measure 0.6ml of 



YA2304-19 reference product reserve, place it in a 20ml measuring bottle, 



dilute it with solvent to the scale, and shake well; Then precisely measure 



1ml, place it in a 10ml measuring bottle, dilute it with solvent to the scale, 



and shake well, then it is ready. (About 0.6μg/ml) 



YA2304-17 Impurity location solution: accurately measure 0.6ml of 



YA2304-17 reference product reserve, place it in a 20ml measuring bottle, 



dilute it with solvent to the scale, and shake well; Then precisely measure 



1ml, place it in a 10ml measuring bottle, dilute it with solvent to the scale, 



and shake well, then it is ready. (About 0.6μg/ml) 



YA2304-10 Impurity location solution: accurately measure 0.6ml of 



YA2304-10 reference product reserve, place it in a 20ml measuring bottle, 



dilute it with solvent to the scale, and shake well; Then precisely measure 



1ml, place it in a 10ml measuring bottle, dilute it with solvent to the scale, 



and shake well, then it is ready. (About 0.6μg/ml) 



Reference solution: Share "Reference solution" under "4.2 System Suitability". 



(YA2304-10, YA2304-17 containing approximately 0.4μg/ml) 



Test solution: Share "test solution" under "4.2 System Suitability". (Approx. 



0.4mg/ml) 



Control solution: Share "Control solution" under "4.2 System Suitability". 



(Approx. 0.4μg/ml) 



System Suitability Solution: Share "System Suitability Solution" under "4.2 



System Suitability". (YA2304-14, YA2304-15, YA2304-16, YA2304-19, 



YA2304-10 and YA2304-17 all approx. 0.8μg/ml) 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 162 of 542 





Page 163
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Specific reserve liquid: Take 1.5ml of each control product reserve liquid of 



YA2304-12, YA2304-14, YA2304-15, YA2304-16, YA2304-18, YA2304-19, 



YA2304-17 and YA2304-10 respectively and place them in the same 20ml 



bottle and dilute them to the scale with solvent. Shake well, then it is ready. 



(Contains YA2304-12, YA2304-14, YA2304-15, YA2304-16, YA2304-18, 



YA2304-19, YA2304-17 and YA2304-10 about 15μg/ml each) 



Specific mixed solution: accurately weigh 10mg of this product, place it in a 



25ml measuring bottle, add an appropriate amount of solvent and ultrasonic 



to dissolve it, then precisely add 1.0ml of specific reserve solution, dilute it 



with solvent to the scale, shake well, and get. (Including YA2304-12, 



YA2304-14, YA2304-15, YA2304-16, YA2304-18, YA2304-19, YA2304-17 



and YA2304-10 are about 0.6μg/ml) 



 **Injection Sequence** 



After the blank solution, Sample system suitability solution, test product 



solution, reference product solution, reference solution, specific mixed 



solution, YA2304-12 impurity location solution, YA2304-14 impurity 



location solution, YA2304-15 impurity location solution, YA2304-16 



impurity location solution, YA2304-18 impurity location solution, YA230 



4-19 Impurity location solution, YA2304-10 impurity location solution and 



YA2304-17 impurity location solution were each injected, and the 



chromatogram was recorded. 



 **Results and Discussion** 



Results of Peak Specificity: 




Solution 



name 




Detection 



wavelength 




Component 



name 




Component 



concentration 



(μg/ml) 




Rt 



(min) 




RRT 




Minimum 



separation 



from 




Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 163 of 542 





Page 164
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



























----------------------------------------------------------------------------------------
|YA2304-12 Impurity locating solution|251nm  |YA2304-12|0.6005 |3.826  |/      |/      |
|------------------------------------|-------|---------|-------|-------|-------|-------|
|YA2304-14 Impurity locating solution|251nm  |YA2304-14|0.6032 |8.268  |/      |/      |
|------------------------------------|-------|---------|-------|-------|-------|-------|
|Contrast solution                   |251nm  |YA2304   |0.4113 |9.378  |/      |/      |
|------------------------------------|-------|---------|-------|-------|-------|-------|
|YA2304-15 Impurity locating solution|251nm  |YA2304-15|0.6055 |10.314 |/      |/      |
|------------------------------------|-------|---------|-------|-------|-------|-------|
|YA2304-17 Impurity locating solution|251nm  |YA2304-17|0.6040 |11.563 |/      |/      |
|------------------------------------|-------|---------|-------|-------|-------|-------|
|YA2304-17 Impurity locating solution|230nm  |230nm    |230nm  |11.556 |/      |/      |
|------------------------------------|-------|---------|-------|-------|-------|-------|
|YA2304-16 Impurity locating solution|251nm  |YA2304-16|0.5797 |11.976 |/      |/      |
|------------------------------------|-------|---------|-------|-------|-------|-------|
|YA2304-18 Impurity locating solution|251nm  |YA2304-18|0.6014 |13.221 |/      |/      |
|------------------------------------|-------|---------|-------|-------|-------|-------|
|YA2304-10 Impurity locating solution|251nm  |YA2304-10|0.6092 |15.316 |/      |/      |
|------------------------------------|-------|---------|-------|-------|-------|-------|
|YA2304-10 Impurity locating solution|230nm  |230nm    |230nm  |15.312 |/      |/      |
|------------------------------------|-------|---------|-------|-------|-------|-------|
|YA2304-19 Impurity locating         |251nm  |YA2304-19|0.6008 |16.496 |/      |/      |
----------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 164 of 542 





Page 165
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 












--------------------------------------------------------------------------------
|Reference solution         |230nm  |YA2304-17|0.6040  |11.558 |/      |/      |
|---------------------------|-------|---------|--------|-------|-------|-------|
|Reference solution         |230nm  |YA2304-10|0.6092  |15.319 |/      |/      |
|---------------------------|-------|---------|--------|-------|-------|-------|
|System Suitability solution|251nm  |YA2304-14|0.8043  |8.255  |0.89   |4.9    |
|---------------------------|-------|---------|--------|-------|-------|-------|
|System Suitability solution|251nm  |YA2304   |402.4291|9.307  |1.00   |4.9    |
|---------------------------|-------|---------|--------|-------|-------|-------|
|System Suitability solution|251nm  |YA2304-15|0.8073  |10.306 |1.11   |5.5    |
|---------------------------|-------|---------|--------|-------|-------|-------|
|System Suitability solution|251nm  |YA2304-17|0.8054  |11.563 |1.24   |1.2    |
|---------------------------|-------|---------|--------|-------|-------|-------|
|System Suitability solution|251nm  |YA2304-16|0.7730  |11.979 |1.29   |1.4    |
|---------------------------|-------|---------|--------|-------|-------|-------|
|System Suitability solution|251nm  |YA2304-10|0.8122  |15.316 |1.65   |5.5    |
|---------------------------|-------|---------|--------|-------|-------|-------|
|System Suitability solution|251nm  |YA2304-19|0.8011  |16.486 |1.77   |5.5    |
|---------------------------|-------|---------|--------|-------|-------|-------|
|Sample solution            |251nm  |YA2304-12|/       |3.815  |0.41   |4.5    |
|---------------------------|-------|---------|--------|-------|-------|-------|
|Sample solution            |251nm  |YA2304   |411.2800|9.292  |1.00   |6.8    |
|---------------------------|-------|---------|--------|-------|-------|-------|
|Sample solution            |251nm  |YA2304-19|/       |16.476 |1.77   |24.4   |
|---------------------------|-------|---------|--------|-------|-------|-------|
|Sample solution            |230nm  |YA2304-17|/       |/      |/      |/      |
|---------------------------|-------|---------|--------|-------|-------|-------|
|Sample solution            |230nm  |YA2304-10|/       |/      |/      |/      |
|---------------------------|-------|---------|--------|-------|-------|-------|
|Specific mixed solution    |251nm  |YA2304-12|0.6005  |3.810  |0.41   |3.1    |
|---------------------------|-------|---------|--------|-------|-------|-------|
|Specific mixed solution    |251nm  |YA2304-14|0.6032  |8.233  |0.89   |4.7    |
|---------------------------|-------|---------|--------|-------|-------|-------|
|Specific mixed solution    |251nm  |YA2304   |410.0400|9.289  |1.00   |5.0    |
|---------------------------|-------|---------|--------|-------|-------|-------|
|Specific mixed solution    |251nm  |YA2304-15|0.6055  |10.295 |1.11   |5.6    |
|---------------------------|-------|---------|--------|-------|-------|-------|
|Specific mixed solution    |251nm  |YA2304-17|0.6040  |11.549 |1.24   |1.2    |
|---------------------------|-------|---------|--------|-------|-------|-------|
|Specific mixed solution    |251nm  |YA2304-16|0.5797  |11.972 |1.29   |1.4    |
|---------------------------|-------|---------|--------|-------|-------|-------|
|Specific mixed solution    |251nm  |YA2304-18|0.6014  |13.207 |1.42   |7.4    |
|---------------------------|-------|---------|--------|-------|-------|-------|
|Specific mixed solution    |251nm  |YA2304-10|0.6092  |15.305 |1.65   |5.7    |
|---------------------------|-------|---------|--------|-------|-------|-------|
|Specific mixed solution    |251nm  |YA2304-19|0.6008  |16.474 |1.77   |5.7    |
|---------------------------|-------|---------|--------|-------|-------|-------|
|Specific mixed solution    |230nm  |YA2304-12|0.6005  |3.806  |0.41   |9.5    |
|---------------------------|-------|---------|--------|-------|-------|-------|
|Specific mixed solution    |230nm  |YA2304-14|0.6032  |8.229  |0.89   |5.0    |
--------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 165 of 542 





Page 166
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 

------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|YA2304-15                                                             |0.6055              |10.291              |1.11                |5.6                 |                    |                    |
|----------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|YA2304-17                                                             |0.6040              |11.547              |1.24                |1.2                 |                    |                    |
|----------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|YA2304-16                                                             |0.5797              |11.967              |1.29                |1.5                 |                    |                    |
|----------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|YA2304-18                                                             |0.6014              |13.203              |1.42                |7.4                 |                    |                    |
|----------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|YA2304-10                                                             |0.6092              |15.304              |1.65                |5.6                 |                    |                    |
|----------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|YA2304-19                                                             |0.6008              |16.470              |1.77                |5.6                 |                    |                    |
|----------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|Conclusion: Blank solution has no interference; In the chromatogram of|Conclusion:         |Conclusion:         |Conclusion:         |Conclusion:         |Conclusion:         |Conclusion:         |
|system suitability solution (251nm), the peakorder was YA2304-14,     |Blank               |Blank               |Blank               |Blank               |Blank               |Blank               |
|YA2304, YA2304-15, YA2304-17, YA2304-16, YA2304-10, YA2304-19. The    |solution            |solution            |solution            |solution            |solution            |solution            |
|minimum separation degree between YA2304 and YA2304-14 and YA2304-15  |has no              |has no              |has no              |has no              |has no              |has no              |
|is required to be 4.9 (NLT 1.5), and the minimum separation degree    |interference;       |interference;       |interference;       |interference;       |interference;       |interference;       |
|between YA2304-17 and YA2304-16 andadjacent peaksis 1.2 (NLT 1.0); In |In the              |In the              |In the              |In the              |In the              |In the              |
|the chromatogram of test product solution (251nm) and specific mixed  |chromatogram        |chromatogram        |chromatogram        |chromatogram        |chromatogram        |chromatogram        |
|solution (251nm), the minimum separation degree between YA2304-17 and |of                  |of                  |of                  |of                  |of                  |of                  |
|YA2304-16 andadjacent peaksis 1.2 (NLT 1.0), and the minimum          |system              |system              |system              |system              |system              |system              |
|separation degree betweenotheradjacent peaksis 3.1 (NLT 1.5). In the  |suitability         |suitability         |suitability         |suitability         |suitability         |suitability         |
|chromatogram of specific mixed solution (230nm), the minimum          |solution            |solution            |solution            |solution            |solution            |solution            |
|separation degree between YA2304-17 and YA2304-16 andadjacent peaks   |(251nm),            |(251nm),            |(251nm),            |(251nm),            |(251nm),            |(251nm),            |
|was 1.2 (NLT 1.0), and the minimum separation degree                  |the                 |the                 |the                 |the                 |the                 |the                 |
|betweenotheradjacent peaks was 5.0 (NLT 1.5). The retention time      |peakorder           |peakorder           |peakorder           |peakorder           |peakorder           |peakorder           |
|ofeach knownimpurity peak in the reference solution, the system       |was                 |was                 |was                 |was                 |was                 |was                 |
|suitability solution, the test product solution and the specific mixed|YA2304-14,          |YA2304-14,          |YA2304-14,          |YA2304-14,          |YA2304-14,          |YA2304-14,          |
|solution was consistent with the corresponding main peak in the       |YA2304,             |YA2304,             |YA2304,             |YA2304,             |YA2304,             |YA2304,             |
|impurity localization solution, and the relative retention time ofeach|YA2304-15,          |YA2304-15,          |YA2304-15,          |YA2304-15,          |YA2304-15,          |YA2304-15,          |
|knownimpurity peak in the specific mixed solution was basically       |YA2304-17,          |YA2304-17,          |YA2304-17,          |YA2304-17,          |YA2304-17,          |YA2304-17,          |
|consistent with the quality standard; The above are in line with the  |YA2304-16,          |YA2304-16,          |YA2304-16,          |YA2304-16,          |YA2304-16,          |YA2304-16,          |
|verification requirements.                                            |YA2304-10,          |YA2304-10,          |YA2304-10,          |YA2304-10,          |YA2304-10,          |YA2304-10,          |
|                                                                      |YA2304-19.          |YA2304-19.          |YA2304-19.          |YA2304-19.          |YA2304-19.          |YA2304-19.          |
|                                                                      |The                 |The                 |The                 |The                 |The                 |The                 |
|                                                                      |minimum             |minimum             |minimum             |minimum             |minimum             |minimum             |
|                                                                      |separation          |separation          |separation          |separation          |separation          |separation          |
|                                                                      |degree              |degree              |degree              |degree              |degree              |degree              |
|                                                                      |between             |between             |between             |between             |between             |between             |
|                                                                      |YA2304              |YA2304              |YA2304              |YA2304              |YA2304              |YA2304              |
|                                                                      |and                 |and                 |and                 |and                 |and                 |and                 |
|                                                                      |YA2304-14           |YA2304-14           |YA2304-14           |YA2304-14           |YA2304-14           |YA2304-14           |
|                                                                      |and                 |and                 |and                 |and                 |and                 |and                 |
|                                                                      |YA2304-15           |YA2304-15           |YA2304-15           |YA2304-15           |YA2304-15           |YA2304-15           |
|                                                                      |is                  |is                  |is                  |is                  |is                  |is                  |
|                                                                      |required            |required            |required            |required            |required            |required            |
|                                                                      |to be               |to be               |to be               |to be               |to be               |to be               |
|                                                                      |4.9                 |4.9                 |4.9                 |4.9                 |4.9                 |4.9                 |
|                                                                      |(NLT                |(NLT                |(NLT                |(NLT                |(NLT                |(NLT                |
|                                                                      |1.5),               |1.5),               |1.5),               |1.5),               |1.5),               |1.5),               |
|                                                                      |and the             |and the             |and the             |and the             |and the             |and the             |
|                                                                      |minimum             |minimum             |minimum             |minimum             |minimum             |minimum             |
|                                                                      |separation          |separation          |separation          |separation          |separation          |separation          |
|                                                                      |degree              |degree              |degree              |degree              |degree              |degree              |
|                                                                      |between             |between             |between             |between             |between             |between             |
|                                                                      |YA2304-17           |YA2304-17           |YA2304-17           |YA2304-17           |YA2304-17           |YA2304-17           |
|                                                                      |and                 |and                 |and                 |and                 |and                 |and                 |
|                                                                      |YA2304-16           |YA2304-16           |YA2304-16           |YA2304-16           |YA2304-16           |YA2304-16           |
|                                                                      |andadjacent         |andadjacent         |andadjacent         |andadjacent         |andadjacent         |andadjacent         |
|                                                                      |peaksis             |peaksis             |peaksis             |peaksis             |peaksis             |peaksis             |
|                                                                      |1.2                 |1.2                 |1.2                 |1.2                 |1.2                 |1.2                 |
|                                                                      |(NLT                |(NLT                |(NLT                |(NLT                |(NLT                |(NLT                |
|                                                                      |1.0);               |1.0);               |1.0);               |1.0);               |1.0);               |1.0);               |
|                                                                      |In the              |In the              |In the              |In the              |In the              |In the              |
|                                                                      |chromatogram        |chromatogram        |chromatogram        |chromatogram        |chromatogram        |chromatogram        |
|                                                                      |of test             |of test             |of test             |of test             |of test             |of test             |
|                                                                      |product             |product             |product             |product             |product             |product             |
|                                                                      |solution            |solution            |solution            |solution            |solution            |solution            |
|                                                                      |(251nm)             |(251nm)             |(251nm)             |(251nm)             |(251nm)             |(251nm)             |
|                                                                      |and                 |and                 |and                 |and                 |and                 |and                 |
|                                                                      |specific            |specific            |specific            |specific            |specific            |specific            |
|                                                                      |mixed               |mixed               |mixed               |mixed               |mixed               |mixed               |
|                                                                      |solution            |solution            |solution            |solution            |solution            |solution            |
|                                                                      |(251nm),            |(251nm),            |(251nm),            |(251nm),            |(251nm),            |(251nm),            |
|                                                                      |the                 |the                 |the                 |the                 |the                 |the                 |
|                                                                      |minimum             |minimum             |minimum             |minimum             |minimum             |minimum             |
|                                                                      |separation          |separation          |separation          |separation          |separation          |separation          |
|                                                                      |degree              |degree              |degree              |degree              |degree              |degree              |
|                                                                      |between             |between             |between             |between             |between             |between             |
|                                                                      |YA2304-17           |YA2304-17           |YA2304-17           |YA2304-17           |YA2304-17           |YA2304-17           |
|                                                                      |and                 |and                 |and                 |and                 |and                 |and                 |
|                                                                      |YA2304-16           |YA2304-16           |YA2304-16           |YA2304-16           |YA2304-16           |YA2304-16           |
|                                                                      |andadjacent         |andadjacent         |andadjacent         |andadjacent         |andadjacent         |andadjacent         |
|                                                                      |peaksis             |peaksis             |peaksis             |peaksis             |peaksis             |peaksis             |
|                                                                      |1.2                 |1.2                 |1.2                 |1.2                 |1.2                 |1.2                 |
|                                                                      |(NLT                |(NLT                |(NLT                |(NLT                |(NLT                |(NLT                |
|                                                                      |1.0),               |1.0),               |1.0),               |1.0),               |1.0),               |1.0),               |
|                                                                      |and the             |and the             |and the             |and the             |and the             |and the             |
|                                                                      |minimum             |minimum             |minimum             |minimum             |minimum             |minimum             |
|                                                                      |separation          |separation          |separation          |separation          |separation          |separation          |
|                                                                      |degree              |degree              |degree              |degree              |degree              |degree              |
|                                                                      |betweenotheradjacent|betweenotheradjacent|betweenotheradjacent|betweenotheradjacent|betweenotheradjacent|betweenotheradjacent|
|                                                                      |peaksis             |peaksis             |peaksis             |peaksis             |peaksis             |peaksis             |
|                                                                      |3.1                 |3.1                 |3.1                 |3.1                 |3.1                 |3.1                 |
|                                                                      |(NLT                |(NLT                |(NLT                |(NLT                |(NLT                |(NLT                |
|                                                                      |1.5).               |1.5).               |1.5).               |1.5).               |1.5).               |1.5).               |
|                                                                      |In the              |In the              |In the              |In the              |In the              |In the              |
|                                                                      |chromatogram        |chromatogram        |chromatogram        |chromatogram        |chromatogram        |chromatogram        |
|                                                                      |of                  |of                  |of                  |of                  |of                  |of                  |
|                                                                      |specific            |specific            |specific            |specific            |specific            |specific            |
|                                                                      |mixed               |mixed               |mixed               |mixed               |mixed               |mixed               |
|                                                                      |solution            |solution            |solution            |solution            |solution            |solution            |
|                                                                      |(230nm),            |(230nm),            |(230nm),            |(230nm),            |(230nm),            |(230nm),            |
|                                                                      |the                 |the                 |the                 |the                 |the                 |the                 |
|                                                                      |minimum             |minimum             |minimum             |minimum             |minimum             |minimum             |
|                                                                      |separation          |separation          |separation          |separation          |separation          |separation          |
|                                                                      |degree              |degree              |degree              |degree              |degree              |degree              |
|                                                                      |between             |between             |between             |between             |between             |between             |
|                                                                      |YA2304-17           |YA2304-17           |YA2304-17           |YA2304-17           |YA2304-17           |YA2304-17           |
|                                                                      |and                 |and                 |and                 |and                 |and                 |and                 |
|                                                                      |YA2304-16           |YA2304-16           |YA2304-16           |YA2304-16           |YA2304-16           |YA2304-16           |
|                                                                      |andadjacent         |andadjacent         |andadjacent         |andadjacent         |andadjacent         |andadjacent         |
|                                                                      |peaks               |peaks               |peaks               |peaks               |peaks               |peaks               |
|                                                                      |was 1.2             |was 1.2             |was 1.2             |was 1.2             |was 1.2             |was 1.2             |
|                                                                      |(NLT                |(NLT                |(NLT                |(NLT                |(NLT                |(NLT                |
|                                                                      |1.0),               |1.0),               |1.0),               |1.0),               |1.0),               |1.0),               |
|                                                                      |and the             |and the             |and the             |and the             |and the             |and the             |
|                                                                      |minimum             |minimum             |minimum             |minimum             |minimum             |minimum             |
|                                                                      |separation          |separation          |separation          |separation          |separation          |separation          |
|                                                                      |degree              |degree              |degree              |degree              |degree              |degree              |
|                                                                      |betweenotheradjacent|betweenotheradjacent|betweenotheradjacent|betweenotheradjacent|betweenotheradjacent|betweenotheradjacent|
|                                                                      |peaks               |peaks               |peaks               |peaks               |peaks               |peaks               |
|                                                                      |was 5.0             |was 5.0             |was 5.0             |was 5.0             |was 5.0             |was 5.0             |
|                                                                      |(NLT                |(NLT                |(NLT                |(NLT                |(NLT                |(NLT                |
|                                                                      |1.5).               |1.5).               |1.5).               |1.5).               |1.5).               |1.5).               |
|                                                                      |The                 |The                 |The                 |The                 |The                 |The                 |
|                                                                      |retention           |retention           |retention           |retention           |retention           |retention           |
|                                                                      |time                |time                |time                |time                |time                |time                |
|                                                                      |ofeach              |ofeach              |ofeach              |ofeach              |ofeach              |ofeach              |
|                                                                      |knownimpurity       |knownimpurity       |knownimpurity       |knownimpurity       |knownimpurity       |knownimpurity       |
|                                                                      |peak in             |peak in             |peak in             |peak in             |peak in             |peak in             |
|                                                                      |the                 |the                 |the                 |the                 |the                 |the                 |
|                                                                      |reference           |reference           |reference           |reference           |reference           |reference           |
|                                                                      |solution,           |solution,           |solution,           |solution,           |solution,           |solution,           |
|                                                                      |the                 |the                 |the                 |the                 |the                 |the                 |
|                                                                      |system              |system              |system              |system              |system              |system              |
|                                                                      |suitability         |suitability         |suitability         |suitability         |suitability         |suitability         |
|                                                                      |solution,           |solution,           |solution,           |solution,           |solution,           |solution,           |
|                                                                      |the                 |the                 |the                 |the                 |the                 |the                 |
|                                                                      |test                |test                |test                |test                |test                |test                |
|                                                                      |product             |product             |product             |product             |product             |product             |
|                                                                      |solution            |solution            |solution            |solution            |solution            |solution            |
|                                                                      |and the             |and the             |and the             |and the             |and the             |and the             |
|                                                                      |specific            |specific            |specific            |specific            |specific            |specific            |
|                                                                      |mixed               |mixed               |mixed               |mixed               |mixed               |mixed               |
|                                                                      |solution            |solution            |solution            |solution            |solution            |solution            |
|                                                                      |was                 |was                 |was                 |was                 |was                 |was                 |
|                                                                      |consistent          |consistent          |consistent          |consistent          |consistent          |consistent          |
|                                                                      |with                |with                |with                |with                |with                |with                |
|                                                                      |the                 |the                 |the                 |the                 |the                 |the                 |
|                                                                      |corresponding       |corresponding       |corresponding       |corresponding       |corresponding       |corresponding       |
|                                                                      |main                |main                |main                |main                |main                |main                |
|                                                                      |peak in             |peak in             |peak in             |peak in             |peak in             |peak in             |
|                                                                      |the                 |the                 |the                 |the                 |the                 |the                 |
|                                                                      |impurity            |impurity            |impurity            |impurity            |impurity            |impurity            |
|                                                                      |localization        |localization        |localization        |localization        |localization        |localization        |
|                                                                      |solution,           |solution,           |solution,           |solution,           |solution,           |solution,           |
|                                                                      |and the             |and the             |and the             |and the             |and the             |and the             |
|                                                                      |relative            |relative            |relative            |relative            |relative            |relative            |
|                                                                      |retention           |retention           |retention           |retention           |retention           |retention           |
|                                                                      |time                |time                |time                |time                |time                |time                |
|                                                                      |ofeach              |ofeach              |ofeach              |ofeach              |ofeach              |ofeach              |
|                                                                      |knownimpurity       |knownimpurity       |knownimpurity       |knownimpurity       |knownimpurity       |knownimpurity       |
|                                                                      |peak in             |peak in             |peak in             |peak in             |peak in             |peak in             |
|                                                                      |the                 |the                 |the                 |the                 |the                 |the                 |
|                                                                      |specific            |specific            |specific            |specific            |specific            |specific            |
|                                                                      |mixed               |mixed               |mixed               |mixed               |mixed               |mixed               |
|                                                                      |solution            |solution            |solution            |solution            |solution            |solution            |
|                                                                      |was                 |was                 |was                 |was                 |was                 |was                 |
|                                                                      |basically           |basically           |basically           |basically           |basically           |basically           |
|                                                                      |consistent          |consistent          |consistent          |consistent          |consistent          |consistent          |
|                                                                      |with                |with                |with                |with                |with                |with                |
|                                                                      |the                 |the                 |the                 |the                 |the                 |the                 |
|                                                                      |quality             |quality             |quality             |quality             |quality             |quality             |
|                                                                      |standard;           |standard;           |standard;           |standard;           |standard;           |standard;           |
|                                                                      |The                 |The                 |The                 |The                 |The                 |The                 |
|                                                                      |above               |above               |above               |above               |above               |above               |
|                                                                      |are in              |are in              |are in              |are in              |are in              |are in              |
|                                                                      |line                |line                |line                |line                |line                |line                |
|                                                                      |with                |with                |with                |with                |with                |with                |
|                                                                      |the                 |the                 |the                 |the                 |the                 |the                 |
|                                                                      |verification        |verification        |verification        |verification        |verification        |verification        |
|                                                                      |requirements.       |requirements.       |requirements.       |requirements.       |requirements.       |requirements.       |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



**ii. Forced Degradation Studies** 



 **Acceptance Criteria** 



The forced degradation test is to examine the stability of the sample 



under acid, alkali, oxidation, high temperature, light and other conditions. 



By examining the separation of impurities from the sample and the material 



balance rate, the feasibility of the method is verified. It is required that the 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 166 of 542 





Page 167
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



degradation degree of the principal component NMT 20% under each 



destruction condition, and the separation degree between the peaks of 



impurities greater than 0.05% in the samples after degradation should NLT 



1.0, the purity Angle of the main peak should be less than the purity 



threshold, and the material balance rate should be between 90% and 110%. 



 **Solution preparation** 



Blank solution: solvent. 



YA2304-14 Reference storage solution: Share "YA2304-14 Reference 



Storage solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304 Reference stock: Share "YA2304 Reference Stock" under "4.1 



Wavelength Selection". (Approx. 200μg/ml) 



YA2304-15 Reference storage solution: Share "YA2304-15 Reference 



Storage Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-16 Reference storage solution: Share "YA2304-16 Reference 



Storage Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-19 Reference storage solution: Share "YA2304-19 Reference 



Storage Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-10 Reference storage Solution: Share "YA2304-10 Reference 



Storage Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-17 Reference storage solution: Share "YA2304-17 Reference 



Storage Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



System suitability solution: Prepare by the same method as "System 



Suitability solution" under "4.2 System Suitability". (YA2304-14, YA2304-15, 



YA2304-16, YA2304-19, YA2304-10 and YA2304-17 are about 0.8μg/ml) 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 167 of 542 





Page 168
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Control product solution ① : Accurately measure 1ml of YA2304 control 



product reserve solution, place it in 20ml measuring bottle, dilute it with 



solvent to scale, and shake well; Accurately measure 1ml of the above 



solution, place it in a 25ml measuring bottle, dilute it with solvent to the 



scale, shake well, and then obtain. (About 0.4μg/ml) 



Control product solution ② : accurately measure 1ml of YA2304-10 and 



YA2304-17 control product reserve solution respectively, place them in 50ml 



measuring bottle, dilute them with solvent to scale, and shake well; 



Accurately measure 1ml of the above solution, place it in a 10ml measuring 



bottle, dilute it with solvent to the scale, shake well, and then obtain. 



(YA2304-10 and YA2304-17 contain about 0.4μg/ml) 



Undamaged test product solution: Take about 10mg of this product, 



weigh it accurately, place it in a 25ml measuring bottle, dissolve it with 



solvent and dilute it to the scale, shake well, and then get. (About 0.4mg/ml) 



High temperature destruction of test product solution: take appropriate 



amount of this product, 105℃ destruction for 5 days, precision weigh about 



10mg, put in 25ml measuring bottle, dissolve with solvent and dilute to the 



scale, shake well, then get. 



Light damage test product solution: Take appropriate amount of this 



product, light damage (25±2℃, 60±10%RH, 4500±500LUX, 90±5μWcm [2] ) 30 



days after damage, precision weigh about 10mg, put in 25ml measuring 



bottle, dissolve with solvent and dilute to the scale, shake well, filter, ready. 



The blank solution of acid and base destruction: take 2ml of 0.1mol/L 



hydrochloric acid solution, place it in 25ml bottle, add 2ml of 0.1mol/L 



sodium hydroxide solution to neutralize it, add 1ml acetonitrile, dilute it with 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 168 of 542 





Page 169
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



solvent to the scale, shake well, and get. 



Acid destruction of test product solution: Take about 10mg of this 



product, put it in 25ml bottle, add 2ml of 0.1mol/L hydrochloric acid 



solution to destroy it for 24h, add 2ml of 0.1mol/L sodium hydroxide solution 



to neutralize it, add 1ml of acetonitrile, dissolve it with solvent and dilute it to 



the scale, shake well, and obtain. 



Alkali destruction test solution: Take about 10mg of this product, place 



it in 25ml bottle, add 2ml of 0.1mol/L of sodium hydroxide solution to 



destroy it for 24h, add 2ml of 0.1mol/L of hydrochloric acid solution to 



neutralize it, add 1ml of acetonitrile, dissolve it with solvent and dilute it to 



the scale, shake well, and obtain. 



Oxidizing and destroying blank solution: take 2ml of 3% hydrogen 



peroxide solution, place it in 25ml measuring bottle, add 0.5ml acetonitrile, 



dilute it with solvent to scale, shake well, and get. 



Oxidizing destruction of test product solution: Take about 10mg of this 



product, weigh it accurately, put it in 25ml bottle, add 2ml of 3% hydrogen 



peroxide solution and destroy it at room temperature for 24h, then add 0.5ml 



of acetonitrile, dilute it with solvent to the scale, shake well, and obtain. 



Sample of light destruction solution: Take about 10mg of this product, 



accurately weigh it, put it in 25ml transparent measuring bottle, dissolve it 



with solvent and dilute it to the scale, shake well, and destroy it under 



(25±2℃, 60±10%RH, 4500±500LUX, 90±5μWcm [2] ) under light condition for 



24h, ready to obtain. 



 **Injection Sequence** 



After the blank solution, the system suitable solution was injected with 1 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 169 of 542 





Page 170
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



needle, the control solution (1) and the control solution (2) were injected with 



2 needles each. The blank solution of oxidation destruction, the blank 



solution of acid and alkali destruction, the undamaged test product solution, 



the acid destruction test product solution, the alkali destruction test product 



solution, the oxidation destruction test product solution, the high 



temperature destruction test product solution, the light destruction test 



product solution and the light destruction solution sample were each 1 



needle, and the chromatogram was recorded. 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 170 of 542 





Page 171
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



 **Results and Discussion** 



Results of Forced Degradation Studies: 








































-----------------------------------------------------------------------------------------------------------------------------------------------------------
|Failure conditions        |Failure conditions        |/           |0.1mol/lhydrochloricacid|Destroy       |3%         |Damage  |4500±500Lux,|4500±500Lux,|
|                          |                          |            |2mL                     |0.1mol/lsodium|hydrogen   |at      |90±5μWcm2   |90±5μWcm2   |
|                          |                          |            |destruction             |hydroxide     |peroxide   |105℃for |destroy     |destroy     |
|                          |                          |            |for 24h                 |2mL for       |2mL        |5d      |solid       |the         |
|                          |                          |            |                        |24h           |destruction|        |samples     |test        |
|                          |                          |            |                        |              |for 24h    |        |for 30d     |solution    |
|                          |                          |            |                        |              |           |        |            |for 24h     |
|--------------------------|--------------------------|------------|------------------------|--------------|-----------|--------|------------|------------|
|Main peak purityAngle     |Main peak purityAngle     |0.313       |0.259                   |0.276         |0.300      |0.266   |0.286       |0.261       |
|--------------------------|--------------------------|------------|------------------------|--------------|-----------|--------|------------|------------|
|Main peak purity threshold|Main peak purity threshold|1.170       |1.104                   |1.207         |1.207      |1.231   |1.110       |1.167       |
|--------------------------|--------------------------|------------|------------------------|--------------|-----------|--------|------------|------------|
|Main peak purity (%)      |Main peak purity (%)      |99.93%      |97.87%                  |99.89%        |99.32%     |99.95%  |99.41%      |99.02%      |
|--------------------------|--------------------------|------------|------------------------|--------------|-----------|--------|------------|------------|
|I m                       |YA2304-12                 |< 0.05%     |< 0.05%                 |0.07%         |< 0.05%    |< 0.05% |< 0.05%     |< 0.05%     |
|--------------------------|--------------------------|------------|------------------------|--------------|-----------|--------|------------|------------|
|I m                       |YA2304-14                 |Not detected|Not detected            |Not detected  |Not        |Not     |< 0.05%     |Not detected|
|                          |                          |            |                        |              |detected   |detected|            |            |
-----------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 171 of 542 





Page 172
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 







-------------------------------------------------------------------------------------------------------------------------
|puri tycontent|YA2304-16        |Not detected|< 0.05%     |Not detected|Not detected|Not detected|< 0.05%     |< 0.05% |
|--------------|-----------------|------------|------------|------------|------------|------------|------------|--------|
|puri tycontent|YA2304-18        |Not detected|Not detected|Not detected|Not detected|Not detected|Not detected|Not     |
|              |                 |            |            |            |            |            |            |detected|
|--------------|-----------------|------------|------------|------------|------------|------------|------------|--------|
|puri tycontent|YA2304-19        |< 0.05%     |< 0.05%     |< 0.05%     |0.12%       |< 0.05%     |0.17%       |0.54%   |
|--------------|-----------------|------------|------------|------------|------------|------------|------------|--------|
|puri tycontent|YA2304-17        |Not detected|Not detected|Not detected|Not detected|Not detected|< 0.05%     |< 0.05% |
|--------------|-----------------|------------|------------|------------|------------|------------|------------|--------|
|puri tycontent|YA2304-10        |Not detected|Not detected|Not detected|Not detected|Not detected|Not detected|Not     |
|              |                 |            |            |            |            |            |            |detected|
|--------------|-----------------|------------|------------|------------|------------|------------|------------|--------|
|puri tycontent|RRT≈0.49 impurity|Not detected|Not detected|Not detected|< 0.05%     |Not detected|Not detected|Not     |
|              |                 |            |            |            |            |            |            |detected|
|--------------|-----------------|------------|------------|------------|------------|------------|------------|--------|
|puri tycontent|RRT≈0.53 impurity|Not detected|Not detected|Not detected|< 0.05%     |Not detected|Not detected|Not     |
|              |                 |            |            |            |            |            |            |detected|
|--------------|-----------------|------------|------------|------------|------------|------------|------------|--------|
|puri tycontent|RRT≈0.58 impurity|Not detected|Not detected|Not detected|< 0.05%     |Not detected|Not detected|Not     |
|              |                 |            |            |            |            |            |            |detected|
|--------------|-----------------|------------|------------|------------|------------|------------|------------|--------|
|puri tycontent|RRT≈0.59 impurity|Not detected|2.02%       |Not detected|Not detected|Not detected|Not detected|< 0.05% |
|--------------|-----------------|------------|------------|------------|------------|------------|------------|--------|
|puri tycontent|RRT≈0.64 impurity|< 0.05%     |Not detected|Not detected|0.43%       |Not detected|< 0.05%     |0.06%   |
|--------------|-----------------|------------|------------|------------|------------|------------|------------|--------|
|puri tycontent|RRT≈0.67 impurity|Not detected|Not detected|Not detected|Not detected|Not detected|Not detected|< 0.05% |
-------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 172 of 542 





Page 173
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 

------------------------------------------------------------------------------------------------------------------------
|       |RRT≈0.71 impurity  |Not detected|Not detected|Not detected|Not detected|Not detected|Not detected|< 0.05%     |
|       |                   |            |            |            |            |            |            |            |
|       |                   |            |            |            |            |            |            |            |
|       |-------------------|------------|------------|------------|------------|------------|------------|------------|
|       |RRT≈0.73 impurities|Not detected|Not detected|Not detected|Not detected|Not detected|< 0.05%     |Not detected|
|       |-------------------|------------|------------|------------|------------|------------|------------|------------|
|       |RRT≈0.79 impurity  |Not detected|Not detected|Not detected|< 0.05%     |Not detected|< 0.05%     |Not detected|
|       |-------------------|------------|------------|------------|------------|------------|------------|------------|
|       |RRT≈0.87 impurity  |Not detected|Not detected|Not detected|Not detected|Not detected|Not detected|0.06%       |
|       |-------------------|------------|------------|------------|------------|------------|------------|------------|
|       |RRT≈0.96 impurity  |Not detected|Not detected|Not detected|Not detected|Not detected|< 0.05%     |0.08%       |
|       |-------------------|------------|------------|------------|------------|------------|------------|------------|
|       |RRT≈1.14 impurities|Not detected|Not detected|Not detected|Not detected|Not detected|< 0.05%     |Not detected|
|       |-------------------|------------|------------|------------|------------|------------|------------|------------|
|       |RRT≈1.16 impurity  |Not detected|Not detected|Not detected|Not detected|Not detected|< 0.05%     |Not detected|
|       |-------------------|------------|------------|------------|------------|------------|------------|------------|
|       |RRT≈1.27 impurity  |< 0.05%     |< 0.05%     |< 0.05%     |< 0.05%     |< 0.05%     |< 0.05%     |< 0.05%     |
|       |-------------------|------------|------------|------------|------------|------------|------------|------------|
|       |RRT≈1.33 impurities|Not detected|Not detected|Not detected|Not detected|Not detected|Not detected|< 0.05%     |
------------------------------------------------------------------------------------------------------------------------



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 173 of 542 





Page 174
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 










----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|RRT≈1.45 impurity                                     |Not                     |Not                     |Not                     |< 0.05%                 |Not                     |Not                     |Not                     |                        |
|                                                      |detected                |detected                |detected                |                        |detected                |detected                |detected                |                        |
|------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|RRT≈1.52 impurity                                     |Not                     |Not                     |Not                     |Not                     |Not                     |Not                     |< 0.05%                 |                        |
|                                                      |detected                |detected                |detected                |detected                |detected                |detected                |                        |                        |
|------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|RRT≈1.53 impurities                                   |Not                     |Not                     |Not                     |Not                     |Not                     |0.05%                   |Not                     |                        |
|                                                      |detected                |detected                |detected                |detected                |detected                |                        |detected                |                        |
|------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|RRT≈1.67 impurity                                     |Not                     |Not                     |Not                     |Not                     |Not                     |< 0.05%                 |Not                     |                        |
|                                                      |detected                |detected                |detected                |detected                |detected                |                        |detected                |                        |
|------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|RRT≈1.74 impurity                                     |Not                     |Not                     |Not                     |Not                     |Not                     |< 0.05%                 |Not                     |                        |
|                                                      |detected                |detected                |detected                |detected                |detected                |                        |detected                |                        |
|------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|Total Miscellaneous                                   |< 0.05%                 |2.02%                   |0.07%                   |0.56%                   |< 0.05%                 |0.22%                   |0.74%                   |                        |
|------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|Material balance ratio                                |Material                |/                       |99.02%                  |100.01%                 |99.91%                  |99.96%                  |98.15%                  |99.59%                  |
|                                                      |balance                 |                        |                        |                        |                        |                        |                        |                        |
|                                                      |ratio                   |                        |                        |                        |                        |                        |                        |                        |
|------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|Conclusion: In the chromatogram of systemapplicability|Conclusion:             |Conclusion:             |Conclusion:             |Conclusion:             |Conclusion:             |Conclusion:             |Conclusion:             |Conclusion:             |
|solution (251nm), the minimum separation degree       |In the                  |In the                  |In the                  |In the                  |In the                  |In the                  |In the                  |In the                  |
|between YA2304 and YA2304-14 and YA2304-15 is 5.8 (NLT|chromatogram            |chromatogram            |chromatogram            |chromatogram            |chromatogram            |chromatogram            |chromatogram            |chromatogram            |
|1.5), and the minimum separation degree between       |of                      |of                      |of                      |of                      |of                      |of                      |of                      |of                      |
|YA2304-17 and YA2304-16 andadjacent peaksis 1.7 (NLT  |systemapplicability     |systemapplicability     |systemapplicability     |systemapplicability     |systemapplicability     |systemapplicability     |systemapplicability     |systemapplicability     |
|1.0). The signal-to-noise ratio (SNR) of the two      |solution                |solution                |solution                |solution                |solution                |solution                |solution                |solution                |
|luminous solutions ①were 37.3 and 40.4 (both greater  |(251nm),                |(251nm),                |(251nm),                |(251nm),                |(251nm),                |(251nm),                |(251nm),                |(251nm),                |
|than 20), respectively, indicating that the           |the                     |the                     |the                     |the                     |the                     |the                     |the                     |the                     |
|systemapplicability met the requirements. There was no|minimum                 |minimum                 |minimum                 |minimum                 |minimum                 |minimum                 |minimum                 |minimum                 |
|significant change in the impurity quality of         |separation              |separation              |separation              |separation              |separation              |separation              |separation              |separation              |
|Finerenone raw materialunder the condition of high    |degree                  |degree                  |degree                  |degree                  |degree                  |degree                  |degree                  |degree                  |
|temperature (105℃for 5d). Under the condition of      |between                 |between                 |between                 |between                 |between                 |between                 |between                 |between                 |
|destruction by weakacid (destruction by 2mL of        |YA2304                  |YA2304                  |YA2304                  |YA2304                  |YA2304                  |YA2304                  |YA2304                  |YA2304                  |
|0.1mol/lhydrochloricacid                              |and                     |and                     |and                     |and                     |and                     |and                     |and                     |and                     |
|                                                      |YA2304-14               |YA2304-14               |YA2304-14               |YA2304-14               |YA2304-14               |YA2304-14               |YA2304-14               |YA2304-14               |
|                                                      |and                     |and                     |and                     |and                     |and                     |and                     |and                     |and                     |
|                                                      |YA2304-15               |YA2304-15               |YA2304-15               |YA2304-15               |YA2304-15               |YA2304-15               |YA2304-15               |YA2304-15               |
|                                                      |is 5.8                  |is 5.8                  |is 5.8                  |is 5.8                  |is 5.8                  |is 5.8                  |is 5.8                  |is 5.8                  |
|                                                      |(NLT                    |(NLT                    |(NLT                    |(NLT                    |(NLT                    |(NLT                    |(NLT                    |(NLT                    |
|                                                      |1.5),                   |1.5),                   |1.5),                   |1.5),                   |1.5),                   |1.5),                   |1.5),                   |1.5),                   |
|                                                      |and the                 |and the                 |and the                 |and the                 |and the                 |and the                 |and the                 |and the                 |
|                                                      |minimum                 |minimum                 |minimum                 |minimum                 |minimum                 |minimum                 |minimum                 |minimum                 |
|                                                      |separation              |separation              |separation              |separation              |separation              |separation              |separation              |separation              |
|                                                      |degree                  |degree                  |degree                  |degree                  |degree                  |degree                  |degree                  |degree                  |
|                                                      |between                 |between                 |between                 |between                 |between                 |between                 |between                 |between                 |
|                                                      |YA2304-17               |YA2304-17               |YA2304-17               |YA2304-17               |YA2304-17               |YA2304-17               |YA2304-17               |YA2304-17               |
|                                                      |and                     |and                     |and                     |and                     |and                     |and                     |and                     |and                     |
|                                                      |YA2304-16               |YA2304-16               |YA2304-16               |YA2304-16               |YA2304-16               |YA2304-16               |YA2304-16               |YA2304-16               |
|                                                      |andadjacent             |andadjacent             |andadjacent             |andadjacent             |andadjacent             |andadjacent             |andadjacent             |andadjacent             |
|                                                      |peaksis                 |peaksis                 |peaksis                 |peaksis                 |peaksis                 |peaksis                 |peaksis                 |peaksis                 |
|                                                      |1.7 (NLT                |1.7 (NLT                |1.7 (NLT                |1.7 (NLT                |1.7 (NLT                |1.7 (NLT                |1.7 (NLT                |1.7                     |
|                                                      |1.0).                   |1.0).                   |1.0).                   |1.0).                   |1.0).                   |1.0).                   |1.0).                   |(NLT                    |
|                                                      |The                     |The                     |The                     |The                     |The                     |The                     |The                     |1.0).                   |
|                                                      |signal-to-noise         |signal-to-noise         |signal-to-noise         |signal-to-noise         |signal-to-noise         |signal-to-noise         |signal-to-noise         |The                     |
|                                                      |ratio                   |ratio                   |ratio                   |ratio                   |ratio                   |ratio                   |ratio                   |signal-to-noise         |
|                                                      |(SNR) of                |(SNR) of                |(SNR) of                |(SNR) of                |(SNR) of                |(SNR) of                |(SNR) of                |ratio                   |
|                                                      |the two                 |the two                 |the two                 |the two                 |the two                 |the two                 |the two                 |(SNR)                   |
|                                                      |luminous                |luminous                |luminous                |luminous                |luminous                |luminous                |luminous                |of the                  |
|                                                      |solutions               |solutions               |solutions               |solutions               |solutions               |solutions               |solutions               |two                     |
|                                                      |①were                   |①were                   |①were                   |①were                   |①were                   |①were                   |①were                   |luminous                |
|                                                      |37.3 and                |37.3 and                |37.3 and                |37.3 and                |37.3 and                |37.3 and                |37.3 and                |solutions               |
|                                                      |40.4                    |40.4                    |40.4                    |40.4                    |40.4                    |40.4                    |40.4                    |①were                   |
|                                                      |(both                   |(both                   |(both                   |(both                   |(both                   |(both                   |(both                   |37.3                    |
|                                                      |greater                 |greater                 |greater                 |greater                 |greater                 |greater                 |greater                 |and                     |
|                                                      |than                    |than                    |than                    |than                    |than                    |than                    |than                    |40.4                    |
|                                                      |20),                    |20),                    |20),                    |20),                    |20),                    |20),                    |20),                    |(both                   |
|                                                      |respectively,           |respectively,           |respectively,           |respectively,           |respectively,           |respectively,           |respectively,           |greater                 |
|                                                      |indicating              |indicating              |indicating              |indicating              |indicating              |indicating              |indicating              |than                    |
|                                                      |that the                |that the                |that the                |that the                |that the                |that the                |that the                |20),                    |
|                                                      |systemapplicability     |systemapplicability     |systemapplicability     |systemapplicability     |systemapplicability     |systemapplicability     |systemapplicability     |respectively,           |
|                                                      |met the                 |met the                 |met the                 |met the                 |met the                 |met the                 |met the                 |indicating              |
|                                                      |requirements.           |requirements.           |requirements.           |requirements.           |requirements.           |requirements.           |requirements.           |that                    |
|                                                      |There                   |There                   |There                   |There                   |There                   |There                   |There                   |the                     |
|                                                      |was no                  |was no                  |was no                  |was no                  |was no                  |was no                  |was no                  |systemapplicability     |
|                                                      |significant             |significant             |significant             |significant             |significant             |significant             |significant             |met the                 |
|                                                      |change                  |change                  |change                  |change                  |change                  |change                  |change                  |requirements.           |
|                                                      |in the                  |in the                  |in the                  |in the                  |in the                  |in the                  |in the                  |There                   |
|                                                      |impurity                |impurity                |impurity                |impurity                |impurity                |impurity                |impurity                |was no                  |
|                                                      |quality                 |quality                 |quality                 |quality                 |quality                 |quality                 |quality                 |significant             |
|                                                      |of                      |of                      |of                      |of                      |of                      |of                      |of                      |change                  |
|                                                      |Finerenone              |Finerenone              |Finerenone              |Finerenone              |Finerenone              |Finerenone              |Finerenone              |in the                  |
|                                                      |raw                     |raw                     |raw                     |raw                     |raw                     |raw                     |raw                     |impurity                |
|                                                      |materialunder           |materialunder           |materialunder           |materialunder           |materialunder           |materialunder           |materialunder           |quality                 |
|                                                      |the                     |the                     |the                     |the                     |the                     |the                     |the                     |of                      |
|                                                      |condition               |condition               |condition               |condition               |condition               |condition               |condition               |Finerenone              |
|                                                      |of high                 |of high                 |of high                 |of high                 |of high                 |of high                 |of high                 |raw                     |
|                                                      |temperature             |temperature             |temperature             |temperature             |temperature             |temperature             |temperature             |materialunder           |
|                                                      |(105℃for                |(105℃for                |(105℃for                |(105℃for                |(105℃for                |(105℃for                |(105℃for                |the                     |
|                                                      |5d).                    |5d).                    |5d).                    |5d).                    |5d).                    |5d).                    |5d).                    |condition               |
|                                                      |Under                   |Under                   |Under                   |Under                   |Under                   |Under                   |Under                   |of high                 |
|                                                      |the                     |the                     |the                     |the                     |the                     |the                     |the                     |temperature             |
|                                                      |condition               |condition               |condition               |condition               |condition               |condition               |condition               |(105℃for                |
|                                                      |of                      |of                      |of                      |of                      |of                      |of                      |of                      |5d).                    |
|                                                      |destruction             |destruction             |destruction             |destruction             |destruction             |destruction             |destruction             |Under                   |
|                                                      |by                      |by                      |by                      |by                      |by                      |by                      |by                      |the                     |
|                                                      |weakacid                |weakacid                |weakacid                |weakacid                |weakacid                |weakacid                |weakacid                |condition               |
|                                                      |(destruction            |(destruction            |(destruction            |(destruction            |(destruction            |(destruction            |(destruction            |of                      |
|                                                      |by 2mL                  |by 2mL                  |by 2mL                  |by 2mL                  |by 2mL                  |by 2mL                  |by 2mL                  |destruction             |
|                                                      |of                      |of                      |of                      |of                      |of                      |of                      |of                      |by                      |
|                                                      |0.1mol/lhydrochloricacid|0.1mol/lhydrochloricacid|0.1mol/lhydrochloricacid|0.1mol/lhydrochloricacid|0.1mol/lhydrochloricacid|0.1mol/lhydrochloricacid|0.1mol/lhydrochloricacid|weakacid                |
|                                                      |                        |                        |                        |                        |                        |                        |                        |(destruction            |
|                                                      |                        |                        |                        |                        |                        |                        |                        |by 2mL                  |
|                                                      |                        |                        |                        |                        |                        |                        |                        |of                      |
|                                                      |                        |                        |                        |                        |                        |                        |                        |0.1mol/lhydrochloricacid|
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 174 of 542 





Page 175
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



for 24h), Finerenone was mainly degraded to produce known impurities YA2144-16 (content < 0.05%) and unknown impurities of RRT≈0.59 



(content 2.02%). The known impurity YA2304-12 (content 0.07%) was mainly degraded under the condition of weak base (destruction of 2mL of 



0.1mol/l sodium hydroxide for 24h). The degradation of Finerenone under oxidation destruction (2mL destruction of 3% hydrogen peroxide for 



24h) mainly produced unknown impurities YA2304-19 (content 0.12%) and RRT≈0.64 (content 0.43%). The solid samples of Finerenone were 



destroyed by light (4500±500Lux, 90±5μWcm [2] for 30d) degradation mainly produced 5 known impurities YA2304-14, YA2304-15, YA2304-16, 



YA2304-17, YA2304-19, and unknown impurities with RRT≈1.53 (content of 0.05%). The 5 known impurities produced by degradation except 



the impurity YA2304-19 content of 0.17%, the other known impurities produced by degradation content of < 0.05%; Two known impurities, 



YA2144-16 and YA2144-19, and three unknown impurities, RRT≈0.64, RRT≈0.87 and RRT≈0.96, were mainly produced by the degradation of 



fenelidone bulk drug solution by light (4500±500Lux, 90±5μWcm [2] destroying the test product solution for 24h). The contents of YA2304-16 and 



YA2304-19 produced by degradation were < 0.05% and 0.54%, and the contents of RRT≈0.64, RRT≈0.87 and RRT≈0.96 produced by degradation 



were 0.06%, 0.06% and 0.08%, respectively. Under each failure condition, the degradation degree of principal component was less than 20%, 



and the purity Angle of main peak was less than the purity threshold. The material balance rate under each destruction condition is in the range 



of 90%~110%, and the peaking separation degree of impurities greater than 0.05% in the degraded samples is NLT 1.0, which can be effectively 



separated, indicating that the method has good specificity. Meet the verification requirements. 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 175 of 542 





Page 176
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**d. Limit of Detection (LOD) and Limit of Quantitation (LOQ)** 



 **Acceptance Criteria** 



The limit of quantitation (LOQ) and the limit of detection (LOD) are 



achieved by testing and diluting the signal-to-noise ratio of each impurity 



reference solution with a certain concentration. The signal-to-noise ratio of 



each impurity peak in 6 LOQ solutions is NLT 10, the RSD of each impurity 



peak retention time should NMT 2.0%, and the RSD of the peak area should 



NMT 10%. The signal-to-noise ratio of each impurity peak in 3-needle LOD 



solution is NLT 3. 



 **Solution preparation** 



Blank solution: solvent 



YA2304-12 Reference storage solution: Share "YA2304-12 Reference Storage 



solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-14 Reference storage solution: Share "YA2304-14 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304 Reference stock: Share "YA2304 Reference Stock" under "4.1 



Wavelength Selection". (Approx. 200μg/ml) 



YA2304-15 Reference storage solution: Share "YA2304-15 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-16 Reference storage solution: Share "YA2304-16 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 176 of 542 





Page 177
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



YA2304-18 Reference storage solution: Share "YA2304-18 Reference Storage 



Solution" under "3.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-19 Reference storage solution: Share "YA2304-19 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-10 Reference storage Solution: Share "YA2304-10 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-17 Reference storage solution: Share "YA2304-17 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



Quantitative limited stock solution: Accurately measure 1ml of each 



reference liquid for YA2304-12, YA2304-14, YA2304, YA2304-15, YA2304-16, 



YA2304-18, YA2304-19, YA2304-10 and YA2304-17 and place them in the 



same 20ml bottle. Dilute to the scale with solvent, shake well, and then get. 



Limited quantitation solution: Accurately measure 0.3ml of limited 



quantitation reserve liquid, place it in a 25ml measuring bottle, dilute it with 



solvent to the scale, shake well, and get. (Parallel preparation of 6 parts) 



Detection limit solution: accurately measure the first dose limit solution 5ml, 



place it in a 10ml measuring bottle, dilute it with solvent to the scale, shake 



well, and then get. 



 **Injection Sequence** 



After the blank solution, 6 parts of the limited quantitative solution were 



injected with 1 needle each, and the detection limited solution was injected 



with 3 needles repeatedly, and the chromatogram was recorded. 



 **Results and Discussion** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 177 of 542 





Page 178
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Results of LOQ Determination: 










































----------------------------------------------------------------------------------------------------------------------------------------------------------------
|YA2304-12|Limited quantitative solution①                                      |0.1201         |0.0300         |3.796          |162 9          |14. 3          |
|---------|--------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|
|YA2304-12|Limited quantification solution②                                    |Limited        |Limited        |3.799          |164 2          |15. 1          |
|         |                                                                    |quantification |quantification |               |               |               |
|         |                                                                    |solution②      |solution②      |               |               |               |
|---------|--------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|
|YA2304-12|Limited quantification solution③                                    |Limited        |Limited        |3.804          |163 4          |15. 1          |
|         |                                                                    |quantification |quantification |               |               |               |
|         |                                                                    |solution③      |solution③      |               |               |               |
|---------|--------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|
|YA2304-12|Limited quantification solution④                                    |Limited        |Limited        |3.798          |168 3          |14. 1          |
|         |                                                                    |quantification |quantification |               |               |               |
|         |                                                                    |solution④      |solution④      |               |               |               |
|---------|--------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|
|YA2304-12|Limited quantitation solution⑤                                      |Limited        |Limited        |3.801          |155 6          |14. 6          |
|         |                                                                    |quantitation   |quantitation   |               |               |               |
|         |                                                                    |solution⑤      |solution⑤      |               |               |               |
|---------|--------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|
|YA2304-12|Limited quantification solution⑥                                    |Limited        |Limited        |3.803          |173 5          |15. 4          |
|         |                                                                    |quantification |quantification |               |               |               |
|         |                                                                    |solution⑥      |solution⑥      |               |               |               |
|---------|--------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|
|YA2304-12|RSD                                                                 |RSD            |RSD            |0.09%          |4%             |/              |
|---------|--------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|
|YA2304-12|Verdict: The limiting solution concentration ofimpurity YA2304-12   |Verdict: The   |Verdict: The   |Verdict:       |Verdict:       |Verdict:       |
|         |was 0.1201μg/ml (relative to 0.0300% of the test product            |limiting       |limiting       |The            |The            |The            |
|         |concentration), the RSD of the retention time of 6 parts of the     |solution       |solution       |limiting       |limiting       |limiting       |
|         |limiting solution was 0.09% (no more than 2.0%), the RSD of the     |concentration  |concentration  |solution       |solution       |solution       |
|         |peakarea was 4% (no more than 10%), and theS/Nranged from 14.1 to   |ofimpurity     |ofimpurity     |concentration  |concentration  |concentration  |
|         |15.4. All of them were greater than 10. Meet verification           |YA2304-12 was  |YA2304-12 was  |ofimpurity     |ofimpurity     |ofimpurity     |
|         |requirements.                                                       |0.1201μg/ml    |0.1201μg/ml    |YA2304-12      |YA2304-12      |YA2304-12      |
|         |                                                                    |(relative to   |(relative to   |was            |was            |was            |
|         |                                                                    |0.0300% of the |0.0300% of the |0.1201μg/ml    |0.1201μg/ml    |0.1201μg/ml    |
|         |                                                                    |test product   |test product   |(relative      |(relative      |(relative      |
|         |                                                                    |concentration),|concentration),|to             |to             |to             |
|         |                                                                    |the RSD of the |the RSD of the |0.0300%        |0.0300%        |0.0300%        |
|         |                                                                    |retention time |retention time |of the         |of the         |of the         |
|         |                                                                    |of 6 parts of  |of 6 parts of  |test           |test           |test           |
|         |                                                                    |the limiting   |the limiting   |product        |product        |product        |
|         |                                                                    |solution was   |solution was   |concentration),|concentration),|concentration),|
|         |                                                                    |0.09% (no more |0.09% (no more |the RSD        |the RSD        |the RSD        |
|         |                                                                    |than 2.0%),    |than 2.0%),    |of the         |of the         |of the         |
|         |                                                                    |the RSD of the |the RSD of the |retention      |retention      |retention      |
|         |                                                                    |peakarea was   |peakarea was   |time of        |time of        |time of        |
|         |                                                                    |4% (no more    |4% (no more    |6 parts        |6 parts        |6 parts        |
|         |                                                                    |than 10%), and |than 10%), and |of the         |of the         |of the         |
|         |                                                                    |theS/Nranged   |theS/Nranged   |limiting       |limiting       |limiting       |
|         |                                                                    |from 14.1 to   |from 14.1 to   |solution       |solution       |solution       |
|         |                                                                    |15.4. All of   |15.4. All of   |was            |was            |was            |
|         |                                                                    |them were      |them were      |0.09%          |0.09%          |0.09%          |
|         |                                                                    |greater than   |greater than   |(no            |(no            |(no            |
|         |                                                                    |10. Meet       |10. Meet       |more           |more           |more           |
|         |                                                                    |verification   |verification   |than           |than           |than           |
|         |                                                                    |requirements.  |requirements.  |2.0%),         |2.0%),         |2.0%),         |
|         |                                                                    |               |               |the RSD        |the RSD        |the RSD        |
|         |                                                                    |               |               |of the         |of the         |of the         |
|         |                                                                    |               |               |peakarea       |peakarea       |peakarea       |
|         |                                                                    |               |               |was 4%         |was 4%         |was 4%         |
|         |                                                                    |               |               |(no            |(no            |(no            |
|         |                                                                    |               |               |more           |more           |more           |
|         |                                                                    |               |               |than           |than           |than           |
|         |                                                                    |               |               |10%),          |10%),          |10%),          |
|         |                                                                    |               |               |and            |and            |and            |
|         |                                                                    |               |               |theS/Nranged   |theS/Nranged   |theS/Nranged   |
|         |                                                                    |               |               |from           |from           |from           |
|         |                                                                    |               |               |14.1 to        |14.1 to        |14.1 to        |
|         |                                                                    |               |               |15.4.          |15.4.          |15.4.          |
|         |                                                                    |               |               |All of         |All of         |All of         |
|         |                                                                    |               |               |them           |them           |them           |
|         |                                                                    |               |               |were           |were           |were           |
|         |                                                                    |               |               |greater        |greater        |greater        |
|         |                                                                    |               |               |than           |than           |than           |
|         |                                                                    |               |               |10.            |10.            |10.            |
|         |                                                                    |               |               |Meet           |Meet           |Meet           |
|         |                                                                    |               |               |verification   |verification   |verification   |
|         |                                                                    |               |               |requirements.  |requirements.  |requirements.  |
|---------|--------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|
|YA2304-14|Limited quantitative                                                |0.1206         |0.0302         |8.167          |204 4          |11. 1          |
----------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 178 of 542 





Page 179
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 





































---------------------------------------------------------------------------------------------------------------------------------------------------------
|Limited quantification solution②                                      |Limited       |Limited       |8.173         |200 4        |11. 7        |       |
|                                                                      |quantification|quantification|              |             |             |       |
|                                                                      |solution②     |solution②     |              |             |             |       |
|----------------------------------------------------------------------|--------------|--------------|--------------|-------------|-------------|-------|
|Limited quantification solution③                                      |Limited       |Limited       |8.180         |202 2        |11. 8        |       |
|                                                                      |quantification|quantification|              |             |             |       |
|                                                                      |solution③     |solution③     |              |             |             |       |
|----------------------------------------------------------------------|--------------|--------------|--------------|-------------|-------------|-------|
|Limited quantification solution④                                      |Limited       |Limited       |8.174         |187 0        |10. 4        |       |
|                                                                      |quantification|quantification|              |             |             |       |
|                                                                      |solution④     |solution④     |              |             |             |       |
|----------------------------------------------------------------------|--------------|--------------|--------------|-------------|-------------|-------|
|Limited quantification solution⑤                                      |Limited       |Limited       |8.178         |200 7        |11. 2        |       |
|                                                                      |quantification|quantification|              |             |             |       |
|                                                                      |solution⑤     |solution⑤     |              |             |             |       |
|----------------------------------------------------------------------|--------------|--------------|--------------|-------------|-------------|-------|
|Limited quantification solution⑥                                      |Limited       |Limited       |8.174         |199 7        |11. 7        |       |
|                                                                      |quantification|quantification|              |             |             |       |
|                                                                      |solution⑥     |solution⑥     |              |             |             |       |
|----------------------------------------------------------------------|--------------|--------------|--------------|-------------|-------------|-------|
|RSD                                                                   |RSD           |RSD           |0.06%         |4%           |/            |       |
|----------------------------------------------------------------------|--------------|--------------|--------------|-------------|-------------|-------|
|Verdict: The limiting solution concentration ofimpurity YA2304-14 was |Verdict: The  |Verdict: The  |Verdict:      |Verdict:     |Verdict:     |       |
|0.1206μg/ml (relative to 0.0302% of the test product), the RSD of the |limiting      |limiting      |The           |The          |The          |       |
|retention time of 6 parts of the limiting solution was 0.06% (no more |solution      |solution      |limiting      |limiting     |limiting     |       |
|than 2.0%), the RSD of the peakarea was 4% (no more than 10%), and    |concentration |concentration |solution      |solution     |solution     |       |
|theS/Nranged from 10.4 to 11.8. Were all greater than 10. Meet        |ofimpurity    |ofimpurity    |concentration |concentration|concentration|       |
|verification requirements.                                            |YA2304-14 was |YA2304-14 was |ofimpurity    |ofimpurity   |ofimpurity   |       |
|                                                                      |0.1206μg/ml   |0.1206μg/ml   |YA2304-14     |YA2304-14    |YA2304-14    |       |
|                                                                      |(relative to  |(relative to  |was           |was          |was          |       |
|                                                                      |0.0302% of the|0.0302% of the|0.1206μg/ml   |0.1206μg/ml  |0.1206μg/ml  |       |
|                                                                      |test product),|test product),|(relative     |(relative    |(relative    |       |
|                                                                      |the RSD of the|the RSD of the|to            |to           |to           |       |
|                                                                      |retention time|retention time|0.0302%       |0.0302%      |0.0302%      |       |
|                                                                      |of 6 parts of |of 6 parts of |of the        |of the       |of the       |       |
|                                                                      |the limiting  |the limiting  |test          |test         |test         |       |
|                                                                      |solution was  |solution was  |product),     |product),    |product),    |       |
|                                                                      |0.06% (no more|0.06% (no more|the RSD       |the RSD      |the RSD      |       |
|                                                                      |than 2.0%),   |than 2.0%),   |of the        |of the       |of the       |       |
|                                                                      |the RSD of the|the RSD of the|retention     |retention    |retention    |       |
|                                                                      |peakarea was  |peakarea was  |time of       |time of      |time of      |       |
|                                                                      |4% (no more   |4% (no more   |6 parts       |6 parts      |6 parts      |       |
|                                                                      |than 10%), and|than 10%), and|of the        |of the       |of the       |       |
|                                                                      |theS/Nranged  |theS/Nranged  |limiting      |limiting     |limiting     |       |
|                                                                      |from 10.4 to  |from 10.4 to  |solution      |solution     |solution     |       |
|                                                                      |11.8. Were all|11.8. Were all|was           |was          |was          |       |
|                                                                      |greater than  |greater than  |0.06%         |0.06%        |0.06%        |       |
|                                                                      |10. Meet      |10. Meet      |(no           |(no          |(no          |       |
|                                                                      |verification  |verification  |more          |more         |more         |       |
|                                                                      |requirements. |requirements. |than          |than         |than         |       |
|                                                                      |              |              |2.0%),        |2.0%),       |2.0%),       |       |
|                                                                      |              |              |the RSD       |the RSD      |the RSD      |       |
|                                                                      |              |              |of the        |of the       |of the       |       |
|                                                                      |              |              |peakarea      |peakarea     |peakarea     |       |
|                                                                      |              |              |was 4%        |was 4%       |was 4%       |       |
|                                                                      |              |              |(no           |(no          |(no          |       |
|                                                                      |              |              |more          |more         |more         |       |
|                                                                      |              |              |than          |than         |than         |       |
|                                                                      |              |              |10%),         |10%),        |10%),        |       |
|                                                                      |              |              |and           |and          |and          |       |
|                                                                      |              |              |theS/Nranged  |theS/Nranged |theS/Nranged |       |
|                                                                      |              |              |from          |from         |from         |       |
|                                                                      |              |              |10.4 to       |10.4 to      |10.4 to      |       |
|                                                                      |              |              |11.8.         |11.8.        |11.8.        |       |
|                                                                      |              |              |Were          |Were         |Were         |       |
|                                                                      |              |              |all           |all          |all          |       |
|                                                                      |              |              |greater       |greater      |greater      |       |
|                                                                      |              |              |than          |than         |than         |       |
|                                                                      |              |              |10.           |10.          |10.          |       |
|                                                                      |              |              |Meet          |Meet         |Meet         |       |
|                                                                      |              |              |verification  |verification |verification |       |
|                                                                      |              |              |requirements. |requirements.|requirements.|       |
|----------------------------------------------------------------------|--------------|--------------|--------------|-------------|-------------|-------|
|YA2304 (in place ofunknownimpurities)                                 |Limited       |0.1229        |0.0307        |9.319        |209 5        |15. 2  |
|                                                                      |quantification|              |              |             |             |       |
|                                                                      |solution①     |              |              |             |             |       |
|----------------------------------------------------------------------|--------------|--------------|--------------|-------------|-------------|-------|
|YA2304 (in place ofunknownimpurities)                                 |Limited       |Limited       |Limited       |9.322        |199 9        |16. 1  |
|                                                                      |quantification|quantification|quantification|             |             |       |
|                                                                      |solution②     |solution②     |solution②     |             |             |       |
|----------------------------------------------------------------------|--------------|--------------|--------------|-------------|-------------|-------|
|YA2304 (in place ofunknownimpurities)                                 |Limited       |Limited       |Limited       |9.329        |202 4        |16. 0  |
|                                                                      |quantitation  |quantitation  |quantitation  |             |             |       |
|                                                                      |solution③     |solution③     |solution③     |             |             |       |
|----------------------------------------------------------------------|--------------|--------------|--------------|-------------|-------------|-------|
|YA2304 (in place ofunknownimpurities)                                 |Limited       |Limited       |Limited       |9.324        |210          |15.    |
---------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 179 of 542 





Page 180
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 







































-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Limited quantification solution⑤                                      |Limited           |Limited           |9.328             |208 3             |16. 1             |       |
|                                                                      |quantification    |quantification    |                  |                  |                  |       |
|                                                                      |solution⑤         |solution⑤         |                  |                  |                  |       |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|-------|
|Limited quantification solution⑥                                      |Limited           |Limited           |9.327             |209 7             |16. 8             |       |
|                                                                      |quantification    |quantification    |                  |                  |                  |       |
|                                                                      |solution⑥         |solution⑥         |                  |                  |                  |       |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|-------|
|RSD                                                                   |RSD               |RSD               |0.05%             |2.2 %             |/                 |       |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|-------|
|Verdict: The RSD of principal component YA2304 (in place              |Verdict: The      |Verdict: The      |Verdict:          |Verdict:          |Verdict:          |       |
|ofunknownimpurity) was 0.1229μg/ml (relative to 0.0307% of test       |RSD of            |RSD of            |The RSD           |The RSD           |The RSD           |       |
|substance), the RSD of retention time and peakarea of 6 parts of RSD  |principal         |principal         |of                |of                |of                |       |
|were 0.05% (no more than 2.0%) and 2.2% (no more than 10%),           |component         |component         |principal         |principal         |principal         |       |
|respectively. S/Nranged from 15.1 to 16.8, all of which were greater  |YA2304 (in        |YA2304 (in        |component         |component         |component         |       |
|than 10. Meet the verification requirements.                          |place             |place             |YA2304            |YA2304            |YA2304            |       |
|                                                                      |ofunknownimpurity)|ofunknownimpurity)|(in               |(in               |(in               |       |
|                                                                      |was               |was               |place             |place             |place             |       |
|                                                                      |0.1229μg/ml       |0.1229μg/ml       |ofunknownimpurity)|ofunknownimpurity)|ofunknownimpurity)|       |
|                                                                      |(relative to      |(relative to      |was               |was               |was               |       |
|                                                                      |0.0307% of        |0.0307% of        |0.1229μg/ml       |0.1229μg/ml       |0.1229μg/ml       |       |
|                                                                      |test              |test              |(relative         |(relative         |(relative         |       |
|                                                                      |substance),       |substance),       |to                |to                |to                |       |
|                                                                      |the RSD of        |the RSD of        |0.0307%           |0.0307%           |0.0307%           |       |
|                                                                      |retention time    |retention time    |of test           |of test           |of test           |       |
|                                                                      |and peakarea      |and peakarea      |substance),       |substance),       |substance),       |       |
|                                                                      |of 6 parts of     |of 6 parts of     |the RSD           |the RSD           |the RSD           |       |
|                                                                      |RSD were 0.05%    |RSD were 0.05%    |of                |of                |of                |       |
|                                                                      |(no more than     |(no more than     |retention         |retention         |retention         |       |
|                                                                      |2.0%) and 2.2%    |2.0%) and 2.2%    |time              |time              |time              |       |
|                                                                      |(no more than     |(no more than     |and               |and               |and               |       |
|                                                                      |10%),             |10%),             |peakarea          |peakarea          |peakarea          |       |
|                                                                      |respectively.     |respectively.     |of 6              |of 6              |of 6              |       |
|                                                                      |S/Nranged from    |S/Nranged from    |parts             |parts             |parts             |       |
|                                                                      |15.1 to 16.8,     |15.1 to 16.8,     |of RSD            |of RSD            |of RSD            |       |
|                                                                      |all of which      |all of which      |were              |were              |were              |       |
|                                                                      |were greater      |were greater      |0.05%             |0.05%             |0.05%             |       |
|                                                                      |than 10. Meet     |than 10. Meet     |(no               |(no               |(no               |       |
|                                                                      |the               |the               |more              |more              |more              |       |
|                                                                      |verification      |verification      |than              |than              |than              |       |
|                                                                      |requirements.     |requirements.     |2.0%)             |2.0%)             |2.0%)             |       |
|                                                                      |                  |                  |and               |and               |and               |       |
|                                                                      |                  |                  |2.2%              |2.2%              |2.2%              |       |
|                                                                      |                  |                  |(no               |(no               |(no               |       |
|                                                                      |                  |                  |more              |more              |more              |       |
|                                                                      |                  |                  |than              |than              |than              |       |
|                                                                      |                  |                  |10%),             |10%),             |10%),             |       |
|                                                                      |                  |                  |respectively.     |respectively.     |respectively.     |       |
|                                                                      |                  |                  |S/Nranged         |S/Nranged         |S/Nranged         |       |
|                                                                      |                  |                  |from              |from              |from              |       |
|                                                                      |                  |                  |15.1 to           |15.1 to           |15.1 to           |       |
|                                                                      |                  |                  |16.8,             |16.8,             |16.8,             |       |
|                                                                      |                  |                  |all of            |all of            |all of            |       |
|                                                                      |                  |                  |which             |which             |which             |       |
|                                                                      |                  |                  |were              |were              |were              |       |
|                                                                      |                  |                  |greater           |greater           |greater           |       |
|                                                                      |                  |                  |than              |than              |than              |       |
|                                                                      |                  |                  |10.               |10.               |10.               |       |
|                                                                      |                  |                  |Meet              |Meet              |Meet              |       |
|                                                                      |                  |                  |the               |the               |the               |       |
|                                                                      |                  |                  |verification      |verification      |verification      |       |
|                                                                      |                  |                  |requirements.     |requirements.     |requirements.     |       |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|-------|
|YA2304-15                                                             |Limited           |0.1211            |0.0303            |10.266            |173 7             |14. 4  |
|                                                                      |quantitation      |                  |                  |                  |                  |       |
|                                                                      |solution①         |                  |                  |                  |                  |       |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|-------|
|YA2304-15                                                             |Limited           |Limited           |Limited           |10.269            |178 7             |15. 4  |
|                                                                      |quantification    |quantification    |quantification    |                  |                  |       |
|                                                                      |solution②         |solution②         |solution②         |                  |                  |       |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|-------|
|YA2304-15                                                             |Limited           |Limited           |Limited           |10.276            |169 5             |15. 3  |
|                                                                      |quantification    |quantification    |quantification    |                  |                  |       |
|                                                                      |solution③         |solution③         |solution③         |                  |                  |       |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|-------|
|YA2304-15                                                             |Limited           |Limited           |Limited           |10.269            |168 9             |14. 1  |
|                                                                      |quantification    |quantification    |quantification    |                  |                  |       |
|                                                                      |solution④         |solution④         |solution④         |                  |                  |       |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|-------|
|YA2304-15                                                             |Limited           |Limited           |Limited           |10.273            |182 5             |15. 3  |
|                                                                      |quantification    |quantification    |quantification    |                  |                  |       |
|                                                                      |solution⑤         |solution⑤         |solution⑤         |                  |                  |       |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|-------|
|YA2304-15                                                             |Limited           |Limited           |Limited           |10.276            |169 4             |15. 3  |
|                                                                      |quantification    |quantification    |quantification    |                  |                  |       |
|                                                                      |solution⑥         |solution⑥         |solution⑥         |                  |                  |       |
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 180 of 542 





Page 181
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 

























------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Verdict: The limiting solution concentration ofimpurity YA2304-15 was |Verdict:      |Verdict:      |Verdict:      |Verdict:      |Verdict:      |              |
|0.1211μg/ml (relative to 0.0303% of the test product), the RSD of the |The           |The           |The           |The           |The           |              |
|retention time of 6 parts of the limiting solution was 0.05% (no more |limiting      |limiting      |limiting      |limiting      |limiting      |              |
|than 2.0%), the RSD of the peakarea was 4% (no more than 10%), and    |solution      |solution      |solution      |solution      |solution      |              |
|theS/Nranged from 14.1 to 15.4. All of them were greater than 10. Meet|concentration |concentration |concentration |concentration |concentration |              |
|verification requirements.                                            |ofimpurity    |ofimpurity    |ofimpurity    |ofimpurity    |ofimpurity    |              |
|                                                                      |YA2304-15     |YA2304-15     |YA2304-15     |YA2304-15     |YA2304-15     |              |
|                                                                      |was           |was           |was           |was           |was           |              |
|                                                                      |0.1211μg/ml   |0.1211μg/ml   |0.1211μg/ml   |0.1211μg/ml   |0.1211μg/ml   |              |
|                                                                      |(relative     |(relative     |(relative     |(relative     |(relative     |              |
|                                                                      |to            |to            |to            |to            |to            |              |
|                                                                      |0.0303%       |0.0303%       |0.0303%       |0.0303%       |0.0303%       |              |
|                                                                      |of the        |of the        |of the        |of the        |of the        |              |
|                                                                      |test          |test          |test          |test          |test          |              |
|                                                                      |product),     |product),     |product),     |product),     |product),     |              |
|                                                                      |the RSD       |the RSD       |the RSD       |the RSD       |the RSD       |              |
|                                                                      |of the        |of the        |of the        |of the        |of the        |              |
|                                                                      |retention     |retention     |retention     |retention     |retention     |              |
|                                                                      |time of       |time of       |time of       |time of       |time of       |              |
|                                                                      |6 parts       |6 parts       |6 parts       |6 parts       |6 parts       |              |
|                                                                      |of the        |of the        |of the        |of the        |of the        |              |
|                                                                      |limiting      |limiting      |limiting      |limiting      |limiting      |              |
|                                                                      |solution      |solution      |solution      |solution      |solution      |              |
|                                                                      |was           |was           |was           |was           |was           |              |
|                                                                      |0.05%         |0.05%         |0.05%         |0.05%         |0.05%         |              |
|                                                                      |(no           |(no           |(no           |(no           |(no           |              |
|                                                                      |more          |more          |more          |more          |more          |              |
|                                                                      |than          |than          |than          |than          |than          |              |
|                                                                      |2.0%),        |2.0%),        |2.0%),        |2.0%),        |2.0%),        |              |
|                                                                      |the RSD       |the RSD       |the RSD       |the RSD       |the RSD       |              |
|                                                                      |of the        |of the        |of the        |of the        |of the        |              |
|                                                                      |peakarea      |peakarea      |peakarea      |peakarea      |peakarea      |              |
|                                                                      |was 4%        |was 4%        |was 4%        |was 4%        |was 4%        |              |
|                                                                      |(no           |(no           |(no           |(no           |(no           |              |
|                                                                      |more          |more          |more          |more          |more          |              |
|                                                                      |than          |than          |than          |than          |than          |              |
|                                                                      |10%),         |10%),         |10%),         |10%),         |10%),         |              |
|                                                                      |and           |and           |and           |and           |and           |              |
|                                                                      |theS/Nranged  |theS/Nranged  |theS/Nranged  |theS/Nranged  |theS/Nranged  |              |
|                                                                      |from          |from          |from          |from          |from          |              |
|                                                                      |14.1 to       |14.1 to       |14.1 to       |14.1 to       |14.1 to       |              |
|                                                                      |15.4.         |15.4.         |15.4.         |15.4.         |15.4.         |              |
|                                                                      |All of        |All of        |All of        |All of        |All of        |              |
|                                                                      |them          |them          |them          |them          |them          |              |
|                                                                      |were          |were          |were          |were          |were          |              |
|                                                                      |greater       |greater       |greater       |greater       |greater       |              |
|                                                                      |than          |than          |than          |than          |than          |              |
|                                                                      |10.           |10.           |10.           |10.           |10.           |              |
|                                                                      |Meet          |Meet          |Meet          |Meet          |Meet          |              |
|                                                                      |verification  |verification  |verification  |verification  |verification  |              |
|                                                                      |requirements. |requirements. |requirements. |requirements. |requirements. |              |
|----------------------------------------------------------------------|--------------|--------------|--------------|--------------|--------------|--------------|
|YA2304-17 (230nm)                                                     |Limited       |0.1208        |0.0302        |11.493        |314 3         |15. 4         |
|                                                                      |quantitation  |              |              |              |              |              |
|                                                                      |solution①     |              |              |              |              |              |
|----------------------------------------------------------------------|--------------|--------------|--------------|--------------|--------------|--------------|
|YA2304-17 (230nm)                                                     |Limited       |Limited       |Limited       |11.496        |325 8         |16. 5         |
|                                                                      |quantification|quantification|quantification|              |              |              |
|                                                                      |solution②     |solution②     |solution②     |              |              |              |
|----------------------------------------------------------------------|--------------|--------------|--------------|--------------|--------------|--------------|
|YA2304-17 (230nm)                                                     |Limited       |Limited       |Limited       |11.503        |323 3         |14. 7         |
|                                                                      |quantification|quantification|quantification|              |              |              |
|                                                                      |solution③     |solution③     |solution③     |              |              |              |
|----------------------------------------------------------------------|--------------|--------------|--------------|--------------|--------------|--------------|
|YA2304-17 (230nm)                                                     |Limited       |Limited       |Limited       |11.496        |318 1         |14. 3         |
|                                                                      |quantification|quantification|quantification|              |              |              |
|                                                                      |solution④     |solution④     |solution④     |              |              |              |
|----------------------------------------------------------------------|--------------|--------------|--------------|--------------|--------------|--------------|
|YA2304-17 (230nm)                                                     |Limited       |Limited       |Limited       |11.501        |317 0         |14. 1         |
|                                                                      |quantification|quantification|quantification|              |              |              |
|                                                                      |solution⑤     |solution⑤     |solution⑤     |              |              |              |
|----------------------------------------------------------------------|--------------|--------------|--------------|--------------|--------------|--------------|
|YA2304-17 (230nm)                                                     |Limited       |Limited       |Limited       |11.504        |322 0         |15. 0         |
|                                                                      |quantification|quantification|quantification|              |              |              |
|                                                                      |solution⑥     |solution⑥     |solution⑥     |              |              |              |
|----------------------------------------------------------------------|--------------|--------------|--------------|--------------|--------------|--------------|
|YA2304-17 (230nm)                                                     |RSD           |RSD           |RSD           |0.04%         |1.4 %         |/             |
|----------------------------------------------------------------------|--------------|--------------|--------------|--------------|--------------|--------------|
|YA2304-17 (230nm)                                                     |Verdict: The  |Verdict: The  |Verdict: The  |Verdict: The  |Verdict: The  |Verdict:      |
|                                                                      |limited       |limited       |limited       |limited       |limited       |The           |
|                                                                      |quantification|quantification|quantification|quantification|quantification|limited       |
|                                                                      |solution      |solution      |solution      |solution      |solution      |quantification|
|                                                                      |concentration |concentration |concentration |concentration |concentration |solution      |
|                                                                      |ofimpurity    |ofimpurity    |ofimpurity    |ofimpurity    |ofimpurity    |concentration |
|                                                                      |YA2304-17 was |YA2304-17 was |YA2304-17 was |YA2304-17 was |YA2304-17 was |ofimpurity    |
|                                                                      |0.1208μg/ml   |0.1208μg/ml   |0.1208μg/ml   |0.1208μg/ml   |0.1208μg/ml   |YA2304-17     |
|                                                                      |(relative to  |(relative to  |(relative to  |(relative to  |(relative to  |was           |
|                                                                      |0.0302% of the|0.0302% of the|0.0302% of the|0.0302% of    |0.0302% of    |0.1208μg/ml   |
|                                                                      |test product),|test product),|test product),|the test      |the test      |(relative     |
|                                                                      |the RSD of the|the RSD of the|the RSD of the|product), the |product), the |to            |
|                                                                      |retention time|retention time|retention time|RSD of the    |RSD of the    |0.0302%       |
|                                                                      |of 6 parts of |of 6 parts of |of 6 parts of |retention     |retention     |of the        |
|                                                                      |the limited   |the limited   |the limited   |time of 6     |time of 6     |test          |
|                                                                      |quantification|quantification|quantification|parts of the  |parts of the  |product),     |
|                                                                      |solution was  |solution was  |solution was  |limited       |limited       |the RSD       |
|                                                                      |0.04% (no more|0.04% (no more|0.04% (no more|quantification|quantification|of the        |
|                                                                      |than 2.0%),   |than 2.0%),   |than 2.0%),   |solution was  |solution was  |retention     |
|                                                                      |the RSD of the|the RSD of the|the RSD of the|0.04% (no     |0.04% (no     |time of       |
|                                                                      |peakarea was  |peakarea was  |peakarea was  |more than     |more than     |6 parts       |
|                                                                      |1.4% (no more |1.4% (no more |1.4% (no more |2.0%), the    |2.0%), the    |of the        |
|                                                                      |than 10%), and|than 10%), and|than 10%), and|RSD of the    |RSD of the    |limited       |
|                                                                      |theS/Nranged  |theS/Nranged  |theS/Nranged  |peakarea was  |peakarea was  |quantification|
|                                                                      |from 14.1 to  |from 14.1 to  |from 14.1 to  |1.4% (no more |1.4% (no more |solution      |
|                                                                      |16.5. Were all|16.5. Were all|16.5. Were all|than 10%),    |than 10%),    |was           |
|                                                                      |greater than  |greater than  |greater than  |and           |and           |0.04%         |
|                                                                      |10. Meet      |10. Meet      |10. Meet      |theS/Nranged  |theS/Nranged  |(no           |
|                                                                      |verification  |verification  |verification  |from 14.1 to  |from 14.1 to  |more          |
|                                                                      |requirements. |requirements. |requirements. |16.5. Were    |16.5. Were    |than          |
|                                                                      |              |              |              |all greater   |all greater   |2.0%),        |
|                                                                      |              |              |              |than 10. Meet |than 10. Meet |the RSD       |
|                                                                      |              |              |              |verification  |verification  |of the        |
|                                                                      |              |              |              |requirements. |requirements. |peakarea      |
|                                                                      |              |              |              |              |              |was           |
|                                                                      |              |              |              |              |              |1.4%          |
|                                                                      |              |              |              |              |              |(no           |
|                                                                      |              |              |              |              |              |more          |
|                                                                      |              |              |              |              |              |than          |
|                                                                      |              |              |              |              |              |10%),         |
|                                                                      |              |              |              |              |              |and           |
|                                                                      |              |              |              |              |              |theS/Nranged  |
|                                                                      |              |              |              |              |              |from          |
|                                                                      |              |              |              |              |              |14.1 to       |
|                                                                      |              |              |              |              |              |16.5.         |
|                                                                      |              |              |              |              |              |Were          |
|                                                                      |              |              |              |              |              |all           |
|                                                                      |              |              |              |              |              |greater       |
|                                                                      |              |              |              |              |              |than          |
|                                                                      |              |              |              |              |              |10.           |
|                                                                      |              |              |              |              |              |Meet          |
|                                                                      |              |              |              |              |              |verification  |
|                                                                      |              |              |              |              |              |requirements. |
------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 181 of 542 





Page 182
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 











































--------------------------------------------------------------------------------------------------------------------------------------------------------
|YA2304-16|Limited quantification solution②                                    |Limited       |Limited       |11.924       |190 7        |15. 6        |
|         |                                                                    |quantification|quantification|             |             |             |
|         |                                                                    |solution②     |solution②     |             |             |             |
|---------|--------------------------------------------------------------------|--------------|--------------|-------------|-------------|-------------|
|YA2304-16|Limited quantification solution③                                    |Limited       |Limited       |11.931       |189 8        |15. 3        |
|         |                                                                    |quantification|quantification|             |             |             |
|         |                                                                    |solution③     |solution③     |             |             |             |
|---------|--------------------------------------------------------------------|--------------|--------------|-------------|-------------|-------------|
|YA2304-16|Limited quantification solution④                                    |Limited       |Limited       |11.922       |186 2        |14. 2        |
|         |                                                                    |quantification|quantification|             |             |             |
|         |                                                                    |solution④     |solution④     |             |             |             |
|---------|--------------------------------------------------------------------|--------------|--------------|-------------|-------------|-------------|
|YA2304-16|Limited quantification solution⑤                                    |Limited       |Limited       |11.928       |192 8        |15. 2        |
|         |                                                                    |quantification|quantification|             |             |             |
|         |                                                                    |solution⑤     |solution⑤     |             |             |             |
|---------|--------------------------------------------------------------------|--------------|--------------|-------------|-------------|-------------|
|YA2304-16|Limited quantification solution⑥                                    |Limited       |Limited       |11.932       |184 8        |15. 5        |
|         |                                                                    |quantification|quantification|             |             |             |
|         |                                                                    |solution⑥     |solution⑥     |             |             |             |
|---------|--------------------------------------------------------------------|--------------|--------------|-------------|-------------|-------------|
|YA2304-16|RSD                                                                 |RSD           |RSD           |0.05%        |2.1 %        |/            |
|---------|--------------------------------------------------------------------|--------------|--------------|-------------|-------------|-------------|
|YA2304-16|Conclusion: The limiting solution concentration ofimpurity YA2304-16|Conclusion:   |Conclusion:   |Conclusion:  |Conclusion:  |Conclusion:  |
|         |was 0.1159μg/ml (relative to 0.0290% of the test product), the RSD  |The limiting  |The limiting  |The          |The          |The          |
|         |of the retention time of 6 parts of the limiting solution was 0.05% |solution      |solution      |limiting     |limiting     |limiting     |
|         |(no more than 2.0%), the RSD of the peakarea was 2.1% (no more than |concentration |concentration |solution     |solution     |solution     |
|         |10%), and theS/Nranged from 14.2 to 15.6. Were all greater than 10. |ofimpurity    |ofimpurity    |concentration|concentration|concentration|
|         |Meet verification requirements.                                     |YA2304-16 was |YA2304-16 was |ofimpurity   |ofimpurity   |ofimpurity   |
|         |                                                                    |0.1159μg/ml   |0.1159μg/ml   |YA2304-16    |YA2304-16    |YA2304-16    |
|         |                                                                    |(relative to  |(relative to  |was          |was          |was          |
|         |                                                                    |0.0290% of the|0.0290% of the|0.1159μg/ml  |0.1159μg/ml  |0.1159μg/ml  |
|         |                                                                    |test product),|test product),|(relative    |(relative    |(relative    |
|         |                                                                    |the RSD of the|the RSD of the|to           |to           |to           |
|         |                                                                    |retention time|retention time|0.0290%      |0.0290%      |0.0290%      |
|         |                                                                    |of 6 parts of |of 6 parts of |of the       |of the       |of the       |
|         |                                                                    |the limiting  |the limiting  |test         |test         |test         |
|         |                                                                    |solution was  |solution was  |product),    |product),    |product),    |
|         |                                                                    |0.05% (no more|0.05% (no more|the RSD      |the RSD      |the RSD      |
|         |                                                                    |than 2.0%),   |than 2.0%),   |of the       |of the       |of the       |
|         |                                                                    |the RSD of the|the RSD of the|retention    |retention    |retention    |
|         |                                                                    |peakarea was  |peakarea was  |time of      |time of      |time of      |
|         |                                                                    |2.1% (no more |2.1% (no more |6 parts      |6 parts      |6 parts      |
|         |                                                                    |than 10%), and|than 10%), and|of the       |of the       |of the       |
|         |                                                                    |theS/Nranged  |theS/Nranged  |limiting     |limiting     |limiting     |
|         |                                                                    |from 14.2 to  |from 14.2 to  |solution     |solution     |solution     |
|         |                                                                    |15.6. Were all|15.6. Were all|was          |was          |was          |
|         |                                                                    |greater than  |greater than  |0.05%        |0.05%        |0.05%        |
|         |                                                                    |10. Meet      |10. Meet      |(no          |(no          |(no          |
|         |                                                                    |verification  |verification  |more         |more         |more         |
|         |                                                                    |requirements. |requirements. |than         |than         |than         |
|         |                                                                    |              |              |2.0%),       |2.0%),       |2.0%),       |
|         |                                                                    |              |              |the RSD      |the RSD      |the RSD      |
|         |                                                                    |              |              |of the       |of the       |of the       |
|         |                                                                    |              |              |peakarea     |peakarea     |peakarea     |
|         |                                                                    |              |              |was          |was          |was          |
|         |                                                                    |              |              |2.1%         |2.1%         |2.1%         |
|         |                                                                    |              |              |(no          |(no          |(no          |
|         |                                                                    |              |              |more         |more         |more         |
|         |                                                                    |              |              |than         |than         |than         |
|         |                                                                    |              |              |10%),        |10%),        |10%),        |
|         |                                                                    |              |              |and          |and          |and          |
|         |                                                                    |              |              |theS/Nranged |theS/Nranged |theS/Nranged |
|         |                                                                    |              |              |from         |from         |from         |
|         |                                                                    |              |              |14.2 to      |14.2 to      |14.2 to      |
|         |                                                                    |              |              |15.6.        |15.6.        |15.6.        |
|         |                                                                    |              |              |Were         |Were         |Were         |
|         |                                                                    |              |              |all          |all          |all          |
|         |                                                                    |              |              |greater      |greater      |greater      |
|         |                                                                    |              |              |than         |than         |than         |
|         |                                                                    |              |              |10.          |10.          |10.          |
|         |                                                                    |              |              |Meet         |Meet         |Meet         |
|         |                                                                    |              |              |verification |verification |verification |
|         |                                                                    |              |              |requirements.|requirements.|requirements.|
|---------|--------------------------------------------------------------------|--------------|--------------|-------------|-------------|-------------|
|YA2304-18|Limited quantitative solution①                                      |0.1203        |0.0301        |13.167       |187 2        |13. 9        |
|---------|--------------------------------------------------------------------|--------------|--------------|-------------|-------------|-------------|
|YA2304-18|Limited quantification solution②                                    |Limited       |Limited       |13.169       |170 6        |14. 6        |
|         |                                                                    |quantification|quantification|             |             |             |
|         |                                                                    |solution②     |solution②     |             |             |             |
|---------|--------------------------------------------------------------------|--------------|--------------|-------------|-------------|-------------|
|YA2304-18|Limited                                                             |Limited       |Limited       |13.177       |186          |14.          |
--------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 182 of 542 





Page 183
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 







































---------------------------------------------------------------------------------------------------------------------------------------------------------
|Limited quantification solution④                                      |Limited       |Limited       |13.170        |185 0        |13. 7        |       |
|                                                                      |quantification|quantification|              |             |             |       |
|                                                                      |solution④     |solution④     |              |             |             |       |
|----------------------------------------------------------------------|--------------|--------------|--------------|-------------|-------------|-------|
|Limited quantification solution⑤                                      |Limited       |Limited       |13.171        |188 3        |14. 6        |       |
|                                                                      |quantification|quantification|              |             |             |       |
|                                                                      |solution⑤     |solution⑤     |              |             |             |       |
|----------------------------------------------------------------------|--------------|--------------|--------------|-------------|-------------|-------|
|Limited quantification solution⑥                                      |Limited       |Limited       |13.178        |175 1        |14. 8        |       |
|                                                                      |quantification|quantification|              |             |             |       |
|                                                                      |solution⑥     |solution⑥     |              |             |             |       |
|----------------------------------------------------------------------|--------------|--------------|--------------|-------------|-------------|-------|
|RSD                                                                   |RSD           |RSD           |0.04%         |5%           |/            |       |
|----------------------------------------------------------------------|--------------|--------------|--------------|-------------|-------------|-------|
|Verdict: The limiting solution concentration ofimpurity YA2304-18 was |Verdict: The  |Verdict: The  |Verdict:      |Verdict:     |Verdict:     |       |
|0.1203μg/ml (relative to 0.0301% of the test product), the RSD of the |limiting      |limiting      |The           |The          |The          |       |
|retention time of 6 parts of the limiting solution was 0.04% (no more |solution      |solution      |limiting      |limiting     |limiting     |       |
|than 2.0%), the RSD of the peakarea was 5% (no more than 10%), and    |concentration |concentration |solution      |solution     |solution     |       |
|theS/Nwas between 13.7 and 14.8. Were all greater than 10. Meet       |ofimpurity    |ofimpurity    |concentration |concentration|concentration|       |
|verification requirements.                                            |YA2304-18 was |YA2304-18 was |ofimpurity    |ofimpurity   |ofimpurity   |       |
|                                                                      |0.1203μg/ml   |0.1203μg/ml   |YA2304-18     |YA2304-18    |YA2304-18    |       |
|                                                                      |(relative to  |(relative to  |was           |was          |was          |       |
|                                                                      |0.0301% of the|0.0301% of the|0.1203μg/ml   |0.1203μg/ml  |0.1203μg/ml  |       |
|                                                                      |test product),|test product),|(relative     |(relative    |(relative    |       |
|                                                                      |the RSD of the|the RSD of the|to            |to           |to           |       |
|                                                                      |retention time|retention time|0.0301%       |0.0301%      |0.0301%      |       |
|                                                                      |of 6 parts of |of 6 parts of |of the        |of the       |of the       |       |
|                                                                      |the limiting  |the limiting  |test          |test         |test         |       |
|                                                                      |solution was  |solution was  |product),     |product),    |product),    |       |
|                                                                      |0.04% (no more|0.04% (no more|the RSD       |the RSD      |the RSD      |       |
|                                                                      |than 2.0%),   |than 2.0%),   |of the        |of the       |of the       |       |
|                                                                      |the RSD of the|the RSD of the|retention     |retention    |retention    |       |
|                                                                      |peakarea was  |peakarea was  |time of       |time of      |time of      |       |
|                                                                      |5% (no more   |5% (no more   |6 parts       |6 parts      |6 parts      |       |
|                                                                      |than 10%), and|than 10%), and|of the        |of the       |of the       |       |
|                                                                      |theS/Nwas     |theS/Nwas     |limiting      |limiting     |limiting     |       |
|                                                                      |between 13.7  |between 13.7  |solution      |solution     |solution     |       |
|                                                                      |and 14.8. Were|and 14.8. Were|was           |was          |was          |       |
|                                                                      |all greater   |all greater   |0.04%         |0.04%        |0.04%        |       |
|                                                                      |than 10. Meet |than 10. Meet |(no           |(no          |(no          |       |
|                                                                      |verification  |verification  |more          |more         |more         |       |
|                                                                      |requirements. |requirements. |than          |than         |than         |       |
|                                                                      |              |              |2.0%),        |2.0%),       |2.0%),       |       |
|                                                                      |              |              |the RSD       |the RSD      |the RSD      |       |
|                                                                      |              |              |of the        |of the       |of the       |       |
|                                                                      |              |              |peakarea      |peakarea     |peakarea     |       |
|                                                                      |              |              |was 5%        |was 5%       |was 5%       |       |
|                                                                      |              |              |(no           |(no          |(no          |       |
|                                                                      |              |              |more          |more         |more         |       |
|                                                                      |              |              |than          |than         |than         |       |
|                                                                      |              |              |10%),         |10%),        |10%),        |       |
|                                                                      |              |              |and           |and          |and          |       |
|                                                                      |              |              |theS/Nwas     |theS/Nwas    |theS/Nwas    |       |
|                                                                      |              |              |between       |between      |between      |       |
|                                                                      |              |              |13.7          |13.7         |13.7         |       |
|                                                                      |              |              |and           |and          |and          |       |
|                                                                      |              |              |14.8.         |14.8.        |14.8.        |       |
|                                                                      |              |              |Were          |Were         |Were         |       |
|                                                                      |              |              |all           |all          |all          |       |
|                                                                      |              |              |greater       |greater      |greater      |       |
|                                                                      |              |              |than          |than         |than         |       |
|                                                                      |              |              |10.           |10.          |10.          |       |
|                                                                      |              |              |Meet          |Meet         |Meet         |       |
|                                                                      |              |              |verification  |verification |verification |       |
|                                                                      |              |              |requirements. |requirements.|requirements.|       |
|----------------------------------------------------------------------|--------------|--------------|--------------|-------------|-------------|-------|
|YA2304-10 (230nm)                                                     |Limited       |0.1218        |0.0305        |15.271       |276 2        |12. 1  |
|                                                                      |quantification|              |              |             |             |       |
|                                                                      |solution①     |              |              |             |             |       |
|----------------------------------------------------------------------|--------------|--------------|--------------|-------------|-------------|-------|
|YA2304-10 (230nm)                                                     |Limited       |Limited       |Limited       |15.274       |273 5        |12. 6  |
|                                                                      |quantification|quantification|quantification|             |             |       |
|                                                                      |solution②     |solution②     |solution②     |             |             |       |
|----------------------------------------------------------------------|--------------|--------------|--------------|-------------|-------------|-------|
|YA2304-10 (230nm)                                                     |Limited       |Limited       |Limited       |15.282       |259 7        |11. 1  |
|                                                                      |quantification|quantification|quantification|             |             |       |
|                                                                      |solution③     |solution③     |solution③     |             |             |       |
|----------------------------------------------------------------------|--------------|--------------|--------------|-------------|-------------|-------|
|YA2304-10 (230nm)                                                     |Limited       |Limited       |Limited       |15.275       |274 2        |11. 0  |
|                                                                      |quantification|quantification|quantification|             |             |       |
|                                                                      |solution④     |solution④     |solution④     |             |             |       |
|----------------------------------------------------------------------|--------------|--------------|--------------|-------------|-------------|-------|
|YA2304-10 (230nm)                                                     |Limited       |Limited       |Limited       |15.277       |266 0        |10. 6  |
|                                                                      |quantification|quantification|quantification|             |             |       |
|                                                                      |solution⑤     |solution⑤     |solution⑤     |             |             |       |
---------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 183 of 542 





Page 184
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 








































---------------------------------------------------------------------------------------------------------------------------------------------------------------
|RSD                                                                   |RSD           |RSD           |0.028%        |2.9 %        |/            |             |
|----------------------------------------------------------------------|--------------|--------------|--------------|-------------|-------------|-------------|
|Verdict: The limiting solution concentration ofimpurity YA2304-10 was |Verdict:      |Verdict:      |Verdict:      |Verdict:     |Verdict:     |             |
|0.1218μg/ml (relative to 0.0305% of the test product), the RSD of the |The           |The           |The           |The          |The          |             |
|retention time of 6 parts of the limiting solution was 0.028% (no more|limiting      |limiting      |limiting      |limiting     |limiting     |             |
|than 2.0%), the RSD of the peakarea was 2.9% (no more than 10%), and  |solution      |solution      |solution      |solution     |solution     |             |
|theS/Nwas between 10.6 and 12.6. Were all greater than 10. Meet       |concentration |concentration |concentration |concentration|concentration|             |
|verification requirements.                                            |ofimpurity    |ofimpurity    |ofimpurity    |ofimpurity   |ofimpurity   |             |
|                                                                      |YA2304-10     |YA2304-10     |YA2304-10     |YA2304-10    |YA2304-10    |             |
|                                                                      |was           |was           |was           |was          |was          |             |
|                                                                      |0.1218μg/ml   |0.1218μg/ml   |0.1218μg/ml   |0.1218μg/ml  |0.1218μg/ml  |             |
|                                                                      |(relative     |(relative     |(relative     |(relative    |(relative    |             |
|                                                                      |to            |to            |to            |to           |to           |             |
|                                                                      |0.0305%       |0.0305%       |0.0305%       |0.0305%      |0.0305%      |             |
|                                                                      |of the        |of the        |of the        |of the       |of the       |             |
|                                                                      |test          |test          |test          |test         |test         |             |
|                                                                      |product),     |product),     |product),     |product),    |product),    |             |
|                                                                      |the RSD       |the RSD       |the RSD       |the RSD      |the RSD      |             |
|                                                                      |of the        |of the        |of the        |of the       |of the       |             |
|                                                                      |retention     |retention     |retention     |retention    |retention    |             |
|                                                                      |time of       |time of       |time of       |time of      |time of      |             |
|                                                                      |6 parts       |6 parts       |6 parts       |6 parts      |6 parts      |             |
|                                                                      |of the        |of the        |of the        |of the       |of the       |             |
|                                                                      |limiting      |limiting      |limiting      |limiting     |limiting     |             |
|                                                                      |solution      |solution      |solution      |solution     |solution     |             |
|                                                                      |was           |was           |was           |was          |was          |             |
|                                                                      |0.028%        |0.028%        |0.028%        |0.028%       |0.028%       |             |
|                                                                      |(no           |(no           |(no           |(no          |(no          |             |
|                                                                      |more          |more          |more          |more         |more         |             |
|                                                                      |than          |than          |than          |than         |than         |             |
|                                                                      |2.0%),        |2.0%),        |2.0%),        |2.0%),       |2.0%),       |             |
|                                                                      |the RSD       |the RSD       |the RSD       |the RSD      |the RSD      |             |
|                                                                      |of the        |of the        |of the        |of the       |of the       |             |
|                                                                      |peakarea      |peakarea      |peakarea      |peakarea     |peakarea     |             |
|                                                                      |was           |was           |was           |was          |was          |             |
|                                                                      |2.9%          |2.9%          |2.9%          |2.9%         |2.9%         |             |
|                                                                      |(no           |(no           |(no           |(no          |(no          |             |
|                                                                      |more          |more          |more          |more         |more         |             |
|                                                                      |than          |than          |than          |than         |than         |             |
|                                                                      |10%),         |10%),         |10%),         |10%),        |10%),        |             |
|                                                                      |and           |and           |and           |and          |and          |             |
|                                                                      |theS/Nwas     |theS/Nwas     |theS/Nwas     |theS/Nwas    |theS/Nwas    |             |
|                                                                      |between       |between       |between       |between      |between      |             |
|                                                                      |10.6          |10.6          |10.6          |10.6         |10.6         |             |
|                                                                      |and           |and           |and           |and          |and          |             |
|                                                                      |12.6.         |12.6.         |12.6.         |12.6.        |12.6.        |             |
|                                                                      |Were          |Were          |Were          |Were         |Were         |             |
|                                                                      |all           |all           |all           |all          |all          |             |
|                                                                      |greater       |greater       |greater       |greater      |greater      |             |
|                                                                      |than          |than          |than          |than         |than         |             |
|                                                                      |10.           |10.           |10.           |10.          |10.          |             |
|                                                                      |Meet          |Meet          |Meet          |Meet         |Meet         |             |
|                                                                      |verification  |verification  |verification  |verification |verification |             |
|                                                                      |requirements. |requirements. |requirements. |requirements.|requirements.|             |
|----------------------------------------------------------------------|--------------|--------------|--------------|-------------|-------------|-------------|
|YA2304-19                                                             |Limited       |0.1202        |0.0300        |16.431       |299 4        |17. 5        |
|                                                                      |quantitative  |              |              |             |             |             |
|                                                                      |solution①     |              |              |             |             |             |
|----------------------------------------------------------------------|--------------|--------------|--------------|-------------|-------------|-------------|
|YA2304-19                                                             |Limited       |Limited       |Limited       |16.434       |318 8        |19. 1        |
|                                                                      |quantification|quantification|quantification|             |             |             |
|                                                                      |solution②     |solution②     |solution②     |             |             |             |
|----------------------------------------------------------------------|--------------|--------------|--------------|-------------|-------------|-------------|
|YA2304-19                                                             |Limited       |Limited       |Limited       |16.442       |304 6        |19. 0        |
|                                                                      |quantification|quantification|quantification|             |             |             |
|                                                                      |solution③     |solution③     |solution③     |             |             |             |
|----------------------------------------------------------------------|--------------|--------------|--------------|-------------|-------------|-------------|
|YA2304-19                                                             |Limited       |Limited       |Limited       |16.437       |312 2        |17. 6        |
|                                                                      |quantification|quantification|quantification|             |             |             |
|                                                                      |solution④     |solution④     |solution④     |             |             |             |
|----------------------------------------------------------------------|--------------|--------------|--------------|-------------|-------------|-------------|
|YA2304-19                                                             |Limited       |Limited       |Limited       |16.438       |300 5        |18. 5        |
|                                                                      |quantification|quantification|quantification|             |             |             |
|                                                                      |solution⑤     |solution⑤     |solution⑤     |             |             |             |
|----------------------------------------------------------------------|--------------|--------------|--------------|-------------|-------------|-------------|
|YA2304-19                                                             |Limited       |Limited       |Limited       |16.438       |313 9        |19. 5        |
|                                                                      |quantification|quantification|quantification|             |             |             |
|                                                                      |solution⑥     |solution⑥     |solution⑥     |             |             |             |
|----------------------------------------------------------------------|--------------|--------------|--------------|-------------|-------------|-------------|
|YA2304-19                                                             |RSD           |RSD           |RSD           |0.023%       |2.6 %        |/            |
|----------------------------------------------------------------------|--------------|--------------|--------------|-------------|-------------|-------------|
|YA2304-19                                                             |Verdict: The  |Verdict: The  |Verdict: The  |Verdict: The |Verdict: The |Verdict:     |
|                                                                      |limiting      |limiting      |limiting      |limiting     |limiting     |The          |
|                                                                      |solution      |solution      |solution      |solution     |solution     |limiting     |
|                                                                      |concentration |concentration |concentration |concentration|concentration|solution     |
|                                                                      |ofimpurity    |ofimpurity    |ofimpurity    |ofimpurity   |ofimpurity   |concentration|
|                                                                      |YA2304-19 was |YA2304-19 was |YA2304-19 was |YA2304-19 was|YA2304-19 was|ofimpurity   |
|                                                                      |0.1202μg/ml   |0.1202μg/ml   |0.1202μg/ml   |0.1202μg/ml  |0.1202μg/ml  |YA2304-19    |
|                                                                      |(relative to  |(relative to  |(relative to  |(relative to |(relative to |was          |
|                                                                      |0.0300% of the|0.0300% of the|0.0300% of the|0.0300% of   |0.0300% of   |0.1202μg/ml  |
|                                                                      |test product),|test product),|test product),|the test     |the test     |(relative    |
|                                                                      |the RSD of the|the RSD of the|the RSD of the|product), the|product), the|to           |
|                                                                      |              |              |              |RSD of the   |RSD of the   |0.0300%      |
|                                                                      |              |              |              |             |             |of the       |
|                                                                      |              |              |              |             |             |test         |
|                                                                      |              |              |              |             |             |product),    |
|                                                                      |              |              |              |             |             |the RSD      |
|                                                                      |              |              |              |             |             |of the       |
---------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 184 of 542 





Page 185
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



retention time of 6 parts of the limiting solution was 0.023% (no more 



than 2.0%), the RSD of the peak area was 2.6% (no more than 10%), 



and the S/N was between 17.5 and 19.5. Were all greater than 10. Meet 



verification requirements. 



Results of LOD Determination: 

























































-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|YA2304-12|1                                                                   |0.0601            |0.0150            |3.799             |832               |7.3               |
|---------|--------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|
|YA2304-12|2                                                                   |2                 |2                 |3.799             |831               |7.3               |
|---------|--------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|
|YA2304-12|3                                                                   |3                 |3                 |3.802             |804               |6.8               |
|---------|--------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|
|YA2304-12|Conclusion: The detection limit solution concentration ofimpurity   |Conclusion:       |Conclusion:       |Conclusion:       |Conclusion:       |Conclusion:       |
|         |YA2304-12 is 0.0601μg/ml (relative to 0.0150% of the test product   |The               |The               |The               |The               |The               |
|         |concentration), and theS/Nof the 3-needle detection limit solutionis|detection         |detection         |detection         |detection         |detection         |
|         |between 6.8 and 7.3, all of whichare greater than 3. In line with   |limit             |limit             |limit             |limit             |limit             |
|         |the verification requirements.                                      |solution          |solution          |solution          |solution          |solution          |
|         |                                                                    |concentration     |concentration     |concentration     |concentration     |concentration     |
|         |                                                                    |ofimpurity        |ofimpurity        |ofimpurity        |ofimpurity        |ofimpurity        |
|         |                                                                    |YA2304-12         |YA2304-12         |YA2304-12         |YA2304-12         |YA2304-12         |
|         |                                                                    |is                |is                |is                |is                |is                |
|         |                                                                    |0.0601μg/ml       |0.0601μg/ml       |0.0601μg/ml       |0.0601μg/ml       |0.0601μg/ml       |
|         |                                                                    |(relative         |(relative         |(relative         |(relative         |(relative         |
|         |                                                                    |to                |to                |to                |to                |to                |
|         |                                                                    |0.0150%           |0.0150%           |0.0150%           |0.0150%           |0.0150%           |
|         |                                                                    |of the            |of the            |of the            |of the            |of the            |
|         |                                                                    |test              |test              |test              |test              |test              |
|         |                                                                    |product           |product           |product           |product           |product           |
|         |                                                                    |concentration),   |concentration),   |concentration),   |concentration),   |concentration),   |
|         |                                                                    |and               |and               |and               |and               |and               |
|         |                                                                    |theS/Nof          |theS/Nof          |theS/Nof          |theS/Nof          |theS/Nof          |
|         |                                                                    |the               |the               |the               |the               |the               |
|         |                                                                    |3-needle          |3-needle          |3-needle          |3-needle          |3-needle          |
|         |                                                                    |detection         |detection         |detection         |detection         |detection         |
|         |                                                                    |limit             |limit             |limit             |limit             |limit             |
|         |                                                                    |solutionis        |solutionis        |solutionis        |solutionis        |solutionis        |
|         |                                                                    |between           |between           |between           |between           |between           |
|         |                                                                    |6.8 and           |6.8 and           |6.8 and           |6.8 and           |6.8 and           |
|         |                                                                    |7.3,              |7.3,              |7.3,              |7.3,              |7.3,              |
|         |                                                                    |all of            |all of            |all of            |all of            |all of            |
|         |                                                                    |whichare          |whichare          |whichare          |whichare          |whichare          |
|         |                                                                    |greater           |greater           |greater           |greater           |greater           |
|         |                                                                    |than 3.           |than 3.           |than 3.           |than 3.           |than 3.           |
|         |                                                                    |In line           |In line           |In line           |In line           |In line           |
|         |                                                                    |with              |with              |with              |with              |with              |
|         |                                                                    |the               |the               |the               |the               |the               |
|         |                                                                    |verification      |verification      |verification      |verification      |verification      |
|         |                                                                    |requirements.     |requirements.     |requirements.     |requirements.     |requirements.     |
|---------|--------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|
|YA2304-14|1                                                                   |0.0603            |0.0151            |8.175             |1000              |5.8               |
|---------|--------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|
|YA2304-14|2                                                                   |2                 |2                 |8.167             |936               |5.5               |
|---------|--------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|
|YA2304-14|3                                                                   |3                 |3                 |8.176             |964               |5.2               |
|---------|--------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|
|YA2304-14|Conclusion: The limit solution concentration ofimpurity YA2304-14 is|Conclusion: The   |Conclusion: The   |Conclusion: The   |Conclusion: The   |Conclusion: The   |
|         |0.0603μg/ml (relative to 0.0151% of the test product), and theS/Nof |limit solution    |limit solution    |limit solution    |limit solution    |limit solution    |
|         |the 3-needle limit solutionis between 5.2 and 5.8, all of whichare  |concentration     |concentration     |concentration     |concentration     |concentration     |
|         |greater than 3. In line with the verification requirements.         |ofimpurity        |ofimpurity        |ofimpurity        |ofimpurity        |ofimpurity        |
|         |                                                                    |YA2304-14 is      |YA2304-14 is      |YA2304-14 is      |YA2304-14 is      |YA2304-14 is      |
|         |                                                                    |0.0603μg/ml       |0.0603μg/ml       |0.0603μg/ml       |0.0603μg/ml       |0.0603μg/ml       |
|         |                                                                    |(relative to      |(relative to      |(relative to      |(relative to      |(relative to      |
|         |                                                                    |0.0151% of the    |0.0151% of the    |0.0151% of the    |0.0151% of the    |0.0151% of the    |
|         |                                                                    |test product),    |test product),    |test product),    |test product),    |test product),    |
|         |                                                                    |and theS/Nof      |and theS/Nof      |and theS/Nof      |and theS/Nof      |and theS/Nof      |
|         |                                                                    |the 3-needle      |the 3-needle      |the 3-needle      |the 3-needle      |the 3-needle      |
|         |                                                                    |limit             |limit             |limit             |limit             |limit             |
|         |                                                                    |solutionis        |solutionis        |solutionis        |solutionis        |solutionis        |
|         |                                                                    |between 5.2 and   |between 5.2 and   |between 5.2 and   |between 5.2 and   |between 5.2 and   |
|         |                                                                    |5.8, all of       |5.8, all of       |5.8, all of       |5.8, all of       |5.8, all of       |
|         |                                                                    |whichare          |whichare          |whichare          |whichare          |whichare          |
|         |                                                                    |greater than 3.   |greater than 3.   |greater than 3.   |greater than 3.   |greater than 3.   |
|         |                                                                    |In line with      |In line with      |In line with      |In line with      |In line with      |
|         |                                                                    |the               |the               |the               |the               |the               |
|         |                                                                    |verification      |verification      |verification      |verification      |verification      |
|         |                                                                    |requirements.     |requirements.     |requirements.     |requirements.     |requirements.     |
|---------|--------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|
|YA2304   |1                                                                   |0.0615            |0.0154            |9.322             |1234              |9.3               |
|---------|--------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|
|YA2304   |2                                                                   |2                 |2                 |9.321             |1138              |8.9               |
|---------|--------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|
|YA2304   |3                                                                   |3                 |3                 |9.327             |1166              |8.5               |
|---------|--------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|
|YA2304   |Conclusion: The limited solution concentration of principal         |Conclusion: The   |Conclusion: The   |Conclusion: The   |Conclusion: The   |Conclusion: The   |
|         |component YA2304 (in place ofunknownimpurity) was 0.0615μg/ml       |limited           |limited           |limited           |limited           |limited           |
|         |(relative to 0.0154% of the test substance), and theS/Nof the       |solution          |solution          |solution          |solution          |solution          |
|         |3-needle limited                                                    |concentration     |concentration     |concentration     |concentration     |concentration     |
|         |                                                                    |of principal      |of principal      |of principal      |of principal      |of principal      |
|         |                                                                    |component         |component         |component         |component         |component         |
|         |                                                                    |YA2304 (in        |YA2304 (in        |YA2304 (in        |YA2304 (in        |YA2304 (in        |
|         |                                                                    |place             |place             |place             |place             |place             |
|         |                                                                    |ofunknownimpurity)|ofunknownimpurity)|ofunknownimpurity)|ofunknownimpurity)|ofunknownimpurity)|
|         |                                                                    |was 0.0615μg/ml   |was 0.0615μg/ml   |was 0.0615μg/ml   |was 0.0615μg/ml   |was 0.0615μg/ml   |
|         |                                                                    |(relative to      |(relative to      |(relative to      |(relative to      |(relative to      |
|         |                                                                    |0.0154% of the    |0.0154% of the    |0.0154% of the    |0.0154% of the    |0.0154% of the    |
|         |                                                                    |test              |test              |test              |test              |test              |
|         |                                                                    |substance), and   |substance), and   |substance), and   |substance), and   |substance), and   |
|         |                                                                    |theS/Nof the      |theS/Nof the      |theS/Nof the      |theS/Nof the      |theS/Nof the      |
|         |                                                                    |3-needle          |3-needle          |3-needle          |3-needle          |3-needle          |
|         |                                                                    |limited           |limited           |limited           |limited           |limited           |
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 185 of 542 





Page 186
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 




















































------------------------------------------------------------------------------------------------------------------------------------------------------
|YA2304-15        |1                                                           |0.0605       |0.0151       |10.270       |909          |7.7          |
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|YA2304-15        |2                                                           |2            |2            |10.271       |911          |8.1          |
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|YA2304-15        |3                                                           |3            |3            |10.274       |851          |6.9          |
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|YA2304-15        |Conclusion: The limit solution concentration ofimpurity     |Conclusion:  |Conclusion:  |Conclusion:  |Conclusion:  |Conclusion:  |
|                 |YA2304-15 is 0.0605μg/ml (relative to 0.0151% of the test   |The          |The          |The          |The          |The          |
|                 |product), and theS/Nof the 3-needle limit solutionis between|limit        |limit        |limit        |limit        |limit        |
|                 |6.9 and 8.1, all of whichare greater than 3. In line with   |solution     |solution     |solution     |solution     |solution     |
|                 |the verification requirements.                              |concentration|concentration|concentration|concentration|concentration|
|                 |                                                            |ofimpurity   |ofimpurity   |ofimpurity   |ofimpurity   |ofimpurity   |
|                 |                                                            |YA2304-15    |YA2304-15    |YA2304-15    |YA2304-15    |YA2304-15    |
|                 |                                                            |is           |is           |is           |is           |is           |
|                 |                                                            |0.0605μg/ml  |0.0605μg/ml  |0.0605μg/ml  |0.0605μg/ml  |0.0605μg/ml  |
|                 |                                                            |(relative    |(relative    |(relative    |(relative    |(relative    |
|                 |                                                            |to           |to           |to           |to           |to           |
|                 |                                                            |0.0151%      |0.0151%      |0.0151%      |0.0151%      |0.0151%      |
|                 |                                                            |of the       |of the       |of the       |of the       |of the       |
|                 |                                                            |test         |test         |test         |test         |test         |
|                 |                                                            |product),    |product),    |product),    |product),    |product),    |
|                 |                                                            |and          |and          |and          |and          |and          |
|                 |                                                            |theS/Nof     |theS/Nof     |theS/Nof     |theS/Nof     |theS/Nof     |
|                 |                                                            |the          |the          |the          |the          |the          |
|                 |                                                            |3-needle     |3-needle     |3-needle     |3-needle     |3-needle     |
|                 |                                                            |limit        |limit        |limit        |limit        |limit        |
|                 |                                                            |solutionis   |solutionis   |solutionis   |solutionis   |solutionis   |
|                 |                                                            |between      |between      |between      |between      |between      |
|                 |                                                            |6.9 and      |6.9 and      |6.9 and      |6.9 and      |6.9 and      |
|                 |                                                            |8.1,         |8.1,         |8.1,         |8.1,         |8.1,         |
|                 |                                                            |all of       |all of       |all of       |all of       |all of       |
|                 |                                                            |whichare     |whichare     |whichare     |whichare     |whichare     |
|                 |                                                            |greater      |greater      |greater      |greater      |greater      |
|                 |                                                            |than 3.      |than 3.      |than 3.      |than 3.      |than 3.      |
|                 |                                                            |In line      |In line      |In line      |In line      |In line      |
|                 |                                                            |with         |with         |with         |with         |with         |
|                 |                                                            |the          |the          |the          |the          |the          |
|                 |                                                            |verification |verification |verification |verification |verification |
|                 |                                                            |requirements.|requirements.|requirements.|requirements.|requirements.|
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|YA2304-17 (230nm)|1                                                           |0.0604       |0.0151       |11.498       |1613         |7.6          |
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|YA2304-17 (230nm)|2                                                           |2            |2            |11.497       |1637         |8.0          |
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|YA2304-17 (230nm)|3                                                           |3            |3            |11.503       |1624         |7.8          |
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|YA2304-17 (230nm)|Conclusion: The limit solution concentration ofimpurity     |Conclusion:  |Conclusion:  |Conclusion:  |Conclusion:  |Conclusion:  |
|                 |YA2304-17 is 0.0604μg/ml (relative to 0.0151% of the test   |The limit    |The limit    |The limit    |The limit    |The limit    |
|                 |product), and theS/Nof the 3-needle limit solution ranges   |solution     |solution     |solution     |solution     |solution     |
|                 |from 7.6 to 8.0, all of whichare greater than 3. In line    |concentration|concentration|concentration|concentration|concentration|
|                 |with the verification requirements.                         |ofimpurity   |ofimpurity   |ofimpurity   |ofimpurity   |ofimpurity   |
|                 |                                                            |YA2304-17 is |YA2304-17 is |YA2304-17 is |YA2304-17 is |YA2304-17 is |
|                 |                                                            |0.0604μg/ml  |0.0604μg/ml  |0.0604μg/ml  |0.0604μg/ml  |0.0604μg/ml  |
|                 |                                                            |(relative to |(relative to |(relative to |(relative to |(relative to |
|                 |                                                            |0.0151% of   |0.0151% of   |0.0151% of   |0.0151% of   |0.0151% of   |
|                 |                                                            |the test     |the test     |the test     |the test     |the test     |
|                 |                                                            |product), and|product), and|product), and|product), and|product), and|
|                 |                                                            |theS/Nof the |theS/Nof the |theS/Nof the |theS/Nof the |theS/Nof the |
|                 |                                                            |3-needle     |3-needle     |3-needle     |3-needle     |3-needle     |
|                 |                                                            |limit        |limit        |limit        |limit        |limit        |
|                 |                                                            |solution     |solution     |solution     |solution     |solution     |
|                 |                                                            |ranges from  |ranges from  |ranges from  |ranges from  |ranges from  |
|                 |                                                            |7.6 to 8.0,  |7.6 to 8.0,  |7.6 to 8.0,  |7.6 to 8.0,  |7.6 to 8.0,  |
|                 |                                                            |all of       |all of       |all of       |all of       |all of       |
|                 |                                                            |whichare     |whichare     |whichare     |whichare     |whichare     |
|                 |                                                            |greater than |greater than |greater than |greater than |greater than |
|                 |                                                            |3. In line   |3. In line   |3. In line   |3. In line   |3. In line   |
|                 |                                                            |with the     |with the     |with the     |with the     |with the     |
|                 |                                                            |verification |verification |verification |verification |verification |
|                 |                                                            |requirements.|requirements.|requirements.|requirements.|requirements.|
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|YA2304-16        |1                                                           |0.0580       |0.0145       |11.926       |961          |7.6          |
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|YA2304-16        |2                                                           |2            |2            |11.921       |984          |7.6          |
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|YA2304-16        |3                                                           |3            |3            |11.930       |1006         |7.3          |
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|YA2304-16        |Conclusion: The limit solution concentration ofimpurity     |Conclusion:  |Conclusion:  |Conclusion:  |Conclusion:  |Conclusion:  |
|                 |YA2304-16 is 0.0580μg/ml (relative to 0.0145% of the test   |The limit    |The limit    |The limit    |The limit    |The limit    |
|                 |product), and theS/Nof the 3-needle limit solution ranges   |solution     |solution     |solution     |solution     |solution     |
|                 |from 7.3 to 7.6, all of whichare greater than 3. In line    |concentration|concentration|concentration|concentration|concentration|
|                 |with the verification requirements.                         |ofimpurity   |ofimpurity   |ofimpurity   |ofimpurity   |ofimpurity   |
|                 |                                                            |YA2304-16 is |YA2304-16 is |YA2304-16 is |YA2304-16 is |YA2304-16 is |
|                 |                                                            |0.0580μg/ml  |0.0580μg/ml  |0.0580μg/ml  |0.0580μg/ml  |0.0580μg/ml  |
|                 |                                                            |(relative to |(relative to |(relative to |(relative to |(relative to |
|                 |                                                            |0.0145% of   |0.0145% of   |0.0145% of   |0.0145% of   |0.0145% of   |
|                 |                                                            |the test     |the test     |the test     |the test     |the test     |
|                 |                                                            |product), and|product), and|product), and|product), and|product), and|
|                 |                                                            |theS/Nof the |theS/Nof the |theS/Nof the |theS/Nof the |theS/Nof the |
|                 |                                                            |3-needle     |3-needle     |3-needle     |3-needle     |3-needle     |
|                 |                                                            |limit        |limit        |limit        |limit        |limit        |
|                 |                                                            |solution     |solution     |solution     |solution     |solution     |
|                 |                                                            |ranges from  |ranges from  |ranges from  |ranges from  |ranges from  |
|                 |                                                            |7.3 to 7.6,  |7.3 to 7.6,  |7.3 to 7.6,  |7.3 to 7.6,  |7.3 to 7.6,  |
|                 |                                                            |all of       |all of       |all of       |all of       |all of       |
|                 |                                                            |whichare     |whichare     |whichare     |whichare     |whichare     |
|                 |                                                            |greater than |greater than |greater than |greater than |greater than |
|                 |                                                            |3. In line   |3. In line   |3. In line   |3. In line   |3. In line   |
|                 |                                                            |with the     |with the     |with the     |with the     |with the     |
|                 |                                                            |verification |verification |verification |verification |verification |
|                 |                                                            |requirements.|requirements.|requirements.|requirements.|requirements.|
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|YA2304-18        |1                                                           |0.0601       |0.0150       |13.174       |976          |7.5          |
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|YA2304-18        |2                                                           |2            |2            |13.171       |965          |7.3          |
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|YA2304-18        |3                                                           |3            |3            |13.176       |913          |6.6          |
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|YA2304-18        |Conclusion: The limit solution concentration ofimpurity     |Conclusion:  |Conclusion:  |Conclusion:  |Conclusion:  |Conclusion:  |
|                 |YA2304-18 is 0.0601μg/ml (relative to 0.0150% of the test   |The limit    |The limit    |The limit    |The limit    |The limit    |
|                 |product), and theS/Nof the 3-needle limit solutionis between|solution     |solution     |solution     |solution     |solution     |
|                 |6.6 and 7.5, all of whichare greater than 3. In line with   |concentration|concentration|concentration|concentration|concentration|
|                 |the verification requirements.                              |ofimpurity   |ofimpurity   |ofimpurity   |ofimpurity   |ofimpurity   |
|                 |                                                            |YA2304-18 is |YA2304-18 is |YA2304-18 is |YA2304-18 is |YA2304-18 is |
|                 |                                                            |0.0601μg/ml  |0.0601μg/ml  |0.0601μg/ml  |0.0601μg/ml  |0.0601μg/ml  |
|                 |                                                            |(relative to |(relative to |(relative to |(relative to |(relative to |
|                 |                                                            |0.0150% of   |0.0150% of   |0.0150% of   |0.0150% of   |0.0150% of   |
|                 |                                                            |the test     |the test     |the test     |the test     |the test     |
|                 |                                                            |product), and|product), and|product), and|product), and|product), and|
|                 |                                                            |theS/Nof the |theS/Nof the |theS/Nof the |theS/Nof the |theS/Nof the |
|                 |                                                            |3-needle     |3-needle     |3-needle     |3-needle     |3-needle     |
|                 |                                                            |limit        |limit        |limit        |limit        |limit        |
|                 |                                                            |solutionis   |solutionis   |solutionis   |solutionis   |solutionis   |
|                 |                                                            |between 6.6  |between 6.6  |between 6.6  |between 6.6  |between 6.6  |
|                 |                                                            |and 7.5, all |and 7.5, all |and 7.5, all |and 7.5, all |and 7.5, all |
|                 |                                                            |of whichare  |of whichare  |of whichare  |of whichare  |of whichare  |
|                 |                                                            |greater than |greater than |greater than |greater than |greater than |
|                 |                                                            |3. In line   |3. In line   |3. In line   |3. In line   |3. In line   |
|                 |                                                            |with the     |with the     |with the     |with the     |with the     |
|                 |                                                            |verification |verification |verification |verification |verification |
|                 |                                                            |requirements.|requirements.|requirements.|requirements.|requirements.|
------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 186 of 542 





Page 187
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 




























------------------------------------------------------------------------------------------------------------------------------------------------------
|YA2304-10 (230nm)|2                                                           |2            |2            |15.274       |1443         |5.9          |
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|YA2304-10 (230nm)|3                                                           |3            |3            |15.278       |1364         |5.9          |
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|YA2304-10 (230nm)|Conclusion: The limit solution concentration ofimpurity     |Conclusion:  |Conclusion:  |Conclusion:  |Conclusion:  |Conclusion:  |
|                 |YA2304-10 is 0.0609μg/ml (relative to 0.0152% of the test   |The          |The          |The          |The          |The          |
|                 |product), and theS/Nof the 3-needle limit solutionis between|limit        |limit        |limit        |limit        |limit        |
|                 |5.8 and 5.9, all of whichare greater than 3. In line with   |solution     |solution     |solution     |solution     |solution     |
|                 |the verification requirements.                              |concentration|concentration|concentration|concentration|concentration|
|                 |                                                            |ofimpurity   |ofimpurity   |ofimpurity   |ofimpurity   |ofimpurity   |
|                 |                                                            |YA2304-10    |YA2304-10    |YA2304-10    |YA2304-10    |YA2304-10    |
|                 |                                                            |is           |is           |is           |is           |is           |
|                 |                                                            |0.0609μg/ml  |0.0609μg/ml  |0.0609μg/ml  |0.0609μg/ml  |0.0609μg/ml  |
|                 |                                                            |(relative    |(relative    |(relative    |(relative    |(relative    |
|                 |                                                            |to           |to           |to           |to           |to           |
|                 |                                                            |0.0152%      |0.0152%      |0.0152%      |0.0152%      |0.0152%      |
|                 |                                                            |of the       |of the       |of the       |of the       |of the       |
|                 |                                                            |test         |test         |test         |test         |test         |
|                 |                                                            |product),    |product),    |product),    |product),    |product),    |
|                 |                                                            |and          |and          |and          |and          |and          |
|                 |                                                            |theS/Nof     |theS/Nof     |theS/Nof     |theS/Nof     |theS/Nof     |
|                 |                                                            |the          |the          |the          |the          |the          |
|                 |                                                            |3-needle     |3-needle     |3-needle     |3-needle     |3-needle     |
|                 |                                                            |limit        |limit        |limit        |limit        |limit        |
|                 |                                                            |solutionis   |solutionis   |solutionis   |solutionis   |solutionis   |
|                 |                                                            |between      |between      |between      |between      |between      |
|                 |                                                            |5.8 and      |5.8 and      |5.8 and      |5.8 and      |5.8 and      |
|                 |                                                            |5.9,         |5.9,         |5.9,         |5.9,         |5.9,         |
|                 |                                                            |all of       |all of       |all of       |all of       |all of       |
|                 |                                                            |whichare     |whichare     |whichare     |whichare     |whichare     |
|                 |                                                            |greater      |greater      |greater      |greater      |greater      |
|                 |                                                            |than 3.      |than 3.      |than 3.      |than 3.      |than 3.      |
|                 |                                                            |In line      |In line      |In line      |In line      |In line      |
|                 |                                                            |with         |with         |with         |with         |with         |
|                 |                                                            |the          |the          |the          |the          |the          |
|                 |                                                            |verification |verification |verification |verification |verification |
|                 |                                                            |requirements.|requirements.|requirements.|requirements.|requirements.|
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|YA2304-19        |1                                                           |0.0601       |0.0150       |16.435       |1486         |9.1          |
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|YA2304-19        |2                                                           |2            |2            |16.437       |1557         |9.6          |
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|YA2304-19        |3                                                           |3            |3            |16.440       |1557         |8.6          |
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|YA2304-19        |Conclusion: The detection limit solution concentration      |Conclusion:  |Conclusion:  |Conclusion:  |Conclusion:  |Conclusion:  |
|                 |ofimpurity YA2304-19 is 0.0601μg/ml (relative to 0.0150% of |The detection|The detection|The detection|The detection|The detection|
|                 |the test product), and theS/Nof the 3-needle detection limit|limit        |limit        |limit        |limit        |limit        |
|                 |solutionis between 8.6 and 9.6, all of whichare greater than|solution     |solution     |solution     |solution     |solution     |
|                 |3. In line with the verification requirements.              |concentration|concentration|concentration|concentration|concentration|
|                 |                                                            |ofimpurity   |ofimpurity   |ofimpurity   |ofimpurity   |ofimpurity   |
|                 |                                                            |YA2304-19 is |YA2304-19 is |YA2304-19 is |YA2304-19 is |YA2304-19 is |
|                 |                                                            |0.0601μg/ml  |0.0601μg/ml  |0.0601μg/ml  |0.0601μg/ml  |0.0601μg/ml  |
|                 |                                                            |(relative to |(relative to |(relative to |(relative to |(relative to |
|                 |                                                            |0.0150% of   |0.0150% of   |0.0150% of   |0.0150% of   |0.0150% of   |
|                 |                                                            |the test     |the test     |the test     |the test     |the test     |
|                 |                                                            |product), and|product), and|product), and|product), and|product), and|
|                 |                                                            |theS/Nof the |theS/Nof the |theS/Nof the |theS/Nof the |theS/Nof the |
|                 |                                                            |3-needle     |3-needle     |3-needle     |3-needle     |3-needle     |
|                 |                                                            |detection    |detection    |detection    |detection    |detection    |
|                 |                                                            |limit        |limit        |limit        |limit        |limit        |
|                 |                                                            |solutionis   |solutionis   |solutionis   |solutionis   |solutionis   |
|                 |                                                            |between 8.6  |between 8.6  |between 8.6  |between 8.6  |between 8.6  |
|                 |                                                            |and 9.6, all |and 9.6, all |and 9.6, all |and 9.6, all |and 9.6, all |
|                 |                                                            |of whichare  |of whichare  |of whichare  |of whichare  |of whichare  |
|                 |                                                            |greater than |greater than |greater than |greater than |greater than |
|                 |                                                            |3. In line   |3. In line   |3. In line   |3. In line   |3. In line   |
|                 |                                                            |with the     |with the     |with the     |with the     |with the     |
|                 |                                                            |verification |verification |verification |verification |verification |
|                 |                                                            |requirements.|requirements.|requirements.|requirements.|requirements.|
------------------------------------------------------------------------------------------------------------------------------------------------------

**e. Linearity and Range** 



 **Acceptance Criteria** 



Known impurities at 251nm wavelength (YA2304-12, YA2304-14, 



YA2304-15, YA2304-16, YA2304-18 and YA2304-19) and 230nm wavelength 



(YA2304-10, YA2304-17) : Within the range of limited quantitation 



concentration ~ equivalent to 0.3% of the test product solution concentration, 



6 concentration points were selected fairly evenly, and the concentration of 



each impurity was taken as the horizontal coordinate and the peak area was 



taken as the vertical coordinate as the linear regression curve. The regression 



coefficient R of the obtained linear graph should NLT 0.990, and the RSD of 



the response factor should NMT 10%. Y-axis intercepts are within 25% of 



100% response value. 



Unknown impurities at 251nm wavelength (substituted by YA2304) : Within 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 187 of 542 





Page 188
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



the range of limited quantitation concentration ~ equivalent to 0.3% of the 



test product solution concentration, 6 concentration points were selected 



fairly uniformly, and the concentration of each impurity was taken as the 



horizontal coordinate and the peak area was taken as the vertical coordinate 



as the linear regression curve. The regression coefficient (R) of the regression 



curve was NLT 0.990, and the RSD of the response factor was not more than 



10%. Y-axis intercept accounted for 100% of the response value of the 



percentage within 25%. 



 **Solution Preparation** 



Blank solution: solvent 



YA2304-12 Reference storage solution: Share "YA2304-12 Reference Storage 



solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-14 Reference storage solution: Share "YA2304-14 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304 Reference stock: Share "YA2304 Reference Stock" under "4.1 



Wavelength Selection". (Approx. 200μg/ml) 



YA2304-15 Reference storage solution: Share "YA2304-15 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-16 Reference storage solution: Share "YA2304-16 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-18 Reference storage solution: Share "YA2304-18 Reference storage 



solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-19 Reference storage solution: Share "YA2304-19 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 188 of 542 





Page 189
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



YA2304-10 Reference storage Solution: Share "YA2304-10 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-17 Reference storage solution: Share "YA2304-17 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



Linear reserve solution: Take 1.0ml of each control product reserve liquid of 



YA2304-12, YA2304-14, YA2304, YA2304-15, YA2304-16, YA2304-18, 



YA2304-19, YA2304-10 and YA2304-17 and place them in a 20ml measuring 



bottle. Dilute to the scale with solvent, shake well, and then get. (Both about 



10μg/ml) 



Linear solution ① (LOQ solution) : prepared by the same method as "Limit of 



quantification solution" under "Limits of quantification and Detection Limits 



4.4". 



Linear solution ② (equivalent to 0.05% of the test product solution) : 



accurately measure 0.5ml of linear reserve solution, place it in a 25ml 



measuring bottle, dilute it with solvent to the scale, shake well, and obtain. 



(About 0.2μg/ml) 



Linear solution ③ (equivalent to 0.10% of the test product solution) : 



accurately measure 1.0ml of linear reserve solution, place it in a 25ml 



measuring bottle, dilute it with solvent to the scale, shake well, and obtain. 



(About 0.4μg/ml) 



Linear solution ④ (equivalent to 0.15% of the test solution) : accurately 



measure 1.5ml of linear reserve liquid, place it in 25ml measuring bottle, 



dilute it with solvent to the scale, shake well, and get. (About 0.6μg/ml) 



Linear solution ⑤ (equivalent to 0.20% of the test product solution) : 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 189 of 542 





Page 190
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



accurately measure 2.0ml of linear reserve liquid, place it in a 25ml 



measuring bottle, dilute it with solvent to the scale, shake well, and get. 



(About 0.8μg/ml) 



Linear solution ⑥ (equivalent to 0.30% of the test product solution) : 



accurately measure 3.0ml of linear reserve liquid, place it in a 25ml 



measuring bottle, dilute it with solvent to the scale, shake well, and get. 



(About 1.2μg/ml) 



 **Injection Sequence** 



~ 
After the blank solution, the linear solution ① ⑥ was injected with 1 needle 



each from low concentration to high concentration, and the chromatogram 



was recorded. 



 **Results and Discussion** 
























--------------------------------------------------------------------------------------------------------------------------------
|Names ofimpurities|Solution name   |Equivalent to test product solution concentration         |Concentration|Peakarea|Response|
|                  |                |percentage /%                                             |/(μg/ml)     |        |factor  |
|------------------|----------------|----------------------------------------------------------|-------------|--------|--------|
|YA2304- 12        |Linear solution①|0.0300                                                    |0.1201       |1669    |13896   |
|------------------|----------------|----------------------------------------------------------|-------------|--------|--------|
|YA2304- 12        |Linear solution②|0.0500                                                    |0.2002       |2892    |14447   |
|------------------|----------------|----------------------------------------------------------|-------------|--------|--------|
|YA2304- 12        |Linear solution③|0.1001                                                    |0.4004       |5582    |13943   |
|------------------|----------------|----------------------------------------------------------|-------------|--------|--------|
|YA2304- 12        |Linear solution④|0.1501                                                    |0.6005       |8337    |13883   |
|------------------|----------------|----------------------------------------------------------|-------------|--------|--------|
|YA2304- 12        |Linear solution⑤|0.2002                                                    |0.8007       |11146   |13920   |
|------------------|----------------|----------------------------------------------------------|-------------|--------|--------|
|YA2304- 12        |Linear solution⑥|0.3003                                                    |1.2011       |16748   |13944   |
--------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 190 of 542 





Page 191
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 















------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Linear graph                                                                  |Linear                   |                         |                         |                         |       |
|                                                                              |graph                    |                         |                         |                         |       |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|Linearequations                                                               |Linearequations          |y =                      |y =                      |y =                      |       |
|                                                                              |                         |13896x                   |13896x                   |13896x                   |       |
|                                                                              |                         |+                        |+                        |+                        |       |
|                                                                              |                         |33.018                   |33.018                   |33.018                   |       |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|Correlation coefficientR                                                      |Correlation              |0.99997                  |0.99997                  |0.99997                  |       |
|                                                                              |coefficientR             |                         |                         |                         |       |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|Absolute value ofY-axisinterceptas % /% of 100% response value                |Absolute value           |0.39                     |0.39                     |0.39                     |       |
|                                                                              |ofY-axisinterceptas      |                         |                         |                         |       |
|                                                                              |% /% of 100%             |                         |                         |                         |       |
|                                                                              |response value           |                         |                         |                         |       |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|Conclusion: At 251nm wavelength, the RSD of YA2304-12 in the concentration    |Conclusion: At           |Conclusion:              |Conclusion:              |Conclusion:              |       |
|range of 0.1201μg/ml~1.2011μg/mlis 1.6%, less than 10%. The linearequationisy |251nm wavelength,        |At                       |At                       |At                       |       |
|= 13896x + 33.018, and the correlation coefficientRis 0.99997, greater than   |the RSD of               |251nm                    |251nm                    |251nm                    |       |
|0.990. The absolute value ofY-axisinterceptaccounts for 0.39% of 100% response|YA2304-12 in the         |wavelength,              |wavelength,              |wavelength,              |       |
|value, whichis less than 25%; Itindicates thatimpurity YA2304-12 hasa good    |concentration range      |the RSD                  |the RSD                  |the RSD                  |       |
|linear relationship in the concentration range of 0.1201μg/ml~1.2011μg/ml.    |of                       |of                       |of                       |of                       |       |
|                                                                              |0.1201μg/ml~1.2011μg/mlis|YA2304-12                |YA2304-12                |YA2304-12                |       |
|                                                                              |1.6%, less than          |in the                   |in the                   |in the                   |       |
|                                                                              |10%. The                 |concentration            |concentration            |concentration            |       |
|                                                                              |linearequationisy =      |range                    |range                    |range                    |       |
|                                                                              |13896x + 33.018,         |of                       |of                       |of                       |       |
|                                                                              |and the correlation      |0.1201μg/ml~1.2011μg/mlis|0.1201μg/ml~1.2011μg/mlis|0.1201μg/ml~1.2011μg/mlis|       |
|                                                                              |coefficientRis           |1.6%,                    |1.6%,                    |1.6%,                    |       |
|                                                                              |0.99997, greater         |less                     |less                     |less                     |       |
|                                                                              |than 0.990. The          |than                     |than                     |than                     |       |
|                                                                              |absolute value           |10%.                     |10%.                     |10%.                     |       |
|                                                                              |ofY-axisinterceptaccounts|The                      |The                      |The                      |       |
|                                                                              |for 0.39% of 100%        |linearequationisy        |linearequationisy        |linearequationisy        |       |
|                                                                              |response value,          |=                        |=                        |=                        |       |
|                                                                              |whichis less than        |13896x                   |13896x                   |13896x                   |       |
|                                                                              |25%; Itindicates         |+                        |+                        |+                        |       |
|                                                                              |thatimpurity             |33.018,                  |33.018,                  |33.018,                  |       |
|                                                                              |YA2304-12 hasa good      |and the                  |and the                  |and the                  |       |
|                                                                              |linear relationship      |correlation              |correlation              |correlation              |       |
|                                                                              |in the                   |coefficientRis           |coefficientRis           |coefficientRis           |       |
|                                                                              |concentration range      |0.99997,                 |0.99997,                 |0.99997,                 |       |
|                                                                              |of                       |greater                  |greater                  |greater                  |       |
|                                                                              |0.1201μg/ml~1.2011μg/ml. |than                     |than                     |than                     |       |
|                                                                              |                         |0.990.                   |0.990.                   |0.990.                   |       |
|                                                                              |                         |The                      |The                      |The                      |       |
|                                                                              |                         |absolute                 |absolute                 |absolute                 |       |
|                                                                              |                         |value                    |value                    |value                    |       |
|                                                                              |                         |ofY-axisinterceptaccounts|ofY-axisinterceptaccounts|ofY-axisinterceptaccounts|       |
|                                                                              |                         |for                      |for                      |for                      |       |
|                                                                              |                         |0.39%                    |0.39%                    |0.39%                    |       |
|                                                                              |                         |of 100%                  |of 100%                  |of 100%                  |       |
|                                                                              |                         |response                 |response                 |response                 |       |
|                                                                              |                         |value,                   |value,                   |value,                   |       |
|                                                                              |                         |whichis                  |whichis                  |whichis                  |       |
|                                                                              |                         |less                     |less                     |less                     |       |
|                                                                              |                         |than                     |than                     |than                     |       |
|                                                                              |                         |25%;                     |25%;                     |25%;                     |       |
|                                                                              |                         |Itindicates              |Itindicates              |Itindicates              |       |
|                                                                              |                         |thatimpurity             |thatimpurity             |thatimpurity             |       |
|                                                                              |                         |YA2304-12                |YA2304-12                |YA2304-12                |       |
|                                                                              |                         |hasa                     |hasa                     |hasa                     |       |
|                                                                              |                         |good                     |good                     |good                     |       |
|                                                                              |                         |linear                   |linear                   |linear                   |       |
|                                                                              |                         |relationship             |relationship             |relationship             |       |
|                                                                              |                         |in the                   |in the                   |in the                   |       |
|                                                                              |                         |concentration            |concentration            |concentration            |       |
|                                                                              |                         |range                    |range                    |range                    |       |
|                                                                              |                         |of                       |of                       |of                       |       |
|                                                                              |                         |0.1201μg/ml~1.2011μg/ml. |0.1201μg/ml~1.2011μg/ml. |0.1201μg/ml~1.2011μg/ml. |       |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 14                                                                    |Linear solution①         |0.0302                   |0.1206                   |1957                     |16221  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 14                                                                    |Linear solution②         |0.0503                   |0.2011                   |3275                     |16288  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 14                                                                    |Linear solution③         |0.1005                   |0.4021                   |6460                     |16064  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 14                                                                    |Linear solution④         |0.1508                   |0.6032                   |9837                     |16308  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 14                                                                    |Linear solution⑤         |0.2011                   |0.8043                   |13285                    |16518  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 14                                                                    |Linear solution⑥         |0.3016                   |1.2064                   |19868                    |16468  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 14                                                                    |Response factor RSD/%    |Response factor RSD/%    |1.1                      |1.1                      |1.1    |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 191 of 542 





Page 192
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 















------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Linearequations                                                               |Linearequations          |y =                      |y =                      |y =                      |       |
|                                                                              |                         |16536x                   |16536x                   |16536x                   |       |
|                                                                              |                         |-                        |-                        |-                        |       |
|                                                                              |                         |85.568                   |85.568                   |85.568                   |       |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|Correlation coefficientR                                                      |Correlation              |0.99995                  |0.99995                  |0.99995                  |       |
|                                                                              |coefficientR             |                         |                         |                         |       |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|Absolute value ofY-axisinterceptas % /% of 100% response value                |Absolute value           |0.87                     |0.87                     |0.87                     |       |
|                                                                              |ofY-axisinterceptas      |                         |                         |                         |       |
|                                                                              |% /% of 100%             |                         |                         |                         |       |
|                                                                              |response value           |                         |                         |                         |       |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|Conclusion: At 251nm wavelength, the RSD of YA2304-14 in the concentration    |Conclusion: At           |Conclusion:              |Conclusion:              |Conclusion:              |       |
|range of 0.1206μg/ml~1.2064μg/mlis 1.1%, less than 10%. The linearequationisy |251nm wavelength,        |At                       |At                       |At                       |       |
|= 16536x-85.568, and the correlation coefficientRis 0.99995, greater than     |the RSD of               |251nm                    |251nm                    |251nm                    |       |
|0.990. The absolute value ofY-axisinterceptaccounts for 0.87% of 100% response|YA2304-14 in the         |wavelength,              |wavelength,              |wavelength,              |       |
|value, whichis less than 25%; Itindicates thatimpurity YA2304-14 hasa good    |concentration range      |the RSD                  |the RSD                  |the RSD                  |       |
|linear relationship in the concentration range of 0.1206μg/ml~1.2064μg/ml.    |of                       |of                       |of                       |of                       |       |
|                                                                              |0.1206μg/ml~1.2064μg/mlis|YA2304-14                |YA2304-14                |YA2304-14                |       |
|                                                                              |1.1%, less than          |in the                   |in the                   |in the                   |       |
|                                                                              |10%. The                 |concentration            |concentration            |concentration            |       |
|                                                                              |linearequationisy =      |range                    |range                    |range                    |       |
|                                                                              |16536x-85.568, and       |of                       |of                       |of                       |       |
|                                                                              |the correlation          |0.1206μg/ml~1.2064μg/mlis|0.1206μg/ml~1.2064μg/mlis|0.1206μg/ml~1.2064μg/mlis|       |
|                                                                              |coefficientRis           |1.1%,                    |1.1%,                    |1.1%,                    |       |
|                                                                              |0.99995, greater         |less                     |less                     |less                     |       |
|                                                                              |than 0.990. The          |than                     |than                     |than                     |       |
|                                                                              |absolute value           |10%.                     |10%.                     |10%.                     |       |
|                                                                              |ofY-axisinterceptaccounts|The                      |The                      |The                      |       |
|                                                                              |for 0.87% of 100%        |linearequationisy        |linearequationisy        |linearequationisy        |       |
|                                                                              |response value,          |=                        |=                        |=                        |       |
|                                                                              |whichis less than        |16536x-85.568,           |16536x-85.568,           |16536x-85.568,           |       |
|                                                                              |25%; Itindicates         |and the                  |and the                  |and the                  |       |
|                                                                              |thatimpurity             |correlation              |correlation              |correlation              |       |
|                                                                              |YA2304-14 hasa good      |coefficientRis           |coefficientRis           |coefficientRis           |       |
|                                                                              |linear relationship      |0.99995,                 |0.99995,                 |0.99995,                 |       |
|                                                                              |in the                   |greater                  |greater                  |greater                  |       |
|                                                                              |concentration range      |than                     |than                     |than                     |       |
|                                                                              |of                       |0.990.                   |0.990.                   |0.990.                   |       |
|                                                                              |0.1206μg/ml~1.2064μg/ml. |The                      |The                      |The                      |       |
|                                                                              |                         |absolute                 |absolute                 |absolute                 |       |
|                                                                              |                         |value                    |value                    |value                    |       |
|                                                                              |                         |ofY-axisinterceptaccounts|ofY-axisinterceptaccounts|ofY-axisinterceptaccounts|       |
|                                                                              |                         |for                      |for                      |for                      |       |
|                                                                              |                         |0.87%                    |0.87%                    |0.87%                    |       |
|                                                                              |                         |of 100%                  |of 100%                  |of 100%                  |       |
|                                                                              |                         |response                 |response                 |response                 |       |
|                                                                              |                         |value,                   |value,                   |value,                   |       |
|                                                                              |                         |whichis                  |whichis                  |whichis                  |       |
|                                                                              |                         |less                     |less                     |less                     |       |
|                                                                              |                         |than                     |than                     |than                     |       |
|                                                                              |                         |25%;                     |25%;                     |25%;                     |       |
|                                                                              |                         |Itindicates              |Itindicates              |Itindicates              |       |
|                                                                              |                         |thatimpurity             |thatimpurity             |thatimpurity             |       |
|                                                                              |                         |YA2304-14                |YA2304-14                |YA2304-14                |       |
|                                                                              |                         |hasa                     |hasa                     |hasa                     |       |
|                                                                              |                         |good                     |good                     |good                     |       |
|                                                                              |                         |linear                   |linear                   |linear                   |       |
|                                                                              |                         |relationship             |relationship             |relationship             |       |
|                                                                              |                         |in the                   |in the                   |in the                   |       |
|                                                                              |                         |concentration            |concentration            |concentration            |       |
|                                                                              |                         |range                    |range                    |range                    |       |
|                                                                              |                         |of                       |of                       |of                       |       |
|                                                                              |                         |0.1206μg/ml~1.2064μg/ml. |0.1206μg/ml~1.2064μg/ml. |0.1206μg/ml~1.2064μg/ml. |       |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304 (principa lcompone ntinstead ofunknow nimpurity)                       |Linear solution①         |0.0307                   |0.1229                   |2058                     |16740  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304 (principa lcompone ntinstead ofunknow nimpurity)                       |Linear solution②         |0.0512                   |0.2049                   |3438                     |16779  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304 (principa lcompone ntinstead ofunknow nimpurity)                       |Linear solution③         |0.1025                   |0.4098                   |6805                     |16605  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304 (principa lcompone ntinstead ofunknow nimpurity)                       |Linear solution④         |0.1537                   |0.6147                   |10130                    |16479  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304 (principa lcompone ntinstead ofunknow nimpurity)                       |Linear solution⑤         |0.2049                   |0.8196                   |13463                    |16426  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304 (principa lcompone ntinstead ofunknow nimpurity)                       |Linear solution⑥         |0.3074                   |1.2294                   |20246                    |16468  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304 (principa lcompone ntinstead ofunknow nimpurity)                       |Response factor RSD/%    |Response factor RSD/%    |1.0                      |1.0                      |1.0    |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 192 of 542 





Page 193
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 















--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Linearequations                                                               |Linearequations         |y =                     |y =                     |y =                     |       |
|                                                                              |                        |16404x                  |16404x                  |16404x                  |       |
|                                                                              |                        |+                       |+                       |+                       |       |
|                                                                              |                        |57.399                  |57.399                  |57.399                  |       |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|-------|
|Correlation coefficientR                                                      |Correlation             |1.000                   |1.000                   |1.000                   |       |
|                                                                              |coefficientR            |                        |                        |                        |       |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|-------|
|Absolute value ofY-axisinterceptas % /% of 100% response value                |Absolute value          |0.87                    |0.87                    |0.87                    |       |
|                                                                              |ofY-axisinterceptas     |                        |                        |                        |       |
|                                                                              |% /% of 100%            |                        |                        |                        |       |
|                                                                              |response value          |                        |                        |                        |       |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|-------|
|Conclusion: At 251nm wavelength, the RSD of YA2304 (principal componentinstead|Conclusion: At          |Conclusion:             |Conclusion:             |Conclusion:             |       |
|ofunknownimpurity) is 1.0%, less than 10%, in the concentration range of      |251nm wavelength,       |At                      |At                      |At                      |       |
|0.1229μg/ml~1.2294μg/ml. The linearequationisy = 16404x + 57.399, and the     |the RSD of YA2304       |251nm                   |251nm                   |251nm                   |       |
|correlation coefficientRis 1.000, greater than 0.990. The percentage          |(principal              |wavelength,             |wavelength,             |wavelength,             |       |
|ofY-axisintercept in 100% response value is 0.87%, whichis within 25%;        |componentinstead        |the RSD                 |the RSD                 |the RSD                 |       |
|Thisindicates that YA2304 (principal componentinstead ofunknownimpurity) hasa |ofunknownimpurity)      |of                      |of                      |of                      |       |
|good linear relationship in the concentration range of                        |is 1.0%, less than      |YA2304                  |YA2304                  |YA2304                  |       |
|0.1229μg/ml~1.2294μg/ml.                                                      |10%, in the             |(principal              |(principal              |(principal              |       |
|                                                                              |concentration range     |componentinstead        |componentinstead        |componentinstead        |       |
|                                                                              |of                      |ofunknownimpurity)      |ofunknownimpurity)      |ofunknownimpurity)      |       |
|                                                                              |0.1229μg/ml~1.2294μg/ml.|is                      |is                      |is                      |       |
|                                                                              |The                     |1.0%,                   |1.0%,                   |1.0%,                   |       |
|                                                                              |linearequationisy =     |less                    |less                    |less                    |       |
|                                                                              |16404x + 57.399,        |than                    |than                    |than                    |       |
|                                                                              |and the correlation     |10%, in                 |10%, in                 |10%, in                 |       |
|                                                                              |coefficientRis          |the                     |the                     |the                     |       |
|                                                                              |1.000, greater than     |concentration           |concentration           |concentration           |       |
|                                                                              |0.990. The              |range                   |range                   |range                   |       |
|                                                                              |percentage              |of                      |of                      |of                      |       |
|                                                                              |ofY-axisintercept       |0.1229μg/ml~1.2294μg/ml.|0.1229μg/ml~1.2294μg/ml.|0.1229μg/ml~1.2294μg/ml.|       |
|                                                                              |in 100% response        |The                     |The                     |The                     |       |
|                                                                              |value is 0.87%,         |linearequationisy       |linearequationisy       |linearequationisy       |       |
|                                                                              |whichis within 25%;     |=                       |=                       |=                       |       |
|                                                                              |Thisindicates that      |16404x                  |16404x                  |16404x                  |       |
|                                                                              |YA2304 (principal       |+                       |+                       |+                       |       |
|                                                                              |componentinstead        |57.399,                 |57.399,                 |57.399,                 |       |
|                                                                              |ofunknownimpurity)      |and the                 |and the                 |and the                 |       |
|                                                                              |hasa good linear        |correlation             |correlation             |correlation             |       |
|                                                                              |relationship in the     |coefficientRis          |coefficientRis          |coefficientRis          |       |
|                                                                              |concentration range     |1.000,                  |1.000,                  |1.000,                  |       |
|                                                                              |of                      |greater                 |greater                 |greater                 |       |
|                                                                              |0.1229μg/ml~1.2294μg/ml.|than                    |than                    |than                    |       |
|                                                                              |                        |0.990.                  |0.990.                  |0.990.                  |       |
|                                                                              |                        |The                     |The                     |The                     |       |
|                                                                              |                        |percentage              |percentage              |percentage              |       |
|                                                                              |                        |ofY-axisintercept       |ofY-axisintercept       |ofY-axisintercept       |       |
|                                                                              |                        |in 100%                 |in 100%                 |in 100%                 |       |
|                                                                              |                        |response                |response                |response                |       |
|                                                                              |                        |value                   |value                   |value                   |       |
|                                                                              |                        |is                      |is                      |is                      |       |
|                                                                              |                        |0.87%,                  |0.87%,                  |0.87%,                  |       |
|                                                                              |                        |whichis                 |whichis                 |whichis                 |       |
|                                                                              |                        |within                  |within                  |within                  |       |
|                                                                              |                        |25%;                    |25%;                    |25%;                    |       |
|                                                                              |                        |Thisindicates           |Thisindicates           |Thisindicates           |       |
|                                                                              |                        |that                    |that                    |that                    |       |
|                                                                              |                        |YA2304                  |YA2304                  |YA2304                  |       |
|                                                                              |                        |(principal              |(principal              |(principal              |       |
|                                                                              |                        |componentinstead        |componentinstead        |componentinstead        |       |
|                                                                              |                        |ofunknownimpurity)      |ofunknownimpurity)      |ofunknownimpurity)      |       |
|                                                                              |                        |hasa                    |hasa                    |hasa                    |       |
|                                                                              |                        |good                    |good                    |good                    |       |
|                                                                              |                        |linear                  |linear                  |linear                  |       |
|                                                                              |                        |relationship            |relationship            |relationship            |       |
|                                                                              |                        |in the                  |in the                  |in the                  |       |
|                                                                              |                        |concentration           |concentration           |concentration           |       |
|                                                                              |                        |range                   |range                   |range                   |       |
|                                                                              |                        |of                      |of                      |of                      |       |
|                                                                              |                        |0.1229μg/ml~1.2294μg/ml.|0.1229μg/ml~1.2294μg/ml.|0.1229μg/ml~1.2294μg/ml.|       |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|-------|
|YA2304- 15                                                                    |Linear solution①        |0.0303                  |0.1211                  |1801                    |14873  |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|-------|
|YA2304- 15                                                                    |Linear solution②        |0.0505                  |0.2018                  |2828                    |14013  |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|-------|
|YA2304- 15                                                                    |Linear solution③        |0.1009                  |0.4036                  |5854                    |14503  |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|-------|
|YA2304- 15                                                                    |Linear solution④        |0.1514                  |0.6055                  |8660                    |14303  |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|-------|
|YA2304- 15                                                                    |Linear solution⑤        |0.2018                  |0.8073                  |11573                   |14336  |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|-------|
|YA2304- 15                                                                    |Linear solution⑥        |0.3027                  |1.2109                  |17425                   |14390  |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|-------|
|YA2304- 15                                                                    |Response factor RSD/%   |Response factor RSD/%   |2.0                     |2.0                     |2.0    |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 193 of 542 





Page 194
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 















------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Linearequations                                                               |Linearequations          |y =                      |y =                      |y =                      |       |
|                                                                              |                         |14367x                   |14367x                   |14367x                   |       |
|                                                                              |                         |+                        |+                        |+                        |       |
|                                                                              |                         |1.2724                   |1.2724                   |1.2724                   |       |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|Correlation coefficientR                                                      |Correlation              |0.99996                  |0.99996                  |0.99996                  |       |
|                                                                              |coefficientR             |                         |                         |                         |       |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|Absolute value ofY-axisinterceptas % /% of 100% response value                |Absolute value           |0.015                    |0.015                    |0.015                    |       |
|                                                                              |ofY-axisinterceptas      |                         |                         |                         |       |
|                                                                              |% /% of 100%             |                         |                         |                         |       |
|                                                                              |response value           |                         |                         |                         |       |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|Conclusion: At 251nm wavelength, the RSD of YA2304-15 in the concentration    |Conclusion: At           |Conclusion:              |Conclusion:              |Conclusion:              |       |
|range of 0.1211μg/ml~1.2109μg/mlis 2.0%, less than 10%. The linearequationisy |251nm wavelength,        |At                       |At                       |At                       |       |
|= 14367x + 1.2724, and the correlation coefficientRis 0.99996, greater than   |the RSD of               |251nm                    |251nm                    |251nm                    |       |
|0.990. The absolute value ofY-axisinterceptasa percentage of 100% response    |YA2304-15 in the         |wavelength,              |wavelength,              |wavelength,              |       |
|value is 0.015%, within 25%; Itindicates thatimpurity YA2304-15 hasa good     |concentration range      |the RSD                  |the RSD                  |the RSD                  |       |
|linear relationship in the concentration range of 0.1211μg/ml~1.2109μg/ml.    |of                       |of                       |of                       |of                       |       |
|                                                                              |0.1211μg/ml~1.2109μg/mlis|YA2304-15                |YA2304-15                |YA2304-15                |       |
|                                                                              |2.0%, less than          |in the                   |in the                   |in the                   |       |
|                                                                              |10%. The                 |concentration            |concentration            |concentration            |       |
|                                                                              |linearequationisy =      |range                    |range                    |range                    |       |
|                                                                              |14367x + 1.2724,         |of                       |of                       |of                       |       |
|                                                                              |and the correlation      |0.1211μg/ml~1.2109μg/mlis|0.1211μg/ml~1.2109μg/mlis|0.1211μg/ml~1.2109μg/mlis|       |
|                                                                              |coefficientRis           |2.0%,                    |2.0%,                    |2.0%,                    |       |
|                                                                              |0.99996, greater         |less                     |less                     |less                     |       |
|                                                                              |than 0.990. The          |than                     |than                     |than                     |       |
|                                                                              |absolute value           |10%.                     |10%.                     |10%.                     |       |
|                                                                              |ofY-axisinterceptasa     |The                      |The                      |The                      |       |
|                                                                              |percentage of 100%       |linearequationisy        |linearequationisy        |linearequationisy        |       |
|                                                                              |response value is        |=                        |=                        |=                        |       |
|                                                                              |0.015%, within 25%;      |14367x                   |14367x                   |14367x                   |       |
|                                                                              |Itindicates              |+                        |+                        |+                        |       |
|                                                                              |thatimpurity             |1.2724,                  |1.2724,                  |1.2724,                  |       |
|                                                                              |YA2304-15 hasa good      |and the                  |and the                  |and the                  |       |
|                                                                              |linear relationship      |correlation              |correlation              |correlation              |       |
|                                                                              |in the                   |coefficientRis           |coefficientRis           |coefficientRis           |       |
|                                                                              |concentration range      |0.99996,                 |0.99996,                 |0.99996,                 |       |
|                                                                              |of                       |greater                  |greater                  |greater                  |       |
|                                                                              |0.1211μg/ml~1.2109μg/ml. |than                     |than                     |than                     |       |
|                                                                              |                         |0.990.                   |0.990.                   |0.990.                   |       |
|                                                                              |                         |The                      |The                      |The                      |       |
|                                                                              |                         |absolute                 |absolute                 |absolute                 |       |
|                                                                              |                         |value                    |value                    |value                    |       |
|                                                                              |                         |ofY-axisinterceptasa     |ofY-axisinterceptasa     |ofY-axisinterceptasa     |       |
|                                                                              |                         |percentage               |percentage               |percentage               |       |
|                                                                              |                         |of 100%                  |of 100%                  |of 100%                  |       |
|                                                                              |                         |response                 |response                 |response                 |       |
|                                                                              |                         |value                    |value                    |value                    |       |
|                                                                              |                         |is                       |is                       |is                       |       |
|                                                                              |                         |0.015%,                  |0.015%,                  |0.015%,                  |       |
|                                                                              |                         |within                   |within                   |within                   |       |
|                                                                              |                         |25%;                     |25%;                     |25%;                     |       |
|                                                                              |                         |Itindicates              |Itindicates              |Itindicates              |       |
|                                                                              |                         |thatimpurity             |thatimpurity             |thatimpurity             |       |
|                                                                              |                         |YA2304-15                |YA2304-15                |YA2304-15                |       |
|                                                                              |                         |hasa                     |hasa                     |hasa                     |       |
|                                                                              |                         |good                     |good                     |good                     |       |
|                                                                              |                         |linear                   |linear                   |linear                   |       |
|                                                                              |                         |relationship             |relationship             |relationship             |       |
|                                                                              |                         |in the                   |in the                   |in the                   |       |
|                                                                              |                         |concentration            |concentration            |concentration            |       |
|                                                                              |                         |range                    |range                    |range                    |       |
|                                                                              |                         |of                       |of                       |of                       |       |
|                                                                              |                         |0.1211μg/ml~1.2109μg/ml. |0.1211μg/ml~1.2109μg/ml. |0.1211μg/ml~1.2109μg/ml. |       |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 16                                                                    |Linear solution          |0.0290                   |0.1159                   |1942                     |16749  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 16                                                                    |Linear solution②         |0.0483                   |0.1932                   |3175                     |16430  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 16                                                                    |Linear solution③         |0.0966                   |0.3865                   |6371                     |16484  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 16                                                                    |Linear solution④         |0.1449                   |0.5797                   |9607                     |16571  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 16                                                                    |Linear solution⑤         |0.1932                   |0.7730                   |12706                    |16438  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 16                                                                    |Linear solution⑥         |0.2899                   |1.1595                   |19121                    |16491  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 16                                                                    |Response factor RSD/%    |Response factor RSD/%    |0.8                      |0.8                      |0.8    |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 194 of 542 





Page 195
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 















------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Linearequations                                                               |Linearequations          |y =                      |y =                      |y =                      |       |
|                                                                              |                         |16470x                   |16470x                   |16470x                   |       |
|                                                                              |                         |+                        |+                        |+                        |       |
|                                                                              |                         |14.525                   |14.525                   |14.525                   |       |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|Correlation coefficientR                                                      |Correlation              |1.000                    |1.000                    |1.000                    |       |
|                                                                              |coefficientR             |                         |                         |                         |       |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|Absolute value ofY-axisinterceptas % /% of 100% response value                |Absolute value           |0.15                     |0.15                     |0.15                     |       |
|                                                                              |ofY-axisinterceptas      |                         |                         |                         |       |
|                                                                              |% /% of 100%             |                         |                         |                         |       |
|                                                                              |response value           |                         |                         |                         |       |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|Conclusion: At 251nm wavelength, the RSD of YA2304-16 in the concentration    |Conclusion: At           |Conclusion:              |Conclusion:              |Conclusion:              |       |
|range of 0.1159μg/ml~1.1595μg/mlis 0.8%, less than 10%. The linearequationisy |251nm wavelength,        |At                       |At                       |At                       |       |
|= 16470x + 14.525, and the correlation coefficientRis 1.000, greater than     |the RSD of               |251nm                    |251nm                    |251nm                    |       |
|0.990. The absolute value ofY-axisinterceptasa percentage of 100% response    |YA2304-16 in the         |wavelength,              |wavelength,              |wavelength,              |       |
|value is 0.15%, within 25%; Itindicates thatimpurity YA2304-16 hasa good      |concentration range      |the RSD                  |the RSD                  |the RSD                  |       |
|linear relationship in the concentration range of 0.1159μg/ml~1.1595μg/ml.    |of                       |of                       |of                       |of                       |       |
|                                                                              |0.1159μg/ml~1.1595μg/mlis|YA2304-16                |YA2304-16                |YA2304-16                |       |
|                                                                              |0.8%, less than          |in the                   |in the                   |in the                   |       |
|                                                                              |10%. The                 |concentration            |concentration            |concentration            |       |
|                                                                              |linearequationisy =      |range                    |range                    |range                    |       |
|                                                                              |16470x + 14.525,         |of                       |of                       |of                       |       |
|                                                                              |and the correlation      |0.1159μg/ml~1.1595μg/mlis|0.1159μg/ml~1.1595μg/mlis|0.1159μg/ml~1.1595μg/mlis|       |
|                                                                              |coefficientRis           |0.8%,                    |0.8%,                    |0.8%,                    |       |
|                                                                              |1.000, greater than      |less                     |less                     |less                     |       |
|                                                                              |0.990. The absolute      |than                     |than                     |than                     |       |
|                                                                              |value                    |10%.                     |10%.                     |10%.                     |       |
|                                                                              |ofY-axisinterceptasa     |The                      |The                      |The                      |       |
|                                                                              |percentage of 100%       |linearequationisy        |linearequationisy        |linearequationisy        |       |
|                                                                              |response value is        |=                        |=                        |=                        |       |
|                                                                              |0.15%, within 25%;       |16470x                   |16470x                   |16470x                   |       |
|                                                                              |Itindicates              |+                        |+                        |+                        |       |
|                                                                              |thatimpurity             |14.525,                  |14.525,                  |14.525,                  |       |
|                                                                              |YA2304-16 hasa good      |and the                  |and the                  |and the                  |       |
|                                                                              |linear relationship      |correlation              |correlation              |correlation              |       |
|                                                                              |in the                   |coefficientRis           |coefficientRis           |coefficientRis           |       |
|                                                                              |concentration range      |1.000,                   |1.000,                   |1.000,                   |       |
|                                                                              |of                       |greater                  |greater                  |greater                  |       |
|                                                                              |0.1159μg/ml~1.1595μg/ml. |than                     |than                     |than                     |       |
|                                                                              |                         |0.990.                   |0.990.                   |0.990.                   |       |
|                                                                              |                         |The                      |The                      |The                      |       |
|                                                                              |                         |absolute                 |absolute                 |absolute                 |       |
|                                                                              |                         |value                    |value                    |value                    |       |
|                                                                              |                         |ofY-axisinterceptasa     |ofY-axisinterceptasa     |ofY-axisinterceptasa     |       |
|                                                                              |                         |percentage               |percentage               |percentage               |       |
|                                                                              |                         |of 100%                  |of 100%                  |of 100%                  |       |
|                                                                              |                         |response                 |response                 |response                 |       |
|                                                                              |                         |value                    |value                    |value                    |       |
|                                                                              |                         |is                       |is                       |is                       |       |
|                                                                              |                         |0.15%,                   |0.15%,                   |0.15%,                   |       |
|                                                                              |                         |within                   |within                   |within                   |       |
|                                                                              |                         |25%;                     |25%;                     |25%;                     |       |
|                                                                              |                         |Itindicates              |Itindicates              |Itindicates              |       |
|                                                                              |                         |thatimpurity             |thatimpurity             |thatimpurity             |       |
|                                                                              |                         |YA2304-16                |YA2304-16                |YA2304-16                |       |
|                                                                              |                         |hasa                     |hasa                     |hasa                     |       |
|                                                                              |                         |good                     |good                     |good                     |       |
|                                                                              |                         |linear                   |linear                   |linear                   |       |
|                                                                              |                         |relationship             |relationship             |relationship             |       |
|                                                                              |                         |in the                   |in the                   |in the                   |       |
|                                                                              |                         |concentration            |concentration            |concentration            |       |
|                                                                              |                         |range                    |range                    |range                    |       |
|                                                                              |                         |of                       |of                       |of                       |       |
|                                                                              |                         |0.1159μg/ml~1.1595μg/ml. |0.1159μg/ml~1.1595μg/ml. |0.1159μg/ml~1.1595μg/ml. |       |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 18                                                                    |Linear solution①         |0.0301                   |0.1203                   |1751                     |14559  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 18                                                                    |Linear solution②         |0.0501                   |0.2005                   |2973                     |14832  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 18                                                                    |Linear solution③         |0.1002                   |0.4009                   |6094                     |15201  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 18                                                                    |Linear solution④         |0.1503                   |0.6014                   |9008                     |14980  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 18                                                                    |Linear solution⑤         |0.2005                   |0.8018                   |12043                    |15020  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 18                                                                    |Linear solution⑥         |0.3007                   |1.2027                   |17988                    |14956  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 18                                                                    |Response factor RSD/%    |Response factor RSD/%    |1.5                      |1.5                      |1.5    |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 195 of 542 





Page 196
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 















------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Linearequations                                                               |Linearequations          |y =                      |y =                      |y =                      |       |
|                                                                              |                         |14990x-3.7556            |14990x-3.7556            |14990x-3.7556            |       |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|Correlation coefficientR                                                      |Correlation              |0.99996                  |0.99996                  |0.99996                  |       |
|                                                                              |coefficientR             |                         |                         |                         |       |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|Absolute value ofY-axisinterceptas % /% of 100% response value                |Absolute value           |0.042                    |0.042                    |0.042                    |       |
|                                                                              |ofY-axisinterceptas      |                         |                         |                         |       |
|                                                                              |% /% of 100%             |                         |                         |                         |       |
|                                                                              |response value           |                         |                         |                         |       |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|Conclusion: At 251nm wavelength, the RSD of YA2304-18 in the concentration    |Conclusion: At           |Conclusion:              |Conclusion:              |Conclusion:              |       |
|range of 0.1203μg/ml~1.2027μg/mlis 1.5%, less than 10%. The linearequationisy |251nm wavelength,        |At 251nm                 |At 251nm                 |At 251nm                 |       |
|= 14990x-3.7556, and the correlation coefficientRis 0.99996, greater than     |the RSD of               |wavelength,              |wavelength,              |wavelength,              |       |
|0.990. The absolute value ofY-axisinterceptasa percentage of 100% response    |YA2304-18 in the         |the RSD of               |the RSD of               |the RSD of               |       |
|value is 0.042%, whichis within 25%; Itindicates thatimpurity YA2304-18 hasa  |concentration range      |YA2304-18 in             |YA2304-18 in             |YA2304-18 in             |       |
|good linear relationship in the concentration range of                        |of                       |the                      |the                      |the                      |       |
|0.1203μg/ml~1.2027μg/ml.                                                      |0.1203μg/ml~1.2027μg/mlis|concentration            |concentration            |concentration            |       |
|                                                                              |1.5%, less than          |range of                 |range of                 |range of                 |       |
|                                                                              |10%. The                 |0.1203μg/ml~1.2027μg/mlis|0.1203μg/ml~1.2027μg/mlis|0.1203μg/ml~1.2027μg/mlis|       |
|                                                                              |linearequationisy =      |1.5%, less               |1.5%, less               |1.5%, less               |       |
|                                                                              |14990x-3.7556, and       |than 10%. The            |than 10%. The            |than 10%. The            |       |
|                                                                              |the correlation          |linearequationisy        |linearequationisy        |linearequationisy        |       |
|                                                                              |coefficientRis           |=                        |=                        |=                        |       |
|                                                                              |0.99996, greater         |14990x-3.7556,           |14990x-3.7556,           |14990x-3.7556,           |       |
|                                                                              |than 0.990. The          |and the                  |and the                  |and the                  |       |
|                                                                              |absolute value           |correlation              |correlation              |correlation              |       |
|                                                                              |ofY-axisinterceptasa     |coefficientRis           |coefficientRis           |coefficientRis           |       |
|                                                                              |percentage of 100%       |0.99996,                 |0.99996,                 |0.99996,                 |       |
|                                                                              |response value is        |greater than             |greater than             |greater than             |       |
|                                                                              |0.042%, whichis          |0.990. The               |0.990. The               |0.990. The               |       |
|                                                                              |within 25%;              |absolute                 |absolute                 |absolute                 |       |
|                                                                              |Itindicates              |value                    |value                    |value                    |       |
|                                                                              |thatimpurity             |ofY-axisinterceptasa     |ofY-axisinterceptasa     |ofY-axisinterceptasa     |       |
|                                                                              |YA2304-18 hasa good      |percentage of            |percentage of            |percentage of            |       |
|                                                                              |linear relationship      |100% response            |100% response            |100% response            |       |
|                                                                              |in the                   |value is                 |value is                 |value is                 |       |
|                                                                              |concentration range      |0.042%,                  |0.042%,                  |0.042%,                  |       |
|                                                                              |of                       |whichis                  |whichis                  |whichis                  |       |
|                                                                              |0.1203μg/ml~1.2027μg/ml. |within 25%;              |within 25%;              |within 25%;              |       |
|                                                                              |                         |Itindicates              |Itindicates              |Itindicates              |       |
|                                                                              |                         |thatimpurity             |thatimpurity             |thatimpurity             |       |
|                                                                              |                         |YA2304-18                |YA2304-18                |YA2304-18                |       |
|                                                                              |                         |hasa good                |hasa good                |hasa good                |       |
|                                                                              |                         |linear                   |linear                   |linear                   |       |
|                                                                              |                         |relationship             |relationship             |relationship             |       |
|                                                                              |                         |in the                   |in the                   |in the                   |       |
|                                                                              |                         |concentration            |concentration            |concentration            |       |
|                                                                              |                         |range of                 |range of                 |range of                 |       |
|                                                                              |                         |0.1203μg/ml~1.2027μg/ml. |0.1203μg/ml~1.2027μg/ml. |0.1203μg/ml~1.2027μg/ml. |       |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 17                                                                    |Linear solution①         |0.0302                   |0.1208                   |3143                     |26017  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 17                                                                    |Linear solution②         |0.0503                   |0.2013                   |5288                     |26264  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 17                                                                    |Linear solution③         |0.1007                   |0.4027                   |10626                    |26388  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 17                                                                    |Linear solution④         |0.1510                   |0.6040                   |16044                    |26562  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 17                                                                    |Linear solution⑤         |0.2013                   |0.8054                   |21376                    |26542  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 17                                                                    |Linear solution⑥         |0.3020                   |1.2080                   |32097                    |26569  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 17                                                                    |Response factor RSD/%    |Response factor RSD/%    |0.9                      |0.9                      |0.9    |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 196 of 542 





Page 197
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 















--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Linearequations                                                               |Linearequations         |y =                     |y =                     |y =                     |       |
|                                                                              |                        |26638x                  |26638x                  |26638x                  |       |
|                                                                              |                        |-                       |-                       |-                       |       |
|                                                                              |                        |75.991                  |75.991                  |75.991                  |       |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|-------|
|Correlation coefficientR                                                      |Correlation             |1.000                   |1.000                   |1.000                   |       |
|                                                                              |coefficientR            |                        |                        |                        |       |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|-------|
|Absolute value ofY-axisinterceptas % /% of 100% response value                |Absolute value          |0.48                    |0.48                    |0.48                    |       |
|                                                                              |ofY-axisinterceptas     |                        |                        |                        |       |
|                                                                              |% /% of 100%            |                        |                        |                        |       |
|                                                                              |response value          |                        |                        |                        |       |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|-------|
|Conclusion: Under the condition of 230nm wavelength, the RSD of YA2304-17 is  |Conclusion: Under       |Conclusion:             |Conclusion:             |Conclusion:             |       |
|0.9%, less than 10%, in the concentration range of 0.1208μg/ml~1.2080μg/ml.   |the condition of        |Under                   |Under                   |Under                   |       |
|The linearequationisy = 26638x-75.991, and the correlation coefficientRis     |230nm wavelength,       |the                     |the                     |the                     |       |
|1.000, greater than 0.990. The absolute value ofY-axisinterceptasa percentage |the RSD of              |condition               |condition               |condition               |       |
|of 100% response value is 0.48%, within 25%; Itindicates thatimpurity         |YA2304-17 is 0.9%,      |of                      |of                      |of                      |       |
|YA2304-17 hasa good linear relationship in the concentration range of         |less than 10%, in       |230nm                   |230nm                   |230nm                   |       |
|0.1208μg/ml~1.2080μg/ml.                                                      |the concentration       |wavelength,             |wavelength,             |wavelength,             |       |
|                                                                              |range of                |the RSD                 |the RSD                 |the RSD                 |       |
|                                                                              |0.1208μg/ml~1.2080μg/ml.|of                      |of                      |of                      |       |
|                                                                              |The                     |YA2304-17               |YA2304-17               |YA2304-17               |       |
|                                                                              |linearequationisy =     |is                      |is                      |is                      |       |
|                                                                              |26638x-75.991, and      |0.9%,                   |0.9%,                   |0.9%,                   |       |
|                                                                              |the correlation         |less                    |less                    |less                    |       |
|                                                                              |coefficientRis          |than                    |than                    |than                    |       |
|                                                                              |1.000, greater than     |10%, in                 |10%, in                 |10%, in                 |       |
|                                                                              |0.990. The absolute     |the                     |the                     |the                     |       |
|                                                                              |value                   |concentration           |concentration           |concentration           |       |
|                                                                              |ofY-axisinterceptasa    |range                   |range                   |range                   |       |
|                                                                              |percentage of 100%      |of                      |of                      |of                      |       |
|                                                                              |response value is       |0.1208μg/ml~1.2080μg/ml.|0.1208μg/ml~1.2080μg/ml.|0.1208μg/ml~1.2080μg/ml.|       |
|                                                                              |0.48%, within 25%;      |The                     |The                     |The                     |       |
|                                                                              |Itindicates             |linearequationisy       |linearequationisy       |linearequationisy       |       |
|                                                                              |thatimpurity            |=                       |=                       |=                       |       |
|                                                                              |YA2304-17 hasa good     |26638x-75.991,          |26638x-75.991,          |26638x-75.991,          |       |
|                                                                              |linear relationship     |and the                 |and the                 |and the                 |       |
|                                                                              |in the                  |correlation             |correlation             |correlation             |       |
|                                                                              |concentration range     |coefficientRis          |coefficientRis          |coefficientRis          |       |
|                                                                              |of                      |1.000,                  |1.000,                  |1.000,                  |       |
|                                                                              |0.1208μg/ml~1.2080μg/ml.|greater                 |greater                 |greater                 |       |
|                                                                              |                        |than                    |than                    |than                    |       |
|                                                                              |                        |0.990.                  |0.990.                  |0.990.                  |       |
|                                                                              |                        |The                     |The                     |The                     |       |
|                                                                              |                        |absolute                |absolute                |absolute                |       |
|                                                                              |                        |value                   |value                   |value                   |       |
|                                                                              |                        |ofY-axisinterceptasa    |ofY-axisinterceptasa    |ofY-axisinterceptasa    |       |
|                                                                              |                        |percentage              |percentage              |percentage              |       |
|                                                                              |                        |of 100%                 |of 100%                 |of 100%                 |       |
|                                                                              |                        |response                |response                |response                |       |
|                                                                              |                        |value                   |value                   |value                   |       |
|                                                                              |                        |is                      |is                      |is                      |       |
|                                                                              |                        |0.48%,                  |0.48%,                  |0.48%,                  |       |
|                                                                              |                        |within                  |within                  |within                  |       |
|                                                                              |                        |25%;                    |25%;                    |25%;                    |       |
|                                                                              |                        |Itindicates             |Itindicates             |Itindicates             |       |
|                                                                              |                        |thatimpurity            |thatimpurity            |thatimpurity            |       |
|                                                                              |                        |YA2304-17               |YA2304-17               |YA2304-17               |       |
|                                                                              |                        |hasa                    |hasa                    |hasa                    |       |
|                                                                              |                        |good                    |good                    |good                    |       |
|                                                                              |                        |linear                  |linear                  |linear                  |       |
|                                                                              |                        |relationship            |relationship            |relationship            |       |
|                                                                              |                        |in the                  |in the                  |in the                  |       |
|                                                                              |                        |concentration           |concentration           |concentration           |       |
|                                                                              |                        |range                   |range                   |range                   |       |
|                                                                              |                        |of                      |of                      |of                      |       |
|                                                                              |                        |0.1208μg/ml~1.2080μg/ml.|0.1208μg/ml~1.2080μg/ml.|0.1208μg/ml~1.2080μg/ml.|       |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|-------|
|YA2304- 10                                                                    |Linear solution①        |0.0305                  |0.1218                  |2603                    |21366  |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|-------|
|YA2304- 10                                                                    |Linear solution②        |0.0508                  |0.2031                  |4267                    |21014  |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|-------|
|YA2304- 10                                                                    |Linear solution③        |0.1015                  |0.4061                  |8180                    |20143  |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|-------|
|YA2304- 10                                                                    |Linear solution④        |0.1523                  |0.6092                  |12086                   |19841  |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|-------|
|YA2304- 10                                                                    |Linear solution⑤        |0.2031                  |0.8122                  |16286                   |20052  |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|-------|
|YA2304- 10                                                                    |Linear solution⑥        |0.3046                  |1.2183                  |24255                   |19909  |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|-------|
|YA2304- 10                                                                    |Response factor RSD/%   |Response factor RSD/%   |4                       |4                       |4      |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 197 of 542 





Page 198
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 















------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Linearequations                                                               |Linearequations          |y =                      |y =                      |y =                      |       |
|                                                                              |                         |19735x                   |19735x                   |19735x                   |       |
|                                                                              |                         |+                        |+                        |+                        |       |
|                                                                              |                         |192.83                   |192.83                   |192.83                   |       |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|Correlation coefficientR                                                      |Correlation              |0.99996                  |0.99996                  |0.99996                  |       |
|                                                                              |coefficientR             |                         |                         |                         |       |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|Absolute value ofY-axisinterceptas % /% of 100% response value                |Absolute value           |2.4                      |2.4                      |2.4                      |       |
|                                                                              |ofY-axisinterceptas      |                         |                         |                         |       |
|                                                                              |% /% of 100%             |                         |                         |                         |       |
|                                                                              |response value           |                         |                         |                         |       |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|Conclusion: Under the condition of 230nm wavelength, the RSD of YA2304-10 is  |Conclusion: Under        |Conclusion:              |Conclusion:              |Conclusion:              |       |
|4%, less than 10%, in the concentration range of 0.1218μg/ml~1.2183μg/ml. The |the condition of         |Under                    |Under                    |Under                    |       |
|linearequationisy = 19735x + 192.83, and the correlation coefficientRis       |230nm wavelength,        |the                      |the                      |the                      |       |
|0.99996, greater than 0.990. The absolute value ofY-axisinterceptaccounts for |the RSD of               |condition                |condition                |condition                |       |
|2.4% of 100% response value, whichis within 25%; Itindicates thatimpurity     |YA2304-10 is 4%,         |of                       |of                       |of                       |       |
|YA2304-10 hasagood linear relationship in the concentration range of          |less than 10%, in        |230nm                    |230nm                    |230nm                    |       |
|0.1218μg/ml~1.2183μg/ml.                                                      |the concentration        |wavelength,              |wavelength,              |wavelength,              |       |
|                                                                              |range of                 |the RSD                  |the RSD                  |the RSD                  |       |
|                                                                              |0.1218μg/ml~1.2183μg/ml. |of                       |of                       |of                       |       |
|                                                                              |The                      |YA2304-10                |YA2304-10                |YA2304-10                |       |
|                                                                              |linearequationisy =      |is 4%,                   |is 4%,                   |is 4%,                   |       |
|                                                                              |19735x + 192.83,         |less                     |less                     |less                     |       |
|                                                                              |and the correlation      |than                     |than                     |than                     |       |
|                                                                              |coefficientRis           |10%, in                  |10%, in                  |10%, in                  |       |
|                                                                              |0.99996, greater         |the                      |the                      |the                      |       |
|                                                                              |than 0.990. The          |concentration            |concentration            |concentration            |       |
|                                                                              |absolute value           |range                    |range                    |range                    |       |
|                                                                              |ofY-axisinterceptaccounts|of                       |of                       |of                       |       |
|                                                                              |for 2.4% of 100%         |0.1218μg/ml~1.2183μg/ml. |0.1218μg/ml~1.2183μg/ml. |0.1218μg/ml~1.2183μg/ml. |       |
|                                                                              |response value,          |The                      |The                      |The                      |       |
|                                                                              |whichis within 25%;      |linearequationisy        |linearequationisy        |linearequationisy        |       |
|                                                                              |Itindicates              |=                        |=                        |=                        |       |
|                                                                              |thatimpurity             |19735x                   |19735x                   |19735x                   |       |
|                                                                              |YA2304-10 hasagood       |+                        |+                        |+                        |       |
|                                                                              |linear relationship      |192.83,                  |192.83,                  |192.83,                  |       |
|                                                                              |in the                   |and the                  |and the                  |and the                  |       |
|                                                                              |concentration range      |correlation              |correlation              |correlation              |       |
|                                                                              |of                       |coefficientRis           |coefficientRis           |coefficientRis           |       |
|                                                                              |0.1218μg/ml~1.2183μg/ml. |0.99996,                 |0.99996,                 |0.99996,                 |       |
|                                                                              |                         |greater                  |greater                  |greater                  |       |
|                                                                              |                         |than                     |than                     |than                     |       |
|                                                                              |                         |0.990.                   |0.990.                   |0.990.                   |       |
|                                                                              |                         |The                      |The                      |The                      |       |
|                                                                              |                         |absolute                 |absolute                 |absolute                 |       |
|                                                                              |                         |value                    |value                    |value                    |       |
|                                                                              |                         |ofY-axisinterceptaccounts|ofY-axisinterceptaccounts|ofY-axisinterceptaccounts|       |
|                                                                              |                         |for                      |for                      |for                      |       |
|                                                                              |                         |2.4% of                  |2.4% of                  |2.4% of                  |       |
|                                                                              |                         |100%                     |100%                     |100%                     |       |
|                                                                              |                         |response                 |response                 |response                 |       |
|                                                                              |                         |value,                   |value,                   |value,                   |       |
|                                                                              |                         |whichis                  |whichis                  |whichis                  |       |
|                                                                              |                         |within                   |within                   |within                   |       |
|                                                                              |                         |25%;                     |25%;                     |25%;                     |       |
|                                                                              |                         |Itindicates              |Itindicates              |Itindicates              |       |
|                                                                              |                         |thatimpurity             |thatimpurity             |thatimpurity             |       |
|                                                                              |                         |YA2304-10                |YA2304-10                |YA2304-10                |       |
|                                                                              |                         |hasagood                 |hasagood                 |hasagood                 |       |
|                                                                              |                         |linear                   |linear                   |linear                   |       |
|                                                                              |                         |relationship             |relationship             |relationship             |       |
|                                                                              |                         |in the                   |in the                   |in the                   |       |
|                                                                              |                         |concentration            |concentration            |concentration            |       |
|                                                                              |                         |range                    |range                    |range                    |       |
|                                                                              |                         |of                       |of                       |of                       |       |
|                                                                              |                         |0.1218μg/ml~1.2183μg/ml. |0.1218μg/ml~1.2183μg/ml. |0.1218μg/ml~1.2183μg/ml. |       |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 19                                                                    |Linear solution①         |0.0300                   |0.1202                   |3087                     |25690  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 19                                                                    |Linear solution②         |0.0501                   |0.2003                   |5054                     |25236  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 19                                                                    |Linear solution③         |0.1001                   |0.4005                   |10300                    |25715  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 19                                                                    |Linear solution④         |0.1502                   |0.6008                   |15189                    |25281  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 19                                                                    |Linear solution⑤         |0.2003                   |0.8011                   |20363                    |25419  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 19                                                                    |Linear solution⑥         |0.3004                   |1.2016                   |30691                    |25541  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------|
|YA2304- 19                                                                    |Response factor RSD/%    |Response factor RSD/%    |0.8                      |0.8                      |0.8    |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 198 of 542 





Page 199
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 










--------------------------------------------------------------------------------------------
|       |Linear graph                                                  |                   |
|       |                                                              |                   |
|       |                                                              |                   |
|       |--------------------------------------------------------------|-------------------|
|       |Linearequation                                                |y = 25507x - 18.855|
|       |--------------------------------------------------------------|-------------------|
|       |Correlation coefficientR                                      |0.99997            |
|       |--------------------------------------------------------------|-------------------|
|       |Absolute value ofY-axisinterceptas % /% of 100% response value|0.12               |
--------------------------------------------------------------------------------------------

Validation Results of Correction Factor (f): 
















---------------------------------------------------------------------------------------------------------------------------------------------
|Names ofimpurities                                                                            |Linearequation|Standard      |Determination |
|                                                                                              |slope         |regulations   |results       |
|----------------------------------------------------------------------------------------------|--------------|--------------|--------------|
|YA2304-12                                                                                     |13896         |1.2           |1.2           |
|----------------------------------------------------------------------------------------------|--------------|--------------|--------------|
|YA2304-14                                                                                     |16536         |1.0           |1.0           |
|----------------------------------------------------------------------------------------------|--------------|--------------|--------------|
|YA2304                                                                                        |16404         |1.0           |1.0           |
|----------------------------------------------------------------------------------------------|--------------|--------------|--------------|
|YA2304-15                                                                                     |14367         |1.2           |1.1           |
|----------------------------------------------------------------------------------------------|--------------|--------------|--------------|
|YA2304-16                                                                                     |16470         |1.0           |1.0           |
|----------------------------------------------------------------------------------------------|--------------|--------------|--------------|
|YA2304-18                                                                                     |14990         |1.1           |1.1           |
|----------------------------------------------------------------------------------------------|--------------|--------------|--------------|
|YA2304-19                                                                                     |25507         |0.7           |0.6           |
|----------------------------------------------------------------------------------------------|--------------|--------------|--------------|
|Verdict: The correction factors of YA2304-12, YA2304-14, YA2304-15, YA2304-16, YA2304-18,     |Verdict: The  |Verdict:      |Verdict: The  |
|YA2304-18 and YA2304-19 relative to the principal component YA2304 are 1.18, 0.99, 1.14, 1.00 |correction    |The           |correction    |
|and 1.0, respectively, based on the impurities and the slope of the principal component       |factors of    |correction    |factors of    |
|linearequation 9, 0.64, revised to approximately 1.2, 1.0,                                    |YA2304-12,    |factors of    |YA2304-12,    |
|                                                                                              |YA2304-14,    |YA2304-12,    |YA2304-14,    |
|                                                                                              |YA2304-15,    |YA2304-14,    |YA2304-15,    |
|                                                                                              |YA2304-16,    |YA2304-15,    |YA2304-16,    |
|                                                                                              |YA2304-18,    |YA2304-16,    |YA2304-18,    |
|                                                                                              |YA2304-18 and |YA2304-18,    |YA2304-18 and |
|                                                                                              |YA2304-19     |YA2304-18     |YA2304-19     |
|                                                                                              |relative to   |and           |relative to   |
|                                                                                              |the principal |YA2304-19     |the principal |
|                                                                                              |component     |relative to   |component     |
|                                                                                              |YA2304 are    |the           |YA2304 are    |
|                                                                                              |1.18, 0.99,   |principal     |1.18, 0.99,   |
|                                                                                              |1.14, 1.00 and|component     |1.14, 1.00    |
|                                                                                              |1.0,          |YA2304 are    |and 1.0,      |
|                                                                                              |respectively, |1.18, 0.99,   |respectively, |
|                                                                                              |based on the  |1.14, 1.00    |based on the  |
|                                                                                              |impurities and|and 1.0,      |impurities    |
|                                                                                              |the slope of  |respectively, |and the slope |
|                                                                                              |the principal |based on      |of the        |
|                                                                                              |component     |the           |principal     |
|                                                                                              |linearequation|impurities    |component     |
|                                                                                              |9, 0.64,      |and the       |linearequation|
|                                                                                              |revised to    |slope of      |9, 0.64,      |
|                                                                                              |approximately |the           |revised to    |
|                                                                                              |1.2, 1.0,     |principal     |approximately |
|                                                                                              |              |component     |1.2, 1.0,     |
|                                                                                              |              |linearequation|              |
|                                                                                              |              |9, 0.64,      |              |
|                                                                                              |              |revised to    |              |
|                                                                                              |              |approximately |              |
|                                                                                              |              |1.2, 1.0,     |              |
---------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 199 of 542 





Page 200
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



1.1, 1.0, 1.1, 0.6. Compared with the correction factors specified in the quality 



standard, except for impurity YA2304-15 and impurity YA2304-19, the correction 



factors are 0.1 different from the standard comparison, and the other impurities are 



consistent within the deviation range. Therefore, the correction factor in the quality 



standard is not revised. 



**f. Accuracy** 



 **Acceptance Criteria** 



The accuracy of unknown impurities is achieved by determining the recovery 



rate between the theoretical addition and the actual detected amount of 



YA2304 reference in the solvent at different concentrations (LOQ 



concentration, 100% limit concentration and 150% limit concentration). It is 



required that the recovery rate of unknown impurity LOQ concentration 



solution ~150% limit concentration solution should be 85%~110%, and the 



RSD of recovery NMT 10%. 



The recovery rate of known impurities is by adding each impurity in the test 



product solution within the range of 30% limit concentration ~ 150% limit 



concentration of each impurity reference products (note: Impurity 



YA2304-10 is added to 0.045% test product solution concentration ~ 0.225% 



test product solution concentration impurity reference), and the recovery 



rate between the theoretical added amount and the actual detected amount 



is achieved. It is required that the recovery rate of known impurity 30% limit 



concentration sampling solution ~150% limit concentration solution is 



85%~110%, and the RSD of each impurity recovery rate NMT 10%. 



 **Solution Preparation** 



**i. Identified Impurities** 



Blank solution: solvent 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 200 of 542 





Page 201
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



YA2304-12 Reference storage solution: Share "YA2304-12 Reference Storage 



solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-14 Reference storage solution: Share "YA2304-14 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-15 Reference storage solution: Share "YA2304-15 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-16 Reference storage solution: Share "YA2304-16 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-18 Reference storage solution: Share "YA2304-18 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-19 Reference storage solution: Share "YA2304-19 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-10 Reference storage Solution: Share "YA2304-10 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-17 Reference storage solution: Share "YA2304-17 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



Test product solution: Take YA2304 sample about 10mg, weigh it accurately, 



put it in 25ml measuring bottle, dissolve it with solvent and dilute it to scale, 



shake well, and then get it. Prepare 2 parts in parallel. (About 0.4mg/ml) 



Mixed reference solution: accurately measure 1ml each of YA2304-10 



reference solution, YA2304-17 reference solution and YA2304 reference 



solution, place them in the same 20ml bottle, dilute to scale with solvent, and 



shake well; Precisely measure 1ml of the above solution, place it in a 25ml 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 201 of 542 





Page 202
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



measuring bottle, dilute it with solvent to the scale, shake well, and then 



obtain. (YA2304-10, YA2304-17 and YA2304 contain about 0.4μg/ml) 



System suitability solution: Accurately weigh YA2304 reference product 



about 10mg, place it in 25ml bottle, add appropriate amount of solvent to 



dissolve by ultrasound, then accurately add 100μl each of YA2304-14, 



YA2304-15, YA2304-16, YA2304-19, YA2304-10 and YA2304-17 reference 



product reserve solution. Dilute with solvent to scale, shake well, ready. 



(YA2304-14, YA2304-15, YA2304-16, YA2304-19, YA2304-10 and 



YA2304-17 all about 0.8μg/ml) 



Sample recovery reserve liquid: Take 1.5ml of each control product reserve 



liquid of YA2304-12, YA2304-14, YA2304-15, YA2304-16, YA2304-18, 



YA2304-19, YA2304-17 and YA2304-10 into the same 20ml measuring bottle 



and dilute it to the scale with solvent. Shake well, then it is ready. (About 



15μg/ml) 



30% sample recovery solution (Note: YA2304-10 is 0.045% test solution 



concentration) : Take YA2304 sample about 10mg, accurately weigh, put into 



25ml measuring bottle, add appropriate amount of solvent to dissolve by 



ultrasound, accurately add 0.3ml of sample recovery liquid, dilute with 



solvent to scale, shake well, and then obtain. Prepare 3 parts in parallel. 



100% sample recovery solution (Note: YA2304-10 is 0.15% test product 



solution concentration) : Take about 10mg of YA2304 sample, accurately 



weigh it, place it in a 25ml measuring bottle, add an appropriate amount of 



solvent to dissolve it by ultrasound, accurately add 1.0ml of the reserve liquid 



with sample recovery rate, dilute it with solvent to the scale, shake well, and 



obtain. Prepare 3 parts in parallel. 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 202 of 542 





Page 203
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



150% sample recovery solution (Note: YA2304-10 is 0.225% test product 



solution concentration) : Take about 10mg of YA2304 sample, accurately 



weigh it, place it in 25ml measuring bottle, add an appropriate amount of 



solvent to dissolve by ultrasound, accurately add 1.5ml of the reserve liquid 



with sample recovery rate, dilute it with solvent to the scale, shake well, and 



obtain. Prepare 3 parts in parallel. 



**ii. Unidentified Impurities** 



Blank solution: solvent 



YA2304 Reference storage solution: Share "YA2304 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



Recovery rate of reserve liquid: accurately measure YA2304 reference 



product reserve liquid 1ml, place it in 20ml measuring bottle, dilute it with 



solvent to scale, shake well, then obtain. (About 10μg/ml) 



Control product solution: accurately measure the recovery rate of 1ml of 



reserve liquid, put it in a 25ml measuring bottle, dilute it with solvent to the 



scale, shake well, and then get. (About 0.4μg/ml) 



LOQ recovery solution: accurately measure the recovery rate of 0.3ml of 



reserve liquid, put it in a 25ml measuring bottle, dilute it with solvent to the 



scale, shake well, and then get. 3 parts in parallel (about 0.12μg/ml) 



100% recovery solution: accurately measure the recovery rate of the reserve 



liquid 1.0ml, put it in a 25ml measuring bottle, dilute it with solvent to the 



scale, shake well, and then obtain. 3 parts in parallel (about 0.4μg/ml) 



150% recovery solution: accurately measure the recovery rate of 1.5ml of the 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 203 of 542 





Page 204
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



reserve liquid, put it in a 25ml measuring bottle, dilute it with solvent to the 



scale, shake well, and then obtain. 3 parts in parallel (about 0.6μg/ml) 



 **Injection Sequence** 



After the blank solution, 1 needle was injected into the system suitability 



solution, 2 needles into the mixed control solution, 1 needle into each of 2 



sample solutions and 9 sample recovery solutions; 2 needles were injected 



into the control solution and 1 needle into each of the 9 recovery solutions, 



and the chromatogram was recorded. 



 **Results and Discussion** 



Results of Accuracy Study: 
























--------------------------------------------------------------------------
|YA2304- 12|30% sample recovery solution①|0.0248 |0.1802 |0.1992 |96.8   |
|----------|-----------------------------|-------|-------|-------|-------|
|YA2304- 12|30% sample recovery solution②|0.0249 |0.1802 |0.2054 |100.1  |
|----------|-----------------------------|-------|-------|-------|-------|
|YA2304- 12|30% recovery solution③       |0.0249 |0.1802 |0.2048 |99.9   |
|----------|-----------------------------|-------|-------|-------|-------|
|YA2304- 12|100% recovery solution①      |0.0251 |0.6005 |0.6142 |98.1   |
|----------|-----------------------------|-------|-------|-------|-------|
|YA2304- 12|100% recovery solution②      |0.0252 |0.6005 |0.6143 |98.1   |
|----------|-----------------------------|-------|-------|-------|-------|
|YA2304- 12|100% recovery solution③      |0.0251 |0.6005 |0.6266 |100.2  |
|----------|-----------------------------|-------|-------|-------|-------|
|YA2304- 12|150% recovery solution①      |0.0251 |0.9008 |0.9121 |98.5   |
|----------|-----------------------------|-------|-------|-------|-------|
|YA2304- 12|150% recovery solution②      |0.0251 |0.9008 |0.9046 |97.6   |
|----------|-----------------------------|-------|-------|-------|-------|
|YA2304- 12|150% recovery solution③      |0.0252 |0.9008 |0.9083 |98.0   |
--------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 204 of 542 





Page 205
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 







































------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|RSD (%)                                                                       |RSD (%)                  |RSD (%)                  |RSD (%)                  |1.3                      |             |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------|
|Verdict: The impurity YA2304-12 in the test product was 0.006%. The control   |Verdict:                 |Verdict:                 |Verdict:                 |Verdict:                 |             |
|product YA2304-12 wasadded to the test product in the limit concentration     |The                      |The                      |The                      |The                      |             |
|range of 30%~150% (thatis, 0.1802μg/ml~0.9008μg/ml). The recovery rate ofeach |impurity                 |impurity                 |impurity                 |impurity                 |             |
|concentration point was 96.8%~100.2%. In the range of 85%~110%; The average   |YA2304-12                |YA2304-12                |YA2304-12                |YA2304-12                |             |
|recovery rate was 98.6%. The RSD of recovery was 1.3%, less than 10%;         |in the                   |in the                   |in the                   |in the                   |             |
|Therefore, the accuracy ofimpurity YA2304-12 is good in the range of          |test                     |test                     |test                     |test                     |             |
|0.1802μg/ml~0.9008μg/ml.                                                      |product                  |product                  |product                  |product                  |             |
|                                                                              |was                      |was                      |was                      |was                      |             |
|                                                                              |0.006%.                  |0.006%.                  |0.006%.                  |0.006%.                  |             |
|                                                                              |The                      |The                      |The                      |The                      |             |
|                                                                              |control                  |control                  |control                  |control                  |             |
|                                                                              |product                  |product                  |product                  |product                  |             |
|                                                                              |YA2304-12                |YA2304-12                |YA2304-12                |YA2304-12                |             |
|                                                                              |wasadded                 |wasadded                 |wasadded                 |wasadded                 |             |
|                                                                              |to the                   |to the                   |to the                   |to the                   |             |
|                                                                              |test                     |test                     |test                     |test                     |             |
|                                                                              |product                  |product                  |product                  |product                  |             |
|                                                                              |in the                   |in the                   |in the                   |in the                   |             |
|                                                                              |limit                    |limit                    |limit                    |limit                    |             |
|                                                                              |concentration            |concentration            |concentration            |concentration            |             |
|                                                                              |range                    |range                    |range                    |range                    |             |
|                                                                              |of                       |of                       |of                       |of                       |             |
|                                                                              |30%~150%                 |30%~150%                 |30%~150%                 |30%~150%                 |             |
|                                                                              |(thatis,                 |(thatis,                 |(thatis,                 |(thatis,                 |             |
|                                                                              |0.1802μg/ml~0.9008μg/ml).|0.1802μg/ml~0.9008μg/ml).|0.1802μg/ml~0.9008μg/ml).|0.1802μg/ml~0.9008μg/ml).|             |
|                                                                              |The                      |The                      |The                      |The                      |             |
|                                                                              |recovery                 |recovery                 |recovery                 |recovery                 |             |
|                                                                              |rate                     |rate                     |rate                     |rate                     |             |
|                                                                              |ofeach                   |ofeach                   |ofeach                   |ofeach                   |             |
|                                                                              |concentration            |concentration            |concentration            |concentration            |             |
|                                                                              |point                    |point                    |point                    |point                    |             |
|                                                                              |was                      |was                      |was                      |was                      |             |
|                                                                              |96.8%~100.2%.            |96.8%~100.2%.            |96.8%~100.2%.            |96.8%~100.2%.            |             |
|                                                                              |In the                   |In the                   |In the                   |In the                   |             |
|                                                                              |range                    |range                    |range                    |range                    |             |
|                                                                              |of                       |of                       |of                       |of                       |             |
|                                                                              |85%~110%;                |85%~110%;                |85%~110%;                |85%~110%;                |             |
|                                                                              |The                      |The                      |The                      |The                      |             |
|                                                                              |average                  |average                  |average                  |average                  |             |
|                                                                              |recovery                 |recovery                 |recovery                 |recovery                 |             |
|                                                                              |rate                     |rate                     |rate                     |rate                     |             |
|                                                                              |was                      |was                      |was                      |was                      |             |
|                                                                              |98.6%.                   |98.6%.                   |98.6%.                   |98.6%.                   |             |
|                                                                              |The RSD                  |The RSD                  |The RSD                  |The RSD                  |             |
|                                                                              |of                       |of                       |of                       |of                       |             |
|                                                                              |recovery                 |recovery                 |recovery                 |recovery                 |             |
|                                                                              |was                      |was                      |was                      |was                      |             |
|                                                                              |1.3%,                    |1.3%,                    |1.3%,                    |1.3%,                    |             |
|                                                                              |less                     |less                     |less                     |less                     |             |
|                                                                              |than                     |than                     |than                     |than                     |             |
|                                                                              |10%;                     |10%;                     |10%;                     |10%;                     |             |
|                                                                              |Therefore,               |Therefore,               |Therefore,               |Therefore,               |             |
|                                                                              |the                      |the                      |the                      |the                      |             |
|                                                                              |accuracy                 |accuracy                 |accuracy                 |accuracy                 |             |
|                                                                              |ofimpurity               |ofimpurity               |ofimpurity               |ofimpurity               |             |
|                                                                              |YA2304-12                |YA2304-12                |YA2304-12                |YA2304-12                |             |
|                                                                              |is good                  |is good                  |is good                  |is good                  |             |
|                                                                              |in the                   |in the                   |in the                   |in the                   |             |
|                                                                              |range                    |range                    |range                    |range                    |             |
|                                                                              |of                       |of                       |of                       |of                       |             |
|                                                                              |0.1802μg/ml~0.9008μg/ml. |0.1802μg/ml~0.9008μg/ml. |0.1802μg/ml~0.9008μg/ml. |0.1802μg/ml~0.9008μg/ml. |             |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------|
|Impuritie sName                                                               |Solution name            |Test quantity (μg/ml)    |Amountadded (μg/ml)      |Measuredamount (μg/ml)   |Recovery     |
|                                                                              |                         |                         |                         |                         |rate         |
|                                                                              |                         |                         |                         |                         |(%)          |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------|
|YA2304- 14                                                                    |30% recovery solution①   |Not detected             |0.1810                   |0.1830                   |101.1        |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------|
|YA2304- 14                                                                    |30% sample recovery      |30% sample recovery      |0.1810                   |0.1810                   |100.0        |
|                                                                              |solution②                |solution②                |                         |                         |             |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------|
|YA2304- 14                                                                    |30% recovery solution③   |30% recovery solution③   |0.1810                   |0.1849                   |102.2        |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------|
|YA2304- 14                                                                    |100% recovery solution①  |100% recovery solution①  |0.6032                   |0.5880                   |97.5         |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------|
|YA2304- 14                                                                    |100% recovery solution②  |100% recovery solution②  |0.6032                   |0.5879                   |97.5         |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------|
|YA2304- 14                                                                    |100% recovery solution③  |100% recovery solution③  |0.6032                   |0.5846                   |96.9         |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------|
|YA2304- 14                                                                    |150% recovery solution①  |150% recovery solution①  |0.9048                   |0.8827                   |97.6         |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------|
|YA2304- 14                                                                    |150% recovery solution②  |150% recovery solution②  |0.9048                   |0.8781                   |97.0         |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------|
|YA2304- 14                                                                    |150% recovery solution③  |150% recovery solution③  |0.9048                   |0.8760                   |96.8         |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------|
|YA2304- 14                                                                    |Average recovery rate (%)|Average recovery rate (%)|Average recovery rate (%)|Average recovery rate (%)|98.5         |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------|
|YA2304- 14                                                                    |RSD (%)                  |RSD (%)                  |RSD (%)                  |RSD (%)                  |2.1          |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------|
|YA2304- 14                                                                    |Conclusions: The impurity|Conclusions: The impurity|Conclusions: The impurity|Conclusions: The impurity|Conclusions: |
|                                                                              |YA2304-14 was not        |YA2304-14 was not        |YA2304-14 was not        |YA2304-14 was not        |The          |
|                                                                              |detected in the test     |detected in the test     |detected in the test     |detected in the test     |impurity     |
|                                                                              |product, and the control |product, and the control |product, and the control |product, and the control |YA2304-14    |
|                                                                              |product YA2304-14        |product YA2304-14        |product YA2304-14        |product YA2304-14        |was not      |
|                                                                              |wasadded to the test     |wasadded to the test     |wasadded to the test     |wasadded to the test     |detected     |
|                                                                              |product in the limit     |product in the limit     |product in the limit     |product in the limit     |in the       |
|                                                                              |concentration range of   |concentration range of   |concentration range of   |concentration range of   |test         |
|                                                                              |30% to 150% (thatis, in  |30% to 150% (thatis, in  |30% to 150% (thatis, in  |30% to 150% (thatis, in  |product,     |
|                                                                              |the range of 0.1810μg/ml |the range of 0.1810μg/ml |the range of 0.1810μg/ml |the range of 0.1810μg/ml |and the      |
|                                                                              |to 0.9048μg/ml). The     |to 0.9048μg/ml). The     |to 0.9048μg/ml). The     |to 0.9048μg/ml). The     |control      |
|                                                                              |recoveries ofeach        |recoveries ofeach        |recoveries ofeach        |recoveries ofeach        |product      |
|                                                                              |concentration point were |concentration point were |concentration point were |concentration point were |YA2304-14    |
|                                                                              |96.8% to 102.2%, and the |96.8% to 102.2%, and the |96.8% to 102.2%, and the |96.8% to 102.2%, and the |wasadded     |
|                                                                              |recoveries were 85% to   |recoveries were 85% to   |recoveries were 85% to   |recoveries were 85% to   |to the       |
|                                                                              |110%. The average        |110%. The average        |110%. The average        |110%. The average        |test         |
|                                                                              |recoveries were 98.5%;   |recoveries were 98.5%;   |recoveries were 98.5%;   |recoveries were 98.5%;   |product      |
|                                                                              |The RSD of recovery was  |The RSD of recovery was  |The RSD of recovery was  |The RSD of recovery was  |in the       |
|                                                                              |2.1%, less than 10%;     |2.1%, less than 10%;     |2.1%, less than 10%;     |2.1%, less than 10%;     |limit        |
|                                                                              |Therefore, the accuracy  |Therefore, the accuracy  |Therefore, the accuracy  |Therefore, the accuracy  |concentration|
|                                                                              |ofimpurity YA2304-14 was |ofimpurity YA2304-14 was |ofimpurity YA2304-14 was |ofimpurity YA2304-14 was |range of     |
|                                                                              |                         |                         |                         |                         |30% to       |
|                                                                              |                         |                         |                         |                         |150%         |
|                                                                              |                         |                         |                         |                         |(thatis,     |
|                                                                              |                         |                         |                         |                         |in the       |
|                                                                              |                         |                         |                         |                         |range of     |
|                                                                              |                         |                         |                         |                         |0.1810μg/ml  |
|                                                                              |                         |                         |                         |                         |to           |
|                                                                              |                         |                         |                         |                         |0.9048μg/ml).|
|                                                                              |                         |                         |                         |                         |The          |
|                                                                              |                         |                         |                         |                         |recoveries   |
|                                                                              |                         |                         |                         |                         |ofeach       |
|                                                                              |                         |                         |                         |                         |concentration|
|                                                                              |                         |                         |                         |                         |point        |
|                                                                              |                         |                         |                         |                         |were         |
|                                                                              |                         |                         |                         |                         |96.8% to     |
|                                                                              |                         |                         |                         |                         |102.2%,      |
|                                                                              |                         |                         |                         |                         |and the      |
|                                                                              |                         |                         |                         |                         |recoveries   |
|                                                                              |                         |                         |                         |                         |were 85%     |
|                                                                              |                         |                         |                         |                         |to 110%.     |
|                                                                              |                         |                         |                         |                         |The          |
|                                                                              |                         |                         |                         |                         |average      |
|                                                                              |                         |                         |                         |                         |recoveries   |
|                                                                              |                         |                         |                         |                         |were         |
|                                                                              |                         |                         |                         |                         |98.5%;       |
|                                                                              |                         |                         |                         |                         |The RSD      |
|                                                                              |                         |                         |                         |                         |of           |
|                                                                              |                         |                         |                         |                         |recovery     |
|                                                                              |                         |                         |                         |                         |was          |
|                                                                              |                         |                         |                         |                         |2.1%,        |
|                                                                              |                         |                         |                         |                         |less         |
|                                                                              |                         |                         |                         |                         |than         |
|                                                                              |                         |                         |                         |                         |10%;         |
|                                                                              |                         |                         |                         |                         |Therefore,   |
|                                                                              |                         |                         |                         |                         |the          |
|                                                                              |                         |                         |                         |                         |accuracy     |
|                                                                              |                         |                         |                         |                         |ofimpurity   |
|                                                                              |                         |                         |                         |                         |YA2304-14    |
|                                                                              |                         |                         |                         |                         |was          |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 205 of 542 





Page 206
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 

























































----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Impuritie sName|Solution name                                                         |Quantity                  |Amountadded               |Measuredamount            |Recovery                  |
|               |                                                                      |of test                   |(μg/ml)                   |(μg/ml)                   |rate                      |
|               |                                                                      |product                   |                          |                          |(%)                       |
|               |                                                                      |detected                  |                          |                          |                          |
|               |                                                                      |(μg/ml)                   |                          |                          |                          |
|---------------|----------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|YA2304- 15     |30% recovery solution①                                                |Not                       |0.1816                    |0.1867                    |102.8                     |
|               |                                                                      |detected                  |                          |                          |                          |
|---------------|----------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|YA2304- 15     |30% sample recovery solution②                                         |30%                       |0.1816                    |0.1858                    |102.3                     |
|               |                                                                      |sample                    |                          |                          |                          |
|               |                                                                      |recovery                  |                          |                          |                          |
|               |                                                                      |solution②                 |                          |                          |                          |
|---------------|----------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|YA2304- 15     |30% recovery solution③                                                |30%                       |0.1816                    |0.1857                    |102.2                     |
|               |                                                                      |recovery                  |                          |                          |                          |
|               |                                                                      |solution③                 |                          |                          |                          |
|---------------|----------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|YA2304- 15     |100% recovery solution①                                               |100%                      |0.6055                    |0.5950                    |98.3                      |
|               |                                                                      |recovery                  |                          |                          |                          |
|               |                                                                      |solution①                 |                          |                          |                          |
|---------------|----------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|YA2304- 15     |100% recovery solution②                                               |100%                      |0.6055                    |0.6005                    |99.2                      |
|               |                                                                      |recovery                  |                          |                          |                          |
|               |                                                                      |solution②                 |                          |                          |                          |
|---------------|----------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|YA2304- 15     |100% sample recovery solution③                                        |100%                      |0.6055                    |0.5982                    |98.8                      |
|               |                                                                      |sample                    |                          |                          |                          |
|               |                                                                      |recovery                  |                          |                          |                          |
|               |                                                                      |solution③                 |                          |                          |                          |
|---------------|----------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|YA2304- 15     |150% recovery solution①                                               |150%                      |0.9082                    |0.8881                    |97.8                      |
|               |                                                                      |recovery                  |                          |                          |                          |
|               |                                                                      |solution①                 |                          |                          |                          |
|---------------|----------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|YA2304- 15     |150% recovery solution②                                               |150%                      |0.9082                    |0.8878                    |97.8                      |
|               |                                                                      |recovery                  |                          |                          |                          |
|               |                                                                      |solution②                 |                          |                          |                          |
|---------------|----------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|YA2304- 15     |150% recovery solution③                                               |150%                      |0.9082                    |0.8951                    |98.6                      |
|               |                                                                      |recovery                  |                          |                          |                          |
|               |                                                                      |solution③                 |                          |                          |                          |
|---------------|----------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|YA2304- 15     |Average recovery rate (%)                                             |Average                   |Average                   |Average                   |99.7                      |
|               |                                                                      |recovery                  |recovery                  |recovery rate             |                          |
|               |                                                                      |rate (%)                  |rate (%)                  |(%)                       |                          |
|---------------|----------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|YA2304- 15     |RSD (%)                                                               |RSD (%)                   |RSD (%)                   |RSD (%)                   |2.1                       |
|---------------|----------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|YA2304- 15     |Conclusions: The impurity YA2304-15 was not detected in the test      |Conclusions:              |Conclusions:              |Conclusions:              |Conclusions:              |
|               |product. The control product YA2304-15 wasadded in the limit          |The                       |The                       |The impurity              |The                       |
|               |concentration range of 30%~150% (0.1816μg/ml~0.9082μg/ml). The        |impurity                  |impurity                  |YA2304-15 was             |impurity                  |
|               |recoveries ofeach concentration point were 97.8%~102.8%, and the      |YA2304-15                 |YA2304-15                 |not detected              |YA2304-15                 |
|               |recoveries were 85%~110%. The average recoveries were 99.7%; The RSD  |was not                   |was not                   |in the test               |was not                   |
|               |of recovery was 2.1%, less than 10%; Therefore, the accuracy          |detected                  |detected in               |product. The              |detected                  |
|               |ofimpurity YA2304-15 was good in the range of 0.1816μg/ml~0.9082μg/ml.|in the                    |the test                  |control                   |in the                    |
|               |                                                                      |test                      |product.                  |product                   |test                      |
|               |                                                                      |product.                  |The control               |YA2304-15                 |product.                  |
|               |                                                                      |The                       |product                   |wasadded in               |The                       |
|               |                                                                      |control                   |YA2304-15                 |the limit                 |control                   |
|               |                                                                      |product                   |wasadded in               |concentration             |product                   |
|               |                                                                      |YA2304-15                 |the limit                 |range of                  |YA2304-15                 |
|               |                                                                      |wasadded                  |concentration             |30%~150%                  |wasadded                  |
|               |                                                                      |in the                    |range of                  |(0.1816μg/ml~0.9082μg/ml).|in the                    |
|               |                                                                      |limit                     |30%~150%                  |The recoveries            |limit                     |
|               |                                                                      |concentration             |(0.1816μg/ml~0.9082μg/ml).|ofeach                    |concentration             |
|               |                                                                      |range of                  |The                       |concentration             |range of                  |
|               |                                                                      |30%~150%                  |recoveries                |point were                |30%~150%                  |
|               |                                                                      |(0.1816μg/ml~0.9082μg/ml).|ofeach                    |97.8%~102.8%,             |(0.1816μg/ml~0.9082μg/ml).|
|               |                                                                      |The                       |concentration             |and the                   |The                       |
|               |                                                                      |recoveries                |point were                |recoveries                |recoveries                |
|               |                                                                      |ofeach                    |97.8%~102.8%,             |were 85%~110%.            |ofeach                    |
|               |                                                                      |concentration             |and the                   |The average               |concentration             |
|               |                                                                      |point                     |recoveries                |recoveries                |point                     |
|               |                                                                      |were                      |were                      |were 99.7%;               |were                      |
|               |                                                                      |97.8%~102.8%,             |85%~110%.                 |The RSD of                |97.8%~102.8%,             |
|               |                                                                      |and the                   |The average               |recovery was              |and the                   |
|               |                                                                      |recoveries                |recoveries                |2.1%, less                |recoveries                |
|               |                                                                      |were                      |were 99.7%;               |than 10%;                 |were                      |
|               |                                                                      |85%~110%.                 |The RSD of                |Therefore, the            |85%~110%.                 |
|               |                                                                      |The                       |recovery                  |accuracy                  |The                       |
|               |                                                                      |average                   |was 2.1%,                 |ofimpurity                |average                   |
|               |                                                                      |recoveries                |less than                 |YA2304-15 was             |recoveries                |
|               |                                                                      |were                      |10%;                      |good in the               |were                      |
|               |                                                                      |99.7%;                    |Therefore,                |range of                  |99.7%;                    |
|               |                                                                      |The RSD                   |the                       |0.1816μg/ml~0.9082μg/ml.  |The RSD                   |
|               |                                                                      |of                        |accuracy                  |                          |of                        |
|               |                                                                      |recovery                  |ofimpurity                |                          |recovery                  |
|               |                                                                      |was 2.1%,                 |YA2304-15                 |                          |was                       |
|               |                                                                      |less than                 |was good in               |                          |2.1%,                     |
|               |                                                                      |10%;                      |the range                 |                          |less                      |
|               |                                                                      |Therefore,                |of                        |                          |than                      |
|               |                                                                      |the                       |0.1816μg/ml~0.9082μg/ml.  |                          |10%;                      |
|               |                                                                      |accuracy                  |                          |                          |Therefore,                |
|               |                                                                      |ofimpurity                |                          |                          |the                       |
|               |                                                                      |YA2304-15                 |                          |                          |accuracy                  |
|               |                                                                      |was good                  |                          |                          |ofimpurity                |
|               |                                                                      |in the                    |                          |                          |YA2304-15                 |
|               |                                                                      |range of                  |                          |                          |was good                  |
|               |                                                                      |0.1816μg/ml~0.9082μg/ml.  |                          |                          |in the                    |
|               |                                                                      |                          |                          |                          |range of                  |
|               |                                                                      |                          |                          |                          |0.1816μg/ml~0.9082μg/ml.  |
|---------------|----------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|Impuritie sName|Solution name                                                         |Quantity of test product  |Amountadded (μg/ml)       |Measuredamount (μg/ml)    |Recovery rate (%)         |
|               |                                                                      |detected (μg/ml)          |                          |                          |                          |
|---------------|----------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|YA2304- 16     |30% recovery solution①                                                |Not detected              |0.1739                    |0.1606                    |92.4                      |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 206 of 542 





Page 207
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 





































-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|30% recovery solution③                                                        |30%                       |0.1739                    |0.1625                    |93.4                      |        |
|                                                                              |recovery                  |                          |                          |                          |        |
|                                                                              |solution③                 |                          |                          |                          |        |
|------------------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|--------|
|100% recovery solution①                                                       |100%                      |0.5797                    |0.5519                    |95.2                      |        |
|                                                                              |recovery                  |                          |                          |                          |        |
|                                                                              |solution①                 |                          |                          |                          |        |
|------------------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|--------|
|100% recovery solution②                                                       |100%                      |0.5797                    |0.5515                    |95.1                      |        |
|                                                                              |recovery                  |                          |                          |                          |        |
|                                                                              |solution②                 |                          |                          |                          |        |
|------------------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|--------|
|100% recovery solution③                                                       |100%                      |0.5797                    |0.5516                    |95.1                      |        |
|                                                                              |recovery                  |                          |                          |                          |        |
|                                                                              |solution③                 |                          |                          |                          |        |
|------------------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|--------|
|150% recovery solution①                                                       |150%                      |0.8696                    |0.8297                    |95.4                      |        |
|                                                                              |recovery                  |                          |                          |                          |        |
|                                                                              |solution①                 |                          |                          |                          |        |
|------------------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|--------|
|150% recovery solution②                                                       |150%                      |0.8696                    |0.8282                    |95.2                      |        |
|                                                                              |recovery                  |                          |                          |                          |        |
|                                                                              |solution②                 |                          |                          |                          |        |
|------------------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|--------|
|150% recovery solution③                                                       |150%                      |0.8696                    |0.8240                    |94.7                      |        |
|                                                                              |recovery                  |                          |                          |                          |        |
|                                                                              |solution③                 |                          |                          |                          |        |
|------------------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|--------|
|Average recovery rate (%)                                                     |Average                   |Average                   |Average                   |94.2                      |        |
|                                                                              |recovery                  |recovery                  |recovery                  |                          |        |
|                                                                              |rate (%)                  |rate                      |rate                      |                          |        |
|                                                                              |                          |(%)                       |(%)                       |                          |        |
|------------------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|--------|
|RSD (%)                                                                       |RSD (%)                   |RSD (%)                   |RSD (%)                   |1.6                       |        |
|------------------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|--------|
|Conclusions: The impurity YA2304-16 was not detected in the test product, and |Conclusions:              |Conclusions:              |Conclusions:              |Conclusions:              |        |
|the control product YA2304-16 wasadded in the limit concentration range of    |The                       |The                       |The                       |The                       |        |
|30%~150% (0.1739μg/ml~0.8696μg/ml). The recoveries ofeach concentration point |impurity                  |impurity                  |impurity                  |impurity                  |        |
|were 91.3%~95.4%, and the recoveries were 85%~110%. The average recoveries    |YA2304-16                 |YA2304-16                 |YA2304-16                 |YA2304-16                 |        |
|were 94.2%; The RSD of recovery was 1.6%, less than 10%. Therefore, the       |was not                   |was not                   |was not                   |was not                   |        |
|accuracy ofimpurity YA2304-16 was good in the range of                        |detected                  |detected                  |detected                  |detected                  |        |
|0.1739μg/ml~0.8696μg/ml.                                                      |in the                    |in the                    |in the                    |in the                    |        |
|                                                                              |test                      |test                      |test                      |test                      |        |
|                                                                              |product,                  |product,                  |product,                  |product,                  |        |
|                                                                              |and the                   |and the                   |and the                   |and the                   |        |
|                                                                              |control                   |control                   |control                   |control                   |        |
|                                                                              |product                   |product                   |product                   |product                   |        |
|                                                                              |YA2304-16                 |YA2304-16                 |YA2304-16                 |YA2304-16                 |        |
|                                                                              |wasadded                  |wasadded                  |wasadded                  |wasadded                  |        |
|                                                                              |in the                    |in the                    |in the                    |in the                    |        |
|                                                                              |limit                     |limit                     |limit                     |limit                     |        |
|                                                                              |concentration             |concentration             |concentration             |concentration             |        |
|                                                                              |range of                  |range of                  |range of                  |range                     |        |
|                                                                              |30%~150%                  |30%~150%                  |30%~150%                  |of                        |        |
|                                                                              |(0.1739μg/ml~0.8696μg/ml).|(0.1739μg/ml~0.8696μg/ml).|(0.1739μg/ml~0.8696μg/ml).|30%~150%                  |        |
|                                                                              |The                       |The                       |The                       |(0.1739μg/ml~0.8696μg/ml).|        |
|                                                                              |recoveries                |recoveries                |recoveries                |The                       |        |
|                                                                              |ofeach                    |ofeach                    |ofeach                    |recoveries                |        |
|                                                                              |concentration             |concentration             |concentration             |ofeach                    |        |
|                                                                              |point                     |point                     |point                     |concentration             |        |
|                                                                              |were                      |were                      |were                      |point                     |        |
|                                                                              |91.3%~95.4%,              |91.3%~95.4%,              |91.3%~95.4%,              |were                      |        |
|                                                                              |and the                   |and the                   |and the                   |91.3%~95.4%,              |        |
|                                                                              |recoveries                |recoveries                |recoveries                |and the                   |        |
|                                                                              |were                      |were                      |were                      |recoveries                |        |
|                                                                              |85%~110%.                 |85%~110%.                 |85%~110%.                 |were                      |        |
|                                                                              |The                       |The                       |The                       |85%~110%.                 |        |
|                                                                              |average                   |average                   |average                   |The                       |        |
|                                                                              |recoveries                |recoveries                |recoveries                |average                   |        |
|                                                                              |were                      |were                      |were                      |recoveries                |        |
|                                                                              |94.2%;                    |94.2%;                    |94.2%;                    |were                      |        |
|                                                                              |The RSD                   |The RSD                   |The RSD                   |94.2%;                    |        |
|                                                                              |of                        |of                        |of                        |The RSD                   |        |
|                                                                              |recovery                  |recovery                  |recovery                  |of                        |        |
|                                                                              |was 1.6%,                 |was                       |was                       |recovery                  |        |
|                                                                              |less than                 |1.6%,                     |1.6%,                     |was                       |        |
|                                                                              |10%.                      |less                      |less                      |1.6%,                     |        |
|                                                                              |Therefore,                |than                      |than                      |less                      |        |
|                                                                              |the                       |10%.                      |10%.                      |than                      |        |
|                                                                              |accuracy                  |Therefore,                |Therefore,                |10%.                      |        |
|                                                                              |ofimpurity                |the                       |the                       |Therefore,                |        |
|                                                                              |YA2304-16                 |accuracy                  |accuracy                  |the                       |        |
|                                                                              |was good                  |ofimpurity                |ofimpurity                |accuracy                  |        |
|                                                                              |in the                    |YA2304-16                 |YA2304-16                 |ofimpurity                |        |
|                                                                              |range of                  |was good                  |was good                  |YA2304-16                 |        |
|                                                                              |0.1739μg/ml~0.8696μg/ml.  |in the                    |in the                    |was                       |        |
|                                                                              |                          |range of                  |range of                  |good in                   |        |
|                                                                              |                          |0.1739μg/ml~0.8696μg/ml.  |0.1739μg/ml~0.8696μg/ml.  |the                       |        |
|                                                                              |                          |                          |                          |range                     |        |
|                                                                              |                          |                          |                          |of                        |        |
|                                                                              |                          |                          |                          |0.1739μg/ml~0.8696μg/ml.  |        |
|------------------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|--------|
|Impuritie sName                                                               |Solution name             |Quantity of test product  |Dosage (μg/ml)            |Measuredamount (μg/ml)    |Recovery|
|                                                                              |                          |detected (μg/ml)          |                          |                          |rate    |
|                                                                              |                          |                          |                          |                          |(%)     |
|------------------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|--------|
|YA2304- 18                                                                    |30% recovery solution①    |Not detected              |0.1804                    |0.1762                    |97.7    |
|------------------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|--------|
|YA2304- 18                                                                    |30% sample recovery       |30% sample recovery       |0.1804                    |0.1777                    |98.5    |
|                                                                              |solution②                 |solution②                 |                          |                          |        |
|------------------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|--------|
|YA2304- 18                                                                    |30% recovery solution③    |30% recovery solution③    |0.1804                    |0.1760                    |97.5    |
|------------------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|--------|
|YA2304- 18                                                                    |100% recovery solution①   |100% recovery solution①   |0.6014                    |0.5856                    |97.4    |
|------------------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|--------|
|YA2304- 18                                                                    |100% recovery solution②   |100% recovery solution②   |0.6014                    |0.5921                    |98.5    |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 207 of 542 





Page 208
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 
























---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|150% recovery solution①                                                       |150%                    |0.9020                  |0.8734                  |96.8                    |        |
|                                                                              |recovery                |                        |                        |                        |        |
|                                                                              |solution①               |                        |                        |                        |        |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|--------|
|150% recovery solution②                                                       |150%                    |0.9020                  |0.8742                  |96.9                    |        |
|                                                                              |recovery                |                        |                        |                        |        |
|                                                                              |solution②               |                        |                        |                        |        |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|--------|
|150% recovery solution③                                                       |150%                    |0.9020                  |0.8775                  |97.3                    |        |
|                                                                              |recovery                |                        |                        |                        |        |
|                                                                              |solution③               |                        |                        |                        |        |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|--------|
|Average recovery rate (%)                                                     |Average                 |Average                 |Average                 |97.6                    |        |
|                                                                              |recovery                |recovery                |recovery                |                        |        |
|                                                                              |rate (%)                |rate                    |rate                    |                        |        |
|                                                                              |                        |(%)                     |(%)                     |                        |        |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|--------|
|RSD (%)                                                                       |RSD (%)                 |RSD (%)                 |RSD (%)                 |0.7                     |        |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|--------|
|Conclusions: The impurity YA2304-18 was not detected in the test product, and |Conclusions:            |Conclusions:            |Conclusions:            |Conclusions:            |        |
|the control product YA2304-18 wasadded to the test product in the limit       |The                     |The                     |The                     |The                     |        |
|concentration range of 30% to 150% (thatis, 0.1804μg/ml to 0.9020μg/ml). The  |impurity                |impurity                |impurity                |impurity                |        |
|recoveries ofeach concentration point were 96.8% to 98.5%, andall were 85% to |YA2304-18               |YA2304-18               |YA2304-18               |YA2304-18               |        |
|110%. The average recoveries were 97.6%; The RSD of recovery was 0.7%, less   |was not                 |was not                 |was not                 |was not                 |        |
|than 10%; Therefore, the accuracy ofimpurity YA2304-18 was good in the range  |detected                |detected                |detected                |detected                |        |
|of 0.1804μg/ml~0.9020μg/ml.                                                   |in the                  |in the                  |in the                  |in the                  |        |
|                                                                              |test                    |test                    |test                    |test                    |        |
|                                                                              |product,                |product,                |product,                |product,                |        |
|                                                                              |and the                 |and the                 |and the                 |and the                 |        |
|                                                                              |control                 |control                 |control                 |control                 |        |
|                                                                              |product                 |product                 |product                 |product                 |        |
|                                                                              |YA2304-18               |YA2304-18               |YA2304-18               |YA2304-18               |        |
|                                                                              |wasadded                |wasadded                |wasadded                |wasadded                |        |
|                                                                              |to the                  |to the                  |to the                  |to the                  |        |
|                                                                              |test                    |test                    |test                    |test                    |        |
|                                                                              |product                 |product                 |product                 |product                 |        |
|                                                                              |in the                  |in the                  |in the                  |in the                  |        |
|                                                                              |limit                   |limit                   |limit                   |limit                   |        |
|                                                                              |concentration           |concentration           |concentration           |concentration           |        |
|                                                                              |range of                |range of                |range of                |range                   |        |
|                                                                              |30% to                  |30% to                  |30% to                  |of 30%                  |        |
|                                                                              |150%                    |150%                    |150%                    |to 150%                 |        |
|                                                                              |(thatis,                |(thatis,                |(thatis,                |(thatis,                |        |
|                                                                              |0.1804μg/ml             |0.1804μg/ml             |0.1804μg/ml             |0.1804μg/ml             |        |
|                                                                              |to                      |to                      |to                      |to                      |        |
|                                                                              |0.9020μg/ml).           |0.9020μg/ml).           |0.9020μg/ml).           |0.9020μg/ml).           |        |
|                                                                              |The                     |The                     |The                     |The                     |        |
|                                                                              |recoveries              |recoveries              |recoveries              |recoveries              |        |
|                                                                              |ofeach                  |ofeach                  |ofeach                  |ofeach                  |        |
|                                                                              |concentration           |concentration           |concentration           |concentration           |        |
|                                                                              |point                   |point                   |point                   |point                   |        |
|                                                                              |were                    |were                    |were                    |were                    |        |
|                                                                              |96.8% to                |96.8% to                |96.8% to                |96.8%                   |        |
|                                                                              |98.5%,                  |98.5%,                  |98.5%,                  |to                      |        |
|                                                                              |andall                  |andall                  |andall                  |98.5%,                  |        |
|                                                                              |were 85%                |were 85%                |were 85%                |andall                  |        |
|                                                                              |to 110%.                |to 110%.                |to 110%.                |were                    |        |
|                                                                              |The                     |The                     |The                     |85% to                  |        |
|                                                                              |average                 |average                 |average                 |110%.                   |        |
|                                                                              |recoveries              |recoveries              |recoveries              |The                     |        |
|                                                                              |were                    |were                    |were                    |average                 |        |
|                                                                              |97.6%;                  |97.6%;                  |97.6%;                  |recoveries              |        |
|                                                                              |The RSD                 |The RSD                 |The RSD                 |were                    |        |
|                                                                              |of                      |of                      |of                      |97.6%;                  |        |
|                                                                              |recovery                |recovery                |recovery                |The RSD                 |        |
|                                                                              |was 0.7%,               |was                     |was                     |of                      |        |
|                                                                              |less than               |0.7%,                   |0.7%,                   |recovery                |        |
|                                                                              |10%;                    |less                    |less                    |was                     |        |
|                                                                              |Therefore,              |than                    |than                    |0.7%,                   |        |
|                                                                              |the                     |10%;                    |10%;                    |less                    |        |
|                                                                              |accuracy                |Therefore,              |Therefore,              |than                    |        |
|                                                                              |ofimpurity              |the                     |the                     |10%;                    |        |
|                                                                              |YA2304-18               |accuracy                |accuracy                |Therefore,              |        |
|                                                                              |was good                |ofimpurity              |ofimpurity              |the                     |        |
|                                                                              |in the                  |YA2304-18               |YA2304-18               |accuracy                |        |
|                                                                              |range of                |was good                |was good                |ofimpurity              |        |
|                                                                              |0.1804μg/ml~0.9020μg/ml.|in the                  |in the                  |YA2304-18               |        |
|                                                                              |                        |range of                |range of                |was                     |        |
|                                                                              |                        |0.1804μg/ml~0.9020μg/ml.|0.1804μg/ml~0.9020μg/ml.|good in                 |        |
|                                                                              |                        |                        |                        |the                     |        |
|                                                                              |                        |                        |                        |range                   |        |
|                                                                              |                        |                        |                        |of                      |        |
|                                                                              |                        |                        |                        |0.1804μg/ml~0.9020μg/ml.|        |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|--------|
|Impuritie sName                                                               |Solution name           |Quantity of test product|Amountadded (μg/ml)     |Measuredamount (μg/ml)  |Recovery|
|                                                                              |                        |detected (μg/ml)        |                        |                        |rate    |
|                                                                              |                        |                        |                        |                        |(%)     |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|--------|
|YA2304- 19                                                                    |30% recovery solution①  |0.0359                  |0.1802                  |0.2094                  |96.3    |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|--------|
|YA2304- 19                                                                    |30% sample recovery     |0.0360                  |0.1802                  |0.2271                  |106.0   |
|                                                                              |solution②               |                        |                        |                        |        |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|--------|
|YA2304- 19                                                                    |30% recovery solution③  |0.0359                  |0.1802                  |0.2021                  |92.2    |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|--------|
|YA2304- 19                                                                    |100% recovery solution① |0.0362                  |0.6008                  |0.6206                  |97.3    |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|--------|
|YA2304- 19                                                                    |100% recovery solution② |0.0363                  |0.6008                  |0.6123                  |95.9    |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|--------|
|YA2304- 19                                                                    |100% recovery solution③ |0.0362                  |0.6008                  |0.6123                  |95.9    |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|--------|
|YA2304- 19                                                                    |150% recovery solution① |0.0363                  |0.9012                  |0.9011                  |96.0    |
|------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|--------|
|YA2304- 19                                                                    |150% recovery solution② |0.0363                  |0.9012                  |0.9003                  |95.9    |
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 208 of 542 





Page 209
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 







































------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Average recovery rate (%)                                                     |Average                  |Average                  |Average                  |96.8                     |                         |
|                                                                              |recovery                 |recovery                 |recovery                 |                         |                         |
|                                                                              |rate                     |rate                     |rate                     |                         |                         |
|                                                                              |(%)                      |(%)                      |(%)                      |                         |                         |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|RSD (%)                                                                       |RSD (%)                  |RSD (%)                  |RSD (%)                  |4                        |                         |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|Verdict: The impurity YA2304-19 in the test product was 0.009%. The control   |Verdict:                 |Verdict:                 |Verdict:                 |Verdict:                 |                         |
|product YA2304-19 in the limit concentration range of 30%~150% wasadded to the|The                      |The                      |The                      |The                      |                         |
|test product (thatis, 0.1802μg/ml~0.9012μg/ml). The recovery rate ofeach      |impurity                 |impurity                 |impurity                 |impurity                 |                         |
|concentration point was 92.2%~106.0%. In the range of 85%~110%; The average   |YA2304-19                |YA2304-19                |YA2304-19                |YA2304-19                |                         |
|recovery rate was 96.8%. The RSD of recovery was 4%, less than 10%; Therefore,|in the                   |in the                   |in the                   |in the                   |                         |
|the accuracy ofimpurity YA2304-19 is good in the range of                     |test                     |test                     |test                     |test                     |                         |
|0.1802μg/ml~0.9012μg/ml.                                                      |product                  |product                  |product                  |product                  |                         |
|                                                                              |was                      |was                      |was                      |was                      |                         |
|                                                                              |0.009%.                  |0.009%.                  |0.009%.                  |0.009%.                  |                         |
|                                                                              |The                      |The                      |The                      |The                      |                         |
|                                                                              |control                  |control                  |control                  |control                  |                         |
|                                                                              |product                  |product                  |product                  |product                  |                         |
|                                                                              |YA2304-19                |YA2304-19                |YA2304-19                |YA2304-19                |                         |
|                                                                              |in the                   |in the                   |in the                   |in the                   |                         |
|                                                                              |limit                    |limit                    |limit                    |limit                    |                         |
|                                                                              |concentration            |concentration            |concentration            |concentration            |                         |
|                                                                              |range of                 |range of                 |range of                 |range                    |                         |
|                                                                              |30%~150%                 |30%~150%                 |30%~150%                 |of                       |                         |
|                                                                              |wasadded                 |wasadded                 |wasadded                 |30%~150%                 |                         |
|                                                                              |to the                   |to the                   |to the                   |wasadded                 |                         |
|                                                                              |test                     |test                     |test                     |to the                   |                         |
|                                                                              |product                  |product                  |product                  |test                     |                         |
|                                                                              |(thatis,                 |(thatis,                 |(thatis,                 |product                  |                         |
|                                                                              |0.1802μg/ml~0.9012μg/ml).|0.1802μg/ml~0.9012μg/ml).|0.1802μg/ml~0.9012μg/ml).|(thatis,                 |                         |
|                                                                              |The                      |The                      |The                      |0.1802μg/ml~0.9012μg/ml).|                         |
|                                                                              |recovery                 |recovery                 |recovery                 |The                      |                         |
|                                                                              |rate                     |rate                     |rate                     |recovery                 |                         |
|                                                                              |ofeach                   |ofeach                   |ofeach                   |rate                     |                         |
|                                                                              |concentration            |concentration            |concentration            |ofeach                   |                         |
|                                                                              |point                    |point                    |point                    |concentration            |                         |
|                                                                              |was                      |was                      |was                      |point                    |                         |
|                                                                              |92.2%~106.0%.            |92.2%~106.0%.            |92.2%~106.0%.            |was                      |                         |
|                                                                              |In the                   |In the                   |In the                   |92.2%~106.0%.            |                         |
|                                                                              |range of                 |range of                 |range of                 |In the                   |                         |
|                                                                              |85%~110%;                |85%~110%;                |85%~110%;                |range                    |                         |
|                                                                              |The                      |The                      |The                      |of                       |                         |
|                                                                              |average                  |average                  |average                  |85%~110%;                |                         |
|                                                                              |recovery                 |recovery                 |recovery                 |The                      |                         |
|                                                                              |rate was                 |rate was                 |rate was                 |average                  |                         |
|                                                                              |96.8%.                   |96.8%.                   |96.8%.                   |recovery                 |                         |
|                                                                              |The RSD                  |The RSD                  |The RSD                  |rate                     |                         |
|                                                                              |of                       |of                       |of                       |was                      |                         |
|                                                                              |recovery                 |recovery                 |recovery                 |96.8%.                   |                         |
|                                                                              |was 4%,                  |was 4%,                  |was 4%,                  |The RSD                  |                         |
|                                                                              |less                     |less                     |less                     |of                       |                         |
|                                                                              |than                     |than                     |than                     |recovery                 |                         |
|                                                                              |10%;                     |10%;                     |10%;                     |was 4%,                  |                         |
|                                                                              |Therefore,               |Therefore,               |Therefore,               |less                     |                         |
|                                                                              |the                      |the                      |the                      |than                     |                         |
|                                                                              |accuracy                 |accuracy                 |accuracy                 |10%;                     |                         |
|                                                                              |ofimpurity               |ofimpurity               |ofimpurity               |Therefore,               |                         |
|                                                                              |YA2304-19                |YA2304-19                |YA2304-19                |the                      |                         |
|                                                                              |is good                  |is good                  |is good                  |accuracy                 |                         |
|                                                                              |in the                   |in the                   |in the                   |ofimpurity               |                         |
|                                                                              |range of                 |range of                 |range of                 |YA2304-19                |                         |
|                                                                              |0.1802μg/ml~0.9012μg/ml. |0.1802μg/ml~0.9012μg/ml. |0.1802μg/ml~0.9012μg/ml. |is good                  |                         |
|                                                                              |                         |                         |                         |in the                   |                         |
|                                                                              |                         |                         |                         |range                    |                         |
|                                                                              |                         |                         |                         |of                       |                         |
|                                                                              |                         |                         |                         |0.1802μg/ml~0.9012μg/ml. |                         |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|Impuritie sName                                                               |Solution name            |Quantity of test product |Amountadded (μg/ml)      |Measuredamount (μg/ml)   |Recovery                 |
|                                                                              |                         |detected (μg/ml)         |                         |                         |rate                     |
|                                                                              |                         |                         |                         |                         |(%)                      |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|YA2304- 10 (230nm)                                                            |45% sample recovery      |Not detected             |0.1827                   |0.1848                   |101.1                    |
|                                                                              |solution①                |                         |                         |                         |                         |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|YA2304- 10 (230nm)                                                            |45% sample recovery      |45% sample recovery      |0.1827                   |0.1848                   |101.1                    |
|                                                                              |solution②                |solution②                |                         |                         |                         |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|YA2304- 10 (230nm)                                                            |45% sample recovery      |45% sample recovery      |0.1827                   |0.1815                   |99.3                     |
|                                                                              |solution③                |solution③                |                         |                         |                         |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|YA2304- 10 (230nm)                                                            |150% recovery solution①  |150% recovery solution①  |0.6092                   |0.5928                   |97.3                     |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|YA2304- 10 (230nm)                                                            |150% recovery solution②  |150% recovery solution②  |0.6092                   |0.5990                   |98.3                     |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|YA2304- 10 (230nm)                                                            |150% recovery solution③  |150% recovery solution③  |0.6092                   |0.5948                   |97.6                     |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|YA2304- 10 (230nm)                                                            |225% recovery solution①  |225% recovery solution①  |0.9137                   |0.8880                   |97.2                     |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|YA2304- 10 (230nm)                                                            |225% recovery solution②  |225% recovery solution②  |0.9137                   |0.8936                   |97.8                     |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|YA2304- 10 (230nm)                                                            |225% recovery solution③  |225% recovery solution③  |0.9137                   |0.8880                   |97.2                     |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|YA2304- 10 (230nm)                                                            |Average recovery (%)     |Average recovery (%)     |Average recovery (%)     |Average recovery (%)     |98.6                     |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|YA2304- 10 (230nm)                                                            |RSD (%)                  |RSD (%)                  |RSD (%)                  |RSD (%)                  |1.7                      |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|YA2304- 10 (230nm)                                                            |Verdict: The impurity    |Verdict: The impurity    |Verdict: The impurity    |Verdict: The impurity    |Verdict:                 |
|                                                                              |YA2304-10 was not        |YA2304-10 was not        |YA2304-10 was not        |YA2304-10 was not        |The                      |
|                                                                              |detected in the test     |detected in the test     |detected in the test     |detected in the test     |impurity                 |
|                                                                              |product, and the control |product, and the control |product, and the control |product, and the control |YA2304-10                |
|                                                                              |product YA2304-10        |product YA2304-10        |product YA2304-10        |product YA2304-10        |was not                  |
|                                                                              |wasadded in the          |wasadded in the          |wasadded in the          |wasadded in the          |detected                 |
|                                                                              |concentration range of   |concentration range of   |concentration range of   |concentration range of   |in the                   |
|                                                                              |0.045%~0.225% of the test|0.045%~0.225% of the test|0.045%~0.225% of the test|0.045%~0.225% of the test|test                     |
|                                                                              |product (thatis,         |product (thatis,         |product (thatis,         |product (thatis,         |product,                 |
|                                                                              |0.1827μg/ml~0.9137μg/ml).|0.1827μg/ml~0.9137μg/ml).|0.1827μg/ml~0.9137μg/ml).|0.1827μg/ml~0.9137μg/ml).|and the                  |
|                                                                              |The recovery rate ofeach |The recovery rate ofeach |The recovery rate ofeach |The recovery rate ofeach |control                  |
|                                                                              |concentration point was  |concentration point was  |concentration point was  |concentration point was  |product                  |
|                                                                              |97.2%~101.1%. In the     |97.2%~101.1%. In the     |97.2%~101.1%. In the     |97.2%~101.1%. In the     |YA2304-10                |
|                                                                              |                         |                         |                         |                         |wasadded                 |
|                                                                              |                         |                         |                         |                         |in the                   |
|                                                                              |                         |                         |                         |                         |concentration            |
|                                                                              |                         |                         |                         |                         |range of                 |
|                                                                              |                         |                         |                         |                         |0.045%~0.225%            |
|                                                                              |                         |                         |                         |                         |of the                   |
|                                                                              |                         |                         |                         |                         |test                     |
|                                                                              |                         |                         |                         |                         |product                  |
|                                                                              |                         |                         |                         |                         |(thatis,                 |
|                                                                              |                         |                         |                         |                         |0.1827μg/ml~0.9137μg/ml).|
|                                                                              |                         |                         |                         |                         |The                      |
|                                                                              |                         |                         |                         |                         |recovery                 |
|                                                                              |                         |                         |                         |                         |rate                     |
|                                                                              |                         |                         |                         |                         |ofeach                   |
|                                                                              |                         |                         |                         |                         |concentration            |
|                                                                              |                         |                         |                         |                         |point                    |
|                                                                              |                         |                         |                         |                         |was                      |
|                                                                              |                         |                         |                         |                         |97.2%~101.1%.            |
|                                                                              |                         |                         |                         |                         |In the                   |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 209 of 542 





Page 210
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 






















































--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Impuritie sName   |Solution name                                                      |Quantity                |Amountadded             |Measuredamount          |Recovery                |
|                  |                                                                   |of test                 |(μg/ml)                 |(μg/ml)                 |rate                    |
|                  |                                                                   |product                 |                        |                        |(%)                     |
|                  |                                                                   |detected                |                        |                        |                        |
|                  |                                                                   |(μg/ml)                 |                        |                        |                        |
|------------------|-------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|
|YA2304- 17 (230nm)|30% sample recovery solution①                                      |Not                     |0.1812                  |0.1757                  |96.9                    |
|                  |                                                                   |detected                |                        |                        |                        |
|------------------|-------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|
|YA2304- 17 (230nm)|30% sample recovery solution②                                      |30%                     |0.1812                  |0.1779                  |98.2                    |
|                  |                                                                   |sample                  |                        |                        |                        |
|                  |                                                                   |recovery                |                        |                        |                        |
|                  |                                                                   |solution②               |                        |                        |                        |
|------------------|-------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|
|YA2304- 17 (230nm)|30% recovery solution③                                             |30%                     |0.1812                  |0.1779                  |98.2                    |
|                  |                                                                   |recovery                |                        |                        |                        |
|                  |                                                                   |solution③               |                        |                        |                        |
|------------------|-------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|
|YA2304- 17 (230nm)|100% recovery solution①                                            |100%                    |0.6040                  |0.5915                  |97.9                    |
|                  |                                                                   |recovery                |                        |                        |                        |
|                  |                                                                   |solution①               |                        |                        |                        |
|------------------|-------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|
|YA2304- 17 (230nm)|100% recovery solution②                                            |100%                    |0.6040                  |0.5944                  |98.4                    |
|                  |                                                                   |recovery                |                        |                        |                        |
|                  |                                                                   |solution②               |                        |                        |                        |
|------------------|-------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|
|YA2304- 17 (230nm)|100% recovery solution③                                            |100%                    |0.6040                  |0.5925                  |98.1                    |
|                  |                                                                   |recovery                |                        |                        |                        |
|                  |                                                                   |solution③               |                        |                        |                        |
|------------------|-------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|
|YA2304- 17 (230nm)|150% recovery solution①                                            |150%                    |0.9060                  |0.8922                  |98.5                    |
|                  |                                                                   |recovery                |                        |                        |                        |
|                  |                                                                   |solution①               |                        |                        |                        |
|------------------|-------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|
|YA2304- 17 (230nm)|150% recovery solution②                                            |150%                    |0.9060                  |0.8903                  |98.3                    |
|                  |                                                                   |recovery                |                        |                        |                        |
|                  |                                                                   |solution②               |                        |                        |                        |
|------------------|-------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|
|YA2304- 17 (230nm)|150% recovery solution③                                            |150%                    |0.9060                  |0.8929                  |98.5                    |
|                  |                                                                   |recovery                |                        |                        |                        |
|                  |                                                                   |solution③               |                        |                        |                        |
|------------------|-------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|
|YA2304- 17 (230nm)|Average recovery rate (%)                                          |Average                 |Average                 |Average                 |98.1                    |
|                  |                                                                   |recovery                |recovery                |recovery rate           |                        |
|                  |                                                                   |rate (%)                |rate (%)                |(%)                     |                        |
|------------------|-------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|
|YA2304- 17 (230nm)|RSD (%)                                                            |RSD (%)                 |RSD (%)                 |RSD (%)                 |0.5                     |
|------------------|-------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|
|YA2304- 17 (230nm)|Conclusions: The impurity YA2304-17 was not detected in the test   |Conclusions:            |Conclusions:            |Conclusions:            |Conclusions:            |
|                  |product, and the control product YA2304-17 wasadded to the test    |The                     |The                     |The impurity            |The                     |
|                  |product in the limit concentration range of 30% to 150% (thatis,   |impurity                |impurity                |YA2304-17 was           |impurity                |
|                  |0.1812μg/ml to 0.9060μg/ml). The recoveries ofeach concentration   |YA2304-17               |YA2304-17               |not detected            |YA2304-17               |
|                  |point were 96.9% to 98.5%, andall were 85% to 110%. The average    |was not                 |was not                 |in the test             |was not                 |
|                  |recoveries were 98.1%; The RSD of recovery was 0.5%, less than 10%;|detected                |detected in             |product, and            |detected                |
|                  |Therefore, the accuracy ofimpurity YA2304-17 was good in the range |in the                  |the test                |the control             |in the                  |
|                  |of 0.1812μg/ml~0.9060μg/ml.                                        |test                    |product,                |product                 |test                    |
|                  |                                                                   |product,                |and the                 |YA2304-17               |product,                |
|                  |                                                                   |and the                 |control                 |wasadded to             |and the                 |
|                  |                                                                   |control                 |product                 |the test                |control                 |
|                  |                                                                   |product                 |YA2304-17               |product in the          |product                 |
|                  |                                                                   |YA2304-17               |wasadded to             |limit                   |YA2304-17               |
|                  |                                                                   |wasadded                |the test                |concentration           |wasadded                |
|                  |                                                                   |to the                  |product in              |range of 30%            |to the                  |
|                  |                                                                   |test                    |the limit               |to 150%                 |test                    |
|                  |                                                                   |product                 |concentration           |(thatis,                |product                 |
|                  |                                                                   |in the                  |range of                |0.1812μg/ml to          |in the                  |
|                  |                                                                   |limit                   |30% to 150%             |0.9060μg/ml).           |limit                   |
|                  |                                                                   |concentration           |(thatis,                |The recoveries          |concentration           |
|                  |                                                                   |range of                |0.1812μg/ml             |ofeach                  |range of                |
|                  |                                                                   |30% to                  |to                      |concentration           |30% to                  |
|                  |                                                                   |150%                    |0.9060μg/ml).           |point were              |150%                    |
|                  |                                                                   |(thatis,                |The                     |96.9% to                |(thatis,                |
|                  |                                                                   |0.1812μg/ml             |recoveries              |98.5%, andall           |0.1812μg/ml             |
|                  |                                                                   |to                      |ofeach                  |were 85% to             |to                      |
|                  |                                                                   |0.9060μg/ml).           |concentration           |110%. The               |0.9060μg/ml).           |
|                  |                                                                   |The                     |point were              |average                 |The                     |
|                  |                                                                   |recoveries              |96.9% to                |recoveries              |recoveries              |
|                  |                                                                   |ofeach                  |98.5%,                  |were 98.1%;             |ofeach                  |
|                  |                                                                   |concentration           |andall were             |The RSD of              |concentration           |
|                  |                                                                   |point                   |85% to                  |recovery was            |point                   |
|                  |                                                                   |were                    |110%. The               |0.5%, less              |were                    |
|                  |                                                                   |96.9% to                |average                 |than 10%;               |96.9% to                |
|                  |                                                                   |98.5%,                  |recoveries              |Therefore, the          |98.5%,                  |
|                  |                                                                   |andall                  |were 98.1%;             |accuracy                |andall                  |
|                  |                                                                   |were 85%                |The RSD of              |ofimpurity              |were 85%                |
|                  |                                                                   |to 110%.                |recovery                |YA2304-17 was           |to 110%.                |
|                  |                                                                   |The                     |was 0.5%,               |good in the             |The                     |
|                  |                                                                   |average                 |less than               |range of                |average                 |
|                  |                                                                   |recoveries              |10%;                    |0.1812μg/ml~0.9060μg/ml.|recoveries              |
|                  |                                                                   |were                    |Therefore,              |                        |were                    |
|                  |                                                                   |98.1%;                  |the                     |                        |98.1%;                  |
|                  |                                                                   |The RSD                 |accuracy                |                        |The RSD                 |
|                  |                                                                   |of                      |ofimpurity              |                        |of                      |
|                  |                                                                   |recovery                |YA2304-17               |                        |recovery                |
|                  |                                                                   |was 0.5%,               |was good in             |                        |was                     |
|                  |                                                                   |less than               |the range               |                        |0.5%,                   |
|                  |                                                                   |10%;                    |of                      |                        |less                    |
|                  |                                                                   |Therefore,              |0.1812μg/ml~0.9060μg/ml.|                        |than                    |
|                  |                                                                   |the                     |                        |                        |10%;                    |
|                  |                                                                   |accuracy                |                        |                        |Therefore,              |
|                  |                                                                   |ofimpurity              |                        |                        |the                     |
|                  |                                                                   |YA2304-17               |                        |                        |accuracy                |
|                  |                                                                   |was good                |                        |                        |ofimpurity              |
|                  |                                                                   |in the                  |                        |                        |YA2304-17               |
|                  |                                                                   |range of                |                        |                        |was good                |
|                  |                                                                   |0.1812μg/ml~0.9060μg/ml.|                        |                        |in the                  |
|                  |                                                                   |                        |                        |                        |range of                |
|                  |                                                                   |                        |                        |                        |0.1812μg/ml~0.9060μg/ml.|
|------------------|-------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|
|Impuritie sName   |Solution name                                                      |Quantity of test product|Amountadded (μg/ml)     |Measured quantity       |Recovery rate (%)       |
|                  |                                                                   |detected                |                        |(μg/ml)                 |                        |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 210 of 542 





Page 211
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



























------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|YA2304 (principa lcompone ntinstead ofunknow nimpurity)|LOQ recovery solution①        |/                        |0.1229                   |0.1270                   |103.3                    |
|-------------------------------------------------------|------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|YA2304 (principa lcompone ntinstead ofunknow nimpurity)|LOQ recovery solution②        |LOQ                      |0.1229                   |0.1232                   |100.2                    |
|                                                       |                              |recovery                 |                         |                         |                         |
|                                                       |                              |solution②                |                         |                         |                         |
|-------------------------------------------------------|------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|YA2304 (principa lcompone ntinstead ofunknow nimpurity)|LOQ recovery solution③        |LOQ                      |0.1229                   |0.1295                   |105.3                    |
|                                                       |                              |recovery                 |                         |                         |                         |
|                                                       |                              |solution③                |                         |                         |                         |
|-------------------------------------------------------|------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|YA2304 (principa lcompone ntinstead ofunknow nimpurity)|100% recovery solution①       |100%                     |0.4098                   |0.4078                   |99.5                     |
|                                                       |                              |recovery                 |                         |                         |                         |
|                                                       |                              |solution①                |                         |                         |                         |
|-------------------------------------------------------|------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|YA2304 (principa lcompone ntinstead ofunknow nimpurity)|100% recovery solution②       |100%                     |0.4098                   |0.4114                   |100.4                    |
|                                                       |                              |recovery                 |                         |                         |                         |
|                                                       |                              |solution②                |                         |                         |                         |
|-------------------------------------------------------|------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|YA2304 (principa lcompone ntinstead ofunknow nimpurity)|100% recovery solution③       |100%                     |0.4098                   |0.4139                   |101.0                    |
|                                                       |                              |recovery                 |                         |                         |                         |
|                                                       |                              |solution③                |                         |                         |                         |
|-------------------------------------------------------|------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|YA2304 (principa lcompone ntinstead ofunknow nimpurity)|150% recovery solution①       |150%                     |0.6147                   |0.6227                   |101.3                    |
|                                                       |                              |recovery                 |                         |                         |                         |
|                                                       |                              |solution①                |                         |                         |                         |
|-------------------------------------------------------|------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|YA2304 (principa lcompone ntinstead ofunknow nimpurity)|150% recovery solution②       |150%                     |0.6147                   |0.6139                   |99.9                     |
|                                                       |                              |recovery                 |                         |                         |                         |
|                                                       |                              |solution②                |                         |                         |                         |
|-------------------------------------------------------|------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|YA2304 (principa lcompone ntinstead ofunknow nimpurity)|150% recovery solution③       |150%                     |0.6147                   |0.6176                   |100.5                    |
|                                                       |                              |recovery                 |                         |                         |                         |
|                                                       |                              |solution③                |                         |                         |                         |
|-------------------------------------------------------|------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|YA2304 (principa lcompone ntinstead ofunknow nimpurity)|Average recovery rate (%)     |Average                  |Average                  |Average                  |101.3                    |
|                                                       |                              |recovery                 |recovery                 |recovery                 |                         |
|                                                       |                              |rate (%)                 |rate                     |rate                     |                         |
|                                                       |                              |                         |(%)                      |(%)                      |                         |
|-------------------------------------------------------|------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|YA2304 (principa lcompone ntinstead ofunknow nimpurity)|RSD (%)                       |RSD (%)                  |RSD (%)                  |RSD (%)                  |1.9                      |
|-------------------------------------------------------|------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|YA2304 (principa lcompone ntinstead ofunknow nimpurity)|Conclusion: YA2304 (principal |Conclusion:              |Conclusion:              |Conclusion:              |Conclusion:              |
|                                                       |componentinstead              |YA2304                   |YA2304                   |YA2304                   |YA2304                   |
|                                                       |ofunknownimpurity) wasadded to|(principal               |(principal               |(principal               |(principal               |
|                                                       |the solvent in the limit      |componentinstead         |componentinstead         |componentinstead         |componentinstead         |
|                                                       |concentration range of        |ofunknownimpurity)       |ofunknownimpurity)       |ofunknownimpurity)       |ofunknownimpurity)       |
|                                                       |LOQ~150% (thatis,             |wasadded                 |wasadded                 |wasadded                 |wasadded                 |
|                                                       |0.1229μg/ml~0.6147μg/ml), and |to the                   |to the                   |to the                   |to the                   |
|                                                       |the recoveries ofeach         |solvent                  |solvent                  |solvent                  |solvent                  |
|                                                       |concentration point were      |in the                   |in the                   |in the                   |in the                   |
|                                                       |99.5%-105.3%, andall were     |limit                    |limit                    |limit                    |limit                    |
|                                                       |between 85% and 110%. The     |concentration            |concentration            |concentration            |concentration            |
|                                                       |average recovery rate was     |range of                 |range of                 |range of                 |range                    |
|                                                       |101.3%. The RSD of recovery   |LOQ~150%                 |LOQ~150%                 |LOQ~150%                 |of                       |
|                                                       |was 1.9%, less than 10%;      |(thatis,                 |(thatis,                 |(thatis,                 |LOQ~150%                 |
|                                                       |Therefore, the impurity YA2304|0.1229μg/ml~0.6147μg/ml),|0.1229μg/ml~0.6147μg/ml),|0.1229μg/ml~0.6147μg/ml),|(thatis,                 |
|                                                       |(principal componentinstead   |and the                  |and the                  |and the                  |0.1229μg/ml~0.6147μg/ml),|
|                                                       |ofunknownimpurity) was in the |recoveries               |recoveries               |recoveries               |and the                  |
|                                                       |range of                      |ofeach                   |ofeach                   |ofeach                   |recoveries               |
|                                                       |0.1229μg/ml~0.6147μg/ml, and  |concentration            |concentration            |concentration            |ofeach                   |
|                                                       |the accuracy was good.        |point                    |point                    |point                    |concentration            |
|                                                       |                              |were                     |were                     |were                     |point                    |
|                                                       |                              |99.5%-105.3%,            |99.5%-105.3%,            |99.5%-105.3%,            |were                     |
|                                                       |                              |andall                   |andall                   |andall                   |99.5%-105.3%,            |
|                                                       |                              |were                     |were                     |were                     |andall                   |
|                                                       |                              |between                  |between                  |between                  |were                     |
|                                                       |                              |85% and                  |85% and                  |85% and                  |between                  |
|                                                       |                              |110%. The                |110%.                    |110%.                    |85% and                  |
|                                                       |                              |average                  |The                      |The                      |110%.                    |
|                                                       |                              |recovery                 |average                  |average                  |The                      |
|                                                       |                              |rate was                 |recovery                 |recovery                 |average                  |
|                                                       |                              |101.3%.                  |rate was                 |rate was                 |recovery                 |
|                                                       |                              |The RSD                  |101.3%.                  |101.3%.                  |rate                     |
|                                                       |                              |of                       |The RSD                  |The RSD                  |was                      |
|                                                       |                              |recovery                 |of                       |of                       |101.3%.                  |
|                                                       |                              |was 1.9%,                |recovery                 |recovery                 |The RSD                  |
|                                                       |                              |less than                |was                      |was                      |of                       |
|                                                       |                              |10%;                     |1.9%,                    |1.9%,                    |recovery                 |
|                                                       |                              |Therefore,               |less                     |less                     |was                      |
|                                                       |                              |the                      |than                     |than                     |1.9%,                    |
|                                                       |                              |impurity                 |10%;                     |10%;                     |less                     |
|                                                       |                              |YA2304                   |Therefore,               |Therefore,               |than                     |
|                                                       |                              |(principal               |the                      |the                      |10%;                     |
|                                                       |                              |componentinstead         |impurity                 |impurity                 |Therefore,               |
|                                                       |                              |ofunknownimpurity)       |YA2304                   |YA2304                   |the                      |
|                                                       |                              |was in                   |(principal               |(principal               |impurity                 |
|                                                       |                              |the range                |componentinstead         |componentinstead         |YA2304                   |
|                                                       |                              |of                       |ofunknownimpurity)       |ofunknownimpurity)       |(principal               |
|                                                       |                              |0.1229μg/ml~0.6147μg/ml, |was in                   |was in                   |componentinstead         |
|                                                       |                              |and the                  |the                      |the                      |ofunknownimpurity)       |
|                                                       |                              |accuracy                 |range of                 |range of                 |was in                   |
|                                                       |                              |was good.                |0.1229μg/ml~0.6147μg/ml, |0.1229μg/ml~0.6147μg/ml, |the                      |
|                                                       |                              |                         |and the                  |and the                  |range                    |
|                                                       |                              |                         |accuracy                 |accuracy                 |of                       |
|                                                       |                              |                         |was                      |was                      |0.1229μg/ml~0.6147μg/ml, |
|                                                       |                              |                         |good.                    |good.                    |and the                  |
|                                                       |                              |                         |                         |                         |accuracy                 |
|                                                       |                              |                         |                         |                         |was                      |
|                                                       |                              |                         |                         |                         |good.                    |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**g. Precision** 



Precision refers to the proximity between the results obtained by multiple 



sampling of the same uniform test product under specified test conditions, 



and its precision is judged by examining repeatability and intermediate 



precision. 



**i. Repeatability** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 211 of 542 





Page 212
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



 **Acceptance Criteria** 



6 repeatable sample solutions were prepared by Analyst A on date A and 



determined by instrument A. The blank solution should be free of 



interference; Reference solution chromatogram (230nm), the peak order is 



YA2304-17, YA2304-10; In the chromatogram of system suitability solution 



(251nm), the peak order is YA2304-14, YA2304, YA2304-15, YA2304-17, 



YA2304-16, YA2304-10, YA2304-19. The separation degree between YA2304 



and YA2304-14 and YA2304-15 should be NLT 1.5, and the separation 



degree between YA2304-17 and YA2304-16 and adjacent peaks should be 



NLT 1.0; In the contrast solution chromatogram (251nm), the signal-to-noise 



ratio (S/N) of the main peak should NLT 20. In 6 samples of repetitive test 



solution with limited concentration, the impurity peak less than 0.5 times of 



the main peak area of the control solution should be ignored, and the RSD of 



other impurities should NMT 5%, and the RSD of total impurity should NMT 



5%. 



 **Solution Preparation** 



Blank solution: solvent 



YA2304-12 Reference storage solution: Share "YA2304-12 Reference Storage 



solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-14 Reference storage solution: Share "YA2304-14 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304 Reference stock: Share "YA2304 Reference Stock" under "4.1 



Wavelength Selection". (Approx. 200μg/ml) 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 212 of 542 





Page 213
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



YA2304-15 Reference storage solution: Share "YA2304-15 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-16 Reference storage solution: Share "YA2304-16 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-18 Reference storage solution: Share "YA2304-18 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-19 Reference storage solution: Share "YA2304-19 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-10 Reference storage Solution: Share "YA2304-10 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-17 Reference storage solution: Share "YA2304-17 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



System suitability solution: Share "System Suitability Solution" under "4.3.2 



Forced degradation Test". 



Reference solution: share "reference solution ②" under "4.3.2 Forced 



degradation Test". (YA2304-10, YA2304-17 containing about 0.4μg/ml) 



Repeatable reference stock solution: Accurately measure 0.75ml of each of 



YA2304-12, YA2304-14, YA2304-15, YA2304-16, YA2304-18, YA2304-19, 



YA2304-17 and YA2304-10 of the reference product reserves, place them in a 



10ml measuring bottle, and dilute them to the scale with solvent. Shake well, 



then it is ready. 



Repeatable test product solution: accurately weigh the YA2304 sample about 



10mg, place it in 25ml measuring bottle, add an appropriate amount of 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 213 of 542 





Page 214
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



solvent to dissolve by ultrasound, accurately add 1ml repeatable reference 



product reserve solution, dilute it with solvent to scale, shake well, and 



obtain. (6 copies were prepared in parallel, named as repeatable test product 



solution ①~⑥) 



Control solution: accurately measure 1ml of the test product solution, place 



it in a 20ml measuring bottle, dilute it with solvent to the scale, and shake 



well; Precision measure 1ml of the above solution, place it in a 50ml 



measuring bottle, dilute it with solvent to the scale, shake well, and then get. 



~ 
(named as control solution ① ⑥) 



 **Injection Sequence** 



After the blank solution, 1 needle was injected into the system suitability 



solution, 2 needles into the control solution, 1 needle into each of 6 control 



solutions and 6 repetitive test solutions, and the chromatogram was 



recorded. 



 **Results and Discussion** 



Results of Repeatability Study: 





































--------------------------------------------------------------------------------------------------
|Impuri ty content /%|Impurity YA2304- 12|0.156  |0.154  |0.157  |0.155  |0.155  |0.156  |0.7    |
|--------------------|-------------------|-------|-------|-------|-------|-------|-------|-------|
|Impuri ty content /%|Impurity YA2304- 14|0.149  |0.148  |0.148  |0.150  |0.149  |0.149  |0.5    |
|--------------------|-------------------|-------|-------|-------|-------|-------|-------|-------|
|Impuri ty content /%|Impurity           |0.158  |0.155  |0.157  |0.156  |0.156  |0.156  |0.7    |
--------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 214 of 542 





Page 215
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 




























--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Impurity YA2304- 16                                   |0.141            |0.138            |0.139            |0.139            |0.140            |0.139            |0.9              |                 |
|------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|Impurity YA2304- 18                                   |0.148            |0.146            |0.148            |0.147            |0.147            |0.146            |0.5              |                 |
|------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|Impurity YA2304- 19                                   |0.166            |0.165            |0.167            |0.172            |0.164            |0.164            |1.7              |                 |
|------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|Impurity YA2304- 17                                   |0.147            |0.147            |0.148            |0.148            |0.148            |0.146            |0.6              |                 |
|------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|Impurity YA2304- 10                                   |0.148            |0.147            |0.148            |0.148            |0.148            |0.147            |0.4              |                 |
|------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|Unknow nimpurity (RRT≈0.6 4)                          |<0.05%           |<0.05 %          |<0.05 %          |<0.05 %          |<0.05%           |<0.05%           |/                |                 |
|------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|Unknow nimpurity (RRT≈1.2 7)                          |<0.05%           |<0.05 %          |<0.05 %          |<0.05 %          |<0.05%           |<0.05%           |/                |                 |
|------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|Totalimpurity                                         |1.213            |1.201            |1.212            |1.215            |1.206            |1.204            |0.5              |                 |
|------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|Verdict: Impurities YA2304-12, YA2304-14, YA2304-15,  |Verdict:         |Verdict:         |Verdict:         |Verdict:         |Verdict:         |Verdict:         |Verdict:         |Verdict:         |
|YA2304-16, YA2304-18 and YA2304-19 were calculated by |Impurities       |Impurities       |Impurities       |Impurities       |Impurities       |Impurities       |Impurities       |Impurities       |
|the principal component self-control method with      |YA2304-12,       |YA2304-12,       |YA2304-12,       |YA2304-12,       |YA2304-12,       |YA2304-12,       |YA2304-12,       |YA2304-12,       |
|correction factorunder the wavelength of 251nm.       |YA2304-14,       |YA2304-14,       |YA2304-14,       |YA2304-14,       |YA2304-14,       |YA2304-14,       |YA2304-14,       |YA2304-14,       |
|Impurities YA2304-10 and YA2304-17 were calculated at |YA2304-15,       |YA2304-15,       |YA2304-15,       |YA2304-15,       |YA2304-15,       |YA2304-15,       |YA2304-15,       |YA2304-15,       |
|230nm wavelength byexternal standard method. The      |YA2304-16,       |YA2304-16,       |YA2304-16,       |YA2304-16,       |YA2304-16,       |YA2304-16,       |YA2304-16,       |YA2304-16,       |
|impurity peak less than 0.5 times of the main peakarea|YA2304-18        |YA2304-18        |YA2304-18        |YA2304-18        |YA2304-18        |YA2304-18        |YA2304-18        |YA2304-18        |
|of the control solution wasignored in the 6 samples   |and              |and              |and              |and              |and              |and              |and              |and              |
|with limited concentration repeatable test solution.  |YA2304-19        |YA2304-19        |YA2304-19        |YA2304-19        |YA2304-19        |YA2304-19        |YA2304-19        |YA2304-19        |
|The RSD ofotherimpurities was less than 5%, and the   |were             |were             |were             |were             |were             |were             |were             |were             |
|RSD of totalimpurities was less than 5%, which met the|calculated       |calculated       |calculated       |calculated       |calculated       |calculated       |calculated       |calculated       |
|requirements. The method has good repeatability.      |by the           |by the           |by the           |by the           |by the           |by the           |by the           |by the           |
|                                                      |principal        |principal        |principal        |principal        |principal        |principal        |principal        |principal        |
|                                                      |component        |component        |component        |component        |component        |component        |component        |component        |
|                                                      |self-control     |self-control     |self-control     |self-control     |self-control     |self-control     |self-control     |self-control     |
|                                                      |method           |method           |method           |method           |method           |method           |method           |method           |
|                                                      |with             |with             |with             |with             |with             |with             |with             |with             |
|                                                      |correction       |correction       |correction       |correction       |correction       |correction       |correction       |correction       |
|                                                      |factorunder      |factorunder      |factorunder      |factorunder      |factorunder      |factorunder      |factorunder      |factorunder      |
|                                                      |the              |the              |the              |the              |the              |the              |the              |the              |
|                                                      |wavelength       |wavelength       |wavelength       |wavelength       |wavelength       |wavelength       |wavelength       |wavelength       |
|                                                      |of               |of               |of               |of               |of               |of               |of               |of               |
|                                                      |251nm.           |251nm.           |251nm.           |251nm.           |251nm.           |251nm.           |251nm.           |251nm.           |
|                                                      |Impurities       |Impurities       |Impurities       |Impurities       |Impurities       |Impurities       |Impurities       |Impurities       |
|                                                      |YA2304-10        |YA2304-10        |YA2304-10        |YA2304-10        |YA2304-10        |YA2304-10        |YA2304-10        |YA2304-10        |
|                                                      |and              |and              |and              |and              |and              |and              |and              |and              |
|                                                      |YA2304-17        |YA2304-17        |YA2304-17        |YA2304-17        |YA2304-17        |YA2304-17        |YA2304-17        |YA2304-17        |
|                                                      |were             |were             |were             |were             |were             |were             |were             |were             |
|                                                      |calculated       |calculated       |calculated       |calculated       |calculated       |calculated       |calculated       |calculated       |
|                                                      |at               |at               |at               |at               |at               |at               |at               |at               |
|                                                      |230nm            |230nm            |230nm            |230nm            |230nm            |230nm            |230nm            |230nm            |
|                                                      |wavelength       |wavelength       |wavelength       |wavelength       |wavelength       |wavelength       |wavelength       |wavelength       |
|                                                      |byexternal       |byexternal       |byexternal       |byexternal       |byexternal       |byexternal       |byexternal       |byexternal       |
|                                                      |standard         |standard         |standard         |standard         |standard         |standard         |standard         |standard         |
|                                                      |method.          |method.          |method.          |method.          |method.          |method.          |method.          |method.          |
|                                                      |The              |The              |The              |The              |The              |The              |The              |The              |
|                                                      |impurity         |impurity         |impurity         |impurity         |impurity         |impurity         |impurity         |impurity         |
|                                                      |peak             |peak             |peak             |peak             |peak             |peak             |peak             |peak             |
|                                                      |less             |less             |less             |less             |less             |less             |less             |less             |
|                                                      |than             |than             |than             |than             |than             |than             |than             |than             |
|                                                      |0.5              |0.5              |0.5              |0.5              |0.5              |0.5              |0.5              |0.5              |
|                                                      |times            |times            |times            |times            |times            |times            |times            |times            |
|                                                      |of the           |of the           |of the           |of the           |of the           |of the           |of the           |of the           |
|                                                      |main             |main             |main             |main             |main             |main             |main             |main             |
|                                                      |peakarea         |peakarea         |peakarea         |peakarea         |peakarea         |peakarea         |peakarea         |peakarea         |
|                                                      |of the           |of the           |of the           |of the           |of the           |of the           |of the           |of the           |
|                                                      |control          |control          |control          |control          |control          |control          |control          |control          |
|                                                      |solution         |solution         |solution         |solution         |solution         |solution         |solution         |solution         |
|                                                      |wasignored       |wasignored       |wasignored       |wasignored       |wasignored       |wasignored       |wasignored       |wasignored       |
|                                                      |in the           |in the           |in the           |in the           |in the           |in the           |in the           |in the           |
|                                                      |6                |6                |6                |6                |6                |6                |6                |6                |
|                                                      |samples          |samples          |samples          |samples          |samples          |samples          |samples          |samples          |
|                                                      |with             |with             |with             |with             |with             |with             |with             |with             |
|                                                      |limited          |limited          |limited          |limited          |limited          |limited          |limited          |limited          |
|                                                      |concentration    |concentration    |concentration    |concentration    |concentration    |concentration    |concentration    |concentration    |
|                                                      |repeatable       |repeatable       |repeatable       |repeatable       |repeatable       |repeatable       |repeatable       |repeatable       |
|                                                      |test             |test             |test             |test             |test             |test             |test             |test             |
|                                                      |solution.        |solution.        |solution.        |solution.        |solution.        |solution.        |solution.        |solution.        |
|                                                      |The RSD          |The RSD          |The RSD          |The RSD          |The RSD          |The RSD          |The RSD          |The RSD          |
|                                                      |ofotherimpurities|ofotherimpurities|ofotherimpurities|ofotherimpurities|ofotherimpurities|ofotherimpurities|ofotherimpurities|ofotherimpurities|
|                                                      |was              |was              |was              |was              |was              |was              |was              |was              |
|                                                      |less             |less             |less             |less             |less             |less             |less             |less             |
|                                                      |than             |than             |than             |than             |than             |than             |than             |than             |
|                                                      |5%, and          |5%, and          |5%, and          |5%, and          |5%, and          |5%, and          |5%, and          |5%, and          |
|                                                      |the RSD          |the RSD          |the RSD          |the RSD          |the RSD          |the RSD          |the RSD          |the RSD          |
|                                                      |of               |of               |of               |of               |of               |of               |of               |of               |
|                                                      |totalimpurities  |totalimpurities  |totalimpurities  |totalimpurities  |totalimpurities  |totalimpurities  |totalimpurities  |totalimpurities  |
|                                                      |was              |was              |was              |was              |was              |was              |was              |was              |
|                                                      |less             |less             |less             |less             |less             |less             |less             |less             |
|                                                      |than             |than             |than             |than             |than             |than             |than             |than             |
|                                                      |5%,              |5%,              |5%,              |5%,              |5%,              |5%,              |5%,              |5%,              |
|                                                      |which            |which            |which            |which            |which            |which            |which            |which            |
|                                                      |met the          |met the          |met the          |met the          |met the          |met the          |met the          |met the          |
|                                                      |requirements.    |requirements.    |requirements.    |requirements.    |requirements.    |requirements.    |requirements.    |requirements.    |
|                                                      |The              |The              |The              |The              |The              |The              |The              |The              |
|                                                      |method           |method           |method           |method           |method           |method           |method           |method           |
|                                                      |has              |has              |has              |has              |has              |has              |has              |has              |
|                                                      |good             |good             |good             |good             |good             |good             |good             |good             |
|                                                      |repeatability.   |repeatability.   |repeatability.   |repeatability.   |repeatability.   |repeatability.   |repeatability.   |repeatability.   |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**ii. Intermediate Precision** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 215 of 542 





Page 216
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



 **Acceptance Criteria** 



6 parts of intermediate precision test product solution were prepared by 



Analyst B on date B and determined by instrument B. The blank solution 



should be free of interference; Reference solution chromatogram (230nm), 



the peak order is YA2304-17, YA2304-10; In the chromatogram of system 



suitability solution (251nm), the peak order is YA2304-14, YA2304, 



YA2304-15, YA2304-17, YA2304-16, YA2304-10, YA2304-19. The 



separation degree between YA2304 and YA2304-14 and YA2304-15 should 



be NLT 1.5, and the separation degree between YA2304-17 and YA2304-16 



and adjacent peaks should be NLT 1.0; In the chromatogram obtained by 



contrast solution (251nm) for 6 consecutive days, the RSD of the main peak 



NMT 1.0%, the RSD of the peak area NMT 5%, and the signal-to-noise ratio 



(S/N) should NLT 20. In 6 intermediate precision test solutions, the impurity 



peak less than 0.5 times of the main peak area of the control solution should 



be ignored, the RSD of other impurities should NMT 5%, and the RSD of total 



impurity should NMT 5%. 



In the results of 12 tests of repeatability and intermediate precision, the RSD 



of other impurities NMT 10% and the RSD of total impurities NMT 10% if the 



impurity peak is less than 0.5 times the main peak area of the control 



solution. 



 **Solution Preparation** 



Blank solution: solvent 



YA2304-12 Reference storage solution: Share "YA2304-12 Reference Storage 



solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 216 of 542 





Page 217
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



YA2304-14 Reference storage solution: Share "YA2304-14 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304 Reference stock: Share "YA2304 Reference Stock" under "4.1 



Wavelength Selection". (Approx. 200μg/ml) 



YA2304-15 Reference storage solution: Share "YA2304-15 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-16 Reference storage solution: Share "YA2304-16 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-18 Reference storage solution: Share "YA2304-18 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-19 Reference storage solution: Share "YA2304-19 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-10 Reference storage Solution: Share "YA2304-10 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-17 Reference storage solution: Share "YA2304-17 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



System suitability solution: Prepare by the same method as "System 



Suitability solution" under "4.2 System Suitability". (YA2304-14, YA2304-15, 



YA2304-16, YA2304-19, YA2304-10 and YA2304-17 are about 0.8μg/ml) 



Reference solution: Prepare it by the same method as "reference solution" 



under "4.2 System Suitability". (YA2304-10 and YA2304-17 both contain 



about 0.4μg/ml) 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 217 of 542 





Page 218
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Intermediate precision control product reserve liquid: Take 0.75ml of each 



control product reserve liquid of YA2304-12, YA2304-14, YA2304-15, 



YA2304-16, YA2304-18, YA2304-19, YA2304-17 and YA2304-10 and place 



them in a 10ml measuring bottle and dilute them to the scale with solvent. 



Shake well, then it is ready. 



Intermediate precision test product solution: accurately weigh the YA2304 



sample about 10mg, place it in a 25ml measuring bottle, add an appropriate 



amount of solvent and ultrasonic to dissolve it, then precisely add 1ml of the 



intermediate precision control product reserve, dilute it with solvent to the 



scale, shake well, and obtain. (6 parts were prepared in parallel, named as 



~ 
intermediate precision test product solution ① ⑥) 



Control solution: accurately measure 1ml of the test product solution, place 



it in a 20ml measuring bottle, dilute it with solvent to the scale, and shake 



well; Precision measure 1ml of the above solution, place it in a 50ml 



measuring bottle, dilute it with solvent to the scale, shake well, and then get. 



~ 
(named as control solution ① ⑥) 



 **Injection Sequence** 



After the blank solution, 1 needle was injected into the system suitable 



solution, 2 needles were injected into the control solution, 6 needles were 



repeated into the control solution, 1 needle was injected into the control 



solution ②~⑥ and 1 needle was injected into the intermediate precision test 



solution ①~⑥, and the chromatogram was recorded. 



 **Results and Discussion** 



System Suitability of Intermediate Precision Study: 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 218 of 542 





Page 219
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 























































-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|System suitabilit ysolution (251nm)                           |RT                  |8.335               |9.348               |10.352              |11.561              |11.561              |12.027              |
|                                                              |(min)               |                    |                    |                    |                    |                    |                    |
|--------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|System suitabilit ysolution (251nm)                           |Minimum             |Minimum             |5.7                 |Minimum             |Minimum             |Minimum             |1.6                 |
|                                                              |separation          |separation          |                    |separation          |separation          |separation          |                    |
|                                                              |between             |between             |                    |between             |between             |between             |                    |
|                                                              |YA2304              |YA2304              |                    |YA2304-17           |YA2304-17           |YA2304-17           |                    |
|                                                              |and                 |and                 |                    |and                 |and                 |and                 |                    |
|                                                              |YA2304-14           |YA2304-14           |                    |YA2304-16           |YA2304-16           |YA2304-16           |                    |
|                                                              |and                 |and                 |                    |andadjacent         |andadjacent         |andadjacent         |                    |
|                                                              |YA2304-15           |YA2304-15           |                    |peaks               |peaks               |peaks               |                    |
|--------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|Map name                                                      |Number of           |Main peak           |Main                |Main                |Main                |Principal           |Principal           |
|                                                              |samplesinjected     |retention           |peak                |peakarea            |peakarea            |peak                |peak                |
|                                                              |                    |time (min)          |retention           |                    |                    |signal-to-noise     |signal-to-noise     |
|                                                              |                    |                    |time                |                    |                    |ratio (S/N)         |ratio               |
|                                                              |                    |                    |(min)               |                    |                    |                    |(S/N)               |
|--------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|Control solution (251nm)                                      |1                   |9.394               |9.394               |7013                |7013                |93.2                |93.2                |
|--------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|Control solution (251nm)                                      |2                   |9.380               |9.380               |6926                |6926                |99.1                |99.1                |
|--------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|Control solution (251nm)                                      |3                   |9.384               |9.384               |6843                |6843                |107.0               |107.0               |
|--------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|Control solution (251nm)                                      |4                   |9.404               |9.404               |6972                |6972                |107.7               |107.7               |
|--------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|Control solution (251nm)                                      |5                   |9.414               |9.414               |7098                |7098                |139.5               |139.5               |
|--------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|Control solution (251nm)                                      |6                   |9.409               |9.409               |7247                |7247                |83.1                |83.1                |
|--------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|Control solution (251nm)                                      |RSD(n=6)            |0.15                |0.15                |2.1                 |2.1                 |/                   |/                   |
|--------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|Conclusion: There was no interference in the blank solution,  |Conclusion:         |Conclusion:         |Conclusion:         |Conclusion:         |Conclusion:         |Conclusion:         |Conclusion:         |
|the chromatogram of the control solution (230nm), the peak    |There was no        |There was           |There was           |There was           |There was           |There was no        |There was no        |
|sequence was YA2304-17, YA2304-10; In the chromatogram of     |interference in     |no                  |no                  |no                  |no                  |interference in     |interference in     |
|system suitable solution (251nm), the peakorder was YA2304-14,|the blank           |interference        |interference        |interference        |interference        |the blank           |the blank           |
|YA2304, YA2304-15, YA2304-17, YA2304-16, YA2304-10, YA2304-19.|solution, the       |in the              |in the              |in the              |in the              |solution, the       |solution, the       |
|The minimum separation degree between YA2304 and YA2304-14 and|chromatogram of     |blank               |blank               |blank               |blank               |chromatogram of     |chromatogram of     |
|YA2304-15 is 5.7 (NLT 1.5), and the minimum separation degree |the control         |solution,           |solution,           |solution,           |solution,           |the control         |the control         |
|between YA2304-17 and YA2304-16 andadjacent peaksis 1.6 (NLT  |solution            |the                 |the                 |the                 |the                 |solution            |solution            |
|1.0); In the chromatogramobtained by contrast solution (251nm)|(230nm), the        |chromatogram        |chromatogram        |chromatogram        |chromatogram        |(230nm), the        |(230nm), the        |
|for 6 consecutive days, the RSD of the main peak retention    |peak sequence       |of the              |of the              |of the              |of the              |peak sequence       |peak sequence       |
|time was 0.15% (not more than 1.0%), the RSD of the main      |was YA2304-17,      |control             |control             |control             |control             |was YA2304-17,      |was YA2304-17,      |
|peakarea was 2.1% (not more than 5%), and the signal-to-noise |YA2304-10; In       |solution            |solution            |solution            |solution            |YA2304-10; In       |YA2304-10; In       |
|ratio (S/N) was NLT 20. Inaccordance with the verification    |the                 |(230nm),            |(230nm),            |(230nm),            |(230nm),            |the                 |the                 |
|requirements.                                                 |chromatogram of     |the peak            |the peak            |the peak            |the peak            |chromatogram of     |chromatogram of     |
|                                                              |system suitable     |sequence            |sequence            |sequence            |sequence            |system suitable     |system suitable     |
|                                                              |solution            |was                 |was                 |was                 |was                 |solution            |solution            |
|                                                              |(251nm), the        |YA2304-17,          |YA2304-17,          |YA2304-17,          |YA2304-17,          |(251nm), the        |(251nm), the        |
|                                                              |peakorder was       |YA2304-10;          |YA2304-10;          |YA2304-10;          |YA2304-10;          |peakorder was       |peakorder was       |
|                                                              |YA2304-14,          |In the              |In the              |In the              |In the              |YA2304-14,          |YA2304-14,          |
|                                                              |YA2304,             |chromatogram        |chromatogram        |chromatogram        |chromatogram        |YA2304,             |YA2304,             |
|                                                              |YA2304-15,          |of system           |of system           |of system           |of system           |YA2304-15,          |YA2304-15,          |
|                                                              |YA2304-17,          |suitable            |suitable            |suitable            |suitable            |YA2304-17,          |YA2304-17,          |
|                                                              |YA2304-16,          |solution            |solution            |solution            |solution            |YA2304-16,          |YA2304-16,          |
|                                                              |YA2304-10,          |(251nm),            |(251nm),            |(251nm),            |(251nm),            |YA2304-10,          |YA2304-10,          |
|                                                              |YA2304-19. The      |the                 |the                 |the                 |the                 |YA2304-19. The      |YA2304-19. The      |
|                                                              |minimum             |peakorder           |peakorder           |peakorder           |peakorder           |minimum             |minimum             |
|                                                              |separation          |was                 |was                 |was                 |was                 |separation          |separation          |
|                                                              |degree between      |YA2304-14,          |YA2304-14,          |YA2304-14,          |YA2304-14,          |degree between      |degree between      |
|                                                              |YA2304 and          |YA2304,             |YA2304,             |YA2304,             |YA2304,             |YA2304 and          |YA2304 and          |
|                                                              |YA2304-14 and       |YA2304-15,          |YA2304-15,          |YA2304-15,          |YA2304-15,          |YA2304-14 and       |YA2304-14 and       |
|                                                              |YA2304-15 is        |YA2304-17,          |YA2304-17,          |YA2304-17,          |YA2304-17,          |YA2304-15 is        |YA2304-15 is        |
|                                                              |5.7 (NLT 1.5),      |YA2304-16,          |YA2304-16,          |YA2304-16,          |YA2304-16,          |5.7 (NLT 1.5),      |5.7 (NLT 1.5),      |
|                                                              |and the minimum     |YA2304-10,          |YA2304-10,          |YA2304-10,          |YA2304-10,          |and the minimum     |and the minimum     |
|                                                              |separation          |YA2304-19.          |YA2304-19.          |YA2304-19.          |YA2304-19.          |separation          |separation          |
|                                                              |degree between      |The                 |The                 |The minimum         |The minimum         |degree between      |degree between      |
|                                                              |YA2304-17 and       |minimum             |minimum             |separation          |separation          |YA2304-17 and       |YA2304-17 and       |
|                                                              |YA2304-16           |separation          |separation          |degree              |degree              |YA2304-16           |YA2304-16           |
|                                                              |andadjacent         |degree              |degree              |between             |between             |andadjacent         |andadjacent         |
|                                                              |peaksis 1.6         |between             |between             |YA2304 and          |YA2304 and          |peaksis 1.6         |peaksis 1.6         |
|                                                              |(NLT 1.0); In       |YA2304 and          |YA2304              |YA2304-14           |YA2304-14           |(NLT 1.0); In       |(NLT 1.0); In       |
|                                                              |the                 |YA2304-14           |and                 |and                 |and                 |the                 |the                 |
|                                                              |chromatogramobtained|and                 |YA2304-14           |YA2304-15           |YA2304-15           |chromatogramobtained|chromatogramobtained|
|                                                              |by contrast         |YA2304-15           |and                 |is 5.7 (NLT         |is 5.7 (NLT         |by contrast         |by contrast         |
|                                                              |solution            |is 5.7              |YA2304-15           |1.5), and           |1.5), and           |solution            |solution            |
|                                                              |(251nm) for 6       |(NLT 1.5),          |is 5.7              |the minimum         |the minimum         |(251nm) for 6       |(251nm) for 6       |
|                                                              |consecutive         |and the             |(NLT                |separation          |separation          |consecutive         |consecutive         |
|                                                              |days, the RSD       |minimum             |1.5), and           |degree              |degree              |days, the RSD       |days, the RSD       |
|                                                              |of the main         |separation          |the                 |between             |between             |of the main         |of the main         |
|                                                              |peak retention      |degree              |minimum             |YA2304-17           |YA2304-17           |peak retention      |peak retention      |
|                                                              |time was 0.15%      |between             |separation          |and                 |and                 |time was 0.15%      |time was 0.15%      |
|                                                              |(not more than      |YA2304-17           |degree              |YA2304-16           |YA2304-16           |(not more than      |(not more than      |
|                                                              |1.0%), the RSD      |and                 |between             |andadjacent         |andadjacent         |1.0%), the RSD      |1.0%), the RSD      |
|                                                              |of the main         |YA2304-16           |YA2304-17           |peaksis 1.6         |peaksis 1.6         |of the main         |of the main         |
|                                                              |peakarea was        |andadjacent         |and                 |(NLT 1.0);          |(NLT 1.0);          |peakarea was        |peakarea was        |
|                                                              |2.1% (not more      |peaksis             |YA2304-16           |In the              |In the              |2.1% (not more      |2.1% (not more      |
|                                                              |than 5%), and       |1.6 (NLT            |andadjacent         |chromatogramobtained|chromatogramobtained|than 5%), and       |than 5%), and       |
|                                                              |the                 |1.0); In            |peaksis             |by contrast         |by contrast         |the                 |the                 |
|                                                              |signal-to-noise     |the                 |1.6 (NLT            |solution            |solution            |signal-to-noise     |signal-to-noise     |
|                                                              |ratio (S/N) was     |chromatogramobtained|1.0); In            |(251nm) for         |(251nm) for         |ratio (S/N) was     |ratio (S/N) was     |
|                                                              |NLT 20.             |by                  |the                 |6                   |6                   |NLT 20.             |NLT 20.             |
|                                                              |Inaccordance        |contrast            |chromatogramobtained|consecutive         |consecutive         |Inaccordance        |Inaccordance        |
|                                                              |with the            |solution            |by                  |days, the           |days, the           |with the            |with the            |
|                                                              |verification        |(251nm)             |contrast            |RSD of the          |RSD of the          |verification        |verification        |
|                                                              |requirements.       |for 6               |solution            |main peak           |main peak           |requirements.       |requirements.       |
|                                                              |                    |consecutive         |(251nm)             |retention           |retention           |                    |                    |
|                                                              |                    |days, the           |for 6               |time was            |time was            |                    |                    |
|                                                              |                    |RSD of the          |consecutive         |0.15% (not          |0.15% (not          |                    |                    |
|                                                              |                    |main peak           |days, the           |more than           |more than           |                    |                    |
|                                                              |                    |retention           |RSD of              |1.0%), the          |1.0%), the          |                    |                    |
|                                                              |                    |time was            |the main            |RSD of the          |RSD of the          |                    |                    |
|                                                              |                    |0.15% (not          |peak                |main                |main                |                    |                    |
|                                                              |                    |more than           |retention           |peakarea            |peakarea            |                    |                    |
|                                                              |                    |1.0%), the          |time was            |was 2.1%            |was 2.1%            |                    |                    |
|                                                              |                    |RSD of the          |0.15%               |(not more           |(not more           |                    |                    |
|                                                              |                    |main                |(not more           |than 5%),           |than 5%),           |                    |                    |
|                                                              |                    |peakarea            |than                |and the             |and the             |                    |                    |
|                                                              |                    |was 2.1%            |1.0%),              |signal-to-noise     |signal-to-noise     |                    |                    |
|                                                              |                    |(not more           |the RSD             |ratio (S/N)         |ratio (S/N)         |                    |                    |
|                                                              |                    |than 5%),           |of the              |was NLT 20.         |was NLT 20.         |                    |                    |
|                                                              |                    |and the             |main                |Inaccordance        |Inaccordance        |                    |                    |
|                                                              |                    |signal-to-noise     |peakarea            |with the            |with the            |                    |                    |
|                                                              |                    |ratio               |was 2.1%            |verification        |verification        |                    |                    |
|                                                              |                    |(S/N) was           |(not more           |requirements.       |requirements.       |                    |                    |
|                                                              |                    |NLT 20.             |than 5%),           |                    |                    |                    |                    |
|                                                              |                    |Inaccordance        |and the             |                    |                    |                    |                    |
|                                                              |                    |with the            |signal-to-noise     |                    |                    |                    |                    |
|                                                              |                    |verification        |ratio               |                    |                    |                    |                    |
|                                                              |                    |requirements.       |(S/N) was           |                    |                    |                    |                    |
|                                                              |                    |                    |NLT 20.             |                    |                    |                    |                    |
|                                                              |                    |                    |Inaccordance        |                    |                    |                    |                    |
|                                                              |                    |                    |with the            |                    |                    |                    |                    |
|                                                              |                    |                    |verification        |                    |                    |                    |                    |
|                                                              |                    |                    |requirements.       |                    |                    |                    |                    |
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 219 of 542 





Page 220
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 








































-------------------------------------------------------------------------------------------------------------------------------
|Name of solution     |Name of solution          |Repeatable test      |Repeat  |Repeat |Repeat |Repetitive|Repetitive|RSD (%)|
|                     |                          |product①             |test    |sample③|sample④|test      |test      |(n=6)  |
|                     |                          |                     |product②|       |       |product⑤  |product⑥  |       |
|---------------------|--------------------------|---------------------|--------|-------|-------|----------|----------|-------|
|Impurit yco ntent / %|Impurity YA2304-12        |0.156                |0.154   |0.157  |0.155  |0.155     |0.156     |0.7    |
|---------------------|--------------------------|---------------------|--------|-------|-------|----------|----------|-------|
|Impurit yco ntent / %|Impurity YA2304-14        |0.149                |0.148   |0.148  |0.150  |0.149     |0.149     |0.5    |
|---------------------|--------------------------|---------------------|--------|-------|-------|----------|----------|-------|
|Impurit yco ntent / %|Impurity YA2304-15        |0.158                |0.155   |0.157  |0.156  |0.156     |0.156     |0.7    |
|---------------------|--------------------------|---------------------|--------|-------|-------|----------|----------|-------|
|Impurit yco ntent / %|Impurity YA2304-16        |0.141                |0.138   |0.139  |0.139  |0.140     |0.139     |0.9    |
|---------------------|--------------------------|---------------------|--------|-------|-------|----------|----------|-------|
|Impurit yco ntent / %|Impurity YA2304-18        |0.148                |0.146   |0.148  |0.147  |0.147     |0.146     |0.5    |
|---------------------|--------------------------|---------------------|--------|-------|-------|----------|----------|-------|
|Impurit yco ntent / %|Impurity YA2304-19        |0.166                |0.165   |0.167  |0.172  |0.164     |0.164     |1.7    |
|---------------------|--------------------------|---------------------|--------|-------|-------|----------|----------|-------|
|Impurit yco ntent / %|Impurity YA2304-17        |0.147                |0.147   |0.148  |0.148  |0.148     |0.146     |0.6    |
|---------------------|--------------------------|---------------------|--------|-------|-------|----------|----------|-------|
|Impurit yco ntent / %|Impurity YA2304-10        |0.148                |0.147   |0.148  |0.148  |0.148     |0.147     |0.4    |
|---------------------|--------------------------|---------------------|--------|-------|-------|----------|----------|-------|
|Impurit yco ntent / %|Unknownimpurity (RRT≈0.64)|<0.05%               |<0.05%  |<0.05% |<0.05% |<0.05%    |<0.05%    |/      |
|---------------------|--------------------------|---------------------|--------|-------|-------|----------|----------|-------|
|Impurit yco ntent / %|Unknownimpurity (RRT≈1.27)|<0.05%               |<0.05%  |<0.05% |<0.05% |<0.05%    |<0.05%    |/      |
|---------------------|--------------------------|---------------------|--------|-------|-------|----------|----------|-------|
|Impurit yco ntent / %|Totalimpurity             |1.213                |1.201   |1.212  |1.215  |1.206     |1.204     |0.5    |
-------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 220 of 542 





Page 221
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Verdict: Impurities YA2304-12, YA2304-14,     |Verdict:         |Verdict:         |Verdict:         |Verdict:         |Verdict:         |Verdict:         |Verdict:         |Verdict:         |Verdict:         |
|YA2304-15, YA2304-16, YA2304-18 and YA2304-19 |Impurities       |Impurities       |Impurities       |Impurities       |Impurities       |Impurities       |Impurities       |Impurities       |Impurities       |
|were calculated by the principal component    |YA2304-12,       |YA2304-12,       |YA2304-12,       |YA2304-12,       |YA2304-12,       |YA2304-12,       |YA2304-12,       |YA2304-12,       |YA2304-12,       |
|self-control method with correction           |YA2304-14,       |YA2304-14,       |YA2304-14,       |YA2304-14,       |YA2304-14,       |YA2304-14,       |YA2304-14,       |YA2304-14,       |YA2304-14,       |
|factorunder the wavelength of 251nm.          |YA2304-15,       |YA2304-15,       |YA2304-15,       |YA2304-15,       |YA2304-15,       |YA2304-15,       |YA2304-15,       |YA2304-15,       |YA2304-15,       |
|Impurities YA2304-10 and YA2304-17 were       |YA2304-16,       |YA2304-16,       |YA2304-16,       |YA2304-16,       |YA2304-16,       |YA2304-16,       |YA2304-16,       |YA2304-16,       |YA2304-16,       |
|calculated at 230nm wavelength byexternal     |YA2304-18        |YA2304-18        |YA2304-18        |YA2304-18        |YA2304-18        |YA2304-18        |YA2304-18        |YA2304-18        |YA2304-18        |
|standard method. The impurity peak less than  |and              |and              |and              |and              |and              |and              |and              |and              |and              |
|0.5 times of the main peakarea of the control |YA2304-19        |YA2304-19        |YA2304-19        |YA2304-19        |YA2304-19        |YA2304-19        |YA2304-19        |YA2304-19        |YA2304-19        |
|solution wasignored in the 6 samples with     |were             |were             |were             |were             |were             |were             |were             |were             |were             |
|limited concentration repeatable test         |calculated       |calculated       |calculated       |calculated       |calculated       |calculated       |calculated       |calculated       |calculated       |
|solution. The RSD ofotherimpurities was less  |by the           |by the           |by the           |by the           |by the           |by the           |by the           |by the           |by the           |
|than 5%, and the RSD of totalimpurities was   |principal        |principal        |principal        |principal        |principal        |principal        |principal        |principal        |principal        |
|less than 5%, which met the requirements. The |component        |component        |component        |component        |component        |component        |component        |component        |component        |
|method has good repeatability.                |self-control     |self-control     |self-control     |self-control     |self-control     |self-control     |self-control     |self-control     |self-control     |
|                                              |method           |method           |method           |method           |method           |method           |method           |method           |method           |
|                                              |with             |with             |with             |with             |with             |with             |with             |with             |with             |
|                                              |correction       |correction       |correction       |correction       |correction       |correction       |correction       |correction       |correction       |
|                                              |factorunder      |factorunder      |factorunder      |factorunder      |factorunder      |factorunder      |factorunder      |factorunder      |factorunder      |
|                                              |the              |the              |the              |the              |the              |the              |the              |the              |the              |
|                                              |wavelength       |wavelength       |wavelength       |wavelength       |wavelength       |wavelength       |wavelength       |wavelength       |wavelength       |
|                                              |of               |of               |of               |of               |of               |of               |of               |of               |of               |
|                                              |251nm.           |251nm.           |251nm.           |251nm.           |251nm.           |251nm.           |251nm.           |251nm.           |251nm.           |
|                                              |Impurities       |Impurities       |Impurities       |Impurities       |Impurities       |Impurities       |Impurities       |Impurities       |Impurities       |
|                                              |YA2304-10        |YA2304-10        |YA2304-10        |YA2304-10        |YA2304-10        |YA2304-10        |YA2304-10        |YA2304-10        |YA2304-10        |
|                                              |and              |and              |and              |and              |and              |and              |and              |and              |and              |
|                                              |YA2304-17        |YA2304-17        |YA2304-17        |YA2304-17        |YA2304-17        |YA2304-17        |YA2304-17        |YA2304-17        |YA2304-17        |
|                                              |were             |were             |were             |were             |were             |were             |were             |were             |were             |
|                                              |calculated       |calculated       |calculated       |calculated       |calculated       |calculated       |calculated       |calculated       |calculated       |
|                                              |at               |at               |at               |at               |at               |at               |at               |at               |at               |
|                                              |230nm            |230nm            |230nm            |230nm            |230nm            |230nm            |230nm            |230nm            |230nm            |
|                                              |wavelength       |wavelength       |wavelength       |wavelength       |wavelength       |wavelength       |wavelength       |wavelength       |wavelength       |
|                                              |byexternal       |byexternal       |byexternal       |byexternal       |byexternal       |byexternal       |byexternal       |byexternal       |byexternal       |
|                                              |standard         |standard         |standard         |standard         |standard         |standard         |standard         |standard         |standard         |
|                                              |method.          |method.          |method.          |method.          |method.          |method.          |method.          |method.          |method.          |
|                                              |The              |The              |The              |The              |The              |The              |The              |The              |The              |
|                                              |impurity         |impurity         |impurity         |impurity         |impurity         |impurity         |impurity         |impurity         |impurity         |
|                                              |peak             |peak             |peak             |peak             |peak             |peak             |peak             |peak             |peak             |
|                                              |less             |less             |less             |less             |less             |less             |less             |less             |less             |
|                                              |than             |than             |than             |than             |than             |than             |than             |than             |than             |
|                                              |0.5              |0.5              |0.5              |0.5              |0.5              |0.5              |0.5              |0.5              |0.5              |
|                                              |times            |times            |times            |times            |times            |times            |times            |times            |times            |
|                                              |of the           |of the           |of the           |of the           |of the           |of the           |of the           |of the           |of the           |
|                                              |main             |main             |main             |main             |main             |main             |main             |main             |main             |
|                                              |peakarea         |peakarea         |peakarea         |peakarea         |peakarea         |peakarea         |peakarea         |peakarea         |peakarea         |
|                                              |of the           |of the           |of the           |of the           |of the           |of the           |of the           |of the           |of the           |
|                                              |control          |control          |control          |control          |control          |control          |control          |control          |control          |
|                                              |solution         |solution         |solution         |solution         |solution         |solution         |solution         |solution         |solution         |
|                                              |wasignored       |wasignored       |wasignored       |wasignored       |wasignored       |wasignored       |wasignored       |wasignored       |wasignored       |
|                                              |in the           |in the           |in the           |in the           |in the           |in the           |in the           |in the           |in the           |
|                                              |6                |6                |6                |6                |6                |6                |6                |6                |6                |
|                                              |samples          |samples          |samples          |samples          |samples          |samples          |samples          |samples          |samples          |
|                                              |with             |with             |with             |with             |with             |with             |with             |with             |with             |
|                                              |limited          |limited          |limited          |limited          |limited          |limited          |limited          |limited          |limited          |
|                                              |concentration    |concentration    |concentration    |concentration    |concentration    |concentration    |concentration    |concentration    |concentration    |
|                                              |repeatable       |repeatable       |repeatable       |repeatable       |repeatable       |repeatable       |repeatable       |repeatable       |repeatable       |
|                                              |test             |test             |test             |test             |test             |test             |test             |test             |test             |
|                                              |solution.        |solution.        |solution.        |solution.        |solution.        |solution.        |solution.        |solution.        |solution.        |
|                                              |The RSD          |The RSD          |The RSD          |The RSD          |The RSD          |The RSD          |The RSD          |The RSD          |The RSD          |
|                                              |ofotherimpurities|ofotherimpurities|ofotherimpurities|ofotherimpurities|ofotherimpurities|ofotherimpurities|ofotherimpurities|ofotherimpurities|ofotherimpurities|
|                                              |was              |was              |was              |was              |was              |was              |was              |was              |was              |
|                                              |less             |less             |less             |less             |less             |less             |less             |less             |less             |
|                                              |than             |than             |than             |than             |than             |than             |than             |than             |than             |
|                                              |5%, and          |5%, and          |5%, and          |5%, and          |5%, and          |5%, and          |5%, and          |5%, and          |5%, and          |
|                                              |the RSD          |the RSD          |the RSD          |the RSD          |the RSD          |the RSD          |the RSD          |the RSD          |the RSD          |
|                                              |of               |of               |of               |of               |of               |of               |of               |of               |of               |
|                                              |totalimpurities  |totalimpurities  |totalimpurities  |totalimpurities  |totalimpurities  |totalimpurities  |totalimpurities  |totalimpurities  |totalimpurities  |
|                                              |was              |was              |was              |was              |was              |was              |was              |was              |was              |
|                                              |less             |less             |less             |less             |less             |less             |less             |less             |less             |
|                                              |than             |than             |than             |than             |than             |than             |than             |than             |than             |
|                                              |5%,              |5%,              |5%,              |5%,              |5%,              |5%,              |5%,              |5%,              |5%,              |
|                                              |which            |which            |which            |which            |which            |which            |which            |which            |which            |
|                                              |met the          |met the          |met the          |met the          |met the          |met the          |met the          |met the          |met the          |
|                                              |requirements.    |requirements.    |requirements.    |requirements.    |requirements.    |requirements.    |requirements.    |requirements.    |requirements.    |
|                                              |The              |The              |The              |The              |The              |The              |The              |The              |The              |
|                                              |method           |method           |method           |method           |method           |method           |method           |method           |method           |
|                                              |has              |has              |has              |has              |has              |has              |has              |has              |has              |
|                                              |good             |good             |good             |good             |good             |good             |good             |good             |good             |
|                                              |repeatability.   |repeatability.   |repeatability.   |repeatability.   |repeatability.   |repeatability.   |repeatability.   |repeatability.   |repeatability.   |
|----------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|Solution name                                 |Solution name    |Intermediate     |Intermediate     |Intermediate     |Intermediate     |Intermediate     |Intermediate     |RSD (%) (n=6)    |RSD (%) (n=12)   |
|                                              |                 |precision test   |precision test   |precision sample③|precision test   |precision test   |precision test   |                 |                 |
|                                              |                 |product①         |product②         |                 |product④         |product⑤         |product⑥         |                 |                 |
|----------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|Im purity con tent /%                         |Impurity         |0.145            |0.148            |0.150            |0.150            |0.151            |0.149            |1.5              |2.6              |
|                                              |YA2304-12        |                 |                 |                 |                 |                 |                 |                 |                 |
|----------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|Im purity con tent /%                         |Impurity         |0.142            |0.142            |0.147            |0.144            |0.146            |0.143            |1.4              |2.0              |
|                                              |YA2304-14        |                 |                 |                 |                 |                 |                 |                 |                 |
|----------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|Im purity con tent /%                         |Impurity         |0.151            |0.151            |0.154            |0.153            |0.154            |0.153            |1.0              |1.5              |
|                                              |YA2304-15        |                 |                 |                 |                 |                 |                 |                 |                 |
|----------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|Im purity con tent /%                         |Impurity         |0.131            |0.131            |0.135            |0.135            |0.135            |0.133            |1.6              |2.6              |
|                                              |YA2304-16        |                 |                 |                 |                 |                 |                 |                 |                 |
|----------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|Im purity con tent /%                         |Impurity         |0.140            |0.140            |0.145            |0.144            |0.143            |0.141            |1.4              |2.0              |
|                                              |YA2304-18        |                 |                 |                 |                 |                 |                 |                 |                 |
|----------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|Im purity con tent /%                         |Impurity         |0.164            |0.163            |0.171            |0.171            |0.167            |0.165            |2.1              |1.9              |
|                                              |YA2304-19        |                 |                 |                 |                 |                 |                 |                 |                 |
|----------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|Im purity con tent /%                         |Impurity         |0.142            |0.142            |0.142            |0.142            |0.142            |0.142            |0.22             |2.1              |
|                                              |YA2304-17        |                 |                 |                 |                 |                 |                 |                 |                 |
|----------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|Im purity con tent /%                         |Impurity         |0.148            |0.146            |0.144            |0.146            |0.146            |0.148            |1.1              |0.9              |
|                                              |YA2304-10        |                 |                 |                 |                 |                 |                 |                 |                 |
|----------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|Im purity con tent /%                         |Unknownimpurity  |<0.05%           |<0.05%           |<0.05%           |<0.05%           |<0.05%           |<0.05%           |/                |<0.05%           |
|                                              |(RRT≈0.64)       |                 |                 |                 |                 |                 |                 |                 |                 |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 221 of 542 





Page 222
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 










------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Totalimpurity                                 |1.163            |1.162            |1.188            |1.185            |1.185            |1.174            |1.0              |1.6              |                 |
|----------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|Conclusion: Impurities YA2304-12, YA2304-14,  |Conclusion:      |Conclusion:      |Conclusion:      |Conclusion:      |Conclusion:      |Conclusion:      |Conclusion:      |Conclusion:      |Conclusion:      |
|YA2304-15, YA2304-16, YA2304-18 and YA2304-19 |Impurities       |Impurities       |Impurities       |Impurities       |Impurities       |Impurities       |Impurities       |Impurities       |Impurities       |
|were calculated by the principal component    |YA2304-12,       |YA2304-12,       |YA2304-12,       |YA2304-12,       |YA2304-12,       |YA2304-12,       |YA2304-12,       |YA2304-12,       |YA2304-12,       |
|self-control method with correction           |YA2304-14,       |YA2304-14,       |YA2304-14,       |YA2304-14,       |YA2304-14,       |YA2304-14,       |YA2304-14,       |YA2304-14,       |YA2304-14,       |
|factorunder the wavelength of 251nm.          |YA2304-15,       |YA2304-15,       |YA2304-15,       |YA2304-15,       |YA2304-15,       |YA2304-15,       |YA2304-15,       |YA2304-15,       |YA2304-15,       |
|Impurities YA2304-10 and YA2304-17 were       |YA2304-16,       |YA2304-16,       |YA2304-16,       |YA2304-16,       |YA2304-16,       |YA2304-16,       |YA2304-16,       |YA2304-16,       |YA2304-16,       |
|calculated at 230nm wavelength byexternal     |YA2304-18        |YA2304-18        |YA2304-18        |YA2304-18        |YA2304-18        |YA2304-18        |YA2304-18        |YA2304-18        |YA2304-18        |
|standard method. The impurity peak less than  |and              |and              |and              |and              |and              |and              |and              |and              |and              |
|0.5 times of the main peakarea of the control |YA2304-19        |YA2304-19        |YA2304-19        |YA2304-19        |YA2304-19        |YA2304-19        |YA2304-19        |YA2304-19        |YA2304-19        |
|solution wasignored in the 6 parts            |were             |were             |were             |were             |were             |were             |were             |were             |were             |
|ofintermediate precision test solution with   |calculated       |calculated       |calculated       |calculated       |calculated       |calculated       |calculated       |calculated       |calculated       |
|limit concentration. The RSD ofotherimpurities|by the           |by the           |by the           |by the           |by the           |by the           |by the           |by the           |by the           |
|was less than 5%, and the RSD of              |principal        |principal        |principal        |principal        |principal        |principal        |principal        |principal        |principal        |
|totalimpurities was less than 5%, which met   |component        |component        |component        |component        |component        |component        |component        |component        |component        |
|the requirements. The intermediate precision  |self-control     |self-control     |self-control     |self-control     |self-control     |self-control     |self-control     |self-control     |self-control     |
|of this methodis good. In the 12 tests of     |method           |method           |method           |method           |method           |method           |method           |method           |method           |
|repeatability andintermediate precision, the  |with             |with             |with             |with             |with             |with             |with             |with             |with             |
|impurity peak less than 0.5 times of the main |correction       |correction       |correction       |correction       |correction       |correction       |correction       |correction       |correction       |
|peakarea of the control solution wasignored,  |factorunder      |factorunder      |factorunder      |factorunder      |factorunder      |factorunder      |factorunder      |factorunder      |factorunder      |
|the RSD ofotherimpurities was less than 10%,  |the              |the              |the              |the              |the              |the              |the              |the              |the              |
|and the RSD of totalimpurities was less than  |wavelength       |wavelength       |wavelength       |wavelength       |wavelength       |wavelength       |wavelength       |wavelength       |wavelength       |
|10%, which met the requirements.              |of               |of               |of               |of               |of               |of               |of               |of               |of               |
|                                              |251nm.           |251nm.           |251nm.           |251nm.           |251nm.           |251nm.           |251nm.           |251nm.           |251nm.           |
|                                              |Impurities       |Impurities       |Impurities       |Impurities       |Impurities       |Impurities       |Impurities       |Impurities       |Impurities       |
|                                              |YA2304-10        |YA2304-10        |YA2304-10        |YA2304-10        |YA2304-10        |YA2304-10        |YA2304-10        |YA2304-10        |YA2304-10        |
|                                              |and              |and              |and              |and              |and              |and              |and              |and              |and              |
|                                              |YA2304-17        |YA2304-17        |YA2304-17        |YA2304-17        |YA2304-17        |YA2304-17        |YA2304-17        |YA2304-17        |YA2304-17        |
|                                              |were             |were             |were             |were             |were             |were             |were             |were             |were             |
|                                              |calculated       |calculated       |calculated       |calculated       |calculated       |calculated       |calculated       |calculated       |calculated       |
|                                              |at               |at               |at               |at               |at               |at               |at               |at               |at               |
|                                              |230nm            |230nm            |230nm            |230nm            |230nm            |230nm            |230nm            |230nm            |230nm            |
|                                              |wavelength       |wavelength       |wavelength       |wavelength       |wavelength       |wavelength       |wavelength       |wavelength       |wavelength       |
|                                              |byexternal       |byexternal       |byexternal       |byexternal       |byexternal       |byexternal       |byexternal       |byexternal       |byexternal       |
|                                              |standard         |standard         |standard         |standard         |standard         |standard         |standard         |standard         |standard         |
|                                              |method.          |method.          |method.          |method.          |method.          |method.          |method.          |method.          |method.          |
|                                              |The              |The              |The              |The              |The              |The              |The              |The              |The              |
|                                              |impurity         |impurity         |impurity         |impurity         |impurity         |impurity         |impurity         |impurity         |impurity         |
|                                              |peak             |peak             |peak             |peak             |peak             |peak             |peak             |peak             |peak             |
|                                              |less             |less             |less             |less             |less             |less             |less             |less             |less             |
|                                              |than             |than             |than             |than             |than             |than             |than             |than             |than             |
|                                              |0.5              |0.5              |0.5              |0.5              |0.5              |0.5              |0.5              |0.5              |0.5              |
|                                              |times            |times            |times            |times            |times            |times            |times            |times            |times            |
|                                              |of the           |of the           |of the           |of the           |of the           |of the           |of the           |of the           |of the           |
|                                              |main             |main             |main             |main             |main             |main             |main             |main             |main             |
|                                              |peakarea         |peakarea         |peakarea         |peakarea         |peakarea         |peakarea         |peakarea         |peakarea         |peakarea         |
|                                              |of the           |of the           |of the           |of the           |of the           |of the           |of the           |of the           |of the           |
|                                              |control          |control          |control          |control          |control          |control          |control          |control          |control          |
|                                              |solution         |solution         |solution         |solution         |solution         |solution         |solution         |solution         |solution         |
|                                              |wasignored       |wasignored       |wasignored       |wasignored       |wasignored       |wasignored       |wasignored       |wasignored       |wasignored       |
|                                              |in the           |in the           |in the           |in the           |in the           |in the           |in the           |in the           |in the           |
|                                              |6 parts          |6 parts          |6 parts          |6 parts          |6 parts          |6 parts          |6 parts          |6 parts          |6 parts          |
|                                              |ofintermediate   |ofintermediate   |ofintermediate   |ofintermediate   |ofintermediate   |ofintermediate   |ofintermediate   |ofintermediate   |ofintermediate   |
|                                              |precision        |precision        |precision        |precision        |precision        |precision        |precision        |precision        |precision        |
|                                              |test             |test             |test             |test             |test             |test             |test             |test             |test             |
|                                              |solution         |solution         |solution         |solution         |solution         |solution         |solution         |solution         |solution         |
|                                              |with             |with             |with             |with             |with             |with             |with             |with             |with             |
|                                              |limit            |limit            |limit            |limit            |limit            |limit            |limit            |limit            |limit            |
|                                              |concentration.   |concentration.   |concentration.   |concentration.   |concentration.   |concentration.   |concentration.   |concentration.   |concentration.   |
|                                              |The RSD          |The RSD          |The RSD          |The RSD          |The RSD          |The RSD          |The RSD          |The RSD          |The RSD          |
|                                              |ofotherimpurities|ofotherimpurities|ofotherimpurities|ofotherimpurities|ofotherimpurities|ofotherimpurities|ofotherimpurities|ofotherimpurities|ofotherimpurities|
|                                              |was              |was              |was              |was              |was              |was              |was              |was              |was              |
|                                              |less             |less             |less             |less             |less             |less             |less             |less             |less             |
|                                              |than             |than             |than             |than             |than             |than             |than             |than             |than             |
|                                              |5%, and          |5%, and          |5%, and          |5%, and          |5%, and          |5%, and          |5%, and          |5%, and          |5%, and          |
|                                              |the RSD          |the RSD          |the RSD          |the RSD          |the RSD          |the RSD          |the RSD          |the RSD          |the RSD          |
|                                              |of               |of               |of               |of               |of               |of               |of               |of               |of               |
|                                              |totalimpurities  |totalimpurities  |totalimpurities  |totalimpurities  |totalimpurities  |totalimpurities  |totalimpurities  |totalimpurities  |totalimpurities  |
|                                              |was              |was              |was              |was              |was              |was              |was              |was              |was              |
|                                              |less             |less             |less             |less             |less             |less             |less             |less             |less             |
|                                              |than             |than             |than             |than             |than             |than             |than             |than             |than             |
|                                              |5%,              |5%,              |5%,              |5%,              |5%,              |5%,              |5%,              |5%,              |5%,              |
|                                              |which            |which            |which            |which            |which            |which            |which            |which            |which            |
|                                              |met the          |met the          |met the          |met the          |met the          |met the          |met the          |met the          |met the          |
|                                              |requirements.    |requirements.    |requirements.    |requirements.    |requirements.    |requirements.    |requirements.    |requirements.    |requirements.    |
|                                              |The              |The              |The              |The              |The              |The              |The              |The              |The              |
|                                              |intermediate     |intermediate     |intermediate     |intermediate     |intermediate     |intermediate     |intermediate     |intermediate     |intermediate     |
|                                              |precision        |precision        |precision        |precision        |precision        |precision        |precision        |precision        |precision        |
|                                              |of this          |of this          |of this          |of this          |of this          |of this          |of this          |of this          |of this          |
|                                              |methodis         |methodis         |methodis         |methodis         |methodis         |methodis         |methodis         |methodis         |methodis         |
|                                              |good.            |good.            |good.            |good.            |good.            |good.            |good.            |good.            |good.            |
|                                              |In the           |In the           |In the           |In the           |In the           |In the           |In the           |In the           |In the           |
|                                              |12               |12               |12               |12               |12               |12               |12               |12               |12               |
|                                              |tests            |tests            |tests            |tests            |tests            |tests            |tests            |tests            |tests            |
|                                              |of               |of               |of               |of               |of               |of               |of               |of               |of               |
|                                              |repeatability    |repeatability    |repeatability    |repeatability    |repeatability    |repeatability    |repeatability    |repeatability    |repeatability    |
|                                              |andintermediate  |andintermediate  |andintermediate  |andintermediate  |andintermediate  |andintermediate  |andintermediate  |andintermediate  |andintermediate  |
|                                              |precision,       |precision,       |precision,       |precision,       |precision,       |precision,       |precision,       |precision,       |precision,       |
|                                              |the              |the              |the              |the              |the              |the              |the              |the              |the              |
|                                              |impurity         |impurity         |impurity         |impurity         |impurity         |impurity         |impurity         |impurity         |impurity         |
|                                              |peak             |peak             |peak             |peak             |peak             |peak             |peak             |peak             |peak             |
|                                              |less             |less             |less             |less             |less             |less             |less             |less             |less             |
|                                              |than             |than             |than             |than             |than             |than             |than             |than             |than             |
|                                              |0.5              |0.5              |0.5              |0.5              |0.5              |0.5              |0.5              |0.5              |0.5              |
|                                              |times            |times            |times            |times            |times            |times            |times            |times            |times            |
|                                              |of the           |of the           |of the           |of the           |of the           |of the           |of the           |of the           |of the           |
|                                              |main             |main             |main             |main             |main             |main             |main             |main             |main             |
|                                              |peakarea         |peakarea         |peakarea         |peakarea         |peakarea         |peakarea         |peakarea         |peakarea         |peakarea         |
|                                              |of the           |of the           |of the           |of the           |of the           |of the           |of the           |of the           |of the           |
|                                              |control          |control          |control          |control          |control          |control          |control          |control          |control          |
|                                              |solution         |solution         |solution         |solution         |solution         |solution         |solution         |solution         |solution         |
|                                              |wasignored,      |wasignored,      |wasignored,      |wasignored,      |wasignored,      |wasignored,      |wasignored,      |wasignored,      |wasignored,      |
|                                              |the RSD          |the RSD          |the RSD          |the RSD          |the RSD          |the RSD          |the RSD          |the RSD          |the RSD          |
|                                              |ofotherimpurities|ofotherimpurities|ofotherimpurities|ofotherimpurities|ofotherimpurities|ofotherimpurities|ofotherimpurities|ofotherimpurities|ofotherimpurities|
|                                              |was              |was              |was              |was              |was              |was              |was              |was              |was              |
|                                              |less             |less             |less             |less             |less             |less             |less             |less             |less             |
|                                              |than             |than             |than             |than             |than             |than             |than             |than             |than             |
|                                              |10%,             |10%,             |10%,             |10%,             |10%,             |10%,             |10%,             |10%,             |10%,             |
|                                              |and the          |and the          |and the          |and the          |and the          |and the          |and the          |and the          |and the          |
|                                              |RSD of           |RSD of           |RSD of           |RSD of           |RSD of           |RSD of           |RSD of           |RSD of           |RSD of           |
|                                              |totalimpurities  |totalimpurities  |totalimpurities  |totalimpurities  |totalimpurities  |totalimpurities  |totalimpurities  |totalimpurities  |totalimpurities  |
|                                              |was              |was              |was              |was              |was              |was              |was              |was              |was              |
|                                              |less             |less             |less             |less             |less             |less             |less             |less             |less             |
|                                              |than             |than             |than             |than             |than             |than             |than             |than             |than             |
|                                              |10%,             |10%,             |10%,             |10%,             |10%,             |10%,             |10%,             |10%,             |10%,             |
|                                              |which            |which            |which            |which            |which            |which            |which            |which            |which            |
|                                              |met the          |met the          |met the          |met the          |met the          |met the          |met the          |met the          |met the          |
|                                              |requirements.    |requirements.    |requirements.    |requirements.    |requirements.    |requirements.    |requirements.    |requirements.    |requirements.    |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 222 of 542 





Page 223
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**h. Solution Stability Studies** 



 **Acceptance Criteria** 



Each solution is placed under 5℃ (refrigerated) condition, and the control 



solution, system suitability solution and test product solution are injected at 



different times. The chromatogram of system suitability solution is required 



to be (251nm). The peak order is YA2304-14, YA2304, YA2304-15, 



YA2304-16, YA2304-17, YA2304-10, YA2304-19, and the separation degree 



between YA2304 and YA2304-14 and YA2304-15 should NLT 1.5. The 



separation degree between YA2304-17 and YA2304-16 and adjacent peaks 



should NLT 1.0; In the chromatogram of the control product solution 



(230nm), the peak sequence was YA2304-17, YA2304-10; The RSD of the 



peak-peak area of each impurity in the chromatogram of the reference 



solution NMT 10%. In the chromatogram of the control solution (251nm), the 



signal-to-noise ratio (S/N) of the main peak should NLT 20, the RSD of the 



peak area NMT 10%, the impurity peak less than 0.5 times the main peak 



area of the control solution should not be ignored in the chromatogram of the 



test solution and the solution with the maximum concentration and 



miscellaneous test product, and the RSD of the peak area of other single 



impurities NMT 10%. And there should be no new impurities that interfere 



with the detection of related substances. 



 **Solution Preparation** 



Blank solution: solvent 



YA2304-12 Reference storage solution: Share "YA2304-12 Reference Storage 



solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 223 of 542 





Page 224
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



YA2304-14 Reference storage solution: Share "YA2304-14 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-15 Reference storage solution: Share "YA2304-15 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-16 Reference storage solution: Share "YA2304-16 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-18 Reference storage solution: Share "YA2304-18 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-19 Reference storage solution: Share "YA2304-19 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-10 Reference storage Solution: Share "YA2304-10 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-17 Reference storage solution: Share "YA2304-17 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



Reference solution: Prepare it by the same method as "reference solution" 



under "4.2 System Suitability". (YA2304-10, YA2304-17 containing about 



0.4μg/ml) 



Test solution: Prepare the test solution by the same method as "test solution" 



under "4.2 System Suitability". (Approx. 0.4mg/ml) 



Reference solution: Prepare it by the same method as "reference solution" 



under "4.2 System Applicability". (Approx. 0.4μg/ml) 



System Suitability Solution: Share "System Suitability Solution" from "4.6 



Accuracy" known impurity. (YA2304-14, YA2304-15, YA2304-16, YA2304-19, 



YA2304-10 and YA2304-17 all approx. 0.8μg/ml) 



Impurity reserve liquid: Accurately measure 0.75ml of each control product 



reserve liquid of YA2304-12, YA2304-14, YA2304-15, YA2304-16, 



YA2304-18, YA2304-19, YA2304-17 and YA2304-10 into the same 10ml 



bottle and dilute it to the scale with solvent. Shake well, then it is ready. 



(Contains YA2304-12, YA2304-14, YA2304-15, YA2304-16, YA2304-18, 



YA2304-19, YA2304-17 and YA2304-10 about 15μg/ml each) 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 224 of 542 





Page 225
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Add mixed test product solution: accurately weigh 10mg of this product, 



place it in a 25ml measuring bottle, add an appropriate amount of solvent 



and ultrasonic to dissolve it, then accurately add 1.0ml of impurity reserve 



liquid, dilute it with solvent to the scale, shake well, and get. (Including 



YA2304-12, YA2304-14, YA2304-15, YA2304-16, YA2304-18, YA2304-19, 



YA2304-17 and YA2304-10 are about 0.6μg/ml) 



 **Injection Sequence** 



The suitable solution of the system was placed at 5℃, 1 needle was injected 



at 0h, 8h, 19h, 26.5h, 46h, 59h and 100h respectively, and the 



chromatogram was recorded. 



The mixed test solution was placed at 5℃, and 1 needle was injected at 0h, 



8h, 19h, 25h, 46h, 59h and 100h, respectively, and the chromatogram was 



recorded. 



The test solution was placed at 5℃, and 1 needle was injected at 0h, 8h, 19h, 



38.5h, 46h, 59h and 100h, respectively, and the chromatogram was 



recorded. 



The control solution was placed at 5℃ and injected with 1 needle each at 0h, 



8h, 19h, 39h, 46h, 59h and 100h, respectively, and the chromatogram was 



recorded. 



The control solution was placed at 5℃, and 1 needle was injected at 0h, 8h, 



19h, 38h, 46h, 59h and 100h, respectively, and the chromatogram was 



recorded. 



 **Results and Discussion** 



System suitability solution stability test results: 









-------------------------------------------------------------------------------------
|Investigati onitems|0h     |8h     |19h    |38h    |46h    |59h    |100h   |100h   |
-------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 225 of 542 





Page 226
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 










----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Principal peak signal-to-noise ratio                  |75.4           |65.3           |92.2           |89.8           |54.0           |103.0          |92.8           |/              |
|------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|Conclusion: When the control solution was placed at   |Conclusion:    |Conclusion:    |Conclusion:    |Conclusion:    |Conclusion:    |Conclusion:    |Conclusion:    |Conclusion:    |
|5℃for 100h, the chromatogram of the control solution  |When           |When           |When           |When           |When           |When           |When           |When           |
|(251nm) showed that the main peak signal-to-noise     |the            |the            |the            |the            |the            |the            |the            |the            |
|ratio (S/N) was NLT 54.0 (required to be NLT 20), and |control        |control        |control        |control        |control        |control        |control        |control        |
|the RSD of the peakarea was 1.7% (required to be no   |solution       |solution       |solution       |solution       |solution       |solution       |solution       |solution       |
|more than 10%). All of the above meet the verification|was            |was            |was            |was            |was            |was            |was            |was            |
|requirements, indicating that the control solutionis  |placed         |placed         |placed         |placed         |placed         |placed         |placed         |placed         |
|stable within 100hunder 5℃.                           |at             |at             |at             |at             |at             |at             |at             |at             |
|                                                      |5℃for          |5℃for          |5℃for          |5℃for          |5℃for          |5℃for          |5℃for          |5℃for          |
|                                                      |100h,          |100h,          |100h,          |100h,          |100h,          |100h,          |100h,          |100h,          |
|                                                      |the            |the            |the            |the            |the            |the            |the            |the            |
|                                                      |chromatogram   |chromatogram   |chromatogram   |chromatogram   |chromatogram   |chromatogram   |chromatogram   |chromatogram   |
|                                                      |of the         |of the         |of the         |of the         |of the         |of the         |of the         |of the         |
|                                                      |control        |control        |control        |control        |control        |control        |control        |control        |
|                                                      |solution       |solution       |solution       |solution       |solution       |solution       |solution       |solution       |
|                                                      |(251nm)        |(251nm)        |(251nm)        |(251nm)        |(251nm)        |(251nm)        |(251nm)        |(251nm)        |
|                                                      |showed         |showed         |showed         |showed         |showed         |showed         |showed         |showed         |
|                                                      |that           |that           |that           |that           |that           |that           |that           |that           |
|                                                      |the            |the            |the            |the            |the            |the            |the            |the            |
|                                                      |main           |main           |main           |main           |main           |main           |main           |main           |
|                                                      |peak           |peak           |peak           |peak           |peak           |peak           |peak           |peak           |
|                                                      |signal-to-noise|signal-to-noise|signal-to-noise|signal-to-noise|signal-to-noise|signal-to-noise|signal-to-noise|signal-to-noise|
|                                                      |ratio          |ratio          |ratio          |ratio          |ratio          |ratio          |ratio          |ratio          |
|                                                      |(S/N)          |(S/N)          |(S/N)          |(S/N)          |(S/N)          |(S/N)          |(S/N)          |(S/N)          |
|                                                      |was NLT        |was NLT        |was NLT        |was NLT        |was NLT        |was NLT        |was NLT        |was NLT        |
|                                                      |54.0           |54.0           |54.0           |54.0           |54.0           |54.0           |54.0           |54.0           |
|                                                      |(required      |(required      |(required      |(required      |(required      |(required      |(required      |(required      |
|                                                      |to be          |to be          |to be          |to be          |to be          |to be          |to be          |to be          |
|                                                      |NLT            |NLT            |NLT            |NLT            |NLT            |NLT            |NLT            |NLT            |
|                                                      |20),           |20),           |20),           |20),           |20),           |20),           |20),           |20),           |
|                                                      |and the        |and the        |and the        |and the        |and the        |and the        |and the        |and the        |
|                                                      |RSD of         |RSD of         |RSD of         |RSD of         |RSD of         |RSD of         |RSD of         |RSD of         |
|                                                      |the            |the            |the            |the            |the            |the            |the            |the            |
|                                                      |peakarea       |peakarea       |peakarea       |peakarea       |peakarea       |peakarea       |peakarea       |peakarea       |
|                                                      |was            |was            |was            |was            |was            |was            |was            |was            |
|                                                      |1.7%           |1.7%           |1.7%           |1.7%           |1.7%           |1.7%           |1.7%           |1.7%           |
|                                                      |(required      |(required      |(required      |(required      |(required      |(required      |(required      |(required      |
|                                                      |to be          |to be          |to be          |to be          |to be          |to be          |to be          |to be          |
|                                                      |no more        |no more        |no more        |no more        |no more        |no more        |no more        |no more        |
|                                                      |than           |than           |than           |than           |than           |than           |than           |than           |
|                                                      |10%).          |10%).          |10%).          |10%).          |10%).          |10%).          |10%).          |10%).          |
|                                                      |All of         |All of         |All of         |All of         |All of         |All of         |All of         |All of         |
|                                                      |the            |the            |the            |the            |the            |the            |the            |the            |
|                                                      |above          |above          |above          |above          |above          |above          |above          |above          |
|                                                      |meet           |meet           |meet           |meet           |meet           |meet           |meet           |meet           |
|                                                      |the            |the            |the            |the            |the            |the            |the            |the            |
|                                                      |verification   |verification   |verification   |verification   |verification   |verification   |verification   |verification   |
|                                                      |requirements,  |requirements,  |requirements,  |requirements,  |requirements,  |requirements,  |requirements,  |requirements,  |
|                                                      |indicating     |indicating     |indicating     |indicating     |indicating     |indicating     |indicating     |indicating     |
|                                                      |that           |that           |that           |that           |that           |that           |that           |that           |
|                                                      |the            |the            |the            |the            |the            |the            |the            |the            |
|                                                      |control        |control        |control        |control        |control        |control        |control        |control        |
|                                                      |solutionis     |solutionis     |solutionis     |solutionis     |solutionis     |solutionis     |solutionis     |solutionis     |
|                                                      |stable         |stable         |stable         |stable         |stable         |stable         |stable         |stable         |
|                                                      |within         |within         |within         |within         |within         |within         |within         |within         |
|                                                      |100hunder      |100hunder      |100hunder      |100hunder      |100hunder      |100hunder      |100hunder      |100hunder      |
|                                                      |5℃.            |5℃.            |5℃.            |5℃.            |5℃.            |5℃.            |5℃.            |5℃.            |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Stability test results of control solution: 





































---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Investigati onItems                           |Impurity      |0h            |8h            |19h           |39h           |46h           |59h           |100h          |100h          |
|                                              |names         |              |              |              |              |              |              |              |              |
|----------------------------------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Peakarea                                      |YA2304-       |1103 7        |1099 0        |1104 2        |1109 6        |1100 6        |1123 5        |1103 1        |0.8           |
|                                              |17            |              |              |              |              |              |              |              |              |
|----------------------------------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Peakarea                                      |YA2304-       |8322          |8233          |8327          |8411          |8336          |8361          |8219          |0.9           |
|                                              |10            |              |              |              |              |              |              |              |              |
|----------------------------------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Conclusion: When the control solution was     |Conclusion:   |Conclusion:   |Conclusion:   |Conclusion:   |Conclusion:   |Conclusion:   |Conclusion:   |Conclusion:   |Conclusion:   |
|placed at 5℃for 100h, the chromatogram of the |When the      |When          |When          |When          |When          |When          |When          |When          |When          |
|control solution (230nm) was followed by      |control       |the           |the           |the           |the           |the           |the           |the           |the           |
|YA2304-17 and YA2304-10, and the RSD of the   |solution      |control       |control       |control       |control       |control       |control       |control       |control       |
|peak-peakarea ofeachimpurity in the           |was           |solution      |solution      |solution      |solution      |solution      |solution      |solution      |solution      |
|chromatogram was no more than 0.9% (required  |placed        |was           |was           |was           |was           |was           |was           |was           |was           |
|to be no more than 10%). The verification     |at 5℃for      |placed        |placed        |placed        |placed        |placed        |placed        |placed        |placed        |
|requirements were met, indicating that the    |100h,         |at            |at            |at            |at            |at            |at            |at            |at            |
|control solution was stable within 100hunder  |the           |5℃for         |5℃for         |5℃for         |5℃for         |5℃for         |5℃for         |5℃for         |5℃for         |
|5℃.                                           |chromatogram  |100h,         |100h,         |100h,         |100h,         |100h,         |100h,         |100h,         |100h,         |
|                                              |of the        |the           |the           |the           |the           |the           |the           |the           |the           |
|                                              |control       |chromatogram  |chromatogram  |chromatogram  |chromatogram  |chromatogram  |chromatogram  |chromatogram  |chromatogram  |
|                                              |solution      |of the        |of the        |of the        |of the        |of the        |of the        |of the        |of the        |
|                                              |(230nm)       |control       |control       |control       |control       |control       |control       |control       |control       |
|                                              |was           |solution      |solution      |solution      |solution      |solution      |solution      |solution      |solution      |
|                                              |followed      |(230nm)       |(230nm)       |(230nm)       |(230nm)       |(230nm)       |(230nm)       |(230nm)       |(230nm)       |
|                                              |by            |was           |was           |was           |was           |was           |was           |was           |was           |
|                                              |YA2304-17     |followed      |followed      |followed      |followed      |followed      |followed      |followed      |followed      |
|                                              |and           |by            |by            |by            |by            |by            |by            |by            |by            |
|                                              |YA2304-10,    |YA2304-17     |YA2304-17     |YA2304-17     |YA2304-17     |YA2304-17     |YA2304-17     |YA2304-17     |YA2304-17     |
|                                              |and the       |and           |and           |and           |and           |and           |and           |and           |and           |
|                                              |RSD of        |YA2304-10,    |YA2304-10,    |YA2304-10,    |YA2304-10,    |YA2304-10,    |YA2304-10,    |YA2304-10,    |YA2304-10,    |
|                                              |the           |and the       |and the       |and the       |and the       |and the       |and the       |and the       |and the       |
|                                              |peak-peakarea |RSD of        |RSD of        |RSD of        |RSD of        |RSD of        |RSD of        |RSD of        |RSD of        |
|                                              |ofeachimpurity|the           |the           |the           |the           |the           |the           |the           |the           |
|                                              |in the        |peak-peakarea |peak-peakarea |peak-peakarea |peak-peakarea |peak-peakarea |peak-peakarea |peak-peakarea |peak-peakarea |
|                                              |chromatogram  |ofeachimpurity|ofeachimpurity|ofeachimpurity|ofeachimpurity|ofeachimpurity|ofeachimpurity|ofeachimpurity|ofeachimpurity|
|                                              |was no        |in the        |in the        |in the        |in the        |in the        |in the        |in the        |in the        |
|                                              |more          |chromatogram  |chromatogram  |chromatogram  |chromatogram  |chromatogram  |chromatogram  |chromatogram  |chromatogram  |
|                                              |than          |was no        |was no        |was no        |was no        |was no        |was no        |was no        |was no        |
|                                              |0.9%          |more          |more          |more          |more          |more          |more          |more          |more          |
|                                              |(required     |than          |than          |than          |than          |than          |than          |than          |than          |
|                                              |to be no      |0.9%          |0.9%          |0.9%          |0.9%          |0.9%          |0.9%          |0.9%          |0.9%          |
|                                              |more          |(required     |(required     |(required     |(required     |(required     |(required     |(required     |(required     |
|                                              |than          |to be         |to be         |to be         |to be         |to be         |to be         |to be         |to be         |
|                                              |10%).         |no more       |no more       |no more       |no more       |no more       |no more       |no more       |no more       |
|                                              |The           |than          |than          |than          |than          |than          |than          |than          |than          |
|                                              |verification  |10%).         |10%).         |10%).         |10%).         |10%).         |10%).         |10%).         |10%).         |
|                                              |requirements  |The           |The           |The           |The           |The           |The           |The           |The           |
|                                              |were          |verification  |verification  |verification  |verification  |verification  |verification  |verification  |verification  |
|                                              |met,          |requirements  |requirements  |requirements  |requirements  |requirements  |requirements  |requirements  |requirements  |
|                                              |indicating    |were          |were          |were          |were          |were          |were          |were          |were          |
|                                              |that the      |met,          |met,          |met,          |met,          |met,          |met,          |met,          |met,          |
|                                              |control       |indicating    |indicating    |indicating    |indicating    |indicating    |indicating    |indicating    |indicating    |
|                                              |solution      |that          |that          |that          |that          |that          |that          |that          |that          |
|                                              |was           |the           |the           |the           |the           |the           |the           |the           |the           |
|                                              |stable        |control       |control       |control       |control       |control       |control       |control       |control       |
|                                              |within        |solution      |solution      |solution      |solution      |solution      |solution      |solution      |solution      |
|                                              |100hunder     |was           |was           |was           |was           |was           |was           |was           |was           |
|                                              |5℃.           |stable        |stable        |stable        |stable        |stable        |stable        |stable        |stable        |
|                                              |              |within        |within        |within        |within        |within        |within        |within        |within        |
|                                              |              |100hunder     |100hunder     |100hunder     |100hunder     |100hunder     |100hunder     |100hunder     |100hunder     |
|                                              |              |5℃.           |5℃.           |5℃.           |5℃.           |5℃.           |5℃.           |5℃.           |5℃.           |
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Stability test results of system suitability solution: 































-------------------------------------------------------------------------------------------------------------------------------
|InvestigationItems                                            |0h      |8h      |19h     |26.5 h. |46h     |59h     |100h    |
|--------------------------------------------------------------|--------|--------|--------|--------|--------|--------|--------|
|Degree of separation between YA2304 and YA2304-14             |5.9     |6.0     |5.9     |5.9     |5.9     |5.8     |5.8     |
|--------------------------------------------------------------|--------|--------|--------|--------|--------|--------|--------|
|Degree of separation between YA2304 and YA2304-15             |6.8     |6.9     |6.8     |6.8     |6.8     |6.8     |6.7     |
|--------------------------------------------------------------|--------|--------|--------|--------|--------|--------|--------|
|Minimum separation between YA2304-17 andadjacent peaks        |1.6     |1.6     |1.6     |1.6     |1.6     |2.2     |2.2     |
|--------------------------------------------------------------|--------|--------|--------|--------|--------|--------|--------|
|Minimum separation degree between YA2304-16 andadjacent peaks |1.6     |1.6     |1.6     |1.6     |1.6     |1.6     |1.6     |
|--------------------------------------------------------------|--------|--------|--------|--------|--------|--------|--------|
|Verdict: The system suitable solution was placed at 5℃ for    |Verdict:|Verdict:|Verdict:|Verdict:|Verdict:|Verdict:|Verdict:|
|100h, and the                                                 |The     |The     |The     |The     |The     |The     |The     |
|                                                              |system  |system  |system  |system  |system  |system  |system  |
|                                                              |suitable|suitable|suitable|suitable|suitable|suitable|suitable|
|                                                              |solution|solution|solution|solution|solution|solution|solution|
|                                                              |was     |was     |was     |was     |was     |was     |was     |
|                                                              |placed  |placed  |placed  |placed  |placed  |placed  |placed  |
|                                                              |at 5℃   |at 5℃   |at 5℃   |at 5℃   |at 5℃   |at 5℃   |at 5℃   |
|                                                              |for     |for     |for     |for     |for     |for     |for     |
|                                                              |100h,   |100h,   |100h,   |100h,   |100h,   |100h,   |100h,   |
|                                                              |and the |and the |and the |and the |and the |and the |and the |
-------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 226 of 542 





Page 227
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



chromatogram of the system suitable solution was 251nm. The peak order was 



YA2304-14, YA2304, YA2304-15, YA2304-17, YA2304-16, YA2304-10, YA2304-19. 



The minimum separation degree between YA2304 and YA2304-14 and YA2304-15 is 



NLT 5.8 (NLT 1.5 required), and the minimum separation degree between YA2304-17 



and YA2304-16 and adjacent peaks is NLT 1.6 (NLT 1.0 required); All of the above 



meet the verification requirements, indicating that the system suitable solution is 



stable within 100h under 5℃. 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 227 of 542 





Page 228
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Stability test results of test solutions： 





































































-----------------------------------------------------------------------------------------------------------------------------------------
|Impuri typeakare a|Impurity YA2304-12        |251nm          |382     |333     |343     |386     |467     |337     |356     |Content   |
|                  |                          |               |        |        |        |        |        |        |        |<         |
|                  |                          |               |        |        |        |        |        |        |        |0.05%,    |
|                  |                          |               |        |        |        |        |        |        |        |RSD       |
|                  |                          |               |        |        |        |        |        |        |        |does      |
|                  |                          |               |        |        |        |        |        |        |        |not do    |
|                  |                          |               |        |        |        |        |        |        |        |statistics|
|------------------|--------------------------|---------------|--------|--------|--------|--------|--------|--------|--------|----------|
|Impuri typeakare a|Unknownimpurity (RRT≈0.64)|Unknownimpurity|1182    |1090    |1360    |1327    |1308    |1166    |458     |Content < |
|                  |                          |(RRT≈0.64)     |        |        |        |        |        |        |        |0.05%, RSD|
|                  |                          |               |        |        |        |        |        |        |        |did not do|
|                  |                          |               |        |        |        |        |        |        |        |statistics|
|------------------|--------------------------|---------------|--------|--------|--------|--------|--------|--------|--------|----------|
|Impuri typeakare a|Impurity YA2304-14        |Impurity       |Not     |Not     |Not     |Not     |Not     |Not     |Not     |Content < |
|                  |                          |YA2304-14      |detected|detected|detected|detected|detected|detected|detected|0.05%, RSD|
|                  |                          |               |        |        |        |        |        |        |        |does not  |
|                  |                          |               |        |        |        |        |        |        |        |do        |
|                  |                          |               |        |        |        |        |        |        |        |statistics|
|------------------|--------------------------|---------------|--------|--------|--------|--------|--------|--------|--------|----------|
|Impuri typeakare a|Impurity YA2304-15        |Impurity       |Not     |Not     |Not     |Not     |Not     |Not     |Not     |Content < |
|                  |                          |YA2304-15      |detected|detected|detected|detected|detected|detected|detected|0.05%, RSD|
|                  |                          |               |        |        |        |        |        |        |        |does not  |
|                  |                          |               |        |        |        |        |        |        |        |do        |
|                  |                          |               |        |        |        |        |        |        |        |statistics|
|------------------|--------------------------|---------------|--------|--------|--------|--------|--------|--------|--------|----------|
|Impuri typeakare a|Unknownimpurity (RRT≈1.27)|Unknownimpurity|1220    |1198    |1161    |1174    |1266    |1201    |1181    |Content < |
|                  |                          |(RRT≈1.27)     |        |        |        |        |        |        |        |0.05%, RSD|
|                  |                          |               |        |        |        |        |        |        |        |does not  |
|                  |                          |               |        |        |        |        |        |        |        |do        |
|                  |                          |               |        |        |        |        |        |        |        |statistics|
|------------------|--------------------------|---------------|--------|--------|--------|--------|--------|--------|--------|----------|
|Impuri typeakare a|Impurity YA2304-16        |Impurity       |Not     |Not     |Not     |Not     |Not     |Not     |Not     |Content < |
|                  |                          |YA2304-16      |detected|detected|detected|detected|detected|detected|detected|0.05%, RSD|
|                  |                          |               |        |        |        |        |        |        |        |does not  |
|                  |                          |               |        |        |        |        |        |        |        |do        |
|                  |                          |               |        |        |        |        |        |        |        |statistics|
|------------------|--------------------------|---------------|--------|--------|--------|--------|--------|--------|--------|----------|
|Impuri typeakare a|Impurity YA2304-18        |Impurity       |Not     |Not     |Not     |Not     |Not     |Not     |Not     |Content < |
|                  |                          |YA2304-18      |detected|detected|detected|detected|detected|detected|detected|0.05%, RSD|
|                  |                          |               |        |        |        |        |        |        |        |does not  |
|                  |                          |               |        |        |        |        |        |        |        |do        |
|                  |                          |               |        |        |        |        |        |        |        |statistics|
|------------------|--------------------------|---------------|--------|--------|--------|--------|--------|--------|--------|----------|
|Impuri typeakare a|Impurity YA2304-19        |Impurity       |560     |481     |575     |611     |588     |767     |409     |Content < |
|                  |                          |YA2304-19      |        |        |        |        |        |        |        |0.05%, RSD|
|                  |                          |               |        |        |        |        |        |        |        |does not  |
|                  |                          |               |        |        |        |        |        |        |        |do        |
|                  |                          |               |        |        |        |        |        |        |        |statistics|
-----------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 228 of 542 





Page 229
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 


































----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Impurity YA2304-10                    |Impurity         |Not              |Not              |Not              |Not              |Not              |Not              |Not              |Content          |                 |
|                                      |YA2304-10        |detected         |detected         |detected         |detected         |detected         |detected         |detected         |<                |                 |
|                                      |                 |                 |                 |                 |                 |                 |                 |                 |0.05%,           |                 |
|                                      |                 |                 |                 |                 |                 |                 |                 |                 |RSD              |                 |
|                                      |                 |                 |                 |                 |                 |                 |                 |                 |does             |                 |
|                                      |                 |                 |                 |                 |                 |                 |                 |                 |not do           |                 |
|                                      |                 |                 |                 |                 |                 |                 |                 |                 |statistics       |                 |
|--------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|Conclusion: When the test solution was|Conclusion:      |Conclusion:      |Conclusion:      |Conclusion:      |Conclusion:      |Conclusion:      |Conclusion:      |Conclusion:      |Conclusion:      |Conclusion:      |
|placed at 5℃for 100h, the impurity    |When the         |When the         |When the         |When the         |When the         |When the         |When the         |When the         |When the         |When             |
|peak smaller than 0.5 times of the    |test             |test             |test             |test             |test             |test             |test             |test             |test             |the              |
|main peakarea of the control solution |solution         |solution         |solution         |solution         |solution         |solution         |solution         |solution         |solution         |test             |
|wasignored in the chromatogram of the |was              |was              |was              |was              |was              |was              |was              |was              |was placed       |solution         |
|test solution. The knownimpurities    |placed at        |placed           |placed           |placed           |placed           |placed           |placed           |placed           |at 5℃for         |was              |
|were detectedexcept YA2304-12 and     |5℃for            |at 5℃for         |at 5℃for         |at 5℃for         |at 5℃for         |at 5℃for         |at 5℃for         |at 5℃for         |100h, the        |placed           |
|YA2304-19, and both were less than    |100h, the        |100h,            |100h,            |100h,            |100h,            |100h,            |100h,            |100h,            |impurity         |at               |
|0.05%, and the rest were not detected.|impurity         |the              |the              |the              |the              |the              |the              |the              |peak             |5℃for            |
|Other single unknownimpurities were   |peak             |impurity         |impurity         |impurity         |impurity         |impurity         |impurity         |impurity         |smaller          |100h,            |
|all less than 0.05%, the RSD          |smaller          |peak             |peak             |peak             |peak             |peak             |peak             |peak             |than 0.5         |the              |
|ofeachimpurity peakarea was not       |than 0.5         |smaller          |smaller          |smaller          |smaller          |smaller          |smaller          |smaller          |times of         |impurity         |
|counted (not more than 10%), and no   |times of         |than 0.5         |than 0.5         |than 0.5         |than 0.5         |than 0.5         |than 0.5         |than 0.5         |the main         |peak             |
|newimpurities were added to interfere |the main         |times of         |times of         |times of         |times of         |times of         |times of         |times of         |peakarea         |smaller          |
|with the detection of related         |peakarea         |the main         |the main         |the main         |the main         |the main         |the main         |the main         |of the           |than             |
|substances. The above are in line with|of the           |peakarea         |peakarea         |peakarea         |peakarea         |peakarea         |peakarea         |peakarea         |control          |0.5              |
|the verification requirements,        |control          |of the           |of the           |of the           |of the           |of the           |of the           |of the           |solution         |times            |
|indicating that the test solutionis   |solution         |control          |control          |control          |control          |control          |control          |control          |wasignored       |of the           |
|stable within 100hunder 5℃.           |wasignored       |solution         |solution         |solution         |solution         |solution         |solution         |solution         |in the           |main             |
|                                      |in the           |wasignored       |wasignored       |wasignored       |wasignored       |wasignored       |wasignored       |wasignored       |chromatogram     |peakarea         |
|                                      |chromatogram     |in the           |in the           |in the           |in the           |in the           |in the           |in the           |of the           |of the           |
|                                      |of the           |chromatogram     |chromatogram     |chromatogram     |chromatogram     |chromatogram     |chromatogram     |chromatogram     |test             |control          |
|                                      |test             |of the           |of the           |of the           |of the           |of the           |of the           |of the           |solution.        |solution         |
|                                      |solution.        |test             |test             |test             |test             |test             |test             |test             |The              |wasignored       |
|                                      |The              |solution.        |solution.        |solution.        |solution.        |solution.        |solution.        |solution.        |knownimpurities  |in the           |
|                                      |knownimpurities  |The              |The              |The              |The              |The              |The              |The              |were             |chromatogram     |
|                                      |were             |knownimpurities  |knownimpurities  |knownimpurities  |knownimpurities  |knownimpurities  |knownimpurities  |knownimpurities  |detectedexcept   |of the           |
|                                      |detectedexcept   |were             |were             |were             |were             |were             |were             |were             |YA2304-12        |test             |
|                                      |YA2304-12        |detectedexcept   |detectedexcept   |detectedexcept   |detectedexcept   |detectedexcept   |detectedexcept   |detectedexcept   |and              |solution.        |
|                                      |and              |YA2304-12        |YA2304-12        |YA2304-12        |YA2304-12        |YA2304-12        |YA2304-12        |YA2304-12        |YA2304-19,       |The              |
|                                      |YA2304-19,       |and              |and              |and              |and              |and              |and              |and              |and both         |knownimpurities  |
|                                      |and both         |YA2304-19,       |YA2304-19,       |YA2304-19,       |YA2304-19,       |YA2304-19,       |YA2304-19,       |YA2304-19,       |were less        |were             |
|                                      |were less        |and both         |and both         |and both         |and both         |and both         |and both         |and both         |than             |detectedexcept   |
|                                      |than             |were             |were             |were             |were             |were             |were             |were             |0.05%, and       |YA2304-12        |
|                                      |0.05%,           |less             |less             |less             |less             |less             |less             |less             |the rest         |and              |
|                                      |and the          |than             |than             |than             |than             |than             |than             |than             |were not         |YA2304-19,       |
|                                      |rest were        |0.05%,           |0.05%,           |0.05%,           |0.05%,           |0.05%,           |0.05%,           |0.05%,           |detected.        |and              |
|                                      |not              |and the          |and the          |and the          |and the          |and the          |and the          |and the          |Other            |both             |
|                                      |detected.        |rest             |rest             |rest             |rest             |rest             |rest             |rest             |single           |were             |
|                                      |Other            |were not         |were not         |were not         |were not         |were not         |were not         |were not         |unknownimpurities|less             |
|                                      |single           |detected.        |detected.        |detected.        |detected.        |detected.        |detected.        |detected.        |were all         |than             |
|                                      |unknownimpurities|Other            |Other            |Other            |Other            |Other            |Other            |Other            |less than        |0.05%,           |
|                                      |were all         |single           |single           |single           |single           |single           |single           |single           |0.05%, the       |and the          |
|                                      |less than        |unknownimpurities|unknownimpurities|unknownimpurities|unknownimpurities|unknownimpurities|unknownimpurities|unknownimpurities|RSD              |rest             |
|                                      |0.05%,           |were all         |were all         |were all         |were all         |were all         |were all         |were all         |ofeachimpurity   |were             |
|                                      |the RSD          |less             |less             |less             |less             |less             |less             |less             |peakarea         |not              |
|                                      |ofeachimpurity   |than             |than             |than             |than             |than             |than             |than             |was not          |detected.        |
|                                      |peakarea         |0.05%,           |0.05%,           |0.05%,           |0.05%,           |0.05%,           |0.05%,           |0.05%,           |counted          |Other            |
|                                      |was not          |the RSD          |the RSD          |the RSD          |the RSD          |the RSD          |the RSD          |the RSD          |(not more        |single           |
|                                      |counted          |ofeachimpurity   |ofeachimpurity   |ofeachimpurity   |ofeachimpurity   |ofeachimpurity   |ofeachimpurity   |ofeachimpurity   |than 10%),       |unknownimpurities|
|                                      |(not more        |peakarea         |peakarea         |peakarea         |peakarea         |peakarea         |peakarea         |peakarea         |and no           |were             |
|                                      |than             |was not          |was not          |was not          |was not          |was not          |was not          |was not          |newimpurities    |all              |
|                                      |10%), and        |counted          |counted          |counted          |counted          |counted          |counted          |counted          |were added       |less             |
|                                      |no               |(not             |(not             |(not             |(not             |(not             |(not             |(not             |to               |than             |
|                                      |newimpurities    |more             |more             |more             |more             |more             |more             |more             |interfere        |0.05%,           |
|                                      |were             |than             |than             |than             |than             |than             |than             |than             |with the         |the RSD          |
|                                      |added to         |10%),            |10%),            |10%),            |10%),            |10%),            |10%),            |10%),            |detection        |ofeachimpurity   |
|                                      |interfere        |and no           |and no           |and no           |and no           |and no           |and no           |and no           |of related       |peakarea         |
|                                      |with the         |newimpurities    |newimpurities    |newimpurities    |newimpurities    |newimpurities    |newimpurities    |newimpurities    |substances.      |was not          |
|                                      |detection        |were             |were             |were             |were             |were             |were             |were             |The above        |counted          |
|                                      |of               |added to         |added to         |added to         |added to         |added to         |added to         |added to         |are in           |(not             |
|                                      |related          |interfere        |interfere        |interfere        |interfere        |interfere        |interfere        |interfere        |line with        |more             |
|                                      |substances.      |with the         |with the         |with the         |with the         |with the         |with the         |with the         |the              |than             |
|                                      |The above        |detection        |detection        |detection        |detection        |detection        |detection        |detection        |verification     |10%),            |
|                                      |are in           |of               |of               |of               |of               |of               |of               |of               |requirements,    |and no           |
|                                      |line with        |related          |related          |related          |related          |related          |related          |related          |indicating       |newimpurities    |
|                                      |the              |substances.      |substances.      |substances.      |substances.      |substances.      |substances.      |substances.      |that the         |were             |
|                                      |verification     |The              |The              |The              |The              |The              |The              |The              |test             |added            |
|                                      |requirements,    |above            |above            |above            |above            |above            |above            |above            |solutionis       |to               |
|                                      |indicating       |are in           |are in           |are in           |are in           |are in           |are in           |are in           |stable           |interfere        |
|                                      |that the         |line             |line             |line             |line             |line             |line             |line             |within           |with             |
|                                      |test             |with the         |with the         |with the         |with the         |with the         |with the         |with the         |100hunder        |the              |
|                                      |solutionis       |verification     |verification     |verification     |verification     |verification     |verification     |verification     |5℃.              |detection        |
|                                      |stable           |requirements,    |requirements,    |requirements,    |requirements,    |requirements,    |requirements,    |requirements,    |                 |of               |
|                                      |within           |indicating       |indicating       |indicating       |indicating       |indicating       |indicating       |indicating       |                 |related          |
|                                      |100hunder        |that the         |that the         |that the         |that the         |that the         |that the         |that the         |                 |substances.      |
|                                      |5℃.              |test             |test             |test             |test             |test             |test             |test             |                 |The              |
|                                      |                 |solutionis       |solutionis       |solutionis       |solutionis       |solutionis       |solutionis       |solutionis       |                 |above            |
|                                      |                 |stable           |stable           |stable           |stable           |stable           |stable           |stable           |                 |are in           |
|                                      |                 |within           |within           |within           |within           |within           |within           |within           |                 |line             |
|                                      |                 |100hunder        |100hunder        |100hunder        |100hunder        |100hunder        |100hunder        |100hunder        |                 |with             |
|                                      |                 |5℃.              |5℃.              |5℃.              |5℃.              |5℃.              |5℃.              |5℃.              |                 |the              |
|                                      |                 |                 |                 |                 |                 |                 |                 |                 |                 |verification     |
|                                      |                 |                 |                 |                 |                 |                 |                 |                 |                 |requirements,    |
|                                      |                 |                 |                 |                 |                 |                 |                 |                 |                 |indicating       |
|                                      |                 |                 |                 |                 |                 |                 |                 |                 |                 |that             |
|                                      |                 |                 |                 |                 |                 |                 |                 |                 |                 |the              |
|                                      |                 |                 |                 |                 |                 |                 |                 |                 |                 |test             |
|                                      |                 |                 |                 |                 |                 |                 |                 |                 |                 |solutionis       |
|                                      |                 |                 |                 |                 |                 |                 |                 |                 |                 |stable           |
|                                      |                 |                 |                 |                 |                 |                 |                 |                 |                 |within           |
|                                      |                 |                 |                 |                 |                 |                 |                 |                 |                 |100hunder        |
|                                      |                 |                 |                 |                 |                 |                 |                 |                 |                 |5℃.              |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Stability test results of solution with miscellaneous test products 


































-----------------------------------------------------------------------------------------------------------------------------------
|Im purity pea karea|Impurity YA2304-12        |251nm          |8738   |8628   |8837   |8744   |8810   |8825   |8731   |0.9       |
|-------------------|--------------------------|---------------|-------|-------|-------|-------|-------|-------|-------|----------|
|Im purity pea karea|Unknownimpurity (RRT≈0.64)|Unknownimpurity|/      |945    |1233   |1061   |1491   |1223   |1666   |Content   |
|                   |                          |(RRT≈0.64)     |       |       |       |       |       |       |       |<         |
|                   |                          |               |       |       |       |       |       |       |       |0.05%,    |
|                   |                          |               |       |       |       |       |       |       |       |RSD       |
|                   |                          |               |       |       |       |       |       |       |       |does      |
|                   |                          |               |       |       |       |       |       |       |       |not do    |
|                   |                          |               |       |       |       |       |       |       |       |statistics|
|-------------------|--------------------------|---------------|-------|-------|-------|-------|-------|-------|-------|----------|
|Im purity pea karea|Impurity YA2304-14        |Impurity       |10267  |9809   |9895   |10078  |10015  |10050  |9889   |1.6       |
|                   |                          |YA2304-14      |       |       |       |       |       |       |       |          |
|-------------------|--------------------------|---------------|-------|-------|-------|-------|-------|-------|-------|----------|
|Im purity pea karea|Impurity YA2304-15        |Impurity       |8793   |8747   |8744   |8807   |8888   |8899   |8669   |1.0       |
|                   |                          |YA2304-15      |       |       |       |       |       |       |       |          |
|-------------------|--------------------------|---------------|-------|-------|-------|-------|-------|-------|-------|----------|
|Im purity pea karea|Unknownimpurity (RRT≈1.27)|Unknownimpurity|1082   |1049   |1104   |1109   |1096   |1102   |1107   |Content < |
|                   |                          |(RRT≈1.27)     |       |       |       |       |       |       |       |0.05%, RSD|
|                   |                          |               |       |       |       |       |       |       |       |did not do|
|                   |                          |               |       |       |       |       |       |       |       |statistics|
|-------------------|--------------------------|---------------|-------|-------|-------|-------|-------|-------|-------|----------|
|Im purity pea karea|Impurity YA2304-16        |Impurity       |9394   |9292   |9227   |9074   |8798   |8843   |8449   |4         |
|                   |                          |YA2304-16      |       |       |       |       |       |       |       |          |
-----------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 229 of 542 





Page 230
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 













--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Impurity YA2304-19                    |Impurity             |15639                |15602                |15665                |15644                |15942                |15998                |15712                |1.1                  |                     |
|                                      |YA2304-19            |                     |                     |                     |                     |                     |                     |                     |                     |                     |
|--------------------------------------|---------------------|---------------------|---------------------|---------------------|---------------------|---------------------|---------------------|---------------------|---------------------|---------------------|
|Impurity YA2304-17                    |230nm                |16023                |15969                |15952                |15986                |16017                |16400                |16199                |1.1                  |                     |
|--------------------------------------|---------------------|---------------------|---------------------|---------------------|---------------------|---------------------|---------------------|---------------------|---------------------|---------------------|
|Impurity YA2304-10                    |Impurity             |12233                |12086                |12173                |12076                |12218                |12178                |11975                |0.8                  |                     |
|                                      |YA2304-10            |                     |                     |                     |                     |                     |                     |                     |                     |                     |
|--------------------------------------|---------------------|---------------------|---------------------|---------------------|---------------------|---------------------|---------------------|---------------------|---------------------|---------------------|
|Conclusions: The impurity peak less   |Conclusions:         |Conclusions:         |Conclusions:         |Conclusions:         |Conclusions:         |Conclusions:         |Conclusions:         |Conclusions:         |Conclusions:         |Conclusions:         |
|than 0.5 times the main peakarea of   |The                  |The                  |The                  |The                  |The                  |The                  |The                  |The                  |The                  |The                  |
|the control solution wasignored in the|impurity             |impurity             |impurity             |impurity             |impurity             |impurity             |impurity             |impurity             |impurity             |impurity             |
|chromatogram of the impurity          |peak less            |peak                 |peak                 |peak                 |peak                 |peak                 |peak                 |peak                 |peak                 |peak                 |
|solutionadded at 5℃for 100h. At       |than 0.5             |less                 |less                 |less                 |less                 |less                 |less                 |less                 |less                 |less                 |
|230mwavelength, the RSD of the        |times the            |than                 |than                 |than                 |than                 |than                 |than                 |than                 |than                 |than                 |
|knownimpurity YA2304-17 and YA2304-10 |main                 |0.5                  |0.5                  |0.5                  |0.5                  |0.5                  |0.5                  |0.5                  |0.5                  |0.5                  |
|was not greater than 1.1% (10% is not |peakarea             |times                |times                |times                |times                |times                |times                |times                |times                |times                |
|required). At 251nm wavelength, the   |of the               |the                  |the                  |the                  |the                  |the                  |the                  |the                  |the                  |the                  |
|RSD of knownimpurities YA2304-12,     |control              |main                 |main                 |main                 |main                 |main                 |main                 |main                 |main                 |main                 |
|YA2304-14, YA2304-15, YA2304-16,      |solution             |peakarea             |peakarea             |peakarea             |peakarea             |peakarea             |peakarea             |peakarea             |peakarea             |peakarea             |
|YA2304-18 and YA2304-19 are not       |wasignored           |of the               |of the               |of the               |of the               |of the               |of the               |of the               |of the               |of the               |
|greater than 4% (10% is not required);|in the               |control              |control              |control              |control              |control              |control              |control              |control              |control              |
|The RSD ofother single                |chromatogram         |solution             |solution             |solution             |solution             |solution             |solution             |solution             |solution             |solution             |
|unknownimpurityis less than 0.05%, the|of the               |wasignored           |wasignored           |wasignored           |wasignored           |wasignored           |wasignored           |wasignored           |wasignored           |wasignored           |
|RSD of the single unknownimpurityis   |impurity             |in the               |in the               |in the               |in the               |in the               |in the               |in the               |in the               |in the               |
|not counted (not more than 10%), and  |solutionadded        |chromatogram         |chromatogram         |chromatogram         |chromatogram         |chromatogram         |chromatogram         |chromatogram         |chromatogram         |chromatogram         |
|no newimpurityinterferes with the     |at 5℃for             |of the               |of the               |of the               |of the               |of the               |of the               |of the               |of the               |of the               |
|detection of related substances; The  |100h. At             |impurity             |impurity             |impurity             |impurity             |impurity             |impurity             |impurity             |impurity             |impurity             |
|above are in line with the            |230mwavelength,      |solutionadded        |solutionadded        |solutionadded        |solutionadded        |solutionadded        |solutionadded        |solutionadded        |solutionadded        |solutionadded        |
|verification requirements, indicating |the RSD              |at                   |at                   |at                   |at                   |at                   |at                   |at                   |at                   |at                   |
|that the solution ofaddedimpurityis   |of the               |5℃for                |5℃for                |5℃for                |5℃for                |5℃for                |5℃for                |5℃for                |5℃for                |5℃for                |
|stable within 100hat 5℃.              |knownimpurity        |100h.                |100h.                |100h.                |100h.                |100h.                |100h.                |100h.                |100h.                |100h.                |
|                                      |YA2304-17            |At                   |At                   |At                   |At                   |At                   |At                   |At                   |At                   |At                   |
|                                      |and                  |230mwavelength,      |230mwavelength,      |230mwavelength,      |230mwavelength,      |230mwavelength,      |230mwavelength,      |230mwavelength,      |230mwavelength,      |230mwavelength,      |
|                                      |YA2304-10            |the RSD              |the RSD              |the RSD              |the RSD              |the RSD              |the RSD              |the RSD              |the RSD              |the RSD              |
|                                      |was not              |of the               |of the               |of the               |of the               |of the               |of the               |of the               |of the               |of the               |
|                                      |greater              |knownimpurity        |knownimpurity        |knownimpurity        |knownimpurity        |knownimpurity        |knownimpurity        |knownimpurity        |knownimpurity        |knownimpurity        |
|                                      |than 1.1%            |YA2304-17            |YA2304-17            |YA2304-17            |YA2304-17            |YA2304-17            |YA2304-17            |YA2304-17            |YA2304-17            |YA2304-17            |
|                                      |(10% is              |and                  |and                  |and                  |and                  |and                  |and                  |and                  |and                  |and                  |
|                                      |not                  |YA2304-10            |YA2304-10            |YA2304-10            |YA2304-10            |YA2304-10            |YA2304-10            |YA2304-10            |YA2304-10            |YA2304-10            |
|                                      |required).           |was not              |was not              |was not              |was not              |was not              |was not              |was not              |was not              |was not              |
|                                      |At 251nm             |greater              |greater              |greater              |greater              |greater              |greater              |greater              |greater              |greater              |
|                                      |wavelength,          |than                 |than                 |than                 |than                 |than                 |than                 |than                 |than                 |than                 |
|                                      |the RSD              |1.1%                 |1.1%                 |1.1%                 |1.1%                 |1.1%                 |1.1%                 |1.1%                 |1.1%                 |1.1%                 |
|                                      |of                   |(10% is              |(10% is              |(10% is              |(10% is              |(10% is              |(10% is              |(10% is              |(10% is              |(10% is              |
|                                      |knownimpurities      |not                  |not                  |not                  |not                  |not                  |not                  |not                  |not                  |not                  |
|                                      |YA2304-12,           |required).           |required).           |required).           |required).           |required).           |required).           |required).           |required).           |required).           |
|                                      |YA2304-14,           |At                   |At                   |At                   |At                   |At                   |At                   |At                   |At                   |At                   |
|                                      |YA2304-15,           |251nm                |251nm                |251nm                |251nm                |251nm                |251nm                |251nm                |251nm                |251nm                |
|                                      |YA2304-16,           |wavelength,          |wavelength,          |wavelength,          |wavelength,          |wavelength,          |wavelength,          |wavelength,          |wavelength,          |wavelength,          |
|                                      |YA2304-18            |the RSD              |the RSD              |the RSD              |the RSD              |the RSD              |the RSD              |the RSD              |the RSD              |the RSD              |
|                                      |and                  |of                   |of                   |of                   |of                   |of                   |of                   |of                   |of                   |of                   |
|                                      |YA2304-19            |knownimpurities      |knownimpurities      |knownimpurities      |knownimpurities      |knownimpurities      |knownimpurities      |knownimpurities      |knownimpurities      |knownimpurities      |
|                                      |are not              |YA2304-12,           |YA2304-12,           |YA2304-12,           |YA2304-12,           |YA2304-12,           |YA2304-12,           |YA2304-12,           |YA2304-12,           |YA2304-12,           |
|                                      |greater              |YA2304-14,           |YA2304-14,           |YA2304-14,           |YA2304-14,           |YA2304-14,           |YA2304-14,           |YA2304-14,           |YA2304-14,           |YA2304-14,           |
|                                      |than 4%              |YA2304-15,           |YA2304-15,           |YA2304-15,           |YA2304-15,           |YA2304-15,           |YA2304-15,           |YA2304-15,           |YA2304-15,           |YA2304-15,           |
|                                      |(10% is              |YA2304-16,           |YA2304-16,           |YA2304-16,           |YA2304-16,           |YA2304-16,           |YA2304-16,           |YA2304-16,           |YA2304-16,           |YA2304-16,           |
|                                      |not                  |YA2304-18            |YA2304-18            |YA2304-18            |YA2304-18            |YA2304-18            |YA2304-18            |YA2304-18            |YA2304-18            |YA2304-18            |
|                                      |required);           |and                  |and                  |and                  |and                  |and                  |and                  |and                  |and                  |and                  |
|                                      |The RSD              |YA2304-19            |YA2304-19            |YA2304-19            |YA2304-19            |YA2304-19            |YA2304-19            |YA2304-19            |YA2304-19            |YA2304-19            |
|                                      |ofother              |are not              |are not              |are not              |are not              |are not              |are not              |are not              |are not              |are not              |
|                                      |single               |greater              |greater              |greater              |greater              |greater              |greater              |greater              |greater              |greater              |
|                                      |unknownimpurityis    |than 4%              |than 4%              |than 4%              |than 4%              |than 4%              |than 4%              |than 4%              |than 4%              |than 4%              |
|                                      |less than            |(10% is              |(10% is              |(10% is              |(10% is              |(10% is              |(10% is              |(10% is              |(10% is              |(10% is              |
|                                      |0.05%,               |not                  |not                  |not                  |not                  |not                  |not                  |not                  |not                  |not                  |
|                                      |the RSD              |required);           |required);           |required);           |required);           |required);           |required);           |required);           |required);           |required);           |
|                                      |of the               |The RSD              |The RSD              |The RSD              |The RSD              |The RSD              |The RSD              |The RSD              |The RSD              |The RSD              |
|                                      |single               |ofother              |ofother              |ofother              |ofother              |ofother              |ofother              |ofother              |ofother              |ofother              |
|                                      |unknownimpurityis    |single               |single               |single               |single               |single               |single               |single               |single               |single               |
|                                      |not                  |unknownimpurityis    |unknownimpurityis    |unknownimpurityis    |unknownimpurityis    |unknownimpurityis    |unknownimpurityis    |unknownimpurityis    |unknownimpurityis    |unknownimpurityis    |
|                                      |counted              |less                 |less                 |less                 |less                 |less                 |less                 |less                 |less                 |less                 |
|                                      |(not more            |than                 |than                 |than                 |than                 |than                 |than                 |than                 |than                 |than                 |
|                                      |than                 |0.05%,               |0.05%,               |0.05%,               |0.05%,               |0.05%,               |0.05%,               |0.05%,               |0.05%,               |0.05%,               |
|                                      |10%), and            |the RSD              |the RSD              |the RSD              |the RSD              |the RSD              |the RSD              |the RSD              |the RSD              |the RSD              |
|                                      |no                   |of the               |of the               |of the               |of the               |of the               |of the               |of the               |of the               |of the               |
|                                      |newimpurityinterferes|single               |single               |single               |single               |single               |single               |single               |single               |single               |
|                                      |with the             |unknownimpurityis    |unknownimpurityis    |unknownimpurityis    |unknownimpurityis    |unknownimpurityis    |unknownimpurityis    |unknownimpurityis    |unknownimpurityis    |unknownimpurityis    |
|                                      |detection            |not                  |not                  |not                  |not                  |not                  |not                  |not                  |not                  |not                  |
|                                      |of                   |counted              |counted              |counted              |counted              |counted              |counted              |counted              |counted              |counted              |
|                                      |related              |(not                 |(not                 |(not                 |(not                 |(not                 |(not                 |(not                 |(not                 |(not                 |
|                                      |substances;          |more                 |more                 |more                 |more                 |more                 |more                 |more                 |more                 |more                 |
|                                      |The above            |than                 |than                 |than                 |than                 |than                 |than                 |than                 |than                 |than                 |
|                                      |are in               |10%),                |10%),                |10%),                |10%),                |10%),                |10%),                |10%),                |10%),                |10%),                |
|                                      |line with            |and no               |and no               |and no               |and no               |and no               |and no               |and no               |and no               |and no               |
|                                      |the                  |newimpurityinterferes|newimpurityinterferes|newimpurityinterferes|newimpurityinterferes|newimpurityinterferes|newimpurityinterferes|newimpurityinterferes|newimpurityinterferes|newimpurityinterferes|
|                                      |verification         |with                 |with                 |with                 |with                 |with                 |with                 |with                 |with                 |with                 |
|                                      |requirements,        |the                  |the                  |the                  |the                  |the                  |the                  |the                  |the                  |the                  |
|                                      |indicating           |detection            |detection            |detection            |detection            |detection            |detection            |detection            |detection            |detection            |
|                                      |that the             |of                   |of                   |of                   |of                   |of                   |of                   |of                   |of                   |of                   |
|                                      |solution             |related              |related              |related              |related              |related              |related              |related              |related              |related              |
|                                      |ofaddedimpurityis    |substances;          |substances;          |substances;          |substances;          |substances;          |substances;          |substances;          |substances;          |substances;          |
|                                      |stable               |The                  |The                  |The                  |The                  |The                  |The                  |The                  |The                  |The                  |
|                                      |within               |above                |above                |above                |above                |above                |above                |above                |above                |above                |
|                                      |100hat               |are in               |are in               |are in               |are in               |are in               |are in               |are in               |are in               |are in               |
|                                      |5℃.                  |line                 |line                 |line                 |line                 |line                 |line                 |line                 |line                 |line                 |
|                                      |                     |with                 |with                 |with                 |with                 |with                 |with                 |with                 |with                 |with                 |
|                                      |                     |the                  |the                  |the                  |the                  |the                  |the                  |the                  |the                  |the                  |
|                                      |                     |verification         |verification         |verification         |verification         |verification         |verification         |verification         |verification         |verification         |
|                                      |                     |requirements,        |requirements,        |requirements,        |requirements,        |requirements,        |requirements,        |requirements,        |requirements,        |requirements,        |
|                                      |                     |indicating           |indicating           |indicating           |indicating           |indicating           |indicating           |indicating           |indicating           |indicating           |
|                                      |                     |that                 |that                 |that                 |that                 |that                 |that                 |that                 |that                 |that                 |
|                                      |                     |the                  |the                  |the                  |the                  |the                  |the                  |the                  |the                  |the                  |
|                                      |                     |solution             |solution             |solution             |solution             |solution             |solution             |solution             |solution             |solution             |
|                                      |                     |ofaddedimpurityis    |ofaddedimpurityis    |ofaddedimpurityis    |ofaddedimpurityis    |ofaddedimpurityis    |ofaddedimpurityis    |ofaddedimpurityis    |ofaddedimpurityis    |ofaddedimpurityis    |
|                                      |                     |stable               |stable               |stable               |stable               |stable               |stable               |stable               |stable               |stable               |
|                                      |                     |within               |within               |within               |within               |within               |within               |within               |within               |within               |
|                                      |                     |100hat               |100hat               |100hat               |100hat               |100hat               |100hat               |100hat               |100hat               |100hat               |
|                                      |                     |5℃.                  |5℃.                  |5℃.                  |5℃.                  |5℃.                  |5℃.                  |5℃.                  |5℃.                  |5℃.                  |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 230 of 542 





Page 231
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**i. Robustness** 



 **Acceptance Criteria** 



Durability is achieved by examining the content of various impurities in 



the test solution under normal chromatographic conditions (changing the 



column temperature, the initial proportion of mobile phase, the flow rate, the 



column lot number) and testing the limit concentration under normal 



chromatographic conditions. It is required that in the spectrum obtained by 



the system applicable solution under each condition (251nm), the peak order 



is YA2304-14, YA2304, YA2304-15, YA2304-17, YA2304-16, YA2304-10, 



YA2304-19. The separation degree between YA2304 and YA2304-14 and 



YA2304-15 should be NLT 1.5, and the separation degree between 



YA2304-17 and YA2304-16 and adjacent peaks should be NLT 1.0; In the 



chromatogram of the reference product solution (230nm), the order of the 



peaks is YA2304-17, YA2304-10; In the control solution chromatogram 



(251nm), the signal-to-noise ratio (S/N) of the main peak should NLT 20. 



Under different conditions of the same chromatographic parameters, the 



RSDS of each impurity content greater than 0.05% in the test product NMT 



10%, and the RSDS of total impurity content NMT 10%; Or the absolute 



deviation of the impurity content NMT 20% of the limit value, the absolute 



deviation of the total impurity content NMT 40% of the limit value. 



Variations of Method Parameters in Robustness Study 









-----------------------------------------
|Column temperatu|20 ℃   |18 ° C, 22 ° C|
-----------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 231 of 542 





Page 232
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 
























--------------------------------------------------------------------------------------------------------------------------
|Initial ratio of mobile phase|Mobile phaseA- Mobile phaseB (85:15)                                          |Mobile     |
|                             |                                                                              |phaseA-    |
|                             |                                                                              |Mobile     |
|                             |                                                                              |phaseB     |
|                             |                                                                              |(87:13),   |
|                             |                                                                              |Mobile     |
|                             |                                                                              |phaseA-    |
|                             |                                                                              |Mobile     |
|                             |                                                                              |phaseB     |
|                             |                                                                              |(83:17)    |
|-----------------------------|------------------------------------------------------------------------------|-----------|
|Flow rate                    |1.0 ml/min                                                                    |0.95ml/min,|
|                             |                                                                              |1.05ml/min |
|-----------------------------|------------------------------------------------------------------------------|-----------|
|Chromato graphic column      |Column 1 (YMC TrairtC18 4.6×150mm, 3μm, SN: 117EB10004, Serial No. : CXC18-05)|Column 2   |
|                             |                                                                              |(YMC       |
|                             |                                                                              |TrairtC18  |
|                             |                                                                              |4.6×150mm, |
|                             |                                                                              |3μm, SN:   |
|                             |                                                                              |129ZB00034,|
|                             |                                                                              |No. :      |
|                             |                                                                              |ZJC18-35)  |
--------------------------------------------------------------------------------------------------------------------------

 **Solution Preparation** 



Blank solution: solvent 



YA2304-12 Reference storage solution: Share "YA2304-12 Reference Storage 



solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-14 Reference storage solution: Share "YA2304-14 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304 Reference stock: Share "YA2304 Reference Stock" under "4.1 



Wavelength Selection". (Approx. 200μg/ml) 



YA2304-15 Reference storage solution: Share "YA2304-15 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-16 Reference storage solution: Share "YA2304-16 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-18 Reference storage solution: Share "YA2304-18 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-19 Reference storage solution: Share "YA2304-19 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 232 of 542 





Page 233
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



YA2304-10 Reference storage Solution: Share "YA2304-10 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



YA2304-17 Reference storage solution: Share "YA2304-17 Reference Storage 



Solution" under "4.1 Wavelength Selection". (Approx. 200μg/ml) 



Reference solution: share "Reference solution ②" under "4.3.2 Forced 



degradation Test". (YA2304-10, YA2304-17 containing about 0.4μg/ml) 



System suitability solution: Share "System Suitability solution" under "4.3.2 



Forced degradation Test". 



Impurity reserve solution: Prepare by the same method as "impurity reserve 



solution" under "4.8 Solution stability". (Each about 15μg/ml) 



Add impurity test product solution: accurately weigh YA2304 sample about 



10mg, put it in 25ml measuring bottle, add appropriate amount of solvent to 



dissolve by ultrasound, accurately add 1ml of impurity reserve liquid, dilute 



it with solvent to scale, shake well, and then get. (Prepared 2 parts in parallel, 



~ 
named as adding miscellaneous test product solution ① ②) 



Control solution: accurately measure 1ml of mixed test product solution, 



place it in a 20ml measuring bottle, dilute it with solvent to the scale, and 



shake well; Precision measure 1ml of the above solution, place it in a 50ml 



measuring bottle, dilute it with solvent to the scale, shake well, and then get. 



~ 
(named as control solution ① ②) 



 **Injection Sequence** 



After the blank solution, under different durability conditions (normal 



condition, column temperature, flow rate, initial proportion of mobile phase, 



column), the system suitable solution was injected with 1 needle, the control 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 233 of 542 





Page 234
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



solution was injected with 2 needles, 2 control solution and 2 mixed test 



solution with 1 needle each, and the chromatogram was recorded. 



 **Results and Discussion** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 234 of 542 





Page 235
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Table 3.2.S.4.3.1-19 Durability test results - Test of system suitability 


































------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Chromato graphic Conditions                                   |Parameter          |Separation         |Degree             |Minimum            |Minimum            |Sample             |Sample             |
|                                                              |values             |degree             |of                 |separation         |separation         |Injection          |Injection          |
|                                                              |                   |between            |separation         |degree             |degree             |1                  |2                  |
|                                                              |                   |YA2304             |between            |between            |between            |                   |                   |
|                                                              |                   |and                |YA2304             |YA2304-17          |YA2304-16          |                   |                   |
|                                                              |                   |YA2304-14          |and                |andadjacent        |andadjacent        |                   |                   |
|                                                              |                   |                   |YA2304-15          |peaks              |peaks              |                   |                   |
|--------------------------------------------------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|
|Column temperatu re (C)                                       |20                 |5.8                |6.8                |2.2                |1.6                |99.1               |107.5              |
|--------------------------------------------------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|
|Column temperatu re (C)                                       |18                 |5.7                |6.6                |1.2                |1.9                |104.4              |75.9               |
|--------------------------------------------------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|
|Column temperatu re (C)                                       |22                 |5.8                |6.9                |3.5                |1.4                |86.0               |91.1               |
|--------------------------------------------------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|
|Flow rate (ml/min)                                            |1.0                |5.8                |6.8                |2.2                |1.6                |99.1               |107.5              |
|--------------------------------------------------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|
|Flow rate (ml/min)                                            |0.95               |5.7                |6.7                |1.7                |1.7                |109.8              |106.6              |
|--------------------------------------------------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|
|Flow rate (ml/min)                                            |1.05               |5.9                |6.9                |2.8                |1.6                |96.8               |106.5              |
|--------------------------------------------------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|
|Mobile phaseA- Mobile phaseB                                  |85:15              |5.8                |6.8                |2.2                |1.6                |99.1               |107.5              |
|--------------------------------------------------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|
|Mobile phaseA- Mobile phaseB                                  |83:17(ratio        |6.0                |6.9                |2.5                |1.6                |78.8               |81.5               |
|                                                              |1)                 |                   |                   |                   |                   |                   |                   |
|--------------------------------------------------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|
|Mobile phaseA- Mobile phaseB                                  |87:13              |5.6                |6.7                |2.0                |1.7                |96.5               |90.9               |
|                                                              |(ratio 2)          |                   |                   |                   |                   |                   |                   |
|--------------------------------------------------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|
|Column                                                        |Column 1           |5.8                |6.8                |2.2                |1.6                |99.1               |107.5              |
|--------------------------------------------------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|
|Column                                                        |Column 2           |5.6                |6.4                |1.7                |1.6                |72.5               |67.2               |
|--------------------------------------------------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|
|Conclusion: Under single factor change of column temperature, |Conclusion:        |Conclusion:        |Conclusion:        |Conclusion:        |Conclusion:        |Conclusion:        |Conclusion:        |
|flow rate, initial ratio of fluidity, chromatographic column  |Under              |Under              |Under              |Under              |Under              |Under              |Under              |
|and normal chromatographic conditions, the peakorder of       |single             |single             |single             |single             |single             |single             |single             |
|contrast solution (230nm) is YA2304-17, YA2304-10; In the     |factor             |factor             |factor             |factor             |factor             |factor             |factor             |
|chromatogram of system suitability solution (251nm), the      |change of          |change of          |change of          |change of          |change of          |change of          |change of          |
|peakorder was YA2304-14, YA2304, YA2304-15, YA2304-17,        |column             |column             |column             |column             |column             |column             |column             |
|unknownimpurities, YA2304-16, YA2304-10, YA2304-19. The       |temperature,       |temperature,       |temperature,       |temperature,       |temperature,       |temperature,       |temperature,       |
|minimum separation degree between YA2304 and YA2304-14 and    |flow rate,         |flow rate,         |flow rate,         |flow rate,         |flow rate,         |flow               |flow               |
|YA2304-15 is NLT 5.6 (NLT 1.5 required), and the minimum      |initial            |initial            |initial            |initial            |initial            |rate,              |rate,              |
|separation degree between YA2304-17 and YA2304-16 andadjacent |ratio of           |ratio of           |ratio of           |ratio of           |ratio of           |initial            |initial            |
|peaksis 1.2 (NLT 1.0 required); In the contrast solution      |fluidity,          |fluidity,          |fluidity,          |fluidity,          |fluidity,          |ratio of           |ratio of           |
|chromatogram (251nm), the signal-to-noise ratio of the        |chromatographic    |chromatographic    |chromatographic    |chromatographic    |chromatographic    |fluidity,          |fluidity,          |
|mainpeak was NLT 67.2(NLT 20), and the systemapplicability met|column and         |column and         |column and         |column and         |column and         |chromatographic    |chromatographic    |
|the verification requirements.                                |normal             |normal             |normal             |normal             |normal             |column             |column             |
|                                                              |chromatographic    |chromatographic    |chromatographic    |chromatographic    |chromatographic    |and                |and                |
|                                                              |conditions,        |conditions,        |conditions,        |conditions,        |conditions,        |normal             |normal             |
|                                                              |the                |the                |the                |the                |the                |chromatographic    |chromatographic    |
|                                                              |peakorder          |peakorder          |peakorder          |peakorder          |peakorder          |conditions,        |conditions,        |
|                                                              |of contrast        |of                 |of                 |of contrast        |of contrast        |the                |the                |
|                                                              |solution           |contrast           |contrast           |solution           |solution           |peakorder          |peakorder          |
|                                                              |(230nm) is         |solution           |solution           |(230nm) is         |(230nm) is         |of                 |of                 |
|                                                              |YA2304-17,         |(230nm) is         |(230nm) is         |YA2304-17,         |YA2304-17,         |contrast           |contrast           |
|                                                              |YA2304-10;         |YA2304-17,         |YA2304-17,         |YA2304-10;         |YA2304-10;         |solution           |solution           |
|                                                              |In the             |YA2304-10;         |YA2304-10;         |In the             |In the             |(230nm)            |(230nm)            |
|                                                              |chromatogram       |In the             |In the             |chromatogram       |chromatogram       |is                 |is                 |
|                                                              |of system          |chromatogram       |chromatogram       |of system          |of system          |YA2304-17,         |YA2304-17,         |
|                                                              |suitability        |of system          |of system          |suitability        |suitability        |YA2304-10;         |YA2304-10;         |
|                                                              |solution           |suitability        |suitability        |solution           |solution           |In the             |In the             |
|                                                              |(251nm),           |solution           |solution           |(251nm),           |(251nm),           |chromatogram       |chromatogram       |
|                                                              |the                |(251nm),           |(251nm),           |the                |the                |of system          |of system          |
|                                                              |peakorder          |the                |the                |peakorder          |peakorder          |suitability        |suitability        |
|                                                              |was                |peakorder          |peakorder          |was                |was                |solution           |solution           |
|                                                              |YA2304-14,         |was                |was                |YA2304-14,         |YA2304-14,         |(251nm),           |(251nm),           |
|                                                              |YA2304,            |YA2304-14,         |YA2304-14,         |YA2304,            |YA2304,            |the                |the                |
|                                                              |YA2304-15,         |YA2304,            |YA2304,            |YA2304-15,         |YA2304-15,         |peakorder          |peakorder          |
|                                                              |YA2304-17,         |YA2304-15,         |YA2304-15,         |YA2304-17,         |YA2304-17,         |was                |was                |
|                                                              |unknownimpurities, |YA2304-17,         |YA2304-17,         |unknownimpurities, |unknownimpurities, |YA2304-14,         |YA2304-14,         |
|                                                              |YA2304-16,         |unknownimpurities, |unknownimpurities, |YA2304-16,         |YA2304-16,         |YA2304,            |YA2304,            |
|                                                              |YA2304-10,         |YA2304-16,         |YA2304-16,         |YA2304-10,         |YA2304-10,         |YA2304-15,         |YA2304-15,         |
|                                                              |YA2304-19.         |YA2304-10,         |YA2304-10,         |YA2304-19.         |YA2304-19.         |YA2304-17,         |YA2304-17,         |
|                                                              |The minimum        |YA2304-19.         |YA2304-19.         |The minimum        |The minimum        |unknownimpurities, |unknownimpurities, |
|                                                              |separation         |The                |The                |separation         |separation         |YA2304-16,         |YA2304-16,         |
|                                                              |degree             |minimum            |minimum            |degree             |degree             |YA2304-10,         |YA2304-10,         |
|                                                              |between            |separation         |separation         |between            |between            |YA2304-19.         |YA2304-19.         |
|                                                              |YA2304 and         |degree             |degree             |YA2304 and         |YA2304 and         |The                |The                |
|                                                              |YA2304-14          |between            |between            |YA2304-14          |YA2304-14          |minimum            |minimum            |
|                                                              |and                |YA2304 and         |YA2304 and         |and                |and                |separation         |separation         |
|                                                              |YA2304-15          |YA2304-14          |YA2304-14          |YA2304-15          |YA2304-15          |degree             |degree             |
|                                                              |is NLT 5.6         |and                |and                |is NLT 5.6         |is NLT 5.6         |between            |between            |
|                                                              |(NLT 1.5           |YA2304-15          |YA2304-15          |(NLT 1.5           |(NLT 1.5           |YA2304             |YA2304             |
|                                                              |required),         |is NLT 5.6         |is NLT 5.6         |required),         |required),         |and                |and                |
|                                                              |and the            |(NLT 1.5           |(NLT 1.5           |and the            |and the            |YA2304-14          |YA2304-14          |
|                                                              |minimum            |required),         |required),         |minimum            |minimum            |and                |and                |
|                                                              |separation         |and the            |and the            |separation         |separation         |YA2304-15          |YA2304-15          |
|                                                              |degree             |minimum            |minimum            |degree             |degree             |is NLT             |is NLT             |
|                                                              |between            |separation         |separation         |between            |between            |5.6 (NLT           |5.6 (NLT           |
|                                                              |YA2304-17          |degree             |degree             |YA2304-17          |YA2304-17          |1.5                |1.5                |
|                                                              |and                |between            |between            |and                |and                |required),         |required),         |
|                                                              |YA2304-16          |YA2304-17          |YA2304-17          |YA2304-16          |YA2304-16          |and the            |and the            |
|                                                              |andadjacent        |and                |and                |andadjacent        |andadjacent        |minimum            |minimum            |
|                                                              |peaksis 1.2        |YA2304-16          |YA2304-16          |peaksis 1.2        |peaksis 1.2        |separation         |separation         |
|                                                              |(NLT 1.0           |andadjacent        |andadjacent        |(NLT 1.0           |(NLT 1.0           |degree             |degree             |
|                                                              |required);         |peaksis            |peaksis            |required);         |required);         |between            |between            |
|                                                              |In the             |1.2 (NLT           |1.2 (NLT           |In the             |In the             |YA2304-17          |YA2304-17          |
|                                                              |contrast           |1.0                |1.0                |contrast           |contrast           |and                |and                |
|                                                              |solution           |required);         |required);         |solution           |solution           |YA2304-16          |YA2304-16          |
|                                                              |chromatogram       |In the             |In the             |chromatogram       |chromatogram       |andadjacent        |andadjacent        |
|                                                              |(251nm),           |contrast           |contrast           |(251nm),           |(251nm),           |peaksis            |peaksis            |
|                                                              |the                |solution           |solution           |the                |the                |1.2 (NLT           |1.2 (NLT           |
|                                                              |signal-to-noise    |chromatogram       |chromatogram       |signal-to-noise    |signal-to-noise    |1.0                |1.0                |
|                                                              |ratio of           |(251nm),           |(251nm),           |ratio of           |ratio of           |required);         |required);         |
|                                                              |the                |the                |the                |the                |the                |In the             |In the             |
|                                                              |mainpeak           |signal-to-noise    |signal-to-noise    |mainpeak           |mainpeak           |contrast           |contrast           |
|                                                              |was NLT            |ratio of           |ratio of           |was NLT            |was NLT            |solution           |solution           |
|                                                              |67.2(NLT           |the                |the                |67.2(NLT           |67.2(NLT           |chromatogram       |chromatogram       |
|                                                              |20), and           |mainpeak           |mainpeak           |20), and           |20), and           |(251nm),           |(251nm),           |
|                                                              |the                |was NLT            |was NLT            |the                |the                |the                |the                |
|                                                              |systemapplicability|67.2(NLT           |67.2(NLT           |systemapplicability|systemapplicability|signal-to-noise    |signal-to-noise    |
|                                                              |met the            |20), and           |20), and           |met the            |met the            |ratio of           |ratio of           |
|                                                              |verification       |the                |the                |verification       |verification       |the                |the                |
|                                                              |requirements.      |systemapplicability|systemapplicability|requirements.      |requirements.      |mainpeak           |mainpeak           |
|                                                              |                   |met the            |met the            |                   |                   |was NLT            |was NLT            |
|                                                              |                   |verification       |verification       |                   |                   |67.2(NLT           |67.2(NLT           |
|                                                              |                   |requirements.      |requirements.      |                   |                   |20), and           |20), and           |
|                                                              |                   |                   |                   |                   |                   |the                |the                |
|                                                              |                   |                   |                   |                   |                   |systemapplicability|systemapplicability|
|                                                              |                   |                   |                   |                   |                   |met the            |met the            |
|                                                              |                   |                   |                   |                   |                   |verification       |verification       |
|                                                              |                   |                   |                   |                   |                   |requirements.      |requirements.      |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 235 of 542 





Page 236
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Durability test results 


































































----------------------------------------------------------------------------------------------------------------------------------------------
|Chromato graphy       |Parameter|Impurity|Impurity|Impurity|Impurity|Impurity|Impurity|Impurity|Impurity|Unknow    |Unknow    |Totalimpurity|
|Conditions            |Values   |YA2304- |YA2304- |YA2304- |YA2304- |YA2304- |YA2304- |YA2304- |YA2304- |nimpurity |nimpurity |             |
|                      |         |12      |14      |15      |16      |18      |19      |17      |10      |(RRT≈0.   |(RRT≈1.   |             |
|                      |         |        |        |        |        |        |        |        |        |64)       |26)       |             |
|----------------------|---------|--------|--------|--------|--------|--------|--------|--------|--------|----------|----------|-------------|
|Column temperature (C)|20       |0.152   |0.146   |0.153   |0.130   |0.137   |0.163   |0.143   |0.145   |< 0.05%   |< 0.05%   |1.169        |
|----------------------|---------|--------|--------|--------|--------|--------|--------|--------|--------|----------|----------|-------------|
|Column temperature (C)|20       |0.152   |0.145   |0.155   |0.130   |0.137   |0.165   |0.147   |0.149   |< 0.05%   |< 0.05%   |1.180        |
|----------------------|---------|--------|--------|--------|--------|--------|--------|--------|--------|----------|----------|-------------|
|Column temperature (C)|18       |0.150   |0.142   |0.151   |0.128   |0.136   |0.161   |0.144   |0.144   |< 0.05%   |< 0.05%   |1.155        |
|----------------------|---------|--------|--------|--------|--------|--------|--------|--------|--------|----------|----------|-------------|
|Column temperature (C)|18       |0.157   |0.150   |0.157   |0.135   |0.141   |0.169   |0.147   |0.147   |< 0.05%   |< 0.05%   |1.202        |
|----------------------|---------|--------|--------|--------|--------|--------|--------|--------|--------|----------|----------|-------------|
|Column temperature (C)|22       |0.149   |0.146   |0.151   |0.128   |0.134   |0.161   |0.143   |0.145   |< 0.05%   |< 0.05%   |1.155        |
|----------------------|---------|--------|--------|--------|--------|--------|--------|--------|--------|----------|----------|-------------|
|Column temperature (C)|22       |0.156   |0.150   |0.159   |0.133   |0.138   |0.169   |0.146   |0.149   |< 0.05%   |< 0.05%   |1.200        |
|----------------------|---------|--------|--------|--------|--------|--------|--------|--------|--------|----------|----------|-------------|
|RSD/%                 |RSD/%    |2.2     |2.3     |2.1     |2.2     |1.7     |2.3     |1.4     |1.5     |Content < |Content < |1.8          |
|                      |         |        |        |        |        |        |        |        |        |0.05%, do |0.05%, no |             |
|                      |         |        |        |        |        |        |        |        |        |not do    |statistics|             |
|                      |         |        |        |        |        |        |        |        |        |statistics|          |             |
|----------------------|---------|--------|--------|--------|--------|--------|--------|--------|--------|----------|----------|-------------|
|Flow rate (ml/min)    |1.0      |0.152   |0.146   |0.153   |0.130   |0.137   |0.163   |0.143   |0.145   |< 0.05%   |< 0.05%   |1.169        |
|----------------------|---------|--------|--------|--------|--------|--------|--------|--------|--------|----------|----------|-------------|
|Flow rate (ml/min)    |1.0      |0.152   |0.145   |0.155   |0.130   |0.137   |0.165   |0.147   |0.149   |< 0.05%   |< 0.05%   |1.180        |
|----------------------|---------|--------|--------|--------|--------|--------|--------|--------|--------|----------|----------|-------------|
|Flow rate (ml/min)    |0.95     |0.150   |0.142   |0.150   |0.125   |0.131   |0.161   |0.142   |0.144   |< 0.05%   |< 0.05%   |1.145        |
|----------------------|---------|--------|--------|--------|--------|--------|--------|--------|--------|----------|----------|-------------|
|Flow rate (ml/min)    |0.95     |0.156   |0.147   |0.156   |0.130   |0.136   |0.168   |0.145   |0.146   |< 0.05%   |< 0.05%   |1.184        |
|----------------------|---------|--------|--------|--------|--------|--------|--------|--------|--------|----------|----------|-------------|
|Flow rate (ml/min)    |1.05     |0.150   |0.147   |0.154   |0.127   |0.132   |0.163   |0.143   |0.144   |< 0.05%   |< 0.05%   |1.161        |
|----------------------|---------|--------|--------|--------|--------|--------|--------|--------|--------|----------|----------|-------------|
|Flow rate (ml/min)    |1.05     |0.156   |0.151   |0.158   |0.129   |0.138   |0.168   |0.148   |0.148   |< 0.05%   |< 0.05%   |1.196        |
----------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 236 of 542 





Page 237
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 

























































------------------------------------------------------------------------------------------------------------------------------
|Mobile phaseA- Mobile |85:15  |0.152  |0.146  |0.153  |0.130  |0.137  |0.163  |0.143  |0.145  |< 0.05%   |< 0.05%   |1.169  |
|phaseB                |       |       |       |       |       |       |       |       |       |          |          |       |
|----------------------|-------|-------|-------|-------|-------|-------|-------|-------|-------|----------|----------|-------|
|Mobile phaseA- Mobile |85:15  |0.152  |0.145  |0.155  |0.130  |0.137  |0.165  |0.147  |0.149  |< 0.05%   |< 0.05%   |1.180  |
|phaseB                |       |       |       |       |       |       |       |       |       |          |          |       |
|----------------------|-------|-------|-------|-------|-------|-------|-------|-------|-------|----------|----------|-------|
|Mobile phaseA- Mobile |83:17  |0.152  |0.149  |0.152  |0.126  |0.131  |0.163  |0.143  |0.142  |< 0.05%   |< 0.05%   |1.158  |
|phaseB                |(ratio |       |       |       |       |       |       |       |       |          |          |       |
|                      |1)     |       |       |       |       |       |       |       |       |          |          |       |
|----------------------|-------|-------|-------|-------|-------|-------|-------|-------|-------|----------|----------|-------|
|Mobile phaseA- Mobile |83:17  |0.159  |0.150  |0.158  |0.129  |0.137  |0.170  |0.148  |0.147  |< 0.05%   |< 0.05%   |1.198  |
|phaseB                |(ratio |       |       |       |       |       |       |       |       |          |          |       |
|                      |1)     |       |       |       |       |       |       |       |       |          |          |       |
|----------------------|-------|-------|-------|-------|-------|-------|-------|-------|-------|----------|----------|-------|
|Mobile phaseA- Mobile |87:13  |0.148  |0.143  |0.149  |0.123  |0.130  |0.162  |0.143  |0.142  |< 0.05%   |< 0.05%   |1.139  |
|phaseB                |(ratio |       |       |       |       |       |       |       |       |          |          |       |
|                      |2)     |       |       |       |       |       |       |       |       |          |          |       |
|----------------------|-------|-------|-------|-------|-------|-------|-------|-------|-------|----------|----------|-------|
|Mobile phaseA- Mobile |87:13  |0.154  |0.148  |0.156  |0.126  |0.134  |0.169  |0.146  |0.147  |< 0.05%   |< 0.05%   |1.179  |
|phaseB                |(ratio |       |       |       |       |       |       |       |       |          |          |       |
|                      |2)     |       |       |       |       |       |       |       |       |          |          |       |
|----------------------|-------|-------|-------|-------|-------|-------|-------|-------|-------|----------|----------|-------|
|RSD/%                 |RSD/%  |2.4    |1.8    |2.2    |2.6    |2.6    |2.0    |1.6    |1.9    |Content   |Content   |1.8    |
|                      |       |       |       |       |       |       |       |       |       |<         |<         |       |
|                      |       |       |       |       |       |       |       |       |       |0.05%,    |0.05%,    |       |
|                      |       |       |       |       |       |       |       |       |       |do not    |no        |       |
|                      |       |       |       |       |       |       |       |       |       |do        |statistics|       |
|                      |       |       |       |       |       |       |       |       |       |statistics|          |       |
|----------------------|-------|-------|-------|-------|-------|-------|-------|-------|-------|----------|----------|-------|
|Column                |Column |0.152  |0.146  |0.153  |0.130  |0.137  |0.163  |0.143  |0.145  |< 0.05%   |< 0.05%   |1.169  |
|                      |1      |       |       |       |       |       |       |       |       |          |          |       |
|----------------------|-------|-------|-------|-------|-------|-------|-------|-------|-------|----------|----------|-------|
|Column                |Column |0.152  |0.145  |0.155  |0.130  |0.137  |0.165  |0.147  |0.149  |< 0.05%   |< 0.05%   |1.180  |
|                      |1      |       |       |       |       |       |       |       |       |          |          |       |
|----------------------|-------|-------|-------|-------|-------|-------|-------|-------|-------|----------|----------|-------|
|Column                |Column |0.153  |0.144  |0.150  |0.119  |0.125  |0.162  |0.141  |0.142  |< 0.05%   |< 0.05%   |1.136  |
|                      |2      |       |       |       |       |       |       |       |       |          |          |       |
|----------------------|-------|-------|-------|-------|-------|-------|-------|-------|-------|----------|----------|-------|
|Column                |Column |0.158  |0.149  |0.156  |0.120  |0.127  |0.169  |0.144  |0.145  |< 0.05%   |< 0.05%   |1.169  |
|                      |2      |       |       |       |       |       |       |       |       |          |          |       |
|----------------------|-------|-------|-------|-------|-------|-------|-------|-------|-------|----------|----------|-------|
|RSD/%                 |RSD/%  |1.8    |1.7    |1.7    |6%     |5%     |1.9    |1.9    |2.1    |Content < |Content < |1.7    |
|                      |       |       |       |       |       |       |       |       |       |0.05%, do |0.05%, no |       |
|                      |       |       |       |       |       |       |       |       |       |not do    |statistic |       |
------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 237 of 542 





Page 238
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 










-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Conclusion: RSD ofimpurity    |Conclusion:       |Conclusion:       |Conclusion:       |Conclusion:       |Conclusion:       |Conclusion:       |Conclusion:       |Conclusion:       |Conclusion:       |Conclusion:       |Conclusion:       |
|YA2304-12 is less than 2.4%   |RSD               |RSD               |RSD               |RSD               |RSD               |RSD               |RSD               |RSD               |RSD               |RSD               |RSD               |
|(less than 10% is required)   |ofimpurity        |ofimpurity        |ofimpurity        |ofimpurity        |ofimpurity        |ofimpurity        |ofimpurity        |ofimpurity        |ofimpurity        |ofimpurity        |ofimpurity        |
|under column temperature, flow|YA2304-12         |YA2304-12         |YA2304-12         |YA2304-12         |YA2304-12         |YA2304-12         |YA2304-12         |YA2304-12         |YA2304-12         |YA2304-12         |YA2304-12         |
|rate, initial ratio of mobile |is less           |is less           |is less           |is less           |is less           |is less           |is less           |is less           |is less           |is less           |is less           |
|phase and normal              |than              |than              |than              |than              |than              |than              |than              |than              |than              |than              |than              |
|chromatography conditions.    |2.4%              |2.4%              |2.4%              |2.4%              |2.4%              |2.4%              |2.4%              |2.4%              |2.4%              |2.4%              |2.4%              |
|RSDS of YA2304-14 were no more|(less             |(less             |(less             |(less             |(less             |(less             |(less             |(less             |(less             |(less             |(less             |
|than 2.3% (no more than 10%   |than              |than              |than              |than              |than              |than              |than              |than              |than              |than              |than              |
|required). RSD of YA2304-15   |10% is            |10% is            |10% is            |10% is            |10% is            |10% is            |10% is            |10% is            |10% is            |10% is            |10% is            |
|content shall NMT 2.2% (NMT   |required)         |required)         |required)         |required)         |required)         |required)         |required)         |required)         |required)         |required)         |required)         |
|10%); RSD of YA2304-16 content|under             |under             |under             |under             |under             |under             |under             |under             |under             |under             |under             |
|shall NMT 6% (NMT 10%); RSD of|column            |column            |column            |column            |column            |column            |column            |column            |column            |column            |column            |
|YA2304-18 content shall NMT 5%|temperature,      |temperature,      |temperature,      |temperature,      |temperature,      |temperature,      |temperature,      |temperature,      |temperature,      |temperature,      |temperature,      |
|(NMT 10%); RSD of YA2304-19   |flow              |flow              |flow              |flow              |flow              |flow              |flow              |flow              |flow              |flow              |flow              |
|content shall NMT 2.3% (NMT   |rate,             |rate,             |rate,             |rate,             |rate,             |rate,             |rate,             |rate,             |rate,             |rate,             |rate,             |
|10%); RSD of YA2304-17 content|initial           |initial           |initial           |initial           |initial           |initial           |initial           |initial           |initial           |initial           |initial           |
|should NMT 1.9% (NMT 10%); RSD|ratio             |ratio             |ratio             |ratio             |ratio             |ratio             |ratio             |ratio             |ratio             |ratio             |ratio             |
|of YA2304-10 content should   |of                |of                |of                |of                |of                |of                |of                |of                |of                |of                |of                |
|NMT 2.1% (NMT 10%); The       |mobile            |mobile            |mobile            |mobile            |mobile            |mobile            |mobile            |mobile            |mobile            |mobile            |mobile            |
|contents ofunknownimpurity    |phase             |phase             |phase             |phase             |phase             |phase             |phase             |phase             |phase             |phase             |phase             |
|RRT≈0.64 andunknownimpurity   |and               |and               |and               |and               |and               |and               |and               |and               |and               |and               |and               |
|RRT≈1.26 are less than 0.05,  |normal            |normal            |normal            |normal            |normal            |normal            |normal            |normal            |normal            |normal            |normal            |
|and RSDis notused for         |chromatography    |chromatography    |chromatography    |chromatography    |chromatography    |chromatography    |chromatography    |chromatography    |chromatography    |chromatography    |chromatography    |
|statistics. All of them met   |conditions.       |conditions.       |conditions.       |conditions.       |conditions.       |conditions.       |conditions.       |conditions.       |conditions.       |conditions.       |conditions.       |
|the verification conditions.  |RSDS of           |RSDS of           |RSDS of           |RSDS of           |RSDS of           |RSDS of           |RSDS of           |RSDS of           |RSDS of           |RSDS of           |RSDS of           |
|                              |YA2304-14         |YA2304-14         |YA2304-14         |YA2304-14         |YA2304-14         |YA2304-14         |YA2304-14         |YA2304-14         |YA2304-14         |YA2304-14         |YA2304-14         |
|                              |were no           |were no           |were no           |were no           |were no           |were no           |were no           |were no           |were no           |were no           |were no           |
|                              |more              |more              |more              |more              |more              |more              |more              |more              |more              |more              |more              |
|                              |than              |than              |than              |than              |than              |than              |than              |than              |than              |than              |than              |
|                              |2.3%              |2.3%              |2.3%              |2.3%              |2.3%              |2.3%              |2.3%              |2.3%              |2.3%              |2.3%              |2.3%              |
|                              |(no               |(no               |(no               |(no               |(no               |(no               |(no               |(no               |(no               |(no               |(no               |
|                              |more              |more              |more              |more              |more              |more              |more              |more              |more              |more              |more              |
|                              |than              |than              |than              |than              |than              |than              |than              |than              |than              |than              |than              |
|                              |10%               |10%               |10%               |10%               |10%               |10%               |10%               |10%               |10%               |10%               |10%               |
|                              |required).        |required).        |required).        |required).        |required).        |required).        |required).        |required).        |required).        |required).        |required).        |
|                              |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |
|                              |YA2304-15         |YA2304-15         |YA2304-15         |YA2304-15         |YA2304-15         |YA2304-15         |YA2304-15         |YA2304-15         |YA2304-15         |YA2304-15         |YA2304-15         |
|                              |content           |content           |content           |content           |content           |content           |content           |content           |content           |content           |content           |
|                              |shall             |shall             |shall             |shall             |shall             |shall             |shall             |shall             |shall             |shall             |shall             |
|                              |NMT               |NMT               |NMT               |NMT               |NMT               |NMT               |NMT               |NMT               |NMT               |NMT               |NMT               |
|                              |2.2%              |2.2%              |2.2%              |2.2%              |2.2%              |2.2%              |2.2%              |2.2%              |2.2%              |2.2%              |2.2%              |
|                              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |
|                              |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |
|                              |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |
|                              |YA2304-16         |YA2304-16         |YA2304-16         |YA2304-16         |YA2304-16         |YA2304-16         |YA2304-16         |YA2304-16         |YA2304-16         |YA2304-16         |YA2304-16         |
|                              |content           |content           |content           |content           |content           |content           |content           |content           |content           |content           |content           |
|                              |shall             |shall             |shall             |shall             |shall             |shall             |shall             |shall             |shall             |shall             |shall             |
|                              |NMT 6%            |NMT 6%            |NMT 6%            |NMT 6%            |NMT 6%            |NMT 6%            |NMT 6%            |NMT 6%            |NMT 6%            |NMT 6%            |NMT 6%            |
|                              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |
|                              |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |
|                              |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |
|                              |YA2304-18         |YA2304-18         |YA2304-18         |YA2304-18         |YA2304-18         |YA2304-18         |YA2304-18         |YA2304-18         |YA2304-18         |YA2304-18         |YA2304-18         |
|                              |content           |content           |content           |content           |content           |content           |content           |content           |content           |content           |content           |
|                              |shall             |shall             |shall             |shall             |shall             |shall             |shall             |shall             |shall             |shall             |shall             |
|                              |NMT 5%            |NMT 5%            |NMT 5%            |NMT 5%            |NMT 5%            |NMT 5%            |NMT 5%            |NMT 5%            |NMT 5%            |NMT 5%            |NMT 5%            |
|                              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |
|                              |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |
|                              |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |
|                              |YA2304-19         |YA2304-19         |YA2304-19         |YA2304-19         |YA2304-19         |YA2304-19         |YA2304-19         |YA2304-19         |YA2304-19         |YA2304-19         |YA2304-19         |
|                              |content           |content           |content           |content           |content           |content           |content           |content           |content           |content           |content           |
|                              |shall             |shall             |shall             |shall             |shall             |shall             |shall             |shall             |shall             |shall             |shall             |
|                              |NMT               |NMT               |NMT               |NMT               |NMT               |NMT               |NMT               |NMT               |NMT               |NMT               |NMT               |
|                              |2.3%              |2.3%              |2.3%              |2.3%              |2.3%              |2.3%              |2.3%              |2.3%              |2.3%              |2.3%              |2.3%              |
|                              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |
|                              |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |
|                              |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |
|                              |YA2304-17         |YA2304-17         |YA2304-17         |YA2304-17         |YA2304-17         |YA2304-17         |YA2304-17         |YA2304-17         |YA2304-17         |YA2304-17         |YA2304-17         |
|                              |content           |content           |content           |content           |content           |content           |content           |content           |content           |content           |content           |
|                              |should            |should            |should            |should            |should            |should            |should            |should            |should            |should            |should            |
|                              |NMT               |NMT               |NMT               |NMT               |NMT               |NMT               |NMT               |NMT               |NMT               |NMT               |NMT               |
|                              |1.9%              |1.9%              |1.9%              |1.9%              |1.9%              |1.9%              |1.9%              |1.9%              |1.9%              |1.9%              |1.9%              |
|                              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |
|                              |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |
|                              |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |
|                              |YA2304-10         |YA2304-10         |YA2304-10         |YA2304-10         |YA2304-10         |YA2304-10         |YA2304-10         |YA2304-10         |YA2304-10         |YA2304-10         |YA2304-10         |
|                              |content           |content           |content           |content           |content           |content           |content           |content           |content           |content           |content           |
|                              |should            |should            |should            |should            |should            |should            |should            |should            |should            |should            |should            |
|                              |NMT               |NMT               |NMT               |NMT               |NMT               |NMT               |NMT               |NMT               |NMT               |NMT               |NMT               |
|                              |2.1%              |2.1%              |2.1%              |2.1%              |2.1%              |2.1%              |2.1%              |2.1%              |2.1%              |2.1%              |2.1%              |
|                              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |
|                              |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |
|                              |The               |The               |The               |The               |The               |The               |The               |The               |The               |The               |The               |
|                              |contents          |contents          |contents          |contents          |contents          |contents          |contents          |contents          |contents          |contents          |contents          |
|                              |ofunknownimpurity |ofunknownimpurity |ofunknownimpurity |ofunknownimpurity |ofunknownimpurity |ofunknownimpurity |ofunknownimpurity |ofunknownimpurity |ofunknownimpurity |ofunknownimpurity |ofunknownimpurity |
|                              |RRT≈0.64          |RRT≈0.64          |RRT≈0.64          |RRT≈0.64          |RRT≈0.64          |RRT≈0.64          |RRT≈0.64          |RRT≈0.64          |RRT≈0.64          |RRT≈0.64          |RRT≈0.64          |
|                              |andunknownimpurity|andunknownimpurity|andunknownimpurity|andunknownimpurity|andunknownimpurity|andunknownimpurity|andunknownimpurity|andunknownimpurity|andunknownimpurity|andunknownimpurity|andunknownimpurity|
|                              |RRT≈1.26          |RRT≈1.26          |RRT≈1.26          |RRT≈1.26          |RRT≈1.26          |RRT≈1.26          |RRT≈1.26          |RRT≈1.26          |RRT≈1.26          |RRT≈1.26          |RRT≈1.26          |
|                              |are               |are               |are               |are               |are               |are               |are               |are               |are               |are               |are               |
|                              |less              |less              |less              |less              |less              |less              |less              |less              |less              |less              |less              |
|                              |than              |than              |than              |than              |than              |than              |than              |than              |than              |than              |than              |
|                              |0.05,             |0.05,             |0.05,             |0.05,             |0.05,             |0.05,             |0.05,             |0.05,             |0.05,             |0.05,             |0.05,             |
|                              |and               |and               |and               |and               |and               |and               |and               |and               |and               |and               |and               |
|                              |RSDis             |RSDis             |RSDis             |RSDis             |RSDis             |RSDis             |RSDis             |RSDis             |RSDis             |RSDis             |RSDis             |
|                              |notused           |notused           |notused           |notused           |notused           |notused           |notused           |notused           |notused           |notused           |notused           |
|                              |for               |for               |for               |for               |for               |for               |for               |for               |for               |for               |for               |
|                              |statistics.       |statistics.       |statistics.       |statistics.       |statistics.       |statistics.       |statistics.       |statistics.       |statistics.       |statistics.       |statistics.       |
|                              |All of            |All of            |All of            |All of            |All of            |All of            |All of            |All of            |All of            |All of            |All of            |
|                              |them              |them              |them              |them              |them              |them              |them              |them              |them              |them              |them              |
|                              |met the           |met the           |met the           |met the           |met the           |met the           |met the           |met the           |met the           |met the           |met the           |
|                              |verification      |verification      |verification      |verification      |verification      |verification      |verification      |verification      |verification      |verification      |verification      |
|                              |conditions.       |conditions.       |conditions.       |conditions.       |conditions.       |conditions.       |conditions.       |conditions.       |conditions.       |conditions.       |conditions.       |
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**III. Summary of Method Validation** 



Summaries of Method Validation of Related Substances in Finerenone 












----------------------------------------------------------------------------------------------------------------------------------
|Wavele ngth selection|Impurities YA2304-10 and YA2304-17 have large absorption at 230nm wavelength; The       |Impurities       |
|                     |principal component andimpurities YA2304-12, YA2304-14, YA2304-15, YA2304-16, YA2304-18 |YA2304-10        |
|                     |and YA2304-19 all have large absorption at 251nm wavelength.                            |and              |
|                     |                                                                                        |YA2304-17        |
|                     |                                                                                        |have             |
|                     |                                                                                        |greaterabsorption|
|                     |                                                                                        |at               |
|                     |                                                                                        |230nm            |
|                     |                                                                                        |wavelength;      |
|                     |                                                                                        |The              |
|                     |                                                                                        |principal        |
|                     |                                                                                        |component        |
|                     |                                                                                        |andimpurities    |
|                     |                                                                                        |YA2304-12,       |
|                     |                                                                                        |YA2304-14,       |
|                     |                                                                                        |YA2304-15,       |
|                     |                                                                                        |YA2304-16,       |
|                     |                                                                                        |YA2304-18        |
|                     |                                                                                        |and              |
|                     |                                                                                        |YA2304-19        |
|                     |                                                                                        |all              |
|                     |                                                                                        |have             |
|                     |                                                                                        |large            |
|                     |                                                                                        |absorption       |
|                     |                                                                                        |at               |
|                     |                                                                                        |251nm.           |
|                     |                                                                                        |In the           |
|                     |                                                                                        |mixed            |
|                     |                                                                                        |control          |
|                     |                                                                                        |product          |
|                     |                                                                                        |solution①,       |
|                     |                                                                                        |The              |
|                     |                                                                                        |retention        |
|                     |                                                                                        |times            |
|                     |                                                                                        |of               |
|                     |                                                                                        |YA2304-10,       |
|                     |                                                                                        |ya2304-17,       |
|                     |                                                                                        |ya2304-12,       |
|                     |                                                                                        |ya2304-14,       |
|                     |                                                                                        |YA2304,          |
|                     |                                                                                        |ya2304-15,       |
|                     |                                                                                        |YA2304-16,       |
|                     |                                                                                        |ya2304-18        |
|                     |                                                                                        |and              |
|                     |                                                                                        |ya2304-19        |
|                     |                                                                                        |were             |
|                     |                                                                                        |15.278min,       |
|                     |                                                                                        |11.524min        |
|                     |                                                                                        |and              |
|                     |                                                                                        |3.791m,          |
|                     |                                                                                        |respectivelyin,  |
|                     |                                                                                        |8.175min,        |
|                     |                                                                                        |9.329min,        |
|                     |                                                                                        |10.295min,       |
|                     |                                                                                        |11.942min,       |
|                     |                                                                                        |13.183min,       |
|                     |                                                                                        |16.435min,       |
|                     |                                                                                        |mixed            |
|                     |                                                                                        |control          |
|                     |                                                                                        |solution         |
|                     |                                                                                        |①spectral        |
|                     |                                                                                        |diagramisas      |
|                     |                                                                                        |follows:         |
----------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 238 of 542 





Page 239
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 












-------------------------------------------------------------------------------------------------------------------------------------
|System suitability|The blank solution should have no interference, and the chromatogram of the reference      |There               |
|                  |solution (230nm), the peakorderis YA2304-17, YA2304-10; In the chromatogram of system      |was no              |
|                  |suitability solution (251nm), the peakorderis YA2304-14, YA2304, YA2304-15, YA2304-17,     |interference        |
|                  |YA2304-16, YA2304-10, YA2304-19. The separation degree between YA2304 and YA2304-14 and    |in the              |
|                  |YA2304-15 should be NLT 1.5, and the separation degree between YA2304-17 and YA2304-16     |blank               |
|                  |andadjacent peaks should be NLT 1.0; Compared with the chromatogram of solution (251nm) for|solution,           |
|                  |6 consecutive days, the RSD of the main                                                    |and in              |
|                  |                                                                                           |the                 |
|                  |                                                                                           |chromatogram        |
|                  |                                                                                           |of the              |
|                  |                                                                                           |control             |
|                  |                                                                                           |solution            |
|                  |                                                                                           |(230nm),            |
|                  |                                                                                           |the                 |
|                  |                                                                                           |peakexit            |
|                  |                                                                                           |sequence            |
|                  |                                                                                           |was                 |
|                  |                                                                                           |YA2304-17           |
|                  |                                                                                           |and                 |
|                  |                                                                                           |YA2304-10;          |
|                  |                                                                                           |In the              |
|                  |                                                                                           |chromatogram        |
|                  |                                                                                           |of                  |
|                  |                                                                                           |system              |
|                  |                                                                                           |suitability         |
|                  |                                                                                           |solution            |
|                  |                                                                                           |(251nm),            |
|                  |                                                                                           |the                 |
|                  |                                                                                           |peakorderis         |
|                  |                                                                                           |YA2304-14,          |
|                  |                                                                                           |YA2304,             |
|                  |                                                                                           |YA2304-15,          |
|                  |                                                                                           |YA2304-17,          |
|                  |                                                                                           |YA2304-16,          |
|                  |                                                                                           |YA2304-10,          |
|                  |                                                                                           |YA2304-19.          |
|                  |                                                                                           |The                 |
|                  |                                                                                           |minimum             |
|                  |                                                                                           |separation          |
|                  |                                                                                           |degree              |
|                  |                                                                                           |between             |
|                  |                                                                                           |YA2304              |
|                  |                                                                                           |and                 |
|                  |                                                                                           |YA2304-14           |
|                  |                                                                                           |and                 |
|                  |                                                                                           |YA2304-15           |
|                  |                                                                                           |is 4.9              |
|                  |                                                                                           |(NLT                |
|                  |                                                                                           |1.5),               |
|                  |                                                                                           |and the             |
|                  |                                                                                           |minimum             |
|                  |                                                                                           |separation          |
|                  |                                                                                           |degree              |
|                  |                                                                                           |between             |
|                  |                                                                                           |YA2304-17           |
|                  |                                                                                           |and                 |
|                  |                                                                                           |YA2304-16           |
|                  |                                                                                           |andadjacent         |
|                  |                                                                                           |peaksis             |
|                  |                                                                                           |1.2                 |
|                  |                                                                                           |(NLT                |
|                  |                                                                                           |1.0);               |
|                  |                                                                                           |In the              |
|                  |                                                                                           |chromatogramobtained|
|                  |                                                                                           |by                  |
|                  |                                                                                           |contrast            |
|                  |                                                                                           |solution            |
|                  |                                                                                           |(251nm)             |
|                  |                                                                                           |for 6               |
|                  |                                                                                           |consecutive         |
|                  |                                                                                           |days,               |
|                  |                                                                                           |the RSD             |
|                  |                                                                                           |of main             |
|                  |                                                                                           |peak                |
|                  |                                                                                           |retention           |
|                  |                                                                                           |time                |
|                  |                                                                                           |was                 |
|                  |                                                                                           |0.05%               |
|                  |                                                                                           |(not                |
|                  |                                                                                           |more                |
|                  |                                                                                           |than                |
|                  |                                                                                           |1.0%),              |
|                  |                                                                                           |the RSD             |
|                  |                                                                                           |of main             |
|                  |                                                                                           |peakarea            |
|                  |                                                                                           |was                 |
|                  |                                                                                           |1.5%                |
|                  |                                                                                           |(not                |
|                  |                                                                                           |more                |
|                  |                                                                                           |than                |
|                  |                                                                                           |5%),                |
|                  |                                                                                           |and the             |
|                  |                                                                                           |signal-to-noise     |
|                  |                                                                                           |ratio               |
|                  |                                                                                           |(S/N)               |
|                  |                                                                                           |was NLT             |
|                  |                                                                                           |20. All             |
|                  |                                                                                           |the                 |
|                  |                                                                                           |above               |
|                  |                                                                                           |meet                |
|                  |                                                                                           |the                 |
|                  |                                                                                           |verification        |
|                  |                                                                                           |requirements,       |
|                  |                                                                                           |indicating          |
|                  |                                                                                           |that                |
|                  |                                                                                           |the                 |
|                  |                                                                                           |method              |
|                  |                                                                                           |has                 |
|                  |                                                                                           |goodapplicability   |
|                  |                                                                                           |in                  |
|                  |                                                                                           |system.             |
-------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 239 of 542 





Page 240
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 




































-------------------------------------------------------------------------------------------------------------------------------------
|Speci fici ty|Pe akiden tifi ca tion|Blank solution should be free ofinterference; In the chromatogram of     |The                 |
|             |                      |system suitability solution (251nm), the peakorderis YA2304-14, YA2304,  |blank               |
|             |                      |YA2304-15, YA2304-17, YA2304-16, YA2304-10, YA2304-19, The separation    |solution            |
|             |                      |degree between YA2304 and YA2304-14 and YA2304-15 should be NLT 1.5, and |has no              |
|             |                      |the separation degree between YA2304-17 and YA2304-16 andadjacent peaks  |interference;       |
|             |                      |should be NLT 1.0; In the chromatogram of test product solution (251nm)  |In the              |
|             |                      |and specific mixed solution (251nm), the separation degree between       |chromatogram        |
|             |                      |YA2304-17 and YA2304-16 andadjacent peaks should NLT 1.0, and the        |of                  |
|             |                      |separation degree betweenotheradjacent peaks should NLT 1.5; The         |system              |
|             |                      |retention time ofeach knownimpurity peak in the reference solution,      |suitability         |
|             |                      |system suitability solution, test product solution and specific mixed    |solution            |
|             |                      |solution should be                                                       |(251nm),            |
|             |                      |                                                                         |the                 |
|             |                      |                                                                         |peakorderis         |
|             |                      |                                                                         |YA2304-14,          |
|             |                      |                                                                         |YA2304,             |
|             |                      |                                                                         |YA2304-15,          |
|             |                      |                                                                         |YA2304-17,          |
|             |                      |                                                                         |YA2304-16,          |
|             |                      |                                                                         |YA2304-10,          |
|             |                      |                                                                         |YA2304-19,          |
|             |                      |                                                                         |The                 |
|             |                      |                                                                         |minimum             |
|             |                      |                                                                         |separation          |
|             |                      |                                                                         |degree              |
|             |                      |                                                                         |between             |
|             |                      |                                                                         |YA2304              |
|             |                      |                                                                         |and                 |
|             |                      |                                                                         |YA2304-14           |
|             |                      |                                                                         |and                 |
|             |                      |                                                                         |YA2304-15           |
|             |                      |                                                                         |is                  |
|             |                      |                                                                         |required            |
|             |                      |                                                                         |to be               |
|             |                      |                                                                         |4.9                 |
|             |                      |                                                                         |(NLT                |
|             |                      |                                                                         |1.5),               |
|             |                      |                                                                         |and the             |
|             |                      |                                                                         |minimum             |
|             |                      |                                                                         |separation          |
|             |                      |                                                                         |degree              |
|             |                      |                                                                         |between             |
|             |                      |                                                                         |YA2304-17           |
|             |                      |                                                                         |and                 |
|             |                      |                                                                         |YA2304-16           |
|             |                      |                                                                         |andadjacent         |
|             |                      |                                                                         |peaksis             |
|             |                      |                                                                         |1.2                 |
|             |                      |                                                                         |(NLT                |
|             |                      |                                                                         |1.0);               |
|             |                      |                                                                         |In the              |
|             |                      |                                                                         |chromatogram        |
|             |                      |                                                                         |of test             |
|             |                      |                                                                         |product             |
|             |                      |                                                                         |solution            |
|             |                      |                                                                         |(251nm)             |
|             |                      |                                                                         |and                 |
|             |                      |                                                                         |specific            |
|             |                      |                                                                         |mixed               |
|             |                      |                                                                         |solution            |
|             |                      |                                                                         |(251nm),            |
|             |                      |                                                                         |the                 |
|             |                      |                                                                         |minimum             |
|             |                      |                                                                         |separation          |
|             |                      |                                                                         |degree              |
|             |                      |                                                                         |between             |
|             |                      |                                                                         |YA2304-17           |
|             |                      |                                                                         |and                 |
|             |                      |                                                                         |YA2304-16           |
|             |                      |                                                                         |andadjacent         |
|             |                      |                                                                         |peaksis             |
|             |                      |                                                                         |1.2                 |
|             |                      |                                                                         |(NLT                |
|             |                      |                                                                         |1.0),               |
|             |                      |                                                                         |and the             |
|             |                      |                                                                         |minimum             |
|             |                      |                                                                         |separation          |
|             |                      |                                                                         |degree              |
|             |                      |                                                                         |betweenotheradjacent|
|             |                      |                                                                         |peaksis             |
|             |                      |                                                                         |3.1                 |
|             |                      |                                                                         |(NLT                |
|             |                      |                                                                         |1.5).               |
|             |                      |                                                                         |In the              |
|             |                      |                                                                         |chromatogram        |
|             |                      |                                                                         |of                  |
|             |                      |                                                                         |specific            |
|             |                      |                                                                         |mixed               |
|             |                      |                                                                         |solution            |
|             |                      |                                                                         |(230nm),            |
|             |                      |                                                                         |the                 |
|             |                      |                                                                         |minimum             |
|             |                      |                                                                         |separation          |
|             |                      |                                                                         |degree              |
|             |                      |                                                                         |between             |
|             |                      |                                                                         |YA2304-17           |
|             |                      |                                                                         |and                 |
|             |                      |                                                                         |YA2304-16           |
|             |                      |                                                                         |andadjacent         |
|             |                      |                                                                         |peaks               |
|             |                      |                                                                         |was 1.2             |
|             |                      |                                                                         |(NLT                |
|             |                      |                                                                         |1.0),               |
|             |                      |                                                                         |and the             |
|             |                      |                                                                         |minimum             |
|             |                      |                                                                         |separation          |
|             |                      |                                                                         |degree              |
|             |                      |                                                                         |betweenotheradjacent|
|             |                      |                                                                         |peaks               |
|             |                      |                                                                         |was 5.0             |
|             |                      |                                                                         |(NLT                |
|             |                      |                                                                         |1.5).               |
|             |                      |                                                                         |The                 |
|             |                      |                                                                         |retention           |
|             |                      |                                                                         |time                |
|             |                      |                                                                         |ofeach              |
|             |                      |                                                                         |knownimpurity       |
|             |                      |                                                                         |peak in             |
|             |                      |                                                                         |the                 |
|             |                      |                                                                         |reference           |
|             |                      |                                                                         |solution,           |
|             |                      |                                                                         |the                 |
|             |                      |                                                                         |system              |
|             |                      |                                                                         |suitability         |
|             |                      |                                                                         |solution,           |
|             |                      |                                                                         |the                 |
|             |                      |                                                                         |test                |
|             |                      |                                                                         |product             |
|             |                      |                                                                         |solution            |
|             |                      |                                                                         |and the             |
|             |                      |                                                                         |specific            |
|             |                      |                                                                         |mixed               |
|             |                      |                                                                         |solution            |
|             |                      |                                                                         |was                 |
|             |                      |                                                                         |consistent          |
|             |                      |                                                                         |with                |
|             |                      |                                                                         |the                 |
|             |                      |                                                                         |corresponding       |
|             |                      |                                                                         |main                |
|             |                      |                                                                         |peak in             |
|             |                      |                                                                         |the                 |
|             |                      |                                                                         |impurity            |
|             |                      |                                                                         |localization        |
|             |                      |                                                                         |solution,           |
|             |                      |                                                                         |and the             |
|             |                      |                                                                         |relative            |
|             |                      |                                                                         |retention           |
|             |                      |                                                                         |time                |
|             |                      |                                                                         |ofeach              |
|             |                      |                                                                         |knownimpurity       |
|             |                      |                                                                         |peak in             |
|             |                      |                                                                         |the                 |
|             |                      |                                                                         |specific            |
|             |                      |                                                                         |mixed               |
|             |                      |                                                                         |solution            |
|             |                      |                                                                         |was                 |
|             |                      |                                                                         |basically           |
|             |                      |                                                                         |consistent          |
|             |                      |                                                                         |with                |
|             |                      |                                                                         |the                 |
|             |                      |                                                                         |quality             |
|             |                      |                                                                         |standard.           |
|             |                      |                                                                         |The                 |
|             |                      |                                                                         |concentration       |
|             |                      |                                                                         |of                  |
|             |                      |                                                                         |YA2304-10,          |
|             |                      |                                                                         |YA2304-17,          |
|             |                      |                                                                         |YA2304-12,          |
|             |                      |                                                                         |YA2304-14,          |
|             |                      |                                                                         |YA2304-15,          |
|             |                      |                                                                         |YA2304-16,          |
|             |                      |                                                                         |YA2304-18           |
|             |                      |                                                                         |and                 |
|             |                      |                                                                         |YA2304-19           |
|             |                      |                                                                         |in the              |
|             |                      |                                                                         |specific            |
|             |                      |                                                                         |mixed               |
|             |                      |                                                                         |solution            |
|             |                      |                                                                         |was                 |
|             |                      |                                                                         |0.15%               |
|             |                      |                                                                         |of the              |
|             |                      |                                                                         |concentration       |
|             |                      |                                                                         |of                  |
|             |                      |                                                                         |principal           |
|             |                      |                                                                         |components          |
|             |                      |                                                                         |in the              |
|             |                      |                                                                         |test                |
|             |                      |                                                                         |solution.           |
|             |                      |                                                                         |**Nam**             |
|             |                      |                                                                         |**eof**             |
|             |                      |                                                                         |**the**             |
|             |                      |                                                                         |**Testi**           |
|             |                      |                                                                         |**ng**              |
|             |                      |                                                                         |**Wavel**           |
|             |                      |                                                                         |**Component**       |
|             |                      |                                                                         |**name**            |
|             |                      |                                                                         |**Compone**         |
|             |                      |                                                                         |**nt**              |
|             |                      |                                                                         |**concentr**        |
|             |                      |                                                                         |**Rt**              |
|             |                      |                                                                         |**(min)**           |
|             |                      |                                                                         |**RRT**             |
|             |                      |                                                                         |**Minimu**          |
|             |                      |                                                                         |**m**               |
|             |                      |                                                                         |**separati**        |
|             |                      |                                                                         |**The**             |
|             |                      |                                                                         |**percentage**      |
|             |                      |                                                                         |**equivalent**      |
-------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 240 of 542 





Page 241
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 
























---------------------------------------------------------------------------------------------------------------------------------------
|       |       |consistent with the   |       |solution|ength  |         |ation   |       |       |on          |to the       |       |
|       |       |corresponding main    |       |        |       |         |(μg/ml) |       |       |fromadjacent|concentration|       |
|       |       |peak in the impurity  |       |        |       |         |        |       |       |peaks       |of the       |       |
|       |       |positioning solution, |       |        |       |         |        |       |       |            |principal    |       |
|       |       |and the relative      |       |        |       |         |        |       |       |            |component    |       |
|       |       |retention time ofeach |       |        |       |         |        |       |       |            |in the       |       |
|       |       |knownimpurity peak in |       |        |       |         |        |       |       |            |test         |       |
|       |       |the specific mixed    |       |        |       |         |        |       |       |            |solution     |       |
|       |       |solution should be    |       |        |       |         |        |       |       |            |             |       |
|       |       |basically consistent  |       |        |       |         |        |       |       |            |             |       |
|       |       |with the quality      |       |        |       |         |        |       |       |            |             |       |
|       |       |standard.             |       |        |       |         |        |       |       |            |             |       |
|       |       |                      |       |        |       |         |        |       |       |            |             |       |
|       |       |                      |       |        |       |         |        |       |       |            |             |       |
|       |       |                      |       |        |       |         |        |       |       |            |             |       |
|       |       |                      |       |        |       |         |        |       |       |            |             |       |
|       |       |                      |       |        |       |         |        |       |       |            |             |       |
|       |       |                      |       |        |       |         |        |       |       |            |             |       |
|       |       |                      |       |        |       |         |        |       |       |            |             |       |
|       |       |                      |       |        |       |         |        |       |       |            |             |       |
|       |       |                      |       |        |       |         |        |       |       |            |             |       |
|       |       |                      |       |        |       |         |        |       |       |            |             |       |
|       |       |                      |       |        |       |         |        |       |       |            |             |       |
|       |       |                      |       |        |       |         |        |       |       |            |             |       |
|       |       |                      |       |        |       |         |        |       |       |            |             |       |
|       |       |                      |       |--------|-------|---------|--------|-------|-------|------------|-------------|       |
|       |       |                      |       |Speci   |251n m |YA2304-12|0.6005  |3.810  |0.41   |3.1         |0.15%                |
|       |       |                      |       |fic     |       |         |        |       |       |            |                     |
|       |       |                      |       |mixed   |       |         |        |       |       |            |                     |
|       |       |                      |       |soluti  |       |         |        |       |       |            |                     |
|       |       |                      |       |on      |       |         |        |       |       |            |                     |
|       |       |                      |       |        |       |---------|--------|-------|-------|------------|---------------------|
|       |       |                      |       |        |       |YA2304-14|0.6032  |8.233  |0.89   |4.7         |0.15%                |
|       |       |                      |       |        |       |---------|--------|-------|-------|------------|---------------------|
|       |       |                      |       |        |       |YA2304   |410.0400|9.289  |1.00   |5.0         |100%                 |
|       |       |                      |       |        |       |---------|--------|-------|-------|------------|---------------------|
|       |       |                      |       |        |       |YA2304-15|0.6055  |10.295 |1.11   |5.6         |0.15%                |
|       |       |                      |       |        |       |---------|--------|-------|-------|------------|---------------------|
|       |       |                      |       |        |       |YA2304-17|0.6040  |11.549 |1.24   |1.2         |0.15%                |
|       |       |                      |       |        |       |---------|--------|-------|-------|------------|---------------------|
|       |       |                      |       |        |       |YA2304-16|0.5797  |11.972 |1.29   |1.4         |0.15%                |
|       |       |                      |       |        |       |---------|--------|-------|-------|------------|---------------------|
|       |       |                      |       |        |       |YA2304-18|0.6014  |13.207 |1.42   |7.4         |0.15%                |
|       |       |                      |       |        |       |---------|--------|-------|-------|------------|---------------------|
|       |       |                      |       |        |       |YA2304-10|0.6092  |15.305 |1.65   |5.7         |0.15%                |
|       |       |                      |       |        |       |---------|--------|-------|-------|------------|---------------------|
|       |       |                      |       |        |       |YA2304-19|0.6008  |16.474 |1.77   |5.7         |0.15%                |
|       |       |                      |       |        |-------|---------|--------|-------|-------|------------|---------------------|
|       |       |                      |       |        |230n m |YA2304-12|0.6005  |3.806  |0.41   |9.5         |0.15%                |
|       |       |                      |       |        |       |---------|--------|-------|-------|------------|---------------------|
|       |       |                      |       |        |       |YA2304-14|0.6032  |8.229  |0.89   |5.0         |0.15%                |
|       |       |                      |       |        |       |---------|--------|-------|-------|------------|---------------------|
|       |       |                      |       |        |       |YA2304   |410.0400|9.285  |1.00   |5.0         |100%                 |
|       |       |                      |       |        |       |---------|--------|-------|-------|------------|---------------------|
|       |       |                      |       |        |       |YA2304-15|0.6055  |10.291 |1.11   |5.6         |0.15%                |
|       |       |                      |       |        |       |---------|--------|-------|-------|------------|---------------------|
|       |       |                      |       |        |       |YA2304-17|0.6040  |11.547 |1.24   |1.2         |0.15%                |
|       |       |                      |       |        |       |---------|--------|-------|-------|------------|---------------------|
|       |       |                      |       |        |       |YA2304-16|0.5797  |11.967 |1.29   |1.5         |0.15%                |
|       |       |                      |       |        |       |---------|--------|-------|-------|------------|---------------------|
|       |       |                      |       |        |       |YA2304-18|0.6014  |13.203 |1.42   |7.4         |0.15%                |
|       |       |                      |       |        |       |---------|--------|-------|-------|------------|---------------------|
|       |       |                      |       |        |       |YA2304-10|0.6092  |15.304 |1.65   |5.6         |0.15%                |
---------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 241 of 542 





Page 242
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



The chromatogram of the specific mixed solution at 251nm is as follows: 



The chromatogram of the specific mixture at 230nm is as follows: 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 242 of 542 





Page 243
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 
























---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Limits of quantifi cation and detection|Limits of quantifi cation and |TheS/Nof        |       |**Impurity** |**Detection         |**Limitofquantitation**|                    |
|                                       |detection                     |non-nellidone   |       |**/principa**|limits**            |                       |                    |
|                                       |                              |andallimpurities|       |**l**        |                    |                       |                    |
|                                       |                              |in the          |       |**compone**  |                    |                       |                    |
|                                       |                              |6 RMS           |       |**nt**       |                    |                       |                    |
|                                       |                              |should          |       |             |                    |                       |                    |
|                                       |                              |be NLT          |       |             |                    |                       |                    |
|                                       |                              |10, the         |       |             |                    |                       |                    |
|                                       |                              |RSD of          |       |             |                    |                       |                    |
|                                       |                              |the             |       |             |                    |                       |                    |
|                                       |                              |peak            |       |             |                    |                       |                    |
|                                       |                              |retention       |       |             |                    |                       |                    |
|                                       |                              |time            |       |             |                    |                       |                    |
|                                       |                              |ofeach          |       |             |                    |                       |                    |
|                                       |                              |component       |       |             |                    |                       |                    |
|                                       |                              |should          |       |             |                    |                       |                    |
|                                       |                              |be no           |       |             |                    |                       |                    |
|                                       |                              |more            |       |             |                    |                       |                    |
|                                       |                              |than            |       |             |                    |                       |                    |
|                                       |                              |2.0%,           |       |             |                    |                       |                    |
|                                       |                              |and the         |       |             |                    |                       |                    |
|                                       |                              |RSD of          |       |             |                    |                       |                    |
|                                       |                              |the             |       |             |                    |                       |                    |
|                                       |                              |peakarea        |       |             |                    |                       |                    |
|                                       |                              |should          |       |             |                    |                       |                    |
|                                       |                              |be NLT          |       |             |                    |                       |                    |
|                                       |                              |10%.            |       |             |                    |                       |                    |
|                                       |                              |TheS/Nof        |       |             |                    |                       |                    |
|                                       |                              |fineridone      |       |             |                    |                       |                    |
|                                       |                              |andeachimpurity |       |             |                    |                       |                    |
|                                       |                              |in the          |       |             |                    |                       |                    |
|                                       |                              |3-needle        |       |             |                    |                       |                    |
|                                       |                              |detection       |       |             |                    |                       |                    |
|                                       |                              |limited         |       |             |                    |                       |                    |
|                                       |                              |solutionatlas   |       |             |                    |                       |                    |
|                                       |                              |was NLT         |       |             |                    |                       |                    |
|                                       |                              |3.              |       |             |                    |                       |                    |
|---------------------------------------|------------------------------|----------------|-------|-------------|--------------------|-----------------------|--------------------|
|Limits of quantifi cation and detection|Limits of quantifi cation and |TheS/Nof        |       |**Impurity** |**Concentration     |**Concentration        |**Concentration     |
|                                       |detection                     |non-nellidone   |       |**/principa**|(equivalent         |(equivalent to the**   |(equivalent         |
|                                       |                              |andallimpurities|       |**l**        |to the**            |**test product         |to                  |
|                                       |                              |in the 6 RMS    |       |**compone**  |**percentage        |solution**             |the**               |
|                                       |                              |should be NLT   |       |**nt**       |of                  |**concentration        |**test              |
|                                       |                              |10, the RSD of  |       |             |solution**          |percentage)**          |product             |
|                                       |                              |the peak        |       |             |**concentration     |                       |solution**          |
|                                       |                              |retention time  |       |             |of the test         |                       |**concentration     |
|                                       |                              |ofeach component|       |             |product)**          |                       |percentage)**       |
|                                       |                              |should be no    |       |             |                    |                       |                    |
|                                       |                              |more than 2.0%, |       |             |                    |                       |                    |
|                                       |                              |and the RSD of  |       |             |                    |                       |                    |
|                                       |                              |the peakarea    |       |             |                    |                       |                    |
|                                       |                              |should be NLT   |       |             |                    |                       |                    |
|                                       |                              |10%. TheS/Nof   |       |             |                    |                       |                    |
|                                       |                              |fineridone      |       |             |                    |                       |                    |
|                                       |                              |andeachimpurity |       |             |                    |                       |                    |
|                                       |                              |in the 3-needle |       |             |                    |                       |                    |
|                                       |                              |detection       |       |             |                    |                       |                    |
|                                       |                              |limited         |       |             |                    |                       |                    |
|                                       |                              |solutionatlas   |       |             |                    |                       |                    |
|                                       |                              |was NLT 3.      |       |             |                    |                       |                    |
|---------------------------------------|------------------------------|----------------|-------|-------------|--------------------|-----------------------|--------------------|
|Limits of quantifi cation and detection|Limits of quantifi cation and |TheS/Nof        |       |YA2304-1 2   |0.0601μg/ml         |0.1201μg/ml (0.0300%)  |0.1201μg/ml         |
|                                       |detection                     |non-nellidone   |       |             |(0.0150%)           |                       |(0.0300%)           |
|                                       |                              |andallimpurities|       |             |                    |                       |                    |
|                                       |                              |in the 6 RMS    |       |             |                    |                       |                    |
|                                       |                              |should be NLT   |       |             |                    |                       |                    |
|                                       |                              |10, the RSD of  |       |             |                    |                       |                    |
|                                       |                              |the peak        |       |             |                    |                       |                    |
|                                       |                              |retention time  |       |             |                    |                       |                    |
|                                       |                              |ofeach component|       |             |                    |                       |                    |
|                                       |                              |should be no    |       |             |                    |                       |                    |
|                                       |                              |more than 2.0%, |       |             |                    |                       |                    |
|                                       |                              |and the RSD of  |       |             |                    |                       |                    |
|                                       |                              |the peakarea    |       |             |                    |                       |                    |
|                                       |                              |should be NLT   |       |             |                    |                       |                    |
|                                       |                              |10%. TheS/Nof   |       |             |                    |                       |                    |
|                                       |                              |fineridone      |       |             |                    |                       |                    |
|                                       |                              |andeachimpurity |       |             |                    |                       |                    |
|                                       |                              |in the 3-needle |       |             |                    |                       |                    |
|                                       |                              |detection       |       |             |                    |                       |                    |
|                                       |                              |limited         |       |             |                    |                       |                    |
|                                       |                              |solutionatlas   |       |             |                    |                       |                    |
|                                       |                              |was NLT 3.      |       |             |                    |                       |                    |
|---------------------------------------|------------------------------|----------------|-------|-------------|--------------------|-----------------------|--------------------|
|Limits of quantifi cation and detection|Limits of quantifi cation and |TheS/Nof        |       |YA2304-1 4   |0.0603μg/ml         |0.1206μg/ml (0.0302%)  |0.1206μg/ml         |
|                                       |detection                     |non-nellidone   |       |             |(0.0151%)           |                       |(0.0302%)           |
|                                       |                              |andallimpurities|       |             |                    |                       |                    |
|                                       |                              |in the 6 RMS    |       |             |                    |                       |                    |
|                                       |                              |should be NLT   |       |             |                    |                       |                    |
|                                       |                              |10, the RSD of  |       |             |                    |                       |                    |
|                                       |                              |the peak        |       |             |                    |                       |                    |
|                                       |                              |retention time  |       |             |                    |                       |                    |
|                                       |                              |ofeach component|       |             |                    |                       |                    |
|                                       |                              |should be no    |       |             |                    |                       |                    |
|                                       |                              |more than 2.0%, |       |             |                    |                       |                    |
|                                       |                              |and the RSD of  |       |             |                    |                       |                    |
|                                       |                              |the peakarea    |       |             |                    |                       |                    |
|                                       |                              |should be NLT   |       |             |                    |                       |                    |
|                                       |                              |10%. TheS/Nof   |       |             |                    |                       |                    |
|                                       |                              |fineridone      |       |             |                    |                       |                    |
|                                       |                              |andeachimpurity |       |             |                    |                       |                    |
|                                       |                              |in the 3-needle |       |             |                    |                       |                    |
|                                       |                              |detection       |       |             |                    |                       |                    |
|                                       |                              |limited         |       |             |                    |                       |                    |
|                                       |                              |solutionatlas   |       |             |                    |                       |                    |
|                                       |                              |was NLT 3.      |       |             |                    |                       |                    |
|---------------------------------------|------------------------------|----------------|-------|-------------|--------------------|-----------------------|--------------------|
|Limits of quantifi cation and detection|Limits of quantifi cation and |TheS/Nof        |       |YA2304       |0.0615μg/ml(0.0154%)|0.1229μg/ml(0.0307%)   |0.1229μg/ml(0.0307%)|
|                                       |detection                     |non-nellidone   |       |             |                    |                       |                    |
|                                       |                              |andallimpurities|       |             |                    |                       |                    |
|                                       |                              |in the 6 RMS    |       |             |                    |                       |                    |
|                                       |                              |should be NLT   |       |             |                    |                       |                    |
|                                       |                              |10, the RSD of  |       |             |                    |                       |                    |
|                                       |                              |the peak        |       |             |                    |                       |                    |
|                                       |                              |retention time  |       |             |                    |                       |                    |
|                                       |                              |ofeach component|       |             |                    |                       |                    |
|                                       |                              |should be no    |       |             |                    |                       |                    |
|                                       |                              |more than 2.0%, |       |             |                    |                       |                    |
|                                       |                              |and the RSD of  |       |             |                    |                       |                    |
|                                       |                              |the peakarea    |       |             |                    |                       |                    |
|                                       |                              |should be NLT   |       |             |                    |                       |                    |
|                                       |                              |10%. TheS/Nof   |       |             |                    |                       |                    |
|                                       |                              |fineridone      |       |             |                    |                       |                    |
|                                       |                              |andeachimpurity |       |             |                    |                       |                    |
|                                       |                              |in the 3-needle |       |             |                    |                       |                    |
|                                       |                              |detection       |       |             |                    |                       |                    |
|                                       |                              |limited         |       |             |                    |                       |                    |
|                                       |                              |solutionatlas   |       |             |                    |                       |                    |
|                                       |                              |was NLT 3.      |       |             |                    |                       |                    |
|---------------------------------------|------------------------------|----------------|-------|-------------|--------------------|-----------------------|--------------------|
|Limits of quantifi cation and detection|Limits of quantifi cation and |TheS/Nof        |       |YA2304-1 5   |0.0605μg/ml         |0.1211μg/ml (0.0303%)  |0.1211μg/ml         |
|                                       |detection                     |non-nellidone   |       |             |(0.0151%)           |                       |(0.0303%)           |
|                                       |                              |andallimpurities|       |             |                    |                       |                    |
|                                       |                              |in the 6 RMS    |       |             |                    |                       |                    |
|                                       |                              |should be NLT   |       |             |                    |                       |                    |
|                                       |                              |10, the RSD of  |       |             |                    |                       |                    |
|                                       |                              |the peak        |       |             |                    |                       |                    |
|                                       |                              |retention time  |       |             |                    |                       |                    |
|                                       |                              |ofeach component|       |             |                    |                       |                    |
|                                       |                              |should be no    |       |             |                    |                       |                    |
|                                       |                              |more than 2.0%, |       |             |                    |                       |                    |
|                                       |                              |and the RSD of  |       |             |                    |                       |                    |
|                                       |                              |the peakarea    |       |             |                    |                       |                    |
|                                       |                              |should be NLT   |       |             |                    |                       |                    |
|                                       |                              |10%. TheS/Nof   |       |             |                    |                       |                    |
|                                       |                              |fineridone      |       |             |                    |                       |                    |
|                                       |                              |andeachimpurity |       |             |                    |                       |                    |
|                                       |                              |in the 3-needle |       |             |                    |                       |                    |
|                                       |                              |detection       |       |             |                    |                       |                    |
|                                       |                              |limited         |       |             |                    |                       |                    |
|                                       |                              |solutionatlas   |       |             |                    |                       |                    |
|                                       |                              |was NLT 3.      |       |             |                    |                       |                    |
|---------------------------------------|------------------------------|----------------|-------|-------------|--------------------|-----------------------|--------------------|
|Limits of quantifi cation and detection|Limits of quantifi cation and |TheS/Nof        |       |YA2304-1     |0.0604μg/ml(0.0151%)|0.1208μg/ml(0.0302%)   |0.1208μg/ml(0.0302%)|
|                                       |detection                     |non-nellidone   |       |             |                    |                       |                    |
|                                       |                              |andallimpurities|       |             |                    |                       |                    |
|                                       |                              |in the 6 RMS    |       |             |                    |                       |                    |
|                                       |                              |should be NLT   |       |             |                    |                       |                    |
|                                       |                              |10, the RSD of  |       |             |                    |                       |                    |
|                                       |                              |the peak        |       |             |                    |                       |                    |
|                                       |                              |retention time  |       |             |                    |                       |                    |
|                                       |                              |ofeach component|       |             |                    |                       |                    |
|                                       |                              |should be no    |       |             |                    |                       |                    |
|                                       |                              |more than 2.0%, |       |             |                    |                       |                    |
|                                       |                              |and the RSD of  |       |             |                    |                       |                    |
|                                       |                              |the peakarea    |       |             |                    |                       |                    |
|                                       |                              |should be NLT   |       |             |                    |                       |                    |
|                                       |                              |10%. TheS/Nof   |       |             |                    |                       |                    |
|                                       |                              |fineridone      |       |             |                    |                       |                    |
|                                       |                              |andeachimpurity |       |             |                    |                       |                    |
|                                       |                              |in the 3-needle |       |             |                    |                       |                    |
|                                       |                              |detection       |       |             |                    |                       |                    |
|                                       |                              |limited         |       |             |                    |                       |                    |
|                                       |                              |solutionatlas   |       |             |                    |                       |                    |
|                                       |                              |was NLT 3.      |       |             |                    |                       |                    |
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 243 of 542 





Page 244
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 
















































---------------------------------------------------------------------------------------------------------------------------------------------------------------
|YA2304-1 6                              |0.0580μg/ml (0.0145%)|0.1159μg/ml|0.1159μg/ml  |0.1159μg/ml    |0.1159μg/ml    |                  |         |       |
|                                        |                     |(0.0290%)  |(0.0290%)    |(0.0290%)      |(0.0290%)      |                  |         |       |
|----------------------------------------|---------------------|-----------|-------------|---------------|---------------|------------------|---------|-------|
|YA2304-1 8                              |0.0601μg/ml (0.0150%)|0.1203μg/ml|0.1203μg/ml  |0.1203μg/ml    |0.1203μg/ml    |                  |         |       |
|                                        |                     |(0.0301%)  |(0.0301%)    |(0.0301%)      |(0.0301%)      |                  |         |       |
|----------------------------------------|---------------------|-----------|-------------|---------------|---------------|------------------|---------|-------|
|YA2304-1 0                              |0.0609μg/ml (0.0152%)|0.1218μg/ml|0.1218μg/ml  |0.1218μg/ml    |0.1218μg/ml    |                  |         |       |
|                                        |                     |(0.0305%)  |(0.0305%)    |(0.0305%)      |(0.0305%)      |                  |         |       |
|----------------------------------------|---------------------|-----------|-------------|---------------|---------------|------------------|---------|-------|
|YA2304-1 9                              |0.0601μg/ml (0.0150%)|0.1202μg/ml|0.1202μg/ml  |0.1202μg/ml    |0.1202μg/ml    |                  |         |       |
|                                        |                     |(0.0300%)  |(0.0300%)    |(0.0300%)      |(0.0300%)      |                  |         |       |
|----------------------------------------|---------------------|-----------|-------------|---------------|---------------|------------------|---------|-------|
|Linearity, range and correcti on factors|Knownimpurities at   |           |**Impuritie**|**Concentration|**Concentration|**Linearequation**|**Corre**|       |
|                                        |251nm wavelength     |           |**s /**      |(equivalent    |(equivalent    |                  |**ction**|       |
|                                        |(YA2304-12,          |           |**Principal**|to             |to             |                  |**facto**|       |
|                                        |YA2304-14, YA2304-15,|           |**compone**  |percentage**   |percentage**   |                  |**r**    |       |
|                                        |YA2304-16, YA2304-18 |           |**nt**       |**of           |**of           |                  |         |       |
|                                        |and YA2304-19) and   |           |             |solution       |solution       |                  |         |       |
|                                        |230nm wavelength     |           |             |concentration  |concentration  |                  |         |       |
|                                        |(YA2304-10,          |           |             |of test        |of test        |                  |         |       |
|                                        |YA2304-17) : Within  |           |             |product)**     |product)**     |                  |         |       |
|                                        |the range of limited |           |             |               |               |                  |         |       |
|                                        |quantitation         |           |             |               |               |                  |         |       |
|                                        |concentration ~      |           |             |               |               |                  |         |       |
|                                        |equivalent to 0.3% of|           |             |               |               |                  |         |       |
|                                        |the test product     |           |             |               |               |                  |         |       |
|                                        |solution             |           |             |               |               |                  |         |       |
|                                        |concentration, 6     |           |             |               |               |                  |         |       |
|                                        |concentration points |           |             |               |               |                  |         |       |
|                                        |were selected        |           |             |               |               |                  |         |       |
|                                        |fairlyevenly, and the|           |             |               |               |                  |         |       |
|                                        |concentration        |           |             |               |               |                  |         |       |
|                                        |ofeachimpurity was   |           |             |               |               |                  |         |       |
|                                        |takenas the          |           |             |               |               |                  |         |       |
|                                        |horizontal coordinate|           |             |               |               |                  |         |       |
|                                        |and the peakarea was |           |             |               |               |                  |         |       |
|                                        |takenas the vertical |           |             |               |               |                  |         |       |
|                                        |coordinate as the    |           |             |               |               |                  |         |       |
|                                        |linear regression    |           |             |               |               |                  |         |       |
|                                        |curve. The regression|           |             |               |               |                  |         |       |
|                                        |coefficientR of the  |           |             |               |               |                  |         |       |
|                                        |obtained linear graph|           |             |               |               |                  |         |       |
|                                        |should NLT 0.990, and|           |             |               |               |                  |         |       |
|                                        |the RSD of the       |           |             |               |               |                  |         |       |
|                                        |response factor      |           |             |               |               |                  |         |       |
|                                        |should NMT 10%.      |           |             |               |               |                  |         |       |
|                                        |Y-axis               |           |             |               |               |                  |         |       |
|----------------------------------------|---------------------|-----------|-------------|---------------|---------------|------------------|---------|-------|
|Linearity, range and correcti on factors|Knownimpurities at   |           |YA2304-1 2   |0.1201μg/ml to |0.1201μg/ml to |y = 13896x +      |1.2      |1.2    |
|                                        |251nm wavelength     |           |             |1.2011μg/ml    |1.2011μg/ml    |33.018            |         |       |
|                                        |(YA2304-12,          |           |             |(0.0300% to    |(0.0300% to    |                  |         |       |
|                                        |YA2304-14, YA2304-15,|           |             |0.3003%)       |0.3003%)       |                  |         |       |
|                                        |YA2304-16, YA2304-18 |           |             |               |               |                  |         |       |
|                                        |and YA2304-19) and   |           |             |               |               |                  |         |       |
|                                        |230nm wavelength     |           |             |               |               |                  |         |       |
|                                        |(YA2304-10,          |           |             |               |               |                  |         |       |
|                                        |YA2304-17) : Within  |           |             |               |               |                  |         |       |
|                                        |the range of limited |           |             |               |               |                  |         |       |
|                                        |quantitation         |           |             |               |               |                  |         |       |
|                                        |concentration ~      |           |             |               |               |                  |         |       |
|                                        |equivalent to 0.3% of|           |             |               |               |                  |         |       |
|                                        |the test product     |           |             |               |               |                  |         |       |
|                                        |solution             |           |             |               |               |                  |         |       |
|                                        |concentration, 6     |           |             |               |               |                  |         |       |
|                                        |concentration points |           |             |               |               |                  |         |       |
|                                        |were selected        |           |             |               |               |                  |         |       |
|                                        |fairlyevenly, and the|           |             |               |               |                  |         |       |
|                                        |concentration        |           |             |               |               |                  |         |       |
|                                        |ofeachimpurity was   |           |             |               |               |                  |         |       |
|                                        |takenas the          |           |             |               |               |                  |         |       |
|                                        |horizontal coordinate|           |             |               |               |                  |         |       |
|                                        |and the peakarea was |           |             |               |               |                  |         |       |
|                                        |takenas the vertical |           |             |               |               |                  |         |       |
|                                        |coordinate as the    |           |             |               |               |                  |         |       |
|                                        |linear regression    |           |             |               |               |                  |         |       |
|                                        |curve. The regression|           |             |               |               |                  |         |       |
|                                        |coefficientR of the  |           |             |               |               |                  |         |       |
|                                        |obtained linear graph|           |             |               |               |                  |         |       |
|                                        |should NLT 0.990, and|           |             |               |               |                  |         |       |
|                                        |the RSD of the       |           |             |               |               |                  |         |       |
|                                        |response factor      |           |             |               |               |                  |         |       |
|                                        |should NMT 10%.      |           |             |               |               |                  |         |       |
|                                        |Y-axis               |           |             |               |               |                  |         |       |
|----------------------------------------|---------------------|-----------|-------------|---------------|---------------|------------------|---------|-------|
|Linearity, range and correcti on factors|Knownimpurities at   |           |YA2304-1 4   |0.1206μg/ml to |0.1206μg/ml to |y = 16536x-85.568 |1.0      |1.0    |
|                                        |251nm wavelength     |           |             |1.2064μg/ml    |1.2064μg/ml    |                  |         |       |
|                                        |(YA2304-12,          |           |             |(0.0302% to    |(0.0302% to    |                  |         |       |
|                                        |YA2304-14, YA2304-15,|           |             |0.3016%)       |0.3016%)       |                  |         |       |
|                                        |YA2304-16, YA2304-18 |           |             |               |               |                  |         |       |
|                                        |and YA2304-19) and   |           |             |               |               |                  |         |       |
|                                        |230nm wavelength     |           |             |               |               |                  |         |       |
|                                        |(YA2304-10,          |           |             |               |               |                  |         |       |
|                                        |YA2304-17) : Within  |           |             |               |               |                  |         |       |
|                                        |the range of limited |           |             |               |               |                  |         |       |
|                                        |quantitation         |           |             |               |               |                  |         |       |
|                                        |concentration ~      |           |             |               |               |                  |         |       |
|                                        |equivalent to 0.3% of|           |             |               |               |                  |         |       |
|                                        |the test product     |           |             |               |               |                  |         |       |
|                                        |solution             |           |             |               |               |                  |         |       |
|                                        |concentration, 6     |           |             |               |               |                  |         |       |
|                                        |concentration points |           |             |               |               |                  |         |       |
|                                        |were selected        |           |             |               |               |                  |         |       |
|                                        |fairlyevenly, and the|           |             |               |               |                  |         |       |
|                                        |concentration        |           |             |               |               |                  |         |       |
|                                        |ofeachimpurity was   |           |             |               |               |                  |         |       |
|                                        |takenas the          |           |             |               |               |                  |         |       |
|                                        |horizontal coordinate|           |             |               |               |                  |         |       |
|                                        |and the peakarea was |           |             |               |               |                  |         |       |
|                                        |takenas the vertical |           |             |               |               |                  |         |       |
|                                        |coordinate as the    |           |             |               |               |                  |         |       |
|                                        |linear regression    |           |             |               |               |                  |         |       |
|                                        |curve. The regression|           |             |               |               |                  |         |       |
|                                        |coefficientR of the  |           |             |               |               |                  |         |       |
|                                        |obtained linear graph|           |             |               |               |                  |         |       |
|                                        |should NLT 0.990, and|           |             |               |               |                  |         |       |
|                                        |the RSD of the       |           |             |               |               |                  |         |       |
|                                        |response factor      |           |             |               |               |                  |         |       |
|                                        |should NMT 10%.      |           |             |               |               |                  |         |       |
|                                        |Y-axis               |           |             |               |               |                  |         |       |
|----------------------------------------|---------------------|-----------|-------------|---------------|---------------|------------------|---------|-------|
|Linearity, range and correcti on factors|Knownimpurities at   |           |YA2304       |0.1229μg/ml to |0.1229μg/ml to |y = 16404x +      |1.0      |1.0    |
|                                        |251nm wavelength     |           |             |1.2294μg/ml    |1.2294μg/ml    |57.399            |         |       |
|                                        |(YA2304-12,          |           |             |(0.0307% to    |(0.0307% to    |                  |         |       |
|                                        |YA2304-14, YA2304-15,|           |             |0.3074%)       |0.3074%)       |                  |         |       |
|                                        |YA2304-16, YA2304-18 |           |             |               |               |                  |         |       |
|                                        |and YA2304-19) and   |           |             |               |               |                  |         |       |
|                                        |230nm wavelength     |           |             |               |               |                  |         |       |
|                                        |(YA2304-10,          |           |             |               |               |                  |         |       |
|                                        |YA2304-17) : Within  |           |             |               |               |                  |         |       |
|                                        |the range of limited |           |             |               |               |                  |         |       |
|                                        |quantitation         |           |             |               |               |                  |         |       |
|                                        |concentration ~      |           |             |               |               |                  |         |       |
|                                        |equivalent to 0.3% of|           |             |               |               |                  |         |       |
|                                        |the test product     |           |             |               |               |                  |         |       |
|                                        |solution             |           |             |               |               |                  |         |       |
|                                        |concentration, 6     |           |             |               |               |                  |         |       |
|                                        |concentration points |           |             |               |               |                  |         |       |
|                                        |were selected        |           |             |               |               |                  |         |       |
|                                        |fairlyevenly, and the|           |             |               |               |                  |         |       |
|                                        |concentration        |           |             |               |               |                  |         |       |
|                                        |ofeachimpurity was   |           |             |               |               |                  |         |       |
|                                        |takenas the          |           |             |               |               |                  |         |       |
|                                        |horizontal coordinate|           |             |               |               |                  |         |       |
|                                        |and the peakarea was |           |             |               |               |                  |         |       |
|                                        |takenas the vertical |           |             |               |               |                  |         |       |
|                                        |coordinate as the    |           |             |               |               |                  |         |       |
|                                        |linear regression    |           |             |               |               |                  |         |       |
|                                        |curve. The regression|           |             |               |               |                  |         |       |
|                                        |coefficientR of the  |           |             |               |               |                  |         |       |
|                                        |obtained linear graph|           |             |               |               |                  |         |       |
|                                        |should NLT 0.990, and|           |             |               |               |                  |         |       |
|                                        |the RSD of the       |           |             |               |               |                  |         |       |
|                                        |response factor      |           |             |               |               |                  |         |       |
|                                        |should NMT 10%.      |           |             |               |               |                  |         |       |
|                                        |Y-axis               |           |             |               |               |                  |         |       |
|----------------------------------------|---------------------|-----------|-------------|---------------|---------------|------------------|---------|-------|
|Linearity, range and correcti on factors|Knownimpurities at   |           |YA2304-1 5   |0.1211μg/ml to |0.1211μg/ml to |y = 14367x +      |1.1      |1.1    |
|                                        |251nm wavelength     |           |             |1.2109μg/ml    |1.2109μg/ml    |1.2724            |         |       |
|                                        |(YA2304-12,          |           |             |(0.0303% to    |(0.0303% to    |                  |         |       |
|                                        |YA2304-14, YA2304-15,|           |             |0.3027%)       |0.3027%)       |                  |         |       |
|                                        |YA2304-16, YA2304-18 |           |             |               |               |                  |         |       |
|                                        |and YA2304-19) and   |           |             |               |               |                  |         |       |
|                                        |230nm wavelength     |           |             |               |               |                  |         |       |
|                                        |(YA2304-10,          |           |             |               |               |                  |         |       |
|                                        |YA2304-17) : Within  |           |             |               |               |                  |         |       |
|                                        |the range of limited |           |             |               |               |                  |         |       |
|                                        |quantitation         |           |             |               |               |                  |         |       |
|                                        |concentration ~      |           |             |               |               |                  |         |       |
|                                        |equivalent to 0.3% of|           |             |               |               |                  |         |       |
|                                        |the test product     |           |             |               |               |                  |         |       |
|                                        |solution             |           |             |               |               |                  |         |       |
|                                        |concentration, 6     |           |             |               |               |                  |         |       |
|                                        |concentration points |           |             |               |               |                  |         |       |
|                                        |were selected        |           |             |               |               |                  |         |       |
|                                        |fairlyevenly, and the|           |             |               |               |                  |         |       |
|                                        |concentration        |           |             |               |               |                  |         |       |
|                                        |ofeachimpurity was   |           |             |               |               |                  |         |       |
|                                        |takenas the          |           |             |               |               |                  |         |       |
|                                        |horizontal coordinate|           |             |               |               |                  |         |       |
|                                        |and the peakarea was |           |             |               |               |                  |         |       |
|                                        |takenas the vertical |           |             |               |               |                  |         |       |
|                                        |coordinate as the    |           |             |               |               |                  |         |       |
|                                        |linear regression    |           |             |               |               |                  |         |       |
|                                        |curve. The regression|           |             |               |               |                  |         |       |
|                                        |coefficientR of the  |           |             |               |               |                  |         |       |
|                                        |obtained linear graph|           |             |               |               |                  |         |       |
|                                        |should NLT 0.990, and|           |             |               |               |                  |         |       |
|                                        |the RSD of the       |           |             |               |               |                  |         |       |
|                                        |response factor      |           |             |               |               |                  |         |       |
|                                        |should NMT 10%.      |           |             |               |               |                  |         |       |
|                                        |Y-axis               |           |             |               |               |                  |         |       |
|----------------------------------------|---------------------|-----------|-------------|---------------|---------------|------------------|---------|-------|
|Linearity, range and correcti on factors|Knownimpurities at   |           |YA2304-1 6   |0.1159μg/ml to |0.1159μg/ml to |y = 16470x +      |1.0      |1.0    |
|                                        |251nm wavelength     |           |             |1.1595μg/ml    |1.1595μg/ml    |14.525            |         |       |
|                                        |(YA2304-12,          |           |             |(0.0290% to    |(0.0290% to    |                  |         |       |
|                                        |YA2304-14, YA2304-15,|           |             |0.2899%)       |0.2899%)       |                  |         |       |
|                                        |YA2304-16, YA2304-18 |           |             |               |               |                  |         |       |
|                                        |and YA2304-19) and   |           |             |               |               |                  |         |       |
|                                        |230nm wavelength     |           |             |               |               |                  |         |       |
|                                        |(YA2304-10,          |           |             |               |               |                  |         |       |
|                                        |YA2304-17) : Within  |           |             |               |               |                  |         |       |
|                                        |the range of limited |           |             |               |               |                  |         |       |
|                                        |quantitation         |           |             |               |               |                  |         |       |
|                                        |concentration ~      |           |             |               |               |                  |         |       |
|                                        |equivalent to 0.3% of|           |             |               |               |                  |         |       |
|                                        |the test product     |           |             |               |               |                  |         |       |
|                                        |solution             |           |             |               |               |                  |         |       |
|                                        |concentration, 6     |           |             |               |               |                  |         |       |
|                                        |concentration points |           |             |               |               |                  |         |       |
|                                        |were selected        |           |             |               |               |                  |         |       |
|                                        |fairlyevenly, and the|           |             |               |               |                  |         |       |
|                                        |concentration        |           |             |               |               |                  |         |       |
|                                        |ofeachimpurity was   |           |             |               |               |                  |         |       |
|                                        |takenas the          |           |             |               |               |                  |         |       |
|                                        |horizontal coordinate|           |             |               |               |                  |         |       |
|                                        |and the peakarea was |           |             |               |               |                  |         |       |
|                                        |takenas the vertical |           |             |               |               |                  |         |       |
|                                        |coordinate as the    |           |             |               |               |                  |         |       |
|                                        |linear regression    |           |             |               |               |                  |         |       |
|                                        |curve. The regression|           |             |               |               |                  |         |       |
|                                        |coefficientR of the  |           |             |               |               |                  |         |       |
|                                        |obtained linear graph|           |             |               |               |                  |         |       |
|                                        |should NLT 0.990, and|           |             |               |               |                  |         |       |
|                                        |the RSD of the       |           |             |               |               |                  |         |       |
|                                        |response factor      |           |             |               |               |                  |         |       |
|                                        |should NMT 10%.      |           |             |               |               |                  |         |       |
|                                        |Y-axis               |           |             |               |               |                  |         |       |
|----------------------------------------|---------------------|-----------|-------------|---------------|---------------|------------------|---------|-------|
|Linearity, range and correcti on factors|Knownimpurities at   |           |YA2304-1 8   |0.1203μg/ml to |0.1203μg/ml to |y = 14990x-3.7556 |1.1      |1.1    |
|                                        |251nm wavelength     |           |             |1.2027μg/ml    |1.2027μg/ml    |                  |         |       |
|                                        |(YA2304-12,          |           |             |(0.0301% to    |(0.0301% to    |                  |         |       |
|                                        |YA2304-14, YA2304-15,|           |             |0.3007%)       |0.3007%)       |                  |         |       |
|                                        |YA2304-16, YA2304-18 |           |             |               |               |                  |         |       |
|                                        |and YA2304-19) and   |           |             |               |               |                  |         |       |
|                                        |230nm wavelength     |           |             |               |               |                  |         |       |
|                                        |(YA2304-10,          |           |             |               |               |                  |         |       |
|                                        |YA2304-17) : Within  |           |             |               |               |                  |         |       |
|                                        |the range of limited |           |             |               |               |                  |         |       |
|                                        |quantitation         |           |             |               |               |                  |         |       |
|                                        |concentration ~      |           |             |               |               |                  |         |       |
|                                        |equivalent to 0.3% of|           |             |               |               |                  |         |       |
|                                        |the test product     |           |             |               |               |                  |         |       |
|                                        |solution             |           |             |               |               |                  |         |       |
|                                        |concentration, 6     |           |             |               |               |                  |         |       |
|                                        |concentration points |           |             |               |               |                  |         |       |
|                                        |were selected        |           |             |               |               |                  |         |       |
|                                        |fairlyevenly, and the|           |             |               |               |                  |         |       |
|                                        |concentration        |           |             |               |               |                  |         |       |
|                                        |ofeachimpurity was   |           |             |               |               |                  |         |       |
|                                        |takenas the          |           |             |               |               |                  |         |       |
|                                        |horizontal coordinate|           |             |               |               |                  |         |       |
|                                        |and the peakarea was |           |             |               |               |                  |         |       |
|                                        |takenas the vertical |           |             |               |               |                  |         |       |
|                                        |coordinate as the    |           |             |               |               |                  |         |       |
|                                        |linear regression    |           |             |               |               |                  |         |       |
|                                        |curve. The regression|           |             |               |               |                  |         |       |
|                                        |coefficientR of the  |           |             |               |               |                  |         |       |
|                                        |obtained linear graph|           |             |               |               |                  |         |       |
|                                        |should NLT 0.990, and|           |             |               |               |                  |         |       |
|                                        |the RSD of the       |           |             |               |               |                  |         |       |
|                                        |response factor      |           |             |               |               |                  |         |       |
|                                        |should NMT 10%.      |           |             |               |               |                  |         |       |
|                                        |Y-axis               |           |             |               |               |                  |         |       |
---------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 244 of 542 





Page 245
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



----------------------------------------------------------------------------------------
|YA2304-1 0|0.1218μg/ml to 1.2183μg/ml (0.0305% to 0.3046%)|y = 19735x + 192.83|/      |
|----------|-----------------------------------------------|-------------------|-------|
|YA2304-1 9|0.1202μg/ml~1.2016μg/ml (0.0300%~0.3004%)      |y = 25507x - 18.855|0.6    |
----------------------------------------------------------------------------------------






























------------------------------------------------------------------------------------------------------------------------------------------------------
|Accura cy|Unknownimpurities: The recovery rate ofunknownimpurity LOQ  |       |**Impurity/prin**|**Conditions           |**Average**|**RSD**|       |
|         |concentration sampling solution ~150% limit concentration   |       |**cipal**        |of                     |**recovery |       |       |
|         |solutionis 85%~110%, and the RSD of recovery rate NMT 10%.  |       |**component**    |labeling**             |rate**     |       |       |
|         |Knownimpurities: The recovery rate                          |       |                 |                       |           |       |       |
|---------|------------------------------------------------------------|-------|-----------------|-----------------------|-----------|-------|-------|
|Accura cy|Unknownimpurities: The recovery rate ofunknownimpurity LOQ  |       |YA2304-12        |Added                  |98.6%, n=9 |1.3%,  |1.3%,  |
|         |concentration sampling solution ~150% limit concentration   |       |                 |0.1802μg/ml~0.9008μg/m |           |n=9    |n=9    |
|         |solutionis 85%~110%, and the RSD of recovery rate NMT 10%.  |       |                 |                       |           |       |       |
|         |Knownimpurities: The recovery rate                          |       |                 |                       |           |       |       |
|---------|------------------------------------------------------------|-------|-----------------|-----------------------|-----------|-------|-------|
|Accura cy|Unknownimpurities: The recovery rate ofunknownimpurity LOQ  |       |YA2304-14        |Added                  |98.5%, n=9 |2.1%,  |2.1%,  |
|         |concentration sampling solution ~150% limit concentration   |       |                 |0.1810μg/ml~0.9048μg/ml|           |n=9    |n=9    |
|         |solutionis 85%~110%, and the RSD of recovery rate NMT 10%.  |       |                 |                       |           |       |       |
|         |Knownimpurities: The recovery rate                          |       |                 |                       |           |       |       |
------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 245 of 542 





Page 246
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 

































--------------------------------------------------------------------------
|YA2304-12|0.7%, n=6           |1.5%, n=6           |2.6%, n=12          |
|---------|--------------------|--------------------|--------------------|
|YA2304-14|0.5%, n=6           |1.4%, n=6           |2.0%, n=12          |
|---------|--------------------|--------------------|--------------------|
|YA2304-15|0.7%, n=6           |1.0%, n=6           |1.5%, n=12          |
|---------|--------------------|--------------------|--------------------|
|YA2304-16|0.9%, n=6           |1.6%, n=6           |2.6%, n=12          |
|---------|--------------------|--------------------|--------------------|
|YA2304-18|0.5%, n=6           |1.4%, n=6           |2.0%, n=12          |
|---------|--------------------|--------------------|--------------------|
|YA2304-19|1.7%, n=6           |2.1%, n=6           |1.9%, n=12          |
|---------|--------------------|--------------------|--------------------|
|YA2304-10|0.6%, n=6           |0.22%, n=6          |2.1%, n=12          |
|---------|--------------------|--------------------|--------------------|
|YA2304-17|0.4%, n=6           |1.1%, n=6           |0.9%, n=12          |
|---------|--------------------|--------------------|--------------------|
|Other    |Contentsall < 0.05%,|Content < 0.05%, not|Content < 0.05%, not|
--------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|of knownimpurity 30% limit concentration solution ~150% limit |                 |YA2304-16        |Added                  |94.2%,           |1.6%,            |1.6%,            |                 |
|concentration solutionis 85%~110%, and the RSD ofeachimpurity |                 |                 |0.1739μg/ml~0.8696μg/ml|n=9              |n=9              |n=9              |                 |
|recovery rate NMT 10%.                                        |                 |                 |                       |                 |                 |                 |                 |
|--------------------------------------------------------------|-----------------|-----------------|-----------------------|-----------------|-----------------|-----------------|-----------------|
|of knownimpurity 30% limit concentration solution ~150% limit |                 |YA2304-18        |Added                  |97.6%,           |0.7%,            |0.7%,            |                 |
|concentration solutionis 85%~110%, and the RSD ofeachimpurity |                 |                 |0.1804μg/ml~0.9020μg/ml|n=9              |n=9              |n=9              |                 |
|recovery rate NMT 10%.                                        |                 |                 |                       |                 |                 |                 |                 |
|--------------------------------------------------------------|-----------------|-----------------|-----------------------|-----------------|-----------------|-----------------|-----------------|
|of knownimpurity 30% limit concentration solution ~150% limit |                 |YA2304-19        |Added                  |96.8%,           |4%. n=9          |4%. n=9          |                 |
|concentration solutionis 85%~110%, and the RSD ofeachimpurity |                 |                 |0.1802μg/ml~0.9012μg/ml|n=9              |                 |                 |                 |
|recovery rate NMT 10%.                                        |                 |                 |                       |                 |                 |                 |                 |
|--------------------------------------------------------------|-----------------|-----------------|-----------------------|-----------------|-----------------|-----------------|-----------------|
|of knownimpurity 30% limit concentration solution ~150% limit |                 |YA2304-10        |Added                  |98.6%,           |1.7%,            |1.7%,            |                 |
|concentration solutionis 85%~110%, and the RSD ofeachimpurity |                 |                 |0.1827μg/ml~0.9137μg/ml|n=9              |n=9              |n=9              |                 |
|recovery rate NMT 10%.                                        |                 |                 |                       |                 |                 |                 |                 |
|--------------------------------------------------------------|-----------------|-----------------|-----------------------|-----------------|-----------------|-----------------|-----------------|
|of knownimpurity 30% limit concentration solution ~150% limit |                 |YA2304-17        |Added                  |98.1%,           |0.5%,            |0.5%,            |                 |
|concentration solutionis 85%~110%, and the RSD ofeachimpurity |                 |                 |0.1812μg/ml~0.9060μg/ml|n=9              |n=9              |n=9              |                 |
|recovery rate NMT 10%.                                        |                 |                 |                       |                 |                 |                 |                 |
|--------------------------------------------------------------|-----------------|-----------------|-----------------------|-----------------|-----------------|-----------------|-----------------|
|of knownimpurity 30% limit concentration solution ~150% limit |                 |YA2304           |Add                    |101.3%,          |1.9%,            |1.9%,            |                 |
|concentration solutionis 85%~110%, and the RSD ofeachimpurity |                 |                 |0.1229μg/ml~0.6147μg/ml|n=9              |n=9              |n=9              |                 |
|recovery rate NMT 10%.                                        |                 |                 |                       |                 |                 |                 |                 |
|--------------------------------------------------------------|-----------------|-----------------|-----------------------|-----------------|-----------------|-----------------|-----------------|
|Precision                                                     |Repeatability    |**Impurities**   |**Impurities**         |**Impurities**   |**Impurities**   |**Impurities**   |**Impurities**   |
|                                                              |andintermediate  |**repeatability**|**repeatability**      |**repeatability**|**repeatability**|**repeatability**|**repeatability**|
|                                                              |precision:       |**Intermediate** |**Intermediate**       |**Intermediate** |**Intermediate** |**Intermediate** |**Intermediate** |
|                                                              |The              |**precision**    |**precision**          |**precision**    |**precision**    |**precision**    |**precision**    |
|                                                              |impurity         |**Precision**    |**Precision** YA2304-12|**Precision**    |**Precision**    |**Precision**    |**Precision**    |
|                                                              |peak             |YA2304-12        |0.7%, n=6 1.5%, n=6    |YA2304-12        |YA2304-12        |YA2304-12        |YA2304-12        |
|                                                              |less             |0.7%, n=6        |2.6%, n=12 YA2304-14   |0.7%,            |0.7%,            |0.7%,            |0.7%,            |
|                                                              |than             |1.5%, n=6        |0.5%, n=6 1.4%, n=6    |n=6              |n=6              |n=6              |n=6              |
|                                                              |0.5              |2.6%,            |2.0%, n=12 YA2304-15   |1.5%,            |1.5%,            |1.5%,            |1.5%,            |
|                                                              |times            |n=12             |0.7%, n=6 1.0%, n=6    |n=6              |n=6              |n=6              |n=6              |
|                                                              |the              |YA2304-14        |1.5%, n=12 YA2304-16   |2.6%,            |2.6%,            |2.6%,            |2.6%,            |
|                                                              |main             |0.5%, n=6        |0.9%, n=6 1.6%, n=6    |n=12             |n=12             |n=12             |n=12             |
|                                                              |peakarea         |1.4%, n=6        |2.6%, n=12 YA2304-18   |YA2304-14        |YA2304-14        |YA2304-14        |YA2304-14        |
|                                                              |of the           |2.0%,            |0.5%, n=6 1.4%, n=6    |0.5%,            |0.5%,            |0.5%,            |0.5%,            |
|                                                              |control          |n=12             |2.0%, n=12 YA2304-19   |n=6              |n=6              |n=6              |n=6              |
|                                                              |solution         |YA2304-15        |1.7%, n=6 2.1%, n=6    |1.4%,            |1.4%,            |1.4%,            |1.4%,            |
|                                                              |wasignored       |0.7%, n=6        |1.9%, n=12 YA2304-10   |n=6              |n=6              |n=6              |n=6              |
|                                                              |in the           |1.0%, n=6        |0.6%, n=6 0.22%, n=6   |2.0%,            |2.0%,            |2.0%,            |2.0%,            |
|                                                              |repetitive       |1.5%,            |2.1%, n=12 YA2304-17   |n=12             |n=12             |n=12             |n=12             |
|                                                              |test             |n=12             |0.4%, n=6 1.1%, n=6    |YA2304-15        |YA2304-15        |YA2304-15        |YA2304-15        |
|                                                              |solution         |YA2304-16        |0.9%, n=12 Other       |0.7%,            |0.7%,            |0.7%,            |0.7%,            |
|                                                              |of 6             |0.9%, n=6        |Contentsall < 0.05%,   |n=6              |n=6              |n=6              |n=6              |
|                                                              |parts            |1.6%, n=6        |Content < 0.05%, not   |1.0%,            |1.0%,            |1.0%,            |1.0%,            |
|                                                              |plus             |2.6%,            |Content < 0.05%, not   |n=6              |n=6              |n=6              |n=6              |
|                                                              |limit            |n=12             |                       |1.5%,            |1.5%,            |1.5%,            |1.5%,            |
|                                                              |concentration.   |YA2304-18        |                       |n=12             |n=12             |n=12             |n=12             |
|                                                              |The RSD          |0.5%, n=6        |                       |YA2304-16        |YA2304-16        |YA2304-16        |YA2304-16        |
|                                                              |ofotherimpurities|1.4%, n=6        |                       |0.9%,            |0.9%,            |0.9%,            |0.9%,            |
|                                                              |should           |2.0%,            |                       |n=6              |n=6              |n=6              |n=6              |
|                                                              |NMT 5%,          |n=12             |                       |1.6%,            |1.6%,            |1.6%,            |1.6%,            |
|                                                              |and the          |YA2304-19        |                       |n=6              |n=6              |n=6              |n=6              |
|                                                              |RSD of           |1.7%, n=6        |                       |2.6%,            |2.6%,            |2.6%,            |2.6%,            |
|                                                              |totalimpurity    |2.1%, n=6        |                       |n=12             |n=12             |n=12             |n=12             |
|                                                              |should           |1.9%,            |                       |YA2304-18        |YA2304-18        |YA2304-18        |YA2304-18        |
|                                                              |NMT 5%.          |n=12             |                       |0.5%,            |0.5%,            |0.5%,            |0.5%,            |
|                                                              |In the           |YA2304-10        |                       |n=6              |n=6              |n=6              |n=6              |
|                                                              |results          |0.6%, n=6        |                       |1.4%,            |1.4%,            |1.4%,            |1.4%,            |
|                                                              |of 12            |0.22%,           |                       |n=6              |n=6              |n=6              |n=6              |
|                                                              |tests            |n=6 2.1%,        |                       |2.0%,            |2.0%,            |2.0%,            |2.0%,            |
|                                                              |of               |n=12             |                       |n=12             |n=12             |n=12             |n=12             |
|                                                              |repeatability    |YA2304-17        |                       |YA2304-19        |YA2304-19        |YA2304-19        |YA2304-19        |
|                                                              |andintermediate  |0.4%, n=6        |                       |1.7%,            |1.7%,            |1.7%,            |1.7%,            |
|                                                              |precision,       |1.1%, n=6        |                       |n=6              |n=6              |n=6              |n=6              |
|                                                              |the              |0.9%,            |                       |2.1%,            |2.1%,            |2.1%,            |2.1%,            |
|                                                              |RSDS             |n=12             |                       |n=6              |n=6              |n=6              |n=6              |
|                                                              |ofotherimpurities|Other            |                       |1.9%,            |1.9%,            |1.9%,            |1.9%,            |
|                                                              |thatare          |Contentsall      |                       |n=12             |n=12             |n=12             |n=12             |
|                                                              |less             |< 0.05%,         |                       |YA2304-10        |YA2304-10        |YA2304-10        |YA2304-10        |
|                                                              |than             |Content <        |                       |0.6%,            |0.6%,            |0.6%,            |0.6%,            |
|                                                              |0.5              |0.05%,           |                       |n=6              |n=6              |n=6              |n=6              |
|                                                              |times            |not              |                       |0.22%,           |0.22%,           |0.22%,           |0.22%,           |
|                                                              |of the           |Content <        |                       |n=6              |n=6              |n=6              |n=6              |
|                                                              |mainpeakarea     |0.05%,           |                       |2.1%,            |2.1%,            |2.1%,            |2.1%,            |
|                                                              |                 |not              |                       |n=12             |n=12             |n=12             |n=12             |
|                                                              |                 |                 |                       |YA2304-17        |YA2304-17        |YA2304-17        |YA2304-17        |
|                                                              |                 |                 |                       |0.4%,            |0.4%,            |0.4%,            |0.4%,            |
|                                                              |                 |                 |                       |n=6              |n=6              |n=6              |n=6              |
|                                                              |                 |                 |                       |1.1%,            |1.1%,            |1.1%,            |1.1%,            |
|                                                              |                 |                 |                       |n=6              |n=6              |n=6              |n=6              |
|                                                              |                 |                 |                       |0.9%,            |0.9%,            |0.9%,            |0.9%,            |
|                                                              |                 |                 |                       |n=12             |n=12             |n=12             |n=12             |
|                                                              |                 |                 |                       |Other            |Other            |Other            |Other            |
|                                                              |                 |                 |                       |Contentsall      |Contentsall      |Contentsall      |Contentsall      |
|                                                              |                 |                 |                       |<                |<                |<                |<                |
|                                                              |                 |                 |                       |0.05%,           |0.05%,           |0.05%,           |0.05%,           |
|                                                              |                 |                 |                       |Content          |Content          |Content          |Content          |
|                                                              |                 |                 |                       |<                |<                |<                |<                |
|                                                              |                 |                 |                       |0.05%,           |0.05%,           |0.05%,           |0.05%,           |
|                                                              |                 |                 |                       |not              |not              |not              |not              |
|                                                              |                 |                 |                       |Content          |Content          |Content          |Content          |
|                                                              |                 |                 |                       |<                |<                |<                |<                |
|                                                              |                 |                 |                       |0.05%,           |0.05%,           |0.05%,           |0.05%,           |
|                                                              |                 |                 |                       |not              |not              |not              |not              |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 246 of 542 





Page 247
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 


















----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|of the control solution should not be more than 10%, and the  |                 |Total             |0.5%,             |1.0%,             |1.6%,             |1.6%,             |                  |
|RSDS of totalimpurities should not be more than 10%.          |                 |Clutter           |n=6               |n=6               |n=12              |n=12              |                  |
|--------------------------------------------------------------|-----------------|------------------|------------------|------------------|------------------|------------------|------------------|
|Solutio nstability                                            |Each             |Control           |Control           |Control           |Control           |Control           |Control           |
|                                                              |solution         |solution:         |solution:         |solution:         |solution:         |solution:         |solution:         |
|                                                              |was              |under             |under             |under             |under             |under             |under             |
|                                                              |placed           |the               |the               |the               |the               |the               |the               |
|                                                              |at 5℃            |condition         |condition         |condition         |condition         |condition         |condition         |
|                                                              |(refrigerated)   |of                |of                |of                |of                |of                |of                |
|                                                              |fora             |5℃for             |5℃for             |5℃for             |5℃for             |5℃for             |5℃for             |
|                                                              |period           |100h,             |100h,             |100h,             |100h,             |100h,             |100h,             |
|                                                              |of               |the               |the               |the               |the               |the               |the               |
|                                                              |time.            |chromatogram      |chromatogram      |chromatogram      |chromatogram      |chromatogram      |chromatogram      |
|                                                              |During           |of the            |of the            |of the            |of the            |of the            |of the            |
|                                                              |the              |control           |control           |control           |control           |control           |control           |
|                                                              |investigation,   |solution          |solution          |solution          |solution          |solution          |solution          |
|                                                              |the              |(251nm),          |(251nm),          |(251nm),          |(251nm),          |(251nm),          |(251nm),          |
|                                                              |signal-to-noise  |the               |the               |the               |the               |the               |the               |
|                                                              |ratio            |main              |main              |main              |main              |main              |main              |
|                                                              |(S/N)            |peak              |peak              |peak              |peak              |peak              |peak              |
|                                                              |of the           |signal-to-noise   |signal-to-noise   |signal-to-noise   |signal-to-noise   |signal-to-noise   |signal-to-noise   |
|                                                              |main             |ratio             |ratio             |ratio             |ratio             |ratio             |ratio             |
|                                                              |peak             |(S/N)             |(S/N)             |(S/N)             |(S/N)             |(S/N)             |(S/N)             |
|                                                              |(251nm)          |is NLT            |is NLT            |is NLT            |is NLT            |is NLT            |is NLT            |
|                                                              |in the           |54.0              |54.0              |54.0              |54.0              |54.0              |54.0              |
|                                                              |chromatogram     |(NLT              |(NLT              |(NLT              |(NLT              |(NLT              |(NLT              |
|                                                              |of the           |20),              |20),              |20),              |20),              |20),              |20),              |
|                                                              |control          |and the           |and the           |and the           |and the           |and the           |and the           |
|                                                              |solution         |peakarea          |peakarea          |peakarea          |peakarea          |peakarea          |peakarea          |
|                                                              |should           |RSDis             |RSDis             |RSDis             |RSDis             |RSDis             |RSDis             |
|                                                              |NLT 20,          |1.7%              |1.7%              |1.7%              |1.7%              |1.7%              |1.7%              |
|                                                              |and the          |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |(NMT              |
|                                                              |RSD of           |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |
|                                                              |the              |The               |The               |The               |The               |The               |The               |
|                                                              |peakarea         |above             |above             |above             |above             |above             |above             |
|                                                              |NMT              |are in            |are in            |are in            |are in            |are in            |are in            |
|                                                              |10%;             |line              |line              |line              |line              |line              |line              |
|                                                              |The              |with              |with              |with              |with              |with              |with              |
|                                                              |peakarea         |the               |the               |the               |the               |the               |the               |
|                                                              |RSD              |verification      |verification      |verification      |verification      |verification      |verification      |
|                                                              |ofeachimpurity   |requirements,     |requirements,     |requirements,     |requirements,     |requirements,     |requirements,     |
|                                                              |in the           |indicating        |indicating        |indicating        |indicating        |indicating        |indicating        |
|                                                              |chromatogram     |that              |that              |that              |that              |that              |that              |
|                                                              |of the           |the               |the               |the               |the               |the               |the               |
|                                                              |control          |control           |control           |control           |control           |control           |control           |
|                                                              |solution         |solutionis        |solutionis        |solutionis        |solutionis        |solutionis        |solutionis        |
|                                                              |(230nm)          |stable            |stable            |stable            |stable            |stable            |stable            |
|                                                              |NMT              |within            |within            |within            |within            |within            |within            |
|                                                              |10%; In          |100hunder         |100hunder         |100hunder         |100hunder         |100hunder         |100hunder         |
|                                                              |the              |5℃.               |5℃.               |5℃.               |5℃.               |5℃.               |5℃.               |
|                                                              |chromatogram     |Reference         |Reference         |Reference         |Reference         |Reference         |Reference         |
|                                                              |of               |solution:         |solution:         |solution:         |solution:         |solution:         |solution:         |
|                                                              |system           |placed            |placed            |placed            |placed            |placed            |placed            |
|                                                              |suitability      |at                |at                |at                |at                |at                |at                |
|                                                              |solution         |5℃for             |5℃for             |5℃for             |5℃for             |5℃for             |5℃for             |
|                                                              |(251nm),         |100h,             |100h,             |100h,             |100h,             |100h,             |100h,             |
|                                                              |the              |the               |the               |the               |the               |the               |the               |
|                                                              |peakexit         |chromatogram      |chromatogram      |chromatogram      |chromatogram      |chromatogram      |chromatogram      |
|                                                              |sequence         |of the            |of the            |of the            |of the            |of the            |of the            |
|                                                              |is               |reference         |reference         |reference         |reference         |reference         |reference         |
|                                                              |YA2304-14,       |solution          |solution          |solution          |solution          |solution          |solution          |
|                                                              |YA2304,          |(230nm),          |(230nm),          |(230nm),          |(230nm),          |(230nm),          |(230nm),          |
|                                                              |YA2304-15,       |the               |the               |the               |the               |the               |the               |
|                                                              |YA2304-17,       |peakorderis       |peakorderis       |peakorderis       |peakorderis       |peakorderis       |peakorderis       |
|                                                              |YA2304-16,       |YA2304-17,        |YA2304-17,        |YA2304-17,        |YA2304-17,        |YA2304-17,        |YA2304-17,        |
|                                                              |YA2304-10,       |YA2304-10,        |YA2304-10,        |YA2304-10,        |YA2304-10,        |YA2304-10,        |YA2304-10,        |
|                                                              |YA2304-19.       |the RSD           |the RSD           |the RSD           |the RSD           |the RSD           |the RSD           |
|                                                              |The              |of the            |of the            |of the            |of the            |of the            |of the            |
|                                                              |separation       |peak-peakarea     |peak-peakarea     |peak-peakarea     |peak-peakarea     |peak-peakarea     |peak-peakarea     |
|                                                              |degree           |ofeachimpurity    |ofeachimpurity    |ofeachimpurity    |ofeachimpurity    |ofeachimpurity    |ofeachimpurity    |
|                                                              |between          |in the            |in the            |in the            |in the            |in the            |in the            |
|                                                              |YA2304           |chromatogram      |chromatogram      |chromatogram      |chromatogram      |chromatogram      |chromatogram      |
|                                                              |and              |of the            |of the            |of the            |of the            |of the            |of the            |
|                                                              |YA2304-14        |reference         |reference         |reference         |reference         |reference         |reference         |
|                                                              |and              |solutionis        |solutionis        |solutionis        |solutionis        |solutionis        |solutionis        |
|                                                              |YA2304-15        |not               |not               |not               |not               |not               |not               |
|                                                              |should           |more              |more              |more              |more              |more              |more              |
|                                                              |be NLT           |than              |than              |than              |than              |than              |than              |
|                                                              |1.5,             |0.9%              |0.9%              |0.9%              |0.9%              |0.9%              |0.9%              |
|                                                              |and the          |(the              |(the              |(the              |(the              |(the              |(the              |
|                                                              |separation       |requirementis     |requirementis     |requirementis     |requirementis     |requirementis     |requirementis     |
|                                                              |degree           |not               |not               |not               |not               |not               |not               |
|                                                              |between          |more              |more              |more              |more              |more              |more              |
|                                                              |YA2304-17        |than              |than              |than              |than              |than              |than              |
|                                                              |and              |10%);             |10%);             |10%);             |10%);             |10%);             |10%);             |
|                                                              |YA2304-16        |The               |The               |The               |The               |The               |The               |
|                                                              |andadjacent      |verification      |verification      |verification      |verification      |verification      |verification      |
|                                                              |peaks            |requirements      |requirements      |requirements      |requirements      |requirements      |requirements      |
|                                                              |should           |were              |were              |were              |were              |were              |were              |
|                                                              |be NLT           |met,              |met,              |met,              |met,              |met,              |met,              |
|                                                              |1.0; If          |indicating        |indicating        |indicating        |indicating        |indicating        |indicating        |
|                                                              |the              |that              |that              |that              |that              |that              |that              |
|                                                              |impurity         |the               |the               |the               |the               |the               |the               |
|                                                              |peak             |control           |control           |control           |control           |control           |control           |
|                                                              |less             |solution          |solution          |solution          |solution          |solution          |solution          |
|                                                              |than             |was               |was               |was               |was               |was               |was               |
|                                                              |0.5              |stable            |stable            |stable            |stable            |stable            |stable            |
|                                                              |times            |within            |within            |within            |within            |within            |within            |
|                                                              |the              |100hunder         |100hunder         |100hunder         |100hunder         |100hunder         |100hunder         |
|                                                              |main             |5℃.               |5℃.               |5℃.               |5℃.               |5℃.               |5℃.               |
|                                                              |peakarea         |System            |System            |System            |System            |System            |System            |
|                                                              |of the           |suitability       |suitability       |suitability       |suitability       |suitability       |suitability       |
|                                                              |control          |solution:         |solution:         |solution:         |solution:         |solution:         |solution:         |
|                                                              |solutionisignored|Placed            |Placed            |Placed            |Placed            |Placed            |Placed            |
|                                                              |in the           |at                |at                |at                |at                |at                |at                |
|                                                              |chromatogram     |5℃for             |5℃for             |5℃for             |5℃for             |5℃for             |5℃for             |
|                                                              |of the           |100h,             |100h,             |100h,             |100h,             |100h,             |100h,             |
|                                                              |test             |the               |the               |the               |the               |the               |the               |
|                                                              |product          |chromatogram      |chromatogram      |chromatogram      |chromatogram      |chromatogram      |chromatogram      |
|                                                              |solution         |of                |of                |of                |of                |of                |of                |
|                                                              |and the          |system            |system            |system            |system            |system            |system            |
|                                                              |limited          |suitability       |suitability       |suitability       |suitability       |suitability       |suitability       |
|                                                              |concentration    |solution          |solution          |solution          |solution          |solution          |solution          |
|                                                              |of               |(251nm),          |(251nm),          |(251nm),          |(251nm),          |(251nm),          |(251nm),          |
|                                                              |                 |the               |the               |the               |the               |the               |the               |
|                                                              |                 |peakorderis       |peakorderis       |peakorderis       |peakorderis       |peakorderis       |peakorderis       |
|                                                              |                 |YA2304-14,        |YA2304-14,        |YA2304-14,        |YA2304-14,        |YA2304-14,        |YA2304-14,        |
|                                                              |                 |YA2304,           |YA2304,           |YA2304,           |YA2304,           |YA2304,           |YA2304,           |
|                                                              |                 |YA2304-15,        |YA2304-15,        |YA2304-15,        |YA2304-15,        |YA2304-15,        |YA2304-15,        |
|                                                              |                 |YA2304-17,        |YA2304-17,        |YA2304-17,        |YA2304-17,        |YA2304-17,        |YA2304-17,        |
|                                                              |                 |YA2304-16,        |YA2304-16,        |YA2304-16,        |YA2304-16,        |YA2304-16,        |YA2304-16,        |
|                                                              |                 |YA2304-10,        |YA2304-10,        |YA2304-10,        |YA2304-10,        |YA2304-10,        |YA2304-10,        |
|                                                              |                 |YA2304-19,        |YA2304-19,        |YA2304-19,        |YA2304-19,        |YA2304-19,        |YA2304-19,        |
|                                                              |                 |The               |The               |The               |The               |The               |The               |
|                                                              |                 |minimum           |minimum           |minimum           |minimum           |minimum           |minimum           |
|                                                              |                 |separation        |separation        |separation        |separation        |separation        |separation        |
|                                                              |                 |degree            |degree            |degree            |degree            |degree            |degree            |
|                                                              |                 |between           |between           |between           |between           |between           |between           |
|                                                              |                 |YA2304            |YA2304            |YA2304            |YA2304            |YA2304            |YA2304            |
|                                                              |                 |and               |and               |and               |and               |and               |and               |
|                                                              |                 |YA2304-14         |YA2304-14         |YA2304-14         |YA2304-14         |YA2304-14         |YA2304-14         |
|                                                              |                 |and               |and               |and               |and               |and               |and               |
|                                                              |                 |YA2304-15         |YA2304-15         |YA2304-15         |YA2304-15         |YA2304-15         |YA2304-15         |
|                                                              |                 |is NLT            |is NLT            |is NLT            |is NLT            |is NLT            |is NLT            |
|                                                              |                 |5.8               |5.8               |5.8               |5.8               |5.8               |5.8               |
|                                                              |                 |(NLT              |(NLT              |(NLT              |(NLT              |(NLT              |(NLT              |
|                                                              |                 |1.5               |1.5               |1.5               |1.5               |1.5               |1.5               |
|                                                              |                 |required),        |required),        |required),        |required),        |required),        |required),        |
|                                                              |                 |and the           |and the           |and the           |and the           |and the           |and the           |
|                                                              |                 |minimum           |minimum           |minimum           |minimum           |minimum           |minimum           |
|                                                              |                 |separation        |separation        |separation        |separation        |separation        |separation        |
|                                                              |                 |degree            |degree            |degree            |degree            |degree            |degree            |
|                                                              |                 |between           |between           |between           |between           |between           |between           |
|                                                              |                 |YA2304-17         |YA2304-17         |YA2304-17         |YA2304-17         |YA2304-17         |YA2304-17         |
|                                                              |                 |and               |and               |and               |and               |and               |and               |
|                                                              |                 |YA2304-16         |YA2304-16         |YA2304-16         |YA2304-16         |YA2304-16         |YA2304-16         |
|                                                              |                 |andadjacent       |andadjacent       |andadjacent       |andadjacent       |andadjacent       |andadjacent       |
|                                                              |                 |peaksis           |peaksis           |peaksis           |peaksis           |peaksis           |peaksis           |
|                                                              |                 |NLT 1.6           |NLT 1.6           |NLT 1.6           |NLT 1.6           |NLT 1.6           |NLT 1.6           |
|                                                              |                 |(NLT              |(NLT              |(NLT              |(NLT              |(NLT              |(NLT              |
|                                                              |                 |1.0               |1.0               |1.0               |1.0               |1.0               |1.0               |
|                                                              |                 |required);        |required);        |required);        |required);        |required);        |required);        |
|                                                              |                 |All of            |All of            |All of            |All of            |All of            |All of            |
|                                                              |                 |the               |the               |the               |the               |the               |the               |
|                                                              |                 |above             |above             |above             |above             |above             |above             |
|                                                              |                 |meet              |meet              |meet              |meet              |meet              |meet              |
|                                                              |                 |the               |the               |the               |the               |the               |the               |
|                                                              |                 |verification      |verification      |verification      |verification      |verification      |verification      |
|                                                              |                 |requirements,     |requirements,     |requirements,     |requirements,     |requirements,     |requirements,     |
|                                                              |                 |indicating        |indicating        |indicating        |indicating        |indicating        |indicating        |
|                                                              |                 |that              |that              |that              |that              |that              |that              |
|                                                              |                 |the               |the               |the               |the               |the               |the               |
|                                                              |                 |system            |system            |system            |system            |system            |system            |
|                                                              |                 |suitable          |suitable          |suitable          |suitable          |suitable          |suitable          |
|                                                              |                 |solutionis        |solutionis        |solutionis        |solutionis        |solutionis        |solutionis        |
|                                                              |                 |stable            |stable            |stable            |stable            |stable            |stable            |
|                                                              |                 |within            |within            |within            |within            |within            |within            |
|                                                              |                 |100hunder         |100hunder         |100hunder         |100hunder         |100hunder         |100hunder         |
|                                                              |                 |5℃.               |5℃.               |5℃.               |5℃.               |5℃.               |5℃.               |
|                                                              |                 |Test              |Test              |Test              |Test              |Test              |Test              |
|                                                              |                 |solution:         |solution:         |solution:         |solution:         |solution:         |solution:         |
|                                                              |                 |After             |After             |After             |After             |After             |After             |
|                                                              |                 |being             |being             |being             |being             |being             |being             |
|                                                              |                 |placed            |placed            |placed            |placed            |placed            |placed            |
|                                                              |                 |at                |at                |at                |at                |at                |at                |
|                                                              |                 |5℃for             |5℃for             |5℃for             |5℃for             |5℃for             |5℃for             |
|                                                              |                 |100h,             |100h,             |100h,             |100h,             |100h,             |100h,             |
|                                                              |                 |impurity          |impurity          |impurity          |impurity          |impurity          |impurity          |
|                                                              |                 |peaks             |peaks             |peaks             |peaks             |peaks             |peaks             |
|                                                              |                 |smaller           |smaller           |smaller           |smaller           |smaller           |smaller           |
|                                                              |                 |than              |than              |than              |than              |than              |than              |
|                                                              |                 |0.5               |0.5               |0.5               |0.5               |0.5               |0.5               |
|                                                              |                 |times             |times             |times             |times             |times             |times             |
|                                                              |                 |the               |the               |the               |the               |the               |the               |
|                                                              |                 |main              |main              |main              |main              |main              |main              |
|                                                              |                 |peak-peakarea     |peak-peakarea     |peak-peakarea     |peak-peakarea     |peak-peakarea     |peak-peakarea     |
|                                                              |                 |of                |of                |of                |of                |of                |of                |
|                                                              |                 |control           |control           |control           |control           |control           |control           |
|                                                              |                 |solution          |solution          |solution          |solution          |solution          |solution          |
|                                                              |                 |were              |were              |were              |were              |were              |were              |
|                                                              |                 |ignored           |ignored           |ignored           |ignored           |ignored           |ignored           |
|                                                              |                 |in the            |in the            |in the            |in the            |in the            |in the            |
|                                                              |                 |chromatogram      |chromatogram      |chromatogram      |chromatogram      |chromatogram      |chromatogram      |
|                                                              |                 |of test           |of test           |of test           |of test           |of test           |of test           |
|                                                              |                 |solution.         |solution.         |solution.         |solution.         |solution.         |solution.         |
|                                                              |                 |Knownimpurities   |Knownimpurities   |Knownimpurities   |Knownimpurities   |Knownimpurities   |Knownimpurities   |
|                                                              |                 |were              |were              |were              |were              |were              |were              |
|                                                              |                 |detectedexcept    |detectedexcept    |detectedexcept    |detectedexcept    |detectedexcept    |detectedexcept    |
|                                                              |                 |YA2304-12         |YA2304-12         |YA2304-12         |YA2304-12         |YA2304-12         |YA2304-12         |
|                                                              |                 |and               |and               |and               |and               |and               |and               |
|                                                              |                 |YA2304-19,        |YA2304-19,        |YA2304-19,        |YA2304-19,        |YA2304-19,        |YA2304-19,        |
|                                                              |                 |both of           |both of           |both of           |both of           |both of           |both of           |
|                                                              |                 |which             |which             |which             |which             |which             |which             |
|                                                              |                 |were              |were              |were              |were              |were              |were              |
|                                                              |                 |less              |less              |less              |less              |less              |less              |
|                                                              |                 |than              |than              |than              |than              |than              |than              |
|                                                              |                 |0.05%,            |0.05%,            |0.05%,            |0.05%,            |0.05%,            |0.05%,            |
|                                                              |                 |andotherimpurities|andotherimpurities|andotherimpurities|andotherimpurities|andotherimpurities|andotherimpurities|
|                                                              |                 |were              |were              |were              |were              |were              |were              |
|                                                              |                 |not               |not               |not               |not               |not               |not               |
|                                                              |                 |detected.         |detected.         |detected.         |detected.         |detected.         |detected.         |
|                                                              |                 |Other             |Other             |Other             |Other             |Other             |Other             |
|                                                              |                 |single            |single            |single            |single            |single            |single            |
|                                                              |                 |unknownimpurities |unknownimpurities |unknownimpurities |unknownimpurities |unknownimpurities |unknownimpurities |
|                                                              |                 |were              |were              |were              |were              |were              |were              |
|                                                              |                 |all               |all               |all               |all               |all               |all               |
|                                                              |                 |less              |less              |less              |less              |less              |less              |
|                                                              |                 |than              |than              |than              |than              |than              |than              |
|                                                              |                 |0.05%,            |0.05%,            |0.05%,            |0.05%,            |0.05%,            |0.05%,            |
|                                                              |                 |the RSD           |the RSD           |the RSD           |the RSD           |the RSD           |the RSD           |
|                                                              |                 |ofeachimpurity    |ofeachimpurity    |ofeachimpurity    |ofeachimpurity    |ofeachimpurity    |ofeachimpurity    |
|                                                              |                 |peakarea          |peakarea          |peakarea          |peakarea          |peakarea          |peakarea          |
|                                                              |                 |was not           |was not           |was not           |was not           |was not           |was not           |
|                                                              |                 |counted           |counted           |counted           |counted           |counted           |counted           |
|                                                              |                 |(not              |(not              |(not              |(not              |(not              |(not              |
|                                                              |                 |more              |more              |more              |more              |more              |more              |
|                                                              |                 |than              |than              |than              |than              |than              |than              |
|                                                              |                 |10%),             |10%),             |10%),             |10%),             |10%),             |10%),             |
|                                                              |                 |and no            |and no            |and no            |and no            |and no            |and no            |
|                                                              |                 |newimpurities     |newimpurities     |newimpurities     |newimpurities     |newimpurities     |newimpurities     |
|                                                              |                 |were              |were              |were              |were              |were              |were              |
|                                                              |                 |added             |added             |added             |added             |added             |added             |
|                                                              |                 |to                |to                |to                |to                |to                |to                |
|                                                              |                 |interfere         |interfere         |interfere         |interfere         |interfere         |interfere         |
|                                                              |                 |with              |with              |with              |with              |with              |with              |
|                                                              |                 |the               |the               |the               |the               |the               |the               |
|                                                              |                 |detection         |detection         |detection         |detection         |detection         |detection         |
|                                                              |                 |of                |of                |of                |of                |of                |of                |
|                                                              |                 |related           |related           |related           |related           |related           |related           |
|                                                              |                 |substances.       |substances.       |substances.       |substances.       |substances.       |substances.       |
|                                                              |                 |The               |The               |The               |The               |The               |The               |
|                                                              |                 |above             |above             |above             |above             |above             |above             |
|                                                              |                 |are in            |are in            |are in            |are in            |are in            |are in            |
|                                                              |                 |line              |line              |line              |line              |line              |line              |
|                                                              |                 |with              |with              |with              |with              |with              |with              |
|                                                              |                 |the               |the               |the               |the               |the               |the               |
|                                                              |                 |verification      |verification      |verification      |verification      |verification      |verification      |
|                                                              |                 |requirements,     |requirements,     |requirements,     |requirements,     |requirements,     |requirements,     |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 247 of 542 





Page 248
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 












--------------------------------------------------------------------------------------------------------------------------------------
|Durability|Under the condition of single factor change column temperature, flow rate, initial gradient of     |Column               |
|          |mobile phase, column lot number and normal chromatographic conditions, the chromatogramobtained by |temperature          |
|          |system suitability solutionundereach condition (251nm) is required. The peakorderis YA2304-14,     |20℃±2℃,              |
|          |YA2304, YA2304-15, YA2304-17, YA2304-16, YA2304-10, YA2304-19, and the separation degree between   |mobile               |
|          |YA2304 and YA2304-14 and YA2304-15 should NLT 1.5. The separation degree between                   |phase                |
|          |                                                                                                   |ratio                |
|          |                                                                                                   |(85:15)              |
|          |                                                                                                   |±2,                  |
|          |                                                                                                   |flow                 |
|          |                                                                                                   |rate                 |
|          |                                                                                                   |1.0ml/min±0.05ml/min,|
|          |                                                                                                   |different            |
|          |                                                                                                   |batches              |
|          |                                                                                                   |of                   |
|          |                                                                                                   |chromatographic      |
|          |                                                                                                   |columns              |
|          |                                                                                                   |were                 |
|          |                                                                                                   |investigatedas       |
|          |                                                                                                   |follows:             |
|          |                                                                                                   |Systemapplicability: |
|          |                                                                                                   |Reference            |
|          |                                                                                                   |solution             |
|          |                                                                                                   |chromatogram         |
|          |                                                                                                   |(230nm),             |
|          |                                                                                                   |the                  |
|          |                                                                                                   |peak                 |
|          |                                                                                                   |sequence             |
|          |                                                                                                   |was                  |
|          |                                                                                                   |YA2304-17,           |
|          |                                                                                                   |YA2304-10;           |
|          |                                                                                                   |In the               |
|          |                                                                                                   |chromatogram         |
|          |                                                                                                   |of                   |
|          |                                                                                                   |system               |
|          |                                                                                                   |suitability          |
|          |                                                                                                   |solution             |
|          |                                                                                                   |(251nm),             |
|          |                                                                                                   |the                  |
|          |                                                                                                   |peakexit             |
|          |                                                                                                   |sequence             |
|          |                                                                                                   |was                  |
|          |                                                                                                   |YA2304-14,           |
|          |                                                                                                   |YA2304,              |
|          |                                                                                                   |YA2304-15,           |
|          |                                                                                                   |YA2304-17,           |
|          |                                                                                                   |unknownimpurities,   |
|          |                                                                                                   |YA2304-16,           |
|          |                                                                                                   |YA2304-10,           |
|          |                                                                                                   |YA2304-19,           |
|          |                                                                                                   |The                  |
|          |                                                                                                   |minimum              |
|          |                                                                                                   |separation           |
|          |                                                                                                   |degree               |
|          |                                                                                                   |between              |
|          |                                                                                                   |YA2304               |
|          |                                                                                                   |and                  |
|          |                                                                                                   |YA2304-14            |
|          |                                                                                                   |and                  |
|          |                                                                                                   |YA2304-15            |
|          |                                                                                                   |is NLT               |
|          |                                                                                                   |5.6                  |
|          |                                                                                                   |(NLT                 |
|          |                                                                                                   |1.5                  |
|          |                                                                                                   |required),           |
|          |                                                                                                   |and the              |
|          |                                                                                                   |minimum              |
|          |                                                                                                   |separation           |
|          |                                                                                                   |degree               |
|          |                                                                                                   |between              |
|          |                                                                                                   |YA2304-17            |
|          |                                                                                                   |and                  |
|          |                                                                                                   |YA2304-16            |
|          |                                                                                                   |andadjacent          |
|          |                                                                                                   |peaksis              |
|          |                                                                                                   |1.2                  |
|          |                                                                                                   |(NLT                 |
|          |                                                                                                   |1.0                  |
|          |                                                                                                   |required);           |
|          |                                                                                                   |In the               |
|          |                                                                                                   |contrast             |
|          |                                                                                                   |solution             |
|          |                                                                                                   |chromatogram         |
|          |                                                                                                   |(251nm),             |
|          |                                                                                                   |the                  |
|          |                                                                                                   |signal-to-noise      |
|          |                                                                                                   |ratio                |
|          |                                                                                                   |of the               |
|          |                                                                                                   |main                 |
|          |                                                                                                   |peak                 |
|          |                                                                                                   |was NLT              |
|          |                                                                                                   |67.2                 |
|          |                                                                                                   |(NLT                 |
|          |                                                                                                   |20),                 |
|          |                                                                                                   |and the              |
|          |                                                                                                   |systemapplicability  |
|          |                                                                                                   |met the              |
|          |                                                                                                   |verification         |
|          |                                                                                                   |requirements.        |
|          |                                                                                                   |Sample               |
|          |                                                                                                   |solution:            |
|          |                                                                                                   |the RSD              |
|          |                                                                                                   |ofimpurity           |
|          |                                                                                                   |YA2304-12            |
|          |                                                                                                   |is no                |
|          |                                                                                                   |more                 |
|          |                                                                                                   |than                 |
|          |                                                                                                   |2.4%                 |
|          |                                                                                                   |(the                 |
--------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 248 of 542 





Page 249
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 




YA2304-17 and YA2304-16 and adjacent 



peaks should NLT 1.0; In the 



chromatogram of the control product 



solution (230nm), the peak sequence 



was YA2304-17, YA2304-10; In the 



control solution chromatogram (251nm), 



the signal-to-noise ratio (S/N) of the 



main peak should NLT 20. 



Under different conditions of the 



same chromatographic parameters, the 



RSDS of each impurity content greater 



than 0.05% in the test product NMT 



10%, and the RSDS of total impurity 



content NMT 10%; Or the absolute 



deviation of the impurity content NMT 



20% of the limit value, the absolute 



deviation of the total impurity content 



NMT 40% of the limit value. 




requirement is no more than 10%); RSD of YA2304-14 shall NMT 2.3% (NMT 10%); RSD of 



YA2304-15 content shall NMT 2.2% (NMT 10%); RSD of YA2304-16 content shall NMT 6% 



(NMT 10%); RSD of YA2304-18 content shall NMT 5% (NMT 10%); RSD of YA2304-19 



content shall NMT 2.3% (NMT 10%); RSD of YA2304-17 content should NMT 1.9% (NMT 



10%); RSD of YA2304-10 content should NMT 2.1% (NMT 10%); The contents of unknown 



impurity RRT≈0.64 and unknown impurity RRT≈1.26 are less than 0.05, and RSD is not 



used for statistics. All of them met the verification conditions. 




Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 249 of 542 





Page 250
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.4.3.2 Methodological verification of relevant substances II of** 


**finished products** 



**I. Analytical Procedures** 



Please refer to the analytical procedures of related substances in Finerenone 



in _section 3.2.S.4.2_ . 



**II. Validation Results and Discussion** 



**a. Wavelength selection** 



 **Acceptance Criteria** 



The detection wavelength is selected by ultraviolet scanning of the principal 



component at 200nm ~ 400nm wavelength, requiring all impurities 



(YA2304-52, imidazole and 4-dimethylaminopyridine) to have greater 



absorption at 210nm wavelength. 



 **Solution preparation** 



Solvent: acetonitrile: water (50:50) 



Blank solution: solvent. 



YA2304-52 reference product reserve liquid (about 100μg/ml) : accurately 



weigh YA2304-52 reference product about 5mg, place it in a 50ml bottle, add 



an appropriate amount of solvent to dissolve by ultrasound, dilute it with 



solvent to the scale, shake well, and obtain. 



Imidazole reference liquid (about 100μg/ml) : accurately weigh imidazole 



reference liquid (about 5mg), place it in a 50ml measuring bottle, add 



appropriate amount of solvent and ultrasonic to dissolve it, dilute it with 



solvent to the scale, shake well, and then obtain. 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 250 of 542 





Page 251
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



4-dimethylaminopyridine (DMAP) reference product reserve liquid (about 



100μg/ml) : precision weigh 4-dimethylaminopyridine reference product 



about 5mg, put in a 50ml bottle, add the appropriate amount of solvent 



ultrasonic to dissolve, dilute with solvent to the scale, shake well, ready. 



Reference product solution: precisely measure YA2304-52 reference product 



reserve liquid, imidazole reference product reserve liquid and 



4-dimethylaminopyridine reference product reserve liquid 1ml, put in the 



same 20ml bottle, dilute with solvent to the scale, shake well, ready. (About 



5μg/ml for each) 



 **Injection procedure** 



After the chromatographic system balance, take the blank solution and the 



reference solution each injection 1 needle, record the chromatogram. 



 **Measurement results** 



test results of detection wavelength selection 


















--------------------------------------------------------------
|Reference solution                |YA2304-52|6.392  |is     |
|----------------------------------|---------|-------|-------|
|Reference solution                |Imidazole|7.362  |is     |
|----------------------------------|---------|-------|-------|
|Reference solution                |DMAP     |16.667 |is     |
|----------------------------------|---------|-------|-------|
|Reference solution wavelength scan|         |       |       |
--------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 251 of 542 





Page 252
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Conclusion: All impurities (YA2304-52, imidazole and 4-dimethylaminopyridine) have 



great absorption at 210nm wavelength. 



**(4.2) System applicability** 



 **Acceptance Criteria** 



The blank solution should be free of interference; The control solution should 



be injected for 6 consecutive times, and the peak order should be YA2304-52, 



imidazole and 4-dimethylaminopyridine. The separation degree between 



imidazole peak and YA2304-52 peak should be NLT 1.5, the retention time 



RSD of each impurity peak should be no more than 1.0%, and the RSD of the 



peak area of each impurity peak should be no more than 5%. 



 **Solution preparation** 



Blank solution: solvent. 



YA2304-52 Reference storage solution (approx. 100μg/ml) : Share 



YA2304-52 reference storage solution under "4.1 wavelength selection". 



Imidazole reference product reserve (approx. 100μg/ml) : Imidazole reference 



product reserve under "4.1 wavelength selection". 



4-dimethylaminopyridine (DMAP) reference storage solution (about 



100μg/ml) : 4-dimethylaminopyridine (DMAP) storage solution under "4.1 



wavelength selection". 



Reference product solution: according to "4.1 wavelength selection" under 



the reference product solution prepared by the same method. (Each about 



5μg/ml) 



 **Injection procedure** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 252 of 542 





Page 253
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



After the chromatographic system was balanced, the blank solution was 



injected with 1 needle, the control solution was injected with 6 needles again, 



and the chromatogram was recorded. 



 **Measurement results** 



Results of system suitability test 



































































----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Investigation parameters                              |Investigation           |1                       |2                       |3                       |4                       |5                       |6                       |6                       |
|                                                      |parameters              |                        |                        |                        |                        |                        |                        |                        |
|------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|YA230 4-52                                            |RT (min)                |6.348                   |6.354                   |6.361                   |6.357                   |6.347                   |6.347                   |0.10%                   |
|------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|YA230 4-52                                            |Peakarea                |24168                   |24307                   |23941                   |24129                   |23890                   |24107                   |0.7%                    |
|------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|Imidazole                                             |RT (min)                |7.389                   |7.388                   |7.390                   |7.390                   |7.386                   |7.384                   |0.04%                   |
|------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|Imidazole                                             |Peakarea                |41795 3                 |41800 4                 |41776 4                 |41971 1                 |41871 1                 |41875 6                 |0.18%                   |
|------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|DMAP                                                  |RT (min)                |16.764                  |16.764                  |16.771                  |16.774                  |16.771                  |16.767                  |0.025 %                 |
|------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|DMAP                                                  |Peakarea                |45883 2                 |45868 8                 |45820 8                 |45761 9                 |46089 2                 |46086 8                 |0.4%                    |
|------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|Degree of separation betweenimidazole peak and        |Degree of               |1.9                     |1.9                     |1.9                     |1.9                     |1.9                     |1.9                     |/                       |
|YA2304-52 peak                                        |separation              |                        |                        |                        |                        |                        |                        |                        |
|                                                      |betweenimidazole        |                        |                        |                        |                        |                        |                        |                        |
|                                                      |peak and                |                        |                        |                        |                        |                        |                        |                        |
|                                                      |YA2304-52               |                        |                        |                        |                        |                        |                        |                        |
|                                                      |peak                    |                        |                        |                        |                        |                        |                        |                        |
|------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|Conclusion: The blank solution has no interference;   |Conclusion: The         |Conclusion:             |Conclusion:             |Conclusion:             |Conclusion:             |Conclusion:             |Conclusion:             |Conclusion:             |
|The control solution wasinjected for 6 consecutive    |blank solution          |The                     |The                     |The                     |The                     |The                     |The                     |The                     |
|times, and the peakorder was YA2304-52, imidazole and |has no                  |blank                   |blank                   |blank                   |blank                   |blank                   |blank                   |blank                   |
|4-dimethylaminopyridine. The separation degree        |interference;           |solution                |solution                |solution                |solution                |solution                |solution                |solution                |
|betweenimidazole peak and YA2304-52 peak was 1.9 (NLT |The control             |has no                  |has no                  |has no                  |has no                  |has no                  |has no                  |has no                  |
|1.5), and the retention time RSD ofeachimpurity peak  |solution                |interference;           |interference;           |interference;           |interference;           |interference;           |interference;           |interference;           |
|was no more than 0.10% (NMT 1.0%). The RSD of the     |wasinjected for         |The                     |The                     |The                     |The                     |The                     |The                     |The                     |
|peakarea ofeachimpurity peak was no more than 0.7%    |6 consecutive           |control                 |control                 |control                 |control                 |control                 |control                 |control                 |
|(NMT 5%); All the above meet the verification         |times, and the          |solution                |solution                |solution                |solution                |solution                |solution                |solution                |
|requirements, indicating that the method has good     |peakorder was           |wasinjected             |wasinjected             |wasinjected             |wasinjected             |wasinjected             |wasinjected             |wasinjected             |
|systemapplicability.                                  |YA2304-52,              |for 6                   |for 6                   |for 6                   |for 6                   |for 6                   |for 6                   |for 6                   |
|                                                      |imidazole and           |consecutive             |consecutive             |consecutive             |consecutive             |consecutive             |consecutive             |consecutive             |
|                                                      |4-dimethylaminopyridine.|times,                  |times,                  |times,                  |times,                  |times,                  |times,                  |times,                  |
|                                                      |The separation          |and the                 |and the                 |and the                 |and the                 |and the                 |and the                 |and the                 |
|                                                      |degree                  |peakorder               |peakorder               |peakorder               |peakorder               |peakorder               |peakorder               |peakorder               |
|                                                      |betweenimidazole        |was                     |was                     |was                     |was                     |was                     |was                     |was                     |
|                                                      |peak and                |YA2304-52,              |YA2304-52,              |YA2304-52,              |YA2304-52,              |YA2304-52,              |YA2304-52,              |YA2304-52,              |
|                                                      |YA2304-52 peak          |imidazole               |imidazole               |imidazole               |imidazole               |imidazole               |imidazole               |imidazole               |
|                                                      |was 1.9 (NLT            |and                     |and                     |and                     |and                     |and                     |and                     |and                     |
|                                                      |1.5), and the           |4-dimethylaminopyridine.|4-dimethylaminopyridine.|4-dimethylaminopyridine.|4-dimethylaminopyridine.|4-dimethylaminopyridine.|4-dimethylaminopyridine.|4-dimethylaminopyridine.|
|                                                      |retention time          |The                     |The                     |The                     |The                     |The                     |The                     |The                     |
|                                                      |RSD                     |separation              |separation              |separation              |separation              |separation              |separation              |separation              |
|                                                      |ofeachimpurity          |degree                  |degree                  |degree                  |degree                  |degree                  |degree                  |degree                  |
|                                                      |peak was no more        |betweenimidazole        |betweenimidazole        |betweenimidazole        |betweenimidazole        |betweenimidazole        |betweenimidazole        |betweenimidazole        |
|                                                      |than 0.10% (NMT         |peak                    |peak                    |peak                    |peak                    |peak                    |peak                    |peak                    |
|                                                      |1.0%). The RSD          |and                     |and                     |and                     |and                     |and                     |and                     |and                     |
|                                                      |of the peakarea         |YA2304-52               |YA2304-52               |YA2304-52               |YA2304-52               |YA2304-52               |YA2304-52               |YA2304-52               |
|                                                      |ofeachimpurity          |peak                    |peak                    |peak                    |peak                    |peak                    |peak                    |peak                    |
|                                                      |peak was no more        |was 1.9                 |was 1.9                 |was 1.9                 |was 1.9                 |was 1.9                 |was 1.9                 |was 1.9                 |
|                                                      |than 0.7% (NMT          |(NLT                    |(NLT                    |(NLT                    |(NLT                    |(NLT                    |(NLT                    |(NLT                    |
|                                                      |5%); All the            |1.5),                   |1.5),                   |1.5),                   |1.5),                   |1.5),                   |1.5),                   |1.5),                   |
|                                                      |above meet the          |and the                 |and the                 |and the                 |and the                 |and the                 |and the                 |and the                 |
|                                                      |verification            |retention               |retention               |retention               |retention               |retention               |retention               |retention               |
|                                                      |requirements,           |time                    |time                    |time                    |time                    |time                    |time                    |time                    |
|                                                      |indicating that         |RSD                     |RSD                     |RSD                     |RSD                     |RSD                     |RSD                     |RSD                     |
|                                                      |the method has          |ofeachimpurity          |ofeachimpurity          |ofeachimpurity          |ofeachimpurity          |ofeachimpurity          |ofeachimpurity          |ofeachimpurity          |
|                                                      |good                    |peak                    |peak                    |peak                    |peak                    |peak                    |peak                    |peak                    |
|                                                      |systemapplicability.    |was no                  |was no                  |was no                  |was no                  |was no                  |was no                  |was no                  |
|                                                      |                        |more                    |more                    |more                    |more                    |more                    |more                    |more                    |
|                                                      |                        |than                    |than                    |than                    |than                    |than                    |than                    |than                    |
|                                                      |                        |0.10%                   |0.10%                   |0.10%                   |0.10%                   |0.10%                   |0.10%                   |0.10%                   |
|                                                      |                        |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |
|                                                      |                        |1.0%).                  |1.0%).                  |1.0%).                  |1.0%).                  |1.0%).                  |1.0%).                  |1.0%).                  |
|                                                      |                        |The RSD                 |The RSD                 |The RSD                 |The RSD                 |The RSD                 |The RSD                 |The RSD                 |
|                                                      |                        |of the                  |of the                  |of the                  |of the                  |of the                  |of the                  |of the                  |
|                                                      |                        |peakarea                |peakarea                |peakarea                |peakarea                |peakarea                |peakarea                |peakarea                |
|                                                      |                        |ofeachimpurity          |ofeachimpurity          |ofeachimpurity          |ofeachimpurity          |ofeachimpurity          |ofeachimpurity          |ofeachimpurity          |
|                                                      |                        |peak                    |peak                    |peak                    |peak                    |peak                    |peak                    |peak                    |
|                                                      |                        |was no                  |was no                  |was no                  |was no                  |was no                  |was no                  |was no                  |
|                                                      |                        |more                    |more                    |more                    |more                    |more                    |more                    |more                    |
|                                                      |                        |than                    |than                    |than                    |than                    |than                    |than                    |than                    |
|                                                      |                        |0.7%                    |0.7%                    |0.7%                    |0.7%                    |0.7%                    |0.7%                    |0.7%                    |
|                                                      |                        |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |
|                                                      |                        |5%);                    |5%);                    |5%);                    |5%);                    |5%);                    |5%);                    |5%);                    |
|                                                      |                        |All the                 |All the                 |All the                 |All the                 |All the                 |All the                 |All the                 |
|                                                      |                        |above                   |above                   |above                   |above                   |above                   |above                   |above                   |
|                                                      |                        |meet                    |meet                    |meet                    |meet                    |meet                    |meet                    |meet                    |
|                                                      |                        |the                     |the                     |the                     |the                     |the                     |the                     |the                     |
|                                                      |                        |verification            |verification            |verification            |verification            |verification            |verification            |verification            |
|                                                      |                        |requirements,           |requirements,           |requirements,           |requirements,           |requirements,           |requirements,           |requirements,           |
|                                                      |                        |indicating              |indicating              |indicating              |indicating              |indicating              |indicating              |indicating              |
|                                                      |                        |that                    |that                    |that                    |that                    |that                    |that                    |that                    |
|                                                      |                        |the                     |the                     |the                     |the                     |the                     |the                     |the                     |
|                                                      |                        |method                  |method                  |method                  |method                  |method                  |method                  |method                  |
|                                                      |                        |has                     |has                     |has                     |has                     |has                     |has                     |has                     |
|                                                      |                        |good                    |good                    |good                    |good                    |good                    |good                    |good                    |
|                                                      |                        |systemapplicability.    |systemapplicability.    |systemapplicability.    |systemapplicability.    |systemapplicability.    |systemapplicability.    |systemapplicability.    |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**(4.3) Specificity** 



 **Acceptance Criteria** 



The blank solution should be free of interference; In the chromatogram 



obtained from the control solution, the peak order is YA2304-52, imidazole, 



4-dimethylaminopyridine, and the separation degree between the imidazole 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 253 of 542 





Page 254
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



peak and YA2304-52 peak should NLT 1.5. The retention time of each 



impurity peak in the control solution, the test solution and the specific mixed 



solution should be consistent with the retention time of the main peak in the 



impurity localization solution. The separation degree between the imidazole 



peak and YA2304-52 peak in the specific mixed solution should be NLT 1.5. 



All impurities studied under the related substances of the finished product 



(including YA2304-10, YA2304-12, YA2304-14, YA2304-15, YA2304-16, 



YA2304-17, YA2304-18 and YA2304-19) shall not interfere with YA2304-52, 



imidazole and imidazole in the tested product 4-dimethylaminopyridine test. 



 **Solution preparation** 



Blank solution: solvent. 



YA2304-52 Reference storage solution (approx. 100μg/ml) : Share 



YA2304-52 reference storage solution under "4.1 wavelength selection". 



Imidazole reference product reserve (approx. 100μg/ml) : Imidazole reference 



product reserve under "4.1 wavelength selection". 



4-dimethylaminopyridine (DMAP) reference reserve liquid (about 100μg/ml) : 



Share 4-dimethylaminopyridine (DMAP) reserve liquid under "4.1 wavelength 



selection". 



YA2304-10 reference product reserve liquid (about 200μg/ml) : accurately 



weigh YA2304-10 reference product about 5mg, put it in 25ml measuring 



bottle, add appropriate amount of solvent to dissolve by ultrasound, dilute it 



with solvent to the scale, shake well, and then obtain. 



YA2304-12 reference product reserve (about 200μg/ml) : precision weigh 



YA2304-12 reference product about 5mg, place in 25ml measuring bottle, 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 254 of 542 





Page 255
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



add appropriate amount of solvent and ultrasonic to dissolve, dilute with 



solvent to the scale, shake well, ready. 



YA2304-14 reference product reserve liquid (about 200μg/ml) : precisely 



weigh YA2304-14 reference product about 5mg, place it in 25ml measuring 



bottle, add acetonitrile to dissolve by ultrasound, dilute it with acetonitrile to 



the scale, shake well, and then obtain. 



YA2304-15 reference product reserve liquid (about 200μg/ml) : precisely 



weigh YA2304-15 reference product about 5mg, place it in 25ml measuring 



bottle, add appropriate amount of acetonitrile to dissolve, dilute it with 



acetonitrile to the scale, shake well, and then obtain. 



YA2304-16 reference product reserve liquid (about 200μg/ml) : Accurately 



weigh about 5mg of YA2304-16 reference product, place it in a 25ml bottle, 



add acetonitrile to dissolve by ultrasound, dilute it with acetonitrile to the 



scale, shake well, and obtain. 



YA2304-17 reference product reserve liquid (about 200μg/ml) : precisely 



weigh YA2304-17 reference product about 5mg, place it in 25ml measuring 



bottle, add appropriate amount of solvent to dissolve by ultrasound, dilute it 



with solvent to the scale, shake well, and then obtain. 



YA2304-18 reference product reserve liquid (about 200μg/ml) : precisely 



weigh YA2304-18 reference product about 5mg, place it in 25ml measuring 



bottle, add acetonitrile to dissolve by ultrasound, dilute it with acetonitrile to 



the scale, shake well, and then obtain. 



YA2304-19 reference product reserve liquid (about 200μg/ml) : precisely 



weigh YA2304-19 reference product about 5mg, place it in 25ml measuring 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 255 of 542 





Page 256
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



bottle, add appropriate amount of acetonitrile to dissolve, dilute it with 



acetonitrile to the scale, shake well, and then obtain. 



Reference solution: Share the reference solution under "4.2 System 



Suitability". (Approx. 5μg/ml each) 



YA2304-52 positioning solution: Accurately measure 1ml of YA2304-52 



reference product reserve, place it in a 20ml measuring bottle, dilute it with 



solvent to the scale, shake well, and then obtain. (About 5μg/ml) 



Imidazole positioning solution: accurately measure 1ml of imidazole 



reference product reserve liquid, place it in 20ml measuring bottle, dilute it 



with solvent to the scale, shake well, and then obtain. (About 5μg/ml) 



4-dimethylaminopyridine (DMAP) positioning solution: accurately measure 



4-dimethylaminopyridine (DMAP) reference product reserve liquid 1ml, 



placed in 20ml measuring bottle, diluted with solvent to scale, shake well, 



ready. (About 5μg/ml) 



YA2304-10 positioning solution: Accurately measure 1ml of YA2304-10 



reference product reserve, place it in a 25ml measuring bottle, dilute it with 



solvent to the scale, shake well, and then obtain. (About 8μg/ml) 



YA2304-12 positioning solution: accurately measure 1ml of YA2304-12 



reference product reserve, place it in a 25ml measuring bottle, dilute it with 



solvent to the scale, shake well, and then obtain. (About 8μg/ml) 



YA2304-14 positioning solution: accurately measure 1ml of YA2304-14 



reference product reserve, place it in a 25ml measuring bottle, dilute it with 



solvent to the scale, shake well, and then obtain. (About 8μg/ml) 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 256 of 542 





Page 257
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



YA2304-15 positioning solution: accurately measure 1ml of YA2304-15 



reference product reserve liquid, place it in a 25ml measuring bottle, dilute it 



with solvent to the scale, shake well, and then obtain. (About 8μg/ml) 



YA2304-16 positioning solution: accurately measure 1ml of YA2304-16 



reference product reserve, place it in a 25ml measuring bottle, dilute it with 



solvent to the scale, shake well, and then obtain. (About 8μg/ml) 



YA2304-17 Positioning solution: Accurately measure 1ml of YA2304-17 



reference product reserve, place it in a 25ml measuring bottle, dilute it with 



solvent to the scale, shake well, and then obtain. (About 8μg/ml) 



YA2304-18 positioning solution: Accurately measure 1ml of YA2304-18 



reference product reserve, place it in a 25ml measuring bottle, dilute it with 



solvent to the scale, shake well, and then obtain. (About 8μg/ml) 



YA2304-19 positioning solution: Accurately measure 1ml of YA2304-19 



reference product reserve, place it in a 25ml measuring bottle, dilute it with 



solvent to the scale, shake well, and then obtain. (About 8μg/ml) 



Test product solution: Take YA2304 about 100mg, accurately weigh it, place 



it in a 20ml measuring bottle, add an appropriate amount of solvent and 



ultrasonic to dissolve it, dilute it with solvent to the scale, shake well, and get 



it. (About 5mg/ml) 



Specific mixed solution: Take YA2304 test product about 100mg, weigh it 



accurately, place it in a 20ml bottle, add an appropriate amount of solvent to 



dissolve by ultrasound, then add YA2304-52 reference product reserve, 



imidazole reference product reserve and 4-dimethylaminopyridine reference 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 257 of 542 





Page 258
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



product reserve 1ml each, dilute it with solvent to the scale, shake well, and 



obtain. (Finerenone about 5mg/ml, each impurity about 5μg/ml) 



 **Injection procedure** 



After the chromatographic system balance, take blank solution, reference 



solution, test solution, specific mixed solution and each impurity location 



solution into 1 needle, record the chromatogram. (The chromatogram was 



obtained by sharing the test solution under the item "4.8 solution stability" 



for 2h; The control product solution shared the atlas obtained from the test 



product solution under "4.8 solution stability" for 16h) 



 **Measurement results** 



























------------------------------------------------------------------
|Blank solution                |/        |/      |/      |no     |
|------------------------------|---------|-------|-------|-------|
|YA2304-10 Positioning solution|YA2304-10|8.9522 |19.424 |no     |
|------------------------------|---------|-------|-------|-------|
|YA2304-12 Positioning solution|YA2304-12|8.4174 |19.649 |no     |
|------------------------------|---------|-------|-------|-------|
|YA2304-14 Positioning solution|YA2304-14|8.1736 |21.933 |no     |
|------------------------------|---------|-------|-------|-------|
|YA2304-15 Positioning solution|YA2304-15|7.9170 |24.256 |no     |
|------------------------------|---------|-------|-------|-------|
|YA2304-16 Positioning solution|YA2304-16|7.5335 |23.470 |no     |
|------------------------------|---------|-------|-------|-------|
|YA2304-17 Positioning solution|YA2304-17|8.6177 |11.377 |no     |
|------------------------------|---------|-------|-------|-------|
|YA2304-18 Positioning solution|YA2304-18|8.1525 |25.279 |no     |
|------------------------------|---------|-------|-------|-------|
|YA2304-19 Positioning solution|YA2304-19|7.8582 |20.263 |no     |
|------------------------------|---------|-------|-------|-------|
|YA2304-52 Positioning solution|YA2304-52|5.2991 |6.354  |/      |
------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 258 of 542 





Page 259
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 




















































--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|DMAP positioning solution                                                             |DMAP                    |5.1695                  |16.747                  |/                       |
|--------------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|
|Solution name                                                                         |Substance               |Concentration           |RT                      |Degree                  |
|                                                                                      |name                    |(μg/ml)                 |(min)                   |of                      |
|                                                                                      |                        |                        |                        |separation              |
|                                                                                      |                        |                        |                        |from                    |
|                                                                                      |                        |                        |                        |the                     |
|                                                                                      |                        |                        |                        |previous                |
|                                                                                      |                        |                        |                        |peak                    |
|--------------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|
|Reference solution                                                                    |YA2304-52               |5.2991                  |6.332                   |/                       |
|--------------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|
|Reference solution                                                                    |Imidazole               |5.1637                  |7.380                   |1.9                     |
|--------------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|
|Reference solution                                                                    |DMAP                    |5.1695                  |16.750                  |14.9                    |
|--------------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|
|Solution for the test product                                                         |YA2304-52               |/                       |/                       |/                       |
|--------------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|
|Solution for the test product                                                         |Imidazole               |/                       |/                       |/                       |
|--------------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|
|Solution for the test product                                                         |DMAP                    |/                       |/                       |/                       |
|--------------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|
|Solution for the test product                                                         |YA2304                  |5014.600 0              |Peakoverload,           |/                       |
|                                                                                      |                        |                        |uncredited              |                        |
|--------------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|
|Specific mixed solution                                                               |YA2304-52               |5.2991                  |6.354                   |/                       |
|--------------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|
|Specific mixed solution                                                               |Imidazole               |5.1637                  |7.386                   |1.9                     |
|--------------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|
|Specific mixed solution                                                               |DMAP                    |5.1695                  |16.756                  |15.0                    |
|--------------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|
|Specific mixed solution                                                               |YA2304                  |5017.350 0              |Peakoverload,           |/                       |
|                                                                                      |                        |                        |uncredited              |                        |
|--------------------------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|
|Conclusion: the blank solution has no interference; In the chromatogramobtained from  |Conclusion:             |Conclusion:             |Conclusion:             |Conclusion:             |
|the control solution, the sequence of peaks was YA2304-52, imidazole,                 |the blank               |the blank               |the blank               |the blank               |
|4-dimethylaminopyridine, and the separation degree betweenimidazole peaks and         |solution                |solution has            |solution has            |solution                |
|YA2304-52 peaks was 1.9 (required to be NLT 1.5). The retention time ofeachimpurity   |has no                  |no                      |no                      |has no                  |
|peak in the control solution, the test solution and the specific mixed solution was   |interference;           |interference;           |interference;           |interference;           |
|consistent with that of the main peak in the impurity positioning solution. The       |In the                  |In the                  |In the                  |In the                  |
|separation degree between the imidazole peak and YA2304-52 peak in the specific mixed |chromatogramobtained    |chromatogramobtained    |chromatogramobtained    |chromatogramobtained    |
|solution was 1.9 (NLT 1.5); The impurities studiedunder the related substances of     |from the                |from the                |from the                |from the                |
|finished products (including YA2304-10, YA2304-12, YA2304-14, YA2304-15, YA2304-16,   |control                 |control                 |control                 |control                 |
|YA2304-17, YA2304-18 and YA2304-19) did notinterfere with YA2304-52, imidazole and 4- |solution,               |solution, the           |solution, the           |solution,               |
|in the test product Detection of dimethylaminopyridine.                               |the                     |sequence of             |sequence of             |the                     |
|                                                                                      |sequence                |peaks was               |peaks was               |sequence                |
|                                                                                      |of peaks                |YA2304-52,              |YA2304-52,              |of peaks                |
|                                                                                      |was                     |imidazole,              |imidazole,              |was                     |
|                                                                                      |YA2304-52,              |4-dimethylaminopyridine,|4-dimethylaminopyridine,|YA2304-52,              |
|                                                                                      |imidazole,              |and the                 |and the                 |imidazole,              |
|                                                                                      |4-dimethylaminopyridine,|separation              |separation              |4-dimethylaminopyridine,|
|                                                                                      |and the                 |degree                  |degree                  |and the                 |
|                                                                                      |separation              |betweenimidazole        |betweenimidazole        |separation              |
|                                                                                      |degree                  |peaks and               |peaks and               |degree                  |
|                                                                                      |betweenimidazole        |YA2304-52               |YA2304-52               |betweenimidazole        |
|                                                                                      |peaks and               |peaks was 1.9           |peaks was 1.9           |peaks and               |
|                                                                                      |YA2304-52               |(required to            |(required to            |YA2304-52               |
|                                                                                      |peaks was               |be NLT 1.5).            |be NLT 1.5).            |peaks was               |
|                                                                                      |1.9                     |The retention           |The retention           |1.9                     |
|                                                                                      |(required               |time                    |time                    |(required               |
|                                                                                      |to be NLT               |ofeachimpurity          |ofeachimpurity          |to be NLT               |
|                                                                                      |1.5). The               |peak in the             |peak in the             |1.5). The               |
|                                                                                      |retention               |control                 |control                 |retention               |
|                                                                                      |time                    |solution, the           |solution, the           |time                    |
|                                                                                      |ofeachimpurity          |test solution           |test solution           |ofeachimpurity          |
|                                                                                      |peak in                 |and the                 |and the                 |peak in                 |
|                                                                                      |the                     |specific                |specific                |the                     |
|                                                                                      |control                 |mixed                   |mixed                   |control                 |
|                                                                                      |solution,               |solution was            |solution was            |solution,               |
|                                                                                      |the test                |consistent              |consistent              |the test                |
|                                                                                      |solution                |with that of            |with that of            |solution                |
|                                                                                      |and the                 |the main peak           |the main peak           |and the                 |
|                                                                                      |specific                |in the                  |in the                  |specific                |
|                                                                                      |mixed                   |impurity                |impurity                |mixed                   |
|                                                                                      |solution                |positioning             |positioning             |solution                |
|                                                                                      |was                     |solution. The           |solution. The           |was                     |
|                                                                                      |consistent              |separation              |separation              |consistent              |
|                                                                                      |with that               |degree                  |degree                  |with that               |
|                                                                                      |of the                  |between the             |between the             |of the                  |
|                                                                                      |main peak               |imidazole               |imidazole               |main peak               |
|                                                                                      |in the                  |peak and                |peak and                |in the                  |
|                                                                                      |impurity                |YA2304-52               |YA2304-52               |impurity                |
|                                                                                      |positioning             |peak in the             |peak in the             |positioning             |
|                                                                                      |solution.               |specific                |specific                |solution.               |
|                                                                                      |The                     |mixed                   |mixed                   |The                     |
|                                                                                      |separation              |solution was            |solution was            |separation              |
|                                                                                      |degree                  |1.9 (NLT                |1.9 (NLT                |degree                  |
|                                                                                      |between                 |1.5); The               |1.5); The               |between                 |
|                                                                                      |the                     |impurities              |impurities              |the                     |
|                                                                                      |imidazole               |studiedunder            |studiedunder            |imidazole               |
|                                                                                      |peak and                |the related             |the related             |peak and                |
|                                                                                      |YA2304-52               |substances of           |substances of           |YA2304-52               |
|                                                                                      |peak in                 |finished                |finished                |peak in                 |
|                                                                                      |the                     |products                |products                |the                     |
|                                                                                      |specific                |(including              |(including              |specific                |
|                                                                                      |mixed                   |YA2304-10,              |YA2304-10,              |mixed                   |
|                                                                                      |solution                |YA2304-12,              |YA2304-12,              |solution                |
|                                                                                      |was 1.9                 |YA2304-14,              |YA2304-14,              |was 1.9                 |
|                                                                                      |(NLT                    |YA2304-15,              |YA2304-15,              |(NLT 1.5);              |
|                                                                                      |1.5); The               |YA2304-16,              |YA2304-16,              |The                     |
|                                                                                      |impurities              |YA2304-17,              |YA2304-17,              |impurities              |
|                                                                                      |studiedunder            |YA2304-18 and           |YA2304-18 and           |studiedunder            |
|                                                                                      |the                     |YA2304-19)              |YA2304-19)              |the                     |
|                                                                                      |related                 |did                     |did                     |related                 |
|                                                                                      |substances              |notinterfere            |notinterfere            |substances              |
|                                                                                      |of                      |with                    |with                    |of                      |
|                                                                                      |finished                |YA2304-52,              |YA2304-52,              |finished                |
|                                                                                      |products                |imidazole and           |imidazole and           |products                |
|                                                                                      |(including              |4- in the               |4- in the               |(including              |
|                                                                                      |YA2304-10,              |test product            |test product            |YA2304-10,              |
|                                                                                      |YA2304-12,              |Detection of            |Detection of            |YA2304-12,              |
|                                                                                      |YA2304-14,              |dimethylaminopyridine.  |dimethylaminopyridine.  |YA2304-14,              |
|                                                                                      |YA2304-15,              |                        |                        |YA2304-15,              |
|                                                                                      |YA2304-16,              |                        |                        |YA2304-16,              |
|                                                                                      |YA2304-17,              |                        |                        |YA2304-17,              |
|                                                                                      |YA2304-18               |                        |                        |YA2304-18               |
|                                                                                      |and                     |                        |                        |and                     |
|                                                                                      |YA2304-19)              |                        |                        |YA2304-19)              |
|                                                                                      |did                     |                        |                        |did                     |
|                                                                                      |notinterfere            |                        |                        |notinterfere            |
|                                                                                      |with                    |                        |                        |with                    |
|                                                                                      |YA2304-52,              |                        |                        |YA2304-52,              |
|                                                                                      |imidazole               |                        |                        |imidazole               |
|                                                                                      |and 4- in               |                        |                        |and 4- in               |
|                                                                                      |the test                |                        |                        |the test                |
|                                                                                      |product                 |                        |                        |product                 |
|                                                                                      |Detection               |                        |                        |Detection               |
|                                                                                      |of                      |                        |                        |of                      |
|                                                                                      |dimethylaminopyridine.  |                        |                        |dimethylaminopyridine.  |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**(4.4) Limits of quantification and detection** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 259 of 542 





Page 260
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



 **Acceptance Criteria** 



The S/N of each impurity in the 6 limited quantification solution maps 



should NLT 10, the RSD of the peak retention time of each impurity should 



not be more than 2.0%, and the RSD of the peak area should not be more 



than 10%. The S/N of each impurity in the 3-needle detection limited 



solution atlas should NLT 3. 



 **Solution preparation** 



Blank solution: solvent. 



YA2304-52 Reference storage solution (approx. 100μg/ml) : Share 



YA2304-52 reference storage solution under "4.1 wavelength selection". 



Imidazole reference product reserve (approx. 100μg/ml) : Imidazole reference 



product reserve under "4.1 wavelength selection". 



4-dimethylaminopyridine (DMAP) reference reserve liquid (about 100μg/ml) : 



Share 4-dimethylaminopyridine (DMAP) reserve liquid under "4.1 wavelength 



selection". 



Quantitative limited reserve liquid: accurately measure imidazole reference 



product reserve liquid 400μl and 4-dimethylaminopyridine (DMAP) reference 



product reserve liquid 300μl, put in the same 20ml bottle, dilute with solvent 



to the scale, shake well, it is obtained. 



Limited quantitative solution: precisely measure YA2304-52 reference 



product reserve liquid 250μl and limit quantitative reserve liquid 1ml, place 



in the same 20ml measuring bottle, dilute with solvent to scale, shake well, 



ready. Prepare 6 parts in parallel. 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 260 of 542 





Page 261
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Detection limit solution: accurately remove the first limit of quantification 



solution 3ml, place it in a 10ml measuring bottle, dilute it with solvent to the 



scale, shake well, and then get. 



 **Injection procedure** 



After the chromatographic system was balanced, the blank solution and the 



parallel preparation of 6 parts of the limited quantitative solution were 



injected with 1 needle each, the detection of the limited solution was repeated 



with 3 needles, and the chromatogram was recorded. 



 **Measurement results** 



Results of limit of quantitation test 






























------------------------------------------------------------------------------------------------------------------------
|YA2304 -52|Limited quantitative solution①  |1.3248                          |0.03%            |6.337  |5472   |24.0   |
|----------|--------------------------------|--------------------------------|-----------------|-------|-------|-------|
|YA2304 -52|Limited quantification solution②|Limited quantification solution②|Limited          |6.348  |5344   |23.5   |
|          |                                |                                |quantification   |       |       |       |
|          |                                |                                |solution②        |       |       |       |
|----------|--------------------------------|--------------------------------|-----------------|-------|-------|-------|
|YA2304 -52|Limited quantification solution③|Limited quantification solution③|Limited          |6.352  |5352   |34.9   |
|          |                                |                                |quantification   |       |       |       |
|          |                                |                                |solution③        |       |       |       |
|----------|--------------------------------|--------------------------------|-----------------|-------|-------|-------|
|YA2304 -52|Limited quantification solution④|Limited quantification solution④|Limited          |6.340  |5391   |26.9   |
|          |                                |                                |quantification   |       |       |       |
|          |                                |                                |solution④        |       |       |       |
|----------|--------------------------------|--------------------------------|-----------------|-------|-------|-------|
|YA2304 -52|Limited quantification solution⑤|Limited quantification solution⑤|Limited          |6.355  |5307   |27.5   |
|          |                                |                                |quantification   |       |       |       |
|          |                                |                                |solution⑤        |       |       |       |
|----------|--------------------------------|--------------------------------|-----------------|-------|-------|-------|
|YA2304 -52|Limited quantification solution⑥|Limited quantification solution⑥|Limited          |6.337  |5087   |27.8   |
|          |                                |                                |quantification   |       |       |       |
|          |                                |                                |solution⑥        |       |       |       |
------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 261 of 542 





Page 262
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 




























-----------------------------------------------------------------------------------------------------------------------------------------------------------------
|Conclusion: The limited quantification concentration of YA2304-52 was |Conclusion:   |Conclusion:   |Conclusion:   |Conclusion:   |Conclusion:   |             |
|1.3248μg/ml, which wasequivalent to 0.03% of the solution             |The           |The           |The           |The           |The           |             |
|concentration of the tested product. The signal to noise ratio (S/N)  |limited       |limited       |limited       |limited       |limited       |             |
|of YA2304-52 peaks in the 6 limited quantification solutions were all |quantification|quantification|quantification|quantification|quantification|             |
|in the range of 23.5~34.9 (the requirement should be greater than 10).|concentration |concentration |concentration |concentration |concentration |             |
|The RSD of retention time was 0.13% (no more than 2.0% required), and |of            |of            |of            |of            |of            |             |
|the RSD of peakarea was 2.5% (no more than 10% required); All of the  |YA2304-52     |YA2304-52     |YA2304-52     |YA2304-52     |YA2304-52     |             |
|above meet the verification requirements.                             |was           |was           |was           |was           |was           |             |
|                                                                      |1.3248μg/ml,  |1.3248μg/ml,  |1.3248μg/ml,  |1.3248μg/ml,  |1.3248μg/ml,  |             |
|                                                                      |which         |which         |which         |which         |which         |             |
|                                                                      |wasequivalent |wasequivalent |wasequivalent |wasequivalent |wasequivalent |             |
|                                                                      |to            |to            |to            |to            |to            |             |
|                                                                      |0.03%         |0.03%         |0.03%         |0.03%         |0.03%         |             |
|                                                                      |of the        |of the        |of the        |of the        |of the        |             |
|                                                                      |solution      |solution      |solution      |solution      |solution      |             |
|                                                                      |concentration |concentration |concentration |concentration |concentration |             |
|                                                                      |of the        |of the        |of the        |of the        |of the        |             |
|                                                                      |tested        |tested        |tested        |tested        |tested        |             |
|                                                                      |product.      |product.      |product.      |product.      |product.      |             |
|                                                                      |The           |The           |The           |The           |The           |             |
|                                                                      |signal        |signal        |signal        |signal        |signal        |             |
|                                                                      |to            |to            |to            |to            |to            |             |
|                                                                      |noise         |noise         |noise         |noise         |noise         |             |
|                                                                      |ratio         |ratio         |ratio         |ratio         |ratio         |             |
|                                                                      |(S/N)         |(S/N)         |(S/N)         |(S/N)         |(S/N)         |             |
|                                                                      |of            |of            |of            |of            |of            |             |
|                                                                      |YA2304-52     |YA2304-52     |YA2304-52     |YA2304-52     |YA2304-52     |             |
|                                                                      |peaks         |peaks         |peaks         |peaks         |peaks         |             |
|                                                                      |in the        |in the        |in the        |in the        |in the        |             |
|                                                                      |6             |6             |6             |6             |6             |             |
|                                                                      |limited       |limited       |limited       |limited       |limited       |             |
|                                                                      |quantification|quantification|quantification|quantification|quantification|             |
|                                                                      |solutions     |solutions     |solutions     |solutions     |solutions     |             |
|                                                                      |were          |were          |were          |were          |were          |             |
|                                                                      |all in        |all in        |all in        |all in        |all in        |             |
|                                                                      |the           |the           |the           |the           |the           |             |
|                                                                      |range         |range         |range         |range         |range         |             |
|                                                                      |of            |of            |of            |of            |of            |             |
|                                                                      |23.5~34.9     |23.5~34.9     |23.5~34.9     |23.5~34.9     |23.5~34.9     |             |
|                                                                      |(the          |(the          |(the          |(the          |(the          |             |
|                                                                      |requirement   |requirement   |requirement   |requirement   |requirement   |             |
|                                                                      |should        |should        |should        |should        |should        |             |
|                                                                      |be            |be            |be            |be            |be            |             |
|                                                                      |greater       |greater       |greater       |greater       |greater       |             |
|                                                                      |than          |than          |than          |than          |than          |             |
|                                                                      |10).          |10).          |10).          |10).          |10).          |             |
|                                                                      |The RSD       |The RSD       |The RSD       |The RSD       |The RSD       |             |
|                                                                      |of            |of            |of            |of            |of            |             |
|                                                                      |retention     |retention     |retention     |retention     |retention     |             |
|                                                                      |time          |time          |time          |time          |time          |             |
|                                                                      |was           |was           |was           |was           |was           |             |
|                                                                      |0.13%         |0.13%         |0.13%         |0.13%         |0.13%         |             |
|                                                                      |(no           |(no           |(no           |(no           |(no           |             |
|                                                                      |more          |more          |more          |more          |more          |             |
|                                                                      |than          |than          |than          |than          |than          |             |
|                                                                      |2.0%          |2.0%          |2.0%          |2.0%          |2.0%          |             |
|                                                                      |required),    |required),    |required),    |required),    |required),    |             |
|                                                                      |and the       |and the       |and the       |and the       |and the       |             |
|                                                                      |RSD of        |RSD of        |RSD of        |RSD of        |RSD of        |             |
|                                                                      |peakarea      |peakarea      |peakarea      |peakarea      |peakarea      |             |
|                                                                      |was           |was           |was           |was           |was           |             |
|                                                                      |2.5%          |2.5%          |2.5%          |2.5%          |2.5%          |             |
|                                                                      |(no           |(no           |(no           |(no           |(no           |             |
|                                                                      |more          |more          |more          |more          |more          |             |
|                                                                      |than          |than          |than          |than          |than          |             |
|                                                                      |10%           |10%           |10%           |10%           |10%           |             |
|                                                                      |required);    |required);    |required);    |required);    |required);    |             |
|                                                                      |All of        |All of        |All of        |All of        |All of        |             |
|                                                                      |the           |the           |the           |the           |the           |             |
|                                                                      |above         |above         |above         |above         |above         |             |
|                                                                      |meet          |meet          |meet          |meet          |meet          |             |
|                                                                      |the           |the           |the           |the           |the           |             |
|                                                                      |verification  |verification  |verification  |verification  |verification  |             |
|                                                                      |requirements. |requirements. |requirements. |requirements. |requirements. |             |
|----------------------------------------------------------------------|--------------|--------------|--------------|--------------|--------------|-------------|
|Imidazo le                                                            |Limited       |0.1033        |0.002%        |7.384         |8362          |39.4         |
|                                                                      |quantitative  |              |              |              |              |             |
|                                                                      |solution①     |              |              |              |              |             |
|----------------------------------------------------------------------|--------------|--------------|--------------|--------------|--------------|-------------|
|Imidazo le                                                            |Limited       |Limited       |Limited       |7.383         |8180          |39.3         |
|                                                                      |quantification|quantification|quantification|              |              |             |
|                                                                      |solution②     |solution②     |solution②     |              |              |             |
|----------------------------------------------------------------------|--------------|--------------|--------------|--------------|--------------|-------------|
|Imidazo le                                                            |Limited       |Limited       |Limited       |7.385         |8001          |56.5         |
|                                                                      |quantification|quantification|quantification|              |              |             |
|                                                                      |solution③     |solution③     |solution③     |              |              |             |
|----------------------------------------------------------------------|--------------|--------------|--------------|--------------|--------------|-------------|
|Imidazo le                                                            |Limited       |Limited       |Limited       |7.378         |8414          |46.0         |
|                                                                      |quantification|quantification|quantification|              |              |             |
|                                                                      |solution④     |solution④     |solution④     |              |              |             |
|----------------------------------------------------------------------|--------------|--------------|--------------|--------------|--------------|-------------|
|Imidazo le                                                            |Limited       |Limited       |Limited       |7.390         |8005          |44.2         |
|                                                                      |quantification|quantification|quantification|              |              |             |
|                                                                      |solution⑤     |solution⑤     |solution⑤     |              |              |             |
|----------------------------------------------------------------------|--------------|--------------|--------------|--------------|--------------|-------------|
|Imidazo le                                                            |Limited       |Limited       |Limited       |7.389         |7675          |45.4         |
|                                                                      |quantification|quantification|quantification|              |              |             |
|                                                                      |solution⑥     |solution⑥     |solution⑥     |              |              |             |
|----------------------------------------------------------------------|--------------|--------------|--------------|--------------|--------------|-------------|
|Imidazo le                                                            |RSD           |RSD           |RSD           |0.06%         |4%            |/            |
|----------------------------------------------------------------------|--------------|--------------|--------------|--------------|--------------|-------------|
|Imidazo le                                                            |Verdict: The  |Verdict: The  |Verdict: The  |Verdict: The  |Verdict: The  |Verdict:     |
|                                                                      |limit of      |limit of      |limit of      |limit of      |limit of      |The          |
|                                                                      |quantization  |quantization  |quantization  |quantization  |quantization  |limit        |
|                                                                      |ofimidazole   |ofimidazole   |ofimidazole   |ofimidazole   |ofimidazole   |of           |
|                                                                      |was           |was           |was           |was           |was           |quantization |
|                                                                      |0.1033μg/ml,  |0.1033μg/ml,  |0.1033μg/ml,  |0.1033μg/ml,  |0.1033μg/ml,  |ofimidazole  |
|                                                                      |which         |which         |which         |which         |which         |was          |
|                                                                      |wasequivalent |wasequivalent |wasequivalent |wasequivalent |wasequivalent |0.1033μg/ml, |
|                                                                      |to 0.002% of  |to 0.002% of  |to 0.002% of  |to 0.002% of  |to 0.002% of  |which        |
|                                                                      |the           |the           |the           |the           |the           |wasequivalent|
|                                                                      |concentration |concentration |concentration |concentration |concentration |to           |
|                                                                      |of the tested |of the tested |of the tested |of the tested |of the tested |0.002%       |
|                                                                      |solution. The |solution. The |solution. The |solution. The |solution. The |of the       |
|                                                                      |signal to     |signal to     |signal to     |signal to     |signal to     |concentration|
|                                                                      |noise ratio   |noise ratio   |noise ratio   |noise ratio   |noise ratio   |of the       |
|                                                                      |(S/N) of the  |(S/N) of the  |(S/N) of the  |(S/N) of the  |(S/N) of the  |tested       |
|                                                                      |imidazole peak|imidazole peak|imidazole peak|imidazole peak|imidazole peak|solution.    |
|                                                                      |in the 6      |in the 6      |in the 6      |in the 6      |in the 6      |The          |
|                                                                      |limited       |limited       |limited       |limited       |limited       |signal       |
|                                                                      |quantization  |quantization  |quantization  |quantization  |quantization  |to           |
|                                                                      |solutions were|solutions were|solutions were|solutions were|solutions were|noise        |
|                                                                      |all in the    |all in the    |all in the    |all in the    |all in the    |ratio        |
|                                                                      |range of      |range of      |range of      |range of      |range of      |(S/N)        |
|                                                                      |39.3~56.5 (the|39.3~56.5 (the|39.3~56.5 (the|39.3~56.5 (the|39.3~56.5 (the|of the       |
|                                                                      |requirement   |requirement   |requirement   |requirement   |requirement   |imidazole    |
|                                                                      |should be     |should be     |should be     |should be     |should be     |peak in      |
|                                                                      |greater than  |greater than  |greater than  |greater than  |greater than  |the 6        |
|                                                                      |10), and the  |10), and the  |10), and the  |10), and the  |10), and the  |limited      |
|                                                                      |RSD of the    |RSD of the    |RSD of the    |RSD of the    |RSD of the    |quantization |
|                                                                      |retention time|retention time|retention time|retention time|retention time|solutions    |
|                                                                      |was 0.06% (the|was 0.06% (the|was 0.06% (the|was 0.06% (the|was 0.06% (the|were         |
|                                                                      |requirement   |requirement   |requirement   |requirement   |requirement   |all in       |
|                                                                      |should NMT    |should NMT    |should NMT    |should NMT    |should NMT    |the          |
|                                                                      |2.0%). The RSD|2.0%). The RSD|2.0%). The RSD|2.0%). The RSD|2.0%). The RSD|range        |
|                                                                      |of the        |of the        |of the        |of the        |of the        |of           |
|                                                                      |peakarea was  |peakarea was  |peakarea was  |peakarea was  |peakarea was  |39.3~56.5    |
|                                                                      |4% (NMT 10%); |4% (NMT 10%); |4% (NMT 10%); |4% (NMT 10%); |4% (NMT 10%); |(the         |
|                                                                      |All of the    |All of the    |All of the    |All of the    |All of the    |requirement  |
|                                                                      |above meet the|above meet the|above meet the|above meet the|above meet the|should       |
|                                                                      |verification  |verification  |verification  |verification  |verification  |be           |
|                                                                      |requirements. |requirements. |requirements. |requirements. |requirements. |greater      |
|                                                                      |              |              |              |              |              |than         |
|                                                                      |              |              |              |              |              |10),         |
|                                                                      |              |              |              |              |              |and the      |
|                                                                      |              |              |              |              |              |RSD of       |
|                                                                      |              |              |              |              |              |the          |
|                                                                      |              |              |              |              |              |retention    |
|                                                                      |              |              |              |              |              |time         |
|                                                                      |              |              |              |              |              |was          |
|                                                                      |              |              |              |              |              |0.06%        |
|                                                                      |              |              |              |              |              |(the         |
|                                                                      |              |              |              |              |              |requirement  |
|                                                                      |              |              |              |              |              |should       |
|                                                                      |              |              |              |              |              |NMT          |
|                                                                      |              |              |              |              |              |2.0%).       |
|                                                                      |              |              |              |              |              |The RSD      |
|                                                                      |              |              |              |              |              |of the       |
|                                                                      |              |              |              |              |              |peakarea     |
|                                                                      |              |              |              |              |              |was 4%       |
|                                                                      |              |              |              |              |              |(NMT         |
|                                                                      |              |              |              |              |              |10%);        |
|                                                                      |              |              |              |              |              |All of       |
|                                                                      |              |              |              |              |              |the          |
|                                                                      |              |              |              |              |              |above        |
|                                                                      |              |              |              |              |              |meet         |
|                                                                      |              |              |              |              |              |the          |
|                                                                      |              |              |              |              |              |verification |
|                                                                      |              |              |              |              |              |requirements.|
|----------------------------------------------------------------------|--------------|--------------|--------------|--------------|--------------|-------------|
|DMAP                                                                  |Limited       |0.0775        |0.002%        |16.749        |6368          |22.3         |
|                                                                      |quantification|              |              |              |              |             |
|                                                                      |solution①     |              |              |              |              |             |
|----------------------------------------------------------------------|--------------|--------------|--------------|--------------|--------------|-------------|
|DMAP                                                                  |Limited       |Limited       |Limited       |16.822        |7206          |22.4         |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 262 of 542 





Page 263
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 










-----------------------------------------------------------------------------------
|       |quantification solution②|                |       |       |       |       |
|       |                        |                |       |       |       |       |
|       |                        |                |       |       |       |       |
|       |------------------------|                |       |-------|-------|-------|
|       |Limited quantification solution③         |       |16.765 |6718   |32.8   |
|       |-----------------------------------------|       |-------|-------|-------|
|       |Limited quantification solution④         |       |16.789 |7661   |27.4   |
|       |-----------------------------------------|       |-------|-------|-------|
|       |Limited quantification solution⑤         |       |16.784 |7547   |28.0   |
|       |-----------------------------------------|       |-------|-------|-------|
|       |Limited quantitation solution⑥           |       |16.767 |6117   |23.6   |
|       |-----------------------------------------|       |-------|-------|-------|
|       |RSD                                              |0.16%  |10%    |/      |
-----------------------------------------------------------------------------------

Test results of detection limits 


































--------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|YA2304 -52|1                                                                  |0.3974           |0.008%           |6.340            |1263             |6.5              |
|----------|-------------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|YA2304 -52|2                                                                  |2                |2                |6.362            |946              |5.2              |
|----------|-------------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|YA2304 -52|3                                                                  |3                |3                |6.346            |1129             |6.3              |
|----------|-------------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|YA2304 -52|Conclusion: The detection limit concentration of YA2304-52 is      |Conclusion:      |Conclusion:      |Conclusion:      |Conclusion:      |Conclusion:      |
|          |0.3974μg/ml, whichisequivalent to 0.008% of the concentration of   |The              |The              |The              |The              |The              |
|          |the test solution. The signal-to-noise ratio (S/N) of YA2304-52    |detection        |detection        |detection        |detection        |detection        |
|          |peakafter repeatedinjection of the detection limit solutionis in   |limit            |limit            |limit            |limit            |limit            |
|          |the range of 5.2~6.5 (the requirement should be greater than 3),   |concentration    |concentration    |concentration    |concentration    |concentration    |
|          |which meets the verification requirements.                         |of               |of               |of               |of               |of               |
|          |                                                                   |YA2304-52        |YA2304-52        |YA2304-52        |YA2304-52        |YA2304-52        |
|          |                                                                   |is               |is               |is               |is               |is               |
|          |                                                                   |0.3974μg/ml,     |0.3974μg/ml,     |0.3974μg/ml,     |0.3974μg/ml,     |0.3974μg/ml,     |
|          |                                                                   |whichisequivalent|whichisequivalent|whichisequivalent|whichisequivalent|whichisequivalent|
|          |                                                                   |to               |to               |to               |to               |to               |
|          |                                                                   |0.008%           |0.008%           |0.008%           |0.008%           |0.008%           |
|          |                                                                   |of the           |of the           |of the           |of the           |of the           |
|          |                                                                   |concentration    |concentration    |concentration    |concentration    |concentration    |
|          |                                                                   |of the           |of the           |of the           |of the           |of the           |
|          |                                                                   |test             |test             |test             |test             |test             |
|          |                                                                   |solution.        |solution.        |solution.        |solution.        |solution.        |
|          |                                                                   |The              |The              |The              |The              |The              |
|          |                                                                   |signal-to-noise  |signal-to-noise  |signal-to-noise  |signal-to-noise  |signal-to-noise  |
|          |                                                                   |ratio            |ratio            |ratio            |ratio            |ratio            |
|          |                                                                   |(S/N)            |(S/N)            |(S/N)            |(S/N)            |(S/N)            |
|          |                                                                   |of               |of               |of               |of               |of               |
|          |                                                                   |YA2304-52        |YA2304-52        |YA2304-52        |YA2304-52        |YA2304-52        |
|          |                                                                   |peakafter        |peakafter        |peakafter        |peakafter        |peakafter        |
|          |                                                                   |repeatedinjection|repeatedinjection|repeatedinjection|repeatedinjection|repeatedinjection|
|          |                                                                   |of the           |of the           |of the           |of the           |of the           |
|          |                                                                   |detection        |detection        |detection        |detection        |detection        |
|          |                                                                   |limit            |limit            |limit            |limit            |limit            |
|          |                                                                   |solutionis       |solutionis       |solutionis       |solutionis       |solutionis       |
|          |                                                                   |in the           |in the           |in the           |in the           |in the           |
|          |                                                                   |range            |range            |range            |range            |range            |
|          |                                                                   |of               |of               |of               |of               |of               |
|          |                                                                   |5.2~6.5          |5.2~6.5          |5.2~6.5          |5.2~6.5          |5.2~6.5          |
|          |                                                                   |(the             |(the             |(the             |(the             |(the             |
|          |                                                                   |requirement      |requirement      |requirement      |requirement      |requirement      |
|          |                                                                   |should           |should           |should           |should           |should           |
|          |                                                                   |be               |be               |be               |be               |be               |
|          |                                                                   |greater          |greater          |greater          |greater          |greater          |
|          |                                                                   |than             |than             |than             |than             |than             |
|          |                                                                   |3),              |3),              |3),              |3),              |3),              |
|          |                                                                   |which            |which            |which            |which            |which            |
|          |                                                                   |meets            |meets            |meets            |meets            |meets            |
|          |                                                                   |the              |the              |the              |the              |the              |
|          |                                                                   |verification     |verification     |verification     |verification     |verification     |
|          |                                                                   |requirements.    |requirements.    |requirements.    |requirements.    |requirements.    |
|----------|-------------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|3.        |1                                                                  |0.0310           |0.0006%          |7.396            |2597             |11.9             |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 263 of 542 





Page 264
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 





















--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Imidazo le|3                                                                  |3                      |3                      |7.387                  |2584                   |13.6                   |
|----------|-------------------------------------------------------------------|-----------------------|-----------------------|-----------------------|-----------------------|-----------------------|
|Imidazo le|Conclusion: The detection limit concentration ofimidazole is       |Conclusion:            |Conclusion:            |Conclusion:            |Conclusion:            |Conclusion:            |
|          |0.0310μg/ml, whichisequivalent to 0.0006% of the concentration of  |The                    |The                    |The                    |The                    |The                    |
|          |the test solution. The signal-to-noise ratio (S/N) of the 3-needle |detection              |detection              |detection              |detection              |detection              |
|          |imidazole peakafter repeatedinjection of the detection limit       |limit                  |limit                  |limit                  |limit                  |limit                  |
|          |solutionis in the range of 11.8~13.6 (the requirement should be    |concentration          |concentration          |concentration          |concentration          |concentration          |
|          |greater than 3), which meets the verification requirements.        |ofimidazole            |ofimidazole            |ofimidazole            |ofimidazole            |ofimidazole            |
|          |                                                                   |is                     |is                     |is                     |is                     |is                     |
|          |                                                                   |0.0310μg/ml,           |0.0310μg/ml,           |0.0310μg/ml,           |0.0310μg/ml,           |0.0310μg/ml,           |
|          |                                                                   |whichisequivalent      |whichisequivalent      |whichisequivalent      |whichisequivalent      |whichisequivalent      |
|          |                                                                   |to                     |to                     |to                     |to                     |to                     |
|          |                                                                   |0.0006%                |0.0006%                |0.0006%                |0.0006%                |0.0006%                |
|          |                                                                   |of the                 |of the                 |of the                 |of the                 |of the                 |
|          |                                                                   |concentration          |concentration          |concentration          |concentration          |concentration          |
|          |                                                                   |of the                 |of the                 |of the                 |of the                 |of the                 |
|          |                                                                   |test                   |test                   |test                   |test                   |test                   |
|          |                                                                   |solution.              |solution.              |solution.              |solution.              |solution.              |
|          |                                                                   |The                    |The                    |The                    |The                    |The                    |
|          |                                                                   |signal-to-noise        |signal-to-noise        |signal-to-noise        |signal-to-noise        |signal-to-noise        |
|          |                                                                   |ratio                  |ratio                  |ratio                  |ratio                  |ratio                  |
|          |                                                                   |(S/N)                  |(S/N)                  |(S/N)                  |(S/N)                  |(S/N)                  |
|          |                                                                   |of the                 |of the                 |of the                 |of the                 |of the                 |
|          |                                                                   |3-needle               |3-needle               |3-needle               |3-needle               |3-needle               |
|          |                                                                   |imidazole              |imidazole              |imidazole              |imidazole              |imidazole              |
|          |                                                                   |peakafter              |peakafter              |peakafter              |peakafter              |peakafter              |
|          |                                                                   |repeatedinjection      |repeatedinjection      |repeatedinjection      |repeatedinjection      |repeatedinjection      |
|          |                                                                   |of the                 |of the                 |of the                 |of the                 |of the                 |
|          |                                                                   |detection              |detection              |detection              |detection              |detection              |
|          |                                                                   |limit                  |limit                  |limit                  |limit                  |limit                  |
|          |                                                                   |solutionis             |solutionis             |solutionis             |solutionis             |solutionis             |
|          |                                                                   |in the                 |in the                 |in the                 |in the                 |in the                 |
|          |                                                                   |range                  |range                  |range                  |range                  |range                  |
|          |                                                                   |of                     |of                     |of                     |of                     |of                     |
|          |                                                                   |11.8~13.6              |11.8~13.6              |11.8~13.6              |11.8~13.6              |11.8~13.6              |
|          |                                                                   |(the                   |(the                   |(the                   |(the                   |(the                   |
|          |                                                                   |requirement            |requirement            |requirement            |requirement            |requirement            |
|          |                                                                   |should                 |should                 |should                 |should                 |should                 |
|          |                                                                   |be                     |be                     |be                     |be                     |be                     |
|          |                                                                   |greater                |greater                |greater                |greater                |greater                |
|          |                                                                   |than                   |than                   |than                   |than                   |than                   |
|          |                                                                   |3),                    |3),                    |3),                    |3),                    |3),                    |
|          |                                                                   |which                  |which                  |which                  |which                  |which                  |
|          |                                                                   |meets                  |meets                  |meets                  |meets                  |meets                  |
|          |                                                                   |the                    |the                    |the                    |the                    |the                    |
|          |                                                                   |verification           |verification           |verification           |verification           |verification           |
|          |                                                                   |requirements.          |requirements.          |requirements.          |requirements.          |requirements.          |
|----------|-------------------------------------------------------------------|-----------------------|-----------------------|-----------------------|-----------------------|-----------------------|
|DMAP      |1                                                                  |0.0233                 |0.0005%                |16.879                 |1814                   |5.0                    |
|----------|-------------------------------------------------------------------|-----------------------|-----------------------|-----------------------|-----------------------|-----------------------|
|DMAP      |2                                                                  |2                      |2                      |16.804                 |1708                   |4.6                    |
|----------|-------------------------------------------------------------------|-----------------------|-----------------------|-----------------------|-----------------------|-----------------------|
|DMAP      |3                                                                  |3                      |3                      |16.844                 |1164                   |4.7                    |
|----------|-------------------------------------------------------------------|-----------------------|-----------------------|-----------------------|-----------------------|-----------------------|
|DMAP      |Conclusion: The detection limit concentration of                   |Conclusion: The        |Conclusion: The        |Conclusion: The        |Conclusion: The        |Conclusion: The        |
|          |4-dimethylaminopyridine (DMAP) is 0.0233μg/ml, whichisequivalent to|detection limit        |detection limit        |detection limit        |detection limit        |detection limit        |
|          |0.0005% of the concentration of the test solution. The             |concentration of       |concentration of       |concentration of       |concentration of       |concentration of       |
|          |signal-to-noise ratio (S/N) of the DMAP peak of the detection limit|4-dimethylaminopyridine|4-dimethylaminopyridine|4-dimethylaminopyridine|4-dimethylaminopyridine|4-dimethylaminopyridine|
|          |solutionis in the range of 4.6~5.0 (the requirement should be      |(DMAP) is              |(DMAP) is              |(DMAP) is              |(DMAP) is              |(DMAP) is              |
|          |greater than 3), which meets the verification requirements.        |0.0233μg/ml,           |0.0233μg/ml,           |0.0233μg/ml,           |0.0233μg/ml,           |0.0233μg/ml,           |
|          |                                                                   |whichisequivalent      |whichisequivalent      |whichisequivalent      |whichisequivalent      |whichisequivalent      |
|          |                                                                   |to 0.0005% of the      |to 0.0005% of the      |to 0.0005% of the      |to 0.0005% of the      |to 0.0005% of the      |
|          |                                                                   |concentration of       |concentration of       |concentration of       |concentration of       |concentration of       |
|          |                                                                   |the test               |the test               |the test               |the test               |the test               |
|          |                                                                   |solution. The          |solution. The          |solution. The          |solution. The          |solution. The          |
|          |                                                                   |signal-to-noise        |signal-to-noise        |signal-to-noise        |signal-to-noise        |signal-to-noise        |
|          |                                                                   |ratio (S/N) of         |ratio (S/N) of         |ratio (S/N) of         |ratio (S/N) of         |ratio (S/N) of         |
|          |                                                                   |the DMAP peak of       |the DMAP peak of       |the DMAP peak of       |the DMAP peak of       |the DMAP peak of       |
|          |                                                                   |the detection          |the detection          |the detection          |the detection          |the detection          |
|          |                                                                   |limit solutionis       |limit solutionis       |limit solutionis       |limit solutionis       |limit solutionis       |
|          |                                                                   |in the range of        |in the range of        |in the range of        |in the range of        |in the range of        |
|          |                                                                   |4.6~5.0 (the           |4.6~5.0 (the           |4.6~5.0 (the           |4.6~5.0 (the           |4.6~5.0 (the           |
|          |                                                                   |requirement            |requirement            |requirement            |requirement            |requirement            |
|          |                                                                   |should be greater      |should be greater      |should be greater      |should be greater      |should be greater      |
|          |                                                                   |than 3), which         |than 3), which         |than 3), which         |than 3), which         |than 3), which         |
|          |                                                                   |meets the              |meets the              |meets the              |meets the              |meets the              |
|          |                                                                   |verification           |verification           |verification           |verification           |verification           |
|          |                                                                   |requirements.          |requirements.          |requirements.          |requirements.          |requirements.          |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**(4.5) Linearity and range** 



 **Acceptance Criteria** 



In the range equivalent to the LOQ concentration of each impurity ~ 200% 



limit concentration, take 6 concentration points more evenly, take the 



concentration of each impurity as the horizontal coordinate, the peak area as 



the vertical coordinate as the linear regression curve, the regression 



coefficient R of the linear graph should NLT 0.990, the RSD of the response 



factor should NMT 10%. Y-axis intercepts are within 25% of 100% response 



value. 



 **Solution Preparation** 



Blank solution: solvent. 



YA2304-52 Reference storage solution (approx. 100μg/ml) : Share 



YA2304-52 reference storage solution under "4.1 wavelength selection". 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 264 of 542 





Page 265
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Imidazole reference product reserve (approx. 100μg/ml) : Imidazole reference 



product reserve under "4.1 wavelength selection". 



4-dimethylaminopyridine (DMAP) reference reserve liquid (about 100μg/ml) : 



Share 4-dimethylaminopyridine (DMAP) reserve liquid under "4.1 wavelength 



selection". 



Linear solution ① : share the 6th dose limit solution prepared in parallel 



under the item "4.4 dose limit and detection limit". 



Linear solution ② : precisely measure 0.5ml of YA2304-52 reference product 



reserve, imidazole reference product reserve and 4-dimethylaminopyridine 



reference product reserve in the same 20ml bottle, dilute to the scale with 



solvent, shake well, and obtain. (Each about 2.5μg/ml) 



Linear solution ③ : Precision measure YA2304-52 reference product reserve 



liquid, imidazole reference product reserve liquid and 



4-dimethylaminopyridine reference product reserve liquid of 0.75ml, place in 



the same 20ml bottle, dilute with solvent to scale, shake well, then obtain. 



(Each about 3.75μg/ml) 



Linear solution ④ : Accurately measure YA2304-52 reference product reserve, 



imidazole reference product reserve and 4-dimethylaminopyridine reference 



product reserve of 1ml each, place in the same 20ml bottle, dilute with 



solvent to scale, shake well, and obtain. (Each about 5μg/ml) 



Linear solution ⑤ : precisely measure YA2304-52 reference product reserve 



liquid, imidazole reference product reserve liquid and 



4-dimethylaminopyridine reference product reserve liquid of 1.5ml, place in 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 265 of 542 





Page 266
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



the same 20ml bottle, dilute to the scale with solvent, shake well, then obtain. 



(Each about 7.5μg/ml) 



Linear solution ⑥ : Accurately measure YA2304-52 reference product reserve 



liquid, imidazole reference product reserve liquid and 



4-dimethylaminopyridine reference product reserve liquid 2ml, place in the 



same 20ml bottle, dilute with solvent to scale, shake well, and obtain. (Each 



about 10μg/ml) 



 **Injection procedure** 



After the chromatographic system is balanced, take a blank solution into 1 



needle, linear solution ①~ linear solution ⑥ from low concentration to high 



concentration into 1 needle, record the chromatogram. 



 **Measurement results** 
























----------------------------------------------------------------------------
|YA230 4-52|Linear solution①   |0.03%              |1.3248 |5103   |3852   |
|----------|-------------------|-------------------|-------|-------|-------|
|YA230 4-52|Linear solution②   |0.05%              |2.6495 |11692  |4413   |
|----------|-------------------|-------------------|-------|-------|-------|
|YA230 4-52|Linear solution③   |0.08%              |3.9743 |18083  |4550   |
|----------|-------------------|-------------------|-------|-------|-------|
|YA230 4-52|Linear solution④   |0.11%              |5.2991 |24926  |4704   |
|----------|-------------------|-------------------|-------|-------|-------|
|YA230 4-52|Linear solution⑤   |0.16%              |7.9486 |38602  |4856   |
|----------|-------------------|-------------------|-------|-------|-------|
|YA230 4-52|Linear solution⑥   |0.21%              |10.5982|52524  |4956   |
|----------|-------------------|-------------------|-------|-------|-------|
|YA230 4-52|Response factor RSD|Response factor RSD|9%     |9%     |9%     |
----------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 266 of 542 





Page 267
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 















------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Linearequations                                                               |Linearequations                |Y =                            |Y =                            |Y =                            |       |
|                                                                              |                               |5118-1965.5                    |5118-1965.5                    |5118-1965.5                    |       |
|                                                                              |                               |x                              |x                              |x                              |       |
|------------------------------------------------------------------------------|-------------------------------|-------------------------------|-------------------------------|-------------------------------|-------|
|Slope                                                                         |Slope                          |5118                           |5118                           |5118                           |       |
|------------------------------------------------------------------------------|-------------------------------|-------------------------------|-------------------------------|-------------------------------|-------|
|Correlation coefficient_ r_                                                   |Correlation                    |0.9999                         |0.9999                         |0.9999                         |       |
|                                                                              |coefficient_ r_                |                               |                               |                               |       |
|------------------------------------------------------------------------------|-------------------------------|-------------------------------|-------------------------------|-------------------------------|-------|
|Absolute value ofY-axisinterceptasa percentage of 100% response value         |Absolute value                 |8.32%                          |8.32%                          |8.32%                          |       |
|                                                                              |ofY-axisinterceptasa           |                               |                               |                               |       |
|                                                                              |percentage of                  |                               |                               |                               |       |
|                                                                              |100% response                  |                               |                               |                               |       |
|                                                                              |value                          |                               |                               |                               |       |
|------------------------------------------------------------------------------|-------------------------------|-------------------------------|-------------------------------|-------------------------------|-------|
|Conclusion: When YA2304-52 is in the concentration range of                   |Conclusion: When               |Conclusion:                    |Conclusion:                    |Conclusion:                    |       |
|1.3248μg/ml~10.5982μg/ml, the linearequationisy=5118x-1965.5, the correlation |YA2304-52 is in the            |When                           |When                           |When                           |       |
|coefficient_ r_ is 0.9999 (NLT 0.990), and the RSD of the response factoris 9%|concentration range            |YA2304-52                      |YA2304-52                      |YA2304-52                      |       |
|(NMT 10%). The absolute value ofY-axisinterceptasapercentage of 100% response |of                             |is in the                      |is in the                      |is in the                      |       |
|value is 8.32% (not more than 25% required). All the above meet the           |1.3248μg/ml~10.5982μg/ml,      |concentration                  |concentration                  |concentration                  |       |
|requirements, indicating thatunder this method, when YA2304-52 is in the      |the                            |range of                       |range of                       |range of                       |       |
|concentration range of 1.3248μg/ml~10.5982μg/ml, the linear relationship      |linearequationisy=5118x-1965.5,|1.3248μg/ml~10.5982μg/ml,      |1.3248μg/ml~10.5982μg/ml,      |1.3248μg/ml~10.5982μg/ml,      |       |
|between peakarea and concentrationis good.                                    |the correlation                |the                            |the                            |the                            |       |
|                                                                              |coefficient_ r_ is             |linearequationisy=5118x-1965.5,|linearequationisy=5118x-1965.5,|linearequationisy=5118x-1965.5,|       |
|                                                                              |0.9999 (NLT 0.990),            |the                            |the                            |the                            |       |
|                                                                              |and the RSD of the             |correlation                    |correlation                    |correlation                    |       |
|                                                                              |response factoris 9%           |coefficient_                   |coefficient_                   |coefficient_                   |       |
|                                                                              |(NMT 10%). The                 |r_ is                          |r_ is                          |r_ is                          |       |
|                                                                              |absolute value                 |0.9999 (NLT                    |0.9999 (NLT                    |0.9999 (NLT                    |       |
|                                                                              |ofY-axisinterceptasapercentage |0.990), and                    |0.990), and                    |0.990), and                    |       |
|                                                                              |of 100% response               |the RSD of                     |the RSD of                     |the RSD of                     |       |
|                                                                              |value is 8.32% (not            |the                            |the                            |the                            |       |
|                                                                              |more than 25%                  |response                       |response                       |response                       |       |
|                                                                              |required). All the             |factoris 9%                    |factoris 9%                    |factoris 9%                    |       |
|                                                                              |above meet the                 |(NMT 10%).                     |(NMT 10%).                     |(NMT 10%).                     |       |
|                                                                              |requirements,                  |The                            |The                            |The                            |       |
|                                                                              |indicating thatunder           |absolute                       |absolute                       |absolute                       |       |
|                                                                              |this method, when              |value                          |value                          |value                          |       |
|                                                                              |YA2304-52 is in the            |ofY-axisinterceptasapercentage |ofY-axisinterceptasapercentage |ofY-axisinterceptasapercentage |       |
|                                                                              |concentration range            |of 100%                        |of 100%                        |of 100%                        |       |
|                                                                              |of                             |response                       |response                       |response                       |       |
|                                                                              |1.3248μg/ml~10.5982μg/ml,      |value is                       |value is                       |value is                       |       |
|                                                                              |the linear                     |8.32% (not                     |8.32% (not                     |8.32% (not                     |       |
|                                                                              |relationship between           |more than                      |more than                      |more than                      |       |
|                                                                              |peakarea and                   |25%                            |25%                            |25%                            |       |
|                                                                              |concentrationis                |required).                     |required).                     |required).                     |       |
|                                                                              |good.                          |All the                        |All the                        |All the                        |       |
|                                                                              |                               |above meet                     |above meet                     |above meet                     |       |
|                                                                              |                               |the                            |the                            |the                            |       |
|                                                                              |                               |requirements,                  |requirements,                  |requirements,                  |       |
|                                                                              |                               |indicating                     |indicating                     |indicating                     |       |
|                                                                              |                               |thatunder                      |thatunder                      |thatunder                      |       |
|                                                                              |                               |this                           |this                           |this                           |       |
|                                                                              |                               |method,                        |method,                        |method,                        |       |
|                                                                              |                               |when                           |when                           |when                           |       |
|                                                                              |                               |YA2304-52                      |YA2304-52                      |YA2304-52                      |       |
|                                                                              |                               |is in the                      |is in the                      |is in the                      |       |
|                                                                              |                               |concentration                  |concentration                  |concentration                  |       |
|                                                                              |                               |range of                       |range of                       |range of                       |       |
|                                                                              |                               |1.3248μg/ml~10.5982μg/ml,      |1.3248μg/ml~10.5982μg/ml,      |1.3248μg/ml~10.5982μg/ml,      |       |
|                                                                              |                               |the linear                     |the linear                     |the linear                     |       |
|                                                                              |                               |relationship                   |relationship                   |relationship                   |       |
|                                                                              |                               |between                        |between                        |between                        |       |
|                                                                              |                               |peakarea                       |peakarea                       |peakarea                       |       |
|                                                                              |                               |and                            |and                            |and                            |       |
|                                                                              |                               |concentrationis                |concentrationis                |concentrationis                |       |
|                                                                              |                               |good.                          |good.                          |good.                          |       |
|------------------------------------------------------------------------------|-------------------------------|-------------------------------|-------------------------------|-------------------------------|-------|
|Imidazole                                                                     |Linear solution①               |0.002%                         |0.1033                         |7966                           |77135  |
|------------------------------------------------------------------------------|-------------------------------|-------------------------------|-------------------------------|-------------------------------|-------|
|Imidazole                                                                     |Linear solution②               |0.05%                          |2.5818                         |207402                         |80332  |
|------------------------------------------------------------------------------|-------------------------------|-------------------------------|-------------------------------|-------------------------------|-------|
|Imidazole                                                                     |Linear solution③               |0.08%                          |3.8727                         |314281                         |81152  |
|------------------------------------------------------------------------------|-------------------------------|-------------------------------|-------------------------------|-------------------------------|-------|
|Imidazole                                                                     |Linear solution④               |0.10%                          |5.1637                         |417642                         |80881  |
|------------------------------------------------------------------------------|-------------------------------|-------------------------------|-------------------------------|-------------------------------|-------|
|Imidazole                                                                     |Linear solution⑤               |0.15%                          |7.7455                         |636837                         |82220  |
|------------------------------------------------------------------------------|-------------------------------|-------------------------------|-------------------------------|-------------------------------|-------|
|Imidazole                                                                     |Linear solution⑥               |0.21%                          |10.3273                        |856435                         |82929  |
|------------------------------------------------------------------------------|-------------------------------|-------------------------------|-------------------------------|-------------------------------|-------|
|Imidazole                                                                     |Response factor RSD            |Response factor RSD            |2.5%                           |2.5%                           |2.5%   |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 267 of 542 





Page 268
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 















----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Linearequations                                                               |Linearequations                 |Y =                             |Y =                             |Y =                             |       |
|                                                                              |                                |83064-5713.7                    |83064-5713.7                    |83064-5713.7                    |       |
|                                                                              |                                |x                               |x                               |x                               |       |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|-------|
|Slope                                                                         |Slope                           |83064                           |83064                           |83064                           |       |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|-------|
|Correlation coefficient_ r_                                                   |Correlation                     |0.9999                          |0.9999                          |0.9999                          |       |
|                                                                              |coefficient_ r_                 |                                |                                |                                |       |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|-------|
|Absolute value ofY-axisinterceptasa percentage of 100% response value         |Absolute value                  |1.39%                           |1.39%                           |1.39%                           |       |
|                                                                              |ofY-axisinterceptasa            |                                |                                |                                |       |
|                                                                              |percentage of                   |                                |                                |                                |       |
|                                                                              |100% response                   |                                |                                |                                |       |
|                                                                              |value                           |                                |                                |                                |       |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|-------|
|Conclusion: Whenimidazole is in the concentration range of                    |Conclusion:                     |Conclusion:                     |Conclusion:                     |Conclusion:                     |       |
|0.1033μg/ml~10.3273μg/ml, the linearequationisy=83064x-5713.7, the correlation|Whenimidazole is in             |Whenimidazole                   |Whenimidazole                   |Whenimidazole                   |       |
|coefficient_ r_ is 0.9999 (NLT 0.990), and the RSD of the response factoris   |the concentration               |is in the                       |is in the                       |is in the                       |       |
|2.5% (NMT 10%). The absolute value ofY-axisinterceptasapercentage of 100%     |range of                        |concentration                   |concentration                   |concentration                   |       |
|response value is 1.39% (required not to be greater than 25%). All the above  |0.1033μg/ml~10.3273μg/ml,       |range of                        |range of                        |range of                        |       |
|meet the requirements, indicating thatunder this method, whenimidazole is in  |the                             |0.1033μg/ml~10.3273μg/ml,       |0.1033μg/ml~10.3273μg/ml,       |0.1033μg/ml~10.3273μg/ml,       |       |
|the concentration range of 0.1033μg/ml~10.3273μg/ml, the linear relationship  |linearequationisy=83064x-5713.7,|the                             |the                             |the                             |       |
|between peakarea and concentrationis good.                                    |the correlation                 |linearequationisy=83064x-5713.7,|linearequationisy=83064x-5713.7,|linearequationisy=83064x-5713.7,|       |
|                                                                              |coefficient_ r_ is              |the                             |the                             |the                             |       |
|                                                                              |0.9999 (NLT 0.990),             |correlation                     |correlation                     |correlation                     |       |
|                                                                              |and the RSD of the              |coefficient_                    |coefficient_                    |coefficient_                    |       |
|                                                                              |response factoris               |r_ is 0.9999                    |r_ is 0.9999                    |r_ is 0.9999                    |       |
|                                                                              |2.5% (NMT 10%). The             |(NLT 0.990),                    |(NLT 0.990),                    |(NLT 0.990),                    |       |
|                                                                              |absolute value                  |and the RSD                     |and the RSD                     |and the RSD                     |       |
|                                                                              |ofY-axisinterceptasapercentage  |of the                          |of the                          |of the                          |       |
|                                                                              |of 100% response                |response                        |response                        |response                        |       |
|                                                                              |value is 1.39%                  |factoris                        |factoris                        |factoris                        |       |
|                                                                              |(required not to be             |2.5% (NMT                       |2.5% (NMT                       |2.5% (NMT                       |       |
|                                                                              |greater than 25%).              |10%). The                       |10%). The                       |10%). The                       |       |
|                                                                              |All the above meet              |absolute                        |absolute                        |absolute                        |       |
|                                                                              |the requirements,               |value                           |value                           |value                           |       |
|                                                                              |indicating thatunder            |ofY-axisinterceptasapercentage  |ofY-axisinterceptasapercentage  |ofY-axisinterceptasapercentage  |       |
|                                                                              |this method,                    |of 100%                         |of 100%                         |of 100%                         |       |
|                                                                              |whenimidazole is in             |response                        |response                        |response                        |       |
|                                                                              |the concentration               |value is                        |value is                        |value is                        |       |
|                                                                              |range of                        |1.39%                           |1.39%                           |1.39%                           |       |
|                                                                              |0.1033μg/ml~10.3273μg/ml,       |(required                       |(required                       |(required                       |       |
|                                                                              |the linear                      |not to be                       |not to be                       |not to be                       |       |
|                                                                              |relationship between            |greater than                    |greater than                    |greater than                    |       |
|                                                                              |peakarea and                    |25%). All                       |25%). All                       |25%). All                       |       |
|                                                                              |concentrationis                 |the above                       |the above                       |the above                       |       |
|                                                                              |good.                           |meet the                        |meet the                        |meet the                        |       |
|                                                                              |                                |requirements,                   |requirements,                   |requirements,                   |       |
|                                                                              |                                |indicating                      |indicating                      |indicating                      |       |
|                                                                              |                                |thatunder                       |thatunder                       |thatunder                       |       |
|                                                                              |                                |this method,                    |this method,                    |this method,                    |       |
|                                                                              |                                |whenimidazole                   |whenimidazole                   |whenimidazole                   |       |
|                                                                              |                                |is in the                       |is in the                       |is in the                       |       |
|                                                                              |                                |concentration                   |concentration                   |concentration                   |       |
|                                                                              |                                |range of                        |range of                        |range of                        |       |
|                                                                              |                                |0.1033μg/ml~10.3273μg/ml,       |0.1033μg/ml~10.3273μg/ml,       |0.1033μg/ml~10.3273μg/ml,       |       |
|                                                                              |                                |the linear                      |the linear                      |the linear                      |       |
|                                                                              |                                |relationship                    |relationship                    |relationship                    |       |
|                                                                              |                                |between                         |between                         |between                         |       |
|                                                                              |                                |peakarea and                    |peakarea and                    |peakarea and                    |       |
|                                                                              |                                |concentrationis                 |concentrationis                 |concentrationis                 |       |
|                                                                              |                                |good.                           |good.                           |good.                           |       |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|-------|
|DMAP                                                                          |Linear solution①                |0.002%                          |0.0775                          |6879                            |88713  |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|-------|
|DMAP                                                                          |Linear solution②                |0.05%                           |2.5848                          |230453                          |89159  |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|-------|
|DMAP                                                                          |Linear solution③                |0.08%                           |3.8771                          |346096                          |89266  |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|-------|
|DMAP                                                                          |Linear solution④                |0.10%                           |5.1695                          |465309                          |90010  |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|-------|
|DMAP                                                                          |Linear solution⑤                |0.16%                           |7.7543                          |710454                          |91621  |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|-------|
|DMAP                                                                          |Linear solution⑥                |0.21%                           |10.3390                         |969730                          |93793  |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|-------|
|DMAP                                                                          |Response factor RSD             |Response factor RSD             |2.2%                            |2.2%                            |2.2%   |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 268 of 542 





Page 269
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 










----------------------------------------------------------------------------------------------
|       |Linear graph                                                         |              |
|       |                                                                     |              |
|       |                                                                     |              |
|       |---------------------------------------------------------------------|--------------|
|       |Linearequations                                                      |y=93774x-10958|
|       |---------------------------------------------------------------------|--------------|
|       |Slope                                                                |93774         |
|       |---------------------------------------------------------------------|--------------|
|       |Correlation coefficientr                                             |0.9997        |
|       |---------------------------------------------------------------------|--------------|
|       |Absolute value ofY-axisinterceptasa percentage of 100% response value|2.39%         |
----------------------------------------------------------------------------------------------

**(4.6) Accuracy** 



 **Acceptance Criteria** 



The recovery rate of known impurities is achieved by adding each impurity 



reference in the test product solution within the range of 50% concentration 



to 150% limit concentration, and testing the recovery rate between the 



theoretical addition amount and the actual detection amount. The required 



recovery rate is 80%~115%, and the RSD of the recovery rate of each 



impurity is not more than 10%. 



 **Solution preparation** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 269 of 542 





Page 270
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Blank solution: solvent. 



YA2304-52 Reference storage solution (approx. 100μg/ml) : Share 



YA2304-52 reference storage solution under "4.1 wavelength selection". 



Imidazole reference product reserve (approx. 100μg/ml) : Imidazole reference 



product reserve under "4.1 wavelength selection". 



4-dimethylaminopyridine (DMAP) reference storage solution (about 



100μg/ml) : Share 4-dimethylaminopyridine (DMAP) storage solution under 



"4.1 wavelength selection". 



Reference product solution: according to "4.1 wavelength selection" under 



the reference product solution prepared by the same method. (Each about 



5μg/ml) 



Test product solution: Prepare the test product solution under "4.3 specific 



properties" by the same method. Prepare 2 parts in parallel. 



50% recovery solution: Take YA2304 test product about 100mg, weigh it 



accurately, place it in 20ml measuring bottle, add appropriate amount of 



solvent to dissolve by ultrasound, then add YA2304-52 reference product 



reserve, imidazole reference product reserve and 4-dimethylaminopyridine 



reference product reserve 0.5ml each, dilute with solvent to scale, shake well, 



and obtain. 3 parts were prepared in parallel. (Finerenone about 5mg/ml, 



each impurity about 2.5μg/ml) 



100% recovery solution: Take YA2304 test product about 100mg, accurately 



weigh, put into 20ml bottle, add appropriate amount of solvent to dissolve by 



ultrasound, add YA2304-52 reference product reserve liquid, imidazole 



reference product reserve liquid and 4-dimethylaminopyridine reference 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 270 of 542 





Page 271
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



product reserve liquid 1.0ml each, dilute with solvent to scale, shake well, 



then obtain. 3 parts were prepared in parallel. (Finerenone about 5mg/ml, 



each impurity about 5μg/ml) 



150% recovery solution: Take YA2304 test product about 100mg, accurately 



weigh, put into 20ml bottle, add appropriate amount of solvent to dissolve by 



ultrasound, add YA2304-52 reference product reserve, imidazole reference 



product reserve and 4-dimethylaminopyridine reference product reserve 



1.5ml each, dilute with solvent to scale, shake well, then obtain. 3 parts were 



prepared in parallel. (Finerenone about 5mg/ml, each impurity about 



7.5μg/ml) 



 **Injection procedure** 



After the chromatographic system was balanced, the blank solution was 



injected with 1 needle, the control solution was injected with 2 needles 



repeatedly, 2 samples of test solution and 9 recovery solutions were injected 



with 1 needle each, and the chromatogram was recorded. 



 **Measurement results** 






























------------------------------------------------------------------------------
|YA2304-5 2|50% recovery solution -1 |2.6495 |2.4303 |91.7%  |99.3%  |5%     |
|----------|-------------------------|-------|-------|-------|-------|-------|
|YA2304-5 2|50% recovery solution -2 |2.6495 |2.5275 |95.4%  |95.4%  |95.4%  |
|----------|-------------------------|-------|-------|-------|-------|-------|
|YA2304-5 2|50% recovery solution -3 |2.6495 |2.4833 |93.7%  |93.7%  |93.7%  |
|----------|-------------------------|-------|-------|-------|-------|-------|
|YA2304-5 2|100% recovery solution -1|5.2991 |5.3386 |100.7% |100.7% |100.7% |
|----------|-------------------------|-------|-------|-------|-------|-------|
|YA2304-5 2|100% recovery            |5.2991 |5.4065 |102.0% |102.0% |102.0% |
------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 271 of 542 





Page 272
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 













------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|100% recovery solution -3                                             |5.2991            |5.4013            |101.9%            |101.9%            |101.9%            |                  |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|------------------|
|150% recovery solution -1                                             |7.9486            |8.0957            |101.8%            |101.8%            |101.8%            |                  |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|------------------|
|150% recovery solution -2                                             |7.9486            |8.1642            |102.7%            |102.7%            |102.7%            |                  |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|------------------|
|150% recovery solution -3                                             |7.9486            |8.2538            |103.8%            |103.8%            |103.8%            |                  |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|------------------|
|Conclusions: YA2304-52 wasaddedinto the test samples at concentrations|Conclusions:      |Conclusions:      |Conclusions:      |Conclusions:      |Conclusions:      |                  |
|ranging from 2.6495μg/ml to 7.9486μg/ml. The recoveries were all in   |YA2304-52         |YA2304-52         |YA2304-52         |YA2304-52         |YA2304-52         |                  |
|the range of 91.7% to 103.8% (85% to 110%), and the RSD of the        |wasaddedinto      |wasaddedinto      |wasaddedinto      |wasaddedinto      |wasaddedinto      |                  |
|recoveries was 5% (less than 10%). All the above met the requirements,|the               |the               |the               |the               |the               |                  |
|indicating that the method had goodaccuracy in detecting YA2304-52    |test              |test              |test              |test              |test              |                  |
|content.                                                              |samples           |samples           |samples           |samples           |samples           |                  |
|                                                                      |at                |at                |at                |at                |at                |                  |
|                                                                      |concentrations    |concentrations    |concentrations    |concentrations    |concentrations    |                  |
|                                                                      |ranging           |ranging           |ranging           |ranging           |ranging           |                  |
|                                                                      |from              |from              |from              |from              |from              |                  |
|                                                                      |2.6495μg/ml       |2.6495μg/ml       |2.6495μg/ml       |2.6495μg/ml       |2.6495μg/ml       |                  |
|                                                                      |to                |to                |to                |to                |to                |                  |
|                                                                      |7.9486μg/ml.      |7.9486μg/ml.      |7.9486μg/ml.      |7.9486μg/ml.      |7.9486μg/ml.      |                  |
|                                                                      |The               |The               |The               |The               |The               |                  |
|                                                                      |recoveries        |recoveries        |recoveries        |recoveries        |recoveries        |                  |
|                                                                      |were              |were              |were              |were              |were              |                  |
|                                                                      |all in            |all in            |all in            |all in            |all in            |                  |
|                                                                      |the               |the               |the               |the               |the               |                  |
|                                                                      |range             |range             |range             |range             |range             |                  |
|                                                                      |of                |of                |of                |of                |of                |                  |
|                                                                      |91.7%             |91.7%             |91.7%             |91.7%             |91.7%             |                  |
|                                                                      |to                |to                |to                |to                |to                |                  |
|                                                                      |103.8%            |103.8%            |103.8%            |103.8%            |103.8%            |                  |
|                                                                      |(85% to           |(85% to           |(85% to           |(85% to           |(85% to           |                  |
|                                                                      |110%),            |110%),            |110%),            |110%),            |110%),            |                  |
|                                                                      |and the           |and the           |and the           |and the           |and the           |                  |
|                                                                      |RSD of            |RSD of            |RSD of            |RSD of            |RSD of            |                  |
|                                                                      |the               |the               |the               |the               |the               |                  |
|                                                                      |recoveries        |recoveries        |recoveries        |recoveries        |recoveries        |                  |
|                                                                      |was 5%            |was 5%            |was 5%            |was 5%            |was 5%            |                  |
|                                                                      |(less             |(less             |(less             |(less             |(less             |                  |
|                                                                      |than              |than              |than              |than              |than              |                  |
|                                                                      |10%).             |10%).             |10%).             |10%).             |10%).             |                  |
|                                                                      |All the           |All the           |All the           |All the           |All the           |                  |
|                                                                      |above             |above             |above             |above             |above             |                  |
|                                                                      |met the           |met the           |met the           |met the           |met the           |                  |
|                                                                      |requirements,     |requirements,     |requirements,     |requirements,     |requirements,     |                  |
|                                                                      |indicating        |indicating        |indicating        |indicating        |indicating        |                  |
|                                                                      |that              |that              |that              |that              |that              |                  |
|                                                                      |the               |the               |the               |the               |the               |                  |
|                                                                      |method            |method            |method            |method            |method            |                  |
|                                                                      |had               |had               |had               |had               |had               |                  |
|                                                                      |goodaccuracy      |goodaccuracy      |goodaccuracy      |goodaccuracy      |goodaccuracy      |                  |
|                                                                      |in                |in                |in                |in                |in                |                  |
|                                                                      |detecting         |detecting         |detecting         |detecting         |detecting         |                  |
|                                                                      |YA2304-52         |YA2304-52         |YA2304-52         |YA2304-52         |YA2304-52         |                  |
|                                                                      |content.          |content.          |content.          |content.          |content.          |                  |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|------------------|
|Imidazole                                                             |50% recovery      |2.5818            |2.5271            |97.9%             |99.5%             |1.5%              |
|                                                                      |solution -1       |                  |                  |                  |                  |                  |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|------------------|
|Imidazole                                                             |50% recovery      |2.5818            |2.5098            |97.2%             |97.2%             |97.2%             |
|                                                                      |solution -2       |                  |                  |                  |                  |                  |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|------------------|
|Imidazole                                                             |50% recovery      |2.5818            |2.5329            |98.1%             |98.1%             |98.1%             |
|                                                                      |solution -3       |                  |                  |                  |                  |                  |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|------------------|
|Imidazole                                                             |100% recovery     |5.1637            |5.1654            |100.0%            |100.0%            |100.0%            |
|                                                                      |solution -1       |                  |                  |                  |                  |                  |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|------------------|
|Imidazole                                                             |100% recovery     |5.1637            |5.2085            |100.9%            |100.9%            |100.9%            |
|                                                                      |solution -2       |                  |                  |                  |                  |                  |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|------------------|
|Imidazole                                                             |100% recovery     |5.1637            |5.1694            |100.1%            |100.1%            |100.1%            |
|                                                                      |solution -3       |                  |                  |                  |                  |                  |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|------------------|
|Imidazole                                                             |150% recovery     |7.7455            |7.8567            |101.4%            |101.4%            |101.4%            |
|                                                                      |solution -1       |                  |                  |                  |                  |                  |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|------------------|
|Imidazole                                                             |150% recovery     |7.7455            |7.7757            |100.4%            |100.4%            |100.4%            |
|                                                                      |solution -2       |                  |                  |                  |                  |                  |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|------------------|
|Imidazole                                                             |150% recovery     |7.7455            |7.7179            |99.6%             |99.6%             |99.6%             |
|                                                                      |solution -3       |                  |                  |                  |                  |                  |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|------------------|
|Imidazole                                                             |Conclusions:      |Conclusions:      |Conclusions:      |Conclusions:      |Conclusions:      |Conclusions:      |
|                                                                      |The recoveries    |The recoveries    |The recoveries    |The recoveries    |The recoveries    |The               |
|                                                                      |ofimidazole       |ofimidazole       |ofimidazole       |ofimidazole       |ofimidazole       |recoveries        |
|                                                                      |control           |control           |control           |control           |control           |ofimidazole       |
|                                                                      |products in       |products in       |products in       |products in       |products in       |control           |
|                                                                      |the               |the               |the               |the               |the               |products          |
|                                                                      |concentration     |concentration     |concentration     |concentration     |concentration     |in the            |
|                                                                      |range of          |range of          |range of          |range of          |range of          |concentration     |
|                                                                      |2.5818μg/ml to    |2.5818μg/ml to    |2.5818μg/ml to    |2.5818μg/ml to    |2.5818μg/ml to    |range             |
|                                                                      |7.7455μg/ml       |7.7455μg/ml       |7.7455μg/ml       |7.7455μg/ml       |7.7455μg/ml       |of                |
|                                                                      |were in the       |were in the       |were in the       |were in the       |were in the       |2.5818μg/ml       |
|                                                                      |range of 97.2%    |range of 97.2%    |range of 97.2%    |range of 97.2%    |range of 97.2%    |to                |
|                                                                      |to 101.4% (85%    |to 101.4% (85%    |to 101.4% (85%    |to 101.4% (85%    |to 101.4% (85%    |7.7455μg/ml       |
|                                                                      |to 110%), and     |to 110%), and     |to 110%), and     |to 110%), and     |to 110%), and     |were in           |
|                                                                      |the RSD of        |the RSD of        |the RSD of        |the RSD of        |the RSD of        |the               |
|                                                                      |recovery was      |recovery was      |recovery was      |recovery was      |recovery was      |range             |
|                                                                      |1.5% (no more     |1.5% (no more     |1.5% (no more     |1.5% (no more     |1.5% (no more     |of                |
|                                                                      |than 10%). All    |than 10%). All    |than 10%). All    |than 10%). All    |than 10%). All    |97.2%             |
|                                                                      |of the above      |of the above      |of the above      |of the above      |of the above      |to                |
|                                                                      |met the           |met the           |met the           |met the           |met the           |101.4%            |
|                                                                      |requirements,     |requirements,     |requirements,     |requirements,     |requirements,     |(85% to           |
|                                                                      |indicating        |indicating        |indicating        |indicating        |indicating        |110%),            |
|                                                                      |that the          |that the          |that the          |that the          |that the          |and the           |
|                                                                      |method            |method            |method            |method            |method            |RSD of            |
|                                                                      |wasaccurate in    |wasaccurate in    |wasaccurate in    |wasaccurate in    |wasaccurate in    |recovery          |
|                                                                      |detectingimidazole|detectingimidazole|detectingimidazole|detectingimidazole|detectingimidazole|was               |
|                                                                      |content.          |content.          |content.          |content.          |content.          |1.5%              |
|                                                                      |                  |                  |                  |                  |                  |(no               |
|                                                                      |                  |                  |                  |                  |                  |more              |
|                                                                      |                  |                  |                  |                  |                  |than              |
|                                                                      |                  |                  |                  |                  |                  |10%).             |
|                                                                      |                  |                  |                  |                  |                  |All of            |
|                                                                      |                  |                  |                  |                  |                  |the               |
|                                                                      |                  |                  |                  |                  |                  |above             |
|                                                                      |                  |                  |                  |                  |                  |met the           |
|                                                                      |                  |                  |                  |                  |                  |requirements,     |
|                                                                      |                  |                  |                  |                  |                  |indicating        |
|                                                                      |                  |                  |                  |                  |                  |that              |
|                                                                      |                  |                  |                  |                  |                  |the               |
|                                                                      |                  |                  |                  |                  |                  |method            |
|                                                                      |                  |                  |                  |                  |                  |wasaccurate       |
|                                                                      |                  |                  |                  |                  |                  |in                |
|                                                                      |                  |                  |                  |                  |                  |detectingimidazole|
|                                                                      |                  |                  |                  |                  |                  |content.          |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 272 of 542 





Page 273
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 
















--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|DMAP   |50% recovery solution -2                                              |2.5848                 |2.6040                 |100.7%                 |100.7%                 |100.7%                 |
|-------|----------------------------------------------------------------------|-----------------------|-----------------------|-----------------------|-----------------------|-----------------------|
|DMAP   |50% recovery solution -3                                              |2.5848                 |2.6423                 |102.2%                 |102.2%                 |102.2%                 |
|-------|----------------------------------------------------------------------|-----------------------|-----------------------|-----------------------|-----------------------|-----------------------|
|DMAP   |100% recovery solution-1                                              |5.1695                 |5.2211                 |101.0%                 |101.0%                 |101.0%                 |
|-------|----------------------------------------------------------------------|-----------------------|-----------------------|-----------------------|-----------------------|-----------------------|
|DMAP   |100% recovery solution -2                                             |5.1695                 |5.2575                 |101.7%                 |101.7%                 |101.7%                 |
|-------|----------------------------------------------------------------------|-----------------------|-----------------------|-----------------------|-----------------------|-----------------------|
|DMAP   |100% recovery solution -3                                             |5.1695                 |5.1986                 |100.6%                 |100.6%                 |100.6%                 |
|-------|----------------------------------------------------------------------|-----------------------|-----------------------|-----------------------|-----------------------|-----------------------|
|DMAP   |150% recovery solution -1                                             |7.7543                 |8.0727                 |104.1%                 |104.1%                 |104.1%                 |
|-------|----------------------------------------------------------------------|-----------------------|-----------------------|-----------------------|-----------------------|-----------------------|
|DMAP   |150% recovery solution -2                                             |7.7543                 |8.1400                 |105.0%                 |105.0%                 |105.0%                 |
|-------|----------------------------------------------------------------------|-----------------------|-----------------------|-----------------------|-----------------------|-----------------------|
|DMAP   |150% recovery solution -3                                             |7.7543                 |8.0275                 |103.5%                 |103.5%                 |103.5%                 |
|-------|----------------------------------------------------------------------|-----------------------|-----------------------|-----------------------|-----------------------|-----------------------|
|DMAP   |Conclusions: The recoveries of 4-dimethylaminopyridine (DMAP) in the  |Conclusions:           |Conclusions:           |Conclusions:           |Conclusions:           |Conclusions:           |
|       |concentration range of 2.5848μg/ml to 7.7543μg/ml were all in the     |The                    |The                    |The                    |The                    |The                    |
|       |range of 100.0% to 105.0% (85% to 110%), and the RSD of recovery was  |recoveries             |recoveries             |recoveries             |recoveries             |recoveries             |
|       |1.8% (less than 10%). All the above met the requirements, indicating  |of                     |of                     |of                     |of                     |of                     |
|       |that the method wasaccurate in detecting the content of               |4-dimethylaminopyridine|4-dimethylaminopyridine|4-dimethylaminopyridine|4-dimethylaminopyridine|4-dimethylaminopyridine|
|       |4-dimethylaminopyridine (DMAP).                                       |(DMAP)                 |(DMAP)                 |(DMAP)                 |(DMAP)                 |(DMAP)                 |
|       |                                                                      |in the                 |in the                 |in the                 |in the                 |in the                 |
|       |                                                                      |concentration          |concentration          |concentration          |concentration          |concentration          |
|       |                                                                      |range                  |range                  |range                  |range                  |range                  |
|       |                                                                      |of                     |of                     |of                     |of                     |of                     |
|       |                                                                      |2.5848μg/ml            |2.5848μg/ml            |2.5848μg/ml            |2.5848μg/ml            |2.5848μg/ml            |
|       |                                                                      |to                     |to                     |to                     |to                     |to                     |
|       |                                                                      |7.7543μg/ml            |7.7543μg/ml            |7.7543μg/ml            |7.7543μg/ml            |7.7543μg/ml            |
|       |                                                                      |were                   |were                   |were                   |were                   |were                   |
|       |                                                                      |all in                 |all in                 |all in                 |all in                 |all in                 |
|       |                                                                      |the                    |the                    |the                    |the                    |the                    |
|       |                                                                      |range                  |range                  |range                  |range                  |range                  |
|       |                                                                      |of                     |of                     |of                     |of                     |of                     |
|       |                                                                      |100.0%                 |100.0%                 |100.0%                 |100.0%                 |100.0%                 |
|       |                                                                      |to                     |to                     |to                     |to                     |to                     |
|       |                                                                      |105.0%                 |105.0%                 |105.0%                 |105.0%                 |105.0%                 |
|       |                                                                      |(85% to                |(85% to                |(85% to                |(85% to                |(85% to                |
|       |                                                                      |110%),                 |110%),                 |110%),                 |110%),                 |110%),                 |
|       |                                                                      |and the                |and the                |and the                |and the                |and the                |
|       |                                                                      |RSD of                 |RSD of                 |RSD of                 |RSD of                 |RSD of                 |
|       |                                                                      |recovery               |recovery               |recovery               |recovery               |recovery               |
|       |                                                                      |was                    |was                    |was                    |was                    |was                    |
|       |                                                                      |1.8%                   |1.8%                   |1.8%                   |1.8%                   |1.8%                   |
|       |                                                                      |(less                  |(less                  |(less                  |(less                  |(less                  |
|       |                                                                      |than                   |than                   |than                   |than                   |than                   |
|       |                                                                      |10%).                  |10%).                  |10%).                  |10%).                  |10%).                  |
|       |                                                                      |All the                |All the                |All the                |All the                |All the                |
|       |                                                                      |above                  |above                  |above                  |above                  |above                  |
|       |                                                                      |met the                |met the                |met the                |met the                |met the                |
|       |                                                                      |requirements,          |requirements,          |requirements,          |requirements,          |requirements,          |
|       |                                                                      |indicating             |indicating             |indicating             |indicating             |indicating             |
|       |                                                                      |that                   |that                   |that                   |that                   |that                   |
|       |                                                                      |the                    |the                    |the                    |the                    |the                    |
|       |                                                                      |method                 |method                 |method                 |method                 |method                 |
|       |                                                                      |wasaccurate            |wasaccurate            |wasaccurate            |wasaccurate            |wasaccurate            |
|       |                                                                      |in                     |in                     |in                     |in                     |in                     |
|       |                                                                      |detecting              |detecting              |detecting              |detecting              |detecting              |
|       |                                                                      |the                    |the                    |the                    |the                    |the                    |
|       |                                                                      |content                |content                |content                |content                |content                |
|       |                                                                      |of                     |of                     |of                     |of                     |of                     |
|       |                                                                      |4-dimethylaminopyridine|4-dimethylaminopyridine|4-dimethylaminopyridine|4-dimethylaminopyridine|4-dimethylaminopyridine|
|       |                                                                      |(DMAP).                |(DMAP).                |(DMAP).                |(DMAP).                |(DMAP).                |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**(4.7) Precision** 



Precision refers to the proximity between the results obtained by multiple 



sampling of the same uniform test product under specified test conditions, 



and its precision is judged by examining repeatability and intermediate 



precision. 



**(4.7.1) Repeatability** 



 **Acceptance Criteria** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 273 of 542 





Page 274
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



6 copies of repeatable sample solution were prepared by analyst A on date A 



and measured by instrument A. The blank solution was required to be free of 



interference; The separation degree between the imidazole peak and 



YA2304-52 peak in the control solution should be NLT 1.5; The RSD of all 



impurities in the solution of 6 repeatable test products NMT 10%. 



 **Solution preparation** 



Blank solution: solvent. 



YA2304-52 Reference storage solution (approx. 100μg/ml) : Share 



YA2304-52 reference storage solution under "4.1 wavelength selection". 



Imidazole reference product reserve (approx. 100μg/ml) : Imidazole reference 



product reserve under "4.1 wavelength selection". 



4-dimethylaminopyridine (DMAP) reference solution (approx. 100μg/ml) : 



Share 4-dimethylaminopyridine (DMAP) under "43.1 wavelength selection". 



Reference solution: Prepare it by the same method as the reference solution 



under "4.1 wavelength selection". (Each about 5μg/ml) 



Repetitive test product solution: Take YA2304 test product about 100mg, 



accurately weigh it, place it in a 20ml measuring bottle, add appropriate 



amount of solvent to dissolve by ultrasound, then add YA2304-52 reference 



product reserve, imidazole reference product reserve and 



4-dimethylaminopyridine reference product reserve 1.0ml each, dilute with 



solvent to scale, shake well, and obtain. 6 parts were prepared in parallel. 



(YA2304 about 5mg/ml, each impurity about 5μg/ml) 



 **Injection procedure** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 274 of 542 





Page 275
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



After the chromatographic system was balanced, 1 needle was injected into 



the blank solution, 2 needles into the control solution, 1 needle into each of 



the 6 repetitive test product solutions, and the chromatogram was recorded. 



 **Determination result** 











































------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Reference solution                                    |Degree          |Degree          |Degree          |1               |1               |1               |1               |2.0             |
|                                                      |of              |of              |of              |                |                |                |                |                |
|                                                      |separation      |separation      |separation      |                |                |                |                |                |
|                                                      |betweenimidazole|betweenimidazole|betweenimidazole|                |                |                |                |                |
|                                                      |peaks           |peaks           |peaks           |                |                |                |                |                |
|                                                      |and             |and             |and             |                |                |                |                |                |
|                                                      |YA2304-52       |YA2304-52       |YA2304-52       |                |                |                |                |                |
|                                                      |peaks           |peaks           |peaks           |                |                |                |                |                |
|------------------------------------------------------|----------------|----------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Reference solution                                    |Degree of       |Degree of       |Degree of       |2               |2               |2               |2               |2.0             |
|                                                      |separation      |separation      |separation      |                |                |                |                |                |
|                                                      |betweenimidazole|betweenimidazole|betweenimidazole|                |                |                |                |                |
|                                                      |peaks and       |peaks and       |peaks and       |                |                |                |                |                |
|                                                      |YA2304-52 peaks |YA2304-52 peaks |YA2304-52 peaks |                |                |                |                |                |
|------------------------------------------------------|----------------|----------------|----------------|----------------|----------------|----------------|----------------|----------------|
|InvestigationItems                                    |Solution name   |Solution name   |Solution name   |Solution        |Solution        |Solution        |Solution        |RSD             |
|                                                      |                |                |                |name            |name            |name            |name            |                |
|------------------------------------------------------|----------------|----------------|----------------|----------------|----------------|----------------|----------------|----------------|
|InvestigationItems                                    |Repeated test   |Repetiti ve test|Repetiti ve test|Repetiti        |Repetiti        |Repetiti        |Repetiti        |Repetiti        |
|                                                      |product solution|product solution|product solution|ve test         |ve test         |ve test         |ve test         |ve test         |
|                                                      |1               |2               |3               |product         |product         |product         |product         |product         |
|                                                      |                |                |                |solution        |solution        |solution        |solution        |solution        |
|                                                      |                |                |                |3               |4               |5               |6               |6               |
|------------------------------------------------------|----------------|----------------|----------------|----------------|----------------|----------------|----------------|----------------|
|YA2304-52 content                                     |0.11%           |0.10%           |0.10%           |0.10%           |0.10%           |0.10%           |0.11%           |1.2%            |
|------------------------------------------------------|----------------|----------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Imidazole content                                     |0.10%           |0.10%           |0.10%           |0.10%           |0.10%           |0.10%           |0.10%           |0.9%            |
|------------------------------------------------------|----------------|----------------|----------------|----------------|----------------|----------------|----------------|----------------|
|DMAP content                                          |0.10%           |0.10%           |0.10%           |0.10%           |0.10%           |0.10%           |0.10%           |1.6%            |
|------------------------------------------------------|----------------|----------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Conclusion: The blank solution has no interference;   |Conclusion: The |Conclusion: The |Conclusion: The |Conclusion:     |Conclusion:     |Conclusion:     |Conclusion:     |Conclusion:     |
|The separation degree betweenimidazole peaks and      |blank solution  |blank solution  |blank solution  |The             |The             |The             |The             |The             |
|YA2304-52 peaks in control solution was 2.0 (NLT 1.5  |has no          |has no          |has no          |blank           |blank           |blank           |blank           |blank           |
|required). The RSDS ofallimpurities in the 6          |interference;   |interference;   |interference;   |solution        |solution        |solution        |solution        |solution        |
|repeatable samples were no more than 1.6% (no more    |The separation  |The separation  |The separation  |has no          |has no          |has no          |has no          |has no          |
|than 10% required); All the above met the verification|degree          |degree          |degree          |interference;   |interference;   |interference;   |interference;   |interference;   |
|requirements, indicating that the method has good     |betweenimidazole|betweenimidazole|betweenimidazole|The             |The             |The             |The             |The             |
|repeatability.                                        |peaks and       |peaks and       |peaks and       |separation      |separation      |separation      |separation      |separation      |
|                                                      |YA2304-52 peaks |YA2304-52 peaks |YA2304-52 peaks |degree          |degree          |degree          |degree          |degree          |
|                                                      |in control      |in control      |in control      |betweenimidazole|betweenimidazole|betweenimidazole|betweenimidazole|betweenimidazole|
|                                                      |solution was 2.0|solution was 2.0|solution was 2.0|peaks           |peaks           |peaks           |peaks           |peaks           |
|                                                      |(NLT 1.5        |(NLT 1.5        |(NLT 1.5        |and             |and             |and             |and             |and             |
|                                                      |required). The  |required). The  |required). The  |YA2304-52       |YA2304-52       |YA2304-52       |YA2304-52       |YA2304-52       |
|                                                      |RSDS            |RSDS            |RSDS            |peaks in        |peaks in        |peaks in        |peaks in        |peaks in        |
|                                                      |ofallimpurities |ofallimpurities |ofallimpurities |control         |control         |control         |control         |control         |
|                                                      |in the 6        |in the 6        |in the 6        |solution        |solution        |solution        |solution        |solution        |
|                                                      |repeatable      |repeatable      |repeatable      |was 2.0         |was 2.0         |was 2.0         |was 2.0         |was 2.0         |
|                                                      |samples were no |samples were no |samples were no |(NLT 1.5        |(NLT 1.5        |(NLT 1.5        |(NLT 1.5        |(NLT 1.5        |
|                                                      |more than 1.6%  |more than 1.6%  |more than 1.6%  |required).      |required).      |required).      |required).      |required).      |
|                                                      |(no more than   |(no more than   |(no more than   |The RSDS        |The RSDS        |The RSDS        |The RSDS        |The RSDS        |
|                                                      |10% required);  |10% required);  |10% required);  |ofallimpurities |ofallimpurities |ofallimpurities |ofallimpurities |ofallimpurities |
|                                                      |All the above   |All the above   |All the above   |in the 6        |in the 6        |in the 6        |in the 6        |in the 6        |
|                                                      |met the         |met the         |met the         |repeatable      |repeatable      |repeatable      |repeatable      |repeatable      |
|                                                      |verification    |verification    |verification    |samples         |samples         |samples         |samples         |samples         |
|                                                      |requirements,   |requirements,   |requirements,   |were no         |were no         |were no         |were no         |were no         |
|                                                      |indicating that |indicating that |indicating that |more            |more            |more            |more            |more            |
|                                                      |the method has  |the method has  |the method has  |than            |than            |than            |than            |than            |
|                                                      |good            |good            |good            |1.6% (no        |1.6% (no        |1.6% (no        |1.6% (no        |1.6% (no        |
|                                                      |repeatability.  |repeatability.  |repeatability.  |more            |more            |more            |more            |more            |
|                                                      |                |                |                |than 10%        |than 10%        |than 10%        |than 10%        |than 10%        |
|                                                      |                |                |                |required);      |required);      |required);      |required);      |required);      |
|                                                      |                |                |                |All the         |All the         |All the         |All the         |All the         |
|                                                      |                |                |                |above           |above           |above           |above           |above           |
|                                                      |                |                |                |met the         |met the         |met the         |met the         |met the         |
|                                                      |                |                |                |verification    |verification    |verification    |verification    |verification    |
|                                                      |                |                |                |requirements,   |requirements,   |requirements,   |requirements,   |requirements,   |
|                                                      |                |                |                |indicating      |indicating      |indicating      |indicating      |indicating      |
|                                                      |                |                |                |that the        |that the        |that the        |that the        |that the        |
|                                                      |                |                |                |method          |method          |method          |method          |method          |
|                                                      |                |                |                |has good        |has good        |has good        |has good        |has good        |
|                                                      |                |                |                |repeatability.  |repeatability.  |repeatability.  |repeatability.  |repeatability.  |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**(4.7.2) Intermediate precision** 



 **Brief Description** 



6 intermediate precision sample solutions were prepared by Analyst B on 



date B. It is required that the blank solution should be interference free; The 



control solution was injected for 6 consecutive times, and the peak order was 



YA2304-52, imidazole and 4-dimethylaminopyridine. The separation degree 



between imidazole peak and YA2304-52 peak should be NLT 1.5, the 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 275 of 542 





Page 276
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



retention time RSD of each impurity peak should be no more than 1.0%, and 



the RSD of the peak area of each impurity peak should be no more than 5%. 



RSD of all impurities in 6 intermediate precision test solutions NMT 10%. 



The RSD of each impurity content NMT 10% for the results of 12 tests of 



repeatability and intermediate precision. 



 **Solution preparation** 



Blank solution: solvent. 



YA2304-52 Reference storage solution (about 100μg/ml) : Share YA2304-52 



reference storage solution under "4.1 Wavelength selection". 



Imidazole reference product reserve (approx. 100μg/ml) : Imidazole reference 



product reserve under "4.1 wavelength selection". 



4-dimethylaminopyridine (DMAP) reference reserve liquid (about 100μg/ml) : 



Share 4-dimethylaminopyridine (DMAP) reserve liquid under "4.1 wavelength 



selection". 



Reference product solution: according to "4.1 wavelength selection" under 



the reference product solution prepared by the same method. (Each about 



5μg/ml) 



Intermediate precision test solution: Take YA2304 test product about 100mg, 



weigh it accurately, place it in a 20ml measuring bottle, add appropriate 



amount of solvent to dissolve by ultrasound, then add YA2304-52 reference 



product reserve liquid, imidazole reference product reserve liquid and 



4-dimethylaminopyridine reference product reserve liquid 1.0ml each, dilute 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 276 of 542 





Page 277
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



it with solvent to the scale, shake well, and obtain. 6 parts were prepared in 



parallel. (YA2304 about 5mg/ml, each impurity about 5μg/ml) 



 **Injection procedure** 



Intermediate precision - System applicability: After the chromatographic 



system balance, take blank solution into 1 needle, control solution into 6 



needles, record the chromatogram. 



Intermediate precision - Sample detection: After the chromatographic system 



was balanced, 1 needle was injected into the blank solution, 2 needles were 



injected into the control solution, and 1 needle was injected into each of the 6 



intermediate precision test solutions, and the chromatogram was recorded. 



 **Determination result** 



Results of intermediate precision - system suitability test 









































































----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Investigation parameters                              |Investigation           |1                       |2                       |3                       |4                       |5                       |6                       |6                       |
|                                                      |parameters              |                        |                        |                        |                        |                        |                        |                        |
|------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|YA230 4-52                                            |RT (min)                |6.348                   |6.348                   |6.351                   |6.351                   |6.354                   |6.351                   |0.04%                   |
|------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|YA230 4-52                                            |Peakarea                |25275                   |25258                   |25184                   |25462                   |25289                   |25551                   |0.6%                    |
|------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|imidazole                                             |RT (min)                |7.348                   |7.348                   |7.350                   |7.352                   |7.353                   |7.352                   |0.030 %                 |
|------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|imidazole                                             |Peakarea                |41650 3                 |41639 8                 |41707 9                 |41785 9                 |41758 3                 |41799 7                 |0.17%                   |
|------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|DMAP                                                  |RT (min)                |16.646                  |16.647                  |16.652                  |16.657                  |16.659                  |16.657                  |0.04%                   |
|------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|DMAP                                                  |Peakarea                |47114 1                 |47143 3                 |47226 3                 |47320 7                 |46753 7                 |47310 5                 |0.5%                    |
|------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|Degree of separation betweenimidazole peak and        |Degree of               |1.9                     |1.9                     |1.9                     |1.9                     |1.9                     |1.9                     |/                       |
|YA2304-52 peak                                        |separation              |                        |                        |                        |                        |                        |                        |                        |
|                                                      |betweenimidazole        |                        |                        |                        |                        |                        |                        |                        |
|                                                      |peak and                |                        |                        |                        |                        |                        |                        |                        |
|                                                      |YA2304-52               |                        |                        |                        |                        |                        |                        |                        |
|                                                      |peak                    |                        |                        |                        |                        |                        |                        |                        |
|------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|Conclusion: The blank solution has no interference;   |Conclusion: The         |Conclusion:             |Conclusion:             |Conclusion:             |Conclusion:             |Conclusion:             |Conclusion:             |Conclusion:             |
|The control solution wasinjected for 6 consecutive    |blank solution          |The                     |The                     |The                     |The                     |The                     |The                     |The                     |
|times, and the peakorder was YA2304-52, imidazole and |has no                  |blank                   |blank                   |blank                   |blank                   |blank                   |blank                   |blank                   |
|4-dimethylaminopyridine. The separation degree        |interference;           |solution                |solution                |solution                |solution                |solution                |solution                |solution                |
|betweenimidazole peak and                             |The control             |has no                  |has no                  |has no                  |has no                  |has no                  |has no                  |has no                  |
|                                                      |solution                |interference;           |interference;           |interference;           |interference;           |interference;           |interference;           |interference;           |
|                                                      |wasinjected for         |The                     |The                     |The                     |The                     |The                     |The                     |The                     |
|                                                      |6 consecutive           |control                 |control                 |control                 |control                 |control                 |control                 |control                 |
|                                                      |times, and the          |solution                |solution                |solution                |solution                |solution                |solution                |solution                |
|                                                      |peakorder was           |wasinjected             |wasinjected             |wasinjected             |wasinjected             |wasinjected             |wasinjected             |wasinjected             |
|                                                      |YA2304-52,              |for 6                   |for 6                   |for 6                   |for 6                   |for 6                   |for 6                   |for 6                   |
|                                                      |imidazole and           |consecutive             |consecutive             |consecutive             |consecutive             |consecutive             |consecutive             |consecutive             |
|                                                      |4-dimethylaminopyridine.|times,                  |times,                  |times,                  |times,                  |times,                  |times,                  |times,                  |
|                                                      |The separation          |and the                 |and the                 |and the                 |and the                 |and the                 |and the                 |and the                 |
|                                                      |degree                  |peakorder               |peakorder               |peakorder               |peakorder               |peakorder               |peakorder               |peakorder               |
|                                                      |betweenimidazole        |was                     |was                     |was                     |was                     |was                     |was                     |was                     |
|                                                      |peak and                |YA2304-52,              |YA2304-52,              |YA2304-52,              |YA2304-52,              |YA2304-52,              |YA2304-52,              |YA2304-52,              |
|                                                      |                        |imidazole               |imidazole               |imidazole               |imidazole               |imidazole               |imidazole               |imidazole               |
|                                                      |                        |and                     |and                     |and                     |and                     |and                     |and                     |and                     |
|                                                      |                        |4-dimethylaminopyridine.|4-dimethylaminopyridine.|4-dimethylaminopyridine.|4-dimethylaminopyridine.|4-dimethylaminopyridine.|4-dimethylaminopyridine.|4-dimethylaminopyridine.|
|                                                      |                        |The                     |The                     |The                     |The                     |The                     |The                     |The                     |
|                                                      |                        |separation              |separation              |separation              |separation              |separation              |separation              |separation              |
|                                                      |                        |degree                  |degree                  |degree                  |degree                  |degree                  |degree                  |degree                  |
|                                                      |                        |betweenimidazole        |betweenimidazole        |betweenimidazole        |betweenimidazole        |betweenimidazole        |betweenimidazole        |betweenimidazole        |
|                                                      |                        |peak                    |peak                    |peak                    |peak                    |peak                    |peak                    |peak                    |
|                                                      |                        |and                     |and                     |and                     |and                     |and                     |and                     |and                     |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 277 of 542 





Page 278
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



YA2304-52 peak was 1.9 (NLT 1.5), and the retention time RSD of each impurity peak 



was no more than 0.04%(NMT 1.0%). The RSD of the peak area of each impurity peak 



was no more than 0.6% (NMT 5%); All the above meet the verification requirements, 



indicating that the method has good system applicability. 



Results of repeatability test 


























































----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Investigati onitems                                   |RSD (n         |Repetiti       |Repetiti       |Repetiti       |Repeated       |Repetiti       |Repetiti       |Repetiti       |
|                                                      |= 6) 1         |ve test        |ve test        |ve test        |test           |ve test        |ve test        |ve test        |
|                                                      |Repeat         |produc         |produc         |produc         |produc         |produc         |produc         |produc         |
|                                                      |test           |tsolution      |tsolution      |tsolution      |tsolution      |tsolution      |tsolution      |tsolution      |
|                                                      |solution       |2              |3              |4              |5              |6              |6              |6              |
|------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|YA2304-52 content                                     |0.11%          |0.10%          |0.10%          |0.10%          |0.10%          |0.11%          |1.2%           |1.2%           |
|------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|Imidazole content                                     |0.10%          |0.10%          |0.10%          |0.10%          |0.10%          |0.10%          |0.9%           |0.9%           |
|------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|DMAP content                                          |0.10%          |0.10%          |0.10%          |0.10%          |0.10%          |0.10%          |1.6%           |1.6%           |
|------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|Surveyitems                                           |Solution       |Solution       |Solution       |Solution       |Solution       |Solution       |RSD (n=6       |RSD (n=1       |
|                                                      |name           |name           |name           |name           |name           |name           |)              |2)             |
|------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|Surveyitems                                           |Interme        |Interme        |Interme        |Interme        |Interme        |Interme        |Interme        |Interme        |
|                                                      |diate          |diate          |diate          |diate          |diate          |diate          |diate          |diate          |
|                                                      |precision      |precisio       |precisio       |precisio       |precisio       |precisio       |precisio       |precisio       |
|                                                      |test           |nsample        |nsample        |nsample        |nsample        |nsample        |nsample        |nsample        |
|                                                      |sample         |solution       |solution       |solution       |solution       |solution       |solution       |solution       |
|                                                      |solution       |2              |3              |4              |5              |6              |6              |6              |
|                                                      |1              |               |               |               |               |               |               |               |
|------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|YA2304-52 content                                     |0.10%          |0.11%          |0.11%          |0.11%          |0.11%          |0.10%          |1.1 %          |1.1 %          |
|------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|Imidazole content                                     |0.10%          |0.10%          |0.10%          |0.10%          |0.10%          |0.10%          |1.1 %          |1.8 %          |
|------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|DMAP content                                          |0.10%          |0.10%          |0.11%          |0.11%          |0.11%          |0.10%          |1.3 %          |2.2 %          |
|------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|Conclusion: RSDS ofallimpurities in 6 intermediate    |Conclusion:    |Conclusion:    |Conclusion:    |Conclusion:    |Conclusion:    |Conclusion:    |Conclusion:    |Conclusion:    |
|precision test solutionsare not more than 1.3% (the   |RSDS           |RSDS           |RSDS           |RSDS           |RSDS           |RSDS           |RSDS           |RSDS           |
|requirementis not more than 10%). All the above meet  |ofallimpurities|ofallimpurities|ofallimpurities|ofallimpurities|ofallimpurities|ofallimpurities|ofallimpurities|ofallimpurities|
|the verification requirements, indicating that the    |in 6           |in 6           |in 6           |in 6           |in 6           |in 6           |in 6           |in 6           |
|intermediate precision of the methodis good; RSDS     |intermediate   |intermediate   |intermediate   |intermediate   |intermediate   |intermediate   |intermediate   |intermediate   |
|ofallimpurities in 12 repetitive test products        |precision      |precision      |precision      |precision      |precision      |precision      |precision      |precision      |
|andintermediate precision test products were not more |test           |test           |test           |test           |test           |test           |test           |test           |
|than 2.2% (the requirement was not more than 10%); The|solutionsare   |solutionsare   |solutionsare   |solutionsare   |solutionsare   |solutionsare   |solutionsare   |solutionsare   |
|above all meet the verification requirements,         |not more       |not more       |not more       |not more       |not more       |not more       |not more       |not more       |
|indicating that the method has good                   |than 1.3%      |than 1.3%      |than 1.3%      |than 1.3%      |than 1.3%      |than 1.3%      |than 1.3%      |than 1.3%      |
|                                                      |(the           |(the           |(the           |(the           |(the           |(the           |(the           |(the           |
|                                                      |requirementis  |requirementis  |requirementis  |requirementis  |requirementis  |requirementis  |requirementis  |requirementis  |
|                                                      |not more       |not more       |not more       |not more       |not more       |not more       |not more       |not more       |
|                                                      |than           |than           |than           |than           |than           |than           |than           |than           |
|                                                      |10%). All      |10%). All      |10%). All      |10%). All      |10%). All      |10%). All      |10%). All      |10%). All      |
|                                                      |the above      |the above      |the above      |the above      |the above      |the above      |the above      |the above      |
|                                                      |meet the       |meet the       |meet the       |meet the       |meet the       |meet the       |meet the       |meet the       |
|                                                      |verification   |verification   |verification   |verification   |verification   |verification   |verification   |verification   |
|                                                      |requirements,  |requirements,  |requirements,  |requirements,  |requirements,  |requirements,  |requirements,  |requirements,  |
|                                                      |indicating     |indicating     |indicating     |indicating     |indicating     |indicating     |indicating     |indicating     |
|                                                      |that the       |that the       |that the       |that the       |that the       |that the       |that the       |that the       |
|                                                      |intermediate   |intermediate   |intermediate   |intermediate   |intermediate   |intermediate   |intermediate   |intermediate   |
|                                                      |precision      |precision      |precision      |precision      |precision      |precision      |precision      |precision      |
|                                                      |of the         |of the         |of the         |of the         |of the         |of the         |of the         |of the         |
|                                                      |methodis       |methodis       |methodis       |methodis       |methodis       |methodis       |methodis       |methodis       |
|                                                      |good;          |good;          |good;          |good;          |good;          |good;          |good;          |good;          |
|                                                      |RSDS           |RSDS           |RSDS           |RSDS           |RSDS           |RSDS           |RSDS           |RSDS           |
|                                                      |ofallimpurities|ofallimpurities|ofallimpurities|ofallimpurities|ofallimpurities|ofallimpurities|ofallimpurities|ofallimpurities|
|                                                      |in 12          |in 12          |in 12          |in 12          |in 12          |in 12          |in 12          |in 12          |
|                                                      |repetitive     |repetitive     |repetitive     |repetitive     |repetitive     |repetitive     |repetitive     |repetitive     |
|                                                      |test           |test           |test           |test           |test           |test           |test           |test           |
|                                                      |products       |products       |products       |products       |products       |products       |products       |products       |
|                                                      |andintermediate|andintermediate|andintermediate|andintermediate|andintermediate|andintermediate|andintermediate|andintermediate|
|                                                      |precision      |precision      |precision      |precision      |precision      |precision      |precision      |precision      |
|                                                      |test           |test           |test           |test           |test           |test           |test           |test           |
|                                                      |products       |products       |products       |products       |products       |products       |products       |products       |
|                                                      |were not       |were not       |were not       |were not       |were not       |were not       |were not       |were not       |
|                                                      |more than      |more than      |more than      |more than      |more than      |more than      |more than      |more than      |
|                                                      |2.2% (the      |2.2% (the      |2.2% (the      |2.2% (the      |2.2% (the      |2.2% (the      |2.2% (the      |2.2% (the      |
|                                                      |requirement    |requirement    |requirement    |requirement    |requirement    |requirement    |requirement    |requirement    |
|                                                      |was not        |was not        |was not        |was not        |was not        |was not        |was not        |was not        |
|                                                      |more than      |more than      |more than      |more than      |more than      |more than      |more than      |more than      |
|                                                      |10%); The      |10%); The      |10%); The      |10%); The      |10%); The      |10%); The      |10%); The      |10%); The      |
|                                                      |above all      |above all      |above all      |above all      |above all      |above all      |above all      |above all      |
|                                                      |meet the       |meet the       |meet the       |meet the       |meet the       |meet the       |meet the       |meet the       |
|                                                      |verification   |verification   |verification   |verification   |verification   |verification   |verification   |verification   |
|                                                      |requirements,  |requirements,  |requirements,  |requirements,  |requirements,  |requirements,  |requirements,  |requirements,  |
|                                                      |indicating     |indicating     |indicating     |indicating     |indicating     |indicating     |indicating     |indicating     |
|                                                      |that the       |that the       |that the       |that the       |that the       |that the       |that the       |that the       |
|                                                      |method         |method         |method         |method         |method         |method         |method         |method         |
|                                                      |has good       |has good       |has good       |has good       |has good       |has good       |has good       |has good       |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 278 of 542 





Page 279
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



precision. 



**(4.8) Solution stability** 



 **Brief Description** 



Each solution is placed in a 5℃ injector, and the control solution and test 



solution are injected at different times. The separation degree between 



imidazole peak and YA2304-52 peak in the control solution should be NLT 



1.5, and the RSD of the peak area of each impurity peak should be no more 



than 5%; The RSDS of all impurities in the test solution should NMT 10%, 



and no new impurities to be measured (YA2304-52, imidazole, 



4-dimethylaminopyridine) should be detected. 



 **Solution preparation** 



Blank solution: solvent. 



Reference solution: Share the reference solution under "4.2 System 



Suitability". (Approx. 5μg/ml) 



Test solution: Share the test solution under "4.3 specific Properties". 



 **Injection Sequence** 



After the chromatographic system was balanced, the control solution placed 



in the 5℃ injector was injected with 1 needle at 0h, 2h, 4h, 16h, 24h, 40h 



and 48h respectively, and the test solution placed in the 5℃ injector was 



injected with 1 needle at 0h, 2h, 4h, 12h, 20h, 36h and 44h respectively to 



record the chromatogram. (The chromatogram of reference solution 0h and 



2h shared the chromatogram of reference solution 1 and 4 needles of 



repeated injection of 6 needles under "4.2 system applicability", and the 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 279 of 542 





Page 280
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



chromatogram of reference solution 16h shared the chromatogram of 



reference solution under "4.3 specificity"; The test product solution 2h atlas 



was shared with the test product solution under "4.3 specificity") 



 **Measurement results** 



Stability test results of reference solution 
















































-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|InvestigationItems                            |InvestigationItems|0h              |2h              |4h              |16h             |24h             |40h             |48h             |48h             |
|----------------------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Peakarea                                      |YA230 4-52        |24168           |24129           |23898           |24389           |24371           |24282           |24439           |0.8 %           |
|----------------------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Peakarea                                      |Imida zole        |41795 3         |41971 1         |41872 0         |42153 2         |42406 2         |41994 6         |42191 7         |0.5 %           |
|----------------------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Peakarea                                      |DMAP              |45883 2         |45761 9         |46219 1         |46923 3         |47399 0         |47453 2         |47218 2         |1.6 %           |
|----------------------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Degree of separation betweenimidazole peaks   |Degree of         |1.9             |1.9             |1.9             |1.9             |1.9             |2.0             |2.0             |/               |
|and YA2304-52 peaks                           |separation        |                |                |                |                |                |                |                |                |
|                                              |betweenimidazole  |                |                |                |                |                |                |                |                |
|                                              |peaks and         |                |                |                |                |                |                |                |                |
|                                              |YA2304-52 peaks   |                |                |                |                |                |                |                |                |
|----------------------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Conclusion: When the control solution was     |Conclusion: When  |Conclusion:     |Conclusion:     |Conclusion:     |Conclusion:     |Conclusion:     |Conclusion:     |Conclusion:     |Conclusion:     |
|placed in the 5℃injector for 48 h, the        |the control       |When            |When            |When            |When            |When            |When            |When            |When            |
|separation degree betweenimidazole peak and   |solution was      |the             |the             |the             |the             |the             |the             |the             |the             |
|YA2304-52 peak was NLT 1.9 (required to be NLT|placed in the     |control         |control         |control         |control         |control         |control         |control         |control         |
|1.5), and the RSD of the peak-peakarea        |5℃injector for 48 |solution        |solution        |solution        |solution        |solution        |solution        |solution        |solution        |
|ofeachimpurity was not more than 1.6%         |h, the separation |was             |was             |was             |was             |was             |was             |was             |was             |
|(required to be no more than 5%). All the     |degree            |placed          |placed          |placed          |placed          |placed          |placed          |placed          |placed          |
|above met the verification requirements,      |betweenimidazole  |in the          |in the          |in the          |in the          |in the          |in the          |in the          |in the          |
|indicating that the control product solution  |peak and YA2304-52|5℃injector      |5℃injector      |5℃injector      |5℃injector      |5℃injector      |5℃injector      |5℃injector      |5℃injector      |
|was stable within 48hafter being placed in the|peak was NLT 1.9  |for 48          |for 48          |for 48          |for 48          |for 48          |for 48          |for 48          |for 48          |
|5℃injector.                                   |(required to be   |h, the          |h, the          |h, the          |h, the          |h, the          |h, the          |h, the          |h, the          |
|                                              |NLT 1.5), and the |separation      |separation      |separation      |separation      |separation      |separation      |separation      |separation      |
|                                              |RSD of the        |degree          |degree          |degree          |degree          |degree          |degree          |degree          |degree          |
|                                              |peak-peakarea     |betweenimidazole|betweenimidazole|betweenimidazole|betweenimidazole|betweenimidazole|betweenimidazole|betweenimidazole|betweenimidazole|
|                                              |ofeachimpurity was|peak            |peak            |peak            |peak            |peak            |peak            |peak            |peak            |
|                                              |not more than 1.6%|and             |and             |and             |and             |and             |and             |and             |and             |
|                                              |(required to be no|YA2304-52       |YA2304-52       |YA2304-52       |YA2304-52       |YA2304-52       |YA2304-52       |YA2304-52       |YA2304-52       |
|                                              |more than 5%). All|peak            |peak            |peak            |peak            |peak            |peak            |peak            |peak            |
|                                              |the above met the |was NLT         |was NLT         |was NLT         |was NLT         |was NLT         |was NLT         |was NLT         |was NLT         |
|                                              |verification      |1.9             |1.9             |1.9             |1.9             |1.9             |1.9             |1.9             |1.9             |
|                                              |requirements,     |(required       |(required       |(required       |(required       |(required       |(required       |(required       |(required       |
|                                              |indicating that   |to be           |to be           |to be           |to be           |to be           |to be           |to be           |to be           |
|                                              |the control       |NLT             |NLT             |NLT             |NLT             |NLT             |NLT             |NLT             |NLT             |
|                                              |product solution  |1.5),           |1.5),           |1.5),           |1.5),           |1.5),           |1.5),           |1.5),           |1.5),           |
|                                              |was stable within |and the         |and the         |and the         |and the         |and the         |and the         |and the         |and the         |
|                                              |48hafter being    |RSD of          |RSD of          |RSD of          |RSD of          |RSD of          |RSD of          |RSD of          |RSD of          |
|                                              |placed in the     |the             |the             |the             |the             |the             |the             |the             |the             |
|                                              |5℃injector.       |peak-peakarea   |peak-peakarea   |peak-peakarea   |peak-peakarea   |peak-peakarea   |peak-peakarea   |peak-peakarea   |peak-peakarea   |
|                                              |                  |ofeachimpurity  |ofeachimpurity  |ofeachimpurity  |ofeachimpurity  |ofeachimpurity  |ofeachimpurity  |ofeachimpurity  |ofeachimpurity  |
|                                              |                  |was not         |was not         |was not         |was not         |was not         |was not         |was not         |was not         |
|                                              |                  |more            |more            |more            |more            |more            |more            |more            |more            |
|                                              |                  |than            |than            |than            |than            |than            |than            |than            |than            |
|                                              |                  |1.6%            |1.6%            |1.6%            |1.6%            |1.6%            |1.6%            |1.6%            |1.6%            |
|                                              |                  |(required       |(required       |(required       |(required       |(required       |(required       |(required       |(required       |
|                                              |                  |to be           |to be           |to be           |to be           |to be           |to be           |to be           |to be           |
|                                              |                  |no more         |no more         |no more         |no more         |no more         |no more         |no more         |no more         |
|                                              |                  |than            |than            |than            |than            |than            |than            |than            |than            |
|                                              |                  |5%).            |5%).            |5%).            |5%).            |5%).            |5%).            |5%).            |5%).            |
|                                              |                  |All the         |All the         |All the         |All the         |All the         |All the         |All the         |All the         |
|                                              |                  |above           |above           |above           |above           |above           |above           |above           |above           |
|                                              |                  |met the         |met the         |met the         |met the         |met the         |met the         |met the         |met the         |
|                                              |                  |verification    |verification    |verification    |verification    |verification    |verification    |verification    |verification    |
|                                              |                  |requirements,   |requirements,   |requirements,   |requirements,   |requirements,   |requirements,   |requirements,   |requirements,   |
|                                              |                  |indicating      |indicating      |indicating      |indicating      |indicating      |indicating      |indicating      |indicating      |
|                                              |                  |that            |that            |that            |that            |that            |that            |that            |that            |
|                                              |                  |the             |the             |the             |the             |the             |the             |the             |the             |
|                                              |                  |control         |control         |control         |control         |control         |control         |control         |control         |
|                                              |                  |product         |product         |product         |product         |product         |product         |product         |product         |
|                                              |                  |solution        |solution        |solution        |solution        |solution        |solution        |solution        |solution        |
|                                              |                  |was             |was             |was             |was             |was             |was             |was             |was             |
|                                              |                  |stable          |stable          |stable          |stable          |stable          |stable          |stable          |stable          |
|                                              |                  |within          |within          |within          |within          |within          |within          |within          |within          |
|                                              |                  |48hafter        |48hafter        |48hafter        |48hafter        |48hafter        |48hafter        |48hafter        |48hafter        |
|                                              |                  |being           |being           |being           |being           |being           |being           |being           |being           |
|                                              |                  |placed          |placed          |placed          |placed          |placed          |placed          |placed          |placed          |
|                                              |                  |in the          |in the          |in the          |in the          |in the          |in the          |in the          |in the          |
|                                              |                  |5℃injector.     |5℃injector.     |5℃injector.     |5℃injector.     |5℃injector.     |5℃injector.     |5℃injector.     |5℃injector.     |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------




































----------------------------------------------------------------------------------------------------------------------------
|InvestigationItems|InvestigationItems|Test solution|Test solution|Test        |Test    |Test    |Test    |Test    |RSD    |
|                  |                  |             |             |solution    |solution|solution|solution|solution|       |
|------------------|------------------|-------------|-------------|------------|--------|--------|--------|--------|-------|
|InvestigationItems|InvestigationItems|0h           |2h           |4h          |12h     |20h     |36h     |44h     |44h    |
|------------------|------------------|-------------|-------------|------------|--------|--------|--------|--------|-------|
|Co ntent          |YA2304 -52        |Not detected |Not detected |Not detected|Not     |Not     |Not     |Not     |/      |
|                  |                  |             |             |            |detected|detected|detected|detected|       |
|------------------|------------------|-------------|-------------|------------|--------|--------|--------|--------|-------|
|Co ntent          |Imidazo le        |Not detected |Not detected |Not detected|Not     |Not     |Not     |Not     |/      |
|                  |                  |             |             |            |detected|detected|detected|detected|       |
----------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 280 of 542 





Page 281
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 































------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Conclusion: YA2304-52, imidazole and          |Conclusion:            |Conclusion:            |Conclusion:            |Conclusion:            |Conclusion:            |Conclusion:            |Conclusion:            |Conclusion:            |Conclusion:            |
|4-dimethylaminopyridine (DMAP) were not       |YA2304-52,             |YA2304-52,             |YA2304-52,             |YA2304-52,             |YA2304-52,             |YA2304-52,             |YA2304-52,             |YA2304-52,             |YA2304-52,             |
|detected when the sample solution was placed  |imidazole              |imidazole              |imidazole              |imidazole              |imidazole              |imidazole              |imidazole              |imidazole              |imidazole              |
|in the sample injector at 5℃for 44h, and no   |and                    |and                    |and                    |and                    |and                    |and                    |and                    |and                    |and                    |
|otherimpurity peaksaffecting the detection of |4-dimethylaminopyridine|4-dimethylaminopyridine|4-dimethylaminopyridine|4-dimethylaminopyridine|4-dimethylaminopyridine|4-dimethylaminopyridine|4-dimethylaminopyridine|4-dimethylaminopyridine|4-dimethylaminopyridine|
|the above three impurities were detected. The |(DMAP)                 |(DMAP)                 |(DMAP)                 |(DMAP)                 |(DMAP)                 |(DMAP)                 |(DMAP)                 |(DMAP)                 |(DMAP)                 |
|resultsindicated that the tested product      |were                   |were                   |were                   |were                   |were                   |were                   |were                   |were                   |were                   |
|solution was stable for 44hafter being placed |not                    |not                    |not                    |not                    |not                    |not                    |not                    |not                    |not                    |
|in the 5℃injector.                            |detected               |detected               |detected               |detected               |detected               |detected               |detected               |detected               |detected               |
|                                              |when                   |when                   |when                   |when                   |when                   |when                   |when                   |when                   |when                   |
|                                              |the                    |the                    |the                    |the                    |the                    |the                    |the                    |the                    |the                    |
|                                              |sample                 |sample                 |sample                 |sample                 |sample                 |sample                 |sample                 |sample                 |sample                 |
|                                              |solution               |solution               |solution               |solution               |solution               |solution               |solution               |solution               |solution               |
|                                              |was                    |was                    |was                    |was                    |was                    |was                    |was                    |was                    |was                    |
|                                              |placed                 |placed                 |placed                 |placed                 |placed                 |placed                 |placed                 |placed                 |placed                 |
|                                              |in the                 |in the                 |in the                 |in the                 |in the                 |in the                 |in the                 |in the                 |in the                 |
|                                              |sample                 |sample                 |sample                 |sample                 |sample                 |sample                 |sample                 |sample                 |sample                 |
|                                              |injector               |injector               |injector               |injector               |injector               |injector               |injector               |injector               |injector               |
|                                              |at                     |at                     |at                     |at                     |at                     |at                     |at                     |at                     |at                     |
|                                              |5℃for                  |5℃for                  |5℃for                  |5℃for                  |5℃for                  |5℃for                  |5℃for                  |5℃for                  |5℃for                  |
|                                              |44h,                   |44h,                   |44h,                   |44h,                   |44h,                   |44h,                   |44h,                   |44h,                   |44h,                   |
|                                              |and no                 |and no                 |and no                 |and no                 |and no                 |and no                 |and no                 |and no                 |and no                 |
|                                              |otherimpurity          |otherimpurity          |otherimpurity          |otherimpurity          |otherimpurity          |otherimpurity          |otherimpurity          |otherimpurity          |otherimpurity          |
|                                              |peaksaffecting         |peaksaffecting         |peaksaffecting         |peaksaffecting         |peaksaffecting         |peaksaffecting         |peaksaffecting         |peaksaffecting         |peaksaffecting         |
|                                              |the                    |the                    |the                    |the                    |the                    |the                    |the                    |the                    |the                    |
|                                              |detection              |detection              |detection              |detection              |detection              |detection              |detection              |detection              |detection              |
|                                              |of the                 |of the                 |of the                 |of the                 |of the                 |of the                 |of the                 |of the                 |of the                 |
|                                              |above                  |above                  |above                  |above                  |above                  |above                  |above                  |above                  |above                  |
|                                              |three                  |three                  |three                  |three                  |three                  |three                  |three                  |three                  |three                  |
|                                              |impurities             |impurities             |impurities             |impurities             |impurities             |impurities             |impurities             |impurities             |impurities             |
|                                              |were                   |were                   |were                   |were                   |were                   |were                   |were                   |were                   |were                   |
|                                              |detected.              |detected.              |detected.              |detected.              |detected.              |detected.              |detected.              |detected.              |detected.              |
|                                              |The                    |The                    |The                    |The                    |The                    |The                    |The                    |The                    |The                    |
|                                              |resultsindicated       |resultsindicated       |resultsindicated       |resultsindicated       |resultsindicated       |resultsindicated       |resultsindicated       |resultsindicated       |resultsindicated       |
|                                              |that                   |that                   |that                   |that                   |that                   |that                   |that                   |that                   |that                   |
|                                              |the                    |the                    |the                    |the                    |the                    |the                    |the                    |the                    |the                    |
|                                              |tested                 |tested                 |tested                 |tested                 |tested                 |tested                 |tested                 |tested                 |tested                 |
|                                              |product                |product                |product                |product                |product                |product                |product                |product                |product                |
|                                              |solution               |solution               |solution               |solution               |solution               |solution               |solution               |solution               |solution               |
|                                              |was                    |was                    |was                    |was                    |was                    |was                    |was                    |was                    |was                    |
|                                              |stable                 |stable                 |stable                 |stable                 |stable                 |stable                 |stable                 |stable                 |stable                 |
|                                              |for                    |for                    |for                    |for                    |for                    |for                    |for                    |for                    |for                    |
|                                              |44hafter               |44hafter               |44hafter               |44hafter               |44hafter               |44hafter               |44hafter               |44hafter               |44hafter               |
|                                              |being                  |being                  |being                  |being                  |being                  |being                  |being                  |being                  |being                  |
|                                              |placed                 |placed                 |placed                 |placed                 |placed                 |placed                 |placed                 |placed                 |placed                 |
|                                              |in the                 |in the                 |in the                 |in the                 |in the                 |in the                 |in the                 |in the                 |in the                 |
|                                              |5℃injector.            |5℃injector.            |5℃injector.            |5℃injector.            |5℃injector.            |5℃injector.            |5℃injector.            |5℃injector.            |5℃injector.            |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 281 of 542 





Page 282
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**III. Summary of Method Validation** 



Methodological Verification Results of Finished Product Related Substances II 












-----------------------------------------------------------------------------------------------------------------------------------------
|Wavele ngth selection|Allimpurities (YA2304-52, imidazole and 4-dimethylaminopyridine) have greaterabsorption |Allimpurities           |
|                     |at 210nm wavelength                                                                     |(YA2304-52,             |
|                     |                                                                                        |imidazole               |
|                     |                                                                                        |and                     |
|                     |                                                                                        |4-dimethylaminopyridine)|
|                     |                                                                                        |have                    |
|                     |                                                                                        |greaterabsorption       |
|                     |                                                                                        |at                      |
|                     |                                                                                        |210nm                   |
|                     |                                                                                        |wavelength.             |
|                     |                                                                                        |In the                  |
|                     |                                                                                        |control                 |
|                     |                                                                                        |solution,               |
|                     |                                                                                        |the                     |
|                     |                                                                                        |retention               |
|                     |                                                                                        |time of                 |
|                     |                                                                                        |YA2144-52,              |
|                     |                                                                                        |imidazole               |
|                     |                                                                                        |and                     |
|                     |                                                                                        |4-dimethylaminopyridine |
|                     |                                                                                        |was                     |
|                     |                                                                                        |6.392min,               |
|                     |                                                                                        |7.362min                |
|                     |                                                                                        |and                     |
|                     |                                                                                        |16.667min,              |
|                     |                                                                                        |respectively.           |
|                     |                                                                                        |The                     |
|                     |                                                                                        |spectral                |
|                     |                                                                                        |diagram                 |
|                     |                                                                                        |of the                  |
|                     |                                                                                        |control                 |
|                     |                                                                                        |solutionisas            |
|                     |                                                                                        |follows:                |
|---------------------|----------------------------------------------------------------------------------------|------------------------|
|System suitability   |The blank solution should be free ofinterference; The control solution should be        |There was no            |
|                     |injected for 6 consecutive times, and the peakorder should be YA2304-52, imidazole and  |interference in the     |
|                     |4-dimethylaminopyridine. The separation degree betweenimidazole                         |blank solution; The     |
|                     |                                                                                        |control solution        |
|                     |                                                                                        |wasinjected for 6       |
|                     |                                                                                        |consecutive times, the  |
|                     |                                                                                        |peakorder was YA2304-52,|
|                     |                                                                                        |imidazole,              |
|                     |                                                                                        |4-dimethylaminopyridine,|
|                     |                                                                                        |the separation degree   |
|                     |                                                                                        |betweenimidazole peak   |
|                     |                                                                                        |and YA2304-52 peak was  |
|                     |                                                                                        |1.9 (NLT 1.5), and the  |
|                     |                                                                                        |retention time RSD      |
|                     |                                                                                        |ofeachimpurity peak was |
|                     |                                                                                        |no more than 0.10%(NMT  |
|                     |                                                                                        |1.0%). The RSD of the   |
|                     |                                                                                        |peakarea ofeachimpurity |
|                     |                                                                                        |peak was no more than   |
|                     |                                                                                        |0.7% (NMT 5%); All the  |
|                     |                                                                                        |above meet the          |
|                     |                                                                                        |verification            |
|                     |                                                                                        |requirements, indicating|
|                     |                                                                                        |that the method has good|
|                     |                                                                                        |system                  |
-----------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 282 of 542 





Page 283
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 

































-----------------------------------------------------------------------------------------------------------------------------------------
|Specificity|The blank solution should be free ofinterference; In the chromatogramobtained from the control    |Blank                   |
|           |solution, the peakorderis YA2304-52, imidazole, 4-dimethylaminopyridine, and the separation degree|solution                |
|           |between the imidazole peak and YA2304-52 peak should NLT 1.5. The retention time ofeachimpurity   |withoutinterference;    |
|           |peak in the control solution, the test solution and the specific mixed solution should be         |In the                  |
|           |consistent with the retention time of the main peak in the impurity localization solution. The    |chromatogramobtained    |
|           |separation degree between the imidazole peak and YA2304-52 peak in the specific mixed solution    |from                    |
|           |should be NLT 1.5. Allimpurities studiedunder the related substances of the finished product      |the                     |
|           |(including YA2304-10, YA2304-12,                                                                  |control                 |
|           |                                                                                                  |solution,               |
|           |                                                                                                  |the                     |
|           |                                                                                                  |peakorder               |
|           |                                                                                                  |was                     |
|           |                                                                                                  |YA2304-52,              |
|           |                                                                                                  |imidazole,              |
|           |                                                                                                  |4-dimethylaminopyridine,|
|           |                                                                                                  |and the                 |
|           |                                                                                                  |separation              |
|           |                                                                                                  |degree                  |
|           |                                                                                                  |between                 |
|           |                                                                                                  |the                     |
|           |                                                                                                  |imidazole               |
|           |                                                                                                  |peak                    |
|           |                                                                                                  |and                     |
|           |                                                                                                  |YA2304-52               |
|           |                                                                                                  |peak                    |
|           |                                                                                                  |was 1.9                 |
|           |                                                                                                  |(required               |
|           |                                                                                                  |to be                   |
|           |                                                                                                  |NLT                     |
|           |                                                                                                  |1.5);                   |
|           |                                                                                                  |The                     |
|           |                                                                                                  |retention               |
|           |                                                                                                  |time                    |
|           |                                                                                                  |ofeachimpurity          |
|           |                                                                                                  |peak in                 |
|           |                                                                                                  |the                     |
|           |                                                                                                  |control                 |
|           |                                                                                                  |solution,               |
|           |                                                                                                  |the                     |
|           |                                                                                                  |test                    |
|           |                                                                                                  |solution                |
|           |                                                                                                  |and the                 |
|           |                                                                                                  |specific                |
|           |                                                                                                  |mixed                   |
|           |                                                                                                  |solution                |
|           |                                                                                                  |was                     |
|           |                                                                                                  |consistent              |
|           |                                                                                                  |with                    |
|           |                                                                                                  |that of                 |
|           |                                                                                                  |the                     |
|           |                                                                                                  |main                    |
|           |                                                                                                  |peak in                 |
|           |                                                                                                  |the                     |
|           |                                                                                                  |impurity                |
|           |                                                                                                  |positioning             |
|           |                                                                                                  |solution.               |
|           |                                                                                                  |The                     |
|           |                                                                                                  |separation              |
|           |                                                                                                  |degree                  |
|           |                                                                                                  |between                 |
|           |                                                                                                  |the                     |
|           |                                                                                                  |imidazole               |
|           |                                                                                                  |peak                    |
|           |                                                                                                  |and                     |
|           |                                                                                                  |YA2304-52               |
|           |                                                                                                  |peak in                 |
|           |                                                                                                  |the                     |
|           |                                                                                                  |specific                |
|           |                                                                                                  |mixed                   |
|           |                                                                                                  |solution                |
|           |                                                                                                  |was 1.9                 |
|           |                                                                                                  |(NLT                    |
|           |                                                                                                  |1.5);                   |
|           |                                                                                                  |The                     |
|           |                                                                                                  |impurities              |
|           |                                                                                                  |studiedunder            |
|           |                                                                                                  |the                     |
|           |                                                                                                  |related                 |
|           |                                                                                                  |substances              |
|           |                                                                                                  |of                      |
|           |                                                                                                  |finished                |
|           |                                                                                                  |products                |
|           |                                                                                                  |(including              |
|           |                                                                                                  |YA2304-10,              |
|           |                                                                                                  |YA2304-12,              |
|           |                                                                                                  |YA2304-14,              |
|           |                                                                                                  |YA2304-15,              |
|           |                                                                                                  |YA2304-16,              |
|           |                                                                                                  |YA2304-17,              |
|           |                                                                                                  |YA2304-18               |
|           |                                                                                                  |and                     |
|           |                                                                                                  |YA2304-19)              |
|           |                                                                                                  |did                     |
|           |                                                                                                  |notinterfere            |
|           |                                                                                                  |with                    |
|           |                                                                                                  |YA2304-52,              |
|           |                                                                                                  |imidazole               |
|           |                                                                                                  |and 4-                  |
|           |                                                                                                  |in the                  |
|           |                                                                                                  |test                    |
|           |                                                                                                  |product                 |
|           |                                                                                                  |Detection               |
|           |                                                                                                  |of                      |
|           |                                                                                                  |dimethylaminopyridine.  |
|           |                                                                                                  |The                     |
|           |                                                                                                  |concentration           |
|           |                                                                                                  |of                      |
|           |                                                                                                  |YA2304-52,              |
|           |                                                                                                  |imidazole               |
|           |                                                                                                  |and                     |
|           |                                                                                                  |4-dimethylaminopyridine |
|           |                                                                                                  |in the                  |
|           |                                                                                                  |specific                |
|           |                                                                                                  |mixed                   |
|           |                                                                                                  |solution                |
|           |                                                                                                  |was                     |
|           |                                                                                                  |0.10%                   |
|           |                                                                                                  |of the                  |
|           |                                                                                                  |principal               |
|           |                                                                                                  |component               |
|           |                                                                                                  |concentration           |
|           |                                                                                                  |in the                  |
|           |                                                                                                  |test                    |
|           |                                                                                                  |solution.               |
|           |                                                                                                  |**Name**                |
|           |                                                                                                  |**of**                  |
|           |                                                                                                  |**soluti**              |
|           |                                                                                                  |**on**                  |
|           |                                                                                                  |**Compone**             |
|           |                                                                                                  |**nt                    |
|           |                                                                                                  |name**                  |
|           |                                                                                                  |**Compone**             |
|           |                                                                                                  |**nt**                  |
|           |                                                                                                  |**concentra**           |
|           |                                                                                                  |**tion**                |
|           |                                                                                                  |**(μg/ml)**             |
|           |                                                                                                  |**Rt                    |
|           |                                                                                                  |(min)**                 |
|           |                                                                                                  |**Degree                |
|           |                                                                                                  |of**                    |
|           |                                                                                                  |**separation**          |
|           |                                                                                                  |**from                  |
|           |                                                                                                  |the**                   |
|           |                                                                                                  |**previous**            |
|           |                                                                                                  |**peak**                |
|           |                                                                                                  |**The                   |
|           |                                                                                                  |percentage**            |
|           |                                                                                                  |**equivalent            |
|           |                                                                                                  |to                      |
|           |                                                                                                  |the**                   |
|           |                                                                                                  |**concentrationof**     |
|           |                                                                                                  |**the                   |
|           |                                                                                                  |principal**             |
|           |                                                                                                  |**component             |
|           |                                                                                                  |in                      |
|           |                                                                                                  |the**                   |
|           |                                                                                                  |**test                  |
|           |                                                                                                  |solution**              |
|           |                                                                                                  |Specifi                 |
|           |                                                                                                  |cmixed                  |
|           |                                                                                                  |YA2304-52               |
|           |                                                                                                  |5.2991                  |
|           |                                                                                                  |6.354 /                 |
|           |                                                                                                  |0.10%                   |
|           |                                                                                                  |Imidazole               |
|           |                                                                                                  |5.1637                  |
|           |                                                                                                  |7.386                   |
|           |                                                                                                  |1.9                     |
|           |                                                                                                  |0.10%                   |
|           |                                                                                                  |DMAP                    |
|           |                                                                                                  |5.1695                  |
|           |                                                                                                  |16.756                  |
|           |                                                                                                  |15.0                    |
|           |                                                                                                  |0.10%                   |
-----------------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------
|Specifi cmixed|YA2304-52|5.2991 |6.354  |/      |0.10%  |
|--------------|---------|-------|-------|-------|-------|
|Specifi cmixed|Imidazole|5.1637 |7.386  |1.9    |0.10%  |
|--------------|---------|-------|-------|-------|-------|
|Specifi cmixed|DMAP     |5.1695 |16.756 |15.0   |0.10%  |
----------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 283 of 542 





Page 284
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 













































----------------------------------------------------------------------------------------------------------------------------------------------------------------
|Limits of quantifi cation and detection|TheS/Nofeachimpurity in the 6 limited |       |**Impurities**         |**Detection    |**Limit        |               |
|                                       |quantitation solution maps should NLT |       |                       |Limits**       |of             |               |
|                                       |10, the RSDS of the peak retention    |       |                       |               |quantitation** |               |
|                                       |time ofeachimpurity should not be more|       |                       |               |               |               |
|                                       |than 2.0%, and the RSDS of the        |       |                       |               |               |               |
|                                       |peakarea should not be more than 10%. |       |                       |               |               |               |
|                                       |TheS/Nofeachimpurity in the 3-needle  |       |                       |               |               |               |
|                                       |detection limited solutionatlas       |       |                       |               |               |               |
|---------------------------------------|--------------------------------------|-------|-----------------------|---------------|---------------|---------------|
|Limits of quantifi cation and detection|TheS/Nofeachimpurity in the 6 limited |       |**Impurities**         |**Concentration|**Concentration|**Concentration|
|                                       |quantitation solution maps should NLT |       |                       |(equivalent    |(equivalent to |(equivalent    |
|                                       |10, the RSDS of the peak retention    |       |                       |to** **the     |the** **test   |to             |
|                                       |time ofeachimpurity should not be more|       |                       |concentration  |product        |the**          |
|                                       |than 2.0%, and the RSDS of the        |       |                       |percentage     |solution**     |**test         |
|                                       |peakarea should not be more than 10%. |       |                       |of** **the     |**concentration|product        |
|                                       |TheS/Nofeachimpurity in the 3-needle  |       |                       |test           |percentage)**  |solution**     |
|                                       |detection limited solutionatlas       |       |                       |product        |               |**concentration|
|                                       |                                      |       |                       |solution)**    |               |percentage)**  |
|---------------------------------------|--------------------------------------|-------|-----------------------|---------------|---------------|---------------|
|Limits of quantifi cation and detection|TheS/Nofeachimpurity in the 6 limited |       |YA2304-52              |0.3974μg/ml    |1.3248μg/ml    |1.3248μg/ml    |
|                                       |quantitation solution maps should NLT |       |                       |(0.008%)       |(0.03%)        |(0.03%)        |
|                                       |10, the RSDS of the peak retention    |       |                       |               |               |               |
|                                       |time ofeachimpurity should not be more|       |                       |               |               |               |
|                                       |than 2.0%, and the RSDS of the        |       |                       |               |               |               |
|                                       |peakarea should not be more than 10%. |       |                       |               |               |               |
|                                       |TheS/Nofeachimpurity in the 3-needle  |       |                       |               |               |               |
|                                       |detection limited solutionatlas       |       |                       |               |               |               |
|---------------------------------------|--------------------------------------|-------|-----------------------|---------------|---------------|---------------|
|Limits of quantifi cation and detection|TheS/Nofeachimpurity in the 6 limited |       |Imidazole              |0.0310μg/ml    |0.1033μg/ml    |0.1033μg/ml    |
|                                       |quantitation solution maps should NLT |       |                       |(0.0006%)      |(0.002%)       |(0.002%)       |
|                                       |10, the RSDS of the peak retention    |       |                       |               |               |               |
|                                       |time ofeachimpurity should not be more|       |                       |               |               |               |
|                                       |than 2.0%, and the RSDS of the        |       |                       |               |               |               |
|                                       |peakarea should not be more than 10%. |       |                       |               |               |               |
|                                       |TheS/Nofeachimpurity in the 3-needle  |       |                       |               |               |               |
|                                       |detection limited solutionatlas       |       |                       |               |               |               |
|---------------------------------------|--------------------------------------|-------|-----------------------|---------------|---------------|---------------|
|Limits of quantifi cation and detection|TheS/Nofeachimpurity in the 6 limited |       |4-dimethylaminopyridine|0.0233μg/ml    |0.0775μg/ml    |0.0775μg/ml    |
|                                       |quantitation solution maps should NLT |       |                       |(0.0005%)      |(0.002%)       |(0.002%)       |
|                                       |10, the RSDS of the peak retention    |       |                       |               |               |               |
|                                       |time ofeachimpurity should not be more|       |                       |               |               |               |
|                                       |than 2.0%, and the RSDS of the        |       |                       |               |               |               |
|                                       |peakarea should not be more than 10%. |       |                       |               |               |               |
|                                       |TheS/Nofeachimpurity in the 3-needle  |       |                       |               |               |               |
|                                       |detection limited solutionatlas       |       |                       |               |               |               |
----------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 284 of 542 





Page 285
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 


















---------------------------------------------------------------------------------------------
|YA2304-52                |1.3248μg/ml to 10.5982μg/ml (0.03% to 0.0.21%)|Y = 5118-1965.5 x |
|-------------------------|----------------------------------------------|------------------|
|Imidazole                |0.1033μg/ml~10.3273μg/ml (0.002%~0.21%)       |Y = 83064-5713.7 x|
|-------------------------|----------------------------------------------|------------------|
|4- dimethylamino pyridine|0.0775μg/ml to 10.3390μg/ml (0.002% to 0.21%) |y=93774x-10958    |
---------------------------------------------------------------------------------------------



























----------------------------------------------------------------------------------
|YA2304-52                |Added 2.6495μg/ml to 7.9486μg/ml|99.3%, n=9 |5%, n=9  |
|-------------------------|--------------------------------|-----------|---------|
|Imidazole                |Added 2.5818μg/ml to 7.7455μg/ml|99.5%, n=9 |1.5%, n=9|
|-------------------------|--------------------------------|-----------|---------|
|4- dimethylamino pyridine|Added 2.5848μg/ml~7.7543μg/ml   |102.1%, n=9|1.8%, n=9|
----------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------------
|Linearity vs. Range|In the range equivalent to the LOQ concentration ofeachimpurity ~ 200% limit              |**Impurities**          |
|                   |concentration, take 6 concentration points more evenly, take the concentration            |**Concentration         |
|                   |ofeachimpurityas the horizontal coordinate and the peakarea as the vertical coordinate as |(equivalent             |
|                   |the linear regression curve, the regression coefficientR of the linear graph should NLT   |to the                  |
|                   |0.990, and the RSD of the response factor should not be more than 10%. Y-axisinterceptsare|percentage**            |
|                   |within 25% of 100% response value.                                                        |**of                    |
|                   |                                                                                          |solution                |
|                   |                                                                                          |concentration           |
|                   |                                                                                          |of the                  |
|                   |                                                                                          |test                    |
|                   |                                                                                          |product)**              |
|                   |                                                                                          |**Linearequation**      |
|                   |                                                                                          |YA2304-52               |
|                   |                                                                                          |1.3248μg/ml             |
|                   |                                                                                          |to                      |
|                   |                                                                                          |10.5982μg/ml            |
|                   |                                                                                          |(0.03%                  |
|                   |                                                                                          |to                      |
|                   |                                                                                          |0.0.21%)                |
|                   |                                                                                          |Y =                     |
|                   |                                                                                          |5118-1965.5             |
|                   |                                                                                          |xImidazole              |
|                   |                                                                                          |0.1033μg/ml~10.3273μg/ml|
|                   |                                                                                          |(0.002%~0.21%)          |
|                   |                                                                                          |Y =                     |
|                   |                                                                                          |83064-5713.7            |
|                   |                                                                                          |x 4-                    |
|                   |                                                                                          |dimethylamino           |
|                   |                                                                                          |pyridine                |
|                   |                                                                                          |0.0775μg/ml             |
|                   |                                                                                          |to                      |
|                   |                                                                                          |10.3390μg/ml            |
|                   |                                                                                          |(0.002%                 |
|                   |                                                                                          |to                      |
|                   |                                                                                          |0.21%)                  |
|                   |                                                                                          |y=93774x-10958          |
|-------------------|------------------------------------------------------------------------------------------|------------------------|
|Accura cy          |The recovery rate of knownimpuritiesisachieved byaddingeachimpurity reference in the range|**Impurities** **Marking|
|                   |of 50% concentration to 150% limit concentration in the test product solution, and testing|condition** **Average** |
|                   |the recovery rate between the theoreticaladditionamount and the actual detectionamount.   |**recovery rate**       |
|                   |The required recovery rate is 80%~115%, and the RSD of the recovery rate ofeach           |**RSD** YA2304-52 Added |
|                   |                                                                                          |2.6495μg/ml to          |
|                   |                                                                                          |7.9486μg/ml 99.3%, n=9  |
|                   |                                                                                          |5%, n=9 Imidazole Added |
|                   |                                                                                          |2.5818μg/ml to          |
|                   |                                                                                          |7.7455μg/ml 99.5%, n=9  |
|                   |                                                                                          |1.5%, n=9 4-            |
|                   |                                                                                          |dimethylamino pyridine  |
|                   |                                                                                          |Added                   |
|                   |                                                                                          |2.5848μg/ml~7.7543μg/ml |
|                   |                                                                                          |102.1%, n=9 1.8%, n=9   |
-----------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 285 of 542 





Page 286
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 





















--------------------------------------------------------
|YA2304-52              |1.2%, n=6|1.1%, n=6|1.1%, n=12|
|-----------------------|---------|---------|----------|
|Imidazole              |0.9%, n=6|1.1%, n=6|1.8%, n=12|
|-----------------------|---------|---------|----------|
|4-dimethylaminopyridine|1.6%, n=6|1.3%, n=6|2.2%, n=12|
--------------------------------------------------------
----------------------------------------------------------------------------------------------------------------------------------------
|Precision         |Repeatability andintermediate precision: the RSD ofeachimpurity in 6 repeatability         |**Impurities**         |
|                  |(orintermediate precision test product) solution NMT 10%. Precision: Repeatability         |**Repeatability**      |
|                  |andintermediate precision 12 test results, eachimpurity content RSD NMT 10%.               |**Intermediate**       |
|                  |                                                                                           |**precision**          |
|                  |                                                                                           |**Precision**          |
|                  |                                                                                           |YA2304-52              |
|                  |                                                                                           |1.2%,                  |
|                  |                                                                                           |n=6                    |
|                  |                                                                                           |1.1%,                  |
|                  |                                                                                           |n=6                    |
|                  |                                                                                           |1.1%,                  |
|                  |                                                                                           |n=12                   |
|                  |                                                                                           |Imidazole              |
|                  |                                                                                           |0.9%,                  |
|                  |                                                                                           |n=6                    |
|                  |                                                                                           |1.1%,                  |
|                  |                                                                                           |n=6                    |
|                  |                                                                                           |1.8%,                  |
|                  |                                                                                           |n=12                   |
|                  |                                                                                           |4-dimethylaminopyridine|
|                  |                                                                                           |1.6%,                  |
|                  |                                                                                           |n=6                    |
|                  |                                                                                           |1.3%,                  |
|                  |                                                                                           |n=6                    |
|                  |                                                                                           |2.2%,                  |
|                  |                                                                                           |n=12                   |
|------------------|-------------------------------------------------------------------------------------------|-----------------------|
|Solutio nstability|Each solution was placedina 5℃ injector, and the control solution and the test solution    |Control solution:      |
|                  |were injected at different times. The separation degree betweenimidazole peak and YA2304-52|Within 48 hof being    |
|                  |peak in the control solution NLT 1.5, and the RSD of the peakarea ofeachimpurity peak      |placedina 5℃injector,  |
|                  |should be no more than 5%; The RSDS ofallimpurities in the test solution NMT 10%, and no   |the separation degree  |
|                  |newimpurities to be measured (YA2304-52, imidazole, 4-dimethylaminopyridine) should be     |betweenimidazole peak  |
|                  |detected.                                                                                  |and YA2304-52 peak was |
|                  |                                                                                           |NLT 1.9 (required to be|
|                  |                                                                                           |NLT 1.5), and the RSD  |
|                  |                                                                                           |ofeachimpurity peakarea|
|                  |                                                                                           |was not more than 1.6% |
|                  |                                                                                           |(required to be no more|
|                  |                                                                                           |than 5%); The above all|
|                  |                                                                                           |met the verification   |
|                  |                                                                                           |requirements,          |
|                  |                                                                                           |indicating that the    |
|                  |                                                                                           |control solution was   |
|                  |                                                                                           |stable within 48hafter |
|                  |                                                                                           |being placed in the    |
|                  |                                                                                           |5℃injector. Test       |
|                  |                                                                                           |product solution:      |
|                  |                                                                                           |YA2304-52, imidazole   |
|                  |                                                                                           |and                    |
|                  |                                                                                           |4-dimethylaminopyridine|
|                  |                                                                                           |(DMAP) were not        |
|                  |                                                                                           |detected within        |
|                  |                                                                                           |44hafter being placed  |
|                  |                                                                                           |in the sample injector |
|                  |                                                                                           |at 5℃, and no          |
|                  |                                                                                           |otherimpurity          |
|                  |                                                                                           |peaksaffecting the     |
|                  |                                                                                           |detection of the above |
|                  |                                                                                           |three impurities were  |
|                  |                                                                                           |detected; The          |
|                  |                                                                                           |resultsindicated that  |
|                  |                                                                                           |the test solution was  |
|                  |                                                                                           |stable within 44hafter |
|                  |                                                                                           |being placed in the 5℃ |
|                  |                                                                                           |injector. The above    |
|                  |                                                                                           |solutions do not need  |
|                  |                                                                                           |new preparation for    |
|                  |                                                                                           |temporaryuse.          |
----------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 286 of 542 





Page 287
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.4.3.3 Methodological verification of Enantiomers of finished** 


**products** 



**I. Analytical Procedures** 



Please refer to the analytical procedures of Enantiomers in Finerenone in 



_section 3.2.S.4.2_ . 



**II. Validation Results and Discussion** 



**a. Wavelength selection** 



 **Acceptance Criteria** 



The selection of detection wavelength requires UV scanning of impurity 



YA2304-20 at 200nm ~ 400nm wavelength, impurity YA2304-20 should have 



greater absorption at 251nm. 



 **Solution preparation** 



Solvent: acetonitrile: water (30:70，v/v) 



Blank solution: solvent. 



Reserve liquid of reference product: Take YA2304-20 about 7.5mg of 



reference product, accurately weigh it, place it in a 50ml measuring bottle, 



add appropriate amount of solvent to dissolve by ultrasound, cool it, dilute it 



with solvent to scale, shake well, and then get. (Approx. 150μg/ml) 



Control product solution: accurately measure 1ml of the control product 



reserve solution, place it in a 100ml measuring bottle, dilute it with solvent to 



the scale, shake well, and get. 



 **Injection procedure** 



After the blank solution, 1 needle of the mixed control solution was injected 



and the chromatogram was recorded. 



 **Measurement results** 



Name of Test Retention time Maximum absorption wavelength (nm) 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 287 of 542 





Page 288
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 















----------------------------------------------------------------------------------------------------------------------------------
|Reference solution               |YA2304-2 0                                                          |25.626      |205.9,      |
|                                 |                                                                    |            |250.8,      |
|                                 |                                                                    |            |292.4,      |
|                                 |                                                                    |            |340.3       |
|---------------------------------|--------------------------------------------------------------------|------------|------------|
|Spectrogram of reference solution|                                                                    |            |            |
|---------------------------------|--------------------------------------------------------------------|------------|------------|
|Conclusion                       |Impurity YA2304-20 hasa large absorption at 251nm, which meets the  |Impurity    |Impurity    |
|                                 |verification requirements                                           |YA2304-20   |YA2304-20   |
|                                 |                                                                    |hasa        |hasa        |
|                                 |                                                                    |large       |large       |
|                                 |                                                                    |absorption  |absorption  |
|                                 |                                                                    |at          |at          |
|                                 |                                                                    |251nm,      |251nm,      |
|                                 |                                                                    |which       |which       |
|                                 |                                                                    |meets       |meets       |
|                                 |                                                                    |the         |the         |
|                                 |                                                                    |verification|verification|
|                                 |                                                                    |requirements|requirements|
----------------------------------------------------------------------------------------------------------------------------------

**(4.2) System suitability** 



 **Acceptance Criteria** 



The blank solution should be free of interference; The separation degree 



between the main peak and YA2304-20 peak in the chromatogram of system 



suitability solution should be greater than 1.5; In the chromatogram 



obtained for 6 consecutive days, the signal-to-noise ratio (S/N) of YA2304-20 



peak should NLT 30, the RSD of the retention time NMT 1.0%, and the RSD of 



the peak area NMT 5%. 



 **Solution Preparation** 



Blank solution: solvent. 



Reference product reserve solution: Prepare the reference product reserve 



solution according to "4.1 wavelength selection" under the same method. 



Reference solution: prepared in the same way as the reference solution under 



"4.1 wavelength selection". 



System suitability solution: Take YA2304 reference product about 20mg, 



accurately weigh it, place it in a 20ml measuring bottle, dissolve it with the 



reference product solution and dilute it to the scale, shake well, and then get 



it. 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 288 of 542 





Page 289
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



 **Injection procedure** 



After the instrument is balanced, 1 needle of blank solution is injected, 1 



needle of system suitability solution is injected, and 6 needles of control 



solution are injected continuously. 



 **Measurement results** 































----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|System suitability solution                                                           |1                   |3.0                 |3.0                 |3.0                 |
|--------------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|
|Reference solution                                                                    |Sample              |Retention           |Peakarea            |Signal-to-noise     |
|                                                                                      |number              |time                |                    |ratio               |
|                                                                                      |                    |(min)               |                    |                    |
|--------------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|
|Reference solution                                                                    |1                   |24.926              |23887               |80.8                |
|--------------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|
|Reference solution                                                                    |2                   |24.933              |23768               |72.6                |
|--------------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|
|Reference solution                                                                    |3                   |24.922              |23570               |76.0                |
|--------------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|
|Reference solution                                                                    |4                   |24.926              |23907               |72.3                |
|--------------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|
|Reference solution                                                                    |5                   |24.882              |23670               |71.5                |
|--------------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|
|Reference solution                                                                    |6                   |24.912              |23708               |83.4                |
|--------------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|
|Reference solution                                                                    |RSD%(n=6)           |0.08                |0.6                 |/                   |
|--------------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|
|Conclusion: The blank solution has no interference; The separation degree between     |Conclusion:         |Conclusion:         |Conclusion:         |Conclusion: The     |
|YA2304-20 peak and main peak in the systemapplicability solutionis 3.0 (the           |The blank           |The blank           |The                 |blank solution      |
|requirement should NLT 1.5). In the chromatogramobtained from the control product     |solution            |solution            |blank               |has no              |
|solution, the signal-to-noise ratio of the main peak was between 71.5 and 83.4 (the   |has no              |has no              |solution            |interference;       |
|requirement should be NLT 30); The RSD of peak retention time of YA2304-20 in the     |interference;       |interference;       |has no              |The separation      |
|photoproduct solution for 6 consecutive days was 0.08% (the requirement should NMT    |The                 |The                 |interference;       |degree between      |
|1.0%); The RSD of peakarea is 0.6% (the requirement should NMT 5%); All meet the      |separation          |separation          |The                 |YA2304-20 peak      |
|verification requirements. It shows that this method has good systemapplicability.    |degree              |degree              |separation          |and main peak       |
|                                                                                      |between             |between             |degree              |in the              |
|                                                                                      |YA2304-20           |YA2304-20           |between             |systemapplicability |
|                                                                                      |peak and            |peak and            |YA2304-20           |solutionis 3.0      |
|                                                                                      |main peak           |main peak           |peak and            |(the                |
|                                                                                      |in the              |in the              |main                |requirement         |
|                                                                                      |systemapplicability |systemapplicability |peak in             |should NLT          |
|                                                                                      |solutionis          |solutionis          |the                 |1.5). In the        |
|                                                                                      |3.0 (the            |3.0 (the            |systemapplicability |chromatogramobtained|
|                                                                                      |requirement         |requirement         |solutionis          |from the            |
|                                                                                      |should              |should              |3.0 (the            |control product     |
|                                                                                      |NLT 1.5).           |NLT 1.5).           |requirement         |solution, the       |
|                                                                                      |In the              |In the              |should              |signal-to-noise     |
|                                                                                      |chromatogramobtained|chromatogramobtained|NLT                 |ratio of the        |
|                                                                                      |from the            |from the            |1.5). In            |main peak was       |
|                                                                                      |control             |control             |the                 |between 71.5        |
|                                                                                      |product             |product             |chromatogramobtained|and 83.4 (the       |
|                                                                                      |solution,           |solution,           |from the            |requirement         |
|                                                                                      |the                 |the                 |control             |should be NLT       |
|                                                                                      |signal-to-noise     |signal-to-noise     |product             |30); The RSD of     |
|                                                                                      |ratio of            |ratio of            |solution,           |peak retention      |
|                                                                                      |the main            |the main            |the                 |time of             |
|                                                                                      |peak was            |peak was            |signal-to-noise     |YA2304-20 in        |
|                                                                                      |between             |between             |ratio of            |the                 |
|                                                                                      |71.5 and            |71.5 and            |the main            |photoproduct        |
|                                                                                      |83.4 (the           |83.4 (the           |peak was            |solution for 6      |
|                                                                                      |requirement         |requirement         |between             |consecutive         |
|                                                                                      |should be           |should be           |71.5 and            |days was 0.08%      |
|                                                                                      |NLT 30);            |NLT 30);            |83.4                |(the                |
|                                                                                      |The RSD             |The RSD             |(the                |requirement         |
|                                                                                      |of peak             |of peak             |requirement         |should NMT          |
|                                                                                      |retention           |retention           |should              |1.0%); The RSD      |
|                                                                                      |time of             |time of             |be NLT              |of peakarea is      |
|                                                                                      |YA2304-20           |YA2304-20           |30); The            |0.6% (the           |
|                                                                                      |in the              |in the              |RSD of              |requirement         |
|                                                                                      |photoproduct        |photoproduct        |peak                |should NMT 5%);     |
|                                                                                      |solution            |solution            |retention           |All meet the        |
|                                                                                      |for 6               |for 6               |time of             |verification        |
|                                                                                      |consecutive         |consecutive         |YA2304-20           |requirements.       |
|                                                                                      |days was            |days was            |in the              |It shows that       |
|                                                                                      |0.08%               |0.08%               |photoproduct        |this method has     |
|                                                                                      |(the                |(the                |solution            |good                |
|                                                                                      |requirement         |requirement         |for 6               |systemapplicability.|
|                                                                                      |should              |should              |consecutive         |                    |
|                                                                                      |NMT                 |NMT                 |days was            |                    |
|                                                                                      |1.0%);              |1.0%);              |0.08%               |                    |
|                                                                                      |The RSD             |The RSD             |(the                |                    |
|                                                                                      |of                  |of                  |requirement         |                    |
|                                                                                      |peakarea            |peakarea            |should              |                    |
|                                                                                      |is 0.6%             |is 0.6%             |NMT                 |                    |
|                                                                                      |(the                |(the                |1.0%);              |                    |
|                                                                                      |requirement         |requirement         |The RSD             |                    |
|                                                                                      |should              |should              |of                  |                    |
|                                                                                      |NMT 5%);            |NMT 5%);            |peakarea            |                    |
|                                                                                      |All meet            |All meet            |is 0.6%             |                    |
|                                                                                      |the                 |the                 |(the                |                    |
|                                                                                      |verification        |verification        |requirement         |                    |
|                                                                                      |requirements.       |requirements.       |should              |                    |
|                                                                                      |It shows            |It shows            |NMT 5%);            |                    |
|                                                                                      |that this           |that this           |All meet            |                    |
|                                                                                      |method              |method              |the                 |                    |
|                                                                                      |has good            |has good            |verification        |                    |
|                                                                                      |systemapplicability.|systemapplicability.|requirements.       |                    |
|                                                                                      |                    |                    |It shows            |                    |
|                                                                                      |                    |                    |that                |                    |
|                                                                                      |                    |                    |this                |                    |
|                                                                                      |                    |                    |method              |                    |
|                                                                                      |                    |                    |has good            |                    |
|                                                                                      |                    |                    |systemapplicability.|                    |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**(4.3) Specificity** 



**(4.3.1) Peak identification test** 



 **Acceptance Criteria** 



The blank solution should be free of interference; The separation degree 



between the main peak and YA2304-20 peak in the system suitability 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 289 of 542 





Page 290
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



solution should be greater than 1.5; The peak signal-to-noise ratio (S/N) of 



YA2304-20 in the chromatogram of reference solution should NLT 30; The 



separation degree between YA2304-20 peaks and adjacent peaks in the 



chromatogram of test solution and specific mixed solution should be greater 



than 1.5, and the retention time should be consistent with the peak retention 



time of YA2304-20 in the chromatogram of control solution. Other single 



impurity localization solutions do not interfere with YA2304-20 peak 



production. 



 **Solution preparation** 



Blank solution: solvent. 



Reference stock solution: Share reference stock solution under "4.2 System 



Suitability". 



Reference solution: Prepare the reference solution in the same way as the 



reference solution under "4.1 wavelength selection". 



System suitability solution: Share system suitability solution under "4.2 



System Suitability". 



YA2304 reference product reserve liquid: Take about 7.5mg of this product, 



accurately weigh it, place it in a 50ml measuring bottle, add an appropriate 



amount of solvent to dissolve with ultrasound, cool it, dilute it with solvent to 



the scale, shake well, and then get. 



YA2304 positioning solution: precisely measure 1ml of YA2304 reference 



product reserve solution, place it in 100ml measuring bottle, dilute it with 



solvent to scale, shake well, ready. 



Test product solution: Take about 20mg of this product, weigh it accurately, 



put it in a 20ml measuring bottle, dissolve it with solvent and dilute it to the 



scale, shake well, ready. 



Specific mixed solution: Take about 20mg of this product, accurately weigh it, 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 290 of 542 





Page 291
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



put it in a 20ml measuring bottle, dissolve it with the control product 



solution and dilute it to the scale, shake well, ready. 



YA2304-10 Reference product reserve liquid: Take YA2304-10 reference 



product about 5mg, accurately weigh, put into 25ml measuring bottle, 



dissolve with solvent and dilute to the scale, shake well, ready. (Approx. 



200μg/ml) 



YA2304-12 reference product reserve liquid: Take YA2304-12 reference 



product about 5mg, accurately weigh, put into 25ml measuring bottle, 



dissolve with solvent and dilute to scale, shake well, and then obtain. (Approx. 



200μg/ml) 



YA2304-14 reference product reserve liquid: Take YA2304-14 reference 



product about 5mg, accurately weigh, put into 25ml measuring bottle, 



dissolve with acetonitrile and dilute to scale, shake well, and then obtain. 



(Approx. 200μg/ml) 



YA2304-15 reference product reserve liquid: Take YA2304-15 reference 



product about 5mg, accurately weigh, put into 25ml measuring bottle, 



dissolve with acetonitrile and dilute to scale, shake well, and then obtain. 



(Approx. 200μg/ml) 



YA2304-16 reference product reserve liquid: Take YA2304-16 reference 



product about 5mg, accurately weigh, place in 25ml bottle, dissolve with 



acetonitrile and dilute to scale, shake well, ready. (Approx. 200μg/ml) 



YA2304-17 reference product reserve liquid: Take YA2304-17 reference 



product about 5mg, accurately weigh, put into 25ml measuring bottle, 



dissolve with solvent and dilute to scale, shake well, and then obtain. (Approx. 



200μg/ml) 



YA2304-18 reference product reserve liquid: Take YA2304-18 reference 



product about 5mg, accurately weigh, put into 25ml measuring bottle, 



dissolve with acetonitrile and dilute to scale, shake well, and then obtain. 



(Approx. 200μg/ml) 



YA2304-19 reference product reserve liquid: Take YA2304-19 reference 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 291 of 542 





Page 292
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



product about 5mg, accurately weigh, put into 25ml measuring bottle, 



dissolve with acetonitrile and dilute to scale, shake well, then obtain. (Approx. 



200μg/ml) 



YA2304-10 positioning solution: Accurately measure 0.75ml of YA2304-10 



reference product reserve into 100ml measuring bottle, dilute with solvent to 



scale, shake well, and then obtain. 



YA2304-12 positioning solution: precisely measure 0.75ml of YA2304-12 



reference storage solution into 100ml measuring bottle, dilute it with solvent 



to scale, shake well, ready. 



YA2304-14 positioning solution: precisely measure 0.75ml of YA2304-14 



reference storage solution into 100ml measuring bottle, dilute with solvent to 



scale, shake well, ready. 



YA2304-15 positioning solution: precisely measure 0.75ml of YA2304-15 



reference product storage solution into 100ml measuring bottle, dilute with 



solvent to scale, shake well, ready. 



YA2304-16 positioning solution: precisely measure 0.75ml of YA2304-16 



reference storage solution into 100ml measuring bottle, dilute with solvent to 



scale, shake well, ready. 



YA2304-17 positioning solution: precisely measure 0.75ml of YA2304-17 



reference storage solution into 100ml measuring bottle, dilute with solvent to 



scale, shake well, ready. 



YA2304-18 positioning solution: precisely measure 0.75ml of YA2304-18 



reference storage solution into 100ml measuring bottle, dilute with solvent to 



scale, shake well, ready. 



YA2304-19 positioning solution: precisely measure 0.75ml of YA2304-19 



reference product storage solution into 100ml measuring bottle, dilute with 



solvent to scale, shake well, ready. 



 **Injection Sequence** 



After the instrument is balanced, 1 needle is injected into blank solution, 1 



needle is injected into system suitability solution, 1 needle is injected into 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 292 of 542 





Page 293
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



reference solution, 1 needle is injected into test solution, 1 needle is injected 



into specific mixed solution, and the other positioning solutions are injected 



into 1 needle respectively. 



 **Measurement results** 



































































-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|System suitability solution                                                   |YA2304              |1021.2271           |20.180              |3.0                 |/                   |
|------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|System suitability solution                                                   |YA2304-20           |1.4983              |24.852              |24.852              |24.852              |
|------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|Reference solution                                                            |YA2304-20           |1.4983              |24.858              |/                   |62.2                |
|------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|YA2304 Locate solution                                                        |YA2304              |1.5559              |20.240              |/                   |/                   |
|------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|YA2304-10 Locates the solution                                                |YA2304-10           |1.5534              |3.906               |/                   |/                   |
|------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|YA2304-12 Locate the solution                                                 |YA2304-12           |1.4942              |5.627               |/                   |/                   |
|------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|YA2304-12 Locate the solution                                                 |YA2304-12           |1.4942              |5.935               |/                   |/                   |
|------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|YA2304-14 Locate the solution                                                 |YA2304-14           |1.5137              |15.696              |/                   |/                   |
|------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|YA2304-14 Locate the solution                                                 |YA2304-14           |1.5137              |18.853              |/                   |/                   |
|------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|YA2304-15 Locate the solution                                                 |YA2304-15           |1.5366              |22.827              |/                   |/                   |
|------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|YA2304-15 Locate the solution                                                 |YA2304-15           |1.5366              |27.493              |/                   |/                   |
|------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|YA2304-16 Locate the solution                                                 |YA2304-16           |1.4226              |11.400              |/                   |/                   |
|------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|YA2304-16 Locate the solution                                                 |YA2304-16           |1.4226              |12.070              |/                   |/                   |
|------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|YA2304-17 Locate the solution                                                 |YA2304-17           |1.5798              |4.505               |/                   |/                   |
|------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|YA2304-18 Locate the solution                                                 |YA2304-18           |1.5268              |15.456              |/                   |/                   |
|------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|YA2304-18 Locate the solution                                                 |YA2304-18           |1.5268              |15.956              |/                   |/                   |
|------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|YA2304-19 Locate the solution                                                 |YA2304-19           |1.5790              |18.768              |/                   |/                   |
|------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|YA2304-19 Locate the solution                                                 |YA2304-19           |1.5790              |21.475              |/                   |/                   |
|------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|Sample solution                                                               |YA2304              |1003.6000           |20.182              |3.0                 |/                   |
|------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|Sample solution                                                               |YA2304-20           |/                   |24.794              |24.794              |/                   |
|------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|Specific mixed solution                                                       |YA2304              |1033.1000           |20.183              |3.0                 |/                   |
|------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|Specific mixed solution                                                       |YA2304-20           |1.4983              |24.872              |24.872              |/                   |
|------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|--------------------|
|Conclusion: Blank solution has no interference; The separation degree between |Conclusion:         |Conclusion:         |Conclusion:         |Conclusion:         |Conclusion:         |
|YA2304-20 peak and main peak in the systemapplicability solutionis 3.0 (the   |Blank               |Blank               |Blank               |Blank               |Blank               |
|requirement should NLT 1.5). In the chromatogramobtained from the control     |solution            |solution            |solution            |solution            |solution            |
|solution, S/Nwas 62.2 (the requirement should NLT 30); The separation degree  |has no              |has no              |has no              |has no              |has no              |
|                                                                              |interference;       |interference;       |interference;       |interference;       |interference;       |
|                                                                              |The                 |The                 |The                 |The                 |The                 |
|                                                                              |separation          |separation          |separation          |separation          |separation          |
|                                                                              |degree              |degree              |degree              |degree              |degree              |
|                                                                              |between             |between             |between             |between             |between             |
|                                                                              |YA2304-20           |YA2304-20           |YA2304-20           |YA2304-20           |YA2304-20           |
|                                                                              |peak and            |peak and            |peak                |peak                |peak                |
|                                                                              |main peak           |main peak           |and                 |and                 |and                 |
|                                                                              |in the              |in the              |main                |main                |main                |
|                                                                              |systemapplicability |systemapplicability |peak in             |peak in             |peak in             |
|                                                                              |solutionis          |solutionis          |the                 |the                 |the                 |
|                                                                              |3.0 (the            |3.0 (the            |systemapplicability |systemapplicability |systemapplicability |
|                                                                              |requirement         |requirement         |solutionis          |solutionis          |solutionis          |
|                                                                              |should              |should              |3.0                 |3.0                 |3.0                 |
|                                                                              |NLT 1.5).           |NLT 1.5).           |(the                |(the                |(the                |
|                                                                              |In the              |In the              |requirement         |requirement         |requirement         |
|                                                                              |chromatogramobtained|chromatogramobtained|should              |should              |should              |
|                                                                              |from the            |from the            |NLT                 |NLT                 |NLT                 |
|                                                                              |control             |control             |1.5).               |1.5).               |1.5).               |
|                                                                              |solution,           |solution,           |In the              |In the              |In the              |
|                                                                              |S/Nwas              |S/Nwas              |chromatogramobtained|chromatogramobtained|chromatogramobtained|
|                                                                              |62.2 (the           |62.2 (the           |from                |from                |from                |
|                                                                              |requirement         |requirement         |the                 |the                 |the                 |
|                                                                              |should              |should              |control             |control             |control             |
|                                                                              |NLT 30);            |NLT 30);            |solution,           |solution,           |solution,           |
|                                                                              |The                 |The                 |S/Nwas              |S/Nwas              |S/Nwas              |
|                                                                              |separation          |separation          |62.2                |62.2                |62.2                |
|                                                                              |degree              |degree              |(the                |(the                |(the                |
|                                                                              |                    |                    |requirement         |requirement         |requirement         |
|                                                                              |                    |                    |should              |should              |should              |
|                                                                              |                    |                    |NLT                 |NLT                 |NLT                 |
|                                                                              |                    |                    |30);                |30);                |30);                |
|                                                                              |                    |                    |The                 |The                 |The                 |
|                                                                              |                    |                    |separation          |separation          |separation          |
|                                                                              |                    |                    |degree              |degree              |degree              |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 293 of 542 





Page 294
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



between YA2304-20 peaks and adjacent peaks in the specific mixed solution and the 



test solution was greater than 1.5, and the retention time was consistent with that of 



YA2304-20 peaks in the chromatogram of the control solution. Impurities YA2304-12, 



YA2304-14, YA2304-15, YA2304-16, YA2304-18 and YA2304-19 all have a chiral 



center, so the above impurities all have two peaks under the current chromatographic 



conditions. Other single impurities (YA2304-10, YA2304-12, YA2304-14, YA2304-15, 



YA2304-16, YA2304-17, YA2304-18 and YA2304-19) do not interfere with the peak of 



YA2304-20; Meet the requirements of verification. 



**(4.3.2) Forced degradation test** 



 **Acceptance Criteria** 



The blank solution should be free of interference; The separation degree 



between the main peak and YA2304-20 peak in the system suitability 



solution should be greater than 1.5; The peak signal-to-noise ratio (S/N) of 



YA2304-20 in the chromatogram of reference solution should NLT 30; The 



degradation degree of principal component NMT 20% under each failure 



condition; After degradation, the separation degree of all impurities in the 



sample and YA2304-20 should NLT 1.0. 



 **Solution preparation** 



Blank solution: solvent. 



Reference product reserve solution: Prepare the reference product reserve 



solution according to "4.1 wavelength selection" under the same method. 



Reference solution: prepared in the same way as the reference solution under 



"4.1 wavelength selection". 



System suitability solution: prepared in the same way as system suitability 



solution under "4.1 wavelength selection". 



Undamaged test product solution: take about 20mg of this product, 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 294 of 542 





Page 295
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



accurately weigh it, place it in a 20ml measuring bottle, add an appropriate 



amount of solvent to dissolve by ultrasound, cool it, dilute it with solvent to 



the scale, shake well, and get. 



Acid destruction blank solution: take 2ml of 0.1mol/L hydrochloric acid 



solution, place it in 20ml measuring bottle, add 2ml of 0.1mol/L sodium 



hydroxide solution to neutralize it, dilute it with solvent to the scale, shake 



well, and get it. 



Acid destruction of test product solution: take about 20mg of this product, 



accurately weigh it, place it in 20ml bottle, add 2ml of 0.1mol/L hydrochloric 



acid solution at room temperature for destruction for 24h, add 2ml of 



0.1mol/L sodium hydroxide solution for neutralization, add an appropriate 



amount of solvent to dissolve by ultrasound, dilute it with solvent to the scale, 



shake well, and obtain. 



Alkali destruction blank solution: take 2ml of 0.1mol/L sodium hydroxide 



solution, place it in 20ml measuring bottle, add 2ml of 0.1mol/L hydrochloric 



acid solution to neutralize it, dilute it with solvent to the scale, shake well, 



and obtain. 



Alkali destruction test product solution: take about 20mg of this product, 



weigh it accurately, put it in 20ml measuring bottle, add 2ml of 0.1mol/L 



sodium hydroxide solution at room temperature for destruction for 24h, add 



2ml of 0.1mol/L hydrochloric acid solution for neutralization, add an 



appropriate amount of solvent to dissolve by ultrasound, dilute it with 



solvent to the scale, shake well, and obtain. 



Oxidizing destruction of blank solution: take 2ml of 3% hydrogen peroxide 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 295 of 542 





Page 296
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



solution, place it in 20ml measuring bottle, dilute it with solvent to the scale, 



shake well, and obtain. 



Oxidizing destruction of test product solution: Take about 20mg of this 



product, weigh it accurately, put it in 20ml bottle, add 2ml of 3% hydrogen 



peroxide solution and destroy it at room temperature for 24h, add an 



appropriate amount of solvent and ultrasonic to dissolve it, dilute it with 



solvent to the scale, shake well, and obtain. 



High temperature destruction of the test product solution: accurately weigh 



about 20mg of this product damaged for 5 days at 105℃, place it in a 20ml 



measuring bottle, add an appropriate amount of solvent and ultrasonic to 



dissolve it, dilute it with solvent to the scale, shake well, and obtain. 



Light damage test product solution: accurately weigh about 20mg of this 



product after 20 days of damage under light (25±2℃, 4500±500Lux, 



90±5μWcm [2] ), place it in a 20ml bottle, add an appropriate amount of solvent 



to dissolve by ultrasound, dilute it with solvent to the scale, shake well, and 



obtain. 



 **Injection Sequence** 



After the instrument balance, blank solution, system suitability solution, 



reference solution, undamaged test product solution, acid damage blank 



solution, alkali damage blank solution, oxidation damage blank solution, 



acid damage test product solution, alkali damage test product solution, 



oxidation damage test product solution, high temperature damage test 



product solution, light damage test product solution into 1 needle each. 



 **Test result** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 296 of 542 





Page 297
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 





































-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|System suitability solution                                                           |/                       |2.6                |/                  |/                  |
|--------------------------------------------------------------------------------------|------------------------|-------------------|-------------------|-------------------|
|Reference solution                                                                    |/                       |/                  |/                  |33.7               |
|--------------------------------------------------------------------------------------|------------------------|-------------------|-------------------|-------------------|
|Undamaged test product solution                                                       |/                       |/                  |/                  |/                  |
|--------------------------------------------------------------------------------------|------------------------|-------------------|-------------------|-------------------|
|Acid destroys test solution                                                           |Destroy                 |/                  |1.25               |/                  |
|                                                                                      |2ml of                  |                   |                   |                   |
|                                                                                      |0.1mol/Lhydrochloricacid|                   |                   |                   |
|                                                                                      |solution                |                   |                   |                   |
|                                                                                      |for 24h                 |                   |                   |                   |
|--------------------------------------------------------------------------------------|------------------------|-------------------|-------------------|-------------------|
|Alkali destroys the test solution                                                     |Destroy 2ml of          |/                  |/                  |/                  |
|                                                                                      |0.1mol/Lsodium hydroxide|                   |                   |                   |
|                                                                                      |solution for 24h        |                   |                   |                   |
|--------------------------------------------------------------------------------------|------------------------|-------------------|-------------------|-------------------|
|Destroy the test product solution byoxidation                                         |2ml 3% hydrogen peroxide|/                  |5.18               |/                  |
|                                                                                      |solution was destroyed  |                   |                   |                   |
|                                                                                      |at room temperature for |                   |                   |                   |
|                                                                                      |24h                     |                   |                   |                   |
|--------------------------------------------------------------------------------------|------------------------|-------------------|-------------------|-------------------|
|The test product solution was destroyed at high temperature                           |105℃damage for 5 days   |/                  |/                  |/                  |
|--------------------------------------------------------------------------------------|------------------------|-------------------|-------------------|-------------------|
|Light destroyed the test solution                                                     |Light damage (25±2 ° C, |/                  |0.18               |/                  |
|                                                                                      |4500±500Lux, 90±5μWcm2) |                   |                   |                   |
|                                                                                      |for 20 days             |                   |                   |                   |
|--------------------------------------------------------------------------------------|------------------------|-------------------|-------------------|-------------------|
|Conclusion: The blank solution has no interference; The systemapplicability meets the |Conclusion: The blank   |Conclusion:        |Conclusion:        |Conclusion:        |
|requirements; The degradation degree of principal components was 1.25% underacid      |solution has no         |The                |The                |The                |
|damage, 5.18% underoxidation damage, 0.18% under light damage, andalkali damage and   |interference; The       |blank              |blank              |blank              |
|high temperature damage did not degrade principal components. Impurity YA2304-20 was  |systemapplicability     |solution           |solution           |solution           |
|not degradedunder the conditions ofacid, alkali, oxidation, high temperature and      |meets the requirements; |has no             |has no             |has no             |
|light.                                                                                |The degradation degree  |interference;      |interference;      |interference;      |
|                                                                                      |of principal components |The                |The                |The                |
|                                                                                      |was 1.25% underacid     |systemapplicability|systemapplicability|systemapplicability|
|                                                                                      |damage, 5.18%           |meets              |meets              |meets              |
|                                                                                      |underoxidation damage,  |the                |the                |the                |
|                                                                                      |0.18% under light       |requirements;      |requirements;      |requirements;      |
|                                                                                      |damage, andalkali damage|The                |The                |The                |
|                                                                                      |and high temperature    |degradation        |degradation        |degradation        |
|                                                                                      |damage did not degrade  |degree             |degree             |degree             |
|                                                                                      |principal components.   |of                 |of                 |of                 |
|                                                                                      |Impurity YA2304-20 was  |principal          |principal          |principal          |
|                                                                                      |not degradedunder the   |components         |components         |components         |
|                                                                                      |conditions ofacid,      |was                |was                |was                |
|                                                                                      |alkali, oxidation, high |1.25%              |1.25%              |1.25%              |
|                                                                                      |temperature and light.  |underacid          |underacid          |underacid          |
|                                                                                      |                        |damage,            |damage,            |damage,            |
|                                                                                      |                        |5.18%              |5.18%              |5.18%              |
|                                                                                      |                        |underoxidation     |underoxidation     |underoxidation     |
|                                                                                      |                        |damage,            |damage,            |damage,            |
|                                                                                      |                        |0.18%              |0.18%              |0.18%              |
|                                                                                      |                        |under              |under              |under              |
|                                                                                      |                        |light              |light              |light              |
|                                                                                      |                        |damage,            |damage,            |damage,            |
|                                                                                      |                        |andalkali          |andalkali          |andalkali          |
|                                                                                      |                        |damage             |damage             |damage             |
|                                                                                      |                        |and                |and                |and                |
|                                                                                      |                        |high               |high               |high               |
|                                                                                      |                        |temperature        |temperature        |temperature        |
|                                                                                      |                        |damage             |damage             |damage             |
|                                                                                      |                        |did not            |did not            |did not            |
|                                                                                      |                        |degrade            |degrade            |degrade            |
|                                                                                      |                        |principal          |principal          |principal          |
|                                                                                      |                        |components.        |components.        |components.        |
|                                                                                      |                        |Impurity           |Impurity           |Impurity           |
|                                                                                      |                        |YA2304-20          |YA2304-20          |YA2304-20          |
|                                                                                      |                        |was not            |was not            |was not            |
|                                                                                      |                        |degradedunder      |degradedunder      |degradedunder      |
|                                                                                      |                        |the                |the                |the                |
|                                                                                      |                        |conditions         |conditions         |conditions         |
|                                                                                      |                        |ofacid,            |ofacid,            |ofacid,            |
|                                                                                      |                        |alkali,            |alkali,            |alkali,            |
|                                                                                      |                        |oxidation,         |oxidation,         |oxidation,         |
|                                                                                      |                        |high               |high               |high               |
|                                                                                      |                        |temperature        |temperature        |temperature        |
|                                                                                      |                        |and                |and                |and                |
|                                                                                      |                        |light.             |light.             |light.             |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**(4.4) Limits of quantification and detection** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 297 of 542 





Page 298
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



 **Acceptance Criteria** 



The signal to noise ratio (S/N) of each impurity peak in 6 LOQ solutions 



should NLT 10, the RSD of retention time should not be more than 2.0%, and 



the RSD of peak area should not be more than 10%. 



The SNR (S/N) of each impurity peak in the 3-pin detection limit (LOD) 



solution should NLT 3. 



 **Solution preparation** 



Blank solution: solvent. 



Reference stock solution: Share reference stock solution under "4.2 System 



Suitability". 



Reference stock solution YA2304: Share reference stock solution YA2304 



under "4.3.1 Peak Identification Test". 



LOQ solution: Accurately measure 1ml of YA2304 reference product reserve 



solution and 1ml of reference product reserve solution, place in the same 



100ml bottle, dilute to scale with solvent, and shake well; Accurately 



measure 5ml of the solution into 25ml measuring bottle, dilute it with solvent 



to the scale, shake well, and then get. (Dispense 6 parts in parallel) 



LOD solution: Accurately measure the first part of limited quantification 



solution 3ml, place it in a 10ml measuring bottle, dilute it with solvent to the 



scale, shake well, and then get. 



 **Injection Sequence** 



After the balance of the instrument, 1 needle was injected into the blank 



solution, 1 needle was injected into the 6 parts of limited quantitation 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 298 of 542 





Page 299
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



solution, and 3 needles were injected into the detection limited solution 



continuously. 



 **Measurement results** 



Results of limit of quantitation test 










































--------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|YA230 4   |LOQ solution 1                                                     |0.3112           |0.03             |20.404           |4914             |18.6             |
|----------|-------------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|YA230 4   |LOQ Solution2                                                      |LOQ              |LOQ              |20.366           |4939             |18.9             |
|          |                                                                   |Solution2        |Solution2        |                 |                 |                 |
|----------|-------------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|YA230 4   |LOQ solution 3                                                     |LOQ              |LOQ              |20.410           |5091             |19.9             |
|          |                                                                   |solution         |solution         |                 |                 |                 |
|          |                                                                   |3                |3                |                 |                 |                 |
|----------|-------------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|YA230 4   |LOQ Solution 4                                                     |LOQ              |LOQ              |20.408           |5200             |17.6             |
|          |                                                                   |Solution         |Solution         |                 |                 |                 |
|          |                                                                   |4                |4                |                 |                 |                 |
|----------|-------------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|YA230 4   |LOQ Solution 5                                                     |LOQ              |LOQ              |20.355           |4823             |19.1             |
|          |                                                                   |Solution         |Solution         |                 |                 |                 |
|          |                                                                   |5                |5                |                 |                 |                 |
|----------|-------------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|YA230 4   |LOQ solution 6                                                     |LOQ              |LOQ              |20.424           |4925             |15.8             |
|          |                                                                   |solution         |solution         |                 |                 |                 |
|          |                                                                   |6                |6                |                 |                 |                 |
|----------|-------------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|YA230 4   |RSD%                                                               |RSD%             |RSD%             |0.14             |2.8              |/                |
|----------|-------------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|YA230 4   |Conclusion: The concentration of YA2304 in LOQ solutionis 0.3112   |Conclusion:      |Conclusion:      |Conclusion:      |Conclusion:      |Conclusion:      |
|          |μg/ml, whichisequivalent to 0.03% of the concentration of test     |The              |The              |The              |The              |The              |
|          |product. TheS/Nof YA2304 peak in 6 LOQ solution spectra ranges from|concentration    |concentration    |concentration    |concentration    |concentration    |
|          |15.8 to 19.9 (the requirement should be NLT 10), and the RSD of    |of YA2304        |of YA2304        |of               |of               |of               |
|          |retention time is 0.14% (the requirement should be no more than    |in LOQ           |in LOQ           |YA2304           |YA2304           |YA2304           |
|          |2.0%). The RSD of the peakarea was 2.8% (the requirement should NMT|solutionis       |solutionis       |in LOQ           |in LOQ           |in LOQ           |
|          |10%), which met the verification requirements.                     |0.3112           |0.3112           |solutionis       |solutionis       |solutionis       |
|          |                                                                   |μg/ml,           |μg/ml,           |0.3112           |0.3112           |0.3112           |
|          |                                                                   |whichisequivalent|whichisequivalent|μg/ml,           |μg/ml,           |μg/ml,           |
|          |                                                                   |to 0.03%         |to 0.03%         |whichisequivalent|whichisequivalent|whichisequivalent|
|          |                                                                   |of the           |of the           |to               |to               |to               |
|          |                                                                   |concentration    |concentration    |0.03%            |0.03%            |0.03%            |
|          |                                                                   |of test          |of test          |of the           |of the           |of the           |
|          |                                                                   |product.         |product.         |concentration    |concentration    |concentration    |
|          |                                                                   |TheS/Nof         |TheS/Nof         |of test          |of test          |of test          |
|          |                                                                   |YA2304           |YA2304           |product.         |product.         |product.         |
|          |                                                                   |peak in 6        |peak in 6        |TheS/Nof         |TheS/Nof         |TheS/Nof         |
|          |                                                                   |LOQ              |LOQ              |YA2304           |YA2304           |YA2304           |
|          |                                                                   |solution         |solution         |peak in          |peak in          |peak in          |
|          |                                                                   |spectra          |spectra          |6 LOQ            |6 LOQ            |6 LOQ            |
|          |                                                                   |ranges           |ranges           |solution         |solution         |solution         |
|          |                                                                   |from 15.8        |from 15.8        |spectra          |spectra          |spectra          |
|          |                                                                   |to 19.9          |to 19.9          |ranges           |ranges           |ranges           |
|          |                                                                   |(the             |(the             |from             |from             |from             |
|          |                                                                   |requirement      |requirement      |15.8 to          |15.8 to          |15.8 to          |
|          |                                                                   |should be        |should be        |19.9             |19.9             |19.9             |
|          |                                                                   |NLT 10),         |NLT 10),         |(the             |(the             |(the             |
|          |                                                                   |and the          |and the          |requirement      |requirement      |requirement      |
|          |                                                                   |RSD of           |RSD of           |should           |should           |should           |
|          |                                                                   |retention        |retention        |be NLT           |be NLT           |be NLT           |
|          |                                                                   |time is          |time is          |10),             |10),             |10),             |
|          |                                                                   |0.14%            |0.14%            |and the          |and the          |and the          |
|          |                                                                   |(the             |(the             |RSD of           |RSD of           |RSD of           |
|          |                                                                   |requirement      |requirement      |retention        |retention        |retention        |
|          |                                                                   |should be        |should be        |time is          |time is          |time is          |
|          |                                                                   |no more          |no more          |0.14%            |0.14%            |0.14%            |
|          |                                                                   |than             |than             |(the             |(the             |(the             |
|          |                                                                   |2.0%).           |2.0%).           |requirement      |requirement      |requirement      |
|          |                                                                   |The RSD          |The RSD          |should           |should           |should           |
|          |                                                                   |of the           |of the           |be no            |be no            |be no            |
|          |                                                                   |peakarea         |peakarea         |more             |more             |more             |
|          |                                                                   |was 2.8%         |was 2.8%         |than             |than             |than             |
|          |                                                                   |(the             |(the             |2.0%).           |2.0%).           |2.0%).           |
|          |                                                                   |requirement      |requirement      |The RSD          |The RSD          |The RSD          |
|          |                                                                   |should           |should           |of the           |of the           |of the           |
|          |                                                                   |NMT 10%),        |NMT 10%),        |peakarea         |peakarea         |peakarea         |
|          |                                                                   |which met        |which met        |was              |was              |was              |
|          |                                                                   |the              |the              |2.8%             |2.8%             |2.8%             |
|          |                                                                   |verification     |verification     |(the             |(the             |(the             |
|          |                                                                   |requirements.    |requirements.    |requirement      |requirement      |requirement      |
|          |                                                                   |                 |                 |should           |should           |should           |
|          |                                                                   |                 |                 |NMT              |NMT              |NMT              |
|          |                                                                   |                 |                 |10%),            |10%),            |10%),            |
|          |                                                                   |                 |                 |which            |which            |which            |
|          |                                                                   |                 |                 |met the          |met the          |met the          |
|          |                                                                   |                 |                 |verification     |verification     |verification     |
|          |                                                                   |                 |                 |requirements.    |requirements.    |requirements.    |
|----------|-------------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|YA230 4-20|LOQ Solution 1                                                     |0.2997           |0.03             |25.100           |4859             |14.2             |
|----------|-------------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|YA230 4-20|LOQ Solution 2                                                     |LOQ Solution 2   |LOQ Solution 2   |25.149           |4747             |14.1             |
|----------|-------------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|YA230 4-20|LOQ Solution 3                                                     |LOQ Solution 3   |LOQ Solution 3   |25.151           |4791             |15.1             |
|----------|-------------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|YA230 4-20|LOQ Solution 4                                                     |LOQ Solution 4   |LOQ Solution 4   |25.076           |4581             |12.8             |
|----------|-------------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|YA230 4-20|LOQ Solution 5                                                     |LOQ Solution 5   |LOQ Solution 5   |25.078           |4797             |14.5             |
|----------|-------------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|YA230 4-20|LOQ solution 6                                                     |LOQ solution 6   |LOQ solution 6   |25.020           |4727             |12.2             |
|----------|-------------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|YA230 4-20|RSD%                                                               |RSD%             |RSD%             |0.20             |2.0              |/                |
|----------|-------------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|YA230 4-20|Verdict: The concentration of YA2304-20 in LOQ solution was 0.2997 |Verdict: The     |Verdict: The     |Verdict: The     |Verdict: The     |Verdict: The     |
|          |μg/ml, equivalent to 0.03% of the concentration of test product.   |concentration of |concentration of |concentration of |concentration of |concentration of |
|          |TheS/Nof YA2304-20 peaks in 6 LOQ solution spectra ranged from 12.2|YA2304-20 in LOQ |YA2304-20 in LOQ |YA2304-20 in LOQ |YA2304-20 in LOQ |YA2304-20 in LOQ |
|          |to 15.1 (the requirement should be NLT 10), and the RSD of         |solution was     |solution was     |solution was     |solution was     |solution was     |
|          |retention time was 0.20% (the requirement should be no more than   |0.2997 μg/ml,    |0.2997 μg/ml,    |0.2997 μg/ml,    |0.2997 μg/ml,    |0.2997 μg/ml,    |
|          |2.0%). The RSD of the peakarea was 2.0% (the requirement should NMT|equivalent to    |equivalent to    |equivalent to    |equivalent to    |equivalent to    |
|          |10%), which met the verification requirements.                     |0.03% of the     |0.03% of the     |0.03% of the     |0.03% of the     |0.03% of the     |
|          |                                                                   |concentration of |concentration of |concentration of |concentration of |concentration of |
|          |                                                                   |test product.    |test product.    |test product.    |test product.    |test product.    |
|          |                                                                   |TheS/Nof         |TheS/Nof         |TheS/Nof         |TheS/Nof         |TheS/Nof         |
|          |                                                                   |YA2304-20 peaks  |YA2304-20 peaks  |YA2304-20 peaks  |YA2304-20 peaks  |YA2304-20 peaks  |
|          |                                                                   |in 6 LOQ solution|in 6 LOQ solution|in 6 LOQ solution|in 6 LOQ solution|in 6 LOQ solution|
|          |                                                                   |spectra ranged   |spectra ranged   |spectra ranged   |spectra ranged   |spectra ranged   |
|          |                                                                   |from 12.2 to 15.1|from 12.2 to 15.1|from 12.2 to 15.1|from 12.2 to 15.1|from 12.2 to 15.1|
|          |                                                                   |(the requirement |(the requirement |(the requirement |(the requirement |(the requirement |
|          |                                                                   |should be NLT    |should be NLT    |should be NLT    |should be NLT    |should be NLT    |
|          |                                                                   |10), and the RSD |10), and the RSD |10), and the RSD |10), and the RSD |10), and the RSD |
|          |                                                                   |of retention time|of retention time|of retention time|of retention time|of retention time|
|          |                                                                   |was 0.20% (the   |was 0.20% (the   |was 0.20% (the   |was 0.20% (the   |was 0.20% (the   |
|          |                                                                   |requirement      |requirement      |requirement      |requirement      |requirement      |
|          |                                                                   |should be no more|should be no more|should be no more|should be no more|should be no more|
|          |                                                                   |than 2.0%). The  |than 2.0%). The  |than 2.0%). The  |than 2.0%). The  |than 2.0%). The  |
|          |                                                                   |RSD of the       |RSD of the       |RSD of the       |RSD of the       |RSD of the       |
|          |                                                                   |peakarea was 2.0%|peakarea was 2.0%|peakarea was 2.0%|peakarea was 2.0%|peakarea was 2.0%|
|          |                                                                   |(the requirement |(the requirement |(the requirement |(the requirement |(the requirement |
|          |                                                                   |should NMT 10%), |should NMT 10%), |should NMT 10%), |should NMT 10%), |should NMT 10%), |
|          |                                                                   |which met the    |which met the    |which met the    |which met the    |which met the    |
|          |                                                                   |verification     |verification     |verification     |verification     |verification     |
|          |                                                                   |requirements.    |requirements.    |requirements.    |requirements.    |requirements.    |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 299 of 542 





Page 300
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Detection limit test results 













































--------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|YA230 4   |1                                                                  |0.0934           |0.01             |20.443           |1503             |6.3              |
|----------|-------------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|YA230 4   |2                                                                  |2                |2                |20.379           |1874             |7.5              |
|----------|-------------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|YA230 4   |3                                                                  |3                |3                |20.469           |1643             |6.9              |
|----------|-------------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|YA230 4   |Conclusion: The concentration of YA2304 in LOD solutionis 0.0934   |Conclusion:      |Conclusion:      |Conclusion:      |Conclusion:      |Conclusion:      |
|          |μg/ml, whichisequivalent to 0.01% of the concentration of the test |The              |The              |The              |The              |The              |
|          |product. TheS/Nof YA2304 peak in the 3-needle mapis between 6.3 and|concentration    |concentration    |concentration    |concentration    |concentration    |
|          |7.5 (the requirement should be NLT 3), which meets the verification|of               |of               |of               |of               |of               |
|          |requirements.                                                      |YA2304           |YA2304           |YA2304           |YA2304           |YA2304           |
|          |                                                                   |in LOD           |in LOD           |in LOD           |in LOD           |in LOD           |
|          |                                                                   |solutionis       |solutionis       |solutionis       |solutionis       |solutionis       |
|          |                                                                   |0.0934           |0.0934           |0.0934           |0.0934           |0.0934           |
|          |                                                                   |μg/ml,           |μg/ml,           |μg/ml,           |μg/ml,           |μg/ml,           |
|          |                                                                   |whichisequivalent|whichisequivalent|whichisequivalent|whichisequivalent|whichisequivalent|
|          |                                                                   |to               |to               |to               |to               |to               |
|          |                                                                   |0.01%            |0.01%            |0.01%            |0.01%            |0.01%            |
|          |                                                                   |of the           |of the           |of the           |of the           |of the           |
|          |                                                                   |concentration    |concentration    |concentration    |concentration    |concentration    |
|          |                                                                   |of the           |of the           |of the           |of the           |of the           |
|          |                                                                   |test             |test             |test             |test             |test             |
|          |                                                                   |product.         |product.         |product.         |product.         |product.         |
|          |                                                                   |TheS/Nof         |TheS/Nof         |TheS/Nof         |TheS/Nof         |TheS/Nof         |
|          |                                                                   |YA2304           |YA2304           |YA2304           |YA2304           |YA2304           |
|          |                                                                   |peak in          |peak in          |peak in          |peak in          |peak in          |
|          |                                                                   |the              |the              |the              |the              |the              |
|          |                                                                   |3-needle         |3-needle         |3-needle         |3-needle         |3-needle         |
|          |                                                                   |mapis            |mapis            |mapis            |mapis            |mapis            |
|          |                                                                   |between          |between          |between          |between          |between          |
|          |                                                                   |6.3 and          |6.3 and          |6.3 and          |6.3 and          |6.3 and          |
|          |                                                                   |7.5              |7.5              |7.5              |7.5              |7.5              |
|          |                                                                   |(the             |(the             |(the             |(the             |(the             |
|          |                                                                   |requirement      |requirement      |requirement      |requirement      |requirement      |
|          |                                                                   |should           |should           |should           |should           |should           |
|          |                                                                   |be NLT           |be NLT           |be NLT           |be NLT           |be NLT           |
|          |                                                                   |3),              |3),              |3),              |3),              |3),              |
|          |                                                                   |which            |which            |which            |which            |which            |
|          |                                                                   |meets            |meets            |meets            |meets            |meets            |
|          |                                                                   |the              |the              |the              |the              |the              |
|          |                                                                   |verification     |verification     |verification     |verification     |verification     |
|          |                                                                   |requirements.    |requirements.    |requirements.    |requirements.    |requirements.    |
|----------|-------------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|YA230 4-20|1                                                                  |0.0899           |0.01             |25.037           |1564             |5.2              |
|----------|-------------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|YA230 4-20|2                                                                  |2                |2                |25.075           |1529             |5.4              |
|----------|-------------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|YA230 4-20|3                                                                  |3                |3                |25.262           |1335             |4.7              |
|----------|-------------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|YA230 4-20|Conclusion: The concentration of YA2304-20 in LOD solutionis 0.0899|Conclusion: The  |Conclusion: The  |Conclusion: The  |Conclusion: The  |Conclusion: The  |
|          |μg/ml, whichisequivalent to 0.01% of the concentration of the test |concentration of |concentration of |concentration of |concentration of |concentration of |
|          |product. TheS/Nof YA2304-20 peak in the 3-needle atlasis between   |YA2304-20 in LOD |YA2304-20 in LOD |YA2304-20 in LOD |YA2304-20 in LOD |YA2304-20 in LOD |
|          |4.7 and 5.4 (the requirement should be NLT 3), which meets the     |solutionis 0.0899|solutionis 0.0899|solutionis 0.0899|solutionis 0.0899|solutionis 0.0899|
|          |verification requirements.                                         |μg/ml,           |μg/ml,           |μg/ml,           |μg/ml,           |μg/ml,           |
|          |                                                                   |whichisequivalent|whichisequivalent|whichisequivalent|whichisequivalent|whichisequivalent|
|          |                                                                   |to 0.01% of the  |to 0.01% of the  |to 0.01% of the  |to 0.01% of the  |to 0.01% of the  |
|          |                                                                   |concentration of |concentration of |concentration of |concentration of |concentration of |
|          |                                                                   |the test product.|the test product.|the test product.|the test product.|the test product.|
|          |                                                                   |TheS/Nof         |TheS/Nof         |TheS/Nof         |TheS/Nof         |TheS/Nof         |
|          |                                                                   |YA2304-20 peak in|YA2304-20 peak in|YA2304-20 peak in|YA2304-20 peak in|YA2304-20 peak in|
|          |                                                                   |the 3-needle     |the 3-needle     |the 3-needle     |the 3-needle     |the 3-needle     |
|          |                                                                   |atlasis between  |atlasis between  |atlasis between  |atlasis between  |atlasis between  |
|          |                                                                   |4.7 and 5.4 (the |4.7 and 5.4 (the |4.7 and 5.4 (the |4.7 and 5.4 (the |4.7 and 5.4 (the |
|          |                                                                   |requirement      |requirement      |requirement      |requirement      |requirement      |
|          |                                                                   |should be NLT 3),|should be NLT 3),|should be NLT 3),|should be NLT 3),|should be NLT 3),|
|          |                                                                   |which meets the  |which meets the  |which meets the  |which meets the  |which meets the  |
|          |                                                                   |verification     |verification     |verification     |verification     |verification     |
|          |                                                                   |requirements.    |requirements.    |requirements.    |requirements.    |requirements.    |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**(4.5) Linearity and range** 



 **Acceptance Criteria** 



Within the limit concentration range of YA2304-20 LOQ concentration ~ 



200%, 6 concentration points were selected as linear regression curves with 



the concentration as the horizontal coordinate and YA2304-20 peak area as 



the vertical coordinate. The regression coefficient (R) of the regression curve 



was NLT 0.990, and the RSD of the response factor NMT 10%. Y-axis 



intercept accounts for less than 25% of 100% response value. 



 **Solution preparation** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 300 of 542 





Page 301
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Blank solution: solvent. 



Reference stock solution: Share reference stock solution under "4.2 System 



Suitability". 



Reference stock solution YA2304: Share reference stock solution YA2304 



under "4.3.1 Peak Identification Test". 



Linear reserve liquid: precisely measure 1.0ml of the reference reserve liquid 



and 1.0ml of the YA2304 reference reserve liquid, place them in the same 



10ml measuring bottle, dilute them with solvent to the scale, and shake well 



to obtain. 



Linear solution 1 (LOQ solution) : prepared in the same way as the 



quantitative limit solution under "4.4 quantitative limit and detection limit". 



Linear solution 2 (40% limit solution) : accurately measure 0.4ml linear 



reserve solution, place it in 10ml measuring bottle, dilute it with solvent to 



the scale, shake well, and then obtain. 



Linear solution 3 (80% limit solution) : Accurately measure 0.8ml linear 



reserve solution, place it in 10ml measuring bottle, dilute it with solvent to 



the scale, shake well, and obtain. 



Linear solution 4 (100% limit solution) : precisely measure 1.0ml linear 



reserve solution, place it in 10ml measuring bottle, dilute it with solvent to 



the scale, shake well, and get. 



Linear solution 5 (150% limit solution) : precisely measure 1.5ml linear 



reserve solution, place it in 10ml measuring bottle, dilute it with solvent to 



the scale, shake well, and get. 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 301 of 542 





Page 302
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Linear solution 6 (200% limit solution) : accurately measure 2ml linear 



reserve solution, place it in 10ml measuring bottle, dilute it with solvent to 



the scale, shake well, and get. 



 **Injection Sequence** 



After instrument balance, blank solution 1 needle, each linear solution from 



low concentration to high concentration 1 needle injection. 



 **Measurement results** 



Results of linear and range tests 
























------------------------------------------------------------------------------
|YA230 4|Linear Solution 1    |0.03                 |0.3112 |5080   |16324.77|
|-------|---------------------|---------------------|-------|-------|--------|
|YA230 4|Linear solution 2    |0.06                 |0.6224 |9791   |15731.87|
|-------|---------------------|---------------------|-------|-------|--------|
|YA230 4|Linear Solution 3    |0.12                 |1.2447 |19328  |15527.81|
|-------|---------------------|---------------------|-------|-------|--------|
|YA230 4|Linear solution 4    |0.16                 |1.5559 |24393  |15677.56|
|-------|---------------------|---------------------|-------|-------|--------|
|YA230 4|Linear Solution 5    |0.23                 |2.3339 |36500  |15639.21|
|-------|---------------------|---------------------|-------|-------|--------|
|YA230 4|Linear solution 6    |0.31                 |3.1118 |49358  |15861.37|
|-------|---------------------|---------------------|-------|-------|--------|
|YA230 4|Response factor RSD/%|Response factor RSD/%|1.8    |1.8    |1.8     |
|-------|---------------------|---------------------|-------|-------|--------|
|YA230 4|Linear graph         |Linear graph         |       |       |        |
------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 302 of 542 





Page 303
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 






















-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Correlation coefficientR                                                      |Correlation                     |0.9999                          |0.9999                          |0.9999                          |                                |
|                                                                              |coefficientR                    |                                |                                |                                |                                |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|
|AbsoluteY-axisintercept percentage /% of 100% response value                  |AbsoluteY-axisintercept         |0.34                            |0.34                            |0.34                            |                                |
|                                                                              |percentage                      |                                |                                |                                |                                |
|                                                                              |/% of 100%                      |                                |                                |                                |                                |
|                                                                              |response                        |                                |                                |                                |                                |
|                                                                              |value                           |                                |                                |                                |                                |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|
|Conclusion: YA2304 is in the range of 0.3112~3.1118 μg/ml, the                |Conclusion: YA2304 is           |Conclusion:                     |Conclusion:                     |Conclusion:                     |                                |
|linearequationisy=15788x-79.892, R=0.9999 (should NLT 0.990), the response    |in the range of                 |YA2304                          |YA2304                          |YA2304                          |                                |
|factor RSDis 1.8% (should not be more than 10%). The absolute value           |0.3112~3.1118 μg/ml,            |is in                           |is in                           |is in                           |                                |
|ofY-axisinterceptaccounts for 0.34% of 100% response value (NMT 25%),         |the                             |the                             |the                             |the                             |                                |
|indicating that YA2304 detected by this method hasagood linear relationship in|linearequationisy=15788x-79.892,|range                           |range                           |range                           |                                |
|the range of 0.3112~3.1118 μg/ml.                                             |R=0.9999 (should NLT            |of                              |of                              |of                              |                                |
|                                                                              |0.990), the response            |0.3112~3.1118                   |0.3112~3.1118                   |0.3112~3.1118                   |                                |
|                                                                              |factor RSDis 1.8%               |μg/ml,                          |μg/ml,                          |μg/ml,                          |                                |
|                                                                              |(should not be more             |the                             |the                             |the                             |                                |
|                                                                              |than 10%). The absolute         |linearequationisy=15788x-79.892,|linearequationisy=15788x-79.892,|linearequationisy=15788x-79.892,|                                |
|                                                                              |value                           |R=0.9999                        |R=0.9999                        |R=0.9999                        |                                |
|                                                                              |ofY-axisinterceptaccounts       |(should                         |(should                         |(should                         |                                |
|                                                                              |for 0.34% of 100%               |NLT                             |NLT                             |NLT                             |                                |
|                                                                              |response value (NMT             |0.990),                         |0.990),                         |0.990),                         |                                |
|                                                                              |25%), indicating that           |the                             |the                             |the                             |                                |
|                                                                              |YA2304 detected by this         |response                        |response                        |response                        |                                |
|                                                                              |method hasagood linear          |factor                          |factor                          |factor                          |                                |
|                                                                              |relationship in the             |RSDis                           |RSDis                           |RSDis                           |                                |
|                                                                              |range of 0.3112~3.1118          |1.8%                            |1.8%                            |1.8%                            |                                |
|                                                                              |μg/ml.                          |(should                         |(should                         |(should                         |                                |
|                                                                              |                                |not be                          |not be                          |not be                          |                                |
|                                                                              |                                |more                            |more                            |more                            |                                |
|                                                                              |                                |than                            |than                            |than                            |                                |
|                                                                              |                                |10%).                           |10%).                           |10%).                           |                                |
|                                                                              |                                |The                             |The                             |The                             |                                |
|                                                                              |                                |absolute                        |absolute                        |absolute                        |                                |
|                                                                              |                                |value                           |value                           |value                           |                                |
|                                                                              |                                |ofY-axisinterceptaccounts       |ofY-axisinterceptaccounts       |ofY-axisinterceptaccounts       |                                |
|                                                                              |                                |for                             |for                             |for                             |                                |
|                                                                              |                                |0.34%                           |0.34%                           |0.34%                           |                                |
|                                                                              |                                |of 100%                         |of 100%                         |of 100%                         |                                |
|                                                                              |                                |response                        |response                        |response                        |                                |
|                                                                              |                                |value                           |value                           |value                           |                                |
|                                                                              |                                |(NMT                            |(NMT                            |(NMT                            |                                |
|                                                                              |                                |25%),                           |25%),                           |25%),                           |                                |
|                                                                              |                                |indicating                      |indicating                      |indicating                      |                                |
|                                                                              |                                |that                            |that                            |that                            |                                |
|                                                                              |                                |YA2304                          |YA2304                          |YA2304                          |                                |
|                                                                              |                                |detected                        |detected                        |detected                        |                                |
|                                                                              |                                |by this                         |by this                         |by this                         |                                |
|                                                                              |                                |method                          |method                          |method                          |                                |
|                                                                              |                                |hasagood                        |hasagood                        |hasagood                        |                                |
|                                                                              |                                |linear                          |linear                          |linear                          |                                |
|                                                                              |                                |relationship                    |relationship                    |relationship                    |                                |
|                                                                              |                                |in the                          |in the                          |in the                          |                                |
|                                                                              |                                |range                           |range                           |range                           |                                |
|                                                                              |                                |of                              |of                              |of                              |                                |
|                                                                              |                                |0.3112~3.1118                   |0.3112~3.1118                   |0.3112~3.1118                   |                                |
|                                                                              |                                |μg/ml.                          |μg/ml.                          |μg/ml.                          |                                |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|
|YA230 4-20                                                                    |Linear Solution 1               |0.03                            |0.2997                          |4602                            |15357.23                        |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|
|YA230 4-20                                                                    |Linear Solution 2               |0.06                            |0.5993                          |9081                            |15152.00                        |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|
|YA230 4-20                                                                    |Linear Solution 3               |0.12                            |1.1987                          |18112                           |15110.29                        |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|
|YA230 4-20                                                                    |Linear solution 4               |0.15                            |1.4983                          |22706                           |15154.34                        |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|
|YA230 4-20                                                                    |Linear Solution 5               |0.22                            |2.2475                          |33698                           |14993.71                        |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|
|YA230 4-20                                                                    |Linear solution 6               |0.30                            |2.9966                          |45656                           |15235.76                        |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|
|YA230 4-20                                                                    |Response factor RSD/%           |Response factor RSD/%           |0.9                             |0.9                             |0.9                             |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|
|YA230 4-20                                                                    |Linear graph                    |Linear graph                    |                                |                                |                                |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|
|YA230 4-20                                                                    |Linearequations                 |Linearequations                 |Y = 15161-28.894 x              |Y = 15161-28.894 x              |Y =                             |
|                                                                              |                                |                                |                                |                                |15161-28.894                    |
|                                                                              |                                |                                |                                |                                |x                               |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|
|YA230 4-20                                                                    |Correlation coefficientR        |Correlation coefficientR        |0.9999                          |0.9999                          |0.9999                          |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|
|YA230 4-20                                                                    |AbsoluteY-axisintercept         |AbsoluteY-axisintercept         |0.13                            |0.13                            |0.13                            |
|                                                                              |percentage /% of 100% response  |percentage /% of 100% response  |                                |                                |                                |
|                                                                              |value                           |value                           |                                |                                |                                |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|
|YA230 4-20                                                                    |Conclusion: YA2304-20 in the    |Conclusion: YA2304-20 in the    |Conclusion: YA2304-20 in the    |Conclusion: YA2304-20 in the    |Conclusion:                     |
|                                                                              |range of 0.2997~2.9966 μg/ml,   |range of 0.2997~2.9966 μg/ml,   |range of 0.2997~2.9966 μg/ml,   |range of 0.2997~2.9966 μg/ml,   |YA2304-20 in                    |
|                                                                              |the                             |the                             |the                             |the                             |the range of                    |
|                                                                              |linearequationisy=15161x-28.894,|linearequationisy=15161x-28.894,|linearequationisy=15161x-28.894,|linearequationisy=15161x-28.894,|0.2997~2.9966                   |
|                                                                              |R=0.9999 (should NLT 0.990), the|R=0.9999 (should NLT 0.990), the|R=0.9999 (should NLT 0.990), the|R=0.9999 (should NLT 0.990), the|μg/ml, the                      |
|                                                                              |response factor RSDis 0.9%      |response factor RSDis 0.9%      |response factor RSDis 0.9%      |response factor RSDis 0.9%      |linearequationisy=15161x-28.894,|
|                                                                              |(should not be more than 10%).  |(should not be more than 10%).  |(should not be more than 10%).  |(should not be more than 10%).  |R=0.9999                        |
|                                                                              |The absolute value of           |The absolute value of           |The absolute value of           |The absolute value of           |(should NLT                     |
|                                                                              |                                |                                |                                |                                |0.990), the                     |
|                                                                              |                                |                                |                                |                                |response                        |
|                                                                              |                                |                                |                                |                                |factor RSDis                    |
|                                                                              |                                |                                |                                |                                |0.9% (should                    |
|                                                                              |                                |                                |                                |                                |not be more                     |
|                                                                              |                                |                                |                                |                                |than 10%).                      |
|                                                                              |                                |                                |                                |                                |The absolute                    |
|                                                                              |                                |                                |                                |                                |value of                        |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 303 of 542 





Page 304
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Y-axis intercept accounts for 0.13% of 100% response value (NMT 25%), 



indicating that YA2304-20 detected by this method has a good linear 



relationship in the range of 0.2997~2.9966 μg/ml. 



**(4.6) Accuracy** 



 **Brief Description** 



Accuracy is achieved by determining the ratio (recovery rate) between the 



actual detected amount and the theoretical amount of YA2304-20 reference 



product added to the test product at different concentrations (30% to 150% 



limit concentration). It is required that the signal to noise ratio (S/N) of 



YA2304-20 peak in the chromatogram of the reference product should NLT 



30; The 30% limit concentration recovery rate should be between 85% and 



110%, the 100% to 150% limit concentration recovery rate should be 



between 90% and 108%, and the RSD of the recovery rate of 9 recovery 



samples NMT 10%. 



 **Solution preparation** 



Blank solution: solvent. 



Test product solution: Take about 20mg of this product, weigh it accurately, 



place it in a 20ml measuring bottle, add an appropriate amount of solvent to 



dissolve by ultrasound, cool it, dilute it with solvent to the scale, shake well, 



and then get. (Parallel preparation of 2 parts) 



Reference product reserve liquid: The reference product reserve liquid 



under "4.1 wavelength selection" is prepared in the same way. 



Reference solution: prepared in the same way as the reference solution 



under "4.1 wavelength selection". 



System suitability solution: Share system suitability solution under "4.2 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 304 of 542 





Page 305
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



System Suitability". 



Reserve solution with sample recovery rate: accurately measure 2.5ml of 



the control product reserve solution, place it in a 25ml measuring bottle, 



dilute it with solvent to the scale, shake well, and then obtain. 



30% sample recovery solution: take about 20mg of this product, 



accurately weigh it, put it in a 20ml bottle, add an appropriate amount of 



solvent to dissolve by ultrasound, cool it, accurately add 0.6ml of sample 



recovery liquid, dilute it with solvent to the scale, shake well, and get. 



(Dispense 3 parts in parallel) 



100% sample recovery solution: Take about 20mg of this product, weigh 



it accurately, place it in a 20ml measuring bottle, add an appropriate amount 



of solvent to dissolve by ultrasound, cool it, accurately add the reserve liquid 



with sample recovery rate of 2.0ml, dilute it with solvent to the scale, shake 



well, and get. (Dispense 3 parts in parallel) 



150% sample recovery solution: Take about 20mg of this product, weigh 



it accurately, place it in a 20ml measuring bottle, add an appropriate amount 



of solvent to dissolve by ultrasound, cool it, accurately add the reserve liquid 



with sample recovery rate of 3.0ml, dilute it with solvent to the scale, shake 



well, and get. (Dispense 3 parts in parallel) 



 **Injection procedure** 



After the balance of the instrument, 1 needle was injected into the blank 



solution, 1 needle was injected into the system suitability solution, 2 needles 



were injected into the control solution, 1 needle was injected into the test 



solution, and 1 needle was injected into the solution with each recovery rate. 



 **Measurement results** 
























---------------------------------------------------------------------------
|YA2304-2 0|30% sample recovery solution 1|0.1465 |0.4587 |0.5893 |96.5   |
---------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 305 of 542 





Page 306
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 

---------------------------------------------------------------------------
|       |30% addition recovery solution 2 |0.1515 |0.4587 |0.5901 |95.6   |
|       |                                 |       |       |       |       |
|       |                                 |       |       |       |       |
|       |---------------------------------|-------|-------|-------|-------|
|       |30% addition recovery solution 3 |0.1478 |0.4587 |0.5810 |94.5   |
|       |---------------------------------|-------|-------|-------|-------|
|       |100% sample recovery solution 1  |0.1452 |1.5289 |1.6581 |99.0   |
|       |---------------------------------|-------|-------|-------|-------|
|       |100% addition recovery solution 2|0.1499 |1.5289 |1.6870 |100.5  |
|       |---------------------------------|-------|-------|-------|-------|
|       |100% addition recovery solution 3|0.1493 |1.5289 |1.6798 |100.1  |
|       |---------------------------------|-------|-------|-------|-------|
|       |150% addition recovery solution 1|0.1545 |2.2933 |2.4359 |99.5   |
|       |---------------------------------|-------|-------|-------|-------|
|       |150% addition recovery solution 2|0.1474 |2.2933 |2.4672 |101.2  |
|       |---------------------------------|-------|-------|-------|-------|
|       |150% addition recovery solution 3|0.1498 |2.2933 |2.4294 |99.4   |
|       |---------------------------------|-------|-------|-------|-------|
|       |Average recovery rate (%)                                |98.5   |
|       |---------------------------------------------------------|-------|
|       |RSD (%)                                                  |2.4    |
---------------------------------------------------------------------------



**(4.7) Precision** 



Precision refers to the proximity between the results obtained by multiple 



sampling of the same uniform test product under specified test conditions, 



and its precision is judged by examining repeatability and reproducibility. 



**(4.7.1) Repeatability** 



 **Acceptance Criteria** 



6 repeatable sample solutions were prepared by Analyst A on date A and 



determined by instrument A. It is required that the separation degree 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 306 of 542 





Page 307
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



between the main peak and YA2304-20 in the chromatogram of system 



suitability solution should be greater than 1.5; The signal to noise ratio (S/N) 



of YA2304-20 peak in the chromatogram of reference solution should NLT 30; 



The RSD of YA2304-20 in 6 repetitive test solutions should NMT 10%. 



 **Solution Preparation** 



Blank solution: solvent. 



Reference stock solution: Share reference stock solution under "4.6 



Accuracy". 



Reference product solution: prepared in the same way as the reference 



product solution under "4.1 wavelength selection". 



System suitability solution: Share system suitability solution under "4.2 



System Suitability". 



Repeatable reserve solution: accurately measure 2.5ml of the control product 



reserve solution, place it in a 25ml measuring bottle, dilute it with solvent to 



the scale, shake well, and then obtain. 



Repeatable test solution: take about 20mg of this product, accurately weigh 



it, place it in 20ml measuring bottle, add an appropriate amount of solvent to 



dissolve by ultrasound, cool it, add 2.0ml repeatable reserve liquid precisely, 



dilute it with solvent to the scale, shake well, ready. (Parallel preparation of 6 



parts) 



 **Injection procedure** 



After the instrument is balanced, 1 needle is injected into blank solution, 1 



needle is injected into system suitability solution, 1 needle is injected into 



control solution, and 1 needle is injected into repeated test solution. 



 **Measurement results** 













---------------------------------------------
|System suitability solution|1      |3.0    |
---------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 307 of 542 





Page 308
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 
















------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Reference solution                                            |Reference          |1                  |1                  |91.4               |91.4               |91.4               |91.4               |
|                                                              |solution           |                   |                   |                   |                   |                   |                   |
|--------------------------------------------------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|
|Reference solution                                            |Reference          |2                  |2                  |68.2               |68.2               |68.2               |68.2               |
|                                                              |solution           |                   |                   |                   |                   |                   |                   |
|--------------------------------------------------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|
|Repeat test product                                           |1                  |2                  |3                  |4                  |5                  |6                  |RSD/%              |
|--------------------------------------------------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|
|YA2304-20 content /%                                          |0.17               |0.17               |0.17               |0.17               |0.17               |0.18               |2.5                |
|--------------------------------------------------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|
|Conclusion: The systemapplicability meets the requirements;   |Conclusion:        |Conclusion:        |Conclusion:        |Conclusion:        |Conclusion:        |Conclusion:        |Conclusion:        |
|The RSD of YA2304-20 in 6 repetitive test products was 2.5%   |The                |The                |The                |The                |The                |The                |The                |
|(the requirement NMT 10%). It met the verification            |systemapplicability|systemapplicability|systemapplicability|systemapplicability|systemapplicability|systemapplicability|systemapplicability|
|requirements, indicating that the method had good             |meets the          |meets              |meets              |meets              |meets              |meets              |meets              |
|repeatability.                                                |requirements;      |the                |the                |the                |the                |the                |the                |
|                                                              |The RSD            |requirements;      |requirements;      |requirements;      |requirements;      |requirements;      |requirements;      |
|                                                              |of                 |The RSD            |The RSD            |The RSD            |The RSD            |The RSD            |The RSD            |
|                                                              |YA2304-20          |of                 |of                 |of                 |of                 |of                 |of                 |
|                                                              |in 6               |YA2304-20          |YA2304-20          |YA2304-20          |YA2304-20          |YA2304-20          |YA2304-20          |
|                                                              |repetitive         |in 6               |in 6               |in 6               |in 6               |in 6               |in 6               |
|                                                              |test               |repetitive         |repetitive         |repetitive         |repetitive         |repetitive         |repetitive         |
|                                                              |products           |test               |test               |test               |test               |test               |test               |
|                                                              |was 2.5%           |products           |products           |products           |products           |products           |products           |
|                                                              |(the               |was                |was                |was                |was                |was                |was                |
|                                                              |requirement        |2.5%               |2.5%               |2.5%               |2.5%               |2.5%               |2.5%               |
|                                                              |NMT 10%).          |(the               |(the               |(the               |(the               |(the               |(the               |
|                                                              |It met             |requirement        |requirement        |requirement        |requirement        |requirement        |requirement        |
|                                                              |the                |NMT                |NMT                |NMT                |NMT                |NMT                |NMT                |
|                                                              |verification       |10%).              |10%).              |10%).              |10%).              |10%).              |10%).              |
|                                                              |requirements,      |It met             |It met             |It met             |It met             |It met             |It met             |
|                                                              |indicating         |the                |the                |the                |the                |the                |the                |
|                                                              |that the           |verification       |verification       |verification       |verification       |verification       |verification       |
|                                                              |method             |requirements,      |requirements,      |requirements,      |requirements,      |requirements,      |requirements,      |
|                                                              |had good           |indicating         |indicating         |indicating         |indicating         |indicating         |indicating         |
|                                                              |repeatability.     |that               |that               |that               |that               |that               |that               |
|                                                              |                   |the                |the                |the                |the                |the                |the                |
|                                                              |                   |method             |method             |method             |method             |method             |method             |
|                                                              |                   |had                |had                |had                |had                |had                |had                |
|                                                              |                   |good               |good               |good               |good               |good               |good               |
|                                                              |                   |repeatability.     |repeatability.     |repeatability.     |repeatability.     |repeatability.     |repeatability.     |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**(4.7.2) Reproducibility** 



 **Brief Description** 



6 reproducible sample solutions were prepared by QC personnel B on date B 



and determined by instrument B. It is required that the separation degree 



between the main peak and YA2304-20 peak in the chromatogram of system 



suitability solution should be greater than 1.5; The signal-to-noise ratio (S/N) 



of peak YA2304-20 in the chromatogram obtained for 6 consecutive days 



should NLT 30, the RSD of the retention time NMT 1.0%, and the RSD of the 



peak area NMT 5%. In 6 reproducible sample solutions, the RSD of 



YA2304-20 NMT 10%. 



For the results of 12 repeatability and reproducibility tests, the RSD of 



YA2304-20 NMT 10%. 



 **Solution preparation** 



Blank solution: solvent 



Reference stock solution: Share the reference stock solution under "4.6 



Accuracy". 



Reference product solution: prepared in the same way as the reference 



product solution under "4.1 wavelength selection". 



System suitability solution: the system suitability solution under "4.2 



System suitability" is prepared in the same way. 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 308 of 542 





Page 309
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Reproducible reserve solution: accurately measure 2.5ml of the control 



product reserve solution, place it in a 25ml measuring bottle, dilute it with 



solvent to the scale, shake well, and then obtain 



Reproducible test solution: Take about 20mg of this product, accurately 



weigh it, place it in a 20ml measuring bottle, add an appropriate amount of 



solvent to dissolve by ultrasound, cool it, add 2.0ml of reproducible reserve 



liquid precisely, dilute it with solvent to the scale, shake well, and obtain. 



(Parallel preparation of 6 parts) 



 **Injection procedure** 



After the balance of the instrument, 1 needle was injected into the blank 



solution, 1 needle was injected into the system suitability solution, 6 needles 



were injected into the control solution continuously, and 1 needle was 



injected into each of the reproducible test solution. 



 **Measurement results** 



Reproducibility - system suitability test results 






























----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|System suitability solution                                                           |1                   |2.6                 |2.6                 |2.6                 |
|--------------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|
|Reference solution                                                                    |Sample              |Retention           |Peakarea            |Signal-to-noise     |
|                                                                                      |number              |time                |                    |ratio               |
|                                                                                      |                    |(min)               |                    |                    |
|--------------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|
|Reference solution                                                                    |1                   |21.708              |26122               |49.3                |
|--------------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|
|Reference solution                                                                    |2                   |21.699              |27518               |45.7                |
|--------------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|
|Reference solution                                                                    |3                   |21.657              |26997               |41.9                |
|--------------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|
|Reference solution                                                                    |4                   |21.674              |27146               |43.6                |
|--------------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|
|Reference solution                                                                    |5                   |21.634              |27328               |41.4                |
|--------------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|
|Reference solution                                                                    |6                   |21.659              |27296               |43.5                |
|--------------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|
|Reference solution                                                                    |RSD%(n=6)           |0.13                |1.9                 |/                   |
|--------------------------------------------------------------------------------------|--------------------|--------------------|--------------------|--------------------|
|Conclusion: The blank solution has no interference; The separation degree between     |Conclusion:         |Conclusion:         |Conclusion:         |Conclusion: The     |
|YA2304-20 peak and the main peak in the systemapplicability solutionis 2.6 (the       |The blank           |The blank           |The                 |blank solution      |
|requirement should NLT 1.5). In the chromatogramobtained from the control product     |solution            |solution            |blank               |has no              |
|solution, the signal-to-noise ratio of the main peak was between 41.4 and 49.3 (the   |has no              |has no              |solution            |interference;       |
|requirement should NLT 30); The RSD of peak retention time of YA2304-20 for 6         |interference;       |interference;       |has no              |The separation      |
|consecutive days was 0.13% (the requirement should be no more than 1.0%); The RSD% of |The                 |The                 |interference;       |degree between      |
|peakarea is 1.9% (the requirement should NMT 5%); All meet the verification           |separation          |separation          |The                 |YA2304-20 peak      |
|requirements. It shows that this method hasgood systemapplicability.                  |degree              |degree              |separation          |and the main        |
|                                                                                      |between             |between             |degree              |peak in the         |
|                                                                                      |YA2304-20           |YA2304-20           |between             |systemapplicability |
|                                                                                      |peak and            |peak and            |YA2304-20           |solutionis 2.6      |
|                                                                                      |the main            |the main            |peak and            |(the                |
|                                                                                      |peak in             |peak in             |the main            |requirement         |
|                                                                                      |the                 |the                 |peak in             |should NLT          |
|                                                                                      |systemapplicability |systemapplicability |the                 |1.5). In the        |
|                                                                                      |solutionis          |solutionis          |systemapplicability |chromatogramobtained|
|                                                                                      |2.6 (the            |2.6 (the            |solutionis          |from the            |
|                                                                                      |requirement         |requirement         |2.6 (the            |control product     |
|                                                                                      |should              |should              |requirement         |solution, the       |
|                                                                                      |NLT 1.5).           |NLT 1.5).           |should              |signal-to-noise     |
|                                                                                      |In the              |In the              |NLT                 |ratio of the        |
|                                                                                      |chromatogramobtained|chromatogramobtained|1.5). In            |main peak was       |
|                                                                                      |from the            |from the            |the                 |between 41.4        |
|                                                                                      |control             |control             |chromatogramobtained|and 49.3 (the       |
|                                                                                      |product             |product             |from the            |requirement         |
|                                                                                      |solution,           |solution,           |control             |should NLT 30);     |
|                                                                                      |the                 |the                 |product             |The RSD of peak     |
|                                                                                      |signal-to-noise     |signal-to-noise     |solution,           |retention time      |
|                                                                                      |ratio of            |ratio of            |the                 |of YA2304-20        |
|                                                                                      |the main            |the main            |signal-to-noise     |for 6               |
|                                                                                      |peak was            |peak was            |ratio of            |consecutive         |
|                                                                                      |between             |between             |the main            |days was 0.13%      |
|                                                                                      |41.4 and            |41.4 and            |peak was            |(the                |
|                                                                                      |49.3 (the           |49.3 (the           |between             |requirement         |
|                                                                                      |requirement         |requirement         |41.4 and            |should be no        |
|                                                                                      |should              |should              |49.3                |more than           |
|                                                                                      |NLT 30);            |NLT 30);            |(the                |1.0%); The RSD%     |
|                                                                                      |The RSD             |The RSD             |requirement         |of peakarea is      |
|                                                                                      |of peak             |of peak             |should              |1.9% (the           |
|                                                                                      |retention           |retention           |NLT 30);            |requirement         |
|                                                                                      |time of             |time of             |The RSD             |should NMT 5%);     |
|                                                                                      |YA2304-20           |YA2304-20           |of peak             |All meet the        |
|                                                                                      |for 6               |for 6               |retention           |verification        |
|                                                                                      |consecutive         |consecutive         |time of             |requirements.       |
|                                                                                      |days was            |days was            |YA2304-20           |It shows that       |
|                                                                                      |0.13%               |0.13%               |for 6               |this method         |
|                                                                                      |(the                |(the                |consecutive         |hasgood             |
|                                                                                      |requirement         |requirement         |days was            |systemapplicability.|
|                                                                                      |should be           |should be           |0.13%               |                    |
|                                                                                      |no more             |no more             |(the                |                    |
|                                                                                      |than                |than                |requirement         |                    |
|                                                                                      |1.0%);              |1.0%);              |should              |                    |
|                                                                                      |The RSD%            |The RSD%            |be no               |                    |
|                                                                                      |of                  |of                  |more                |                    |
|                                                                                      |peakarea            |peakarea            |than                |                    |
|                                                                                      |is 1.9%             |is 1.9%             |1.0%);              |                    |
|                                                                                      |(the                |(the                |The RSD%            |                    |
|                                                                                      |requirement         |requirement         |of                  |                    |
|                                                                                      |should              |should              |peakarea            |                    |
|                                                                                      |NMT 5%);            |NMT 5%);            |is 1.9%             |                    |
|                                                                                      |All meet            |All meet            |(the                |                    |
|                                                                                      |the                 |the                 |requirement         |                    |
|                                                                                      |verification        |verification        |should              |                    |
|                                                                                      |requirements.       |requirements.       |NMT 5%);            |                    |
|                                                                                      |It shows            |It shows            |All meet            |                    |
|                                                                                      |that this           |that this           |the                 |                    |
|                                                                                      |method              |method              |verification        |                    |
|                                                                                      |hasgood             |hasgood             |requirements.       |                    |
|                                                                                      |systemapplicability.|systemapplicability.|It shows            |                    |
|                                                                                      |                    |                    |that                |                    |
|                                                                                      |                    |                    |this                |                    |
|                                                                                      |                    |                    |method              |                    |
|                                                                                      |                    |                    |hasgood             |                    |
|                                                                                      |                    |                    |systemapplicability.|                    |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Precision test results 



Results of repeatability test Reproducibility test results 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 309 of 542 





Page 310
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 






















------------------------------------------------------------------------------------------------------------------------------------------------
|Repeatable test product solution 1                                                            |0.17           |Reproducible   |0.17           |
|                                                                                              |               |test           |               |
|                                                                                              |               |product        |               |
|                                                                                              |               |solution       |               |
|                                                                                              |               |1              |               |
|----------------------------------------------------------------------------------------------|---------------|---------------|---------------|
|Reproducible sample solution 2                                                                |0.17           |Reproducible   |0.16           |
|                                                                                              |               |test product   |               |
|                                                                                              |               |solution 2     |               |
|----------------------------------------------------------------------------------------------|---------------|---------------|---------------|
|Repeatable sample solution 3                                                                  |0.17           |Reproducible   |0.16           |
|                                                                                              |               |test           |               |
|                                                                                              |               |solution 3     |               |
|----------------------------------------------------------------------------------------------|---------------|---------------|---------------|
|Reproducible sample solution 4                                                                |0.17           |Reproducible   |0.18           |
|                                                                                              |               |test product   |               |
|                                                                                              |               |solution 4     |               |
|----------------------------------------------------------------------------------------------|---------------|---------------|---------------|
|Reproducible sample solution 5                                                                |0.17           |Reproducible   |0.17           |
|                                                                                              |               |test product   |               |
|                                                                                              |               |solution 5     |               |
|----------------------------------------------------------------------------------------------|---------------|---------------|---------------|
|Repeatable sample solution 6                                                                  |0.18           |Reproducible   |0.18           |
|                                                                                              |               |test product   |               |
|                                                                                              |               |solution 6     |               |
|----------------------------------------------------------------------------------------------|---------------|---------------|---------------|
|RSD/% (n=6)                                                                                   |2.5            |RSD/% (n=6)    |5              |
|----------------------------------------------------------------------------------------------|---------------|---------------|---------------|
|Precision RSD/% (n=12)                                                                        |Precision      |4              |4              |
|                                                                                              |RSD/%          |               |               |
|                                                                                              |(n=12)         |               |               |
|----------------------------------------------------------------------------------------------|---------------|---------------|---------------|
|Conclusion: The RSD of YA2304-20 in 6 reproducible samples was 5% (the requirement NMT 10%).  |Conclusion:    |Conclusion:    |Conclusion:    |
|The method met the requirements of verification, indicating good reproducibility of the       |The RSD        |The RSD of     |The RSD        |
|method. The RSD of YA2304-20 measured for 12 times of repeatability and reproducibility was 4%|of             |YA2304-20 in   |of             |
|(the requirement NMT 10%), which met the verification requirements, indicating that the method|YA2304-20      |6              |YA2304-20      |
|had good precision.                                                                           |in 6           |reproducible   |in 6           |
|                                                                                              |reproducible   |samples was    |reproducible   |
|                                                                                              |samples        |5% (the        |samples        |
|                                                                                              |was 5%         |requirement    |was 5%         |
|                                                                                              |(the           |NMT 10%).      |(the           |
|                                                                                              |requirement    |The method     |requirement    |
|                                                                                              |NMT 10%).      |met the        |NMT            |
|                                                                                              |The            |requirements   |10%).          |
|                                                                                              |method         |of             |The            |
|                                                                                              |met the        |verification,  |method         |
|                                                                                              |requirements   |indicating     |met the        |
|                                                                                              |of             |good           |requirements   |
|                                                                                              |verification,  |reproducibility|of             |
|                                                                                              |indicating     |of the         |verification,  |
|                                                                                              |good           |method. The    |indicating     |
|                                                                                              |reproducibility|RSD of         |good           |
|                                                                                              |of the         |YA2304-20      |reproducibility|
|                                                                                              |method.        |measured for   |of the         |
|                                                                                              |The RSD        |12 times of    |method.        |
|                                                                                              |of             |repeatability  |The RSD        |
|                                                                                              |YA2304-20      |and            |of             |
|                                                                                              |measured       |reproducibility|YA2304-20      |
|                                                                                              |for 12         |was 4% (the    |measured       |
|                                                                                              |times of       |requirement    |for 12         |
|                                                                                              |repeatability  |NMT 10%),      |times          |
|                                                                                              |and            |which met      |of             |
|                                                                                              |reproducibility|the            |repeatability  |
|                                                                                              |was 4%         |verification   |and            |
|                                                                                              |(the           |requirements,  |reproducibility|
|                                                                                              |requirement    |indicating     |was 4%         |
|                                                                                              |NMT 10%),      |that the       |(the           |
|                                                                                              |which met      |method had     |requirement    |
|                                                                                              |the            |good           |NMT            |
|                                                                                              |verification   |precision.     |10%),          |
|                                                                                              |requirements,  |               |which          |
|                                                                                              |indicating     |               |met the        |
|                                                                                              |that the       |               |verification   |
|                                                                                              |method         |               |requirements,  |
|                                                                                              |had good       |               |indicating     |
|                                                                                              |precision.     |               |that           |
|                                                                                              |               |               |the            |
|                                                                                              |               |               |method         |
|                                                                                              |               |               |had            |
|                                                                                              |               |               |good           |
|                                                                                              |               |               |precision.     |
------------------------------------------------------------------------------------------------------------------------------------------------

**(4.8) Solution stability** 



 **Brief Description** 



The system suitability solution, the control solution and the test product 



solution were placed at room temperature for a period of time, and the 



samples were injected at different time points. The separation degree 



between YA2304-20 peak and the main peak in the chromatogram of the 



system suitability solution should NLT 1.5; The peak signal-to-noise ratio 



(S/N) of YA2304-20 in the chromatogram of reference solution should NLT 30, 



and the RSD of peak area should not be more than 5%; In the chromatogram 



obtained by the test product solution, the RSD of YA2304-20 NMT 10% 



according to the peak area calculation by external standard method, and 



there shall be no new peak generation that interferes with the detection of 



YA2304-20. 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 310 of 542 





Page 311
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



 **Solution preparation** 



Reference solution: Share the reference solution under "4.2 System 



Suitability". 



System Suitability solution: Share system suitability solution under "4.2 



System Suitability". 



Test product solution: Share test product solution under "4.3 Specificity 



- Peak identification". 



 **Injection Sequence** 



The system suitable solution was injected at 0h, 6h, 14.5h, 22h, 29h, 



49h, 3d, 4d and 5d respectively. (System suitability solution 0h is system 



suitability solution under "System suitability", system suitability solution 6h 



is system suitability solution under "particularity-peak identification", 



system suitability solution 3d is system suitability solution under the second 



"accuracy", system suitability solution 4d is system suitability solution 



under the third "accuracy". System suitability solution 5d is system 



suitability solution under "repeatability",) 



The control solution was injected at 0h, 6h, 14.5h, 22h, 29h and 49h, 



respectively. (Reference solution 0h was the reference solution under "system 



suitability", and reference solution 6h was the reference solution under 



"particularity-peak identification") 



Sample solution was injected at 0h, 8.5h, 16h and 23h, respectively. 



 **Measurement resultss** 



Stability test results of solution 






















-------------------------------------------------------------------------------------------------------------------
|Time point|Degree of Separation|Point in Time|Peakarea|Signal- to-noise ratio|Point in time|YA2304-20 content (%)|
|----------|--------------------|-------------|--------|----------------------|-------------|---------------------|
|0h        |3.0                 |0h           |23887   |80.8                  |0h           |0.0111               |
|----------|--------------------|-------------|--------|----------------------|-------------|---------------------|
|6h        |3.0                 |6h           |23747   |62.2                  |8.5 h.       |0.0101               |
|----------|--------------------|-------------|--------|----------------------|-------------|---------------------|
|14.5 h.   |3.0                 |14.5 h.      |23929   |77.2                  |16h          |0.0112               |
|----------|--------------------|-------------|--------|----------------------|-------------|---------------------|
|22h       |3.1                 |22h          |23487   |80.3                  |23h          |0.0091               |
|----------|--------------------|-------------|--------|----------------------|-------------|---------------------|
|29h       |3.1                 |29h          |23527   |62.7                  |/            |/                    |
|----------|--------------------|-------------|--------|----------------------|-------------|---------------------|
|49h       |3.1                 |49h          |23260   |74.6                  |/            |/                    |
-------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 311 of 542 





Page 312
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 

------------------------------------------------------------------------------------------------------------------------------------------------------------
|4d                                                                    |3.0          |/            |/            |/            |/            |/            |
|----------------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|-------------|
|5d                                                                    |3.0          |/            |/            |/            |/            |/            |
|----------------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|-------------|
|RSD/%                                                                 |/            |/            |1.1          |/            |/            |10           |
|----------------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|-------------|
|Conclusion: Within 5 days at room temperature, the separation degree  |Conclusion:  |Conclusion:  |Conclusion:  |Conclusion:  |Conclusion:  |Conclusion:  |
|between YA2304-20 peaks and main peaks in the system suitability      |Within       |Within       |Within       |Within       |Within       |Within       |
|solutionis greater than 1.5 (the requirement should be NLT 1.5), which|5 days       |5 days       |5 days       |5 days       |5 days       |5 days       |
|meets the verification requirements, indicating that the system       |at room      |at room      |at room      |at room      |at room      |at room      |
|suitability solutionis stable within 5 days at room temperature.      |temperature, |temperature, |temperature, |temperature, |temperature, |temperature, |
|Within 49hat room temperature, the RSD of YA2304-20 peaks in the      |the          |the          |the          |the          |the          |the          |
|control solution was 1.1% (not more than 10%). The peak-to-noise ratio|separation   |separation   |separation   |separation   |separation   |separation   |
|of YA2304-20 was between 62.2 and 80.3 (the requirement should NLT    |degree       |degree       |degree       |degree       |degree       |degree       |
|30), which met the verification requirements, indicating that the     |between      |between      |between      |between      |between      |between      |
|control solution was stable within 49hat room temperature. Within     |YA2304-20    |YA2304-20    |YA2304-20    |YA2304-20    |YA2304-20    |YA2304-20    |
|23hat room temperature, the RSD of YA2304-20 in the test solutionis   |peaks        |peaks        |peaks        |peaks        |peaks        |peaks        |
|10% (the requirement NMT 10%), which meets the verification           |and          |and          |and          |and          |and          |and          |
|requirements, indicating that the test solutionis stable within23hat  |main         |main         |main         |main         |main         |main         |
|room temperature.                                                     |peaks        |peaks        |peaks        |peaks        |peaks        |peaks        |
|                                                                      |in the       |in the       |in the       |in the       |in the       |in the       |
|                                                                      |system       |system       |system       |system       |system       |system       |
|                                                                      |suitability  |suitability  |suitability  |suitability  |suitability  |suitability  |
|                                                                      |solutionis   |solutionis   |solutionis   |solutionis   |solutionis   |solutionis   |
|                                                                      |greater      |greater      |greater      |greater      |greater      |greater      |
|                                                                      |than         |than         |than         |than         |than         |than         |
|                                                                      |1.5          |1.5          |1.5          |1.5          |1.5          |1.5          |
|                                                                      |(the         |(the         |(the         |(the         |(the         |(the         |
|                                                                      |requirement  |requirement  |requirement  |requirement  |requirement  |requirement  |
|                                                                      |should       |should       |should       |should       |should       |should       |
|                                                                      |be NLT       |be NLT       |be NLT       |be NLT       |be NLT       |be NLT       |
|                                                                      |1.5),        |1.5),        |1.5),        |1.5),        |1.5),        |1.5),        |
|                                                                      |which        |which        |which        |which        |which        |which        |
|                                                                      |meets        |meets        |meets        |meets        |meets        |meets        |
|                                                                      |the          |the          |the          |the          |the          |the          |
|                                                                      |verification |verification |verification |verification |verification |verification |
|                                                                      |requirements,|requirements,|requirements,|requirements,|requirements,|requirements,|
|                                                                      |indicating   |indicating   |indicating   |indicating   |indicating   |indicating   |
|                                                                      |that         |that         |that         |that         |that         |that         |
|                                                                      |the          |the          |the          |the          |the          |the          |
|                                                                      |system       |system       |system       |system       |system       |system       |
|                                                                      |suitability  |suitability  |suitability  |suitability  |suitability  |suitability  |
|                                                                      |solutionis   |solutionis   |solutionis   |solutionis   |solutionis   |solutionis   |
|                                                                      |stable       |stable       |stable       |stable       |stable       |stable       |
|                                                                      |within       |within       |within       |within       |within       |within       |
|                                                                      |5 days       |5 days       |5 days       |5 days       |5 days       |5 days       |
|                                                                      |at room      |at room      |at room      |at room      |at room      |at room      |
|                                                                      |temperature. |temperature. |temperature. |temperature. |temperature. |temperature. |
|                                                                      |Within       |Within       |Within       |Within       |Within       |Within       |
|                                                                      |49hat        |49hat        |49hat        |49hat        |49hat        |49hat        |
|                                                                      |room         |room         |room         |room         |room         |room         |
|                                                                      |temperature, |temperature, |temperature, |temperature, |temperature, |temperature, |
|                                                                      |the RSD      |the RSD      |the RSD      |the RSD      |the RSD      |the RSD      |
|                                                                      |of           |of           |of           |of           |of           |of           |
|                                                                      |YA2304-20    |YA2304-20    |YA2304-20    |YA2304-20    |YA2304-20    |YA2304-20    |
|                                                                      |peaks        |peaks        |peaks        |peaks        |peaks        |peaks        |
|                                                                      |in the       |in the       |in the       |in the       |in the       |in the       |
|                                                                      |control      |control      |control      |control      |control      |control      |
|                                                                      |solution     |solution     |solution     |solution     |solution     |solution     |
|                                                                      |was          |was          |was          |was          |was          |was          |
|                                                                      |1.1%         |1.1%         |1.1%         |1.1%         |1.1%         |1.1%         |
|                                                                      |(not         |(not         |(not         |(not         |(not         |(not         |
|                                                                      |more         |more         |more         |more         |more         |more         |
|                                                                      |than         |than         |than         |than         |than         |than         |
|                                                                      |10%).        |10%).        |10%).        |10%).        |10%).        |10%).        |
|                                                                      |The          |The          |The          |The          |The          |The          |
|                                                                      |peak-to-noise|peak-to-noise|peak-to-noise|peak-to-noise|peak-to-noise|peak-to-noise|
|                                                                      |ratio        |ratio        |ratio        |ratio        |ratio        |ratio        |
|                                                                      |of           |of           |of           |of           |of           |of           |
|                                                                      |YA2304-20    |YA2304-20    |YA2304-20    |YA2304-20    |YA2304-20    |YA2304-20    |
|                                                                      |was          |was          |was          |was          |was          |was          |
|                                                                      |between      |between      |between      |between      |between      |between      |
|                                                                      |62.2         |62.2         |62.2         |62.2         |62.2         |62.2         |
|                                                                      |and          |and          |and          |and          |and          |and          |
|                                                                      |80.3         |80.3         |80.3         |80.3         |80.3         |80.3         |
|                                                                      |(the         |(the         |(the         |(the         |(the         |(the         |
|                                                                      |requirement  |requirement  |requirement  |requirement  |requirement  |requirement  |
|                                                                      |should       |should       |should       |should       |should       |should       |
|                                                                      |NLT          |NLT          |NLT          |NLT          |NLT          |NLT          |
|                                                                      |30),         |30),         |30),         |30),         |30),         |30),         |
|                                                                      |which        |which        |which        |which        |which        |which        |
|                                                                      |met the      |met the      |met the      |met the      |met the      |met the      |
|                                                                      |verification |verification |verification |verification |verification |verification |
|                                                                      |requirements,|requirements,|requirements,|requirements,|requirements,|requirements,|
|                                                                      |indicating   |indicating   |indicating   |indicating   |indicating   |indicating   |
|                                                                      |that         |that         |that         |that         |that         |that         |
|                                                                      |the          |the          |the          |the          |the          |the          |
|                                                                      |control      |control      |control      |control      |control      |control      |
|                                                                      |solution     |solution     |solution     |solution     |solution     |solution     |
|                                                                      |was          |was          |was          |was          |was          |was          |
|                                                                      |stable       |stable       |stable       |stable       |stable       |stable       |
|                                                                      |within       |within       |within       |within       |within       |within       |
|                                                                      |49hat        |49hat        |49hat        |49hat        |49hat        |49hat        |
|                                                                      |room         |room         |room         |room         |room         |room         |
|                                                                      |temperature. |temperature. |temperature. |temperature. |temperature. |temperature. |
|                                                                      |Within       |Within       |Within       |Within       |Within       |Within       |
|                                                                      |23hat        |23hat        |23hat        |23hat        |23hat        |23hat        |
|                                                                      |room         |room         |room         |room         |room         |room         |
|                                                                      |temperature, |temperature, |temperature, |temperature, |temperature, |temperature, |
|                                                                      |the RSD      |the RSD      |the RSD      |the RSD      |the RSD      |the RSD      |
|                                                                      |of           |of           |of           |of           |of           |of           |
|                                                                      |YA2304-20    |YA2304-20    |YA2304-20    |YA2304-20    |YA2304-20    |YA2304-20    |
|                                                                      |in the       |in the       |in the       |in the       |in the       |in the       |
|                                                                      |test         |test         |test         |test         |test         |test         |
|                                                                      |solutionis   |solutionis   |solutionis   |solutionis   |solutionis   |solutionis   |
|                                                                      |10%          |10%          |10%          |10%          |10%          |10%          |
|                                                                      |(the         |(the         |(the         |(the         |(the         |(the         |
|                                                                      |requirement  |requirement  |requirement  |requirement  |requirement  |requirement  |
|                                                                      |NMT          |NMT          |NMT          |NMT          |NMT          |NMT          |
|                                                                      |10%),        |10%),        |10%),        |10%),        |10%),        |10%),        |
|                                                                      |which        |which        |which        |which        |which        |which        |
|                                                                      |meets        |meets        |meets        |meets        |meets        |meets        |
|                                                                      |the          |the          |the          |the          |the          |the          |
|                                                                      |verification |verification |verification |verification |verification |verification |
|                                                                      |requirements,|requirements,|requirements,|requirements,|requirements,|requirements,|
|                                                                      |indicating   |indicating   |indicating   |indicating   |indicating   |indicating   |
|                                                                      |that         |that         |that         |that         |that         |that         |
|                                                                      |the          |the          |the          |the          |the          |the          |
|                                                                      |test         |test         |test         |test         |test         |test         |
|                                                                      |solutionis   |solutionis   |solutionis   |solutionis   |solutionis   |solutionis   |
|                                                                      |stable       |stable       |stable       |stable       |stable       |stable       |
|                                                                      |within23hat  |within23hat  |within23hat  |within23hat  |within23hat  |within23hat  |
|                                                                      |room         |room         |room         |room         |room         |room         |
|                                                                      |temperature. |temperature. |temperature. |temperature. |temperature. |temperature. |
------------------------------------------------------------------------------------------------------------------------------------------------------------



**(4.9) Durability** 



 **Acceptance Criteria** 



The separation degree between YA2304-20 peak and main peak should NLT 



1.5 when column temperature, wavelength, flow rate, initial ratio of mobile 



phase and normal chromatographic conditions are changed by single factor. 



The peak signal-to-noise ratio of YA2304-20 in the chromatogram of 



reference solution should NLT 30; RSD of YA2304-20 in test product solution 



shall NMT 10%. 



 **Solution Preparation** 



Blank solution: solvent. 



Reference stock solution: Share reference stock solution under "4.6 



Accuracy". 



Reference product solution: prepared in the same way as the reference 



product solution under "4.1 wavelength selection". 



System suitability solution: The system suitability solution under "4.2 



System Suitability" is prepared in the same way. 



Durable reserve solution: accurately measure 2.5ml of the reference product 



reserve solution, place it in a 25ml measuring bottle, dilute it with solvent to 



the scale, shake well, and then obtain. 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 312 of 542 





Page 313
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Durability test solution: Take about 20mg of this product, accurately weigh it, 



put it in 20ml measuring bottle, add appropriate amount of solvent and 



ultrasonic to dissolve it, cool it, accurately measure 2.0ml of durable storage 



liquid, put it in the same 20ml measuring bottle, dilute it with solvent to the 



scale, shake well, and get it. (Parallel preparation of 2 parts) 



The variation of the condition parameters is as follows: 
















------------------------------------------------------------------------------------------------------------------------
|Column temperature           |40 ℃                                |38℃, 42℃                                           |
|-----------------------------|------------------------------------|---------------------------------------------------|
|Initial ratio of mobile phase|Mobile phaseA- Mobile phaseB (70:30)|Mobile phaseA- Mobile phaseB (72:28), Mobile       |
|                             |                                    |phaseA- Mobile phaseB (68:32)                      |
|-----------------------------|------------------------------------|---------------------------------------------------|
|Flow rate                    |1.0 ml/min                          |0.95ml/min, 1.05ml/min                             |
|-----------------------------|------------------------------------|---------------------------------------------------|
|Wavelength                   |251nm                               |249nm, 253nm                                       |
------------------------------------------------------------------------------------------------------------------------

 **Injection procedure** 



Under different chromatographic conditions, 1 needle of blank solution, 1 



needle of system suitability solution, 2 needles of reference solution and 1 



needle of durability test product solution were injected respectively. 



 **Measurement results** 



Results of durability - system suitability test 





















------------------------------------------------------------------------------------------------------------------------
|Chromatographic Conditions  |Degree of separation between the main peak and YA2304-20 peaks in system |1      |2      |
|                            |suitability solution                                                     |       |       |
|----------------------------|-------------------------------------------------------------------------|-------|-------|
|Normal conditions           |2.5                                                                      |66.5   |64.4   |
|----------------------------|-------------------------------------------------------------------------|-------|-------|
|Column temperature 38 ° C   |2.5                                                                      |60.0   |65.4   |
|----------------------------|-------------------------------------------------------------------------|-------|-------|
|Column temperature 42℃      |2.5                                                                      |70.4   |77.1   |
|----------------------------|-------------------------------------------------------------------------|-------|-------|
|The flow rate was 0.95ml/min|2.5                                                                      |63.0   |62.4   |
------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 313 of 542 





Page 314
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 










------------------------------------------------------------------------------------------------------------------------------------------------
|Mobile phase ratio (72:28)                                                                    |1.9            |46.2           |48.9           |
|----------------------------------------------------------------------------------------------|---------------|---------------|---------------|
|Mobile phase ratio (68:32)                                                                    |1.8            |64.3           |59.3           |
|----------------------------------------------------------------------------------------------|---------------|---------------|---------------|
|Wavelength 249nm                                                                              |1.9            |31.4           |35.3           |
|----------------------------------------------------------------------------------------------|---------------|---------------|---------------|
|Wavelength 253nm                                                                              |1.9            |34.7           |35.4           |
|----------------------------------------------------------------------------------------------|---------------|---------------|---------------|
|Conclusion: Under different chromatographic conditions, the separation degree between         |Conclusion:    |Conclusion:    |Conclusion:    |
|YA2304-20 peak and main peak in the system suitability solutionis between 1.9 and 2.5 (the    |Under          |Under          |Under          |
|requirement should be NLT 1.5), which meets the verification requirements. The main peak      |different      |different      |different      |
|signal-to-noise ratio (SNR) in the chromatogram of the control solution was between 31.4 and  |chromatographic|chromatographic|chromatographic|
|77.1 (the requirement should be NLT 30), which met the verification requirements.             |conditions,    |conditions,    |conditions,    |
|                                                                                              |the            |the            |the            |
|                                                                                              |separation     |separation     |separation     |
|                                                                                              |degree         |degree         |degree         |
|                                                                                              |between        |between        |between        |
|                                                                                              |YA2304-20      |YA2304-20      |YA2304-20      |
|                                                                                              |peak           |peak           |peak           |
|                                                                                              |and            |and            |and            |
|                                                                                              |main           |main           |main           |
|                                                                                              |peak in        |peak in        |peak in        |
|                                                                                              |the            |the            |the            |
|                                                                                              |system         |system         |system         |
|                                                                                              |suitability    |suitability    |suitability    |
|                                                                                              |solutionis     |solutionis     |solutionis     |
|                                                                                              |between        |between        |between        |
|                                                                                              |1.9 and        |1.9 and        |1.9 and        |
|                                                                                              |2.5            |2.5            |2.5            |
|                                                                                              |(the           |(the           |(the           |
|                                                                                              |requirement    |requirement    |requirement    |
|                                                                                              |should         |should         |should         |
|                                                                                              |be NLT         |be NLT         |be NLT         |
|                                                                                              |1.5),          |1.5),          |1.5),          |
|                                                                                              |which          |which          |which          |
|                                                                                              |meets          |meets          |meets          |
|                                                                                              |the            |the            |the            |
|                                                                                              |verification   |verification   |verification   |
|                                                                                              |requirements.  |requirements.  |requirements.  |
|                                                                                              |The            |The            |The            |
|                                                                                              |main           |main           |main           |
|                                                                                              |peak           |peak           |peak           |
|                                                                                              |signal-to-noise|signal-to-noise|signal-to-noise|
|                                                                                              |ratio          |ratio          |ratio          |
|                                                                                              |(SNR)          |(SNR)          |(SNR)          |
|                                                                                              |in the         |in the         |in the         |
|                                                                                              |chromatogram   |chromatogram   |chromatogram   |
|                                                                                              |of the         |of the         |of the         |
|                                                                                              |control        |control        |control        |
|                                                                                              |solution       |solution       |solution       |
|                                                                                              |was            |was            |was            |
|                                                                                              |between        |between        |between        |
|                                                                                              |31.4           |31.4           |31.4           |
|                                                                                              |and            |and            |and            |
|                                                                                              |77.1           |77.1           |77.1           |
|                                                                                              |(the           |(the           |(the           |
|                                                                                              |requirement    |requirement    |requirement    |
|                                                                                              |should         |should         |should         |
|                                                                                              |be NLT         |be NLT         |be NLT         |
|                                                                                              |30),           |30),           |30),           |
|                                                                                              |which          |which          |which          |
|                                                                                              |met the        |met the        |met the        |
|                                                                                              |verification   |verification   |verification   |
|                                                                                              |requirements.  |requirements.  |requirements.  |
------------------------------------------------------------------------------------------------------------------------------------------------

Durability test results 


















-------------------------------------------------------------------------------------
|Column temperature (° C)|38     |Durability test product solution 1|0.17   |2.6    |
|------------------------|-------|----------------------------------|-------|-------|
|Column temperature (° C)|38     |Durability test sample solution 2 |0.16   |0.16   |
|------------------------|-------|----------------------------------|-------|-------|
|Column temperature (° C)|40     |Durability test sample solution 1 |0.17   |0.17   |
|------------------------|-------|----------------------------------|-------|-------|
|Column temperature (° C)|40     |Durability test sample solution 2 |0.17   |0.17   |
|------------------------|-------|----------------------------------|-------|-------|
|Column temperature (° C)|42     |Durability test product solution 1|0.17   |0.17   |
|------------------------|-------|----------------------------------|-------|-------|
|Column temperature (° C)|42     |Durability test sample solution 2 |0.16   |0.16   |
|------------------------|-------|----------------------------------|-------|-------|
|Flow rate (ml/min)      |0.95   |Durability test solution 1        |0.17   |2.4    |
|------------------------|-------|----------------------------------|-------|-------|
|Flow rate (ml/min)      |0.95   |Durability test sample solution 2 |0.16   |0.16   |
|------------------------|-------|----------------------------------|-------|-------|
|Flow rate (ml/min)      |1.00   |Durability test sample solution 1 |0.17   |0.17   |
|------------------------|-------|----------------------------------|-------|-------|
|Flow rate (ml/min)      |1.00   |Durability test sample solution 2 |0.17   |0.17   |
-------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 314 of 542 





Page 315
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



















------------------------------------------------------------------------------------------------------------------------------------------------
|1.05                                                                                  |Durability   |0.16         |0.16         |             |
|                                                                                      |test         |             |             |             |
|                                                                                      |sample       |             |             |             |
|                                                                                      |solution     |             |             |             |
|                                                                                      |2            |             |             |             |
|--------------------------------------------------------------------------------------|-------------|-------------|-------------|-------------|
|Wavelength (nm)                                                                       |249          |Durability   |0.17         |2.3          |
|                                                                                      |             |test         |             |             |
|                                                                                      |             |solution     |             |             |
|                                                                                      |             |1            |             |             |
|--------------------------------------------------------------------------------------|-------------|-------------|-------------|-------------|
|Wavelength (nm)                                                                       |249          |Durability   |0.16         |0.16         |
|                                                                                      |             |test         |             |             |
|                                                                                      |             |sample       |             |             |
|                                                                                      |             |solution 2   |             |             |
|--------------------------------------------------------------------------------------|-------------|-------------|-------------|-------------|
|Wavelength (nm)                                                                       |251          |Durability   |0.17         |0.17         |
|                                                                                      |             |test         |             |             |
|                                                                                      |             |sample       |             |             |
|                                                                                      |             |solution 1   |             |             |
|--------------------------------------------------------------------------------------|-------------|-------------|-------------|-------------|
|Wavelength (nm)                                                                       |251          |Durability   |0.17         |0.17         |
|                                                                                      |             |test         |             |             |
|                                                                                      |             |sample       |             |             |
|                                                                                      |             |solution 2   |             |             |
|--------------------------------------------------------------------------------------|-------------|-------------|-------------|-------------|
|Wavelength (nm)                                                                       |253          |Durability   |0.17         |0.17         |
|                                                                                      |             |test         |             |             |
|                                                                                      |             |sample       |             |             |
|                                                                                      |             |solution 1   |             |             |
|--------------------------------------------------------------------------------------|-------------|-------------|-------------|-------------|
|Wavelength (nm)                                                                       |253          |Durability   |0.16         |0.16         |
|                                                                                      |             |test         |             |             |
|                                                                                      |             |sample       |             |             |
|                                                                                      |             |solution 2   |             |             |
|--------------------------------------------------------------------------------------|-------------|-------------|-------------|-------------|
|Mobile phase ratio                                                                    |72:28        |Durability   |0.16         |2.4          |
|                                                                                      |             |test         |             |             |
|                                                                                      |             |product      |             |             |
|                                                                                      |             |solution 1   |             |             |
|--------------------------------------------------------------------------------------|-------------|-------------|-------------|-------------|
|Mobile phase ratio                                                                    |72:28        |Durability   |0.16         |0.16         |
|                                                                                      |             |test         |             |             |
|                                                                                      |             |sample       |             |             |
|                                                                                      |             |solution 2   |             |             |
|--------------------------------------------------------------------------------------|-------------|-------------|-------------|-------------|
|Mobile phase ratio                                                                    |70:30        |Durability   |0.17         |0.17         |
|                                                                                      |             |test         |             |             |
|                                                                                      |             |sample       |             |             |
|                                                                                      |             |solution 1   |             |             |
|--------------------------------------------------------------------------------------|-------------|-------------|-------------|-------------|
|Mobile phase ratio                                                                    |70:30        |Durability   |0.17         |0.17         |
|                                                                                      |             |test         |             |             |
|                                                                                      |             |sample       |             |             |
|                                                                                      |             |solution 2   |             |             |
|--------------------------------------------------------------------------------------|-------------|-------------|-------------|-------------|
|Mobile phase ratio                                                                    |68:32        |Durability   |0.17         |0.17         |
|                                                                                      |             |test         |             |             |
|                                                                                      |             |sample       |             |             |
|                                                                                      |             |solution 1   |             |             |
|--------------------------------------------------------------------------------------|-------------|-------------|-------------|-------------|
|Mobile phase ratio                                                                    |68:32        |Durability   |0.16         |0.16         |
|                                                                                      |             |test         |             |             |
|                                                                                      |             |sample       |             |             |
|                                                                                      |             |solution 2   |             |             |
|--------------------------------------------------------------------------------------|-------------|-------------|-------------|-------------|
|Conclusion: RSD of YA2304-20 was 2.6% (should NMT 10%) under different column         |Conclusion:  |Conclusion:  |Conclusion:  |Conclusion:  |
|temperature conditions, which met the verification requirements; At different flow    |RSD of       |RSD of       |RSD of       |RSD of       |
|rates, the RSD of YA2304-20 in test samples was 2.4% (should NMT 10%), which met the  |YA2304-20    |YA2304-20    |YA2304-20    |YA2304-20    |
|verification requirements; Under different wavelength conditions, the RSD of YA2304-20|was 2.6%     |was 2.6%     |was          |was          |
|in the test product was 2.3% (should NMT 10%), which met the verification             |(should      |(should      |2.6%         |2.6%         |
|requirements; Under different mobile phase ratios, the RSD of YA2304-20 in the test   |NMT 10%)     |NMT 10%)     |(should      |(should      |
|product was 2.4% (should NMT 10%), which met the verification requirements, indicating|under        |under        |NMT          |NMT          |
|that the durability of the method was good.                                           |different    |different    |10%)         |10%)         |
|                                                                                      |column       |column       |under        |under        |
|                                                                                      |temperature  |temperature  |different    |different    |
|                                                                                      |conditions,  |conditions,  |column       |column       |
|                                                                                      |which met    |which met    |temperature  |temperature  |
|                                                                                      |the          |the          |conditions,  |conditions,  |
|                                                                                      |verification |verification |which        |which        |
|                                                                                      |requirements;|requirements;|met the      |met the      |
|                                                                                      |At           |At           |verification |verification |
|                                                                                      |different    |different    |requirements;|requirements;|
|                                                                                      |flow         |flow         |At           |At           |
|                                                                                      |rates, the   |rates, the   |different    |different    |
|                                                                                      |RSD of       |RSD of       |flow         |flow         |
|                                                                                      |YA2304-20    |YA2304-20    |rates,       |rates,       |
|                                                                                      |in test      |in test      |the RSD      |the RSD      |
|                                                                                      |samples      |samples      |of           |of           |
|                                                                                      |was 2.4%     |was 2.4%     |YA2304-20    |YA2304-20    |
|                                                                                      |(should      |(should      |in test      |in test      |
|                                                                                      |NMT 10%),    |NMT 10%),    |samples      |samples      |
|                                                                                      |which met    |which met    |was          |was          |
|                                                                                      |the          |the          |2.4%         |2.4%         |
|                                                                                      |verification |verification |(should      |(should      |
|                                                                                      |requirements;|requirements;|NMT          |NMT          |
|                                                                                      |Under        |Under        |10%),        |10%),        |
|                                                                                      |different    |different    |which        |which        |
|                                                                                      |wavelength   |wavelength   |met the      |met the      |
|                                                                                      |conditions,  |conditions,  |verification |verification |
|                                                                                      |the RSD of   |the RSD of   |requirements;|requirements;|
|                                                                                      |YA2304-20    |YA2304-20    |Under        |Under        |
|                                                                                      |in the       |in the       |different    |different    |
|                                                                                      |test         |test         |wavelength   |wavelength   |
|                                                                                      |product      |product      |conditions,  |conditions,  |
|                                                                                      |was 2.3%     |was 2.3%     |the RSD      |the RSD      |
|                                                                                      |(should      |(should      |of           |of           |
|                                                                                      |NMT 10%),    |NMT 10%),    |YA2304-20    |YA2304-20    |
|                                                                                      |which met    |which met    |in the       |in the       |
|                                                                                      |the          |the          |test         |test         |
|                                                                                      |verification |verification |product      |product      |
|                                                                                      |requirements;|requirements;|was          |was          |
|                                                                                      |Under        |Under        |2.3%         |2.3%         |
|                                                                                      |different    |different    |(should      |(should      |
|                                                                                      |mobile       |mobile       |NMT          |NMT          |
|                                                                                      |phase        |phase        |10%),        |10%),        |
|                                                                                      |ratios,      |ratios,      |which        |which        |
|                                                                                      |the RSD of   |the RSD of   |met the      |met the      |
|                                                                                      |YA2304-20    |YA2304-20    |verification |verification |
|                                                                                      |in the       |in the       |requirements;|requirements;|
|                                                                                      |test         |test         |Under        |Under        |
|                                                                                      |product      |product      |different    |different    |
|                                                                                      |was 2.4%     |was 2.4%     |mobile       |mobile       |
|                                                                                      |(should      |(should      |phase        |phase        |
|                                                                                      |NMT 10%),    |NMT 10%),    |ratios,      |ratios,      |
|                                                                                      |which met    |which met    |the RSD      |the RSD      |
|                                                                                      |the          |the          |of           |of           |
|                                                                                      |verification |verification |YA2304-20    |YA2304-20    |
|                                                                                      |requirements,|requirements,|in the       |in the       |
|                                                                                      |indicating   |indicating   |test         |test         |
|                                                                                      |that the     |that the     |product      |product      |
|                                                                                      |durability   |durability   |was          |was          |
|                                                                                      |of the       |of the       |2.4%         |2.4%         |
|                                                                                      |method was   |method was   |(should      |(should      |
|                                                                                      |good.        |good.        |NMT          |NMT          |
|                                                                                      |             |             |10%),        |10%),        |
|                                                                                      |             |             |which        |which        |
|                                                                                      |             |             |met the      |met the      |
|                                                                                      |             |             |verification |verification |
|                                                                                      |             |             |requirements,|requirements,|
|                                                                                      |             |             |indicating   |indicating   |
|                                                                                      |             |             |that         |that         |
|                                                                                      |             |             |the          |the          |
|                                                                                      |             |             |durability   |durability   |
|                                                                                      |             |             |of the       |of the       |
|                                                                                      |             |             |method       |method       |
|                                                                                      |             |             |was          |was          |
|                                                                                      |             |             |good.        |good.        |
------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 315 of 542 





Page 316
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**III. Summary of Method Validation** 



Methodological Verification Results of Finished Product Enantiomer 


















-------------------------------------------------------------------------------------------------------------------------------------
|Wavele ngth selection|Wavele ngth selection|YA2304-20 should havea large absorption at 251nm.                 |Impurity            |
|                     |                     |                                                                  |YA2304-20           |
|                     |                     |                                                                  |has                 |
|                     |                     |                                                                  |greaterabsorption   |
|                     |                     |                                                                  |at                  |
|                     |                     |                                                                  |251nm.              |
|                     |                     |                                                                  |In the              |
|                     |                     |                                                                  |control             |
|                     |                     |                                                                  |solution,           |
|                     |                     |                                                                  |the                 |
|                     |                     |                                                                  |retention           |
|                     |                     |                                                                  |time of             |
|                     |                     |                                                                  |YA2304-20           |
|                     |                     |                                                                  |is                  |
|                     |                     |                                                                  |25.626min.          |
|                     |                     |                                                                  |The                 |
|                     |                     |                                                                  |spectrogram         |
|                     |                     |                                                                  |of the              |
|                     |                     |                                                                  |control             |
|                     |                     |                                                                  |solutionisas        |
|                     |                     |                                                                  |follows:            |
|---------------------|---------------------|------------------------------------------------------------------|--------------------|
|Systemapplica bility |Systemapplica bility |The blank solution should be free ofinterference; The separation  |The blank           |
|                     |                     |degree between the main peak and YA2304-20 peak in the            |solution has no     |
|                     |                     |chromatogram of system suitability solution should be greater than|interference; The   |
|                     |                     |1.5; In the chromatogramobtained for 6 consecutive days, the      |separation degree   |
|                     |                     |signal-to-noise ratio (S/N) of YA2304-20 peak should NLT 30, the  |between the main    |
|                     |                     |RSD of the retention time NMT 1.0%, and the RSD of the peakarea   |peak and            |
|                     |                     |NMT5%.                                                            |YA2304-20 peak in   |
|                     |                     |                                                                  |the system          |
|                     |                     |                                                                  |suitability         |
|                     |                     |                                                                  |solutionis 3.0      |
|                     |                     |                                                                  |(the requirement    |
|                     |                     |                                                                  |should NLT 1.5);    |
|                     |                     |                                                                  |In the              |
|                     |                     |                                                                  |chromatogramobtained|
|                     |                     |                                                                  |from the control    |
|                     |                     |                                                                  |product solution,   |
|                     |                     |                                                                  |the                 |
|                     |                     |                                                                  |signal-to-noise     |
|                     |                     |                                                                  |ratio of the main   |
|                     |                     |                                                                  |peak was between    |
|                     |                     |                                                                  |71.5 and 83.4       |
|                     |                     |                                                                  |(the requirement    |
|                     |                     |                                                                  |should be NLT       |
|                     |                     |                                                                  |30); The RSD of     |
|                     |                     |                                                                  |peak retention      |
|                     |                     |                                                                  |time of YA2304-20   |
|                     |                     |                                                                  |in the              |
|                     |                     |                                                                  |photoproduct        |
|                     |                     |                                                                  |solution for 6      |
|                     |                     |                                                                  |consecutive days    |
|                     |                     |                                                                  |was 0.08% (the      |
|                     |                     |                                                                  |requirement         |
|                     |                     |                                                                  |should NMT 1.0%);   |
|                     |                     |                                                                  |The RSD of          |
|                     |                     |                                                                  |peakarea is 0.6%    |
|                     |                     |                                                                  |(the requirement    |
|                     |                     |                                                                  |should NMT 5%);     |
|                     |                     |                                                                  |All meet the        |
|                     |                     |                                                                  |verification        |
|                     |                     |                                                                  |requirements. It    |
|                     |                     |                                                                  |shows that this     |
|                     |                     |                                                                  |method has good     |
|                     |                     |                                                                  |systemapplicability.|
|---------------------|---------------------|------------------------------------------------------------------|--------------------|
|S pe                 |Pea kide             |Blank solution should be free ofinterference; The separation      |The blank solution  |
|                     |                     |degree between the mainpeak and YA2304-20                         |has no interference;|
|                     |                     |                                                                  |The separation      |
|                     |                     |                                                                  |degree between the  |
|                     |                     |                                                                  |main peak and       |
|                     |                     |                                                                  |YA2304-20 peak in   |
|                     |                     |                                                                  |the system          |
|                     |                     |                                                                  |suitability         |
|                     |                     |                                                                  |solutionis 3.0 (the |
|                     |                     |                                                                  |requirement should  |
|                     |                     |                                                                  |NLT 1.5); Inthe     |
|                     |                     |                                                                  |chromatogramobtained|
|                     |                     |                                                                  |from the control    |
|                     |                     |                                                                  |solution, S/Nwas    |
|                     |                     |                                                                  |62.2 (the           |
-------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 316 of 542 





Page 317
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 




peak in the system suitability solution 
should be greater than 1.5; The peak 
signal-to-noise ratio (S/N) of YA2304-20 
in the chromatogram of reference 
solution should NLT 30; The separation 
degree between YA2304-20 peaks and 
adjacent peaks in the chromatogram of 
test solution and specific mixed solution 
should be greater than 1.5, and the 
retention time should be consistent with 
the peak retention time of YA2304-20 in 
the chromatogram of control solution. 
Other single impurity localization 
solutions do not interfere with 
YA2304-20 peak production. 




requirement should NLT 30); The separation degree between YA2304-20 peaks and 
adjacent peaks in the specific mixed solution and the test solution was greater than 1.5, 
and the retention time was consistent with that of YA2304-20 peaks in the chromatogram 
of the control solution. Impurities YA2304-12, YA2304-14, YA2304-15, YA2304-16, 
YA2304-18 and YA2304-19 all have a chiral center, so the above impurities all have two 
peaks under the current chromatographic conditions. Other single impurities (YA2304-10, 
YA2304-12, YA2304-14, YA2304-15, YA2304-16, YA2304-17, YA2304-18 and YA2304-19) 
do not interfere with the peak of YA2304-20; Meet the requirements of verification. The 
concentration of YA2304-20 in the specific mixed solution is equal to 0.15% of the 
principal component concentration in the test solution. 




ci 



fi 


ci 



t 


y 




ntifi 



cati 



on 


test 




































---------------------------------------------------------------------
|Specific mixed solution|YA2304   |1033.1000|20.183 |3.0    |100%   |
|-----------------------|---------|---------|-------|-------|-------|
|Specific mixed solution|YA2304-20|1.4983   |24.872 |24.872 |0.15%  |
---------------------------------------------------------------------

The chromatogram of the specific mixed solution is as follows: 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 317 of 542 





Page 318
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 


















---------------------------------------------------------------------------------------------------------------------------------------------
|**Impurity/** **principal** **compone** **nt**|**Concentration (equivalent to the** **concentration percentage|**Concentration             |
|                                              |of the** **testproduct solution)**                             |(equivalent                 |
|                                              |                                                               |to                          |
|                                              |                                                               |the**                       |
|                                              |                                                               |**test                      |
|                                              |                                                               |product                     |
|                                              |                                                               |solution**                  |
|                                              |                                                               |**concentrationpercentage)**|
|----------------------------------------------|---------------------------------------------------------------|----------------------------|
|YA2304-2 0                                    |0.0899μg/ml (0.01%)                                            |0.3112μg/ml (0.03%)         |
|----------------------------------------------|---------------------------------------------------------------|----------------------------|
|YA2304                                        |0.0934μg/ml (0.01%)                                            |0.2997μg/ml (0.03%)         |
---------------------------------------------------------------------------------------------------------------------------------------------
























---------------------------------------------------------------------------
|YA2304-2 0|0.2997μg/ml to 2.9966μg/ml (0.03% to 0.30%)|Y = 15161-28.894 x|
|----------|-------------------------------------------|------------------|
|YA2304    |0.3112μg/ml~3.1118μg/ml (0.03%~0.31%)      |Y = 15788-79.892 x|
---------------------------------------------------------------------------

-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Limits of quantifi cation and detection|Limits of quantifi    |The                 |**Impurity/**               |**Impurity/**               |**Impurity/**               |**Impurity/**               |**Impurity/**               |**Impurity/**               |
|                                       |cation and detection  |average             |**principal**               |**principal**               |**principal**               |**principal**               |**principal**               |**principal**               |
|                                       |                      |signal-to-noise     |**compone**                 |**compone**                 |**compone**                 |**compone**                 |**compone**                 |**compone**                 |
|                                       |                      |ratio               |**nt**                      |**nt**                      |**nt**                      |**nt**                      |**nt**                      |**nt**                      |
|                                       |                      |(S/N)               |**Detection                 |**Detection                 |**Detection                 |**Detection                 |**Detection                 |**Detection                 |
|                                       |                      |ofeachimpurity      |limits**                    |limits**                    |limits**                    |limits**                    |limits**                    |limits**                    |
|                                       |                      |peak in             |**Limit                     |**Limit                     |**Limit                     |**Limit                     |**Limit                     |**Limit                     |
|                                       |                      |6 LOQ               |of                          |of                          |of                          |of                          |of                          |of                          |
|                                       |                      |solutions           |quantitation**              |quantitation**              |quantitation**              |quantitation**              |quantitation**              |quantitation**              |
|                                       |                      |should              |**Concentration             |**Concentration             |**Concentration             |**Concentration             |**Concentration             |**Concentration             |
|                                       |                      |NLT 10,             |(equivalent                 |(equivalent                 |(equivalent                 |(equivalent                 |(equivalent                 |(equivalent                 |
|                                       |                      |the RSD             |to                          |to                          |to                          |to                          |to                          |to                          |
|                                       |                      |of                  |the**                       |the**                       |the**                       |the**                       |the**                       |the**                       |
|                                       |                      |retention           |**concentration             |**concentration             |**concentration             |**concentration             |**concentration             |**concentration             |
|                                       |                      |time                |percentage                  |percentage                  |percentage                  |percentage                  |percentage                  |percentage                  |
|                                       |                      |should              |of                          |of                          |of                          |of                          |of                          |of                          |
|                                       |                      |NMT                 |the**                       |the**                       |the**                       |the**                       |the**                       |the**                       |
|                                       |                      |2.0%,               |**testproduct               |**testproduct               |**testproduct               |**testproduct               |**testproduct               |**testproduct               |
|                                       |                      |and the             |solution)**                 |solution)**                 |solution)**                 |solution)**                 |solution)**                 |solution)**                 |
|                                       |                      |RSD of              |**Concentration             |**Concentration             |**Concentration             |**Concentration             |**Concentration             |**Concentration             |
|                                       |                      |peakarea            |(equivalent                 |(equivalent                 |(equivalent                 |(equivalent                 |(equivalent                 |(equivalent                 |
|                                       |                      |should              |to                          |to                          |to                          |to                          |to                          |to                          |
|                                       |                      |NMT                 |the**                       |the**                       |the**                       |the**                       |the**                       |the**                       |
|                                       |                      |10%.                |**test                      |**test                      |**test                      |**test                      |**test                      |**test                      |
|                                       |                      |The SNR             |product                     |product                     |product                     |product                     |product                     |product                     |
|                                       |                      |(S/N)               |solution**                  |solution**                  |solution**                  |solution**                  |solution**                  |solution**                  |
|                                       |                      |ofeachimpurity      |**concentrationpercentage)**|**concentrationpercentage)**|**concentrationpercentage)**|**concentrationpercentage)**|**concentrationpercentage)**|**concentrationpercentage)**|
|                                       |                      |peak in             |YA2304-2                    |YA2304-2                    |YA2304-2                    |YA2304-2                    |YA2304-2                    |YA2304-2                    |
|                                       |                      |the                 |0                           |0                           |0                           |0                           |0                           |0                           |
|                                       |                      |3-pin               |0.0899μg/ml                 |0.0899μg/ml                 |0.0899μg/ml                 |0.0899μg/ml                 |0.0899μg/ml                 |0.0899μg/ml                 |
|                                       |                      |detection           |(0.01%)                     |(0.01%)                     |(0.01%)                     |(0.01%)                     |(0.01%)                     |(0.01%)                     |
|                                       |                      |limit               |0.3112μg/ml                 |0.3112μg/ml                 |0.3112μg/ml                 |0.3112μg/ml                 |0.3112μg/ml                 |0.3112μg/ml                 |
|                                       |                      |(LOD)               |(0.03%)                     |(0.03%)                     |(0.03%)                     |(0.03%)                     |(0.03%)                     |(0.03%)                     |
|                                       |                      |solution            |YA2304                      |YA2304                      |YA2304                      |YA2304                      |YA2304                      |YA2304                      |
|                                       |                      |should              |0.0934μg/ml                 |0.0934μg/ml                 |0.0934μg/ml                 |0.0934μg/ml                 |0.0934μg/ml                 |0.0934μg/ml                 |
|                                       |                      |NLT3.               |(0.01%)                     |(0.01%)                     |(0.01%)                     |(0.01%)                     |(0.01%)                     |(0.01%)                     |
|                                       |                      |                    |0.2997μg/ml                 |0.2997μg/ml                 |0.2997μg/ml                 |0.2997μg/ml                 |0.2997μg/ml                 |0.2997μg/ml                 |
|                                       |                      |                    |(0.03%)                     |(0.03%)                     |(0.03%)                     |(0.03%)                     |(0.03%)                     |(0.03%)                     |
|---------------------------------------|----------------------|--------------------|----------------------------|----------------------------|----------------------------|----------------------------|----------------------------|----------------------------|
|Linearity vs. range                    |Linearity vs. range   |With the            |**Impuritie** **s /**       |**Impuritie** **s /**       |**Impuritie** **s /**       |**Impuritie** **s /**       |**Impuritie** **s /**       |**Impuritie** **s /**       |
|                                       |                      |concentrationas     |**Principal** **compone**   |**Principal** **compone**   |**Principal** **compone**   |**Principal** **compone**   |**Principal** **compone**   |**Principal** **compone**   |
|                                       |                      |the horizontal      |**nt** **Concentration      |**nt** **Concentration      |**nt** **Concentration      |**nt** **Concentration      |**nt** **Concentration      |**nt** **Concentration      |
|                                       |                      |coordinate and      |(equivalent to percentage** |(equivalent to percentage** |(equivalent to percentage** |(equivalent to percentage** |(equivalent to percentage** |(equivalent to percentage** |
|                                       |                      |the peakarea as     |**of solution concentration |**of solution concentration |**of solution concentration |**of solution concentration |**of solution concentration |**of solution concentration |
|                                       |                      |the vertical        |of test product)**          |of test product)**          |of test product)**          |of test product)**          |of test product)**          |of test product)**          |
|                                       |                      |coordinate as       |**Linearequation** YA2304-2 |**Linearequation** YA2304-2 |**Linearequation** YA2304-2 |**Linearequation** YA2304-2 |**Linearequation** YA2304-2 |**Linearequation** YA2304-2 |
|                                       |                      |the linear          |0 0.2997μg/ml to 2.9966μg/ml|0 0.2997μg/ml to 2.9966μg/ml|0 0.2997μg/ml to 2.9966μg/ml|0 0.2997μg/ml to 2.9966μg/ml|0 0.2997μg/ml to 2.9966μg/ml|0 0.2997μg/ml to 2.9966μg/ml|
|                                       |                      |regression          |(0.03% to 0.30%) Y =        |(0.03% to 0.30%) Y =        |(0.03% to 0.30%) Y =        |(0.03% to 0.30%) Y =        |(0.03% to 0.30%) Y =        |(0.03% to 0.30%) Y =        |
|                                       |                      |curve, the          |15161-28.894 xYA2304        |15161-28.894 xYA2304        |15161-28.894 xYA2304        |15161-28.894 xYA2304        |15161-28.894 xYA2304        |15161-28.894 xYA2304        |
|                                       |                      |regression          |0.3112μg/ml~3.1118μg/ml     |0.3112μg/ml~3.1118μg/ml     |0.3112μg/ml~3.1118μg/ml     |0.3112μg/ml~3.1118μg/ml     |0.3112μg/ml~3.1118μg/ml     |0.3112μg/ml~3.1118μg/ml     |
|                                       |                      |coefficient (R)     |(0.03%~0.31%) Y =           |(0.03%~0.31%) Y =           |(0.03%~0.31%) Y =           |(0.03%~0.31%) Y =           |(0.03%~0.31%) Y =           |(0.03%~0.31%) Y =           |
|                                       |                      |of the              |15788-79.892 x              |15788-79.892 x              |15788-79.892 x              |15788-79.892 x              |15788-79.892 x              |15788-79.892 x              |
|                                       |                      |regression          |                            |                            |                            |                            |                            |                            |
|                                       |                      |curve is            |                            |                            |                            |                            |                            |                            |
|                                       |                      |required to be      |                            |                            |                            |                            |                            |                            |
|                                       |                      |NLT 0.990, the      |                            |                            |                            |                            |                            |                            |
|                                       |                      |RSD of the          |                            |                            |                            |                            |                            |                            |
|                                       |                      |response factor     |                            |                            |                            |                            |                            |                            |
|                                       |                      |NMT 10%, and        |                            |                            |                            |                            |                            |                            |
|                                       |                      |theY-axisinterceptis|                            |                            |                            |                            |                            |                            |
|                                       |                      |less than 25%       |                            |                            |                            |                            |                            |                            |
|                                       |                      |of the              |                            |                            |                            |                            |                            |                            |
|                                       |                      |percentage of       |                            |                            |                            |                            |                            |                            |
|                                       |                      |100% response       |                            |                            |                            |                            |                            |                            |
|                                       |                      |value.              |                            |                            |                            |                            |                            |                            |
|---------------------------------------|----------------------|--------------------|----------------------------|----------------------------|----------------------------|----------------------------|----------------------------|----------------------------|
|Accura                                 |Accura                |The required 30%    |                            |**Impurities**              |**Marking condition**       |**Average**                 |**RSD**                     |                            |
|                                       |                      |limit               |                            |                            |                            |                            |                            |                            |
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 318 of 542 





Page 319
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 









-------------------------------------------------------------
|YA2304-20|Added 0.4587μg/ml~2.2933μg/m|98.5%, n=9|2.4%, n=9|
-------------------------------------------------------------






--------------------------------------
|YA2304-20|2.5%, n=6|5%, n=6|4%, n=12|
--------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------
|Precision         |Repeatability and reproducibility: RSD of YA2304-20 in 6 repeatability (or reproducibility)|**Impurities**       |
|                  |test solution shall NMT 10%. For the results of 12 repeatability and reproducibility tests,|**repeatability**    |
|                  |the RSD of YA2304-20 should NMT 10%.                                                       |**Reproducibility**  |
|                  |                                                                                           |**Precision**        |
|                  |                                                                                           |YA2304-20            |
|                  |                                                                                           |2.5%,                |
|                  |                                                                                           |n=6 5%,              |
|                  |                                                                                           |n=6 4%,              |
|                  |                                                                                           |n=12                 |
|------------------|-------------------------------------------------------------------------------------------|---------------------|
|Solutio nstability|The system suitability solution, the control solution and the test product solution were   |System suitability   |
|                  |placed at room temperature fora period of time, and the samples were injected at different |solution: within 5   |
|                  |time points. The separation degree between YA2304-20 peak and the main peak in the         |days at room         |
|                  |chromatogram of the system suitability solution should NLT 1.5; The peak signal-to-noise   |temperature, the     |
|                  |ratio (S/N) of YA2304-20 in the chromatogram of reference solution should NLT 30, and the  |separation degree    |
|                  |RSD of peakarea should not be more than 5%; In the chromatogramobtained by the test product|between the main     |
|                  |solution, the RSD of YA2304-20 NMT 10% according to the peakarea calculation byexternal    |peak and YA2304-20   |
|                  |standard method, and there shall be no new peak generation thatinterferes with the         |peak was greater     |
|                  |detection of YA2304-20.                                                                    |than 1.5 (the        |
|                  |                                                                                           |requirement should   |
|                  |                                                                                           |be NLT 1.5), which   |
|                  |                                                                                           |met the              |
|                  |                                                                                           |verification         |
|                  |                                                                                           |requirements,        |
|                  |                                                                                           |indicating that the  |
|                  |                                                                                           |system suitability   |
|                  |                                                                                           |solution was stable  |
|                  |                                                                                           |within 5 days at     |
|                  |                                                                                           |room temperature.    |
|                  |                                                                                           |Reference solution:  |
|                  |                                                                                           |within 49hat room    |
|                  |                                                                                           |temperature, the     |
|                  |                                                                                           |RSD of YA2304-20     |
|                  |                                                                                           |was 1.1% (not more   |
|                  |                                                                                           |than 10% required);  |
|                  |                                                                                           |The peak-to-noise    |
|                  |                                                                                           |ratio of YA2304-20   |
|                  |                                                                                           |was between 62.2     |
|                  |                                                                                           |and 80.3 (the        |
|                  |                                                                                           |requirement should   |
|                  |                                                                                           |NLT 30), which met   |
|                  |                                                                                           |the verification     |
|                  |                                                                                           |requirements,        |
|                  |                                                                                           |indicating that the  |
|                  |                                                                                           |control solution     |
|                  |                                                                                           |was stable within    |
|                  |                                                                                           |49hat room           |
|                  |                                                                                           |temperature. Test    |
|                  |                                                                                           |product solution:    |
|                  |                                                                                           |within 23hat room    |
|                  |                                                                                           |temperature, the     |
|                  |                                                                                           |RSD of YA2304-20 in  |
|                  |                                                                                           |the test product     |
|                  |                                                                                           |solutionis 10% (the  |
|                  |                                                                                           |requirement NMT      |
|                  |                                                                                           |10%), which meets    |
|                  |                                                                                           |the verification     |
|                  |                                                                                           |requirements,        |
|                  |                                                                                           |indicating that the  |
|                  |                                                                                           |test product         |
|                  |                                                                                           |solutionis stable    |
|                  |                                                                                           |within 23hat room    |
|                  |                                                                                           |temperature. The     |
|                  |                                                                                           |above solutions do   |
|                  |                                                                                           |not need new         |
|                  |                                                                                           |preparation for      |
|                  |                                                                                           |temporaryuse.        |
|------------------|-------------------------------------------------------------------------------------------|---------------------|
|Durability        |The separation degree between YA2304-20 peak and main peak should NLT 1.5 when column      |The column           |
|                  |temperature,                                                                               |temperature was      |
|                  |                                                                                           |40℃±2℃, the mobile   |
|                  |                                                                                           |phase ratio was      |
|                  |                                                                                           |(70:30) ±2, the      |
|                  |                                                                                           |flow rate was        |
|                  |                                                                                           |1.0ml/min±0.05ml/min,|
|                  |                                                                                           |and the wavelength   |
|                  |                                                                                           |was 251nm±2nm. The   |
|                  |                                                                                           |measurements were    |
|                  |                                                                                           |as follows:          |
--------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 319 of 542 





Page 320
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 




wavelength, flow rate, mobile phase 
initiation ratio and normal 
chromatographic conditions are changed 
by single factor; The peak signal-to-noise 
ratio of YA2304-20 in the chromatogram 
of reference solution should NLT 30; 
RSD of YA2304-20 in test product 
solution shall NMT 10%. 




System suitability: Under different chromatographic conditions, the separation degree 
between the main peak and YA2304-20 peak in the system suitability solution is between 
1.9 and 2.5 (the requirement should be NLT 1.5), which meets the verification 
requirements. The main peak signal-to-noise ratio in the chromatogram of the reference 
product solution was between 31.4 and 77.1 (the requirement should be NLT 30), which 
met the verification requirements. 

Test product solution: under different chromatographic conditions, the RSD of 
YA2304-20 in the test product was no more than 10%, which met the verification 
requirements. 




Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 320 of 542 





Page 321
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.4.3.4 Method Validation of Residual Solvents in Finerenone** 



**I. Analytical Procedures** 



Please refer to the analytical procedures of residual solvents in Finerenone in 



_section 3.2.S.4.2_ . 



**II. Validation Results and Discussion** 



**a. System Suitability Determination** 



 **Acceptance Criteria** 



The blank solution should be free of interference; In the chromatogram 



obtained for 6 consecutive days, ethanol, isopropyl alcohol, ethyl acetate, 



secondary butanol, tetrahydrofuran, toluene, n-methylpyrrolidone peaks in 



turn, and the separation degree between each adjacent peak should be 



greater than 1.5. The RSD of the peak retention time of each solvent peak 



should NMT 1.0%, and the RSD of the peak area should NMT 10%. 



 **Solution Preparation** 



Solvent: N, n-dimethylformamide (DMF). 



Ethanol reference product reserve liquid: precision weigh ethanol about 



1000mg, put in 20ml bottle, dissolve with solvent and dilute to the scale, 



shake well, ready. (About 50000μg/ml) 



Isopropyl alcohol control product reserve liquid: precision weigh isopropyl 



alcohol about 1000mg, put in 20ml measuring bottle, dissolve with solvent 



and dilute to the scale, shake well, ready. (About 50000μg/ml) 



Ethyl acetate reference product reserve liquid: precision weigh about 1000mg 



of ethyl acetate, place in 20ml measuring bottle, dissolve and dilute with 



solvent to scale, shake well, ready. (Approx. 50000μg/ml) 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 321 of 542 





Page 322
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Secondary butanol reference product reserve liquid: precision weigh 



secondary butanol about 1000mg, place in 20ml bottle, dissolve and dilute 



with solvent to scale, shake well, then get. (About 50000μg/ml) 



Tetrahydrofuran reference product reserve liquid: accurately weigh 



tetrahydrofuran about 144mg, put it in 20ml bottle, dissolve it with solvent 



and dilute it to the scale, shake well, and then get. (About 7200μg/ml) 



Toluene control product reserve liquid: precision weigh toluene about 178mg, 



place in 20ml bottle, dissolve and dilute with solvent to scale, shake well, 



ready. (About 8900μg/ml) 



N-methylpyrrolidone reference product reserve liquid: accurately weigh 



N-methylpyrrolidone about 106mg, place in 20ml bottle, dissolve with 



solvent and dilute to the scale, shake well, ready. (About 5300μg/ml) 



Mixed reference product reserve liquid: precision measure ethanol reference 



product reserve liquid, isopropyl alcohol reference product reserve liquid, 



ethyl acetate reference product reserve liquid, secondary butanol reference 



product reserve liquid, tetrahydrofuran reference product reserve liquid, 



toluene reference product reserve liquid, N-methylpyrrolidone reference 



product reserve liquid 1.0ml each, put in 20ml bottle, dilute with solvent to 



the scale, shake well, ready. (Ethanol about 2500μg/ml, isopropyl alcohol 



about 2500μg/ml, ethyl acetate about 2500μg/ml, secondary butanol about 



2500μg/ml, tetrahydrofuran about 360μg/ml, toluene about 445μg/ml, 



N-methylpyrrolidone about 265μg/ml) 



Reference product solution: accurately measure 1.0ml of the mixed reference 



product reserve solution, place it in a 10ml bottle, dilute it with solvent to the 



scale, shake well, and obtain. (Ethanol about 250μg/ml, isopropyl alcohol 



about 250μg/ml, ethyl acetate about 250μg/ml, secondary butanol about 



250μg/ml, tetrahydrofuran about 36μg/ml, toluene about 44.5μg/ml, 



N-methylpyrrolidone about 26.5μg/ml) 



 **Injection Sequence** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 322 of 542 





Page 323
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



After the blank solution, the chromatogram was recorded by continuously 



feeding 6 samples of the sample solution. 



 **Measurement results** 



Results of system suitability test 





































































































































































































































-----------------------------------------------------------------------------------------------------------
|Name of solvent     |Parameter values|1        |2        |3        |4        |5        |6        |6      |
|--------------------|----------------|---------|---------|---------|---------|---------|---------|-------|
|Ethanol             |RT (min)        |8.229    |8.233    |8.225    |8.222    |8.244    |8.246    |0.1 3  |
|--------------------|----------------|---------|---------|---------|---------|---------|---------|-------|
|Ethanol             |Peakarea        |213.384 7|212.027 1|212.046 9|214.143 1|214.544 0|210.275 3|0.8    |
|--------------------|----------------|---------|---------|---------|---------|---------|---------|-------|
|Ethanol             |Separati on     |/        |/        |/        |/        |/        |/        |/      |
|--------------------|----------------|---------|---------|---------|---------|---------|---------|-------|
|Isop ropylalcohol   |RT (min)        |9.598    |9.602    |9.592    |9.588    |9.615    |9.615    |0.1 2  |
|--------------------|----------------|---------|---------|---------|---------|---------|---------|-------|
|Isop ropylalcohol   |Peakarea        |234.440 3|232.133 5|233.380 2|235.553 1|235.459 3|230.100 3|1.0    |
|--------------------|----------------|---------|---------|---------|---------|---------|---------|-------|
|Isop ropylalcohol   |Separati on     |7.7      |7.7      |7.5      |7.7      |7.6      |7.7      |/      |
|--------------------|----------------|---------|---------|---------|---------|---------|---------|-------|
|Eth ylaceta te      |RT (min)        |14.220   |14.226   |14.216   |14.212   |14.237   |14.238   |0.0 8  |
|--------------------|----------------|---------|---------|---------|---------|---------|---------|-------|
|Eth ylaceta te      |Peakarea        |182.367 6|180.927 4|182.574 7|183.074 1|182.910 2|178.844 8|0.9    |
|--------------------|----------------|---------|---------|---------|---------|---------|---------|-------|
|Eth ylaceta te      |Separati on     |27.0     |27.1     |26.8     |27.1     |26.9     |27.2     |/      |
|--------------------|----------------|---------|---------|---------|---------|---------|---------|-------|
|Seco nda ry buta nol|RT (min)        |14.509   |14.513   |14.506   |14.500   |14.525   |14.526   |0.0 8  |
|--------------------|----------------|---------|---------|---------|---------|---------|---------|-------|
|Seco nda ry buta nol|Peakarea        |278.148 3|273.979 9|275.482 0|280.511 2|278.060 0|276.126 7|0.9    |
|--------------------|----------------|---------|---------|---------|---------|---------|---------|-------|
|Seco nda ry buta nol|Separati on     |1.8      |1.8      |1.8      |1.8      |1.8      |1.8      |/      |
|--------------------|----------------|---------|---------|---------|---------|---------|---------|-------|
|tetrahy drofuran    |RT (min)        |14.807   |14.809   |14.801   |14.798   |14.823   |14.822   |0.0 8  |
|--------------------|----------------|---------|---------|---------|---------|---------|---------|-------|
|tetrahy drofuran    |Peakarea        |36.6421  |36.1685  |36.3647  |36.9569  |36.3910  |36.6089  |0.8    |
|--------------------|----------------|---------|---------|---------|---------|---------|---------|-------|
|tetrahy drofuran    |Separati on     |1.9      |1.9      |1.8      |1.9      |1.9      |1.9      |/      |
|--------------------|----------------|---------|---------|---------|---------|---------|---------|-------|
|Tolu ene            |RT (min)        |20.138   |20.136   |20.128   |20.129   |20.149   |20.149   |0.0 5  |
|--------------------|----------------|---------|---------|---------|---------|---------|---------|-------|
|Tolu ene            |Peakarea        |96.0328  |94.9365  |96.0452  |96.5924  |96.2772  |94.3475  |1.0    |
|--------------------|----------------|---------|---------|---------|---------|---------|---------|-------|
|Tolu ene            |Separati on     |37.8     |37.8     |37.7     |37.6     |37.7     |37.7     |/      |
|--------------------|----------------|---------|---------|---------|---------|---------|---------|-------|
|N-m                 |RT(min)         |31.455   |31.450   |31.447   |31.453   |31.460   |31.454   |0.0    |
-----------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 323 of 542 





Page 324
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 













------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|ethy lpyr rolidone                                    |Peakarea              |25.8942               |25.3002               |24.9786               |25.4332               |24.8897               |23.9517               |2.7                   |
|------------------------------------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|ethy lpyr rolidone                                    |Separati              |94.9                  |94.5                  |94.5                  |94.1                  |94.4                  |94.4                  |/                     |
|                                                      |on                    |                      |                      |                      |                      |                      |                      |                      |
|------------------------------------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|Conclusion: There was no interference in the blank    |Conclusion:           |Conclusion:           |Conclusion:           |Conclusion:           |Conclusion:           |Conclusion:           |Conclusion:           |Conclusion:           |
|solution. In the chromatogramobtained for 6           |There                 |There                 |There                 |There                 |There                 |There                 |There                 |There                 |
|consecutive days, peaks ofethanol, isopropylalcohol,  |was no                |was no                |was no                |was no                |was no                |was no                |was no                |was no                |
|ethylacetate, secondary butanol, tetrahydrofuran,     |interference          |interference          |interference          |interference          |interference          |interference          |interference          |interference          |
|toluene andn-methylpyrrolidone appeared successively, |in the                |in the                |in the                |in the                |in the                |in the                |in the                |in the                |
|and the separation degree betweeneachadjacent solvent |blank                 |blank                 |blank                 |blank                 |blank                 |blank                 |blank                 |blank                 |
|peak was greater than 1.5 (the requirement was greater|solution.             |solution.             |solution.             |solution.             |solution.             |solution.             |solution.             |solution.             |
|than 1.5). The RSD ofethanol peak retention time was  |In the                |In the                |In the                |In the                |In the                |In the                |In the                |In the                |
|0.13% (required less than 1.0%), and the RSD of       |chromatogramobtained  |chromatogramobtained  |chromatogramobtained  |chromatogramobtained  |chromatogramobtained  |chromatogramobtained  |chromatogramobtained  |chromatogramobtained  |
|peakarea was 0.8% (required less than 10%). The RSD   |for 6                 |for 6                 |for 6                 |for 6                 |for 6                 |for 6                 |for 6                 |for 6                 |
|ofisopropylalcohol peak retention time was 0.12% (NMT |consecutive           |consecutive           |consecutive           |consecutive           |consecutive           |consecutive           |consecutive           |consecutive           |
|1.0%), and the RSD of peakarea was 1.0% (NMT 10%); The|days,                 |days,                 |days,                 |days,                 |days,                 |days,                 |days,                 |days,                 |
|RSD of the ethylacetate peak was 0.08% (NMT 1.0%), and|peaks                 |peaks                 |peaks                 |peaks                 |peaks                 |peaks                 |peaks                 |peaks                 |
|the RSD of the peakarea was 0.9% (NMT 10%); The RSD of|ofethanol,            |ofethanol,            |ofethanol,            |ofethanol,            |ofethanol,            |ofethanol,            |ofethanol,            |ofethanol,            |
|secondary butanol was 0.08% (NMT 1.0%), and the RSD of|isopropylalcohol,     |isopropylalcohol,     |isopropylalcohol,     |isopropylalcohol,     |isopropylalcohol,     |isopropylalcohol,     |isopropylalcohol,     |isopropylalcohol,     |
|peakarea was 0.9% (NMT 10%); The RSD of the peak      |ethylacetate,         |ethylacetate,         |ethylacetate,         |ethylacetate,         |ethylacetate,         |ethylacetate,         |ethylacetate,         |ethylacetate,         |
|retention time of tetrahydrofuran was 0.08% (NMT      |secondary             |secondary             |secondary             |secondary             |secondary             |secondary             |secondary             |secondary             |
|1.0%), and the RSD of the peakarea was 0.8% (NMT 10%);|butanol,              |butanol,              |butanol,              |butanol,              |butanol,              |butanol,              |butanol,              |butanol,              |
|The RSD of toluene peak was 0.05% (NMT 1.0%), and the |tetrahydrofuran,      |tetrahydrofuran,      |tetrahydrofuran,      |tetrahydrofuran,      |tetrahydrofuran,      |tetrahydrofuran,      |tetrahydrofuran,      |tetrahydrofuran,      |
|RSD of peakarea was 1.0% (NMT 10%); The RSD of        |toluene               |toluene               |toluene               |toluene               |toluene               |toluene               |toluene               |toluene               |
|theN-methylpyrrolidone peak was 0.015% (NMT 1.0%), and|andn-methylpyrrolidone|andn-methylpyrrolidone|andn-methylpyrrolidone|andn-methylpyrrolidone|andn-methylpyrrolidone|andn-methylpyrrolidone|andn-methylpyrrolidone|andn-methylpyrrolidone|
|the RSD of the peakarea was 2.7% (NMT 10%); All the   |appeared              |appeared              |appeared              |appeared              |appeared              |appeared              |appeared              |appeared              |
|above meet the verification requirements, indicating  |successively,         |successively,         |successively,         |successively,         |successively,         |successively,         |successively,         |successively,         |
|that the method hasgoodapplicability in system.       |and the               |and the               |and the               |and the               |and the               |and the               |and the               |and the               |
|                                                      |separation            |separation            |separation            |separation            |separation            |separation            |separation            |separation            |
|                                                      |degree                |degree                |degree                |degree                |degree                |degree                |degree                |degree                |
|                                                      |betweeneachadjacent   |betweeneachadjacent   |betweeneachadjacent   |betweeneachadjacent   |betweeneachadjacent   |betweeneachadjacent   |betweeneachadjacent   |betweeneachadjacent   |
|                                                      |solvent               |solvent               |solvent               |solvent               |solvent               |solvent               |solvent               |solvent               |
|                                                      |peak was              |peak                  |peak                  |peak                  |peak                  |peak                  |peak                  |peak                  |
|                                                      |greater               |was                   |was                   |was                   |was                   |was                   |was                   |was                   |
|                                                      |than 1.5              |greater               |greater               |greater               |greater               |greater               |greater               |greater               |
|                                                      |(the                  |than                  |than                  |than                  |than                  |than                  |than                  |than                  |
|                                                      |requirement           |1.5                   |1.5                   |1.5                   |1.5                   |1.5                   |1.5                   |1.5                   |
|                                                      |was                   |(the                  |(the                  |(the                  |(the                  |(the                  |(the                  |(the                  |
|                                                      |greater               |requirement           |requirement           |requirement           |requirement           |requirement           |requirement           |requirement           |
|                                                      |than                  |was                   |was                   |was                   |was                   |was                   |was                   |was                   |
|                                                      |1.5).                 |greater               |greater               |greater               |greater               |greater               |greater               |greater               |
|                                                      |The RSD               |than                  |than                  |than                  |than                  |than                  |than                  |than                  |
|                                                      |ofethanol             |1.5).                 |1.5).                 |1.5).                 |1.5).                 |1.5).                 |1.5).                 |1.5).                 |
|                                                      |peak                  |The RSD               |The RSD               |The RSD               |The RSD               |The RSD               |The RSD               |The RSD               |
|                                                      |retention             |ofethanol             |ofethanol             |ofethanol             |ofethanol             |ofethanol             |ofethanol             |ofethanol             |
|                                                      |time was              |peak                  |peak                  |peak                  |peak                  |peak                  |peak                  |peak                  |
|                                                      |0.13%                 |retention             |retention             |retention             |retention             |retention             |retention             |retention             |
|                                                      |(required             |time                  |time                  |time                  |time                  |time                  |time                  |time                  |
|                                                      |less                  |was                   |was                   |was                   |was                   |was                   |was                   |was                   |
|                                                      |than                  |0.13%                 |0.13%                 |0.13%                 |0.13%                 |0.13%                 |0.13%                 |0.13%                 |
|                                                      |1.0%),                |(required             |(required             |(required             |(required             |(required             |(required             |(required             |
|                                                      |and the               |less                  |less                  |less                  |less                  |less                  |less                  |less                  |
|                                                      |RSD of                |than                  |than                  |than                  |than                  |than                  |than                  |than                  |
|                                                      |peakarea              |1.0%),                |1.0%),                |1.0%),                |1.0%),                |1.0%),                |1.0%),                |1.0%),                |
|                                                      |was 0.8%              |and the               |and the               |and the               |and the               |and the               |and the               |and the               |
|                                                      |(required             |RSD of                |RSD of                |RSD of                |RSD of                |RSD of                |RSD of                |RSD of                |
|                                                      |less                  |peakarea              |peakarea              |peakarea              |peakarea              |peakarea              |peakarea              |peakarea              |
|                                                      |than                  |was                   |was                   |was                   |was                   |was                   |was                   |was                   |
|                                                      |10%).                 |0.8%                  |0.8%                  |0.8%                  |0.8%                  |0.8%                  |0.8%                  |0.8%                  |
|                                                      |The RSD               |(required             |(required             |(required             |(required             |(required             |(required             |(required             |
|                                                      |ofisopropylalcohol    |less                  |less                  |less                  |less                  |less                  |less                  |less                  |
|                                                      |peak                  |than                  |than                  |than                  |than                  |than                  |than                  |than                  |
|                                                      |retention             |10%).                 |10%).                 |10%).                 |10%).                 |10%).                 |10%).                 |10%).                 |
|                                                      |time was              |The RSD               |The RSD               |The RSD               |The RSD               |The RSD               |The RSD               |The RSD               |
|                                                      |0.12%                 |ofisopropylalcohol    |ofisopropylalcohol    |ofisopropylalcohol    |ofisopropylalcohol    |ofisopropylalcohol    |ofisopropylalcohol    |ofisopropylalcohol    |
|                                                      |(NMT                  |peak                  |peak                  |peak                  |peak                  |peak                  |peak                  |peak                  |
|                                                      |1.0%),                |retention             |retention             |retention             |retention             |retention             |retention             |retention             |
|                                                      |and the               |time                  |time                  |time                  |time                  |time                  |time                  |time                  |
|                                                      |RSD of                |was                   |was                   |was                   |was                   |was                   |was                   |was                   |
|                                                      |peakarea              |0.12%                 |0.12%                 |0.12%                 |0.12%                 |0.12%                 |0.12%                 |0.12%                 |
|                                                      |was 1.0%              |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |
|                                                      |(NMT                  |1.0%),                |1.0%),                |1.0%),                |1.0%),                |1.0%),                |1.0%),                |1.0%),                |
|                                                      |10%);                 |and the               |and the               |and the               |and the               |and the               |and the               |and the               |
|                                                      |The RSD               |RSD of                |RSD of                |RSD of                |RSD of                |RSD of                |RSD of                |RSD of                |
|                                                      |of the                |peakarea              |peakarea              |peakarea              |peakarea              |peakarea              |peakarea              |peakarea              |
|                                                      |ethylacetate          |was                   |was                   |was                   |was                   |was                   |was                   |was                   |
|                                                      |peak was              |1.0%                  |1.0%                  |1.0%                  |1.0%                  |1.0%                  |1.0%                  |1.0%                  |
|                                                      |0.08%                 |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |
|                                                      |(NMT                  |10%);                 |10%);                 |10%);                 |10%);                 |10%);                 |10%);                 |10%);                 |
|                                                      |1.0%),                |The RSD               |The RSD               |The RSD               |The RSD               |The RSD               |The RSD               |The RSD               |
|                                                      |and the               |of the                |of the                |of the                |of the                |of the                |of the                |of the                |
|                                                      |RSD of                |ethylacetate          |ethylacetate          |ethylacetate          |ethylacetate          |ethylacetate          |ethylacetate          |ethylacetate          |
|                                                      |the                   |peak                  |peak                  |peak                  |peak                  |peak                  |peak                  |peak                  |
|                                                      |peakarea              |was                   |was                   |was                   |was                   |was                   |was                   |was                   |
|                                                      |was 0.9%              |0.08%                 |0.08%                 |0.08%                 |0.08%                 |0.08%                 |0.08%                 |0.08%                 |
|                                                      |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |
|                                                      |10%);                 |1.0%),                |1.0%),                |1.0%),                |1.0%),                |1.0%),                |1.0%),                |1.0%),                |
|                                                      |The RSD               |and the               |and the               |and the               |and the               |and the               |and the               |and the               |
|                                                      |of                    |RSD of                |RSD of                |RSD of                |RSD of                |RSD of                |RSD of                |RSD of                |
|                                                      |secondary             |the                   |the                   |the                   |the                   |the                   |the                   |the                   |
|                                                      |butanol               |peakarea              |peakarea              |peakarea              |peakarea              |peakarea              |peakarea              |peakarea              |
|                                                      |was                   |was                   |was                   |was                   |was                   |was                   |was                   |was                   |
|                                                      |0.08%                 |0.9%                  |0.9%                  |0.9%                  |0.9%                  |0.9%                  |0.9%                  |0.9%                  |
|                                                      |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |
|                                                      |1.0%),                |10%);                 |10%);                 |10%);                 |10%);                 |10%);                 |10%);                 |10%);                 |
|                                                      |and the               |The RSD               |The RSD               |The RSD               |The RSD               |The RSD               |The RSD               |The RSD               |
|                                                      |RSD of                |of                    |of                    |of                    |of                    |of                    |of                    |of                    |
|                                                      |peakarea              |secondary             |secondary             |secondary             |secondary             |secondary             |secondary             |secondary             |
|                                                      |was 0.9%              |butanol               |butanol               |butanol               |butanol               |butanol               |butanol               |butanol               |
|                                                      |(NMT                  |was                   |was                   |was                   |was                   |was                   |was                   |was                   |
|                                                      |10%);                 |0.08%                 |0.08%                 |0.08%                 |0.08%                 |0.08%                 |0.08%                 |0.08%                 |
|                                                      |The RSD               |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |
|                                                      |of the                |1.0%),                |1.0%),                |1.0%),                |1.0%),                |1.0%),                |1.0%),                |1.0%),                |
|                                                      |peak                  |and the               |and the               |and the               |and the               |and the               |and the               |and the               |
|                                                      |retention             |RSD of                |RSD of                |RSD of                |RSD of                |RSD of                |RSD of                |RSD of                |
|                                                      |time of               |peakarea              |peakarea              |peakarea              |peakarea              |peakarea              |peakarea              |peakarea              |
|                                                      |tetrahydrofuran       |was                   |was                   |was                   |was                   |was                   |was                   |was                   |
|                                                      |was                   |0.9%                  |0.9%                  |0.9%                  |0.9%                  |0.9%                  |0.9%                  |0.9%                  |
|                                                      |0.08%                 |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |
|                                                      |(NMT                  |10%);                 |10%);                 |10%);                 |10%);                 |10%);                 |10%);                 |10%);                 |
|                                                      |1.0%),                |The RSD               |The RSD               |The RSD               |The RSD               |The RSD               |The RSD               |The RSD               |
|                                                      |and the               |of the                |of the                |of the                |of the                |of the                |of the                |of the                |
|                                                      |RSD of                |peak                  |peak                  |peak                  |peak                  |peak                  |peak                  |peak                  |
|                                                      |the                   |retention             |retention             |retention             |retention             |retention             |retention             |retention             |
|                                                      |peakarea              |time of               |time of               |time of               |time of               |time of               |time of               |time of               |
|                                                      |was 0.8%              |tetrahydrofuran       |tetrahydrofuran       |tetrahydrofuran       |tetrahydrofuran       |tetrahydrofuran       |tetrahydrofuran       |tetrahydrofuran       |
|                                                      |(NMT                  |was                   |was                   |was                   |was                   |was                   |was                   |was                   |
|                                                      |10%);                 |0.08%                 |0.08%                 |0.08%                 |0.08%                 |0.08%                 |0.08%                 |0.08%                 |
|                                                      |The RSD               |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |
|                                                      |of                    |1.0%),                |1.0%),                |1.0%),                |1.0%),                |1.0%),                |1.0%),                |1.0%),                |
|                                                      |toluene               |and the               |and the               |and the               |and the               |and the               |and the               |and the               |
|                                                      |peak was              |RSD of                |RSD of                |RSD of                |RSD of                |RSD of                |RSD of                |RSD of                |
|                                                      |0.05%                 |the                   |the                   |the                   |the                   |the                   |the                   |the                   |
|                                                      |(NMT                  |peakarea              |peakarea              |peakarea              |peakarea              |peakarea              |peakarea              |peakarea              |
|                                                      |1.0%),                |was                   |was                   |was                   |was                   |was                   |was                   |was                   |
|                                                      |and the               |0.8%                  |0.8%                  |0.8%                  |0.8%                  |0.8%                  |0.8%                  |0.8%                  |
|                                                      |RSD of                |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |
|                                                      |peakarea              |10%);                 |10%);                 |10%);                 |10%);                 |10%);                 |10%);                 |10%);                 |
|                                                      |was 1.0%              |The RSD               |The RSD               |The RSD               |The RSD               |The RSD               |The RSD               |The RSD               |
|                                                      |(NMT                  |of                    |of                    |of                    |of                    |of                    |of                    |of                    |
|                                                      |10%);                 |toluene               |toluene               |toluene               |toluene               |toluene               |toluene               |toluene               |
|                                                      |The RSD               |peak                  |peak                  |peak                  |peak                  |peak                  |peak                  |peak                  |
|                                                      |of                    |was                   |was                   |was                   |was                   |was                   |was                   |was                   |
|                                                      |theN-methylpyrrolidone|0.05%                 |0.05%                 |0.05%                 |0.05%                 |0.05%                 |0.05%                 |0.05%                 |
|                                                      |peak was              |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |
|                                                      |0.015%                |1.0%),                |1.0%),                |1.0%),                |1.0%),                |1.0%),                |1.0%),                |1.0%),                |
|                                                      |(NMT                  |and the               |and the               |and the               |and the               |and the               |and the               |and the               |
|                                                      |1.0%),                |RSD of                |RSD of                |RSD of                |RSD of                |RSD of                |RSD of                |RSD of                |
|                                                      |and the               |peakarea              |peakarea              |peakarea              |peakarea              |peakarea              |peakarea              |peakarea              |
|                                                      |RSD of                |was                   |was                   |was                   |was                   |was                   |was                   |was                   |
|                                                      |the                   |1.0%                  |1.0%                  |1.0%                  |1.0%                  |1.0%                  |1.0%                  |1.0%                  |
|                                                      |peakarea              |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |
|                                                      |was 2.7%              |10%);                 |10%);                 |10%);                 |10%);                 |10%);                 |10%);                 |10%);                 |
|                                                      |(NMT                  |The RSD               |The RSD               |The RSD               |The RSD               |The RSD               |The RSD               |The RSD               |
|                                                      |10%);                 |of                    |of                    |of                    |of                    |of                    |of                    |of                    |
|                                                      |All the               |theN-methylpyrrolidone|theN-methylpyrrolidone|theN-methylpyrrolidone|theN-methylpyrrolidone|theN-methylpyrrolidone|theN-methylpyrrolidone|theN-methylpyrrolidone|
|                                                      |above                 |peak                  |peak                  |peak                  |peak                  |peak                  |peak                  |peak                  |
|                                                      |meet the              |was                   |was                   |was                   |was                   |was                   |was                   |was                   |
|                                                      |verification          |0.015%                |0.015%                |0.015%                |0.015%                |0.015%                |0.015%                |0.015%                |
|                                                      |requirements,         |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |
|                                                      |indicating            |1.0%),                |1.0%),                |1.0%),                |1.0%),                |1.0%),                |1.0%),                |1.0%),                |
|                                                      |that the              |and the               |and the               |and the               |and the               |and the               |and the               |and the               |
|                                                      |method                |RSD of                |RSD of                |RSD of                |RSD of                |RSD of                |RSD of                |RSD of                |
|                                                      |hasgoodapplicability  |the                   |the                   |the                   |the                   |the                   |the                   |the                   |
|                                                      |in                    |peakarea              |peakarea              |peakarea              |peakarea              |peakarea              |peakarea              |peakarea              |
|                                                      |system.               |was                   |was                   |was                   |was                   |was                   |was                   |was                   |
|                                                      |                      |2.7%                  |2.7%                  |2.7%                  |2.7%                  |2.7%                  |2.7%                  |2.7%                  |
|                                                      |                      |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |(NMT                  |
|                                                      |                      |10%);                 |10%);                 |10%);                 |10%);                 |10%);                 |10%);                 |10%);                 |
|                                                      |                      |All the               |All the               |All the               |All the               |All the               |All the               |All the               |
|                                                      |                      |above                 |above                 |above                 |above                 |above                 |above                 |above                 |
|                                                      |                      |meet                  |meet                  |meet                  |meet                  |meet                  |meet                  |meet                  |
|                                                      |                      |the                   |the                   |the                   |the                   |the                   |the                   |the                   |
|                                                      |                      |verification          |verification          |verification          |verification          |verification          |verification          |verification          |
|                                                      |                      |requirements,         |requirements,         |requirements,         |requirements,         |requirements,         |requirements,         |requirements,         |
|                                                      |                      |indicating            |indicating            |indicating            |indicating            |indicating            |indicating            |indicating            |
|                                                      |                      |that                  |that                  |that                  |that                  |that                  |that                  |that                  |
|                                                      |                      |the                   |the                   |the                   |the                   |the                   |the                   |the                   |
|                                                      |                      |method                |method                |method                |method                |method                |method                |method                |
|                                                      |                      |hasgoodapplicability  |hasgoodapplicability  |hasgoodapplicability  |hasgoodapplicability  |hasgoodapplicability  |hasgoodapplicability  |hasgoodapplicability  |
|                                                      |                      |in                    |in                    |in                    |in                    |in                    |in                    |in                    |
|                                                      |                      |system.               |system.               |system.               |system.               |system.               |system.               |system.               |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**b. Specificity** 



 **Acceptance Criteria** 



There is no interference in the blank solution. In the control solution, the 



peaks of ethanol, isopropyl alcohol, ethyl acetate, secondary butanol, 



tetrahydrofuran, toluene and n-methylpyrrolidone come out successively, 



and the separation degree between the adjacent peaks should be greater 



than 1.5; The separation degree of each solvent peak and adjacent peaks in 



the specific mixed solution and the test product solution is NLT 1.5, the 



retention time of each known solvent peak in the specific mixed solution and 



the test product solution should be consistent with the retention time of each 



solvent positioning solution, and other solvent positioning solutions (benzene, 



piperidine) have no interference with the target solvent peak. 



 **Solution preparation** 



Blank solution: solvent (N, n-dimethylformamide). 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 324 of 542 





Page 325
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Ethanol reference stock: Share ethanol reference stock under "4.1 System 



Suitability". (Approx. 50,000 μg/ml) 



Isopropyl alcohol reference reserve: Share isopropyl alcohol reference reserve 



under "4.1 System Suitability". (Approx. 50,000 μg/ml) 



Ethyl acetate reference reserve: Share the ethyl acetate reference reserve 



under "4.1 System Suitability". (Approx. 50,000 μg/ml) 



Secondary butanol reference product reserve: Share secondary butanol 



versus reference product reserve solution under "4.1 System Suitability". 



(Approx. 50,000 μg/ml) 



Tetrahydrofuran reference storage solution: Share tetrahydrofuran reference 



storage solution under "4.1 System Suitability". (Approx. 7200μg/ml) 



Toluene reference reserve: Share toluene reference reserve under "4.1 System 



Suitability". (Approx. 8900μg/ml) 



N-methylpyrrolidone reference stock: Share the N-methylpyrrolidone 



reference stock under "4.1 System Suitability". (Approx. 5300μg/ml) 



Piperidine control product reserve liquid: precision weigh piperidine about 



1000mg, place in 20ml bottle, dissolve with solvent and dilute to scale, shake 



well, ready. (Approx. 50000μg/ml) 



Benzene reference product reserve liquid: precision weigh about 40mg 



benzene, put it in 200ml bottle, dissolve it with solvent and dilute it to the 



scale, shake well; Then accurately measure 1ml, put it in 10ml measuring 



bottle, dissolve it with solvent and dilute it to the scale, shake well, and then 



get. Get it now. (About 20μg/ml) 



Reference product reserve liquid: precision measure ethanol reference 



product reserve liquid, isopropyl alcohol reference product reserve liquid, 



ethyl acetate reference product reserve liquid, secondary butanol reference 



product reserve liquid, tetrahydrofuran reference product reserve liquid, 



toluene reference product reserve liquid, N-methylpyrrolidone reference 



product reserve liquid 1.0ml each, put in 20ml bottle, dilute with solvent to 



scale, shake well, ready. (Ethanol about 2500μg/ml, isopropyl alcohol about 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 325 of 542 





Page 326
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



2500μg/ml, ethyl acetate about 2500μg/ml, secondary butanol about 



2500μg/ml, tetrahydrofuran about 360μg/ml, toluene about 445μg/ml, 



N-methylpyrrolidone about 265μg/ml) 



Control product solution: accurately measure 1.0ml of control product 



reserve solution, place it in 10ml bottle, dilute it with solvent to scale, shake 



well, and obtain. (Ethanol about 250μg/ml, isopropyl alcohol about 



250μg/ml, ethyl acetate about 250μg/ml, secondary butanol about 



250μg/ml, tetrahydrofuran about 36μg/ml, toluene about 44.5μg/ml, 



N-methylpyrrolidone about 26.5μg/ml) 



Mixed control product reserve liquid: Take a precise measure of 1.0ml each of 



ethanol reference liquid, isopropyl alcohol reference liquid, ethyl acetate 



reference liquid, secondary butanol reference liquid, tetrahydrofuran 



reference liquid, toluene reference liquid, N-methylpyrrolidone reference 



liquid, piperidine reference liquid and benzene reference liquid, put them in a 



20ml bottle and dilute them to the scale with solvent. Shake well, then get. 



(Ethanol about 2500μg/ml, isopropyl alcohol about 2500μg/ml, ethyl 



acetate about 2500μg/ml, secondary butanol about 2500μg/ml, 



tetrahydrofuran about 360μg/ml, toluene about 445μg/ml, 



N-methylpyrrolidone about 265μg/ml, piperidine about 2500μg/ml, benzene 



about 1μg /ml) 



Ethanol positioning solution: accurately measure 0.1ml of ethanol reference 



product reserve liquid, place it in 20ml measuring bottle, dilute it with 



solvent to scale, shake well, and get. (About 250μg/ml) 



Isopropyl alcohol positioning solution: accurately measure 0.1ml of isopropyl 



alcohol reference product reserve solution, place it in 20ml measuring bottle, 



dilute it with solvent to the scale, shake well, and obtain. (About 250μg/ml) 



Ethyl acetate positioning solution: accurately measure 0.1ml of ethyl acetate 



reference product reserve solution, place it in a 20ml measuring bottle, dilute 



it with solvent to the scale, shake well, and obtain. (About 250μg/ml) 



Secondary butanol positioning solution: accurately measure secondary 



butanol reference product reserve liquid 0.1ml, place it in 20ml measuring 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 326 of 542 





Page 327
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



bottle, dilute it with solvent to the scale, shake well, and then obtain. (About 



250μg/ml) 



Tetrahydrofuran positioning solution: precisely measure tetrahydrofuran 



reference product reserve liquid 0.1ml, place in 20ml measuring bottle, dilute 



with solvent to scale, shake well, ready. (about 36μg/ml) 



Toluene positioning solution: accurately measure toluene reference product 



reserve liquid 0.1ml, place in 20ml measuring bottle, dilute with solvent to 



scale, shake well, ready. (About 44.5μg/ml) 



N-methylpyrrolidone positioning solution: accurately measure 0.1ml of 



N-methylpyrrolidone reference product reserve solution, place it in 20ml 



measuring bottle, dilute it with solvent to the scale, shake well, and obtain. 



(About 26.5μg/ml) 



Piperidine positioning solution: precisely measure 0.1ml of piperidine control 



product reserve, place it in a 20ml measuring bottle, dilute it with solvent to 



the scale, shake well, and obtain. (About 250μg/ml) 



Benzene positioning solution: Accurately measure 0.1ml of benzene 



reference product reserve liquid, place it in a 20ml measuring bottle, dilute it 



with solvent to the scale, shake well, and obtain. (About 0.1μg/ml) 



Test product solution: Accurately weigh about 0.5g of this product, place it in 



10ml measuring bottle, dissolve it with solvent and dilute it to the scale, 



shake well, and then get. (About 50mg/ml) 



Specific mixed solution: Accurately weigh about 0.5g of this product, place it 



in 10ml measuring bottle, add 1.0ml of mixed control product reserve 



solution, dissolve it with solvent and dilute it to the scale, shake well, and 



then get. 



 **Injection Sequence** 



After the blank solution, the positioning solution, the reference solution, the 



test product solution and the specific mixed solution were injected 



respectively, and the chromatogram was recorded. 



 **Measurement resultss** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 327 of 542 





Page 328
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 































































-----------------------------------------------------------------------------------------------------------
|Solution name                           |Component name     |Component name|Component name|Component name|
|----------------------------------------|-------------------|--------------|--------------|--------------|
|Ethanol locating solution               |Ethanol            |250.278       |8.167         |/             |
|----------------------------------------|-------------------|--------------|--------------|--------------|
|Isopropylalcohol positioning solution   |Isopropylalcohol   |250.410       |9.516         |/             |
|----------------------------------------|-------------------|--------------|--------------|--------------|
|Ethylacetate positioning solution       |Ethylacetate       |248.695       |14.149        |/             |
|----------------------------------------|-------------------|--------------|--------------|--------------|
|Secondary butanol positioning solution  |Sec-butanol        |250.585       |14.429        |/             |
|----------------------------------------|-------------------|--------------|--------------|--------------|
|Tetrahydrofuran locator solution        |tetrahydrofuran    |36.588        |14.731        |/             |
|----------------------------------------|-------------------|--------------|--------------|--------------|
|Toluene locator solution                |Toluene            |50.025        |20.058        |/             |
|----------------------------------------|-------------------|--------------|--------------|--------------|
|N-methylpyrrolidone positioning solution|N-methylpyrrolidone|27.6875       |31.386        |/             |
|----------------------------------------|-------------------|--------------|--------------|--------------|
|Piperidine positioning solution         |Piperidine         |0.1033        |/             |/             |
|----------------------------------------|-------------------|--------------|--------------|--------------|
|Benzene locator solution                |benzene            |251.4725      |/             |/             |
|----------------------------------------|-------------------|--------------|--------------|--------------|
|Reference solution                      |Ethylalcohol       |250.278       |8.151         |/             |
|----------------------------------------|-------------------|--------------|--------------|--------------|
|Reference solution                      |Isopropylalcohol   |250.410       |9.503         |8.2           |
|----------------------------------------|-------------------|--------------|--------------|--------------|
|Reference solution                      |Ethylacetate       |248.695       |14.143        |28.3          |
|----------------------------------------|-------------------|--------------|--------------|--------------|
|Reference solution                      |sec-butanol        |250.585       |14.429        |1.8           |
|----------------------------------------|-------------------|--------------|--------------|--------------|
|Reference solution                      |tetrahydrofuran    |36.588        |14.729        |1.9           |
|----------------------------------------|-------------------|--------------|--------------|--------------|
|Reference solution                      |Toluene            |50.025        |20.061        |37.7          |
|----------------------------------------|-------------------|--------------|--------------|--------------|
|Reference solution                      |N-methylpyrrolidone|27.6875       |31.388        |95.5          |
|----------------------------------------|-------------------|--------------|--------------|--------------|
|Sample solution                         |Ethanol            |/             |8.166         |/             |
|----------------------------------------|-------------------|--------------|--------------|--------------|
|Sample solution                         |Isopropylalcohol   |/             |/             |/             |
|----------------------------------------|-------------------|--------------|--------------|--------------|
|Sample solution                         |Ethylacetate       |/             |/             |/             |
|----------------------------------------|-------------------|--------------|--------------|--------------|
|Sample solution                         |sec-butanol        |/             |/             |/             |
|----------------------------------------|-------------------|--------------|--------------|--------------|
|Sample solution                         |tetrahydrofuran    |/             |/             |/             |
|----------------------------------------|-------------------|--------------|--------------|--------------|
|Sample solution                         |Toluene            |/             |/             |/             |
|----------------------------------------|-------------------|--------------|--------------|--------------|
|Sample solution                         |N-methylpyrrolidone|/             |/             |/             |
|----------------------------------------|-------------------|--------------|--------------|--------------|
|Sample solution                         |Piperidine         |/             |/             |/             |
|----------------------------------------|-------------------|--------------|--------------|--------------|
|Sample solution                         |benzene            |/             |/             |/             |
|----------------------------------------|-------------------|--------------|--------------|--------------|
|Specific mixed solution                 |Ethanol            |250.278       |8.149         |/             |
|----------------------------------------|-------------------|--------------|--------------|--------------|
|Specific mixed solution                 |Isopropylalcohol   |250.410       |9.504         |8.2           |
-----------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 328 of 542 





Page 329
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 










------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|sec-butanol                                                                           |250.585               |14.429                |1.8                   |                      |
|--------------------------------------------------------------------------------------|----------------------|----------------------|----------------------|----------------------|
|tetrahydrofuran                                                                       |36.588                |14.728                |1.9                   |                      |
|--------------------------------------------------------------------------------------|----------------------|----------------------|----------------------|----------------------|
|Toluene                                                                               |50.025                |20.061                |37.5                  |                      |
|--------------------------------------------------------------------------------------|----------------------|----------------------|----------------------|----------------------|
|N-methylpyrrolidone                                                                   |27.6875               |31.390                |94.3                  |                      |
|--------------------------------------------------------------------------------------|----------------------|----------------------|----------------------|----------------------|
|Conclusion: There was no interference in the blank solution. In the control solution, |Conclusion:           |Conclusion:           |Conclusion:           |Conclusion:           |
|the peaks ofethanol, isopropylalcohol, ethylacetate, secondary butanol,               |There                 |There                 |There                 |There                 |
|tetrahydrofuran, toluene andn-methylpyrrolidone appeared successively, and the        |was no                |was no                |was no                |was no                |
|separation degree betweeneachadjacent solvent peak was greater than 1.5 (the          |interference          |interference          |interference          |interference          |
|requirement was greater than 1.5). The separation degree betweenindividual solvent    |in the                |in the                |in the                |in the                |
|peaks andadjacent peaks in the specific mixed solution and the test solutionis NLT    |blank                 |blank                 |blank                 |blank                 |
|1.5, the retention time ofeach known solvent peak in the specific mixed solution and  |solution.             |solution.             |solution.             |solution.             |
|the test solutionis consistent with the retention time ofeach solvent-locating        |In the                |In the                |In the                |In the                |
|solution, andother solvent-locating solutions (benzene, piperidine) have no           |control               |control               |control               |control               |
|interference with the target solvent peak. All of the above meet the verification     |solution,             |solution,             |solution,             |solution,             |
|requirements, indicating that the method has good specificity.                        |the                   |the                   |the                   |the                   |
|                                                                                      |peaks                 |peaks                 |peaks                 |peaks                 |
|                                                                                      |ofethanol,            |ofethanol,            |ofethanol,            |ofethanol,            |
|                                                                                      |isopropylalcohol,     |isopropylalcohol,     |isopropylalcohol,     |isopropylalcohol,     |
|                                                                                      |ethylacetate,         |ethylacetate,         |ethylacetate,         |ethylacetate,         |
|                                                                                      |secondary             |secondary             |secondary             |secondary             |
|                                                                                      |butanol,              |butanol,              |butanol,              |butanol,              |
|                                                                                      |tetrahydrofuran,      |tetrahydrofuran,      |tetrahydrofuran,      |tetrahydrofuran,      |
|                                                                                      |toluene               |toluene               |toluene               |toluene               |
|                                                                                      |andn-methylpyrrolidone|andn-methylpyrrolidone|andn-methylpyrrolidone|andn-methylpyrrolidone|
|                                                                                      |appeared              |appeared              |appeared              |appeared              |
|                                                                                      |successively,         |successively,         |successively,         |successively,         |
|                                                                                      |and the               |and the               |and the               |and the               |
|                                                                                      |separation            |separation            |separation            |separation            |
|                                                                                      |degree                |degree                |degree                |degree                |
|                                                                                      |betweeneachadjacent   |betweeneachadjacent   |betweeneachadjacent   |betweeneachadjacent   |
|                                                                                      |solvent               |solvent               |solvent               |solvent               |
|                                                                                      |peak                  |peak                  |peak                  |peak                  |
|                                                                                      |was                   |was                   |was                   |was                   |
|                                                                                      |greater               |greater               |greater               |greater               |
|                                                                                      |than                  |than                  |than                  |than                  |
|                                                                                      |1.5                   |1.5                   |1.5                   |1.5                   |
|                                                                                      |(the                  |(the                  |(the                  |(the                  |
|                                                                                      |requirement           |requirement           |requirement           |requirement           |
|                                                                                      |was                   |was                   |was                   |was                   |
|                                                                                      |greater               |greater               |greater               |greater               |
|                                                                                      |than                  |than                  |than                  |than                  |
|                                                                                      |1.5).                 |1.5).                 |1.5).                 |1.5).                 |
|                                                                                      |The                   |The                   |The                   |The                   |
|                                                                                      |separation            |separation            |separation            |separation            |
|                                                                                      |degree                |degree                |degree                |degree                |
|                                                                                      |betweenindividual     |betweenindividual     |betweenindividual     |betweenindividual     |
|                                                                                      |solvent               |solvent               |solvent               |solvent               |
|                                                                                      |peaks                 |peaks                 |peaks                 |peaks                 |
|                                                                                      |andadjacent           |andadjacent           |andadjacent           |andadjacent           |
|                                                                                      |peaks                 |peaks                 |peaks                 |peaks                 |
|                                                                                      |in the                |in the                |in the                |in the                |
|                                                                                      |specific              |specific              |specific              |specific              |
|                                                                                      |mixed                 |mixed                 |mixed                 |mixed                 |
|                                                                                      |solution              |solution              |solution              |solution              |
|                                                                                      |and the               |and the               |and the               |and the               |
|                                                                                      |test                  |test                  |test                  |test                  |
|                                                                                      |solutionis            |solutionis            |solutionis            |solutionis            |
|                                                                                      |NLT                   |NLT                   |NLT                   |NLT                   |
|                                                                                      |1.5,                  |1.5,                  |1.5,                  |1.5,                  |
|                                                                                      |the                   |the                   |the                   |the                   |
|                                                                                      |retention             |retention             |retention             |retention             |
|                                                                                      |time                  |time                  |time                  |time                  |
|                                                                                      |ofeach                |ofeach                |ofeach                |ofeach                |
|                                                                                      |known                 |known                 |known                 |known                 |
|                                                                                      |solvent               |solvent               |solvent               |solvent               |
|                                                                                      |peak in               |peak in               |peak in               |peak in               |
|                                                                                      |the                   |the                   |the                   |the                   |
|                                                                                      |specific              |specific              |specific              |specific              |
|                                                                                      |mixed                 |mixed                 |mixed                 |mixed                 |
|                                                                                      |solution              |solution              |solution              |solution              |
|                                                                                      |and the               |and the               |and the               |and the               |
|                                                                                      |test                  |test                  |test                  |test                  |
|                                                                                      |solutionis            |solutionis            |solutionis            |solutionis            |
|                                                                                      |consistent            |consistent            |consistent            |consistent            |
|                                                                                      |with                  |with                  |with                  |with                  |
|                                                                                      |the                   |the                   |the                   |the                   |
|                                                                                      |retention             |retention             |retention             |retention             |
|                                                                                      |time                  |time                  |time                  |time                  |
|                                                                                      |ofeach                |ofeach                |ofeach                |ofeach                |
|                                                                                      |solvent-locating      |solvent-locating      |solvent-locating      |solvent-locating      |
|                                                                                      |solution,             |solution,             |solution,             |solution,             |
|                                                                                      |andother              |andother              |andother              |andother              |
|                                                                                      |solvent-locating      |solvent-locating      |solvent-locating      |solvent-locating      |
|                                                                                      |solutions             |solutions             |solutions             |solutions             |
|                                                                                      |(benzene,             |(benzene,             |(benzene,             |(benzene,             |
|                                                                                      |piperidine)           |piperidine)           |piperidine)           |piperidine)           |
|                                                                                      |have no               |have no               |have no               |have no               |
|                                                                                      |interference          |interference          |interference          |interference          |
|                                                                                      |with                  |with                  |with                  |with                  |
|                                                                                      |the                   |the                   |the                   |the                   |
|                                                                                      |target                |target                |target                |target                |
|                                                                                      |solvent               |solvent               |solvent               |solvent               |
|                                                                                      |peak.                 |peak.                 |peak.                 |peak.                 |
|                                                                                      |All of                |All of                |All of                |All of                |
|                                                                                      |the                   |the                   |the                   |the                   |
|                                                                                      |above                 |above                 |above                 |above                 |
|                                                                                      |meet                  |meet                  |meet                  |meet                  |
|                                                                                      |the                   |the                   |the                   |the                   |
|                                                                                      |verification          |verification          |verification          |verification          |
|                                                                                      |requirements,         |requirements,         |requirements,         |requirements,         |
|                                                                                      |indicating            |indicating            |indicating            |indicating            |
|                                                                                      |that                  |that                  |that                  |that                  |
|                                                                                      |the                   |the                   |the                   |the                   |
|                                                                                      |method                |method                |method                |method                |
|                                                                                      |has                   |has                   |has                   |has                   |
|                                                                                      |good                  |good                  |good                  |good                  |
|                                                                                      |specificity.          |specificity.          |specificity.          |specificity.          |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**(4.3) Limits of quantification and detection** 



 **Acceptance Criteria** 



The S/N of each solvent peak in 6 LOQ solution maps should be NLT 10, the 



RSD of retention time should be no more than 2.0%, and the RSD of peak 



area should be no more than 10%. The S/N of each solvent peak in the 



3-needle Limit of detection (LOD) solution atlas should be NLT 3. 



 **Solution Preparation** 



Blank solution: solvent (N, n-dimethylformamide). 



Ethanol reference stock: Share ethanol reference stock under "4.1 System 



Suitability". (Approx. 50,000 μg/ml) 



Isopropyl alcohol reference stock: Share isopropyl alcohol reference stock 



under "4.1 System Suitability". (Approx. 50,000 μg/ml) 



Ethyl acetate reference reserve: Share the ethyl acetate reference reserve 



under "4.1 System Suitability". (Approx. 50,000 μg/ml) 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 329 of 542 





Page 330
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Secondary butanol reference product reserve: Share secondary butanol 



versus reference product reserve solution under "4.1 System Suitability". 



(Approx. 50,000 μg/ml) 



Tetrahydrofuran reference storage solution: Share tetrahydrofuran reference 



storage solution under "4.1 System Suitability". (Approx. 7200μg/ml) 



Toluene reference reserve: Share toluene reference reserve under "4.1 System 



Suitability". (Approx. 8900μg/ml) 



N-methylpyrrolidone reference stock: Share the N-methylpyrrolidone 



reference stock under "4.1 System Suitability". (Approx. 5300μg/ml) 



Quantitative limited stock solution: Precise measurement of ethanol 



reference liquid 0.2ml, isopropyl alcohol reference liquid 0.2ml, ethyl acetate 



reference liquid 0.2ml, secondary butanol reference liquid 0.15ml, 



tetrahydrofuran reference liquid 1ml, toluene reference liquid 0.4ml, 



N-methylpyrrolidone reference liquid 1ml, Place in the same 10ml measuring 



bottle, dilute with solvent and set the volume to the scale, shake well, then 



measure 1ml precisely, place in 20ml measuring bottle, dilute with solvent 



and set the volume to the scale, shake well, then obtain. 



Limit of quantitation (LOQ) solution: accurately measure 1ml of limited 



quantitation reserve liquid, place it in 10ml measuring bottle, dilute it with 



solvent and set the volume to the scale, shake well, and then get. (Dispense 6 



parts in parallel) 



Limit of detection (LOD) solution: Accurately measure the first part of the 



limit of quantification solution 3ml, place it in a 10ml measuring bottle, 



dilute it with solvent to the scale, shake well, and get. 



 **Injection Sequence** 



After the blank solution, 6 parts of limited quantitation solution and 3 



needles of limited detection solution were injected respectively, and the 



chromatogram was recorded. 



 **Measurement resultss** 



Results of limit of quantitation test 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 330 of 542 





Page 331
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 










































----------------------------------------------------------------------------------------------------------------------------------------------------------------
|Ethanol          |Limited quantitative Solution 1                             |5.006          |0.01           |8.261          |4.7576         |12.2           |
|-----------------|------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|
|Ethanol          |Limited quantitative Solution 2                             |Limited        |Limited        |8.263          |5.0132         |15.7           |
|                 |                                                            |quantitative   |quantitative   |               |               |               |
|                 |                                                            |Solution       |Solution       |               |               |               |
|                 |                                                            |2              |2              |               |               |               |
|-----------------|------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|
|Ethanol          |Limited quantitative Solution 3                             |Limited        |Limited        |8.254          |4.8740         |14.7           |
|                 |                                                            |quantitative   |quantitative   |               |               |               |
|                 |                                                            |Solution 3     |Solution 3     |               |               |               |
|-----------------|------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|
|Ethanol          |Limited quantitative Solution 4                             |Limited        |Limited        |8.256          |4.7694         |13.7           |
|                 |                                                            |quantitative   |quantitative   |               |               |               |
|                 |                                                            |Solution 4     |Solution 4     |               |               |               |
|-----------------|------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|
|Ethanol          |Limited quantitative Solution 5                             |Limited        |Limited        |8.255          |5.0251         |15.6           |
|                 |                                                            |quantitative   |quantitative   |               |               |               |
|                 |                                                            |Solution 5     |Solution 5     |               |               |               |
|-----------------|------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|
|Ethanol          |Limited quantitative solution 6                             |Limited        |Limited        |8.260          |4.9149         |14.3           |
|                 |                                                            |quantitative   |quantitative   |               |               |               |
|                 |                                                            |solution 6     |solution 6     |               |               |               |
|-----------------|------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|
|Ethanol          |RSD (%)                                                     |RSD (%)        |RSD (%)        |0.05           |2.4            |/              |
|-----------------|------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|
|Ethanol          |Verdict: TheS/Nofethanol in 6 limited quantification        |Verdict:       |Verdict:       |Verdict:       |Verdict:       |Verdict:       |
|                 |solution chromatograms was between 12.2-15.7 (NLT 10        |TheS/Nofethanol|TheS/Nofethanol|TheS/Nofethanol|TheS/Nofethanol|TheS/Nofethanol|
|                 |required), the RSD of retention time was 0.05% (no more than|in 6 limited   |in 6 limited   |in 6           |in 6           |in 6           |
|                 |2.0% required), the RSD of peakarea was 2.4% (no more than  |quantification |quantification |limited        |limited        |limited        |
|                 |10% required), and the limited quantification concentration |solution       |solution       |quantification |quantification |quantification |
|                 |ofethanol was 5.006μg/ml. Equivalent to 0.01% of the        |chromatograms  |chromatograms  |solution       |solution       |solution       |
|                 |concentration of the test product; The above are in line    |was between    |was between    |chromatograms  |chromatograms  |chromatograms  |
|                 |with the verification requirements.                         |12.2-15.7      |12.2-15.7      |was            |was            |was            |
|                 |                                                            |(NLT 10        |(NLT 10        |between        |between        |between        |
|                 |                                                            |required),     |required),     |12.2-15.7      |12.2-15.7      |12.2-15.7      |
|                 |                                                            |the RSD of     |the RSD of     |(NLT 10        |(NLT 10        |(NLT 10        |
|                 |                                                            |retention      |retention      |required),     |required),     |required),     |
|                 |                                                            |time was       |time was       |the RSD        |the RSD        |the RSD        |
|                 |                                                            |0.05% (no      |0.05% (no      |of             |of             |of             |
|                 |                                                            |more than      |more than      |retention      |retention      |retention      |
|                 |                                                            |2.0%           |2.0%           |time           |time           |time           |
|                 |                                                            |required),     |required),     |was            |was            |was            |
|                 |                                                            |the RSD of     |the RSD of     |0.05%          |0.05%          |0.05%          |
|                 |                                                            |peakarea was   |peakarea was   |(no            |(no            |(no            |
|                 |                                                            |2.4% (no       |2.4% (no       |more           |more           |more           |
|                 |                                                            |more than      |more than      |than           |than           |than           |
|                 |                                                            |10%            |10%            |2.0%           |2.0%           |2.0%           |
|                 |                                                            |required),     |required),     |required),     |required),     |required),     |
|                 |                                                            |and the        |and the        |the RSD        |the RSD        |the RSD        |
|                 |                                                            |limited        |limited        |of             |of             |of             |
|                 |                                                            |quantification |quantification |peakarea       |peakarea       |peakarea       |
|                 |                                                            |concentration  |concentration  |was            |was            |was            |
|                 |                                                            |ofethanol      |ofethanol      |2.4%           |2.4%           |2.4%           |
|                 |                                                            |was            |was            |(no            |(no            |(no            |
|                 |                                                            |5.006μg/ml.    |5.006μg/ml.    |more           |more           |more           |
|                 |                                                            |Equivalent     |Equivalent     |than           |than           |than           |
|                 |                                                            |to 0.01% of    |to 0.01% of    |10%            |10%            |10%            |
|                 |                                                            |the            |the            |required),     |required),     |required),     |
|                 |                                                            |concentration  |concentration  |and the        |and the        |and the        |
|                 |                                                            |of the test    |of the test    |limited        |limited        |limited        |
|                 |                                                            |product; The   |product; The   |quantification |quantification |quantification |
|                 |                                                            |above are in   |above are in   |concentration  |concentration  |concentration  |
|                 |                                                            |line with      |line with      |ofethanol      |ofethanol      |ofethanol      |
|                 |                                                            |the            |the            |was            |was            |was            |
|                 |                                                            |verification   |verification   |5.006μg/ml.    |5.006μg/ml.    |5.006μg/ml.    |
|                 |                                                            |requirements.  |requirements.  |Equivalent     |Equivalent     |Equivalent     |
|                 |                                                            |               |               |to             |to             |to             |
|                 |                                                            |               |               |0.01%          |0.01%          |0.01%          |
|                 |                                                            |               |               |of the         |of the         |of the         |
|                 |                                                            |               |               |concentration  |concentration  |concentration  |
|                 |                                                            |               |               |of the         |of the         |of the         |
|                 |                                                            |               |               |test           |test           |test           |
|                 |                                                            |               |               |product;       |product;       |product;       |
|                 |                                                            |               |               |The            |The            |The            |
|                 |                                                            |               |               |above          |above          |above          |
|                 |                                                            |               |               |are in         |are in         |are in         |
|                 |                                                            |               |               |line           |line           |line           |
|                 |                                                            |               |               |with           |with           |with           |
|                 |                                                            |               |               |the            |the            |the            |
|                 |                                                            |               |               |verification   |verification   |verification   |
|                 |                                                            |               |               |requirements.  |requirements.  |requirements.  |
|-----------------|------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|
|Isopro pylalcohol|Limited quantitative Solution 1                             |5.008          |0.01           |9.613          |5.3135         |11.9           |
|-----------------|------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|
|Isopro pylalcohol|Limited quantification solution 2                           |Limited        |Limited        |9.617          |5.1179         |15.2           |
|                 |                                                            |quantification |quantification |               |               |               |
|                 |                                                            |solution 2     |solution 2     |               |               |               |
|-----------------|------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|
|Isopro pylalcohol|Limited quantificatio                                       |Limited        |Limited        |9.613          |4.8142         |14.2           |
|                 |                                                            |quantificatio  |quantificatio  |               |               |               |
----------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 331 of 542 





Page 332
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 

























--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Limited quantitative Solution 4                                       |Limited                 |Limited                 |9.613                   |4.7635                  |13.2                    |                    |
|                                                                      |quantitative            |quantitative            |                        |                        |                        |                    |
|                                                                      |Solution                |Solution                |                        |                        |                        |                    |
|                                                                      |4                       |4                       |                        |                        |                        |                    |
|----------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|--------------------|
|Limited quantitative Solution 5                                       |Limited                 |Limited                 |9.611                   |5.1899                  |14.8                    |                    |
|                                                                      |quantitative            |quantitative            |                        |                        |                        |                    |
|                                                                      |Solution 5              |Solution 5              |                        |                        |                        |                    |
|----------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|--------------------|
|Limited quantitative solution 6                                       |Limited                 |Limited                 |9.614                   |4.7570                  |13.8                    |                    |
|                                                                      |quantitative            |quantitative            |                        |                        |                        |                    |
|                                                                      |solution 6              |solution 6              |                        |                        |                        |                    |
|----------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|--------------------|
|RSD (%)                                                               |RSD (%)                 |RSD (%)                 |0.021                   |5                       |/                       |                    |
|----------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|--------------------|
|Verdict: TheS/Nofisopropylalcohol in 6 limited quantification solution|Verdict:                |Verdict:                |Verdict:                |Verdict:                |Verdict:                |                    |
|chromatograms ranged from 11.9 to 15.2 (NLT 10 required), the RSD of  |TheS/Nofisopropylalcohol|TheS/Nofisopropylalcohol|TheS/Nofisopropylalcohol|TheS/Nofisopropylalcohol|TheS/Nofisopropylalcohol|                    |
|retention time was 0.021% (no more than 2.0% required), the RSD of    |in 6 limited            |in 6 limited            |in 6                    |in 6                    |in 6                    |                    |
|peakarea was 5% (no more than 10% required), and the limited          |quantification          |quantification          |limited                 |limited                 |limited                 |                    |
|quantification concentration ofisopropylalcohol was 5.008μg/ml.       |solution                |solution                |quantification          |quantification          |quantification          |                    |
|Equivalent to 0.01% of the concentration of the test product; The     |chromatograms           |chromatograms           |solution                |solution                |solution                |                    |
|above are in line with the verification requirements.                 |ranged from             |ranged from             |chromatograms           |chromatograms           |chromatograms           |                    |
|                                                                      |11.9 to 15.2            |11.9 to 15.2            |ranged                  |ranged                  |ranged                  |                    |
|                                                                      |(NLT 10                 |(NLT 10                 |from                    |from                    |from                    |                    |
|                                                                      |required),              |required),              |11.9 to                 |11.9 to                 |11.9 to                 |                    |
|                                                                      |the RSD of              |the RSD of              |15.2                    |15.2                    |15.2                    |                    |
|                                                                      |retention               |retention               |(NLT 10                 |(NLT 10                 |(NLT 10                 |                    |
|                                                                      |time was                |time was                |required),              |required),              |required),              |                    |
|                                                                      |0.021% (no              |0.021% (no              |the RSD                 |the RSD                 |the RSD                 |                    |
|                                                                      |more than               |more than               |of                      |of                      |of                      |                    |
|                                                                      |2.0%                    |2.0%                    |retention               |retention               |retention               |                    |
|                                                                      |required),              |required),              |time                    |time                    |time                    |                    |
|                                                                      |the RSD of              |the RSD of              |was                     |was                     |was                     |                    |
|                                                                      |peakarea was            |peakarea was            |0.021%                  |0.021%                  |0.021%                  |                    |
|                                                                      |5% (no more             |5% (no more             |(no                     |(no                     |(no                     |                    |
|                                                                      |than 10%                |than 10%                |more                    |more                    |more                    |                    |
|                                                                      |required),              |required),              |than                    |than                    |than                    |                    |
|                                                                      |and the                 |and the                 |2.0%                    |2.0%                    |2.0%                    |                    |
|                                                                      |limited                 |limited                 |required),              |required),              |required),              |                    |
|                                                                      |quantification          |quantification          |the RSD                 |the RSD                 |the RSD                 |                    |
|                                                                      |concentration           |concentration           |of                      |of                      |of                      |                    |
|                                                                      |ofisopropylalcohol      |ofisopropylalcohol      |peakarea                |peakarea                |peakarea                |                    |
|                                                                      |was                     |was                     |was 5%                  |was 5%                  |was 5%                  |                    |
|                                                                      |5.008μg/ml.             |5.008μg/ml.             |(no                     |(no                     |(no                     |                    |
|                                                                      |Equivalent              |Equivalent              |more                    |more                    |more                    |                    |
|                                                                      |to 0.01% of             |to 0.01% of             |than                    |than                    |than                    |                    |
|                                                                      |the                     |the                     |10%                     |10%                     |10%                     |                    |
|                                                                      |concentration           |concentration           |required),              |required),              |required),              |                    |
|                                                                      |of the test             |of the test             |and the                 |and the                 |and the                 |                    |
|                                                                      |product; The            |product; The            |limited                 |limited                 |limited                 |                    |
|                                                                      |above are in            |above are in            |quantification          |quantification          |quantification          |                    |
|                                                                      |line with               |line with               |concentration           |concentration           |concentration           |                    |
|                                                                      |the                     |the                     |ofisopropylalcohol      |ofisopropylalcohol      |ofisopropylalcohol      |                    |
|                                                                      |verification            |verification            |was                     |was                     |was                     |                    |
|                                                                      |requirements.           |requirements.           |5.008μg/ml.             |5.008μg/ml.             |5.008μg/ml.             |                    |
|                                                                      |                        |                        |Equivalent              |Equivalent              |Equivalent              |                    |
|                                                                      |                        |                        |to                      |to                      |to                      |                    |
|                                                                      |                        |                        |0.01%                   |0.01%                   |0.01%                   |                    |
|                                                                      |                        |                        |of the                  |of the                  |of the                  |                    |
|                                                                      |                        |                        |concentration           |concentration           |concentration           |                    |
|                                                                      |                        |                        |of the                  |of the                  |of the                  |                    |
|                                                                      |                        |                        |test                    |test                    |test                    |                    |
|                                                                      |                        |                        |product;                |product;                |product;                |                    |
|                                                                      |                        |                        |The                     |The                     |The                     |                    |
|                                                                      |                        |                        |above                   |above                   |above                   |                    |
|                                                                      |                        |                        |are in                  |are in                  |are in                  |                    |
|                                                                      |                        |                        |line                    |line                    |line                    |                    |
|                                                                      |                        |                        |with                    |with                    |with                    |                    |
|                                                                      |                        |                        |the                     |the                     |the                     |                    |
|                                                                      |                        |                        |verification            |verification            |verification            |                    |
|                                                                      |                        |                        |requirements.           |requirements.           |requirements.           |                    |
|----------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|--------------------|
|Ethylacetate                                                          |Limit of quantification |4.974                   |0.01                    |14.230                  |3.7080                  |11.2                |
|                                                                      |Solution 1              |                        |                        |                        |                        |                    |
|----------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|--------------------|
|Ethylacetate                                                          |Limited quantitative    |Limited quantitative    |Limited quantitative    |14.222                  |3.6889                  |14.2                |
|                                                                      |Solution 2              |Solution 2              |Solution 2              |                        |                        |                    |
|----------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|--------------------|
|Ethylacetate                                                          |Limited quantitative    |Limited quantitative    |Limited quantitative    |14.227                  |3.7113                  |13.4                |
|                                                                      |Solution 3              |Solution 3              |Solution 3              |                        |                        |                    |
|----------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|--------------------|
|Ethylacetate                                                          |Limited quantitative    |Limited quantitative    |Limited quantitative    |14.222                  |3.6914                  |12.4                |
|                                                                      |Solution 4              |Solution 4              |Solution 4              |                        |                        |                    |
|----------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|--------------------|
|Ethylacetate                                                          |Limited quantitative    |Limited quantitative    |Limited quantitative    |14.229                  |3.7151                  |13.8                |
|                                                                      |Solution 5              |Solution 5              |Solution 5              |                        |                        |                    |
|----------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|--------------------|
|Ethylacetate                                                          |Limited quantitative    |Limited quantitative    |Limited quantitative    |14.219                  |3.6656                  |12.9                |
|                                                                      |solution 6              |solution 6              |solution 6              |                        |                        |                    |
|----------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|--------------------|
|Ethylacetate                                                          |RSD (%)                 |RSD (%)                 |RSD (%)                 |0.04                    |0.6                     |/                   |
|----------------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|--------------------|
|Ethylacetate                                                          |Verdict:                |Verdict:                |Verdict:                |Verdict:                |Verdict:                |Verdict:            |
|                                                                      |TheS/Nofethylacetate in |TheS/Nofethylacetate in |TheS/Nofethylacetate in |TheS/Nofethylacetate in |TheS/Nofethylacetate in |TheS/Nofethylacetate|
|                                                                      |6 limited quantification|6 limited quantification|6 limited quantification|6 limited quantification|6 limited quantification|in 6                |
|                                                                      |solution chromatograms  |solution chromatograms  |solution chromatograms  |solution chromatograms  |solution chromatograms  |limited             |
|                                                                      |was between 11.2-14.2   |was between 11.2-14.2   |was between 11.2-14.2   |was between 11.2-14.2   |was between 11.2-14.2   |quantification      |
|                                                                      |(NLT 10 required), the  |(NLT 10 required), the  |(NLT 10 required), the  |(NLT 10 required), the  |(NLT 10 required), the  |solution            |
|                                                                      |RSD of                  |RSD of                  |RSD of                  |RSD of                  |RSD of                  |chromatograms       |
|                                                                      |                        |                        |                        |                        |                        |was                 |
|                                                                      |                        |                        |                        |                        |                        |between             |
|                                                                      |                        |                        |                        |                        |                        |11.2-14.2           |
|                                                                      |                        |                        |                        |                        |                        |(NLT 10             |
|                                                                      |                        |                        |                        |                        |                        |required),          |
|                                                                      |                        |                        |                        |                        |                        |the RSD             |
|                                                                      |                        |                        |                        |                        |                        |of                  |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 332 of 542 





Page 333
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



























------------------------------------------------------------------------------------------------------------------------------------------------------
|SEC-butanol      |Limited quantification solution 1                           |3.759        |0.008        |14.518       |4.1822       |10.6         |
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|SEC-butanol      |Limited quantitative Solution 2                             |Limited      |Limited      |14.519       |4.1487       |13.8         |
|                 |                                                            |quantitative |quantitative |             |             |             |
|                 |                                                            |Solution     |Solution     |             |             |             |
|                 |                                                            |2            |2            |             |             |             |
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|SEC-butanol      |Limited quantitative Solution 3                             |Limited      |Limited      |14.524       |4.1204       |12.8         |
|                 |                                                            |quantitative |quantitative |             |             |             |
|                 |                                                            |Solution 3   |Solution 3   |             |             |             |
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|SEC-butanol      |Limited quantitative Solution 4                             |Limited      |Limited      |14.517       |4.1730       |12.2         |
|                 |                                                            |quantitative |quantitative |             |             |             |
|                 |                                                            |Solution 4   |Solution 4   |             |             |             |
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|SEC-butanol      |Limited quantitative Solution 5                             |Limited      |Limited      |14.517       |4.0965       |13.1         |
|                 |                                                            |quantitative |quantitative |             |             |             |
|                 |                                                            |Solution 5   |Solution 5   |             |             |             |
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|SEC-butanol      |Limited quantitative solution 6                             |Limited      |Limited      |14.514       |4.0401       |12.3         |
|                 |                                                            |quantitative |quantitative |             |             |             |
|                 |                                                            |solution 6   |solution 6   |             |             |             |
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|SEC-butanol      |RSD (%)                                                     |RSD (%)      |RSD (%)      |0.023        |1.3          |/            |
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|SEC-butanol      |Verdict: TheS/Nof secondary butanol in 6 limited            |Verdict:     |Verdict:     |Verdict:     |Verdict:     |Verdict:     |
|                 |quantitation solution chromatograms ranged from 10.6 to 13.8|TheS/Nof     |TheS/Nof     |TheS/Nof     |TheS/Nof     |TheS/Nof     |
|                 |(NLT 10 required), the RSD of retention time was 0.023% (no |secondary    |secondary    |secondary    |secondary    |secondary    |
|                 |more than 2.0% required), the RSD of peakarea was 1.3% (no  |butanol in 6 |butanol in 6 |butanol      |butanol      |butanol      |
|                 |more than 10% required), and the limited quantitation       |limited      |limited      |in 6         |in 6         |in 6         |
|                 |concentration of secondary butanol was 3.759μg/ml.          |quantitation |quantitation |limited      |limited      |limited      |
|                 |Equivalent to the concentration of the test product 0.008%; |solution     |solution     |quantitation |quantitation |quantitation |
|                 |The above are in line with the verification requirements.   |chromatograms|chromatograms|solution     |solution     |solution     |
|                 |                                                            |ranged from  |ranged from  |chromatograms|chromatograms|chromatograms|
|                 |                                                            |10.6 to 13.8 |10.6 to 13.8 |ranged       |ranged       |ranged       |
|                 |                                                            |(NLT 10      |(NLT 10      |from         |from         |from         |
|                 |                                                            |required),   |required),   |10.6 to      |10.6 to      |10.6 to      |
|                 |                                                            |the RSD of   |the RSD of   |13.8         |13.8         |13.8         |
|                 |                                                            |retention    |retention    |(NLT 10      |(NLT 10      |(NLT 10      |
|                 |                                                            |time was     |time was     |required),   |required),   |required),   |
|                 |                                                            |0.023% (no   |0.023% (no   |the RSD      |the RSD      |the RSD      |
|                 |                                                            |more than    |more than    |of           |of           |of           |
|                 |                                                            |2.0%         |2.0%         |retention    |retention    |retention    |
|                 |                                                            |required),   |required),   |time         |time         |time         |
|                 |                                                            |the RSD of   |the RSD of   |was          |was          |was          |
|                 |                                                            |peakarea was |peakarea was |0.023%       |0.023%       |0.023%       |
|                 |                                                            |1.3% (no     |1.3% (no     |(no          |(no          |(no          |
|                 |                                                            |more than    |more than    |more         |more         |more         |
|                 |                                                            |10%          |10%          |than         |than         |than         |
|                 |                                                            |required),   |required),   |2.0%         |2.0%         |2.0%         |
|                 |                                                            |and the      |and the      |required),   |required),   |required),   |
|                 |                                                            |limited      |limited      |the RSD      |the RSD      |the RSD      |
|                 |                                                            |quantitation |quantitation |of           |of           |of           |
|                 |                                                            |concentration|concentration|peakarea     |peakarea     |peakarea     |
|                 |                                                            |of secondary |of secondary |was          |was          |was          |
|                 |                                                            |butanol was  |butanol was  |1.3%         |1.3%         |1.3%         |
|                 |                                                            |3.759μg/ml.  |3.759μg/ml.  |(no          |(no          |(no          |
|                 |                                                            |Equivalent   |Equivalent   |more         |more         |more         |
|                 |                                                            |to the       |to the       |than         |than         |than         |
|                 |                                                            |concentration|concentration|10%          |10%          |10%          |
|                 |                                                            |of the test  |of the test  |required),   |required),   |required),   |
|                 |                                                            |product      |product      |and the      |and the      |and the      |
|                 |                                                            |0.008%; The  |0.008%; The  |limited      |limited      |limited      |
|                 |                                                            |above are in |above are in |quantitation |quantitation |quantitation |
|                 |                                                            |line with    |line with    |concentration|concentration|concentration|
|                 |                                                            |the          |the          |of           |of           |of           |
|                 |                                                            |verification |verification |secondary    |secondary    |secondary    |
|                 |                                                            |requirements.|requirements.|butanol      |butanol      |butanol      |
|                 |                                                            |             |             |was          |was          |was          |
|                 |                                                            |             |             |3.759μg/ml.  |3.759μg/ml.  |3.759μg/ml.  |
|                 |                                                            |             |             |Equivalent   |Equivalent   |Equivalent   |
|                 |                                                            |             |             |to the       |to the       |to the       |
|                 |                                                            |             |             |concentration|concentration|concentration|
|                 |                                                            |             |             |of the       |of the       |of the       |
|                 |                                                            |             |             |test         |test         |test         |
|                 |                                                            |             |             |product      |product      |product      |
|                 |                                                            |             |             |0.008%;      |0.008%;      |0.008%;      |
|                 |                                                            |             |             |The          |The          |The          |
|                 |                                                            |             |             |above        |above        |above        |
|                 |                                                            |             |             |are in       |are in       |are in       |
|                 |                                                            |             |             |line         |line         |line         |
|                 |                                                            |             |             |with         |with         |with         |
|                 |                                                            |             |             |the          |the          |the          |
|                 |                                                            |             |             |verification |verification |verification |
|                 |                                                            |             |             |requirements.|requirements.|requirements.|
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|Tetrah ydrofu ran|Limited quantitative Solution 1                             |3.659        |0.007        |14.810       |4.2917       |13.4         |
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|Tetrah ydrofu ran|Limited quantitative Solution 2                             |Limited      |Limited      |14.813       |4.1655       |16.8         |
|                 |                                                            |quantitative |quantitative |             |             |             |
|                 |                                                            |Solution 2   |Solution 2   |             |             |             |
|-----------------|------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|
|Tetrah ydrofu ran|Limited quantitative                                        |Limited      |Limited      |14.814       |4.1972       |15.7         |
|                 |                                                            |quantitative |quantitative |             |             |             |
------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 333 of 542 





Page 334
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 

























-----------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Limited quantitative Solution 4                                       |Limited        |Limited        |14.813         |4.1060         |14.8           |              |
|                                                                      |quantitative   |quantitative   |               |               |               |              |
|                                                                      |Solution       |Solution       |               |               |               |              |
|                                                                      |4              |4              |               |               |               |              |
|----------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|--------------|
|Limited quantitative Solution 5                                       |Limited        |Limited        |14.810         |4.1467         |16.2           |              |
|                                                                      |quantitative   |quantitative   |               |               |               |              |
|                                                                      |Solution 5     |Solution 5     |               |               |               |              |
|----------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|--------------|
|Limited quantitative solution 6                                       |Limited        |Limited        |14.811         |4.2390         |15.4           |              |
|                                                                      |quantitative   |quantitative   |               |               |               |              |
|                                                                      |solution 6     |solution 6     |               |               |               |              |
|----------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|--------------|
|RSD (%)                                                               |RSD (%)        |RSD (%)        |0.012          |1.6            |/              |              |
|----------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|--------------|
|Conclusion: TheS/Nof tetrahydrofuran in 6 limited quantification      |Conclusion:    |Conclusion:    |Conclusion:    |Conclusion:    |Conclusion:    |              |
|solution chromatograms was between 13.4-16.8 (NLT 10), the RSD of     |TheS/Nof       |TheS/Nof       |TheS/Nof       |TheS/Nof       |TheS/Nof       |              |
|retention time was 0.012% (no more than 2.0%), the RSD of peakarea was|tetrahydrofuran|tetrahydrofuran|tetrahydrofuran|tetrahydrofuran|tetrahydrofuran|              |
|1.6% (no more than 10%), and the limiting concentration of            |in 6 limited   |in 6 limited   |in 6           |in 6           |in 6           |              |
|tetrahydrofuran was 3.659μg/ml. Equivalent to the concentration of the|quantification |quantification |limited        |limited        |limited        |              |
|test product 0.007%; The above are in line with the verification      |solution       |solution       |quantification |quantification |quantification |              |
|requirements.                                                         |chromatograms  |chromatograms  |solution       |solution       |solution       |              |
|                                                                      |was between    |was between    |chromatograms  |chromatograms  |chromatograms  |              |
|                                                                      |13.4-16.8      |13.4-16.8      |was            |was            |was            |              |
|                                                                      |(NLT 10),      |(NLT 10),      |between        |between        |between        |              |
|                                                                      |the RSD of     |the RSD of     |13.4-16.8      |13.4-16.8      |13.4-16.8      |              |
|                                                                      |retention      |retention      |(NLT           |(NLT           |(NLT           |              |
|                                                                      |time was       |time was       |10),           |10),           |10),           |              |
|                                                                      |0.012% (no     |0.012% (no     |the RSD        |the RSD        |the RSD        |              |
|                                                                      |more than      |more than      |of             |of             |of             |              |
|                                                                      |2.0%), the     |2.0%), the     |retention      |retention      |retention      |              |
|                                                                      |RSD of         |RSD of         |time           |time           |time           |              |
|                                                                      |peakarea was   |peakarea was   |was            |was            |was            |              |
|                                                                      |1.6% (no       |1.6% (no       |0.012%         |0.012%         |0.012%         |              |
|                                                                      |more than      |more than      |(no            |(no            |(no            |              |
|                                                                      |10%), and      |10%), and      |more           |more           |more           |              |
|                                                                      |the limiting   |the limiting   |than           |than           |than           |              |
|                                                                      |concentration  |concentration  |2.0%),         |2.0%),         |2.0%),         |              |
|                                                                      |of             |of             |the RSD        |the RSD        |the RSD        |              |
|                                                                      |tetrahydrofuran|tetrahydrofuran|of             |of             |of             |              |
|                                                                      |was            |was            |peakarea       |peakarea       |peakarea       |              |
|                                                                      |3.659μg/ml.    |3.659μg/ml.    |was            |was            |was            |              |
|                                                                      |Equivalent     |Equivalent     |1.6%           |1.6%           |1.6%           |              |
|                                                                      |to the         |to the         |(no            |(no            |(no            |              |
|                                                                      |concentration  |concentration  |more           |more           |more           |              |
|                                                                      |of the test    |of the test    |than           |than           |than           |              |
|                                                                      |product        |product        |10%),          |10%),          |10%),          |              |
|                                                                      |0.007%; The    |0.007%; The    |and the        |and the        |and the        |              |
|                                                                      |above are in   |above are in   |limiting       |limiting       |limiting       |              |
|                                                                      |line with      |line with      |concentration  |concentration  |concentration  |              |
|                                                                      |the            |the            |of             |of             |of             |              |
|                                                                      |verification   |verification   |tetrahydrofuran|tetrahydrofuran|tetrahydrofuran|              |
|                                                                      |requirements.  |requirements.  |was            |was            |was            |              |
|                                                                      |               |               |3.659μg/ml.    |3.659μg/ml.    |3.659μg/ml.    |              |
|                                                                      |               |               |Equivalent     |Equivalent     |Equivalent     |              |
|                                                                      |               |               |to the         |to the         |to the         |              |
|                                                                      |               |               |concentration  |concentration  |concentration  |              |
|                                                                      |               |               |of the         |of the         |of the         |              |
|                                                                      |               |               |test           |test           |test           |              |
|                                                                      |               |               |product        |product        |product        |              |
|                                                                      |               |               |0.007%;        |0.007%;        |0.007%;        |              |
|                                                                      |               |               |The            |The            |The            |              |
|                                                                      |               |               |above          |above          |above          |              |
|                                                                      |               |               |are in         |are in         |are in         |              |
|                                                                      |               |               |line           |line           |line           |              |
|                                                                      |               |               |with           |with           |with           |              |
|                                                                      |               |               |the            |the            |the            |              |
|                                                                      |               |               |verification   |verification   |verification   |              |
|                                                                      |               |               |requirements.  |requirements.  |requirements.  |              |
|----------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|--------------|
|Tolue ne                                                              |Limited        |2.001          |0.004          |20.134         |4.0267         |13.7          |
|                                                                      |quantitative   |               |               |               |               |              |
|                                                                      |Solution 1     |               |               |               |               |              |
|----------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|--------------|
|Tolue ne                                                              |Limited        |Limited        |Limited        |20.134         |4.0244         |17.5          |
|                                                                      |quantitative   |quantitative   |quantitative   |               |               |              |
|                                                                      |Solution 2     |Solution 2     |Solution 2     |               |               |              |
|----------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|--------------|
|Tolue ne                                                              |Limited        |Limited        |Limited        |20.135         |4.0668         |16.5          |
|                                                                      |quantitative   |quantitative   |quantitative   |               |               |              |
|                                                                      |Solution 3     |Solution 3     |Solution 3     |               |               |              |
|----------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|--------------|
|Tolue ne                                                              |Limited        |Limited        |Limited        |20.134         |3.9945         |15.5          |
|                                                                      |quantitative   |quantitative   |quantitative   |               |               |              |
|                                                                      |Solution 4     |Solution 4     |Solution 4     |               |               |              |
|----------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|--------------|
|Tolue ne                                                              |Limited        |Limited        |Limited        |20.134         |4.0965         |17.1          |
|                                                                      |quantitative   |quantitative   |quantitative   |               |               |              |
|                                                                      |Solution 5     |Solution 5     |Solution 5     |               |               |              |
|----------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|--------------|
|Tolue ne                                                              |Limited        |Limited        |Limited        |20.133         |4.1527         |16.2          |
|                                                                      |quantitative   |quantitative   |quantitative   |               |               |              |
|                                                                      |solution 6     |solution 6     |solution 6     |               |               |              |
|----------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|--------------|
|Tolue ne                                                              |RSD (%)        |RSD (%)        |RSD (%)        |0.004          |1.5            |/             |
|----------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|--------------|
|Tolue ne                                                              |Verdict:       |Verdict:       |Verdict:       |Verdict:       |Verdict:       |Verdict:      |
|                                                                      |TheS/Nof       |TheS/Nof       |TheS/Nof       |TheS/Nof       |TheS/Nof       |TheS/Nof      |
|                                                                      |toluene in 6   |toluene in 6   |toluene in 6   |toluene in 6   |toluene in 6   |toluene       |
|                                                                      |limited        |limited        |limited        |limited        |limited        |in 6          |
|                                                                      |quantification |quantification |quantification |quantification |quantification |limited       |
|                                                                      |solution       |solution       |solution       |solution       |solution       |quantification|
|                                                                      |chromatograms  |chromatograms  |chromatograms  |chromatograms  |chromatograms  |solution      |
|                                                                      |was between    |was between    |was between    |was between    |was between    |chromatograms |
|                                                                      |13.7-17.5 (NLT |13.7-17.5 (NLT |13.7-17.5 (NLT |13.7-17.5 (NLT |13.7-17.5 (NLT |was           |
|                                                                      |10), the RSD of|10), the RSD of|10), the RSD of|10), the RSD of|10), the RSD of|between       |
|                                                                      |retention time |retention time |retention time |retention time |retention time |13.7-17.5     |
|                                                                      |was 0.004% (no |was 0.004% (no |was 0.004% (no |was 0.004% (no |was 0.004% (no |(NLT          |
|                                                                      |more than      |more than      |more than      |more than      |more than      |10),          |
|                                                                      |2.0%), the RSD |2.0%), the RSD |2.0%), the RSD |2.0%), the RSD |2.0%), the RSD |the RSD       |
|                                                                      |of peakarea was|of peakarea was|of peakarea was|of peakarea was|of peakarea was|of            |
|                                                                      |1.5% (no more  |1.5% (no more  |1.5% (no more  |1.5% (no more  |1.5% (no more  |retention     |
|                                                                      |               |               |               |               |               |time          |
|                                                                      |               |               |               |               |               |was           |
|                                                                      |               |               |               |               |               |0.004%        |
|                                                                      |               |               |               |               |               |(no           |
|                                                                      |               |               |               |               |               |more          |
|                                                                      |               |               |               |               |               |than          |
|                                                                      |               |               |               |               |               |2.0%),        |
|                                                                      |               |               |               |               |               |the RSD       |
|                                                                      |               |               |               |               |               |of            |
|                                                                      |               |               |               |               |               |peakarea      |
|                                                                      |               |               |               |               |               |was           |
|                                                                      |               |               |               |               |               |1.5%          |
|                                                                      |               |               |               |               |               |(no           |
|                                                                      |               |               |               |               |               |more          |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 334 of 542 





Page 335
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 
















---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|N-met hylpyr rolido ne|Limited quantitative Solution 1                        |2.769                             |0.006                             |31.457                            |3.2895                            |10.3                              |
|----------------------|-------------------------------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|
|N-met hylpyr rolido ne|Limited quantitative Solution 2                        |Limited                           |Limited                           |31.460                            |3.4857                            |14.6                              |
|                      |                                                       |quantitative                      |quantitative                      |                                  |                                  |                                  |
|                      |                                                       |Solution                          |Solution                          |                                  |                                  |                                  |
|                      |                                                       |2                                 |2                                 |                                  |                                  |                                  |
|----------------------|-------------------------------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|
|N-met hylpyr rolido ne|Limited quantitative Solution 3                        |Limited                           |Limited                           |31.463                            |3.5691                            |13.9                              |
|                      |                                                       |quantitative                      |quantitative                      |                                  |                                  |                                  |
|                      |                                                       |Solution 3                        |Solution 3                        |                                  |                                  |                                  |
|----------------------|-------------------------------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|
|N-met hylpyr rolido ne|Limited quantitative Solution 4                        |Limited                           |Limited                           |31.463                            |3.3893                            |12.8                              |
|                      |                                                       |quantitative                      |quantitative                      |                                  |                                  |                                  |
|                      |                                                       |Solution 4                        |Solution 4                        |                                  |                                  |                                  |
|----------------------|-------------------------------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|
|N-met hylpyr rolido ne|Limited quantitative Solution 5                        |Limited                           |Limited                           |31.459                            |3.5359                            |14.3                              |
|                      |                                                       |quantitative                      |quantitative                      |                                  |                                  |                                  |
|                      |                                                       |Solution 5                        |Solution 5                        |                                  |                                  |                                  |
|----------------------|-------------------------------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|
|N-met hylpyr rolido ne|Limited quantification solution 6                      |Limited                           |Limited                           |31.459                            |3.3758                            |13.2                              |
|                      |                                                       |quantification                    |quantification                    |                                  |                                  |                                  |
|                      |                                                       |solution 6                        |solution 6                        |                                  |                                  |                                  |
|----------------------|-------------------------------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|
|N-met hylpyr rolido ne|RSD (%)                                                |RSD (%)                           |RSD (%)                           |0.008                             |4                                 |/                                 |
|----------------------|-------------------------------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|
|N-met hylpyr rolido ne|Verdict: TheS/NofN-methylpyrrolidone in 6 limited      |Verdict:                          |Verdict:                          |Verdict:                          |Verdict:                          |Verdict:                          |
|                      |quantification solution chromatograms ranged from      |TheS/NofN-methylpyrrolidone       |TheS/NofN-methylpyrrolidone       |TheS/NofN-methylpyrrolidone       |TheS/NofN-methylpyrrolidone       |TheS/NofN-methylpyrrolidone       |
|                      |10.3-14.6 (NLT 10 required), the RSD of retention time |in 6 limited                      |in 6 limited                      |in 6                              |in 6                              |in 6                              |
|                      |was 0.008% (no more than 2.0% required), the RSD of    |quantification                    |quantification                    |limited                           |limited                           |limited                           |
|                      |peakarea was 4% (no more than 10% required), and the   |solution                          |solution                          |quantification                    |quantification                    |quantification                    |
|                      |limited quantification                                 |chromatograms                     |chromatograms                     |solution                          |solution                          |solution                          |
|                      |concentrationofN-methylpyrrolidone was 2.769μg/ml.     |ranged from                       |ranged from                       |chromatograms                     |chromatograms                     |chromatograms                     |
|                      |Equivalent to the concentration of the test product    |10.3-14.6 (NLT                    |10.3-14.6 (NLT                    |ranged                            |ranged                            |ranged                            |
|                      |0.006%; The above are in line with the verification    |10 required),                     |10 required),                     |from                              |from                              |from                              |
|                      |requirements.                                          |the RSD of                        |the RSD of                        |10.3-14.6                         |10.3-14.6                         |10.3-14.6                         |
|                      |                                                       |retention time                    |retention time                    |(NLT 10                           |(NLT 10                           |(NLT 10                           |
|                      |                                                       |was 0.008% (no                    |was 0.008% (no                    |required),                        |required),                        |required),                        |
|                      |                                                       |more than 2.0%                    |more than 2.0%                    |the RSD                           |the RSD                           |the RSD                           |
|                      |                                                       |required), the                    |required), the                    |of                                |of                                |of                                |
|                      |                                                       |RSD of                            |RSD of                            |retention                         |retention                         |retention                         |
|                      |                                                       |peakarea was                      |peakarea was                      |time                              |time                              |time                              |
|                      |                                                       |4% (no more                       |4% (no more                       |was                               |was                               |was                               |
|                      |                                                       |than 10%                          |than 10%                          |0.008%                            |0.008%                            |0.008%                            |
|                      |                                                       |required), and                    |required), and                    |(no                               |(no                               |(no                               |
|                      |                                                       |the limited                       |the limited                       |more                              |more                              |more                              |
|                      |                                                       |quantification                    |quantification                    |than                              |than                              |than                              |
|                      |                                                       |concentrationofN-methylpyrrolidone|concentrationofN-methylpyrrolidone|2.0%                              |2.0%                              |2.0%                              |
|                      |                                                       |was                               |was                               |required),                        |required),                        |required),                        |
|                      |                                                       |2.769μg/ml.                       |2.769μg/ml.                       |the RSD                           |the RSD                           |the RSD                           |
|                      |                                                       |Equivalent to                     |Equivalent to                     |of                                |of                                |of                                |
|                      |                                                       |the                               |the                               |peakarea                          |peakarea                          |peakarea                          |
|                      |                                                       |concentration                     |concentration                     |was 4%                            |was 4%                            |was 4%                            |
|                      |                                                       |of the test                       |of the test                       |(no                               |(no                               |(no                               |
|                      |                                                       |product                           |product                           |more                              |more                              |more                              |
|                      |                                                       |0.006%; The                       |0.006%; The                       |than                              |than                              |than                              |
|                      |                                                       |above are in                      |above are in                      |10%                               |10%                               |10%                               |
|                      |                                                       |line with the                     |line with the                     |required),                        |required),                        |required),                        |
|                      |                                                       |verification                      |verification                      |and the                           |and the                           |and the                           |
|                      |                                                       |requirements.                     |requirements.                     |limited                           |limited                           |limited                           |
|                      |                                                       |                                  |                                  |quantification                    |quantification                    |quantification                    |
|                      |                                                       |                                  |                                  |concentrationofN-methylpyrrolidone|concentrationofN-methylpyrrolidone|concentrationofN-methylpyrrolidone|
|                      |                                                       |                                  |                                  |was                               |was                               |was                               |
|                      |                                                       |                                  |                                  |2.769μg/ml.                       |2.769μg/ml.                       |2.769μg/ml.                       |
|                      |                                                       |                                  |                                  |Equivalent                        |Equivalent                        |Equivalent                        |
|                      |                                                       |                                  |                                  |to the                            |to the                            |to the                            |
|                      |                                                       |                                  |                                  |concentration                     |concentration                     |concentration                     |
|                      |                                                       |                                  |                                  |of the                            |of the                            |of the                            |
|                      |                                                       |                                  |                                  |test                              |test                              |test                              |
|                      |                                                       |                                  |                                  |product                           |product                           |product                           |
|                      |                                                       |                                  |                                  |0.006%;                           |0.006%;                           |0.006%;                           |
|                      |                                                       |                                  |                                  |The                               |The                               |The                               |
|                      |                                                       |                                  |                                  |above                             |above                             |above                             |
|                      |                                                       |                                  |                                  |are in                            |are in                            |are in                            |
|                      |                                                       |                                  |                                  |line                              |line                              |line                              |
|                      |                                                       |                                  |                                  |with                              |with                              |with                              |
|                      |                                                       |                                  |                                  |the                               |the                               |the                               |
|                      |                                                       |                                  |                                  |verification                      |verification                      |verification                      |
|                      |                                                       |                                  |                                  |requirements.                     |requirements.                     |requirements.                     |
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Test results of detection limits 
























----------------------------------------------------------------------------------
|Ethanol|Detection limit solution|1      |1.502  |0.003  |8.290  |1.966 4|3.7    |
|-------|------------------------|-------|-------|-------|-------|-------|-------|
|Ethanol|Detection limit solution|2      |2      |2      |8.277  |1.953  |3.5    |
----------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 335 of 542 





Page 336
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 





















































































































-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|3                                                             |3                       |3                       |8.263                   |1.932 4                 |3.2                     |                        |                        |
|--------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|Conclusion: TheS/Nofethanol in the 3-needle detection limit   |Conclusion:             |Conclusion:             |Conclusion:             |Conclusion:             |Conclusion:             |Conclusion:             |                        |
|solution chromatogram was between 3.2-3.7 (the requirement was|TheS/Nofethanol         |TheS/Nofethanol         |TheS/Nofethanol         |TheS/Nofethanol         |TheS/Nofethanol         |TheS/Nofethanol         |                        |
|NLT 3), and the detection limit concentration ofethanol was   |in the                  |in the                  |in the                  |in the                  |in the                  |in the                  |                        |
|1.502μg/ml, which wasequivalent to the concentration of test  |3-needle                |3-needle                |3-needle                |3-needle                |3-needle                |3-needle                |                        |
|product 0.003%. All the above are in line with the            |detection               |detection               |detection               |detection               |detection               |detection               |                        |
|verification requirements.                                    |limit                   |limit                   |limit                   |limit                   |limit                   |limit                   |                        |
|                                                              |solution                |solution                |solution                |solution                |solution                |solution                |                        |
|                                                              |chromatogram            |chromatogram            |chromatogram            |chromatogram            |chromatogram            |chromatogram            |                        |
|                                                              |was                     |was                     |was                     |was                     |was                     |was                     |                        |
|                                                              |between                 |between                 |between                 |between                 |between                 |between                 |                        |
|                                                              |3.2-3.7                 |3.2-3.7                 |3.2-3.7                 |3.2-3.7                 |3.2-3.7                 |3.2-3.7                 |                        |
|                                                              |(the                    |(the                    |(the                    |(the                    |(the                    |(the                    |                        |
|                                                              |requirement             |requirement             |requirement             |requirement             |requirement             |requirement             |                        |
|                                                              |was NLT                 |was NLT                 |was NLT                 |was NLT                 |was NLT                 |was NLT                 |                        |
|                                                              |3), and                 |3), and                 |3), and                 |3), and                 |3), and                 |3), and                 |                        |
|                                                              |the                     |the                     |the                     |the                     |the                     |the                     |                        |
|                                                              |detection               |detection               |detection               |detection               |detection               |detection               |                        |
|                                                              |limit                   |limit                   |limit                   |limit                   |limit                   |limit                   |                        |
|                                                              |concentration           |concentration           |concentration           |concentration           |concentration           |concentration           |                        |
|                                                              |ofethanol               |ofethanol               |ofethanol               |ofethanol               |ofethanol               |ofethanol               |                        |
|                                                              |was                     |was                     |was                     |was                     |was                     |was                     |                        |
|                                                              |1.502μg/ml,             |1.502μg/ml,             |1.502μg/ml,             |1.502μg/ml,             |1.502μg/ml,             |1.502μg/ml,             |                        |
|                                                              |which                   |which                   |which                   |which                   |which                   |which                   |                        |
|                                                              |wasequivalent           |wasequivalent           |wasequivalent           |wasequivalent           |wasequivalent           |wasequivalent           |                        |
|                                                              |to the                  |to the                  |to the                  |to the                  |to the                  |to the                  |                        |
|                                                              |concentration           |concentration           |concentration           |concentration           |concentration           |concentration           |                        |
|                                                              |of test                 |of test                 |of test                 |of test                 |of test                 |of test                 |                        |
|                                                              |product                 |product                 |product                 |product                 |product                 |product                 |                        |
|                                                              |0.003%.                 |0.003%.                 |0.003%.                 |0.003%.                 |0.003%.                 |0.003%.                 |                        |
|                                                              |All the                 |All the                 |All the                 |All the                 |All the                 |All the                 |                        |
|                                                              |above                   |above                   |above                   |above                   |above                   |above                   |                        |
|                                                              |are in                  |are in                  |are in                  |are in                  |are in                  |are in                  |                        |
|                                                              |line                    |line                    |line                    |line                    |line                    |line                    |                        |
|                                                              |with                    |with                    |with                    |with                    |with                    |with                    |                        |
|                                                              |the                     |the                     |the                     |the                     |the                     |the                     |                        |
|                                                              |verification            |verification            |verification            |verification            |verification            |verification            |                        |
|                                                              |requirements.           |requirements.           |requirements.           |requirements.           |requirements.           |requirements.           |                        |
|--------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|Isopropylalcohol                                              |Detection limit         |1                       |1.502                   |0.003                   |9.655                   |2.680 9                 |4.7                     |
|                                                              |solution                |                        |                        |                        |                        |                        |                        |
|--------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|Isopropylalcohol                                              |Detection limit         |2                       |2                       |2                       |9.633                   |2.605 1                 |4.0                     |
|                                                              |solution                |                        |                        |                        |                        |                        |                        |
|--------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|Isopropylalcohol                                              |Detection limit         |3                       |3                       |3                       |9.614                   |2.612 5                 |4.0                     |
|                                                              |solution                |                        |                        |                        |                        |                        |                        |
|--------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|Isopropylalcohol                                              |Conclusion:             |Conclusion:             |Conclusion:             |Conclusion:             |Conclusion:             |Conclusion:             |Conclusion:             |
|                                                              |TheS/Nofisopropylalcohol|TheS/Nofisopropylalcohol|TheS/Nofisopropylalcohol|TheS/Nofisopropylalcohol|TheS/Nofisopropylalcohol|TheS/Nofisopropylalcohol|TheS/Nofisopropylalcohol|
|                                                              |in the 3-needle         |in the 3-needle         |in the 3-needle         |in the 3-needle         |in the 3-needle         |in the 3-needle         |in the                  |
|                                                              |detection limit         |detection limit         |detection limit         |detection limit         |detection limit         |detection limit         |3-needle                |
|                                                              |solution                |solution                |solution                |solution                |solution                |solution                |detection               |
|                                                              |chromatogram            |chromatogram            |chromatogram            |chromatogram            |chromatogram            |chromatogram            |limit                   |
|                                                              |was between             |was between             |was between             |was between             |was between             |was between             |solution                |
|                                                              |4.0-4.7 (the            |4.0-4.7 (the            |4.0-4.7 (the            |4.0-4.7 (the            |4.0-4.7 (the            |4.0-4.7 (the            |chromatogram            |
|                                                              |requirement was         |requirement was         |requirement was         |requirement was         |requirement was         |requirement was         |was                     |
|                                                              |NLT 3), and the         |NLT 3), and the         |NLT 3), and the         |NLT 3), and the         |NLT 3), and the         |NLT 3), and the         |between                 |
|                                                              |detection limit         |detection limit         |detection limit         |detection limit         |detection limit         |detection limit         |4.0-4.7                 |
|                                                              |concentration           |concentration           |concentration           |concentration           |concentration           |concentration           |(the                    |
|                                                              |ofisopropylalcohol      |ofisopropylalcohol      |ofisopropylalcohol      |ofisopropylalcohol      |ofisopropylalcohol      |ofisopropylalcohol      |requirement             |
|                                                              |was 1.502μg/ml,         |was 1.502μg/ml,         |was 1.502μg/ml,         |was 1.502μg/ml,         |was 1.502μg/ml,         |was 1.502μg/ml,         |was NLT                 |
|                                                              |which                   |which                   |which                   |which                   |which                   |which                   |3), and                 |
|                                                              |wasequivalent           |wasequivalent           |wasequivalent           |wasequivalent           |wasequivalent           |wasequivalent           |the                     |
|                                                              |to the                  |to the                  |to the                  |to the                  |to the                  |to the                  |detection               |
|                                                              |concentration           |concentration           |concentration           |concentration           |concentration           |concentration           |limit                   |
|                                                              |of test product         |of test product         |of test product         |of test product         |of test product         |of test product         |concentration           |
|                                                              |0.003%. All the         |0.003%. All the         |0.003%. All the         |0.003%. All the         |0.003%. All the         |0.003%. All the         |ofisopropylalcohol      |
|                                                              |above were in           |above were in           |above were in           |above were in           |above were in           |above were in           |was                     |
|                                                              |line with the           |line with the           |line with the           |line with the           |line with the           |line with the           |1.502μg/ml,             |
|                                                              |verification            |verification            |verification            |verification            |verification            |verification            |which                   |
|                                                              |requirements.           |requirements.           |requirements.           |requirements.           |requirements.           |requirements.           |wasequivalent           |
|                                                              |                        |                        |                        |                        |                        |                        |to the                  |
|                                                              |                        |                        |                        |                        |                        |                        |concentration           |
|                                                              |                        |                        |                        |                        |                        |                        |of test                 |
|                                                              |                        |                        |                        |                        |                        |                        |product                 |
|                                                              |                        |                        |                        |                        |                        |                        |0.003%.                 |
|                                                              |                        |                        |                        |                        |                        |                        |All the                 |
|                                                              |                        |                        |                        |                        |                        |                        |above                   |
|                                                              |                        |                        |                        |                        |                        |                        |were in                 |
|                                                              |                        |                        |                        |                        |                        |                        |line                    |
|                                                              |                        |                        |                        |                        |                        |                        |with                    |
|                                                              |                        |                        |                        |                        |                        |                        |the                     |
|                                                              |                        |                        |                        |                        |                        |                        |verification            |
|                                                              |                        |                        |                        |                        |                        |                        |requirements.           |
|--------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|Ethylacetate                                                  |Detection limit solution|1                       |1.492                   |0.003                   |14.26 3                 |2.238 2                 |4.7                     |
|--------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|Ethylacetate                                                  |Detection limit solution|2                       |2                       |2                       |14.24 3                 |2.208 0                 |3.9                     |
|--------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|Ethylacetate                                                  |Detection limit solution|3                       |3                       |3                       |14.23 4                 |2.056 4                 |3.8                     |
|--------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|Ethylacetate                                                  |Conclusion:             |Conclusion:             |Conclusion:             |Conclusion:             |Conclusion:             |Conclusion:             |Conclusion:             |
|                                                              |TheS/Nofethylacetate in |TheS/Nofethylacetate in |TheS/Nofethylacetate in |TheS/Nofethylacetate in |TheS/Nofethylacetate in |TheS/Nofethylacetate in |TheS/Nofethylacetate in |
|                                                              |the 3-needle detection  |the 3-needle detection  |the 3-needle detection  |the 3-needle detection  |the 3-needle detection  |the 3-needle detection  |the 3-needle detection  |
|                                                              |limit solution          |limit solution          |limit solution          |limit solution          |limit solution          |limit solution          |limit solution          |
|                                                              |chromatogram was between|chromatogram was between|chromatogram was between|chromatogram was between|chromatogram was between|chromatogram was between|chromatogram was between|
|                                                              |3.8-4.7 (required to be |3.8-4.7 (required to be |3.8-4.7 (required to be |3.8-4.7 (required to be |3.8-4.7 (required to be |3.8-4.7 (required to be |3.8-4.7 (required to be |
|                                                              |NLT 3), and the         |NLT 3), and the         |NLT 3), and the         |NLT 3), and the         |NLT 3), and the         |NLT 3), and the         |NLT 3), and the         |
|                                                              |detection limit         |detection limit         |detection limit         |detection limit         |detection limit         |detection limit         |detection limit         |
|                                                              |concentration           |concentration           |concentration           |concentration           |concentration           |concentration           |concentration           |
|                                                              |ofethylacetate was      |ofethylacetate was      |ofethylacetate was      |ofethylacetate was      |ofethylacetate was      |ofethylacetate was      |ofethylacetate was      |
|                                                              |1.492μg/ml, which       |1.492μg/ml, which       |1.492μg/ml, which       |1.492μg/ml, which       |1.492μg/ml, which       |1.492μg/ml, which       |1.492μg/ml, which       |
|                                                              |wasequivalent to the    |wasequivalent to the    |wasequivalent to the    |wasequivalent to the    |wasequivalent to the    |wasequivalent to the    |wasequivalent to the    |
|                                                              |concentration of test   |concentration of test   |concentration of test   |concentration of test   |concentration of test   |concentration of test   |concentration of test   |
|                                                              |product 0.003%. All the |product 0.003%. All the |product 0.003%. All the |product 0.003%. All the |product 0.003%. All the |product 0.003%. All the |product 0.003%. All the |
|                                                              |above were in line with |above were in line with |above were in line with |above were in line with |above were in line with |above were in line with |above were in line with |
|                                                              |the verification        |the verification        |the verification        |the verification        |the verification        |the verification        |the verification        |
|                                                              |requirements.           |requirements.           |requirements.           |requirements.           |requirements.           |requirements.           |requirements.           |
|--------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|SEC-butanol                                                   |Detection limit solution|1                       |1.128                   |0.002                   |14.55 3                 |2.370 6                 |4.2                     |
|--------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|SEC-butanol                                                   |Detection limit solution|2                       |2                       |2                       |14.53 0                 |2.270 6                 |3.7                     |
|--------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|SEC-butanol                                                   |Detection limit solution|3                       |3                       |3                       |14.51 4                 |2.285 8                 |3.6                     |
|--------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|SEC-butanol                                                   |Conclusion: TheS/Nof    |Conclusion: TheS/Nof    |Conclusion: TheS/Nof    |Conclusion: TheS/Nof    |Conclusion: TheS/Nof    |Conclusion: TheS/Nof    |Conclusion: TheS/Nof    |
|                                                              |secondary butanol in the|secondary butanol in the|secondary butanol in the|secondary butanol in the|secondary butanol in the|secondary butanol in the|secondary butanol in the|
|                                                              |3-needle detection      |3-needle detection      |3-needle detection      |3-needle detection      |3-needle detection      |3-needle detection      |3-needle detection      |
|                                                              |limited solution        |limited solution        |limited solution        |limited solution        |limited solution        |limited solution        |limited solution        |
|                                                              |chromatogram was between|chromatogram was between|chromatogram was between|chromatogram was between|chromatogram was between|chromatogram was between|chromatogram was between|
|                                                              |3.6-4.2 (the requirement|3.6-4.2 (the requirement|3.6-4.2 (the requirement|3.6-4.2 (the requirement|3.6-4.2 (the requirement|3.6-4.2 (the requirement|3.6-4.2 (the requirement|
|                                                              |was NLT 3), and the     |was NLT 3), and the     |was NLT 3), and the     |was NLT 3), and the     |was NLT 3), and the     |was NLT 3), and the     |was NLT 3), and the     |
|                                                              |detection limited       |detection limited       |detection limited       |detection limited       |detection limited       |detection limited       |detection limited       |
|                                                              |concentration of        |concentration of        |concentration of        |concentration of        |concentration of        |concentration of        |concentration of        |
|                                                              |secondary butanol was   |secondary butanol was   |secondary butanol was   |secondary butanol was   |secondary butanol was   |secondary butanol was   |secondary butanol was   |
|                                                              |1.128μg/ml, which       |1.128μg/ml, which       |1.128μg/ml, which       |1.128μg/ml, which       |1.128μg/ml, which       |1.128μg/ml, which       |1.128μg/ml, which       |
|                                                              |wasequivalent to the    |wasequivalent to the    |wasequivalent to the    |wasequivalent to the    |wasequivalent to the    |wasequivalent to the    |wasequivalent to the    |
|                                                              |concentration of test   |concentration of test   |concentration of test   |concentration of test   |concentration of test   |concentration of test   |concentration of test   |
|                                                              |product 0.002%. All of  |product 0.002%. All of  |product 0.002%. All of  |product 0.002%. All of  |product 0.002%. All of  |product 0.002%. All of  |product 0.002%. All of  |
|                                                              |the above are in line   |the above are in line   |the above are in line   |the above are in line   |the above are in line   |the above are in line   |the above are in line   |
|                                                              |with the verification   |with the verification   |with the verification   |with the verification   |with the verification   |with the verification   |with the verification   |
|                                                              |requirements.           |requirements.           |requirements.           |requirements.           |requirements.           |requirements.           |requirements.           |
|--------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|Tetrahydrofu ran                                              |Detection limit solution|1                       |1.098                   |0.002                   |14.84 1                 |2.205 5                 |5.0                     |
|--------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|Tetrahydrofu ran                                              |Detection limit solution|2                       |2                       |2                       |14.83 7                 |1.921 5                 |4.2                     |
|--------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|Tetrahydrofu ran                                              |Detection limit solution|3                       |3                       |3                       |14.81 2                 |2.128 6                 |4.3                     |
|--------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|Tetrahydrofu ran                                              |Conclusion: TheS/Nof    |Conclusion: TheS/Nof    |Conclusion: TheS/Nof    |Conclusion: TheS/Nof    |Conclusion: TheS/Nof    |Conclusion: TheS/Nof    |Conclusion: TheS/Nof    |
|                                                              |tetrahydrofuran in the  |tetrahydrofuran in the  |tetrahydrofuran in the  |tetrahydrofuran in the  |tetrahydrofuran in the  |tetrahydrofuran in the  |tetrahydrofuran in the  |
|                                                              |3-needle detection limit|3-needle detection limit|3-needle detection limit|3-needle detection limit|3-needle detection limit|3-needle detection limit|3-needle detection limit|
|                                                              |solution chromatogram   |solution chromatogram   |solution chromatogram   |solution chromatogram   |solution chromatogram   |solution chromatogram   |solution chromatogram   |
|                                                              |was between 4.2-5.0 (the|was between 4.2-5.0 (the|was between 4.2-5.0 (the|was between 4.2-5.0 (the|was between 4.2-5.0 (the|was between 4.2-5.0 (the|was between 4.2-5.0 (the|
|                                                              |requirement was NLT 3), |requirement was NLT 3), |requirement was NLT 3), |requirement was NLT 3), |requirement was NLT 3), |requirement was NLT 3), |requirement was NLT 3), |
|                                                              |and the detection limit |and the detection limit |and the detection limit |and the detection limit |and the detection limit |and the detection limit |and the detection limit |
|                                                              |concentration of        |concentration of        |concentration of        |concentration of        |concentration of        |concentration of        |concentration of        |
|                                                              |tetrahydrofuran was     |tetrahydrofuran was     |tetrahydrofuran was     |tetrahydrofuran was     |tetrahydrofuran was     |tetrahydrofuran was     |tetrahydrofuran was     |
|                                                              |1.098μg/ml, which       |1.098μg/ml, which       |1.098μg/ml, which       |1.098μg/ml, which       |1.098μg/ml, which       |1.098μg/ml, which       |1.098μg/ml, which       |
|                                                              |wasequivalent to the    |wasequivalent to the    |wasequivalent to the    |wasequivalent to the    |wasequivalent to the    |wasequivalent to the    |wasequivalent to the    |
|                                                              |concentration of test   |concentration of test   |concentration of test   |concentration of test   |concentration of test   |concentration of test   |concentration of test   |
|                                                              |product 0.002%. All the |product 0.002%. All the |product 0.002%. All the |product 0.002%. All the |product 0.002%. All the |product 0.002%. All the |product 0.002%. All the |
|                                                              |above are in line with  |above are in line with  |above are in line with  |above are in line with  |above are in line with  |above are in line with  |above are in line with  |
|                                                              |the verification        |the verification        |the verification        |the verification        |the verification        |the verification        |the verification        |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 336 of 542 





Page 337
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 








































































------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Toluene             |Detection limit solution                         |1                                 |0.600                             |0.001                             |20.15 7                           |2.264 3                           |5.3                               |
|--------------------|-------------------------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|
|Toluene             |Detection limit solution                         |2                                 |2                                 |2                                 |20.14 6                           |2.171 2                           |4.7                               |
|--------------------|-------------------------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|
|Toluene             |Detection limit solution                         |3                                 |3                                 |3                                 |20.13 5                           |2.140 3                           |4.4                               |
|--------------------|-------------------------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|
|Toluene             |Conclusion: TheS/Nof toluene in the 3-needle     |Conclusion:                       |Conclusion:                       |Conclusion:                       |Conclusion:                       |Conclusion:                       |Conclusion:                       |
|                    |detection limit solution chromatogram was between|TheS/Nof                          |TheS/Nof                          |TheS/Nof                          |TheS/Nof                          |TheS/Nof                          |TheS/Nof                          |
|                    |4.4-5.3 (NLT 3), and the detection limit         |toluene                           |toluene                           |toluene                           |toluene                           |toluene                           |toluene                           |
|                    |concentration of toluene was 0.600μg/ml, which   |in the                            |in the                            |in the                            |in the                            |in the                            |in the                            |
|                    |wasequivalent to the concentration of test       |3-needle                          |3-needle                          |3-needle                          |3-needle                          |3-needle                          |3-needle                          |
|                    |product 0.001%. All the above are in line with   |detection                         |detection                         |detection                         |detection                         |detection                         |detection                         |
|                    |the verification requirements.                   |limit                             |limit                             |limit                             |limit                             |limit                             |limit                             |
|                    |                                                 |solution                          |solution                          |solution                          |solution                          |solution                          |solution                          |
|                    |                                                 |chromatogram                      |chromatogram                      |chromatogram                      |chromatogram                      |chromatogram                      |chromatogram                      |
|                    |                                                 |was                               |was                               |was                               |was                               |was                               |was                               |
|                    |                                                 |between                           |between                           |between                           |between                           |between                           |between                           |
|                    |                                                 |4.4-5.3                           |4.4-5.3                           |4.4-5.3                           |4.4-5.3                           |4.4-5.3                           |4.4-5.3                           |
|                    |                                                 |(NLT                              |(NLT                              |(NLT                              |(NLT                              |(NLT                              |(NLT                              |
|                    |                                                 |3), and                           |3), and                           |3), and                           |3), and                           |3), and                           |3), and                           |
|                    |                                                 |the                               |the                               |the                               |the                               |the                               |the                               |
|                    |                                                 |detection                         |detection                         |detection                         |detection                         |detection                         |detection                         |
|                    |                                                 |limit                             |limit                             |limit                             |limit                             |limit                             |limit                             |
|                    |                                                 |concentration                     |concentration                     |concentration                     |concentration                     |concentration                     |concentration                     |
|                    |                                                 |of                                |of                                |of                                |of                                |of                                |of                                |
|                    |                                                 |toluene                           |toluene                           |toluene                           |toluene                           |toluene                           |toluene                           |
|                    |                                                 |was                               |was                               |was                               |was                               |was                               |was                               |
|                    |                                                 |0.600μg/ml,                       |0.600μg/ml,                       |0.600μg/ml,                       |0.600μg/ml,                       |0.600μg/ml,                       |0.600μg/ml,                       |
|                    |                                                 |which                             |which                             |which                             |which                             |which                             |which                             |
|                    |                                                 |wasequivalent                     |wasequivalent                     |wasequivalent                     |wasequivalent                     |wasequivalent                     |wasequivalent                     |
|                    |                                                 |to the                            |to the                            |to the                            |to the                            |to the                            |to the                            |
|                    |                                                 |concentration                     |concentration                     |concentration                     |concentration                     |concentration                     |concentration                     |
|                    |                                                 |of test                           |of test                           |of test                           |of test                           |of test                           |of test                           |
|                    |                                                 |product                           |product                           |product                           |product                           |product                           |product                           |
|                    |                                                 |0.001%.                           |0.001%.                           |0.001%.                           |0.001%.                           |0.001%.                           |0.001%.                           |
|                    |                                                 |All the                           |All the                           |All the                           |All the                           |All the                           |All the                           |
|                    |                                                 |above                             |above                             |above                             |above                             |above                             |above                             |
|                    |                                                 |are in                            |are in                            |are in                            |are in                            |are in                            |are in                            |
|                    |                                                 |line                              |line                              |line                              |line                              |line                              |line                              |
|                    |                                                 |with                              |with                              |with                              |with                              |with                              |with                              |
|                    |                                                 |the                               |the                               |the                               |the                               |the                               |the                               |
|                    |                                                 |verification                      |verification                      |verification                      |verification                      |verification                      |verification                      |
|                    |                                                 |requirements.                     |requirements.                     |requirements.                     |requirements.                     |requirements.                     |requirements.                     |
|--------------------|-------------------------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|
|N-methylpyr rolidone|Detection limit solution                         |1                                 |0.831                             |0.002                             |31.48 2                           |2.320 9                           |4.8                               |
|--------------------|-------------------------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|
|N-methylpyr rolidone|Detection limit solution                         |2                                 |2                                 |2                                 |31.47 4                           |1.785 2                           |3.5                               |
|--------------------|-------------------------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|
|N-methylpyr rolidone|Detection limit solution                         |3                                 |3                                 |3                                 |31.46 1                           |2.560 3                           |4.4                               |
|--------------------|-------------------------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|----------------------------------|
|N-methylpyr rolidone|Conclusion: TheS/NofN-methylpyrrolidone in       |Conclusion:                       |Conclusion:                       |Conclusion:                       |Conclusion:                       |Conclusion:                       |Conclusion:                       |
|                    |3-needle limited solution chromatogram ranges    |TheS/NofN-methylpyrrolidone       |TheS/NofN-methylpyrrolidone       |TheS/NofN-methylpyrrolidone       |TheS/NofN-methylpyrrolidone       |TheS/NofN-methylpyrrolidone       |TheS/NofN-methylpyrrolidone       |
|                    |from 3.5-4.8 (NLT 3 is required), and the        |in 3-needle                       |in 3-needle                       |in 3-needle                       |in 3-needle                       |in 3-needle                       |in 3-needle                       |
|                    |detection limited                                |limited                           |limited                           |limited                           |limited                           |limited                           |limited                           |
|                    |concentrationofN-methylpyrrolidone is 0.831μg/ml,|solution                          |solution                          |solution                          |solution                          |solution                          |solution                          |
|                    |whichisequivalent to the concentration of test   |chromatogram                      |chromatogram                      |chromatogram                      |chromatogram                      |chromatogram                      |chromatogram                      |
|                    |product 0.002%. Allthe above were in line with   |ranges from                       |ranges from                       |ranges from                       |ranges from                       |ranges from                       |ranges from                       |
|                    |the verification requirements.                   |3.5-4.8 (NLT                      |3.5-4.8 (NLT                      |3.5-4.8 (NLT                      |3.5-4.8 (NLT                      |3.5-4.8 (NLT                      |3.5-4.8 (NLT                      |
|                    |                                                 |3 is                              |3 is                              |3 is                              |3 is                              |3 is                              |3 is                              |
|                    |                                                 |required),                        |required),                        |required),                        |required),                        |required),                        |required),                        |
|                    |                                                 |and the                           |and the                           |and the                           |and the                           |and the                           |and the                           |
|                    |                                                 |detection                         |detection                         |detection                         |detection                         |detection                         |detection                         |
|                    |                                                 |limited                           |limited                           |limited                           |limited                           |limited                           |limited                           |
|                    |                                                 |concentrationofN-methylpyrrolidone|concentrationofN-methylpyrrolidone|concentrationofN-methylpyrrolidone|concentrationofN-methylpyrrolidone|concentrationofN-methylpyrrolidone|concentrationofN-methylpyrrolidone|
|                    |                                                 |is                                |is                                |is                                |is                                |is                                |is                                |
|                    |                                                 |0.831μg/ml,                       |0.831μg/ml,                       |0.831μg/ml,                       |0.831μg/ml,                       |0.831μg/ml,                       |0.831μg/ml,                       |
|                    |                                                 |whichisequivalent                 |whichisequivalent                 |whichisequivalent                 |whichisequivalent                 |whichisequivalent                 |whichisequivalent                 |
|                    |                                                 |to the                            |to the                            |to the                            |to the                            |to the                            |to the                            |
|                    |                                                 |concentration                     |concentration                     |concentration                     |concentration                     |concentration                     |concentration                     |
|                    |                                                 |of test                           |of test                           |of test                           |of test                           |of test                           |of test                           |
|                    |                                                 |product                           |product                           |product                           |product                           |product                           |product                           |
|                    |                                                 |0.002%.                           |0.002%.                           |0.002%.                           |0.002%.                           |0.002%.                           |0.002%.                           |
|                    |                                                 |Allthe above                      |Allthe above                      |Allthe above                      |Allthe above                      |Allthe above                      |Allthe above                      |
|                    |                                                 |were in line                      |were in line                      |were in line                      |were in line                      |were in line                      |were in line                      |
|                    |                                                 |with the                          |with the                          |with the                          |with the                          |with the                          |with the                          |
|                    |                                                 |verification                      |verification                      |verification                      |verification                      |verification                      |verification                      |
|                    |                                                 |requirements.                     |requirements.                     |requirements.                     |requirements.                     |requirements.                     |requirements.                     |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**(4.4) Linearity and range** 



 **Acceptance Criteria** 



In equivalent to the LOQ concentration of each solvent ~200% limit 



concentration range, relatively uniform take 6 concentration points, the 



impurity concentration as the horizontal coordinate, the peak area as the 



vertical coordinate, the regression coefficient R of the linear graph should 



NLT 0.990, the RSD of the response factor should not be more than 10%, 



Y-axis intercept absolute value accounted for 100% of the response value of 



the percentage should be less than 25%. 



 **Solution Preparation** 



Blank solution: solvent (N, n-dimethylformamide). 



Ethanol reference stock: Share ethanol reference stock under "4.1 



System Suitability". (Approx. 50,000 μg/ml) 



Isopropyl alcohol reference reserve: Share isopropyl alcohol reference 



reserve under "4.1 System Suitability". (Approx. 50,000 μg/ml) 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 337 of 542 





Page 338
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Ethyl acetate reference reserve: Share the ethyl acetate reference reserve 



under "4.1 System Suitability". (Approx. 50,000 μg/ml) 



Secondary butanol reference product reserve: Share secondary butanol 



versus reference product reserve solution under "4.1 System Suitability". 



(Approx. 50,000 μg/ml) 



Tetrahydrofuran reference storage solution: Share tetrahydrofuran 



reference storage solution under "4.1 System Suitability". (Approx. 



7200μg/ml) 



Toluene reference reserve: Share toluene reference reserve under "4.1 



System Suitability". (Approx. 8900μg/ml) 



N-methylpyrrolidone reference stock: Share the N-methylpyrrolidone 



reference stock under "4.1 System Suitability". (Approx. 5300μg/ml) 



Linear reserve liquid: precision measure ethanol reference product 



reserve liquid, isopropyl alcohol reference product reserve liquid, ethyl 



acetate reference product reserve liquid, secondary butanol reference 



product reserve liquid, tetrahydrofuran reference product reserve liquid, 



toluene reference product reserve liquid, N-methylpyrrolidone reference 



product reserve liquid 1.0ml each, placed in a 20ml bottle, diluted with 



solvent to the scale, shake well, ready. (Ethanol about 2500μg/ml, isopropyl 



alcohol about 2500μg/ml, ethyl acetate about 2500μg/ml, secondary 



butanol about 2500μg/ml, tetrahydrofuran about 360μg/ml, toluene about 



445μg/ml, N-methylpyrrolidone about 265μg/ml) 



Linear solution 1 (LOQ solution) : Share the first limit of quantification 



solution under "4.3 limits of quantification and detection limits" 



Linear solution 2 (30% limit concentration) : Accurately measure 0.3ml 



of linear reserve solution, place it in 10ml measuring bottle, dilute it with 



solvent to the scale, shake well, and then obtain. 



Linear solution 3 (80% limit concentration) : Accurately measure 0.8ml 



linear reserve solution, place it in a 10ml measuring bottle, dilute it with 



solvent to the scale, shake well, and obtain. 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 338 of 542 





Page 339
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Linear solution 4 (100% limit concentration) : precisely measure 1.0ml of 



linear reserve liquid, place it in a 10ml measuring bottle, dilute it with solvent 



to the scale, shake well, and get. 



Linear solution 5 (150% limit concentration) : precision measure 1.5ml 



linear reserve solution, place it in 10ml measuring bottle, dilute it with 



solvent to the scale, shake well, ready. 



Linear solution 6 (200% limit concentration) : precision measure 2.0ml 



linear reserve solution, place it in 10ml measuring bottle, dilute it with 



solvent to the scale, shake well, ready. 



 **Injection Sequence** 



After the blank solution, the linear solution of each concentration was 



injected respectively, and the chromatogram was recorded. 



 **Measurement resultss** 



Results of linear and range tests 

























--------------------------------------------------------------------------------------------
|Ethanol|Linear solution 1           |0.0100                      |5.006  |4.1186  |0.8228 |
|-------|----------------------------|----------------------------|-------|--------|-------|
|Ethanol|Linear Solution 2           |0.1502                      |75.083 |73.1266 |0.9739 |
|-------|----------------------------|----------------------------|-------|--------|-------|
|Ethanol|Linear Solution 3           |0.4004                      |200.222|187.5907|0.9369 |
|-------|----------------------------|----------------------------|-------|--------|-------|
|Ethanol|Linear solution 4           |0.5006                      |250.278|233.5749|0.9333 |
|-------|----------------------------|----------------------------|-------|--------|-------|
|Ethanol|Linear Solution 5           |0.7508                      |375.416|333.7332|0.8890 |
|-------|----------------------------|----------------------------|-------|--------|-------|
|Ethanol|Linear solution 6           |1.0011                      |500.555|470.8123|0.9406 |
|-------|----------------------------|----------------------------|-------|--------|-------|
|Ethanol|RSD/% of the response factor|RSD/% of the response factor|6      |6       |6      |
--------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 339 of 542 





Page 340
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 















----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Linearequations                                                               |Linearequations                 |Y =                             |Y =                             |Y =                             |       |
|                                                                              |                                |0.923 +                         |0.923 +                         |0.923 +                         |       |
|                                                                              |                                |0.7951                          |0.7951                          |0.7951                          |       |
|                                                                              |                                |x                               |x                               |x                               |       |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|-------|
|Correlation coefficientR                                                      |Correlation                     |0.999                           |0.999                           |0.999                           |       |
|                                                                              |coefficientR                    |                                |                                |                                |       |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|-------|
|Absolute value ofY-axisinterceptasa percentage /% of 100% response value      |Absolute value                  |0.34                            |0.34                            |0.34                            |       |
|                                                                              |ofY-axisinterceptasa            |                                |                                |                                |       |
|                                                                              |percentage /%                   |                                |                                |                                |       |
|                                                                              |of 100%                         |                                |                                |                                |       |
|                                                                              |response value                  |                                |                                |                                |       |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|-------|
|The verdict: In the concentration range of 5.006μg/ml ~ 500.555μg/ml, with the|The verdict: In the             |The                             |The                             |The                             |       |
|concentrationas the horizontal coordinate and the peakarea as the vertical    |concentration range             |verdict:                        |verdict:                        |verdict:                        |       |
|coordinate as the standard curve, the obtained                                |of 5.006μg/ml ~                 |In the                          |In the                          |In the                          |       |
|linearequationisy=0.923x+0.7951, and the correlation coefficientis 0.999 (the |500.555μg/ml, with              |concentration                   |concentration                   |concentration                   |       |
|requirementis NLT 0.990). The RSD of the response factoris 6% (NMT 10%), and  |the concentrationas             |range                           |range                           |range                           |       |
|the absolute value of theY-axisinterceptaccounts for 0.34% of the 100%        |the horizontal                  |of                              |of                              |of                              |       |
|response value (required within 25%); All the above meet the verification     |coordinate and the              |5.006μg/ml                      |5.006μg/ml                      |5.006μg/ml                      |       |
|requirements, indicating that the analytical method hasa good linear          |peakarea as the                 |~                               |~                               |~                               |       |
|relationship in the concentration range of 5.006μg/ml ~ 500.555μg/ml          |vertical coordinate             |500.555μg/ml,                   |500.555μg/ml,                   |500.555μg/ml,                   |       |
|forethanol detection.                                                         |as the standard                 |with                            |with                            |with                            |       |
|                                                                              |curve, the obtained             |the                             |the                             |the                             |       |
|                                                                              |linearequationisy=0.923x+0.7951,|concentrationas                 |concentrationas                 |concentrationas                 |       |
|                                                                              |and the correlation             |the                             |the                             |the                             |       |
|                                                                              |coefficientis 0.999             |horizontal                      |horizontal                      |horizontal                      |       |
|                                                                              |(the requirementis              |coordinate                      |coordinate                      |coordinate                      |       |
|                                                                              |NLT 0.990). The RSD             |and the                         |and the                         |and the                         |       |
|                                                                              |of the response                 |peakarea                        |peakarea                        |peakarea                        |       |
|                                                                              |factoris 6% (NMT                |as the                          |as the                          |as the                          |       |
|                                                                              |10%), and the                   |vertical                        |vertical                        |vertical                        |       |
|                                                                              |absolute value of               |coordinate                      |coordinate                      |coordinate                      |       |
|                                                                              |theY-axisinterceptaccounts      |as the                          |as the                          |as the                          |       |
|                                                                              |for 0.34% of the                |standard                        |standard                        |standard                        |       |
|                                                                              |100% response value             |curve,                          |curve,                          |curve,                          |       |
|                                                                              |(required within                |the                             |the                             |the                             |       |
|                                                                              |25%); All the above             |obtained                        |obtained                        |obtained                        |       |
|                                                                              |meet the                        |linearequationisy=0.923x+0.7951,|linearequationisy=0.923x+0.7951,|linearequationisy=0.923x+0.7951,|       |
|                                                                              |verification                    |and the                         |and the                         |and the                         |       |
|                                                                              |requirements,                   |correlation                     |correlation                     |correlation                     |       |
|                                                                              |indicating that the             |coefficientis                   |coefficientis                   |coefficientis                   |       |
|                                                                              |analytical method               |0.999                           |0.999                           |0.999                           |       |
|                                                                              |hasa good linear                |(the                            |(the                            |(the                            |       |
|                                                                              |relationship in the             |requirementis                   |requirementis                   |requirementis                   |       |
|                                                                              |concentration range             |NLT                             |NLT                             |NLT                             |       |
|                                                                              |of 5.006μg/ml ~                 |0.990).                         |0.990).                         |0.990).                         |       |
|                                                                              |500.555μg/ml                    |The RSD                         |The RSD                         |The RSD                         |       |
|                                                                              |forethanol                      |of the                          |of the                          |of the                          |       |
|                                                                              |detection.                      |response                        |response                        |response                        |       |
|                                                                              |                                |factoris                        |factoris                        |factoris                        |       |
|                                                                              |                                |6% (NMT                         |6% (NMT                         |6% (NMT                         |       |
|                                                                              |                                |10%),                           |10%),                           |10%),                           |       |
|                                                                              |                                |and the                         |and the                         |and the                         |       |
|                                                                              |                                |absolute                        |absolute                        |absolute                        |       |
|                                                                              |                                |value                           |value                           |value                           |       |
|                                                                              |                                |of                              |of                              |of                              |       |
|                                                                              |                                |theY-axisinterceptaccounts      |theY-axisinterceptaccounts      |theY-axisinterceptaccounts      |       |
|                                                                              |                                |for                             |for                             |for                             |       |
|                                                                              |                                |0.34%                           |0.34%                           |0.34%                           |       |
|                                                                              |                                |of the                          |of the                          |of the                          |       |
|                                                                              |                                |100%                            |100%                            |100%                            |       |
|                                                                              |                                |response                        |response                        |response                        |       |
|                                                                              |                                |value                           |value                           |value                           |       |
|                                                                              |                                |(required                       |(required                       |(required                       |       |
|                                                                              |                                |within                          |within                          |within                          |       |
|                                                                              |                                |25%);                           |25%);                           |25%);                           |       |
|                                                                              |                                |All the                         |All the                         |All the                         |       |
|                                                                              |                                |above                           |above                           |above                           |       |
|                                                                              |                                |meet                            |meet                            |meet                            |       |
|                                                                              |                                |the                             |the                             |the                             |       |
|                                                                              |                                |verification                    |verification                    |verification                    |       |
|                                                                              |                                |requirements,                   |requirements,                   |requirements,                   |       |
|                                                                              |                                |indicating                      |indicating                      |indicating                      |       |
|                                                                              |                                |that                            |that                            |that                            |       |
|                                                                              |                                |the                             |the                             |the                             |       |
|                                                                              |                                |analytical                      |analytical                      |analytical                      |       |
|                                                                              |                                |method                          |method                          |method                          |       |
|                                                                              |                                |hasa                            |hasa                            |hasa                            |       |
|                                                                              |                                |good                            |good                            |good                            |       |
|                                                                              |                                |linear                          |linear                          |linear                          |       |
|                                                                              |                                |relationship                    |relationship                    |relationship                    |       |
|                                                                              |                                |in the                          |in the                          |in the                          |       |
|                                                                              |                                |concentration                   |concentration                   |concentration                   |       |
|                                                                              |                                |range                           |range                           |range                           |       |
|                                                                              |                                |of                              |of                              |of                              |       |
|                                                                              |                                |5.006μg/ml                      |5.006μg/ml                      |5.006μg/ml                      |       |
|                                                                              |                                |~                               |~                               |~                               |       |
|                                                                              |                                |500.555μg/ml                    |500.555μg/ml                    |500.555μg/ml                    |       |
|                                                                              |                                |forethanol                      |forethanol                      |forethanol                      |       |
|                                                                              |                                |detection.                      |detection.                      |detection.                      |       |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|-------|
|Isop ropy lAlco hol                                                           |Linear Solution 1               |0.0100                          |5.008                           |4.8550                          |0.9694 |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|-------|
|Isop ropy lAlco hol                                                           |Linear Solution 2               |0.1502                          |75.123                          |72.2137                         |0.9613 |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|-------|
|Isop ropy lAlco hol                                                           |Linear solution 3               |0.4007                          |200.328                         |196.5378                        |0.9811 |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|-------|
|Isop ropy lAlco hol                                                           |Linear solution 4               |0.5008                          |250.410                         |240.5275                        |0.9605 |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|-------|
|Isop ropy lAlco hol                                                           |Linear Solution 5               |0.7512                          |375.615                         |355.4473                        |0.9463 |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|-------|
|Isop ropy lAlco hol                                                           |Linear solution 6               |1.0016                          |500.820                         |504.4516                        |1.0073 |
|------------------------------------------------------------------------------|--------------------------------|--------------------------------|--------------------------------|--------------------------------|-------|
|Isop ropy lAlco hol                                                           |RSD/% of the response factor    |RSD/% of the response factor    |2.2                             |2.2                             |2.2    |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 340 of 542 





Page 341
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 















--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Linearequations                                                               |Linearequations                  |Y =                              |Y =                              |Y =                              |       |
|                                                                              |                                 |0.9917-3.6091                    |0.9917-3.6091                    |0.9917-3.6091                    |       |
|                                                                              |                                 |x                                |x                                |x                                |       |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Correlation coefficientR                                                      |Correlation                      |0.999                            |0.999                            |0.999                            |       |
|                                                                              |coefficientR                     |                                 |                                 |                                 |       |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Absolute value ofY-axisinterceptasa percentage /% of 100% response value      |Absolute value                   |1.5                              |1.5                              |1.5                              |       |
|                                                                              |ofY-axisinterceptasa             |                                 |                                 |                                 |       |
|                                                                              |percentage /%                    |                                 |                                 |                                 |       |
|                                                                              |of 100%                          |                                 |                                 |                                 |       |
|                                                                              |response value                   |                                 |                                 |                                 |       |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Conclusion: Isopropylalcohol in the concentration range of 5.008μg/ml ~       |Conclusion:                      |Conclusion:                      |Conclusion:                      |Conclusion:                      |       |
|500.820μg/ml, with the concentrationas the horizontal coordinate and the      |Isopropylalcohol in              |Isopropylalcohol                 |Isopropylalcohol                 |Isopropylalcohol                 |       |
|peakarea as the vertical coordinate as the standard curve, the obtained       |the concentration                |in the                           |in the                           |in the                           |       |
|linearequationisy=0.9917x-3.6091, and the correlation coefficientis 0.999 (the|range of 5.008μg/ml              |concentration                    |concentration                    |concentration                    |       |
|requirementis NLT 0.990). RSD of the response factor was 2.2% (NMT 10%), and  |~ 500.820μg/ml, with             |range of                         |range of                         |range of                         |       |
|the absolute value of theY-axisinterceptaccounted for 1.5% of the 100%        |the concentrationas              |5.008μg/ml ~                     |5.008μg/ml ~                     |5.008μg/ml ~                     |       |
|response value (required within 25%); All of the above meet the verification  |the horizontal                   |500.820μg/ml,                    |500.820μg/ml,                    |500.820μg/ml,                    |       |
|requirements, indicating that the analytical method hasagood linear           |coordinate and the               |with the                         |with the                         |with the                         |       |
|relationship in the concentration range of 5.008μg/ml ~ 500.820μg/ml.         |peakarea as the                  |concentrationas                  |concentrationas                  |concentrationas                  |       |
|                                                                              |vertical coordinate              |the                              |the                              |the                              |       |
|                                                                              |as the standard                  |horizontal                       |horizontal                       |horizontal                       |       |
|                                                                              |curve, the obtained              |coordinate                       |coordinate                       |coordinate                       |       |
|                                                                              |linearequationisy=0.9917x-3.6091,|and the                          |and the                          |and the                          |       |
|                                                                              |and the correlation              |peakarea as                      |peakarea as                      |peakarea as                      |       |
|                                                                              |coefficientis 0.999              |the vertical                     |the vertical                     |the vertical                     |       |
|                                                                              |(the requirementis               |coordinate as                    |coordinate as                    |coordinate as                    |       |
|                                                                              |NLT 0.990). RSD of               |the standard                     |the standard                     |the standard                     |       |
|                                                                              |the response factor              |curve, the                       |curve, the                       |curve, the                       |       |
|                                                                              |was 2.2% (NMT 10%),              |obtained                         |obtained                         |obtained                         |       |
|                                                                              |and the absolute                 |linearequationisy=0.9917x-3.6091,|linearequationisy=0.9917x-3.6091,|linearequationisy=0.9917x-3.6091,|       |
|                                                                              |value of                         |and the                          |and the                          |and the                          |       |
|                                                                              |theY-axisinterceptaccounted      |correlation                      |correlation                      |correlation                      |       |
|                                                                              |for 1.5% of the 100%             |coefficientis                    |coefficientis                    |coefficientis                    |       |
|                                                                              |response value                   |0.999 (the                       |0.999 (the                       |0.999 (the                       |       |
|                                                                              |(required within                 |requirementis                    |requirementis                    |requirementis                    |       |
|                                                                              |25%); All of the                 |NLT 0.990).                      |NLT 0.990).                      |NLT 0.990).                      |       |
|                                                                              |above meet the                   |RSD of the                       |RSD of the                       |RSD of the                       |       |
|                                                                              |verification                     |response                         |response                         |response                         |       |
|                                                                              |requirements,                    |factor was                       |factor was                       |factor was                       |       |
|                                                                              |indicating that the              |2.2% (NMT                        |2.2% (NMT                        |2.2% (NMT                        |       |
|                                                                              |analytical method                |10%), and the                    |10%), and the                    |10%), and the                    |       |
|                                                                              |hasagood linear                  |absolute                         |absolute                         |absolute                         |       |
|                                                                              |relationship in the              |value of                         |value of                         |value of                         |       |
|                                                                              |concentration range              |theY-axisinterceptaccounted      |theY-axisinterceptaccounted      |theY-axisinterceptaccounted      |       |
|                                                                              |of 5.008μg/ml ~                  |for 1.5% of                      |for 1.5% of                      |for 1.5% of                      |       |
|                                                                              |500.820μg/ml.                    |the 100%                         |the 100%                         |the 100%                         |       |
|                                                                              |                                 |response                         |response                         |response                         |       |
|                                                                              |                                 |value                            |value                            |value                            |       |
|                                                                              |                                 |(required                        |(required                        |(required                        |       |
|                                                                              |                                 |within 25%);                     |within 25%);                     |within 25%);                     |       |
|                                                                              |                                 |All of the                       |All of the                       |All of the                       |       |
|                                                                              |                                 |above meet                       |above meet                       |above meet                       |       |
|                                                                              |                                 |the                              |the                              |the                              |       |
|                                                                              |                                 |verification                     |verification                     |verification                     |       |
|                                                                              |                                 |requirements,                    |requirements,                    |requirements,                    |       |
|                                                                              |                                 |indicating                       |indicating                       |indicating                       |       |
|                                                                              |                                 |that the                         |that the                         |that the                         |       |
|                                                                              |                                 |analytical                       |analytical                       |analytical                       |       |
|                                                                              |                                 |method                           |method                           |method                           |       |
|                                                                              |                                 |hasagood                         |hasagood                         |hasagood                         |       |
|                                                                              |                                 |linear                           |linear                           |linear                           |       |
|                                                                              |                                 |relationship                     |relationship                     |relationship                     |       |
|                                                                              |                                 |in the                           |in the                           |in the                           |       |
|                                                                              |                                 |concentration                    |concentration                    |concentration                    |       |
|                                                                              |                                 |range of                         |range of                         |range of                         |       |
|                                                                              |                                 |5.008μg/ml ~                     |5.008μg/ml ~                     |5.008μg/ml ~                     |       |
|                                                                              |                                 |500.820μg/ml.                    |500.820μg/ml.                    |500.820μg/ml.                    |       |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Ethy lacetate                                                                 |Linear solution 1                |0.0099                           |4.974                            |3.8354                           |0.7711 |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Ethy lacetate                                                                 |Linear Solution 2                |0.1492                           |74.609                           |56.1242                          |0.7522 |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Ethy lacetate                                                                 |Linear Solution 3                |0.3979                           |198.956                          |152.6369                         |0.7672 |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Ethy lacetate                                                                 |Linear solution 4                |0.4974                           |248.695                          |185.6191                         |0.7464 |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Ethy lacetate                                                                 |Linear Solution 5                |0.7461                           |373.043                          |274.8493                         |0.7368 |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Ethy lacetate                                                                 |Linear solution 6                |0.9948                           |497.390                          |388.8026                         |0.7817 |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Ethy lacetate                                                                 |RSD/% of the response factor     |RSD/% of the response factor     |2.3                              |2.3                              |2.3    |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 341 of 542 





Page 342
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 















--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Linearequations                                                               |Linearequations               |Y =                           |Y =                           |Y =                           |       |
|                                                                              |                              |0.7696-2.3                    |0.7696-2.3                    |0.7696-2.3                    |       |
|                                                                              |                              |x                             |x                             |x                             |       |
|------------------------------------------------------------------------------|------------------------------|------------------------------|------------------------------|------------------------------|-------|
|Correlation coefficientR                                                      |Correlation                   |0.999                         |0.999                         |0.999                         |       |
|                                                                              |coefficientR                  |                              |                              |                              |       |
|------------------------------------------------------------------------------|------------------------------|------------------------------|------------------------------|------------------------------|-------|
|Absolute value ofY-axisinterceptasa percentage /% of 100% response value      |Absolute value                |1.2                           |1.2                           |1.2                           |       |
|                                                                              |ofY-axisinterceptasa          |                              |                              |                              |       |
|                                                                              |percentage /%                 |                              |                              |                              |       |
|                                                                              |of 100%                       |                              |                              |                              |       |
|                                                                              |response value                |                              |                              |                              |       |
|------------------------------------------------------------------------------|------------------------------|------------------------------|------------------------------|------------------------------|-------|
|The verdict: Ethylacetate in the concentration range of 4.974μg/ml ~          |The verdict:                  |The                           |The                           |The                           |       |
|497.390μg/ml, with the concentrationas the horizontal coordinate and the      |Ethylacetate in the           |verdict:                      |verdict:                      |verdict:                      |       |
|peakarea as the vertical coordinate as the standard curve, the obtained       |concentration range           |Ethylacetate                  |Ethylacetate                  |Ethylacetate                  |       |
|linearequationisy=0.7696x-2.3, the correlation coefficientis 0.999 (the       |of 4.974μg/ml ~               |in the                        |in the                        |in the                        |       |
|requirementis NLT 0.990). The RSD of the response factor was 2.3% (NMT 10%),  |497.390μg/ml, with            |concentration                 |concentration                 |concentration                 |       |
|and the absolute value of theY-axisinterceptaccounted for 1.2% of the 100%    |the concentrationas           |range of                      |range of                      |range of                      |       |
|response value (required within 25%); All of the above meet the verification  |the horizontal                |4.974μg/ml                    |4.974μg/ml                    |4.974μg/ml                    |       |
|requirements, indicating that the analytical method hasagood linear           |coordinate and the            |~                             |~                             |~                             |       |
|relationship in the concentration range of 4.974μg/ml ~ 497.390μg/ml.         |peakarea as the               |497.390μg/ml,                 |497.390μg/ml,                 |497.390μg/ml,                 |       |
|                                                                              |vertical coordinate           |with the                      |with the                      |with the                      |       |
|                                                                              |as the standard               |concentrationas               |concentrationas               |concentrationas               |       |
|                                                                              |curve, the obtained           |the                           |the                           |the                           |       |
|                                                                              |linearequationisy=0.7696x-2.3,|horizontal                    |horizontal                    |horizontal                    |       |
|                                                                              |the correlation               |coordinate                    |coordinate                    |coordinate                    |       |
|                                                                              |coefficientis 0.999           |and the                       |and the                       |and the                       |       |
|                                                                              |(the requirementis            |peakarea                      |peakarea                      |peakarea                      |       |
|                                                                              |NLT 0.990). The RSD           |as the                        |as the                        |as the                        |       |
|                                                                              |of the response               |vertical                      |vertical                      |vertical                      |       |
|                                                                              |factor was 2.3% (NMT          |coordinate                    |coordinate                    |coordinate                    |       |
|                                                                              |10%), and the                 |as the                        |as the                        |as the                        |       |
|                                                                              |absolute value of             |standard                      |standard                      |standard                      |       |
|                                                                              |theY-axisinterceptaccounted   |curve, the                    |curve, the                    |curve, the                    |       |
|                                                                              |for 1.2% of the 100%          |obtained                      |obtained                      |obtained                      |       |
|                                                                              |response value                |linearequationisy=0.7696x-2.3,|linearequationisy=0.7696x-2.3,|linearequationisy=0.7696x-2.3,|       |
|                                                                              |(required within              |the                           |the                           |the                           |       |
|                                                                              |25%); All of the              |correlation                   |correlation                   |correlation                   |       |
|                                                                              |above meet the                |coefficientis                 |coefficientis                 |coefficientis                 |       |
|                                                                              |verification                  |0.999 (the                    |0.999 (the                    |0.999 (the                    |       |
|                                                                              |requirements,                 |requirementis                 |requirementis                 |requirementis                 |       |
|                                                                              |indicating that the           |NLT                           |NLT                           |NLT                           |       |
|                                                                              |analytical method             |0.990).                       |0.990).                       |0.990).                       |       |
|                                                                              |hasagood linear               |The RSD of                    |The RSD of                    |The RSD of                    |       |
|                                                                              |relationship in the           |the                           |the                           |the                           |       |
|                                                                              |concentration range           |response                      |response                      |response                      |       |
|                                                                              |of 4.974μg/ml ~               |factor was                    |factor was                    |factor was                    |       |
|                                                                              |497.390μg/ml.                 |2.3% (NMT                     |2.3% (NMT                     |2.3% (NMT                     |       |
|                                                                              |                              |10%), and                     |10%), and                     |10%), and                     |       |
|                                                                              |                              |the                           |the                           |the                           |       |
|                                                                              |                              |absolute                      |absolute                      |absolute                      |       |
|                                                                              |                              |value of                      |value of                      |value of                      |       |
|                                                                              |                              |theY-axisinterceptaccounted   |theY-axisinterceptaccounted   |theY-axisinterceptaccounted   |       |
|                                                                              |                              |for 1.2%                      |for 1.2%                      |for 1.2%                      |       |
|                                                                              |                              |of the                        |of the                        |of the                        |       |
|                                                                              |                              |100%                          |100%                          |100%                          |       |
|                                                                              |                              |response                      |response                      |response                      |       |
|                                                                              |                              |value                         |value                         |value                         |       |
|                                                                              |                              |(required                     |(required                     |(required                     |       |
|                                                                              |                              |within                        |within                        |within                        |       |
|                                                                              |                              |25%); All                     |25%); All                     |25%); All                     |       |
|                                                                              |                              |of the                        |of the                        |of the                        |       |
|                                                                              |                              |above meet                    |above meet                    |above meet                    |       |
|                                                                              |                              |the                           |the                           |the                           |       |
|                                                                              |                              |verification                  |verification                  |verification                  |       |
|                                                                              |                              |requirements,                 |requirements,                 |requirements,                 |       |
|                                                                              |                              |indicating                    |indicating                    |indicating                    |       |
|                                                                              |                              |that the                      |that the                      |that the                      |       |
|                                                                              |                              |analytical                    |analytical                    |analytical                    |       |
|                                                                              |                              |method                        |method                        |method                        |       |
|                                                                              |                              |hasagood                      |hasagood                      |hasagood                      |       |
|                                                                              |                              |linear                        |linear                        |linear                        |       |
|                                                                              |                              |relationship                  |relationship                  |relationship                  |       |
|                                                                              |                              |in the                        |in the                        |in the                        |       |
|                                                                              |                              |concentration                 |concentration                 |concentration                 |       |
|                                                                              |                              |range of                      |range of                      |range of                      |       |
|                                                                              |                              |4.974μg/ml                    |4.974μg/ml                    |4.974μg/ml                    |       |
|                                                                              |                              |~                             |~                             |~                             |       |
|                                                                              |                              |497.390μg/ml.                 |497.390μg/ml.                 |497.390μg/ml.                 |       |
|------------------------------------------------------------------------------|------------------------------|------------------------------|------------------------------|------------------------------|-------|
|Sec- buta nol                                                                 |Linear solution 1             |0.0075                        |3.759                         |4.2595                        |1.1332 |
|------------------------------------------------------------------------------|------------------------------|------------------------------|------------------------------|------------------------------|-------|
|Sec- buta nol                                                                 |Linear Solution 2             |0.1504                        |75.176                        |87.9476                       |1.1699 |
|------------------------------------------------------------------------------|------------------------------|------------------------------|------------------------------|------------------------------|-------|
|Sec- buta nol                                                                 |Linear Solution 3             |0.4009                        |200.468                       |240.1952                      |1.1982 |
|------------------------------------------------------------------------------|------------------------------|------------------------------|------------------------------|------------------------------|-------|
|Sec- buta nol                                                                 |Linear solution 4             |0.5012                        |250.585                       |291.3112                      |1.1625 |
|------------------------------------------------------------------------------|------------------------------|------------------------------|------------------------------|------------------------------|-------|
|Sec- buta nol                                                                 |Linear Solution 5             |0.7518                        |375.878                       |435.1142                      |1.1576 |
|------------------------------------------------------------------------------|------------------------------|------------------------------|------------------------------|------------------------------|-------|
|Sec- buta nol                                                                 |Linear solution 6             |1.0023                        |501.170                       |615.3318                      |1.2278 |
|------------------------------------------------------------------------------|------------------------------|------------------------------|------------------------------|------------------------------|-------|
|Sec- buta nol                                                                 |RSD/% of the response factor  |RSD/% of the response factor  |2.9                           |2.9                           |2.9    |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 342 of 542 





Page 343
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 















--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Linearequations                                                               |Linearequations                  |Y =                              |Y =                              |Y =                              |       |
|                                                                              |                                 |1.2102-4.7656                    |1.2102-4.7656                    |1.2102-4.7656                    |       |
|                                                                              |                                 |x                                |x                                |x                                |       |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Correlation coefficientR                                                      |Correlation                      |0.999                            |0.999                            |0.999                            |       |
|                                                                              |coefficientR                     |                                 |                                 |                                 |       |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Absolute value ofY-axisinterceptasa percentage /% of 100% response value      |Absolute value                   |1.6                              |1.6                              |1.6                              |       |
|                                                                              |ofY-axisinterceptasa             |                                 |                                 |                                 |       |
|                                                                              |percentage /%                    |                                 |                                 |                                 |       |
|                                                                              |of 100%                          |                                 |                                 |                                 |       |
|                                                                              |response value                   |                                 |                                 |                                 |       |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|The verdict: In the concentration range of 3.759μg/ml ~ 501.170μg/ml, with the|The verdict: In the              |The verdict:                     |The verdict:                     |The verdict:                     |       |
|concentrationas the horizontal coordinate and the peakarea as the vertical    |concentration range              |In the                           |In the                           |In the                           |       |
|coordinate as the standard curve, the obtained                                |of 3.759μg/ml ~                  |concentration                    |concentration                    |concentration                    |       |
|linearequationisy=1.2102x-4.7656, and the correlation coefficientis 0.999 (the|501.170μg/ml, with               |range of                         |range of                         |range of                         |       |
|requirementis NLT 0.990). The RSD of the response factor was 2.9% (NMT 10%),  |the concentrationas              |3.759μg/ml ~                     |3.759μg/ml ~                     |3.759μg/ml ~                     |       |
|the absolute value of theY-axisinterceptaccounted for 1.6% of the 100%        |the horizontal                   |501.170μg/ml,                    |501.170μg/ml,                    |501.170μg/ml,                    |       |
|response value (required within 25%); All of the above meet the verification  |coordinate and the               |with the                         |with the                         |with the                         |       |
|requirements, indicating that the analytical method hasa good linear          |peakarea as the                  |concentrationas                  |concentrationas                  |concentrationas                  |       |
|relationship in the concentration range of 5.045μg/ml ~ 504.54μg/ml.          |vertical coordinate              |the                              |the                              |the                              |       |
|                                                                              |as the standard                  |horizontal                       |horizontal                       |horizontal                       |       |
|                                                                              |curve, the obtained              |coordinate                       |coordinate                       |coordinate                       |       |
|                                                                              |linearequationisy=1.2102x-4.7656,|and the                          |and the                          |and the                          |       |
|                                                                              |and the correlation              |peakarea as                      |peakarea as                      |peakarea as                      |       |
|                                                                              |coefficientis 0.999              |the vertical                     |the vertical                     |the vertical                     |       |
|                                                                              |(the requirementis               |coordinate as                    |coordinate as                    |coordinate as                    |       |
|                                                                              |NLT 0.990). The RSD              |the standard                     |the standard                     |the standard                     |       |
|                                                                              |of the response                  |curve, the                       |curve, the                       |curve, the                       |       |
|                                                                              |factor was 2.9% (NMT             |obtained                         |obtained                         |obtained                         |       |
|                                                                              |10%), the absolute               |linearequationisy=1.2102x-4.7656,|linearequationisy=1.2102x-4.7656,|linearequationisy=1.2102x-4.7656,|       |
|                                                                              |value of                         |and the                          |and the                          |and the                          |       |
|                                                                              |theY-axisinterceptaccounted      |correlation                      |correlation                      |correlation                      |       |
|                                                                              |for 1.6% of the 100%             |coefficientis                    |coefficientis                    |coefficientis                    |       |
|                                                                              |response value                   |0.999 (the                       |0.999 (the                       |0.999 (the                       |       |
|                                                                              |(required within                 |requirementis                    |requirementis                    |requirementis                    |       |
|                                                                              |25%); All of the                 |NLT 0.990).                      |NLT 0.990).                      |NLT 0.990).                      |       |
|                                                                              |above meet the                   |The RSD of                       |The RSD of                       |The RSD of                       |       |
|                                                                              |verification                     |the response                     |the response                     |the response                     |       |
|                                                                              |requirements,                    |factor was                       |factor was                       |factor was                       |       |
|                                                                              |indicating that the              |2.9% (NMT                        |2.9% (NMT                        |2.9% (NMT                        |       |
|                                                                              |analytical method                |10%), the                        |10%), the                        |10%), the                        |       |
|                                                                              |hasa good linear                 |absolute                         |absolute                         |absolute                         |       |
|                                                                              |relationship in the              |value of                         |value of                         |value of                         |       |
|                                                                              |concentration range              |theY-axisinterceptaccounted      |theY-axisinterceptaccounted      |theY-axisinterceptaccounted      |       |
|                                                                              |of 5.045μg/ml ~                  |for 1.6% of                      |for 1.6% of                      |for 1.6% of                      |       |
|                                                                              |504.54μg/ml.                     |the 100%                         |the 100%                         |the 100%                         |       |
|                                                                              |                                 |response                         |response                         |response                         |       |
|                                                                              |                                 |value                            |value                            |value                            |       |
|                                                                              |                                 |(required                        |(required                        |(required                        |       |
|                                                                              |                                 |within 25%);                     |within 25%);                     |within 25%);                     |       |
|                                                                              |                                 |All of the                       |All of the                       |All of the                       |       |
|                                                                              |                                 |above meet                       |above meet                       |above meet                       |       |
|                                                                              |                                 |the                              |the                              |the                              |       |
|                                                                              |                                 |verification                     |verification                     |verification                     |       |
|                                                                              |                                 |requirements,                    |requirements,                    |requirements,                    |       |
|                                                                              |                                 |indicating                       |indicating                       |indicating                       |       |
|                                                                              |                                 |that the                         |that the                         |that the                         |       |
|                                                                              |                                 |analytical                       |analytical                       |analytical                       |       |
|                                                                              |                                 |method hasa                      |method hasa                      |method hasa                      |       |
|                                                                              |                                 |good linear                      |good linear                      |good linear                      |       |
|                                                                              |                                 |relationship                     |relationship                     |relationship                     |       |
|                                                                              |                                 |in the                           |in the                           |in the                           |       |
|                                                                              |                                 |concentration                    |concentration                    |concentration                    |       |
|                                                                              |                                 |range of                         |range of                         |range of                         |       |
|                                                                              |                                 |5.045μg/ml ~                     |5.045μg/ml ~                     |5.045μg/ml ~                     |       |
|                                                                              |                                 |504.54μg/ml.                     |504.54μg/ml.                     |504.54μg/ml.                     |       |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Tetrahy drofuran                                                              |Linear Solution 1                |0.0073                           |3.659                            |4.3828                           |1.1979 |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Tetrahy drofuran                                                              |Linear Solution 2                |0.0220                           |10.976                           |11.9074                          |1.0848 |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Tetrahy drofuran                                                              |Linear solution 3                |0.0585                           |29.270                           |32.1304                          |1.0977 |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Tetrahy drofuran                                                              |Linear solution 4                |0.0732                           |36.588                           |38.7867                          |1.0601 |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Tetrahy drofuran                                                              |Linear Solution 5                |0.1098                           |54.881                           |57.9125                          |1.0552 |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Tetrahy drofuran                                                              |Linear solution 6                |0.1464                           |73.175                           |80.0393                          |1.0938 |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Tetrahy drofuran                                                              |RSD/% of the response factor     |RSD/% of the response factor     |5                                |5                                |5      |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 343 of 542 





Page 344
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 















--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Linearequations                                                               |Linearequations                  |Y =                              |Y =                              |Y =                              |       |
|                                                                              |                                 |1.0779                           |1.0779                           |1.0779                           |       |
|                                                                              |                                 |+                                |+                                |+                                |       |
|                                                                              |                                 |0.0623                           |0.0623                           |0.0623                           |       |
|                                                                              |                                 |x                                |x                                |x                                |       |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Correlation coefficientR                                                      |Correlation                      |0.9995                           |0.9995                           |0.9995                           |       |
|                                                                              |coefficientR                     |                                 |                                 |                                 |       |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Absolute value ofY-axisinterceptasa percentage /% of 100% response value      |Absolute value                   |0.16                             |0.16                             |0.16                             |       |
|                                                                              |ofY-axisinterceptasa             |                                 |                                 |                                 |       |
|                                                                              |percentage /%                    |                                 |                                 |                                 |       |
|                                                                              |of 100%                          |                                 |                                 |                                 |       |
|                                                                              |response value                   |                                 |                                 |                                 |       |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|The verdict: In the concentration range of 3.659μg/ml ~ 73.175μg/ml, with the |The verdict: In the              |The                              |The                              |The                              |       |
|concentrationas the horizontal coordinate and the peakarea as the vertical    |concentration range              |verdict:                         |verdict:                         |verdict:                         |       |
|coordinate as the standard curve, the obtained                                |of 3.659μg/ml ~                  |In the                           |In the                           |In the                           |       |
|linearequationisy=1.0779x+0.0623, and the correlation coefficientis 0.9995    |73.175μg/ml, with                |concentration                    |concentration                    |concentration                    |       |
|(the requirementis NLT 0.990). The RSD of the response factoris 5% (NMT 10%), |the concentrationas              |range                            |range                            |range                            |       |
|and the absolute value of theY-axisinterceptaccounts for 0.16% of the 100%    |the horizontal                   |of                               |of                               |of                               |       |
|response value (required within 25%); All the above met the verification      |coordinate and the               |3.659μg/ml                       |3.659μg/ml                       |3.659μg/ml                       |       |
|requirements, indicating that the analytical method for the detection of      |peakarea as the                  |~                                |~                                |~                                |       |
|tetrahydrofuran hasagood linear relationship in the concentration range of    |vertical coordinate              |73.175μg/ml,                     |73.175μg/ml,                     |73.175μg/ml,                     |       |
|3.659μg/ml ~ 73.175μg/ml.                                                     |as the standard                  |with                             |with                             |with                             |       |
|                                                                              |curve, the obtained              |the                              |the                              |the                              |       |
|                                                                              |linearequationisy=1.0779x+0.0623,|concentrationas                  |concentrationas                  |concentrationas                  |       |
|                                                                              |and the correlation              |the                              |the                              |the                              |       |
|                                                                              |coefficientis 0.9995             |horizontal                       |horizontal                       |horizontal                       |       |
|                                                                              |(the requirementis               |coordinate                       |coordinate                       |coordinate                       |       |
|                                                                              |NLT 0.990). The RSD              |and the                          |and the                          |and the                          |       |
|                                                                              |of the response                  |peakarea                         |peakarea                         |peakarea                         |       |
|                                                                              |factoris 5% (NMT                 |as the                           |as the                           |as the                           |       |
|                                                                              |10%), and the                    |vertical                         |vertical                         |vertical                         |       |
|                                                                              |absolute value of                |coordinate                       |coordinate                       |coordinate                       |       |
|                                                                              |theY-axisinterceptaccounts       |as the                           |as the                           |as the                           |       |
|                                                                              |for 0.16% of the                 |standard                         |standard                         |standard                         |       |
|                                                                              |100% response value              |curve,                           |curve,                           |curve,                           |       |
|                                                                              |(required within                 |the                              |the                              |the                              |       |
|                                                                              |25%); All the above              |obtained                         |obtained                         |obtained                         |       |
|                                                                              |met the verification             |linearequationisy=1.0779x+0.0623,|linearequationisy=1.0779x+0.0623,|linearequationisy=1.0779x+0.0623,|       |
|                                                                              |requirements,                    |and the                          |and the                          |and the                          |       |
|                                                                              |indicating that the              |correlation                      |correlation                      |correlation                      |       |
|                                                                              |analytical method                |coefficientis                    |coefficientis                    |coefficientis                    |       |
|                                                                              |for the detection of             |0.9995                           |0.9995                           |0.9995                           |       |
|                                                                              |tetrahydrofuran                  |(the                             |(the                             |(the                             |       |
|                                                                              |hasagood linear                  |requirementis                    |requirementis                    |requirementis                    |       |
|                                                                              |relationship in the              |NLT                              |NLT                              |NLT                              |       |
|                                                                              |concentration range              |0.990).                          |0.990).                          |0.990).                          |       |
|                                                                              |of 3.659μg/ml ~                  |The RSD                          |The RSD                          |The RSD                          |       |
|                                                                              |73.175μg/ml.                     |of the                           |of the                           |of the                           |       |
|                                                                              |                                 |response                         |response                         |response                         |       |
|                                                                              |                                 |factoris                         |factoris                         |factoris                         |       |
|                                                                              |                                 |5% (NMT                          |5% (NMT                          |5% (NMT                          |       |
|                                                                              |                                 |10%),                            |10%),                            |10%),                            |       |
|                                                                              |                                 |and the                          |and the                          |and the                          |       |
|                                                                              |                                 |absolute                         |absolute                         |absolute                         |       |
|                                                                              |                                 |value                            |value                            |value                            |       |
|                                                                              |                                 |of                               |of                               |of                               |       |
|                                                                              |                                 |theY-axisinterceptaccounts       |theY-axisinterceptaccounts       |theY-axisinterceptaccounts       |       |
|                                                                              |                                 |for                              |for                              |for                              |       |
|                                                                              |                                 |0.16%                            |0.16%                            |0.16%                            |       |
|                                                                              |                                 |of the                           |of the                           |of the                           |       |
|                                                                              |                                 |100%                             |100%                             |100%                             |       |
|                                                                              |                                 |response                         |response                         |response                         |       |
|                                                                              |                                 |value                            |value                            |value                            |       |
|                                                                              |                                 |(required                        |(required                        |(required                        |       |
|                                                                              |                                 |within                           |within                           |within                           |       |
|                                                                              |                                 |25%);                            |25%);                            |25%);                            |       |
|                                                                              |                                 |All the                          |All the                          |All the                          |       |
|                                                                              |                                 |above                            |above                            |above                            |       |
|                                                                              |                                 |met the                          |met the                          |met the                          |       |
|                                                                              |                                 |verification                     |verification                     |verification                     |       |
|                                                                              |                                 |requirements,                    |requirements,                    |requirements,                    |       |
|                                                                              |                                 |indicating                       |indicating                       |indicating                       |       |
|                                                                              |                                 |that                             |that                             |that                             |       |
|                                                                              |                                 |the                              |the                              |the                              |       |
|                                                                              |                                 |analytical                       |analytical                       |analytical                       |       |
|                                                                              |                                 |method                           |method                           |method                           |       |
|                                                                              |                                 |for the                          |for the                          |for the                          |       |
|                                                                              |                                 |detection                        |detection                        |detection                        |       |
|                                                                              |                                 |of                               |of                               |of                               |       |
|                                                                              |                                 |tetrahydrofuran                  |tetrahydrofuran                  |tetrahydrofuran                  |       |
|                                                                              |                                 |hasagood                         |hasagood                         |hasagood                         |       |
|                                                                              |                                 |linear                           |linear                           |linear                           |       |
|                                                                              |                                 |relationship                     |relationship                     |relationship                     |       |
|                                                                              |                                 |in the                           |in the                           |in the                           |       |
|                                                                              |                                 |concentration                    |concentration                    |concentration                    |       |
|                                                                              |                                 |range                            |range                            |range                            |       |
|                                                                              |                                 |of                               |of                               |of                               |       |
|                                                                              |                                 |3.659μg/ml                       |3.659μg/ml                       |3.659μg/ml                       |       |
|                                                                              |                                 |~                                |~                                |~                                |       |
|                                                                              |                                 |73.175μg/ml.                     |73.175μg/ml.                     |73.175μg/ml.                     |       |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Tolu ene                                                                      |Linear solution 1                |0.0040                           |2.001                            |4.2723                           |2.1351 |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Tolu ene                                                                      |Linear Solution 2                |0.0300                           |15.008                           |29.9444                          |1.9953 |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Tolu ene                                                                      |Linear Solution 3                |0.0800                           |40.020                           |79.6923                          |1.9913 |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Tolu ene                                                                      |Linear solution 4                |0.1001                           |50.025                           |97.5511                          |1.9500 |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Tolu ene                                                                      |Linear solution 5                |0.1501                           |75.038                           |144.6969                         |1.9283 |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Tolu ene                                                                      |Linear solution 6                |0.2001                           |100.050                          |204.0250                         |2.0392 |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Tolu ene                                                                      |RSD/% of the response factor     |RSD/% of the response factor     |4                                |4                                |4      |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 344 of 542 





Page 345
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 















--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Linearequations                                                               |Linearequations                  |Y =                              |Y =                              |Y =                              |       |
|                                                                              |                                 |2.0063-0.9813                    |2.0063-0.9813                    |2.0063-0.9813                    |       |
|                                                                              |                                 |x                                |x                                |x                                |       |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Correlation coefficientR                                                      |Correlation                      |0.999                            |0.999                            |0.999                            |       |
|                                                                              |coefficientR                     |                                 |                                 |                                 |       |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|Absolute value ofY-axisinterceptasa percentage /% of 100% response value      |Absolute value                   |1.1                              |1.1                              |1.1                              |       |
|                                                                              |ofY-axisinterceptasa             |                                 |                                 |                                 |       |
|                                                                              |percentage /%                    |                                 |                                 |                                 |       |
|                                                                              |of 100%                          |                                 |                                 |                                 |       |
|                                                                              |response value                   |                                 |                                 |                                 |       |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|The verdict: The concentration of toluene in the range of 2.001μg/ml ~        |The verdict: The                 |The verdict:                     |The verdict:                     |The verdict:                     |       |
|100.050μg/ml, with the concentrationas the horizontal coordinate and the      |concentration of                 |The                              |The                              |The                              |       |
|peakarea as the vertical coordinate as the standard curve, the obtained       |toluene in the range             |concentration                    |concentration                    |concentration                    |       |
|linearequationisy=2.0063x-0.9813, the correlation coefficientis 0.999 (the    |of 2.001μg/ml ~                  |of toluene in                    |of toluene in                    |of toluene in                    |       |
|requirementis NLT 0.990). RSD of response factoris 4% (NMT 10%), the absolute |100.050μg/ml, with               |the range of                     |the range of                     |the range of                     |       |
|value ofY-axisinterceptaccounts for 1.1% of 100% response value (required     |the concentrationas              |2.001μg/ml ~                     |2.001μg/ml ~                     |2.001μg/ml ~                     |       |
|within 25%); All the above meet the verification requirements, indicating that|the horizontal                   |100.050μg/ml,                    |100.050μg/ml,                    |100.050μg/ml,                    |       |
|the analytical method hasa good linear relationship in the concentration range|coordinate and the               |with the                         |with the                         |with the                         |       |
|of 2.001μg/ml ~ 100.050μg/ml.                                                 |peakarea as the                  |concentrationas                  |concentrationas                  |concentrationas                  |       |
|                                                                              |vertical coordinate              |the                              |the                              |the                              |       |
|                                                                              |as the standard                  |horizontal                       |horizontal                       |horizontal                       |       |
|                                                                              |curve, the obtained              |coordinate                       |coordinate                       |coordinate                       |       |
|                                                                              |linearequationisy=2.0063x-0.9813,|and the                          |and the                          |and the                          |       |
|                                                                              |the correlation                  |peakarea as                      |peakarea as                      |peakarea as                      |       |
|                                                                              |coefficientis 0.999              |the vertical                     |the vertical                     |the vertical                     |       |
|                                                                              |(the requirementis               |coordinate as                    |coordinate as                    |coordinate as                    |       |
|                                                                              |NLT 0.990). RSD of               |the standard                     |the standard                     |the standard                     |       |
|                                                                              |response factoris 4%             |curve, the                       |curve, the                       |curve, the                       |       |
|                                                                              |(NMT 10%), the                   |obtained                         |obtained                         |obtained                         |       |
|                                                                              |absolute value                   |linearequationisy=2.0063x-0.9813,|linearequationisy=2.0063x-0.9813,|linearequationisy=2.0063x-0.9813,|       |
|                                                                              |ofY-axisinterceptaccounts        |the                              |the                              |the                              |       |
|                                                                              |for 1.1% of 100%                 |correlation                      |correlation                      |correlation                      |       |
|                                                                              |response value                   |coefficientis                    |coefficientis                    |coefficientis                    |       |
|                                                                              |(required within                 |0.999 (the                       |0.999 (the                       |0.999 (the                       |       |
|                                                                              |25%); All the above              |requirementis                    |requirementis                    |requirementis                    |       |
|                                                                              |meet the                         |NLT 0.990).                      |NLT 0.990).                      |NLT 0.990).                      |       |
|                                                                              |verification                     |RSD of                           |RSD of                           |RSD of                           |       |
|                                                                              |requirements,                    |response                         |response                         |response                         |       |
|                                                                              |indicating that the              |factoris 4%                      |factoris 4%                      |factoris 4%                      |       |
|                                                                              |analytical method                |(NMT 10%),                       |(NMT 10%),                       |(NMT 10%),                       |       |
|                                                                              |hasa good linear                 |the absolute                     |the absolute                     |the absolute                     |       |
|                                                                              |relationship in the              |value                            |value                            |value                            |       |
|                                                                              |concentration range              |ofY-axisinterceptaccounts        |ofY-axisinterceptaccounts        |ofY-axisinterceptaccounts        |       |
|                                                                              |of 2.001μg/ml ~                  |for 1.1% of                      |for 1.1% of                      |for 1.1% of                      |       |
|                                                                              |100.050μg/ml.                    |100% response                    |100% response                    |100% response                    |       |
|                                                                              |                                 |value                            |value                            |value                            |       |
|                                                                              |                                 |(required                        |(required                        |(required                        |       |
|                                                                              |                                 |within 25%);                     |within 25%);                     |within 25%);                     |       |
|                                                                              |                                 |All the above                    |All the above                    |All the above                    |       |
|                                                                              |                                 |meet the                         |meet the                         |meet the                         |       |
|                                                                              |                                 |verification                     |verification                     |verification                     |       |
|                                                                              |                                 |requirements,                    |requirements,                    |requirements,                    |       |
|                                                                              |                                 |indicating                       |indicating                       |indicating                       |       |
|                                                                              |                                 |that the                         |that the                         |that the                         |       |
|                                                                              |                                 |analytical                       |analytical                       |analytical                       |       |
|                                                                              |                                 |method hasa                      |method hasa                      |method hasa                      |       |
|                                                                              |                                 |good linear                      |good linear                      |good linear                      |       |
|                                                                              |                                 |relationship                     |relationship                     |relationship                     |       |
|                                                                              |                                 |in the                           |in the                           |in the                           |       |
|                                                                              |                                 |concentration                    |concentration                    |concentration                    |       |
|                                                                              |                                 |range of                         |range of                         |range of                         |       |
|                                                                              |                                 |2.001μg/ml ~                     |2.001μg/ml ~                     |2.001μg/ml ~                     |       |
|                                                                              |                                 |100.050μg/ml.                    |100.050μg/ml.                    |100.050μg/ml.                    |       |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|N-methy lpyr rolidone                                                         |Linear Solution 1                |0.0055                           |2.769                            |2.9231                           |1.0557 |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|N-methy lpyr rolidone                                                         |Linear Solution 2                |0.0166                           |8.306                            |8.4062                           |1.0120 |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|N-methy lpyr rolidone                                                         |Linear Solution 3                |0.0443                           |22.150                           |20.3112                          |0.9170 |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|N-methy lpyr rolidone                                                         |Linear solution 4                |0.0554                           |27.688                           |25.2571                          |0.9122 |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|N-methy lpyr rolidone                                                         |Linear Solution 5                |0.0831                           |41.531                           |37.7702                          |0.9094 |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|N-methy lpyr rolidone                                                         |Linear solution 6                |0.1108                           |55.375                           |57.1453                          |1.0320 |
|------------------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|-------|
|N-methy lpyr rolidone                                                         |RSD/% of the response factor     |RSD/% of the response factor     |7                                |7                                |7      |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 345 of 542 





Page 346
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 










------------------------------------------------------------------------------------------------------
|       |Linear graph                                                            |                   |
|       |                                                                        |                   |
|       |                                                                        |                   |
|       |------------------------------------------------------------------------|-------------------|
|       |Linearequations                                                         |Y = 0.9965-0.9081 x|
|       |------------------------------------------------------------------------|-------------------|
|       |Correlation coefficientR                                                |0.995              |
|       |------------------------------------------------------------------------|-------------------|
|       |Absolute value ofY-axisinterceptasa percentage /% of 100% response value|3.6                |
------------------------------------------------------------------------------------------------------

**(4.5) Accuracy** 



 **Brief Description** 



Add each solvent reference in the limit concentration range of 30%~150% to 



the test product, the recovery rate of each solvent is required to be between 



85% ~ 115%, and the recovery RSD NMT 10%. 



 **Solution preparation** 



Blank solution: solvent (N, n-dimethylformamide). 



Ethanol reference stock: Share ethanol reference stock under "4.1 System 



Suitability". (Approx. 50,000 μg/ml) 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 346 of 542 





Page 347
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Isopropyl alcohol reference reserve: Share isopropyl alcohol reference reserve 



under "4.1 System Suitability". (Approx. 50,000 μg/ml) 



Ethyl acetate reference reserve: Share the ethyl acetate reference reserve 



under "4.1 System Suitability". (Approx. 50,000 μg/ml) 



Secondary butanol reference product reserve: Share secondary butanol 



versus reference product reserve solution under "4.1 System Suitability". 



(Approx. 50,000 μg/ml) 



Tetrahydrofuran reference storage solution: Share tetrahydrofuran reference 



storage solution under "4.1 System Suitability". (Approx. 7200μg/ml) 



Toluene reference reserve: Share toluene reference reserve under "4.1 System 



Suitability". (Approx. 8900μg/ml) 



N-methylpyrrolidone reference stock: Share the N-methylpyrrolidone 



reference stock under "4.1 System Suitability". (Approx. 5300μg/ml) 



Recovery reserve: Share linear reserve under "4.4 linear and range" 



Control product solution: accurately measure the recovery rate of the reserve 



liquid 1.0ml, put it in a 10ml measuring bottle, and then dilute it with solvent 



to the scale, shake well, and then obtain. 



Test product solution: Accurately weigh about 0.5g of this product, place it in 



10ml measuring bottle, dissolve it with solvent and dilute it to the scale, 



shake well, ready. (Parallel preparation of 2 servings) 



30% sample recovery solution: precision weigh about 0.5g of this product, 



precision weigh, put in 10ml measuring bottle, then precision measure the 



recovery of 0.3ml of reserve liquid placed in the same measuring bottle, 



dissolve with solvent and dilute to the scale, shake well, and then get. 



(Parallel preparation of 3 parts) 



100% sample recovery solution: precision weigh about 0.5g of this product, 



precision weigh, put in 10ml measuring bottle, then precision measure the 



recovery of reserve liquid 1.0ml put in the same measuring bottle, dissolve 



with solvent and dilute to the scale, shake well, and then get. (Parallel 



preparation of 3 parts) 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 347 of 542 





Page 348
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



150% sample recovery solution: precision weigh about 0.5g of this product, 



precision weigh, put in 10ml measuring bottle, then precision measure the 



recovery reserve liquid 1.5ml put in the same measuring bottle, dissolve with 



solvent and dilute to the scale, shake well, and then get. (Parallel preparation 



of 3 parts) 



 **Injection procedure** 



After the blank solution, the control product solution, the test product 



solution and the recovery solution of each concentration were injected 



respectively, and the chromatogram was recorded. 



 **Measurement resultss** 



Accuracy test results 



















































--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Etha nol       |30% sample recovery solution 1                                        |51.2415                          |75.0833                          |122.8447                         |95.4                             |
|---------------|----------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|
|Etha nol       |30% addition recovery solution2                                       |51.3641                          |75.0833                          |124.7496                         |97.7                             |
|---------------|----------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|
|Etha nol       |30% addition recovery solution 3                                      |51.2293                          |75.0833                          |123.6445                         |96.4                             |
|---------------|----------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|
|Etha nol       |100% sample recovery solution 1                                       |51.1619                          |250.2775                         |303.9775                         |101.0                            |
|---------------|----------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|
|Etha nol       |100% addition recovery solution 2                                     |51.1169                          |250.2775                         |304.6158                         |101.3                            |
|---------------|----------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|
|Etha nol       |100% addition recovery solution 3                                     |51.3560                          |250.2775                         |305.8432                         |101.7                            |
|---------------|----------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|
|Etha nol       |150% addition recovery solution 1                                     |51.4449                          |375.4163                         |466.2005                         |110.5                            |
|---------------|----------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|
|Etha nol       |150% addition recovery solution 2                                     |51.2569                          |375.4163                         |438.8007                         |103.2                            |
|---------------|----------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|
|Etha nol       |150% addition recovery solution 3                                     |51.1138                          |375.4163                         |440.8515                         |103.8                            |
|---------------|----------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|
|Etha nol       |Average recovery /%                                                   |Average                          |Average                          |Average                          |101.2                            |
|               |                                                                      |recovery                         |recovery                         |recovery                         |                                 |
|               |                                                                      |/%                               |/%                               |/%                               |                                 |
|---------------|----------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|
|Etha nol       |Recovery rate RSD/%                                                   |Recovery                         |Recovery                         |Recovery                         |5                                |
|               |                                                                      |rate                             |rate                             |rate                             |                                 |
|               |                                                                      |RSD/%                            |RSD/%                            |RSD/%                            |                                 |
|---------------|----------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|
|Etha nol       |Conclusion: Ethanol was detected in the samples, and                  |Conclusion:                      |Conclusion:                      |Conclusion:                      |Conclusion:                      |
|               |75.0833μg/ml-375.4163μg/mlethanol control wasaddedinto the samples.   |Ethanol                          |Ethanol                          |Ethanol                          |Ethanol                          |
|               |The recoveries of 9 samples were all in the range of 95.4%-110.5% (the|was                              |was                              |was                              |was                              |
|               |requirement was 85%-115%), and the average recovery was 101.2%. The   |detected                         |detected                         |detected                         |detected                         |
|               |recovery RSD was 5% (the requirement was not more than 10%); All the  |in the                           |in the                           |in the                           |in the                           |
|               |above met the verification requirements, indicating that the method   |samples,                         |samples,                         |samples,                         |samples,                         |
|               |wasaccurate in detecting solventethanol in YA2304.                    |and                              |and                              |and                              |and                              |
|               |                                                                      |75.0833μg/ml-375.4163μg/mlethanol|75.0833μg/ml-375.4163μg/mlethanol|75.0833μg/ml-375.4163μg/mlethanol|75.0833μg/ml-375.4163μg/mlethanol|
|               |                                                                      |control                          |control                          |control                          |control                          |
|               |                                                                      |wasaddedinto                     |wasaddedinto                     |wasaddedinto                     |wasaddedinto                     |
|               |                                                                      |the                              |the                              |the                              |the                              |
|               |                                                                      |samples.                         |samples.                         |samples.                         |samples.                         |
|               |                                                                      |The                              |The                              |The                              |The                              |
|               |                                                                      |recoveries                       |recoveries                       |recoveries                       |recoveries                       |
|               |                                                                      |of 9                             |of 9                             |of 9                             |of 9                             |
|               |                                                                      |samples                          |samples                          |samples                          |samples                          |
|               |                                                                      |were all                         |were all                         |were all                         |were                             |
|               |                                                                      |in the                           |in the                           |in the                           |all in                           |
|               |                                                                      |range of                         |range of                         |range of                         |the                              |
|               |                                                                      |95.4%-110.5%                     |95.4%-110.5%                     |95.4%-110.5%                     |range                            |
|               |                                                                      |(the                             |(the                             |(the                             |of                               |
|               |                                                                      |requirement                      |requirement                      |requirement                      |95.4%-110.5%                     |
|               |                                                                      |was                              |was                              |was                              |(the                             |
|               |                                                                      |85%-115%),                       |85%-115%),                       |85%-115%),                       |requirement                      |
|               |                                                                      |and the                          |and the                          |and the                          |was                              |
|               |                                                                      |average                          |average                          |average                          |85%-115%),                       |
|               |                                                                      |recovery                         |recovery                         |recovery                         |and the                          |
|               |                                                                      |was                              |was                              |was                              |average                          |
|               |                                                                      |101.2%.                          |101.2%.                          |101.2%.                          |recovery                         |
|               |                                                                      |The                              |The                              |The                              |was                              |
|               |                                                                      |recovery                         |recovery                         |recovery                         |101.2%.                          |
|               |                                                                      |RSD was                          |RSD was                          |RSD was                          |The                              |
|               |                                                                      |5% (the                          |5% (the                          |5% (the                          |recovery                         |
|               |                                                                      |requirement                      |requirement                      |requirement                      |RSD was                          |
|               |                                                                      |was not                          |was not                          |was not                          |5% (the                          |
|               |                                                                      |more                             |more                             |more                             |requirement                      |
|               |                                                                      |than                             |than                             |than                             |was not                          |
|               |                                                                      |10%);                            |10%);                            |10%);                            |more                             |
|               |                                                                      |All the                          |All the                          |All the                          |than                             |
|               |                                                                      |above                            |above                            |above                            |10%);                            |
|               |                                                                      |met the                          |met the                          |met the                          |All the                          |
|               |                                                                      |verification                     |verification                     |verification                     |above                            |
|               |                                                                      |requirements,                    |requirements,                    |requirements,                    |met the                          |
|               |                                                                      |indicating                       |indicating                       |indicating                       |verification                     |
|               |                                                                      |that the                         |that the                         |that the                         |requirements,                    |
|               |                                                                      |method                           |method                           |method                           |indicating                       |
|               |                                                                      |wasaccurate                      |wasaccurate                      |wasaccurate                      |that                             |
|               |                                                                      |in                               |in                               |in                               |the                              |
|               |                                                                      |detecting                        |detecting                        |detecting                        |method                           |
|               |                                                                      |solventethanol                   |solventethanol                   |solventethanol                   |wasaccurate                      |
|               |                                                                      |in                               |in                               |in                               |in                               |
|               |                                                                      |YA2304.                          |YA2304.                          |YA2304.                          |detecting                        |
|               |                                                                      |                                 |                                 |                                 |solventethanol                   |
|               |                                                                      |                                 |                                 |                                 |in                               |
|               |                                                                      |                                 |                                 |                                 |YA2304.                          |
|---------------|----------------------------------------------------------------------|---------------------------------|---------------------------------|---------------------------------|---------------------------------|
|Substances Name|Solution name                                                         |Originalamount in test product   |Amountadded (μg/ml)              |Measuredamount (μg/ml)           |Recove ry rate /%                |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 348 of 542 





Page 349
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 




























--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Isopropylalcohol|30% sample recovery solution 1                                       |Not                                       |75.1230                                   |74.0095                                   |98.5                                      |
|                |                                                                     |detected                                  |                                          |                                          |                                          |
|----------------|---------------------------------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|
|Isopropylalcohol|30% sample recovery solution 2                                       |Not                                       |75.1230                                   |74.8906                                   |99.7                                      |
|                |                                                                     |detected                                  |                                          |                                          |                                          |
|----------------|---------------------------------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|
|Isopropylalcohol|30% sample recovery solution 3                                       |Not                                       |75.1230                                   |74.0543                                   |98.6                                      |
|                |                                                                     |detected                                  |                                          |                                          |                                          |
|----------------|---------------------------------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|
|Isopropylalcohol|100% sample recovery solution 1                                      |Not                                       |250.4100                                  |252.7144                                  |100.9                                     |
|                |                                                                     |detected                                  |                                          |                                          |                                          |
|----------------|---------------------------------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|
|Isopropylalcohol|100% sample recovery solution 2                                      |Not                                       |250.4100                                  |253.0627                                  |101.1                                     |
|                |                                                                     |detected                                  |                                          |                                          |                                          |
|----------------|---------------------------------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|
|Isopropylalcohol|100% sample recovery solution 3                                      |Not                                       |250.4100                                  |253.9289                                  |101.4                                     |
|                |                                                                     |detected                                  |                                          |                                          |                                          |
|----------------|---------------------------------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|
|Isopropylalcohol|150% sample recovery solution 1                                      |Not                                       |375.6150                                  |409.5334                                  |109.0                                     |
|                |                                                                     |detected                                  |                                          |                                          |                                          |
|----------------|---------------------------------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|
|Isopropylalcohol|150% sample recovery solution2                                       |Not                                       |375.6150                                  |387.2121                                  |103.1                                     |
|                |                                                                     |detected                                  |                                          |                                          |                                          |
|----------------|---------------------------------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|
|Isopropylalcohol|150% sample recovery solution 3                                      |Not                                       |375.6150                                  |387.0754                                  |103.1                                     |
|                |                                                                     |detected                                  |                                          |                                          |                                          |
|----------------|---------------------------------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|
|Isopropylalcohol|Average recovery rate /%                                             |Average                                   |Average                                   |Average                                   |101.7                                     |
|                |                                                                     |recovery                                  |recovery                                  |recovery                                  |                                          |
|                |                                                                     |rate /%                                   |rate /%                                   |rate /%                                   |                                          |
|----------------|---------------------------------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|
|Isopropylalcohol|Recovery rate RSD/%                                                  |Recovery                                  |Recovery                                  |Recovery                                  |4                                         |
|                |                                                                     |rate                                      |rate                                      |rate                                      |                                          |
|                |                                                                     |RSD/%                                     |RSD/%                                     |RSD/%                                     |                                          |
|----------------|---------------------------------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|
|Isopropylalcohol|Conclusions: Isopropylalcohol was not detected in the samples, and   |Conclusions:                              |Conclusions:                              |Conclusions:                              |Conclusions:                              |
|                |75.1230μg/ml-375.6150μg/mlisopropylalcohol wasaddedinto the samples. |Isopropylalcohol                          |Isopropylalcohol                          |Isopropylalcohol                          |Isopropylalcohol                          |
|                |The recoveries of 9 samples were all in the range of 98.5%-109.0%    |was not                                   |was not                                   |was not                                   |was not                                   |
|                |(the requirements were in the range of 85%-115%), and the average    |detected                                  |detected                                  |detected                                  |detected                                  |
|                |recovery was 101.7%. The recovery RSD was 4% (the requirement was not|in the                                    |in the                                    |in the                                    |in the                                    |
|                |more than 10%); All the above met the verification requirements,     |samples,                                  |samples,                                  |samples,                                  |samples,                                  |
|                |indicating that the method wasaccurate indetectingisopropylalcohol in|and                                       |and                                       |and                                       |and                                       |
|                |YA2304.                                                              |75.1230μg/ml-375.6150μg/mlisopropylalcohol|75.1230μg/ml-375.6150μg/mlisopropylalcohol|75.1230μg/ml-375.6150μg/mlisopropylalcohol|75.1230μg/ml-375.6150μg/mlisopropylalcohol|
|                |                                                                     |wasaddedinto                              |wasaddedinto                              |wasaddedinto                              |wasaddedinto                              |
|                |                                                                     |the                                       |the                                       |the                                       |the                                       |
|                |                                                                     |samples.                                  |samples.                                  |samples.                                  |samples.                                  |
|                |                                                                     |The                                       |The                                       |The                                       |The                                       |
|                |                                                                     |recoveries                                |recoveries                                |recoveries                                |recoveries                                |
|                |                                                                     |of 9                                      |of 9                                      |of 9                                      |of 9                                      |
|                |                                                                     |samples                                   |samples                                   |samples                                   |samples                                   |
|                |                                                                     |were all                                  |were all                                  |were all                                  |were                                      |
|                |                                                                     |in the                                    |in the                                    |in the                                    |all in                                    |
|                |                                                                     |range of                                  |range of                                  |range of                                  |the                                       |
|                |                                                                     |98.5%-109.0%                              |98.5%-109.0%                              |98.5%-109.0%                              |range                                     |
|                |                                                                     |(the                                      |(the                                      |(the                                      |of                                        |
|                |                                                                     |requirements                              |requirements                              |requirements                              |98.5%-109.0%                              |
|                |                                                                     |were in                                   |were in                                   |were in                                   |(the                                      |
|                |                                                                     |the                                       |the                                       |the                                       |requirements                              |
|                |                                                                     |range of                                  |range of                                  |range of                                  |were in                                   |
|                |                                                                     |85%-115%),                                |85%-115%),                                |85%-115%),                                |the                                       |
|                |                                                                     |and the                                   |and the                                   |and the                                   |range                                     |
|                |                                                                     |average                                   |average                                   |average                                   |of                                        |
|                |                                                                     |recovery                                  |recovery                                  |recovery                                  |85%-115%),                                |
|                |                                                                     |was                                       |was                                       |was                                       |and the                                   |
|                |                                                                     |101.7%.                                   |101.7%.                                   |101.7%.                                   |average                                   |
|                |                                                                     |The                                       |The                                       |The                                       |recovery                                  |
|                |                                                                     |recovery                                  |recovery                                  |recovery                                  |was                                       |
|                |                                                                     |RSD was                                   |RSD was                                   |RSD was                                   |101.7%.                                   |
|                |                                                                     |4% (the                                   |4% (the                                   |4% (the                                   |The                                       |
|                |                                                                     |requirement                               |requirement                               |requirement                               |recovery                                  |
|                |                                                                     |was not                                   |was not                                   |was not                                   |RSD was                                   |
|                |                                                                     |more                                      |more                                      |more                                      |4% (the                                   |
|                |                                                                     |than                                      |than                                      |than                                      |requirement                               |
|                |                                                                     |10%);                                     |10%);                                     |10%);                                     |was not                                   |
|                |                                                                     |All the                                   |All the                                   |All the                                   |more                                      |
|                |                                                                     |above                                     |above                                     |above                                     |than                                      |
|                |                                                                     |met the                                   |met the                                   |met the                                   |10%);                                     |
|                |                                                                     |verification                              |verification                              |verification                              |All the                                   |
|                |                                                                     |requirements,                             |requirements,                             |requirements,                             |above                                     |
|                |                                                                     |indicating                                |indicating                                |indicating                                |met the                                   |
|                |                                                                     |that the                                  |that the                                  |that the                                  |verification                              |
|                |                                                                     |method                                    |method                                    |method                                    |requirements,                             |
|                |                                                                     |wasaccurate                               |wasaccurate                               |wasaccurate                               |indicating                                |
|                |                                                                     |indetectingisopropylalcohol               |indetectingisopropylalcohol               |indetectingisopropylalcohol               |that                                      |
|                |                                                                     |in                                        |in                                        |in                                        |the                                       |
|                |                                                                     |YA2304.                                   |YA2304.                                   |YA2304.                                   |method                                    |
|                |                                                                     |                                          |                                          |                                          |wasaccurate                               |
|                |                                                                     |                                          |                                          |                                          |indetectingisopropylalcohol               |
|                |                                                                     |                                          |                                          |                                          |in                                        |
|                |                                                                     |                                          |                                          |                                          |YA2304.                                   |
|----------------|---------------------------------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|
|Substances Name |Solution name                                                        |Originalamount in test product (μg/ml)    |Amountadded (μg/ml)                       |Measuredamount (μg/ml)                    |Recove ry rate /%                         |
|----------------|---------------------------------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|
|Ethylacetate    |30% sample recovery solution 1                                       |Not detected                              |74.6085                                   |73.3037                                   |98.3                                      |
|----------------|---------------------------------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|
|Ethylacetate    |30% sample recovery solution2                                        |Not detected                              |74.6085                                   |74.2183                                   |99.5                                      |
|----------------|---------------------------------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|
|Ethylacetate    |30% sample recovery solution 3                                       |Not detected                              |74.6085                                   |73.1270                                   |98.0                                      |
|----------------|---------------------------------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|
|Ethylacetate    |100% sample recovery solution 1                                      |Not detected                              |248.6950                                  |250.6196                                  |100.8                                     |
|----------------|---------------------------------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|
|Ethylacetate    |100% recovery solution 2                                             |Not detected                              |248.6950                                  |251.0619                                  |101.0                                     |
|----------------|---------------------------------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|
|Ethylacetate    |100% sample recovery solution 3                                      |Not detected                              |248.6950                                  |252.0282                                  |101.3                                     |
|----------------|---------------------------------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|
|Ethylacetate    |150% sample recovery solution 1                                      |Not detected                              |373.0425                                  |402.2260                                  |107.8                                     |
|----------------|---------------------------------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|
|Ethylacetate    |150% sample recovery solution2                                       |Not detected                              |373.0425                                  |383.3969                                  |102.8                                     |
|----------------|---------------------------------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|
|Ethylacetate    |150% sample recovery solution 3                                      |Not detected                              |373.0425                                  |384.7227                                  |103.1                                     |
|----------------|---------------------------------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|
|Ethylacetate    |Average recovery rate /%                                             |Average recovery rate /%                  |Average recovery rate /%                  |Average recovery rate /%                  |101.4                                     |
|----------------|---------------------------------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|
|Ethylacetate    |Recovery rate RSD/%                                                  |Recovery rate RSD/%                       |Recovery rate RSD/%                       |Recovery rate RSD/%                       |3.0                                       |
|----------------|---------------------------------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|------------------------------------------|
|Ethylacetate    |Conclusions: No ethylacetate was detected in the samples.            |Conclusions: No ethylacetate was detected |Conclusions: No ethylacetate was detected |Conclusions: No ethylacetate was detected |Conclusions: No ethylacetate was detected |
|                |74.6085μg/ml-373.0425μg/mlethylacetate wasaddedinto the samples.     |in the samples.                           |in the samples.                           |in the samples.                           |in the samples.                           |
|                |                                                                     |74.6085μg/ml-373.0425μg/mlethylacetate    |74.6085μg/ml-373.0425μg/mlethylacetate    |74.6085μg/ml-373.0425μg/mlethylacetate    |74.6085μg/ml-373.0425μg/mlethylacetate    |
|                |                                                                     |wasaddedinto the samples.                 |wasaddedinto the samples.                 |wasaddedinto the samples.                 |wasaddedinto the samples.                 |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 349 of 542 





Page 350
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 











































----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Substances Name |Solution name                                                        |Original                  |Amountadded               |Measuredamount            |Recove                    |
|                |                                                                     |quantity                  |(μg/ml)                   |(μg/ml)                   |ry rate                   |
|                |                                                                     |in test                   |                          |                          |/%                        |
|                |                                                                     |product                   |                          |                          |                          |
|                |                                                                     |(μg/ml)                   |                          |                          |                          |
|----------------|---------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|sec-butanol     |30% sample recovery solution 1                                       |Not                       |75.1755                   |74.5260                   |99.1                      |
|                |                                                                     |detected                  |                          |                          |                          |
|----------------|---------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|sec-butanol     |30% sample recovery solution2                                        |Not                       |75.1755                   |75.1045                   |99.9                      |
|                |                                                                     |detected                  |                          |                          |                          |
|----------------|---------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|sec-butanol     |30% sample recovery solution 3                                       |Not                       |75.1755                   |74.1757                   |98.7                      |
|                |                                                                     |detected                  |                          |                          |                          |
|----------------|---------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|sec-butanol     |100% sample recovery solution 1                                      |Not                       |250.5850                  |254.1755                  |101.4                     |
|                |                                                                     |detected                  |                          |                          |                          |
|----------------|---------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|sec-butanol     |100% sample recovery solution 2                                      |Not                       |250.5850                  |254.9211                  |101.7                     |
|                |                                                                     |detected                  |                          |                          |                          |
|----------------|---------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|sec-butanol     |100% sample recovery solution 3                                      |Not                       |250.5850                  |255.8160                  |102.1                     |
|                |                                                                     |detected                  |                          |                          |                          |
|----------------|---------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|sec-butanol     |150% sample recovery solution 1                                      |Not                       |375.8775                  |412.4938                  |109.7                     |
|                |                                                                     |detected                  |                          |                          |                          |
|----------------|---------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|sec-butanol     |150% sample recovery solution2                                       |Not                       |375.8775                  |389.1479                  |103.5                     |
|                |                                                                     |detected                  |                          |                          |                          |
|----------------|---------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|sec-butanol     |150% sample recovery solution 3                                      |Not                       |375.8775                  |390.5969                  |103.9                     |
|                |                                                                     |detected                  |                          |                          |                          |
|----------------|---------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|sec-butanol     |Average recovery rate /%                                             |Average                   |Average                   |Average                   |102.2                     |
|                |                                                                     |recovery                  |recovery                  |recovery rate             |                          |
|                |                                                                     |rate /%                   |rate /%                   |/%                        |                          |
|----------------|---------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|sec-butanol     |Recovery rate RSD/%                                                  |Recovery                  |Recovery                  |Recovery rate             |4                         |
|                |                                                                     |rate                      |rate RSD/%                |RSD/%                     |                          |
|                |                                                                     |RSD/%                     |                          |                          |                          |
|----------------|---------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|sec-butanol     |Conclusions: No secondary butanol was detected in the samples.       |Conclusions:              |Conclusions:              |Conclusions:              |Conclusions:              |
|                |75.1755μg/ml-375.8775μg/ml of secondary butanol wasaddedinto the     |No                        |No                        |No secondary              |No                        |
|                |samples. The recoveries of 9 samples were all in the range of        |secondary                 |secondary                 |butanol was               |secondary                 |
|                |98.7%-109.7% (the requirement was 85%-115%), and the average         |butanol                   |butanol was               |detected in               |butanol                   |
|                |recoveries were 102.2%. The RSD of recovery was 4% (NMT 10%); All the|was                       |detected in               |the samples.              |was                       |
|                |above met the verification requirements, indicating that the method  |detected                  |the                       |75.1755μg/ml-375.8775μg/ml|detected                  |
|                |wasaccurate in detecting secondary butanol in YA2304.                |in the                    |samples.                  |of secondary              |in the                    |
|                |                                                                     |samples.                  |75.1755μg/ml-375.8775μg/ml|butanol                   |samples.                  |
|                |                                                                     |75.1755μg/ml-375.8775μg/ml|of                        |wasaddedinto              |75.1755μg/ml-375.8775μg/ml|
|                |                                                                     |of                        |secondary                 |the samples.              |of                        |
|                |                                                                     |secondary                 |butanol                   |The recoveries            |secondary                 |
|                |                                                                     |butanol                   |wasaddedinto              |of 9 samples              |butanol                   |
|                |                                                                     |wasaddedinto              |the                       |were all in               |wasaddedinto              |
|                |                                                                     |the                       |samples.                  |the range of              |the                       |
|                |                                                                     |samples.                  |The                       |98.7%-109.7%              |samples.                  |
|                |                                                                     |The                       |recoveries                |(the                      |The                       |
|                |                                                                     |recoveries                |of 9                      |requirement               |recoveries                |
|                |                                                                     |of 9                      |samples                   |was 85%-115%),            |of 9                      |
|                |                                                                     |samples                   |were all in               |and the                   |samples                   |
|                |                                                                     |were all                  |the range                 |average                   |were                      |
|                |                                                                     |in the                    |of                        |recoveries                |all in                    |
|                |                                                                     |range of                  |98.7%-109.7%              |were 102.2%.              |the                       |
|                |                                                                     |98.7%-109.7%              |(the                      |The RSD of                |range                     |
|                |                                                                     |(the                      |requirement               |recovery was              |of                        |
|                |                                                                     |requirement               |was                       |4% (NMT 10%);             |98.7%-109.7%              |
|                |                                                                     |was                       |85%-115%),                |All the above             |(the                      |
|                |                                                                     |85%-115%),                |and the                   |met the                   |requirement               |
|                |                                                                     |and the                   |average                   |verification              |was                       |
|                |                                                                     |average                   |recoveries                |requirements,             |85%-115%),                |
|                |                                                                     |recoveries                |were                      |indicating                |and the                   |
|                |                                                                     |were                      |102.2%. The               |that the                  |average                   |
|                |                                                                     |102.2%.                   |RSD of                    |method                    |recoveries                |
|                |                                                                     |The RSD                   |recovery                  |wasaccurate in            |were                      |
|                |                                                                     |of                        |was 4% (NMT               |detecting                 |102.2%.                   |
|                |                                                                     |recovery                  |10%); All                 |secondary                 |The RSD                   |
|                |                                                                     |was 4%                    |the above                 |butanol in                |of                        |
|                |                                                                     |(NMT                      |met the                   |YA2304.                   |recovery                  |
|                |                                                                     |10%);                     |verification              |                          |was 4%                    |
|                |                                                                     |All the                   |requirements,             |                          |(NMT                      |
|                |                                                                     |above                     |indicating                |                          |10%);                     |
|                |                                                                     |met the                   |that the                  |                          |All the                   |
|                |                                                                     |verification              |method                    |                          |above                     |
|                |                                                                     |requirements,             |wasaccurate               |                          |met the                   |
|                |                                                                     |indicating                |in                        |                          |verification              |
|                |                                                                     |that the                  |detecting                 |                          |requirements,             |
|                |                                                                     |method                    |secondary                 |                          |indicating                |
|                |                                                                     |wasaccurate               |butanol in                |                          |that                      |
|                |                                                                     |in                        |YA2304.                   |                          |the                       |
|                |                                                                     |detecting                 |                          |                          |method                    |
|                |                                                                     |secondary                 |                          |                          |wasaccurate               |
|                |                                                                     |butanol                   |                          |                          |in                        |
|                |                                                                     |in                        |                          |                          |detecting                 |
|                |                                                                     |YA2304.                   |                          |                          |secondary                 |
|                |                                                                     |                          |                          |                          |butanol                   |
|                |                                                                     |                          |                          |                          |in                        |
|                |                                                                     |                          |                          |                          |YA2304.                   |
|----------------|---------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|Substances Name |Solution name                                                        |Originalamount in test    |Amountadded (μg/ml)       |Measuredamount (μg/ml)    |Recove ry rate /%         |
|                |                                                                     |product (μg/ml)           |                          |                          |                          |
|----------------|---------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|tetrah ydrofuran|30% sample recovery solution 1                                       |Not detected              |10.9763                   |10.8178                   |98.6                      |
|----------------|---------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|tetrah ydrofuran|30% sample recovery solution 2                                       |Not detected              |10.9763                   |10.9247                   |99.5                      |
|----------------|---------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|tetrah ydrofuran|30% sample recovery solution 3                                       |Not detected              |10.9763                   |10.7783                   |98.2                      |
|----------------|---------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|tetrah ydrofuran|100% sample recovery solution 1                                      |Not detected              |36.5875                   |36.8776                   |100.8                     |
|----------------|---------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|tetrah ydrofuran|100% sample recovery solution2                                       |Not detected              |36.5875                   |37.0832                   |101.4                     |
|----------------|---------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|tetrah ydrofuran|100% sample recovery solution 3                                      |Not detected              |36.5875                   |36.9783                   |101.1                     |
|----------------|---------------------------------------------------------------------|--------------------------|--------------------------|--------------------------|--------------------------|
|tetrah ydrofuran|150% sample recovery solution 1                                      |Not detected              |54.8813                   |58.3538                   |106.3                     |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 350 of 542 





Page 351
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 










































------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|150% sample recovery solution 3                                               |Not                      |54.8813                  |56.8066                  |103.5                    |                         |
|                                                                              |detected                 |                         |                         |                         |                         |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|Average recovery rate /%                                                      |Average                  |Average                  |Average                  |101.3                    |                         |
|                                                                              |recovery                 |recovery                 |recovery                 |                         |                         |
|                                                                              |rate /%                  |rate /%                  |rate /%                  |                         |                         |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|Recovery rate RSD/%                                                           |Recovery                 |Recovery                 |Recovery                 |2.6                      |                         |
|                                                                              |rate                     |rate                     |rate                     |                         |                         |
|                                                                              |RSD/%                    |RSD/%                    |RSD/%                    |                         |                         |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|Conclusions: Tetrahydrofuran was not detected in the test products, and       |Conclusions:             |Conclusions:             |Conclusions:             |Conclusions:             |                         |
|10.9763μg/ml-54.8813μg/ml of tetrahydrofuran wasaddedinto the test products.  |Tetrahydrofuran          |Tetrahydrofuran          |Tetrahydrofuran          |Tetrahydrofuran          |                         |
|The recovery rates of 9 samples were all in the range of 98.2%-106.3% (the    |was not                  |was not                  |was not                  |was not                  |                         |
|requirement was 85%-115%), and the average recovery rate was 101.3%. The      |detected                 |detected                 |detected                 |detected                 |                         |
|recovery RSD was 2.6% (the requirement was not more than 10%); All the above  |in the                   |in the                   |in the                   |in the                   |                         |
|met the verification requirements, indicating that the method wasaccurate     |test                     |test                     |test                     |test                     |                         |
|indetecting tetrahydrofuran in YA2304.                                        |products,                |products,                |products,                |products,                |                         |
|                                                                              |and                      |and                      |and                      |and                      |                         |
|                                                                              |10.9763μg/ml-54.8813μg/ml|10.9763μg/ml-54.8813μg/ml|10.9763μg/ml-54.8813μg/ml|10.9763μg/ml-54.8813μg/ml|                         |
|                                                                              |of                       |of                       |of                       |of                       |                         |
|                                                                              |tetrahydrofuran          |tetrahydrofuran          |tetrahydrofuran          |tetrahydrofuran          |                         |
|                                                                              |wasaddedinto             |wasaddedinto             |wasaddedinto             |wasaddedinto             |                         |
|                                                                              |the test                 |the test                 |the test                 |the                      |                         |
|                                                                              |products.                |products.                |products.                |test                     |                         |
|                                                                              |The                      |The                      |The                      |products.                |                         |
|                                                                              |recovery                 |recovery                 |recovery                 |The                      |                         |
|                                                                              |rates of                 |rates of                 |rates of                 |recovery                 |                         |
|                                                                              |9                        |9                        |9                        |rates                    |                         |
|                                                                              |samples                  |samples                  |samples                  |of 9                     |                         |
|                                                                              |were all                 |were all                 |were all                 |samples                  |                         |
|                                                                              |in the                   |in the                   |in the                   |were                     |                         |
|                                                                              |range of                 |range of                 |range of                 |all in                   |                         |
|                                                                              |98.2%-106.3%             |98.2%-106.3%             |98.2%-106.3%             |the                      |                         |
|                                                                              |(the                     |(the                     |(the                     |range                    |                         |
|                                                                              |requirement              |requirement              |requirement              |of                       |                         |
|                                                                              |was                      |was                      |was                      |98.2%-106.3%             |                         |
|                                                                              |85%-115%),               |85%-115%),               |85%-115%),               |(the                     |                         |
|                                                                              |and the                  |and the                  |and the                  |requirement              |                         |
|                                                                              |average                  |average                  |average                  |was                      |                         |
|                                                                              |recovery                 |recovery                 |recovery                 |85%-115%),               |                         |
|                                                                              |rate was                 |rate was                 |rate was                 |and the                  |                         |
|                                                                              |101.3%.                  |101.3%.                  |101.3%.                  |average                  |                         |
|                                                                              |The                      |The                      |The                      |recovery                 |                         |
|                                                                              |recovery                 |recovery                 |recovery                 |rate                     |                         |
|                                                                              |RSD was                  |RSD was                  |RSD was                  |was                      |                         |
|                                                                              |2.6%                     |2.6%                     |2.6%                     |101.3%.                  |                         |
|                                                                              |(the                     |(the                     |(the                     |The                      |                         |
|                                                                              |requirement              |requirement              |requirement              |recovery                 |                         |
|                                                                              |was not                  |was not                  |was not                  |RSD was                  |                         |
|                                                                              |more                     |more                     |more                     |2.6%                     |                         |
|                                                                              |than                     |than                     |than                     |(the                     |                         |
|                                                                              |10%);                    |10%);                    |10%);                    |requirement              |                         |
|                                                                              |All the                  |All the                  |All the                  |was not                  |                         |
|                                                                              |above                    |above                    |above                    |more                     |                         |
|                                                                              |met the                  |met the                  |met the                  |than                     |                         |
|                                                                              |verification             |verification             |verification             |10%);                    |                         |
|                                                                              |requirements,            |requirements,            |requirements,            |All the                  |                         |
|                                                                              |indicating               |indicating               |indicating               |above                    |                         |
|                                                                              |that the                 |that the                 |that the                 |met the                  |                         |
|                                                                              |method                   |method                   |method                   |verification             |                         |
|                                                                              |wasaccurate              |wasaccurate              |wasaccurate              |requirements,            |                         |
|                                                                              |indetecting              |indetecting              |indetecting              |indicating               |                         |
|                                                                              |tetrahydrofuran          |tetrahydrofuran          |tetrahydrofuran          |that                     |                         |
|                                                                              |in                       |in                       |in                       |the                      |                         |
|                                                                              |YA2304.                  |YA2304.                  |YA2304.                  |method                   |                         |
|                                                                              |                         |                         |                         |wasaccurate              |                         |
|                                                                              |                         |                         |                         |indetecting              |                         |
|                                                                              |                         |                         |                         |tetrahydrofuran          |                         |
|                                                                              |                         |                         |                         |in                       |                         |
|                                                                              |                         |                         |                         |YA2304.                  |                         |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|Substances Name                                                               |Solution name            |Originalamount in test   |Amountadded (μg/ml)      |Measuredamount (μg/ml)   |Recove                   |
|                                                                              |                         |product (μg/ml)          |                         |                         |ry rate                  |
|                                                                              |                         |                         |                         |                         |/%                       |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|Tolue ne                                                                      |30% sample recovery      |Not detected             |15.0075                  |14.9077                  |99.3                     |
|                                                                              |solution 1               |                         |                         |                         |                         |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|Tolue ne                                                                      |30% sample recovery      |Not detected             |15.0075                  |15.0652                  |100.4                    |
|                                                                              |solution 2               |                         |                         |                         |                         |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|Tolue ne                                                                      |30% sample recovery      |Not detected             |15.0075                  |14.8431                  |98.9                     |
|                                                                              |solution 3               |                         |                         |                         |                         |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|Tolue ne                                                                      |100% sample recovery     |Not detected             |50.0250                  |50.4010                  |100.8                    |
|                                                                              |solution 1               |                         |                         |                         |                         |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|Tolue ne                                                                      |100% sample recovery     |Not detected             |50.0250                  |50.3329                  |100.6                    |
|                                                                              |solution2                |                         |                         |                         |                         |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|Tolue ne                                                                      |100% sample recovery     |Not detected             |50.0250                  |50.7148                  |101.4                    |
|                                                                              |solution 3               |                         |                         |                         |                         |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|Tolue ne                                                                      |150% sample recovery     |Not detected             |75.0375                  |80.9908                  |107.9                    |
|                                                                              |solution 1               |                         |                         |                         |                         |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|Tolue ne                                                                      |150% sample recovery     |Not detected             |75.0375                  |76.8254                  |102.4                    |
|                                                                              |solution2                |                         |                         |                         |                         |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|Tolue ne                                                                      |150% sample recovery     |Not detected             |75.0375                  |77.1206                  |102.8                    |
|                                                                              |solution 3               |                         |                         |                         |                         |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|Tolue ne                                                                      |Average recovery rate/%  |Average recovery rate/%  |Average recovery rate/%  |Average recovery rate/%  |101.6                    |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|Tolue ne                                                                      |Recovery rate RSD/%      |Recovery rate RSD/%      |Recovery rate RSD/%      |Recovery rate RSD/%      |2.7                      |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|Tolue ne                                                                      |Conclusions: Toluene was |Conclusions: Toluene was |Conclusions: Toluene was |Conclusions: Toluene was |Conclusions:             |
|                                                                              |not detected in the test |not detected in the test |not detected in the test |not detected in the test |Toluene                  |
|                                                                              |products, and toluene    |products, and toluene    |products, and toluene    |products, and toluene    |was not                  |
|                                                                              |control products of      |control products of      |control products of      |control products of      |detected                 |
|                                                                              |15.0075μg/ml-75.0375μg/ml|15.0075μg/ml-75.0375μg/ml|15.0075μg/ml-75.0375μg/ml|15.0075μg/ml-75.0375μg/ml|in the                   |
|                                                                              |were addedinto the test  |were addedinto the test  |were addedinto the test  |were addedinto the test  |test                     |
|                                                                              |products. The recoveries |products. The recoveries |products. The recoveries |products. The recoveries |products,                |
|                                                                              |of 9 samples were all in |of 9 samples were all in |of 9 samples were all in |of 9 samples were all in |and                      |
|                                                                              |the range of 98.9%-107.9%|the range of 98.9%-107.9%|the range of 98.9%-107.9%|the range of 98.9%-107.9%|toluene                  |
|                                                                              |(the requirements were in|(the requirements were in|(the requirements were in|(the requirements were in|control                  |
|                                                                              |the range of 85%-115%),  |the range of 85%-115%),  |the range of 85%-115%),  |the range of 85%-115%),  |products                 |
|                                                                              |and the average          |and the average          |and the average          |and the average          |of                       |
|                                                                              |recoveries were 101.6%.  |recoveries were 101.6%.  |recoveries were 101.6%.  |recoveries were 101.6%.  |15.0075μg/ml-75.0375μg/ml|
|                                                                              |The recovery RSD was 2.7%|The recovery RSD was 2.7%|The recovery RSD was 2.7%|The recovery RSD was 2.7%|were                     |
|                                                                              |(no more than 10%        |(no more than 10%        |(no more than 10%        |(no more than 10%        |addedinto                |
|                                                                              |required); All the above |required); All the above |required); All the above |required); All the above |the                      |
|                                                                              |met the verification     |met the verification     |met the verification     |met the verification     |test                     |
|                                                                              |requirements, indicating |requirements, indicating |requirements, indicating |requirements, indicating |products.                |
|                                                                              |that the method          |that the method          |that the method          |that the method          |The                      |
|                                                                              |wasaccurate in detecting |wasaccurate in detecting |wasaccurate in detecting |wasaccurate in detecting |recoveries               |
|                                                                              |toluene in YA2304.       |toluene in YA2304.       |toluene in YA2304.       |toluene in YA2304.       |of 9                     |
|                                                                              |                         |                         |                         |                         |samples                  |
|                                                                              |                         |                         |                         |                         |were                     |
|                                                                              |                         |                         |                         |                         |all in                   |
|                                                                              |                         |                         |                         |                         |the                      |
|                                                                              |                         |                         |                         |                         |range                    |
|                                                                              |                         |                         |                         |                         |of                       |
|                                                                              |                         |                         |                         |                         |98.9%-107.9%             |
|                                                                              |                         |                         |                         |                         |(the                     |
|                                                                              |                         |                         |                         |                         |requirements             |
|                                                                              |                         |                         |                         |                         |were in                  |
|                                                                              |                         |                         |                         |                         |the                      |
|                                                                              |                         |                         |                         |                         |range                    |
|                                                                              |                         |                         |                         |                         |of                       |
|                                                                              |                         |                         |                         |                         |85%-115%),               |
|                                                                              |                         |                         |                         |                         |and the                  |
|                                                                              |                         |                         |                         |                         |average                  |
|                                                                              |                         |                         |                         |                         |recoveries               |
|                                                                              |                         |                         |                         |                         |were                     |
|                                                                              |                         |                         |                         |                         |101.6%.                  |
|                                                                              |                         |                         |                         |                         |The                      |
|                                                                              |                         |                         |                         |                         |recovery                 |
|                                                                              |                         |                         |                         |                         |RSD was                  |
|                                                                              |                         |                         |                         |                         |2.7%                     |
|                                                                              |                         |                         |                         |                         |(no                      |
|                                                                              |                         |                         |                         |                         |more                     |
|                                                                              |                         |                         |                         |                         |than                     |
|                                                                              |                         |                         |                         |                         |10%                      |
|                                                                              |                         |                         |                         |                         |required);               |
|                                                                              |                         |                         |                         |                         |All the                  |
|                                                                              |                         |                         |                         |                         |above                    |
|                                                                              |                         |                         |                         |                         |met the                  |
|                                                                              |                         |                         |                         |                         |verification             |
|                                                                              |                         |                         |                         |                         |requirements,            |
|                                                                              |                         |                         |                         |                         |indicating               |
|                                                                              |                         |                         |                         |                         |that                     |
|                                                                              |                         |                         |                         |                         |the                      |
|                                                                              |                         |                         |                         |                         |method                   |
|                                                                              |                         |                         |                         |                         |wasaccurate              |
|                                                                              |                         |                         |                         |                         |in                       |
|                                                                              |                         |                         |                         |                         |detecting                |
|                                                                              |                         |                         |                         |                         |toluene                  |
|                                                                              |                         |                         |                         |                         |in                       |
|                                                                              |                         |                         |                         |                         |YA2304.                  |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|Substances Name                                                               |Solution name            |Originalamount in test   |Amountadded (μg/ml)      |Measuredamount (μg/ml)   |Recove ry rate /%        |
|                                                                              |                         |product (μg/ml)          |                         |                         |                         |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|N-met hylpy rrolidone                                                         |30% sample recovery      |Not detected             |8.3063                   |7.5231                   |90.6                     |
|                                                                              |solution 1               |                         |                         |                         |                         |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|N-met hylpy rrolidone                                                         |30% sample recovery      |Not detected             |8.3063                   |7.7719                   |93.6                     |
|                                                                              |solution2                |                         |                         |                         |                         |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|N-met hylpy rrolidone                                                         |30% sample recovery      |Not detected             |8.3063                   |8.1034                   |97.6                     |
|                                                                              |solution 3               |                         |                         |                         |                         |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 351 of 542 





Page 352
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 

------------------------------------------------------------------------------
|       |100% sample recovery solution 1|Not detected|27.6875|26.8509|97.0   |
|       |                               |            |       |       |       |
|       |                               |            |       |       |       |
|       |-------------------------------|------------|-------|-------|-------|
|       |100% sample recovery solution 2|Not detected|27.6875|27.1560|98.1   |
|       |-------------------------------|------------|-------|-------|-------|
|       |100% sample recovery solution 3|Not detected|27.6875|26.9525|97.3   |
|       |-------------------------------|------------|-------|-------|-------|
|       |150% sample recovery solution 1|Not detected|41.5313|46.2093|111.3  |
|       |-------------------------------|------------|-------|-------|-------|
|       |150% sample recovery solution 2|Not detected|41.5313|42.9870|103.5  |
|       |-------------------------------|------------|-------|-------|-------|
|       |150% sample recovery solution 3|Not detected|41.5313|39.6163|95.4   |
|       |-------------------------------|------------|-------|-------|-------|
|       |Average recovery rate /%                                    |98.3   |
|       |------------------------------------------------------------|-------|
|       |Recovery rate RSD/%                                         |7      |
------------------------------------------------------------------------------



**(4.6) Precision** 



Precision refers to the proximity between the results obtained by multiple 



sampling of the same uniform test product under specified test conditions, 



and its precision is judged by examining repeatability and reproducibility. 



**(4.6.1) Repeatability** 



 **Acceptance Criteria** 



6 repeatable sample solutions were prepared by analyst A on date A and 



measured by instrument A; The blank solution should be free from 



interference; In the chromatogram obtained from the control product 



solution, ethanol, isopropyl alcohol, ethyl acetate, secondary butanol, 



tetrahydrofuran, toluene, n-methylpyrrolidone peaks in turn, and the 



separation degree between each adjacent peak should be greater than 1.5. 



The RSD of each solvent in the 6 repeatable test product solutions NMT 10%. 



 **Solution preparation** 



Blank solution: solvent (N, n-dimethylformamide). 



Ethanol reference stock: Share ethanol reference stock under "4.1 System 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 352 of 542 





Page 353
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Suitability". (Approx. 50,000 μg/ml) 



Isopropyl alcohol reference reserve: Share isopropyl alcohol reference reserve 



under "4.1 System Suitability". (Approx. 50,000 μg/ml) 



Ethyl acetate reference reserve: Share the ethyl acetate reference reserve 



under "4.1 System Suitability". (Approx. 50,000 μg/ml) 



Secondary butanol reference product reserve: Share secondary butanol 



versus reference product reserve solution under "4.1 System Suitability". 



(Approx. 50,000 μg/ml) 



Tetrahydrofuran reference storage solution: Share tetrahydrofuran reference 



storage solution under "4.1 System Suitability". (Approx. 7200μg/ml) 



Toluene reference reserve: Share toluene reference reserve under "4.1 System 



Suitability". (Approx. 8900μg/ml) 



N-methylpyrrolidone reference stock: Share the N-methylpyrrolidone 



reference stock under "4.1 System Suitability". (Approx. 5300μg/ml) 



Repeatable reference product reserve liquid: precision measure ethanol 



reference product reserve liquid, isopropyl alcohol reference product reserve 



liquid, ethyl acetate reference product reserve liquid, secondary butanol 



reference product reserve liquid, tetrahydrofuran reference product reserve 



liquid, toluene reference product reserve liquid, N-methylpyrrolidone 



reference product reserve liquid 1.0ml each, put in 20ml bottle, dilute with 



solvent to scale, shake well, and obtain. (Ethanol about 2500μg/ml, 



isopropyl alcohol about 2500μg/ml, ethyl acetate about 2500μg/ml, 



secondary butanol about 2500μg/ml, tetrahydrofuran about 370μg/ml, 



toluene about 445μg/ml, N-methylpyrrolidone about 265μg/ml) 



Reference product solution: Accurately measure 1.0ml of the duplicate 



reference product reserve solution, place it in a 10ml bottle, dilute it with 



solvent to the scale, and shake well. (Ethanol about 250μg/ml, isopropyl 



alcohol about 250μg/ml, ethyl acetate about 250μg/ml, secondary butanol 



about 250μg/ml, tetrahydrofuran about 37μg/ml, toluene about 44.5μg/ml, 



N-methylpyrrolidone about 26.5μg/ml) 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 353 of 542 





Page 354
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Repeatable test product solution: accurately weigh about 0.5g of this product, 



accurately weigh it, put it in 10ml measuring bottle, then accurately measure 



1.0ml of repeatable control product reserve liquid, put it in the same 



measuring bottle, dissolve it with solvent and dilute it to the scale, shake well, 



and obtain. (Parallel preparation of 6 parts) 



 **Injection procedure** 



After the blank solution, the control solution and 6 repetitive test product 



solutions were injected respectively, and the chromatogram was recorded. 



 **Measurement resultss** 



Results of repeatability - system suitability test 

------------------------------------------------------------------------------------------------------------------------------------------------------
|Name of solvent                                                                                       |Reference             |Control               |
|                                                                                                      |solution              |solution              |
|                                                                                                      |-1                    |-2                    |
|------------------------------------------------------------------------------------------------------|----------------------|----------------------|
|Ethanol                                                                                               |/                     |/                     |
|------------------------------------------------------------------------------------------------------|----------------------|----------------------|
|Isopropylalcohol                                                                                      |8.5                   |8.5                   |
|------------------------------------------------------------------------------------------------------|----------------------|----------------------|
|Ethylacetate                                                                                          |28.6                  |28.6                  |
|------------------------------------------------------------------------------------------------------|----------------------|----------------------|
|sec-butanol                                                                                           |1.8                   |1.8                   |
|------------------------------------------------------------------------------------------------------|----------------------|----------------------|
|tetrahydrofuran                                                                                       |1.9                   |1.9                   |
|------------------------------------------------------------------------------------------------------|----------------------|----------------------|
|Toluene                                                                                               |37.8                  |37.6                  |
|------------------------------------------------------------------------------------------------------|----------------------|----------------------|
|N-methylpyrrolidone                                                                                   |93.7                  |93.9                  |
|------------------------------------------------------------------------------------------------------|----------------------|----------------------|
|Conclusion: The blank solution has no interference; Ethanol, isopropylalcohol, ethylacetate, secondary|Conclusion:           |Conclusion:           |
|butanol, tetrahydrofuran, toluene andn-methylpyrrolidone peaked in sequence in the                    |The blank             |The                   |
|chromatogramobtained from the control solution, and the separation degree betweeneachadjacent solvent |solution              |blank                 |
|peak was greater than 1.5 (the requirement was greater than 1.5). The suitability of the system meets |has no                |solution              |
|the requirements.                                                                                     |interference;         |has no                |
|                                                                                                      |Ethanol,              |interference;         |
|                                                                                                      |isopropylalcohol,     |Ethanol,              |
|                                                                                                      |ethylacetate,         |isopropylalcohol,     |
|                                                                                                      |secondary             |ethylacetate,         |
|                                                                                                      |butanol,              |secondary             |
|                                                                                                      |tetrahydrofuran,      |butanol,              |
|                                                                                                      |toluene               |tetrahydrofuran,      |
|                                                                                                      |andn-methylpyrrolidone|toluene               |
|                                                                                                      |peaked in             |andn-methylpyrrolidone|
|                                                                                                      |sequence              |peaked                |
|                                                                                                      |in the                |in                    |
|                                                                                                      |chromatogramobtained  |sequence              |
|                                                                                                      |from the              |in the                |
|                                                                                                      |control               |chromatogramobtained  |
|                                                                                                      |solution,             |from the              |
|                                                                                                      |and the               |control               |
|                                                                                                      |separation            |solution,             |
|                                                                                                      |degree                |and the               |
|                                                                                                      |betweeneachadjacent   |separation            |
|                                                                                                      |solvent               |degree                |
|                                                                                                      |peak was              |betweeneachadjacent   |
|                                                                                                      |greater               |solvent               |
|                                                                                                      |than 1.5              |peak was              |
|                                                                                                      |(the                  |greater               |
|                                                                                                      |requirement           |than 1.5              |
|                                                                                                      |was                   |(the                  |
|                                                                                                      |greater               |requirement           |
|                                                                                                      |than                  |was                   |
|                                                                                                      |1.5). The             |greater               |
|                                                                                                      |suitability           |than                  |
|                                                                                                      |of the                |1.5).                 |
|                                                                                                      |system                |The                   |
|                                                                                                      |meets the             |suitability           |
|                                                                                                      |requirements.         |of the                |
|                                                                                                      |                      |system                |
|                                                                                                      |                      |meets                 |
|                                                                                                      |                      |the                   |
|                                                                                                      |                      |requirements.         |
------------------------------------------------------------------------------------------------------------------------------------------------------



Repeatability test results 




























--------------------------------------------------------------------------------------------------------------------------------
|Name of solvent Solution name|Repetiti ve test produc tsolution 1|Repetiti ve |Repetiti |Repetiti |Repetiti |Repetiti |RSD/ % |
|                             |                                   |test produc |ve test  |ve test  |ve test  |ve test  |(n=6)  |
|                             |                                   |tsolution 2 |produc   |produc   |produc   |produc   |       |
|                             |                                   |            |tsolution|tsolution|tsolution|tsolution|       |
|                             |                                   |            |3        |4        |5        |6        |       |
|-----------------------------|-----------------------------------|------------|---------|---------|---------|---------|-------|
|Ethanol                      |0.5754                             |0.5806      |0.5779   |0.5758   |0.5773   |0.5687   |0.7    |
|-----------------------------|-----------------------------------|------------|---------|---------|---------|---------|-------|
|Isopropyl                    |0.4952                             |0.4992      |0.4955   |0.4953   |0.4918   |0.4882   |0.8    |
--------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 354 of 542 





Page 355
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



















-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Ethylacetate                                                  |0.5128                  |0.5167                  |0.5124                  |0.5123                  |0.5097                  |0.5048                  |0.8                     |
|--------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|Sec-butylalcohol                                              |0.4972                  |0.4949                  |0.4925                  |0.4977                  |0.4880                  |0.4893                  |0.9                     |
|--------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|tetrahydrofuran                                               |0.0756                  |0.0750                  |0.0748                  |0.0753                  |0.0740                  |0.0738                  |1.0                     |
|--------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|Toluene                                                       |0.1033                  |0.1043                  |0.1031                  |0.1034                  |0.1027                  |0.1013                  |1.0                     |
|--------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|N-methylpyrrolidone                                           |0.0592                  |0.0584                  |0.0583                  |0.0579                  |0.0574                  |0.0559                  |2.0                     |
|--------------------------------------------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|------------------------|
|Verdict: The RSD ofethanol content was 0.7% (required less    |Verdict:                |Verdict:                |Verdict:                |Verdict:                |Verdict:                |Verdict:                |Verdict:                |
|than 10%), the RSD ofisopropylalcohol content was 0.8%        |The RSD                 |The RSD                 |The RSD                 |The RSD                 |The RSD                 |The RSD                 |The RSD                 |
|(required less than 10%), the RSD ofethylacetate content was  |ofethanol               |ofethanol               |ofethanol               |ofethanol               |ofethanol               |ofethanol               |ofethanol               |
|0.8% (required less than 10%), and the RSD of secondary       |content                 |content                 |content                 |content                 |content                 |content                 |content                 |
|butanol content was 0.9% (required less than 10%). RSD of     |was                     |was                     |was                     |was                     |was                     |was                     |was                     |
|tetrahydrofuran was 1.0% (NMT 10%), RSD of toluene was 1.0%   |0.7%                    |0.7%                    |0.7%                    |0.7%                    |0.7%                    |0.7%                    |0.7%                    |
|(NMT 10%), and RSDofN-methylpyrrolidone was 2.0% (NMT 10%);   |(required               |(required               |(required               |(required               |(required               |(required               |(required               |
|All the above met the verification requirements, indicating   |less                    |less                    |less                    |less                    |less                    |less                    |less                    |
|that the method had good repeatability.                       |than                    |than                    |than                    |than                    |than                    |than                    |than                    |
|                                                              |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |
|                                                              |the RSD                 |the RSD                 |the RSD                 |the RSD                 |the RSD                 |the RSD                 |the RSD                 |
|                                                              |ofisopropylalcohol      |ofisopropylalcohol      |ofisopropylalcohol      |ofisopropylalcohol      |ofisopropylalcohol      |ofisopropylalcohol      |ofisopropylalcohol      |
|                                                              |content                 |content                 |content                 |content                 |content                 |content                 |content                 |
|                                                              |was                     |was                     |was                     |was                     |was                     |was                     |was                     |
|                                                              |0.8%                    |0.8%                    |0.8%                    |0.8%                    |0.8%                    |0.8%                    |0.8%                    |
|                                                              |(required               |(required               |(required               |(required               |(required               |(required               |(required               |
|                                                              |less                    |less                    |less                    |less                    |less                    |less                    |less                    |
|                                                              |than                    |than                    |than                    |than                    |than                    |than                    |than                    |
|                                                              |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |
|                                                              |the RSD                 |the RSD                 |the RSD                 |the RSD                 |the RSD                 |the RSD                 |the RSD                 |
|                                                              |ofethylacetate          |ofethylacetate          |ofethylacetate          |ofethylacetate          |ofethylacetate          |ofethylacetate          |ofethylacetate          |
|                                                              |content                 |content                 |content                 |content                 |content                 |content                 |content                 |
|                                                              |was                     |was                     |was                     |was                     |was                     |was                     |was                     |
|                                                              |0.8%                    |0.8%                    |0.8%                    |0.8%                    |0.8%                    |0.8%                    |0.8%                    |
|                                                              |(required               |(required               |(required               |(required               |(required               |(required               |(required               |
|                                                              |less                    |less                    |less                    |less                    |less                    |less                    |less                    |
|                                                              |than                    |than                    |than                    |than                    |than                    |than                    |than                    |
|                                                              |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |
|                                                              |and the                 |and the                 |and the                 |and the                 |and the                 |and the                 |and the                 |
|                                                              |RSD of                  |RSD of                  |RSD of                  |RSD of                  |RSD of                  |RSD of                  |RSD of                  |
|                                                              |secondary               |secondary               |secondary               |secondary               |secondary               |secondary               |secondary               |
|                                                              |butanol                 |butanol                 |butanol                 |butanol                 |butanol                 |butanol                 |butanol                 |
|                                                              |content                 |content                 |content                 |content                 |content                 |content                 |content                 |
|                                                              |was                     |was                     |was                     |was                     |was                     |was                     |was                     |
|                                                              |0.9%                    |0.9%                    |0.9%                    |0.9%                    |0.9%                    |0.9%                    |0.9%                    |
|                                                              |(required               |(required               |(required               |(required               |(required               |(required               |(required               |
|                                                              |less                    |less                    |less                    |less                    |less                    |less                    |less                    |
|                                                              |than                    |than                    |than                    |than                    |than                    |than                    |than                    |
|                                                              |10%).                   |10%).                   |10%).                   |10%).                   |10%).                   |10%).                   |10%).                   |
|                                                              |RSD of                  |RSD of                  |RSD of                  |RSD of                  |RSD of                  |RSD of                  |RSD of                  |
|                                                              |tetrahydrofuran         |tetrahydrofuran         |tetrahydrofuran         |tetrahydrofuran         |tetrahydrofuran         |tetrahydrofuran         |tetrahydrofuran         |
|                                                              |was                     |was                     |was                     |was                     |was                     |was                     |was                     |
|                                                              |1.0%                    |1.0%                    |1.0%                    |1.0%                    |1.0%                    |1.0%                    |1.0%                    |
|                                                              |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |
|                                                              |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |
|                                                              |RSD of                  |RSD of                  |RSD of                  |RSD of                  |RSD of                  |RSD of                  |RSD of                  |
|                                                              |toluene                 |toluene                 |toluene                 |toluene                 |toluene                 |toluene                 |toluene                 |
|                                                              |was                     |was                     |was                     |was                     |was                     |was                     |was                     |
|                                                              |1.0%                    |1.0%                    |1.0%                    |1.0%                    |1.0%                    |1.0%                    |1.0%                    |
|                                                              |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |
|                                                              |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |
|                                                              |and                     |and                     |and                     |and                     |and                     |and                     |and                     |
|                                                              |RSDofN-methylpyrrolidone|RSDofN-methylpyrrolidone|RSDofN-methylpyrrolidone|RSDofN-methylpyrrolidone|RSDofN-methylpyrrolidone|RSDofN-methylpyrrolidone|RSDofN-methylpyrrolidone|
|                                                              |was                     |was                     |was                     |was                     |was                     |was                     |was                     |
|                                                              |2.0%                    |2.0%                    |2.0%                    |2.0%                    |2.0%                    |2.0%                    |2.0%                    |
|                                                              |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |
|                                                              |10%);                   |10%);                   |10%);                   |10%);                   |10%);                   |10%);                   |10%);                   |
|                                                              |All the                 |All the                 |All the                 |All the                 |All the                 |All the                 |All the                 |
|                                                              |above                   |above                   |above                   |above                   |above                   |above                   |above                   |
|                                                              |met the                 |met the                 |met the                 |met the                 |met the                 |met the                 |met the                 |
|                                                              |verification            |verification            |verification            |verification            |verification            |verification            |verification            |
|                                                              |requirements,           |requirements,           |requirements,           |requirements,           |requirements,           |requirements,           |requirements,           |
|                                                              |indicating              |indicating              |indicating              |indicating              |indicating              |indicating              |indicating              |
|                                                              |that                    |that                    |that                    |that                    |that                    |that                    |that                    |
|                                                              |the                     |the                     |the                     |the                     |the                     |the                     |the                     |
|                                                              |method                  |method                  |method                  |method                  |method                  |method                  |method                  |
|                                                              |had                     |had                     |had                     |had                     |had                     |had                     |had                     |
|                                                              |good                    |good                    |good                    |good                    |good                    |good                    |good                    |
|                                                              |repeatability.          |repeatability.          |repeatability.          |repeatability.          |repeatability.          |repeatability.          |repeatability.          |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**(4.6.2) Reproducibility** 



 **Acceptance Criteria** 



6 reproducible sample solutions were prepared by Analyst B on date B and 



determined using analytical laboratory instruments. The blank solution 



should be free of interference; In the chromatogram obtained for 6 



consecutive days, ethanol, isopropyl alcohol, ethyl acetate, secondary 



butanol, tetrahydrofuran, toluene, n-methylpyrrolidone peaks in turn, and 



the separation degree between each adjacent peak should be greater than 1.5. 



The RSD of the peak retention time of each solvent peak should NMT 1.0%, 



and the RSD of the peak area should NMT 10%. The RSD of each solvent in 6 



reproducible sample solutions NMT 10%; 



In the results of 12 repeatability and reproducibility tests, the RSD of each 



solvent content NMT 10%. 



 **Solution preparation** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 355 of 542 





Page 356
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Blank solution: solvent (N, n-dimethylformamide). 



Ethanol reference product reserve liquid: precision weigh ethanol about 



1000mg, put in 20ml bottle, dissolve with solvent and dilute to the scale, 



shake well, ready. (About 50000μg/ml) 



Isopropyl alcohol reference product reserve liquid: precision weigh isopropyl 



alcohol about 1000mg, place in 20ml bottle, dissolve with solvent and dilute 



to the scale, shake well, ready. (About 50000μg/ml) 



Ethyl acetate reference product reserve liquid: precision weigh about 1000mg 



of ethyl acetate, place in 20ml measuring bottle, dissolve and dilute with 



solvent to scale, shake well, ready. (Approx. 50000μg/ml) 



Secondary butanol reference product reserve liquid: precision weigh 



secondary butanol about 1000mg, place in 20ml bottle, dissolve and dilute 



with solvent to scale, shake well, then get. (About 50000μg/ml) 



Tetrahydrofuran reference product reserve liquid: accurately weigh 



tetrahydrofuran about 144mg, put it in 20ml bottle, dissolve it with solvent 



and dilute it to the scale, shake well, and then get. (About 7200μg/ml) 



Toluene control product reserve liquid: precision weigh toluene about 178mg, 



place in 20ml bottle, dissolve and dilute with solvent to scale, shake well, 



ready. (About 8900μg/ml) 



N-methylpyrrolidone reference product reserve liquid: accurately weigh 



N-methylpyrrolidone about 106mg, place in 20ml measuring bottle, dissolve 



and dilute with solvent to scale, shake well, then obtain. (About 5300μg/ml) 



Repeatable reference product reserve liquid: precision measure ethanol 



reference product reserve liquid, isopropyl alcohol reference product reserve 



liquid, ethyl acetate reference product reserve liquid, secondary butanol 



reference product reserve liquid, tetrahydrofuran reference product reserve 



liquid, toluene reference product reserve liquid, N-methylpyrrolidone 



reference product reserve liquid 1.0ml each, put in a 20ml bottle, dilute with 



solvent to the scale, shake well, and obtain. (Ethanol about 2500μg/ml, 



isopropyl alcohol about 2500μg/ml, ethyl acetate about 2500μg/ml, 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 356 of 542 





Page 357
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



secondary butanol about 2500μg/ml, tetrahydrofuran about 360μg/ml, 



toluene about 445μg/ml, N-methylpyrrolidone about 265μg/ml) 



Reference solution: Accurately measure 1.0ml of the reproducible reference 



reserve solution, place it in a 10ml measuring bottle, dilute it with solvent to 



the scale, shake well, and obtain. (Ethanol about 250μg/ml, isopropyl 



alcohol about 250μg/ml, ethyl acetate about 250μg/ml, secondary butanol 



about 250μg/ml, tetrahydrofuran about 36μg/ml, toluene about 44.5μg/ml, 



N-methylpyrrolidone about 26.5μg/ml) 



Reproducible test product solution: accurately weigh about 0.5g of this 



product, accurately weigh it, place it in 10ml measuring bottle, then 



accurately measure 1.0ml of reproducible control product reserve liquid, 



place it in the same measuring bottle, dissolve it with solvent and dilute it to 



the scale, shake well, and obtain. (Parallel preparation of 6 servings) 



 **Injection procedure** 



Reproducibility - System suitability: After the blank solution, continuous 



injection 6 for the sample solution, record the chromatogram. 



Reproducibility - Sample testing: After the blank solution, continuously 



inject 2 samples for the image solution and 6 reproducible test solution, and 



record the chromatogram. 



 **Measurement results** 



Reproducibility - system suitability test results 































































--------------------------------------------------------------------------------------------------------
|Name of solvent  |Parameter values|1        |2        |3        |4        |5        |6        |6      |
|-----------------|----------------|---------|---------|---------|---------|---------|---------|-------|
|Etha nol         |RT (min)        |8.529    |8.529    |8.529    |8.525    |8.527    |8.529    |0.02 0 |
|-----------------|----------------|---------|---------|---------|---------|---------|---------|-------|
|Etha nol         |Peakarea        |222.63 71|225.75 16|225.22 03|224.29 74|223.14 25|221.57 64|0.8    |
|-----------------|----------------|---------|---------|---------|---------|---------|---------|-------|
|Etha nol         |Separation      |/        |/        |/        |/        |/        |/        |/      |
|-----------------|----------------|---------|---------|---------|---------|---------|---------|-------|
|Isop ropylalcohol|RT (min)        |9.933    |9.932    |9.932    |9.928    |9.930    |9.932    |0.01 9 |
|-----------------|----------------|---------|---------|---------|---------|---------|---------|-------|
|Isop ropylalcohol|Peakarea        |221.84 10|224.06 69|225.77 57|223.69 06|221.82 37|221.34 30|0.8    |
--------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 357 of 542 





Page 358
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



































































































































































------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Ethylacetate                                          |RT                    |14.546                |14.545                |14.546                |14.543                |14.546                |14.547                |0.01 0                |
|                                                      |(min)                 |                      |                      |                      |                      |                      |                      |                      |
|------------------------------------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|Ethylacetate                                          |Peakarea              |184.41                |187.26                |187.34                |185.48                |185.10                |183.09                |0.9                   |
|                                                      |                      |56                    |00                    |29                    |64                    |12                    |72                    |                      |
|------------------------------------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|Ethylacetate                                          |Separation            |29.0                  |28.9                  |28.8                  |28.9                  |29.0                  |29.1                  |/                     |
|------------------------------------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|Seco ndary bu tanol                                   |RT (min)              |14.815                |14.815                |14.816                |14.813                |14.816                |14.817                |0.01 0                |
|------------------------------------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|Seco ndary bu tanol                                   |Peakarea              |291.66                |297.07                |297.74                |295.10                |294.48                |290.67                |1.0                   |
|                                                      |                      |44                    |76                    |93                    |50                    |60                    |89                    |                      |
|------------------------------------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|Seco ndary bu tanol                                   |Separation            |1.7                   |1.7                   |1.7                   |1.7                   |1.7                   |1.7                   |/                     |
|------------------------------------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|tetra hydrofur an                                     |RT (min)              |15.125                |15.123                |15.124                |15.122                |15.123                |15.126                |0.01 0                |
|------------------------------------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|tetra hydrofur an                                     |Peakarea              |39.618                |41.084                |40.338                |40.160                |41.254                |39.426                |1.9                   |
|                                                      |                      |2                     |2                     |7                     |9                     |7                     |3                     |                      |
|------------------------------------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|tetra hydrofur an                                     |Separation            |2.0                   |2.0                   |2.0                   |2.0                   |2.0                   |2.0                   |/                     |
|------------------------------------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|Tolu ene                                              |RT (min)              |20.400                |20.398                |20.398                |20.398                |20.401                |20.401                |0.00 8                |
|------------------------------------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|Tolu ene                                              |Peakarea              |94.967                |96.218                |96.464                |95.508                |95.164                |94.401                |0.9                   |
|                                                      |                      |9                     |0                     |1                     |1                     |9                     |7                     |                      |
|------------------------------------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|Tolu ene                                              |Separation            |37.4                  |37.2                  |37.4                  |37.3                  |37.2                  |37.4                  |/                     |
|------------------------------------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|N-methy lpyrrolido ne                                 |RT (min)              |31.551                |31.549                |31.549                |31.549                |31.551                |31.552                |0.00 5                |
|------------------------------------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|N-methy lpyrrolido ne                                 |Peakarea              |32.709                |32.704                |32.738                |31.226                |33.035                |32.010                |3.1                   |
|                                                      |                      |8                     |6                     |0                     |5                     |4                     |2                     |                      |
|------------------------------------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|N-methy lpyrrolido ne                                 |Separation            |92.4                  |92.6                  |92.5                  |92.8                  |92.7                  |92.6                  |/                     |
|------------------------------------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|Conclusion: There was no interference in the blank    |Conclusion:           |Conclusion:           |Conclusion:           |Conclusion:           |Conclusion:           |Conclusion:           |Conclusion:           |Conclusion:           |
|solution. In the chromatogramobtained for 6           |There was             |There                 |There                 |There                 |There                 |There                 |There                 |There                 |
|consecutive days, peaks ofethanol, isopropylalcohol,  |no                    |was no                |was no                |was no                |was no                |was no                |was no                |was no                |
|ethylacetate, secondary butanol, tetrahydrofuran,     |interference          |interference          |interference          |interference          |interference          |interference          |interference          |interference          |
|toluene andn-methylpyrrolidone appeared successively, |in the                |in the                |in the                |in the                |in the                |in the                |in the                |in the                |
|and the separation degree betweeneachadjacent solvent |blank                 |blank                 |blank                 |blank                 |blank                 |blank                 |blank                 |blank                 |
|peak was greater than 1.5 (the requirement was greater|solution.             |solution.             |solution.             |solution.             |solution.             |solution.             |solution.             |solution.             |
|than 1.5). The RSD ofethanol peak retention time was  |In the                |In the                |In the                |In the                |In the                |In the                |In the                |In the                |
|0.020% (required less than 1.0%), and the RSD of      |chromatogramobtained  |chromatogramobtained  |chromatogramobtained  |chromatogramobtained  |chromatogramobtained  |chromatogramobtained  |chromatogramobtained  |chromatogramobtained  |
|peakarea was                                          |for 6                 |for 6                 |for 6                 |for 6                 |for 6                 |for 6                 |for 6                 |for 6                 |
|                                                      |consecutive           |consecutive           |consecutive           |consecutive           |consecutive           |consecutive           |consecutive           |consecutive           |
|                                                      |days,                 |days,                 |days,                 |days,                 |days,                 |days,                 |days,                 |days,                 |
|                                                      |peaks                 |peaks                 |peaks                 |peaks                 |peaks                 |peaks                 |peaks                 |peaks                 |
|                                                      |ofethanol,            |ofethanol,            |ofethanol,            |ofethanol,            |ofethanol,            |ofethanol,            |ofethanol,            |ofethanol,            |
|                                                      |isopropylalcohol,     |isopropylalcohol,     |isopropylalcohol,     |isopropylalcohol,     |isopropylalcohol,     |isopropylalcohol,     |isopropylalcohol,     |isopropylalcohol,     |
|                                                      |ethylacetate,         |ethylacetate,         |ethylacetate,         |ethylacetate,         |ethylacetate,         |ethylacetate,         |ethylacetate,         |ethylacetate,         |
|                                                      |secondary             |secondary             |secondary             |secondary             |secondary             |secondary             |secondary             |secondary             |
|                                                      |butanol,              |butanol,              |butanol,              |butanol,              |butanol,              |butanol,              |butanol,              |butanol,              |
|                                                      |tetrahydrofuran,      |tetrahydrofuran,      |tetrahydrofuran,      |tetrahydrofuran,      |tetrahydrofuran,      |tetrahydrofuran,      |tetrahydrofuran,      |tetrahydrofuran,      |
|                                                      |toluene               |toluene               |toluene               |toluene               |toluene               |toluene               |toluene               |toluene               |
|                                                      |andn-methylpyrrolidone|andn-methylpyrrolidone|andn-methylpyrrolidone|andn-methylpyrrolidone|andn-methylpyrrolidone|andn-methylpyrrolidone|andn-methylpyrrolidone|andn-methylpyrrolidone|
|                                                      |appeared              |appeared              |appeared              |appeared              |appeared              |appeared              |appeared              |appeared              |
|                                                      |successively,         |successively,         |successively,         |successively,         |successively,         |successively,         |successively,         |successively,         |
|                                                      |and the               |and the               |and the               |and the               |and the               |and the               |and the               |and the               |
|                                                      |separation            |separation            |separation            |separation            |separation            |separation            |separation            |separation            |
|                                                      |degree                |degree                |degree                |degree                |degree                |degree                |degree                |degree                |
|                                                      |betweeneachadjacent   |betweeneachadjacent   |betweeneachadjacent   |betweeneachadjacent   |betweeneachadjacent   |betweeneachadjacent   |betweeneachadjacent   |betweeneachadjacent   |
|                                                      |solvent               |solvent               |solvent               |solvent               |solvent               |solvent               |solvent               |solvent               |
|                                                      |peak was              |peak                  |peak                  |peak                  |peak                  |peak                  |peak                  |peak                  |
|                                                      |greater               |was                   |was                   |was                   |was                   |was                   |was                   |was                   |
|                                                      |than 1.5              |greater               |greater               |greater               |greater               |greater               |greater               |greater               |
|                                                      |(the                  |than                  |than                  |than                  |than                  |than                  |than                  |than                  |
|                                                      |requirement           |1.5                   |1.5                   |1.5                   |1.5                   |1.5                   |1.5                   |1.5                   |
|                                                      |was                   |(the                  |(the                  |(the                  |(the                  |(the                  |(the                  |(the                  |
|                                                      |greater               |requirement           |requirement           |requirement           |requirement           |requirement           |requirement           |requirement           |
|                                                      |than 1.5).            |was                   |was                   |was                   |was                   |was                   |was                   |was                   |
|                                                      |The RSD               |greater               |greater               |greater               |greater               |greater               |greater               |greater               |
|                                                      |ofethanol             |than                  |than                  |than                  |than                  |than                  |than                  |than                  |
|                                                      |peak                  |1.5).                 |1.5).                 |1.5).                 |1.5).                 |1.5).                 |1.5).                 |1.5).                 |
|                                                      |retention             |The RSD               |The RSD               |The RSD               |The RSD               |The RSD               |The RSD               |The RSD               |
|                                                      |time was              |ofethanol             |ofethanol             |ofethanol             |ofethanol             |ofethanol             |ofethanol             |ofethanol             |
|                                                      |0.020%                |peak                  |peak                  |peak                  |peak                  |peak                  |peak                  |peak                  |
|                                                      |(required             |retention             |retention             |retention             |retention             |retention             |retention             |retention             |
|                                                      |less than             |time                  |time                  |time                  |time                  |time                  |time                  |time                  |
|                                                      |1.0%), and            |was                   |was                   |was                   |was                   |was                   |was                   |was                   |
|                                                      |the RSD of            |0.020%                |0.020%                |0.020%                |0.020%                |0.020%                |0.020%                |0.020%                |
|                                                      |peakarea              |(required             |(required             |(required             |(required             |(required             |(required             |(required             |
|                                                      |was                   |less                  |less                  |less                  |less                  |less                  |less                  |less                  |
|                                                      |                      |than                  |than                  |than                  |than                  |than                  |than                  |than                  |
|                                                      |                      |1.0%),                |1.0%),                |1.0%),                |1.0%),                |1.0%),                |1.0%),                |1.0%),                |
|                                                      |                      |and the               |and the               |and the               |and the               |and the               |and the               |and the               |
|                                                      |                      |RSD of                |RSD of                |RSD of                |RSD of                |RSD of                |RSD of                |RSD of                |
|                                                      |                      |peakarea              |peakarea              |peakarea              |peakarea              |peakarea              |peakarea              |peakarea              |
|                                                      |                      |was                   |was                   |was                   |was                   |was                   |was                   |was                   |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 358 of 542 





Page 359
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



0.8% (required less than 10%). The RSD of isopropyl alcohol peak retention time was 



0.019% (NMT 1.0%), and the RSD of peak area was 0.8% (NMT 10%); The RSD of the 



ethyl acetate peak was 0.010% (NMT 1.0%), and the RSD of the peak area was 0.9% 



(NMT 10%); The RSD of secondary butanol was 0.010% (NMT 1.0%), and the RSD of 



peak area was 1.0% (NMT 10%); The RSD of the peak retention time of 



tetrahydrofuran was 0.010% (NMT 1.0%), and the RSD of the peak area was 1.9% 



(NMT 10%); The RSD of toluene peak was 0.008% (NMT 1.0%), and the RSD of peak 



area was 0.9% (NMT 10%); The RSD of the N-methylpyrrolidone peak was 0.005% 



(NMT 1.0%), and the RSD of the peak area was 2.1% (NMT 10%); The suitability of the 



system met the verification requirements. 



Precision (repeatability and reproducibility) test results 
























































































---------------------------------------------------------------------------------------------------------------------------------------------------------
|Solvent name Solution name|Solvent name Solution name|Repeatability|Repeatability|Repeatability|Repeatability|Repeatability|Repeatability|Repeatability|
|--------------------------|--------------------------|-------------|-------------|-------------|-------------|-------------|-------------|-------------|
|Solvent name Solution name|Solvent name Solution name|1            |2            |3            |4            |5            |6            |RSD (n=6)    |
|--------------------------|--------------------------|-------------|-------------|-------------|-------------|-------------|-------------|-------------|
|Repeatabi lity            |Ethanol                   |0.5754       |0.5806       |0.5779       |0.5758       |0.5773       |0.5687       |0.7%         |
|--------------------------|--------------------------|-------------|-------------|-------------|-------------|-------------|-------------|-------------|
|Repeatabi lity            |Isopropylalcohol          |0.4952       |0.4992       |0.4955       |0.4953       |0.4918       |0.4882       |0.8%         |
|--------------------------|--------------------------|-------------|-------------|-------------|-------------|-------------|-------------|-------------|
|Repeatabi lity            |Ethylacetate              |0.5128       |0.5167       |0.5124       |0.5123       |0.5097       |0.5048       |0.8%         |
|--------------------------|--------------------------|-------------|-------------|-------------|-------------|-------------|-------------|-------------|
|Repeatabi lity            |sec-butanol               |0.4972       |0.4949       |0.4925       |0.4977       |0.4880       |0.4893       |0.9%         |
|--------------------------|--------------------------|-------------|-------------|-------------|-------------|-------------|-------------|-------------|
|Repeatabi lity            |tetrahydrofuran           |0.0756       |0.0750       |0.0748       |0.0753       |0.0740       |0.0738       |1.0%         |
|--------------------------|--------------------------|-------------|-------------|-------------|-------------|-------------|-------------|-------------|
|Repeatabi lity            |Toluene                   |0.1033       |0.1043       |0.1031       |0.1034       |0.1027       |0.1013       |1.0%         |
|--------------------------|--------------------------|-------------|-------------|-------------|-------------|-------------|-------------|-------------|
|Repeatabi lity            |N-methylpyrroli done      |0.0592       |0.0584       |0.0583       |0.0579       |0.0574       |0.0559       |2.0%         |
|--------------------------|--------------------------|-------------|-------------|-------------|-------------|-------------|-------------|-------------|
|Reproduci bi lity         |Ethanol                   |0.5943       |0.6102       |0.6295       |0.5872       |0.5492       |0.5650       |5%           |
|--------------------------|--------------------------|-------------|-------------|-------------|-------------|-------------|-------------|-------------|
|Reproduci bi lity         |Isopropylalcohol          |0.4836       |0.4946       |0.5138       |0.4762       |0.4493       |0.4600       |5%           |
|--------------------------|--------------------------|-------------|-------------|-------------|-------------|-------------|-------------|-------------|
|Reproduci bi lity         |Ethylacetate              |0.5049       |0.5139       |0.5255       |0.4973       |0.4681       |0.4797       |5%           |
|--------------------------|--------------------------|-------------|-------------|-------------|-------------|-------------|-------------|-------------|
|Reproduci bi lity         |sec-butanol               |0.4795       |0.4912       |0.5135       |0.4720       |0.4461       |0.4571       |6%           |
|--------------------------|--------------------------|-------------|-------------|-------------|-------------|-------------|-------------|-------------|
|Reproduci bi lity         |tetrahydrofuran           |0.0775       |0.0804       |0.0815       |0.0782       |0.0723       |0.0731       |5%           |
|--------------------------|--------------------------|-------------|-------------|-------------|-------------|-------------|-------------|-------------|
|Reproduci bi lity         |Toluene                   |0.0996       |0.1014       |0.1042       |0.0982       |0.0926       |0.0947       |5%           |
|--------------------------|--------------------------|-------------|-------------|-------------|-------------|-------------|-------------|-------------|
|Reproduci bi lity         |N-methylpyrroli done      |0.0502       |0.0505       |0.0541       |0.0490       |0.0475       |0.0492       |5%           |
|--------------------------|--------------------------|-------------|-------------|-------------|-------------|-------------|-------------|-------------|
|Precision RSD             |Precision RSD             |4%           |4%           |4%           |4%           |4%           |9%           |/            |
---------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 359 of 542 





Page 360
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 

-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Verdict: The RSD ofethanol content in 6 reproducible samples  |Verdict:                |Verdict:                |Verdict:                |Verdict:                |Verdict:                |Verdict:                |Verdict:                |
|was 0.7% (required less than 10%), the RSD ofisopropylalcohol |The RSD                 |The RSD                 |The RSD                 |The RSD                 |The RSD                 |The RSD                 |The RSD                 |
|content was 0.8% (required less than 10%), the RSD            |ofethanol               |ofethanol               |ofethanol               |ofethanol               |ofethanol               |ofethanol               |ofethanol               |
|ofethylacetate content was 0.8% (required less than 10%) and  |content                 |content                 |content                 |content                 |content                 |content                 |content                 |
|the RSD of secondary butanol content was 0.9% (required less  |in 6                    |in 6                    |in 6                    |in 6                    |in 6                    |in 6                    |in 6                    |
|than 10%). RSD of tetrahydrofuran was 1.0% (NMT 10%), RSD of  |reproducible            |reproducible            |reproducible            |reproducible            |reproducible            |reproducible            |reproducible            |
|toluene was 1.0% (NMT 10%), and RSDofN-methylpyrrolidone was  |samples                 |samples                 |samples                 |samples                 |samples                 |samples                 |samples                 |
|2.0% (NMT 10%); All the above met the verification            |was                     |was                     |was                     |was                     |was                     |was                     |was                     |
|requirements, indicating that the method has good             |0.7%                    |0.7%                    |0.7%                    |0.7%                    |0.7%                    |0.7%                    |0.7%                    |
|reproducibility. The reproducibility andintermediate precision|(required               |(required               |(required               |(required               |(required               |(required               |(required               |
|12 results showed that RSD ofethanol content was 4% (NMT 10%),|less                    |less                    |less                    |less                    |less                    |less                    |less                    |
|RSD ofisopropylalcohol content was 4% (NMT 10%), RSD          |than                    |than                    |than                    |than                    |than                    |than                    |than                    |
|ofethylacetate content was 4% (NMT 10%), and RSD of secondary |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |
|butanol content was 4% (NMT 10%). RSD of tetrahydrofuran was  |the RSD                 |the RSD                 |the RSD                 |the RSD                 |the RSD                 |the RSD                 |the RSD                 |
|4% (NMT 10%), RSD of toluene was 4% (NMT 10%), and            |ofisopropylalcohol      |ofisopropylalcohol      |ofisopropylalcohol      |ofisopropylalcohol      |ofisopropylalcohol      |ofisopropylalcohol      |ofisopropylalcohol      |
|RSDofN-methylpyrrolidone was 9% (NMT 10%); All the above meet |content                 |content                 |content                 |content                 |content                 |content                 |content                 |
|the verification requirements, indicating that the methodis of|was                     |was                     |was                     |was                     |was                     |was                     |was                     |
|good precision.                                               |0.8%                    |0.8%                    |0.8%                    |0.8%                    |0.8%                    |0.8%                    |0.8%                    |
|                                                              |(required               |(required               |(required               |(required               |(required               |(required               |(required               |
|                                                              |less                    |less                    |less                    |less                    |less                    |less                    |less                    |
|                                                              |than                    |than                    |than                    |than                    |than                    |than                    |than                    |
|                                                              |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |
|                                                              |the RSD                 |the RSD                 |the RSD                 |the RSD                 |the RSD                 |the RSD                 |the RSD                 |
|                                                              |ofethylacetate          |ofethylacetate          |ofethylacetate          |ofethylacetate          |ofethylacetate          |ofethylacetate          |ofethylacetate          |
|                                                              |content                 |content                 |content                 |content                 |content                 |content                 |content                 |
|                                                              |was                     |was                     |was                     |was                     |was                     |was                     |was                     |
|                                                              |0.8%                    |0.8%                    |0.8%                    |0.8%                    |0.8%                    |0.8%                    |0.8%                    |
|                                                              |(required               |(required               |(required               |(required               |(required               |(required               |(required               |
|                                                              |less                    |less                    |less                    |less                    |less                    |less                    |less                    |
|                                                              |than                    |than                    |than                    |than                    |than                    |than                    |than                    |
|                                                              |10%)                    |10%)                    |10%)                    |10%)                    |10%)                    |10%)                    |10%)                    |
|                                                              |and the                 |and the                 |and the                 |and the                 |and the                 |and the                 |and the                 |
|                                                              |RSD of                  |RSD of                  |RSD of                  |RSD of                  |RSD of                  |RSD of                  |RSD of                  |
|                                                              |secondary               |secondary               |secondary               |secondary               |secondary               |secondary               |secondary               |
|                                                              |butanol                 |butanol                 |butanol                 |butanol                 |butanol                 |butanol                 |butanol                 |
|                                                              |content                 |content                 |content                 |content                 |content                 |content                 |content                 |
|                                                              |was                     |was                     |was                     |was                     |was                     |was                     |was                     |
|                                                              |0.9%                    |0.9%                    |0.9%                    |0.9%                    |0.9%                    |0.9%                    |0.9%                    |
|                                                              |(required               |(required               |(required               |(required               |(required               |(required               |(required               |
|                                                              |less                    |less                    |less                    |less                    |less                    |less                    |less                    |
|                                                              |than                    |than                    |than                    |than                    |than                    |than                    |than                    |
|                                                              |10%).                   |10%).                   |10%).                   |10%).                   |10%).                   |10%).                   |10%).                   |
|                                                              |RSD of                  |RSD of                  |RSD of                  |RSD of                  |RSD of                  |RSD of                  |RSD of                  |
|                                                              |tetrahydrofuran         |tetrahydrofuran         |tetrahydrofuran         |tetrahydrofuran         |tetrahydrofuran         |tetrahydrofuran         |tetrahydrofuran         |
|                                                              |was                     |was                     |was                     |was                     |was                     |was                     |was                     |
|                                                              |1.0%                    |1.0%                    |1.0%                    |1.0%                    |1.0%                    |1.0%                    |1.0%                    |
|                                                              |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |
|                                                              |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |
|                                                              |RSD of                  |RSD of                  |RSD of                  |RSD of                  |RSD of                  |RSD of                  |RSD of                  |
|                                                              |toluene                 |toluene                 |toluene                 |toluene                 |toluene                 |toluene                 |toluene                 |
|                                                              |was                     |was                     |was                     |was                     |was                     |was                     |was                     |
|                                                              |1.0%                    |1.0%                    |1.0%                    |1.0%                    |1.0%                    |1.0%                    |1.0%                    |
|                                                              |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |
|                                                              |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |
|                                                              |and                     |and                     |and                     |and                     |and                     |and                     |and                     |
|                                                              |RSDofN-methylpyrrolidone|RSDofN-methylpyrrolidone|RSDofN-methylpyrrolidone|RSDofN-methylpyrrolidone|RSDofN-methylpyrrolidone|RSDofN-methylpyrrolidone|RSDofN-methylpyrrolidone|
|                                                              |was                     |was                     |was                     |was                     |was                     |was                     |was                     |
|                                                              |2.0%                    |2.0%                    |2.0%                    |2.0%                    |2.0%                    |2.0%                    |2.0%                    |
|                                                              |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |
|                                                              |10%);                   |10%);                   |10%);                   |10%);                   |10%);                   |10%);                   |10%);                   |
|                                                              |All the                 |All the                 |All the                 |All the                 |All the                 |All the                 |All the                 |
|                                                              |above                   |above                   |above                   |above                   |above                   |above                   |above                   |
|                                                              |met the                 |met the                 |met the                 |met the                 |met the                 |met the                 |met the                 |
|                                                              |verification            |verification            |verification            |verification            |verification            |verification            |verification            |
|                                                              |requirements,           |requirements,           |requirements,           |requirements,           |requirements,           |requirements,           |requirements,           |
|                                                              |indicating              |indicating              |indicating              |indicating              |indicating              |indicating              |indicating              |
|                                                              |that                    |that                    |that                    |that                    |that                    |that                    |that                    |
|                                                              |the                     |the                     |the                     |the                     |the                     |the                     |the                     |
|                                                              |method                  |method                  |method                  |method                  |method                  |method                  |method                  |
|                                                              |has                     |has                     |has                     |has                     |has                     |has                     |has                     |
|                                                              |good                    |good                    |good                    |good                    |good                    |good                    |good                    |
|                                                              |reproducibility.        |reproducibility.        |reproducibility.        |reproducibility.        |reproducibility.        |reproducibility.        |reproducibility.        |
|                                                              |The                     |The                     |The                     |The                     |The                     |The                     |The                     |
|                                                              |reproducibility         |reproducibility         |reproducibility         |reproducibility         |reproducibility         |reproducibility         |reproducibility         |
|                                                              |andintermediate         |andintermediate         |andintermediate         |andintermediate         |andintermediate         |andintermediate         |andintermediate         |
|                                                              |precision               |precision               |precision               |precision               |precision               |precision               |precision               |
|                                                              |12                      |12                      |12                      |12                      |12                      |12                      |12                      |
|                                                              |results                 |results                 |results                 |results                 |results                 |results                 |results                 |
|                                                              |showed                  |showed                  |showed                  |showed                  |showed                  |showed                  |showed                  |
|                                                              |that                    |that                    |that                    |that                    |that                    |that                    |that                    |
|                                                              |RSD                     |RSD                     |RSD                     |RSD                     |RSD                     |RSD                     |RSD                     |
|                                                              |ofethanol               |ofethanol               |ofethanol               |ofethanol               |ofethanol               |ofethanol               |ofethanol               |
|                                                              |content                 |content                 |content                 |content                 |content                 |content                 |content                 |
|                                                              |was 4%                  |was 4%                  |was 4%                  |was 4%                  |was 4%                  |was 4%                  |was 4%                  |
|                                                              |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |
|                                                              |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |
|                                                              |RSD                     |RSD                     |RSD                     |RSD                     |RSD                     |RSD                     |RSD                     |
|                                                              |ofisopropylalcohol      |ofisopropylalcohol      |ofisopropylalcohol      |ofisopropylalcohol      |ofisopropylalcohol      |ofisopropylalcohol      |ofisopropylalcohol      |
|                                                              |content                 |content                 |content                 |content                 |content                 |content                 |content                 |
|                                                              |was 4%                  |was 4%                  |was 4%                  |was 4%                  |was 4%                  |was 4%                  |was 4%                  |
|                                                              |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |
|                                                              |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |
|                                                              |RSD                     |RSD                     |RSD                     |RSD                     |RSD                     |RSD                     |RSD                     |
|                                                              |ofethylacetate          |ofethylacetate          |ofethylacetate          |ofethylacetate          |ofethylacetate          |ofethylacetate          |ofethylacetate          |
|                                                              |content                 |content                 |content                 |content                 |content                 |content                 |content                 |
|                                                              |was 4%                  |was 4%                  |was 4%                  |was 4%                  |was 4%                  |was 4%                  |was 4%                  |
|                                                              |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |
|                                                              |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |
|                                                              |and RSD                 |and RSD                 |and RSD                 |and RSD                 |and RSD                 |and RSD                 |and RSD                 |
|                                                              |of                      |of                      |of                      |of                      |of                      |of                      |of                      |
|                                                              |secondary               |secondary               |secondary               |secondary               |secondary               |secondary               |secondary               |
|                                                              |butanol                 |butanol                 |butanol                 |butanol                 |butanol                 |butanol                 |butanol                 |
|                                                              |content                 |content                 |content                 |content                 |content                 |content                 |content                 |
|                                                              |was 4%                  |was 4%                  |was 4%                  |was 4%                  |was 4%                  |was 4%                  |was 4%                  |
|                                                              |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |
|                                                              |10%).                   |10%).                   |10%).                   |10%).                   |10%).                   |10%).                   |10%).                   |
|                                                              |RSD of                  |RSD of                  |RSD of                  |RSD of                  |RSD of                  |RSD of                  |RSD of                  |
|                                                              |tetrahydrofuran         |tetrahydrofuran         |tetrahydrofuran         |tetrahydrofuran         |tetrahydrofuran         |tetrahydrofuran         |tetrahydrofuran         |
|                                                              |was 4%                  |was 4%                  |was 4%                  |was 4%                  |was 4%                  |was 4%                  |was 4%                  |
|                                                              |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |
|                                                              |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |
|                                                              |RSD of                  |RSD of                  |RSD of                  |RSD of                  |RSD of                  |RSD of                  |RSD of                  |
|                                                              |toluene                 |toluene                 |toluene                 |toluene                 |toluene                 |toluene                 |toluene                 |
|                                                              |was 4%                  |was 4%                  |was 4%                  |was 4%                  |was 4%                  |was 4%                  |was 4%                  |
|                                                              |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |
|                                                              |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |10%),                   |
|                                                              |and                     |and                     |and                     |and                     |and                     |and                     |and                     |
|                                                              |RSDofN-methylpyrrolidone|RSDofN-methylpyrrolidone|RSDofN-methylpyrrolidone|RSDofN-methylpyrrolidone|RSDofN-methylpyrrolidone|RSDofN-methylpyrrolidone|RSDofN-methylpyrrolidone|
|                                                              |was 9%                  |was 9%                  |was 9%                  |was 9%                  |was 9%                  |was 9%                  |was 9%                  |
|                                                              |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |(NMT                    |
|                                                              |10%);                   |10%);                   |10%);                   |10%);                   |10%);                   |10%);                   |10%);                   |
|                                                              |All the                 |All the                 |All the                 |All the                 |All the                 |All the                 |All the                 |
|                                                              |above                   |above                   |above                   |above                   |above                   |above                   |above                   |
|                                                              |meet                    |meet                    |meet                    |meet                    |meet                    |meet                    |meet                    |
|                                                              |the                     |the                     |the                     |the                     |the                     |the                     |the                     |
|                                                              |verification            |verification            |verification            |verification            |verification            |verification            |verification            |
|                                                              |requirements,           |requirements,           |requirements,           |requirements,           |requirements,           |requirements,           |requirements,           |
|                                                              |indicating              |indicating              |indicating              |indicating              |indicating              |indicating              |indicating              |
|                                                              |that                    |that                    |that                    |that                    |that                    |that                    |that                    |
|                                                              |the                     |the                     |the                     |the                     |the                     |the                     |the                     |
|                                                              |methodis                |methodis                |methodis                |methodis                |methodis                |methodis                |methodis                |
|                                                              |of good                 |of good                 |of good                 |of good                 |of good                 |of good                 |of good                 |
|                                                              |precision.              |precision.              |precision.              |precision.              |precision.              |precision.              |precision.              |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



**(4.7) Durability** 



 **Brief Description** 



By changing the chromatographic conditions (changing the initial 



temperature, flow rate, column) and normal chromatographic conditions to 



test the solvent content of each test product solution to achieve, the 



chromatographic diagram obtained by the control product solution, methyl 



ethanol, isopropyl alcohol, ethyl acetate, secondary butanol, tetrahydrofuran, 



toluene, n-methylpyrrolidone peaks in turn, the separation degree between 



the adjacent peaks should be greater than 1.5. Under different conditions of 



the same chromatographic parameters, the RSD of each solvent content to be 



measured in the test product solution should not be 10%. 



Changes in chromatographic conditions for durability test 

------------------------------------------------------------
|Flow rate                 |3.5 ml/min|3.4ml/min, 3.6ml/min|
|--------------------------|----------|--------------------|
|Initial column temperature|40 ℃      |35℃, 45℃            |
|--------------------------|----------|--------------------|
|Column                    |Column 1  |Column 2            |
------------------------------------------------------------



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 360 of 542 





Page 361
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 




(DB-624, 60m*0.53mm, 
3.0μm, SN: US1501943H, 

Serial number: CXGC-1) 



 **Solution preparation** 



Blank solution: solvent (N, n-dimethylformamide). 




(DB-624, 60m*0.53mm, 
3.0μm, SN: US1111842H, 

Serial number: YLGC-2) 




Ethanol reference stock: Share ethanol reference stock under "4.1 System 



Suitability". (Approx. 50,000 μg/ml) 



Isopropyl alcohol reference reserve: Share isopropyl alcohol reference reserve 



under "4.1 System Suitability". (Approx. 50,000 μg/ml) 



Ethyl acetate reference reserve: Share the ethyl acetate reference reserve 



under "4.1 System Suitability". (Approx. 50,000 μg/ml) 



Secondary butanol reference product reserve: Share secondary butanol 



versus reference product reserve solution under "4.1 System Suitability". 



(Approx. 50,000 μg/ml) 



Tetrahydrofuran reference storage solution: Share tetrahydrofuran reference 



storage solution under "4.1 System Suitability". (Approx. 7200μg/ml) 



Toluene reference reserve: Share toluene reference reserve under "4.1 System 



Suitability". (Approx. 8900μg/ml) 



N-methylpyrrolidone reference stock: Share the N-methylpyrrolidone 



reference stock under "4.1 System Suitability". (Approx. 5300μg/ml) 



Durable reference product reserve liquid: precision measure ethanol 



reference product reserve liquid, isopropyl alcohol reference product reserve 



liquid, ethyl acetate reference product reserve liquid, secondary butanol 



reference product reserve liquid, tetrahydrofuran reference product reserve 



liquid, toluene reference product reserve liquid, N-methylpyrrolidone 



reference product reserve liquid 1.0ml each, put in 20ml bottle, dilute with 



solvent to the scale, shake well, ready. (Ethanol about 2500μg/ml, isopropyl 



alcohol about 2500μg/ml, ethyl acetate about 2500μg/ml, secondary 



butanol about 2500μg/ml, tetrahydrofuran about 360μg/ml, toluene about 



445μg/ml, N-methylpyrrolidone about 265μg/ml) 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 361 of 542 





Page 362
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Durability reference product solution: accurately measure 1.0ml of the 



durability reference product reserve solution, place it in a 10ml measuring 



bottle, dilute it with solvent to the scale, shake well, and obtain. (Ethanol 



about 250μg/ml, isopropyl alcohol about 250μg/ml, ethyl acetate about 



250μg/ml, secondary butanol about 250μg/ml, tetrahydrofuran about 



36μg/ml, toluene about 44.5μg/ml, N-methylpyrrolidone about 26.5μg/ml) 



Durability test product solution: precision weigh about 0.5g of this product, 



precision weigh, put in 10ml measuring bottle, then precision measure the 



durability control product reserve liquid 1.0ml put in the same measuring 



bottle, dissolve with solvent and dilute to the scale, shake well, and then get. 



(Parallel preparation of 2 servings) 



 **Injection procedure** 



Under each chromatographic condition, after the blank solution, the control 



product solution and the test product solution were injected respectively, 



and the chromatogram was recorded. 



 **Measurement resultss** 



Results of durability - system suitability test 




































-------------------------------------------------------------------------------------------------------------------------------------------
|Name of solvent                    |Sampleinjecti on Number of|Ethanol|Isopro    |Ethylacetate|sec-butanol|tetrah   |Tolue  |N-methy     |
|                                   |times                     |       |pylalcohol|            |           |ydrofuran|ne     |lpyrrolidone|
|-----------------------------------|--------------------------|-------|----------|------------|-----------|---------|-------|------------|
|Normal conditions                  |1                         |/      |8.8       |28.9        |1.8        |1.9      |37.9   |94.7        |
|-----------------------------------|--------------------------|-------|----------|------------|-----------|---------|-------|------------|
|Normal conditions                  |2                         |/      |8.7       |29.0        |1.8        |1.9      |37.9   |95.0        |
|-----------------------------------|--------------------------|-------|----------|------------|-----------|---------|-------|------------|
|Flow rate (3.4ml/min)              |1                         |/      |8.9       |29.3        |1.8        |2.0      |38.1   |93.6        |
|-----------------------------------|--------------------------|-------|----------|------------|-----------|---------|-------|------------|
|Flow rate (3.4ml/min)              |2                         |/      |8.8       |29.0        |1.8        |2.0      |38.2   |94.0        |
|-----------------------------------|--------------------------|-------|----------|------------|-----------|---------|-------|------------|
|Flow rate (3.6ml/min)              |1                         |/      |8.7       |28.9        |1.8        |1.9      |37.9   |96.0        |
|-----------------------------------|--------------------------|-------|----------|------------|-----------|---------|-------|------------|
|Flow rate (3.6ml/min)              |2                         |/      |8.5       |28.6        |1.8        |1.8      |37.8   |95.7        |
|-----------------------------------|--------------------------|-------|----------|------------|-----------|---------|-------|------------|
|Initial column temperature (35 ° C)|1                         |/      |9.2       |29.6        |1.9        |1.8      |38.4   |94.7        |
|-----------------------------------|--------------------------|-------|----------|------------|-----------|---------|-------|------------|
|Initial column temperature (35 ° C)|2                         |/      |9.3       |29.8        |1.9        |1.8      |38.4   |94.7        |
-------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 362 of 542 





Page 363
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 









-----------------------------------------------------------------------------------------------------
|Initial column temperature (45 ° C)|2      |/      |8.3    |28.3   |1.7    |2.1    |37.4   |94.7   |
|-----------------------------------|-------|-------|-------|-------|-------|-------|-------|-------|
|Column 2                           |1      |/      |8.8    |29.2   |1.8    |1.9    |38.0   |93.6   |
|-----------------------------------|-------|-------|-------|-------|-------|-------|-------|-------|
|Column 2                           |2      |/      |8.9    |29.3   |1.8    |1.9    |37.8   |94.0   |
-----------------------------------------------------------------------------------------------------

Durability test results 





































-------------------------------------------------------------------------------------------------------------------------------------
|Changing conditions       |Changing conditions|Num ber ofinjec|Ethanol|Isopro    |Ethylacetate|sec-bu |tetrahy|Tolue  |N-methy     |
|                          |                   |tions          |       |pylalcohol|            |tanol  |drofur |ne     |lpyrrolidone|
|                          |                   |               |       |          |            |       |an     |       |            |
|--------------------------|-------------------|---------------|-------|----------|------------|-------|-------|-------|------------|
|Veloci ty of flo w        |3.4 ml/min         |1              |0.5963 |0.5123    |0.5227      |0.5077 |0.0764 |0.105 3|0.0556      |
|--------------------------|-------------------|---------------|-------|----------|------------|-------|-------|-------|------------|
|Veloci ty of flo w        |3.4 ml/min         |2              |0.5942 |0.5115    |0.5232      |0.5096 |0.0768 |0.105 2|0.0554      |
|--------------------------|-------------------|---------------|-------|----------|------------|-------|-------|-------|------------|
|Veloci ty of flo w        |3.5 ml/min         |1              |0.5810 |0.4949    |0.5091      |0.4944 |0.0745 |0.102 5|0.0576      |
|--------------------------|-------------------|---------------|-------|----------|------------|-------|-------|-------|------------|
|Veloci ty of flo w        |3.5 ml/min         |2              |0.5730 |0.4880    |0.5019      |0.4884 |0.0733 |0.100 9|0.0609      |
|--------------------------|-------------------|---------------|-------|----------|------------|-------|-------|-------|------------|
|Veloci ty of flo w        |3.6 ml/min         |1              |0.5735 |0.4939    |0.5041      |0.4911 |0.0735 |0.102 1|0.0556      |
|--------------------------|-------------------|---------------|-------|----------|------------|-------|-------|-------|------------|
|Veloci ty of flo w        |3.6 ml/min         |2              |0.5790 |0.4967    |0.5095      |0.4972 |0.0743 |0.102 5|0.0589      |
|--------------------------|-------------------|---------------|-------|----------|------------|-------|-------|-------|------------|
|Veloci ty of flo w        |RSD/% (n=6)        |RSD/% (n=6)    |1.8    |2.1       |1.8         |1.8    |2.0    |1.8    |4           |
|--------------------------|-------------------|---------------|-------|----------|------------|-------|-------|-------|------------|
|Initi al colu mntem per at|35 ℃               |1              |0.5791 |0.4968    |0.5101      |0.4956 |0.0743 |0.103 3|0.0605      |
|--------------------------|-------------------|---------------|-------|----------|------------|-------|-------|-------|------------|
|Initi al colu mntem per at|35 ℃               |2              |0.5811 |0.4963    |0.5098      |0.5016 |0.0735 |0.102 9|0.0618      |
|--------------------------|-------------------|---------------|-------|----------|------------|-------|-------|-------|------------|
|Initi al colu mntem per at|40 ℃               |1              |0.5810 |0.4949    |0.5091      |0.4944 |0.0745 |0.102 5|0.0576      |
|--------------------------|-------------------|---------------|-------|----------|------------|-------|-------|-------|------------|
|Initi al colu mntem per at|40 ℃               |2              |0.5730 |0.4880    |0.5019      |0.4884 |0.0733 |0.100 9|0.0609      |
|--------------------------|-------------------|---------------|-------|----------|------------|-------|-------|-------|------------|
|Initi al colu mntem per at|45 ℃               |1              |0.5829 |0.4985    |0.5117      |0.5002 |0.0738 |0.103 9|0.0613      |
|--------------------------|-------------------|---------------|-------|----------|------------|-------|-------|-------|------------|
|Initi al colu mntem per at|45 ℃               |2              |0.5793 |0.4966    |0.5114      |0.4977 |0.0738 |0.103 2|0.0591      |
|--------------------------|-------------------|---------------|-------|----------|------------|-------|-------|-------|------------|
|Initi al colu mntem per at|RSD/% (n=6)        |RSD/% (n=6)    |0.6    |0.8       |0.8         |1.0    |0.7    |1.0    |2.6         |
-------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 363 of 542 


























Page 364
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



















---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Colu m n                                      |Colu mn               |1                     |0.5963                |0.5123                |0.5227                |0.5077                |0.0764                |0.105 3               |0.0556                |
|                                              |1                     |                      |                      |                      |                      |                      |                      |                      |                      |
|----------------------------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|Colu m n                                      |Colu mn               |2                     |0.5942                |0.5115                |0.5232                |0.5096                |0.0768                |0.105 2               |0.0554                |
|                                              |1                     |                      |                      |                      |                      |                      |                      |                      |                      |
|----------------------------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|Colu m n                                      |Colu mn               |1                     |0.5669                |0.4898                |0.5009                |0.4891                |0.0723                |0.102 0               |0.0576                |
|                                              |2                     |                      |                      |                      |                      |                      |                      |                      |                      |
|----------------------------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|Colu m n                                      |Colu mn               |2                     |0.5752                |0.4921                |0.5071                |0.4964                |0.0750                |0.102 4               |0.0559                |
|                                              |2                     |                      |                      |                      |                      |                      |                      |                      |                      |
|----------------------------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|Colu m n                                      |RSD/%                 |RSD/%                 |2.5                   |2.5                   |2.2                   |2.0                   |2.8                   |1.8                   |1.8                   |
|                                              |(n=4)                 |(n=4)                 |                      |                      |                      |                      |                      |                      |                      |
|----------------------------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|Conclusion: The blank solution has no         |Conclusion:           |Conclusion:           |Conclusion:           |Conclusion:           |Conclusion:           |Conclusion:           |Conclusion:           |Conclusion:           |Conclusion:           |
|interference; Ethanol, isopropylalcohol,      |The                   |The                   |The                   |The                   |The                   |The                   |The                   |The                   |The                   |
|ethylacetate, secondary butanol,              |blank                 |blank                 |blank                 |blank                 |blank                 |blank                 |blank                 |blank                 |blank                 |
|tetrahydrofuran, toluene                      |solution              |solution              |solution              |solution              |solution              |solution              |solution              |solution              |solution              |
|andn-methylpyrrolidone peaks in the           |has no                |has no                |has no                |has no                |has no                |has no                |has no                |has no                |has no                |
|chromatogramobtained from the control solution|interference;         |interference;         |interference;         |interference;         |interference;         |interference;         |interference;         |interference;         |interference;         |
|with the same chromatographic parametersunder |Ethanol,              |Ethanol,              |Ethanol,              |Ethanol,              |Ethanol,              |Ethanol,              |Ethanol,              |Ethanol,              |Ethanol,              |
|different conditions, and the separation      |isopropylalcohol,     |isopropylalcohol,     |isopropylalcohol,     |isopropylalcohol,     |isopropylalcohol,     |isopropylalcohol,     |isopropylalcohol,     |isopropylalcohol,     |isopropylalcohol,     |
|degree betweeneachadjacent solvent peakis     |ethylacetate,         |ethylacetate,         |ethylacetate,         |ethylacetate,         |ethylacetate,         |ethylacetate,         |ethylacetate,         |ethylacetate,         |ethylacetate,         |
|greater than 1.5 (the requirementis greater   |secondary             |secondary             |secondary             |secondary             |secondary             |secondary             |secondary             |secondary             |secondary             |
|than 1.5). RSDS ofeach solvent content in the |butanol,              |butanol,              |butanol,              |butanol,              |butanol,              |butanol,              |butanol,              |butanol,              |butanol,              |
|test product solutionunder different          |tetrahydrofuran,      |tetrahydrofuran,      |tetrahydrofuran,      |tetrahydrofuran,      |tetrahydrofuran,      |tetrahydrofuran,      |tetrahydrofuran,      |tetrahydrofuran,      |tetrahydrofuran,      |
|conditions of the same chromatographic        |toluene               |toluene               |toluene               |toluene               |toluene               |toluene               |toluene               |toluene               |toluene               |
|parameters were all less than 10% (the        |andn-methylpyrrolidone|andn-methylpyrrolidone|andn-methylpyrrolidone|andn-methylpyrrolidone|andn-methylpyrrolidone|andn-methylpyrrolidone|andn-methylpyrrolidone|andn-methylpyrrolidone|andn-methylpyrrolidone|
|requirementis not greater than 10%); All the  |peaks                 |peaks                 |peaks                 |peaks                 |peaks                 |peaks                 |peaks                 |peaks                 |peaks                 |
|above meet the requirements, indicating that  |in the                |in the                |in the                |in the                |in the                |in the                |in the                |in the                |in the                |
|the method has good durability.               |chromatogramobtained  |chromatogramobtained  |chromatogramobtained  |chromatogramobtained  |chromatogramobtained  |chromatogramobtained  |chromatogramobtained  |chromatogramobtained  |chromatogramobtained  |
|                                              |from                  |from                  |from                  |from                  |from                  |from                  |from                  |from                  |from                  |
|                                              |the                   |the                   |the                   |the                   |the                   |the                   |the                   |the                   |the                   |
|                                              |control               |control               |control               |control               |control               |control               |control               |control               |control               |
|                                              |solution              |solution              |solution              |solution              |solution              |solution              |solution              |solution              |solution              |
|                                              |with                  |with                  |with                  |with                  |with                  |with                  |with                  |with                  |with                  |
|                                              |the                   |the                   |the                   |the                   |the                   |the                   |the                   |the                   |the                   |
|                                              |same                  |same                  |same                  |same                  |same                  |same                  |same                  |same                  |same                  |
|                                              |chromatographic       |chromatographic       |chromatographic       |chromatographic       |chromatographic       |chromatographic       |chromatographic       |chromatographic       |chromatographic       |
|                                              |parametersunder       |parametersunder       |parametersunder       |parametersunder       |parametersunder       |parametersunder       |parametersunder       |parametersunder       |parametersunder       |
|                                              |different             |different             |different             |different             |different             |different             |different             |different             |different             |
|                                              |conditions,           |conditions,           |conditions,           |conditions,           |conditions,           |conditions,           |conditions,           |conditions,           |conditions,           |
|                                              |and the               |and the               |and the               |and the               |and the               |and the               |and the               |and the               |and the               |
|                                              |separation            |separation            |separation            |separation            |separation            |separation            |separation            |separation            |separation            |
|                                              |degree                |degree                |degree                |degree                |degree                |degree                |degree                |degree                |degree                |
|                                              |betweeneachadjacent   |betweeneachadjacent   |betweeneachadjacent   |betweeneachadjacent   |betweeneachadjacent   |betweeneachadjacent   |betweeneachadjacent   |betweeneachadjacent   |betweeneachadjacent   |
|                                              |solvent               |solvent               |solvent               |solvent               |solvent               |solvent               |solvent               |solvent               |solvent               |
|                                              |peakis                |peakis                |peakis                |peakis                |peakis                |peakis                |peakis                |peakis                |peakis                |
|                                              |greater               |greater               |greater               |greater               |greater               |greater               |greater               |greater               |greater               |
|                                              |than                  |than                  |than                  |than                  |than                  |than                  |than                  |than                  |than                  |
|                                              |1.5                   |1.5                   |1.5                   |1.5                   |1.5                   |1.5                   |1.5                   |1.5                   |1.5                   |
|                                              |(the                  |(the                  |(the                  |(the                  |(the                  |(the                  |(the                  |(the                  |(the                  |
|                                              |requirementis         |requirementis         |requirementis         |requirementis         |requirementis         |requirementis         |requirementis         |requirementis         |requirementis         |
|                                              |greater               |greater               |greater               |greater               |greater               |greater               |greater               |greater               |greater               |
|                                              |than                  |than                  |than                  |than                  |than                  |than                  |than                  |than                  |than                  |
|                                              |1.5).                 |1.5).                 |1.5).                 |1.5).                 |1.5).                 |1.5).                 |1.5).                 |1.5).                 |1.5).                 |
|                                              |RSDS                  |RSDS                  |RSDS                  |RSDS                  |RSDS                  |RSDS                  |RSDS                  |RSDS                  |RSDS                  |
|                                              |ofeach                |ofeach                |ofeach                |ofeach                |ofeach                |ofeach                |ofeach                |ofeach                |ofeach                |
|                                              |solvent               |solvent               |solvent               |solvent               |solvent               |solvent               |solvent               |solvent               |solvent               |
|                                              |content               |content               |content               |content               |content               |content               |content               |content               |content               |
|                                              |in the                |in the                |in the                |in the                |in the                |in the                |in the                |in the                |in the                |
|                                              |test                  |test                  |test                  |test                  |test                  |test                  |test                  |test                  |test                  |
|                                              |product               |product               |product               |product               |product               |product               |product               |product               |product               |
|                                              |solutionunder         |solutionunder         |solutionunder         |solutionunder         |solutionunder         |solutionunder         |solutionunder         |solutionunder         |solutionunder         |
|                                              |different             |different             |different             |different             |different             |different             |different             |different             |different             |
|                                              |conditions            |conditions            |conditions            |conditions            |conditions            |conditions            |conditions            |conditions            |conditions            |
|                                              |of the                |of the                |of the                |of the                |of the                |of the                |of the                |of the                |of the                |
|                                              |same                  |same                  |same                  |same                  |same                  |same                  |same                  |same                  |same                  |
|                                              |chromatographic       |chromatographic       |chromatographic       |chromatographic       |chromatographic       |chromatographic       |chromatographic       |chromatographic       |chromatographic       |
|                                              |parameters            |parameters            |parameters            |parameters            |parameters            |parameters            |parameters            |parameters            |parameters            |
|                                              |were                  |were                  |were                  |were                  |were                  |were                  |were                  |were                  |were                  |
|                                              |all                   |all                   |all                   |all                   |all                   |all                   |all                   |all                   |all                   |
|                                              |less                  |less                  |less                  |less                  |less                  |less                  |less                  |less                  |less                  |
|                                              |than                  |than                  |than                  |than                  |than                  |than                  |than                  |than                  |than                  |
|                                              |10%                   |10%                   |10%                   |10%                   |10%                   |10%                   |10%                   |10%                   |10%                   |
|                                              |(the                  |(the                  |(the                  |(the                  |(the                  |(the                  |(the                  |(the                  |(the                  |
|                                              |requirementis         |requirementis         |requirementis         |requirementis         |requirementis         |requirementis         |requirementis         |requirementis         |requirementis         |
|                                              |not                   |not                   |not                   |not                   |not                   |not                   |not                   |not                   |not                   |
|                                              |greater               |greater               |greater               |greater               |greater               |greater               |greater               |greater               |greater               |
|                                              |than                  |than                  |than                  |than                  |than                  |than                  |than                  |than                  |than                  |
|                                              |10%);                 |10%);                 |10%);                 |10%);                 |10%);                 |10%);                 |10%);                 |10%);                 |10%);                 |
|                                              |All the               |All the               |All the               |All the               |All the               |All the               |All the               |All the               |All the               |
|                                              |above                 |above                 |above                 |above                 |above                 |above                 |above                 |above                 |above                 |
|                                              |meet                  |meet                  |meet                  |meet                  |meet                  |meet                  |meet                  |meet                  |meet                  |
|                                              |the                   |the                   |the                   |the                   |the                   |the                   |the                   |the                   |the                   |
|                                              |requirements,         |requirements,         |requirements,         |requirements,         |requirements,         |requirements,         |requirements,         |requirements,         |requirements,         |
|                                              |indicating            |indicating            |indicating            |indicating            |indicating            |indicating            |indicating            |indicating            |indicating            |
|                                              |that                  |that                  |that                  |that                  |that                  |that                  |that                  |that                  |that                  |
|                                              |the                   |the                   |the                   |the                   |the                   |the                   |the                   |the                   |the                   |
|                                              |method                |method                |method                |method                |method                |method                |method                |method                |method                |
|                                              |has                   |has                   |has                   |has                   |has                   |has                   |has                   |has                   |has                   |
|                                              |good                  |good                  |good                  |good                  |good                  |good                  |good                  |good                  |good                  |
|                                              |durability.           |durability.           |durability.           |durability.           |durability.           |durability.           |durability.           |durability.           |durability.           |
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 364 of 542 





Page 365
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**III. Summary of Method Validation** 



Summaries of Method Validation of Residual Solvents in Finerenone 












---------------------------------------------------------------------------------------------------------------------------------------
|System suitability|The blank solution should be free ofinterference; In the chromatogramobtained for 6        |There                 |
|                  |consecutive days, ethanol, isopropylalcohol, ethylacetate, secondary butanol,              |was no                |
|                  |tetrahydrofuran, toluene, n-methylpyrrolidone peaks in turn, and the separation degree     |interference          |
|                  |betweeneachadjacent peak should be greater than 1.5. The RSD of the peak retention time    |in the                |
|                  |ofeach solvent peak should NMT 1.0%, and the RSD of the peakarea should NMT 10%.           |blank                 |
|                  |                                                                                           |solution.             |
|                  |                                                                                           |In the                |
|                  |                                                                                           |chromatogramobtained  |
|                  |                                                                                           |from                  |
|                  |                                                                                           |the                   |
|                  |                                                                                           |irradiation           |
|                  |                                                                                           |solution              |
|                  |                                                                                           |for 6                 |
|                  |                                                                                           |consecutive           |
|                  |                                                                                           |years,                |
|                  |                                                                                           |the                   |
|                  |                                                                                           |peaks                 |
|                  |                                                                                           |ofethanol,            |
|                  |                                                                                           |isopropylalcohol,     |
|                  |                                                                                           |ethylacetate,         |
|                  |                                                                                           |secondary             |
|                  |                                                                                           |butanol,              |
|                  |                                                                                           |tetrahydrofuran,      |
|                  |                                                                                           |toluene               |
|                  |                                                                                           |andn-methylpyrrolidone|
|                  |                                                                                           |appeared              |
|                  |                                                                                           |successively,         |
|                  |                                                                                           |and the               |
|                  |                                                                                           |separation            |
|                  |                                                                                           |degree                |
|                  |                                                                                           |betweeneachadjacent   |
|                  |                                                                                           |solvent               |
|                  |                                                                                           |peak                  |
|                  |                                                                                           |was                   |
|                  |                                                                                           |greater               |
|                  |                                                                                           |than                  |
|                  |                                                                                           |1.5                   |
|                  |                                                                                           |(the                  |
|                  |                                                                                           |requirement           |
|                  |                                                                                           |was                   |
|                  |                                                                                           |greater               |
|                  |                                                                                           |than                  |
|                  |                                                                                           |1.5).                 |
|                  |                                                                                           |The RSD               |
|                  |                                                                                           |ofethanol             |
|                  |                                                                                           |peak                  |
|                  |                                                                                           |retention             |
|                  |                                                                                           |time                  |
|                  |                                                                                           |was                   |
|                  |                                                                                           |0.13%                 |
|                  |                                                                                           |(NMT                  |
|                  |                                                                                           |1.0%),                |
|                  |                                                                                           |and the               |
|                  |                                                                                           |RSD of                |
|                  |                                                                                           |peakarea              |
|                  |                                                                                           |was                   |
|                  |                                                                                           |0.8%                  |
|                  |                                                                                           |(NMT                  |
|                  |                                                                                           |10%).                 |
|                  |                                                                                           |The RSD               |
|                  |                                                                                           |ofisopropylalcohol    |
|                  |                                                                                           |peak                  |
|                  |                                                                                           |retention             |
|                  |                                                                                           |time                  |
|                  |                                                                                           |was                   |
|                  |                                                                                           |0.12%                 |
|                  |                                                                                           |(NMT                  |
|                  |                                                                                           |1.0%),                |
|                  |                                                                                           |and the               |
|                  |                                                                                           |RSD of                |
|                  |                                                                                           |peakarea              |
|                  |                                                                                           |was                   |
|                  |                                                                                           |1.0%                  |
|                  |                                                                                           |(NMT                  |
|                  |                                                                                           |10%);                 |
|                  |                                                                                           |The RSD               |
|                  |                                                                                           |of the                |
|                  |                                                                                           |ethylacetate          |
|                  |                                                                                           |peak                  |
|                  |                                                                                           |was                   |
|                  |                                                                                           |0.08%                 |
|                  |                                                                                           |(NMT                  |
|                  |                                                                                           |1.0%),                |
|                  |                                                                                           |and the               |
|                  |                                                                                           |RSD of                |
|                  |                                                                                           |the                   |
|                  |                                                                                           |peakarea              |
|                  |                                                                                           |was                   |
|                  |                                                                                           |0.9%                  |
|                  |                                                                                           |(NMT                  |
|                  |                                                                                           |10%);                 |
|                  |                                                                                           |The RSD               |
|                  |                                                                                           |of                    |
|                  |                                                                                           |secondary             |
|                  |                                                                                           |butanol               |
|                  |                                                                                           |was                   |
|                  |                                                                                           |0.08%                 |
|                  |                                                                                           |(NMT                  |
|                  |                                                                                           |1.0%),                |
|                  |                                                                                           |and the               |
|                  |                                                                                           |RSD of                |
|                  |                                                                                           |peakarea              |
|                  |                                                                                           |was                   |
|                  |                                                                                           |0.9%                  |
|                  |                                                                                           |(NMT                  |
|                  |                                                                                           |10%);                 |
|                  |                                                                                           |The RSD               |
|                  |                                                                                           |of the                |
|                  |                                                                                           |peak                  |
|                  |                                                                                           |retention             |
|                  |                                                                                           |time of               |
|                  |                                                                                           |tetrahydrofuran       |
|                  |                                                                                           |was                   |
|                  |                                                                                           |0.08%                 |
|                  |                                                                                           |(NMT                  |
|                  |                                                                                           |1.0%),                |
|                  |                                                                                           |and the               |
|                  |                                                                                           |RSD of                |
|                  |                                                                                           |the                   |
|                  |                                                                                           |peakarea              |
|                  |                                                                                           |was                   |
|                  |                                                                                           |0.8%                  |
|                  |                                                                                           |(NMT                  |
|                  |                                                                                           |10%);                 |
|                  |                                                                                           |The RSD               |
|                  |                                                                                           |of                    |
|                  |                                                                                           |toluene               |
|                  |                                                                                           |peak                  |
|                  |                                                                                           |was                   |
|                  |                                                                                           |0.05%                 |
|                  |                                                                                           |(NMT                  |
|                  |                                                                                           |1.0%),                |
|                  |                                                                                           |and the               |
|                  |                                                                                           |RSD of                |
|                  |                                                                                           |peakarea              |
|                  |                                                                                           |was                   |
|                  |                                                                                           |1.0%                  |
|                  |                                                                                           |(NMT                  |
|                  |                                                                                           |10%);                 |
|                  |                                                                                           |The RSD               |
|                  |                                                                                           |of                    |
|                  |                                                                                           |theN-methylpyrrolidone|
|                  |                                                                                           |peak                  |
|                  |                                                                                           |was                   |
|                  |                                                                                           |0.015%                |
|                  |                                                                                           |(NMT                  |
|                  |                                                                                           |1.0%),                |
|                  |                                                                                           |and the               |
|                  |                                                                                           |RSD of                |
|                  |                                                                                           |the                   |
|                  |                                                                                           |peakarea              |
|                  |                                                                                           |was                   |
|                  |                                                                                           |2.7%                  |
|                  |                                                                                           |(NMT                  |
|                  |                                                                                           |10%);                 |
|                  |                                                                                           |All the               |
|                  |                                                                                           |above                 |
|                  |                                                                                           |meet                  |
|                  |                                                                                           |the                   |
|                  |                                                                                           |verification          |
|                  |                                                                                           |requirements,         |
|                  |                                                                                           |indicating            |
|                  |                                                                                           |that                  |
|                  |                                                                                           |the                   |
|                  |                                                                                           |method                |
|                  |                                                                                           |hasgoodapplicability  |
|                  |                                                                                           |in                    |
|                  |                                                                                           |system.               |
|------------------|-------------------------------------------------------------------------------------------|----------------------|
|Specificity       |There was no interference in the blank solution. In the control solution, the peaks        |There was no          |
|                  |ofethanol, isopropylalcohol, ethylacetate, secondary butanol, tetrahydrofuran, toluene     |interference in the   |
|                  |andn-methylpyrrolidone appeared                                                            |blank solution. In the|
|                  |                                                                                           |control solution, the |
|                  |                                                                                           |peaks ofethanol,      |
|                  |                                                                                           |isopropylalcohol,     |
|                  |                                                                                           |ethylacetate,         |
|                  |                                                                                           |secondary butanol,    |
|                  |                                                                                           |tetrahydrofuran,      |
|                  |                                                                                           |toluene               |
|                  |                                                                                           |andn-methylpyrrolidone|
|                  |                                                                                           |appeared successively,|
|                  |                                                                                           |and the separation    |
|                  |                                                                                           |degree between the    |
|                  |                                                                                           |peaks ofeachadjacent  |
|                  |                                                                                           |solvent was greater   |
|                  |                                                                                           |than 1.5 (the         |
|                  |                                                                                           |requirement was       |
|                  |                                                                                           |greater than 1.5). The|
|                  |                                                                                           |separation degree     |
|                  |                                                                                           |betweenindividual     |
|                  |                                                                                           |solvent peaks         |
|                  |                                                                                           |andadjacent peaks in  |
|                  |                                                                                           |the specific mixed    |
|                  |                                                                                           |solution and the test |
|                  |                                                                                           |solutionis NLT 1.5,   |
|                  |                                                                                           |the retention time    |
|                  |                                                                                           |ofeach known solvent  |
---------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 365 of 542 





Page 366
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 













































------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|successively, and the         |peak in            |**Soluti**|**Component**   |**Component**   |**Compone**       |**Rt              |**Rt              |**Degree                    |**The                       |**The                       |                            |
|separation degree between the |the                |**on**    |**name**        |**name**        |**nt**            |(min)**           |(min)**           |of**                        |percentage**                |percentage**                |                            |
|adjacent peaks should be      |specific           |**Name**  |                |                |**concentr**      |                  |                  |**separatio**               |**equivalent                |**equivalent                |                            |
|greater than 1.5; The         |mixed              |          |                |                |**ation**         |                  |                  |**nfrom                     |to                          |to                          |                            |
|separation degree ofeach      |solution           |          |                |                |**(μg/ml)**       |                  |                  |the**                       |the**                       |the**                       |                            |
|solvent peak andadjacent peaks|and the            |          |                |                |                  |                  |                  |**previous**                |**concentrationof**         |**concentrationof**         |                            |
|in the specific mixed solution|test               |          |                |                |                  |                  |                  |**peak**                    |**the                       |**the                       |                            |
|and the test product          |solutionis         |          |                |                |                  |                  |                  |                            |principal**                 |principal**                 |                            |
|solutionis NLT 1.5, the       |consistent         |          |                |                |                  |                  |                  |                            |**component                 |**component                 |                            |
|retention time ofeach known   |with               |          |                |                |                  |                  |                  |                            |in                          |in                          |                            |
|solvent peak in the specific  |the                |          |                |                |                  |                  |                  |                            |the**                       |the**                       |                            |
|mixed solution and the test   |retention          |          |                |                |                  |                  |                  |                            |**test                      |**test                      |                            |
|product solution should be    |time               |          |                |                |                  |                  |                  |                            |solution**                  |solution**                  |                            |
|consistent with the retention |ofeach             |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|time ofeach solvent           |solvent            |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|positioning solution, and the |positioning        |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|positioning solution ofother  |solution,          |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|solvents (piperidine, benzene)|andother           |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|has no interference with the  |solvent            |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|target solvent peak.          |positioning        |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |solutions          |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |(benzene,          |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |piperidine)        |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |have no            |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |interference       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |with               |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |the                |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |target             |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |solventpeak.       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**Soluti**         |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**on**             |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**Name**           |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**Component**      |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**name**           |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**Compone**        |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**nt**             |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**concentr**       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**ation**          |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**(μg/ml)**        |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**Rt               |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |(min)**            |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**Degree           |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |of**               |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**separatio**      |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**nfrom            |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |the**              |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**previous**       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**peak**           |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**The              |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |percentage**       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**equivalent       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |to                 |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |the**              |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**concentrationof**|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**the              |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |principal**        |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**component        |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |in                 |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |the**              |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**test             |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |solution**         |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |Specifi            |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |cmixed             |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |solutio            |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |nEthanol           |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |250.278            |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |8.149 /            |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.5%               |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |Isopropylalcohol   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |250.410            |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |9.504              |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |8.2                |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.5%               |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |Ethylacetate       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |248.695            |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |14.145             |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |28.2               |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.5%               |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |sec-butanol        |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |250.585            |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |14.429             |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |1.8                |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.5%               |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |tetrahydrofuran    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |36.588             |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |14.728             |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |1.9                |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.072%             |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |Toluene            |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |50.025             |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |20.061             |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |37.5               |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.089%             |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |N-methylpyrroli    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |done               |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |27.6875            |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |31.390             |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |94.3               |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.053%             |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|------------------------------|-------------------|----------|----------------|----------------|------------------|------------------|------------------|----------------------------|----------------------------|----------------------------|----------------------------|
|successively, and the         |peak in the        |Specifi   |Ethanol         |Ethanol         |250.278           |8.149             |8.149             |/                           |0.5%                        |0.5%                        |                            |
|separation degree between the |specific mixed     |cmixed    |                |                |                  |                  |                  |                            |                            |                            |                            |
|adjacent peaks should be      |solution and the   |solution  |                |                |                  |                  |                  |                            |                            |                            |                            |
|greater than 1.5; The         |test solutionis    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|separation degree ofeach      |consistent with the|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|solvent peak andadjacent peaks|retention time     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|in the specific mixed solution|ofeach solvent     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|and the test product          |positioning        |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|solutionis NLT 1.5, the       |solution, andother |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|retention time ofeach known   |solvent positioning|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|solvent peak in the specific  |solutions (benzene,|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|mixed solution and the test   |piperidine) have no|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|product solution should be    |interference with  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|consistent with the retention |the target         |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|time ofeach solvent           |solventpeak.       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|positioning solution, and the |**Soluti** **on**  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|positioning solution ofother  |**Name**           |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|solvents (piperidine, benzene)|**Component**      |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|has no interference with the  |**name**           |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|target solvent peak.          |**Compone** **nt** |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**concentr**       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**ation**          |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**(μg/ml)** **Rt   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |(min)** **Degree   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |of** **separatio** |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**nfrom the**      |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**previous**       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**peak** **The     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |percentage**       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**equivalent to    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |the**              |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**concentrationof**|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**the principal**  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**component in     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |the** **test       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |solution** Specifi |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |cmixed solutio     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |nEthanol 250.278   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |8.149 / 0.5%       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |Isopropylalcohol   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |250.410 9.504 8.2  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.5% Ethylacetate  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |248.695 14.145 28.2|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.5% sec-butanol   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |250.585 14.429 1.8 |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.5%               |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |tetrahydrofuran    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |36.588 14.728 1.9  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.072% Toluene     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |50.025 20.061 37.5 |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.089%             |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |N-methylpyrroli    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |done 27.6875 31.390|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |94.3 0.053%        |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|------------------------------|-------------------|----------|----------------|----------------|------------------|------------------|------------------|----------------------------|----------------------------|----------------------------|----------------------------|
|successively, and the         |peak in the        |Specifi   |Isopropylalcohol|Isopropylalcohol|250.410           |9.504             |9.504             |8.2                         |0.5%                        |0.5%                        |                            |
|separation degree between the |specific mixed     |cmixed    |                |                |                  |                  |                  |                            |                            |                            |                            |
|adjacent peaks should be      |solution and the   |solution  |                |                |                  |                  |                  |                            |                            |                            |                            |
|greater than 1.5; The         |test solutionis    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|separation degree ofeach      |consistent with the|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|solvent peak andadjacent peaks|retention time     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|in the specific mixed solution|ofeach solvent     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|and the test product          |positioning        |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|solutionis NLT 1.5, the       |solution, andother |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|retention time ofeach known   |solvent positioning|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|solvent peak in the specific  |solutions (benzene,|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|mixed solution and the test   |piperidine) have no|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|product solution should be    |interference with  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|consistent with the retention |the target         |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|time ofeach solvent           |solventpeak.       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|positioning solution, and the |**Soluti** **on**  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|positioning solution ofother  |**Name**           |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|solvents (piperidine, benzene)|**Component**      |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|has no interference with the  |**name**           |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|target solvent peak.          |**Compone** **nt** |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**concentr**       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**ation**          |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**(μg/ml)** **Rt   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |(min)** **Degree   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |of** **separatio** |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**nfrom the**      |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**previous**       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**peak** **The     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |percentage**       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**equivalent to    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |the**              |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**concentrationof**|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**the principal**  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**component in     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |the** **test       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |solution** Specifi |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |cmixed solutio     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |nEthanol 250.278   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |8.149 / 0.5%       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |Isopropylalcohol   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |250.410 9.504 8.2  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.5% Ethylacetate  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |248.695 14.145 28.2|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.5% sec-butanol   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |250.585 14.429 1.8 |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.5%               |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |tetrahydrofuran    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |36.588 14.728 1.9  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.072% Toluene     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |50.025 20.061 37.5 |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.089%             |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |N-methylpyrroli    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |done 27.6875 31.390|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |94.3 0.053%        |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|------------------------------|-------------------|----------|----------------|----------------|------------------|------------------|------------------|----------------------------|----------------------------|----------------------------|----------------------------|
|successively, and the         |peak in the        |Specifi   |Ethylacetate    |Ethylacetate    |248.695           |14.145            |14.145            |28.2                        |0.5%                        |0.5%                        |                            |
|separation degree between the |specific mixed     |cmixed    |                |                |                  |                  |                  |                            |                            |                            |                            |
|adjacent peaks should be      |solution and the   |solution  |                |                |                  |                  |                  |                            |                            |                            |                            |
|greater than 1.5; The         |test solutionis    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|separation degree ofeach      |consistent with the|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|solvent peak andadjacent peaks|retention time     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|in the specific mixed solution|ofeach solvent     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|and the test product          |positioning        |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|solutionis NLT 1.5, the       |solution, andother |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|retention time ofeach known   |solvent positioning|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|solvent peak in the specific  |solutions (benzene,|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|mixed solution and the test   |piperidine) have no|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|product solution should be    |interference with  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|consistent with the retention |the target         |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|time ofeach solvent           |solventpeak.       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|positioning solution, and the |**Soluti** **on**  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|positioning solution ofother  |**Name**           |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|solvents (piperidine, benzene)|**Component**      |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|has no interference with the  |**name**           |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|target solvent peak.          |**Compone** **nt** |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**concentr**       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**ation**          |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**(μg/ml)** **Rt   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |(min)** **Degree   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |of** **separatio** |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**nfrom the**      |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**previous**       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**peak** **The     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |percentage**       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**equivalent to    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |the**              |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**concentrationof**|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**the principal**  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**component in     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |the** **test       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |solution** Specifi |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |cmixed solutio     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |nEthanol 250.278   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |8.149 / 0.5%       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |Isopropylalcohol   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |250.410 9.504 8.2  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.5% Ethylacetate  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |248.695 14.145 28.2|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.5% sec-butanol   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |250.585 14.429 1.8 |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.5%               |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |tetrahydrofuran    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |36.588 14.728 1.9  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.072% Toluene     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |50.025 20.061 37.5 |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.089%             |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |N-methylpyrroli    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |done 27.6875 31.390|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |94.3 0.053%        |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|------------------------------|-------------------|----------|----------------|----------------|------------------|------------------|------------------|----------------------------|----------------------------|----------------------------|----------------------------|
|successively, and the         |peak in the        |Specifi   |sec-butanol     |sec-butanol     |250.585           |14.429            |14.429            |1.8                         |0.5%                        |0.5%                        |                            |
|separation degree between the |specific mixed     |cmixed    |                |                |                  |                  |                  |                            |                            |                            |                            |
|adjacent peaks should be      |solution and the   |solution  |                |                |                  |                  |                  |                            |                            |                            |                            |
|greater than 1.5; The         |test solutionis    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|separation degree ofeach      |consistent with the|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|solvent peak andadjacent peaks|retention time     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|in the specific mixed solution|ofeach solvent     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|and the test product          |positioning        |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|solutionis NLT 1.5, the       |solution, andother |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|retention time ofeach known   |solvent positioning|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|solvent peak in the specific  |solutions (benzene,|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|mixed solution and the test   |piperidine) have no|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|product solution should be    |interference with  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|consistent with the retention |the target         |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|time ofeach solvent           |solventpeak.       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|positioning solution, and the |**Soluti** **on**  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|positioning solution ofother  |**Name**           |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|solvents (piperidine, benzene)|**Component**      |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|has no interference with the  |**name**           |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|target solvent peak.          |**Compone** **nt** |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**concentr**       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**ation**          |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**(μg/ml)** **Rt   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |(min)** **Degree   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |of** **separatio** |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**nfrom the**      |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**previous**       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**peak** **The     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |percentage**       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**equivalent to    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |the**              |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**concentrationof**|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**the principal**  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**component in     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |the** **test       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |solution** Specifi |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |cmixed solutio     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |nEthanol 250.278   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |8.149 / 0.5%       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |Isopropylalcohol   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |250.410 9.504 8.2  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.5% Ethylacetate  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |248.695 14.145 28.2|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.5% sec-butanol   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |250.585 14.429 1.8 |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.5%               |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |tetrahydrofuran    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |36.588 14.728 1.9  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.072% Toluene     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |50.025 20.061 37.5 |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.089%             |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |N-methylpyrroli    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |done 27.6875 31.390|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |94.3 0.053%        |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|------------------------------|-------------------|----------|----------------|----------------|------------------|------------------|------------------|----------------------------|----------------------------|----------------------------|----------------------------|
|successively, and the         |peak in the        |Specifi   |tetrahydrofuran |tetrahydrofuran |36.588            |14.728            |14.728            |1.9                         |0.072%                      |0.072%                      |                            |
|separation degree between the |specific mixed     |cmixed    |                |                |                  |                  |                  |                            |                            |                            |                            |
|adjacent peaks should be      |solution and the   |solution  |                |                |                  |                  |                  |                            |                            |                            |                            |
|greater than 1.5; The         |test solutionis    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|separation degree ofeach      |consistent with the|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|solvent peak andadjacent peaks|retention time     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|in the specific mixed solution|ofeach solvent     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|and the test product          |positioning        |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|solutionis NLT 1.5, the       |solution, andother |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|retention time ofeach known   |solvent positioning|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|solvent peak in the specific  |solutions (benzene,|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|mixed solution and the test   |piperidine) have no|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|product solution should be    |interference with  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|consistent with the retention |the target         |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|time ofeach solvent           |solventpeak.       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|positioning solution, and the |**Soluti** **on**  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|positioning solution ofother  |**Name**           |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|solvents (piperidine, benzene)|**Component**      |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|has no interference with the  |**name**           |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|target solvent peak.          |**Compone** **nt** |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**concentr**       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**ation**          |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**(μg/ml)** **Rt   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |(min)** **Degree   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |of** **separatio** |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**nfrom the**      |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**previous**       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**peak** **The     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |percentage**       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**equivalent to    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |the**              |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**concentrationof**|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**the principal**  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**component in     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |the** **test       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |solution** Specifi |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |cmixed solutio     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |nEthanol 250.278   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |8.149 / 0.5%       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |Isopropylalcohol   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |250.410 9.504 8.2  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.5% Ethylacetate  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |248.695 14.145 28.2|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.5% sec-butanol   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |250.585 14.429 1.8 |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.5%               |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |tetrahydrofuran    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |36.588 14.728 1.9  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.072% Toluene     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |50.025 20.061 37.5 |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.089%             |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |N-methylpyrroli    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |done 27.6875 31.390|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |94.3 0.053%        |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|------------------------------|-------------------|----------|----------------|----------------|------------------|------------------|------------------|----------------------------|----------------------------|----------------------------|----------------------------|
|successively, and the         |peak in the        |Specifi   |Toluene         |Toluene         |50.025            |20.061            |20.061            |37.5                        |0.089%                      |0.089%                      |                            |
|separation degree between the |specific mixed     |cmixed    |                |                |                  |                  |                  |                            |                            |                            |                            |
|adjacent peaks should be      |solution and the   |solution  |                |                |                  |                  |                  |                            |                            |                            |                            |
|greater than 1.5; The         |test solutionis    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|separation degree ofeach      |consistent with the|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|solvent peak andadjacent peaks|retention time     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|in the specific mixed solution|ofeach solvent     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|and the test product          |positioning        |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|solutionis NLT 1.5, the       |solution, andother |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|retention time ofeach known   |solvent positioning|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|solvent peak in the specific  |solutions (benzene,|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|mixed solution and the test   |piperidine) have no|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|product solution should be    |interference with  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|consistent with the retention |the target         |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|time ofeach solvent           |solventpeak.       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|positioning solution, and the |**Soluti** **on**  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|positioning solution ofother  |**Name**           |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|solvents (piperidine, benzene)|**Component**      |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|has no interference with the  |**name**           |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|target solvent peak.          |**Compone** **nt** |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**concentr**       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**ation**          |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**(μg/ml)** **Rt   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |(min)** **Degree   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |of** **separatio** |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**nfrom the**      |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**previous**       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**peak** **The     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |percentage**       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**equivalent to    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |the**              |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**concentrationof**|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**the principal**  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**component in     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |the** **test       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |solution** Specifi |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |cmixed solutio     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |nEthanol 250.278   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |8.149 / 0.5%       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |Isopropylalcohol   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |250.410 9.504 8.2  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.5% Ethylacetate  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |248.695 14.145 28.2|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.5% sec-butanol   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |250.585 14.429 1.8 |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.5%               |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |tetrahydrofuran    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |36.588 14.728 1.9  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.072% Toluene     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |50.025 20.061 37.5 |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.089%             |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |N-methylpyrroli    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |done 27.6875 31.390|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |94.3 0.053%        |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|------------------------------|-------------------|----------|----------------|----------------|------------------|------------------|------------------|----------------------------|----------------------------|----------------------------|----------------------------|
|successively, and the         |peak in the        |Specifi   |N-methylpyrroli |N-methylpyrroli |27.6875           |31.390            |31.390            |94.3                        |0.053%                      |0.053%                      |                            |
|separation degree between the |specific mixed     |cmixed    |done            |done            |                  |                  |                  |                            |                            |                            |                            |
|adjacent peaks should be      |solution and the   |solution  |                |                |                  |                  |                  |                            |                            |                            |                            |
|greater than 1.5; The         |test solutionis    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|separation degree ofeach      |consistent with the|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|solvent peak andadjacent peaks|retention time     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|in the specific mixed solution|ofeach solvent     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|and the test product          |positioning        |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|solutionis NLT 1.5, the       |solution, andother |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|retention time ofeach known   |solvent positioning|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|solvent peak in the specific  |solutions (benzene,|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|mixed solution and the test   |piperidine) have no|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|product solution should be    |interference with  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|consistent with the retention |the target         |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|time ofeach solvent           |solventpeak.       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|positioning solution, and the |**Soluti** **on**  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|positioning solution ofother  |**Name**           |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|solvents (piperidine, benzene)|**Component**      |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|has no interference with the  |**name**           |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|target solvent peak.          |**Compone** **nt** |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**concentr**       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**ation**          |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**(μg/ml)** **Rt   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |(min)** **Degree   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |of** **separatio** |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**nfrom the**      |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**previous**       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**peak** **The     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |percentage**       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**equivalent to    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |the**              |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**concentrationof**|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**the principal**  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |**component in     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |the** **test       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |solution** Specifi |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |cmixed solutio     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |nEthanol 250.278   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |8.149 / 0.5%       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |Isopropylalcohol   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |250.410 9.504 8.2  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.5% Ethylacetate  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |248.695 14.145 28.2|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.5% sec-butanol   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |250.585 14.429 1.8 |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.5%               |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |tetrahydrofuran    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |36.588 14.728 1.9  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.072% Toluene     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |50.025 20.061 37.5 |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |0.089%             |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |N-methylpyrroli    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |done 27.6875 31.390|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |94.3 0.053%        |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|------------------------------|-------------------|----------|----------------|----------------|------------------|------------------|------------------|----------------------------|----------------------------|----------------------------|----------------------------|
|Limits of quantifi cation,    |TheS/Nofeach       |          |**Compone** **nt|**Compone** **nt|**Detection       |**Detection       |**Detection       |**Limitofquantitation**     |**Limitofquantitation**     |**Limitofquantitation**     |                            |
|detection                     |solvent peak in the|          |Name**          |Name**          |Limits**          |Limits**          |Limits**          |                            |                            |                            |                            |
|                              |6 LOQ solution maps|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |should be NLT 10,  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |the RSD of         |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |retention time     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |should be no more  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |than 2.0%, and the |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |RSD of peakarea    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |should be no more  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |than 10%.          |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |TheS/Nofeach       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |solvent peak in the|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |3-needle Limit of  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |detection (LOD)    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |solutionatlas      |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |should be NLT 3.   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|------------------------------|-------------------|----------|----------------|----------------|------------------|------------------|------------------|----------------------------|----------------------------|----------------------------|----------------------------|
|Limits of quantifi cation,    |TheS/Nofeach       |          |**Compone** **nt|**Compone** **nt|**Concentration   |**Concentration   |**Concentration   |**Concentration             |**Concentration             |**Concentration             |**Concentration             |
|detection                     |solvent peak in the|          |Name**          |Name**          |(equivalent       |(equivalent       |(equivalent       |(equivalent to the**        |(equivalent to the**        |(equivalent to the**        |(equivalent                 |
|                              |6 LOQ solution maps|          |                |                |to the**          |to the**          |to the**          |**test product              |**test product              |**test product              |to                          |
|                              |should be NLT 10,  |          |                |                |**percentage      |**percentage      |**percentage      |solution**                  |solution**                  |solution**                  |the**                       |
|                              |the RSD of         |          |                |                |of                |of                |of                |**concentrationpercentage)**|**concentrationpercentage)**|**concentrationpercentage)**|**test                      |
|                              |retention time     |          |                |                |solution**        |solution**        |solution**        |                            |                            |                            |product                     |
|                              |should be no more  |          |                |                |**concentration   |**concentration   |**concentration   |                            |                            |                            |solution**                  |
|                              |than 2.0%, and the |          |                |                |of the            |of the            |of the            |                            |                            |                            |**concentrationpercentage)**|
|                              |RSD of peakarea    |          |                |                |testproduct)**    |testproduct)**    |testproduct)**    |                            |                            |                            |                            |
|                              |should be no more  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |than 10%.          |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |TheS/Nofeach       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |solvent peak in the|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |3-needle Limit of  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |detection (LOD)    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |solutionatlas      |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |should be NLT 3.   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|------------------------------|-------------------|----------|----------------|----------------|------------------|------------------|------------------|----------------------------|----------------------------|----------------------------|----------------------------|
|Limits of quantifi cation,    |TheS/Nofeach       |          |Ethylalcohol    |Ethylalcohol    |1.502μg/ml        |1.502μg/ml        |1.502μg/ml        |5.006μg/ml (0.01%)          |5.006μg/ml (0.01%)          |5.006μg/ml (0.01%)          |5.006μg/ml (0.01%)          |
|detection                     |solvent peak in the|          |                |                |(0.003%)          |(0.003%)          |(0.003%)          |                            |                            |                            |                            |
|                              |6 LOQ solution maps|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |should be NLT 10,  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |the RSD of         |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |retention time     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |should be no more  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |than 2.0%, and the |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |RSD of peakarea    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |should be no more  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |than 10%.          |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |TheS/Nofeach       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |solvent peak in the|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |3-needle Limit of  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |detection (LOD)    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |solutionatlas      |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |should be NLT 3.   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|------------------------------|-------------------|----------|----------------|----------------|------------------|------------------|------------------|----------------------------|----------------------------|----------------------------|----------------------------|
|Limits of quantifi cation,    |TheS/Nofeach       |          |Isopropylalcohol|Isopropylalcohol|1.502μg/ml        |1.502μg/ml        |1.502μg/ml        |5.008μg/ml (0.01%)          |5.008μg/ml (0.01%)          |5.008μg/ml (0.01%)          |5.008μg/ml (0.01%)          |
|detection                     |solvent peak in the|          |                |                |(0.003%)          |(0.003%)          |(0.003%)          |                            |                            |                            |                            |
|                              |6 LOQ solution maps|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |should be NLT 10,  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |the RSD of         |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |retention time     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |should be no more  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |than 2.0%, and the |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |RSD of peakarea    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |should be no more  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |than 10%.          |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |TheS/Nofeach       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |solvent peak in the|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |3-needle Limit of  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |detection (LOD)    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |solutionatlas      |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |should be NLT 3.   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|------------------------------|-------------------|----------|----------------|----------------|------------------|------------------|------------------|----------------------------|----------------------------|----------------------------|----------------------------|
|Limits of quantifi cation,    |TheS/Nofeach       |          |Ethyl           |Ethyl           |1.492μg/ml(0.003%)|1.492μg/ml(0.003%)|1.492μg/ml(0.003%)|4.974μg/ml(0.01%)           |4.974μg/ml(0.01%)           |4.974μg/ml(0.01%)           |4.974μg/ml(0.01%)           |
|detection                     |solvent peak in the|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |6 LOQ solution maps|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |should be NLT 10,  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |the RSD of         |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |retention time     |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |should be no more  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |than 2.0%, and the |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |RSD of peakarea    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |should be no more  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |than 10%.          |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |TheS/Nofeach       |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |solvent peak in the|          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |3-needle Limit of  |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |detection (LOD)    |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |solutionatlas      |          |                |                |                  |                  |                  |                            |                            |                            |                            |
|                              |should be NLT 3.   |          |                |                |                  |                  |                  |                            |                            |                            |                            |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 366 of 542 





Page 367
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



















































----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|sec-butanol         |1.128μg/ml (0.002%)                      |1.128μg/ml        |3.759μg/ml        |3.759μg/ml        |3.759μg/ml             |                       |                  |             |
|                    |                                         |(0.002%)          |(0.008%)          |(0.008%)          |(0.008%)               |                       |                  |             |
|--------------------|-----------------------------------------|------------------|------------------|------------------|-----------------------|-----------------------|------------------|-------------|
|tetrahydro furan    |1.098μg/ml (0.002%)                      |1.098μg/ml        |3.659μg/ml        |3.659μg/ml        |3.659μg/ml             |                       |                  |             |
|                    |                                         |(0.002%)          |(0.007%)          |(0.007%)          |(0.007%)               |                       |                  |             |
|--------------------|-----------------------------------------|------------------|------------------|------------------|-----------------------|-----------------------|------------------|-------------|
|Toluene             |0.600μg/ml(0.001%)                       |0.600μg/ml(0.001%)|2.001μg/ml(0.004%)|2.001μg/ml(0.004%)|2.001μg/ml(0.004%)     |                       |                  |             |
|--------------------|-----------------------------------------|------------------|------------------|------------------|-----------------------|-----------------------|------------------|-------------|
|N-methylp yrrolidone|0.831μg/ml (0.002%)                      |0.831μg/ml        |2.769μg/ml        |2.769μg/ml        |2.769μg/ml             |                       |                  |             |
|                    |                                         |(0.002%)          |(0.006%)          |(0.006%)          |(0.006%)               |                       |                  |             |
|--------------------|-----------------------------------------|------------------|------------------|------------------|-----------------------|-----------------------|------------------|-------------|
|Linearity and range |Within the limit concentration range of  |                  |**Component**     |**Component**     |**Concentration        |**Concentration        |**Linearequation**|             |
|                    |LOQ concentration ~200% ofeach solvent, 6|                  |**Names**         |**Names**         |(equivalent to         |(equivalent            |                  |             |
|                    |concentration points were selected       |                  |                  |                  |the**                  |to                     |                  |             |
|                    |fairlyuniformly, with the concentration  |                  |                  |                  |**concentration        |the**                  |                  |             |
|                    |ofeach solventas the horizontal          |                  |                  |                  |percentage of the      |**concentration        |                  |             |
|                    |coordinate and the peakarea as the       |                  |                  |                  |test** **product       |percentage             |                  |             |
|                    |vertical coordinate. The regression      |                  |                  |                  |solution)**            |of the                 |                  |             |
|                    |coefficientR of the obtained linear graph|                  |                  |                  |                       |test**                 |                  |             |
|                    |should NLT 0.990, and the RSD of the     |                  |                  |                  |                       |**product              |                  |             |
|                    |response factor should not be more than  |                  |                  |                  |                       |solution)**            |                  |             |
|                    |10%. The absoluteY-axisinterceptaccounted|                  |                  |                  |                       |                       |                  |             |
|                    |for 100% of the response value of the    |                  |                  |                  |                       |                       |                  |             |
|                    |percentage should be less than 25%.      |                  |                  |                  |                       |                       |                  |             |
|--------------------|-----------------------------------------|------------------|------------------|------------------|-----------------------|-----------------------|------------------|-------------|
|Linearity and range |Within the limit concentration range of  |                  |Ethanol           |Ethanol           |5.006μg/ml to          |5.006μg/ml to          |Y = 0.923 + 0.7951|Y =          |
|                    |LOQ concentration ~200% ofeach solvent, 6|                  |                  |                  |500.555μg/ml           |500.555μg/ml           |x                 |0.923 +      |
|                    |concentration points were selected       |                  |                  |                  |(0.0100% to            |(0.0100% to            |                  |0.7951       |
|                    |fairlyuniformly, with the concentration  |                  |                  |                  |1.0011%)               |1.0011%)               |                  |x            |
|                    |ofeach solventas the horizontal          |                  |                  |                  |                       |                       |                  |             |
|                    |coordinate and the peakarea as the       |                  |                  |                  |                       |                       |                  |             |
|                    |vertical coordinate. The regression      |                  |                  |                  |                       |                       |                  |             |
|                    |coefficientR of the obtained linear graph|                  |                  |                  |                       |                       |                  |             |
|                    |should NLT 0.990, and the RSD of the     |                  |                  |                  |                       |                       |                  |             |
|                    |response factor should not be more than  |                  |                  |                  |                       |                       |                  |             |
|                    |10%. The absoluteY-axisinterceptaccounted|                  |                  |                  |                       |                       |                  |             |
|                    |for 100% of the response value of the    |                  |                  |                  |                       |                       |                  |             |
|                    |percentage should be less than 25%.      |                  |                  |                  |                       |                       |                  |             |
|--------------------|-----------------------------------------|------------------|------------------|------------------|-----------------------|-----------------------|------------------|-------------|
|Linearity and range |Within the limit concentration range of  |                  |Isopropylalcohol  |Isopropylalcohol  |5.008μg/ml to          |5.008μg/ml to          |Y = 0.9917-3.6091 |Y =          |
|                    |LOQ concentration ~200% ofeach solvent, 6|                  |                  |                  |500.820μg/ml           |500.820μg/ml           |x                 |0.9917-3.6091|
|                    |concentration points were selected       |                  |                  |                  |(0.0100% to            |(0.0100% to            |                  |x            |
|                    |fairlyuniformly, with the concentration  |                  |                  |                  |1.0016%)               |1.0016%)               |                  |             |
|                    |ofeach solventas the horizontal          |                  |                  |                  |                       |                       |                  |             |
|                    |coordinate and the peakarea as the       |                  |                  |                  |                       |                       |                  |             |
|                    |vertical coordinate. The regression      |                  |                  |                  |                       |                       |                  |             |
|                    |coefficientR of the obtained linear graph|                  |                  |                  |                       |                       |                  |             |
|                    |should NLT 0.990, and the RSD of the     |                  |                  |                  |                       |                       |                  |             |
|                    |response factor should not be more than  |                  |                  |                  |                       |                       |                  |             |
|                    |10%. The absoluteY-axisinterceptaccounted|                  |                  |                  |                       |                       |                  |             |
|                    |for 100% of the response value of the    |                  |                  |                  |                       |                       |                  |             |
|                    |percentage should be less than 25%.      |                  |                  |                  |                       |                       |                  |             |
|--------------------|-----------------------------------------|------------------|------------------|------------------|-----------------------|-----------------------|------------------|-------------|
|Linearity and range |Within the limit concentration range of  |                  |Ethylacetate      |Ethylacetate      |4.974μg/ml~497.390μg/ml|4.974μg/ml~497.390μg/ml|Y = 0.7696-2.3 x  |Y =          |
|                    |LOQ concentration ~200% ofeach solvent, 6|                  |                  |                  |(0.0099%~0.9948%)      |(0.0099%~0.9948%)      |                  |0.7696-2.3 x |
|                    |concentration points were selected       |                  |                  |                  |                       |                       |                  |             |
|                    |fairlyuniformly, with the concentration  |                  |                  |                  |                       |                       |                  |             |
|                    |ofeach solventas the horizontal          |                  |                  |                  |                       |                       |                  |             |
|                    |coordinate and the peakarea as the       |                  |                  |                  |                       |                       |                  |             |
|                    |vertical coordinate. The regression      |                  |                  |                  |                       |                       |                  |             |
|                    |coefficientR of the obtained linear graph|                  |                  |                  |                       |                       |                  |             |
|                    |should NLT 0.990, and the RSD of the     |                  |                  |                  |                       |                       |                  |             |
|                    |response factor should not be more than  |                  |                  |                  |                       |                       |                  |             |
|                    |10%. The absoluteY-axisinterceptaccounted|                  |                  |                  |                       |                       |                  |             |
|                    |for 100% of the response value of the    |                  |                  |                  |                       |                       |                  |             |
|                    |percentage should be less than 25%.      |                  |                  |                  |                       |                       |                  |             |
|--------------------|-----------------------------------------|------------------|------------------|------------------|-----------------------|-----------------------|------------------|-------------|
|Linearity and range |Within the limit concentration range of  |                  |sec-butanol       |sec-butanol       |3.759μg/ml~501.170μg/ml|3.759μg/ml~501.170μg/ml|Y = 1.2102-4.7656 |Y =          |
|                    |LOQ concentration ~200% ofeach solvent, 6|                  |                  |                  |(0.0075%~1.0023%)      |(0.0075%~1.0023%)      |x                 |1.2102-4.7656|
|                    |concentration points were selected       |                  |                  |                  |                       |                       |                  |x            |
|                    |fairlyuniformly, with the concentration  |                  |                  |                  |                       |                       |                  |             |
|                    |ofeach solventas the horizontal          |                  |                  |                  |                       |                       |                  |             |
|                    |coordinate and the peakarea as the       |                  |                  |                  |                       |                       |                  |             |
|                    |vertical coordinate. The regression      |                  |                  |                  |                       |                       |                  |             |
|                    |coefficientR of the obtained linear graph|                  |                  |                  |                       |                       |                  |             |
|                    |should NLT 0.990, and the RSD of the     |                  |                  |                  |                       |                       |                  |             |
|                    |response factor should not be more than  |                  |                  |                  |                       |                       |                  |             |
|                    |10%. The absoluteY-axisinterceptaccounted|                  |                  |                  |                       |                       |                  |             |
|                    |for 100% of the response value of the    |                  |                  |                  |                       |                       |                  |             |
|                    |percentage should be less than 25%.      |                  |                  |                  |                       |                       |                  |             |
|--------------------|-----------------------------------------|------------------|------------------|------------------|-----------------------|-----------------------|------------------|-------------|
|Linearity and range |Within the limit concentration range of  |                  |tetrahydrofuran   |tetrahydrofuran   |3.659μg/ml to          |3.659μg/ml to          |Y = 1.0779 +      |Y = 1.0779 + |
|                    |LOQ concentration ~200% ofeach solvent, 6|                  |                  |                  |73.175μg/ml (0.0073% to|73.175μg/ml (0.0073% to|0.0623 x          |0.0623 x     |
|                    |concentration points were selected       |                  |                  |                  |0.1464%)               |0.1464%)               |                  |             |
|                    |fairlyuniformly, with the concentration  |                  |                  |                  |                       |                       |                  |             |
|                    |ofeach solventas the horizontal          |                  |                  |                  |                       |                       |                  |             |
|                    |coordinate and the peakarea as the       |                  |                  |                  |                       |                       |                  |             |
|                    |vertical coordinate. The regression      |                  |                  |                  |                       |                       |                  |             |
|                    |coefficientR of the obtained linear graph|                  |                  |                  |                       |                       |                  |             |
|                    |should NLT 0.990, and the RSD of the     |                  |                  |                  |                       |                       |                  |             |
|                    |response factor should not be more than  |                  |                  |                  |                       |                       |                  |             |
|                    |10%. The absoluteY-axisinterceptaccounted|                  |                  |                  |                       |                       |                  |             |
|                    |for 100% of the response value of the    |                  |                  |                  |                       |                       |                  |             |
|                    |percentage should be less than 25%.      |                  |                  |                  |                       |                       |                  |             |
|--------------------|-----------------------------------------|------------------|------------------|------------------|-----------------------|-----------------------|------------------|-------------|
|Linearity and range |Within the limit concentration range of  |                  |Toluene           |Toluene           |2.001μg/ml~100.050μg/ml|2.001μg/ml~100.050μg/ml|Y = 2.0063-0.9813 |Y =          |
|                    |LOQ concentration ~200% ofeach solvent, 6|                  |                  |                  |(0.0040%~0.2001%)      |(0.0040%~0.2001%)      |x                 |2.0063-0.9813|
|                    |concentration points were selected       |                  |                  |                  |                       |                       |                  |x            |
|                    |fairlyuniformly, with the concentration  |                  |                  |                  |                       |                       |                  |             |
|                    |ofeach solventas the horizontal          |                  |                  |                  |                       |                       |                  |             |
|                    |coordinate and the peakarea as the       |                  |                  |                  |                       |                       |                  |             |
|                    |vertical coordinate. The regression      |                  |                  |                  |                       |                       |                  |             |
|                    |coefficientR of the obtained linear graph|                  |                  |                  |                       |                       |                  |             |
|                    |should NLT 0.990, and the RSD of the     |                  |                  |                  |                       |                       |                  |             |
|                    |response factor should not be more than  |                  |                  |                  |                       |                       |                  |             |
|                    |10%. The absoluteY-axisinterceptaccounted|                  |                  |                  |                       |                       |                  |             |
|                    |for 100% of the response value of the    |                  |                  |                  |                       |                       |                  |             |
|                    |percentage should be less than 25%.      |                  |                  |                  |                       |                       |                  |             |
|--------------------|-----------------------------------------|------------------|------------------|------------------|-----------------------|-----------------------|------------------|-------------|
|Linearity and range |Within the limit concentration range of  |                  |N- methylpyrrolido|N- methylpyrrolido|2.769μg/ml to          |2.769μg/ml to          |Y = 0.9965-0.9081 |Y =          |
|                    |LOQ concentration ~200% ofeach solvent, 6|                  |ne                |ne                |55.375μg/ml (0.0055% to|55.375μg/ml (0.0055% to|x                 |0.9965-0.9081|
|                    |concentration points were selected       |                  |                  |                  |0.1108%)               |0.1108%)               |                  |x            |
|                    |fairlyuniformly, with the concentration  |                  |                  |                  |                       |                       |                  |             |
|                    |ofeach solventas the horizontal          |                  |                  |                  |                       |                       |                  |             |
|                    |coordinate and the peakarea as the       |                  |                  |                  |                       |                       |                  |             |
|                    |vertical coordinate. The regression      |                  |                  |                  |                       |                       |                  |             |
|                    |coefficientR of the obtained linear graph|                  |                  |                  |                       |                       |                  |             |
|                    |should NLT 0.990, and the RSD of the     |                  |                  |                  |                       |                       |                  |             |
|                    |response factor should not be more than  |                  |                  |                  |                       |                       |                  |             |
|                    |10%. The absoluteY-axisinterceptaccounted|                  |                  |                  |                       |                       |                  |             |
|                    |for 100% of the response value of the    |                  |                  |                  |                       |                       |                  |             |
|                    |percentage should be less than 25%.      |                  |                  |                  |                       |                       |                  |             |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 367 of 542 





Page 368
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



















































--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Accura cy|Each solvent withalimit concentration range |       |Ethanol            |Plus                      |Plus                      |101.2%,            |101.2%,      |5%, n=9      |5%, n=9|
|         |of 30% to 150% wasadded to the test product,|       |                   |75.0833μg/ml-375.4163μg/ml|75.0833μg/ml-375.4163μg/ml|n=9                |n=9          |             |       |
|         |and the recovery rate ofeach solvent was    |       |                   |                          |                          |                   |             |             |       |
|         |required to be between 85% and 115%, and the|       |                   |                          |                          |                   |             |             |       |
|         |recovery RSD NMT 10%.                       |       |                   |                          |                          |                   |             |             |       |
|---------|--------------------------------------------|-------|-------------------|--------------------------|--------------------------|-------------------|-------------|-------------|-------|
|Accura cy|Each solvent withalimit concentration range |       |Isopropylalcohol   |Added                     |Added                     |101.7%,            |101.7%,      |4%, n=9      |4%, n=9|
|         |of 30% to 150% wasadded to the test product,|       |                   |75.1230μg/ml-375.6150μg/ml|75.1230μg/ml-375.6150μg/ml|n=9                |n=9          |             |       |
|         |and the recovery rate ofeach solvent was    |       |                   |                          |                          |                   |             |             |       |
|         |required to be between 85% and 115%, and the|       |                   |                          |                          |                   |             |             |       |
|         |recovery RSD NMT 10%.                       |       |                   |                          |                          |                   |             |             |       |
|---------|--------------------------------------------|-------|-------------------|--------------------------|--------------------------|-------------------|-------------|-------------|-------|
|Accura cy|Each solvent withalimit concentration range |       |Ethylacetate       |Marked                    |Marked                    |101.4%,            |101.4%,      |3.0%,        |3.0%,  |
|         |of 30% to 150% wasadded to the test product,|       |                   |74.6085μg/ml-373.0425μg/ml|74.6085μg/ml-373.0425μg/ml|n=9                |n=9          |n=9          |n=9    |
|         |and the recovery rate ofeach solvent was    |       |                   |                          |                          |                   |             |             |       |
|         |required to be between 85% and 115%, and the|       |                   |                          |                          |                   |             |             |       |
|         |recovery RSD NMT 10%.                       |       |                   |                          |                          |                   |             |             |       |
|---------|--------------------------------------------|-------|-------------------|--------------------------|--------------------------|-------------------|-------------|-------------|-------|
|Accura cy|Each solvent withalimit concentration range |       |sec-butanol        |Added                     |Added                     |102.2%,            |102.2%,      |4%, n=9      |4%, n=9|
|         |of 30% to 150% wasadded to the test product,|       |                   |75.1755μg/ml-375.8775μg/ml|75.1755μg/ml-375.8775μg/ml|n=9                |n=9          |             |       |
|         |and the recovery rate ofeach solvent was    |       |                   |                          |                          |                   |             |             |       |
|         |required to be between 85% and 115%, and the|       |                   |                          |                          |                   |             |             |       |
|         |recovery RSD NMT 10%.                       |       |                   |                          |                          |                   |             |             |       |
|---------|--------------------------------------------|-------|-------------------|--------------------------|--------------------------|-------------------|-------------|-------------|-------|
|Accura cy|Each solvent withalimit concentration range |       |tetrahydrofuran    |Added                     |Added                     |101.3%,            |101.3%,      |2.6%,        |2.6%,  |
|         |of 30% to 150% wasadded to the test product,|       |                   |10.9763μg/ml-54.8813μg/ml |10.9763μg/ml-54.8813μg/ml |n=9                |n=9          |n=9          |n=9    |
|         |and the recovery rate ofeach solvent was    |       |                   |                          |                          |                   |             |             |       |
|         |required to be between 85% and 115%, and the|       |                   |                          |                          |                   |             |             |       |
|         |recovery RSD NMT 10%.                       |       |                   |                          |                          |                   |             |             |       |
|---------|--------------------------------------------|-------|-------------------|--------------------------|--------------------------|-------------------|-------------|-------------|-------|
|Accura cy|Each solvent withalimit concentration range |       |Toluene            |Marked                    |Marked                    |101.6%,            |101.6%,      |2.7%,        |2.7%,  |
|         |of 30% to 150% wasadded to the test product,|       |                   |15.0075μg/ml-75.0375μg/ml |15.0075μg/ml-75.0375μg/ml |n=9                |n=9          |n=9          |n=9    |
|         |and the recovery rate ofeach solvent was    |       |                   |                          |                          |                   |             |             |       |
|         |required to be between 85% and 115%, and the|       |                   |                          |                          |                   |             |             |       |
|         |recovery RSD NMT 10%.                       |       |                   |                          |                          |                   |             |             |       |
|---------|--------------------------------------------|-------|-------------------|--------------------------|--------------------------|-------------------|-------------|-------------|-------|
|Accura cy|Each solvent withalimit concentration range |       |N-methylpyrrolidone|Added                     |Added                     |%, n=9             |%, n=9       |7%. n=9      |7%. n=9|
|         |of 30% to 150% wasadded to the test product,|       |                   |8.3063μg/ml-41.5313μg/ml  |8.3063μg/ml-41.5313μg/ml  |                   |             |             |       |
|         |and the recovery rate ofeach solvent was    |       |                   |                          |                          |                   |             |             |       |
|         |required to be between 85% and 115%, and the|       |                   |                          |                          |                   |             |             |       |
|         |recovery RSD NMT 10%.                       |       |                   |                          |                          |                   |             |             |       |
|---------|--------------------------------------------|-------|-------------------|--------------------------|--------------------------|-------------------|-------------|-------------|-------|
|Precision|Repeatability and reproducibility: RSD      |       |**Component**      |**Repeatability**         |**Reproducibility**       |**Reproducibility**|**Precision**|**Precision**|       |
|         |ofeach solvent in 6 repeatability (or       |       |**name**           |                          |                          |                   |             |             |       |
|         |reproducibility) test solution NMT 10%.     |       |                   |                          |                          |                   |             |             |       |
|         |Precision: In the results of 12             |       |                   |                          |                          |                   |             |             |       |
|         |repeatability andintermediate precision     |       |                   |                          |                          |                   |             |             |       |
|         |tests, the RSDS ofeach solvent content NMT  |       |                   |                          |                          |                   |             |             |       |
|         |10%.                                        |       |                   |                          |                          |                   |             |             |       |
|---------|--------------------------------------------|-------|-------------------|--------------------------|--------------------------|-------------------|-------------|-------------|-------|
|Precision|Repeatability and reproducibility: RSD      |       |Ethanol            |0.7%, n=6                 |5%, n=6                   |5%, n=6            |4%, n=12     |4%, n=12     |4%,    |
|         |ofeach solvent in 6 repeatability (or       |       |                   |                          |                          |                   |             |             |n=12   |
|         |reproducibility) test solution NMT 10%.     |       |                   |                          |                          |                   |             |             |       |
|         |Precision: In the results of 12             |       |                   |                          |                          |                   |             |             |       |
|         |repeatability andintermediate precision     |       |                   |                          |                          |                   |             |             |       |
|         |tests, the RSDS ofeach solvent content NMT  |       |                   |                          |                          |                   |             |             |       |
|         |10%.                                        |       |                   |                          |                          |                   |             |             |       |
|---------|--------------------------------------------|-------|-------------------|--------------------------|--------------------------|-------------------|-------------|-------------|-------|
|Precision|Repeatability and reproducibility: RSD      |       |Isopropylalcohol   |0.8%, n=6                 |5%, n=6                   |5%, n=6            |4%, n=12     |4%, n=12     |4%,    |
|         |ofeach solvent in 6 repeatability (or       |       |                   |                          |                          |                   |             |             |n=12   |
|         |reproducibility) test solution NMT 10%.     |       |                   |                          |                          |                   |             |             |       |
|         |Precision: In the results of 12             |       |                   |                          |                          |                   |             |             |       |
|         |repeatability andintermediate precision     |       |                   |                          |                          |                   |             |             |       |
|         |tests, the RSDS ofeach solvent content NMT  |       |                   |                          |                          |                   |             |             |       |
|         |10%.                                        |       |                   |                          |                          |                   |             |             |       |
|---------|--------------------------------------------|-------|-------------------|--------------------------|--------------------------|-------------------|-------------|-------------|-------|
|Precision|Repeatability and reproducibility: RSD      |       |Ethylacetate       |0.8%, n=6                 |5%, n=6                   |5%, n=6            |4%, n=12     |4%, n=12     |4%,    |
|         |ofeach solvent in 6 repeatability (or       |       |                   |                          |                          |                   |             |             |n=12   |
|         |reproducibility) test solution NMT 10%.     |       |                   |                          |                          |                   |             |             |       |
|         |Precision: In the results of 12             |       |                   |                          |                          |                   |             |             |       |
|         |repeatability andintermediate precision     |       |                   |                          |                          |                   |             |             |       |
|         |tests, the RSDS ofeach solvent content NMT  |       |                   |                          |                          |                   |             |             |       |
|         |10%.                                        |       |                   |                          |                          |                   |             |             |       |
|---------|--------------------------------------------|-------|-------------------|--------------------------|--------------------------|-------------------|-------------|-------------|-------|
|Precision|Repeatability and reproducibility: RSD      |       |sec-butanol        |0.9%, n=6                 |6%, n=6                   |6%, n=6            |4%, n=12     |4%, n=12     |4%,    |
|         |ofeach solvent in 6 repeatability (or       |       |                   |                          |                          |                   |             |             |n=12   |
|         |reproducibility) test solution NMT 10%.     |       |                   |                          |                          |                   |             |             |       |
|         |Precision: In the results of 12             |       |                   |                          |                          |                   |             |             |       |
|         |repeatability andintermediate precision     |       |                   |                          |                          |                   |             |             |       |
|         |tests, the RSDS ofeach solvent content NMT  |       |                   |                          |                          |                   |             |             |       |
|         |10%.                                        |       |                   |                          |                          |                   |             |             |       |
|---------|--------------------------------------------|-------|-------------------|--------------------------|--------------------------|-------------------|-------------|-------------|-------|
|Precision|Repeatability and reproducibility: RSD      |       |tetrahydrofuran    |1.0%, n=6                 |5%, n=6                   |5%, n=6            |4%, n=12     |4%, n=12     |4%,    |
|         |ofeach solvent in 6 repeatability (or       |       |                   |                          |                          |                   |             |             |n=12   |
|         |reproducibility) test solution NMT 10%.     |       |                   |                          |                          |                   |             |             |       |
|         |Precision: In the results of 12             |       |                   |                          |                          |                   |             |             |       |
|         |repeatability andintermediate precision     |       |                   |                          |                          |                   |             |             |       |
|         |tests, the RSDS ofeach solvent content NMT  |       |                   |                          |                          |                   |             |             |       |
|         |10%.                                        |       |                   |                          |                          |                   |             |             |       |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 368 of 542 





Page 369
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 












------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|N-methylpyrrolidone|2.0%, n=6                                         |5%, n=6               |9%,                   |9%,                   |                      |                      |                      |
|                   |                                                  |                      |n=12                  |n=12                  |                      |                      |                      |
|-------------------|--------------------------------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|Durability         |By changing the chromatographic conditions        |The                   |The                   |The                   |The                   |The                   |The                   |
|                   |(changing the initial temperature, flow rate,     |initial               |initial               |initial               |initial               |initial               |initial               |
|                   |column) and normal chromatographic conditions to  |flow                  |flow                  |flow                  |flow                  |flow                  |flow                  |
|                   |test the solvent content ofeach test product      |rate                  |rate                  |rate                  |rate                  |rate                  |rate                  |
|                   |solution to achieve, the chromatographic          |was                   |was                   |was                   |was                   |was                   |was                   |
|                   |diagramobtained by the control product solution,  |3.5ml/min±0.1ml/min,  |3.5ml/min±0.1ml/min,  |3.5ml/min±0.1ml/min,  |3.5ml/min±0.1ml/min,  |3.5ml/min±0.1ml/min,  |3.5ml/min±0.1ml/min,  |
|                   |ethanol, isopropylalcohol, ethylacetate, secondary|the                   |the                   |the                   |the                   |the                   |the                   |
|                   |butanol, tetrahydrofuran, toluene,                |initial               |initial               |initial               |initial               |initial               |initial               |
|                   |n-methylpyrrolidone peaks in turn, the separation |column                |column                |column                |column                |column                |column                |
|                   |degree between the adjacent peaks should be       |temperature           |temperature           |temperature           |temperature           |temperature           |temperature           |
|                   |greater than 1.5. Under different conditions of   |was                   |was                   |was                   |was                   |was                   |was                   |
|                   |the same chromatographic parameters, the RSD of   |40℃±5℃,               |40℃±5℃,               |40℃±5℃,               |40℃±5℃,               |40℃±5℃,               |40℃±5℃,               |
|                   |the content ofeach solvent to be measured in the  |and the               |and the               |and the               |and the               |and the               |and the               |
|                   |test product solution NMT 10%.                    |chromatographic       |chromatographic       |chromatographic       |chromatographic       |chromatographic       |chromatographic       |
|                   |                                                  |columns               |columns               |columns               |columns               |columns               |columns               |
|                   |                                                  |with                  |with                  |with                  |with                  |with                  |with                  |
|                   |                                                  |different             |different             |different             |different             |different             |different             |
|                   |                                                  |batches               |batches               |batches               |batches               |batches               |batches               |
|                   |                                                  |were                  |were                  |were                  |were                  |were                  |were                  |
|                   |                                                  |investigatedas        |investigatedas        |investigatedas        |investigatedas        |investigatedas        |investigatedas        |
|                   |                                                  |follows:              |follows:              |follows:              |follows:              |follows:              |follows:              |
|                   |                                                  |Systemapplicability:  |Systemapplicability:  |Systemapplicability:  |Systemapplicability:  |Systemapplicability:  |Systemapplicability:  |
|                   |                                                  |no                    |no                    |no                    |no                    |no                    |no                    |
|                   |                                                  |interference          |interference          |interference          |interference          |interference          |interference          |
|                   |                                                  |from                  |from                  |from                  |from                  |from                  |from                  |
|                   |                                                  |blank                 |blank                 |blank                 |blank                 |blank                 |blank                 |
|                   |                                                  |solution;             |solution;             |solution;             |solution;             |solution;             |solution;             |
|                   |                                                  |Ethanol,              |Ethanol,              |Ethanol,              |Ethanol,              |Ethanol,              |Ethanol,              |
|                   |                                                  |isopropylalcohol,     |isopropylalcohol,     |isopropylalcohol,     |isopropylalcohol,     |isopropylalcohol,     |isopropylalcohol,     |
|                   |                                                  |ethylacetate,         |ethylacetate,         |ethylacetate,         |ethylacetate,         |ethylacetate,         |ethylacetate,         |
|                   |                                                  |secondary             |secondary             |secondary             |secondary             |secondary             |secondary             |
|                   |                                                  |butanol,              |butanol,              |butanol,              |butanol,              |butanol,              |butanol,              |
|                   |                                                  |tetrahydrofuran,      |tetrahydrofuran,      |tetrahydrofuran,      |tetrahydrofuran,      |tetrahydrofuran,      |tetrahydrofuran,      |
|                   |                                                  |toluene               |toluene               |toluene               |toluene               |toluene               |toluene               |
|                   |                                                  |andn-methylpyrrolidone|andn-methylpyrrolidone|andn-methylpyrrolidone|andn-methylpyrrolidone|andn-methylpyrrolidone|andn-methylpyrrolidone|
|                   |                                                  |peaked                |peaked                |peaked                |peaked                |peaked                |peaked                |
|                   |                                                  |in                    |in                    |in                    |in                    |in                    |in                    |
|                   |                                                  |sequence              |sequence              |sequence              |sequence              |sequence              |sequence              |
|                   |                                                  |in the                |in the                |in the                |in the                |in the                |in the                |
|                   |                                                  |chromatogramobtained  |chromatogramobtained  |chromatogramobtained  |chromatogramobtained  |chromatogramobtained  |chromatogramobtained  |
|                   |                                                  |from                  |from                  |from                  |from                  |from                  |from                  |
|                   |                                                  |the                   |the                   |the                   |the                   |the                   |the                   |
|                   |                                                  |control               |control               |control               |control               |control               |control               |
|                   |                                                  |solutionunder         |solutionunder         |solutionunder         |solutionunder         |solutionunder         |solutionunder         |
|                   |                                                  |different             |different             |different             |different             |different             |different             |
|                   |                                                  |conditions            |conditions            |conditions            |conditions            |conditions            |conditions            |
|                   |                                                  |of the                |of the                |of the                |of the                |of the                |of the                |
|                   |                                                  |same                  |same                  |same                  |same                  |same                  |same                  |
|                   |                                                  |chromatographic       |chromatographic       |chromatographic       |chromatographic       |chromatographic       |chromatographic       |
|                   |                                                  |parameters,           |parameters,           |parameters,           |parameters,           |parameters,           |parameters,           |
|                   |                                                  |and the               |and the               |and the               |and the               |and the               |and the               |
|                   |                                                  |separation            |separation            |separation            |separation            |separation            |separation            |
|                   |                                                  |degree                |degree                |degree                |degree                |degree                |degree                |
|                   |                                                  |betweeneachadjacent   |betweeneachadjacent   |betweeneachadjacent   |betweeneachadjacent   |betweeneachadjacent   |betweeneachadjacent   |
|                   |                                                  |solvent               |solvent               |solvent               |solvent               |solvent               |solvent               |
|                   |                                                  |peak                  |peak                  |peak                  |peak                  |peak                  |peak                  |
|                   |                                                  |was                   |was                   |was                   |was                   |was                   |was                   |
|                   |                                                  |greater               |greater               |greater               |greater               |greater               |greater               |
|                   |                                                  |than                  |than                  |than                  |than                  |than                  |than                  |
|                   |                                                  |1.5.                  |1.5.                  |1.5.                  |1.5.                  |1.5.                  |1.5.                  |
|                   |                                                  |Test                  |Test                  |Test                  |Test                  |Test                  |Test                  |
|                   |                                                  |product               |product               |product               |product               |product               |product               |
|                   |                                                  |solution:             |solution:             |solution:             |solution:             |solution:             |solution:             |
|                   |                                                  |RSDS                  |RSDS                  |RSDS                  |RSDS                  |RSDS                  |RSDS                  |
|                   |                                                  |ofeach                |ofeach                |ofeach                |ofeach                |ofeach                |ofeach                |
|                   |                                                  |solvent               |solvent               |solvent               |solvent               |solvent               |solvent               |
|                   |                                                  |content               |content               |content               |content               |content               |content               |
|                   |                                                  |in test               |in test               |in test               |in test               |in test               |in test               |
|                   |                                                  |product               |product               |product               |product               |product               |product               |
|                   |                                                  |solutionunder         |solutionunder         |solutionunder         |solutionunder         |solutionunder         |solutionunder         |
|                   |                                                  |the                   |the                   |the                   |the                   |the                   |the                   |
|                   |                                                  |same                  |same                  |same                  |same                  |same                  |same                  |
|                   |                                                  |chromatographic       |chromatographic       |chromatographic       |chromatographic       |chromatographic       |chromatographic       |
|                   |                                                  |parameters            |parameters            |parameters            |parameters            |parameters            |parameters            |
|                   |                                                  |and                   |and                   |and                   |and                   |and                   |and                   |
|                   |                                                  |different             |different             |different             |different             |different             |different             |
|                   |                                                  |conditions            |conditions            |conditions            |conditions            |conditions            |conditions            |
|                   |                                                  |were                  |were                  |were                  |were                  |were                  |were                  |
|                   |                                                  |all                   |all                   |all                   |all                   |all                   |all                   |
|                   |                                                  |less                  |less                  |less                  |less                  |less                  |less                  |
|                   |                                                  |than                  |than                  |than                  |than                  |than                  |than                  |
|                   |                                                  |10%.                  |10%.                  |10%.                  |10%.                  |10%.                  |10%.                  |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 369 of 542 





Page 370
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.4.3.4 Methodological validation of genotoxic impurities in finished** 


**products** 



**I. Analytical Procedures** 



Chromatographic conditions The capillary column with (50%-phenyl) 



-methylpolysiloxane (Agilent DB-17 MS, 30m*0.25mm, 0.25μm or similar 



polarity) as the fixed liquid was used as the chromatographic column. The 



initial temperature was 50℃, maintained for 3min, and the temperature was 



heated to 230℃ at the rate of 20℃ per minute. Maintenance for 5 minutes; 



Inlet temperature 250℃; The injection volume is 1μl. (Recommended carrier 



gas is helium, carrier gas flow rate is 1.50ml per minute, no shunt injection, 



transmission line temperature 250℃) 



Mass spectrum conditions A triple quadrupole tandem mass spectrometry 



was used as the detector, an electron bombardment source (EI) was used, the 



ion source temperature was 230℃, and the collision gas was nitrogen. It is 



recommended to set scanning parameters according to the following table: 
























---------------------------------------------------------------------------------------------------------
|Dimethyl sulfate    |5.00                |MRM    |40     |66.00 > 48.00* 15.00 V |95.00 > 43.00 0.00 V |
|--------------------|--------------------|-------|-------|-----------------------|---------------------|
|Diethyl sulfate     |Diethyl sulfate     |MRM    |40     |124.90 > 45.10* 12.00 V|45.10 > 43.10 18.00 V|
|--------------------|--------------------|-------|-------|-----------------------|---------------------|
|Diisopropyl sulfate |Diisopropyl sulfate |MRM    |40     |87.00 > 45.10* 6.00 V  |69.00 > 41.10 12.00 V|
|--------------------|--------------------|-------|-------|-----------------------|---------------------|
|Di-sec-butyl sulfate|Di-sec-butyl sulfate|MRM    |40     |101.00 > 45.10* 6.00 V |59.00 > 43.00 30.00 V|
---------------------------------------------------------------------------------------------------------

Note: Bands * are quantitative ion pairs. 



The suitability of the system requires that in the chromatogram of the 



reference product solution, dimethyl sulfate, diethyl sulfate, diisopropyl 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 370 of 542 





Page 371
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



sulfate and di-sec-butyl sulfate peak in turn. The signal-to-noise ratio of 



dimethyl sulfate, diethyl sulfate, diisopropyl sulfate and di-sec-butylsulfate 



should NLT 10 in the chromatogram under quantitative ion of the sensitive 



solution. 



**Assay** 



The solvent, the sensitivity solution, the reference solution and the test 



product solution were each 1μl, and the samples were injected respectively, 



and the chromatogram was recorded. If there are peaks of dimethyl sulfate, 



diethyl sulfate, diisopropyl sulfate and disec-butyl sulfate in the 



chromatogram of the test product solution, the content of each sulfate 



impurity is calculated according to the external standard method and the 



peak area. 



The calculation formula is: 




Assay（ppm） CReference  A test  V 

W  A 




  
（ ） Reference test 




Reference test 




W  A 




Reference 




Creference is the concentration of the reference solution (ng/ml); 



V is the dilution volume (ml) of the test product solution; 



Atest is the peak area of each sulfate impurity in the test product solution; 



Areference is the peak area of each sulfate impurity in the control product solution; 



W is the weight of the test product (mg). 



Limit test product solution chromatogram, if there are dimethyl sulfate, 



diethyl sulfate, diisopropyl sulfate, dibutyl sulfate peak, according to the 



external standard method to calculate the peak area, containing dimethyl 



sulfate, diethyl sulfate, diisopropyl sulfate, dibutyl sulfate NMT 75ppm, the 



sum of genotoxic impurities NMT 250ppm. 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 371 of 542 





Page 372
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**II. Validation Results and Discussion** 



**a. System applicability** 



 **Acceptance Criteria** 



The applicability of the system is achieved by examining the sensitivity 



solution and the reference solution. Take the sensitivity solution to inject 1 



needle and the reference solution to inject 6 needles continuously. The 



signal-to-noise ratio of each impurity peak in the sensitivity solution should 



NLT 10; The RSD for the retention time of each impurity in the luminous 



solution NMT 1%, and the RSD for the peak area NMT 10%. 



 **Solution preparation** 



Solvent: acetonitrile 



Dimethyl sulfate reserve liquid: Take about 15mg of dimethyl sulfate 



reference product, accurately weigh it, place it in a 100ml bottle, dissolve it 



with acetonitrile and dilute it to the scale, shake well, and obtain. 



Diethyl sulfate reserve liquid: Take about 15mg of diethyl sulfate reference 



product, accurately weigh, place in 100ml measuring bottle, dissolve with 



acetonitrile and dilute to the scale, shake well, ready. 



Diisopropyl sulfate reserve liquid: Take about 15mg of diisopropyl sulfate 



control product, accurately weigh, place in 100ml measuring bottle, dissolve 



with acetonitrile and dilute to the scale, shake well, ready. 



Diisopropyl sulfate reserve liquid: Take diisopropyl sulfate reference product 



about 15mg, precision weigh, put in 100ml bottle, dissolve with acetonitrile 



and dilute to the scale, shake well, ready. 



Control product reserve liquid: precisely measure dimethyl sulfate reserve 



liquid, diethyl sulfate reserve liquid, diisopropyl sulfate reserve liquid and 



disec-butyl sulfate reserve liquid 1ml each, in the same 20ml measuring 



bottle, dilute with acetonitrile to the scale, shake well, ready. 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 372 of 542 





Page 373
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Blank solution: solvent (acetonitrile). 



Sensitivity solution: Accurately measure the control product reserve liquid 



10μl into 5ml measuring bottle, dilute with acetonitrile to the scale, shake 



well, ready. 



Control product solution: precisely measure the control product storage 



solution 100μl into 5ml measuring bottle, dilute it with acetonitrile to the 



scale, shake well, ready. 



 **Injection Sequence** 



After the blank solution, the sensitivity solution was injected with 1 



needle, the control solution was injected with 6 needles continuously, and 



the chromatogram was recorded. 



 **Measurement results** 






















































































































































































































------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Names of Components                           |Names              |1                  |2                  |3                  |4                  |5                  |6                  |6                  |6                  |
|                                              |of                 |                   |                   |                   |                   |                   |                   |                   |                   |
|                                              |Components         |                   |                   |                   |                   |                   |                   |                   |                   |
|----------------------------------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|
|Dime thyl sulfa te                            |Retention          |6.468              |6.467              |6.468              |6.462              |6.462              |6.462              |0.0 5              |110.8 7            |
|                                              |time               |                   |                   |                   |                   |                   |                   |                   |                   |
|----------------------------------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|
|Dime thyl sulfa te                            |Peakarea           |18629              |19154              |18883              |18806              |18711              |17566              |2.9                |2.9                |
|                                              |                   |00                 |89                 |46                 |40                 |34                 |25                 |                   |                   |
|----------------------------------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|
|Diet hyl sulfa te                             |Retention          |7.769              |7.769              |7.769              |7.769              |7.769              |7.769              |0                  |179.5 8            |
|                                              |time               |                   |                   |                   |                   |                   |                   |                   |                   |
|----------------------------------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|
|Diet hyl sulfa te                             |Peakarea           |20720              |21082              |21371              |20966              |21114              |19886              |2.5                |2.5                |
|                                              |                   |58                 |23                 |47                 |55                 |52                 |83                 |                   |                   |
|----------------------------------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|
|Diiso prop yl sulfa te                        |Retention          |8.204              |8.204              |8.204              |8.204              |8.204              |8.204              |0                  |54.31              |
|                                              |time               |                   |                   |                   |                   |                   |                   |                   |                   |
|----------------------------------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|
|Diiso prop yl sulfa te                        |Peakarea           |14161              |14500              |14822              |14681              |14552              |13626              |3.0                |3.0                |
|                                              |                   |25                 |26                 |25                 |36                 |42                 |52                 |                   |                   |
|----------------------------------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|
|Di-sec-bu tyl sulfa te                        |Retention          |9.507              |9.507              |9.512              |9.507              |9.507              |9.507              |0.0 21             |43.75              |
|                                              |time               |                   |                   |                   |                   |                   |                   |                   |                   |
|----------------------------------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|
|Di-sec-bu tyl sulfa te                        |Peakarea           |66227 6            |66990 3            |66854 4            |66579 3            |63542 8            |57546 3            |6                  |6                  |
|----------------------------------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|
|Conclusion: The SNR of dimethyl sulfate,      |Conclusion:        |Conclusion:        |Conclusion:        |Conclusion:        |Conclusion:        |Conclusion:        |Conclusion:        |Conclusion:        |Conclusion:        |
|diethyl sulfate, diisopropyl sulfate and      |The SNR of         |The SNR            |The SNR            |The SNR            |The SNR            |The SNR            |The SNR            |The SNR            |The SNR            |
|disec-butyl sulfate in the sensitivity        |dimethyl           |of                 |of                 |of                 |of                 |of                 |of                 |of                 |of                 |
|solution were 110.87, 179.58, 54.31 and 43.75,|sulfate,           |dimethyl           |dimethyl           |dimethyl           |dimethyl           |dimethyl           |dimethyl           |dimethyl           |dimethyl           |
|respectively, all of which were NLT 10. 6 The |diethyl            |sulfate,           |sulfate,           |sulfate,           |sulfate,           |sulfate,           |sulfate,           |sulfate,           |sulfate,           |
|RSD of the retention time of dimethyl sulfate,|sulfate,           |diethyl            |diethyl            |diethyl            |diethyl            |diethyl            |diethyl            |diethyl            |diethyl            |
|diethyl sulfate, diisopropyl sulfate and      |diisopropyl        |sulfate,           |sulfate,           |sulfate,           |sulfate,           |sulfate,           |sulfate,           |sulfate,           |sulfate,           |
|di-sec-butylsulfate in the irradiation        |sulfate            |diisopropyl        |diisopropyl        |diisopropyl        |diisopropyl        |diisopropyl        |diisopropyl        |diisopropyl        |diisopropyl        |
|solution were                                 |and                |sulfate            |sulfate            |sulfate            |sulfate            |sulfate            |sulfate            |sulfate            |sulfate            |
|                                              |disec-butyl        |and                |and                |and                |and                |and                |and                |and                |and                |
|                                              |sulfate in         |disec-butyl        |disec-butyl        |disec-butyl        |disec-butyl        |disec-butyl        |disec-butyl        |disec-butyl        |disec-butyl        |
|                                              |the                |sulfate            |sulfate            |sulfate            |sulfate            |sulfate            |sulfate            |sulfate            |sulfate            |
|                                              |sensitivity        |in the             |in the             |in the             |in the             |in the             |in the             |in the             |in the             |
|                                              |solution           |sensitivity        |sensitivity        |sensitivity        |sensitivity        |sensitivity        |sensitivity        |sensitivity        |sensitivity        |
|                                              |were               |solution           |solution           |solution           |solution           |solution           |solution           |solution           |solution           |
|                                              |110.87,            |were               |were               |were               |were               |were               |were               |were               |were               |
|                                              |179.58,            |110.87,            |110.87,            |110.87,            |110.87,            |110.87,            |110.87,            |110.87,            |110.87,            |
|                                              |54.31 and          |179.58,            |179.58,            |179.58,            |179.58,            |179.58,            |179.58,            |179.58,            |179.58,            |
|                                              |43.75,             |54.31              |54.31              |54.31              |54.31              |54.31              |54.31              |54.31              |54.31              |
|                                              |respectively,      |and                |and                |and                |and                |and                |and                |and                |and                |
|                                              |all of             |43.75,             |43.75,             |43.75,             |43.75,             |43.75,             |43.75,             |43.75,             |43.75,             |
|                                              |which were         |respectively,      |respectively,      |respectively,      |respectively,      |respectively,      |respectively,      |respectively,      |respectively,      |
|                                              |NLT 10. 6          |all of             |all of             |all of             |all of             |all of             |all of             |all of             |all of             |
|                                              |The RSD of         |which              |which              |which              |which              |which              |which              |which              |which              |
|                                              |the                |were               |were               |were               |were               |were               |were               |were               |were               |
|                                              |retention          |NLT 10.            |NLT 10.            |NLT 10.            |NLT 10.            |NLT 10.            |NLT 10.            |NLT 10.            |NLT 10.            |
|                                              |time of            |6 The              |6 The              |6 The              |6 The              |6 The              |6 The              |6 The              |6 The              |
|                                              |dimethyl           |RSD of             |RSD of             |RSD of             |RSD of             |RSD of             |RSD of             |RSD of             |RSD of             |
|                                              |sulfate,           |the                |the                |the                |the                |the                |the                |the                |the                |
|                                              |diethyl            |retention          |retention          |retention          |retention          |retention          |retention          |retention          |retention          |
|                                              |sulfate,           |time of            |time of            |time of            |time of            |time of            |time of            |time of            |time of            |
|                                              |diisopropyl        |dimethyl           |dimethyl           |dimethyl           |dimethyl           |dimethyl           |dimethyl           |dimethyl           |dimethyl           |
|                                              |sulfate            |sulfate,           |sulfate,           |sulfate,           |sulfate,           |sulfate,           |sulfate,           |sulfate,           |sulfate,           |
|                                              |and                |diethyl            |diethyl            |diethyl            |diethyl            |diethyl            |diethyl            |diethyl            |diethyl            |
|                                              |di-sec-butylsulfate|sulfate,           |sulfate,           |sulfate,           |sulfate,           |sulfate,           |sulfate,           |sulfate,           |sulfate,           |
|                                              |in the             |diisopropyl        |diisopropyl        |diisopropyl        |diisopropyl        |diisopropyl        |diisopropyl        |diisopropyl        |diisopropyl        |
|                                              |irradiation        |sulfate            |sulfate            |sulfate            |sulfate            |sulfate            |sulfate            |sulfate            |sulfate            |
|                                              |solution           |and                |and                |and                |and                |and                |and                |and                |and                |
|                                              |were               |di-sec-butylsulfate|di-sec-butylsulfate|di-sec-butylsulfate|di-sec-butylsulfate|di-sec-butylsulfate|di-sec-butylsulfate|di-sec-butylsulfate|di-sec-butylsulfate|
|                                              |                   |in the             |in the             |in the             |in the             |in the             |in the             |in the             |in the             |
|                                              |                   |irradiation        |irradiation        |irradiation        |irradiation        |irradiation        |irradiation        |irradiation        |irradiation        |
|                                              |                   |solution           |solution           |solution           |solution           |solution           |solution           |solution           |solution           |
|                                              |                   |were               |were               |were               |were               |were               |were               |were               |were               |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 373 of 542 





Page 374
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



0.05%, 0%, 0% and 0.021%, respectively, and were all less than 1%. The RSD of the peak 
area of dimethyl sulfate, diethyl sulfate, diisopropyl sulfate and di-sec-butylsulfate in the 
irradiation solution were 2.9%, 2.5%, 3.0% and 6%, respectively, all of which were less 
than 10%, indicating that the system applicability of the method for the detection of 
dimethyl sulfate, diethyl sulfate, diisopropyl sulfate and di-sec-butylsulfate met the 
requirements. 



**(4.2) Specificity** 



 **Acceptance Criteria** 



The retention time of the impurities in the specific mixed solution and the 



reference solution should be consistent with the retention time in the 



impurity localization solution. The peak area of dimethyl sulfate, diethyl 



sulfate, diisopropyl sulfate and dibutyl sulfate in the blank solution NMT 



20% of the average value of the impurity peak area in the mass spectrum of 



the 6 limited quantification solutions. 



 **Solution preparation** 



Blank solution: Blank solution as prepared under 4.1. 



Dimethyl sulfate reserve solution: dimethyl sulfate reserve solution prepared 



under item 4.1. 



Diethyl sulfate storage solution: diethyl sulfate storage solution prepared 



under item 4.1. 



Diisopropyl sulfate reserve solution: diisopropyl sulfate reserve solution 



prepared under item 4.1. 



Disec-butyl sulfate storage solution: disec-butyl sulfate storage solution 



prepared under item 4.1. 



Reference product reserve solution: the reference product reserve solution 



prepared under item 4.1. 



Reference solution: the same reference solution prepared under item 4.1. 



Dimethyl sulfate positioning solution: accurately measure 1ml of dimethyl 



sulfate reserve solution, place it in a 20ml measuring bottle, dilute it with 



acetonitrile to the scale, and shake well; Precision measure 100μl of the 



above solution, place it in a 5ml measuring bottle, dilute it with acetonitrile to 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 374 of 542 





Page 375
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



the scale, shake well, and get. 



Diethyl sulfate positioning solution: accurately measure 1ml of diethyl 



sulfate reserve solution, place it in 20ml measuring bottle, dilute it with 



acetonitrile to the scale, and shake well; Precision measure 100μl of the 



above solution, place it in a 5ml measuring bottle, dilute it with acetonitrile to 



the scale, shake well, and get. 



Diisopropyl sulfate positioning solution: accurately measure 1ml of 



diisopropyl sulfate reserve solution, place it in a 20ml measuring bottle, 



dilute it with acetonitrile to the scale, and shake well; Precision measure 



100μl of the above solution, place it in 5ml measuring bottle, dilute it with 



acetonitrile to the scale, shake well, and get. 



Disec-butyl sulfate positioning solution: accurately measure 1ml of 



disec-butyl sulfate reserve solution, place it in a 20ml measuring bottle, 



dilute it with acetonitrile to the scale, and shake well; Precisely measure the 



above solution 100μl, place it in a 5ml measuring bottle, dilute it with 



acetonitrile to the scale, shake well, and get. 



Test product solution: Take about 10mg of this product, weigh it accurately, 



put it in 5ml measuring bottle, add acetonitrile to appropriate amount, swirl 



to dissolve, then dilute it with acetonitrile to scale, shake well, ready. 



Specific mixed solution: Take about 10mg of this product, accurately weigh it, 



place it in 5ml bottle, add an appropriate amount of acetonitrile to dissolve, 



then precisely add 100μl of control product reserve, dilute it with acetonitrile 



to the scale, shake well, ready. 



 **Injection Sequence** 



Blank solution, reference solution, dimethyl sulfate localization solution, 



diethyl sulfate localization solution, diisopropyl sulfate localization solution, 



di-sec-butyl sulfate localization solution, test product solution and specific 



mixed solution were injected into 1 needle successively, and the 



chromatogram was recorded. 



 **Measurement result** 



Name of solution Component Rt (min) MRM quantifies 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 375 of 542 





Page 376
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 















--------------------------------------------------------------------------------------------------------------------------
|Reference solution                      |Dimethyl sulfate                              |6.462                 |1604486  |
|----------------------------------------|----------------------------------------------|----------------------|---------|
|Reference solution                      |Diethyl sulfate                               |7.769                 |2271452  |
|----------------------------------------|----------------------------------------------|----------------------|---------|
|Reference solution                      |Diisopropyl sulfate                           |8.204                 |1468496  |
|----------------------------------------|----------------------------------------------|----------------------|---------|
|Reference solution                      |Di-sec-butyl sulfate                          |9.507                 |594890   |
|----------------------------------------|----------------------------------------------|----------------------|---------|
|Solution for the test product           |Dimethyl sulfate                              |Not detected          |Not      |
|                                        |                                              |                      |detected |
|----------------------------------------|----------------------------------------------|----------------------|---------|
|Solution for the test product           |Diethyl sulfate                               |Not detected          |Not      |
|                                        |                                              |                      |detected |
|----------------------------------------|----------------------------------------------|----------------------|---------|
|Solution for the test product           |Diisopropyl sulfate                           |Not detected          |Not      |
|                                        |                                              |                      |detected |
|----------------------------------------|----------------------------------------------|----------------------|---------|
|Solution for the test product           |Di-sec-butyl sulfate                          |Not detected          |Not      |
|                                        |                                              |                      |detected |
|----------------------------------------|----------------------------------------------|----------------------|---------|
|Specific mixed solution                 |Dimethyl sulfate                              |6.468                 |1905636  |
|----------------------------------------|----------------------------------------------|----------------------|---------|
|Specific mixed solution                 |Diethyl sulfate                               |7.769                 |2396344  |
|----------------------------------------|----------------------------------------------|----------------------|---------|
|Specific mixed solution                 |Diisopropyl sulfate                           |8.204                 |1722683  |
|----------------------------------------|----------------------------------------------|----------------------|---------|
|Specific mixed solution                 |Di-sec-butyl sulfate                          |9.507                 |803619   |
|----------------------------------------|----------------------------------------------|----------------------|---------|
|Dimethyl sulfate locator solution       |Dimethyl sulfate                              |6.462                 |1917908  |
|----------------------------------------|----------------------------------------------|----------------------|---------|
|Diethyl sulfate locating solution       |Diethyl sulfate                               |7.769                 |2286745  |
|----------------------------------------|----------------------------------------------|----------------------|---------|
|Diisopropyl sulfate positioning solution|Diisopropyl sulfate                           |8.204                 |1438239  |
|----------------------------------------|----------------------------------------------|----------------------|---------|
|Disec-butyl sulfate positioning solution|Di-sec-butyl sulfate                          |9.507                 |622794   |
|----------------------------------------|----------------------------------------------|----------------------|---------|
|Blank solution                          |Dimethyl sulfate                              |Not detected          |Not      |
|                                        |                                              |                      |detected |
|----------------------------------------|----------------------------------------------|----------------------|---------|
|Blank solution                          |Diethyl sulfate                               |Not detected          |Not      |
|                                        |                                              |                      |detected |
|----------------------------------------|----------------------------------------------|----------------------|---------|
|Blank solution                          |Diisopropyl sulfate                           |Not detected          |Not      |
|                                        |                                              |                      |detected |
|----------------------------------------|----------------------------------------------|----------------------|---------|
|Blank solution                          |Di-sec-butyl sulfate                          |Not detected          |Not      |
|                                        |                                              |                      |detected |
|----------------------------------------|----------------------------------------------|----------------------|---------|
|Items                                   |Average of the peakarea of the 6 parts limited|Ratio of the response |Ratio of |
|                                        |                                              |value of the peakarea |the      |
|                                        |                                              |ofeach component of   |response |
|                                        |                                              |the blank solution to |value of |
|                                        |                                              |the peakarea ofeach   |the      |
|                                        |                                              |                      |peakarea |
|                                        |                                              |                      |ofeach   |
|                                        |                                              |                      |component|
|                                        |                                              |                      |of the   |
|                                        |                                              |                      |blank    |
|                                        |                                              |                      |solution |
|                                        |                                              |                      |to the   |
|                                        |                                              |                      |peakarea |
|                                        |                                              |                      |ofeach   |
--------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 376 of 542 





Page 377
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 










------------------------------------------------------------------------------------------------------------------------------------
|Dimethyl sulfate                                                                                      |188679       |Not          |
|                                                                                                      |             |detected     |
|------------------------------------------------------------------------------------------------------|-------------|-------------|
|Diethyl sulfate                                                                                       |216723       |Not          |
|                                                                                                      |             |detected     |
|------------------------------------------------------------------------------------------------------|-------------|-------------|
|Diisopropyl sulfate                                                                                   |139179       |Not          |
|                                                                                                      |             |detected     |
|------------------------------------------------------------------------------------------------------|-------------|-------------|
|Di-sec-butyl sulfate                                                                                  |56839        |Not          |
|                                                                                                      |             |detected     |
|------------------------------------------------------------------------------------------------------|-------------|-------------|
|Conclusion: The retention time of the impurities in the specific mixed solution and the reference     |Conclusion:  |Conclusion:  |
|solutionis consistent with the retention time of the impurities in the localization solution. No      |The          |The          |
|dimethyl sulfate, diethyl sulfate, diisopropyl sulfate and disec-butyl sulfate were detected in the   |retention    |retention    |
|blank solution, indicating that the specificity of the method met the requirements.                   |time of      |time of      |
|                                                                                                      |the          |the          |
|                                                                                                      |impurities   |impurities   |
|                                                                                                      |in the       |in the       |
|                                                                                                      |specific     |specific     |
|                                                                                                      |mixed        |mixed        |
|                                                                                                      |solution     |solution     |
|                                                                                                      |and the      |and the      |
|                                                                                                      |reference    |reference    |
|                                                                                                      |solutionis   |solutionis   |
|                                                                                                      |consistent   |consistent   |
|                                                                                                      |with         |with the     |
|                                                                                                      |the          |retention    |
|                                                                                                      |retention    |time of      |
|                                                                                                      |time of      |the          |
|                                                                                                      |the          |impurities   |
|                                                                                                      |impurities   |in the       |
|                                                                                                      |in the       |localization |
|                                                                                                      |localization |solution.    |
|                                                                                                      |solution.    |No           |
|                                                                                                      |No           |dimethyl     |
|                                                                                                      |dimethyl     |sulfate,     |
|                                                                                                      |sulfate,     |diethyl      |
|                                                                                                      |diethyl      |sulfate,     |
|                                                                                                      |sulfate,     |diisopropyl  |
|                                                                                                      |diisopropyl  |sulfate      |
|                                                                                                      |sulfate      |and          |
|                                                                                                      |and          |disec-butyl  |
|                                                                                                      |disec-butyl  |sulfate      |
|                                                                                                      |sulfate      |were         |
|                                                                                                      |were         |detected     |
|                                                                                                      |detected     |in the       |
|                                                                                                      |in the       |blank        |
|                                                                                                      |blank        |solution,    |
|                                                                                                      |solution,    |indicating   |
|                                                                                                      |indicating   |that the     |
|                                                                                                      |that         |specificity  |
|                                                                                                      |the          |of the       |
|                                                                                                      |specificity  |method       |
|                                                                                                      |of the       |met the      |
|                                                                                                      |method       |requirements.|
|                                                                                                      |met the      |             |
|                                                                                                      |requirements.|             |
------------------------------------------------------------------------------------------------------------------------------------

**(4.3) Limits of quantification and detection** 



 **sketch** 



Limits of quantification and detection are achieved by testing the 



signal-to-noise ratio of a reference solution diluted with a certain 



concentration. It is required that the SNR of all impurities in the 6 limited 



quantitation solutions should NLT 10, the RSD of the retention time of each 



impurity should not be more than 1.0%, and the RSD of the peak area of each 



impurity should not be more than 10%. The signal-to-noise ratio of every 



impurity in the mass spectrogram of the detection limited solution should 



NLT 3. 



 **Solution preparation** 



Blank solution: Blank solution as prepared under 4.1. 



Reference stock solution: the same as the reference stock solution prepared 



under item 4.1. 



Limited quantitation solution: Accurately measure the control product 



reserve solution 10μl into 5ml measuring bottle, dilute it with acetonitrile to 



the scale, shake well, and then obtain. Prepare 6 parts in parallel. 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 377 of 542 





Page 378
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Detection limit solution: Accurately measure the first limit of quantification 



solution 1.5ml into 5ml measuring bottle, dilute with acetonitrile to the scale, 



shake well, and then get. 



 **Injection procedure** 



Take the blank solution and inject 1 needle, the detection limited solution 



and inject 3 needles continuously, 6 parts of the limited quantitative solution 



and inject 1 needle respectively, and record the chromatogram. 



 **Measurement results** 



Results of limit of quantitation test 































-----------------------------------------------------------------------------------------------------------------------------------------------------------
|Dimeth yl sulfate|Limited quantitative Solution 1                             |14.9352       |7.5           |6.468         |193946        |149.9 4       |
|-----------------|------------------------------------------------------------|--------------|--------------|--------------|--------------|--------------|
|Dimeth yl sulfate|Limited quantification solution 2                           |14.9352       |14.9352       |6.462         |191459        |150.6 4       |
|-----------------|------------------------------------------------------------|--------------|--------------|--------------|--------------|--------------|
|Dimeth yl sulfate|Limited quantitative Solution 3                             |14.9352       |14.9352       |6.462         |184126        |150.5 5       |
|-----------------|------------------------------------------------------------|--------------|--------------|--------------|--------------|--------------|
|Dimeth yl sulfate|Limited quantitative Solution 4                             |14.9352       |14.9352       |6.462         |187606        |158.4 5       |
|-----------------|------------------------------------------------------------|--------------|--------------|--------------|--------------|--------------|
|Dimeth yl sulfate|Limited quantitative Solution 5                             |14.9352       |14.9352       |6.462         |181354        |154.7 5       |
|-----------------|------------------------------------------------------------|--------------|--------------|--------------|--------------|--------------|
|Dimeth yl sulfate|Limited quantitative solution 6                             |14.9352       |14.9352       |6.468         |193581        |143.0 7       |
|-----------------|------------------------------------------------------------|--------------|--------------|--------------|--------------|--------------|
|Dimeth yl sulfate|RSD%                                                        |RSD%          |RSD%          |0.05          |2.8           |/             |
|-----------------|------------------------------------------------------------|--------------|--------------|--------------|--------------|--------------|
|Dimeth yl sulfate|Verdict: The limited quantification concentration of        |Verdict:      |Verdict:      |Verdict:      |Verdict:      |Verdict:      |
|                 |dimethyl sulfate was 14.9352ng/ml, which wasequivalent to   |The           |The           |The           |The           |The           |
|                 |7.5ppm of the solution concentration. The RSD of the        |limited       |limited       |limited       |limited       |limited       |
|                 |retention time in 6 parts of the solution was               |quantification|quantification|quantification|quantification|quantification|
|                 |                                                            |concentration |concentration |concentration |concentration |concentration |
|                 |                                                            |of            |of            |of            |of            |of            |
|                 |                                                            |dimethyl      |dimethyl      |dimethyl      |dimethyl      |dimethyl      |
|                 |                                                            |sulfate       |sulfate       |sulfate       |sulfate       |sulfate       |
|                 |                                                            |was           |was           |was           |was           |was           |
|                 |                                                            |14.9352ng/ml, |14.9352ng/ml, |14.9352ng/ml, |14.9352ng/ml, |14.9352ng/ml, |
|                 |                                                            |which         |which         |which         |which         |which         |
|                 |                                                            |wasequivalent |wasequivalent |wasequivalent |wasequivalent |wasequivalent |
|                 |                                                            |to            |to            |to            |to            |to            |
|                 |                                                            |7.5ppm        |7.5ppm        |7.5ppm        |7.5ppm        |7.5ppm        |
|                 |                                                            |of the        |of the        |of the        |of the        |of the        |
|                 |                                                            |solution      |solution      |solution      |solution      |solution      |
|                 |                                                            |concentration.|concentration.|concentration.|concentration.|concentration.|
|                 |                                                            |The RSD       |The RSD       |The RSD       |The RSD       |The RSD       |
|                 |                                                            |of the        |of the        |of the        |of the        |of the        |
|                 |                                                            |retention     |retention     |retention     |retention     |retention     |
|                 |                                                            |time in       |time in       |time in       |time in       |time in       |
|                 |                                                            |6 parts       |6 parts       |6 parts       |6 parts       |6 parts       |
|                 |                                                            |of the        |of the        |of the        |of the        |of the        |
|                 |                                                            |solution      |solution      |solution      |solution      |solution      |
|                 |                                                            |was           |was           |was           |was           |was           |
-----------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 378 of 542 





Page 379
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 





































---------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Diethyl sulfate    |Limited quantitative solution 1                           |15.3648         |7.7             |7.769           |222581          |207.1 3         |
|-------------------|----------------------------------------------------------|----------------|----------------|----------------|----------------|----------------|
|Diethyl sulfate    |Limited quantitative Solution 2                           |15.3648         |15.3648         |7.769           |213753          |167.3 3         |
|-------------------|----------------------------------------------------------|----------------|----------------|----------------|----------------|----------------|
|Diethyl sulfate    |Limited quantitative Solution 3                           |15.3648         |15.3648         |7.769           |217018          |179.4 8         |
|-------------------|----------------------------------------------------------|----------------|----------------|----------------|----------------|----------------|
|Diethyl sulfate    |Limited quantitative Solution 4                           |15.3648         |15.3648         |7.769           |211589          |180.5 1         |
|-------------------|----------------------------------------------------------|----------------|----------------|----------------|----------------|----------------|
|Diethyl sulfate    |Limited quantitative Solution 5                           |15.3648         |15.3648         |7.769           |213217          |152.9 4         |
|-------------------|----------------------------------------------------------|----------------|----------------|----------------|----------------|----------------|
|Diethyl sulfate    |Limited quantitative solution 6                           |15.3648         |15.3648         |7.769           |222181          |191.6 7         |
|-------------------|----------------------------------------------------------|----------------|----------------|----------------|----------------|----------------|
|Diethyl sulfate    |RSD%                                                      |RSD%            |RSD%            |0               |2.2             |/               |
|-------------------|----------------------------------------------------------|----------------|----------------|----------------|----------------|----------------|
|Diethyl sulfate    |Conclusion: The limit of quantitation concentration of    |Conclusion:     |Conclusion:     |Conclusion:     |Conclusion:     |Conclusion:     |
|                   |diethyl sulfate was 15.3648ng/ml, which wasequivalent to  |The             |The             |The             |The             |The             |
|                   |7.7ppm of the solution, the RSD of retention time in 6    |limit           |limit           |limit           |limit           |limit           |
|                   |parts of the solution was 0% (less than 1.0%), the RSD of |of              |of              |of              |of              |of              |
|                   |peakarea was 2.2% (less than 10%), and theS/Nranged from  |quantitation    |quantitation    |quantitation    |quantitation    |quantitation    |
|                   |152.94 to 207.13, all of which were greater than 10. The  |concentration   |concentration   |concentration   |concentration   |concentration   |
|                   |resultsindicated that the method hada good response for   |of              |of              |of              |of              |of              |
|                   |the detection of diethyl sulfate.                         |diethyl         |diethyl         |diethyl         |diethyl         |diethyl         |
|                   |                                                          |sulfate         |sulfate         |sulfate         |sulfate         |sulfate         |
|                   |                                                          |was             |was             |was             |was             |was             |
|                   |                                                          |15.3648ng/ml,   |15.3648ng/ml,   |15.3648ng/ml,   |15.3648ng/ml,   |15.3648ng/ml,   |
|                   |                                                          |which           |which           |which           |which           |which           |
|                   |                                                          |wasequivalent   |wasequivalent   |wasequivalent   |wasequivalent   |wasequivalent   |
|                   |                                                          |to              |to              |to              |to              |to              |
|                   |                                                          |7.7ppm          |7.7ppm          |7.7ppm          |7.7ppm          |7.7ppm          |
|                   |                                                          |of the          |of the          |of the          |of the          |of the          |
|                   |                                                          |solution,       |solution,       |solution,       |solution,       |solution,       |
|                   |                                                          |the RSD         |the RSD         |the RSD         |the RSD         |the RSD         |
|                   |                                                          |of              |of              |of              |of              |of              |
|                   |                                                          |retention       |retention       |retention       |retention       |retention       |
|                   |                                                          |time in         |time in         |time in         |time in         |time in         |
|                   |                                                          |6 parts         |6 parts         |6 parts         |6 parts         |6 parts         |
|                   |                                                          |of the          |of the          |of the          |of the          |of the          |
|                   |                                                          |solution        |solution        |solution        |solution        |solution        |
|                   |                                                          |was 0%          |was 0%          |was 0%          |was 0%          |was 0%          |
|                   |                                                          |(less           |(less           |(less           |(less           |(less           |
|                   |                                                          |than            |than            |than            |than            |than            |
|                   |                                                          |1.0%),          |1.0%),          |1.0%),          |1.0%),          |1.0%),          |
|                   |                                                          |the RSD         |the RSD         |the RSD         |the RSD         |the RSD         |
|                   |                                                          |of              |of              |of              |of              |of              |
|                   |                                                          |peakarea        |peakarea        |peakarea        |peakarea        |peakarea        |
|                   |                                                          |was             |was             |was             |was             |was             |
|                   |                                                          |2.2%            |2.2%            |2.2%            |2.2%            |2.2%            |
|                   |                                                          |(less           |(less           |(less           |(less           |(less           |
|                   |                                                          |than            |than            |than            |than            |than            |
|                   |                                                          |10%),           |10%),           |10%),           |10%),           |10%),           |
|                   |                                                          |and             |and             |and             |and             |and             |
|                   |                                                          |theS/Nranged    |theS/Nranged    |theS/Nranged    |theS/Nranged    |theS/Nranged    |
|                   |                                                          |from            |from            |from            |from            |from            |
|                   |                                                          |152.94          |152.94          |152.94          |152.94          |152.94          |
|                   |                                                          |to              |to              |to              |to              |to              |
|                   |                                                          |207.13,         |207.13,         |207.13,         |207.13,         |207.13,         |
|                   |                                                          |all of          |all of          |all of          |all of          |all of          |
|                   |                                                          |which           |which           |which           |which           |which           |
|                   |                                                          |were            |were            |were            |were            |were            |
|                   |                                                          |greater         |greater         |greater         |greater         |greater         |
|                   |                                                          |than            |than            |than            |than            |than            |
|                   |                                                          |10. The         |10. The         |10. The         |10. The         |10. The         |
|                   |                                                          |resultsindicated|resultsindicated|resultsindicated|resultsindicated|resultsindicated|
|                   |                                                          |that            |that            |that            |that            |that            |
|                   |                                                          |the             |the             |the             |the             |the             |
|                   |                                                          |method          |method          |method          |method          |method          |
|                   |                                                          |hada            |hada            |hada            |hada            |hada            |
|                   |                                                          |good            |good            |good            |good            |good            |
|                   |                                                          |response        |response        |response        |response        |response        |
|                   |                                                          |for the         |for the         |for the         |for the         |for the         |
|                   |                                                          |detection       |detection       |detection       |detection       |detection       |
|                   |                                                          |of              |of              |of              |of              |of              |
|                   |                                                          |diethyl         |diethyl         |diethyl         |diethyl         |diethyl         |
|                   |                                                          |sulfate.        |sulfate.        |sulfate.        |sulfate.        |sulfate.        |
|-------------------|----------------------------------------------------------|----------------|----------------|----------------|----------------|----------------|
|Diisopropyl sulfate|Limited quantitative solution 1                           |15.1417         |7.6             |8.204           |139949          |71.56           |
|-------------------|----------------------------------------------------------|----------------|----------------|----------------|----------------|----------------|
|Diisopropyl sulfate|Limited quantitative Solution 2                           |15.1417         |15.1417         |8.204           |139261          |60.74           |
|-------------------|----------------------------------------------------------|----------------|----------------|----------------|----------------|----------------|
|Diisopropyl sulfate|Limited quantitative Solution 3                           |15.1417         |15.1417         |8.204           |140461          |64.91           |
|-------------------|----------------------------------------------------------|----------------|----------------|----------------|----------------|----------------|
|Diisopropyl sulfate|Limited                                                   |15.1417         |15.1417         |8.204           |139189          |64.38           |
---------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 379 of 542 





Page 380
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 




























------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Limited quantitative Solution 5                                       |15.1417           |15.1417           |8.204             |136057            |52.55             |                  |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|------------------|
|Limited quantitative solution 6                                       |15.1417           |15.1417           |8.204             |140157            |67.31             |                  |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|------------------|
|RSD%                                                                  |RSD%              |RSD%              |0                 |1.2               |/                 |                  |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|------------------|
|Conclusion: The limited quantification concentration of diisopropyl   |Conclusion:       |Conclusion:       |Conclusion:       |Conclusion:       |Conclusion:       |                  |
|sulfate was 15.1417ng/ml, which wasequivalent to 7.6ppm of the test   |The               |The               |The               |The               |The               |                  |
|solution. The RSD of the retention time in 6 parts of the limited     |limited           |limited           |limited           |limited           |limited           |                  |
|quantification solution was 0%, less than 1.0%, the RSD of the        |quantification    |quantification    |quantification    |quantification    |quantification    |                  |
|peakarea was 1.2%, less than 10%, and theS/Nranged from 52.55 to      |concentration     |concentration     |concentration     |concentration     |concentration     |                  |
|71.56, all of which were greater than 10. The resultsindicated that   |of                |of                |of                |of                |of                |                  |
|the response of this method was good for the detection of diisopropyl |diisopropyl       |diisopropyl       |diisopropyl       |diisopropyl       |diisopropyl       |                  |
|sulfate.                                                              |sulfate           |sulfate           |sulfate           |sulfate           |sulfate           |                  |
|                                                                      |was               |was               |was               |was               |was               |                  |
|                                                                      |15.1417ng/ml,     |15.1417ng/ml,     |15.1417ng/ml,     |15.1417ng/ml,     |15.1417ng/ml,     |                  |
|                                                                      |which             |which             |which             |which             |which             |                  |
|                                                                      |wasequivalent     |wasequivalent     |wasequivalent     |wasequivalent     |wasequivalent     |                  |
|                                                                      |to                |to                |to                |to                |to                |                  |
|                                                                      |7.6ppm            |7.6ppm            |7.6ppm            |7.6ppm            |7.6ppm            |                  |
|                                                                      |of the            |of the            |of the            |of the            |of the            |                  |
|                                                                      |test              |test              |test              |test              |test              |                  |
|                                                                      |solution.         |solution.         |solution.         |solution.         |solution.         |                  |
|                                                                      |The RSD           |The RSD           |The RSD           |The RSD           |The RSD           |                  |
|                                                                      |of the            |of the            |of the            |of the            |of the            |                  |
|                                                                      |retention         |retention         |retention         |retention         |retention         |                  |
|                                                                      |time in           |time in           |time in           |time in           |time in           |                  |
|                                                                      |6 parts           |6 parts           |6 parts           |6 parts           |6 parts           |                  |
|                                                                      |of the            |of the            |of the            |of the            |of the            |                  |
|                                                                      |limited           |limited           |limited           |limited           |limited           |                  |
|                                                                      |quantification    |quantification    |quantification    |quantification    |quantification    |                  |
|                                                                      |solution          |solution          |solution          |solution          |solution          |                  |
|                                                                      |was 0%,           |was 0%,           |was 0%,           |was 0%,           |was 0%,           |                  |
|                                                                      |less              |less              |less              |less              |less              |                  |
|                                                                      |than              |than              |than              |than              |than              |                  |
|                                                                      |1.0%,             |1.0%,             |1.0%,             |1.0%,             |1.0%,             |                  |
|                                                                      |the RSD           |the RSD           |the RSD           |the RSD           |the RSD           |                  |
|                                                                      |of the            |of the            |of the            |of the            |of the            |                  |
|                                                                      |peakarea          |peakarea          |peakarea          |peakarea          |peakarea          |                  |
|                                                                      |was               |was               |was               |was               |was               |                  |
|                                                                      |1.2%,             |1.2%,             |1.2%,             |1.2%,             |1.2%,             |                  |
|                                                                      |less              |less              |less              |less              |less              |                  |
|                                                                      |than              |than              |than              |than              |than              |                  |
|                                                                      |10%,              |10%,              |10%,              |10%,              |10%,              |                  |
|                                                                      |and               |and               |and               |and               |and               |                  |
|                                                                      |theS/Nranged      |theS/Nranged      |theS/Nranged      |theS/Nranged      |theS/Nranged      |                  |
|                                                                      |from              |from              |from              |from              |from              |                  |
|                                                                      |52.55             |52.55             |52.55             |52.55             |52.55             |                  |
|                                                                      |to                |to                |to                |to                |to                |                  |
|                                                                      |71.56,            |71.56,            |71.56,            |71.56,            |71.56,            |                  |
|                                                                      |all of            |all of            |all of            |all of            |all of            |                  |
|                                                                      |which             |which             |which             |which             |which             |                  |
|                                                                      |were              |were              |were              |were              |were              |                  |
|                                                                      |greater           |greater           |greater           |greater           |greater           |                  |
|                                                                      |than              |than              |than              |than              |than              |                  |
|                                                                      |10. The           |10. The           |10. The           |10. The           |10. The           |                  |
|                                                                      |resultsindicated  |resultsindicated  |resultsindicated  |resultsindicated  |resultsindicated  |                  |
|                                                                      |that              |that              |that              |that              |that              |                  |
|                                                                      |the               |the               |the               |the               |the               |                  |
|                                                                      |response          |response          |response          |response          |response          |                  |
|                                                                      |of this           |of this           |of this           |of this           |of this           |                  |
|                                                                      |method            |method            |method            |method            |method            |                  |
|                                                                      |was               |was               |was               |was               |was               |                  |
|                                                                      |good              |good              |good              |good              |good              |                  |
|                                                                      |for the           |for the           |for the           |for the           |for the           |                  |
|                                                                      |detection         |detection         |detection         |detection         |detection         |                  |
|                                                                      |of                |of                |of                |of                |of                |                  |
|                                                                      |diisopropyl       |diisopropyl       |diisopropyl       |diisopropyl       |diisopropyl       |                  |
|                                                                      |sulfate.          |sulfate.          |sulfate.          |sulfate.          |sulfate.          |                  |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|------------------|
|Di-sec- butyl sulfate                                                 |Limited           |15.3638           |7.7               |9.507             |57846             |76.76             |
|                                                                      |quantitative      |                  |                  |                  |                  |                  |
|                                                                      |Solution 1        |                  |                  |                  |                  |                  |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|------------------|
|Di-sec- butyl sulfate                                                 |Limited           |15.3638           |15.3638           |9.507             |58220             |59.11             |
|                                                                      |quantitative      |                  |                  |                  |                  |                  |
|                                                                      |Solution 2        |                  |                  |                  |                  |                  |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|------------------|
|Di-sec- butyl sulfate                                                 |Limited           |15.3638           |15.3638           |9.507             |56479             |61.59             |
|                                                                      |quantitative      |                  |                  |                  |                  |                  |
|                                                                      |Solution 3        |                  |                  |                  |                  |                  |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|------------------|
|Di-sec- butyl sulfate                                                 |Limited           |15.3638           |15.3638           |9.507             |57117             |58.01             |
|                                                                      |quantitative      |                  |                  |                  |                  |                  |
|                                                                      |Solution 4        |                  |                  |                  |                  |                  |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|------------------|
|Di-sec- butyl sulfate                                                 |Limited           |15.3638           |15.3638           |9.507             |55235             |56.30             |
|                                                                      |quantitative      |                  |                  |                  |                  |                  |
|                                                                      |Solution 5        |                  |                  |                  |                  |                  |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|------------------|
|Di-sec- butyl sulfate                                                 |Limited           |15.3638           |15.3638           |9.507             |56138             |60.63             |
|                                                                      |quantitative      |                  |                  |                  |                  |                  |
|                                                                      |solution 6        |                  |                  |                  |                  |                  |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|------------------|
|Di-sec- butyl sulfate                                                 |RSD%              |RSD%              |RSD%              |0                 |2.0               |/                 |
|----------------------------------------------------------------------|------------------|------------------|------------------|------------------|------------------|------------------|
|Di-sec- butyl sulfate                                                 |Conclusion: The   |Conclusion: The   |Conclusion: The   |Conclusion: The   |Conclusion: The   |Conclusion:       |
|                                                                      |limited           |limited           |limited           |limited           |limited           |The               |
|                                                                      |quantitation      |quantitation      |quantitation      |quantitation      |quantitation      |limited           |
|                                                                      |concentration of  |concentration of  |concentration of  |concentration of  |concentration of  |quantitation      |
|                                                                      |disec-butylsulfate|disec-butylsulfate|disec-butylsulfate|disec-butylsulfate|disec-butylsulfate|concentration     |
|                                                                      |was               |was               |was               |was               |was               |of                |
|                                                                      |15.3638ng/ml,     |15.3638ng/ml,     |15.3638ng/ml,     |15.3638ng/ml,     |15.3638ng/ml,     |disec-butylsulfate|
|                                                                      |which             |which             |which             |which             |which             |was               |
|                                                                      |wasequivalent to  |wasequivalent to  |wasequivalent to  |wasequivalent to  |wasequivalent to  |15.3638ng/ml,     |
|                                                                      |7.7ppm of the     |7.7ppm of the     |7.7ppm of the     |7.7ppm of the     |7.7ppm of the     |which             |
|                                                                      |solution, the     |solution, the     |solution, the     |solution, the     |solution, the     |wasequivalent     |
|                                                                      |RSD of the        |RSD of the        |RSD of the        |RSD of the        |RSD of the        |to                |
|                                                                      |retention time    |retention time    |retention time    |retention time    |retention time    |7.7ppm            |
|                                                                      |in 6 parts of     |in 6 parts of     |in 6 parts of     |in 6 parts of     |in 6 parts of     |of the            |
|                                                                      |the limited       |the limited       |the limited       |the limited       |the limited       |solution,         |
|                                                                      |quantitation      |quantitation      |quantitation      |quantitation      |quantitation      |the RSD           |
|                                                                      |solution was 0%,  |solution was 0%,  |solution was 0%,  |solution was 0%,  |solution was 0%,  |of the            |
|                                                                      |less than 1.0%,   |less than 1.0%,   |less than 1.0%,   |less than 1.0%,   |less than 1.0%,   |retention         |
|                                                                      |the RSD of the    |the RSD of the    |the RSD of the    |the RSD of the    |the RSD of the    |time in           |
|                                                                      |peakarea was      |peakarea was      |peakarea was      |peakarea was      |peakarea was      |6 parts           |
|                                                                      |2.0%, less than   |2.0%, less than   |2.0%, less than   |2.0%, less than   |2.0%, less than   |of the            |
|                                                                      |10%, and          |10%, and          |10%, and          |10%, and          |10%, and          |limited           |
|                                                                      |                  |                  |                  |                  |                  |quantitation      |
|                                                                      |                  |                  |                  |                  |                  |solution          |
|                                                                      |                  |                  |                  |                  |                  |was 0%,           |
|                                                                      |                  |                  |                  |                  |                  |less              |
|                                                                      |                  |                  |                  |                  |                  |than              |
|                                                                      |                  |                  |                  |                  |                  |1.0%,             |
|                                                                      |                  |                  |                  |                  |                  |the RSD           |
|                                                                      |                  |                  |                  |                  |                  |of the            |
|                                                                      |                  |                  |                  |                  |                  |peakarea          |
|                                                                      |                  |                  |                  |                  |                  |was               |
|                                                                      |                  |                  |                  |                  |                  |2.0%,             |
|                                                                      |                  |                  |                  |                  |                  |less              |
|                                                                      |                  |                  |                  |                  |                  |than              |
|                                                                      |                  |                  |                  |                  |                  |10%,              |
|                                                                      |                  |                  |                  |                  |                  |and               |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 380 of 542 





Page 381
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



the S/N ranged from 56.30 to 76.76, all of which were greater than 10. The 



results indicated that the method had a good response to the detection of 



di-sec-butylsulfate. 



Detection limit test results 






















































------------------------------------------------------------------------------------------------------------------------------------------------------
|Dimeth yl sulfate    |1                                                                       |4.4806           |2.2              |46.09            |
|---------------------|------------------------------------------------------------------------|-----------------|-----------------|-----------------|
|Dimeth yl sulfate    |2                                                                       |2                |2                |40.09            |
|---------------------|------------------------------------------------------------------------|-----------------|-----------------|-----------------|
|Dimeth yl sulfate    |3                                                                       |3                |3                |47.76            |
|---------------------|------------------------------------------------------------------------|-----------------|-----------------|-----------------|
|Dimeth yl sulfate    |Conclusion: The detection limit concentration of dimethyl sulfate is    |Conclusion:      |Conclusion:      |Conclusion:      |
|                     |4.4806ng/ml, whichisequivalent to 2.2ppm of the test solution, and      |The              |The              |The              |
|                     |theS/Nin the detection limit solution for 3 consecutive stitches ranges |detection        |detection        |detection        |
|                     |from 40.09 to 47.76, all of whichare greater than 3. It shows that this |limit            |limit            |limit            |
|                     |method hasa good response to the detection of dimethyl sulfate.         |concentration    |concentration    |concentration    |
|                     |                                                                        |of               |of               |of               |
|                     |                                                                        |dimethyl         |dimethyl         |dimethyl         |
|                     |                                                                        |sulfate          |sulfate          |sulfate          |
|                     |                                                                        |is               |is               |is               |
|                     |                                                                        |4.4806ng/ml,     |4.4806ng/ml,     |4.4806ng/ml,     |
|                     |                                                                        |whichisequivalent|whichisequivalent|whichisequivalent|
|                     |                                                                        |to               |to               |to               |
|                     |                                                                        |2.2ppm           |2.2ppm           |2.2ppm           |
|                     |                                                                        |of the           |of the           |of the           |
|                     |                                                                        |test             |test             |test             |
|                     |                                                                        |solution,        |solution,        |solution,        |
|                     |                                                                        |and              |and              |and              |
|                     |                                                                        |theS/Nin         |theS/Nin         |theS/Nin         |
|                     |                                                                        |the              |the              |the              |
|                     |                                                                        |detection        |detection        |detection        |
|                     |                                                                        |limit            |limit            |limit            |
|                     |                                                                        |solution         |solution         |solution         |
|                     |                                                                        |for 3            |for 3            |for 3            |
|                     |                                                                        |consecutive      |consecutive      |consecutive      |
|                     |                                                                        |stitches         |stitches         |stitches         |
|                     |                                                                        |ranges           |ranges           |ranges           |
|                     |                                                                        |from             |from             |from             |
|                     |                                                                        |40.09            |40.09            |40.09            |
|                     |                                                                        |to               |to               |to               |
|                     |                                                                        |47.76,           |47.76,           |47.76,           |
|                     |                                                                        |all of           |all of           |all of           |
|                     |                                                                        |whichare         |whichare         |whichare         |
|                     |                                                                        |greater          |greater          |greater          |
|                     |                                                                        |than 3.          |than 3.          |than 3.          |
|                     |                                                                        |It               |It               |It               |
|                     |                                                                        |shows            |shows            |shows            |
|                     |                                                                        |that             |that             |that             |
|                     |                                                                        |this             |this             |this             |
|                     |                                                                        |method           |method           |method           |
|                     |                                                                        |hasa             |hasa             |hasa             |
|                     |                                                                        |good             |good             |good             |
|                     |                                                                        |response         |response         |response         |
|                     |                                                                        |to the           |to the           |to the           |
|                     |                                                                        |detection        |detection        |detection        |
|                     |                                                                        |of               |of               |of               |
|                     |                                                                        |dimethyl         |dimethyl         |dimethyl         |
|                     |                                                                        |sulfate.         |sulfate.         |sulfate.         |
|---------------------|------------------------------------------------------------------------|-----------------|-----------------|-----------------|
|Diethyl sulfate      |1                                                                       |4.6094           |2.3              |53.85            |
|---------------------|------------------------------------------------------------------------|-----------------|-----------------|-----------------|
|Diethyl sulfate      |2                                                                       |2                |2                |55.62            |
|---------------------|------------------------------------------------------------------------|-----------------|-----------------|-----------------|
|Diethyl sulfate      |3                                                                       |3                |3                |57.13            |
|---------------------|------------------------------------------------------------------------|-----------------|-----------------|-----------------|
|Diethyl sulfate      |Conclusion: The detection limit concentration of diethyl sulfate was    |Conclusion: The  |Conclusion: The  |Conclusion: The  |
|                     |4.6094ng/ml, which wasequivalent to 2.3ppm of the test solution. S/Nin  |detection limit  |detection limit  |detection limit  |
|                     |the detection limit solution for 3 consecutive needles ranged from 53.85|concentration of |concentration of |concentration of |
|                     |to 57.13, all of which were greater than 3. Itindicates that this method|diethyl sulfate  |diethyl sulfate  |diethyl sulfate  |
|                     |hasagood response to the detection of diethyl sulfate.                  |was 4.6094ng/ml, |was 4.6094ng/ml, |was 4.6094ng/ml, |
|                     |                                                                        |which            |which            |which            |
|                     |                                                                        |wasequivalent to |wasequivalent to |wasequivalent to |
|                     |                                                                        |2.3ppm of the    |2.3ppm of the    |2.3ppm of the    |
|                     |                                                                        |test solution.   |test solution.   |test solution.   |
|                     |                                                                        |S/Nin the        |S/Nin the        |S/Nin the        |
|                     |                                                                        |detection limit  |detection limit  |detection limit  |
|                     |                                                                        |solution for 3   |solution for 3   |solution for 3   |
|                     |                                                                        |consecutive      |consecutive      |consecutive      |
|                     |                                                                        |needles ranged   |needles ranged   |needles ranged   |
|                     |                                                                        |from 53.85 to    |from 53.85 to    |from 53.85 to    |
|                     |                                                                        |57.13, all of    |57.13, all of    |57.13, all of    |
|                     |                                                                        |which were       |which were       |which were       |
|                     |                                                                        |greater than 3.  |greater than 3.  |greater than 3.  |
|                     |                                                                        |Itindicates that |Itindicates that |Itindicates that |
|                     |                                                                        |this method      |this method      |this method      |
|                     |                                                                        |hasagood response|hasagood response|hasagood response|
|                     |                                                                        |to the detection |to the detection |to the detection |
|                     |                                                                        |of diethyl       |of diethyl       |of diethyl       |
|                     |                                                                        |sulfate.         |sulfate.         |sulfate.         |
|---------------------|------------------------------------------------------------------------|-----------------|-----------------|-----------------|
|Diisopropyl sulfate  |1                                                                       |4.5425           |2.3              |18.46            |
|---------------------|------------------------------------------------------------------------|-----------------|-----------------|-----------------|
|Diisopropyl sulfate  |2                                                                       |2                |2                |20.78            |
|---------------------|------------------------------------------------------------------------|-----------------|-----------------|-----------------|
|Diisopropyl sulfate  |3                                                                       |3                |3                |18.67            |
|---------------------|------------------------------------------------------------------------|-----------------|-----------------|-----------------|
|Diisopropyl sulfate  |Conclusion: The detection limit concentration of diisopropyl sulfate was|Conclusion: The  |Conclusion: The  |Conclusion: The  |
|                     |4.5425ng/ml, which wasequivalent to 2.3ppm of the test solution, and    |detection limit  |detection limit  |detection limit  |
|                     |theS/Nin the detection limit solution for 3 consecutive stitches ranged |concentration of |concentration of |concentration of |
|                     |from 18.46 to 20.78, all of which were greater than 3. Itindicates that |diisopropyl      |diisopropyl      |diisopropyl      |
|                     |this method hasa good response to the detection of diisopropyl sulfate. |sulfate was      |sulfate was      |sulfate was      |
|                     |                                                                        |4.5425ng/ml,     |4.5425ng/ml,     |4.5425ng/ml,     |
|                     |                                                                        |which            |which            |which            |
|                     |                                                                        |wasequivalent to |wasequivalent to |wasequivalent to |
|                     |                                                                        |2.3ppm of the    |2.3ppm of the    |2.3ppm of the    |
|                     |                                                                        |test solution,   |test solution,   |test solution,   |
|                     |                                                                        |and theS/Nin the |and theS/Nin the |and theS/Nin the |
|                     |                                                                        |detection limit  |detection limit  |detection limit  |
|                     |                                                                        |solution for 3   |solution for 3   |solution for 3   |
|                     |                                                                        |consecutive      |consecutive      |consecutive      |
|                     |                                                                        |stitches ranged  |stitches ranged  |stitches ranged  |
|                     |                                                                        |from 18.46 to    |from 18.46 to    |from 18.46 to    |
|                     |                                                                        |20.78, all of    |20.78, all of    |20.78, all of    |
|                     |                                                                        |which were       |which were       |which were       |
|                     |                                                                        |greater than 3.  |greater than 3.  |greater than 3.  |
|                     |                                                                        |Itindicates that |Itindicates that |Itindicates that |
|                     |                                                                        |this method hasa |this method hasa |this method hasa |
|                     |                                                                        |good response to |good response to |good response to |
|                     |                                                                        |the detection of |the detection of |the detection of |
|                     |                                                                        |diisopropyl      |diisopropyl      |diisopropyl      |
|                     |                                                                        |sulfate.         |sulfate.         |sulfate.         |
|---------------------|------------------------------------------------------------------------|-----------------|-----------------|-----------------|
|Di-sec- butyl sulfate|1                                                                       |4.6091           |2.3              |16.69            |
|---------------------|------------------------------------------------------------------------|-----------------|-----------------|-----------------|
|Di-sec- butyl sulfate|2                                                                       |2                |2                |26.77            |
|---------------------|------------------------------------------------------------------------|-----------------|-----------------|-----------------|
|Di-sec- butyl sulfate|3                                                                       |3                |3                |19.04            |
------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 381 of 542 





Page 382
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Conclusion: The detection limit concentration of disec-butyl sulfate is 



4.6091ng/ml, which is equivalent to 2.3ppm of the test solution, and the 



S/N in the detection limit solution for 3 consecutive stitches is between 



16.69 and 26.77, all of which are greater than 3. It indicates that this 



method has a good response to the detection of di-sec-butyl sulfate. 



**(4.4) Linearity and range** 



 **Acceptance Criteria** 



In the equivalent of the impurities LOQ~200% limit concentration range, 



more uniform take 6 concentration points, the impurity concentration as the 



horizontal coordinate, the impurity peak area response value as the ordinate, 



as a linear regression curve, the regression coefficient R of the linear graph 



should be NLT 0.990, the Y-axis intercept is within 25% of the 100% 



response value. 



 **Solution preparation** 



Blank solution: Blank solution as prepared under 4.1. 



Linear Solution 1 (LOQ) : Accurately measure the control product reserve 



solution 10μl into 5ml measuring bottle, dilute it with acetonitrile to the scale, 



shake well, and obtain. 



Linear solution 2: Accurately measure the control product reserve 



solution 50μl into a 5ml measuring bottle, dilute it with acetonitrile to the 



scale, shake well, ready. 



Linear solution 3: Accurately measure the control product reserve liquid 



80μl into 5ml measuring bottle, dilute it with acetonitrile to the scale, shake 



well, ready. 



Linear solution 4: Precisely measure the control product reserve liquid 



100μl into 5ml measuring bottle, dilute it with acetonitrile to the scale, shake 



well, ready. 



Linear solution 5: Precisely measure the control product reserve liquid 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 382 of 542 





Page 383
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



150μl into 5ml measuring bottle, dilute it with acetonitrile to the scale, shake 



well, ready. 



Linear solution 6: Accurately measure the control product reserve liquid 



200μl into 5ml measuring bottle, dilute it with acetonitrile to the scale, shake 



well, ready. 



 **Injection Sequence** 



Take a blank solution and inject 1 needle, each linear solution from low 



concentration to high concentration of 1 needle, record the chromatogram. 



 **Measurement results** 



Results of linear and range tests 



























-----------------------------------------------------------------------------------------------------------------
|Dimethyl sulfate|Linear solution 1                                |7.5           |14.9352       |189843        |
|----------------|-------------------------------------------------|--------------|--------------|--------------|
|Dimethyl sulfate|Linear Solution 2                                |37.3          |74.6760       |955650        |
|----------------|-------------------------------------------------|--------------|--------------|--------------|
|Dimethyl sulfate|Linear Solution 3                                |59.7          |119.4816      |1503384       |
|----------------|-------------------------------------------------|--------------|--------------|--------------|
|Dimethyl sulfate|Linear solution 4                                |74.7          |149.3520      |1990355       |
|----------------|-------------------------------------------------|--------------|--------------|--------------|
|Dimethyl sulfate|Linear Solution 5                                |112.0         |224.0280      |2901824       |
|----------------|-------------------------------------------------|--------------|--------------|--------------|
|Dimethyl sulfate|Linear solution 6                                |149.4         |298.7040      |3941888       |
|----------------|-------------------------------------------------|--------------|--------------|--------------|
|Dimethyl sulfate|Linear Chart                                     |              |              |              |
|----------------|-------------------------------------------------|--------------|--------------|--------------|
|Dimethyl sulfate|Linearequations                                  |y=13215x-26946|y=13215x-26946|y=13215x-26946|
|----------------|-------------------------------------------------|--------------|--------------|--------------|
|Dimethyl sulfate|Correlation coefficientR                         |0.9997        |0.9997        |0.9997        |
|----------------|-------------------------------------------------|--------------|--------------|--------------|
|Dimethyl sulfate|Absolute value ofY-axisinterceptasa percentage of|1.4           |1.4           |1.4           |
-----------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 383 of 542 





Page 384
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 















---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|The verdict: In the concentration range of 14.9352~298.7040ng/ml, the                 |The                            |The                            |The                            |                      |
|linearequationisy=13215x-26946, the correlation coefficientis 0.9997, greater than    |verdict:                       |verdict:                       |verdict:                       |                      |
|0.990, and the absolute value ofy-interceptaccounts for 1.4% of 100% response value,  |In the                         |In the                         |In the                         |                      |
|less than 25%. Itindicates that dimethyl sulfate meets the requirements linearly in   |concentration                  |concentration                  |concentration                  |                      |
|the concentration range of 14.9352-298.7040 ng/ml.                                    |range                          |range                          |range                          |                      |
|                                                                                      |of                             |of                             |of                             |                      |
|                                                                                      |14.9352~298.7040ng/ml,         |14.9352~298.7040ng/ml,         |14.9352~298.7040ng/ml,         |                      |
|                                                                                      |the                            |the                            |the                            |                      |
|                                                                                      |linearequationisy=13215x-26946,|linearequationisy=13215x-26946,|linearequationisy=13215x-26946,|                      |
|                                                                                      |the                            |the                            |the                            |                      |
|                                                                                      |correlation                    |correlation                    |correlation                    |                      |
|                                                                                      |coefficientis                  |coefficientis                  |coefficientis                  |                      |
|                                                                                      |0.9997,                        |0.9997,                        |0.9997,                        |                      |
|                                                                                      |greater                        |greater                        |greater                        |                      |
|                                                                                      |than                           |than                           |than                           |                      |
|                                                                                      |0.990,                         |0.990,                         |0.990,                         |                      |
|                                                                                      |and the                        |and the                        |and the                        |                      |
|                                                                                      |absolute                       |absolute                       |absolute                       |                      |
|                                                                                      |value                          |value                          |value                          |                      |
|                                                                                      |ofy-interceptaccounts          |ofy-interceptaccounts          |ofy-interceptaccounts          |                      |
|                                                                                      |for                            |for                            |for                            |                      |
|                                                                                      |1.4% of                        |1.4% of                        |1.4% of                        |                      |
|                                                                                      |100%                           |100%                           |100%                           |                      |
|                                                                                      |response                       |response                       |response                       |                      |
|                                                                                      |value,                         |value,                         |value,                         |                      |
|                                                                                      |less                           |less                           |less                           |                      |
|                                                                                      |than                           |than                           |than                           |                      |
|                                                                                      |25%.                           |25%.                           |25%.                           |                      |
|                                                                                      |Itindicates                    |Itindicates                    |Itindicates                    |                      |
|                                                                                      |that                           |that                           |that                           |                      |
|                                                                                      |dimethyl                       |dimethyl                       |dimethyl                       |                      |
|                                                                                      |sulfate                        |sulfate                        |sulfate                        |                      |
|                                                                                      |meets                          |meets                          |meets                          |                      |
|                                                                                      |the                            |the                            |the                            |                      |
|                                                                                      |requirements                   |requirements                   |requirements                   |                      |
|                                                                                      |linearly                       |linearly                       |linearly                       |                      |
|                                                                                      |in the                         |in the                         |in the                         |                      |
|                                                                                      |concentration                  |concentration                  |concentration                  |                      |
|                                                                                      |range                          |range                          |range                          |                      |
|                                                                                      |of                             |of                             |of                             |                      |
|                                                                                      |14.9352-298.7040               |14.9352-298.7040               |14.9352-298.7040               |                      |
|                                                                                      |ng/ml.                         |ng/ml.                         |ng/ml.                         |                      |
|--------------------------------------------------------------------------------------|-------------------------------|-------------------------------|-------------------------------|----------------------|
|Diethyl sulfate                                                                       |Linear Solution 1              |7.7                            |15.3648                        |225866                |
|--------------------------------------------------------------------------------------|-------------------------------|-------------------------------|-------------------------------|----------------------|
|Diethyl sulfate                                                                       |Linear Solution 2              |38.4                           |76.8240                        |1184267               |
|--------------------------------------------------------------------------------------|-------------------------------|-------------------------------|-------------------------------|----------------------|
|Diethyl sulfate                                                                       |Linear Solution 3              |61.5                           |122.9184                       |1937152               |
|--------------------------------------------------------------------------------------|-------------------------------|-------------------------------|-------------------------------|----------------------|
|Diethyl sulfate                                                                       |Linear solution 4              |76.8                           |153.6480                       |2377909               |
|--------------------------------------------------------------------------------------|-------------------------------|-------------------------------|-------------------------------|----------------------|
|Diethyl sulfate                                                                       |Linear Solution 5              |115.2                          |230.4720                       |3628004               |
|--------------------------------------------------------------------------------------|-------------------------------|-------------------------------|-------------------------------|----------------------|
|Diethyl sulfate                                                                       |Linear solution 6              |153.6                          |307.2960                       |5096780               |
|--------------------------------------------------------------------------------------|-------------------------------|-------------------------------|-------------------------------|----------------------|
|Diethyl sulfate                                                                       |Linear Chart                   |                               |                               |                      |
|--------------------------------------------------------------------------------------|-------------------------------|-------------------------------|-------------------------------|----------------------|
|Diethyl sulfate                                                                       |Linearequations                |y=16542x-91014                 |y=16542x-91014                 |y=16542x-91014        |
|--------------------------------------------------------------------------------------|-------------------------------|-------------------------------|-------------------------------|----------------------|
|Diethyl sulfate                                                                       |Correlation coefficientR       |0.9990                         |0.9990                         |0.9990                |
|--------------------------------------------------------------------------------------|-------------------------------|-------------------------------|-------------------------------|----------------------|
|Diethyl sulfate                                                                       |Absolute value                 |3.7                            |3.7                            |3.7                   |
|                                                                                      |ofY-axisinterceptasa percentage|                               |                               |                      |
|                                                                                      |of 100% response (%)           |                               |                               |                      |
|--------------------------------------------------------------------------------------|-------------------------------|-------------------------------|-------------------------------|----------------------|
|Diethyl sulfate                                                                       |The verdict: In the            |The verdict: In the            |The verdict: In the            |The verdict:          |
|                                                                                      |concentration range of         |concentration range of         |concentration range of         |In the                |
|                                                                                      |15.3648~307.2960ng/ml, the     |15.3648~307.2960ng/ml, the     |15.3648~307.2960ng/ml, the     |concentration         |
|                                                                                      |linearequation of diethyl      |linearequation of diethyl      |linearequation of diethyl      |range of              |
|                                                                                      |sulfate isy=16542x ~ 91014, the|sulfate isy=16542x ~ 91014, the|sulfate isy=16542x ~ 91014, the|15.3648~307.2960ng/ml,|
|                                                                                      |correlation coefficientis      |correlation coefficientis      |correlation coefficientis      |the                   |
|                                                                                      |0.9990, greater than 0.990, and|0.9990, greater than 0.990, and|0.9990, greater than 0.990, and|linearequation        |
|                                                                                      |the absolute value             |the absolute value             |the absolute value             |of diethyl            |
|                                                                                      |ofy-interceptaccounts for 3.7% |ofy-interceptaccounts for 3.7% |ofy-interceptaccounts for 3.7% |sulfate               |
|                                                                                      |of 100% response value, less   |of 100% response value, less   |of 100% response value, less   |isy=16542x ~          |
|                                                                                      |than 25%. Itindicates that     |than 25%. Itindicates that     |than 25%. Itindicates that     |91014, the            |
|                                                                                      |diethyl sulfate meets the      |diethyl sulfate meets the      |diethyl sulfate meets the      |correlation           |
|                                                                                      |requirements linearly in the   |requirements linearly in the   |requirements linearly in the   |coefficientis         |
|                                                                                      |concentration range of         |concentration range of         |concentration range of         |0.9990,               |
|                                                                                      |15.3648~307.2960ng/ml.         |15.3648~307.2960ng/ml.         |15.3648~307.2960ng/ml.         |greater than          |
|                                                                                      |                               |                               |                               |0.990, and the        |
|                                                                                      |                               |                               |                               |absolute value        |
|                                                                                      |                               |                               |                               |ofy-interceptaccounts |
|                                                                                      |                               |                               |                               |for 3.7% of           |
|                                                                                      |                               |                               |                               |100% response         |
|                                                                                      |                               |                               |                               |value, less           |
|                                                                                      |                               |                               |                               |than 25%.             |
|                                                                                      |                               |                               |                               |Itindicates           |
|                                                                                      |                               |                               |                               |that diethyl          |
|                                                                                      |                               |                               |                               |sulfate meets         |
|                                                                                      |                               |                               |                               |the                   |
|                                                                                      |                               |                               |                               |requirements          |
|                                                                                      |                               |                               |                               |linearly in           |
|                                                                                      |                               |                               |                               |the                   |
|                                                                                      |                               |                               |                               |concentration         |
|                                                                                      |                               |                               |                               |range of              |
|                                                                                      |                               |                               |                               |15.3648~307.2960ng/ml.|
|--------------------------------------------------------------------------------------|-------------------------------|-------------------------------|-------------------------------|----------------------|
|Diisopropyl sulfate                                                                   |Linear Solution 1              |7.6                            |15.1417                        |137940                |
|--------------------------------------------------------------------------------------|-------------------------------|-------------------------------|-------------------------------|----------------------|
|Diisopropyl sulfate                                                                   |Linear Solution 2              |37.9                           |75.7085                        |759103                |
|--------------------------------------------------------------------------------------|-------------------------------|-------------------------------|-------------------------------|----------------------|
|Diisopropyl sulfate                                                                   |Linear Solution 3              |60.6                           |121.1336                       |1259134               |
|--------------------------------------------------------------------------------------|-------------------------------|-------------------------------|-------------------------------|----------------------|
|Diisopropyl sulfate                                                                   |Linear solution 4              |75.7                           |151.4170                       |1534192               |
|--------------------------------------------------------------------------------------|-------------------------------|-------------------------------|-------------------------------|----------------------|
|Diisopropyl sulfate                                                                   |Linear Solution 5              |113.6                          |227.1255                       |2376454               |
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 384 of 542 





Page 385
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 















---------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Linear Chart                                                                          |                      |                      |                      |       |
|--------------------------------------------------------------------------------------|----------------------|----------------------|----------------------|-------|
|Linearequations                                                                       |y=11126x-84402        |y=11126x-84402        |y=11126x-84402        |       |
|--------------------------------------------------------------------------------------|----------------------|----------------------|----------------------|-------|
|Correlation coefficientR                                                              |0.9986                |0.9986                |0.9986                |       |
|--------------------------------------------------------------------------------------|----------------------|----------------------|----------------------|-------|
|Absolute value ofY-axisinterceptasa percentage of 100% response (%)                   |5.3                   |5.3                   |5.3                   |       |
|--------------------------------------------------------------------------------------|----------------------|----------------------|----------------------|-------|
|The verdict: In the concentration range of 15.1417~302.8340ng/ml, the linearequation  |The verdict:          |The verdict:          |The verdict:          |       |
|of diisopropyl sulfate isy=11126x-84402, the correlation coefficientis 0.9986, greater|In the                |In the                |In the                |       |
|than 0.990, and the absolute value ofy-interceptis 5.3% of 100% response value, less  |concentration         |concentration         |concentration         |       |
|than 25%. Itindicates that diisopropyl sulfate meets the requirements linearly in the |range of              |range of              |range of              |       |
|concentration range of 15.1417~302.8340ng/ml.                                         |15.1417~302.8340ng/ml,|15.1417~302.8340ng/ml,|15.1417~302.8340ng/ml,|       |
|                                                                                      |the                   |the                   |the                   |       |
|                                                                                      |linearequation        |linearequation        |linearequation        |       |
|                                                                                      |of diisopropyl        |of diisopropyl        |of diisopropyl        |       |
|                                                                                      |sulfate               |sulfate               |sulfate               |       |
|                                                                                      |isy=11126x-84402,     |isy=11126x-84402,     |isy=11126x-84402,     |       |
|                                                                                      |the                   |the                   |the                   |       |
|                                                                                      |correlation           |correlation           |correlation           |       |
|                                                                                      |coefficientis         |coefficientis         |coefficientis         |       |
|                                                                                      |0.9986,               |0.9986,               |0.9986,               |       |
|                                                                                      |greater than          |greater than          |greater than          |       |
|                                                                                      |0.990, and the        |0.990, and the        |0.990, and the        |       |
|                                                                                      |absolute value        |absolute value        |absolute value        |       |
|                                                                                      |ofy-interceptis       |ofy-interceptis       |ofy-interceptis       |       |
|                                                                                      |5.3% of 100%          |5.3% of 100%          |5.3% of 100%          |       |
|                                                                                      |response              |response              |response              |       |
|                                                                                      |value, less           |value, less           |value, less           |       |
|                                                                                      |than 25%.             |than 25%.             |than 25%.             |       |
|                                                                                      |Itindicates           |Itindicates           |Itindicates           |       |
|                                                                                      |that                  |that                  |that                  |       |
|                                                                                      |diisopropyl           |diisopropyl           |diisopropyl           |       |
|                                                                                      |sulfate meets         |sulfate meets         |sulfate meets         |       |
|                                                                                      |the                   |the                   |the                   |       |
|                                                                                      |requirements          |requirements          |requirements          |       |
|                                                                                      |linearly in           |linearly in           |linearly in           |       |
|                                                                                      |the                   |the                   |the                   |       |
|                                                                                      |concentration         |concentration         |concentration         |       |
|                                                                                      |range of              |range of              |range of              |       |
|                                                                                      |15.1417~302.8340ng/ml.|15.1417~302.8340ng/ml.|15.1417~302.8340ng/ml.|       |
|--------------------------------------------------------------------------------------|----------------------|----------------------|----------------------|-------|
|Disec-butyl sulfate                                                                   |Linear Solution 1     |7.7                   |15.3638               |54810  |
|--------------------------------------------------------------------------------------|----------------------|----------------------|----------------------|-------|
|Disec-butyl sulfate                                                                   |Linear Solution 2     |38.4                  |76.8189               |311128 |
|--------------------------------------------------------------------------------------|----------------------|----------------------|----------------------|-------|
|Disec-butyl sulfate                                                                   |Linear solution 3     |61.5                  |122.9102              |528954 |
|--------------------------------------------------------------------------------------|----------------------|----------------------|----------------------|-------|
|Disec-butyl sulfate                                                                   |Linear solution 4     |76.8                  |153.6377              |638145 |
|--------------------------------------------------------------------------------------|----------------------|----------------------|----------------------|-------|
|Disec-butyl sulfate                                                                   |Linear Solution 5     |115.2                 |230.4566              |988606 |
|--------------------------------------------------------------------------------------|----------------------|----------------------|----------------------|-------|
|Disec-butyl sulfate                                                                   |Linear solution 6     |153.6                 |307.2754              |1416224|
|--------------------------------------------------------------------------------------|----------------------|----------------------|----------------------|-------|
|Disec-butyl sulfate                                                                   |Linear Chart          |                      |                      |       |
---------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 385 of 542 





Page 386
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 










--------------------------------------------------------------------------------------------------
|       |Linearequations                                                    |Y = 4616.2 x - 41084|
|       |                                                                   |                    |
|       |                                                                   |                    |
|       |-------------------------------------------------------------------|--------------------|
|       |Correlation coefficientR                                           |0.9982              |
|       |-------------------------------------------------------------------|--------------------|
|       |Absolute value ofY-axisinterceptasa percentage of 100% response (%)|6.1                 |
--------------------------------------------------------------------------------------------------

**(4.5) Repeatability** 



 **Acceptance Criteria** 



Repeatability is achieved by examining the repeatability of the results of 



each component to be tested in the repeatable test product solution. Prepare 



6 parts of repeatable test product solution with 100% limit of the components 



to be tested. The RSD of the content of dimethyl sulfate, diethyl sulfate, 



diisopropyl sulfate and disec-butyl sulfate in the 6 parts of repeatable test 



product solution shall NMT 20%. 



 **Preparation of solution** 



Blank solution: Blank solution as prepared under 4.1. 



Reference stock solution: the same as the reference stock solution 



prepared under item 4.1. 



Reference solution: the same as the reference solution prepared under 



4.1. 



Repeated test product solution: take about 10mg of this product, 



accurately weigh it, place it in a 5ml measuring bottle, add acetonitrile to 



dissolve, then add the control product reserve solution of 100μl, dilute with 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 386 of 542 





Page 387
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



acetonitrile to the scale, shake well, and get. 6 parts were prepared in 



parallel. 



 **Injection procedure** 



1 needle was injected into blank solution, 2 needles were injected into 



control solution continuously, and 1 needle was injected into 6 repetitive test 



product solutions respectively, and the chromatogram was recorded. 



 **Measurement results** 



















--------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Name of solution                                                                      |Dimethyl          |Diethyl           |Diisopropyl       |Di-sec-butyl      |
|                                                                                      |sulfate           |sulfate           |sulfate           |sulfate           |
|--------------------------------------------------------------------------------------|------------------|------------------|------------------|------------------|
|Repetitive test product solution 1                                                    |64.4              |72.2              |67.4              |67.9              |
|--------------------------------------------------------------------------------------|------------------|------------------|------------------|------------------|
|Repetitive test product solution 2                                                    |68.5              |74.3              |69.9              |71.2              |
|--------------------------------------------------------------------------------------|------------------|------------------|------------------|------------------|
|Repetitive test product solution 3                                                    |63.1              |72.4              |67.6              |67.8              |
|--------------------------------------------------------------------------------------|------------------|------------------|------------------|------------------|
|Repetitive test product solution 4                                                    |59.3              |69.5              |64.7              |64.7              |
|--------------------------------------------------------------------------------------|------------------|------------------|------------------|------------------|
|Repeated test product solution 5                                                      |55.5              |74.6              |68.6              |70.2              |
|--------------------------------------------------------------------------------------|------------------|------------------|------------------|------------------|
|Repetitive test product solution 6                                                    |72.3              |75.7              |73.0              |76.8              |
|--------------------------------------------------------------------------------------|------------------|------------------|------------------|------------------|
|Average                                                                               |63.9              |73.1              |68.5              |69.8              |
|--------------------------------------------------------------------------------------|------------------|------------------|------------------|------------------|
|RSD/%                                                                                 |10                |4                 |5                 |6                 |
|--------------------------------------------------------------------------------------|------------------|------------------|------------------|------------------|
|Verdict: The RSD of the content of dimethyl sulfate was 10%, less than 20%, the RSD of|Verdict:          |Verdict:          |Verdict:          |Verdict: The      |
|the content of diethyl sulfate was 4%, less than 20%, the RSD of the content of       |The RSD           |The RSD           |The RSD of        |RSD of the        |
|diisopropyl sulfate was 5%, less than 20%, and the RSD of the content of disec-butyl  |of the            |of the            |the content       |content of        |
|sulfate was 6%, less than 20%. The resultsindicated that the reproducibility of       |content           |content           |of dimethyl       |dimethyl          |
|dimethyl sulfate, diethyl sulfate, diisopropyl sulfate and disec-butylsulfate met the |of                |of                |sulfate was       |sulfate was       |
|requirements.                                                                         |dimethyl          |dimethyl          |10%, less         |10%, less         |
|                                                                                      |sulfate           |sulfate           |than 20%,         |than 20%,         |
|                                                                                      |was 10%,          |was               |the RSD of        |the RSD of        |
|                                                                                      |less              |10%,              |the content       |the content       |
|                                                                                      |than              |less              |of diethyl        |of diethyl        |
|                                                                                      |20%, the          |than              |sulfate was       |sulfate was       |
|                                                                                      |RSD of            |20%,              |4%, less          |4%, less          |
|                                                                                      |the               |the RSD           |than 20%,         |than 20%,         |
|                                                                                      |content           |of the            |the RSD of        |the RSD of        |
|                                                                                      |of                |content           |the content       |the content       |
|                                                                                      |diethyl           |of                |of                |of                |
|                                                                                      |sulfate           |diethyl           |diisopropyl       |diisopropyl       |
|                                                                                      |was 4%,           |sulfate           |sulfate was       |sulfate was       |
|                                                                                      |less              |was 4%,           |5%, less          |5%, less          |
|                                                                                      |than              |less              |than 20%,         |than 20%,         |
|                                                                                      |20%, the          |than              |and the RSD       |and the RSD       |
|                                                                                      |RSD of            |20%,              |of the            |of the            |
|                                                                                      |the               |the RSD           |content of        |content of        |
|                                                                                      |content           |of the            |disec-butyl       |disec-butyl       |
|                                                                                      |of                |content           |sulfate was       |sulfate was       |
|                                                                                      |diisopropyl       |of                |6%, less          |6%, less          |
|                                                                                      |sulfate           |diisopropyl       |than 20%.         |than 20%.         |
|                                                                                      |was 5%,           |sulfate           |The               |The               |
|                                                                                      |less              |was 5%,           |resultsindicated  |resultsindicated  |
|                                                                                      |than              |less              |that the          |that the          |
|                                                                                      |20%, and          |than              |reproducibility   |reproducibility   |
|                                                                                      |the RSD           |20%,              |of dimethyl       |of dimethyl       |
|                                                                                      |of the            |and the           |sulfate,          |sulfate,          |
|                                                                                      |content           |RSD of            |diethyl           |diethyl           |
|                                                                                      |of                |the               |sulfate,          |sulfate,          |
|                                                                                      |disec-butyl       |content           |diisopropyl       |diisopropyl       |
|                                                                                      |sulfate           |of                |sulfate and       |sulfate and       |
|                                                                                      |was 6%,           |disec-butyl       |disec-butylsulfate|disec-butylsulfate|
|                                                                                      |less              |sulfate           |met the           |met the           |
|                                                                                      |than              |was 6%,           |requirements.     |requirements.     |
|                                                                                      |20%. The          |less              |                  |                  |
|                                                                                      |resultsindicated  |than              |                  |                  |
|                                                                                      |that the          |20%.              |                  |                  |
|                                                                                      |reproducibility   |The               |                  |                  |
|                                                                                      |of                |resultsindicated  |                  |                  |
|                                                                                      |dimethyl          |that              |                  |                  |
|                                                                                      |sulfate,          |the               |                  |                  |
|                                                                                      |diethyl           |reproducibility   |                  |                  |
|                                                                                      |sulfate,          |of                |                  |                  |
|                                                                                      |diisopropyl       |dimethyl          |                  |                  |
|                                                                                      |sulfate           |sulfate,          |                  |                  |
|                                                                                      |and               |diethyl           |                  |                  |
|                                                                                      |disec-butylsulfate|sulfate,          |                  |                  |
|                                                                                      |met the           |diisopropyl       |                  |                  |
|                                                                                      |requirements.     |sulfate           |                  |                  |
|                                                                                      |                  |and               |                  |                  |
|                                                                                      |                  |disec-butylsulfate|                  |                  |
|                                                                                      |                  |met the           |                  |                  |
|                                                                                      |                  |requirements.     |                  |                  |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------

**(4.6) Accuracy** 



 **Brief Description** 



Accuracy is achieved by adding each impurity reference in the range of 



30% limit concentration to 150% limit concentration of each impurity in the 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 387 of 542 





Page 388
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



test product solution, and determining the recovery rate between the 



theoretical addition amount and the actual detection amount. The recovery 



rate of each impurity in the test solution should be between 80.0% and 



120.0%, and the RSD of the recovery rate of each impurity NMT 15%. 



 **Solution preparation** 



Blank solution: Blank solution as prepared under 4.1. 



Reference stock solution: the same as the reference stock solution 



prepared under item 4.1. 



Reference solution: the same reference solution prepared under item 4.1. 



Test product solution: Take about 10mg of this product, weigh it 



accurately, place it in a 5ml measuring bottle, add an appropriate amount of 



acetonitrile to dissolve, dilute it with acetonitrile to the scale, shake well, and 



get. Prepare 2 parts in parallel. 



30% standard test product solution: Take about 10mg of this product, 



accurately weigh it, place it in a 5ml measuring bottle, add an appropriate 



amount of acetonitrile to dissolve, accurately add the control product reserve 



liquid 30μl, dilute it with acetonitrile to the scale, shake well, and get. 



Dispense 3 parts in parallel. 



100% standard test product solution: take about 10mg of this product, 



weigh it accurately, place it in a 5ml measuring bottle, add acetonitrile and 



swirl to dissolve, add 100μl of control product reserve liquid precisely, dilute 



it with acetonitrile to the scale, shake well, and get. Dispense 3 parts in 



parallel 



150% standard test product solution: Take about 10mg of this product, 



accurately weigh it, place it in a 5ml measuring bottle, add acetonitrile and 



scroll to dissolve, accurately add the control product reserve liquid 150μl, 



dilute it with acetonitrile to the scale, shake well, and get. Dispense 3 parts in 



parallel. 



 **Injection procedure** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 388 of 542 





Page 389
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



After the blank solution, 2 needles were injected into the control solution 



continuously, 2 samples of test product solution and 9 samples of each 



concentration added standard test product solution were injected into 1 



needle successively, and the chromatogram was recorded. 



 **Results of determination** 






























--------------------------------------------------------------------------------------------------------------------------
|Dimethyl sulfa te|Sample solution 1                   |Not detected|Not detected        |Not detected |Not     |Not     |
|                 |                                    |            |                    |             |detected|detected|
|-----------------|------------------------------------|------------|--------------------|-------------|--------|--------|
|Dimethyl sulfa te|Test product solution 2             |Not detected|Not detected        |Not detected |Not     |Not     |
|                 |                                    |            |                    |             |detected|detected|
|-----------------|------------------------------------|------------|--------------------|-------------|--------|--------|
|Dimethyl sulfa te|Solution name                       |Peakarea    |Amountavailable (ng)|Amountadded  |Measure |Recovery|
|                 |                                    |            |                    |(ng)         |damount |rate (%)|
|                 |                                    |            |                    |             |(ng)    |        |
|-----------------|------------------------------------|------------|--------------------|-------------|--------|--------|
|Dimethyl sulfa te|30% standard test solution 1        |562037      |Not detected        |0.2317       |0.2176  |93.94   |
|-----------------|------------------------------------|------------|--------------------|-------------|--------|--------|
|Dimethyl sulfa te|30% labeled test product solution 2 |566838      |Not detected        |0.2317       |0.2195  |94.74   |
|-----------------|------------------------------------|------------|--------------------|-------------|--------|--------|
|Dimethyl sulfa te|30% labeled test product solution 3 |550588      |Not detected        |0.2317       |0.2132  |92.02   |
|-----------------|------------------------------------|------------|--------------------|-------------|--------|--------|
|Dimethyl sulfa te|100% labeled test product solution 1|195835 6    |Not detected        |0.7722       |0.7583  |98.19   |
|-----------------|------------------------------------|------------|--------------------|-------------|--------|--------|
|Dimethyl sulfa te|100% labeled test product solution 2|195758 6    |Not detected        |0.7722       |0.7580  |98.15   |
|-----------------|------------------------------------|------------|--------------------|-------------|--------|--------|
|Dimethyl sulfa te|100% labeled test product solution 3|192201 1    |Not detected        |0.7722       |0.7442  |96.37   |
--------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 389 of 542 





Page 390
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 

















































-------------------------------------------------------------------------------------------------------------------------------------------------------------
|150% labeled test product solution 2                                  |293070        |Not           |1.1584         |1.1348        |97.96         |        |
|                                                                      |1             |detected      |               |              |              |        |
|----------------------------------------------------------------------|--------------|--------------|---------------|--------------|--------------|--------|
|150% labeled test product solution 3                                  |293539        |Not           |1.1584         |1.1366        |98.12         |        |
|                                                                      |5             |detected      |               |              |              |        |
|----------------------------------------------------------------------|--------------|--------------|---------------|--------------|--------------|--------|
|Average recovery rate (%)                                             |96.33         |96.33         |96.33          |96.33         |96.33         |        |
|----------------------------------------------------------------------|--------------|--------------|---------------|--------------|--------------|--------|
|RSD(%)                                                                |2.4           |2.4           |2.4            |2.4           |2.4           |        |
|----------------------------------------------------------------------|--------------|--------------|---------------|--------------|--------------|--------|
|Verdict: No dimethyl sulfate was detected in the test products. The   |Verdict:      |Verdict:      |Verdict:       |Verdict:      |Verdict:      |        |
|average recovery rate was 96.33% when 30% limit concentration ~150%   |No            |No            |No             |No            |No            |        |
|limit concentration of dimethyl sulfate wasadded to the test products,|dimethyl      |dimethyl      |dimethyl       |dimethyl      |dimethyl      |        |
|the recovery rate was 92.02%~98.19%, 80%~120%, and the RSD of recovery|sulfate       |sulfate       |sulfate        |sulfate       |sulfate       |        |
|was 2.4%. Less than 15%, indicating that the accuracy of this method  |was           |was           |was            |was           |was           |        |
|in detecting dimethyl sulfate in YA2304 meets the requirements.       |detected      |detected      |detected       |detected      |detected      |        |
|                                                                      |in the        |in the        |in the         |in the        |in the        |        |
|                                                                      |test          |test          |test           |test          |test          |        |
|                                                                      |products.     |products.     |products.      |products.     |products.     |        |
|                                                                      |The           |The           |The            |The           |The           |        |
|                                                                      |average       |average       |average        |average       |average       |        |
|                                                                      |recovery      |recovery      |recovery       |recovery      |recovery      |        |
|                                                                      |rate          |rate was      |rate           |rate          |rate          |        |
|                                                                      |was           |96.33%        |was            |was           |was           |        |
|                                                                      |96.33%        |when 30%      |96.33%         |96.33%        |96.33%        |        |
|                                                                      |when          |limit         |when           |when          |when          |        |
|                                                                      |30%           |concentration |30%            |30%           |30%           |        |
|                                                                      |limit         |~150%         |limit          |limit         |limit         |        |
|                                                                      |concentration |limit         |concentration  |concentration |concentration |        |
|                                                                      |~150%         |concentration |~150%          |~150%         |~150%         |        |
|                                                                      |limit         |of            |limit          |limit         |limit         |        |
|                                                                      |concentration |dimethyl      |concentration  |concentration |concentration |        |
|                                                                      |of            |sulfate       |of             |of            |of            |        |
|                                                                      |dimethyl      |wasadded      |dimethyl       |dimethyl      |dimethyl      |        |
|                                                                      |sulfate       |to the        |sulfate        |sulfate       |sulfate       |        |
|                                                                      |wasadded      |test          |wasadded       |wasadded      |wasadded      |        |
|                                                                      |to the        |products,     |to the         |to the        |to the        |        |
|                                                                      |test          |the           |test           |test          |test          |        |
|                                                                      |products,     |recovery      |products,      |products,     |products,     |        |
|                                                                      |the           |rate was      |the            |the           |the           |        |
|                                                                      |recovery      |92.02%~98.19%,|recovery       |recovery      |recovery      |        |
|                                                                      |rate          |80%~120%,     |rate           |rate          |rate          |        |
|                                                                      |was           |and the       |was            |was           |was           |        |
|                                                                      |92.02%~98.19%,|RSD of        |92.02%~98.19%, |92.02%~98.19%,|92.02%~98.19%,|        |
|                                                                      |80%~120%,     |recovery      |80%~120%,      |80%~120%,     |80%~120%,     |        |
|                                                                      |and the       |was           |and the        |and the       |and the       |        |
|                                                                      |RSD of        |2.4%.         |RSD of         |RSD of        |RSD of        |        |
|                                                                      |recovery      |Less          |recovery       |recovery      |recovery      |        |
|                                                                      |was           |than          |was            |was           |was           |        |
|                                                                      |2.4%.         |15%,          |2.4%.          |2.4%.         |2.4%.         |        |
|                                                                      |Less          |indicating    |Less           |Less          |Less          |        |
|                                                                      |than          |that the      |than           |than          |than          |        |
|                                                                      |15%,          |accuracy      |15%,           |15%,          |15%,          |        |
|                                                                      |indicating    |of this       |indicating     |indicating    |indicating    |        |
|                                                                      |that          |method        |that           |that          |that          |        |
|                                                                      |the           |in            |the            |the           |the           |        |
|                                                                      |accuracy      |detecting     |accuracy       |accuracy      |accuracy      |        |
|                                                                      |of this       |dimethyl      |of this        |of this       |of this       |        |
|                                                                      |method        |sulfate       |method         |method        |method        |        |
|                                                                      |in            |in            |in             |in            |in            |        |
|                                                                      |detecting     |YA2304        |detecting      |detecting     |detecting     |        |
|                                                                      |dimethyl      |meets         |dimethyl       |dimethyl      |dimethyl      |        |
|                                                                      |sulfate       |the           |sulfate        |sulfate       |sulfate       |        |
|                                                                      |in            |requirements. |in             |in            |in            |        |
|                                                                      |YA2304        |              |YA2304         |YA2304        |YA2304        |        |
|                                                                      |meets         |              |meets          |meets         |meets         |        |
|                                                                      |the           |              |the            |the           |the           |        |
|                                                                      |requirements. |              |requirements.  |requirements. |requirements. |        |
|----------------------------------------------------------------------|--------------|--------------|---------------|--------------|--------------|--------|
|impu rity Name                                                        |Solution name |Peakarea      |Content        |Content       |Average       |Average |
|                                                                      |              |              |               |              |content       |content |
|----------------------------------------------------------------------|--------------|--------------|---------------|--------------|--------------|--------|
|Diet hyl sulfa te                                                     |Sample        |Not detected  |Not detected   |Not detected  |Not detected  |Not     |
|                                                                      |solution 1    |              |               |              |              |detected|
|----------------------------------------------------------------------|--------------|--------------|---------------|--------------|--------------|--------|
|Diet hyl sulfa te                                                     |Test product  |Not detected  |Not detected   |Not detected  |Not detected  |Not     |
|                                                                      |solution 2    |              |               |              |              |detected|
|----------------------------------------------------------------------|--------------|--------------|---------------|--------------|--------------|--------|
|Diet hyl sulfa te                                                     |Solution name |Peakarea      |Availableamount|Amountadded   |Measure       |Recovery|
|                                                                      |              |              |(ng)           |(ng)          |damount (ng)  |rate (%)|
|----------------------------------------------------------------------|--------------|--------------|---------------|--------------|--------------|--------|
|Diet hyl sulfa te                                                     |30% standard  |642815        |Not detected   |0.2333        |0.2185        |93.66   |
|                                                                      |test solution |              |               |              |              |        |
|                                                                      |1             |              |               |              |              |        |
|----------------------------------------------------------------------|--------------|--------------|---------------|--------------|--------------|--------|
|Diet hyl sulfa te                                                     |30% labeled   |655611        |Not detected   |0.2333        |0.2229        |95.53   |
|                                                                      |test product  |              |               |              |              |        |
|                                                                      |solution 2    |              |               |              |              |        |
|----------------------------------------------------------------------|--------------|--------------|---------------|--------------|--------------|--------|
|Diet hyl sulfa te                                                     |30% labeled   |622481        |Not            |0.2333        |0.2116        |90.70   |
|                                                                      |test          |              |               |              |              |        |
-------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 390 of 542 





Page 391
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 

































-----------------------------------------------------------------------------------------------------------------------------------------------------------------
|100% labeled test product solution 1                                  |231073         |Not            |0.7776         |0.7855         |101.01         |        |
|                                                                      |2              |detected       |               |               |               |        |
|----------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|--------|
|100% labeled test product solution 2                                  |234822         |Not            |0.7776         |0.7982         |102.65         |        |
|                                                                      |4              |detected       |               |               |               |        |
|----------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|--------|
|100% labeled test product solution 3                                  |238347         |Not            |0.7776         |0.8102         |104.19         |        |
|                                                                      |4              |detected       |               |               |               |        |
|----------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|--------|
|150% labeled test solution 1                                          |368677         |Not            |1.1665         |1.2532         |107.44         |        |
|                                                                      |8              |detected       |               |               |               |        |
|----------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|--------|
|150% labeled test product solution 2                                  |366895         |Not            |1.1665         |1.2472         |106.92         |        |
|                                                                      |9              |detected       |               |               |               |        |
|----------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|--------|
|150% labeled test product solution 3                                  |365707         |Not            |1.1665         |1.2432         |106.57         |        |
|                                                                      |7              |detected       |               |               |               |        |
|----------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|--------|
|Average recovery rate (%)                                             |100.96         |100.96         |100.96         |100.96         |100.96         |        |
|----------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|--------|
|RSD(%)                                                                |7              |7              |7              |7              |7              |        |
|----------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|--------|
|Verdict: Diethyl sulfate was not detected in the test products, and   |Verdict:       |Verdict:       |Verdict:       |Verdict:       |Verdict:       |        |
|the average recovery rate was 100.96% when 30% limit concentration    |Diethyl        |Diethyl        |Diethyl        |Diethyl        |Diethyl        |        |
|~150% limit concentration of diethyl sulfate wasadded to the test     |sulfate        |sulfate        |sulfate        |sulfate        |sulfate        |        |
|products, the recovery rate was 90.70%~107.44%, 80%~120%, and the RSD |was not        |was not        |was not        |was not        |was not        |        |
|of recovery was 7%. Less than 15%, indicating that the accuracy of    |detected       |detected       |detected       |detected       |detected       |        |
|this method in detecting diethyl sulfate in YA2304 meets the          |in the         |in the         |in the         |in the         |in the         |        |
|requirements.                                                         |test           |test           |test           |test           |test           |        |
|                                                                      |products,      |products,      |products,      |products,      |products,      |        |
|                                                                      |and the        |and the        |and the        |and the        |and the        |        |
|                                                                      |average        |average        |average        |average        |average        |        |
|                                                                      |recovery       |recovery       |recovery       |recovery       |recovery       |        |
|                                                                      |rate           |rate was       |rate           |rate           |rate           |        |
|                                                                      |was            |100.96%        |was            |was            |was            |        |
|                                                                      |100.96%        |when 30%       |100.96%        |100.96%        |100.96%        |        |
|                                                                      |when           |limit          |when           |when           |when           |        |
|                                                                      |30%            |concentration  |30%            |30%            |30%            |        |
|                                                                      |limit          |~150%          |limit          |limit          |limit          |        |
|                                                                      |concentration  |limit          |concentration  |concentration  |concentration  |        |
|                                                                      |~150%          |concentration  |~150%          |~150%          |~150%          |        |
|                                                                      |limit          |of             |limit          |limit          |limit          |        |
|                                                                      |concentration  |diethyl        |concentration  |concentration  |concentration  |        |
|                                                                      |of             |sulfate        |of             |of             |of             |        |
|                                                                      |diethyl        |wasadded       |diethyl        |diethyl        |diethyl        |        |
|                                                                      |sulfate        |to the         |sulfate        |sulfate        |sulfate        |        |
|                                                                      |wasadded       |test           |wasadded       |wasadded       |wasadded       |        |
|                                                                      |to the         |products,      |to the         |to the         |to the         |        |
|                                                                      |test           |the            |test           |test           |test           |        |
|                                                                      |products,      |recovery       |products,      |products,      |products,      |        |
|                                                                      |the            |rate was       |the            |the            |the            |        |
|                                                                      |recovery       |90.70%~107.44%,|recovery       |recovery       |recovery       |        |
|                                                                      |rate           |80%~120%,      |rate           |rate           |rate           |        |
|                                                                      |was            |and the        |was            |was            |was            |        |
|                                                                      |90.70%~107.44%,|RSD of         |90.70%~107.44%,|90.70%~107.44%,|90.70%~107.44%,|        |
|                                                                      |80%~120%,      |recovery       |80%~120%,      |80%~120%,      |80%~120%,      |        |
|                                                                      |and the        |was 7%.        |and the        |and the        |and the        |        |
|                                                                      |RSD of         |Less           |RSD of         |RSD of         |RSD of         |        |
|                                                                      |recovery       |than           |recovery       |recovery       |recovery       |        |
|                                                                      |was 7%.        |15%,           |was 7%.        |was 7%.        |was 7%.        |        |
|                                                                      |Less           |indicating     |Less           |Less           |Less           |        |
|                                                                      |than           |that the       |than           |than           |than           |        |
|                                                                      |15%,           |accuracy       |15%,           |15%,           |15%,           |        |
|                                                                      |indicating     |of this        |indicating     |indicating     |indicating     |        |
|                                                                      |that           |method         |that           |that           |that           |        |
|                                                                      |the            |in             |the            |the            |the            |        |
|                                                                      |accuracy       |detecting      |accuracy       |accuracy       |accuracy       |        |
|                                                                      |of this        |diethyl        |of this        |of this        |of this        |        |
|                                                                      |method         |sulfate        |method         |method         |method         |        |
|                                                                      |in             |in             |in             |in             |in             |        |
|                                                                      |detecting      |YA2304         |detecting      |detecting      |detecting      |        |
|                                                                      |diethyl        |meets          |diethyl        |diethyl        |diethyl        |        |
|                                                                      |sulfate        |the            |sulfate        |sulfate        |sulfate        |        |
|                                                                      |in             |requirements.  |in             |in             |in             |        |
|                                                                      |YA2304         |               |YA2304         |YA2304         |YA2304         |        |
|                                                                      |meets          |               |meets          |meets          |meets          |        |
|                                                                      |the            |               |the            |the            |the            |        |
|                                                                      |requirements.  |               |requirements.  |requirements.  |requirements.  |        |
|----------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|--------|
|Impuriti es Name                                                      |Solution name  |Peakarea       |Content        |Content        |Average content|Average |
|                                                                      |               |               |               |               |               |content |
|----------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|--------|
|Diisopro pyl sulfa te                                                 |Test product   |Not detected   |Not detected   |Not detected   |Not detected   |Not     |
|                                                                      |solution 1     |               |               |               |               |detected|
|----------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|--------|
|Diisopro pyl sulfa te                                                 |Test product   |Not detecte    |Not detected   |Not detected   |Not detected   |Not     |
|                                                                      |solution 2     |               |               |               |               |detected|
-----------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 391 of 542 





Page 392
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 


































-------------------------------------------------------------------------------------------------------------------------
|       |                                    |d       |                                     |                           |
|       |                                    |        |                                     |                           |
|       |                                    |        |                                     |                           |
|       |------------------------------------|--------|-------------------------------------|---------------------------|
|       |Solution name                       |Peakarea|Amountavailable (ng)|Amountadded (ng)|Measuredamount    |Recovery|
|       |                                    |        |                    |                |(ng)              |rate    |
|       |                                    |        |                    |                |                  |(%)     |
|       |------------------------------------|--------|--------------------|----------------|------------------|--------|
|       |30% standard test solution 1        |438674  |Not detected        |0.2210          |0.2129            |96.31   |
|       |------------------------------------|--------|--------------------|----------------|------------------|--------|
|       |30% labeled test product solution 2 |442129  |Not detected        |0.2210          |0.2145            |97.07   |
|       |------------------------------------|--------|--------------------|----------------|------------------|--------|
|       |30% labeled test product solution 3 |432713  |Not detected        |0.2210          |0.2100            |95.00   |
|       |------------------------------------|--------|--------------------|----------------|------------------|--------|
|       |100% labeled test product solution 1|156759 1|Not detected        |0.7367          |0.7607            |103.25  |
|       |------------------------------------|--------|--------------------|----------------|------------------|--------|
|       |100% labeled test product solution 2|157909 9|Not detected        |0.7367          |0.7662            |104.01  |
|       |------------------------------------|--------|--------------------|----------------|------------------|--------|
|       |100% labeled test product solution 3|160329 9|Not detected        |0.7367          |0.7780            |105.60  |
|       |------------------------------------|--------|--------------------|----------------|------------------|--------|
|       |150% labeled test product solution 1|249530 6|Not detected        |1.1051          |1.2108            |109.57  |
|       |------------------------------------|--------|--------------------|----------------|------------------|--------|
|       |150% labeled test product solution 2|244758 0|Not detected        |1.1051          |1.1877            |107.47  |
|       |------------------------------------|--------|--------------------|----------------|------------------|--------|
|       |150% labeled test product solution 3|247512 3|Not detected        |1.1051          |1.2010            |108.68  |
|       |------------------------------------|--------|--------------------|----------------|------------------|--------|
|       |Average recovery rate (%)           |103.00                                                                    |
|-------|------------------------------------|--------------------------------------------------------------------------|
|       |RSD(%)                              |6                                                                         |
-------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 392 of 542 





Page 393
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 

































----------------------------------------------------------------------------------------------------------------------------
|Impuriti es Name     |Solution name                       |Peakarea    |Content             |Content    |Average |Average |
|                     |                                    |            |                    |           |content |content |
|---------------------|------------------------------------|------------|--------------------|-----------|--------|--------|
|Di-sec-butyl sulfa te|Sample solution 1                   |Not detected|Not detected        |Not        |Not     |Not     |
|                     |                                    |            |                    |detected   |detected|detected|
|---------------------|------------------------------------|------------|--------------------|-----------|--------|--------|
|Di-sec-butyl sulfa te|Test product solution 2             |Not detected|Not detected        |Not        |Not     |Not     |
|                     |                                    |            |                    |detected   |detected|detected|
|---------------------|------------------------------------|------------|--------------------|-----------|--------|--------|
|Di-sec-butyl sulfa te|Solution name                       |Peakarea    |Amountavailable (ng)|Amountadded|Measure |Recovery|
|                     |                                    |            |                    |(ng)       |damount |rate (%)|
|                     |                                    |            |                    |           |(ng)    |        |
|---------------------|------------------------------------|------------|--------------------|-----------|--------|--------|
|Di-sec-butyl sulfa te|30% standard test solution 1        |159119      |Not detected        |0.2306     |0.2053  |89.03   |
|---------------------|------------------------------------|------------|--------------------|-----------|--------|--------|
|Di-sec-butyl sulfa te|30% labeled test product solution 2 |160074      |Not detected        |0.2306     |0.2065  |89.57   |
|---------------------|------------------------------------|------------|--------------------|-----------|--------|--------|
|Di-sec-butyl sulfa te|30% labeled test product solution 3 |164782      |Not detected        |0.2306     |0.2126  |92.20   |
|---------------------|------------------------------------|------------|--------------------|-----------|--------|--------|
|Di-sec-butyl sulfa te|100% labeled test product solution 1|583727      |Not detected        |0.7687     |0.7532  |97.98   |
|---------------------|------------------------------------|------------|--------------------|-----------|--------|--------|
|Di-sec-butyl sulfa te|100% labeled test product solution 2|602244      |Not detected        |0.7687     |0.7771  |101.09  |
|---------------------|------------------------------------|------------|--------------------|-----------|--------|--------|
|Di-sec-butyl sulfa te|100% labeled test product solution 3|603209      |Not detected        |0.7687     |0.7783  |101.25  |
|---------------------|------------------------------------|------------|--------------------|-----------|--------|--------|
|Di-sec-butyl sulfa te|150% labeled test product solution 1|947602      |Not detected        |1.1530     |1.2227  |106.04  |
----------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 393 of 542 





Page 394
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 













-------------------------------------------------------------------------------------------
|       |150% labeled test product solution 2|934005 |Not detected|1.1530 |1.2052 |104.52 |
|       |                                    |       |            |       |       |       |
|       |                                    |       |            |       |       |       |
|       |------------------------------------|-------|------------|-------|-------|-------|
|       |150% labeled test product solution 3|942394 |Not detected|1.1530 |1.2160 |105.46 |
|       |------------------------------------|-------|------------|-------|-------|-------|
|       |Average recovery rate (%)           |98.57                                       |
|       |------------------------------------|--------------------------------------------|
|       |RSD(%)                              |7                                           |
-------------------------------------------------------------------------------------------

**(4.7) Durability** 



 **Brief Description** 



Durability is achieved by changing the chromatographic conditions (starting 



temperature, inlet temperature, carrier gas flow rate) and testing the content 



of various impurities in the test solution with 100% limit concentration of 



impurities under normal chromatographic conditions. Under different 



conditions with the same chromatographic parameters, the signal-to-noise 



ratio of each impurity peak in the sensitivity solution should NLT 10, and the 



RSD of each impurity content in the durability test product NMT 20%. 



Changes in chromatographic conditions of durability test 










-------------------------------------------------------
|Starting temperature |50 ℃      |45 ° C, 55 ° C      |
|---------------------|----------|--------------------|
|Carrier gas flow rate|1.5 ml/min|1.4ml/min, 1.6ml/min|
|---------------------|----------|--------------------|
|Inlet temperature    |250 ℃     |245 ° C, 255 ° C    |
-------------------------------------------------------

 **Solution preparation** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 394 of 542 





Page 395
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Blank solution: Blank solution as prepared under 4.1. 



Sensitivity solution: Sensitivity solution prepared under item 4.1. 



Reference stock solution: the same as the reference stock solution prepared 



under item 4.1. 



Reference solution: the same reference solution prepared under item 4.1. 



Durability test product solution: Take about 10mg of this product, accurately 



weigh it, place it in a 5ml measuring bottle, add an appropriate amount of 



acetonitrile, swirl to dissolve, then add 100μl of control product reserve 



solution, dilute with acetonitrile to the scale, shake well, and get. Parallel 



preparation of 2 parts. 



 **Injection procedure** 



Under each durability chromatographic condition, after the blank solution, 



the sensitivity solution was injected with 1 needle, the control solution was 



injected with 2 needles continuously, and the 2 durability test solution was 



injected with 1 needle each, and the chromatographic diagram was recorded. 



 **Measurement resultss** 



























----------------------------------------------------------------------------------------------------------------------------------------
|Chromatographic Conditions|Parameter values|Sensitivity solution signal-to-noise ratio|Sensitivity    |Sensitivity    |Sensitivity    |
|                          |                |                                          |solution       |solution       |solution       |
|                          |                |                                          |signal-to-noise|signal-to-noise|signal-to-noise|
|                          |                |                                          |ratio          |ratio          |ratio          |
|--------------------------|----------------|------------------------------------------|---------------|---------------|---------------|
|Chromatographic Conditions|Parameter values|Dimethyl sulfate                          |Diethyl sulfate|Diisopropyl    |Di-sec-butyl   |
|                          |                |                                          |               |sulfate        |sulfate        |
|--------------------------|----------------|------------------------------------------|---------------|---------------|---------------|
|Initial temperature (° C) |45              |114.84                                    |95.45          |73.79          |88.31          |
|--------------------------|----------------|------------------------------------------|---------------|---------------|---------------|
|Initial temperature (° C) |50              |122.23                                    |111.70         |74.11          |79.46          |
|--------------------------|----------------|------------------------------------------|---------------|---------------|---------------|
|Initial temperature (° C) |55              |81.76                                     |115.68         |77.89          |79.38          |
|--------------------------|----------------|------------------------------------------|---------------|---------------|---------------|
|Inlet temperat            |245             |93.93                                     |112.23         |80.10          |93.18          |
|--------------------------|----------------|------------------------------------------|---------------|---------------|---------------|
|Inlet temperat            |250             |122.23                                    |111.70         |74.11          |79.46          |
----------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 395 of 542 





Page 396
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 










----------------------------------------------------------------------------------------------------------------------------------------------------------------
|Flow rate (ml/min)                                                            |1.4            |70.22          |125.68         |70.44          |69.16          |
|------------------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|
|Flow rate (ml/min)                                                            |1.5            |122.23         |111.70         |74.11          |79.46          |
|------------------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|
|Flow rate (ml/min)                                                            |1.6            |53.48          |92.02          |69.59          |67.67          |
|------------------------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|
|Conclusion: The SNR of dimethyl sulfate, diethyl sulfate, diisopropyl sulfate |Conclusion:    |Conclusion:    |Conclusion:    |Conclusion:    |Conclusion:    |
|and disec-butyl sulfate in the sensitivity solution were all greater than 10  |The SNR        |The SNR        |The SNR        |The SNR        |The SNR        |
|under the conditions of normal chromatographic parameters, changing the       |of             |of             |of             |of             |of             |
|initial temperature, carrier gas flow rate, inlet temperature and column. The |dimethyl       |dimethyl       |dimethyl       |dimethyl       |dimethyl       |
|suitability of the system met the requirements.                               |sulfate,       |sulfate,       |sulfate,       |sulfate,       |sulfate,       |
|                                                                              |diethyl        |diethyl        |diethyl        |diethyl        |diethyl        |
|                                                                              |sulfate,       |sulfate,       |sulfate,       |sulfate,       |sulfate,       |
|                                                                              |diisopropyl    |diisopropyl    |diisopropyl    |diisopropyl    |diisopropyl    |
|                                                                              |sulfate        |sulfate        |sulfate        |sulfate        |sulfate        |
|                                                                              |and            |and            |and            |and            |and            |
|                                                                              |disec-butyl    |disec-butyl    |disec-butyl    |disec-butyl    |disec-butyl    |
|                                                                              |sulfate        |sulfate        |sulfate        |sulfate        |sulfate        |
|                                                                              |in the         |in the         |in the         |in the         |in the         |
|                                                                              |sensitivity    |sensitivity    |sensitivity    |sensitivity    |sensitivity    |
|                                                                              |solution       |solution       |solution       |solution       |solution       |
|                                                                              |were           |were           |were           |were           |were           |
|                                                                              |all            |all            |all            |all            |all            |
|                                                                              |greater        |greater        |greater        |greater        |greater        |
|                                                                              |than 10        |than 10        |than 10        |than 10        |than 10        |
|                                                                              |under          |under          |under          |under          |under          |
|                                                                              |the            |the            |the            |the            |the            |
|                                                                              |conditions     |conditions     |conditions     |conditions     |conditions     |
|                                                                              |of             |of             |of             |of             |of             |
|                                                                              |normal         |normal         |normal         |normal         |normal         |
|                                                                              |chromatographic|chromatographic|chromatographic|chromatographic|chromatographic|
|                                                                              |parameters,    |parameters,    |parameters,    |parameters,    |parameters,    |
|                                                                              |changing       |changing       |changing       |changing       |changing       |
|                                                                              |the            |the            |the            |the            |the            |
|                                                                              |initial        |initial        |initial        |initial        |initial        |
|                                                                              |temperature,   |temperature,   |temperature,   |temperature,   |temperature,   |
|                                                                              |carrier        |carrier        |carrier        |carrier        |carrier        |
|                                                                              |gas            |gas            |gas            |gas            |gas            |
|                                                                              |flow           |flow           |flow           |flow           |flow           |
|                                                                              |rate,          |rate,          |rate,          |rate,          |rate,          |
|                                                                              |inlet          |inlet          |inlet          |inlet          |inlet          |
|                                                                              |temperature    |temperature    |temperature    |temperature    |temperature    |
|                                                                              |and            |and            |and            |and            |and            |
|                                                                              |column.        |column.        |column.        |column.        |column.        |
|                                                                              |The            |The            |The            |The            |The            |
|                                                                              |suitability    |suitability    |suitability    |suitability    |suitability    |
|                                                                              |of the         |of the         |of the         |of the         |of the         |
|                                                                              |system         |system         |system         |system         |system         |
|                                                                              |met the        |met the        |met the        |met the        |met the        |
|                                                                              |requirements.  |requirements.  |requirements.  |requirements.  |requirements.  |
----------------------------------------------------------------------------------------------------------------------------------------------------------------

Durability - Sample test results 

































-----------------------------------------------------------------------------------------------------------------------------
|Chromatographic Conditio ns|Para meter valu es|Sam ple num ber|Dimethyl sulfate|Diethyl sulfate|Diisopropyl   |Di-sec-butyl|
|                           |                  |               |                |               |sulfate       |sulfate     |
|---------------------------|------------------|---------------|----------------|---------------|--------------|------------|
|Initial temperature (° C)  |45                |1              |65.1            |65.7           |63.8          |65.3        |
|---------------------------|------------------|---------------|----------------|---------------|--------------|------------|
|Initial temperature (° C)  |45                |2              |70.9            |68.8           |64.5          |66.0        |
|---------------------------|------------------|---------------|----------------|---------------|--------------|------------|
|Initial temperature (° C)  |50                |1              |63.6            |70.3           |65.2          |66.9        |
|---------------------------|------------------|---------------|----------------|---------------|--------------|------------|
|Initial temperature (° C)  |50                |2              |68.1            |71.9           |66.6          |67.1        |
|---------------------------|------------------|---------------|----------------|---------------|--------------|------------|
|Initial temperature (° C)  |55                |1              |65.5            |69.6           |64.5          |64.3        |
|---------------------------|------------------|---------------|----------------|---------------|--------------|------------|
|Initial temperature (° C)  |55                |2              |69.3            |69.7           |63.9          |62.8        |
|---------------------------|------------------|---------------|----------------|---------------|--------------|------------|
|Initial temperature (° C)  |RSD/%             |RSD/%          |5               |3.0            |1.7           |2.6         |
|---------------------------|------------------|---------------|----------------|---------------|--------------|------------|
|Inlet temperature (° C)    |245               |1              |66.6            |70.6           |66.5          |67.9        |
|---------------------------|------------------|---------------|----------------|---------------|--------------|------------|
|Inlet temperature (° C)    |245               |2              |72.0            |71.7           |66.8          |67.6        |
|---------------------------|------------------|---------------|----------------|---------------|--------------|------------|
|Inlet temperature (° C)    |250               |1              |63.6            |70.3           |65.2          |66.9        |
|---------------------------|------------------|---------------|----------------|---------------|--------------|------------|
|Inlet temperature (° C)    |250               |2              |68.1            |71.9           |66.6          |67.1        |
|---------------------------|------------------|---------------|----------------|---------------|--------------|------------|
|Inlet temperature (° C)    |255               |1              |66.7            |68.9           |63.6          |64.0        |
|---------------------------|------------------|---------------|----------------|---------------|--------------|------------|
|Inlet temperature (° C)    |255               |2              |73.1            |70.3           |64.6          |64.3        |
|---------------------------|------------------|---------------|----------------|---------------|--------------|------------|
|Inlet temperature (° C)    |RSD/%             |RSD/%          |6               |1.6            |2.0           |2.6         |
|---------------------------|------------------|---------------|----------------|---------------|--------------|------------|
|Flow rate (ml/min)         |1.4               |1              |67.5            |68.7           |63.2          |64.3        |
|---------------------------|------------------|---------------|----------------|---------------|--------------|------------|
|Flow rate (ml/min)         |1.4               |2              |73.8            |70.0           |64.2          |64.5        |
|---------------------------|------------------|---------------|----------------|---------------|--------------|------------|
|Flow rate (ml/min)         |1.5               |1              |63.6            |70.3           |65.2          |66.9        |
|---------------------------|------------------|---------------|----------------|---------------|--------------|------------|
|Flow rate (ml/min)         |1.5               |2              |68.1            |71.9           |66.6          |67.1        |
|---------------------------|------------------|---------------|----------------|---------------|--------------|------------|
|Flow rate (ml/min)         |1.6               |1              |67.9            |67.9           |63.9          |64.4        |
-----------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 396 of 542 





Page 397
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 

------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|RSD/%                                                                 |RSD/%              |6                  |2.0                |1.9                |2.2                |                   |
|----------------------------------------------------------------------|-------------------|-------------------|-------------------|-------------------|-------------------|-------------------|
|Conclusion: The RSDS of dimethyl sulfate, diethyl sulfate, diisopropyl|Conclusion:        |Conclusion:        |Conclusion:        |Conclusion:        |Conclusion:        |Conclusion:        |
|sulfate and disec-butyl sulfate were 5%, 3.0%, 1.7% and 2.6%,         |The                |The                |The                |The                |The                |The                |
|respectively, when the initial column temperature of the two          |RSDS of            |RSDS of            |RSDS of            |RSDS of            |RSDS of            |RSDS of            |
|durability test solutions was 45℃, 50℃and 55℃, all of which were less |dimethyl           |dimethyl           |dimethyl           |dimethyl           |dimethyl           |dimethyl           |
|than 20%. RSDS of dimethyl sulfate, diethyl sulfate, diisopropyl      |sulfate,           |sulfate,           |sulfate,           |sulfate,           |sulfate,           |sulfate,           |
|sulfate and di-sec-butylsulfate were 6%, 2.0%, 1.9% and 2.2%,         |diethyl            |diethyl            |diethyl            |diethyl            |diethyl            |diethyl            |
|respectively, at the flow rates of 1.4ml/min, 1.5ml/min and 1.6ml/min |sulfate,           |sulfate,           |sulfate,           |sulfate,           |sulfate,           |sulfate,           |
|for durability test solutions, all of which were less than 20%. The   |diisopropyl        |diisopropyl        |diisopropyl        |diisopropyl        |diisopropyl        |diisopropyl        |
|RSDS of dimethyl sulfate, diethyl sulfate, diisopropyl sulfate and    |sulfate            |sulfate            |sulfate            |sulfate            |sulfate            |sulfate            |
|di-sec-butylsulfate were 6%, 1.6%, 2.0% and 2.6%, respectively, when  |and                |and                |and                |and                |and                |and                |
|the temperature of the 2 durability test solutions was 245℃, 250℃and  |disec-butyl        |disec-butyl        |disec-butyl        |disec-butyl        |disec-butyl        |disec-butyl        |
|255℃, respectively, and were all less than 20%. The durability of the |sulfate            |sulfate            |sulfate            |sulfate            |sulfate            |sulfate            |
|method met the requirements.                                          |were               |were               |were               |were               |were               |were               |
|                                                                      |5%,                |5%,                |5%,                |5%,                |5%,                |5%,                |
|                                                                      |3.0%,              |3.0%,              |3.0%,              |3.0%,              |3.0%,              |3.0%,              |
|                                                                      |1.7%               |1.7%               |1.7%               |1.7%               |1.7%               |1.7%               |
|                                                                      |and                |and                |and                |and                |and                |and                |
|                                                                      |2.6%,              |2.6%,              |2.6%,              |2.6%,              |2.6%,              |2.6%,              |
|                                                                      |respectively,      |respectively,      |respectively,      |respectively,      |respectively,      |respectively,      |
|                                                                      |when               |when               |when               |when               |when               |when               |
|                                                                      |the                |the                |the                |the                |the                |the                |
|                                                                      |initial            |initial            |initial            |initial            |initial            |initial            |
|                                                                      |column             |column             |column             |column             |column             |column             |
|                                                                      |temperature        |temperature        |temperature        |temperature        |temperature        |temperature        |
|                                                                      |of the             |of the             |of the             |of the             |of the             |of the             |
|                                                                      |two                |two                |two                |two                |two                |two                |
|                                                                      |durability         |durability         |durability         |durability         |durability         |durability         |
|                                                                      |test               |test               |test               |test               |test               |test               |
|                                                                      |solutions          |solutions          |solutions          |solutions          |solutions          |solutions          |
|                                                                      |was                |was                |was                |was                |was                |was                |
|                                                                      |45℃,               |45℃,               |45℃,               |45℃,               |45℃,               |45℃,               |
|                                                                      |50℃and             |50℃and             |50℃and             |50℃and             |50℃and             |50℃and             |
|                                                                      |55℃,               |55℃,               |55℃,               |55℃,               |55℃,               |55℃,               |
|                                                                      |all of             |all of             |all of             |all of             |all of             |all of             |
|                                                                      |which              |which              |which              |which              |which              |which              |
|                                                                      |were               |were               |were               |were               |were               |were               |
|                                                                      |less               |less               |less               |less               |less               |less               |
|                                                                      |than               |than               |than               |than               |than               |than               |
|                                                                      |20%.               |20%.               |20%.               |20%.               |20%.               |20%.               |
|                                                                      |RSDS of            |RSDS of            |RSDS of            |RSDS of            |RSDS of            |RSDS of            |
|                                                                      |dimethyl           |dimethyl           |dimethyl           |dimethyl           |dimethyl           |dimethyl           |
|                                                                      |sulfate,           |sulfate,           |sulfate,           |sulfate,           |sulfate,           |sulfate,           |
|                                                                      |diethyl            |diethyl            |diethyl            |diethyl            |diethyl            |diethyl            |
|                                                                      |sulfate,           |sulfate,           |sulfate,           |sulfate,           |sulfate,           |sulfate,           |
|                                                                      |diisopropyl        |diisopropyl        |diisopropyl        |diisopropyl        |diisopropyl        |diisopropyl        |
|                                                                      |sulfate            |sulfate            |sulfate            |sulfate            |sulfate            |sulfate            |
|                                                                      |and                |and                |and                |and                |and                |and                |
|                                                                      |di-sec-butylsulfate|di-sec-butylsulfate|di-sec-butylsulfate|di-sec-butylsulfate|di-sec-butylsulfate|di-sec-butylsulfate|
|                                                                      |were               |were               |were               |were               |were               |were               |
|                                                                      |6%,                |6%,                |6%,                |6%,                |6%,                |6%,                |
|                                                                      |2.0%,              |2.0%,              |2.0%,              |2.0%,              |2.0%,              |2.0%,              |
|                                                                      |1.9%               |1.9%               |1.9%               |1.9%               |1.9%               |1.9%               |
|                                                                      |and                |and                |and                |and                |and                |and                |
|                                                                      |2.2%,              |2.2%,              |2.2%,              |2.2%,              |2.2%,              |2.2%,              |
|                                                                      |respectively,      |respectively,      |respectively,      |respectively,      |respectively,      |respectively,      |
|                                                                      |at the             |at the             |at the             |at the             |at the             |at the             |
|                                                                      |flow               |flow               |flow               |flow               |flow               |flow               |
|                                                                      |rates              |rates              |rates              |rates              |rates              |rates              |
|                                                                      |of                 |of                 |of                 |of                 |of                 |of                 |
|                                                                      |1.4ml/min,         |1.4ml/min,         |1.4ml/min,         |1.4ml/min,         |1.4ml/min,         |1.4ml/min,         |
|                                                                      |1.5ml/min          |1.5ml/min          |1.5ml/min          |1.5ml/min          |1.5ml/min          |1.5ml/min          |
|                                                                      |and                |and                |and                |and                |and                |and                |
|                                                                      |1.6ml/min          |1.6ml/min          |1.6ml/min          |1.6ml/min          |1.6ml/min          |1.6ml/min          |
|                                                                      |for                |for                |for                |for                |for                |for                |
|                                                                      |durability         |durability         |durability         |durability         |durability         |durability         |
|                                                                      |test               |test               |test               |test               |test               |test               |
|                                                                      |solutions,         |solutions,         |solutions,         |solutions,         |solutions,         |solutions,         |
|                                                                      |all of             |all of             |all of             |all of             |all of             |all of             |
|                                                                      |which              |which              |which              |which              |which              |which              |
|                                                                      |were               |were               |were               |were               |were               |were               |
|                                                                      |less               |less               |less               |less               |less               |less               |
|                                                                      |than               |than               |than               |than               |than               |than               |
|                                                                      |20%.               |20%.               |20%.               |20%.               |20%.               |20%.               |
|                                                                      |The                |The                |The                |The                |The                |The                |
|                                                                      |RSDS of            |RSDS of            |RSDS of            |RSDS of            |RSDS of            |RSDS of            |
|                                                                      |dimethyl           |dimethyl           |dimethyl           |dimethyl           |dimethyl           |dimethyl           |
|                                                                      |sulfate,           |sulfate,           |sulfate,           |sulfate,           |sulfate,           |sulfate,           |
|                                                                      |diethyl            |diethyl            |diethyl            |diethyl            |diethyl            |diethyl            |
|                                                                      |sulfate,           |sulfate,           |sulfate,           |sulfate,           |sulfate,           |sulfate,           |
|                                                                      |diisopropyl        |diisopropyl        |diisopropyl        |diisopropyl        |diisopropyl        |diisopropyl        |
|                                                                      |sulfate            |sulfate            |sulfate            |sulfate            |sulfate            |sulfate            |
|                                                                      |and                |and                |and                |and                |and                |and                |
|                                                                      |di-sec-butylsulfate|di-sec-butylsulfate|di-sec-butylsulfate|di-sec-butylsulfate|di-sec-butylsulfate|di-sec-butylsulfate|
|                                                                      |were               |were               |were               |were               |were               |were               |
|                                                                      |6%,                |6%,                |6%,                |6%,                |6%,                |6%,                |
|                                                                      |1.6%,              |1.6%,              |1.6%,              |1.6%,              |1.6%,              |1.6%,              |
|                                                                      |2.0%               |2.0%               |2.0%               |2.0%               |2.0%               |2.0%               |
|                                                                      |and                |and                |and                |and                |and                |and                |
|                                                                      |2.6%,              |2.6%,              |2.6%,              |2.6%,              |2.6%,              |2.6%,              |
|                                                                      |respectively,      |respectively,      |respectively,      |respectively,      |respectively,      |respectively,      |
|                                                                      |when               |when               |when               |when               |when               |when               |
|                                                                      |the                |the                |the                |the                |the                |the                |
|                                                                      |temperature        |temperature        |temperature        |temperature        |temperature        |temperature        |
|                                                                      |of the             |of the             |of the             |of the             |of the             |of the             |
|                                                                      |2                  |2                  |2                  |2                  |2                  |2                  |
|                                                                      |durability         |durability         |durability         |durability         |durability         |durability         |
|                                                                      |test               |test               |test               |test               |test               |test               |
|                                                                      |solutions          |solutions          |solutions          |solutions          |solutions          |solutions          |
|                                                                      |was                |was                |was                |was                |was                |was                |
|                                                                      |245℃,              |245℃,              |245℃,              |245℃,              |245℃,              |245℃,              |
|                                                                      |250℃and            |250℃and            |250℃and            |250℃and            |250℃and            |250℃and            |
|                                                                      |255℃,              |255℃,              |255℃,              |255℃,              |255℃,              |255℃,              |
|                                                                      |respectively,      |respectively,      |respectively,      |respectively,      |respectively,      |respectively,      |
|                                                                      |and                |and                |and                |and                |and                |and                |
|                                                                      |were               |were               |were               |were               |were               |were               |
|                                                                      |all                |all                |all                |all                |all                |all                |
|                                                                      |less               |less               |less               |less               |less               |less               |
|                                                                      |than               |than               |than               |than               |than               |than               |
|                                                                      |20%.               |20%.               |20%.               |20%.               |20%.               |20%.               |
|                                                                      |The                |The                |The                |The                |The                |The                |
|                                                                      |durability         |durability         |durability         |durability         |durability         |durability         |
|                                                                      |of the             |of the             |of the             |of the             |of the             |of the             |
|                                                                      |method             |method             |method             |method             |method             |method             |
|                                                                      |met the            |met the            |met the            |met the            |met the            |met the            |
|                                                                      |requirements.      |requirements.      |requirements.      |requirements.      |requirements.      |requirements.      |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



**(4.8) Solution stability** 



 **Brief Description** 



Each solution is placed at room temperature, and the sensitivity solution, the 



reference solution and the 100% labeled test product solution are injected at 



different times. The RSD of the peak area response value of each impurity in 



the sensitivity solution, the reference solution and the 100% labeled test 



product solution NMT 10%. 



 **Solution preparation** 



Blank solution: Blank solution as prepared under 4.1. 



Reference stock solution: the same as the reference stock solution prepared 



under item 4.1. 



Sensitivity solution: Sensitivity solution as prepared under item 4.1. 



Reference solution: the same as the reference solution prepared under item 



4.1. 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 397 of 542 





Page 398
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



100% standard test product solution: take about 10mg of this product, 



accurately weigh it, place it in a 5ml measuring bottle, add acetonitrile 



appropriate amount 4 vortex to dissolve, accurately add the reference 



product reserve solution 100μl, dilute it with acetonitrile to the scale, shake 



well, and get. 



 **Injection Sequence** 



Each solution was placed at room temperature, the sensitivity solution, the 



control solution and the 100% standard test solution were injected with 1 



needle at 0h, 1.5h, 3.0h, 4.6h, 6.1h, 7.7h, 9.2h, 10.7h, 12.3h, 13.8h and 



15.3h respectively, and the chromatogram was recorded. 



 **Measurement result** 



Stability test results of sensitivity solution 



















-----------------------------------------------------------------------------------------------------------------------------------------
|Time point (h)                                                                        |Dimethyl   |Diethyl    |Diisopropyl|Di-sec-butyl|
|                                                                                      |sulfate    |sulfate    |sulfate    |sulfate     |
|--------------------------------------------------------------------------------------|-----------|-----------|-----------|------------|
|0                                                                                     |190403     |188948     |119008     |44718       |
|--------------------------------------------------------------------------------------|-----------|-----------|-----------|------------|
|1.5                                                                                   |188412     |187452     |120001     |45940       |
|--------------------------------------------------------------------------------------|-----------|-----------|-----------|------------|
|3.0                                                                                   |184496     |189022     |119921     |46351       |
|--------------------------------------------------------------------------------------|-----------|-----------|-----------|------------|
|4.6                                                                                   |176755     |186169     |117991     |45666       |
|--------------------------------------------------------------------------------------|-----------|-----------|-----------|------------|
|6.1                                                                                   |171826     |183690     |117573     |44664       |
|--------------------------------------------------------------------------------------|-----------|-----------|-----------|------------|
|7.7                                                                                   |168783     |186301     |117518     |44549       |
|--------------------------------------------------------------------------------------|-----------|-----------|-----------|------------|
|9.2                                                                                   |162656     |180525     |112729     |43637       |
|--------------------------------------------------------------------------------------|-----------|-----------|-----------|------------|
|10.7                                                                                  |159591     |175216     |111716     |43572       |
|--------------------------------------------------------------------------------------|-----------|-----------|-----------|------------|
|12.3                                                                                  |155049     |171937     |107037     |42250       |
|--------------------------------------------------------------------------------------|-----------|-----------|-----------|------------|
|13.8                                                                                  |151390     |169294     |105405     |40626       |
|--------------------------------------------------------------------------------------|-----------|-----------|-----------|------------|
|15.3                                                                                  |148599     |166753     |101765     |39844       |
|--------------------------------------------------------------------------------------|-----------|-----------|-----------|------------|
|RSD/%                                                                                 |9          |5          |6          |5           |
|--------------------------------------------------------------------------------------|-----------|-----------|-----------|------------|
|Conclusion: The RSD of the peakarea response of dimethyl sulfate in the sensitive     |Conclusion:|Conclusion:|Conclusion:|Conclusion: |
|solutionis 9%, not more than 10%; The RSD of the peakarea response of diethyl sulfate |The RSD    |The RSD    |The RSD of |The RSD of  |
|was 5%, less than 10%; The RSD of the peakarea response of diisopropyl sulfate was 6%,|of the     |of the     |the        |the peakarea|
|less than 10%; The RSD of the peakarea response of disec-butyl                        |peakarea   |peakarea   |peakarea   |response of |
|                                                                                      |response   |response   |response of|dimethyl    |
|                                                                                      |of         |of         |dimethyl   |sulfate in  |
|                                                                                      |dimethyl   |dimethyl   |sulfate in |the         |
|                                                                                      |sulfate    |sulfate    |the        |sensitive   |
|                                                                                      |in the     |in the     |sensitive  |solutionis  |
|                                                                                      |sensitive  |sensitive  |solutionis |9%, not more|
|                                                                                      |solutionis |solutionis |9%, not    |than 10%;   |
|                                                                                      |9%, not    |9%, not    |more than  |The RSD of  |
|                                                                                      |more       |more       |10%; The   |the peakarea|
|                                                                                      |than       |than       |RSD of the |response of |
|                                                                                      |10%; The   |10%;       |peakarea   |diethyl     |
|                                                                                      |RSD of     |The RSD    |response of|sulfate was |
|                                                                                      |the        |of the     |diethyl    |5%, less    |
|                                                                                      |peakarea   |peakarea   |sulfate was|than 10%;   |
|                                                                                      |response   |response   |5%, less   |The RSD of  |
|                                                                                      |of         |of         |than 10%;  |the peakarea|
|                                                                                      |diethyl    |diethyl    |The RSD of |response of |
|                                                                                      |sulfate    |sulfate    |the        |diisopropyl |
|                                                                                      |was 5%,    |was 5%,    |peakarea   |sulfate was |
|                                                                                      |less       |less       |response of|6%, less    |
|                                                                                      |than       |than       |diisopropyl|than 10%;   |
|                                                                                      |10%; The   |10%;       |sulfate was|The RSD of  |
|                                                                                      |RSD of     |The RSD    |6%, less   |the peakarea|
|                                                                                      |the        |of the     |than 10%;  |response of |
|                                                                                      |peakarea   |peakarea   |The RSD of |disec-butyl |
|                                                                                      |response   |response   |the        |            |
|                                                                                      |of         |of         |peakarea   |            |
|                                                                                      |diisopropyl|diisopropyl|response of|            |
|                                                                                      |sulfate    |sulfate    |disec-butyl|            |
|                                                                                      |was 6%,    |was 6%,    |           |            |
|                                                                                      |less       |less       |           |            |
|                                                                                      |than       |than       |           |            |
|                                                                                      |10%; The   |10%;       |           |            |
|                                                                                      |RSD of     |The RSD    |           |            |
|                                                                                      |the        |of the     |           |            |
|                                                                                      |peakarea   |peakarea   |           |            |
|                                                                                      |response   |response   |           |            |
|                                                                                      |of         |of         |           |            |
|                                                                                      |disec-butyl|disec-butyl|           |            |
-----------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 398 of 542 





Page 399
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



sulfate is 5%, not more than 10%, indicating that the stability of the impurities in the 



sensitive solution meets the requirements, that is, stable within 15.3 h. 



Stability test results of reference solution 



















------------------------------------------------------------------------------------------------------------------------------------------------
|Time point (h)                                                                        |Dimethyl     |Diethyl      |Diisopropyl  |Di-sec-butyl |
|                                                                                      |sulfate      |sulfate      |sulfate      |sulfate      |
|--------------------------------------------------------------------------------------|-------------|-------------|-------------|-------------|
|0                                                                                     |2072209      |2282778      |1414237      |546582       |
|--------------------------------------------------------------------------------------|-------------|-------------|-------------|-------------|
|1.5                                                                                   |2010329      |2212930      |1351951      |514373       |
|--------------------------------------------------------------------------------------|-------------|-------------|-------------|-------------|
|3.0                                                                                   |1952305      |2180200      |1337131      |514936       |
|--------------------------------------------------------------------------------------|-------------|-------------|-------------|-------------|
|4.6                                                                                   |1859120      |2130727      |1304841      |498932       |
|--------------------------------------------------------------------------------------|-------------|-------------|-------------|-------------|
|6.1                                                                                   |1817613      |2118867      |1290160      |497691       |
|--------------------------------------------------------------------------------------|-------------|-------------|-------------|-------------|
|7.7                                                                                   |1746971      |2088184      |1262308      |481474       |
|--------------------------------------------------------------------------------------|-------------|-------------|-------------|-------------|
|9.2                                                                                   |1746533      |2027443      |1225627      |471398       |
|--------------------------------------------------------------------------------------|-------------|-------------|-------------|-------------|
|10.7                                                                                  |1698288      |1992264      |1199260      |456705       |
|--------------------------------------------------------------------------------------|-------------|-------------|-------------|-------------|
|12.3                                                                                  |1628748      |1944962      |1172415      |454139       |
|--------------------------------------------------------------------------------------|-------------|-------------|-------------|-------------|
|13.8                                                                                  |1596695      |1922525      |1148778      |438631       |
|--------------------------------------------------------------------------------------|-------------|-------------|-------------|-------------|
|15.3                                                                                  |1545509      |1886615      |1133133      |431864       |
|--------------------------------------------------------------------------------------|-------------|-------------|-------------|-------------|
|RSD/%                                                                                 |10           |7            |8            |8            |
|--------------------------------------------------------------------------------------|-------------|-------------|-------------|-------------|
|Conclusion: The RSD of the peakarea response of dimethyl sulfate in the control       |Conclusion:  |Conclusion:  |Conclusion:  |Conclusion:  |
|solutionis 10%, not more than 10%; The RSD of the peakarea response of diethyl sulfate|The RSD      |The RSD      |The RSD of   |The RSD of   |
|was 7%, less than 10%; The RSD of the peakarea response of diisopropyl sulfate was 8%,|of the       |of the       |the          |the peakarea |
|less than 10%; The RSD of the peakarea response of disec-butyl sulfate was 8%, not    |peakarea     |peakarea     |peakarea     |response of  |
|more than 10%, indicating that the stability of the impurities in the control solution|response     |response     |response of  |dimethyl     |
|met the requirements, thatis, stable within 15.3 h.                                   |of           |of           |dimethyl     |sulfate in   |
|                                                                                      |dimethyl     |dimethyl     |sulfate in   |the control  |
|                                                                                      |sulfate      |sulfate      |the control  |solutionis   |
|                                                                                      |in the       |in the       |solutionis   |10%, not     |
|                                                                                      |control      |control      |10%, not     |more than    |
|                                                                                      |solutionis   |solutionis   |more than    |10%; The RSD |
|                                                                                      |10%, not     |10%,         |10%; The     |of the       |
|                                                                                      |more         |not          |RSD of the   |peakarea     |
|                                                                                      |than         |more         |peakarea     |response of  |
|                                                                                      |10%; The     |than         |response of  |diethyl      |
|                                                                                      |RSD of       |10%;         |diethyl      |sulfate was  |
|                                                                                      |the          |The RSD      |sulfate was  |7%, less     |
|                                                                                      |peakarea     |of the       |7%, less     |than 10%;    |
|                                                                                      |response     |peakarea     |than 10%;    |The RSD of   |
|                                                                                      |of           |response     |The RSD of   |the peakarea |
|                                                                                      |diethyl      |of           |the          |response of  |
|                                                                                      |sulfate      |diethyl      |peakarea     |diisopropyl  |
|                                                                                      |was 7%,      |sulfate      |response of  |sulfate was  |
|                                                                                      |less         |was 7%,      |diisopropyl  |8%, less     |
|                                                                                      |than         |less         |sulfate was  |than 10%;    |
|                                                                                      |10%; The     |than         |8%, less     |The RSD of   |
|                                                                                      |RSD of       |10%;         |than 10%;    |the peakarea |
|                                                                                      |the          |The RSD      |The RSD of   |response of  |
|                                                                                      |peakarea     |of the       |the          |disec-butyl  |
|                                                                                      |response     |peakarea     |peakarea     |sulfate was  |
|                                                                                      |of           |response     |response of  |8%, not more |
|                                                                                      |diisopropyl  |of           |disec-butyl  |than 10%,    |
|                                                                                      |sulfate      |diisopropyl  |sulfate was  |indicating   |
|                                                                                      |was 8%,      |sulfate      |8%, not      |that the     |
|                                                                                      |less         |was 8%,      |more than    |stability of |
|                                                                                      |than         |less         |10%,         |the          |
|                                                                                      |10%; The     |than         |indicating   |impurities   |
|                                                                                      |RSD of       |10%;         |that the     |in the       |
|                                                                                      |the          |The RSD      |stability    |control      |
|                                                                                      |peakarea     |of the       |of the       |solution met |
|                                                                                      |response     |peakarea     |impurities   |the          |
|                                                                                      |of           |response     |in the       |requirements,|
|                                                                                      |disec-butyl  |of           |control      |thatis,      |
|                                                                                      |sulfate      |disec-butyl  |solution     |stable       |
|                                                                                      |was 8%,      |sulfate      |met the      |within 15.3  |
|                                                                                      |not more     |was 8%,      |requirements,|h.           |
|                                                                                      |than         |not          |thatis,      |             |
|                                                                                      |10%,         |more         |stable       |             |
|                                                                                      |indicating   |than         |within 15.3  |             |
|                                                                                      |that the     |10%,         |h.           |             |
|                                                                                      |stability    |indicating   |             |             |
|                                                                                      |of the       |that         |             |             |
|                                                                                      |impurities   |the          |             |             |
|                                                                                      |in the       |stability    |             |             |
|                                                                                      |control      |of the       |             |             |
|                                                                                      |solution     |impurities   |             |             |
|                                                                                      |met the      |in the       |             |             |
|                                                                                      |requirements,|control      |             |             |
|                                                                                      |thatis,      |solution     |             |             |
|                                                                                      |stable       |met the      |             |             |
|                                                                                      |within       |requirements,|             |             |
|                                                                                      |15.3 h.      |thatis,      |             |             |
|                                                                                      |             |stable       |             |             |
|                                                                                      |             |within       |             |             |
|                                                                                      |             |15.3 h.      |             |             |
------------------------------------------------------------------------------------------------------------------------------------------------

Stability test results of 100% labeled test product solution 



















------------------------------------------------------------------------------------------
|Time point (h)|Dimethyl sulfate|Diethyl sulfate|Diisopropyl sulfate|Di-sec-butyl sulfate|
|--------------|----------------|---------------|-------------------|--------------------|
|0             |2086277         |2331842        |1461126            |571654              |
|--------------|----------------|---------------|-------------------|--------------------|
|1.5           |2012763         |2227395        |1374888            |525995              |
|--------------|----------------|---------------|-------------------|--------------------|
|3.0           |1942224         |2187200        |1347851            |519604              |
|--------------|----------------|---------------|-------------------|--------------------|
|4.6           |1871331         |2157936        |1331608            |516497              |
|--------------|----------------|---------------|-------------------|--------------------|
|6.1           |1835089         |2160943        |1321617            |512831              |
|--------------|----------------|---------------|-------------------|--------------------|
|7.7           |1745523         |2107728        |1280936            |494456              |
|--------------|----------------|---------------|-------------------|--------------------|
|9.2           |1765301         |2068140        |1260113            |487783              |
|--------------|----------------|---------------|-------------------|--------------------|
|10.7          |1696135         |2023748        |1223767            |473809              |
|--------------|----------------|---------------|-------------------|--------------------|
|12.3          |1646900         |1993164        |1201867            |462912              |
------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 399 of 542 





Page 400
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 

--------------------------------------------------------------------------------------------------------------------------------------------------------------------
|15.3                                                                                  |1546866           |1931126           |1163169           |448232            |
|--------------------------------------------------------------------------------------|------------------|------------------|------------------|------------------|
|RSD/%                                                                                 |10                |6                 |8                 |8                 |
|--------------------------------------------------------------------------------------|------------------|------------------|------------------|------------------|
|Conclusion: The RSD of peakarea response of dimethyl sulfate in 100% standard test    |Conclusion:       |Conclusion:       |Conclusion:       |Conclusion:       |
|solutionis 10%, not more than 10%; The RSD of the peakarea response of diethyl sulfate|The RSD           |The RSD           |The RSD           |The RSD           |
|was 6%, less than 10%; The RSD of the peakarea response of diisopropyl sulfate was 8%,|of                |of                |of                |of                |
|less than 10%; The RSD of the peakarea response of disec-butylsulfate was 8%, not more|peakarea          |peakarea          |peakarea          |peakarea          |
|than 10%, indicating that the stability ofimpurities in 100% standard test solution   |response          |response          |response          |response          |
|met the requirements, thatis, stable within 15.3 h.                                   |of                |of                |of                |of                |
|                                                                                      |dimethyl          |dimethyl          |dimethyl          |dimethyl          |
|                                                                                      |sulfate           |sulfate           |sulfate           |sulfate           |
|                                                                                      |in 100%           |in 100%           |in 100%           |in 100%           |
|                                                                                      |standard          |standard          |standard          |standard          |
|                                                                                      |test              |test              |test              |test              |
|                                                                                      |solutionis        |solutionis        |solutionis        |solutionis        |
|                                                                                      |10%,              |10%,              |10%,              |10%,              |
|                                                                                      |not               |not               |not               |not               |
|                                                                                      |more              |more              |more              |more              |
|                                                                                      |than              |than              |than              |than              |
|                                                                                      |10%;              |10%;              |10%;              |10%;              |
|                                                                                      |The RSD           |The RSD           |The RSD           |The RSD           |
|                                                                                      |of the            |of the            |of the            |of the            |
|                                                                                      |peakarea          |peakarea          |peakarea          |peakarea          |
|                                                                                      |response          |response          |response          |response          |
|                                                                                      |of                |of                |of                |of                |
|                                                                                      |diethyl           |diethyl           |diethyl           |diethyl           |
|                                                                                      |sulfate           |sulfate           |sulfate           |sulfate           |
|                                                                                      |was 6%,           |was 6%,           |was 6%,           |was 6%,           |
|                                                                                      |less              |less              |less              |less              |
|                                                                                      |than              |than              |than              |than              |
|                                                                                      |10%;              |10%;              |10%;              |10%;              |
|                                                                                      |The RSD           |The RSD           |The RSD           |The RSD           |
|                                                                                      |of the            |of the            |of the            |of the            |
|                                                                                      |peakarea          |peakarea          |peakarea          |peakarea          |
|                                                                                      |response          |response          |response          |response          |
|                                                                                      |of                |of                |of                |of                |
|                                                                                      |diisopropyl       |diisopropyl       |diisopropyl       |diisopropyl       |
|                                                                                      |sulfate           |sulfate           |sulfate           |sulfate           |
|                                                                                      |was 8%,           |was 8%,           |was 8%,           |was 8%,           |
|                                                                                      |less              |less              |less              |less              |
|                                                                                      |than              |than              |than              |than              |
|                                                                                      |10%;              |10%;              |10%;              |10%;              |
|                                                                                      |The RSD           |The RSD           |The RSD           |The RSD           |
|                                                                                      |of the            |of the            |of the            |of the            |
|                                                                                      |peakarea          |peakarea          |peakarea          |peakarea          |
|                                                                                      |response          |response          |response          |response          |
|                                                                                      |of                |of                |of                |of                |
|                                                                                      |disec-butylsulfate|disec-butylsulfate|disec-butylsulfate|disec-butylsulfate|
|                                                                                      |was 8%,           |was 8%,           |was 8%,           |was 8%,           |
|                                                                                      |not               |not               |not               |not               |
|                                                                                      |more              |more              |more              |more              |
|                                                                                      |than              |than              |than              |than              |
|                                                                                      |10%,              |10%,              |10%,              |10%,              |
|                                                                                      |indicating        |indicating        |indicating        |indicating        |
|                                                                                      |that              |that              |that              |that              |
|                                                                                      |the               |the               |the               |the               |
|                                                                                      |stability         |stability         |stability         |stability         |
|                                                                                      |ofimpurities      |ofimpurities      |ofimpurities      |ofimpurities      |
|                                                                                      |in 100%           |in 100%           |in 100%           |in 100%           |
|                                                                                      |standard          |standard          |standard          |standard          |
|                                                                                      |test              |test              |test              |test              |
|                                                                                      |solution          |solution          |solution          |solution          |
|                                                                                      |met the           |met the           |met the           |met the           |
|                                                                                      |requirements,     |requirements,     |requirements,     |requirements,     |
|                                                                                      |thatis,           |thatis,           |thatis,           |thatis,           |
|                                                                                      |stable            |stable            |stable            |stable            |
|                                                                                      |within            |within            |within            |within            |
|                                                                                      |15.3 h.           |15.3 h.           |15.3 h.           |15.3 h.           |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 400 of 542 





Page 401
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**III. Summary of Method Validation** 



Summary of the results of the verification of the method of genotoxic impurities in the finished product 






























--------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|System suitability                    |The signal-to-noise ratio ofeachimpurity peak  |The SNR            |The SNR            |The SNR             |The SNR             |
|                                      |in the sensitivity solution should NLT 10; The |of                 |of                 |of                  |of                  |
|                                      |RSD of the retention time ofeachimpurity in the|dimethyl           |dimethyl           |dimethyl            |dimethyl            |
|                                      |luminous solution NMT 1%, and the RSD of the   |sulfate,           |sulfate,           |sulfate,            |sulfate,            |
|                                      |peakarea response value NMT 10%.               |diethyl            |diethyl            |diethyl             |diethyl             |
|                                      |                                               |sulfate,           |sulfate,           |sulfate,            |sulfate,            |
|                                      |                                               |diisopropyl        |diisopropyl        |diisopropyl         |diisopropyl         |
|                                      |                                               |sulfate            |sulfate            |sulfate             |sulfate             |
|                                      |                                               |and                |and                |and                 |and                 |
|                                      |                                               |disec-butyl        |disec-butyl        |disec-butyl         |disec-butyl         |
|                                      |                                               |sulfate            |sulfate            |sulfate             |sulfate             |
|                                      |                                               |in the             |in the             |in the              |in the              |
|                                      |                                               |sensitivity        |sensitivity        |sensitivity         |sensitivity         |
|                                      |                                               |solution           |solution           |solution            |solution            |
|                                      |                                               |were               |were               |were                |were                |
|                                      |                                               |110.87,            |110.87,            |110.87,             |110.87,             |
|                                      |                                               |179.58,            |179.58,            |179.58,             |179.58,             |
|                                      |                                               |54.31              |54.31              |54.31               |54.31               |
|                                      |                                               |and                |and                |and                 |and                 |
|                                      |                                               |43.75,             |43.75,             |43.75,              |43.75,              |
|                                      |                                               |respectively,      |respectively,      |respectively,       |respectively,       |
|                                      |                                               |and                |and                |and                 |and                 |
|                                      |                                               |were               |were               |were                |were                |
|                                      |                                               |NLT 10.            |NLT 10.            |NLT 10.             |NLT 10.             |
|                                      |                                               |The RSD            |The RSD            |The RSD             |The RSD             |
|                                      |                                               |of the             |of the             |of the              |of the              |
|                                      |                                               |retention          |retention          |retention           |retention           |
|                                      |                                               |time of            |time of            |time of             |time of             |
|                                      |                                               |dimethyl           |dimethyl           |dimethyl            |dimethyl            |
|                                      |                                               |sulfate,           |sulfate,           |sulfate,            |sulfate,            |
|                                      |                                               |diethyl            |diethyl            |diethyl             |diethyl             |
|                                      |                                               |sulfate,           |sulfate,           |sulfate,            |sulfate,            |
|                                      |                                               |diisopropyl        |diisopropyl        |diisopropyl         |diisopropyl         |
|                                      |                                               |sulfate            |sulfate            |sulfate             |sulfate             |
|                                      |                                               |and                |and                |and                 |and                 |
|                                      |                                               |di-sec-butylsulfate|di-sec-butylsulfate|di-sec-butylsulfate |di-sec-butylsulfate |
|                                      |                                               |in the             |in the             |in the              |in the              |
|                                      |                                               |irradiation        |irradiation        |irradiation         |irradiation         |
|                                      |                                               |solution           |solution           |solution            |solution            |
|                                      |                                               |were               |were               |were                |were                |
|                                      |                                               |0.05%,             |0.05%,             |0.05%,              |0.05%,              |
|                                      |                                               |0%, 0%             |0%, 0%             |0%, 0%              |0%, 0%              |
|                                      |                                               |and                |and                |and                 |and                 |
|                                      |                                               |0.021%,            |0.021%,            |0.021%,             |0.021%,             |
|                                      |                                               |respectively,      |respectively,      |respectively,       |respectively,       |
|                                      |                                               |and                |and                |and                 |and                 |
|                                      |                                               |were               |were               |were                |were                |
|                                      |                                               |not                |not                |not                 |not                 |
|                                      |                                               |greater            |greater            |greater             |greater             |
|                                      |                                               |than               |than               |than                |than                |
|                                      |                                               |1%. The            |1%. The            |1%. The             |1%. The             |
|                                      |                                               |RSD of             |RSD of             |RSD of              |RSD of              |
|                                      |                                               |the                |the                |the                 |the                 |
|                                      |                                               |peakarea           |peakarea           |peakarea            |peakarea            |
|                                      |                                               |of                 |of                 |of                  |of                  |
|                                      |                                               |dimethyl           |dimethyl           |dimethyl            |dimethyl            |
|                                      |                                               |sulfate,           |sulfate,           |sulfate,            |sulfate,            |
|                                      |                                               |diethyl            |diethyl            |diethyl             |diethyl             |
|                                      |                                               |sulfate,           |sulfate,           |sulfate,            |sulfate,            |
|                                      |                                               |diisopropyl        |diisopropyl        |diisopropyl         |diisopropyl         |
|                                      |                                               |sulfate            |sulfate            |sulfate             |sulfate             |
|                                      |                                               |and                |and                |and                 |and                 |
|                                      |                                               |di-sec-butylsulfate|di-sec-butylsulfate|di-sec-butylsulfate |di-sec-butylsulfate |
|                                      |                                               |in the             |in the             |in the              |in the              |
|                                      |                                               |irradiation        |irradiation        |irradiation         |irradiation         |
|                                      |                                               |solution           |solution           |solution            |solution            |
|                                      |                                               |were               |were               |were                |were                |
|                                      |                                               |2.9%,              |2.9%,              |2.9%,               |2.9%,               |
|                                      |                                               |2.5%,              |2.5%,              |2.5%,               |2.5%,               |
|                                      |                                               |3.0%               |3.0%               |3.0%                |3.0%                |
|                                      |                                               |and 6%,            |and 6%,            |and 6%,             |and 6%,             |
|                                      |                                               |respectively,      |respectively,      |respectively,       |respectively,       |
|                                      |                                               |all of             |all of             |all of              |all of              |
|                                      |                                               |which              |which              |which               |which               |
|                                      |                                               |were               |were               |were                |were                |
|                                      |                                               |less               |less               |less                |less                |
|                                      |                                               |than               |than               |than                |than                |
|                                      |                                               |10%,               |10%,               |10%,                |10%,                |
|                                      |                                               |indicating         |indicating         |indicating          |indicating          |
|                                      |                                               |that               |that               |that                |that                |
|                                      |                                               |the                |the                |the                 |the                 |
|                                      |                                               |systemapplicability|systemapplicability|systemapplicability |systemapplicability |
|                                      |                                               |of the             |of the             |of the              |of the              |
|                                      |                                               |method             |method             |method              |method              |
|                                      |                                               |for the            |for the            |for the             |for the             |
|                                      |                                               |detection          |detection          |detection           |detection           |
|                                      |                                               |of                 |of                 |of                  |of                  |
|                                      |                                               |dimethyl           |dimethyl           |dimethyl            |dimethyl            |
|                                      |                                               |sulfate,           |sulfate,           |sulfate,            |sulfate,            |
|                                      |                                               |diethyl            |diethyl            |diethyl             |diethyl             |
|                                      |                                               |sulfate,           |sulfate,           |sulfate,            |sulfate,            |
|                                      |                                               |diisopropyl        |diisopropyl        |diisopropyl         |diisopropyl         |
|                                      |                                               |sulfate            |sulfate            |sulfate             |sulfate             |
|                                      |                                               |and                |and                |and                 |and                 |
|                                      |                                               |di-sec-butylsulfate|di-sec-butylsulfate|di-sec-butylsulfate |di-sec-butylsulfate |
|                                      |                                               |met the            |met the            |met the             |met the             |
|                                      |                                               |requirements.      |requirements.      |requirements.       |requirements.       |
|--------------------------------------|-----------------------------------------------|-------------------|-------------------|--------------------|--------------------|
|Specificity                           |The retention time ofeachimpurity in the       |The retention time |The retention time |The retention time  |The retention time  |
|                                      |specific mixed solution and the control        |ofeachimpurity in  |ofeachimpurity in  |ofeachimpurity in   |ofeachimpurity in   |
|                                      |solution should be consistent with the         |the specific mixed |the specific mixed |the specific mixed  |the specific mixed  |
|                                      |retention time in the impurity localization    |solution and the   |solution and the   |solution and the    |solution and the    |
|                                      |solution. The peakarea response value of       |reference          |reference          |reference           |reference           |
|                                      |dimethyl sulfate, diethyl sulfate, diisopropyl |solutionis         |solutionis         |solutionis          |solutionis          |
|                                      |sulfate and disec-butyl sulfate in the blank   |consistent with the|consistent with the|consistent with the |consistent with the |
|                                      |solution NMT 20% of the average value of the   |retention time     |retention time     |retention time      |retention time      |
|                                      |peakarea response ofeachimpurity in the mass   |ofeachimpurity     |ofeachimpurity     |ofeachimpurity      |ofeachimpurity      |
|                                      |spectrum of 6 limited quantification solutions.|localization       |localization       |localization        |localization        |
|                                      |                                               |solution. Dimethyl |solution. Dimethyl |solution. Dimethyl  |solution. Dimethyl  |
|                                      |                                               |sulfate, diethyl   |sulfate, diethyl   |sulfate, diethyl    |sulfate, diethyl    |
|                                      |                                               |sulfate,           |sulfate,           |sulfate,            |sulfate,            |
|                                      |                                               |diisopropyl sulfate|diisopropyl sulfate|diisopropyl sulfate |diisopropyl sulfate |
|                                      |                                               |and disec-butyl    |and disec-butyl    |and disec-butyl     |and disec-butyl     |
|                                      |                                               |sulfate were not   |sulfate were not   |sulfate were not    |sulfate were not    |
|                                      |                                               |detected in the    |detected in the    |detected in the     |detected in the     |
|                                      |                                               |blank solution,    |blank solution,    |blank solution,     |blank solution,     |
|                                      |                                               |indicating that the|indicating that the|indicating that the |indicating that the |
|                                      |                                               |specificity of the |specificity of the |specificity of the  |specificity of the  |
|                                      |                                               |method met the     |method met the     |method met the      |method met the      |
|                                      |                                               |requirements.      |requirements.      |requirements.       |requirements.       |
|--------------------------------------|-----------------------------------------------|-------------------|-------------------|--------------------|--------------------|
|Limits of quantifi cation and detectio|Itis required that the SNR ofeachimpurity in   |**Impurities**     |**Detection        |**Limitof           |                    |
|                                      |the 6 limited quantitation solutions should NLT|                   |Limits**           |quantitation**      |                    |
|                                      |10, the RSD of the retention time              |                   |                   |                    |                    |
|                                      |ofeachimpurity should not be more than 1.0%,   |                   |                   |                    |                    |
|                                      |and the RSD of thepeak                         |                   |                   |                    |                    |
|--------------------------------------|-----------------------------------------------|-------------------|-------------------|--------------------|--------------------|
|Limits of quantifi cation and detectio|Itis required that the SNR ofeachimpurity in   |**Impurities**     |**Concentration    |**Concentration     |**Concentration     |
|                                      |the 6 limited quantitation solutions should NLT|                   |(equivalent to     |(equivalent to      |(equivalent to      |
|                                      |10, the RSD of the retention time              |                   |the** **percentage |the** **test        |the** **test        |
|                                      |ofeachimpurity should not be more than 1.0%,   |                   |of solution**      |product solution**  |product solution**  |
|                                      |and the RSD of thepeak                         |                   |**concentration of |**concentration     |**concentration     |
|                                      |                                               |                   |the test**         |percentage)**       |percentage)**       |
|                                      |                                               |                   |**product)**       |                    |                    |
|--------------------------------------|-----------------------------------------------|-------------------|-------------------|--------------------|--------------------|
|Limits of quantifi cation and detectio|Itis required that the SNR ofeachimpurity in   |Dimethyl           |4.4806ng/ml(2.2ppm)|14.9352ng/ml(7.5ppm)|14.9352ng/ml(7.5ppm)|
|                                      |the 6 limited quantitation solutions should NLT|                   |                   |                    |                    |
|                                      |10, the RSD of the retention time              |                   |                   |                    |                    |
|                                      |ofeachimpurity should not be more than 1.0%,   |                   |                   |                    |                    |
|                                      |and the RSD of thepeak                         |                   |                   |                    |                    |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 401 of 542 





Page 402
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 
























------------------------------------------------
|Repeatability|10%, n=6|4%, n=6|5%, n=6|6%, n=6|
------------------------------------------------








































------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|n                  |area           |Diethyl       |Diethyl       |4.6094ng/ml   |4.6094ng/ml               |4.6094ng/ml               |4.6094ng/ml               |15.3648ng/ml              |15.3648ng/ml      |15.3648ng/ml      |15.3648ng/ml  |15.3648ng/ml  |
|                   |response       |sulfate       |sulfate       |(2.3ppm)      |(2.3ppm)                  |(2.3ppm)                  |(2.3ppm)                  |(7.7ppm)                  |(7.7ppm)          |(7.7ppm)          |(7.7ppm)      |(7.7ppm)      |
|                   |value          |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |ofeachimpurity |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |should not     |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |be more        |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |than 10%.      |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |The            |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |signal-to-noise|              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |ratio          |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |ofeveryimpurity|              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |in the         |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |mass           |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |spectrogram    |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |of the         |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |detection      |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |limited        |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |solution       |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |should be      |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |NLT 3.         |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|-------------------|---------------|--------------|--------------|--------------|--------------------------|--------------------------|--------------------------|--------------------------|------------------|------------------|--------------|--------------|
|n                  |area response  |Diisopropyl   |Diisopropyl   |4.5425ng/ml   |4.5425ng/ml               |4.5425ng/ml               |4.5425ng/ml               |15.1417ng/ml              |15.1417ng/ml      |15.1417ng/ml      |15.1417ng/ml  |15.1417ng/ml  |
|                   |value          |sulfate       |sulfate       |(2.3ppm)      |(2.3ppm)                  |(2.3ppm)                  |(2.3ppm)                  |(7.6ppm)                  |(7.6ppm)          |(7.6ppm)          |(7.6ppm)      |(7.6ppm)      |
|                   |ofeachimpurity |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |should not be  |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |more than 10%. |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |The            |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |signal-to-noise|              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |ratio          |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |ofeveryimpurity|              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |in the mass    |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |spectrogram of |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |the detection  |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |limited        |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |solution should|              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |be NLT 3.      |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|-------------------|---------------|--------------|--------------|--------------|--------------------------|--------------------------|--------------------------|--------------------------|------------------|------------------|--------------|--------------|
|n                  |area response  |Di-sec-butyl  |Di-sec-butyl  |4.6091ng/ml   |4.6091ng/ml               |4.6091ng/ml               |4.6091ng/ml               |15.3638ng/ml              |15.3638ng/ml      |15.3638ng/ml      |15.3638ng/ml  |15.3638ng/ml  |
|                   |value          |sulfate       |sulfate       |(2.3ppm)      |(2.3ppm)                  |(2.3ppm)                  |(2.3ppm)                  |(7.7ppm)                  |(7.7ppm)          |(7.7ppm)          |(7.7ppm)      |(7.7ppm)      |
|                   |ofeachimpurity |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |should not be  |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |more than 10%. |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |The            |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |signal-to-noise|              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |ratio          |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |ofeveryimpurity|              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |in the mass    |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |spectrogram of |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |the detection  |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |limited        |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |solution should|              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |be NLT 3.      |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|-------------------|---------------|--------------|--------------|--------------|--------------------------|--------------------------|--------------------------|--------------------------|------------------|------------------|--------------|--------------|
|Linearity vs. Range|The regression |              |**Impurities**|**Impurities**|**Concentration           |**Concentration           |**Concentration           |**Concentration           |**Linearequation**|**Linearequation**|              |              |
|                   |coefficientR of|              |              |              |(equivalent               |(equivalent               |(equivalent               |(equivalent               |                  |                  |              |              |
|                   |the obtained   |              |              |              |to the**                  |to the**                  |to the**                  |to the**                  |                  |                  |              |              |
|                   |linear graph   |              |              |              |**percentage              |**percentage              |**percentage              |**percentage              |                  |                  |              |              |
|                   |should be NLT  |              |              |              |of solution               |of solution               |of solution               |of solution               |                  |                  |              |              |
|                   |0.990, and     |              |              |              |concentration             |concentration             |concentration             |concentration             |                  |                  |              |              |
|                   |theY-intercept |              |              |              |of the**                  |of the**                  |of the**                  |of the**                  |                  |                  |              |              |
|                   |should be less |              |              |              |**test                    |**test                    |**test                    |**test                    |                  |                  |              |              |
|                   |than 25% of the|              |              |              |product)**                |product)**                |product)**                |product)**                |                  |                  |              |              |
|                   |100% response  |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |value.         |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|-------------------|---------------|--------------|--------------|--------------|--------------------------|--------------------------|--------------------------|--------------------------|------------------|------------------|--------------|--------------|
|Linearity vs. Range|The regression |              |Dimethyl      |Dimethyl      |14.9352ng/ml~298.7040ng/ml|14.9352ng/ml~298.7040ng/ml|14.9352ng/ml~298.7040ng/ml|14.9352ng/ml~298.7040ng/ml|y=13215x-26946    |y=13215x-26946    |y=13215x-26946|y=13215x-26946|
|                   |coefficientR of|              |sulfate       |sulfate       |(7.5ppm~149.4ppm)         |(7.5ppm~149.4ppm)         |(7.5ppm~149.4ppm)         |(7.5ppm~149.4ppm)         |                  |                  |              |              |
|                   |the obtained   |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |linear graph   |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |should be NLT  |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |0.990, and     |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |theY-intercept |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |should be less |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |than 25% of the|              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |100% response  |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |value.         |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|-------------------|---------------|--------------|--------------|--------------|--------------------------|--------------------------|--------------------------|--------------------------|------------------|------------------|--------------|--------------|
|Linearity vs. Range|The regression |              |Diethyl       |Diethyl       |15.3648ng/ml to           |15.3648ng/ml to           |15.3648ng/ml to           |15.3648ng/ml to           |y=16542x-91014    |y=16542x-91014    |y=16542x-91014|y=16542x-91014|
|                   |coefficientR of|              |sulfate       |sulfate       |307.2960ng/ml (7.7ppm to  |307.2960ng/ml (7.7ppm to  |307.2960ng/ml (7.7ppm to  |307.2960ng/ml (7.7ppm to  |                  |                  |              |              |
|                   |the obtained   |              |              |              |153.6ppm)                 |153.6ppm)                 |153.6ppm)                 |153.6ppm)                 |                  |                  |              |              |
|                   |linear graph   |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |should be NLT  |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |0.990, and     |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |theY-intercept |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |should be less |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |than 25% of the|              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |100% response  |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |value.         |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|-------------------|---------------|--------------|--------------|--------------|--------------------------|--------------------------|--------------------------|--------------------------|------------------|------------------|--------------|--------------|
|Linearity vs. Range|The regression |              |Diisopropyl   |Diisopropyl   |15.1417ng/ml to           |15.1417ng/ml to           |15.1417ng/ml to           |15.1417ng/ml to           |y=11126x-84402    |y=11126x-84402    |y=11126x-84402|y=11126x-84402|
|                   |coefficientR of|              |sulfate       |sulfate       |302.8340ng/ml (7.6ppm to  |302.8340ng/ml (7.6ppm to  |302.8340ng/ml (7.6ppm to  |302.8340ng/ml (7.6ppm to  |                  |                  |              |              |
|                   |the obtained   |              |              |              |151.4ppm)                 |151.4ppm)                 |151.4ppm)                 |151.4ppm)                 |                  |                  |              |              |
|                   |linear graph   |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |should be NLT  |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |0.990, and     |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |theY-intercept |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |should be less |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |than 25% of the|              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |100% response  |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |value.         |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|-------------------|---------------|--------------|--------------|--------------|--------------------------|--------------------------|--------------------------|--------------------------|------------------|------------------|--------------|--------------|
|Linearity vs. Range|The regression |              |Disec-butyl   |Disec-butyl   |15.3638ng/ml to           |15.3638ng/ml to           |15.3638ng/ml to           |15.3638ng/ml to           |Y = 4616.2 x -    |Y = 4616.2 x -    |Y = 4616.2 x -|Y = 4616.2 x -|
|                   |coefficientR of|              |sulfate       |sulfate       |307.2754ng/ml (7.7ppm to  |307.2754ng/ml (7.7ppm to  |307.2754ng/ml (7.7ppm to  |307.2754ng/ml (7.7ppm to  |41084             |41084             |41084         |41084         |
|                   |the obtained   |              |              |              |153.6ppm)                 |153.6ppm)                 |153.6ppm)                 |153.6ppm)                 |                  |                  |              |              |
|                   |linear graph   |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |should be NLT  |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |0.990, and     |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |theY-intercept |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |should be less |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |than 25% of the|              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |100% response  |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |value.         |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|-------------------|---------------|--------------|--------------|--------------|--------------------------|--------------------------|--------------------------|--------------------------|------------------|------------------|--------------|--------------|
|Repeata bility     |The RSD of the |**Impurities**|**Impurities**|**Impurities**|**Impurities** Dimethyl   |**Impurities** Dimethyl   |**Impurities** Dimethyl   |**Impurities** Dimethyl   |**Impurities**    |**Impurities**    |**Impurities**|**Impurities**|
|                   |content of     |Dimethyl      |Dimethyl      |Dimethyl      |sulfate Diethyl sulfate   |sulfate Diethyl sulfate   |sulfate Diethyl sulfate   |sulfate Diethyl sulfate   |Dimethyl sulfate  |Dimethyl sulfate  |Dimethyl      |Dimethyl      |
|                   |dimethyl       |sulfate       |sulfate       |sulfate       |Diisopropyl sulfate       |Diisopropyl sulfate       |Diisopropyl sulfate       |Diisopropyl sulfate       |Diethyl sulfate   |Diethyl sulfate   |sulfate       |sulfate       |
|                   |sulfate,       |Diethyl       |Diethyl       |Diethyl       |Di-sec-butyl sulfate      |Di-sec-butyl sulfate      |Di-sec-butyl sulfate      |Di-sec-butyl sulfate      |Diisopropyl       |Diisopropyl       |Diethyl       |Diethyl       |
|                   |diethyl        |sulfate       |sulfate       |sulfate       |Repeatability 10%, n=6 4%,|Repeatability 10%, n=6 4%,|Repeatability 10%, n=6 4%,|Repeatability 10%, n=6 4%,|sulfate           |sulfate           |sulfate       |sulfate       |
|                   |sulfate,       |Diisopropyl   |Diisopropyl   |Diisopropyl   |n=6 5%, n=6 6%, n=6       |n=6 5%, n=6 6%, n=6       |n=6 5%, n=6 6%, n=6       |n=6 5%, n=6 6%, n=6       |Di-sec-butyl      |Di-sec-butyl      |Diisopropyl   |Diisopropyl   |
|                   |diisopropyl    |sulfate       |sulfate       |sulfate       |                          |                          |                          |                          |sulfate           |sulfate           |sulfate       |sulfate       |
|                   |sulfate and    |Di-sec-butyl  |Di-sec-butyl  |Di-sec-butyl  |                          |                          |                          |                          |Repeatability 10%,|Repeatability 10%,|Di-sec-butyl  |Di-sec-butyl  |
|                   |disec-butyl    |sulfate       |sulfate       |sulfate       |                          |                          |                          |                          |n=6 4%, n=6 5%,   |n=6 4%, n=6 5%,   |sulfate       |sulfate       |
|                   |sulfate in the |Repeatability |Repeatability |Repeatability |                          |                          |                          |                          |n=6 6%, n=6       |n=6 6%, n=6       |Repeatability |Repeatability |
|                   |solution of 6  |10%, n=6 4%,  |10%, n=6 4%,  |10%, n=6 4%,  |                          |                          |                          |                          |                  |                  |10%, n=6 4%,  |10%, n=6 4%,  |
|                   |repeatable test|n=6 5%, n=6   |n=6 5%, n=6   |n=6 5%, n=6   |                          |                          |                          |                          |                  |                  |n=6 5%, n=6   |n=6 5%, n=6   |
|                   |products should|6%, n=6       |6%, n=6       |6%, n=6       |                          |                          |                          |                          |                  |                  |6%, n=6       |6%, n=6       |
|                   |NMT20%.        |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|-------------------|---------------|--------------|--------------|--------------|--------------------------|--------------------------|--------------------------|--------------------------|------------------|------------------|--------------|--------------|
|Accura cy          |Itis required  |              |**Impurities**|**Impurities**|**Impurities**            |**Marking condition**     |**Average** **recovery    |**Average** **recovery    |**Average**       |**RSD**           |              |              |
|                   |that the       |              |              |              |                          |                          |rate**                    |rate**                    |**recovery rate** |                  |              |              |
|                   |recovery rate  |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |ofeachimpurity |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |in the solution|              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |ofeachadded    |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |standard test  |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |product should |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |be between     |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |80.0% and      |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |120.0%, and the|              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |RSD            |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |ofeachimpurity |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |recovery rate  |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |NMT 15%.       |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|-------------------|---------------|--------------|--------------|--------------|--------------------------|--------------------------|--------------------------|--------------------------|------------------|------------------|--------------|--------------|
|Accura cy          |Itis required  |              |Dimethyl      |Dimethyl      |Dimethyl sulfate          |Added 0.2317ng to 1.1584ng|96.33%, n=9               |96.33%, n=9               |96.33%, n=9       |2.4%, n=9         |2.4%, n=9     |2.4%, n=9     |
|                   |that the       |              |sulfate       |sulfate       |                          |                          |                          |                          |                  |                  |              |              |
|                   |recovery rate  |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |ofeachimpurity |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |in the solution|              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |ofeachadded    |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |standard test  |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |product should |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |be between     |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |80.0% and      |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |120.0%, and the|              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |RSD            |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |ofeachimpurity |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |recovery rate  |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |NMT 15%.       |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|-------------------|---------------|--------------|--------------|--------------|--------------------------|--------------------------|--------------------------|--------------------------|------------------|------------------|--------------|--------------|
|Accura cy          |Itis required  |              |Diethyl       |Diethyl       |Diethyl sulfate           |Added 0.2333ng to 1.1665ng|100.96%, n=9              |100.96%, n=9              |100.96%, n=9      |7%, n=9           |7%, n=9       |7%, n=9       |
|                   |that the       |              |sulfate       |sulfate       |                          |                          |                          |                          |                  |                  |              |              |
|                   |recovery rate  |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |ofeachimpurity |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |in the solution|              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |ofeachadded    |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |standard test  |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |product should |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |be between     |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |80.0% and      |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |120.0%, and the|              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |RSD            |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |ofeachimpurity |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |recovery rate  |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |NMT 15%.       |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|-------------------|---------------|--------------|--------------|--------------|--------------------------|--------------------------|--------------------------|--------------------------|------------------|------------------|--------------|--------------|
|Accura cy          |Itis required  |              |Diisopropyl   |Diisopropyl   |Diisopropyl sulfate       |Added 0.2210ng to 1.1051ng|103.00%, n=9              |103.00%, n=9              |103.00%, n=9      |6%, n=9           |6%, n=9       |6%, n=9       |
|                   |that the       |              |sulfate       |sulfate       |                          |                          |                          |                          |                  |                  |              |              |
|                   |recovery rate  |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |ofeachimpurity |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |in the solution|              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |ofeachadded    |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |standard test  |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |product should |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |be between     |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |80.0% and      |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |120.0%, and the|              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |RSD            |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |ofeachimpurity |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |recovery rate  |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |NMT 15%.       |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|-------------------|---------------|--------------|--------------|--------------|--------------------------|--------------------------|--------------------------|--------------------------|------------------|------------------|--------------|--------------|
|Accura cy          |Itis required  |              |Di-sec-butyl  |Di-sec-butyl  |Di-sec-butyl sulfate      |Added 0.2306ng to 1.1530ng|98.57%, n=9               |98.57%, n=9               |98.57%, n=9       |7%, n=9           |7%, n=9       |7%, n=9       |
|                   |that the       |              |sulfate       |sulfate       |                          |                          |                          |                          |                  |                  |              |              |
|                   |recovery rate  |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |ofeachimpurity |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |in the solution|              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |ofeachadded    |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |standard test  |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |product should |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |be between     |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |80.0% and      |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |120.0%, and the|              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |RSD            |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |ofeachimpurity |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |recovery rate  |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|                   |NMT 15%.       |              |              |              |                          |                          |                          |                          |                  |                  |              |              |
|-------------------|---------------|--------------|--------------|--------------|--------------------------|--------------------------|--------------------------|--------------------------|------------------|------------------|--------------|--------------|
|Durabil            |Under different|The initial   |The initial   |The initial   |The initial column        |The initial column        |The initial column        |The initial column        |The initial column|The initial column|The initial   |The initial   |
|                   |conditions of  |column        |column        |column        |temperature was 50℃±5℃,   |temperature was 50℃±5℃,   |temperature was 50℃±5℃,   |temperature was 50℃±5℃,   |temperature was   |temperature was   |column        |column        |
|                   |               |temperature   |temperature   |temperature   |the flow rate of carrier  |the flow rate of carrier  |the flow rate of carrier  |the flow rate of carrier  |50℃±5℃, the flow  |50℃±5℃, the flow  |temperature   |temperature   |
|                   |               |was 50℃±5℃,   |was 50℃±5℃,   |was 50℃±5℃,   |gas was                   |gas was                   |gas was                   |gas was                   |rate of carrier   |rate of carrier   |was 50℃±5℃,   |was 50℃±5℃,   |
|                   |               |the flow rate |the flow rate |the flow rate |                          |                          |                          |                          |gas was           |gas was           |the flow rate |the flow rate |
|                   |               |of carrier gas|of carrier gas|of carrier gas|                          |                          |                          |                          |                  |                  |of carrier gas|of carrier gas|
|                   |               |was           |was           |was           |                          |                          |                          |                          |                  |                  |was           |was           |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 402 of 542 





Page 403
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 















-----------------------------------------------------------------------------------------------------------------------------------
|Stability of solution|Each solutionis placed at room temperature, and the sensitivity solution, the reference |The               |
|                     |solution and the 100% labeled test product solutionare injected at different times. The |RSDS of           |
|                     |RSD of the peakarea response value ofeachimpurity in the sensitivity solution, the      |the               |
|                     |reference solution and the 100% labeled test product solution NMT 10%.                  |peakarea          |
|                     |                                                                                        |response          |
|                     |                                                                                        |of                |
|                     |                                                                                        |dimethyl          |
|                     |                                                                                        |sulfate,          |
|                     |                                                                                        |diethyl           |
|                     |                                                                                        |sulfate,          |
|                     |                                                                                        |diisopropyl       |
|                     |                                                                                        |sulfate           |
|                     |                                                                                        |and               |
|                     |                                                                                        |disec-butylsulfate|
|                     |                                                                                        |were              |
|                     |                                                                                        |9%, 5%,           |
|                     |                                                                                        |6% and            |
|                     |                                                                                        |5%,               |
|                     |                                                                                        |respectively,     |
|                     |                                                                                        |within            |
|                     |                                                                                        |15.3hafter        |
|                     |                                                                                        |the               |
|                     |                                                                                        |sensitivity       |
|                     |                                                                                        |solution          |
|                     |                                                                                        |was               |
|                     |                                                                                        |placed            |
|                     |                                                                                        |at room           |
|                     |                                                                                        |temperature,      |
|                     |                                                                                        |and               |
|                     |                                                                                        |were              |
|                     |                                                                                        |all               |
|                     |                                                                                        |less              |
|                     |                                                                                        |than              |
|                     |                                                                                        |10%.              |
|                     |                                                                                        |The               |
|                     |                                                                                        |verification      |
|                     |                                                                                        |requirements      |
|                     |                                                                                        |were              |
|                     |                                                                                        |met,              |
|                     |                                                                                        |indicating        |
|                     |                                                                                        |that              |
|                     |                                                                                        |the               |
|                     |                                                                                        |sensitive         |
|                     |                                                                                        |solution          |
|                     |                                                                                        |was               |
|                     |                                                                                        |stable            |
|                     |                                                                                        |within            |
|                     |                                                                                        |15.3hat           |
|                     |                                                                                        |room              |
|                     |                                                                                        |temperature.      |
|                     |                                                                                        |The RSD           |
|                     |                                                                                        |of the            |
|                     |                                                                                        |peakarea          |
|                     |                                                                                        |response          |
|                     |                                                                                        |of                |
|                     |                                                                                        |dimethyl          |
|                     |                                                                                        |sulfate,          |
|                     |                                                                                        |diethyl           |
|                     |                                                                                        |sulfate,          |
|                     |                                                                                        |diisopropyl       |
|                     |                                                                                        |sulfate           |
|                     |                                                                                        |and               |
|                     |                                                                                        |disec-butyl       |
|                     |                                                                                        |sulfate           |
|                     |                                                                                        |were              |
|                     |                                                                                        |10%,              |
|                     |                                                                                        |7%, 8%            |
|                     |                                                                                        |and 8%,           |
|                     |                                                                                        |respectively,     |
|                     |                                                                                        |within            |
|                     |                                                                                        |15.3hwhen         |
|                     |                                                                                        |the               |
|                     |                                                                                        |control           |
|                     |                                                                                        |solution          |
|                     |                                                                                        |was               |
|                     |                                                                                        |placed            |
|                     |                                                                                        |at room           |
|                     |                                                                                        |temperature.      |
|                     |                                                                                        |The               |
|                     |                                                                                        |verification      |
|                     |                                                                                        |requirements      |
|                     |                                                                                        |were              |
|                     |                                                                                        |met,              |
|                     |                                                                                        |indicating        |
|                     |                                                                                        |that              |
|                     |                                                                                        |the               |
|                     |                                                                                        |control           |
|                     |                                                                                        |solution          |
|                     |                                                                                        |was               |
|                     |                                                                                        |stable            |
|                     |                                                                                        |within            |
|                     |                                                                                        |15.3hat           |
|                     |                                                                                        |room              |
|                     |                                                                                        |temperature.      |
|                     |                                                                                        |The RSD           |
|                     |                                                                                        |of                |
|                     |                                                                                        |peakarea          |
|                     |                                                                                        |response          |
|                     |                                                                                        |of                |
|                     |                                                                                        |dimethyl          |
|                     |                                                                                        |sulfate,          |
|                     |                                                                                        |diethyl           |
|                     |                                                                                        |sulfate,          |
|                     |                                                                                        |diisopropyl       |
|                     |                                                                                        |sulfate           |
|                     |                                                                                        |and               |
|                     |                                                                                        |disec-butyl       |
|                     |                                                                                        |sulfate           |
|                     |                                                                                        |were              |
|                     |                                                                                        |10%,              |
|                     |                                                                                        |6%, 8%            |
|                     |                                                                                        |and 8%,           |
|                     |                                                                                        |respectively,     |
|                     |                                                                                        |and               |
|                     |                                                                                        |none of           |
|                     |                                                                                        |them              |
|                     |                                                                                        |were              |
|                     |                                                                                        |greater           |
|                     |                                                                                        |than              |
|                     |                                                                                        |10%,              |
|                     |                                                                                        |after             |
|                     |                                                                                        |100%              |
|                     |                                                                                        |standard          |
|                     |                                                                                        |test              |
|                     |                                                                                        |solution          |
|                     |                                                                                        |was               |
|                     |                                                                                        |placed            |
|                     |                                                                                        |at room           |
|                     |                                                                                        |temperature       |
|                     |                                                                                        |for               |
|                     |                                                                                        |15.3h.            |
|                     |                                                                                        |It met            |
|                     |                                                                                        |the               |
|                     |                                                                                        |verification      |
|                     |                                                                                        |requirements,     |
|                     |                                                                                        |indicating        |
|                     |                                                                                        |that              |
|                     |                                                                                        |the               |
|                     |                                                                                        |100%              |
|                     |                                                                                        |labeled           |
|                     |                                                                                        |test              |
|                     |                                                                                        |solution          |
|                     |                                                                                        |was               |
|                     |                                                                                        |stable            |
|                     |                                                                                        |within            |
|                     |                                                                                        |15.3hat           |
|                     |                                                                                        |room              |
|                     |                                                                                        |temperature.      |
|                     |                                                                                        |The               |
|                     |                                                                                        |above             |
|                     |                                                                                        |solutions         |
|                     |                                                                                        |do not            |
|                     |                                                                                        |need to           |
|                     |                                                                                        |be                |
|                     |                                                                                        |usedinthe         |
|                     |                                                                                        |new               |
|                     |                                                                                        |preparation.      |
-----------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 403 of 542 





Page 404
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.4.3.5 Method Validation of assay in Finerenone** 



**I. Analytical Procedures** 



Please refer to the analytical procedures of assay in Finerenone in _section_ 



_3.2.S.4.2_ . 



**II. Validation Results and Discussion** 



**a. Selection of Detection Wavelength** 



 **Acceptance Criteria** 



The selection of detection wavelength is through the ultraviolet scanning of 



the principal component at 200nm ~ 400nm wavelength, and the principal 



component is required to have a large absorption at 251nm. 



 **Solution Preparation** 



Solvent acetonitrile: water (30:70, v/v) 



Blank solution: solvent. 



Reference solution: Accurately weigh YA2304 about 10mg of reference 



product, place it in a 25ml bottle, add an appropriate amount of solvent to 



dissolve by ultrasound, dilute it with solvent to scale, and shake well; 



Accurately measure 1ml of the above solution, place it in a 20ml measuring 



bottle, dilute it with solvent to the scale, shake well, and then obtain. (About 



0.02mg/ml) 



 **Injection procedure** 



After the chromatographic system is balanced, take blank solution and 



reference solution to inject 1 needle each, and record the chromatogram. 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 404 of 542 





Page 405
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



 **Measurement resultss** 



















--------------------------------------------------------------------------------------------------------------------------------------------
|Reference solution                                                 |Finerenone                        |9.833            |is               |
|-------------------------------------------------------------------|----------------------------------|-----------------|-----------------|
|Reference solution wavelength scan                                 |                                  |                 |                 |
|-------------------------------------------------------------------|----------------------------------|-----------------|-----------------|
|Conclusion: The principal component has greaterabsorption at 251nm.|Conclusion: The principal         |Conclusion:      |Conclusion:      |
|                                                                   |component has greaterabsorption at|The              |The              |
|                                                                   |251nm.                            |principal        |principal        |
|                                                                   |                                  |component        |component        |
|                                                                   |                                  |has              |has              |
|                                                                   |                                  |greaterabsorption|greaterabsorption|
|                                                                   |                                  |at               |at               |
|                                                                   |                                  |251nm.           |251nm.           |
--------------------------------------------------------------------------------------------------------------------------------------------

**(4.2) System applicability** 



 **Acceptance Criteria** 



The blank solution should be free from interference; The relative standard 



deviation of the main peak area should NMT 2%, the relative standard 



deviation of the main peak retention time should NMT 2.0%, the theoretical 



plate number should NLT 3000 according to the phenalidone peak, and the 



trailing factor NMT 1.5. 



 **Solution preparation** 



Blank solution: solvent. 



Reference solution: Prepare it by the same method as the reference solution 



under "4.1 wavelength selection". (Approx. 0.02mg/ml) 



 **Injection procedure** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 405 of 542 





Page 406
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



After the chromatographic system was balanced, the blank solution was 



injected with 1 needle, the control solution was injected with 6 needles again, 



and the chromatogram was recorded. 



 **Measurement resultss** 



















----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Investigation parameters                                      |1                |2                |3                |4                |5                |6                |6                |
|--------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|Retention time (min)                                          |9.852            |9.848            |9.850            |9.863            |9.862            |9.861            |0.07%            |
|--------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|Main peakarea                                                 |362915           |362748           |362771           |365085           |364069           |364169           |0.27%            |
|--------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|Main peak trailing factor                                     |1.18             |1.17             |1.18             |1.18             |1.18             |1.18             |/                |
|--------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|Main peak theoretical plate number                            |76308            |76957            |77076            |77267            |77520            |77334            |/                |
|--------------------------------------------------------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|-----------------|
|Conclusion: the blank solution has no interference; The RSD of|Conclusion:      |Conclusion:      |Conclusion:      |Conclusion:      |Conclusion:      |Conclusion:      |Conclusion:      |
|the main peak retention time was 0.07% (required not to exceed|the              |the              |the              |the              |the              |the              |the              |
|2.0%), the RSD of the peakarea was 0.27% (required not to     |blank            |blank            |blank            |blank            |blank            |blank            |blank            |
|exceed 2.0%), and the theoretical plate number of the peak of |solution         |solution         |solution         |solution         |solution         |solution         |solution         |
|finalidone was NLT 76308 (NLT 3000). The trailing factor was  |has no           |has no           |has no           |has no           |has no           |has no           |has no           |
|in the range of 1.17~1.18 (the requirement NMT 1.5). Allabove |interference;    |interference;    |interference;    |interference;    |interference;    |interference;    |interference;    |
|meet the requirements, indicating that the method has         |The RSD          |The RSD          |The RSD          |The RSD          |The RSD          |The RSD          |The RSD          |
|goodapplicability in the system.                              |of the           |of the           |of the           |of the           |of the           |of the           |of the           |
|                                                              |main             |main             |main             |main             |main             |main             |main             |
|                                                              |peak             |peak             |peak             |peak             |peak             |peak             |peak             |
|                                                              |retention        |retention        |retention        |retention        |retention        |retention        |retention        |
|                                                              |time             |time             |time             |time             |time             |time             |time             |
|                                                              |was              |was              |was              |was              |was              |was              |was              |
|                                                              |0.07%            |0.07%            |0.07%            |0.07%            |0.07%            |0.07%            |0.07%            |
|                                                              |(required        |(required        |(required        |(required        |(required        |(required        |(required        |
|                                                              |not to           |not to           |not to           |not to           |not to           |not to           |not to           |
|                                                              |exceed           |exceed           |exceed           |exceed           |exceed           |exceed           |exceed           |
|                                                              |2.0%),           |2.0%),           |2.0%),           |2.0%),           |2.0%),           |2.0%),           |2.0%),           |
|                                                              |the RSD          |the RSD          |the RSD          |the RSD          |the RSD          |the RSD          |the RSD          |
|                                                              |of the           |of the           |of the           |of the           |of the           |of the           |of the           |
|                                                              |peakarea         |peakarea         |peakarea         |peakarea         |peakarea         |peakarea         |peakarea         |
|                                                              |was              |was              |was              |was              |was              |was              |was              |
|                                                              |0.27%            |0.27%            |0.27%            |0.27%            |0.27%            |0.27%            |0.27%            |
|                                                              |(required        |(required        |(required        |(required        |(required        |(required        |(required        |
|                                                              |not to           |not to           |not to           |not to           |not to           |not to           |not to           |
|                                                              |exceed           |exceed           |exceed           |exceed           |exceed           |exceed           |exceed           |
|                                                              |2.0%),           |2.0%),           |2.0%),           |2.0%),           |2.0%),           |2.0%),           |2.0%),           |
|                                                              |and the          |and the          |and the          |and the          |and the          |and the          |and the          |
|                                                              |theoretical      |theoretical      |theoretical      |theoretical      |theoretical      |theoretical      |theoretical      |
|                                                              |plate            |plate            |plate            |plate            |plate            |plate            |plate            |
|                                                              |number           |number           |number           |number           |number           |number           |number           |
|                                                              |of the           |of the           |of the           |of the           |of the           |of the           |of the           |
|                                                              |peak of          |peak of          |peak of          |peak of          |peak of          |peak of          |peak of          |
|                                                              |finalidone       |finalidone       |finalidone       |finalidone       |finalidone       |finalidone       |finalidone       |
|                                                              |was NLT          |was NLT          |was NLT          |was NLT          |was NLT          |was NLT          |was NLT          |
|                                                              |76308            |76308            |76308            |76308            |76308            |76308            |76308            |
|                                                              |(NLT             |(NLT             |(NLT             |(NLT             |(NLT             |(NLT             |(NLT             |
|                                                              |3000).           |3000).           |3000).           |3000).           |3000).           |3000).           |3000).           |
|                                                              |The              |The              |The              |The              |The              |The              |The              |
|                                                              |trailing         |trailing         |trailing         |trailing         |trailing         |trailing         |trailing         |
|                                                              |factor           |factor           |factor           |factor           |factor           |factor           |factor           |
|                                                              |was in           |was in           |was in           |was in           |was in           |was in           |was in           |
|                                                              |the              |the              |the              |the              |the              |the              |the              |
|                                                              |range            |range            |range            |range            |range            |range            |range            |
|                                                              |of               |of               |of               |of               |of               |of               |of               |
|                                                              |1.17~1.18        |1.17~1.18        |1.17~1.18        |1.17~1.18        |1.17~1.18        |1.17~1.18        |1.17~1.18        |
|                                                              |(the             |(the             |(the             |(the             |(the             |(the             |(the             |
|                                                              |requirement      |requirement      |requirement      |requirement      |requirement      |requirement      |requirement      |
|                                                              |NMT              |NMT              |NMT              |NMT              |NMT              |NMT              |NMT              |
|                                                              |1.5).            |1.5).            |1.5).            |1.5).            |1.5).            |1.5).            |1.5).            |
|                                                              |Allabove         |Allabove         |Allabove         |Allabove         |Allabove         |Allabove         |Allabove         |
|                                                              |meet             |meet             |meet             |meet             |meet             |meet             |meet             |
|                                                              |the              |the              |the              |the              |the              |the              |the              |
|                                                              |requirements,    |requirements,    |requirements,    |requirements,    |requirements,    |requirements,    |requirements,    |
|                                                              |indicating       |indicating       |indicating       |indicating       |indicating       |indicating       |indicating       |
|                                                              |that             |that             |that             |that             |that             |that             |that             |
|                                                              |the              |the              |the              |the              |the              |the              |the              |
|                                                              |method           |method           |method           |method           |method           |method           |method           |
|                                                              |has              |has              |has              |has              |has              |has              |has              |
|                                                              |goodapplicability|goodapplicability|goodapplicability|goodapplicability|goodapplicability|goodapplicability|goodapplicability|
|                                                              |in the           |in the           |in the           |in the           |in the           |in the           |in the           |
|                                                              |system.          |system.          |system.          |system.          |system.          |system.          |system.          |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**(4.3) Linearity and range** 



 **Acceptance Criteria** 



In the concentration range equivalent to 60%~140% of the control solution, a 



relatively uniform selection of 5 concentration points, with the concentration 



as the horizontal coordinate and the peak area as the vertical coordinate as 



the linear regression curve, the correlation coefficient (R) of the regression 



curve is NLT 0.998, the RSD of the response factor should NMT 2.0%. The 



absolute value of Y-axis intercept accounts for less than 2% of 100% 



response value. 



 **Solution preparation** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 406 of 542 





Page 407
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Blank solution: solvent. 



YA2304 reference product reserve liquid: Accurately weigh YA2304 reference 



product about 10mg, place in 25ml measuring bottle, add appropriate 



amount of solvent to dissolve by ultrasound, dilute with solvent to scale, 



shake well, and then get. (About 0.4mg/ml) 



Linear solution ① : Accurately measure 0.6ml of YA2304 reference product 



reserve liquid, place it in a 20ml measuring bottle, dilute it with solvent to the 



scale, shake well, and obtain. (about 12μg/ml) 



Linear solution ② : Accurately measure 0.8ml of YA2304 reference product 



reserve liquid, place it in 20ml measuring bottle, dilute it with solvent to the 



scale, shake well, and then obtain. (about 16μg/ml) 



Linear solution ③ : Accurately measure YA2304 reference product reserve 



liquid 1.0ml, place it in a 20ml measuring bottle, dilute it with solvent to the 



scale, shake well, and then obtain. (About 20μg/ml) 



Linear solution ④ : precisely measure 1.2ml of YA2304 reference product 



reserve liquid, place it in a 20ml measuring bottle, dilute it with solvent to the 



scale, shake well, and get. (about 24μg/ml) 



Linear solution ⑤ : Accurately measure 1.4ml of YA2304 reference product 



reserve liquid, place it in 20ml measuring bottle, dilute it with solvent to the 



scale, shake well, and get. (about 28μg/ml) 



 **Injection procedure** 



After the chromatographic system was balanced, the blank solution was 



injected with 1 needle, and the 5 linear solutions were injected with 1 needle 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 407 of 542 





Page 408
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



each from low concentration to high concentration, and the chromatogram 



was recorded. 



 **Measurement resultss** 



Results of linear and range tests 



























---------------------------------------------------------------------------------------------------------------------
|Linear solution①                                               |61.79%      |12.3576     |208458      |16869       |
|---------------------------------------------------------------|------------|------------|------------|------------|
|Linear solution②                                               |82.38%      |16.4768     |275246      |16705       |
|---------------------------------------------------------------|------------|------------|------------|------------|
|Linear solution③                                               |102.98%     |20.5960     |345639      |16782       |
|---------------------------------------------------------------|------------|------------|------------|------------|
|Linear solution④                                               |123.58%     |24.7152     |416368      |16847       |
|---------------------------------------------------------------|------------|------------|------------|------------|
|Linear solution⑤                                               |144.17%     |28.8344     |484119      |16790       |
|---------------------------------------------------------------|------------|------------|------------|------------|
|Response factor RSD                                            |0.4%        |0.4%        |0.4%        |0.4%        |
|---------------------------------------------------------------|------------|------------|------------|------------|
|Linear graph                                                   |            |            |            |            |
|---------------------------------------------------------------|------------|------------|------------|------------|
|Linearequations                                                |y=16810x-256|y=16810x-256|y=16810x-256|y=16810x-256|
|---------------------------------------------------------------|------------|------------|------------|------------|
|Slope                                                          |16810       |16810       |16810       |16810       |
|---------------------------------------------------------------|------------|------------|------------|------------|
|Correlation coefficient_ r_                                    |0.99995     |0.99995     |0.99995     |0.99995     |
|---------------------------------------------------------------|------------|------------|------------|------------|
|Absolute value ofY-axisinterceptasa percentage of 100% response|0.076%      |0.076%      |0.076%      |0.076%      |
---------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 408 of 542 





Page 409
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 

-------------------------------------------------------------------------------------------------------------------------------------------
|Conclusion: When Finerenone was in the concentration range of 12.3576μg/ml~28.8344μg/ml, the linearequation   |Conclusion:               |
|wasy=16810x-256, the correlation coefficient_ r_ was 0.99995 (NLT 0.998), and the RSD of the response factor  |When                      |
|was 0.4% (NMT 2.0%). The absolute value ofY-axisinterceptasa percentage of 100% response value is 0.076% (no  |Finerenone                |
|more than 2.0% required). All of the above meet the requirements, indicating thatunder this method, when      |was in                    |
|Finerenone is in the concentration range of 12.3576μg/ml to 28.8344μg/ml, the linear relationship between     |the                       |
|peakarea and concentrationis good.                                                                            |concentration             |
|                                                                                                              |range                     |
|                                                                                                              |of                        |
|                                                                                                              |12.3576μg/ml~28.8344μg/ml,|
|                                                                                                              |the                       |
|                                                                                                              |linearequation            |
|                                                                                                              |wasy=16810x-256,          |
|                                                                                                              |the                       |
|                                                                                                              |correlation               |
|                                                                                                              |coefficient_              |
|                                                                                                              |r_ was                    |
|                                                                                                              |0.99995                   |
|                                                                                                              |(NLT                      |
|                                                                                                              |0.998),                   |
|                                                                                                              |and the                   |
|                                                                                                              |RSD of                    |
|                                                                                                              |the                       |
|                                                                                                              |response                  |
|                                                                                                              |factor                    |
|                                                                                                              |was                       |
|                                                                                                              |0.4%                      |
|                                                                                                              |(NMT                      |
|                                                                                                              |2.0%).                    |
|                                                                                                              |The                       |
|                                                                                                              |absolute                  |
|                                                                                                              |value                     |
|                                                                                                              |ofY-axisinterceptasa      |
|                                                                                                              |percentage                |
|                                                                                                              |of 100%                   |
|                                                                                                              |response                  |
|                                                                                                              |value                     |
|                                                                                                              |is                        |
|                                                                                                              |0.076%                    |
|                                                                                                              |(no                       |
|                                                                                                              |more                      |
|                                                                                                              |than                      |
|                                                                                                              |2.0%                      |
|                                                                                                              |required).                |
|                                                                                                              |All of                    |
|                                                                                                              |the                       |
|                                                                                                              |above                     |
|                                                                                                              |meet                      |
|                                                                                                              |the                       |
|                                                                                                              |requirements,             |
|                                                                                                              |indicating                |
|                                                                                                              |thatunder                 |
|                                                                                                              |this                      |
|                                                                                                              |method,                   |
|                                                                                                              |when                      |
|                                                                                                              |Finerenone                |
|                                                                                                              |is in                     |
|                                                                                                              |the                       |
|                                                                                                              |concentration             |
|                                                                                                              |range                     |
|                                                                                                              |of                        |
|                                                                                                              |12.3576μg/ml              |
|                                                                                                              |to                        |
|                                                                                                              |28.8344μg/ml,             |
|                                                                                                              |the                       |
|                                                                                                              |linear                    |
|                                                                                                              |relationship              |
|                                                                                                              |between                   |
|                                                                                                              |peakarea                  |
|                                                                                                              |and                       |
|                                                                                                              |concentrationis           |
|                                                                                                              |good.                     |
-------------------------------------------------------------------------------------------------------------------------------------------



**(4.4) Accuracy** 



 **Brief Description** 



Add YA2304 reference in the range of 80% to 120% reference solution 



concentration to the solvent; The recovery rate is required to be between 98% 



and 101%, and the RSD of recovery rate NMT 2.0%. 



 **Solution preparation** 



Blank solution: solvent 



Reference solution: Prepare it by the same method as the reference solution 



under "4.1 wavelength selection". 2 copies were prepared in parallel, in which 



the control solution ② was prepared by sharing the control product reserve 



liquid under "4.3 linearity and range". (Approx. 0.02mg/ml) 



80% recovery solution: precision weigh YA2304 reference product about 8mg, 



put it in 25ml bottle, add appropriate amount of solvent to dissolve by 



ultrasound, dilute with solvent to scale, shake well; Accurately measure 1ml 



of the above solution, place it in a 20ml measuring bottle, dilute it with 



solvent to the scale, shake well, and then obtain. Prepare 3 servings in 



parallel (about 0.016mg/ml) 



100% recovery solution: accurately weigh YA2304 reference product about 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 409 of 542 





Page 410
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



10mg, put it in 25ml bottle, add appropriate amount of solvent to dissolve by 



ultrasound, dilute it with solvent to scale, shake well; Accurately measure 



1ml of the above solution, place it in a 20ml measuring bottle, dilute it with 



solvent to the scale, shake well, and then obtain. Prepare 3 servings in 



parallel (about 0.02mg/ml) 



120% recovery solution: accurately weigh YA2304 reference product about 



12mg, place it in 25ml bottle, add appropriate amount of solvent to dissolve 



by ultrasound, dilute it with solvent to scale, shake well; Accurately measure 



1ml of the above solution, place it in a 20ml measuring bottle, dilute it with 



solvent to the scale, shake well, and then obtain. Prepare 3 servings in 



parallel (about 0.024mg/ml) 



 **Injection procedure** 



After the chromatographic system was balanced, the blank solution was 



injected with 1 needle, the control solution (1) was injected with 6 needles, 



the control solution (2) was injected with 2 needles, the 9 recovery solutions 



were injected with 1 needle each, and the chromatogram was recorded. 



 **Measurement resultss** 



























-------------------------------------------------------------------
|80% recovery solution -1 |16.0417|16.1074|100.4% |99.9%  |0.6%   |
|-------------------------|-------|-------|-------|-------|-------|
|80% recovery solution -2 |16.0038|15.9873|99.9%  |99.9%  |99.9%  |
|-------------------------|-------|-------|-------|-------|-------|
|80% recovery solution -3 |16.0597|16.0472|99.9%  |99.9%  |99.9%  |
|-------------------------|-------|-------|-------|-------|-------|
|100% recovery solution -1|20.7416|20.7942|100.3% |100.3% |100.3% |
|-------------------------|-------|-------|-------|-------|-------|
|100% recovery            |20.6977|20.6882|100.0% |100.0% |100.0% |
-------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 410 of 542 





Page 411
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 

------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|100% recovery solution -3                                                     |20.6897                  |20.7189                  |100.1%                   |100.1%                   |100.1%                   |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|120% recovery solution -1                                                     |24.3747                  |24.2658                  |99.6%                    |99.6%                    |99.6%                    |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|120% recovery solution -2                                                     |24.2889                  |23.9431                  |98.6%                    |98.6%                    |98.6%                    |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|120% recovery solution -3                                                     |24.4963                  |24.5611                  |100.3%                   |100.3%                   |100.3%                   |
|------------------------------------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|Conclusion: 16.0038μg/ml~24.4963μg/ml of YA2304 wasaddedinto the solvent. The |Conclusion:              |Conclusion:              |Conclusion:              |Conclusion:              |Conclusion:              |
|recoveries were 98.6%~100.4% (the requirement was 98%~101%), and the RSD of   |16.0038μg/ml~24.4963μg/ml|16.0038μg/ml~24.4963μg/ml|16.0038μg/ml~24.4963μg/ml|16.0038μg/ml~24.4963μg/ml|16.0038μg/ml~24.4963μg/ml|
|the recovery was 0.6% (the requirement was not more than 2.0%). All the above |of                       |of                       |of                       |of                       |of                       |
|met the verification requirements, indicating the accuracy of the method was  |YA2304                   |YA2304                   |YA2304                   |YA2304                   |YA2304                   |
|good.                                                                         |wasaddedinto             |wasaddedinto             |wasaddedinto             |wasaddedinto             |wasaddedinto             |
|                                                                              |the                      |the                      |the                      |the                      |the                      |
|                                                                              |solvent.                 |solvent.                 |solvent.                 |solvent.                 |solvent.                 |
|                                                                              |The                      |The                      |The                      |The                      |The                      |
|                                                                              |recoveries               |recoveries               |recoveries               |recoveries               |recoveries               |
|                                                                              |were                     |were                     |were                     |were                     |were                     |
|                                                                              |98.6%~100.4%             |98.6%~100.4%             |98.6%~100.4%             |98.6%~100.4%             |98.6%~100.4%             |
|                                                                              |(the                     |(the                     |(the                     |(the                     |(the                     |
|                                                                              |requirement              |requirement              |requirement              |requirement              |requirement              |
|                                                                              |was                      |was                      |was                      |was                      |was                      |
|                                                                              |98%~101%),               |98%~101%),               |98%~101%),               |98%~101%),               |98%~101%),               |
|                                                                              |and the                  |and the                  |and the                  |and the                  |and the                  |
|                                                                              |RSD of                   |RSD of                   |RSD of                   |RSD of                   |RSD of                   |
|                                                                              |the                      |the                      |the                      |the                      |the                      |
|                                                                              |recovery                 |recovery                 |recovery                 |recovery                 |recovery                 |
|                                                                              |was                      |was                      |was                      |was                      |was                      |
|                                                                              |0.6%                     |0.6%                     |0.6%                     |0.6%                     |0.6%                     |
|                                                                              |(the                     |(the                     |(the                     |(the                     |(the                     |
|                                                                              |requirement              |requirement              |requirement              |requirement              |requirement              |
|                                                                              |was not                  |was not                  |was not                  |was not                  |was not                  |
|                                                                              |more                     |more                     |more                     |more                     |more                     |
|                                                                              |than                     |than                     |than                     |than                     |than                     |
|                                                                              |2.0%).                   |2.0%).                   |2.0%).                   |2.0%).                   |2.0%).                   |
|                                                                              |All the                  |All the                  |All the                  |All the                  |All the                  |
|                                                                              |above                    |above                    |above                    |above                    |above                    |
|                                                                              |met the                  |met the                  |met the                  |met the                  |met the                  |
|                                                                              |verification             |verification             |verification             |verification             |verification             |
|                                                                              |requirements,            |requirements,            |requirements,            |requirements,            |requirements,            |
|                                                                              |indicating               |indicating               |indicating               |indicating               |indicating               |
|                                                                              |the                      |the                      |the                      |the                      |the                      |
|                                                                              |accuracy                 |accuracy                 |accuracy                 |accuracy                 |accuracy                 |
|                                                                              |of the                   |of the                   |of the                   |of the                   |of the                   |
|                                                                              |method                   |method                   |method                   |method                   |method                   |
|                                                                              |was                      |was                      |was                      |was                      |was                      |
|                                                                              |good.                    |good.                    |good.                    |good.                    |good.                    |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



**(4.5) Precision** 



Precision refers to the proximity between the results obtained by multiple 



sampling of the same uniform test product under specified test conditions, 



and its precision is judged by examining repeatability and intermediate 



precision. 



**(4.5.1) Repeatability** 



 **Acceptance Criteria** 



The analyst A prepared 6 repeatable sample solutions on the date A, 



measured by instrument A, requiring the first reference solution to be 



continuously sampled for 6 times, the relative standard deviation of the main 



peak area should NMT 2%, the relative standard deviation of the main peak 



retention time should NMT 2.0%, and the theoretical plate number should 



NLT 3000 calculated according to the peak of Finerenone. The trailing factor 



NMT 1.5; The RSD of principal component in 6 repeatable test product 



solutions NMT 1.0%. 



 **Solution preparation** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 411 of 542 





Page 412
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Blank solution: solvent 



Reference solution: Prepare it by the same method as the reference solution 



under "4.1 wavelength selection". Prepare 2 parts in parallel. (Approx. 



0.02mg/ml) 



Repeatable test product solution: accurately weigh about 10mg of this 



product, place it in 25ml measuring bottle, add appropriate amount of 



solvent and ultrasonic to dissolve, dilute it with solvent to scale, shake well; 



Accurately measure 1ml of the above solution, place it in a 20ml measuring 



bottle, dilute it with solvent to the scale, shake well, and then get. Prepare 6 



parts in parallel. (Approx. 0.02mg/ml) 



 **Injection procedure** 



After the chromatographic system was balanced, the blank solution was 



injected with 1 needle, the control solution (1) was injected with 6 needles, 



the control solution (2) was injected with 2 needles, each of the 6 repetitive 



test solutions was injected with 1 needle, and the chromatogram was 



recorded. 



 **Measurement results** 



Results of repeatability - system suitability test 


















-------------------------------------------------------------------------------------
|Investigation parameters   |1      |2      |3      |4      |5      |6      |6      |
|---------------------------|-------|-------|-------|-------|-------|-------|-------|
|Retention time (min)       |9.882  |9.884  |9.883  |9.886  |9.883  |9.885  |0.015 %|
|---------------------------|-------|-------|-------|-------|-------|-------|-------|
|Main peakarea              |340753 |340305 |340824 |341335 |340663 |340895 |0.10%  |
|---------------------------|-------|-------|-------|-------|-------|-------|-------|
|Main peak trailing factor  |1.18   |1.19   |1.18   |1.19   |1.19   |1.19   |/      |
|---------------------------|-------|-------|-------|-------|-------|-------|-------|
|Main peak theoretical plate|79832  |79779  |80060  |79587  |79934  |79660  |/      |
-------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 412 of 542 





Page 413
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 

------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Conclusion: the blank solution has no interference; The RSD of|Conclusion:  |Conclusion:  |Conclusion:  |Conclusion:  |Conclusion:  |Conclusion:  |Conclusion:  |
|the main peak retention time was 0.015% (required not to      |the          |the          |the          |the          |the          |the          |the          |
|exceed 2.0%), the RSD of the peakarea was 0.10% (required not |blank        |blank        |blank        |blank        |blank        |blank        |blank        |
|to exceed 2.0%), and the theoretical plate number of the peak |solution     |solution     |solution     |solution     |solution     |solution     |solution     |
|of finalidone was NLT 79587 (NLT 3000). The trailing factoris |has no       |has no       |has no       |has no       |has no       |has no       |has no       |
|in the range of 1.18~1.19 (the requirement NMT 1.5). The above|interference;|interference;|interference;|interference;|interference;|interference;|interference;|
|all meet the verification requirements, indicating that the   |The RSD      |The RSD      |The RSD      |The RSD      |The RSD      |The RSD      |The RSD      |
|suitability of the system meets the requirements.             |of the       |of the       |of the       |of the       |of the       |of the       |of the       |
|                                                              |main         |main         |main         |main         |main         |main         |main         |
|                                                              |peak         |peak         |peak         |peak         |peak         |peak         |peak         |
|                                                              |retention    |retention    |retention    |retention    |retention    |retention    |retention    |
|                                                              |time         |time         |time         |time         |time         |time         |time         |
|                                                              |was          |was          |was          |was          |was          |was          |was          |
|                                                              |0.015%       |0.015%       |0.015%       |0.015%       |0.015%       |0.015%       |0.015%       |
|                                                              |(required    |(required    |(required    |(required    |(required    |(required    |(required    |
|                                                              |not to       |not to       |not to       |not to       |not to       |not to       |not to       |
|                                                              |exceed       |exceed       |exceed       |exceed       |exceed       |exceed       |exceed       |
|                                                              |2.0%),       |2.0%),       |2.0%),       |2.0%),       |2.0%),       |2.0%),       |2.0%),       |
|                                                              |the RSD      |the RSD      |the RSD      |the RSD      |the RSD      |the RSD      |the RSD      |
|                                                              |of the       |of the       |of the       |of the       |of the       |of the       |of the       |
|                                                              |peakarea     |peakarea     |peakarea     |peakarea     |peakarea     |peakarea     |peakarea     |
|                                                              |was          |was          |was          |was          |was          |was          |was          |
|                                                              |0.10%        |0.10%        |0.10%        |0.10%        |0.10%        |0.10%        |0.10%        |
|                                                              |(required    |(required    |(required    |(required    |(required    |(required    |(required    |
|                                                              |not to       |not to       |not to       |not to       |not to       |not to       |not to       |
|                                                              |exceed       |exceed       |exceed       |exceed       |exceed       |exceed       |exceed       |
|                                                              |2.0%),       |2.0%),       |2.0%),       |2.0%),       |2.0%),       |2.0%),       |2.0%),       |
|                                                              |and the      |and the      |and the      |and the      |and the      |and the      |and the      |
|                                                              |theoretical  |theoretical  |theoretical  |theoretical  |theoretical  |theoretical  |theoretical  |
|                                                              |plate        |plate        |plate        |plate        |plate        |plate        |plate        |
|                                                              |number       |number       |number       |number       |number       |number       |number       |
|                                                              |of the       |of the       |of the       |of the       |of the       |of the       |of the       |
|                                                              |peak of      |peak of      |peak of      |peak of      |peak of      |peak of      |peak of      |
|                                                              |finalidone   |finalidone   |finalidone   |finalidone   |finalidone   |finalidone   |finalidone   |
|                                                              |was NLT      |was NLT      |was NLT      |was NLT      |was NLT      |was NLT      |was NLT      |
|                                                              |79587        |79587        |79587        |79587        |79587        |79587        |79587        |
|                                                              |(NLT         |(NLT         |(NLT         |(NLT         |(NLT         |(NLT         |(NLT         |
|                                                              |3000).       |3000).       |3000).       |3000).       |3000).       |3000).       |3000).       |
|                                                              |The          |The          |The          |The          |The          |The          |The          |
|                                                              |trailing     |trailing     |trailing     |trailing     |trailing     |trailing     |trailing     |
|                                                              |factoris     |factoris     |factoris     |factoris     |factoris     |factoris     |factoris     |
|                                                              |in the       |in the       |in the       |in the       |in the       |in the       |in the       |
|                                                              |range        |range        |range        |range        |range        |range        |range        |
|                                                              |of           |of           |of           |of           |of           |of           |of           |
|                                                              |1.18~1.19    |1.18~1.19    |1.18~1.19    |1.18~1.19    |1.18~1.19    |1.18~1.19    |1.18~1.19    |
|                                                              |(the         |(the         |(the         |(the         |(the         |(the         |(the         |
|                                                              |requirement  |requirement  |requirement  |requirement  |requirement  |requirement  |requirement  |
|                                                              |NMT          |NMT          |NMT          |NMT          |NMT          |NMT          |NMT          |
|                                                              |1.5).        |1.5).        |1.5).        |1.5).        |1.5).        |1.5).        |1.5).        |
|                                                              |The          |The          |The          |The          |The          |The          |The          |
|                                                              |above        |above        |above        |above        |above        |above        |above        |
|                                                              |all          |all          |all          |all          |all          |all          |all          |
|                                                              |meet         |meet         |meet         |meet         |meet         |meet         |meet         |
|                                                              |the          |the          |the          |the          |the          |the          |the          |
|                                                              |verification |verification |verification |verification |verification |verification |verification |
|                                                              |requirements,|requirements,|requirements,|requirements,|requirements,|requirements,|requirements,|
|                                                              |indicating   |indicating   |indicating   |indicating   |indicating   |indicating   |indicating   |
|                                                              |that         |that         |that         |that         |that         |that         |that         |
|                                                              |the          |the          |the          |the          |the          |the          |the          |
|                                                              |suitability  |suitability  |suitability  |suitability  |suitability  |suitability  |suitability  |
|                                                              |of the       |of the       |of the       |of the       |of the       |of the       |of the       |
|                                                              |system       |system       |system       |system       |system       |system       |system       |
|                                                              |meets        |meets        |meets        |meets        |meets        |meets        |meets        |
|                                                              |the          |the          |the          |the          |the          |the          |the          |
|                                                              |requirements.|requirements.|requirements.|requirements.|requirements.|requirements.|requirements.|
------------------------------------------------------------------------------------------------------------------------------------------------------------------



Repeatability test results 































-------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Investigati onitems                                           |Repetiti      |Repetiti      |Repetiti      |Repetiti      |Repetiti      |Repetiti      |Repetiti      |
|                                                              |ve test       |ve test       |ve test       |ve test       |ve test       |ve test       |ve test       |
|                                                              |product       |product       |product       |product       |product       |product       |product       |
|                                                              |solution      |solution      |solution      |solution      |solution      |solution      |solution      |
|                                                              |1             |2             |3             |4             |5             |6             |6             |
|--------------------------------------------------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Principal component content                                   |99.1%         |99.3%         |98.9%         |100.0%        |99.7%         |99.3%         |0.5%          |
|--------------------------------------------------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Conclusion: The RSD of principal component in 6 repeatable    |Conclusion:   |Conclusion:   |Conclusion:   |Conclusion:   |Conclusion:   |Conclusion:   |Conclusion:   |
|samples was 0.5% (the requirement NMT 1.0%), which met the    |The RSD       |The RSD       |The RSD       |The RSD       |The RSD       |The RSD       |The RSD       |
|verification requirements, indicating that the method had good|of            |of            |of            |of            |of            |of            |of            |
|repeatability.                                                |principal     |principal     |principal     |principal     |principal     |principal     |principal     |
|                                                              |component     |component     |component     |component     |component     |component     |component     |
|                                                              |in 6          |in 6          |in 6          |in 6          |in 6          |in 6          |in 6          |
|                                                              |repeatable    |repeatable    |repeatable    |repeatable    |repeatable    |repeatable    |repeatable    |
|                                                              |samples       |samples       |samples       |samples       |samples       |samples       |samples       |
|                                                              |was 0.5%      |was 0.5%      |was 0.5%      |was 0.5%      |was 0.5%      |was 0.5%      |was 0.5%      |
|                                                              |(the          |(the          |(the          |(the          |(the          |(the          |(the          |
|                                                              |requirement   |requirement   |requirement   |requirement   |requirement   |requirement   |requirement   |
|                                                              |NMT           |NMT           |NMT           |NMT           |NMT           |NMT           |NMT           |
|                                                              |1.0%),        |1.0%),        |1.0%),        |1.0%),        |1.0%),        |1.0%),        |1.0%),        |
|                                                              |which         |which         |which         |which         |which         |which         |which         |
|                                                              |met the       |met the       |met the       |met the       |met the       |met the       |met the       |
|                                                              |verification  |verification  |verification  |verification  |verification  |verification  |verification  |
|                                                              |requirements, |requirements, |requirements, |requirements, |requirements, |requirements, |requirements, |
|                                                              |indicating    |indicating    |indicating    |indicating    |indicating    |indicating    |indicating    |
|                                                              |that the      |that the      |that the      |that the      |that the      |that the      |that the      |
|                                                              |method        |method        |method        |method        |method        |method        |method        |
|                                                              |had good      |had good      |had good      |had good      |had good      |had good      |had good      |
|                                                              |repeatability.|repeatability.|repeatability.|repeatability.|repeatability.|repeatability.|repeatability.|
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**(4.5.2) Intermediate precision** 



 **sketch** 



6 intermediate precision test product solutions were prepared by Analyst B 



on date B. The relative standard deviation of the main peak area should NMT 



2%, the relative standard deviation of the main peak retention time should 



NMT 2.0%, the theoretical plate number should NLT 3000, and the trailing 



factor NMT 1.5. The RSD of principal component in 6 intermediate precision 



test product solutions NMT 1.0%. 



For the results of 12 tests of repeatability and intermediate precision, the 



RSD of principal component content NMT 2.0%. 



 **Solution preparation** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 413 of 542 





Page 414
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Blank solution: thinner 



Reference solution: Prepare it by the same method as the reference solution 



under "4.1 wavelength selection". 2 copies were prepared in parallel, in which 



the control solution (1) shared the control solution under "4.1 wavelength 



selection". (Approx. 0.02mg/ml) 



Intermediate precision test product solution: accurately weigh about 10mg of 



this product, place it in a 25ml measuring bottle, add an appropriate amount 



of diluent to dissolve by ultrasound, dilute it with diluent to the scale, and 



shake well; Precision measure 1ml of the above solution, place it in a 20ml 



measuring bottle, dilute it with diluent to the scale, shake well, and then get. 



Prepare 6 parts in parallel. (Approx. 0.02mg/ml) 



 **Injection procedure** 



After the chromatographic system is balanced, take blank solution into 1 



needle, control solution 1 into 6 needles, control solution 2 into 2 needles, 6 



intermediate precision test solution 1 needle each, record the chromatogram. 



 **Measurement results** 



Results of intermediate precision - system suitability test 



















------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Investigation parameters                                      |1            |2            |3            |4            |5            |6            |6            |
|--------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|-------------|-------------|
|Retention time (min)                                          |9.809        |9.798        |9.788        |9.785        |9.796        |9.795        |0.09%        |
|--------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|-------------|-------------|
|Main peakarea                                                 |344187       |345304       |345625       |345620       |345536       |345986       |0.19%        |
|--------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|-------------|-------------|
|Main peak trailing factor                                     |1.23         |1.23         |1.23         |1.23         |1.23         |1.22         |/            |
|--------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|-------------|-------------|
|Main peak theoretical plate number                            |50253        |48230        |48071        |47066        |48322        |48600        |/            |
|--------------------------------------------------------------|-------------|-------------|-------------|-------------|-------------|-------------|-------------|
|Conclusion: the blank solution has no interference; The RSD of|Conclusion:  |Conclusion:  |Conclusion:  |Conclusion:  |Conclusion:  |Conclusion:  |Conclusion:  |
|the main peak                                                 |the          |the          |the          |the          |the          |the          |the          |
|                                                              |blank        |blank        |blank        |blank        |blank        |blank        |blank        |
|                                                              |solution     |solution     |solution     |solution     |solution     |solution     |solution     |
|                                                              |has no       |has no       |has no       |has no       |has no       |has no       |has no       |
|                                                              |interference;|interference;|interference;|interference;|interference;|interference;|interference;|
|                                                              |The RSD      |The RSD      |The RSD      |The RSD      |The RSD      |The RSD      |The RSD      |
|                                                              |of the       |of the       |of the       |of the       |of the       |of the       |of the       |
|                                                              |main         |main         |main         |main         |main         |main         |main         |
|                                                              |peak         |peak         |peak         |peak         |peak         |peak         |peak         |
------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 414 of 542 





Page 415
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



retention time was 0.09% (required not to exceed 2.0%), the RSD of the peak area was 



0.19% (required not to exceed 2.0%), and the theoretical plate number of the peak of 



finalidone was NLT 47066 (NLT 3000). The trailing factor was in the range of 



1.22~1.23 (the requirement NMT 1.5). The above all meet the verification 



requirements, indicating that the suitability of the system meets the requirements. 



Precision test results 






















----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Investigationitems                                    |1              |2              |3              |4              |5              |6              |6              |6              |
|------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|Principal component content                           |99.1%          |99.3%          |98.9%          |100.0 %        |99.7%          |99.3%          |0.5%           |0.5%           |
|------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|Items to examine                                      |Intermediate   |Intermediate   |Intermediate   |Intermediate   |Intermediate   |Intermediate   |RSD            |0.4%           |
|                                                      |precision      |precision      |precision      |precision      |precision      |precision      |(n=6)          |               |
|                                                      |test           |test           |test           |test           |test           |test           |               |               |
|                                                      |product        |product        |product        |product        |product        |product        |               |               |
|                                                      |solution       |solution       |solution       |solution       |solution       |solution       |               |               |
|------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|Items to examine                                      |1              |2              |3              |4              |5              |6              |6              |6              |
|------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|Principal component content                           |99.5%          |99.0%          |99.7%          |99.4%          |99.5%          |98.8%          |0.4%           |0.4%           |
|------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|Conclusion: The RSD of principal component in 6       |Conclusion:    |Conclusion:    |Conclusion:    |Conclusion:    |Conclusion:    |Conclusion:    |Conclusion:    |Conclusion:    |
|intermediate precision test solutions was 0.4% (the   |The RSD of     |The RSD of     |The RSD of     |The RSD of     |The RSD of     |The RSD of     |The RSD        |The RSD        |
|requirement NMT 1.0%), which met the verification     |principal      |principal      |principal      |principal      |principal      |principal      |of             |of             |
|requirements, indicating that the intermediate        |component in   |component in   |component in   |component in   |component in   |component in   |principal      |principal      |
|precision of the method was good. The RSD of principal|6              |6              |6              |6              |6              |6              |component      |component      |
|component in 12 repetitive sample solutions           |intermediate   |intermediate   |intermediate   |intermediate   |intermediate   |intermediate   |in 6           |in 6           |
|andintermediate precision sample solutions was 0.4%   |precision      |precision      |precision      |precision      |precision      |precision      |intermediate   |intermediate   |
|(the requirement NMT 2.0%), which met the verification|test           |test           |test           |test           |test           |test           |precision      |precision      |
|requirements, indicating that the method was of good  |solutions      |solutions      |solutions      |solutions      |solutions      |solutions      |test           |test           |
|precision.                                            |was 0.4%       |was 0.4%       |was 0.4%       |was 0.4%       |was 0.4%       |was 0.4%       |solutions      |solutions      |
|                                                      |(the           |(the           |(the           |(the           |(the           |(the           |was            |was            |
|                                                      |requirement    |requirement    |requirement    |requirement    |requirement    |requirement    |0.4%           |0.4%           |
|                                                      |NMT 1.0%),     |NMT 1.0%),     |NMT 1.0%),     |NMT 1.0%),     |NMT 1.0%),     |NMT 1.0%),     |(the           |(the           |
|                                                      |which met      |which met      |which met      |which met      |which met      |which met      |requirement    |requirement    |
|                                                      |the            |the            |the            |the            |the            |the            |NMT            |NMT            |
|                                                      |verification   |verification   |verification   |verification   |verification   |verification   |1.0%),         |1.0%),         |
|                                                      |requirements,  |requirements,  |requirements,  |requirements,  |requirements,  |requirements,  |which          |which          |
|                                                      |indicating     |indicating     |indicating     |indicating     |indicating     |indicating     |met the        |met the        |
|                                                      |that the       |that the       |that the       |that the       |that the       |that the       |verification   |verification   |
|                                                      |intermediate   |intermediate   |intermediate   |intermediate   |intermediate   |intermediate   |requirements,  |requirements,  |
|                                                      |precision of   |precision of   |precision of   |precision of   |precision of   |precision of   |indicating     |indicating     |
|                                                      |the method     |the method     |the method     |the method     |the method     |the method     |that           |that           |
|                                                      |was good.      |was good.      |was good.      |was good.      |was good.      |was good.      |the            |the            |
|                                                      |The RSD of     |The RSD of     |The RSD of     |The RSD of     |The RSD of     |The RSD of     |intermediate   |intermediate   |
|                                                      |principal      |principal      |principal      |principal      |principal      |principal      |precision      |precision      |
|                                                      |component in   |component in   |component in   |component in   |component in   |component in   |of the         |of the         |
|                                                      |12             |12             |12             |12             |12             |12             |method         |method         |
|                                                      |repetitive     |repetitive     |repetitive     |repetitive     |repetitive     |repetitive     |was            |was            |
|                                                      |sample         |sample         |sample         |sample         |sample         |sample         |good.          |good.          |
|                                                      |solutions      |solutions      |solutions      |solutions      |solutions      |solutions      |The RSD        |The RSD        |
|                                                      |andintermediate|andintermediate|andintermediate|andintermediate|andintermediate|andintermediate|of             |of             |
|                                                      |precision      |precision      |precision      |precision      |precision      |precision      |principal      |principal      |
|                                                      |sample         |sample         |sample         |sample         |sample         |sample         |component      |component      |
|                                                      |solutions      |solutions      |solutions      |solutions      |solutions      |solutions      |in 12          |in 12          |
|                                                      |was 0.4%       |was 0.4%       |was 0.4%       |was 0.4%       |was 0.4%       |was 0.4%       |repetitive     |repetitive     |
|                                                      |(the           |(the           |(the           |(the           |(the           |(the           |sample         |sample         |
|                                                      |requirement    |requirement    |requirement    |requirement    |requirement    |requirement    |solutions      |solutions      |
|                                                      |NMT 2.0%),     |NMT 2.0%),     |NMT 2.0%),     |NMT 2.0%),     |NMT 2.0%),     |NMT 2.0%),     |andintermediate|andintermediate|
|                                                      |which met      |which met      |which met      |which met      |which met      |which met      |precision      |precision      |
|                                                      |the            |the            |the            |the            |the            |the            |sample         |sample         |
|                                                      |verification   |verification   |verification   |verification   |verification   |verification   |solutions      |solutions      |
|                                                      |requirements,  |requirements,  |requirements,  |requirements,  |requirements,  |requirements,  |was            |was            |
|                                                      |indicating     |indicating     |indicating     |indicating     |indicating     |indicating     |0.4%           |0.4%           |
|                                                      |that the       |that the       |that the       |that the       |that the       |that the       |(the           |(the           |
|                                                      |method was     |method was     |method was     |method was     |method was     |method was     |requirement    |requirement    |
|                                                      |of good        |of good        |of good        |of good        |of good        |of good        |NMT            |NMT            |
|                                                      |precision.     |precision.     |precision.     |precision.     |precision.     |precision.     |2.0%),         |2.0%),         |
|                                                      |               |               |               |               |               |               |which          |which          |
|                                                      |               |               |               |               |               |               |met the        |met the        |
|                                                      |               |               |               |               |               |               |verification   |verification   |
|                                                      |               |               |               |               |               |               |requirements,  |requirements,  |
|                                                      |               |               |               |               |               |               |indicating     |indicating     |
|                                                      |               |               |               |               |               |               |that           |that           |
|                                                      |               |               |               |               |               |               |the            |the            |
|                                                      |               |               |               |               |               |               |method         |method         |
|                                                      |               |               |               |               |               |               |was of         |was of         |
|                                                      |               |               |               |               |               |               |good           |good           |
|                                                      |               |               |               |               |               |               |precision.     |precision.     |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**(4.6) Stability of the solution** 



 **Acceptance Criteria** 



Each solution is placed under the 5℃ injector, the control solution and the 



test product solution are injected at different time points, and the theoretical 



plate number in the control solution is required to be NLT 3000 according to 



the peak of Finerenone, and the tail factor NMT 1.5; The RSD of the main 



peak-peak area between the control solution and the test solution NMT 2.0%, 



and no new impurities interfering with the detection of principal components 



should be added. 



 **Solution preparation** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 415 of 542 





Page 416
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Blank solution: solvent. 



Reference solution: Share the reference solution under "4.2 System 



Suitability". (Approx. 0.02mg/ml) 



Test product solution: accurately weigh about 10mg of this product, put it in 



25ml measuring bottle, add appropriate amount of solvent to dissolve by 



ultrasound, dilute it with solvent to scale, shake well; Accurately measure 



1ml of the above solution, place it in a 20ml measuring bottle, dilute it with 



solvent to the scale, shake well, and then get. (About 0.02mg/ml) 



 **Injection procedure** 



After the chromatographic system was balanced, the control solution placed 



in the 5℃ injector was injected at 0h, 2h, 4h, 6h, 12h, 24h, 39h, 54h and 75h, 



and the chromatogram was recorded. (Chromatograms of reference solution 



0h and 2h share the chromatograms of reference solution 1 and 5 with 



repeated injection of 6 needles under "4.2 System Suitability", respectively) 



After the chromatographic system was balanced, the test solution placed in 



the 5℃ injector was injected at 0h, 2h, 4h, 10h, 22h, 37h, 52h and 73h 



respectively, and the chromatogram was recorded. 



 **Results of Determination** 






















-------------------------------------------------------------------------------------------------------------------------
|Reference solution|Reference solution|Reference solution       |Reference solution                |Test       |Test    |
|                  |                  |                         |                                  |product    |product |
|                  |                  |                         |                                  |solution   |solution|
|------------------|------------------|-------------------------|----------------------------------|-----------|--------|
|Inspection time   |Main peakarea     |Main peak trailing factor|Main peak theoretical plate number|Survey time|Main    |
|                  |                  |                         |                                  |           |peakarea|
|------------------|------------------|-------------------------|----------------------------------|-----------|--------|
|0h                |362915            |1.18                     |76308                             |0h         |346965  |
|------------------|------------------|-------------------------|----------------------------------|-----------|--------|
|2h                |364069            |1.18                     |77520                             |2h         |347156  |
|------------------|------------------|-------------------------|----------------------------------|-----------|--------|
|4h                |364017            |1.18                     |76537                             |4h         |348093  |
|------------------|------------------|-------------------------|----------------------------------|-----------|--------|
|6h                |364517            |1.18                     |77200                             |10h        |351717  |
|------------------|------------------|-------------------------|----------------------------------|-----------|--------|
|12h               |365302            |1.18                     |77107                             |22h        |355761  |
|------------------|------------------|-------------------------|----------------------------------|-----------|--------|
|24h               |366661            |1.18                     |79369                             |37h        |347277  |
-------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 416 of 542 





Page 417
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 

----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|54h                                                                           |365063               |1.19                 |81912                |73h                  |360143               |
|------------------------------------------------------------------------------|---------------------|---------------------|---------------------|---------------------|---------------------|
|75h                                                                           |369263               |1.20                 |82877                |/                    |/                    |
|------------------------------------------------------------------------------|---------------------|---------------------|---------------------|---------------------|---------------------|
|RSD                                                                           |0.6%                 |/                    |/                    |/                    |1.4%                 |
|------------------------------------------------------------------------------|---------------------|---------------------|---------------------|---------------------|---------------------|
|Verdict: ①The control solution was placedunder the sample injector at 5℃for   |Verdict:             |Verdict:             |Verdict:             |Verdict:             |Verdict:             |
|75h, the peakarea RSD of the main peakarea was 0.6% (required not to exceed   |①The                 |①The                 |①The                 |①The                 |①The                 |
|2.0%), the theoretical plate number of the peak of finalidone was NLT 76308   |control              |control              |control              |control              |control              |
|(NLT 3000), and the trailing factor was in the range of 1.18~1.20 (required   |solution             |solution             |solution             |solution             |solution             |
|not to exceed 1.5). And no impuritiesinterfering with the detection of        |was                  |was                  |was                  |was                  |was                  |
|Finerenone content were produced, indicating that the reference solution was  |placedunder          |placedunder          |placedunder          |placedunder          |placedunder          |
|stable within 75hafter being placedunder the 5℃injector. ②The sample solution |the                  |the                  |the                  |the                  |the                  |
|was placedunder the 5℃injector for 73h, the RSD of the main peakarea was 1.4% |sample               |sample               |sample               |sample               |sample               |
|(required not to exceed 2.0%), and no impuritiesinterfered with the detection |injector             |injector             |injector             |injector             |injector             |
|of fineridone content, indicating that the sample solution was stable within  |at                   |at                   |at                   |at                   |at                   |
|73hunder the 5℃injector.                                                      |5℃for                |5℃for                |5℃for                |5℃for                |5℃for                |
|                                                                              |75h,                 |75h,                 |75h,                 |75h,                 |75h,                 |
|                                                                              |the                  |the                  |the                  |the                  |the                  |
|                                                                              |peakarea             |peakarea             |peakarea             |peakarea             |peakarea             |
|                                                                              |RSD of               |RSD of               |RSD of               |RSD of               |RSD of               |
|                                                                              |the                  |the                  |the                  |the                  |the                  |
|                                                                              |main                 |main                 |main                 |main                 |main                 |
|                                                                              |peakarea             |peakarea             |peakarea             |peakarea             |peakarea             |
|                                                                              |was                  |was                  |was                  |was                  |was                  |
|                                                                              |0.6%                 |0.6%                 |0.6%                 |0.6%                 |0.6%                 |
|                                                                              |(required            |(required            |(required            |(required            |(required            |
|                                                                              |not to               |not to               |not to               |not to               |not to               |
|                                                                              |exceed               |exceed               |exceed               |exceed               |exceed               |
|                                                                              |2.0%),               |2.0%),               |2.0%),               |2.0%),               |2.0%),               |
|                                                                              |the                  |the                  |the                  |the                  |the                  |
|                                                                              |theoretical          |theoretical          |theoretical          |theoretical          |theoretical          |
|                                                                              |plate                |plate                |plate                |plate                |plate                |
|                                                                              |number               |number               |number               |number               |number               |
|                                                                              |of the               |of the               |of the               |of the               |of the               |
|                                                                              |peak of              |peak of              |peak of              |peak of              |peak of              |
|                                                                              |finalidone           |finalidone           |finalidone           |finalidone           |finalidone           |
|                                                                              |was NLT              |was NLT              |was NLT              |was NLT              |was NLT              |
|                                                                              |76308                |76308                |76308                |76308                |76308                |
|                                                                              |(NLT                 |(NLT                 |(NLT                 |(NLT                 |(NLT                 |
|                                                                              |3000),               |3000),               |3000),               |3000),               |3000),               |
|                                                                              |and the              |and the              |and the              |and the              |and the              |
|                                                                              |trailing             |trailing             |trailing             |trailing             |trailing             |
|                                                                              |factor               |factor               |factor               |factor               |factor               |
|                                                                              |was in               |was in               |was in               |was in               |was in               |
|                                                                              |the                  |the                  |the                  |the                  |the                  |
|                                                                              |range                |range                |range                |range                |range                |
|                                                                              |of                   |of                   |of                   |of                   |of                   |
|                                                                              |1.18~1.20            |1.18~1.20            |1.18~1.20            |1.18~1.20            |1.18~1.20            |
|                                                                              |(required            |(required            |(required            |(required            |(required            |
|                                                                              |not to               |not to               |not to               |not to               |not to               |
|                                                                              |exceed               |exceed               |exceed               |exceed               |exceed               |
|                                                                              |1.5).                |1.5).                |1.5).                |1.5).                |1.5).                |
|                                                                              |And no               |And no               |And no               |And no               |And no               |
|                                                                              |impuritiesinterfering|impuritiesinterfering|impuritiesinterfering|impuritiesinterfering|impuritiesinterfering|
|                                                                              |with                 |with                 |with                 |with                 |with                 |
|                                                                              |the                  |the                  |the                  |the                  |the                  |
|                                                                              |detection            |detection            |detection            |detection            |detection            |
|                                                                              |of                   |of                   |of                   |of                   |of                   |
|                                                                              |Finerenone           |Finerenone           |Finerenone           |Finerenone           |Finerenone           |
|                                                                              |content              |content              |content              |content              |content              |
|                                                                              |were                 |were                 |were                 |were                 |were                 |
|                                                                              |produced,            |produced,            |produced,            |produced,            |produced,            |
|                                                                              |indicating           |indicating           |indicating           |indicating           |indicating           |
|                                                                              |that                 |that                 |that                 |that                 |that                 |
|                                                                              |the                  |the                  |the                  |the                  |the                  |
|                                                                              |reference            |reference            |reference            |reference            |reference            |
|                                                                              |solution             |solution             |solution             |solution             |solution             |
|                                                                              |was                  |was                  |was                  |was                  |was                  |
|                                                                              |stable               |stable               |stable               |stable               |stable               |
|                                                                              |within               |within               |within               |within               |within               |
|                                                                              |75hafter             |75hafter             |75hafter             |75hafter             |75hafter             |
|                                                                              |being                |being                |being                |being                |being                |
|                                                                              |placedunder          |placedunder          |placedunder          |placedunder          |placedunder          |
|                                                                              |the                  |the                  |the                  |the                  |the                  |
|                                                                              |5℃injector.          |5℃injector.          |5℃injector.          |5℃injector.          |5℃injector.          |
|                                                                              |②The                 |②The                 |②The                 |②The                 |②The                 |
|                                                                              |sample               |sample               |sample               |sample               |sample               |
|                                                                              |solution             |solution             |solution             |solution             |solution             |
|                                                                              |was                  |was                  |was                  |was                  |was                  |
|                                                                              |placedunder          |placedunder          |placedunder          |placedunder          |placedunder          |
|                                                                              |the                  |the                  |the                  |the                  |the                  |
|                                                                              |5℃injector           |5℃injector           |5℃injector           |5℃injector           |5℃injector           |
|                                                                              |for                  |for                  |for                  |for                  |for                  |
|                                                                              |73h,                 |73h,                 |73h,                 |73h,                 |73h,                 |
|                                                                              |the RSD              |the RSD              |the RSD              |the RSD              |the RSD              |
|                                                                              |of the               |of the               |of the               |of the               |of the               |
|                                                                              |main                 |main                 |main                 |main                 |main                 |
|                                                                              |peakarea             |peakarea             |peakarea             |peakarea             |peakarea             |
|                                                                              |was                  |was                  |was                  |was                  |was                  |
|                                                                              |1.4%                 |1.4%                 |1.4%                 |1.4%                 |1.4%                 |
|                                                                              |(required            |(required            |(required            |(required            |(required            |
|                                                                              |not to               |not to               |not to               |not to               |not to               |
|                                                                              |exceed               |exceed               |exceed               |exceed               |exceed               |
|                                                                              |2.0%),               |2.0%),               |2.0%),               |2.0%),               |2.0%),               |
|                                                                              |and no               |and no               |and no               |and no               |and no               |
|                                                                              |impuritiesinterfered |impuritiesinterfered |impuritiesinterfered |impuritiesinterfered |impuritiesinterfered |
|                                                                              |with                 |with                 |with                 |with                 |with                 |
|                                                                              |the                  |the                  |the                  |the                  |the                  |
|                                                                              |detection            |detection            |detection            |detection            |detection            |
|                                                                              |of                   |of                   |of                   |of                   |of                   |
|                                                                              |fineridone           |fineridone           |fineridone           |fineridone           |fineridone           |
|                                                                              |content,             |content,             |content,             |content,             |content,             |
|                                                                              |indicating           |indicating           |indicating           |indicating           |indicating           |
|                                                                              |that                 |that                 |that                 |that                 |that                 |
|                                                                              |the                  |the                  |the                  |the                  |the                  |
|                                                                              |sample               |sample               |sample               |sample               |sample               |
|                                                                              |solution             |solution             |solution             |solution             |solution             |
|                                                                              |was                  |was                  |was                  |was                  |was                  |
|                                                                              |stable               |stable               |stable               |stable               |stable               |
|                                                                              |within               |within               |within               |within               |within               |
|                                                                              |73hunder             |73hunder             |73hunder             |73hunder             |73hunder             |
|                                                                              |the                  |the                  |the                  |the                  |the                  |
|                                                                              |5℃injector.          |5℃injector.          |5℃injector.          |5℃injector.          |5℃injector.          |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



**(4.7) Durability** 



 **Brief Description** 



Durability refers to the determination conditions have a small change, the 



Measurement resultss are not affected by the degree of tolerance, by 



examining a single factor to change the chromatographic conditions (change 



column temperature, wavelength, flow rate, different columns) and normal 



chromatographic conditions to test the content of the test product solution to 



achieve. In the chromatogram obtained from the reference product solution, 



the number of theoretical plates should NLT 3000 according to the 



phenalidone peak, and the trailing factor NMT 1.5. Single factor change 



chromatographic conditions and normal chromatographic conditions under 



the test sample solution, the RSD of the principal component content should 



NMT 2.0%. 



Table 3.2.S.4.3.7-10 Changes in chromatographic conditions for durability 



test 



Chromatogra Standard conditions Variable Values 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 417 of 542 





Page 418
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 












----------------------------------------------------------------------------------------------------------------------------
|Column temperature     |20 ℃                                                                                  |22℃,       |
|                       |                                                                                      |18℃        |
|-----------------------|--------------------------------------------------------------------------------------|-----------|
|Wavelength             |251 nm                                                                                |249 nm,    |
|                       |                                                                                      |253 nm     |
|-----------------------|--------------------------------------------------------------------------------------|-----------|
|Flow rate              |1.0 ml/min                                                                            |0.95ml/min,|
|                       |                                                                                      |1.05       |
|                       |                                                                                      |ml/min     |
|-----------------------|--------------------------------------------------------------------------------------|-----------|
|Chromatogra phic column|YMC TrairtC18 (3μm, 4.6mmx 150mm) (serial number: 129ZB00034; Serial number: ZJC18-35)|YMC        |
|                       |                                                                                      |TrairtC18  |
|                       |                                                                                      |(3μm,      |
|                       |                                                                                      |4.6mmx     |
|                       |                                                                                      |150mm)     |
|                       |                                                                                      |(serial    |
|                       |                                                                                      |number:    |
|                       |                                                                                      |117EB10004;|
|                       |                                                                                      |Serial     |
|                       |                                                                                      |number:    |
|                       |                                                                                      |CXC18-05)  |
----------------------------------------------------------------------------------------------------------------------------

 **Solution preparation** 



Blank solution: solvent. 



Reference solution: Prepare it by the same method as the reference solution 



under "4.1 wavelength selection". 2 copies were prepared in parallel, in which 



the reference solution under "4.5.2 intermediate precision" was shared for 



durability of different chromatographic columns, and the rest were shared 



under "4.5.1 repeatability". (Approx. 0.02mg/ml) 



Test product solution: Prepare the test product solution under "4.3 specific 



properties" by the same method. Two samples were prepared in parallel, in 



which, except for the intermediate precision test solution ① and ② under 



"4.5.2 Intermediate precision" for durability of different chromatocolumns, 



the rest were shared with the repetitive test solution ① and ② under "4.5.1 



repeatability". (Approx. 0.02mg/ml) 



 **Injection procedure** 



Under the conditions of different durability (normal conditions, column 



temperature, flow rate, wavelength, different column), after the 



chromatographic system was balanced, the blank solution was injected with 



1 needle, 2 control solution and 2 test solution were injected with 2 needles 



respectively, and the chromatogram was recorded. 



 **Measurement resultss** 




Inspe 



ction 




Parame 



ter 




Reference solution 



① 




Control solution ② 




Test product 



solution 




Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 418 of 542 





Page 419
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 














































--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Normal conditions                                             |Normal         |1.18           |80373          |1.19           |80074          |99.5%          |0.23%          |
|                                                              |conditions     |               |               |               |               |               |               |
|--------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|Normal conditions                                             |Normal         |1.18           |80414          |1.19           |80543          |80543          |80543          |
|                                                              |conditions     |               |               |               |               |               |               |
|--------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|Wave length                                                   |249nm          |1.16           |73280          |1.17           |74216          |99.9%          |99.9%          |
|--------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|Wave length                                                   |249nm          |1.17           |74786          |1.17           |75205          |75205          |75205          |
|--------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|Wave length                                                   |253nm          |1.17           |73925          |1.17           |73825          |99.8%          |99.8%          |
|--------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|Wave length                                                   |253nm          |1.17           |74339          |1.17           |74802          |74802          |74802          |
|--------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|Colu mn temperatu re                                          |18 ℃           |1.20           |80421          |1.20           |80180          |99.5%          |99.5%          |
|--------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|Colu mn temperatu re                                          |18 ℃           |1.19           |79968          |1.20           |80426          |80426          |80426          |
|--------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|Colu mn temperatu re                                          |22 ℃           |1.19           |84752          |1.19           |84360          |99.6%          |99.6%          |
|--------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|Colu mn temperatu re                                          |22 ℃           |1.18           |83317          |1.19           |84331          |84331          |84331          |
|--------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|Flow rate                                                     |0.95           |1.21           |88884          |1.21           |88706          |100.0%         |100.0%         |
|                                                              |ml/min         |               |               |               |               |               |               |
|--------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|Flow rate                                                     |0.95           |1.21           |88534          |1.21           |89418          |89418          |89418          |
|                                                              |ml/min         |               |               |               |               |               |               |
|--------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|Flow rate                                                     |1.05           |1.18           |78257          |1.18           |78226          |99.9%          |99.9%          |
|                                                              |ml/min         |               |               |               |               |               |               |
|--------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|Flow rate                                                     |1.05           |1.19           |78526          |1.19           |78432          |78432          |78432          |
|                                                              |ml/min         |               |               |               |               |               |               |
|--------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|Column 2                                                      |Column 2       |1.18           |84401          |1.18           |84466          |99.4%          |99.4%          |
|--------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|Column 2                                                      |Column 2       |1.18           |85388          |1.18           |84993          |84993          |84993          |
|--------------------------------------------------------------|---------------|---------------|---------------|---------------|---------------|---------------|---------------|
|Conclusion: Under the conditions of column temperature,       |Conclusion:    |Conclusion:    |Conclusion:    |Conclusion:    |Conclusion:    |Conclusion:    |Conclusion:    |
|wavelength, flow rate, different chromatographic columns and  |Under the      |Under          |Under          |Under          |Under          |Under          |Under          |
|normal conditions, the theoretical plate number calculated by |conditions     |the            |the            |the            |the            |the            |the            |
|the peak of fenelidone is NLT 73280 (NLT 3000), and the       |of column      |conditions     |conditions     |conditions     |conditions     |conditions     |conditions     |
|trailing factoris in the range of 1.16~1.21 (NMT 1.5). Under  |temperature,   |of             |of             |of             |of             |of             |of             |
|the condition of single factor change of color, the sample    |wavelength,    |column         |column         |column         |column         |column         |column         |
|solution was testedunder normal chromatographic conditions,   |flow rate,     |temperature,   |temperature,   |temperature,   |temperature,   |temperature,   |temperature,   |
|and the RSD of principal component was 0.23% (not more than   |different      |wavelength,    |wavelength,    |wavelength,    |wavelength,    |wavelength,    |wavelength,    |
|2.0%). The above are in line with the verification            |chromatographic|flow           |flow           |flow           |flow           |flow           |flow           |
|requirements, indicating that the method has good durability. |columns        |rate,          |rate,          |rate,          |rate,          |rate,          |rate,          |
|                                                              |and normal     |different      |different      |different      |different      |different      |different      |
|                                                              |conditions,    |chromatographic|chromatographic|chromatographic|chromatographic|chromatographic|chromatographic|
|                                                              |the            |columns        |columns        |columns        |columns        |columns        |columns        |
|                                                              |theoretical    |and            |and            |and            |and            |and            |and            |
|                                                              |plate          |normal         |normal         |normal         |normal         |normal         |normal         |
|                                                              |number         |conditions,    |conditions,    |conditions,    |conditions,    |conditions,    |conditions,    |
|                                                              |calculated     |the            |the            |the            |the            |the            |the            |
|                                                              |by the         |theoretical    |theoretical    |theoretical    |theoretical    |theoretical    |theoretical    |
|                                                              |peak of        |plate          |plate          |plate          |plate          |plate          |plate          |
|                                                              |fenelidone     |number         |number         |number         |number         |number         |number         |
|                                                              |is NLT         |calculated     |calculated     |calculated     |calculated     |calculated     |calculated     |
|                                                              |73280 (NLT     |by the         |by the         |by the         |by the         |by the         |by the         |
|                                                              |3000), and     |peak of        |peak of        |peak of        |peak of        |peak of        |peak of        |
|                                                              |the            |fenelidone     |fenelidone     |fenelidone     |fenelidone     |fenelidone     |fenelidone     |
|                                                              |trailing       |is NLT         |is NLT         |is NLT         |is NLT         |is NLT         |is NLT         |
|                                                              |factoris       |73280          |73280          |73280          |73280          |73280          |73280          |
|                                                              |in the         |(NLT           |(NLT           |(NLT           |(NLT           |(NLT           |(NLT           |
|                                                              |range of       |3000),         |3000),         |3000),         |3000),         |3000),         |3000),         |
|                                                              |1.16~1.21      |and the        |and the        |and the        |and the        |and the        |and the        |
|                                                              |(NMT 1.5).     |trailing       |trailing       |trailing       |trailing       |trailing       |trailing       |
|                                                              |Under the      |factoris       |factoris       |factoris       |factoris       |factoris       |factoris       |
|                                                              |condition      |in the         |in the         |in the         |in the         |in the         |in the         |
|                                                              |of single      |range          |range          |range          |range          |range          |range          |
|                                                              |factor         |of             |of             |of             |of             |of             |of             |
|                                                              |change of      |1.16~1.21      |1.16~1.21      |1.16~1.21      |1.16~1.21      |1.16~1.21      |1.16~1.21      |
|                                                              |color, the     |(NMT           |(NMT           |(NMT           |(NMT           |(NMT           |(NMT           |
|                                                              |sample         |1.5).          |1.5).          |1.5).          |1.5).          |1.5).          |1.5).          |
|                                                              |solution       |Under          |Under          |Under          |Under          |Under          |Under          |
|                                                              |was            |the            |the            |the            |the            |the            |the            |
|                                                              |testedunder    |condition      |condition      |condition      |condition      |condition      |condition      |
|                                                              |normal         |of             |of             |of             |of             |of             |of             |
|                                                              |chromatographic|single         |single         |single         |single         |single         |single         |
|                                                              |conditions,    |factor         |factor         |factor         |factor         |factor         |factor         |
|                                                              |and the        |change         |change         |change         |change         |change         |change         |
|                                                              |RSD of         |of             |of             |of             |of             |of             |of             |
|                                                              |principal      |color,         |color,         |color,         |color,         |color,         |color,         |
|                                                              |component      |the            |the            |the            |the            |the            |the            |
|                                                              |was 0.23%      |sample         |sample         |sample         |sample         |sample         |sample         |
|                                                              |(not more      |solution       |solution       |solution       |solution       |solution       |solution       |
|                                                              |than           |was            |was            |was            |was            |was            |was            |
|                                                              |2.0%). The     |testedunder    |testedunder    |testedunder    |testedunder    |testedunder    |testedunder    |
|                                                              |above are      |normal         |normal         |normal         |normal         |normal         |normal         |
|                                                              |in line        |chromatographic|chromatographic|chromatographic|chromatographic|chromatographic|chromatographic|
|                                                              |with the       |conditions,    |conditions,    |conditions,    |conditions,    |conditions,    |conditions,    |
|                                                              |verification   |and the        |and the        |and the        |and the        |and the        |and the        |
|                                                              |requirements,  |RSD of         |RSD of         |RSD of         |RSD of         |RSD of         |RSD of         |
|                                                              |indicating     |principal      |principal      |principal      |principal      |principal      |principal      |
|                                                              |that the       |component      |component      |component      |component      |component      |component      |
|                                                              |method has     |was            |was            |was            |was            |was            |was            |
|                                                              |good           |0.23%          |0.23%          |0.23%          |0.23%          |0.23%          |0.23%          |
|                                                              |durability.    |(not           |(not           |(not           |(not           |(not           |(not           |
|                                                              |               |more           |more           |more           |more           |more           |more           |
|                                                              |               |than           |than           |than           |than           |than           |than           |
|                                                              |               |2.0%).         |2.0%).         |2.0%).         |2.0%).         |2.0%).         |2.0%).         |
|                                                              |               |The            |The            |The            |The            |The            |The            |
|                                                              |               |above          |above          |above          |above          |above          |above          |
|                                                              |               |are in         |are in         |are in         |are in         |are in         |are in         |
|                                                              |               |line           |line           |line           |line           |line           |line           |
|                                                              |               |with           |with           |with           |with           |with           |with           |
|                                                              |               |the            |the            |the            |the            |the            |the            |
|                                                              |               |verification   |verification   |verification   |verification   |verification   |verification   |
|                                                              |               |requirements,  |requirements,  |requirements,  |requirements,  |requirements,  |requirements,  |
|                                                              |               |indicating     |indicating     |indicating     |indicating     |indicating     |indicating     |
|                                                              |               |that           |that           |that           |that           |that           |that           |
|                                                              |               |the            |the            |the            |the            |the            |the            |
|                                                              |               |method         |method         |method         |method         |method         |method         |
|                                                              |               |has            |has            |has            |has            |has            |has            |
|                                                              |               |good           |good           |good           |good           |good           |good           |
|                                                              |               |durability.    |durability.    |durability.    |durability.    |durability.    |durability.    |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 419 of 542 





Page 420
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**III. Summary of Method Validation** 



Summaries of Method Validation of Assay in Finerenone 












----------------------------------------------------------------------------------------------------------------------------------
|Wavelength selection|The principal component has large absorption at 251nm wavelength                         |The              |
|                    |                                                                                         |principal        |
|                    |                                                                                         |component        |
|                    |                                                                                         |has              |
|                    |                                                                                         |greaterabsorption|
|                    |                                                                                         |at               |
|                    |                                                                                         |251nm.           |
|                    |                                                                                         |In the           |
|                    |                                                                                         |control          |
|                    |                                                                                         |solution,        |
|                    |                                                                                         |the              |
|                    |                                                                                         |retention        |
|                    |                                                                                         |time of          |
|                    |                                                                                         |Finerenone       |
|                    |                                                                                         |was              |
|                    |                                                                                         |9.833min,        |
|                    |                                                                                         |and the          |
|                    |                                                                                         |spectral         |
|                    |                                                                                         |diagram          |
|                    |                                                                                         |of the           |
|                    |                                                                                         |control          |
|                    |                                                                                         |solution         |
|                    |                                                                                         |wasas            |
|                    |                                                                                         |follows:         |
|--------------------|-----------------------------------------------------------------------------------------|-----------------|
|Systemapplicability |The blank solution should be free ofinterference; The relative standard deviation of the |The blank        |
|                    |main peakarea should NMT 2%, the relative standard deviation of the main peak retention  |solution has no  |
|                    |time should NMT 2.0%, the theoretical plate number should NLT 3000 according to the      |interference; The|
|                    |phenalidone peak, and the                                                                |RSD of the main  |
|                    |                                                                                         |peak retention   |
|                    |                                                                                         |time was 0.07%   |
|                    |                                                                                         |(required not to |
|                    |                                                                                         |exceed 2.0%), the|
|                    |                                                                                         |RSD of the       |
|                    |                                                                                         |peakarea was     |
|                    |                                                                                         |0.27% (required  |
|                    |                                                                                         |not to exceed    |
|                    |                                                                                         |2.0%), and the   |
|                    |                                                                                         |theoretical plate|
|                    |                                                                                         |number of the    |
|                    |                                                                                         |peak of          |
|                    |                                                                                         |fenalidone was   |
|                    |                                                                                         |NLT 76308        |
|                    |                                                                                         |(required NLT    |
|                    |                                                                                         |3000). The       |
|                    |                                                                                         |trailing factor  |
|                    |                                                                                         |was in the range |
|                    |                                                                                         |of 1.17~1.18 (the|
|                    |                                                                                         |requirement NMT  |
|                    |                                                                                         |1.5). Allabove   |
|                    |                                                                                         |meet the         |
|                    |                                                                                         |requirements,    |
|                    |                                                                                         |indicating that  |
|                    |                                                                                         |the method has   |
|                    |                                                                                         |goodapplicability|
|                    |                                                                                         |in the system.   |
----------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 420 of 542 





Page 421
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 


















-----------------------------------------------------------------
|YA2304 |12.3576μg/ml~28.8344μg/ml (61.79%~144.17%)|y=16810x-256|
-----------------------------------------------------------------


















-----------------------------------------------------------------
|YA2304 |Added 16.0038μg/ml to 24.4963μg/ml|99.9%, n=9|0.6%, n=9|
-----------------------------------------------------------------



------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Linearity and range|In the concentration range equivalent to 60%~140% |**Impuriti**             |**Impuriti**             |**Impuriti**             |**Impuriti**             |**Impuriti**             |**Impuriti**             |
|                   |of the control solution, 5 concentration points   |**es**                   |**es**                   |**es**                   |**es**                   |**es**                   |**es**                   |
|                   |were evenly selected, and the concentration was   |**Concentration          |**Concentration          |**Concentration          |**Concentration          |**Concentration          |**Concentration          |
|                   |takenas the horizontal coordinate and the peakarea|(equivalent              |(equivalent              |(equivalent              |(equivalent              |(equivalent              |(equivalent              |
|                   |was takenas the vertical coordinate as the linear |to                       |to                       |to                       |to                       |to                       |to                       |
|                   |regression curve. The correlation coefficient (R) |the**                    |the**                    |the**                    |the**                    |the**                    |the**                    |
|                   |of the regression curve was NLT 0.998, and the RSD|**percentage             |**percentage             |**percentage             |**percentage             |**percentage             |**percentage             |
|                   |of the response factor should NMT 2.0%. The       |of                       |of                       |of                       |of                       |of                       |of                       |
|                   |absolute value ofY-axisinterceptaccounts for less |solution**               |solution**               |solution**               |solution**               |solution**               |solution**               |
|                   |than 2% of 100% response value.                   |**concentration          |**concentration          |**concentration          |**concentration          |**concentration          |**concentration          |
|                   |                                                  |of the                   |of the                   |of the                   |of the                   |of the                   |of the                   |
|                   |                                                  |test                     |test                     |test                     |test                     |test                     |test                     |
|                   |                                                  |product)**               |product)**               |product)**               |product)**               |product)**               |product)**               |
|                   |                                                  |**Linearequation**       |**Linearequation**       |**Linearequation**       |**Linearequation**       |**Linearequation**       |**Linearequation**       |
|                   |                                                  |YA2304                   |YA2304                   |YA2304                   |YA2304                   |YA2304                   |YA2304                   |
|                   |                                                  |12.3576μg/ml~28.8344μg/ml|12.3576μg/ml~28.8344μg/ml|12.3576μg/ml~28.8344μg/ml|12.3576μg/ml~28.8344μg/ml|12.3576μg/ml~28.8344μg/ml|12.3576μg/ml~28.8344μg/ml|
|                   |                                                  |(61.79%~144.17%)         |(61.79%~144.17%)         |(61.79%~144.17%)         |(61.79%~144.17%)         |(61.79%~144.17%)         |(61.79%~144.17%)         |
|                   |                                                  |y=16810x-256             |y=16810x-256             |y=16810x-256             |y=16810x-256             |y=16810x-256             |y=16810x-256             |
|-------------------|--------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|Accuracy           |Add YA2304 reference in the range of 80% reference|**Impurities** **Marking |**Impurities** **Marking |**Impurities** **Marking |**Impurities** **Marking |**Impurities** **Marking |**Impurities** **Marking |
|                   |solution concentration to 120% reference solution |condition** **Average**  |condition** **Average**  |condition** **Average**  |condition** **Average**  |condition** **Average**  |condition** **Average**  |
|                   |concentration to the thinner; The recovery rate is|**recovery** **rate**    |**recovery** **rate**    |**recovery** **rate**    |**recovery** **rate**    |**recovery** **rate**    |**recovery** **rate**    |
|                   |required to be between 98% and 101%, and the RSD  |**RSD** YA2304 Added     |**RSD** YA2304 Added     |**RSD** YA2304 Added     |**RSD** YA2304 Added     |**RSD** YA2304 Added     |**RSD** YA2304 Added     |
|                   |of recovery rate NMT 2.0%.                        |16.0038μg/ml to          |16.0038μg/ml to          |16.0038μg/ml to          |16.0038μg/ml to          |16.0038μg/ml to          |16.0038μg/ml to          |
|                   |                                                  |24.4963μg/ml 99.9%, n=9  |24.4963μg/ml 99.9%, n=9  |24.4963μg/ml 99.9%, n=9  |24.4963μg/ml 99.9%, n=9  |24.4963μg/ml 99.9%, n=9  |24.4963μg/ml 99.9%, n=9  |
|                   |                                                  |0.6%, n=9                |0.6%, n=9                |0.6%, n=9                |0.6%, n=9                |0.6%, n=9                |0.6%, n=9                |
|-------------------|--------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|Precision          |Repeatability andintermediate precision: the RSD  |**Principal**            |**Principal**            |**Principal**            |**Principal**            |**Principal**            |**Principal**            |
|                   |of principal component in 6 repeatability         |**Component**            |**Component**            |**Component**            |**Component**            |**Component**            |**Component**            |
|                   |(orintermediate precision) test product solution  |**Repeatability**        |**Repeatability**        |**Repeatability**        |**Repeatability**        |**Repeatability**        |**Repeatability**        |
|                   |NMT 1.0%. Precision: For the results of 12        |**Intermediate**         |**Intermediate**         |**Intermediate**         |**Intermediate**         |**Intermediate**         |**Intermediate**         |
|                   |repeatability andintermediate precision tests, the|**precision** **Precisi**|**precision** **Precisi**|**precision** **Precisi**|**precision** **Precisi**|**precision** **Precisi**|**precision** **Precisi**|
|                   |RSD of                                            |YA2304 0.5%, n=6 0.4%,   |YA2304 0.5%, n=6 0.4%,   |YA2304 0.5%, n=6 0.4%,   |YA2304 0.5%, n=6 0.4%,   |YA2304 0.5%, n=6 0.4%,   |YA2304 0.5%, n=6 0.4%,   |
|                   |                                                  |n=6 0.4%, n              |n=6 0.4%, n              |n=6 0.4%, n              |n=6 0.4%, n              |n=6 0.4%, n              |n=6 0.4%, n              |
|-------------------|--------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|Precision          |Repeatability andintermediate precision: the RSD  |**Principal**            |**Principal**            |**Repeatability**        |**Intermediate**         |**Precisi**              |                         |
|                   |of principal component in 6 repeatability         |**Component**            |**Component**            |                         |**precision**            |                         |                         |
|                   |(orintermediate precision) test product solution  |**Repeatability**        |                         |                         |                         |                         |                         |
|                   |NMT 1.0%. Precision: For the results of 12        |**Intermediate**         |                         |                         |                         |                         |                         |
|                   |repeatability andintermediate precision tests, the|**precision** **Precisi**|                         |                         |                         |                         |                         |
|                   |RSD of                                            |YA2304 0.5%, n=6 0.4%,   |                         |                         |                         |                         |                         |
|                   |                                                  |n=6 0.4%, n              |                         |                         |                         |                         |                         |
|-------------------|--------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|Precision          |Repeatability andintermediate precision: the RSD  |**Principal**            |YA2304                   |0.5%, n=6                |0.4%, n=6                |0.4%, n                  |=                        |
|                   |of principal component in 6 repeatability         |**Component**            |                         |                         |                         |                         |                         |
|                   |(orintermediate precision) test product solution  |**Repeatability**        |                         |                         |                         |                         |                         |
|                   |NMT 1.0%. Precision: For the results of 12        |**Intermediate**         |                         |                         |                         |                         |                         |
|                   |repeatability andintermediate precision tests, the|**precision** **Precisi**|                         |                         |                         |                         |                         |
|                   |RSD of                                            |YA2304 0.5%, n=6 0.4%,   |                         |                         |                         |                         |                         |
|                   |                                                  |n=6 0.4%, n              |                         |                         |                         |                         |                         |
|-------------------|--------------------------------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|-------------------------|
|Precision          |Repeatability andintermediate precision: the RSD  |**Principal**            |YA2304                   |0.5%, n=6                |0.4%, n=6                |0.4%, n                  |                         |
|                   |of principal component in 6 repeatability         |**Component**            |                         |                         |                         |                         |                         |
|                   |(orintermediate precision) test product solution  |**Repeatability**        |                         |                         |                         |                         |                         |
|                   |NMT 1.0%. Precision: For the results of 12        |**Intermediate**         |                         |                         |                         |                         |                         |
|                   |repeatability andintermediate precision tests, the|**precision** **Precisi**|                         |                         |                         |                         |                         |
|                   |RSD of                                            |YA2304 0.5%, n=6 0.4%,   |                         |                         |                         |                         |                         |
|                   |                                                  |n=6 0.4%, n              |                         |                         |                         |                         |                         |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 421 of 542 





Page 422
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 












--------------------------------------------------------------------------------------------------------------------------------------
|Solution stability|Each solution was placed in the sample injector at 5℃, the control solution and the test   |The                  |
|                  |product solution were injected at different times, and the theoretical plate number in the |control              |
|                  |control solution was required to be NLT 3000 according to the peak of Finerenone, and the  |product              |
|                  |tail factor NMT 1.5; The RSD of the main peak-peakarea between the control solution and the|solution:            |
|                  |test solution NMT 2.0%, and no newimpuritiesinterfering with the detection of principal    |Placedunder          |
|                  |components should be added.                                                                |the                  |
|                  |                                                                                           |5℃injector           |
|                  |                                                                                           |for                  |
|                  |                                                                                           |75h,                 |
|                  |                                                                                           |the                  |
|                  |                                                                                           |peakarea             |
|                  |                                                                                           |RSD of               |
|                  |                                                                                           |the                  |
|                  |                                                                                           |main                 |
|                  |                                                                                           |peakarea             |
|                  |                                                                                           |is 0.6%              |
|                  |                                                                                           |(required            |
|                  |                                                                                           |not to               |
|                  |                                                                                           |exceed               |
|                  |                                                                                           |2.0%),               |
|                  |                                                                                           |the                  |
|                  |                                                                                           |theoretical          |
|                  |                                                                                           |plate                |
|                  |                                                                                           |number               |
|                  |                                                                                           |of the               |
|                  |                                                                                           |peak of              |
|                  |                                                                                           |finalidone           |
|                  |                                                                                           |is NLT               |
|                  |                                                                                           |76308                |
|                  |                                                                                           |(required            |
|                  |                                                                                           |NLT                  |
|                  |                                                                                           |3000),               |
|                  |                                                                                           |and the              |
|                  |                                                                                           |trailing             |
|                  |                                                                                           |factoris             |
|                  |                                                                                           |in the               |
|                  |                                                                                           |range                |
|                  |                                                                                           |of                   |
|                  |                                                                                           |1.18~1.20            |
|                  |                                                                                           |(required            |
|                  |                                                                                           |not to               |
|                  |                                                                                           |exceed               |
|                  |                                                                                           |1.5).                |
|                  |                                                                                           |And no               |
|                  |                                                                                           |impuritiesinterfered |
|                  |                                                                                           |with                 |
|                  |                                                                                           |the                  |
|                  |                                                                                           |detection            |
|                  |                                                                                           |of                   |
|                  |                                                                                           |Finerenone           |
|                  |                                                                                           |content,             |
|                  |                                                                                           |indicating           |
|                  |                                                                                           |that                 |
|                  |                                                                                           |the                  |
|                  |                                                                                           |control              |
|                  |                                                                                           |solution             |
|                  |                                                                                           |was                  |
|                  |                                                                                           |stable               |
|                  |                                                                                           |within               |
|                  |                                                                                           |75hafter             |
|                  |                                                                                           |being                |
|                  |                                                                                           |placedunder          |
|                  |                                                                                           |the                  |
|                  |                                                                                           |5℃sampler.           |
|                  |                                                                                           |Test                 |
|                  |                                                                                           |solution:            |
|                  |                                                                                           |The RSD              |
|                  |                                                                                           |of main              |
|                  |                                                                                           |peakarea             |
|                  |                                                                                           |was                  |
|                  |                                                                                           |1.4%                 |
|                  |                                                                                           |(required            |
|                  |                                                                                           |not to               |
|                  |                                                                                           |exceed               |
|                  |                                                                                           |2.0%)                |
|                  |                                                                                           |within               |
|                  |                                                                                           |73hafter             |
|                  |                                                                                           |being                |
|                  |                                                                                           |placedunder          |
|                  |                                                                                           |the                  |
|                  |                                                                                           |5℃injector,          |
|                  |                                                                                           |and no               |
|                  |                                                                                           |impuritiesinterfered |
|                  |                                                                                           |with                 |
|                  |                                                                                           |the                  |
|                  |                                                                                           |detection            |
|                  |                                                                                           |of                   |
|                  |                                                                                           |Finerenone           |
|                  |                                                                                           |content,             |
|                  |                                                                                           |indicating           |
|                  |                                                                                           |that                 |
|                  |                                                                                           |the                  |
|                  |                                                                                           |test                 |
|                  |                                                                                           |solution             |
|                  |                                                                                           |was                  |
|                  |                                                                                           |stable               |
|                  |                                                                                           |within               |
|                  |                                                                                           |73hafter             |
|                  |                                                                                           |being                |
|                  |                                                                                           |placedunder          |
|                  |                                                                                           |the                  |
|                  |                                                                                           |5℃injector.          |
|                  |                                                                                           |The                  |
|                  |                                                                                           |above                |
|                  |                                                                                           |solutions            |
|                  |                                                                                           |do not               |
|                  |                                                                                           |need                 |
|                  |                                                                                           |new                  |
|                  |                                                                                           |preparation          |
|                  |                                                                                           |for                  |
|                  |                                                                                           |temporaryuse.        |
|------------------|-------------------------------------------------------------------------------------------|---------------------|
|Durability        |Under the conditions of single factor change column temperature, wavelength, flow rate,    |The column           |
|                  |different chromatographic columns and normal chromatographic conditions, the theoretical   |temperature was      |
|                  |plate number calculatedaccording to the peak of Finerenone should NLT 3000, and the        |20℃±2℃, the          |
|                  |trailing factor NMT 1.5. Under single factor change chromatographic conditions and normal  |wavelength was       |
|                  |chromatographic conditions, the RSD of the principal component content should NMT 2.0%.    |251nm±2nm, the flow  |
|                  |                                                                                           |rate was             |
|                  |                                                                                           |1.0ml/min±0.05ml/min,|
|                  |                                                                                           |and the              |
|                  |                                                                                           |chromatographic      |
|                  |                                                                                           |column with          |
|                  |                                                                                           |different batch      |
|                  |                                                                                           |NO.swasinvestigatedas|
|                  |                                                                                           |follows:             |
|                  |                                                                                           |Systemapplicability: |
|                  |                                                                                           |In the               |
|                  |                                                                                           |chromatogramobtained |
|                  |                                                                                           |from the control     |
|                  |                                                                                           |product solution,    |
|                  |                                                                                           |the theoretical      |
|                  |                                                                                           |plate number         |
|                  |                                                                                           |calculated by the    |
|                  |                                                                                           |peak of Finerenone   |
|                  |                                                                                           |was NLT 73280        |
|                  |                                                                                           |(required NLT 3000), |
|                  |                                                                                           |and the trailing     |
|                  |                                                                                           |factor was in the    |
|                  |                                                                                           |range of 1.16~1.21   |
|                  |                                                                                           |(required not to     |
|                  |                                                                                           |exceed 1.5). The     |
|                  |                                                                                           |suitability of the   |
|                  |                                                                                           |system met the       |
|                  |                                                                                           |verification         |
|                  |                                                                                           |requirements. Test   |
|                  |                                                                                           |product solution:    |
|                  |                                                                                           |The test product     |
|                  |                                                                                           |solution was         |
|                  |                                                                                           |testedunder normal   |
|                  |                                                                                           |chromatographic      |
|                  |                                                                                           |conditionsunder      |
|                  |                                                                                           |single factor color  |
|                  |                                                                                           |change condition,    |
|                  |                                                                                           |and the RSD of       |
|                  |                                                                                           |principal component  |
|                  |                                                                                           |was 0.23% (no more   |
|                  |                                                                                           |than 2.0% required); |
|                  |                                                                                           |The                  |
--------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 422 of 542 





Page 423
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



above are in line with the verification requirements. 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 423 of 542 





Page 424
**Drug Master File of Finerenone** 
Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.4.4** **Batch Analyses** 



**Analytical Data of Three Consecutive Batches** 



Analytical data of three commercial scale batches (Batch No.: 231201, 240101 



and 240102) are summarized in _3.2.S.4.4 Table 1_ . All batches were fully tested 



according to the analytical procedures in _section 3.2.S.4.2_ . 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 424 of 542 





Page 425
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Table 3.2.S.4.4-1 Batch Analysis Results of Finerenone 















---------------------------------------------------------------------------------------------------------------------------------------------
|**Batch size**         |**Batch size**                                                        |11.085kg      |9.925kg       |10.215kg      |
|-----------------------|----------------------------------------------------------------------|--------------|--------------|--------------|
|**Date of manufacture**|**Date of manufacture**                                               |Jan. 06,      |Jan.          |Jan. 30,      |
|                       |                                                                      |2024          |19,           |2024          |
|                       |                                                                      |              |2024          |              |
|-----------------------|----------------------------------------------------------------------|--------------|--------------|--------------|
|**Site of manufacture**|**Site of manufacture**                                               |API (II)      |API           |API (II)      |
|                       |                                                                      |Workshop,     |(II)          |Workshop,     |
|                       |                                                                      |Hinye         |Workshop,     |Hinye         |
|                       |                                                                      |Pharmaceutical|Hinye         |Pharmaceutical|
|                       |                                                                      |Co.,          |Pharmaceutical|Co.,          |
|                       |                                                                      |Ltd.          |Co.,          |Ltd.          |
|                       |                                                                      |              |Ltd.          |              |
|-----------------------|----------------------------------------------------------------------|--------------|--------------|--------------|
|**Items**              |**Specifications**                                                    |**Results**   |**Results**   |**Results**   |
|-----------------------|----------------------------------------------------------------------|--------------|--------------|--------------|
|Characters             |white to yellow powder                                                |white powder  |white powder  |white powder  |
|-----------------------|----------------------------------------------------------------------|--------------|--------------|--------------|
|Characters             |Solubility: dissolved in methanol, slightly soluble inethanol,        |Complies      |Complies      |Complies      |
|                       |acetonitrile andacetone, slightly soluble inisopropylalcohol,         |              |              |              |
|                       |andalmostinsoluble in water                                           |              |              |              |
|-----------------------|----------------------------------------------------------------------|--------------|--------------|--------------|
|Identification         |IR: The infrared lightabsorption pattern of this product should be    |Complies      |Complies      |Complies      |
|                       |consistent with that of the control product                           |              |              |              |
|-----------------------|----------------------------------------------------------------------|--------------|--------------|--------------|
|Identification         |HPLC: In the chromatogram recordedunder the enantiomer determination, |Complies      |Complies      |Complies      |
|                       |the retention time of the main peak of the test solution should be    |              |              |              |
|                       |consistent with the retention time of the main peak of the system     |              |              |              |
|                       |suitability solution                                                  |              |              |              |
|-----------------------|----------------------------------------------------------------------|--------------|--------------|--------------|
|Related substancesI    |YA2304-10: NMT 0.10%                                                  |Not detected  |Not detected  |Not detected  |
|-----------------------|----------------------------------------------------------------------|--------------|--------------|--------------|
|Related substancesI    |YA2304-12: NMT 0.15%                                                  |Not detected  |Not detected  |Not detected  |
|-----------------------|----------------------------------------------------------------------|--------------|--------------|--------------|
|Related substancesI    |YA2304-14: NMT 0.15%                                                  |Not detected  |Not detected  |Not detected  |
---------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 425 of 542 





Page 426
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 









-----------------------------------------------------------------------------------------------------------
|YA2304-16: NMT 0.15%               |Not detected                  |Not detected|Not detected|            |
|-----------------------------------|------------------------------|------------|------------|------------|
|YA2304-17: NMT 0.15%               |Not detected                  |Not detected|Not detected|            |
|-----------------------------------|------------------------------|------------|------------|------------|
|YA2304-18: NMT 0.15%               |Not detected                  |Not detected|Not detected|            |
|-----------------------------------|------------------------------|------------|------------|------------|
|YA2304-19: NMT 0.15%               |< 0.05%                       |< 0.05%     |< 0.05%     |            |
|-----------------------------------|------------------------------|------------|------------|------------|
|Other single impurities: NMT 0.1 0%|< 0.05%                       |< 0.05%     |< 0.05%     |            |
|-----------------------------------|------------------------------|------------|------------|------------|
|Totalimpurity: NMT 1.0%            |< 0.05%                       |< 0.05%     |< 0.05%     |            |
|-----------------------------------|------------------------------|------------|------------|------------|
|enantiomers                        |YA2304-20: NMT 0.15%          |0.03%       |0.03%       |0.02%       |
|-----------------------------------|------------------------------|------------|------------|------------|
|Residual solvents                  |Ethanol NMT 0.5%              |0.1%        |0.2%        |0.1%        |
|-----------------------------------|------------------------------|------------|------------|------------|
|Residual solvents                  |Isopropylalcohol NMT 0.5%     |Not detected|Not detected|Not detected|
|-----------------------------------|------------------------------|------------|------------|------------|
|Residual solvents                  |Ethylacetate NMT 0.5%         |Not detected|Not detected|Not detected|
|-----------------------------------|------------------------------|------------|------------|------------|
|Residual solvents                  |Secondary butanol NMT 0.5%    |Not detected|Not detected|Not detected|
|-----------------------------------|------------------------------|------------|------------|------------|
|Residual solvents                  |Tetrahydrofuran NMT 0.072%    |Not detected|Not detected|Not detected|
|-----------------------------------|------------------------------|------------|------------|------------|
|Residual solvents                  |Toluene NMT 0.089%            |Not detected|Not detected|Not detected|
|-----------------------------------|------------------------------|------------|------------|------------|
|Residual solvents                  |N-methylpyrrolidone NMT 0.053%|Not detected|Not detected|Not detected|
|-----------------------------------|------------------------------|------------|------------|------------|
|genotoxicimpurities                |Dimethyl sulfate NMT 75ppm    |Not detected|Not detected|Not detected|
|-----------------------------------|------------------------------|------------|------------|------------|
|genotoxicimpurities                |Diethyl sulfate NMT 75ppm     |Not detected|Not detected|Not detected|
|-----------------------------------|------------------------------|------------|------------|------------|
|genotoxicimpurities                |Diisopropyl sulfate NMT 75ppm |Not detected|Not detected|Not detected|
-----------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 426 of 542 





Page 427
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 












---------------------------------------------------------------------------------------------------------------------
|Sum of genotoxicimpurities NMT 250ppm|Not detected                          |Not detected|Not detected|            |
|-------------------------------------|--------------------------------------|------------|------------|------------|
|Water                                |NMT 0.5%                              |0.05%       |0.04%       |0.2%        |
|-------------------------------------|--------------------------------------|------------|------------|------------|
|Residue onignition                   |NMT 0.1%                              |Complies    |Complies    |Complies    |
|-------------------------------------|--------------------------------------|------------|------------|------------|
|Heavy metals                         |NMT 10ppm                             |Complies    |Complies    |Complies    |
|-------------------------------------|--------------------------------------|------------|------------|------------|
|Microbial limits                     |TAMC: NMT 103CFU/g                    |< 10 CFU/g  |< 10 CFU/g  |<10 CFU/g   |
|-------------------------------------|--------------------------------------|------------|------------|------------|
|Microbial limits                     |TYMC: NMT 102CFU/g                    |< 10 CFU/g  |< 10 CFU/g  |<10 CFU/g   |
|-------------------------------------|--------------------------------------|------------|------------|------------|
|Microbial limits                     |Absence of_ Escherichia coli_ (1g)    |Not detected|Not detected|Not detected|
|-------------------------------------|--------------------------------------|------------|------------|------------|
|Assay                                |98.0% to 102.0% (anhydrous substance).|99.8%       |99.8%       |99.7%       |
---------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 427 of 542 





Page 428
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**Batch Determination** 



The Batch No. of commercial production of APIs can be divided into two cases: 



Batch No. of intermediates and Batch No. of the final drug substance (API). 



1) Batch No. composition of intermediate: product code + year + month + serial 



number (D+YY+MM+ZZ). For example, the Batch No. of an intermediate is 



D220901, where D is the product code, 22 is the year, 09 is the month, 01 is the 



serial number, indicating the first batch of intermediate of a specific API in 



September 2022. 



2) Batch No. composition of the final drug substance (API): year + month + 



product code + serial number (YYYY+MM+X+ZZ), in which the year is 4 digits, the 



month is 2 digits, and the product code is 1 or 2 letters (2 letters are W+ the other 



letter). For example, the Batch No. of an API is 202209D01, in which 2022 is the 



year; 09 is the month; D is the product code; 01 is the serial number, representing 



the first batch of a specific API in September 2022. 



Batch No. composition of API manufactured from trial production in technology 



transfer stage and process validation: 6 digits. 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 428 of 542 





Page 429
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**Certificate of Analysis (COA) of three Commercial Scale Batches** 



COA of Finerenone (Batch No.: 231201) 



COA of Finerenone (Batch No.: 240101) 



COA of Finerenone (Batch No.: 240102) 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 429 of 542 





Page 430
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.4.5** **Justification of Specification** 



The specification of Finerenone was established by the applicant according to 



the Quality Guidelines and Multidisciplinary Guidelines of ICH. The analytical 



procedures of all of the tests (Characters, Identification, Related substances, 



Residual solvents, Loss and Dry, Residue on ignition, Heavy metals, Microbial 



limits and Assay) were established by the applicant and the test methods have 



been well validated. 



**Appearance** 



A qualitative test performed to know the colour of the API. White to yellow 



powder by visual inspection. 



**Solubility** 



Solubility is a basic phenomenon and commonly evaluated parameter which 



helps in pre-formulation studies and to know the dissolution of the API in 



different solvents. dissolved in methanol, slightly soluble in ethanol, 



acetonitrile and acetone, slightly soluble in isopropyl alcohol, and almost 



insoluble in water. 



**Infrared Absorption Spectrophotometry** 



This is a specific test for identification of drug substances by IR using 



validated method. The IR spectra of the substance to be examined should 



comply with that of the Finerenone CRS. Examine by _Standard operating_ 



_procedure of infrared absorption spectrophotometry_ . 



**High Performance Liquid Chromatography** 



In the chromatogram recorded under the enantiomer determination, the 



retention time of the main peak of the test solution should be consistent with 



the retention time of the main peak of the system suitability solution. _(See_ 



_Enantiomer)._ 



**Related substances** 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 430 of 542 





Page 431
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



The _related substances_ of Finerenone was established by the applicant 



according to the _[ICH Q3A(R2): Impurities in New Drug Substances](https://www.cde.org.cn/ichWeb/guideIch/downloadAtt/1/fb4a4ec406cecd99722d2f7c4455d2a1)_ . The 



threshold of Specified Impurity including all of the Impurity (YA2304-14, 



YA2304-15, YA2304-19): NMT 0.15%., YA2304-10: NMT 0.10%; Unspecified 



Impurity was established by the Identified threshold : NMT 0.10%. 



**Enantiomers** 



The _Enantiomers_ of Finerenone was established by the applicant according to 



the _[ICH Q3A(R2): Impurities in New Drug Substances](https://www.cde.org.cn/ichWeb/guideIch/downloadAtt/1/fb4a4ec406cecd99722d2f7c4455d2a1)_ . The threshold of 



Specified Impurity including all of the YA2304-20: NMT 0.15%. 



**Residual solvents** 



The _residual solvents_ of Finerenone was established by the applicant 



according to the _[ICH Q3C(R8) Impurities: Guideline for Residual Solvents](https://www.cde.org.cn/ichWeb/guideIch/downloadAtt/1/1245a501be703877657ab15986adbc16)_ . 



Ethanol NMT 0.5 %; Tetrahydrofuran NMT 0.072%; Toluene NMT 0.089%; 



N-methylpyrrolidone NMT 0.053%. 



**Water** 



NMT 0.5%. Examine in accordance with Standard operating procedure of 



Water by the Karl Fischer determination. 



**Residue on ignition** 



NMT 0.1%. Examine by _Standard operating procedure of residue on ignition_ 



_determination_ . 



**Heavy metals** 



NMT 10ppm. Examine by _Standard operating procedure of heavy metals_ 



_determination_ . 



**Microbial Limits** 



The drug substance Finerenone is a non-sterile API. The applicant established 



microbial limits test in the Finerenone specification according to chapter 



_Microbiological examination of non-sterile products microbial enumeration tests_ 



and _Microbiological examination of non-sterile products control bacteria tests_ : 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 431 of 542 





Page 432
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



   - TAMC is NMT 10 [3] CFU/g; 



   - TYMC is NMT 10 [2] CFU/g; 



_- E.coli_ is absent in each 1 g of sample. 



**Assay** 



A quantitative test performed to know the actual content of API and the 



acceptance criteria has calculated based on the content specified and 



unspecified impurities controlled. It contains NLT 98.0% and NMT 102.0% of 



C21H22N4O3, calculated on the anhydrous substance basis. 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 432 of 542 





Page 433
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.5** **Reference Standards or Materials** 



**I. Reference Standards used for Testing Finerenone** 



In-house working standards has been established. Their basic information is 



as below. 



Table 3.2.S.5-1 Reference Standards used for Testing of Finerenone 






























--------------------------------------------------------------------------
|1      |YA2304-10       |Working standard|DTA304    |99.77% |Purchased*1|
|-------|----------------|----------------|----------|-------|-----------|
|2      |YA2304-12       |Working standard|23081801-C|99.0%  |Selfmade   |
|-------|----------------|----------------|----------|-------|-----------|
|3      |YA2304-14       |Working standard|23082301-C|99.6%  |Selfmade   |
|-------|----------------|----------------|----------|-------|-----------|
|4      |YA2304-15       |Working standard|23082903-C|99.3%  |Selfmade   |
|-------|----------------|----------------|----------|-------|-----------|
|5      |YA2304-16       |Working standard|23082201-C|93.7%  |Selfmade   |
|-------|----------------|----------------|----------|-------|-----------|
|6      |YA2304-17       |Working standard|DMW857    |99.30% |Purchased*1|
|-------|----------------|----------------|----------|-------|-----------|
|7      |YA2304-18       |Working standard|23082802-C|98.9%  |Selfmade   |
|-------|----------------|----------------|----------|-------|-----------|
|8      |YA2304-19       |Working standard|23080701-A|99.4%  |Selfmade   |
|-------|----------------|----------------|----------|-------|-----------|
|9      |YA2304-20       |Working standard|23080401-A|99.2%  |Selfmade   |
|-------|----------------|----------------|----------|-------|-----------|
|10     |YA2304-52       |Working standard|24022801-C|90.8%  |Selfmade   |
|-------|----------------|----------------|----------|-------|-----------|
|11     |Dimethyl sulfate|Working standard|C15128674 |99.759%|Purchased*2|
|-------|----------------|----------------|----------|-------|-----------|
|12     |Diethyl sulfate |Working standard|C14721434 |99.024%|Purchased*2|
--------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 433 of 542 





Page 434
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 












---------------------------------------------------------------------------
|14     |Di-sec-butyl sulfate|Working standard|23110207-H|99.7%  |Selfmade|
|-------|--------------------|----------------|----------|-------|--------|
|15     |YA2304 (Finerenone) |Working standard|23091802-D|99.7%  |Selfmade|
---------------------------------------------------------------------------

*1: Reference standard of YA2304-10, YA2304-17, Diisopropyl sulfate was 
purchased from Shanghai Bidd Pharmaceutical Technology Co., LTD. 



*2: Reference standard of Dimethyl sulfate, Diethyl sulfatewas purchased 



from Shanghai McLean Biochemical Technology Co., LTD. 



The in-house prepared Finerenone (batch No. 23091802-D) is employed as 



working standard. It has been fully characterized in terms of chemical 



structure and purity. Its content value has been assigned by the applicant 



according to Finerenone working standard. 



**II. Description and Establishment of Working Standards** 



YA2304-10 working standard (batch No. DTA304), YA2304-17 working 



standard (batch No. DMW857), Dimethyl sulfate working standard (batch No. 



C15128674), Diethyl sulfate working standard (batch No. C14721434), 



Diisopropyl sulfate working standard (batch No. DLX318) was purchased 



from other companies. 



The description (preparation, specification and analytical procedures) of 



Finerenone(YA2304) working standard, YA2304-12 working standard, 



YA2304-14 working standard, YA2304-15 working standard, YA2304-16 



working standard, YA2304-18 working standard, YA2304-19 working 



standard, YA2304-20 working standard, YA2304-52 working standard and 



Di-sec-butyl sulfate working standard are as follows. 



**(1) YA2304-10 working standard** 



The YA2304-10 reference product used in this application was derived fr 



om Shanghai BidD Medical Technology Co., LTD. It was named D-dibenz 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 434 of 542 





Page 435
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



oyl tartaric acid on the physical label and (2S,3S)-2, 3-BIS (beznoyloxy)s 



uccinic acid on the manufacturer's report. The reference product on the 



invoice is called (2S,3S)-2, 3-bis (benzoyloxy) succinic acid. The applicant 



has confirmed its chemical structure and the content is 99.77% accordi 



ng to the report form provided by the manufacturer. 



Sample lot No.: DTA304 



Structural formula: 



Molecular formula: C18H14O 



Molecular weight: 358.3 



**(1.1) Structural analysis of YA2304-10 reference** 



The chemical structure of the reference product was confirmed by the 



applicant by means of [1] H NMR, [13] C NMR, mass spectrometry and specific curl. 



1H NMR, specific curl and mass spectrometry were provided by Shanghai 



Bider Medical Technology Co., LTD.,and 13C NMR was commissioned by 



Changsha Kangpeng Pharmaceutical Co., LTD. The relevant test results and 



structural analysis are detailed as follows: 



**a. Nuclear Magnetic Resonance (NMR)** 



Instrument model: Bruker Avance AV 400 superconducting pulse Fourier 



transform nuclear magnetic resonance spectrometer 



Test conditions: 



Solvent: DMSO; 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 435 of 542 





Page 436
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Reference: TMS ( [1] H spectrum); 



Resonance frequency of hydrogen spectrum: 400MHz 



Resonant frequency of carbon spectrum: 100MHz 



The number of the hydrocarbon atom in the structure (non-systematic n 



aming, only used for hydrocarbon magnetic spectrum analysis) 



The test data and analytical results of hydrocarbon spectra are shown i 



n Table 3.2.S.5-2 and Table 3.2.S.5-3. 



Table 3.2.S.5-2 [1] H NMR chemical shift value and correlation spectrum of the 



tested sample (from high field to low field) 






















----------------------------------------------------------
|1      |5.95   |s      |/      |2H     |2, 4 - CH       |
|-------|-------|-------|-------|-------|----------------|
|2      |7.62   |t      |/      |4H     |21,23,14,16 - CH|
|-------|-------|-------|-------|-------|----------------|
|3      |7.73   |d      |7.4    |2H     |15, 22 - CH     |
|-------|-------|-------|-------|-------|----------------|
|4      |8.06   |d      |7.3    |4H     |13,17,20,24 - CH|
|-------|-------|-------|-------|-------|----------------|
|5      |13.97  |s      |/      |2H     |9, 7 - OH       |
----------------------------------------------------------

Table 3.2.S.5-3 [13] CNMR chemical shift value and correlation spectrum (from 



high field to low field) of the tested sample 




Peak 




Peak Number of 

Delta ppm 
No. carbon 




Attribution 
carbon 




Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 436 of 542 





Page 437
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



1 

-----------------------------------------
|1      |71.973 |2      |2, 4 - C       |
|-------|-------|-------|---------------|
|2      |128.954|2      |12-3 C         |
|-------|-------|-------|---------------|
|3      |129.517|4      |14,16,21,23 - C|
|-------|-------|-------|---------------|
|4      |129.901|4      |13,17,22,24 - C|
|-------|-------|-------|---------------|
|5      |134.591|2      |15, 22 - C     |
|-------|-------|-------|---------------|
|6      |165.176|2      |11-16 C        |
|-------|-------|-------|---------------|
|7      |167.686|2      |3, 5 - C       |
-----------------------------------------
H-NMR(DMSO-d6, 400Hz) showed 14 hydrogen protons, and the hydrogen 



displacement of each group could be reasonably attributed. 



13C-NMR(DMSO- _d6_ , 100Hz) showed 18 carbon atoms, and the carbon 



displacement of each group could be reasonably assigned. The NMR data 



were in good agreement with the target compound. 



**b, Mass spectrometry (MS)** 



Testing instrument: LC-MS (Manufacturer's spectrum) 



Analytical method: / 



Test data: 



Table 3.2.S.5-4 MS data of the tested sample 

--------------------------------------------------------
|357.1  |[M-H]- |Molecularion peak in negative ion mode|
--------------------------------------------------------



In the negative ion mode, the mass charge ratio m/z is 357.1 peak, which is 



attributed to the molecular ion peak in the negative ion mode, consistent with 



the molecular weight of the target molecule 358.3. 



**c, specific curl** 



Test data: 



Table 3.2.S.5-5 Specific curl of the tested sample 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 437 of 542 





Page 438
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Specific Curl 



116.129 (C=1.31 ETOH) 



The relative rotation value of the control substance is +116.129°, which can 



confirm that the optical rotation configuration is right-handed structure, 



which is consistent with the target molecule. 



**(2) YA2304-12 working standard** 



The reference product YA2304-12 used in this study was self-made by T 



iandi Hengyi Pharmaceutical Co., LTD. It was named 4-(4-aminoformyl-2 



-methoxyphenyl) -5-ethoxy-2, 8-dimethyl-1, 4-dihydro-1, 6-naphthyl-3-for 



mamide on the physical label and the reference product report. The appl 



icant confirmed its chemical structure and content calibration, and the c 



ontent was calculated according to 99.0%. 



Sample lot No.: 23081801-C 



Structural formula: 



Molecular formula: C21H24O4N 



Molecular weight: 396.45 



**(2.1) Preparation method of YA2304-12** 



Add YA2304-8(4.2g), potassium carbonate (2.2g) and DMSO(20 mL) into a 



250 mL flask, slowly add 30% hydrogen peroxide (6 mL) under agitation, stir 



at room temperature for 0.5 h, add water (60 mL) into the reaction system, 



stir for 0.5 h, and filter. Rinse with water (100 mL) and dry at 50 ℃ to obtain 



YA2304-12, white solid (4.3 g). 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 438 of 542 





Page 439
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**(2.2) Structural analysis of YA2304-12 reference** 



The chemical structure of the reference product was confirmed by [1] the 



applicant by means of H NMR, [13] C NMR and mass spectrometry. The mass 



spectrometry was tested by the applicant by himself, [1] and the H NMR and [13] C 



NMR were tested by Changsha Kangpeng Pharmaceutical Co., LTD. The 



relevant test results and structural analysis are detailed as follows: 



**a. Nuclear Magnetic Resonance (NMR)** 



Instrument model: Bruker Avance AV 400 superconducting pulse Fourier 



transform nuclear magnetic resonance spectrometer 



Test conditions: 



Solvent: DMSO; 



Reference material: TMS ( [1] H spectrum); 



Resonance frequency of hydrogen spectrum: 400MHz 



Resonant frequency of carbon spectrum: 100MHz 



The number of the hydrocarbon atom in the structure (non-systematic n 



aming, only used for hydrocarbon magnetic spectrum analysis) 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 439 of 542 





Page 440
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



The test data and analytical results of hydrocarbon spectra are shown i 



n Table 3.2.S.5-6 and Table 3.2.S.5-7. 



Table 3.2.S.5-6 [1] H NMR chemical shift value and correlation spectrum (from 



high field to low field) of the tested sample 






















------------------------------------------------------
|1      |1.063-1.098|t      |6.8     |3H     |27-CH3 |
|-------|-----------|-------|--------|-------|-------|
|2      |2.137      |s      |/       |3H     |28-CH3 |
|-------|-----------|-------|--------|-------|-------|
|3      |2.249      |s      |/       |3H     |22-CH3 |
|-------|-----------|-------|--------|-------|-------|
|4      |3.841      |s      |/       |3H     |24-CH3 |
|-------|-----------|-------|--------|-------|-------|
|5      |4.000-4.041|m      |6.8     |2H     |26-CH2 |
|-------|-----------|-------|--------|-------|-------|
|6      |5.326      |s      |/       |1H     |9-CH   |
|-------|-----------|-------|--------|-------|-------|
|7      |6.672      |bs     |/       |2H     |20-NH2 |
|-------|-----------|-------|--------|-------|-------|
|8      |7.048-7.068|d      |8.0     |1H     |4-CH   |
|-------|-----------|-------|--------|-------|-------|
|9      |7.278      |s      |/       |2H     |8-NH2  |
|-------|-----------|-------|--------|-------|-------|
|10     |7.289-7.313|dd     |7.6, 1.4|1H     |5-CH   |
|-------|-----------|-------|--------|-------|-------|
|11     |7.371-7.377|d      |1.3     |1H     |1-CH   |
|-------|-----------|-------|--------|-------|-------|
|12     |7.553      |s      |/       |1H     |16-CH  |
|-------|-----------|-------|--------|-------|-------|
|13     |7.709      |s      |/       |1H     |12-NH  |
|-------|-----------|-------|--------|-------|-------|
|14     |7.865      |s      |/       |2H     |8-NH2  |
------------------------------------------------------

Table 3.2.S.5-7 [13] C NMR chemical shift values and correlation spectra (from 



high field to low field) of the tested sample 



Number of 
Peak No. Delta ppm Attribution 

carbon atoms 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 440 of 542 





Page 441
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



1 

------------------------------------------
|2      |14.795  |1      |27-bit carbon  |
|-------|--------|-------|---------------|
|3      |18.769  |1      |22-place carbon|
|-------|--------|-------|---------------|
|4      |31.950  |1      |9-bit carbons  |
|-------|--------|-------|---------------|
|5      |56.170  |1      |24-bit carbon  |
|-------|--------|-------|---------------|
|6      |60.989  |1      |26-bit carbon  |
|-------|--------|-------|---------------|
|7      |104.515 |1      |14-bit carbon  |
|-------|--------|-------|---------------|
|8      |105.682 |1      |10-bit carbon  |
|-------|--------|-------|---------------|
|9      |110.334 |1      |3-place carbons|
|-------|--------|-------|---------------|
|10     |111.895 |1      |15-place carbon|
|-------|--------|-------|---------------|
|11     |120.433 |1      |1 bit carbon   |
|-------|--------|-------|---------------|
|12     |130.041 |1      |5-bit carbon   |
|-------|--------|-------|---------------|
|13     |133.912 |1      |4-place carbons|
|-------|--------|-------|---------------|
|14     |139.612 |1      |6-place carbons|
|-------|--------|-------|---------------|
|15     |139.784 |1      |11-bit carbon  |
|-------|--------|-------|---------------|
|16     |144.399,|1      |13-place carbon|
|-------|--------|-------|---------------|
|17     |144.441 |1      |16-bit carbon  |
|-------|--------|-------|---------------|
|18     |155.225 |1      |2-bit carbons  |
|-------|--------|-------|---------------|
|19     |159.845 |1      |18-bit carbon  |
|-------|--------|-------|---------------|
|20     |168.212 |1      |19-carbon      |
|-------|--------|-------|---------------|
|21     |170.093 |1      |7-bit carbons  |
------------------------------------------
H-NMR(DMSO-d6, 400Hz) showed 24 hydrogen protons, and the hydrogen 



displacement of each group could be reasonably attributed. 



13C-NMR(DMSO- _d6_ , 100Hz) showed 21 carbon atoms, and the carbon 



displacement of each group could be reasonably assigned. The NMR data 



were in good agreement with the target compounds. 



**b, Mass spectrometry (MS)** 



Detection instrument: Vanquish-TSQ QUANTIS liquid chromatography-mass 



spectrometry 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 441 of 542 





Page 442
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Analytical method: Chinese Pharmacopoeia 2020 Edition of the four General 



Rules 0512 and 0431 



Test data: 



Table 3.2.S.5-8 MS data of the tested sample 

--------------------------------------------------------
|395.19 |[M-H]- |Molecularion peak in negative ion mode|
--------------------------------------------------------



In the negative ion mode, the mass-charge ratio m/z is 395.19 peak, which is 



attributed to the molecular ion peak in the negative ion mode, which is 



consistent with the molecular weight of the target molecule 396.45. 



**(2.3) Content calibration** 



**Properties** 



This product should be white to white powder. 



**Purity** 



Determination according to high performance liquid chromatography 



(General Rule 0512 of the Fourth part of Chinese Pharmacopoeia, 2020 



Edition). 



Chromatographic conditions: octadecylsilane bonded silica gel was used as 



filler (XBridge Shield RP18, 150×4.6mm, 3.5μm or equivalent column 



performance); A Welch Ghost-Buster Column (4.6×50mm, or equivalent 



ghost-buster column) was installed after the mixer of the pump and before the 



sampler. 0.03% phosphoric acid solution was used as mobile phase A and 



acetonitrile as mobile phase B; Gradient elution is performed according to the 



following table; Column temperature is 25℃; The detection wavelength was 



251nm; The flow rate was 1.0mL per minute; The injection volume was 5µl. 




Mobile 
Time /min 

phase A/% 




Mobile 



phase B/% 




0 95 5 



16.5 50 50 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 442 of 542 





Page 443
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



17 20 80 



22 20 80 



22.5 95 5 



35 95 5 



Solvent 30% acetonitrile 



Take an appropriate amount of this product from the test product solution, 



weigh it accurately, dissolve and dilute it with solvent to make a solution 



containing YA2304-12 about 0.25mg per 1ml. 



Method 5μl of the test solution was accurately measured and injected into the 



liquid chromatograph, and the chromatogram was recorded. The main peak 



purity should NLT 95.0% according to area normalization method. 



The content is calculated according to the purity. 



**(3) YA2304-14 working standard** 



The reference product YA2304-14 used in this study was self-made by T 



iandi Hengyi Pharmaceutical Co., LTD. It was named 4-(4-cyano-2-metho 



xyphenyl) -5-methoxy-2, 8-dimethyl-1, 4-dihydro-1, 6-naphthyl-3-formami 



de on the physical label and the reference product report. The applicant 



confirmed its chemical structure and content calibration, and the conte 



nt was calculated according to 99.6%. 



Sample lot No.: 23082301-C 



Structural formula: 



Molecular formula: C20H20O3N 



Molecular weight: 364.40 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 443 of 542 





Page 444
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**(3.1) Preparation method of YA2304-14** 



Add YA2304-16 (2.0g) and tetrahydrofuran (12mL) into 250 mL flask, stir and 



add CDI (1.2g) in batches, stir for 1 hour, add DMAP (0.07g), and heat up to 



50 ℃. After 2.5 h of agitation, hamethyldisilazane (3.9 g) was added to the 



reaction system, the temperature was raised to reflux reaction for 3 h, and the 



temperature was lowered to 0 ~ 10 ℃. Tetrahydrofuran (1.2 g) and water (1.0 



g) were added to the reaction system, and the temperature was raised to 50 ℃ 



for 20 minutes, and the temperature was lowered to 0 ~ 10 ℃ for 30 minutes, 



and then filtered. Washed with water (30 mL) and dried at 50 ℃, YA2304-14, 



white solid (0.8 g) was obtained. 



**(3.2) Structural analysis of YA2304-14 reference** 



The chemical structure of the reference product was confirmed by the 



applicant through [1] HNMR, [13] CNMR and mass spectrometry, among which the 



mass spectrometry was tested by the applicant himself, and the [1] H NMR and 



13C NMR commissioned Changsha Kangpeng Pharmaceutical Co., LTD for 



testing. the relevant test results and structural analysis are detailed as 



follows: 



**a. Nuclear Magnetic Resonance (NMR)** 



Instrument model: Bruker Avance AV 400 superconducting pulse Fourier 



transform nuclear magnetic resonance spectrometer 



Test conditions: 



Solvent: DMSO; 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 444 of 542 





Page 445
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Reference: TMS ( [1] H spectrum); 



Resonance frequency of hydrogen spectrum: 400MHz 



Resonant frequency of carbon spectrum: 100MHz 



The number of the hydrocarbon atom in the structure (non-systematic n 



aming, only used for hydrocarbon magnetic spectrum analysis) 



The test data of hydrocarbon spectra and the analytical results are sho 



wn in Table 3.2.S.5-9 and Table 3.2.S.5-10. 



Table 3.2.S.5-9 [1] H NMR chemical shift value and correlation spectrum of the 



tested sample (from high field to low field) 






















------------------------------------------------------
|1      |2.141      |s      |/       |3H     |27-CH3 |
|-------|-----------|-------|--------|-------|-------|
|2      |2.188      |s      |/       |3H     |22-CH3 |
|-------|-----------|-------|--------|-------|-------|
|3      |3.616      |s      |/       |3H     |26-CH3 |
|-------|-----------|-------|--------|-------|-------|
|4      |3.824      |s      |/       |3H     |24-CH3 |
|-------|-----------|-------|--------|-------|-------|
|5      |5.406      |s      |/       |1H     |9-CH   |
|-------|-----------|-------|--------|-------|-------|
|6      |6.730-6.828|bs     |/       |2H     |20-NH2 |
|-------|-----------|-------|--------|-------|-------|
|7      |7.098-7.117|d      |7.6     |1H     |4-CH   |
|-------|-----------|-------|--------|-------|-------|
|8      |7.269-7.292|dd     |7.6, 1.2|1H     |5-CH   |
|-------|-----------|-------|--------|-------|-------|
|9      |7.400-7.403|d      |1.2     |1H     |1-CH   |
|-------|-----------|-------|--------|-------|-------|
|10     |7.597      |s      |/       |1H     |16-CH  |
|-------|-----------|-------|--------|-------|-------|
|11     |7.738      |s      |/       |1H     |12-NH  |
------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 445 of 542 





Page 446
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Table 3.2.S.5-10 [13] C NMR chemical shift values and correlation spectra (from 



high field to low field) of the tested sample 



1 

----------------------------------------------
|1           |14.199 |1      |27-place carbon|
|------------|-------|-------|---------------|
|2           |18.398 |1      |22-place carbon|
|------------|-------|-------|---------------|
|Solvent Peak|25.581 |/      |THF            |
|------------|-------|-------|---------------|
|3           |32.977 |1      |9-bit carbon   |
|------------|-------|-------|---------------|
|4           |53.267 |1      |24-place carbon|
|------------|-------|-------|---------------|
|5           |56.789 |1      |26-bit carbon  |
|------------|-------|-------|---------------|
|Solvent peak|67.482 |/      |THF            |
|------------|-------|-------|---------------|
|6           |103.281|1      |14-bit carbon  |
|------------|-------|-------|---------------|
|7           |105.921|1      |10-bit carbon  |
|------------|-------|-------|---------------|
|8           |110.056|1      |3-place carbons|
|------------|-------|-------|---------------|
|9           |112.209|1      |15-place carbon|
|------------|-------|-------|---------------|
|10          |115.155|1      |1 bit carbon   |
|------------|-------|-------|---------------|
|11          |119.383|1      |7-bit carbon   |
|------------|-------|-------|---------------|
|12          |125.343|1      |5-bit carbons  |
|------------|-------|-------|---------------|
|13          |130.958|1      |4-place carbons|
|------------|-------|-------|---------------|
|14          |138.328|1      |11-bit carbon  |
|------------|-------|-------|---------------|
|15          |141.802|1      |6-bit carbons  |
|------------|-------|-------|---------------|
|16          |144.545|1      |13-place carbon|
|------------|-------|-------|---------------|
|17          |144.926|1      |16-bit carbon  |
|------------|-------|-------|---------------|
|18          |156.284|1      |2-bit carbons  |
|------------|-------|-------|---------------|
|19          |160.130|1      |18-bit carbon  |
|------------|-------|-------|---------------|
|20          |170.327|1      |19-carbon      |
----------------------------------------------
H-NMR(DMSO-d6, 400Hz) showed 20 hydrogen protons, and the hydrogen 



displacement of each group could be reasonably attributed. 



13C-NMR(DMSO- _d6_ , 100Hz) showed 20 carbon atoms, and the carbon 



displacement of each group could be reasonably assigned. The NMR data 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 446 of 542 





Page 447
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



were in good agreement with the target compound. 



**b, Mass spectrometry (MS)** 



Detection instrument: Vanquish-TSQ QUANTIS liquid chromatography-mass 



spectrometry 



Analytical method: Chinese Pharmacopoeia 2020 Edition of the four General 



Rules 0512 and 0431 



Test data: 



Table 3.2.S.5-11 MS data of the tested sample 

--------------------------------------------------------
|365.26 |[M+H]+ |Molecularion peak in positive ion mode|
--------------------------------------------------------



In the positive ion mode, the mass charge ratio m/z was detected to be 365.26, 



which was attributed to the molecular ion peak in the positive ion mode, 



consistent with the molecular weight of the target molecule 364.40. 



**(3.3) Content calibration** 



**Properties** 



This product should be white to white powder. 



**purity** 



Determination according to high performance liquid chromatography 



(General Rule 0512 of the Fourth part of Chinese Pharmacopoeia, 2020 



Edition). 



Chromatographic conditions: octadecylsilane bonded silica gel was used as 



filler (XBridge Shield RP18, 150*4.6mm, 3.5μm or equivalent performance 



column); Welch Ghost-Buster Column (4.6×50mm, or equivalent 



ghost-buster column) was installed after the mixer of the pump and before the 



sampler. 0.03% phosphoric acid solution was used as mobile phase A and 



acetonitrile as mobile phase B; Gradient elution is performed according to the 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 447 of 542 





Page 448
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



following table; Column temperature is 25℃; The detection wavelength was 



251nm; The flow rate was 1.0mL per minute; The injection volume was 5µl. 




Mobile 
Time /min 

phase A/% 




Mobile 



phase B/% 




0 95 5 



16.5 50 50 



17 20 80 



22 20 80 



22.5 95 5 



35 95 5 



Solvent 70% acetonitrile 



Take an appropriate amount of this product from the test product solution, 



weigh it accurately, dissolve and dilute it with solvent to make a solution 



containing YA2304-14 about 0.25mg per 1ml. 



Method 5μl of the test solution was accurately measured and injected into the 



liquid chromatograph, and the chromatogram was recorded. The main peak 



purity should NLT 95.0% according to area normalization method. 



The content is calculated according to the purity. 



**(4) YA2304-15 working standard** 



The reference product YA2304-15 used in this study was derived from T 



iandi Hengyi Pharmaceutical Co., LTD. It was named 4-(4-cyano-2-metho 



xyphenyl) -5-isopropoxy-2, 8-dimethyl-1, 4-dihydro-1, 6-naphthyl-3-forma 



mide on the physical label and the reference product report. The applica 



nt confirmed its chemical structure and content calibration, and the con 



tent was calculated according to 99.3%. 



Sample lot No.: 23082903-C 



Structural formula: 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 448 of 542 





Page 449
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Molecular formula: C22H24O3N 



Molecular weight: 392.46 



**(4.1) Preparation method of YA2304-15** 



Add YA2304-18(2.0g) and tetrahydrofuran (21mL) into 250 mL flask, add CDI 



(2.0g) in batches under agitation, add DMAP (0.11g) after 1 hour of agitation, 



heat up to 50℃, add hexamethyldisilazane (6.3g) into the reaction system 



after 2.5 h of agitation. Heating up to reflux reaction for 3 h, cooling down to 



0~10℃, adding tetrahydrofuran (1.2 g) and water (1.0 g) to the reaction 



system, stirring at 80 ℃ for 2 h, cooling down to 0~10℃ for 30 minutes, 



filtering, washing with water (30 mL), drying at 50 ℃, YA2304-15 was 



obtained. White solid (2.6g). 



**(4.2) Structural analysis of YA2304-15 reference** 



The chemical structure of the reference product was confirmed by [1] the 



applicant by means of HNMR, [13] CNMR and mass spectrometry, among which 



the mass spectrometry was tested by the applicant himself, [1] HNMR and [13] 



CNMR commissioned Changsha Kangpeng Pharmaceutical Co., LTD for 



testing. The relevant test atlas and contract for testing are detailed in section 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 449 of 542 





Page 450
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



3.2.R.7.S, and the relevant test results and structural analysis are detailed as 



follows: 



**a. Nuclear Magnetic Resonance (NMR)** 



Instrument model: Bruker Avance AV 400 superconducting pulse Fourier 



transform nuclear magnetic resonance spectrometer 



Test conditions: 



Solvent: DMSO; 



Reference: TMS ( [1] H spectrum); 



Resonance frequency of hydrogen spectrum: 400MHz 



Resonant frequency of carbon spectrum: 100MHz 



The number of the hydrocarbon atom in the structure (non-systematic n 



aming, only used for hydrocarbon magnetic spectrum analysis) 



The test data and analytical results of hydrocarbon spectra are shown i 



n Table 3.2.S.5-12 and Table 3.2.S.5-13. 



Table 3.2.S.5-12 HN [1] MR chemical shift value and correlation spectrum of the 



tested sample (from high field to low field) 






















-----------------------------------------------------
|1      |0.733-0.748|t      |6      |3H     |27-CH3 |
|-------|-----------|-------|-------|-------|-------|
|2      |1.178-1.193|t      |6      |3H     |29-CH3 |
-----------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 450 of 542 





Page 451
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 

-----------------------------------------------------------
|4           |2.203      |s      |/       |3H     |22-CH3 |
|------------|-----------|-------|--------|-------|-------|
|Solvent peak|3.583-3.616|m      |/       |/      |THF    |
|------------|-----------|-------|--------|-------|-------|
|5           |3.835      |s      |/       |3H     |24-CH3 |
|------------|-----------|-------|--------|-------|-------|
|6           |4.956-4.987|m      |/       |1H     |26-CH  |
|------------|-----------|-------|--------|-------|-------|
|7           |5.361      |s      |/       |1H     |9-CH   |
|------------|-----------|-------|--------|-------|-------|
|8           |6.773-6.705|bs     |/       |2H     |20-NH2 |
|------------|-----------|-------|--------|-------|-------|
|9           |7.168-7.188|d      |8.0     |1H     |4-CH   |
|------------|-----------|-------|--------|-------|-------|
|10          |7.274-7.297|dd     |8.0, 1.2|1H     |5-CH   |
|------------|-----------|-------|--------|-------|-------|
|11          |7.370-7.373|d      |1.2     |1H     |1-CH   |
|------------|-----------|-------|--------|-------|-------|
|12          |7.557      |s      |/       |1H     |16-CH  |
|------------|-----------|-------|--------|-------|-------|
|13          |7.675      |s      |/       |1H     |12-NH  |
-----------------------------------------------------------



Table 3.2.S.5-13 CN [13] MR chemical shift values and correlation spectra (from 



high field to low field) of the tested sample 













----------------------------------------------
|1           |14.182 |1      |28-bit carbon  |
|------------|-------|-------|---------------|
|2           |18.556 |1      |22-place carbon|
|------------|-------|-------|---------------|
|3           |21.708 |1      |27-place carbon|
|------------|-------|-------|---------------|
|4           |22.365 |1      |29-place carbon|
|------------|-------|-------|---------------|
|Solvent Peak|25.586 |/      |THF            |
|------------|-------|-------|---------------|
|5           |32.442 |1      |9-bit carbon   |
|------------|-------|-------|---------------|
|6           |56.405 |1      |24-place carbon|
|------------|-------|-------|---------------|
|7           |67.002 |1      |26-bit carbon  |
|------------|-------|-------|---------------|
|Solvent Peak|67.478 |/      |THF            |
|------------|-------|-------|---------------|
|8           |104.245|1      |14-bit carbon  |
|------------|-------|-------|---------------|
|9           |105.756|1      |10-carbon      |
|------------|-------|-------|---------------|
|10          |109.875|1      |3-place carbons|
|------------|-------|-------|---------------|
|11          |111.510|1      |15-place carbon|
----------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 451 of 542 





Page 452
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



1 

-----------------------------------------
|13     |119.462|1      |7-bit carbon   |
|-------|-------|-------|---------------|
|14     |125.154|1      |5-bit carbons  |
|-------|-------|-------|---------------|
|15     |131.563|1      |4-place carbons|
|-------|-------|-------|---------------|
|16     |138.558|1      |11-bit carbon  |
|-------|-------|-------|---------------|
|17     |142.476|1      |6-bit carbons  |
|-------|-------|-------|---------------|
|18     |144.662|1      |13-place carbon|
|-------|-------|-------|---------------|
|19     |144.726|1      |16-bit carbon  |
|-------|-------|-------|---------------|
|20     |156.101|1      |2-bit carbons  |
|-------|-------|-------|---------------|
|21     |159.440|1      |18-bit carbon  |
|-------|-------|-------|---------------|
|22     |170.174|1      |19-bit carbon  |
-----------------------------------------
H-NMR(DMSO-d6, 400Hz) showed 24 hydrogen protons, and the hydrogen 



displacement of each group could be reasonably attributed. 



13C-NMR(DMSO- _d6_ , 100Hz) showed 22 carbon atoms, and the carbon 



displacement of each group could be reasonably attributed, and the NMR 



data were consistent with the target compound. 



**b, Mass spectrometry (MS)** 



Test instrument: Vanquish-TSQ QUANTIS liquid chromatography-mass 



spectrometry 



Analytical method: Chinese Pharmacopoeia 2020 Edition of the four General 



Rules 0512 and 0431 



Test data: 



Table 3.2.S.5-14 MS data of the tested sample 

--------------------------------------------------------
|393.29 |[M+H]+ |Molecularion peak in positive ion mode|
--------------------------------------------------------



In the positive ion mode, the mass-charge ratio m/z is 393.29 peak, which is 



attributed to the molecular ion peak in the positive ion mode, consistent with 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 452 of 542 





Page 453
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



the molecular weight of the target molecule 392.46. 



**(4.3) Content calibration** 



**Properties** 



This product should be white to white powder. 



**Purity** 



Determination according to high performance liquid chromatography 



(General Rule 0512 of the Fourth part of Chinese Pharmacopoeia, 2020 



Edition). 



Chromatographic conditions: octadecylsilane bonded silica gel was used as 



filler (XBridge Shield RP18, 150×4.6mm, 3.5μm or equivalent performance 



column); A Welch Ghost-Buster Column (4.6×50mm, or equivalent 



ghost-buster column) was installed after the mixer of the pump and before the 



sampler. 0.03% phosphoric acid solution was used as mobile phase A and 



acetonitrile as mobile phase B; Gradient elution is performed according to the 



following table; Column temperature is 25℃; The detection wavelength was 



251nm; The flow rate was 1.0mL per minute; The injection volume was 5µl. 




Mobile 
Time /min 

phase A/% 




Mobile 



phase B/% 




0 95 5 



16.5 50 50 



17 20 80 



22 20 80 



22.5 95 5 



35 95 5 



Solvent 70% acetonitrile 



Take an appropriate amount of this product from the test product solution, 



weigh it accurately, dissolve and dilute it with solvent to make a solution 



containing YA2304-15 about 0.25mg per 1ml. 



The test solution of 5μl was accurately measured and injected into the liquid 



chromatograph, and the chromatogram was recorded. The main peak purity 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 453 of 542 





Page 454
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



was NLT 95.0% according to the area normalization method. 



The content is calculated according to the purity. 



**(5) YA2304-16 working standard** 



The reference product YA2304-16 used in this study was derived from T 



iandi Hengyi Pharmaceutical Co., LTD. It was named 4-(4-cyano-2-metho 



xyphenyl) -5-methoxy-2, 8-dimethyl-1, 4-dihydro-1, 6-naphthyl-3-carboxyl 



ic acid on the physical label and the reference product report. The appli 



cant confirmed its chemical structure and content calibration, and the c 



ontent was calculated according to 93.7%. 



Sample lot No.: 23082201-C 



Structural formula: 



Molecular formula: C20H19O4N 



Molecular weight: 365.39 



**(5.1) Preparation method of YA2304-16** 



Add YA2304-50(4.8g), tetrahydrofuran (60 mL) and water (30 mL) into 250 



mL flask, stir and cool to 0~5 ℃, slowly add 7.3% NaOH aq.(12.5 g) into the 



reaction system, and react at 0~5 ℃ for 3 h. Sodium acetate (0.9 g) and 



toluene (50 mL) were added into the reaction system, and the solution was 



divided after stirring at 0 ~ 5 ℃ for 20 minutes. The lower aqueous phase was 



treated with 10% NaOH aq. Adjust the pH to 6.5~7.0, stir at 0~5 ℃ for 30 



minutes, filter, rinse with water (100 mL), dry at 50 ℃, YA2304-16, light 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 454 of 542 





Page 455
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



yellow solid (3.2 g) was obtained. 



**(5.2) Structural analysis of YA2304-16 reference** 



The chemical structure of the reference product was confirmed by the 



applicant by means of [1] H NMR, [13] C NMR and mass spectrometry. The mass 



spectrometry was tested by the applicant by himself, and the [1] H NMR and [13] C 



NMR were tested by Changsha Kangpeng Pharmaceutical Co., LTD. The 



relevant test results and structural analysis are detailed as follows: 



**a. Nuclear Magnetic Resonance (NMR)** 



Instrument model: Bruker Avance AV 400 superconducting pulse Fourier 



transform nuclear magnetic resonance spectrometer 



Test conditions: 



Solvent: DMSO; 



Reference material: TMS ( [1] H spectrum); 



Resonance frequency of hydrogen spectrum: 400MHz 



Resonant frequency of carbon spectrum: 100MHz 



The number of the hydrocarbon atom in the structure (non-systematic n 



aming, only used for hydrocarbon magnetic spectrum analysis) 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 455 of 542 





Page 456
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



The test data and analytical results of hydrocarbon spectra are shown i 



n Table 3.2.S.5-15 and Table 3.2.S.5-16. 



Table 3.2.S.5-15 [1] H NMR chemical shift value and correlation spectrum of the 



tested sample (from high field to low field) 






















-------------------------------------------------------
|1      |2.160      |s      |/      |3H     |27-CH3   |
|-------|-----------|-------|-------|-------|---------|
|2      |2.504      |s      |/      |3H     |22-CH3   |
|-------|-----------|-------|-------|-------|---------|
|3      |3.650      |s      |/      |3H     |24-CH3   |
|-------|-----------|-------|-------|-------|---------|
|4      |3.766      |s      |/      |3H     |26-CH3   |
|-------|-----------|-------|-------|-------|---------|
|5      |5.370      |s      |/      |1H     |9-CH     |
|-------|-----------|-------|-------|-------|---------|
|6      |7.248-7.262|t      |/      |2H     |4, 5 - CH|
|-------|-----------|-------|-------|-------|---------|
|7      |7.340-7.343|d      |/      |1H     |1-CH     |
|-------|-----------|-------|-------|-------|---------|
|8      |7.606      |s      |/      |1H     |16-CH    |
|-------|-----------|-------|-------|-------|---------|
|9      |8.202      |s      |/      |1H     |12-NH    |
|-------|-----------|-------|-------|-------|---------|
|10     |11.481     |s      |/      |1H     |20-COOH  |
-------------------------------------------------------

Table 3.2.S.5-16 [13] C NMR chemical shift values and correlation spectra (from 



high field to low field) of the tested sample 

-------------------------------------------
|1      |14.174 |1      |27-place carbon  |
|-------|-------|-------|-----------------|
|2      |19.272 |1      |Twenty-two carbon|
|-------|-------|-------|-----------------|
|3      |34.223 |1      |9-bit carbons    |
-------------------------------------------



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 456 of 542 





Page 457
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



1 

-------------------------------------------
|5      |56.453 |1      |26-bit carbon    |
|-------|-------|-------|-----------------|
|6      |100.037|1      |14-bit carbon    |
|-------|-------|-------|-----------------|
|7      |103.771|1      |10-bit carbon    |
|-------|-------|-------|-----------------|
|8      |110.034|1      |3-place carbons  |
|-------|-------|-------|-----------------|
|9      |112.438|1      |15-place carbon  |
|-------|-------|-------|-----------------|
|10     |115.416|1      |1 bit carbon     |
|-------|-------|-------|-----------------|
|11     |119.430|1      |7-bit carbon     |
|-------|-------|-------|-----------------|
|12     |124.497|2      |4, 5-place carbon|
|-------|-------|-------|-----------------|
|13     |141.344|1      |6-place carbon   |
|-------|-------|-------|-----------------|
|14     |144.232|2      |13,16 carbon     |
|-------|-------|-------|-----------------|
|15     |147.519|1      |11-bit carbon    |
|-------|-------|-------|-----------------|
|16     |157.660|1      |2-bit carbons    |
|-------|-------|-------|-----------------|
|17     |160.155|1      |18-bit carbon    |
|-------|-------|-------|-----------------|
|18     |168.962|1      |19-carbon        |
-------------------------------------------
H-NMR(DMSO-d6, 400Hz) showed 19 hydrogen protons, and the hydrogen 



displacement of each group could be reasonably attributed. 



13C-NMR(DMSO- _d6_ , 100Hz) showed 20 carbon atoms, and the carbon 



displacement of each group could be reasonably assigned. The NMR data 



were in good agreement with the target compound. 



**b, Mass spectrometry (MS)** 



Detection instrument: Vanquish-TSQ QUANTIS liquid chromatography-mass 



spectrometry 



Analytical method: Chinese Pharmacopoeia 2020 Edition of the four General 



Rules 0512 and 0431 



Test data: 



Table 3.2.S.5-17 MS data of the tested sample 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 457 of 542 





Page 458
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 

--------------------------------------------------------
|366.26 |[M+H]+ |Molecularion peak in positive ion mode|
--------------------------------------------------------



In the positive ion mode, the detected mass-charge ratio m/z is 366.26 peak, 



which is attributed to the molecular ion peak in the positive ion mode, 



consistent with the molecular weight of the target molecule 365.39. 



**(5.3) Content calibration** 



**Properties** 



This product should be like white to yellow powder. 



**purity** 



Determination according to high performance liquid chromatography 



(General Rule 0512 of the Fourth part of Chinese Pharmacopoeia, 2020 



Edition). 



Chromatographic conditions: octadecylsilane bonded silica gel was used as 



filler (XBridge Shield RP18, 150×4.6mm, 3.5μm or equivalent performance 



column); 20mM ammonium acetate solution (pH8.1) (weigh ammonium 



acetate about 1.54g, dissolve in 1000ml pure water, adjust the pH to 8.1 with 



ammonia water) was used as mobile phase A, acetonitrile was used as mobile 



phase B; Gradient elution was performed according to the following table; 



Column temperature is 25℃; The detection wavelength was 251nm; The flow 



rate was 1.0mL per minute; The injection volume was 5µl. 




Mobile 
Time /min 

phase A/% 




Mobile 



phase B/% 




0 95 5 



16.5 50 50 



17 20 80 



22 20 80 



22.5 95 5 



35 95 5 



Solvent acetonitrile 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 458 of 542 





Page 459
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Sample solution take appropriate amount of this product, weigh it accurately, 



dissolve and dilute it with solvent to make a solution containing YA2304-16 



about 0.25mg per 1ml. 



Method 5μl of the test solution was accurately measured and injected into the 



liquid chromatograph, and the chromatogram was recorded. The main peak 



purity should NLT 90.0% according to area normalization method. 



The content is calculated according to the purity. 



**(6) YA2304-17 working standard** 



The control product YA2304-17 used in this application is from Shangha 



i Bide Pharmaceutical Technology Co., LTD., which is named Benzoic aci 



d on the physical label, which is named Benzoic acid on the manufactu 



rer's photo report list, and the control product name is Benzoic acid on 



the invoice. The applicant has confirmed its chemical structure, and acc 



ording to the report provided by the manufacturer, the content is calcul 



ated by 99.30%. 



Sample lot No.: DMW857 



Structural formula: 



Molecular formula: C7H6O 



Molecular weight: 122.12 



**(6.1) Structural analysis of YA2304-17 reference** 



The chemical structure of the reference product was confirmed by [1] the 



applicant by means of H NMR, [13] CNMR and mass spectrometry, among which 



the mass spectrometry was tested by the applicant himself, 1H NMR was 



provided by Shanghai Bider Medical Technology Co., LTD., and 13C NMR 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 459 of 542 





Page 460
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



commissioned Changsha Kangpeng Medical Co., LTD to test. The relevant 



test results and structural analysis are detailed as follows: 



**a. Nuclear Magnetic Resonance (NMR)** 



Instrument model: Bruker Avance AV 400 superconducting pulse Fourier 



transform nuclear magnetic resonance spectrometer 



Test conditions: 



Solvent: DMSO; 



Reference: TMS ( [1] H spectrum); 



Resonance frequency of hydrogen spectrum: 400MHz 



Resonant frequency of carbon spectrum: 100MHz 



The number of the hydrocarbon atom in the structure (non-systematic n 



aming, only used for hydrocarbon magnetic spectrum analysis) 



The test data and analytical results of hydrocarbon spectra are shown i 



n Table 3.2.S.5-18 and Table 3.2.S.5-19. 



Table 3.2.S.5-18 [1] H NMR chemical shift value and correlation spectrum of the 



tested sample (from high field to low field) 






















-------------------------------------------------------------
|1      |5.74 ~ 7.39|m      |/            |2H     |1, 3 - CH|
|-------|-----------|-------|-------------|-------|---------|
|2      |7.71 ~ 7.54|m      |/            |1H     |2-CH     |
|-------|-----------|-------|-------------|-------|---------|
|3      |7.94       |ddd    |7.4, 2.9, 1.6|2H     |4, 6 - CH|
|-------|-----------|-------|-------------|-------|---------|
|4      |12.94      |s      |0.8Hz        |1H     |9-OH     |
-------------------------------------------------------------

Table 3.2.S.5-19 [13] C NMR chemical shift values and correlation spectra of the 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 460 of 542 





Page 461
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



tested sample (from high field to low field) 










1 

-------------------------------------
|1      |128.992|2      |1, 3-placeC|
|-------|-------|-------|-----------|
|2      |129.727|2      |4,6 C's    |
|-------|-------|-------|-----------|
|3      |131.222|1      |5 digitC's |
|-------|-------|-------|-----------|
|4      |133.286|1      |2-bitC     |
|-------|-------|-------|-----------|
|5      |167.796|1      |7-bitC     |
-------------------------------------
H-NMR(DMSO-d6, 400Hz) showed 6 hydrogen protons, and the hydrogen 



displacement of each group could be reasonably attributed. 



13C-NMR(DMSO- _d6_ , 100Hz) showed 7 carbon atoms, and the carbon 



displacement of each group could be reasonably assigned. The NMR data 



were in good agreement with the target compound. 



**b, Mass spectrometry (MS)** 



Detection instrument: Vanquish-TSQ QUANTIS liquid chromatography-mass 



spectrometry 



Analytical method: Chinese Pharmacopoeia 2020 Edition of the four General 



Rules 0512 and 0431 



Test data: 



Table 3.2.S.5-20 MS data of the tested sample 

--------------------------------------------------------
|121.08 |[M-H]- |Molecularion peak in negative ion mode|
--------------------------------------------------------



In the negative ion mode, the mass-charge ratio m/z was detected as 121.08 



peak, which was attributed to the molecular ion peak in the negative ion 



mode, consistent with the molecular weight of the target molecule 122.12. 



**(7) YA2304-18 working standard** 



The reference product YA2304-18 used in this study was derived from T 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 461 of 542 





Page 462
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



iandi Hengyi Pharmaceutical Co., LTD. It was named 4-(4-cyano-2-metho 



xyphenyl) -5-isopropoxy-2, 8-dimethyl-1, 4-dihydro-1, 6-naphthyl-3-carbo 



xylic acid on the physical label and the reference product report. The ap 



plicant confirmed its chemical structure and content calibration, and the 



content was calculated according to 98.9%. 



Sample lot No.: 23082802-C 



Structural formula: 



Molecular formula: C22H23O4N 



Molecular weight: 393.44 



**(7.1) Preparation method of YA2304-18** 



Add YA2304-51(6.0 g), tetrahydrofuran (36 mL) and water (18 mL) into 250 



mL flask, stir and cool to 0~5℃, slowly add 7.3% NaOH aq.(14.7 g) into the 



reaction system, and react at 0~5℃ for 3 h. Sodium acetate (1.1g) and toluene 



(45 mL) were added into the reaction system, stirring at 0~5 ℃ for 20 minutes 



before separating the solution, and the lower aqueous phase was treated with 



10% NaOH aq. Adjust the pH to 6.5~7.0, stir at 0~5 ℃ for 30 minutes, filter, 



rinse with water (100 mL), dry at 50 ℃, YA2304-18, white solid (4.5 g) was 



obtained. 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 462 of 542 





Page 463
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**(7.2) Structural analysis of YA2304-18 reference** 



The chemical structure of the reference product was confirmed by [1] the 



applicant by means of H NMR, [13] C NMR and mass spectrometry. The mass 



spectrometry was tested by the applicant by himself, [1] and the H NMR and [13] C 



NMR were tested by Changsha Kangpeng Pharmaceutical Co., LTD. For 



details about the relevant test graphs and contract, see section 3.2.R.7.S. The 



relevant test results and structural analysis are detailed as follows: 



**a. Nuclear Magnetic Resonance (NMR)** 



Instrument model: Bruker Avance AV 400 superconducting pulse Fourier 



transform nuclear magnetic resonance spectrometer 



Test conditions: 



Solvent: DMSO; 



Reference: TMS ( [1] H spectrum); 



Resonance frequency of hydrogen spectrum: 400MHz 



Resonant frequency of carbon spectrum: 100MHz 



The number of the hydrocarbon atom in the structure (non-systematic n 



aming, only used for hydrocarbon magnetic spectrum analysis) 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 463 of 542 





Page 464
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



The test data and analytical results of hydrocarbon spectra are shown i 



n Table 3.2.S.5-21 and Table 3.2.S.5-22. 



Table 3.2.S.5-21 [1] H NMR chemical shift value and correlation spectrum of the 



tested sample (from high field to low field) 






















----------------------------------------------------------------
|1      |0.829-0.845|d      |6.4    |3H     |27-CH3            |
|-------|-----------|-------|-------|-------|------------------|
|2      |1.209-1.224|d      |6.4    |3H     |29-CH3            |
|-------|-----------|-------|-------|-------|------------------|
|3      |2.144      |s      |/      |3H     |28-CH3            |
|-------|-----------|-------|-------|-------|------------------|
|4      |2.383      |s      |/      |3H     |22-CH3            |
|-------|-----------|-------|-------|-------|------------------|
|5      |3.727      |s      |/      |3H     |24-CH3            |
|-------|-----------|-------|-------|-------|------------------|
|6      |4.968-5.029|m      |/      |1H     |26-CH             |
|-------|-----------|-------|-------|-------|------------------|
|7      |5.307      |s      |/      |1H     |9-CH              |
|-------|-----------|-------|-------|-------|------------------|
|8      |7.275-7.313|d      |/      |3H     |1, four, five - CH|
|-------|-----------|-------|-------|-------|------------------|
|9      |7.570      |s      |/      |1H     |16-CH             |
|-------|-----------|-------|-------|-------|------------------|
|10     |8.119      |s      |/      |1H     |12-NH             |
|-------|-----------|-------|-------|-------|------------------|
|11     |11.429     |s      |/      |1H     |20-COOH           |
----------------------------------------------------------------

Table 3.2.S.5-22 [13] C NMR chemical shift value and correlation spectrum 



(from high field to low field) of the tested sample 

-----------------------------------------
|1      |14.141 |1      |28-bit carbon  |
|-------|-------|-------|---------------|
|2      |19.361 |1      |22-place carbon|
-----------------------------------------



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 464 of 542 





Page 465
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



1 

--------------------------------------------
|4      |22.400 |1      |26-place carbon   |
|-------|-------|-------|------------------|
|5      |34.719 |1      |9-bit carbons     |
|-------|-------|-------|------------------|
|6      |56.188 |1      |24-place carbon   |
|-------|-------|-------|------------------|
|7      |67.091 |1      |26-bit carbon     |
|-------|-------|-------|------------------|
|8      |99.901 |1      |10-bit carbon     |
|-------|-------|-------|------------------|
|9      |104.274|2      |3,14 carbon       |
|-------|-------|-------|------------------|
|10     |109.867|1      |15-position carbon|
|-------|-------|-------|------------------|
|11     |111.681|1      |1 bit carbon      |
|-------|-------|-------|------------------|
|12     |119.520|1      |7-bit carbon      |
|-------|-------|-------|------------------|
|13     |124.126|1      |5-bit carbons     |
|-------|-------|-------|------------------|
|14     |132.412|1      |4-place carbons   |
|-------|-------|-------|------------------|
|15     |141.553|1      |6-place carbons   |
|-------|-------|-------|------------------|
|16     |144.164|1      |13-place carbon   |
|-------|-------|-------|------------------|
|17     |144.836|1      |16-bit carbon     |
|-------|-------|-------|------------------|
|18     |147.451|1      |11 bit carbon     |
|-------|-------|-------|------------------|
|19     |157.793|1      |2-bit carbons     |
|-------|-------|-------|------------------|
|20     |159.446|1      |18-bit carbon     |
|-------|-------|-------|------------------|
|21     |169.063|1      |19-bit carbon     |
--------------------------------------------
H-NMR(DMSO-d6, 400Hz) showed 23 hydrogen protons, and the hydrogen 



displacement of each group could be reasonably attributed. 



13C-NMR(DMSO- _d6_ , 100Hz) showed 22 carbon atoms, and the carbon 



displacement of each group could be reasonably assigned. The NMR data 



were in good agreement with the target compound. 



**b, Mass spectrometry (MS)** 



Detection instrument: Vanquish-TSQ QUANTIS liquid chromatography-mass 



spectrometry 



Analysis methods: General Rules 0512 and 0431 of the fourth edition of 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 465 of 542 





Page 466
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Chinese Pharmacopoeia (2020 edition) 



Test data: 



Table 3.2.S.5-23 MS data of the tested sample 

--------------------------------------------------------
|394.31 |[M+H]+ |Molecularion peak in positive ion mode|
--------------------------------------------------------



In the positive ion mode, the mass-charge ratio m/z is 394.31 peak, which is 



attributed to the molecular ion peak in the positive ion mode, consistent with 



the molecular weight of the target molecule 393.44. 



**(7.3) Content calibration** 



**Properties** 



This product should be white to white powder. 



**Purity** 



Determination according to high performance liquid chromatography 



(General Rule 0512 of the Fourth part of Chinese Pharmacopoeia, 2020 



Edition). 



Chromatographic conditions: octadecylsilane bonded silica gel was used as 



filler (XBridge Shield RP18, 150×4.6mm, 3.5μm or equivalent performance 



column); 20mM ammonium acetate solution (pH 8.1) (weigh ammonium 



acetate about 1.54g, dissolve in 1000ml pure water, adjust the pH to 8.1 with 



ammonia water) was used as mobile phase A, acetonitrile was used as mobile 



phase B; Gradient elution was performed according to the following table; 



Column temperature is 25℃; The detection wavelength was 251nm; The flow 



rate was 1.0mL per minute; The injection volume was 5µl. 




Mobile 
Time /min 

phase A/% 




Mobile 



phase B/% 




0 95 5 



16.5 50 50 



17 20 80 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 466 of 542 





Page 467
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



22 20 80 



22.5 95 5 



35 95 5 



Solvent acetonitrile 



Sample solution take appropriate amount of this product, weigh it accurately, 



dissolve and dilute it with solvent to make a solution containing YA2304-18 



about 0.25mg per 1ml. 



Method 5μl of the test solution was accurately measured and injected into the 



liquid chromatograph, and the chromatogram was recorded. The main peak 



purity should NLT 95.0% according to area normalization method. 



The content is calculated according to the purity. 



**(8) YA2304-19 working standard** 



The reference product YA2304-19 used in this study was from Tiandi He 



ngyi Pharmaceutical Co., LTD. It was named 4-(4-cyano-2-methoxyphenyl) 



-5-ethoxy-2, 8-dimethyl-1, 6-naphthyl-3-formamide on the physical label 



and the reference product report. The applicant confirmed its chemical 



structure and content calibration, and the content was calculated accord 



ing to 99.4%. 



Sample lot No.: 23080701-A 



Structural formula: 



Molecular formula: C21H20O3N 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 467 of 542 





Page 468
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Molecular weight: 376.42 



**(8.1) Preparation method of YA2304-19** 



Add YA2304-7(20.0g), CDI (12.0g) and tetrahydrofuran (100 mL) into 250 mL 



flask, stir to dissolve, control the temperature by 15~20℃, add DMAP (0.64g), 



stir for 10 minutes, rise to 50 ℃ and react for 2 h, add hamethyldisilazane 



(37.4g), stir for 10 minutes. Overnight reaction at 60℃ until the reaction of 



raw material is complete. Drop to 0~5℃, add water (10.4 g) and 



tetrahydrofuran (16.0 g) mixed liquid crystallization, temperature rise reflux 



stirring for 3 h beating, temperature drop to 0~5℃ stirring for 2 h after 



filtration, mother liquor concentrated to dry, column purification (EA/ 



n-heptane =1/1), concentration, recrystallization (EA/ n-heptane =1/5), 



vacuum drying, Yellow granular solid YA2304-19 was obtained. 



**(8.2) Structural analysis of YA2304-19 reference** 



The chemical structure of the reference product was confirmed by [1] the 



applicant by means of H NMR, [13] C NMR and mass spectrometry. The mass 



spectrometry was tested by the applicant by himself, [1] and the H NMR and [13] C 



NMR were tested by Changsha Kangpeng Pharmaceutical Co., LTD. The 



relevant test results and structural analysis are detailed as follows: 



**a. Nuclear Magnetic Resonance (NMR)** 



Instrument model: Bruker Avance AV 400 superconducting pulse Fourier 



transform nuclear magnetic resonance spectrometer 



Test conditions: 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 468 of 542 





Page 469
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Solvent: DMSO; 



Reference: TMS ( [1] H spectrum); 



Resonance frequency of hydrogen spectrum: 400MHz 



Resonant frequency of carbon spectrum: 100MHz 



The number of the hydrocarbon atom in the structure (non-systematic n 



aming, only used for hydrocarbon magnetic spectrum analysis) 



The test data and analytical results of hydrocarbon spectra are shown i 



n Table 3.2.S.5-24 and Table 3.2.S.5-25. 



Table 3.2.S.5-24 [1] H NMR chemical shift value and correlation spectrum of the 



tested sample (from high field to low field) 






















-----------------------------------------------------
|1      |0.702-0.737|t      |/      |3H     |27-CH3 |
|-------|-----------|-------|-------|-------|-------|
|2      |2.508      |s      |/      |3H     |28-CH3 |
|-------|-----------|-------|-------|-------|-------|
|3      |2.719      |s      |/      |3H     |22-CH3 |
|-------|-----------|-------|-------|-------|-------|
|4      |3.669      |s      |/      |3H     |24-CH3 |
|-------|-----------|-------|-------|-------|-------|
|5      |3.945-4.049|m      |/      |2H     |26-CH2 |
|-------|-----------|-------|-------|-------|-------|
|6      |7.318-7.338|d      |/      |1H     |4-CH   |
|-------|-----------|-------|-------|-------|-------|
|7      |7.461-7.465|d      |/      |1H     |5-CH   |
|-------|-----------|-------|-------|-------|-------|
|8      |7.524-7.527|d      |/      |2H     |20-NH2 |
|-------|-----------|-------|-------|-------|-------|
|9      |7.735      |s      |/      |1H     |16-CH  |
|-------|-----------|-------|-------|-------|-------|
|10     |8.041-8.043|d      |/      |1H     |1-CH   |
-----------------------------------------------------

Table 3.2.S.5-25 [13] C NMR chemical shift value and correlation spectrum 



(from high field to low field) of the tested sample 



Peak No. Delta ppm Number of ownership 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 469 of 542 





Page 470
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



1 

-----------------------------------------
|1      |13.585 |1      |28-bit carbon  |
|-------|-------|-------|---------------|
|2      |14.761 |1      |27-bit carbon  |
|-------|-------|-------|---------------|
|3      |24.055 |1      |22-place carbon|
|-------|-------|-------|---------------|
|4      |56.565 |1      |24-place carbon|
|-------|-------|-------|---------------|
|5      |61.687 |1      |26-bit carbon  |
|-------|-------|-------|---------------|
|6      |111.026|1      |14-bit carbon  |
|-------|-------|-------|---------------|
|7      |111.838|1      |10-bit carbon  |
|-------|-------|-------|---------------|
|8      |113.883|1      |7-bit carbons  |
|-------|-------|-------|---------------|
|9      |119.443|1      |15-bit carbon  |
|-------|-------|-------|---------------|
|10     |122.968|1      |1 bit carbon   |
|-------|-------|-------|---------------|
|11     |124.052|1      |6-place carbon |
|-------|-------|-------|---------------|
|12     |130.463|1      |5-bit carbon   |
|-------|-------|-------|---------------|
|13     |133.312|1      |4-place carbons|
|-------|-------|-------|---------------|
|14     |133.765|1      |11-bit carbon  |
|-------|-------|-------|---------------|
|15     |139.899|1      |3-bit carbons  |
|-------|-------|-------|---------------|
|16     |142.589|1      |13-bit carbon  |
|-------|-------|-------|---------------|
|17     |151.139|1      |16-bit carbon  |
|-------|-------|-------|---------------|
|18     |157.750|1      |2-bit carbons  |
|-------|-------|-------|---------------|
|19     |158.515|1      |18-bit carbon  |
|-------|-------|-------|---------------|
|20     |159.484|1      |9-bit carbons  |
|-------|-------|-------|---------------|
|21     |168.540|1      |19-place carbon|
-----------------------------------------
H-NMR(DMSO-d6, 400Hz) showed 20 hydrogen protons, and the hydrogen 



displacement of each group could be reasonably attributed. 



13C-NMR(DMSO- _d6_ , 100Hz) showed 21 carbon atoms, and the carbon 



displacement of each group could be reasonably assigned. The NMR data 



were in good agreement with the target compounds. 



**b, Mass spectrometry (MS)** 



Detection instrument: Vanquish-TSQ QUANTIS liquid chromatography-mass 



spectrometry 



Analytical method: Chinese Pharmacopoeia 2020 Edition of the four General 



Rules 0512 and 0431 



Test data: 



Table 3.2.S.5-26 MS data of the tested sample 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 470 of 542 





Page 471
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 

--------------------------------------------------------
|377.26 |[M+H]+ |Molecularion peak in positive ion mode|
--------------------------------------------------------



In the positive ion mode, the mass-charge ratio m/z is detected to be 377.26 



peak, which is attributed to the molecular ion peak in the positive ion mode, 



consistent with the molecular weight of the target molecule 376.42. 



**(8.3) Content calibration** 



**Properties** 



This product should be like white to yellow powder. 



**Purity** 



Determination according to high performance liquid chromatography 



(General Rule 0512 of the Fourth part of Chinese Pharmacopoeia, 2020 



Edition). 



Chromatographic conditions: octadecylsilane bonded silica gel was used as 



filler (XBridge Shield RP18, 150×4.6mm, 3.5μm or equivalent performance 



column); A Welch Ghost-Buster Column (4.6×50mm, or equivalent 



ghost-buster column) was installed after the mixer of the pump and before the 



sampler. 0.03% phosphoric acid solution was used as mobile phase A and 



acetonitrile as mobile phase B; Gradient elution is performed according to the 



following table; Column temperature is 25℃; The detection wavelength was 



251nm; The flow rate was 1.0mL per minute; The injection volume was 5µl. 




Mobile 
Time /min 

phase A/% 




Mobile 



phase B/% 




0 95 5 



16.5 50 50 



17 20 80 



22 20 80 



22.5 95 5 



35 95 5 



Solvent 70% acetonitrile 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 471 of 542 





Page 472
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Take an appropriate amount of this product from the test product solution, 



weigh it accurately, dissolve and dilute it with solvent to make a solution 



containing YA2304-19 about 0.25mg per 1ml. 



Method 5μl of the test solution was accurately measured and injected into the 



liquid chromatograph, and the chromatogram was recorded. The main peak 



purity should NLT 95.0% according to area normalization method. 



The content is calculated according to the purity. 



**(9) YA2304-20 working standard** 



The reference product YA2304-20 used in this study was derived from T 



iandi Hengyi Pharmaceutical Co., LTD. It was named (4R)-4-(4-cyano-2- 



methoxyphenyl) -5-ethoxy-2, 8-dimethyl-1, 4-dihydro-1, 6-naphthyl-3-for 



mamide on the physical label and the reference product report. The appl 



icant confirmed its chemical structure and content calibration, and the c 



ontent was calculated according to 99.2%. 



Sample lot No.: 23080401-A 



Structural formula: 



Molecular formula: C21H22O3N 



Molecular weight: 378.43 



**(9.1) Preparation method of YA2304-20** 



Take YA2304-9 mother liquor (600ml, obtained by combining multiple 



batches of small experiments), control the temperature by 15~20℃, add 9% 



potassium phosphate solution to pH>7.5, and add water (200ml). Water bath 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 472 of 542 





Page 473
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



temperature control 50℃, decompression concentration until no large 



fraction, a large number of white solid precipitation. Heat preservation 



20~25℃, filtration, wet product added with ethanol (300ml), reflux 



dissolution at high temperature, filtration, concentration under reduced 



pressure to about 110g, reflux at high temperature for 1 hour, cooling to 



0~5℃, crystallization for 2 h, filtration, vacuum drying at 50℃, YA2304-20 



(13.0g) was obtained. 



**(9.2) Structural analysis of YA2304-20 reference product** 



The chemical structure of the reference product was confirmed by [1] the 



applicant by means of H NMR, [13] C NMR, mass spectrometry and chiral liquid 



chromatography. The mass spectrometry and chiral liquid chromatography 



were tested by the applicant by himself, [1] and the H NMR and [13] C NMR were 



tested by Changsha Kangpeng Pharmaceutical Co., LTD. The relevant 



detection spectra and contract for commissioned testing are detailed in 



section 3.2.R.7.S. The relevant test results and structural analysis are listed 



as follows: 



**a. Nuclear Magnetic Resonance (NMR)** 



Instrument model: Bruker Avance AV 400 superconducting pulse Fourier 



transform nuclear magnetic resonance spectrometer 



Test conditions: 



Solvent: DMSO; 



Reference: TMS ( [1] H spectrum); 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 473 of 542 





Page 474
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Resonance frequency of hydrogen spectrum: 400MHz 



Resonant frequency of carbon spectrum: 100MHz 



The number of hydrocarbon atoms in the structure (non-systematic nam 



ing, only used for hydrocarbon magnetic spectrum analysis) 



The test data and analytical results of hydrocarbon spectra are shown i 



n Table 3.2.S.5-27 and Table 3.2.S.5-28 



Table 3.2.S.5-27 [1] H NMR chemical shift value and correlation spectrum of the 



tested sample (from high field to low field) 






















------------------------------------------------------
|1      |1.038-1.073|t      |7.2     |3H     |27-CH3 |
|-------|-----------|-------|--------|-------|-------|
|2      |2.128      |s      |/       |3H     |28-CH3 |
|-------|-----------|-------|--------|-------|-------|
|3      |2.207      |s      |/       |3H     |22-CH3 |
|-------|-----------|-------|--------|-------|-------|
|4      |3.836      |s      |/       |3H     |24-CH3 |
|-------|-----------|-------|--------|-------|-------|
|5      |4.010-4.034|m      |7.2     |2H     |26-CH2 |
|-------|-----------|-------|--------|-------|-------|
|6      |5.396      |s      |/       |1H     |9-CH   |
|-------|-----------|-------|--------|-------|-------|
|7      |6.710-6.785|bs     |/       |2H     |20-NH2 |
|-------|-----------|-------|--------|-------|-------|
|8      |7.160-7.180|d      |7.6     |1H     |4-CH   |
|-------|-----------|-------|--------|-------|-------|
|9      |7.275-7.298|dd     |7.6, 1.4|1H     |5-CH   |
|-------|-----------|-------|--------|-------|-------|
|10     |7.377-7.380|d      |1.3     |1H     |1-CH   |
|-------|-----------|-------|--------|-------|-------|
|11     |7.561      |s      |/       |1H     |16-CH  |
|-------|-----------|-------|--------|-------|-------|
|12     |7.706      |s      |/       |1H     |12-NH  |
------------------------------------------------------

Table 3.2.S.5-28 [13] C NMR chemical shift value and correlation spectrum 



(from high field to low field) of the tested sample 

---------------------------------------
|1      |14.196 |1      |28-bit carbon|
---------------------------------------



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 474 of 542 





Page 475
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



1 

-----------------------------------------
|3      |18.521 |1      |22-place carbon|
|-------|-------|-------|---------------|
|4      |32.868 |1      |9-bit carbons  |
|-------|-------|-------|---------------|
|5      |56.505 |1      |24-place carbon|
|-------|-------|-------|---------------|
|6      |61.006 |1      |26-bit carbon  |
|-------|-------|-------|---------------|
|7      |103.643|1      |14-bit carbon  |
|-------|-------|-------|---------------|
|8      |105.771|1      |10-bit carbon  |
|-------|-------|-------|---------------|
|9      |109.986|1      |2-place carbons|
|-------|-------|-------|---------------|
|10     |111.911|1      |15-place carbon|
|-------|-------|-------|---------------|
|11     |114.583|1      |1 bit carbon   |
|-------|-------|-------|---------------|
|12     |119.432|1      |7-bit carbon   |
|-------|-------|-------|---------------|
|13     |125.223|1      |5-bit carbons  |
|-------|-------|-------|---------------|
|14     |131.366|1      |4-site carbon  |
|-------|-------|-------|---------------|
|15     |138.643|1      |11-bit carbon  |
|-------|-------|-------|---------------|
|16     |142.151|1      |7-bit carbons  |
|-------|-------|-------|---------------|
|17     |144.669|2      |13,16 carbon   |
|-------|-------|-------|---------------|
|18     |156.137|1      |3-bit carbon   |
|-------|-------|-------|---------------|
|19     |159.846|1      |18-bit carbon  |
|-------|-------|-------|---------------|
|20     |170.202|1      |19-bit carbon  |
-----------------------------------------
H-NMR(DMSO-d6, 400Hz) showed 22 hydrogen protons, and the hydrogen 



displacement of each group could be reasonably attributed. 



13C-NMR(DMSO- _d6_ , 100Hz) showed 21 carbon atoms, and the carbon 



displacement of each group could be reasonably assigned. The NMR data 



were in good agreement with the target compounds. 



**b, Mass spectrometry (MS)** 



Detection instrument: Vanquish-TSQ QUANTIS liquid chromatography-mass 



spectrometry 



Analytical method: Chinese Pharmacopoeia 2020 Edition of the four General 



Rules 0512 and 0431 



Test data: 



Table 3.2.S.5-29 MS data of the tested sample 

--------------------------------------------------------
|379.28 |[M+H]+ |Molecularion peak in positive ion mode|
--------------------------------------------------------



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 475 of 542 





Page 476
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



In the positive ion mode, the detected mass-charge ratio m/z is 379.28 peak, 



which is attributed to the molecular ion peak in the positive ion mode, 



consistent with the molecular weight of the target molecule 378.43. 



**c. Chiral liquid chromatography** 



Testing instrument: Waters Acquity Arc 



Analytical methods: General Rule 0512 of the fourth part of Chinese 



Pharmacopoeia (2020 Edition) 



Test data: 



Table 3.2.S.5-30 Retention time of the tested sample 

-----------------------------------------------------------
|YA2304-20 Reference product (lot No.: 23080401-A)|24.858 |
|-------------------------------------------------|-------|
|Control Product YA2304 (lot No.: 23091802-D)     |20.240 |
-----------------------------------------------------------



According to the results under 3.2.S.4.3.3 Specific attribute of product 



enantiomer methodology verification, the retention time of the main peak in 



the control product solution (YA2304-20 positioning solution) was 24.858min, 



and the retention time of the main peak in YA2304 positioning solution was 



20.240min. The separation degree between YA2304 peaks and YA2304-20 



peaks in the system suitability solution was 3.0. 



**d. Configuration confirmation** 



According to the structural analysis of the compound, Finerenone contains a 



chiral center, and Finerenone C9 is in the S configuration. According to the 



preparation process of YA2304, Finerenone is salted out with the resolution 



agent during the resolution step and separated after filtration, while the 



enantiomer YA2304-20 is dissolved in the filtrate. YA2304-20 reference 



product was prepared by caustic collection of filtrate and then refined. 



Finerenone has been proved by single crystal diffraction that C9 has an S 



configuration (see section 3.2.S.3.1 Structure and Physical and Chemical 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 476 of 542 





Page 477
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Properties for details). Based on the confirmed planar structure and the 



principle that the retention time of enantiomers is different under chiral 



chromatography conditions, the results detected by the chiral liquid 



chromatography above are as follows: It can be confirmed that the reference 



product YA2304-20 is the enantiomer of fenelidone. 



**(9.3) Content calibration** 



**Properties** 



This product should be white to white powder. 



**Moisture** 



Take about 0.1g~0.2g of this product, according to the water determination 



method (" Chinese Pharmacopoeia "2020 edition of the fourth part of the 



general rule 0832 coulometric titration method) determination, water content 



shall not exceed 2.0%. 



**Purity** 



Determination according to high performance liquid chromatography 



(General Rule 0512 of the Fourth part of Chinese Pharmacopoeia, 2020 



Edition). 



Solvent acetonitrile-water (30:70) 



Take an appropriate amount of this product from the test product solution, 



dissolve it with a solvent and dilute it into a solution containing about 0.5mg 



per 1ml. 



System suitability reserve liquid precision measure 0.6ml of test product 



solution, place it in 10ml measuring bottle, dilute it with solvent to scale, 



shake well, and then obtain. 



Precision weigh the system suitability solution YA2304 reference product 



about 20mg, put it into a 20ml measuring bottle, then accurately add the 



system suitability reserve solution 1.0ml, dissolve it with solvent and dilute it 



to the scale, shake well, and then obtain. 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 477 of 542 





Page 478
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Chromatographic conditions with silica gel surface covalently bonded 



cellulose - III - (3, 5-dichlorophenyl carbamate) as filler column (CHIRALPAK 



IC, 250×4.6mm, 5μm or equivalent performance); With 20mM ammonium 



acetate buffer (pH adjusted to 3.1 with phosphoric acid) -acetonitrile (70:30) 



as mobile phase, iso-degree elution was performed for 40min; The flow rate 



was 1.0ml per minute. Column temperature was 40℃; The detection 



wavelength was 251nm; Injection volume 5µl. 



System suitability requirements In the system suitability solution 



chromatogram, the separation degree of YA2304 peaks and YA2304-20 peaks 



should be greater than 1.5. 



The test product solution and the system suitability solution were precisely 



measured and injected into the chromatograph respectively to record the 



chromatogram. According to the area normalization method, the main peak 



purity should NLT 95.0%. 



The content is measured by purity x (1- moisture). 



**(10) YA2304-52 working standard** 



The reference product YA2304-52 used in this study was derived from T 



iandi Hengyi Pharmaceutical Co., LTD. It was named D-monobenzoyl tar 



taric acid on the physical label and the reference product report. The ap 



plicant confirmed its chemical structure and content calibration, and the 



content was calculated according to 90.8%. 



Sample lot No.: 24022801-C 



Structural formula: 



Molecular formula: C11H10O 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 478 of 542 





Page 479
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Molecular weight: 254.19 



**(10.1) Preparation method of YA2304-52** 



YA2304-10-Lf1126185589 (5.0g), sodium hydroxide (1.6g), methanol 



(20ml), and water (20ml) were added to the reaction bottle at 45℃ for 2h, then 



lowered to room temperature for filtration, and the pH of the filtrate was 



adjusted to about 7. The chromatography was prepared by reversed-phase 



column under medium pressure and purified, and fractions were collected. 



Freeze-dried 0.72g white solid, YA2304-52. 



**(10.2) Structural analysis of YA2304-52 reference** 



The chemical structure of the reference product was confirmed by the 



applicant through [1] H NMR, [13] C NMR, mass spectrometry, specific curl and 



other testing means. 1H NMR and 13C NMR commissioned Changsha 



Kangpeng Pharmaceutical Co., LTD for testing. The relevant test atlas and 



commissioned test contract are detailed in section 3.2.R.7.S. The relevant test 



results and structural analysis are detailed as follows: 



**a. Nuclear Magnetic Resonance (NMR)** 



Instrument model: Bruker Avance AV 400 superconducting pulse Fourier 



transform nuclear magnetic resonance spectrometer 



Test conditions: 



Solvent: DMSO; 



Reference: TMS ( [1] H spectrum); 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 479 of 542 





Page 480
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Resonance frequency of hydrogen spectrum: 400MHz 



Resonant frequency of carbon spectrum: 100MHz 



The number of the hydrocarbon atom in the structure (non-systematic n 



aming, only used for hydrocarbon magnetic spectrum analysis) 



The test data and analytical results of hydrocarbon spectra are shown i 



n Table 3.2.S.5-31 and Table 3.2.S.5-32 



Table 3.2.S.5-31 [1] H NMR chemical shift value and correlation spectrum of the 



tested sample (from high field to low field) 



















-----------------------------------------------------------
|1      |4.251      |s      |/      |1H     |17-OH        |
|-------|-----------|-------|-------|-------|-------------|
|2      |4.520-4.525|d      |/      |1H     |4-CH         |
|-------|-----------|-------|-------|-------|-------------|
|3      |5.329-5.335|d      |/      |1H     |3-CH         |
|-------|-----------|-------|-------|-------|-------------|
|4      |7.449-7.488|t      |7.6    |2H     |13, 15 - CH  |
|-------|-----------|-------|-------|-------|-------------|
|5      |7.596-7.633|t      |7.6    |1H     |14-CH        |
|-------|-----------|-------|-------|-------|-------------|
|6      |7.977-7.998|t      |7.6    |2H     |, 12 dec - CH|
-----------------------------------------------------------

Table 3.2.S.5-32 [13] C NMR chemical shift value and correlation spectrum 



(from high field to low field) of the tested sample 

------------------------------------
|1      |73.791 |1      |4 digitC  |
|-------|-------|-------|----------|
|2      |77.398 |1      |3-bitC    |
|-------|-------|-------|----------|
|3      |128.666|2      |13,15 C's |
|-------|-------|-------|----------|
|4      |129.110|1      |11 bitC's |
|-------|-------|-------|----------|
|5      |129.701|2      |12,16 C's |
|-------|-------|-------|----------|
|6      |133.891|1      |14 bitC   |
|-------|-------|-------|----------|
|7      |168.029|1      |9 digitC's|
------------------------------------



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 480 of 542 





Page 481
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



1 

---------------------------------
|9      |178.400|1      |2-bitC |
---------------------------------
H-NMR(DMSO-d6, 400Hz) showed 8 hydrogen protons, 2 carboxyl hydrogen 



did not peak, and the hydrogen displacement of each group could be 



reasonably attributed. [13] C-NMR(DMSO- _d6_ , 100Hz) showed 11 carbon atoms, 



and the carbon displacement of each group could be reasonably assigned. 



The NMR data were in good agreement with the target compound. 



**b, Mass spectrometry (MS)** 



Testing instrument: Waters Acquity Arc-QDA liquid chromatography-mass 



spectrometry 



Analytical methods: General Rules 0512 and 0431 of the Fourth part of 



Chinese Pharmacopoeia (2020 Edition) 



Test data: 



Table 3.2.S.5-33 MS data of the tested sample 

--------------------------------------------------------
|253.17 |[M-H]- |Molecularion peak in negative ion mode|
--------------------------------------------------------



In the negative ion mode, the mass-charge ratio m/z is 253.17 peak, which is 



attributed to the molecular ion peak in the negative ion mode, which is 



consistent with the molecular weight of the target molecule 254.19. 



**c. Confirmation of configuration** 



Combined with the analysis of the preparation process of the reference 



product, the two chiral centers in YA2304-52 were introduced from the raw 



material YA2304-10 used in its preparation, and the two chiral centers were 



not affected in the subsequent ester hydrolysis reaction when the hydroxyl 



group was replaced and left. The molecular configuration of the reference 



product YA2304-52 and the raw material YA2304-10 is the same. The specific 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 481 of 542 





Page 482
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



rotation of raw material YA2304-10 (batch NO.: Lf1126185589) is 114.1°, 



that is, the configuration should be (2S,3S). Combined with the preparation 



technology, it can be confirmed that the reference product YA2304-52 is the 



configuration of (2S,3S), that is, the absolute configuration expressed in the 



structural formula by classical chemical correlation method. 



**(10.3) Content calibration** 



**Properties** 



This product should be like white powder. 



**Purity** 



Determination according to high performance liquid chromatography 



(General Rule 0512 of the Fourth part of Chinese Pharmacopoeia, 2020 



Edition). 



Chromatographic conditions: Philomon Comixsil RP-100 (4.6mm×250mm, 



5μm) or equivalent performance column); 0.1% sulfuric acid solution as 



mobile phase A, acetonitrile as mobile phase B; Gradient elution is performed 



according to the following table; The flow rate is 1.0ml per minute; Column 



temperature was 30℃; Sample plate temperature is 5℃; The detection 



wavelength was 210nm; And the injection volume was 20µl. 



Time (min.) Mobile phase A (%) Mobile phase B (%) 



0 86 14 



8.5 86 14 



20 35 65 



23 35 65 



25 20 80 



27 20 80 



28 86 14 



40 86 14 



Solvent 50% acetonitrile 



Take an appropriate amount of this product from the test product solution, 



weigh it accurately, dissolve and dilute it with solvent to make a solution 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 482 of 542 





Page 483
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



containing YA2304-52 about 2mg per 1ml. 



The test product solution was accurately measured 20μl and injected into the 



liquid chromatograph, and the chromatogram was recorded. The main peak 



purity should NLT 90.0% according to area normalization method. 



The content is calculated according to the purity. 



**(11) Dimethyl sulfate working standard** 



The reference product of Dimethyl sulfate used in this application comes from 



Shanghai McLean Biochemical Technology Co., LTD. It is named Dimethyl 



sulfate on the physical label, Dimethyl sulfate on the manufacturer's report, 



and Dimethyl sulfate on the invoice. The chemical structure of Dimethyl 



sulfate was confirmed by the applicant, and the content was 99.759% 



according to the manufacturer's report. 



Sample lot No.: C15128674 



Structural formula: 



Molecular formula: C2H6O4S 



Molecular weight: 126.13 



**(11.1) Structure analysis of dimethyl sulfate reference** 



The chemical structure of the reference product was confirmed by [1] the 



applicant by means of H NMR, [13] C NMR and mass spectrometry. The mass 



spectrometry was tested by the applicant by himself, [1] and the H NMR and [13] C 



NMR were tested by Changsha Kangpeng Pharmaceutical Co., LTD. The 



relevant detection graphs and the contract for entrusted testing are detailed 



in section 3.2.R.7.S. The relevant test results and structural analysis are 



detailed as follows: 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 483 of 542 





Page 484
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**a. Nuclear Magnetic Resonance (NMR)** 



Instrument model: Bruker Avance AV 400 superconducting pulse Fourier 



transform nuclear magnetic resonance spectrometer 



Test conditions: 



Solvent: CDCl3; 



Reference: TMS ( [1] H spectrum); 



Resonance frequency of hydrogen spectrum: 400MHz 



Resonant frequency of carbon spectrum: 100MHz 



The number of the hydrocarbon atom in the structure (non-systematic n 



aming, only used for hydrocarbon magnetic spectrum analysis) 



The test data and analytical results of hydrocarbon spectra are shown i 



n Table 3.2.S.5-35 and Table 3.2.S.5-36 



Table 3.2. [1] H NMR chemical shift value and correlation spectrum (from high 



field to low field) of the tested sample S.5-35 













-------------------------------------------------------
|1      |3.914-3.915|d      |0.6    |6H     |6, 7 - CH|
-------------------------------------------------------

Table 3.2.S.5-36 [13] C NMR chemical shift value and correlation spectrum 



(from high field to low field) of the tested sample 



1 

-------------------------------------
|1      |58.654 |2      |6, 7-placeC|
-------------------------------------
H-NMR(CDCl3, 400Hz) shows 6 hydrogen protons, and the hydrogen 



displacement of each group can be reasonably attributed; [13] C-NMR(CDCl3, 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 484 of 542 





Page 485
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



100Hz) showed 2 carbon atoms, and the carbon displacement of each group 



could be reasonably assigned. The NMR data corresponded well with the 



target compound. 



**b, Mass spectrometry (MS)** 



Testing instrument: Agilent 8890-7010B gas chromatogram-mass 



spectrometry 



Analytical methods: 0521 and 0431 of the Four General Rules of Chinese 



Pharmacopoeia (2020 Edition) 



The results were consistent with dimethyl sulfate in the standard spectrum 



library. 



**(12) diethyl sulfate working standard** 



The reference product of Diethyl sulfate used in this study came from S 



hanghai McLean Biochemical Technology Co., LTD. It was named as Diet 



hyl sulfate on the physical label, Diethyl sulfate on the manufacturer's r 



eport and Diethyl sulfate on the invoice. The chemical structure of the p 



roduct was confirmed by the applicant and its content was 99.024% acc 



ording to the manufacturer's report. 



Sample lot No.: C14721434 



Structural formula: 



Molecular formula: C4H10O4S 



Molecular weight: 154.18 



**(12.1) Structure analysis of diethyl sulfate reference** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 485 of 542 





Page 486
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



The chemical structure of the reference product was confirmed by [1] the 



applicant by means of H NMR, [13] C NMR and mass spectrometry. The mass 



spectrometry was tested by the applicant by himself, [1] and the H NMR and [13] C 



NMR were tested by Changsha Kangpeng Pharmaceutical Co., LTD. For 



details about the relevant detection graphs and contract, see section 



3.2.R.7.S. The relevant test results and structural analysis are detailed as 



follows: 



**a. Nuclear Magnetic Resonance (NMR)** 



Instrument model: Bruker Avance AV 400 superconducting pulse Fourier 



transform nuclear magnetic resonance spectrometer 



Test conditions: 



Solvent: CDCl3; 



Reference: TMS ( [1] H spectrum); 



Resonance frequency of hydrogen spectrum: 400MHz 



Resonant frequency of carbon spectrum: 100MHz 



The number of the hydrocarbon atom in the structure (non-systematic n 



aming, only used for hydrocarbon magnetic spectrum analysis) 



The test data and analytical results of hydrocarbon spectra are shown i 



n Table 3.2.S.5-37 and Table 3.2.S.5-38. 



Table 3.2.S.5-37 [1] H NMR chemical shift value and correlation spectrum of the 



tested sample (from high field to low field) 



Peak Delta ppm Peak Coupling Proton Attributio 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 486 of 542 





Page 487
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 

---------------------------------------------------------
|1      |1.366-1.401|t      |7.2    |6H     |8 or 9 - CH|
|-------|-----------|-------|-------|-------|-----------|
|2      |4.265-4.318|q      |7.1    |4H     |6, 7 - CH  |
---------------------------------------------------------



Table 3.2.S.5-38 [13] C NMR chemical shift value and correlation spectrum 



(from high field to low field) of the tested sample 



1 

---------------------------------------
|1      |14.470 |2      |8, 9-placeC  |
|-------|-------|-------|-------------|
|2      |69.426 |2      |Six, sevenC's|
---------------------------------------
H-NMR(CDCl3, 400Hz) showed 10 hydrogen protons, and the hydrogen 



displacement of each group could be reasonably attributed. [13] C-NMR(CDCl3, 



100Hz) showed 4 carbon atoms, and the carbon displacement of each group 



could be reasonably assigned. The NMR data corresponded well with the 



target compound. 



**b, Mass spectrometry (MS)** 



Testing instrument: Agilent 8890-7010B gas chromatogram-mass 



spectrometry 



Analytical methods: 0521 and 0431 of the Four General Rules of Chinese 



Pharmacopoeia (2020 Edition) 



Detection result: It was consistent with diethyl sulfate in standard spectrum 



library. 



**(13) diisopropyl sulfate working standard** 



The reference product of Diisopropyl Sulfate used in this research applic 



ation came from Shanghai Bidd Pharmaceutical Technology Co., LTD. It 



was named diisopropyl sulfate on the physical label, diisopropyl sulfate 



on the manufacturer's report, and diisopropyl sulfate on the invoice. The 



chemical structure of the product was confirmed by the applicant. Acco 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 487 of 542 





Page 488
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



rding to the report provided by the manufacturer, the content was 97%. 



Sample lot No.: DLX318 



Structural formula: 



Molecular formula: C6H14O4S 



Molecular weight: 182.23 



**(13.1) Structure analysis of diisopropyl sulfate reference** 



The chemical structure of the reference product was confirmed by the 



applicant through [1] H NMR, [13] C NMR and mass spectrometry, among which 



the mass spectrometry was tested by the applicant himself, [1] H NMR was 



provided by Shanghai Bider Medical Technology Co., LTD., [13] and C NMR was 



tested by Changsha Kangpeng Medical Co., LTD. The relevant detection 



spectra and the contract for commissioning are detailed in section 3.2.R.7.S, 



and the relevant test results and structural analysis are detailed as follows: 



**a. Nuclear Magnetic Resonance (NMR)** 



Instrument model: Bruker Avance AV 400 superconducting pulse Fourier 



transform nuclear magnetic resonance spectrometer 



Test conditions: 



Solvent: CDCl3; 



Reference: TMS ( [1] H spectrum); 



Resonance frequency of hydrogen spectrum: 400MHz 



Resonant frequency of carbon spectrum: 100MHz 



The number of the hydrocarbon atom in the structure (non-systematic n 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 488 of 542 





Page 489
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



aming, only used for hydrocarbon magnetic spectrum analysis) 



The test data and analytical results of hydrocarbon spectra are shown i 



n Table 3.2.S.5-39 and Table 3.2.S.5-40. 



Table 3.2.S.5-39 [1] H NMR chemical shift value and correlation spectrum of the 



tested sample (from high field to low field) 













----------------------------------------------------------
|1      |1.43-1.44|d      |/      |12H    |8,9,10,11 - CH|
|-------|---------|-------|-------|-------|--------------|
|2      |4.86-4.93|dt     |/      |2H     |6, 7 - CH     |
----------------------------------------------------------

Table 3.2.S.5-40 [13] C NMR chemical shift values and correlation spectra (from 



high field to low field) of the tested sample 

--------------------------------------------
|1      |22.518 |4      |8,9,10,11 digitC's|
|-------|-------|-------|------------------|
|2      |79.885 |2      |6,7 C's           |
--------------------------------------------



1 
H-NMR(CDCl3, 400Hz) showed 14 hydrogen protons, and the hydrogen 



displacement of each group could be reasonably attributed. [13] C-NMR(CDCl3, 



100Hz) showed 6 carbon atoms, and the carbon displacement of each group 



could be reasonably assigned. The NMR data corresponded well with the 



target compound. 



**b, Mass spectrometry (MS)** 



Testing instrument: Agilent 8890-7010B gas chromatogram-mass 



spectrometry 



Analytical methods: 0521 and 0431 of the Four General Rules of Chinese 



Pharmacopoeia (2020 Edition) 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 489 of 542 





Page 490
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Test data: 



Table 3.2.S.5-41 MS data of the tested sample 

------------------------------------------
|183.0000|[M]+         |Molecularion peak|
|--------|-------------|-----------------|
|167.1000|[M-CH3]+     |Fragmention peak |
|--------|-------------|-----------------|
|138.9000|[M-CHCH3CH3]+|Fragmention peak |
------------------------------------------



The molecular weight of the target is 182.23, and the molecular ion peak of 



the mass-charge ratio of 183.0000 was detected, which is consistent with the 



target molecule. The mass-charge ratio of 167.1000 and 138.9000 was 



detected, which is attributed to the molecular fragment peak after cracking off 



a methyl group and a propyl group, which is consistent with the target 



molecule. 



**(14) disec-butylsulfate working standard** 



The reference product of sec-butyl sulfate used in the process of this st 



udy was from Tiandi Hengyi Pharmaceutical Co., LTD. It was named as 



sec-butyl sulfate on the physical label and the reference product report. 



The applicant confirmed its chemical structure and content calibration, 



and the content was calculated according to 99.7%. 



Sample lot No.: 23110207-H 



Structural formula: 



Molecular formula: C8H18O4S 



Molecular weight: 210.29 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 490 of 542 





Page 491
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**(14.1) Preparation method of disec-butyl sulfate** 



Boric acid (30 g), secondary butanol (360 g) and toluene (200 ml) were added 



into the reaction bottle, and the reaction was continued for 1 h after the reflux 



water separation reaction to anhydrous formation at 135℃. Control the 



temperature below 55℃ and concentrate under pressure (until the 



concentration weighs 100 g), add dichloromethane (100 ml) to dissolve, cool 



down to 0℃, drop concentrated sulfuric acid (55 g), after dripping, keep warm 



at 25~30℃ for 24 h, add dichloromethane, filter, wash organic layer three 



times, wash saturated salt water once, dry anhydrous sodium sulfate. 



Control the temperature below 50℃ vacuum concentration without distillate, 



light yellow oil that is di-sec-butylsulfate. 



**(14.2) Analysis of the structure of disec-butylsulfate reference** 



The chemical structure of the reference product was confirmed by the 



applicant through [1] H NMR, [13] C NMR, mass spectrometry and other detection 



means. The mass spectrometry was tested by the applicant, and the [1] H NMR 



and [13] C NMR were tested by Changsha Kangpeng Pharmaceutical Co., LTD., 



the relevant detection spectrum and the contract for entrusted testing are 



detailed in section 3.2.R.7.S. The relevant test results and structural analysis 



are as follows: 



**a. Nuclear Magnetic Resonance (NMR)** 



Instrument model: Bruker Avance AV 400 superconducting pulse Fourier 



transform nuclear magnetic resonance spectrometer 



Test conditions: 



Solvent: CDCl3; 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 491 of 542 





Page 492
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Reference: TMS ( [1] H spectrum); 



Resonance frequency of hydrogen spectrum: 400MHz 



Resonant frequency of carbon spectrum: 100MHz 



The number of the hydrocarbon atom in the structure (non-systematic n 



aming, only used for hydrocarbon magnetic spectrum analysis) 



The test data and analytical results of hydrocarbon spectra are shown i 



n Table 3.2.S.5-42 and Table 3.2.S.5-43 



Table 3.2.S.5-42 [1] H NMR chemical shift value and correlation spectrum of the 



tested sample (from high field to low field) 






















--------------------------------------------------------
|1      |0.963-1.000|t      |7.2    |6H     |9, 13 - CH|
|-------|-----------|-------|-------|-------|----------|
|2      |1.412-1.428|d      |6.4    |6H     |7, 11 - CH|
|-------|-----------|-------|-------|-------|----------|
|3      |1.679-1.781|m      |/      |4H     |8, 12 - CH|
|-------|-----------|-------|-------|-------|----------|
|4      |4.695-4.742|m      |/      |2H     |6, 10 - CH|
--------------------------------------------------------

Table 3.2.S.5-43 [13] C NMR chemical shift value and correlation spectrum 



(from high field to low field) of the tested sample 

------------------------------------
|1      |9.175  |1      |9 PlaceC  |
|-------|-------|-------|----------|
|2      |9.194  |1      |13 bitC   |
|-------|-------|-------|----------|
|3      |19.820 |1      |7 digitC's|
|-------|-------|-------|----------|
|4      |19.839 |1      |11 bitC   |
|-------|-------|-------|----------|
|5      |29.239 |1      |8-bitC    |
------------------------------------



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 492 of 542 





Page 493
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 

----------------------------------
|7      |84.508 |2      |6,10 C's|
----------------------------------



1 
H-NMR(CDCl3, 400Hz) showed 18 hydrogen protons, and the hydrogen 



displacement of each group could be reasonably attributed. [13] C-NMR(CDCl3, 



100Hz) showed 8 carbon atoms, and the carbon displacement of each group 



could be reasonably assigned. The NMR data corresponded well with the 



target compound. 



**b, Mass spectrometry (MS)** 



Testing instrument: Agilent 8890-7010B gas chromatogram-mass 



spectrometry 



Analytical methods: 0521 and 0431 of the Four General Rules of Chinese 



Pharmacopoeia (2020 Edition) 



Test data: 



Table 3.2.S.5-44 MS data of the tested sample 

--------------------------------------------
|194.9987|[M-CH3]+        |Fragmention peak|
|--------|----------------|----------------|
|180.9999|[M-C2H5]+       |[M-C2H5]+       |
|--------|----------------|----------------|
|152.9994|[M-CHCH2CH3CH3]+|[M-CHCH2CH3CH3]+|
|--------|----------------|----------------|
|57.1996 |-CHCH2CH3CH3+   |-CHCH2CH3CH3+   |
--------------------------------------------



The molecular weight of the target was 210.29, and the detected 



mass-to-charge ratio was 194.9987, 180.9999 and 152.9994, which belonged 



to the molecular fragment peak after splitting one methyl group, one ethyl 



group and one butyl group. The mass-to-charge ratio of 57.1996 was the 



butyl fragment peak, which was consistent with the target molecule. 



**(14.3) Content calibration** 



**Properties** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 493 of 542 





Page 494
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



This product should be light yellow oily liquid. 



**Moisture** 



Take about 0.1~0.3g of this product, according to the water determination 



method (" Chinese Pharmacopoeia "2020 edition of the fourth part of the 



general rule 0832 Coulometric titration method) determination, water content 



should not exceed 1.0%. 



**Purity** 



Determination by gas chromatography (General Rule 0521 of the Fourth part 



of Chinese Pharmacopoeia, 2020 Edition). 



The capillary column with 100% dimethylpolysiloxane (DB-1, 30m×0.32mm, 



1μm or similar polarity) as fixed liquid was used as the chromatographic 



column; The initial column temperature was 50℃ for 3min, and then it was 



heated up to 135℃ at the rate of 10℃/min for 9min, and then heated up to 



230℃ at the rate of 20℃/min for 14.5min. Inlet temperature: 150 ° C; The 



detector is FID detector, the temperature is 250℃; (Recommended carrier gas 



nitrogen, carrier gas flow rate of 3.0ml/min; The air flow rate is 300ml/min; 



Hydrogen flow rate is 30ml/min; The injection volume is 1μl and the shunt 



ratio is 5:1) 



Solvent acetonitrile 



Preparation of test product solution: Take about 70mg of this product, weigh 



it accurately, put it in a 10ml measuring bottle, add acetonitrile to dissolve, 



dilute with acetonitrile to the scale, shake well, as test product solution. 



Determination method: Precisely measure the above test product solution 1µl, 



inject it into the liquid chromatograph, record the chromatogram, according 



to the area normalization method, the main peak purity shall NLT 95.0%. 



The content is measured by purity × (1-moisture). 



**(15) YA2304 working standard** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 494 of 542 





Page 495
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



The reference product YA2304 used in this study was derived from Tian 



di Hengyi Pharmaceutical Co., LTD. It was named Finerenone on the ph 



ysical label and the reference product report. The chemical structure of 



YA2304 was confirmed by the applicant and its content was calibrated. 



The content was 99.7%. 



Sample lot No.: 23091802-D 



Structural formula: 



Molecular formula: C21H22O3N 



Molecular weight: 378.43 



**(15.1) Preparation method of YA2304** 



YA2304-cp (613g) and ethanol (9.81kg) were added to the reactor, and the 



system was heated to 70-80℃ and stirred to dissolve, and then filtered while 



hot. Most of the ethanol was concentrated under pressure at 55℃ and the 



total volume of residual distillate was about 4L. The system was stirred at 



30-40℃ for about 15 h. The temperature was lowered to 0-5℃ and stirred for 



2.0 h. The filter cake was washed with 0-5℃ ethanol (1.5kg), and the filter 



cake was vacuum-dried at 55℃ to obtain white solid (534.8g). 



**(15.2) Structural analysis of YA2304** 



The chemical structure of the reference product was confirmed by [1] the 



applicant by means of H NMR, [13] C NMR, mass spectrometry and chiral liquid 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 495 of 542 





Page 496
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



chromatography. The mass spectrometry and chiral liquid chromatography 



were tested by the applicant by himself, [1] and the H NMR and [13] C NMR were 



tested by Changsha Kangpeng Pharmaceutical Co., LTD. The relevant test 



results and structural analysis are listed as follows: 



**a. Nuclear Magnetic Resonance (NMR)** 



Instrument model: Bruker Avance AV 400 superconducting pulse Fourier 



transform nuclear magnetic resonance spectrometer 



Test conditions: 



Solvent: DMSO; 



Reference: TMS ( [1] H spectrum); 



Resonance frequency of hydrogen spectrum: 400MHz 



Resonant frequency of carbon spectrum: 100MHz 



The number of the hydrocarbon atom in the structure (non-systematic n 



aming, only used for hydrocarbon magnetic spectrum analysis) 



The test data and analytical results of hydrocarbon spectra are shown i 



n Table 3.2.S.5-45 and Table 3.2.S.5-46. 



Table 3.2.S.5-45 [1] H NMR chemical shift value and correlation spectrum (from 



high field to low field) of the tested sample 



Peak Delta ppm Peak Coupling Proton Attributio 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 496 of 542 





Page 497
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 

------------------------------------------------------
|1      |1.038-1.073|t      |7.2     |3H     |27-CH3 |
|-------|-----------|-------|--------|-------|-------|
|2      |2.128      |s      |/       |3H     |28-CH3 |
|-------|-----------|-------|--------|-------|-------|
|3      |2.204      |s      |/       |3H     |22-CH3 |
|-------|-----------|-------|--------|-------|-------|
|4      |3.835      |s      |/       |3H     |24-CH3 |
|-------|-----------|-------|--------|-------|-------|
|5      |4.010-4.034|qd     |7.2     |2H     |26-CH2 |
|-------|-----------|-------|--------|-------|-------|
|6      |5.394      |s      |/       |1H     |9-CH   |
|-------|-----------|-------|--------|-------|-------|
|7      |6.707-6.783|bs     |/       |2H     |20-NH2 |
|-------|-----------|-------|--------|-------|-------|
|8      |7.158-7.178|d      |8.0     |1H     |4-CH   |
|-------|-----------|-------|--------|-------|-------|
|9      |7.276-7.299|dd     |8.0, 1.2|1H     |5-CH   |
|-------|-----------|-------|--------|-------|-------|
|10     |7.377-7.380|d      |1.2     |1H     |1-CH   |
|-------|-----------|-------|--------|-------|-------|
|11     |7.560-7.561|s      |0.4     |1H     |16-CH  |
|-------|-----------|-------|--------|-------|-------|
|12     |7.705      |s      |/       |1H     |12-NH  |
------------------------------------------------------



Table 3.2.S.5-46 [13] C NMR chemical shift value and correlation spectrum 



(from high field to low field) of the tested sample 



1 

-------------------------------------------
|1      |14.202 |1      |28-bit carbon    |
|-------|-------|-------|-----------------|
|2      |14.739 |1      |27-bit carbon    |
|-------|-------|-------|-----------------|
|3      |18.521 |1      |Twenty-two carbon|
|-------|-------|-------|-----------------|
|4      |32.872 |1      |9-bit carbons    |
|-------|-------|-------|-----------------|
|5      |56.509 |1      |24-place carbon  |
|-------|-------|-------|-----------------|
|6      |61.005 |1      |26-bit carbon    |
|-------|-------|-------|-----------------|
|7      |103.640|1      |14-bit carbon    |
|-------|-------|-------|-----------------|
|8      |105.784|1      |10-bit carbon    |
|-------|-------|-------|-----------------|
|9      |109.983|1      |2-place carbons  |
|-------|-------|-------|-----------------|
|10     |111.909|1      |15-place carbon  |
|-------|-------|-------|-----------------|
|11     |114.588|1      |1 bit carbon     |
|-------|-------|-------|-----------------|
|12     |119.434|1      |6-place carbon   |
|-------|-------|-------|-----------------|
|13     |125.223|1      |5-bit carbon     |
|-------|-------|-------|-----------------|
|14     |131.363|1      |4-place carbons  |
|-------|-------|-------|-----------------|
|15     |138.616|1      |11-bit carbon    |
|-------|-------|-------|-----------------|
|16     |142.150|1      |7-bit carbons    |
|-------|-------|-------|-----------------|
|17     |144.646|1      |13-bit carbon    |
|-------|-------|-------|-----------------|
|18     |144.674|1      |16-bit carbon    |
|-------|-------|-------|-----------------|
|19     |156.138|1      |3-site carbon    |
|-------|-------|-------|-----------------|
|20     |159.843|1      |18-bit carbon    |
|-------|-------|-------|-----------------|
|21     |170.190|1      |19-bit carbon    |
-------------------------------------------
H-NMR(DMSO-d6, 400Hz) showed 22 hydrogen protons, and the hydrogen 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 497 of 542 





Page 498
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



displacement of each group could be reasonably attributed. 



13C-NMR(DMSO- _d6_ , 100Hz) showed 21 carbon atoms, and the carbon 



displacement of each group could be reasonably assigned. The NMR data 



were in good agreement with the target compounds. 



**b, Mass spectrometry (MS)** 



Detection instrument: Vanquish-TSQ QUANTIS liquid chromatography-mass 



spectrometry 



Analytical method: Chinese Pharmacopoeia 2020 Edition of the four General 



Rules 0512 and 0431 



Test data: See Table 3.2.S.5-47 



Table 3.2.S.5-47 MS data of the tested sample 

--------------------------------------------------------
|379.27 |[M+H]+ |Molecularion peak in positive ion mode|
--------------------------------------------------------



In the positive ion mode, the mass-charge ratio m/z is detected as 379.27 



peak, which is attributed to the molecular ion peak in the positive ion mode, 



consistent with the molecular weight of the target molecule 378.43. 



**c. Chiral liquid chromatography** 



Testing instrument: Waters Acquity Arc 



Analytical methods: General Rule 0512 of the fourth part of Chinese 



Pharmacopoeia (2020 Edition) 



Test data: 



Table 3.2.S.5-48 Retention time of the tested sample 

-----------------------------------------------------------
|YA2304-20 Reference product (lot No.: 23080401-A)|24.858 |
|-------------------------------------------------|-------|
|Control Product YA2304 (lot No.: 23091802-D)     |20.240 |
-----------------------------------------------------------



According to the results under 3.2.S.4.3.3 Specific attribute of product 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 498 of 542 





Page 499
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



enantiomer methodology verification, the retention time of the main peak in 



the control product solution (YA2304-20 positioning solution) was 24.858min, 



and the retention time of the main peak in YA2304 positioning solution was 



20.240min. The separation degree between YA2304 peaks and YA2304-20 



peaks in the system suitability solution was 3.0. 



**d. Configuration confirmation** 



There is a chiral center in the molecular structure of fineridone, and C9 in the 



structure of Fineridone is S configuration. The applicant has carried out 



single crystal diffraction detection on the sample of Fineridone prepared by 



registered process (lot No.: 231101), and confirmed that its three-dimensional 



structure is consistent with the theory. The preparation process of the 



reference product in this batch is consistent with the registered process, so its 



configuration can be confirmed as S configuration. 



**(15.3) Content calibration** 



**Properties** 



This product should be white to yellow powder. 



**Moisture** 



Take about 0.1g~0.2g of this product, according to the water determination 



method (" Chinese Pharmacopoeia "2020 edition of the fourth part of the 



general rule 0832 Coulometric titration method) determination, water content 



should not exceed 0.5%. 



**Incandescent residue** 



Take about 1.0g of this product, according to the method of incandescent 



residue inspection (" Chinese Pharmacopoeia "2020 edition of the fourth part 



of the General Rule 0841) determination, residual residue shall not exceed 



0.1%. 



**Purity** 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 499 of 542 





Page 500
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Determination according to high performance liquid chromatography 



(General Rule 0512 of the Fourth part of Chinese Pharmacopoeia, 2020 



Edition). 



Chromatographic conditions: octadecylsilane bonded silica gel was used as 



filler (XBridge Shield RP18, 150*4.6mm, 3.5μm or equivalent performance 



column); Welch Ghost-Buster Column (4.6×50mm, or equivalent 



ghost-buster column) was installed after the mixer of the pump and before the 



sampler. 0.03% phosphoric acid solution was used as mobile phase A and 



acetonitrile as mobile phase B; Gradient elution is performed according to the 



following table; Column temperature is 25℃; The detection wavelength was 



251nm; The flow rate was 1.0mL per minute; The injection volume was 5µl. 




Mobile 
Time /min 

phase A/% 




Mobile 



phase B/% 




0 95 5 



16.5 50 50 



17 20 80 



22 20 80 



22.5 95 5 



35 95 5 



Solvent 30% acetonitrile 



Appropriate amount of this product is taken from the test product solution, 



accurately weighed, dissolved and diluted with solvent to make a solution 



containing Finerenone of about 0.25mg per 1ml. 



The main peak purity was NLT 99.0% according to area normalization method. 



5μl of test solution was injected into liquid chromatograph. 



The content is measured by purity × (1- moisture - incandescent residue). 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 500 of 542 





Page 501
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.6** **Container Closure System** 



**I. Description of Container Closure System** 



The container closure system of Finerenone manufactured by Hinye 



Pharmaceutical Co., Ltd. consists of pharmaceutical grade low-density 



polyethylene (LDPE) bag as primary packaging and cardboard drum as 



secondary packaging. 



The packaging procedure is as follows: 



**Primary packaging:** The drug substance is weighed and packed with 



double-layered pharmaceutical grade low-density polyethylene (LDPE) bag 



according to the package size. Lock and seal with cable tie, and transfer to the 



outside packaging room through the transfer window. 



**Secondary packaging:** Put it into cardboard drum as one bag per drum, and 



seal. Fill in packaging label, and affix it to the outside of the drum. 



**Package size:** 0.5 kg/drum, 1.0 kg/drum, 2.0 kg/drum, 3.0 kg/drum, 5.0 



kg/drum, 10.0 kg/drum. 



**II. Specification of Packaging Materials** 



**Primary Packaging Material** 



The specification and analytical method of pharmaceutical grade low-density 



polyethylene (LDPE) bag established by the applicant is as follows: 



Table 3.2.S.6-1 Acceptance Criteria of pharmaceutical grade low-density 



polyethylene (LDPE) bag 









------------------------------------------------------------------------------------------------------------------------
|Appearance|The surface should be smooth, uniform in color, and free of holes, foreign matters, odors, and             |
|          |conglutination. The heat-sealed part of the bag should be flat and free of defects.                        |
------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 501 of 542 





Page 502
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 






















------------------------------------------------------------------------------------------------------------------------
|Size             |Size                                |Size                                |Length: 1100 ± 5mm; Width:|
|                 |                                    |                                    |810 ± 5mm;                |
|-----------------|------------------------------------|------------------------------------|--------------------------|
|Test             |density                             |density                             |0.910～0.935g/cm3         |
|-----------------|------------------------------------|------------------------------------|--------------------------|
|Test             |Residue onignition                  |Residue onignition                  |NMT 0.1%                  |
|-----------------|------------------------------------|------------------------------------|--------------------------|
|Extractables Test|Easyoxide                           |Easyoxide                           |The difference between the|
|                 |                                    |                                    |titration volumesis NMT   |
|                 |                                    |                                    |1.5 mL.                   |
|-----------------|------------------------------------|------------------------------------|--------------------------|
|Extractables Test|Heavy metals                        |Heavy metals                        |NMT 1ppm.                 |
|-----------------|------------------------------------|------------------------------------|--------------------------|
|Extractables Test|Non-volati le substances            |Water                               |The residue of the        |
|                 |                                    |                                    |waterextractis NMT 30.0 mg|
|                 |                                    |                                    |comparing to the blank    |
|                 |                                    |                                    |solution.                 |
|-----------------|------------------------------------|------------------------------------|--------------------------|
|Extractables Test|Non-volati le substances            |65% Ethanol                         |The residue of the 65%    |
|                 |                                    |                                    |ethanolextractis NMT 30.0 |
|                 |                                    |                                    |mg comparing to the blank |
|                 |                                    |                                    |solution.                 |
|-----------------|------------------------------------|------------------------------------|--------------------------|
|Extractables Test|Non-volati le substances            |n-Hexa ne                           |The residue of then-hexane|
|                 |                                    |                                    |extractis NMT 30.0 mg     |
|                 |                                    |                                    |comparing to the blank    |
|                 |                                    |                                    |solution.                 |
|-----------------|------------------------------------|------------------------------------|--------------------------|
|Microbial limit  |Totalaerobic microbial count (TAMC) |Totalaerobic microbial count (TAMC) |NMT 1000 CFU/100 cm2.     |
|-----------------|------------------------------------|------------------------------------|--------------------------|
|Microbial limit  |Total yeasts and moulds count (TYMC)|Total yeasts and moulds count (TYMC)|NMT 100 CFU/100 cm2.      |
|-----------------|------------------------------------|------------------------------------|--------------------------|
|Microbial limit  |Escherichia coli                    |Escherichia coli                    |Absence ofEscherichia coli|
------------------------------------------------------------------------------------------------------------------------

**Test Methods for pharmaceutical grade low-density polyethylene (LDPE)** 



**bag** 



**Appearance** 



Take an appropriate amount of sample, and look directly at it in a bright 



environment with natural light. The surface should be smooth, uniform in 



color, and free of holes, foreign matters, odors, and conglutination. The 



heat-sealed part of the bag should be flat and free of defects. Except for 



“NB046” which is black, all other parts should be transparent. 



**Size** 



Take an appropriate amount of sample and measure the length and width 



with a ruler, which should comply with the acceptance criteria. 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 502 of 542 





Page 503
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Length: 1100 ± 5mm; Width: 810 ± 5mm. 



**Test** 



**Density** 



The sample should be placed in an environment with a temperature of 



(23±2)℃ and a relative humidity of (50±5)% for more than 4h, and then 



perform the test under these conditions. Weigh accurately about 2g of sample, 



immerse it with anhydrous ethanol. (The density of the immersion liquid is 



generally less than the density of the sample. When the material density is 



greater than 1, use water as immersion liquid. When the material density is 



less than 1, use anhydrous ethanol). 



Take an appropriate amount of the sample, place it on the balance, weigh 



accurately and record the mass in the air (a). Then place the sample in a 



certain amount of immersion liquid anhydrous ethanol with a known density 



(ρx), weigh accurately and record the mass (b). The upper end of the sample 



should NLT 10 mm from the liquid surface, and air bubbles should not 



adhere to the surface of the sample. The density of the sample is calculated by 



the following formula. The density should be 0.910～0.935 g/cm3. 



_a_   _x_ 
  
_a_  _b_ 



**Residue on ignition:** 



NMT 0.10 %, using 1.0 g.Examine by _Determination of Residue on Ignition._ 



**Extractables Test** 



Test solution: unless otherwise specified, take an appropriate amount of 



sample, and take three pieces of the sample with an inner surface area of 



about 600 cm [2] each (divided into small pieces of 3 cm in length and 0.3 cm in 



width), place these small pieces in three conical flasks with stoppers, 



respectively, add 200 mL of water (70℃ ± 2℃), 65% ethanol (70℃ ± 2℃), 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 503 of 542 





Page 504
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



n-hexane (58℃ ± 2℃), respectively. After soaking for 2h, take it out, let it cool 



to room temperature, and compensate to original volume using the same 



solvent, and use the obtained solutions as the test solutions (water-extracting 



solution, ethanol-extracting solution, and _n_ -hexane extracting solution). 



Prepare each blank solution in same manner using the same batch of water, 



65% ethanol, and _n_ -hexane respectively. 



**Heavy metals** 



Measure accurately 20 mL of the water-extracting solution, add 2 mL of 



acetate buffer solution (pH 3.5). Perform the test according to the "Operating 



Procedures for the Test of Heavy Metals" (Method 1). The heavy metals is NMT 



1 ppm. 



**Easy oxide** 



Precisely measure 20ml of the water-extracting solution, add 20ml of 



0.002mol/L potassium permanganate titration solution and 1ml of dilute 



sulfuric acid, boil for 3min, and cool rapidly. Add 0.1 g of potassium iodide, 



allow to stand protected from light for 5min, and titrate with 0.01 mol/L 



sodium thiosulfate titration solution. When the titration is near the end point, 



add 5 drops of starch indicator solution, continue to titrate until it becomes 



colorless. Perform a blank titration using 20 mL of the bank solution, The 



difference between the titration volumes is NMT 1.5 mL. 



**Non-volatile substances** 



Measure 100 mL of water-extracting solution, 65% ethanol-extracting 



solutioN, N-hexane extracting solution and the respective blank solution. 



Place them in an evaporating dish that has been dried to a constant weight, 



evaporate in a water bath, then dry at 105℃ for 2h, and weigh the residue 



accurately after cooling. 



The residue of the water extract is NMT 30.0 mg comparing to the blank 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 504 of 542 





Page 505
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



solution. The residue of the 65% ethanol extract is NMT 30.0 mg comparing to 



the blank solution. The residue of the n-hexane extract is NMT 30.0 mg 



comparing to the blank solution. 



**Microbial limits** 



Take the sample and press it on the inner surface with a sterilized metal plate 



with hole area of 20 cm [2] . Slightly moisten the sterile cotton swab with 0.9% 



sterile sodium chloride solution. Use a cotton swab to wipe the hole area of 



the plate 5 times, then use another cotton swab to wipe 5 times. That is to 



say,wipe each hole area with 2 cotton swabs 10 times totally. Wipe 5 hole 



areas with a total area of 100 cm [2] . 



Cut each cotton swab immediately after being used, and put it into an conical 



flask (or large test tube) containing 30 mL of 0.9% sterile sodium chloride 



solution. Put all the cotton swabs into the conical flask (or large test tube), 



shake immediately for 1min to get the sample solution. 



Perform the test with sample solution according to _Operating Procedures for_ 



_the Test of Microbial Limit_ . The acceptance criteria of total aerobic microbial 



count (TAMC) and total yeasts and moulds count (TYMC) are 1000 cfu/100 



cm [2] and 100 cfu/100 cm [2] , respectively. _Escherichia coli_ is not observed. 



The copy of typical COA of pharmaceutical grade low-density polyethylene 



(LDPE) bag analyzed by Hinye Pharmaceutical Co., Ltd. and corresponding 



translation are annexed. 



3.2.S.6 Annex 1 COA of pharmaceutical grade low-density polyethylene 



(LDPE) bag analyzed by Hinye Pharmaceutical Co., Ltd.(Batch No. ) 



3.2.S.6 Annex 2 English translation of COA of pharmaceutical grade 



low-density polyethylene (LDPE) bag analyzed by Hinye Pharmaceutical Co., 



Ltd.(Batch No. ) 



3.2.S.6 Annex 3 COA of pharmaceutical grade low-density polyethylene 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 505 of 542 





Page 506
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



(LDPE) bag analyzed by Hinye Pharmaceutical Co., Ltd.(Batch No. ) 



3.2.S.6 Annex 4 English translation of COA of pharmaceutical grade 



low-density polyethylene (LDPE) bag analyzed by QHinye Pharmaceutical Co., 



Ltd.(Batch No. ) 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 506 of 542 





Page 507
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**Secondary Packaging Material** 



The specification and analytical method of cardboard drum established by the 



applicant is as follows: 



Table 3.2.S.6-2 Acceptance Criteria of Cardboard Drum 















------------------------------------------------------------------------------------------------------------------------
|Appeara nce              |Surface                  |The surface is smooth, clean and free from pollution              |
|                         |                         |andotherabnormal conditions.                                      |
|-------------------------|-------------------------|------------------------------------------------------------------|
|Appeara nce              |Size                     |Inner diameter × height: (310 mm ± 5 mm) × (410 mm ± 5 mm)        |
|-------------------------|-------------------------|------------------------------------------------------------------|
|Appeara nce              |Size                     |Inner diameter × height: (450 mm ± 5 mm) × (500 mm ± 5 mm)        |
|-------------------------|-------------------------|------------------------------------------------------------------|
|Material and construction|Material and construction|The sidewallis convolutely yellow paperboard. The cover and       |
|                         |                         |bottomare wood boards lockinginto sidewall withastainless steel   |
|                         |                         |hoop.                                                             |
------------------------------------------------------------------------------------------------------------------------

**Test Methods for Cardboard Drum** 



**Appearance** 



**Surface** 



Visual inspection. The surface is smooth, clean and free from pollution and 



other abnormal conditions. 



**Size** 



Measure the inner diameter and height of the cardboard with rule. The size 



should comply with the requirements below: 

-------------------------------------
|WB081  |310 mm ± 5 mm|410 mm ± 5 mm|
|-------|-------------|-------------|
|WB465  |450 mm ± 5 mm|500 mm ± 5 mm|
-------------------------------------



**Material** 



Visual inspection. The sidewall is convolutely yellow paperboard. The cover 



and bottom are wood boards locking into sidewall with a stainless steel hoop. 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 507 of 542 





Page 508
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



The copy of typical COA of cardboard drum analyzed by Hinye 



Pharmaceutical Co., Ltd. and corresponding translation are annexed. 



_3.2.S.6 Annex 5_ _COA of cardboard drum analyzed by Hinye Pharmaceutical_ 



_Co., Ltd._ 



_3.2.S.6 Annex 6_ _English translation of COA of cardboard drum analyzed by_ 



_Hinye Pharmaceutical Co., Ltd._ 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 508 of 542 





Page 509
**Drug Master File of Finerenone** 
Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**III. Annexes: COAs** 



3.2.S.6 Annex 1 COA of pharmaceutical grade low-density polyethylene 



(LDPE) bag analyzed by Hinye Pharmaceutical Co., Ltd. (Batch No. ) 



3.2.S.6 Annex 2 English translation of COA of pharmaceutical grade 



low-density polyethylene (LDPE) bag analyzed by Hinye Pharmaceutical Co., 



Ltd.(Batch No. ) 



3.2.S.6 Annex 3 COA of pharmaceutical grade low-density polyethylene 



(LDPE) bag analyzed by Hinye Pharmaceutical Co., Ltd.(Batch No. ) 



3.2.S.6 Annex 4 English translation of COA of pharmaceutical grade 



low-density polyethylene (LDPE) bag analyzed by Hinye Pharmaceutical Co., 



Ltd.(Batch No. ) 



3.2.S.6 Annex 5 COA of cardboard drum analyzed by Hinye Pharmaceutical 



Co., Ltd.(Batch No. ) 



3.2.S.6 Annex 6 English translation of COA of cardboard drum analyzed by 



Hinye Pharmaceutical Co., Ltd. (Batch No. 1 ) 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 509 of 542 





Page 510
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.7 Stability** 



**3.2.S.7.1** **Stability Summary and Conclusions** 



**Batch Tested** 



Long-term and accelerated stability studies were carried out on three 



validation batches (batch No. 231201, 240101 and 240102, batch size: 10 



kg). 



Stress testing was carried out on one Commercial scale batch (batch No. 



240101). It included the effect of high temperature (60 ℃), high humidity 



(92.5% RH, 25℃) and illumination (visible light: 4500±500 LX; near 



ultraviolet: 90±5 μW/cm [2] , 25℃) on Finerenone without packaging. 



The stability batch information and studies conducted are summarized in 



Table 3.2.S.7.1-1. 



**Stability Protocol of Long-term Stability** 



Storage condition: 30℃±2℃/65%RH±5%RH. 



Packaging: double-layered pharmaceutical grade low-density polyethylene 



(LDPE) bag. 



Study period: 4 years for the three validation batches (batch No. 231201, 



240101 and 240102). 



Test points: 0, 3, 6, 9, 12, 18, 24, 36, 48 months for the validation batches 



(batch No. 231201, 240101 and 240102) as needed. 



**Stability Protocol of Accelerated Stability** 



Storage condition: 40℃±2℃/75%RH±5%RH 



Packaging: double-layered pharmaceutical grade low-density polyethylene 



(LDPE) bag. 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 510 of 542 





Page 511
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Study period: 6 months. 



Test points: 0, 3, 6 months for the validation batches (batch No.: 231201, 



240101 and 240102). 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 511 of 542 





Page 512
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 
















------------------------------------------------------------------------------------------------------------------------------------------------
|Batch No.                      |Validation batches                                                    |Validation         |Validation         |
|                               |                                                                      |batches            |batches            |
|-------------------------------|----------------------------------------------------------------------|-------------------|-------------------|
|Batch No.                      |231201                                                                |240101             |240102             |
|-------------------------------|----------------------------------------------------------------------|-------------------|-------------------|
|Batch size                     |10 kg                                                                 |10 kg              |10 kg              |
|-------------------------------|----------------------------------------------------------------------|-------------------|-------------------|
|Manufacturing date             |Jan. 2024                                                             |Jan. 2024          |Jan. 2024          |
|-------------------------------|----------------------------------------------------------------------|-------------------|-------------------|
|Stability studies              |Stress test, Long-term, accelerated                                   |Long-term,         |Long-term,         |
|                               |                                                                      |accelerated        |accelerated        |
|-------------------------------|----------------------------------------------------------------------|-------------------|-------------------|
|starting time                  |Sept. 12, 2022                                                        |Sept. 12,          |Sept. 12,          |
|                               |                                                                      |2022               |2022               |
|-------------------------------|----------------------------------------------------------------------|-------------------|-------------------|
|Testing frequency (time points)|Stress test: 0, 5, 15, 30DLong-term: 0, 3, 6, 9, 12, 18, 24, 36,      |Long-term:         |,                  |
|                               |48,60M; Accelerated: 0, 3, 6 M.                                       |0, 3, 6, 9,        |Long-term:         |
|                               |                                                                      |12, 18, 24,        |0, 3, 6, 9,        |
|                               |                                                                      |36 48 M;           |12, 18, 24,        |
|                               |                                                                      |Accelerated:       |36 48, 60M;        |
|                               |                                                                      |0, 3, 6 M.         |Accelerated:       |
|                               |                                                                      |                   |0, 3, 6 M.         |
|-------------------------------|----------------------------------------------------------------------|-------------------|-------------------|
|Status                         |Long-term: OngoingAccelerated: Completed                              |Long-term:         |Long-term:         |
|                               |                                                                      |OngoingAccelerated:|OngoingAccelerated:|
|                               |                                                                      |Completed          |Completed          |
|-------------------------------|----------------------------------------------------------------------|-------------------|-------------------|
|Completed time points*         |Long-term: 0, 3, 6 M; Accelerated: 0, 3, 6 M.                         |Long-term: 0, 3, 6 |Long-term: 0, 3, 6 |
|                               |                                                                      |M; Accelerated: 0, |M; Accelerated: 0, |
|                               |                                                                      |3, 6 M.            |3, 6 M.            |
------------------------------------------------------------------------------------------------------------------------------------------------


- Stability data available are presented in section 3.2.S.7.3 




Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 512 of 542 





Page 513
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**Stability Specification and Analytical Method** 



The test items are listed in the table below. Process validation batch in the 



long-term stability study, The tests of particle size, microbial limits, XRD at 3, 



9 and 18 months are omitted. The tests of Genotoxic impurities at 3, 9, 12 



and 18 months are omitted. The stability specification is described in the 



table below. The analytical methods are referred to section 3.2.S.4.2. 



Validation of these analytical methods is described in section 3.2.S.4.3. 































------------------------------------------------------------------------------------------------------------------------
|Characters       |Appearance         |White to yellow powder                                                          |
|-----------------|-------------------|--------------------------------------------------------------------------------|
|Tests            |Particle size      |Basically consistent with the results of 0 month                                |
|-----------------|-------------------|--------------------------------------------------------------------------------|
|Tests            |Related substances |YA2304-10 NMT 0.10%； YA2304-12 NMT 0.15%； YA2304-14 NMT 0.15%； YA2304-15 NMT |
|                 |                   |0.15%； YA2304-16 NMT 0.15%； YA2304-17 NMT 0.15%； YA2304-18 NMT 0.15%；       |
|                 |                   |YA2304-19 NMT 0.15%； Individualunspecifiedimpurity NMT 0.10%； Totalimpurities |
|                 |                   |NMT 1.0%                                                                        |
|-----------------|-------------------|--------------------------------------------------------------------------------|
|Tests            |Enantiomers        |YA2304-20 NMT 0.15%                                                             |
|-----------------|-------------------|--------------------------------------------------------------------------------|
|Tests            |Genotoxicimpurities|Dimethyl sulfate NMT 75ppm; Diethyl sulfate NMT 75ppm; Diisopropyl sulfate NMT  |
|                 |                   |75ppm; Disec-butyl sulfate NMT 75ppm; The sum of genotoxicimpurities NMT 250ppm |
|-----------------|-------------------|--------------------------------------------------------------------------------|
|Tests            |Water              |NMT 0.5%                                                                        |
|-----------------|-------------------|--------------------------------------------------------------------------------|
|Tests            |Microbial limits   |TAMC: NMT 103CFU/gTYMC: NMT 102CFU/gAbsence ofEscherichia coli (1g)             |
|-----------------|-------------------|--------------------------------------------------------------------------------|
|Assay            |Assay              |98.0% to 102.0% (anhydrous substance).                                          |
|-----------------|-------------------|--------------------------------------------------------------------------------|
|Crystal form(XRD)|Crystal form(XRD)  |Basically consistent with the results of 0 month                                |
------------------------------------------------------------------------------------------------------------------------

**Stability Study Conclusions, Proposed Storage Conditions and Re-test** 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 513 of 542 





Page 514
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**Period** 



The results of characters, related substances, loss on drying, assay, and 



hygroscopic weight gain of batch 240101 are qualified at condition of high 



temperature (60℃), high humidity (92.5% RH, 25℃) and photolysis (visible 



light: 4500 ± 500 LX; near ultraviolet: 90±5 μW/cm [2] , 25℃) in 30 days. The 



Finerenone drug substance has a good stability under high temperature, high 



humidity and photolysis. 



Currently 6 months of three validation batches (batch No. 231201、240101 



and 240102) has been completed. All data presented at accelerated condition 



40℃±2℃/75%RH±5%RH (6 months) and long–term condition 30℃±2℃ / 



65%RH±5%RH (6 months) met the acceptance criteria, and there is no 



significant change. 



There is no significant change at accelerated condition within 6 months. The 



data of long-term stability already conducted for 6 months met the 



acceptance criteria. No change trends are observed. The applicant request a 



retest period of 24 months for Finerenone packed in double-layered 



pharmaceutical grade low-density polyethylene (LDPE) bag. The storage 



condition is sealed storage. 



**3.2.S.7.2** **Post-approval Stability Protocol and Stability Commitment** 



We, Hinye Pharmaceutical Co., Ltd., hereby make the commitment that the 



long-term stability studies on validation batches (batch No.: 231201, 240101 



and 240102)will be continued throughout the protocol period of 4 years, 



which covers the proposed re-test period. All the stability data obtained on 



these batches will be supplied to authority. 



**Stability Protocol of Long-term Stability** 



Storage condition: 30℃±2℃ / 75%RH±5%RH. 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 514 of 542 





Page 515
**Drug Master File of Finerenone** 


Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Packaging: double-layered pharmaceutical grade low-density polyethylene 



(LDPE) bag. 



Study period: 4 years for the validation batches (batch No.: 231201, 240101 



and 240102). 



Test points: 0, 3, 6, 9, 12, 18, 24, 36 and 48 months as needed. 



Test items: Appearance, related substances, Genotoxic impurities, Water, 



microbial limits, assay, particle size distribution, crystal form. The 



acceptance criteria and test points for each item are listed in the table below. 



Analytical method: the same as the procedures described in section 3.2.S.4.2 



_Analytical Procedures_ . 



Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 515 of 542 





Page 516
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Table 3.2.S.7.2-1 Stability Specification and Test Points of Post-approval Stability Study 






















-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|**Packaging**     |**Packaging**                |double-layered        |double-layered        |double-layered        |double-layered        |double-layered        |double-layered        |double-layered        |double-layered        |double-layered        |
|                  |                             |pharmaceutical        |pharmaceutical        |pharmaceutical        |pharmaceutical        |pharmaceutical        |pharmaceutical        |pharmaceutical        |pharmaceutical        |pharmaceutical        |
|                  |                             |grade                 |grade                 |grade                 |grade                 |grade                 |grade                 |grade                 |grade                 |grade                 |
|                  |                             |low-density           |low-density           |low-density           |low-density           |low-density           |low-density           |low-density           |low-density           |low-density           |
|                  |                             |polyethylene          |polyethylene          |polyethylene          |polyethylene          |polyethylene          |polyethylene          |polyethylene          |polyethylene          |polyethylene          |
|                  |                             |(LDPE)                |(LDPE)                |(LDPE)                |(LDPE)                |(LDPE)                |(LDPE)                |(LDPE)                |(LDPE)                |(LDPE)                |
|                  |                             |bag                   |bag                   |bag                   |bag                   |bag                   |bag                   |bag                   |bag                   |bag                   |
|------------------|-----------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|**Items**         |**Specifications**           |**Timepoints(months)**|**Timepoints(months)**|**Timepoints(months)**|**Timepoints(months)**|**Timepoints(months)**|**Timepoints(months)**|**Timepoints(months)**|**Timepoints(months)**|**Timepoints(months)**|
|------------------|-----------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|**Items**         |**Specifications**           |**0**                 |**3**                 |**6**                 |**9**                 |**12**                |**18**                |**24**                |**36**                |**48**                |
|------------------|-----------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|Appearance        |White to yellow powder       |√                     |√                     |√                     |√                     |√                     |√                     |√                     |√                     |√                     |
|------------------|-----------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|Related substances|YA2304-10 NMT 0.10%；        |√                     |√                     |√                     |√                     |√                     |√                     |√                     |√                     |√                     |
|                  |YA2304-12 NMT 0.15%；        |                      |                      |                      |                      |                      |                      |                      |                      |                      |
|                  |YA2304-14 NMT 0.15%；        |                      |                      |                      |                      |                      |                      |                      |                      |                      |
|                  |YA2304-15 NMT 0.15%；        |                      |                      |                      |                      |                      |                      |                      |                      |                      |
|                  |YA2304-16 NMT 0.15%；        |                      |                      |                      |                      |                      |                      |                      |                      |                      |
|                  |YA2304-17 NMT 0.15%；        |                      |                      |                      |                      |                      |                      |                      |                      |                      |
|                  |YA2304-18 NMT 0.15%；        |                      |                      |                      |                      |                      |                      |                      |                      |                      |
|                  |YA2304-19 NMT 0.15%；        |                      |                      |                      |                      |                      |                      |                      |                      |                      |
|                  |Individualunspecifiedimpurity|                      |                      |                      |                      |                      |                      |                      |                      |                      |
|                  |NMT 0.10%； Totalimpurities  |                      |                      |                      |                      |                      |                      |                      |                      |                      |
|                  |NMT 1.0%                     |                      |                      |                      |                      |                      |                      |                      |                      |                      |
|------------------|-----------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|Enantiomers       |YA2304-20 NMT 0.15%          |√                     |√                     |√                     |√                     |√                     |√                     |√                     |√                     |√                     |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 516 of 542 





Page 517
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 




























---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|**Packaging**      |**Packaging**             |double-layered        |double-layered        |double-layered        |double-layered        |double-layered        |double-layered        |double-layered        |double-layered        |double-layered        |
|                   |                          |pharmaceutical        |pharmaceutical        |pharmaceutical        |pharmaceutical        |pharmaceutical        |pharmaceutical        |pharmaceutical        |pharmaceutical        |pharmaceutical        |
|                   |                          |grade                 |grade                 |grade                 |grade                 |grade                 |grade                 |grade                 |grade                 |grade                 |
|                   |                          |low-density           |low-density           |low-density           |low-density           |low-density           |low-density           |low-density           |low-density           |low-density           |
|                   |                          |polyethylene          |polyethylene          |polyethylene          |polyethylene          |polyethylene          |polyethylene          |polyethylene          |polyethylene          |polyethylene          |
|                   |                          |(LDPE)                |(LDPE)                |(LDPE)                |(LDPE)                |(LDPE)                |(LDPE)                |(LDPE)                |(LDPE)                |(LDPE)                |
|                   |                          |bag                   |bag                   |bag                   |bag                   |bag                   |bag                   |bag                   |bag                   |bag                   |
|-------------------|--------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|**Items**          |**Specifications**        |**Timepoints(months)**|**Timepoints(months)**|**Timepoints(months)**|**Timepoints(months)**|**Timepoints(months)**|**Timepoints(months)**|**Timepoints(months)**|**Timepoints(months)**|**Timepoints(months)**|
|-------------------|--------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|**Items**          |**Specifications**        |**0**                 |**3**                 |**6**                 |**9**                 |**12**                |**18**                |**24**                |**36**                |**48**                |
|-------------------|--------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|Genotoxicimpurities|Dimethyl sulfate NMT      |√                     |×                     |√                     |×                     |×                     |×                     |√                     |√                     |√                     |
|                   |75ppm; Diethyl sulfate NMT|                      |                      |                      |                      |                      |                      |                      |                      |                      |
|                   |75ppm; Diisopropyl sulfate|                      |                      |                      |                      |                      |                      |                      |                      |                      |
|                   |NMT 75ppm; Disec-butyl    |                      |                      |                      |                      |                      |                      |                      |                      |                      |
|                   |sulfate NMT 75ppm; The sum|                      |                      |                      |                      |                      |                      |                      |                      |                      |
|                   |of genotoxicimpurities NMT|                      |                      |                      |                      |                      |                      |                      |                      |                      |
|                   |250ppm                    |                      |                      |                      |                      |                      |                      |                      |                      |                      |
|-------------------|--------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|Water              |NMT 0.5%                  |√                     |√                     |√                     |√                     |√                     |√                     |√                     |√                     |√                     |
|-------------------|--------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|Microbial limits   |TAMC: NMT 103CFU/g; TYMC: |√                     |×                     |√                     |×                     |√                     |×                     |√                     |√                     |√                     |
|                   |NMT 102CFU/g; Absence of_ |                      |                      |                      |                      |                      |                      |                      |                      |                      |
|                   |Escherichia coli_ (1g)    |                      |                      |                      |                      |                      |                      |                      |                      |                      |
|-------------------|--------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|Assay              |98.0% to 102.0% (Anhydrous|√                     |√                     |√                     |√                     |√                     |√                     |√                     |√                     |√                     |
|                   |substance).               |                      |                      |                      |                      |                      |                      |                      |                      |                      |
|-------------------|--------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|Particle size      |Basically consistent with |√                     |×                     |√                     |×                     |√                     |×                     |√                     |√                     |√                     |
|                   |the results of 0 month    |                      |                      |                      |                      |                      |                      |                      |                      |                      |
|-------------------|--------------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|----------------------|
|Crystal form(XRD)  |Basically consistent with |√                     |×                     |√                     |×                     |√                     |×                     |√                     |√                     |√                     |
|                   |the results of 0 month    |                      |                      |                      |                      |                      |                      |                      |                      |                      |
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Note: the cell marked with √indicates that the item will be tested at the corresponding time point; while the cell marked with 



× indicates that the item will be omitted. 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 517 of 542 





Page 518
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**3.2.S.7.3** **Stability Data** 



The stability results for the three validation batches (batch No. 231201, 



240101 and 240102, batch size: 10 kg) are detailed below. 



- long term stability studies: 3.2.S.7.3 _Table 1, Table 2, Table 3._ 



- accelerated stability studies: _3.2.S.7.3_ _Table 4, Table 5, Table 6._ 



Stress testing was carried out on one batch of Finerenone (batch No. 240101). 



It included the effect of high temperature (60℃), high humidity (92.5%RH, 



25℃) and illumination (visible light: 4500 ± 500 LX; near ultraviolet: 90±5 



μW/cm [2] , 25℃). 



- high temperature: _3.2.S.7.3 Table 7_ ; 



- high humidity: _3.2.S.7.3 Table 8_ ; 



- photostability: _3.2.S.7.3 Table 9_ . 



Please note: 



- “Not Detected” is abbreviated as ‘ND’; 



- “NMT” is abbreviated as ‘NMT’. 



- “Not Test” is abbreviated as ‘--’. 



Finerenone 
Confidential Hinye Pharmaceutical Co., Ltd. 



Page 518 of 542 





Page 519
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**Long term stability studies** 



Table 3.2.S.7.3-1 Long-term Stability Data of Finerenone (Batch No. 231201) 
















----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|**Primary package**   |**Primary         |double-layered|double-layered|double-layered|**Storage     |**Storage     |**Storage     |30℃±2℃/       |30℃±2℃/       |30℃±2℃/       |30℃±2℃/       |30℃±2℃/       |
|                      |package**         |pharmaceutical|pharmaceutical|pharmaceutical|condition**   |condition**   |condition**   |65%RH±5%RH    |65%RH±5%RH    |65%RH±5%RH    |65%RH±5%RH    |65%RH±5%RH    |
|                      |                  |grade         |grade         |grade         |              |              |              |              |              |              |              |              |
|                      |                  |low-density   |low-density   |low-density   |              |              |              |              |              |              |              |              |
|                      |                  |polyethylene  |polyethylene  |polyethylene  |              |              |              |              |              |              |              |              |
|                      |                  |(LDPE)        |(LDPE)        |(LDPE)        |              |              |              |              |              |              |              |              |
|                      |                  |bag           |bag           |bag           |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing date**|**Manufacturing   |Jan. 06, 2024 |Jan. 06, 2024 |Jan. 06, 2024 |**Stability   |**Stability   |**Stability   |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |
|                      |date**            |              |              |              |starting**    |starting**    |starting**    |2024          |2024          |2024          |2024          |2024          |
|                      |                  |              |              |              |**date**      |**date**      |**date**      |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing site**|**Manufacturing   |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |
|                      |site**            |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |
|                      |                  |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |
|                      |                  |Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|
|                      |                  |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications**|**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |
|                      |                  |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications**|**0**         |**3**         |**6**         |**6**         |**9**         |**12**        |**12**        |**18**        |**24**        |**36**        |**48**        |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Appearance            |White to yellow   |white powder  |white powder  |white powder  |white powder  |              |              |              |              |              |              |              |
|                      |powder.           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-10 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.10%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-12 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-14 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-15 NMT     |ND            |＜0.05%       |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-16 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-17 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-18 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-19 NMT     |＜0.05%       |＜0.05%       |＜0.05%       |＜0.05%       |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |Other single      |＜0.05%       |＜0.05%       |＜0.05%       |＜0.05%       |              |              |              |              |              |              |              |
|                      |impurities: NMT   |              |              |              |              |              |              |              |              |              |              |              |
|                      |0.10%             |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |Totalimpurity: NMT|＜0.05%       |＜0.05%       |＜0.05%       |＜0.05%       |              |              |              |              |              |              |              |
|                      |1.0%              |              |              |              |              |              |              |              |              |              |              |              |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 519 of 542 





Page 520
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 































-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|**Primary package**   |**Primary          |double-layered|double-layered|double-layered|**Storage     |**Storage     |**Storage     |30℃±2℃/       |30℃±2℃/       |30℃±2℃/       |30℃±2℃/       |30℃±2℃/       |
|                      |package**          |pharmaceutical|pharmaceutical|pharmaceutical|condition**   |condition**   |condition**   |65%RH±5%RH    |65%RH±5%RH    |65%RH±5%RH    |65%RH±5%RH    |65%RH±5%RH    |
|                      |                   |grade         |grade         |grade         |              |              |              |              |              |              |              |              |
|                      |                   |low-density   |low-density   |low-density   |              |              |              |              |              |              |              |              |
|                      |                   |polyethylene  |polyethylene  |polyethylene  |              |              |              |              |              |              |              |              |
|                      |                   |(LDPE)        |(LDPE)        |(LDPE)        |              |              |              |              |              |              |              |              |
|                      |                   |bag           |bag           |bag           |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing date**|**Manufacturing    |Jan. 06, 2024 |Jan. 06, 2024 |Jan. 06, 2024 |**Stability   |**Stability   |**Stability   |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |
|                      |date**             |              |              |              |starting**    |starting**    |starting**    |2024          |2024          |2024          |2024          |2024          |
|                      |                   |              |              |              |**date**      |**date**      |**date**      |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing site**|**Manufacturing    |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |
|                      |site**             |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |
|                      |                   |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |
|                      |                   |Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|
|                      |                   |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications** |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |
|                      |                   |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications** |**0**         |**3**         |**6**         |**6**         |**9**         |**12**        |**12**        |**18**        |**24**        |**36**        |**48**        |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|enantiome rs          |YA2304-20: NMT     |0.03%         |0.03%         |0.04%         |0.04%         |              |              |              |              |              |              |              |
|                      |0.15%              |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Dimethyl sulfate   |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |NMT 75ppm          |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Diethyl sulfate    |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |NMT 75ppm          |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Diisopropyl        |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |sulfate NMT 75 ppm |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Disec-butyl        |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |sulfate NMT 75 ppm |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Sum of             |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |genotoxicimpurities|              |              |              |              |              |              |              |              |              |              |              |
|                      |NMT 250ppm         |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Water                 |NMT 0.5%           |0.05%         |0.1%          |0.05%         |0.05%         |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Microbial limits      |TAMC: NMT 103CFU/g |Complies      |/             |Complies      |Complies      |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Microbial limits      |TYMC: NMT 102CFU/g |Complies      |/             |Complies      |Complies      |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Microbial limits      |Absence            |Complies      |/             |Complies      |Complies      |              |              |              |              |              |              |              |
|                      |ofEscherichia coli |              |              |              |              |              |              |              |              |              |              |              |
|                      |(1g)               |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Assay                 |98.0% to 102.0%    |99.8%         |100.2%        |100.7%        |100.7%        |              |              |              |              |              |              |              |
|                      |(anhydrous         |              |              |              |              |              |              |              |              |              |              |              |
|                      |substance).        |              |              |              |              |              |              |              |              |              |              |              |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 520 of 542 





Page 521
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 


















----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|**Primary package**   |**Primary         |double-layered|double-layered|double-layered|**Storage     |**Storage     |**Storage     |30℃±2℃/       |30℃±2℃/       |30℃±2℃/       |30℃±2℃/       |30℃±2℃/       |
|                      |package**         |pharmaceutical|pharmaceutical|pharmaceutical|condition**   |condition**   |condition**   |65%RH±5%RH    |65%RH±5%RH    |65%RH±5%RH    |65%RH±5%RH    |65%RH±5%RH    |
|                      |                  |grade         |grade         |grade         |              |              |              |              |              |              |              |              |
|                      |                  |low-density   |low-density   |low-density   |              |              |              |              |              |              |              |              |
|                      |                  |polyethylene  |polyethylene  |polyethylene  |              |              |              |              |              |              |              |              |
|                      |                  |(LDPE)        |(LDPE)        |(LDPE)        |              |              |              |              |              |              |              |              |
|                      |                  |bag           |bag           |bag           |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing date**|**Manufacturing   |Jan. 06, 2024 |Jan. 06, 2024 |Jan. 06, 2024 |**Stability   |**Stability   |**Stability   |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |
|                      |date**            |              |              |              |starting**    |starting**    |starting**    |2024          |2024          |2024          |2024          |2024          |
|                      |                  |              |              |              |**date**      |**date**      |**date**      |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing site**|**Manufacturing   |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |
|                      |site**            |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |
|                      |                  |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |
|                      |                  |Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|
|                      |                  |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications**|**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |
|                      |                  |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications**|**0**         |**3**         |**6**         |**6**         |**9**         |**12**        |**12**        |**18**        |**24**        |**36**        |**48**        |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Crystal form XRD      |Basically         |Complies      |/             |Complies      |Complies      |              |              |              |              |              |              |              |
|                      |consistent with   |              |              |              |              |              |              |              |              |              |              |              |
|                      |the results of 0  |              |              |              |              |              |              |              |              |              |              |              |
|                      |month             |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Particle size         |Basically         |D90: 7.712μm  |/             |D90: 6.163μm  |D90: 6.163μm  |              |              |              |              |              |              |              |
|                      |consistent with   |              |              |              |              |              |              |              |              |              |              |              |
|                      |the results of 0  |              |              |              |              |              |              |              |              |              |              |              |
|                      |month             |              |              |              |              |              |              |              |              |              |              |              |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 521 of 542 





Page 522
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Table 3.2.S.7.3-2 Long-term Stability Data of Finerenone (Batch No. 240101) 










----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|**Primary package**   |**Primary         |double-layered|double-layered|double-layered|**Storage     |**Storage     |**Storage     |30℃±2℃/       |30℃±2℃/       |30℃±2℃/       |30℃±2℃/       |30℃±2℃/       |
|                      |package**         |pharmaceutical|pharmaceutical|pharmaceutical|condition**   |condition**   |condition**   |65%RH±5%RH    |65%RH±5%RH    |65%RH±5%RH    |65%RH±5%RH    |65%RH±5%RH    |
|                      |                  |grade         |grade         |grade         |              |              |              |              |              |              |              |              |
|                      |                  |low-density   |low-density   |low-density   |              |              |              |              |              |              |              |              |
|                      |                  |polyethylene  |polyethylene  |polyethylene  |              |              |              |              |              |              |              |              |
|                      |                  |(LDPE)        |(LDPE)        |(LDPE)        |              |              |              |              |              |              |              |              |
|                      |                  |bag           |bag           |bag           |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing date**|**Manufacturing   |Jan. 19, 2024 |Jan. 19, 2024 |Jan. 19, 2024 |**Stability   |**Stability   |**Stability   |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |
|                      |date**            |              |              |              |starting**    |starting**    |starting**    |2024          |2024          |2024          |2024          |2024          |
|                      |                  |              |              |              |**date**      |**date**      |**date**      |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing site**|**Manufacturing   |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |
|                      |site**            |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |
|                      |                  |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |
|                      |                  |Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|
|                      |                  |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications**|**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |
|                      |                  |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications**|**0**         |**3**         |**6**         |**6**         |**9**         |**12**        |**12**        |**18**        |**24**        |**36**        |**48**        |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Appearance            |White to yellow   |white powder  |white powder  |white powder  |white powder  |              |              |              |              |              |              |              |
|                      |powder.           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-10 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.10%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-12 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-14 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-15 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-16 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-17 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-18 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-19 NMT     |＜0.05%       |＜0.05%       |＜0.05%       |＜0.05%       |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |Other single      |＜0.05%       |＜0.05%       |＜0.05%       |＜0.05%       |              |              |              |              |              |              |              |
|                      |impurities: NMT   |              |              |              |              |              |              |              |              |              |              |              |
|                      |0.10%             |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |Totalimpurity: NMT|＜0.05%       |＜0.05%       |＜0.05%       |＜0.05%       |              |              |              |              |              |              |              |
|                      |1.0%              |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|enantiome rs          |YA2304-20: NMT    |0.03%         |0.04%         |0.04%         |0.04%         |              |              |              |              |              |              |              |
|                      |0.15%             |              |              |              |              |              |              |              |              |              |              |              |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 522 of 542 





Page 523
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 







































-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|**Primary package**   |**Primary          |double-layered|double-layered|double-layered|**Storage     |**Storage     |**Storage     |30℃±2℃/       |30℃±2℃/       |30℃±2℃/       |30℃±2℃/       |30℃±2℃/       |
|                      |package**          |pharmaceutical|pharmaceutical|pharmaceutical|condition**   |condition**   |condition**   |65%RH±5%RH    |65%RH±5%RH    |65%RH±5%RH    |65%RH±5%RH    |65%RH±5%RH    |
|                      |                   |grade         |grade         |grade         |              |              |              |              |              |              |              |              |
|                      |                   |low-density   |low-density   |low-density   |              |              |              |              |              |              |              |              |
|                      |                   |polyethylene  |polyethylene  |polyethylene  |              |              |              |              |              |              |              |              |
|                      |                   |(LDPE)        |(LDPE)        |(LDPE)        |              |              |              |              |              |              |              |              |
|                      |                   |bag           |bag           |bag           |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing date**|**Manufacturing    |Jan. 19, 2024 |Jan. 19, 2024 |Jan. 19, 2024 |**Stability   |**Stability   |**Stability   |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |
|                      |date**             |              |              |              |starting**    |starting**    |starting**    |2024          |2024          |2024          |2024          |2024          |
|                      |                   |              |              |              |**date**      |**date**      |**date**      |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing site**|**Manufacturing    |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |
|                      |site**             |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |
|                      |                   |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |
|                      |                   |Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|
|                      |                   |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications** |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |
|                      |                   |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications** |**0**         |**3**         |**6**         |**6**         |**9**         |**12**        |**12**        |**18**        |**24**        |**36**        |**48**        |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Dimethyl sulfate   |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |NMT 75ppm          |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Diethyl sulfate    |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |NMT 75ppm          |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Diisopropyl        |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |sulfate NMT 75 ppm |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Disec-butyl        |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |sulfate NMT 75 ppm |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Sum of             |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |genotoxicimpurities|              |              |              |              |              |              |              |              |              |              |              |
|                      |NMT 250ppm         |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Water                 |NMT 0.5%           |0.04%         |0.1%          |0.04%         |0.04%         |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Microbial limits      |TAMC: NMT 103CFU/g |Complies      |/             |Complies      |Complies      |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Microbial limits      |TYMC: NMT 102CFU/g |Complies      |/             |Complies      |Complies      |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Microbial limits      |Absence            |Complies      |/             |Complies      |Complies      |              |              |              |              |              |              |              |
|                      |ofEscherichia coli |              |              |              |              |              |              |              |              |              |              |              |
|                      |(1g)               |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Assay                 |98.0% to 102.0%    |99.8%         |100.5%        |99.5%         |99.5%         |              |              |              |              |              |              |              |
|                      |(anhydrous         |              |              |              |              |              |              |              |              |              |              |              |
|                      |substance).        |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Crystal form XRD      |Basically          |Complies      |/             |Complies      |Complies      |              |              |              |              |              |              |              |
|                      |consistent with the|              |              |              |              |              |              |              |              |              |              |              |
|                      |results of 0 month |              |              |              |              |              |              |              |              |              |              |              |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 523 of 542 





Page 524
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 















----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|**Primary package**   |**Primary         |double-layered|double-layered|double-layered|**Storage     |**Storage     |**Storage     |30℃±2℃/       |30℃±2℃/       |30℃±2℃/       |30℃±2℃/       |30℃±2℃/       |
|                      |package**         |pharmaceutical|pharmaceutical|pharmaceutical|condition**   |condition**   |condition**   |65%RH±5%RH    |65%RH±5%RH    |65%RH±5%RH    |65%RH±5%RH    |65%RH±5%RH    |
|                      |                  |grade         |grade         |grade         |              |              |              |              |              |              |              |              |
|                      |                  |low-density   |low-density   |low-density   |              |              |              |              |              |              |              |              |
|                      |                  |polyethylene  |polyethylene  |polyethylene  |              |              |              |              |              |              |              |              |
|                      |                  |(LDPE)        |(LDPE)        |(LDPE)        |              |              |              |              |              |              |              |              |
|                      |                  |bag           |bag           |bag           |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing date**|**Manufacturing   |Jan. 19, 2024 |Jan. 19, 2024 |Jan. 19, 2024 |**Stability   |**Stability   |**Stability   |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |
|                      |date**            |              |              |              |starting**    |starting**    |starting**    |2024          |2024          |2024          |2024          |2024          |
|                      |                  |              |              |              |**date**      |**date**      |**date**      |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing site**|**Manufacturing   |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |
|                      |site**            |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |
|                      |                  |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |
|                      |                  |Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|
|                      |                  |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications**|**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |
|                      |                  |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications**|**0**         |**3**         |**6**         |**6**         |**9**         |**12**        |**12**        |**18**        |**24**        |**36**        |**48**        |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Particle size         |Basically         |D90: 7.833μm  |/             |D90: 7.500μm  |D90: 7.500μm  |              |              |              |              |              |              |              |
|                      |consistent with   |              |              |              |              |              |              |              |              |              |              |              |
|                      |the results of 0  |              |              |              |              |              |              |              |              |              |              |              |
|                      |month             |              |              |              |              |              |              |              |              |              |              |              |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 524 of 542 





Page 525
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Table 3.2.S.7.3-3 Long-term Stability Data of Finerenone (Batch No. 240102) 










----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|**Primary package**   |**Primary         |double-layered|double-layered|double-layered|**Storage     |**Storage     |**Storage     |30℃±2℃/       |30℃±2℃/       |30℃±2℃/       |30℃±2℃/       |30℃±2℃/       |
|                      |package**         |pharmaceutical|pharmaceutical|pharmaceutical|condition**   |condition**   |condition**   |65%RH±5%RH    |65%RH±5%RH    |65%RH±5%RH    |65%RH±5%RH    |65%RH±5%RH    |
|                      |                  |grade         |grade         |grade         |              |              |              |              |              |              |              |              |
|                      |                  |low-density   |low-density   |low-density   |              |              |              |              |              |              |              |              |
|                      |                  |polyethylene  |polyethylene  |polyethylene  |              |              |              |              |              |              |              |              |
|                      |                  |(LDPE)        |(LDPE)        |(LDPE)        |              |              |              |              |              |              |              |              |
|                      |                  |bag           |bag           |bag           |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing date**|**Manufacturing   |Jan. 30, 2024 |Jan. 30, 2024 |Jan. 30, 2024 |**Stability   |**Stability   |**Stability   |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |
|                      |date**            |              |              |              |starting**    |starting**    |starting**    |2024          |2024          |2024          |2024          |2024          |
|                      |                  |              |              |              |**date**      |**date**      |**date**      |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing site**|**Manufacturing   |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |
|                      |site**            |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |
|                      |                  |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |
|                      |                  |Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|
|                      |                  |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications**|**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |
|                      |                  |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications**|**0**         |**3**         |**6**         |**6**         |**9**         |**12**        |**12**        |**18**        |**24**        |**36**        |**48**        |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Appearance            |White to yellow   |white powder  |white powder  |white powder  |white powder  |              |              |              |              |              |              |              |
|                      |powder.           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-10 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.10%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-12 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-14 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-15 NMT     |＜0.05%       |＜0.05%       |＜0.05%       |＜0.05%       |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-16 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-17 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-18 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-19 NMT     |＜0.05%       |＜0.05%       |＜0.05%       |＜0.05%       |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |Other single      |＜0.05%       |＜0.05%       |＜0.05%       |＜0.05%       |              |              |              |              |              |              |              |
|                      |impurities: NMT   |              |              |              |              |              |              |              |              |              |              |              |
|                      |0.10%             |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |Totalimpurity: NMT|＜0.05%       |＜0.05%       |＜0.05%       |＜0.05%       |              |              |              |              |              |              |              |
|                      |1.0%              |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|enantiome rs          |YA2304-20: NMT    |0.02%         |0.01%         |0.02%         |0.02%         |              |              |              |              |              |              |              |
|                      |0.15%             |              |              |              |              |              |              |              |              |              |              |              |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 525 of 542 





Page 526
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 







































-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|**Primary package**   |**Primary          |double-layered|double-layered|double-layered|**Storage     |**Storage     |**Storage     |30℃±2℃/       |30℃±2℃/       |30℃±2℃/       |30℃±2℃/       |30℃±2℃/       |
|                      |package**          |pharmaceutical|pharmaceutical|pharmaceutical|condition**   |condition**   |condition**   |65%RH±5%RH    |65%RH±5%RH    |65%RH±5%RH    |65%RH±5%RH    |65%RH±5%RH    |
|                      |                   |grade         |grade         |grade         |              |              |              |              |              |              |              |              |
|                      |                   |low-density   |low-density   |low-density   |              |              |              |              |              |              |              |              |
|                      |                   |polyethylene  |polyethylene  |polyethylene  |              |              |              |              |              |              |              |              |
|                      |                   |(LDPE)        |(LDPE)        |(LDPE)        |              |              |              |              |              |              |              |              |
|                      |                   |bag           |bag           |bag           |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing date**|**Manufacturing    |Jan. 30, 2024 |Jan. 30, 2024 |Jan. 30, 2024 |**Stability   |**Stability   |**Stability   |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |
|                      |date**             |              |              |              |starting**    |starting**    |starting**    |2024          |2024          |2024          |2024          |2024          |
|                      |                   |              |              |              |**date**      |**date**      |**date**      |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing site**|**Manufacturing    |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |
|                      |site**             |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |
|                      |                   |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |
|                      |                   |Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|
|                      |                   |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications** |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |
|                      |                   |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications** |**0**         |**3**         |**6**         |**6**         |**9**         |**12**        |**12**        |**18**        |**24**        |**36**        |**48**        |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Dimethyl sulfate   |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |NMT 75ppm          |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Diethyl sulfate    |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |NMT 75ppm          |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Diisopropyl        |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |sulfate NMT 75 ppm |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Disec-butyl        |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |sulfate NMT 75 ppm |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Sum of             |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |genotoxicimpurities|              |              |              |              |              |              |              |              |              |              |              |
|                      |NMT 250ppm         |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Water                 |NMT 0.5%           |0.2%          |0.1%          |0.1%          |0.1%          |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Microbial limits      |TAMC: NMT 103CFU/g |Complies      |/             |Complies      |Complies      |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Microbial limits      |TYMC: NMT 102CFU/g |Complies      |/             |Complies      |Complies      |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Microbial limits      |Absence            |Complies      |/             |Complies      |Complies      |              |              |              |              |              |              |              |
|                      |ofEscherichia coli |              |              |              |              |              |              |              |              |              |              |              |
|                      |(1g)               |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Assay                 |98.0% to 102.0%    |99.7%         |100.7%        |99.5%         |99.5%         |              |              |              |              |              |              |              |
|                      |(anhydrous         |              |              |              |              |              |              |              |              |              |              |              |
|                      |substance).        |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Crystal form XRD      |Basically          |Complies      |/             |Complies      |Complies      |              |              |              |              |              |              |              |
|                      |consistent with the|              |              |              |              |              |              |              |              |              |              |              |
|                      |results of 0 month |              |              |              |              |              |              |              |              |              |              |              |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 526 of 542 





Page 527
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 















----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|**Primary package**   |**Primary         |double-layered|double-layered|double-layered|**Storage     |**Storage     |**Storage     |30℃±2℃/       |30℃±2℃/       |30℃±2℃/       |30℃±2℃/       |30℃±2℃/       |
|                      |package**         |pharmaceutical|pharmaceutical|pharmaceutical|condition**   |condition**   |condition**   |65%RH±5%RH    |65%RH±5%RH    |65%RH±5%RH    |65%RH±5%RH    |65%RH±5%RH    |
|                      |                  |grade         |grade         |grade         |              |              |              |              |              |              |              |              |
|                      |                  |low-density   |low-density   |low-density   |              |              |              |              |              |              |              |              |
|                      |                  |polyethylene  |polyethylene  |polyethylene  |              |              |              |              |              |              |              |              |
|                      |                  |(LDPE)        |(LDPE)        |(LDPE)        |              |              |              |              |              |              |              |              |
|                      |                  |bag           |bag           |bag           |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing date**|**Manufacturing   |Jan. 30, 2024 |Jan. 30, 2024 |Jan. 30, 2024 |**Stability   |**Stability   |**Stability   |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |
|                      |date**            |              |              |              |starting**    |starting**    |starting**    |2024          |2024          |2024          |2024          |2024          |
|                      |                  |              |              |              |**date**      |**date**      |**date**      |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing site**|**Manufacturing   |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |
|                      |site**            |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |
|                      |                  |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |
|                      |                  |Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|
|                      |                  |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications**|**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |
|                      |                  |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications**|**0**         |**3**         |**6**         |**6**         |**9**         |**12**        |**12**        |**18**        |**24**        |**36**        |**48**        |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Particle size         |Basically         |D90: 8.027μm  |/             |D90: 7.559μm  |D90: 7.559μm  |              |              |              |              |              |              |              |
|                      |consistent with   |              |              |              |              |              |              |              |              |              |              |              |
|                      |the results of 0  |              |              |              |              |              |              |              |              |              |              |              |
|                      |month             |              |              |              |              |              |              |              |              |              |              |              |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 527 of 542 





Page 528
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**Accelerated stability studies** 



Table 3.2.S.7.3-4 Accelerated Stability Data of Finerenone (Batch No. 231201) 










----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|**Primary package**   |**Primary         |double-layered|double-layered|double-layered|**Storage     |**Storage     |**Storage     |40℃±2℃/       |40℃±2℃/       |40℃±2℃/       |40℃±2℃/       |40℃±2℃/       |
|                      |package**         |pharmaceutical|pharmaceutical|pharmaceutical|condition**   |condition**   |condition**   |75%RH±5%RH    |75%RH±5%RH    |75%RH±5%RH    |75%RH±5%RH    |75%RH±5%RH    |
|                      |                  |grade         |grade         |grade         |              |              |              |              |              |              |              |              |
|                      |                  |low-density   |low-density   |low-density   |              |              |              |              |              |              |              |              |
|                      |                  |polyethylene  |polyethylene  |polyethylene  |              |              |              |              |              |              |              |              |
|                      |                  |(LDPE)        |(LDPE)        |(LDPE)        |              |              |              |              |              |              |              |              |
|                      |                  |bag           |bag           |bag           |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing date**|**Manufacturing   |Jan. 06, 2024 |Jan. 06, 2024 |Jan. 06, 2024 |**Stability   |**Stability   |**Stability   |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |
|                      |date**            |              |              |              |starting**    |starting**    |starting**    |2024          |2024          |2024          |2024          |2024          |
|                      |                  |              |              |              |**date**      |**date**      |**date**      |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing site**|**Manufacturing   |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |
|                      |site**            |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |
|                      |                  |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |
|                      |                  |Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|
|                      |                  |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications**|**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |
|                      |                  |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications**|**0**         |**3**         |**6**         |**6**         |**9**         |**12**        |**12**        |**18**        |**24**        |**36**        |**48**        |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Appearance            |White to yellow   |white powder  |white powder  |white powder  |white powder  |              |              |              |              |              |              |              |
|                      |powder.           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-10 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.10%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-12 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-14 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-15 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-16 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-17 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-18 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-19 NMT     |＜0.05%       |＜0.05%       |＜0.05%       |＜0.05%       |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |Other single      |＜0.05%       |＜0.05%       |＜0.05%       |＜0.05%       |              |              |              |              |              |              |              |
|                      |impurities: NMT   |              |              |              |              |              |              |              |              |              |              |              |
|                      |0.10%             |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |Totalimpurity: NMT|＜0.05%       |＜0.05%       |＜0.05%       |＜0.05%       |              |              |              |              |              |              |              |
|                      |1.0%              |              |              |              |              |              |              |              |              |              |              |              |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 528 of 542 





Page 529
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 































-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|**Primary package**   |**Primary          |double-layered|double-layered|double-layered|**Storage     |**Storage     |**Storage     |40℃±2℃/       |40℃±2℃/       |40℃±2℃/       |40℃±2℃/       |40℃±2℃/       |
|                      |package**          |pharmaceutical|pharmaceutical|pharmaceutical|condition**   |condition**   |condition**   |75%RH±5%RH    |75%RH±5%RH    |75%RH±5%RH    |75%RH±5%RH    |75%RH±5%RH    |
|                      |                   |grade         |grade         |grade         |              |              |              |              |              |              |              |              |
|                      |                   |low-density   |low-density   |low-density   |              |              |              |              |              |              |              |              |
|                      |                   |polyethylene  |polyethylene  |polyethylene  |              |              |              |              |              |              |              |              |
|                      |                   |(LDPE)        |(LDPE)        |(LDPE)        |              |              |              |              |              |              |              |              |
|                      |                   |bag           |bag           |bag           |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing date**|**Manufacturing    |Jan. 06, 2024 |Jan. 06, 2024 |Jan. 06, 2024 |**Stability   |**Stability   |**Stability   |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |
|                      |date**             |              |              |              |starting**    |starting**    |starting**    |2024          |2024          |2024          |2024          |2024          |
|                      |                   |              |              |              |**date**      |**date**      |**date**      |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing site**|**Manufacturing    |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |
|                      |site**             |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |
|                      |                   |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |
|                      |                   |Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|
|                      |                   |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications** |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |
|                      |                   |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications** |**0**         |**3**         |**6**         |**6**         |**9**         |**12**        |**12**        |**18**        |**24**        |**36**        |**48**        |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|enantiome rs          |YA2304-20: NMT     |0.03%         |0.03%         |0.04%         |0.04%         |              |              |              |              |              |              |              |
|                      |0.15%              |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Dimethyl sulfate   |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |NMT 75ppm          |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Diethyl sulfate    |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |NMT 75ppm          |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Diisopropyl        |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |sulfate NMT 75 ppm |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Disec-butyl        |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |sulfate NMT 75 ppm |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Sum of             |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |genotoxicimpurities|              |              |              |              |              |              |              |              |              |              |              |
|                      |NMT 250ppm         |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Water                 |NMT 0.5%           |0.05%         |0.1%          |0.04%         |0.04%         |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Microbial limits      |TAMC: NMT 103CFU/g |Complies      |/             |Complies      |Complies      |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Microbial limits      |TYMC: NMT 102CFU/g |Complies      |/             |Complies      |Complies      |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Microbial limits      |Absence            |Complies      |/             |Complies      |Complies      |              |              |              |              |              |              |              |
|                      |ofEscherichia coli |              |              |              |              |              |              |              |              |              |              |              |
|                      |(1g)               |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Assay                 |98.0% to 102.0%    |99.8%         |100.8%        |99.8%         |99.8%         |              |              |              |              |              |              |              |
|                      |(anhydrous         |              |              |              |              |              |              |              |              |              |              |              |
|                      |substance).        |              |              |              |              |              |              |              |              |              |              |              |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 529 of 542 





Page 530
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 


















----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|**Primary package**   |**Primary         |double-layered|double-layered|double-layered|**Storage     |**Storage     |**Storage     |40℃±2℃/       |40℃±2℃/       |40℃±2℃/       |40℃±2℃/       |40℃±2℃/       |
|                      |package**         |pharmaceutical|pharmaceutical|pharmaceutical|condition**   |condition**   |condition**   |75%RH±5%RH    |75%RH±5%RH    |75%RH±5%RH    |75%RH±5%RH    |75%RH±5%RH    |
|                      |                  |grade         |grade         |grade         |              |              |              |              |              |              |              |              |
|                      |                  |low-density   |low-density   |low-density   |              |              |              |              |              |              |              |              |
|                      |                  |polyethylene  |polyethylene  |polyethylene  |              |              |              |              |              |              |              |              |
|                      |                  |(LDPE)        |(LDPE)        |(LDPE)        |              |              |              |              |              |              |              |              |
|                      |                  |bag           |bag           |bag           |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing date**|**Manufacturing   |Jan. 06, 2024 |Jan. 06, 2024 |Jan. 06, 2024 |**Stability   |**Stability   |**Stability   |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |
|                      |date**            |              |              |              |starting**    |starting**    |starting**    |2024          |2024          |2024          |2024          |2024          |
|                      |                  |              |              |              |**date**      |**date**      |**date**      |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing site**|**Manufacturing   |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |
|                      |site**            |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |
|                      |                  |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |
|                      |                  |Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|
|                      |                  |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications**|**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |
|                      |                  |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications**|**0**         |**3**         |**6**         |**6**         |**9**         |**12**        |**12**        |**18**        |**24**        |**36**        |**48**        |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Crystal form XRD      |Basically         |Complies      |/             |Complies      |Complies      |              |              |              |              |              |              |              |
|                      |consistent with   |              |              |              |              |              |              |              |              |              |              |              |
|                      |the results of 0  |              |              |              |              |              |              |              |              |              |              |              |
|                      |month             |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Particle size         |Basically         |D90: 7.712μm  |/             |D90: 6.235μm  |D90: 6.235μm  |              |              |              |              |              |              |              |
|                      |consistent with   |              |              |              |              |              |              |              |              |              |              |              |
|                      |the results of 0  |              |              |              |              |              |              |              |              |              |              |              |
|                      |month             |              |              |              |              |              |              |              |              |              |              |              |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 530 of 542 





Page 531
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Table 3.2.S.7.3-5 Accelerated Stability Data of Finerenone (Batch No. 240101) 










----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|**Primary package**   |**Primary         |double-layered|double-layered|double-layered|**Storage     |**Storage     |**Storage     |40℃±2℃/       |40℃±2℃/       |40℃±2℃/       |40℃±2℃/       |40℃±2℃/       |
|                      |package**         |pharmaceutical|pharmaceutical|pharmaceutical|condition**   |condition**   |condition**   |75%RH±5%RH    |75%RH±5%RH    |75%RH±5%RH    |75%RH±5%RH    |75%RH±5%RH    |
|                      |                  |grade         |grade         |grade         |              |              |              |              |              |              |              |              |
|                      |                  |low-density   |low-density   |low-density   |              |              |              |              |              |              |              |              |
|                      |                  |polyethylene  |polyethylene  |polyethylene  |              |              |              |              |              |              |              |              |
|                      |                  |(LDPE)        |(LDPE)        |(LDPE)        |              |              |              |              |              |              |              |              |
|                      |                  |bag           |bag           |bag           |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing date**|**Manufacturing   |Jan. 19, 2024 |Jan. 19, 2024 |Jan. 19, 2024 |**Stability   |**Stability   |**Stability   |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |
|                      |date**            |              |              |              |starting**    |starting**    |starting**    |2024          |2024          |2024          |2024          |2024          |
|                      |                  |              |              |              |**date**      |**date**      |**date**      |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing site**|**Manufacturing   |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |
|                      |site**            |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |
|                      |                  |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |
|                      |                  |Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|
|                      |                  |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications**|**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |
|                      |                  |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications**|**0**         |**3**         |**6**         |**6**         |**9**         |**12**        |**12**        |**18**        |**24**        |**36**        |**48**        |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Appearance            |White to yellow   |white powder  |white powder  |white powder  |white powder  |              |              |              |              |              |              |              |
|                      |powder.           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-10 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.10%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-12 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-14 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-15 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-16 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-17 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-18 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-19 NMT     |＜0.05%       |＜0.05%       |＜0.05%       |＜0.05%       |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |Other single      |＜0.05%       |＜0.05%       |＜0.05%       |＜0.05%       |              |              |              |              |              |              |              |
|                      |impurities: NMT   |              |              |              |              |              |              |              |              |              |              |              |
|                      |0.10%             |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |Totalimpurity: NMT|＜0.05%       |＜0.05%       |＜0.05%       |＜0.05%       |              |              |              |              |              |              |              |
|                      |1.0%              |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|enantiome rs          |YA2304-20: NMT    |0.03%         |0.03%         |0.05%         |0.05%         |              |              |              |              |              |              |              |
|                      |0.15%             |              |              |              |              |              |              |              |              |              |              |              |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 531 of 542 





Page 532
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 







































-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|**Primary package**   |**Primary          |double-layered|double-layered|double-layered|**Storage     |**Storage     |**Storage     |40℃±2℃/       |40℃±2℃/       |40℃±2℃/       |40℃±2℃/       |40℃±2℃/       |
|                      |package**          |pharmaceutical|pharmaceutical|pharmaceutical|condition**   |condition**   |condition**   |75%RH±5%RH    |75%RH±5%RH    |75%RH±5%RH    |75%RH±5%RH    |75%RH±5%RH    |
|                      |                   |grade         |grade         |grade         |              |              |              |              |              |              |              |              |
|                      |                   |low-density   |low-density   |low-density   |              |              |              |              |              |              |              |              |
|                      |                   |polyethylene  |polyethylene  |polyethylene  |              |              |              |              |              |              |              |              |
|                      |                   |(LDPE)        |(LDPE)        |(LDPE)        |              |              |              |              |              |              |              |              |
|                      |                   |bag           |bag           |bag           |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing date**|**Manufacturing    |Jan. 19, 2024 |Jan. 19, 2024 |Jan. 19, 2024 |**Stability   |**Stability   |**Stability   |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |
|                      |date**             |              |              |              |starting**    |starting**    |starting**    |2024          |2024          |2024          |2024          |2024          |
|                      |                   |              |              |              |**date**      |**date**      |**date**      |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing site**|**Manufacturing    |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |
|                      |site**             |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |
|                      |                   |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |
|                      |                   |Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|
|                      |                   |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications** |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |
|                      |                   |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications** |**0**         |**3**         |**6**         |**6**         |**9**         |**12**        |**12**        |**18**        |**24**        |**36**        |**48**        |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Dimethyl sulfate   |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |NMT 75ppm          |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Diethyl sulfate    |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |NMT 75ppm          |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Diisopropyl        |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |sulfate NMT 75 ppm |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Disec-butyl        |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |sulfate NMT 75 ppm |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Sum of             |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |genotoxicimpurities|              |              |              |              |              |              |              |              |              |              |              |
|                      |NMT 250ppm         |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Water                 |NMT 0.5%           |0.05%         |0.1%          |0.04%         |0.04%         |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Microbial limits      |TAMC: NMT 103CFU/g |Complies      |/             |Complies      |Complies      |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Microbial limits      |TYMC: NMT 102CFU/g |Complies      |/             |Complies      |Complies      |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Microbial limits      |Absence            |Complies      |/             |Complies      |Complies      |              |              |              |              |              |              |              |
|                      |ofEscherichia coli |              |              |              |              |              |              |              |              |              |              |              |
|                      |(1g)               |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Assay                 |98.0% to 102.0%    |99.8%         |100.6%        |99.6%         |99.6%         |              |              |              |              |              |              |              |
|                      |(anhydrous         |              |              |              |              |              |              |              |              |              |              |              |
|                      |substance).        |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Crystal form XRD      |Basically          |Complies      |/             |Complies      |Complies      |              |              |              |              |              |              |              |
|                      |consistent with the|              |              |              |              |              |              |              |              |              |              |              |
|                      |results of 0 month |              |              |              |              |              |              |              |              |              |              |              |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 532 of 542 





Page 533
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 















----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|**Primary package**   |**Primary         |double-layered|double-layered|double-layered|**Storage     |**Storage     |**Storage     |40℃±2℃/       |40℃±2℃/       |40℃±2℃/       |40℃±2℃/       |40℃±2℃/       |
|                      |package**         |pharmaceutical|pharmaceutical|pharmaceutical|condition**   |condition**   |condition**   |75%RH±5%RH    |75%RH±5%RH    |75%RH±5%RH    |75%RH±5%RH    |75%RH±5%RH    |
|                      |                  |grade         |grade         |grade         |              |              |              |              |              |              |              |              |
|                      |                  |low-density   |low-density   |low-density   |              |              |              |              |              |              |              |              |
|                      |                  |polyethylene  |polyethylene  |polyethylene  |              |              |              |              |              |              |              |              |
|                      |                  |(LDPE)        |(LDPE)        |(LDPE)        |              |              |              |              |              |              |              |              |
|                      |                  |bag           |bag           |bag           |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing date**|**Manufacturing   |Jan. 19, 2024 |Jan. 19, 2024 |Jan. 19, 2024 |**Stability   |**Stability   |**Stability   |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |
|                      |date**            |              |              |              |starting**    |starting**    |starting**    |2024          |2024          |2024          |2024          |2024          |
|                      |                  |              |              |              |**date**      |**date**      |**date**      |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing site**|**Manufacturing   |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |
|                      |site**            |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |
|                      |                  |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |
|                      |                  |Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|
|                      |                  |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications**|**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |
|                      |                  |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications**|**0**         |**3**         |**6**         |**6**         |**9**         |**12**        |**12**        |**18**        |**24**        |**36**        |**48**        |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Particle size         |Basically         |D90: 7.833μm  |/             |D90: 7.227μm  |D90: 7.227μm  |              |              |              |              |              |              |              |
|                      |consistent with   |              |              |              |              |              |              |              |              |              |              |              |
|                      |the results of 0  |              |              |              |              |              |              |              |              |              |              |              |
|                      |month             |              |              |              |              |              |              |              |              |              |              |              |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 533 of 542 





Page 534
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Table 3.2.S.7.3-6 Accelerated Stability Data of Finerenone (Batch No. 240102) 










----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|**Primary package**   |**Primary         |double-layered|double-layered|double-layered|**Storage     |**Storage     |**Storage     |40℃±2℃/       |40℃±2℃/       |40℃±2℃/       |40℃±2℃/       |40℃±2℃/       |
|                      |package**         |pharmaceutical|pharmaceutical|pharmaceutical|condition**   |condition**   |condition**   |75%RH±5%RH    |75%RH±5%RH    |75%RH±5%RH    |75%RH±5%RH    |75%RH±5%RH    |
|                      |                  |grade         |grade         |grade         |              |              |              |              |              |              |              |              |
|                      |                  |low-density   |low-density   |low-density   |              |              |              |              |              |              |              |              |
|                      |                  |polyethylene  |polyethylene  |polyethylene  |              |              |              |              |              |              |              |              |
|                      |                  |(LDPE)        |(LDPE)        |(LDPE)        |              |              |              |              |              |              |              |              |
|                      |                  |bag           |bag           |bag           |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing date**|**Manufacturing   |Jan. 30, 2024 |Jan. 30, 2024 |Jan. 30, 2024 |**Stability   |**Stability   |**Stability   |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |
|                      |date**            |              |              |              |starting**    |starting**    |starting**    |2024          |2024          |2024          |2024          |2024          |
|                      |                  |              |              |              |**date**      |**date**      |**date**      |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing site**|**Manufacturing   |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |
|                      |site**            |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |
|                      |                  |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |
|                      |                  |Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|
|                      |                  |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications**|**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |
|                      |                  |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications**|**0**         |**3**         |**6**         |**6**         |**9**         |**12**        |**12**        |**18**        |**24**        |**36**        |**48**        |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Appearance            |White to yellow   |white powder  |white powder  |white powder  |white powder  |              |              |              |              |              |              |              |
|                      |powder.           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-10 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.10%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-12 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-14 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-15 NMT     |＜0.05%       |＜0.05%       |＜0.05%       |＜0.05%       |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-16 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-17 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-18 NMT     |ND            |ND            |ND            |ND            |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |YA2304-19 NMT     |＜0.05%       |＜0.05%       |＜0.05%       |＜0.05%       |              |              |              |              |              |              |              |
|                      |0.15%；           |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |Other single      |＜0.05%       |＜0.05%       |＜0.05%       |＜0.05%       |              |              |              |              |              |              |              |
|                      |impurities: NMT   |              |              |              |              |              |              |              |              |              |              |              |
|                      |0.10%             |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Related substances    |Totalimpurity: NMT|＜0.05%       |＜0.05%       |＜0.05%       |＜0.05%       |              |              |              |              |              |              |              |
|                      |1.0%              |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|enantiome rs          |YA2304-20: NMT    |0.02%         |0.01%         |0.02%         |0.02%         |              |              |              |              |              |              |              |
|                      |0.15%             |              |              |              |              |              |              |              |              |              |              |              |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 534 of 542 





Page 535
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 







































-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|**Primary package**   |**Primary          |double-layered|double-layered|double-layered|**Storage     |**Storage     |**Storage     |40℃±2℃/       |40℃±2℃/       |40℃±2℃/       |40℃±2℃/       |40℃±2℃/       |
|                      |package**          |pharmaceutical|pharmaceutical|pharmaceutical|condition**   |condition**   |condition**   |75%RH±5%RH    |75%RH±5%RH    |75%RH±5%RH    |75%RH±5%RH    |75%RH±5%RH    |
|                      |                   |grade         |grade         |grade         |              |              |              |              |              |              |              |              |
|                      |                   |low-density   |low-density   |low-density   |              |              |              |              |              |              |              |              |
|                      |                   |polyethylene  |polyethylene  |polyethylene  |              |              |              |              |              |              |              |              |
|                      |                   |(LDPE)        |(LDPE)        |(LDPE)        |              |              |              |              |              |              |              |              |
|                      |                   |bag           |bag           |bag           |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing date**|**Manufacturing    |Jan. 30, 2024 |Jan. 30, 2024 |Jan. 30, 2024 |**Stability   |**Stability   |**Stability   |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |
|                      |date**             |              |              |              |starting**    |starting**    |starting**    |2024          |2024          |2024          |2024          |2024          |
|                      |                   |              |              |              |**date**      |**date**      |**date**      |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing site**|**Manufacturing    |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |
|                      |site**             |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |
|                      |                   |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |
|                      |                   |Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|
|                      |                   |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications** |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |
|                      |                   |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications** |**0**         |**3**         |**6**         |**6**         |**9**         |**12**        |**12**        |**18**        |**24**        |**36**        |**48**        |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Dimethyl sulfate   |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |NMT 75ppm          |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Diethyl sulfate    |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |NMT 75ppm          |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Diisopropyl        |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |sulfate NMT 75 ppm |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Disec-butyl        |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |sulfate NMT 75 ppm |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|genotoxicimpurities   |Sum of             |ND            |/             |ND            |ND            |              |              |              |              |              |              |              |
|                      |genotoxicimpurities|              |              |              |              |              |              |              |              |              |              |              |
|                      |NMT 250ppm         |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Water                 |NMT 0.5%           |0.2%          |0.1%          |0.05%         |0.05%         |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Microbial limits      |TAMC: NMT 103CFU/g |Complies      |/             |Complies      |Complies      |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Microbial limits      |TYMC: NMT 102CFU/g |Complies      |/             |Complies      |Complies      |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Microbial limits      |Absence            |Complies      |/             |Complies      |Complies      |              |              |              |              |              |              |              |
|                      |ofEscherichia coli |              |              |              |              |              |              |              |              |              |              |              |
|                      |(1g)               |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Assay                 |98.0% to 102.0%    |99.7%         |100.7%        |101.1%        |101.1%        |              |              |              |              |              |              |              |
|                      |(anhydrous         |              |              |              |              |              |              |              |              |              |              |              |
|                      |substance).        |              |              |              |              |              |              |              |              |              |              |              |
|----------------------|-------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Crystal form XRD      |Basically          |Complies      |/             |Complies      |Complies      |              |              |              |              |              |              |              |
|                      |consistent with the|              |              |              |              |              |              |              |              |              |              |              |
|                      |results of 0 month |              |              |              |              |              |              |              |              |              |              |              |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 535 of 542 





Page 536
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 















----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|**Primary package**   |**Primary         |double-layered|double-layered|double-layered|**Storage     |**Storage     |**Storage     |40℃±2℃/       |40℃±2℃/       |40℃±2℃/       |40℃±2℃/       |40℃±2℃/       |
|                      |package**         |pharmaceutical|pharmaceutical|pharmaceutical|condition**   |condition**   |condition**   |75%RH±5%RH    |75%RH±5%RH    |75%RH±5%RH    |75%RH±5%RH    |75%RH±5%RH    |
|                      |                  |grade         |grade         |grade         |              |              |              |              |              |              |              |              |
|                      |                  |low-density   |low-density   |low-density   |              |              |              |              |              |              |              |              |
|                      |                  |polyethylene  |polyethylene  |polyethylene  |              |              |              |              |              |              |              |              |
|                      |                  |(LDPE)        |(LDPE)        |(LDPE)        |              |              |              |              |              |              |              |              |
|                      |                  |bag           |bag           |bag           |              |              |              |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing date**|**Manufacturing   |Jan. 30, 2024 |Jan. 30, 2024 |Jan. 30, 2024 |**Stability   |**Stability   |**Stability   |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |Feb. 04,      |
|                      |date**            |              |              |              |starting**    |starting**    |starting**    |2024          |2024          |2024          |2024          |2024          |
|                      |                  |              |              |              |**date**      |**date**      |**date**      |              |              |              |              |              |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Manufacturing site**|**Manufacturing   |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |API (II)      |
|                      |site**            |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |Workshop,     |
|                      |                  |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |Hinye         |
|                      |                  |Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|Pharmaceutical|
|                      |                  |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |Co., Ltd.     |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications**|**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |**Time points |
|                      |                  |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |(Months)**    |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|**Items**             |**Specifications**|**0**         |**3**         |**6**         |**6**         |**9**         |**12**        |**12**        |**18**        |**24**        |**36**        |**48**        |
|----------------------|------------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|--------------|
|Particle size         |Basically         |D90: 8.027μm  |/             |D90: 7.246μm  |D90: 7.246μm  |              |              |              |              |              |              |              |
|                      |consistent with   |              |              |              |              |              |              |              |              |              |              |              |
|                      |the results of 0  |              |              |              |              |              |              |              |              |              |              |              |
|                      |month             |              |              |              |              |              |              |              |              |              |              |              |
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 536 of 542 





Page 537
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



**Stress testing** 



Table 3.2.S.7.3-7 High Temperature Stress Test Data of Finerenone (Batch No. 231201) 



















---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|**Manufacturing date**   |**Manufacturing date**            |Jan. 06,          |Jan.            |**Stability     |**Stability     |**Stability     |Feb.            |Feb.            |
|                         |                                  |2024              |06,             |starting        |starting        |starting        |26,             |26,             |
|                         |                                  |                  |2024            |date**          |date**          |date**          |2024            |2024            |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|**Degradation condition**|**Degradation condition**         |High              |High            |High            |High            |High            |High            |High            |
|                         |                                  |temperature       |temperature     |temperature     |temperature     |temperature     |temperature     |temperature     |
|                         |                                  |60℃:              |60℃:            |60℃: place      |60℃: place      |60℃: place      |60℃:            |60℃:            |
|                         |                                  |place             |place           |appropriate     |appropriate     |appropriate     |place           |place           |
|                         |                                  |appropriate       |appropriate     |amount of       |amount of       |amount of       |appropriate     |appropriate     |
|                         |                                  |amount of         |amount          |substance       |substance       |substance       |amount          |amount          |
|                         |                                  |substance         |of              |without         |without         |without         |of              |of              |
|                         |                                  |without           |substance       |package         |package         |package         |substance       |substance       |
|                         |                                  |package           |without         |intoa           |intoa           |intoa           |without         |without         |
|                         |                                  |intoa             |package         |containerevenly,|containerevenly,|containerevenly,|package         |package         |
|                         |                                  |containerevenly,  |intoa           |the             |the             |the             |intoa           |intoa           |
|                         |                                  |the               |containerevenly,|thickness       |thickness       |thickness       |containerevenly,|containerevenly,|
|                         |                                  |thickness         |the             |of              |of              |of              |the             |the             |
|                         |                                  |of                |thickness       |substance       |substance       |substance       |thickness       |thickness       |
|                         |                                  |substance         |of              |is 3 ~ 5        |is 3 ~ 5        |is 3 ~ 5        |of              |of              |
|                         |                                  |is 3 ~ 5          |substance       |mm. Store       |mm. Store       |mm. Store       |substance       |substance       |
|                         |                                  |mm. Store         |is 3 ~          |the culture     |the culture     |the culture     |is 3 ~          |is 3 ~          |
|                         |                                  |the               |5 mm.           |dishinto        |dishinto        |dishinto        |5 mm.           |5 mm.           |
|                         |                                  |culture           |Store           |constant        |constant        |constant        |Store           |Store           |
|                         |                                  |dishinto          |the             |temperature     |temperature     |temperature     |the             |the             |
|                         |                                  |constant          |culture         |oven at         |oven at         |oven at         |culture         |culture         |
|                         |                                  |temperature       |dishinto        |60℃.            |60℃.            |60℃.            |dishinto        |dishinto        |
|                         |                                  |oven at           |constant        |                |                |                |constant        |constant        |
|                         |                                  |60℃.              |temperature     |                |                |                |temperature     |temperature     |
|                         |                                  |                  |oven at         |                |                |                |oven at         |oven at         |
|                         |                                  |                  |60℃.            |                |                |                |60℃.            |60℃.            |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|**Items**                |**Specifications**                |**Specifications**|**Time points** |**Time points** |**Time points** |**Time points** |**Time points** |**Time points** |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|**Items**                |**Specifications**                |**Specifications**|**0d**          |**0d**          |**5d**          |**15d**         |**15d**         |**30d**         |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Appearance               |White to yellow powder.           |White to yellow   |White powder    |White powder    |Off White powder|Yellowish powder|Yellowish powder|Yellowish powder|
|                         |                                  |powder.           |                |                |                |                |                |                |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Related substances       |YA2304-10 NMT 0.10%；             |YA2304-10 NMT     |ND              |ND              |ND              |ND              |ND              |ND              |
|                         |                                  |0.10%；           |                |                |                |                |                |                |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Related substances       |YA2304-12 NMT 0.15%；             |YA2304-12 NMT     |ND              |ND              |＜0.05%         |＜0.05%         |＜0.05%         |＜0.05%         |
|                         |                                  |0.15%；           |                |                |                |                |                |                |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Related substances       |YA2304-14 NMT 0.15%；             |YA2304-14 NMT     |ND              |ND              |＜0.05%         |＜0.05%         |＜0.05%         |＜0.05%         |
|                         |                                  |0.15%；           |                |                |                |                |                |                |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Related substances       |YA2304-15 NMT 0.15%；             |YA2304-15 NMT     |ND              |ND              |ND              |ND              |ND              |ND              |
|                         |                                  |0.15%；           |                |                |                |                |                |                |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Related substances       |YA2304-16 NMT 0.15%；             |YA2304-16 NMT     |ND              |ND              |ND              |ND              |ND              |0.05%           |
|                         |                                  |0.15%；           |                |                |                |                |                |                |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Related substances       |YA2304-17 NMT 0.15%；             |YA2304-17 NMT     |ND              |ND              |ND              |ND              |ND              |ND              |
|                         |                                  |0.15%；           |                |                |                |                |                |                |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Related substances       |YA2304-18 NMT 0.15%；             |YA2304-18 NMT     |ND              |ND              |ND              |ND              |ND              |＜0.05%         |
|                         |                                  |0.15%；           |                |                |                |                |                |                |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Related substances       |YA2304-19 NMT 0.15%；             |YA2304-19 NMT     |＜0.05%         |＜0.05%         |＜0.05%         |0.07%           |0.07%           |0.11%           |
|                         |                                  |0.15%；           |                |                |                |                |                |                |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Related substances       |Other single impurities: NMT 0.10%|Other single      |＜0.05%         |＜0.05%         |＜0.05%         |＜0.05%         |＜0.05%         |0.06%           |
|                         |                                  |impurities: NMT   |                |                |                |                |                |                |
|                         |                                  |0.10%             |                |                |                |                |                |                |
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 537 of 542 





Page 538
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 


















-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|**Manufacturing date**   |**Manufacturing date**              |Jan.              |Jan.            |**Stability     |**Stability     |**Stability     |Feb.            |Feb.            |
|                         |                                    |06,               |06,             |starting        |starting        |starting        |26,             |26,             |
|                         |                                    |2024              |2024            |date**          |date**          |date**          |2024            |2024            |
|-------------------------|------------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|**Degradation condition**|**Degradation condition**           |High              |High            |High            |High            |High            |High            |High            |
|                         |                                    |temperature       |temperature     |temperature     |temperature     |temperature     |temperature     |temperature     |
|                         |                                    |60℃:              |60℃:            |60℃: place      |60℃: place      |60℃: place      |60℃:            |60℃:            |
|                         |                                    |place             |place           |appropriate     |appropriate     |appropriate     |place           |place           |
|                         |                                    |appropriate       |appropriate     |amount of       |amount of       |amount of       |appropriate     |appropriate     |
|                         |                                    |amount            |amount          |substance       |substance       |substance       |amount          |amount          |
|                         |                                    |of                |of              |without         |without         |without         |of              |of              |
|                         |                                    |substance         |substance       |package         |package         |package         |substance       |substance       |
|                         |                                    |without           |without         |intoa           |intoa           |intoa           |without         |without         |
|                         |                                    |package           |package         |containerevenly,|containerevenly,|containerevenly,|package         |package         |
|                         |                                    |intoa             |intoa           |the             |the             |the             |intoa           |intoa           |
|                         |                                    |containerevenly,  |containerevenly,|thickness       |thickness       |thickness       |containerevenly,|containerevenly,|
|                         |                                    |the               |the             |of              |of              |of              |the             |the             |
|                         |                                    |thickness         |thickness       |substance       |substance       |substance       |thickness       |thickness       |
|                         |                                    |of                |of              |is 3 ~ 5        |is 3 ~ 5        |is 3 ~ 5        |of              |of              |
|                         |                                    |substance         |substance       |mm. Store       |mm. Store       |mm. Store       |substance       |substance       |
|                         |                                    |is 3 ~            |is 3 ~          |the culture     |the culture     |the culture     |is 3 ~          |is 3 ~          |
|                         |                                    |5 mm.             |5 mm.           |dishinto        |dishinto        |dishinto        |5 mm.           |5 mm.           |
|                         |                                    |Store             |Store           |constant        |constant        |constant        |Store           |Store           |
|                         |                                    |the               |the             |temperature     |temperature     |temperature     |the             |the             |
|                         |                                    |culture           |culture         |oven at         |oven at         |oven at         |culture         |culture         |
|                         |                                    |dishinto          |dishinto        |60℃.            |60℃.            |60℃.            |dishinto        |dishinto        |
|                         |                                    |constant          |constant        |                |                |                |constant        |constant        |
|                         |                                    |temperature       |temperature     |                |                |                |temperature     |temperature     |
|                         |                                    |oven at           |oven at         |                |                |                |oven at         |oven at         |
|                         |                                    |60℃.              |60℃.            |                |                |                |60℃.            |60℃.            |
|-------------------------|------------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|**Items**                |**Specifications**                  |**Specifications**|**Time points** |**Time points** |**Time points** |**Time points** |**Time points** |**Time points** |
|-------------------------|------------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|**Items**                |**Specifications**                  |**Specifications**|**0d**          |**0d**          |**5d**          |**15d**         |**15d**         |**30d**         |
|-------------------------|------------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Totalimpurity: NMT 1.0%  |Totalimpurity: NMT 1.0%             |＜0.05%           |＜0.05%         |＜0.05%         |0.11%           |0.11%           |0.22%           |                |
|-------------------------|------------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Enantiomers              |YA2304-20: NMT 0.15%                |YA2304-20: NMT    |0.03%           |0.03%           |ND              |ND              |ND              |ND              |
|                         |                                    |0.15%             |                |                |                |                |                |                |
|-------------------------|------------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Water                    |NMT 0.5%                            |NMT 0.5%          |0.05%           |0.05%           |0.03%           |0.05%           |0.05%           |0.06%           |
|-------------------------|------------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Assay                    |98.0% to 102.0% (anhydrous          |98.0% to 102.0%   |99.8%           |99.8%           |100.2%          |99.9%           |99.9%           |99.9%           |
|                         |substance).                         |(anhydrous        |                |                |                |                |                |                |
|                         |                                    |substance).       |                |                |                |                |                |                |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 538 of 542 





Page 539
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Table 3.2.S.7.3-8 High Humidity Stress Test Data of Finerenone (Batch No. 231201) 

























---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|**Manufacturing date**   |**Manufacturing date**            |Jan. 06,          |Jan.            |**Stability     |**Stability     |**Stability     |Feb.            |Feb.            |
|                         |                                  |2024              |06,             |starting        |starting        |starting        |24,             |24,             |
|                         |                                  |                  |2024            |date**          |date**          |date**          |2024            |2024            |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|**Degradation condition**|**Degradation condition**         |High              |High            |High            |High            |High            |High            |High            |
|                         |                                  |humidity          |humidity        |humidity        |humidity        |humidity        |humidity        |humidity        |
|                         |                                  |92.5%RH:          |92.5%RH:        |92.5%RH:        |92.5%RH:        |92.5%RH:        |92.5%RH:        |92.5%RH:        |
|                         |                                  |place             |place           |place           |place           |place           |place           |place           |
|                         |                                  |appropriate       |appropriate     |appropriate     |appropriate     |appropriate     |appropriate     |appropriate     |
|                         |                                  |amount of         |amount          |amount of       |amount of       |amount of       |amount          |amount          |
|                         |                                  |substance         |of              |substance       |substance       |substance       |of              |of              |
|                         |                                  |without           |substance       |without         |without         |without         |substance       |substance       |
|                         |                                  |package           |without         |package         |package         |package         |without         |without         |
|                         |                                  |intoa             |package         |intoa           |intoa           |intoa           |package         |package         |
|                         |                                  |containerevenly,  |intoa           |containerevenly,|containerevenly,|containerevenly,|intoa           |intoa           |
|                         |                                  |the               |containerevenly,|the             |the             |the             |containerevenly,|containerevenly,|
|                         |                                  |thickness         |the             |thickness       |thickness       |thickness       |the             |the             |
|                         |                                  |of                |thickness       |of              |of              |of              |thickness       |thickness       |
|                         |                                  |substance         |of              |substance       |substance       |substance       |of              |of              |
|                         |                                  |is 3 ~ 5          |substance       |is 3 ~ 5        |is 3 ~ 5        |is 3 ~ 5        |substance       |substance       |
|                         |                                  |mm. Store         |is 3 ~          |mm. Store       |mm. Store       |mm. Store       |is 3 ~          |is 3 ~          |
|                         |                                  |the               |5 mm.           |the culture     |the culture     |the culture     |5 mm.           |5 mm.           |
|                         |                                  |culture           |Store           |dish at         |dish at         |dish at         |Store           |Store           |
|                         |                                  |dish at           |the             |condition       |condition       |condition       |the             |the             |
|                         |                                  |condition         |culture         |92.5%RH,        |92.5%RH,        |92.5%RH,        |culture         |culture         |
|                         |                                  |92.5%RH,          |dish at         |25℃.            |25℃.            |25℃.            |dish at         |dish at         |
|                         |                                  |25℃.              |condition       |                |                |                |condition       |condition       |
|                         |                                  |                  |92.5%RH,        |                |                |                |92.5%RH,        |92.5%RH,        |
|                         |                                  |                  |25℃.            |                |                |                |25℃.            |25℃.            |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|**Items**                |**Specifications**                |**Specifications**|**Time points** |**Time points** |**Time points** |**Time points** |**Time points** |**Time points** |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|**Items**                |**Specifications**                |**Specifications**|**0d**          |**0d**          |**5d**          |**15d**         |**15d**         |**30d**         |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Appearance               |White to yellow powder.           |White to yellow   |White powder    |White powder    |White powder    |White powder    |White powder    |White powder    |
|                         |                                  |powder.           |                |                |                |                |                |                |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Related substances       |YA2304-10 NMT 0.10%；             |YA2304-10 NMT     |ND              |ND              |ND              |ND              |ND              |ND              |
|                         |                                  |0.10%；           |                |                |                |                |                |                |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Related substances       |YA2304-12 NMT 0.15%；             |YA2304-12 NMT     |ND              |ND              |＜0.05%         |＜0.05%         |＜0.05%         |＜0.05%         |
|                         |                                  |0.15%；           |                |                |                |                |                |                |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Related substances       |YA2304-14 NMT 0.15%；             |YA2304-14 NMT     |ND              |ND              |ND              |＜0.05%         |＜0.05%         |ND              |
|                         |                                  |0.15%；           |                |                |                |                |                |                |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Related substances       |YA2304-15 NMT 0.15%；             |YA2304-15 NMT     |ND              |ND              |＜0.05%         |＜0.05%         |＜0.05%         |＜0.05%         |
|                         |                                  |0.15%；           |                |                |                |                |                |                |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Related substances       |YA2304-16 NMT 0.15%；             |YA2304-16 NMT     |ND              |ND              |ND              |ND              |ND              |ND              |
|                         |                                  |0.15%；           |                |                |                |                |                |                |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Related substances       |YA2304-17 NMT 0.15%；             |YA2304-17 NMT     |ND              |ND              |ND              |ND              |ND              |ND              |
|                         |                                  |0.15%；           |                |                |                |                |                |                |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Related substances       |YA2304-18 NMT 0.15%；             |YA2304-18 NMT     |ND              |ND              |ND              |ND              |ND              |ND              |
|                         |                                  |0.15%；           |                |                |                |                |                |                |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Related substances       |YA2304-19 NMT 0.15%；             |YA2304-19 NMT     |＜0.05%         |＜0.05%         |＜0.05%         |＜0.05%         |＜0.05%         |＜0.05%         |
|                         |                                  |0.15%；           |                |                |                |                |                |                |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Related substances       |Other single impurities: NMT 0.10%|Other single      |＜0.05%         |＜0.05%         |＜0.05%         |＜0.05%         |＜0.05%         |＜0.05%         |
|                         |                                  |impurities: NMT   |                |                |                |                |                |                |
|                         |                                  |0.10%             |                |                |                |                |                |                |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Related substances       |Totalimpurity: NMT 1.0%           |Totalimpurity: NMT|＜0.05%         |＜0.05%         |＜0.05%         |＜0.05%         |＜0.05%         |＜0.05%         |
|                         |                                  |1.0%              |                |                |                |                |                |                |
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 539 of 542 





Page 540
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 






















-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|**Manufacturing date**   |**Manufacturing date**              |Jan.              |Jan.            |**Stability     |**Stability     |**Stability     |Feb.            |Feb.            |
|                         |                                    |06,               |06,             |starting        |starting        |starting        |24,             |24,             |
|                         |                                    |2024              |2024            |date**          |date**          |date**          |2024            |2024            |
|-------------------------|------------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|**Degradation condition**|**Degradation condition**           |High              |High            |High            |High            |High            |High            |High            |
|                         |                                    |humidity          |humidity        |humidity        |humidity        |humidity        |humidity        |humidity        |
|                         |                                    |92.5%RH:          |92.5%RH:        |92.5%RH:        |92.5%RH:        |92.5%RH:        |92.5%RH:        |92.5%RH:        |
|                         |                                    |place             |place           |place           |place           |place           |place           |place           |
|                         |                                    |appropriate       |appropriate     |appropriate     |appropriate     |appropriate     |appropriate     |appropriate     |
|                         |                                    |amount            |amount          |amount of       |amount of       |amount of       |amount          |amount          |
|                         |                                    |of                |of              |substance       |substance       |substance       |of              |of              |
|                         |                                    |substance         |substance       |without         |without         |without         |substance       |substance       |
|                         |                                    |without           |without         |package         |package         |package         |without         |without         |
|                         |                                    |package           |package         |intoa           |intoa           |intoa           |package         |package         |
|                         |                                    |intoa             |intoa           |containerevenly,|containerevenly,|containerevenly,|intoa           |intoa           |
|                         |                                    |containerevenly,  |containerevenly,|the             |the             |the             |containerevenly,|containerevenly,|
|                         |                                    |the               |the             |thickness       |thickness       |thickness       |the             |the             |
|                         |                                    |thickness         |thickness       |of              |of              |of              |thickness       |thickness       |
|                         |                                    |of                |of              |substance       |substance       |substance       |of              |of              |
|                         |                                    |substance         |substance       |is 3 ~ 5        |is 3 ~ 5        |is 3 ~ 5        |substance       |substance       |
|                         |                                    |is 3 ~            |is 3 ~          |mm. Store       |mm. Store       |mm. Store       |is 3 ~          |is 3 ~          |
|                         |                                    |5 mm.             |5 mm.           |the culture     |the culture     |the culture     |5 mm.           |5 mm.           |
|                         |                                    |Store             |Store           |dish at         |dish at         |dish at         |Store           |Store           |
|                         |                                    |the               |the             |condition       |condition       |condition       |the             |the             |
|                         |                                    |culture           |culture         |92.5%RH,        |92.5%RH,        |92.5%RH,        |culture         |culture         |
|                         |                                    |dish at           |dish at         |25℃.            |25℃.            |25℃.            |dish at         |dish at         |
|                         |                                    |condition         |condition       |                |                |                |condition       |condition       |
|                         |                                    |92.5%RH,          |92.5%RH,        |                |                |                |92.5%RH,        |92.5%RH,        |
|                         |                                    |25℃.              |25℃.            |                |                |                |25℃.            |25℃.            |
|-------------------------|------------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|**Items**                |**Specifications**                  |**Specifications**|**Time points** |**Time points** |**Time points** |**Time points** |**Time points** |**Time points** |
|-------------------------|------------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|**Items**                |**Specifications**                  |**Specifications**|**0d**          |**0d**          |**5d**          |**15d**         |**15d**         |**30d**         |
|-------------------------|------------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Enantiomers              |YA2304-20: NMT 0.15%                |YA2304-20: NMT    |0.03%           |0.03%           |0.02%           |0.02%           |0.02%           |0.02%           |
|                         |                                    |0.15%             |                |                |                |                |                |                |
|-------------------------|------------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Water                    |NMT 0.5%                            |NMT 0.5%          |0.05%           |0.05%           |0.03%           |0.03%           |0.03%           |0.03%           |
|-------------------------|------------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Assay                    |98.0% to 102.0% (anhydrous          |98.0% to 102.0%   |99.8%           |99.8%           |100.0%          |100.3%          |100.3%          |100.0%          |
|                         |substance).                         |(anhydrous        |                |                |                |                |                |                |
|                         |                                    |substance).       |                |                |                |                |                |                |
|-------------------------|------------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Hygroscopic gain (%)     |NMT 5%                              |NMT 5%            |/               |/               |0.04%           |0.02%           |0.02%           |0.05%           |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 540 of 542 





Page 541
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 



Table 3.2.S.7.3-9 Photostability Data of Finerenone (Batch No. 231201) 



















---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|**Manufacturing date**   |**Manufacturing date**            |Jan. 04,          |Jan.            |**Stability     |**Stability     |**Stability     |Feb.            |Feb.            |
|                         |                                  |2024              |04,             |starting        |starting        |starting        |24,             |24,             |
|                         |                                  |                  |2024            |date**          |date**          |date**          |2024            |2024            |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|**Degradation condition**|**Degradation condition**         |Illumination      |Illumination    |Illumination    |Illumination    |Illumination    |Illumination    |Illumination    |
|                         |                                  |(visible          |(visible        |(visible        |(visible        |(visible        |(visible        |(visible        |
|                         |                                  |light:            |light:          |light: 4500     |light: 4500     |light: 4500     |light:          |light:          |
|                         |                                  |4500 ±            |4500 ±          |± 500 LX;       |± 500 LX;       |± 500 LX;       |4500 ±          |4500 ±          |
|                         |                                  |500 LX;           |500 LX;         |nearultraviolet:|nearultraviolet:|nearultraviolet:|500 LX;         |500 LX;         |
|                         |                                  |nearultraviolet:  |nearultraviolet:|90±5            |90±5            |90±5            |nearultraviolet:|nearultraviolet:|
|                         |                                  |90±5              |90±5            |μW/cm2,         |μW/cm2,         |μW/cm2,         |90±5            |90±5            |
|                         |                                  |μW/cm2,           |μW/cm2,         |25℃): place     |25℃): place     |25℃): place     |μW/cm2,         |μW/cm2,         |
|                         |                                  |25℃):             |25℃):           |appropriate     |appropriate     |appropriate     |25℃):           |25℃):           |
|                         |                                  |place             |place           |amount of       |amount of       |amount of       |place           |place           |
|                         |                                  |appropriate       |appropriate     |substance       |substance       |substance       |appropriate     |appropriate     |
|                         |                                  |amount of         |amount          |without         |without         |without         |amount          |amount          |
|                         |                                  |substance         |of              |package         |package         |package         |of              |of              |
|                         |                                  |without           |substance       |intoa           |intoa           |intoa           |substance       |substance       |
|                         |                                  |package           |without         |containerevenly,|containerevenly,|containerevenly,|without         |without         |
|                         |                                  |intoa             |package         |the             |the             |the             |package         |package         |
|                         |                                  |containerevenly,  |intoa           |thickness       |thickness       |thickness       |intoa           |intoa           |
|                         |                                  |the               |containerevenly,|of              |of              |of              |containerevenly,|containerevenly,|
|                         |                                  |thickness         |the             |substance       |substance       |substance       |the             |the             |
|                         |                                  |of                |thickness       |is 3 ~ 5        |is 3 ~ 5        |is 3 ~ 5        |thickness       |thickness       |
|                         |                                  |substance         |of              |mm. Store       |mm. Store       |mm. Store       |of              |of              |
|                         |                                  |is 3 ~ 5          |substance       |the culture     |the culture     |the culture     |substance       |substance       |
|                         |                                  |mm. Store         |is 3 ~          |dish at         |dish at         |dish at         |is 3 ~          |is 3 ~          |
|                         |                                  |the               |5 mm.           |condition:      |condition:      |condition:      |5 mm.           |5 mm.           |
|                         |                                  |culture           |Store           |visible         |visible         |visible         |Store           |Store           |
|                         |                                  |dish at           |the             |light: 4500     |light: 4500     |light: 4500     |the             |the             |
|                         |                                  |condition:        |culture         |± 500 LX;       |± 500 LX;       |± 500 LX;       |culture         |culture         |
|                         |                                  |visible           |dish at         |nearultraviolet:|nearultraviolet:|nearultraviolet:|dish at         |dish at         |
|                         |                                  |light:            |condition:      |90±5            |90±5            |90±5            |condition:      |condition:      |
|                         |                                  |4500 ±            |visible         |μW/cm2,         |μW/cm2,         |μW/cm2,         |visible         |visible         |
|                         |                                  |500 LX;           |light:          |25℃.            |25℃.            |25℃.            |light:          |light:          |
|                         |                                  |nearultraviolet:  |4500 ±          |                |                |                |4500 ±          |4500 ±          |
|                         |                                  |90±5              |500 LX;         |                |                |                |500 LX;         |500 LX;         |
|                         |                                  |μW/cm2,           |nearultraviolet:|                |                |                |nearultraviolet:|nearultraviolet:|
|                         |                                  |25℃.              |90±5            |                |                |                |90±5            |90±5            |
|                         |                                  |                  |μW/cm2,         |                |                |                |μW/cm2,         |μW/cm2,         |
|                         |                                  |                  |25℃.            |                |                |                |25℃.            |25℃.            |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|**Items**                |**Specifications**                |**Specifications**|**Time points** |**Time points** |**Time points** |**Time points** |**Time points** |**Time points** |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|**Items**                |**Specifications**                |**Specifications**|**0d**          |**0d**          |**5d**          |**15d**         |**15d**         |**30d**         |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Appearance               |White to yellow powder.           |White to yellow   |White powder    |White powder    |Off White powder|Yellowish powder|Yellowish powder|Yellowish powder|
|                         |                                  |powder.           |                |                |                |                |                |                |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Related substances       |YA2304-10 NMT 0.10%；             |YA2304-10 NMT     |ND              |ND              |ND              |ND              |ND              |ND              |
|                         |                                  |0.10%；           |                |                |                |                |                |                |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Related substances       |YA2304-12 NMT 0.15%；             |YA2304-12 NMT     |ND              |ND              |＜0.05%         |＜0.05%         |＜0.05%         |＜0.05%         |
|                         |                                  |0.15%；           |                |                |                |                |                |                |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Related substances       |YA2304-14 NMT 0.15%；             |YA2304-14 NMT     |ND              |ND              |＜0.05%         |＜0.05%         |＜0.05%         |＜0.05%         |
|                         |                                  |0.15%；           |                |                |                |                |                |                |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Related substances       |YA2304-15 NMT 0.15%；             |YA2304-15 NMT     |ND              |ND              |＜0.05%         |＜0.05%         |＜0.05%         |＜0.05%         |
|                         |                                  |0.15%；           |                |                |                |                |                |                |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Related substances       |YA2304-16 NMT 0.15%；             |YA2304-16 NMT     |ND              |ND              |＜0.05%         |＜0.05%         |＜0.05%         |＜0.05%         |
|                         |                                  |0.15%；           |                |                |                |                |                |                |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Related substances       |YA2304-17 NMT 0.15%；             |YA2304-17 NMT     |ND              |ND              |ND              |ND              |ND              |ND              |
|                         |                                  |0.15%；           |                |                |                |                |                |                |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Related substances       |YA2304-18 NMT 0.15%；             |YA2304-18 NMT     |ND              |ND              |ND              |ND              |ND              |ND              |
|                         |                                  |0.15%；           |                |                |                |                |                |                |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Related substances       |YA2304-19 NMT 0.15%；             |YA2304-19 NMT     |＜0.05%         |＜0.05%         |0.06%           |0.14%           |0.14%           |0.12%           |
|                         |                                  |0.15%；           |                |                |                |                |                |                |
|-------------------------|----------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Related substances       |Other single impurities: NMT 0.10%|Other single      |＜0.05%         |＜0.05%         |0.08%           |0.12%           |0.12%           |0.11%           |
|                         |                                  |impurities: NMT   |                |                |                |                |                |                |
|                         |                                  |0.10%             |                |                |                |                |                |                |
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 541 of 542 





Page 542
**Drug Master File of Finerenone** 



Document: YA2304-Quality Version: 001 Date:Sep. 2024 










-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|**Manufacturing date**   |**Manufacturing date**              |Jan.              |Jan.            |**Stability     |**Stability     |**Stability     |Feb.            |Feb.            |
|                         |                                    |04,               |04,             |starting        |starting        |starting        |24,             |24,             |
|                         |                                    |2024              |2024            |date**          |date**          |date**          |2024            |2024            |
|-------------------------|------------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|**Degradation condition**|**Degradation condition**           |Illumination      |Illumination    |Illumination    |Illumination    |Illumination    |Illumination    |Illumination    |
|                         |                                    |(visible          |(visible        |(visible        |(visible        |(visible        |(visible        |(visible        |
|                         |                                    |light:            |light:          |light: 4500     |light: 4500     |light: 4500     |light:          |light:          |
|                         |                                    |4500 ±            |4500 ±          |± 500 LX;       |± 500 LX;       |± 500 LX;       |4500 ±          |4500 ±          |
|                         |                                    |500 LX;           |500 LX;         |nearultraviolet:|nearultraviolet:|nearultraviolet:|500 LX;         |500 LX;         |
|                         |                                    |nearultraviolet:  |nearultraviolet:|90±5            |90±5            |90±5            |nearultraviolet:|nearultraviolet:|
|                         |                                    |90±5              |90±5            |μW/cm2,         |μW/cm2,         |μW/cm2,         |90±5            |90±5            |
|                         |                                    |μW/cm2,           |μW/cm2,         |25℃): place     |25℃): place     |25℃): place     |μW/cm2,         |μW/cm2,         |
|                         |                                    |25℃):             |25℃):           |appropriate     |appropriate     |appropriate     |25℃):           |25℃):           |
|                         |                                    |place             |place           |amount of       |amount of       |amount of       |place           |place           |
|                         |                                    |appropriate       |appropriate     |substance       |substance       |substance       |appropriate     |appropriate     |
|                         |                                    |amount            |amount          |without         |without         |without         |amount          |amount          |
|                         |                                    |of                |of              |package         |package         |package         |of              |of              |
|                         |                                    |substance         |substance       |intoa           |intoa           |intoa           |substance       |substance       |
|                         |                                    |without           |without         |containerevenly,|containerevenly,|containerevenly,|without         |without         |
|                         |                                    |package           |package         |the             |the             |the             |package         |package         |
|                         |                                    |intoa             |intoa           |thickness       |thickness       |thickness       |intoa           |intoa           |
|                         |                                    |containerevenly,  |containerevenly,|of              |of              |of              |containerevenly,|containerevenly,|
|                         |                                    |the               |the             |substance       |substance       |substance       |the             |the             |
|                         |                                    |thickness         |thickness       |is 3 ~ 5        |is 3 ~ 5        |is 3 ~ 5        |thickness       |thickness       |
|                         |                                    |of                |of              |mm. Store       |mm. Store       |mm. Store       |of              |of              |
|                         |                                    |substance         |substance       |the culture     |the culture     |the culture     |substance       |substance       |
|                         |                                    |is 3 ~            |is 3 ~          |dish at         |dish at         |dish at         |is 3 ~          |is 3 ~          |
|                         |                                    |5 mm.             |5 mm.           |condition:      |condition:      |condition:      |5 mm.           |5 mm.           |
|                         |                                    |Store             |Store           |visible         |visible         |visible         |Store           |Store           |
|                         |                                    |the               |the             |light: 4500     |light: 4500     |light: 4500     |the             |the             |
|                         |                                    |culture           |culture         |± 500 LX;       |± 500 LX;       |± 500 LX;       |culture         |culture         |
|                         |                                    |dish at           |dish at         |nearultraviolet:|nearultraviolet:|nearultraviolet:|dish at         |dish at         |
|                         |                                    |condition:        |condition:      |90±5            |90±5            |90±5            |condition:      |condition:      |
|                         |                                    |visible           |visible         |μW/cm2,         |μW/cm2,         |μW/cm2,         |visible         |visible         |
|                         |                                    |light:            |light:          |25℃.            |25℃.            |25℃.            |light:          |light:          |
|                         |                                    |4500 ±            |4500 ±          |                |                |                |4500 ±          |4500 ±          |
|                         |                                    |500 LX;           |500 LX;         |                |                |                |500 LX;         |500 LX;         |
|                         |                                    |nearultraviolet:  |nearultraviolet:|                |                |                |nearultraviolet:|nearultraviolet:|
|                         |                                    |90±5              |90±5            |                |                |                |90±5            |90±5            |
|                         |                                    |μW/cm2,           |μW/cm2,         |                |                |                |μW/cm2,         |μW/cm2,         |
|                         |                                    |25℃.              |25℃.            |                |                |                |25℃.            |25℃.            |
|-------------------------|------------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|**Items**                |**Specifications**                  |**Specifications**|**Time points** |**Time points** |**Time points** |**Time points** |**Time points** |**Time points** |
|-------------------------|------------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|**Items**                |**Specifications**                  |**Specifications**|**0d**          |**0d**          |**5d**          |**15d**         |**15d**         |**30d**         |
|-------------------------|------------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Totalimpurity: NMT 1.0%  |Totalimpurity: NMT 1.0%             |＜0.05%           |＜0.05%         |0.14%           |0.30%           |0.30%           |0.22%           |                |
|-------------------------|------------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Enantiomers              |YA2304-20: NMT 0.15%                |YA2304-20: NMT    |0.03%           |0.03%           |ND              |ND              |ND              |ND              |
|                         |                                    |0.15%             |                |                |                |                |                |                |
|-------------------------|------------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Water                    |NMT 0.5%                            |NMT 0.5%          |0.05%           |0.05%           |0.04%           |0.07%           |0.07%           |0.08%           |
|-------------------------|------------------------------------|------------------|----------------|----------------|----------------|----------------|----------------|----------------|
|Assay                    |98.0% to 102.0% (anhydrous          |98.0% to 102.0%   |99.8%           |99.8%           |99.7%           |99.1%           |99.1%           |100.0%          |
|                         |substance).                         |(anhydrous        |                |                |                |                |                |                |
|                         |                                    |substance).       |                |                |                |                |                |                |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Finerenone Confidential Hinye Pharmaceutical Co., Ltd. 



Page 542 of 542 



